Citrus Sinensis ID: 005886
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 671 | 2.2.26 [Sep-21-2011] | |||||||
| Q551H4 | 1028 | Serine/threonine-protein | yes | no | 0.439 | 0.286 | 0.565 | 1e-103 | |
| Q6P9R2 | 527 | Serine/threonine-protein | yes | no | 0.442 | 0.563 | 0.496 | 1e-89 | |
| Q5R495 | 527 | Serine/threonine-protein | yes | no | 0.442 | 0.563 | 0.493 | 1e-88 | |
| Q863I2 | 529 | Serine/threonine-protein | yes | no | 0.442 | 0.561 | 0.490 | 1e-88 | |
| O95747 | 527 | Serine/threonine-protein | yes | no | 0.442 | 0.563 | 0.490 | 3e-88 | |
| Q9Z1W9 | 556 | STE20/SPS1-related prolin | no | no | 0.442 | 0.534 | 0.487 | 3e-85 | |
| Q9UEW8 | 545 | STE20/SPS1-related prolin | no | no | 0.442 | 0.544 | 0.487 | 4e-85 | |
| O88506 | 553 | STE20/SPS1-related prolin | no | no | 0.442 | 0.537 | 0.487 | 5e-85 | |
| Q54XL6 | 574 | Serine/threonine-protein | no | no | 0.433 | 0.506 | 0.469 | 2e-71 | |
| O61122 | 478 | Serine/threonine-protein | no | no | 0.393 | 0.552 | 0.458 | 4e-65 |
| >sp|Q551H4|FRAY2_DICDI Serine/threonine-protein kinase fray2 OS=Dictyostelium discoideum GN=fray2 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 377 bits (967), Expect = e-103, Method: Compositional matrix adjust.
Identities = 169/299 (56%), Positives = 222/299 (74%), Gaps = 4/299 (1%)
Query: 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-DLDGIRREVQT 65
K +P A Y L E +G+G S V RA+C+P E VAIK++DLE C N L+ IR+E+Q
Sbjct: 62 KNYPNSADQYELKETIGKGGSGLVQRAICLPFQENVAIKIIDLEHCKNVSLEEIRKEIQA 121
Query: 66 MRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLK 125
M + +HPNV+ H SF LWV+M +++ GSC IM+ ++P+GFEE VIAT+L+E LK
Sbjct: 122 MSLCHHPNVVAYHTSFVYNESLWVIMDFLSAGSCSDIMRFSFPQGFEEHVIATILKEALK 181
Query: 126 ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMA 185
A+ Y H G IHRD+K+GNILIDSNG I+L+DFGVSA + D G+ SRNTFVGTPCWMA
Sbjct: 182 AICYFHKTGRIHRDIKSGNILIDSNGNIQLSDFGVSATLIDTGE--TSRNTFVGTPCWMA 239
Query: 186 PEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245
PE+M+Q++ YD+ DIWSFGITALELA G APF++YPPMKVLL+TLQN PP L+ + + +
Sbjct: 240 PEIMEQVN-YDYAVDIWSFGITALELARGKAPFAEYPPMKVLLLTLQNPPPSLEGDGESK 298
Query: 246 FSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGERFRML 304
+S SFK+LV CL KDP KRP KL++H FFK A+ D+L + I+ L PLG+R++ML
Sbjct: 299 WSHSFKDLVEKCLQKDPSKRPLPSKLLEHRFFKQAKKPDYLVQHILAKLPPLGQRYQML 357
|
Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q6P9R2|OXSR1_MOUSE Serine/threonine-protein kinase OSR1 OS=Mus musculus GN=Oxsr1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 331 bits (848), Expect = 1e-89, Method: Compositional matrix adjust.
Identities = 154/310 (49%), Positives = 212/310 (68%), Gaps = 13/310 (4%)
Query: 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRV 68
+ ++ DY L E +G G +A V A C P E VAIK ++LEKC +D + +E+Q M
Sbjct: 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKERVAIKRINLEKCQTSMDELLKEIQAMSQ 69
Query: 69 TNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEG------FEEPVIATLLRE 122
+HPN++ + SF LW+VM ++GGS L I+K +G +EP IAT+LRE
Sbjct: 70 CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEPTIATILRE 129
Query: 123 TLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD--RQRSRNTFVGT 180
L+ L YLH +G IHRDVKAGNIL+ +G++++ADFGVSA + GD R + R TFVGT
Sbjct: 130 VLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 181 PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL-- 238
PCWMAPEVM+Q+ GYDFKADIWSFGITA+ELA G AP+ KYPPMKVL++TLQN PP L
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249
Query: 239 ---DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLA 295
D E K++ KSF+++++ CL KDP+KRPTA +L++H FF+ A++ +FL I+
Sbjct: 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQEKILQRAP 309
Query: 296 PLGERFRMLK 305
+ ER + ++
Sbjct: 310 TISERSKKVR 319
|
Regulates downstream kinases in response to environmental stress. May also have a function in regulating the actin cytoskeleton. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5R495|OXSR1_PONAB Serine/threonine-protein kinase OSR1 OS=Pongo abelii GN=OXSR1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 328 bits (841), Expect = 1e-88, Method: Compositional matrix adjust.
Identities = 153/310 (49%), Positives = 211/310 (68%), Gaps = 13/310 (4%)
Query: 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRV 68
+ ++ DY L E +G G +A V A C P E VAIK ++LEKC +D + +E+Q M
Sbjct: 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQ 69
Query: 69 TNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEG------FEEPVIATLLRE 122
+HPN++ + SF LW+VM ++GGS L I+K +G +E IAT+LRE
Sbjct: 70 CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129
Query: 123 TLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD--RQRSRNTFVGT 180
L+ L YLH +G IHRDVKAGNIL+ +G++++ADFGVSA + GD R + R TFVGT
Sbjct: 130 VLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 181 PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL-- 238
PCWMAPEVM+Q+ GYDFKADIWSFGITA+ELA G AP+ KYPPMKVL++TLQN PP L
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249
Query: 239 ---DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLA 295
D E K++ KSF+++++ CL KDP+KRPTA +L++H FF+ A++ +FL I+
Sbjct: 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQEKILQRAP 309
Query: 296 PLGERFRMLK 305
+ ER + ++
Sbjct: 310 TISERAKKVR 319
|
Regulates downstream kinases in response to environmental stress. May also have a function in regulating the actin cytoskeleton. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q863I2|OXSR1_PIG Serine/threonine-protein kinase OSR1 OS=Sus scrofa GN=OXSR1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 328 bits (840), Expect = 1e-88, Method: Compositional matrix adjust.
Identities = 152/310 (49%), Positives = 211/310 (68%), Gaps = 13/310 (4%)
Query: 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRV 68
+ ++ DY L E +G G +A V A C P E VAIK ++LEKC +D + +E+Q M
Sbjct: 10 WSINKDDYELQEVIGSGATAVVQAAYCTPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQ 69
Query: 69 TNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEG------FEEPVIATLLRE 122
+HPN++ + SF LW+VM ++GGS L I+K +G +E IAT+LRE
Sbjct: 70 CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEATIATILRE 129
Query: 123 TLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD--RQRSRNTFVGT 180
L+ L YLH +G IHRDVKAGNIL+ +G++++ADFGVSA + GD R + R TFVGT
Sbjct: 130 VLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 181 PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL-- 238
PCWMAPEVM+Q+ GYDFKADIWSFGITA+ELA G AP+ KYPPMKVL++TLQN PP L
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249
Query: 239 ---DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLA 295
D E K++ KSF+++++ CL KDP+KRPTA +L++H FF+ A++ ++L I+
Sbjct: 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEYLQEKILQRAP 309
Query: 296 PLGERFRMLK 305
+ ER + ++
Sbjct: 310 TISERAKKVR 319
|
Regulates downstream kinases in response to environmental stress. May also have a function in regulating the actin cytoskeleton. Sus scrofa (taxid: 9823) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O95747|OXSR1_HUMAN Serine/threonine-protein kinase OSR1 OS=Homo sapiens GN=OXSR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 326 bits (836), Expect = 3e-88, Method: Compositional matrix adjust.
Identities = 152/310 (49%), Positives = 210/310 (67%), Gaps = 13/310 (4%)
Query: 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRV 68
+ ++ DY L E +G G +A V A C P E VAIK ++LEKC +D + +E+Q M
Sbjct: 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQ 69
Query: 69 TNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEG------FEEPVIATLLRE 122
+HPN++ + SF LW+VM ++GGS L I+K +G +E IAT+LRE
Sbjct: 70 CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129
Query: 123 TLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD--RQRSRNTFVGT 180
L+ L YLH +G IHRDVKAGNIL+ +G++++ADFGVSA + GD R + R TFVGT
Sbjct: 130 VLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 181 PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL-- 238
PCWMAPEVM+Q+ GYDFKADIWSFGITA+ELA G AP+ KYPPMKVL++TLQN PP L
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249
Query: 239 ---DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLA 295
D E K++ KSF+++++ CL KDP+KRPTA +L++H FF+ A++ +FL +
Sbjct: 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQEKTLQRAP 309
Query: 296 PLGERFRMLK 305
+ ER + ++
Sbjct: 310 TISERAKKVR 319
|
Regulates downstream kinases in response to environmental stress. May also have a function in regulating the actin cytoskeleton. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Z1W9|STK39_MOUSE STE20/SPS1-related proline-alanine-rich protein kinase OS=Mus musculus GN=Stk39 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 316 bits (810), Expect = 3e-85, Method: Compositional matrix adjust.
Identities = 151/310 (48%), Positives = 209/310 (67%), Gaps = 13/310 (4%)
Query: 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRV 68
+P+ Y L E +G G +A V ALC P E VAIK ++LEKC +D + +E+Q M
Sbjct: 68 WPICRDAYELQEVIGSGATAVVQAALCKPRQERVAIKRINLEKCQTSMDELLKEIQAMSQ 127
Query: 69 TNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEG------FEEPVIATLLRE 122
+HPNV+ + SF LW+VM ++GGS L I+K G EE +IAT+L+E
Sbjct: 128 CSHPNVVTYYTSFVVKDELWLVMKLLSGGSMLDIIKYIVNRGEHKNGVLEEAIIATILKE 187
Query: 123 TLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD--RQRSRNTFVGT 180
L+ L YLH +G IHRD+KAGNIL+ +G++++ADFGVSA + GD R + R TFVGT
Sbjct: 188 VLEGLDYLHRNGQIHRDLKAGNILLGEDGSVQIADFGVSAFLATGGDVTRNKVRKTFVGT 247
Query: 181 PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL-- 238
PCWMAPEVM+Q+ GYDFKAD+WSFGITA+ELA G AP+ KYPPMKVL++TLQN PP L
Sbjct: 248 PCWMAPEVMEQVRGYDFKADMWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPTLET 307
Query: 239 ---DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLA 295
D E K++ KSF++L++ CL KDP KRPTA +L+K FF+ A++ ++L ++
Sbjct: 308 GVEDKEMMKKYGKSFRKLLSLCLQKDPSKRPTAAELLKCKFFQKAKNREYLIEKLLTRTP 367
Query: 296 PLGERFRMLK 305
+ +R + ++
Sbjct: 368 DIAQRAKKVR 377
|
May act as a mediator of stress-activated signals. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9UEW8|STK39_HUMAN STE20/SPS1-related proline-alanine-rich protein kinase OS=Homo sapiens GN=STK39 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 316 bits (809), Expect = 4e-85, Method: Compositional matrix adjust.
Identities = 151/310 (48%), Positives = 209/310 (67%), Gaps = 13/310 (4%)
Query: 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRV 68
+P+ Y L E +G G +A V ALC P E VAIK ++LEKC +D + +E+Q M
Sbjct: 56 WPICRDAYELQEVIGSGATAVVQAALCKPRQERVAIKRINLEKCQTSMDELLKEIQAMSQ 115
Query: 69 TNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEG------FEEPVIATLLRE 122
+HPNV+ + SF LW+VM ++GGS L I+K G EE +IAT+L+E
Sbjct: 116 CSHPNVVTYYTSFVVKDELWLVMKLLSGGSMLDIIKYIVNRGEHKNGVLEEAIIATILKE 175
Query: 123 TLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD--RQRSRNTFVGT 180
L+ L YLH +G IHRD+KAGNIL+ +G++++ADFGVSA + GD R + R TFVGT
Sbjct: 176 VLEGLDYLHRNGQIHRDLKAGNILLGEDGSVQIADFGVSAFLATGGDVTRNKVRKTFVGT 235
Query: 181 PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL-- 238
PCWMAPEVM+Q+ GYDFKAD+WSFGITA+ELA G AP+ KYPPMKVL++TLQN PP L
Sbjct: 236 PCWMAPEVMEQVRGYDFKADMWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPTLET 295
Query: 239 ---DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLA 295
D E K++ KSF++L++ CL KDP KRPTA +L+K FF+ A++ ++L ++
Sbjct: 296 GVEDKEMMKKYGKSFRKLLSLCLQKDPSKRPTAAELLKCKFFQKAKNREYLIEKLLTRTP 355
Query: 296 PLGERFRMLK 305
+ +R + ++
Sbjct: 356 DIAQRAKKVR 365
|
May act as a mediator of stress-activated signals. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O88506|STK39_RAT STE20/SPS1-related proline-alanine-rich protein kinase OS=Rattus norvegicus GN=Stk39 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 316 bits (809), Expect = 5e-85, Method: Compositional matrix adjust.
Identities = 151/310 (48%), Positives = 209/310 (67%), Gaps = 13/310 (4%)
Query: 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRV 68
+P+ Y L E +G G +A V ALC P E VAIK ++LEKC +D + +E+Q M
Sbjct: 65 WPICRDAYELQEVIGSGATAVVQAALCKPRQERVAIKRINLEKCQTSMDELLKEIQAMSQ 124
Query: 69 TNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEG------FEEPVIATLLRE 122
+HPNV+ + SF LW+VM ++GGS L I+K G EE +IAT+L+E
Sbjct: 125 CSHPNVVTYYTSFVVKDELWLVMKLLSGGSMLDIIKYIVNRGEHKNGVLEEAIIATILKE 184
Query: 123 TLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD--RQRSRNTFVGT 180
L+ L YLH +G IHRD+KAGNIL+ +G++++ADFGVSA + GD R + R TFVGT
Sbjct: 185 VLEGLDYLHRNGQIHRDLKAGNILLGEDGSVQIADFGVSAFLATGGDVTRNKVRKTFVGT 244
Query: 181 PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL-- 238
PCWMAPEVM+Q+ GYDFKAD+WSFGITA+ELA G AP+ KYPPMKVL++TLQN PP L
Sbjct: 245 PCWMAPEVMEQVRGYDFKADMWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPTLET 304
Query: 239 ---DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLA 295
D E K++ KSF++L++ CL KDP KRPTA +L+K FF+ A++ ++L ++
Sbjct: 305 GVEDKEMMKKYGKSFRKLLSLCLQKDPSKRPTAAELLKCKFFQKAKNREYLIEKLLTRTP 364
Query: 296 PLGERFRMLK 305
+ +R + ++
Sbjct: 365 DIAQRAKKVR 374
|
May act as a mediator of stress-activated signals. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54XL6|FRAY1_DICDI Serine/threonine-protein kinase fray1 OS=Dictyostelium discoideum GN=fray1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 270 bits (691), Expect = 2e-71, Method: Compositional matrix adjust.
Identities = 139/296 (46%), Positives = 185/296 (62%), Gaps = 5/296 (1%)
Query: 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNND-LDGIRREVQTMR 67
+P A Y L E +GEG V++A CIPL E VAIKV++L+K + + + +EV+ M
Sbjct: 90 YPSQANQYNLIEPIGEGTEGRVFKAYCIPLKENVAIKVVELDKMDPQFVKDVIKEVKVMN 149
Query: 68 VTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKAL 127
NHPN++ H SF + LW+VM Y+ GGS IMK YP+G E + T+L+ LK L
Sbjct: 150 GNNHPNLIHYHTSFLENNQLWLVMDYLGGGSLADIMKFKYPDGIPEVLAVTVLKSLLKGL 209
Query: 128 VYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPE 187
YLH H IHRD+K+ NILI +GAI+LADFGVSA MF+ + SR T VGTPCWMAPE
Sbjct: 210 EYLHSHQRIHRDLKSDNILIGEDGAIELADFGVSA-MFEK-NTCCSRKTIVGTPCWMAPE 267
Query: 188 VMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF- 246
++ + GY+ DIWSFGITA+EL G P PP KV + L P L E DK
Sbjct: 268 IISE-RGYNQGVDIWSFGITAIELIRGKPPGYDLPPSKVFMNLLFGNSPSLQEEEDKGVC 326
Query: 247 SKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGERFR 302
S +K+LV CL K+P KRP A KL++H FK A+ N+++ ++ L P +R+R
Sbjct: 327 SHLYKDLVDKCLQKEPSKRPNASKLLEHKVFKQAKKNNYIVSHLLHGLTPCEDRYR 382
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O61122|SVKA_DICDI Serine/threonine-protein kinase svkA OS=Dictyostelium discoideum GN=svkA PE=1 SV=1 | Back alignment and function description |
|---|
Score = 249 bits (637), Expect = 4e-65, Method: Compositional matrix adjust.
Identities = 126/275 (45%), Positives = 170/275 (61%), Gaps = 11/275 (4%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVL 75
Y E++G+G V++ + NE +AIK +DLE ++++ I++E+ + P V
Sbjct: 12 YVRQEKIGKGSFGEVFKGINKKTNETIAIKTIDLEDAEDEIEDIQQEINVLSQCESPFVT 71
Query: 76 RAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGH 135
+ SF G LW++M Y+AGGS L +MK P F+E IA +LRE LK L YLH G
Sbjct: 72 KYFGSFLKGSKLWIIMEYLAGGSVLDLMK---PGPFDEGYIAIILRELLKGLEYLHSEGK 128
Query: 136 IHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGY 195
IHRD+KA N+L+ ++G +KLADFGVS + D+ RNTFVGTP WMAPEV++Q GY
Sbjct: 129 IHRDIKAANVLLSASGDVKLADFGVSGQL---TDQMTKRNTFVGTPFWMAPEVIKQ-TGY 184
Query: 196 DFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVT 255
D KADIWS GITALE+A G P + PM+ L + ++ PP L + FSK FKE
Sbjct: 185 DSKADIWSMGITALEMAKGEPPRADLHPMRALFLIPKDPPPTL----EGNFSKGFKEFCA 240
Query: 256 ACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSI 290
CL KDP +RPTA+ L+KH F K A+ L I
Sbjct: 241 LCLNKDPNQRPTAKDLLKHKFIKAAKKTSSLTDLI 275
|
Involved in regulation of actin cytoskeleton organization during cell motility; F-actin fragmenting and capping protein allowing dynamic rearrangements of the actin cytoskeleton. Also part of a regulatory pathway from the centrosome to the midzone, thus regulating the completion of cell division. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 671 | ||||||
| 224060055 | 694 | predicted protein [Populus trichocarpa] | 0.986 | 0.953 | 0.747 | 0.0 | |
| 152926164 | 684 | protein kinase [Carica papaya] | 0.968 | 0.950 | 0.744 | 0.0 | |
| 225452442 | 662 | PREDICTED: uncharacterized protein LOC10 | 0.944 | 0.957 | 0.706 | 0.0 | |
| 449450103 | 671 | PREDICTED: uncharacterized protein LOC10 | 0.938 | 0.938 | 0.682 | 0.0 | |
| 449526415 | 674 | PREDICTED: uncharacterized LOC101205102, | 0.937 | 0.933 | 0.681 | 0.0 | |
| 356571322 | 671 | PREDICTED: uncharacterized protein LOC10 | 0.953 | 0.953 | 0.676 | 0.0 | |
| 356571324 | 664 | PREDICTED: uncharacterized protein LOC10 | 0.946 | 0.956 | 0.676 | 0.0 | |
| 356511670 | 669 | PREDICTED: uncharacterized protein LOC10 | 0.941 | 0.944 | 0.677 | 0.0 | |
| 357495947 | 667 | Serine/threonine protein kinase [Medicag | 0.941 | 0.947 | 0.672 | 0.0 | |
| 296087657 | 600 | unnamed protein product [Vitis vinifera] | 0.837 | 0.936 | 0.724 | 0.0 |
| >gi|224060055|ref|XP_002300034.1| predicted protein [Populus trichocarpa] gi|222847292|gb|EEE84839.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1073 bits (2774), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 516/690 (74%), Positives = 583/690 (84%), Gaps = 28/690 (4%)
Query: 1 MDLVVEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR 60
M+ V EKR+PV+AKDY+LYEE+GEGVSATVYRALCIP N+IVAIKVLDLEKCNNDLDGIR
Sbjct: 1 MEYVSEKRYPVNAKDYKLYEEIGEGVSATVYRALCIPFNQIVAIKVLDLEKCNNDLDGIR 60
Query: 61 REVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLL 120
REVQTM + +HPNVLRAH SFT G+ LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLL
Sbjct: 61 REVQTMSLIDHPNVLRAHGSFTAGYSLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLL 120
Query: 121 RETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGT 180
RETLKALVY+H HGHIHRDVKAGNILIDS+G +KLADFGVSACMFD GDRQRSRNTFVGT
Sbjct: 121 RETLKALVYIHEHGHIHRDVKAGNILIDSDGTVKLADFGVSACMFDTGDRQRSRNTFVGT 180
Query: 181 PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240
PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY
Sbjct: 181 PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240
Query: 241 ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGER 300
ERDKRFSKSFKE+V ACLVKDPKKRPT+EKL+KHHFFK+ARS+D+L R+I+D L+PLGER
Sbjct: 241 ERDKRFSKSFKEMVAACLVKDPKKRPTSEKLLKHHFFKNARSHDYLVRAILDGLSPLGER 300
Query: 301 FRMLKAKEADLLVQNKALYEDKEQLS-------------------------QDYDCMSNA 335
F++LKAKEADLLVQNKALY DKEQ+S QDYDCMSNA
Sbjct: 301 FKILKAKEADLLVQNKALYGDKEQISQQEYIRGISAWNFNLEDLKNQAALIQDYDCMSNA 360
Query: 336 EDPNSSGKQ--NHADVEVPAERLSTESGNHSNATTSQDDGFNNLHDLESSLASFPIKPLQ 393
EDP+ SGKQ + V PAE+L + NHS + SQ+DGFN+LHDLE+SL SFPIKPLQ
Sbjct: 361 EDPDLSGKQMDRYNIVGFPAEKLPPKIANHSISAPSQEDGFNDLHDLETSLPSFPIKPLQ 420
Query: 394 ALKGCFDVGEDDEGATSPSWKGTAHLETD-QFLSKGSLGAIDQESGRNEGENSGRSSSLP 452
ALKGCFDVGE+ GATSP+WK T+ E + Q L++ S A+DQES RNEGENSGRSSSLP
Sbjct: 421 ALKGCFDVGEEAVGATSPNWKVTSQTECEQQVLTELSSSAMDQESERNEGENSGRSSSLP 480
Query: 453 RHVILEHKKFLSGSLIPDNAFSSKKAVGEADRDSLQPKNQSERNYSGPLLYRQRRDTNNL 512
RHVI EHK FL G L+PDNA S KK +G+ +RD LQPK QSERNYSGP+L+RQ+RDTNNL
Sbjct: 481 RHVISEHKSFLGGPLLPDNALSPKKVIGDENRDLLQPKYQSERNYSGPMLHRQKRDTNNL 540
Query: 513 PSAEDTSEGAVVQRKGRFKVTSAELSPKGPINSIFSPVSGGSMSPTTPNFTAASLLPSLQ 572
S EDTSEGAVVQRKGRFKVTSA+LSPKGP N F+PV GGS T N A+S+LPSLQ
Sbjct: 541 SSVEDTSEGAVVQRKGRFKVTSADLSPKGPTNCCFNPVGGGSACATISNPAASSVLPSLQ 600
Query: 573 FILQQNTMQREEIIRLIKYAEETSGKHAESADAGTNDLLQVTPASTKEKELQSQMITLQQ 632
ILQQNT+QREEI++LIKY E+TSGK ES +A TNDLLQ++P T+EKELQ+Q I LQQ
Sbjct: 601 CILQQNTLQREEILKLIKYVEQTSGKLVESGEAATNDLLQISPTWTREKELQAQFIGLQQ 660
Query: 633 RIASIAEELQRQKIKNAQLEKQLHAVVGED 662
+ S+ EELQRQK+KN QLE+QL+A + ++
Sbjct: 661 SVGSLFEELQRQKMKNVQLERQLNAFINKE 690
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|152926164|gb|ABS32235.1| protein kinase [Carica papaya] | Back alignment and taxonomy information |
|---|
Score = 1025 bits (2650), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 507/681 (74%), Positives = 562/681 (82%), Gaps = 31/681 (4%)
Query: 1 MDLVVEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR 60
M+ EKR+PVDA +Y+LYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR
Sbjct: 1 MEHASEKRYPVDAGEYKLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR 60
Query: 61 REVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLL 120
REVQTM +HPN+LRAHCSFT GH LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLL
Sbjct: 61 REVQTMSWIDHPNLLRAHCSFTAGHHLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLL 120
Query: 121 RETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGT 180
RE L+ALVYLHFHGHIHRDVKAGNILIDSNGA+KLADFGVSACMFD GDRQRSRNTFVGT
Sbjct: 121 REVLRALVYLHFHGHIHRDVKAGNILIDSNGAVKLADFGVSACMFDTGDRQRSRNTFVGT 180
Query: 181 PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240
PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY
Sbjct: 181 PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240
Query: 241 ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGER 300
ERDKRFSKSFKE+V ACLVKDPKKRPT+E+L+KH FFKHARSND+LARSI++ LAPLGER
Sbjct: 241 ERDKRFSKSFKEMVAACLVKDPKKRPTSERLLKHPFFKHARSNDYLARSIIEGLAPLGER 300
Query: 301 FRMLKAKEADLLVQNKALYEDKEQLS-------------------------QDYDCMSNA 335
FRMLKAKEA+LL+QNK LYEDKE LS QD D M NA
Sbjct: 301 FRMLKAKEANLLMQNKNLYEDKEHLSQQEYIRGISAWNFNLEDLKCQAALIQDNDVMPNA 360
Query: 336 EDPNSSGKQN--HADVEVPAERLSTESGNHSNATTSQDDGFNNLHDLESSLASFPIKPLQ 393
E+P+ K++ + + +PAER S E N S +DG N+L DLESSLASFPIKPLQ
Sbjct: 361 EEPDVGRKESSRYHEFVLPAERSSPERANISATAHHLEDGLNDLRDLESSLASFPIKPLQ 420
Query: 394 ALKGCFDVGEDDEGATSPSWKGTAHLETD---QFLSKGSLGAIDQESGRNEGENSGRSSS 450
ALKGCFDVGEDD+GATSPSWKGTA D Q L+K + G + Q+SGRN+GENS +SSS
Sbjct: 421 ALKGCFDVGEDDDGATSPSWKGTAPAPLDSRQQILTKSTSGTMFQDSGRNDGENSVQSSS 480
Query: 451 LPRHVILEHKKFLSGSLIPDNAFSSKKAVGEADRDSLQPKNQSERNYSGPLLYRQRRDTN 510
LPRH+ILE +KFLSG +IPDNAFS KK + + DRD Q K +ERNYSGPLLYRQRRD+N
Sbjct: 481 LPRHIILEQQKFLSGPVIPDNAFSPKKIITDGDRDLSQTKYHTERNYSGPLLYRQRRDSN 540
Query: 511 NLPSAEDTSEGAVVQRKGRFKVTSAELSPKGPINSIFSPVSGGSMSPTTPNFTAASLLPS 570
L S EDTSEGAVVQRKGRFKVTSA+LSPKGP N F+PV G SP NFTAAS+LPS
Sbjct: 541 ILAS-EDTSEGAVVQRKGRFKVTSADLSPKGPTNCTFNPVGVGLNSPALLNFTAASILPS 599
Query: 571 LQFILQQNTMQREEIIRLIKYAEETSGKHAESADAGTNDLLQVTPASTKEKELQSQMITL 630
LQ IL QNTMQREEIIRLIKY E+TSGKHA+ D +D+ Q+TP++ +E+EL SQMI L
Sbjct: 600 LQSILLQNTMQREEIIRLIKYVEQTSGKHADPVDVVIDDVSQITPSTPRERELVSQMIQL 659
Query: 631 QQRIASIAEELQRQKIKNAQL 651
QQ I S+ EELQ QK+KN Q+
Sbjct: 660 QQSIGSLIEELQTQKMKNHQV 680
|
Source: Carica papaya Species: Carica papaya Genus: Carica Family: Caricaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225452442|ref|XP_002277585.1| PREDICTED: uncharacterized protein LOC100264532 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 998 bits (2581), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 488/691 (70%), Positives = 556/691 (80%), Gaps = 57/691 (8%)
Query: 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQT 65
EK+FP+DAKDY+LYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQT
Sbjct: 4 EKKFPLDAKDYKLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQT 63
Query: 66 MRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLK 125
M + +HPN+L+AHCSFT+GH LWVVMPYMAGGSCLHIMKS YPEGF+EPVIATLLRE LK
Sbjct: 64 MSLIDHPNLLQAHCSFTSGHTLWVVMPYMAGGSCLHIMKSEYPEGFDEPVIATLLREVLK 123
Query: 126 ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMA 185
ALVYLH HGHIHRDVKAGNILIDSNGA+KLADFGVSACMFDAGDRQRSRNTFVGTPCWMA
Sbjct: 124 ALVYLHNHGHIHRDVKAGNILIDSNGAVKLADFGVSACMFDAGDRQRSRNTFVGTPCWMA 183
Query: 186 PEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245
PEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDK+
Sbjct: 184 PEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKK 243
Query: 246 FSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGERFRMLK 305
FSKSFKE+V CLVKDPKKRPT+EKL KH FFKHARSN++LAR+I++ L PLG+RFR LK
Sbjct: 244 FSKSFKEMVATCLVKDPKKRPTSEKLFKHSFFKHARSNEYLARTILEGLTPLGDRFRTLK 303
Query: 306 AKEADLLVQNKALYEDKEQLS-------------------------QDYDCMSNAEDPNS 340
AKEADLLVQNKALY DKEQLS QDYD +SN +DP+
Sbjct: 304 AKEADLLVQNKALYGDKEQLSQQEYIRGISAWNFNLEDLKNQAALIQDYDVISNVDDPDC 363
Query: 341 SGKQNHADVEVPAERLSTESGNHSNATTSQDDGFNNLHDLESSLASFPIKPLQALKGCFD 400
SNA S +DG N+L +LE+SLASFPI+PLQALKG FD
Sbjct: 364 -----------------------SNAAPSHEDGLNDLSNLENSLASFPIQPLQALKGYFD 400
Query: 401 VGEDDEGATSPSWKGTAHLETDQFLSKGSLGAIDQESGRNEGENSGRSSSLPRHVILEHK 460
V EDD A+S SW+ E++Q ++DQE+ +++GEN GRSSSLPR +I HK
Sbjct: 401 VCEDDGNASSLSWRDVMQSESEQ-------QSVDQEAEKDDGENFGRSSSLPRQIIPGHK 453
Query: 461 KFLSGSLIPDNAFSSKKAVGEADRDSLQPKNQSERNYSGPLLYRQRRDTNNLPSAEDTSE 520
KF SGSL+ DNA S KK G+ DR+++Q + Q ERNYSGPLL+RQ+RDTNN+ S EDT E
Sbjct: 454 KFFSGSLLQDNALSPKKVNGDGDRENIQSRYQPERNYSGPLLHRQKRDTNNISSVEDTPE 513
Query: 521 GAVVQRKGRFKVTSAELSPKGPINSIFSPVSGGSMSPTTPNFTAASLLPSLQFILQQNTM 580
GAVVQ KGRFKVTSAELSPKGP N FS VSGGS SPTTP+ TAAS+LPSLQF+LQQNTM
Sbjct: 514 GAVVQCKGRFKVTSAELSPKGPTNCFFSQVSGGSTSPTTPSLTAASILPSLQFVLQQNTM 573
Query: 581 QREEIIRLIKYAEETSGKHAESADAGTNDLLQVTPASTKEKELQSQMITLQQRIASIAEE 640
QRE I++LIKY E++ G H E +AG+ DL Q+ ST+EKELQSQ+I LQQ I ++ EE
Sbjct: 574 QREGIMKLIKYVEQSCGNHIE--EAGSIDLSQIHAVSTREKELQSQVIHLQQSIGTLVEE 631
Query: 641 LQRQKIKNAQLEKQLHAVVGEDGKMRKENEA 671
LQRQK+KNAQ+E+ L+AV + GK+R+ N A
Sbjct: 632 LQRQKLKNAQVERHLNAVANKVGKVRRGNGA 662
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449450103|ref|XP_004142803.1| PREDICTED: uncharacterized protein LOC101205102 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 944 bits (2439), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 462/677 (68%), Positives = 537/677 (79%), Gaps = 47/677 (6%)
Query: 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQT 65
EK++PV+AKDY L+EEVGEGVSATVY+ALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQT
Sbjct: 6 EKKYPVNAKDYNLHEEVGEGVSATVYKALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQT 65
Query: 66 MRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLK 125
M + +HPN+LRAHCSFT GH LWVVMPYM+GGSCLHIMKSAY EGF+EPVIATLLRE LK
Sbjct: 66 MTLIDHPNLLRAHCSFTAGHHLWVVMPYMSGGSCLHIMKSAYSEGFDEPVIATLLREVLK 125
Query: 126 ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMA 185
ALVYLH HGHIHRDVKAGNIL+DSNG +KLADFGVSACMFD GDRQRSRNTFVGTPCWMA
Sbjct: 126 ALVYLHAHGHIHRDVKAGNILLDSNGTVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 185
Query: 186 PEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245
PEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR
Sbjct: 186 PEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245
Query: 246 FSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGERFRMLK 305
FSKSFKE+V CLVKDPKKRP++EKL+KH FFKHARS D+L R+I+D L PLG+RF+ LK
Sbjct: 246 FSKSFKEMVATCLVKDPKKRPSSEKLLKHPFFKHARSVDYLTRTILDGLDPLGDRFKKLK 305
Query: 306 AKEADLLVQNKALYEDKEQLS-QDY-----------------------DCMSNAEDPN-- 339
AKEADLL QNKALY DKE LS Q+Y D MSN ED +
Sbjct: 306 AKEADLLGQNKALYGDKEHLSQQEYIRGISAWNFNLEDLKNQAALIQDDDMSNIEDLDVH 365
Query: 340 -SSGKQNHADVEVPAERLSTESGNHSNATTSQDDGFNNLHDLESSLASFPIKPLQALKGC 398
+ + + + P E S E +H A SQ+DGFN+LHDLESSLASFP+KPL+ALK C
Sbjct: 366 TTQQRNKNNEFTFPVEGSSLERLSHPTAAASQEDGFNDLHDLESSLASFPMKPLEALKDC 425
Query: 399 FDVGEDDEGATSPSWKGTAHLETDQFLSKGSLGAIDQESGRNEGENSGRSSSLPRHVILE 458
FD+ ED +S S+ +D+E+GR EGE+SG+S SLPRH + E
Sbjct: 426 FDIYED--------------------ISTDSVRPVDRENGRTEGESSGQSGSLPRHYMSE 465
Query: 459 HKKFLSGSLIPDNAFSSKKAVGEADRDSLQPKNQSERNYSGPLLYRQRRDTNNLPSAEDT 518
+K+ SGSLI DNA S KK + DRD LQ K SERNYSGPLLYRQ+RDTNN+ S ED+
Sbjct: 466 NKRSFSGSLISDNAVSPKKITVDGDRDYLQSKLPSERNYSGPLLYRQKRDTNNVSSVEDS 525
Query: 519 SEGAVVQRKGRFKVTSAELSPKGPINSIFSPVSGGSMSPTTPNFTAASLLPSLQFILQQN 578
S+G VVQRKGRFKVTSAELSPKGP+ FSPV GG++SPT+ N T A LLPS+Q ILQQN
Sbjct: 526 SDGTVVQRKGRFKVTSAELSPKGPMTGSFSPVCGGTISPTSLNLTPALLLPSMQCILQQN 585
Query: 579 TMQREEIIRLIKYAEETSGKHAESADAGTNDLLQVTPASTKEKELQSQMITLQQRIASIA 638
+QREEI++LIK E+ +GK+ +++++ TNDLLQV P S +E+ELQSQ++ LQQRI +
Sbjct: 586 IVQREEILKLIKCLEQMTGKNPDASESVTNDLLQVPPTSLRERELQSQVVHLQQRIDHLV 645
Query: 639 EELQRQKIKNAQLEKQL 655
EEL++QK+KN + E+ +
Sbjct: 646 EELEKQKLKNVEFERHV 662
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449526415|ref|XP_004170209.1| PREDICTED: uncharacterized LOC101205102, partial [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 941 bits (2432), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 461/676 (68%), Positives = 536/676 (79%), Gaps = 47/676 (6%)
Query: 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTM 66
K++PV+AKDY L+EEVGEGVSATVY+ALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTM
Sbjct: 10 KKYPVNAKDYNLHEEVGEGVSATVYKALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTM 69
Query: 67 RVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKA 126
+ +HPN+LRAHCSFT GH LWVVMPYM+GGSCLHIMKSAY EGF+EPVIATLLRE LKA
Sbjct: 70 TLIDHPNLLRAHCSFTAGHHLWVVMPYMSGGSCLHIMKSAYSEGFDEPVIATLLREVLKA 129
Query: 127 LVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAP 186
LVYLH HGHIHRDVKAGNIL+DSNG +KLADFGVSACMFD GDRQRSRNTFVGTPCWMAP
Sbjct: 130 LVYLHAHGHIHRDVKAGNILLDSNGTVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAP 189
Query: 187 EVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246
EVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF
Sbjct: 190 EVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 249
Query: 247 SKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGERFRMLKA 306
SKSFKE+V CLVKDPKKRP++EKL+KH FFKHARS D+L R+I+D L PLG+RF+ LKA
Sbjct: 250 SKSFKEMVATCLVKDPKKRPSSEKLLKHPFFKHARSVDYLTRTILDGLDPLGDRFKKLKA 309
Query: 307 KEADLLVQNKALYEDKEQLS-QDY-----------------------DCMSNAEDPN--- 339
KEADLL QNKALY DKE LS Q+Y D MSN ED +
Sbjct: 310 KEADLLGQNKALYGDKEHLSQQEYIRGISAWNFNLEDLKNQAALIQDDDMSNIEDLDVHT 369
Query: 340 SSGKQNHADVEVPAERLSTESGNHSNATTSQDDGFNNLHDLESSLASFPIKPLQALKGCF 399
+ + + + P E S E +H A SQ+DGFN+LHDLESSLASFP+KPL+ALK CF
Sbjct: 370 TQQRNKNNEFTFPVEGSSLERLSHPTAAASQEDGFNDLHDLESSLASFPMKPLEALKDCF 429
Query: 400 DVGEDDEGATSPSWKGTAHLETDQFLSKGSLGAIDQESGRNEGENSGRSSSLPRHVILEH 459
D+ ED +S S+ +D+E+GR EGE+SG+S SLPRH + E+
Sbjct: 430 DIYED--------------------ISTDSVRPVDRENGRTEGESSGQSGSLPRHYMSEN 469
Query: 460 KKFLSGSLIPDNAFSSKKAVGEADRDSLQPKNQSERNYSGPLLYRQRRDTNNLPSAEDTS 519
K+ SGSLI DNA S KK + DRD LQ K SERNYSGPLLYRQ+RDTNN+ S ED+S
Sbjct: 470 KRSFSGSLISDNAVSPKKITVDGDRDYLQSKLPSERNYSGPLLYRQKRDTNNVSSVEDSS 529
Query: 520 EGAVVQRKGRFKVTSAELSPKGPINSIFSPVSGGSMSPTTPNFTAASLLPSLQFILQQNT 579
+G VVQRKGRFKVTSAELSPKGP+ FSPV GG++SPT+ N T A LLPS+Q ILQQN
Sbjct: 530 DGTVVQRKGRFKVTSAELSPKGPMTGSFSPVCGGTISPTSLNLTPALLLPSMQCILQQNI 589
Query: 580 MQREEIIRLIKYAEETSGKHAESADAGTNDLLQVTPASTKEKELQSQMITLQQRIASIAE 639
+QREEI++LIK E+ +GK+ +++++ TNDLLQV P S +E+ELQSQ++ LQQRI + E
Sbjct: 590 VQREEILKLIKCLEQMTGKNPDASESVTNDLLQVPPTSLRERELQSQVVHLQQRIDHLVE 649
Query: 640 ELQRQKIKNAQLEKQL 655
EL++QK+KN + E+ +
Sbjct: 650 ELEKQKLKNVEFERHV 665
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356571322|ref|XP_003553827.1| PREDICTED: uncharacterized protein LOC100778837 isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 934 bits (2415), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 466/689 (67%), Positives = 542/689 (78%), Gaps = 49/689 (7%)
Query: 1 MDLVVEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR 60
M+ V+EKRFP++++DY+LYEEVGEGVSA+VYRALC+PLNEIVAIKVLDLEKCNNDLDGIR
Sbjct: 1 MEHVLEKRFPLNSEDYKLYEEVGEGVSASVYRALCVPLNEIVAIKVLDLEKCNNDLDGIR 60
Query: 61 REVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLL 120
REVQTM + +HPNVLRAHCSFT GH LWVVMPYMAGGSCLHIMKS YPEGFEEPVIATLL
Sbjct: 61 REVQTMNLIDHPNVLRAHCSFTAGHNLWVVMPYMAGGSCLHIMKSNYPEGFEEPVIATLL 120
Query: 121 RETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGT 180
E LKALVYLH HGHIHRDVK+GNIL+DSNGA+KLADFGVSACMFDAGDRQRSRNTFVGT
Sbjct: 121 HEVLKALVYLHAHGHIHRDVKSGNILLDSNGAVKLADFGVSACMFDAGDRQRSRNTFVGT 180
Query: 181 PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240
PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY
Sbjct: 181 PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240
Query: 241 ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGER 300
ERDKRFSK+FKELV CLVKDPKKRP++EKL+KHHFFK AR++ +LAR+I++ LAPLG+R
Sbjct: 241 ERDKRFSKAFKELVATCLVKDPKKRPSSEKLLKHHFFKQARASKYLARTILEGLAPLGDR 300
Query: 301 FRMLKAKEADLLVQNKALYEDKEQLSQ-DY-----------------------DCMSNAE 336
FR+LKAK+ADLLVQNKALYEDK+QLSQ +Y D + NAE
Sbjct: 301 FRLLKAKQADLLVQNKALYEDKDQLSQKEYIRGISAWNFNLEDLKSQAALIQDDDIPNAE 360
Query: 337 DPNSSGKQNHA--DVEVPAERLSTESGNHSNATTSQD--DGFNNLHDLESSLASFPIKPL 392
+ KQ D +V AERLS + NHS+ +QD DGFNNL DLESSLASFP KPL
Sbjct: 361 ESQRDKKQKDRLDDFKVSAERLSPGAANHSDDAPTQDKEDGFNNLPDLESSLASFPSKPL 420
Query: 393 QALKGCFDVGEDDEGATSPSWKGTAHLETDQFLSKGSLGAIDQESGRNEGENSGRSSSLP 452
QALKGCFD+ EDD +SP +L+ D GR + E+SG S+SL
Sbjct: 421 QALKGCFDMCEDDVNNSSPR-----NLDHD---------------GRIDNESSGTSTSLQ 460
Query: 453 RHVILEHKKFLSGSLIPDNAFSSKKAVGEADRDSLQPKNQSERNYSGPLLYRQRRDTNNL 512
++ KKF SGSL+PDN KK V + DRD LQ K S+RN+SGPL YRQ+RDTNNL
Sbjct: 461 QNATSHQKKFPSGSLLPDNFLFPKKIVTDGDRDYLQTKYSSDRNHSGPLQYRQKRDTNNL 520
Query: 513 PSAEDTSEGAVVQRKGRFKVTSAELSPKGPINSIFSPVSGGSMSPTTPNFTAASLLPSLQ 572
P +DTS+GA VQ +GRFKVT A+LSP GP NS P+ + SP PNF + ++LPSLQ
Sbjct: 521 PLVDDTSDGAFVQFRGRFKVTPADLSPMGPSNSTSGPLVSPT-SPPNPNFLSVAILPSLQ 579
Query: 573 FILQQNTMQREEIIRLIKYAEETSGKHAESADAGTNDLLQVTPASTKEKELQSQMITLQQ 632
ILQQN +QREEII+LIKYAE++SGK+ ES +AG D+LQ PA+T+E+EL Q+I LQQ
Sbjct: 580 CILQQNGLQREEIIKLIKYAEQSSGKNTESMEAGIVDILQAPPATTRERELHFQVIQLQQ 639
Query: 633 RIASIAEELQRQKIKNAQLEKQLHAVVGE 661
+ EELQ+QK+KN QLEKQL +++ +
Sbjct: 640 SNGILFEELQKQKMKNVQLEKQLSSMINK 668
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356571324|ref|XP_003553828.1| PREDICTED: uncharacterized protein LOC100778837 isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 931 bits (2406), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 465/687 (67%), Positives = 540/687 (78%), Gaps = 52/687 (7%)
Query: 1 MDLVVEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR 60
M+ V+EKRFP++++DY+LYEEVGEGVSA+VYRALC+PLNEIVAIKVLDLEKCNNDLDGIR
Sbjct: 1 MEHVLEKRFPLNSEDYKLYEEVGEGVSASVYRALCVPLNEIVAIKVLDLEKCNNDLDGIR 60
Query: 61 REVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLL 120
REVQTM + +HPNVLRAHCSFT GH LWVVMPYMAGGSCLHIMKS YPEGFEEPVIATLL
Sbjct: 61 REVQTMNLIDHPNVLRAHCSFTAGHNLWVVMPYMAGGSCLHIMKSNYPEGFEEPVIATLL 120
Query: 121 RETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGT 180
E LKALVYLH HGHIHRDVK+GNIL+DSNGA+KLADFGVSACMFDAGDRQRSRNTFVGT
Sbjct: 121 HEVLKALVYLHAHGHIHRDVKSGNILLDSNGAVKLADFGVSACMFDAGDRQRSRNTFVGT 180
Query: 181 PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240
PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY
Sbjct: 181 PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240
Query: 241 ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGER 300
ERDKRFSK+FKELV CLVKDPKKRP++EKL+KHHFFK AR++ +LAR+I++ LAPLG+R
Sbjct: 241 ERDKRFSKAFKELVATCLVKDPKKRPSSEKLLKHHFFKQARASKYLARTILEGLAPLGDR 300
Query: 301 FRMLKAKEADLLVQNKALYEDKEQLSQ-DY-----------------------DCMSNAE 336
FR+LKAK+ADLLVQNKALYEDK+QLSQ +Y D + NAE
Sbjct: 301 FRLLKAKQADLLVQNKALYEDKDQLSQKEYIRGISAWNFNLEDLKSQAALIQDDDIPNAE 360
Query: 337 DPNSSGKQNHA--DVEVPAERLSTESGNHSNATTSQDDGFNNLHDLESSLASFPIKPLQA 394
+ KQ D +V AERLS + NHS+ DDGFNNL DLESSLASFP KPLQA
Sbjct: 361 ESQRDKKQKDRLDDFKVSAERLSPGAANHSD-----DDGFNNLPDLESSLASFPSKPLQA 415
Query: 395 LKGCFDVGEDDEGATSPSWKGTAHLETDQFLSKGSLGAIDQESGRNEGENSGRSSSLPRH 454
LKGCFD+ EDD +SP +L+ D GR + E+SG S+SL ++
Sbjct: 416 LKGCFDMCEDDVNNSSPR-----NLDHD---------------GRIDNESSGTSTSLQQN 455
Query: 455 VILEHKKFLSGSLIPDNAFSSKKAVGEADRDSLQPKNQSERNYSGPLLYRQRRDTNNLPS 514
KKF SGSL+PDN KK V + DRD LQ K S+RN+SGPL YRQ+RDTNNLP
Sbjct: 456 ATSHQKKFPSGSLLPDNFLFPKKIVTDGDRDYLQTKYSSDRNHSGPLQYRQKRDTNNLPL 515
Query: 515 AEDTSEGAVVQRKGRFKVTSAELSPKGPINSIFSPVSGGSMSPTTPNFTAASLLPSLQFI 574
+DTS+GA VQ +GRFKVT A+LSP GP NS P+ + SP PNF + ++LPSLQ I
Sbjct: 516 VDDTSDGAFVQFRGRFKVTPADLSPMGPSNSTSGPLVSPT-SPPNPNFLSVAILPSLQCI 574
Query: 575 LQQNTMQREEIIRLIKYAEETSGKHAESADAGTNDLLQVTPASTKEKELQSQMITLQQRI 634
LQQN +QREEII+LIKYAE++SGK+ ES +AG D+LQ PA+T+E+EL Q+I LQQ
Sbjct: 575 LQQNGLQREEIIKLIKYAEQSSGKNTESMEAGIVDILQAPPATTRERELHFQVIQLQQSN 634
Query: 635 ASIAEELQRQKIKNAQLEKQLHAVVGE 661
+ EELQ+QK+KN QLEKQL +++ +
Sbjct: 635 GILFEELQKQKMKNVQLEKQLSSMINK 661
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356511670|ref|XP_003524546.1| PREDICTED: uncharacterized protein LOC100784402 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 928 bits (2399), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 467/689 (67%), Positives = 538/689 (78%), Gaps = 57/689 (8%)
Query: 1 MDLVVEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR 60
M+ V+EKRFP++A+DY LYEEVGEGVSA+VYRALC+PLNEIVAIKVLDLEKCNNDLDGIR
Sbjct: 1 MEHVLEKRFPLNAEDYTLYEEVGEGVSASVYRALCVPLNEIVAIKVLDLEKCNNDLDGIR 60
Query: 61 REVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLL 120
REVQTM + ++PNVLRAHCSFT GH LWVVMPYMAGGSCLHIMKS YPEGFEEPVIATLL
Sbjct: 61 REVQTMNLIDYPNVLRAHCSFTAGHNLWVVMPYMAGGSCLHIMKSNYPEGFEEPVIATLL 120
Query: 121 RETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGT 180
E LKALVYLH HGHIHRDVKAGNIL+DSNGA+KLADFGVSACMFD GDRQRSRNTFVGT
Sbjct: 121 HEVLKALVYLHAHGHIHRDVKAGNILLDSNGAVKLADFGVSACMFDTGDRQRSRNTFVGT 180
Query: 181 PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240
PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY
Sbjct: 181 PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240
Query: 241 ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGER 300
ERDK+FSK+FKELV CLVKDPKKRP++EKL+KHHFFK AR++ +LAR+I++ LAPLG+R
Sbjct: 241 ERDKKFSKAFKELVATCLVKDPKKRPSSEKLLKHHFFKQARASKYLARTILEGLAPLGDR 300
Query: 301 FRMLKAKEADLLVQNKALYEDKEQLSQ-DY-----------------------DCMSNAE 336
FRMLKAKEADLLVQNKALYEDK+QLSQ +Y D + NAE
Sbjct: 301 FRMLKAKEADLLVQNKALYEDKDQLSQKEYIRGISAWNFNLEDLKSQAALIQDDDIPNAE 360
Query: 337 DPNSSGKQNHA--DVEVPAERLSTESGNHSNATTSQD--DGFNNLHDLESSLASFPIKPL 392
+P KQ + +V AERLS + NHS+ +QD DGFNNL DLE SL SFP KPL
Sbjct: 361 EPQRDKKQKDRLDNFKVSAERLSAGAANHSDDAPTQDKEDGFNNLQDLEGSLVSFPTKPL 420
Query: 393 QALKGCFDVGEDDEGATSPSWKGTAHLETDQFLSKGSLGAIDQESGRNEGENSGRSSSLP 452
QALKGCFD+ EDD +SP L+ D G ID ES R S+SL
Sbjct: 421 QALKGCFDMCEDDINNSSPR-----DLDHD--------GRIDNESSR-------PSTSLQ 460
Query: 453 RHVILEHKKFLSGSLIPDNAFSSKKAVGEADRDSLQPKNQSERNYSGPLLYRQRRDTNNL 512
++ + KKF SGSL+PDN K V + DRD LQ K SERN+SGPL YRQ+RDTNNL
Sbjct: 461 QNTTSQQKKFPSGSLLPDNFLFPKMVVTDGDRDYLQTKYSSERNHSGPLQYRQKRDTNNL 520
Query: 513 PSAEDTSEGAVVQRKGRFKVTSAELSPKGPINSIFSPVSGGSMSPTTP---NFTAASLLP 569
P +DTS+GA +R+GRF +T +LSP GP NS PV +SPT+P NF + ++LP
Sbjct: 521 PLVDDTSDGAFFRRRGRFTLT--DLSPMGPSNSTSGPV----VSPTSPPNQNFMSTAILP 574
Query: 570 SLQFILQQNTMQREEIIRLIKYAEETSGKHAESADAGTNDLLQVTPASTKEKELQSQMIT 629
SLQ ILQ N +QREEII+LIKYAE++SGK+ ES +AGT D+LQ PA+T+E+EL Q+I
Sbjct: 575 SLQCILQHNGLQREEIIKLIKYAEQSSGKNTESVEAGTGDMLQAPPATTRERELHFQVIQ 634
Query: 630 LQQRIASIAEELQRQKIKNAQLEKQLHAV 658
LQQ I S+ EELQRQK+KN QLEKQL+++
Sbjct: 635 LQQSIGSLVEELQRQKMKNVQLEKQLNSM 663
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357495947|ref|XP_003618262.1| Serine/threonine protein kinase [Medicago truncatula] gi|355493277|gb|AES74480.1| Serine/threonine protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 926 bits (2393), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 466/693 (67%), Positives = 546/693 (78%), Gaps = 61/693 (8%)
Query: 1 MDLVVEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR 60
M+ + EKR+P+ AKDY+LYEEVGEGVSA+VYRALCIPLNEIVAIKVLDLEKCNNDLDGIR
Sbjct: 1 MERISEKRYPLSAKDYKLYEEVGEGVSASVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR 60
Query: 61 REVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLL 120
REVQTM + +HPN+LRAHCSFT GH LWVVMP+M+GGSCLHIMKS++PEGF+EPVIAT+L
Sbjct: 61 REVQTMSLIDHPNLLRAHCSFTAGHSLWVVMPFMSGGSCLHIMKSSFPEGFDEPVIATVL 120
Query: 121 RETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGT 180
RE LKALVYLH HGHIHRDVKAGNIL+D+NG++K+ADFGVSACMFD GDRQRSRNTFVGT
Sbjct: 121 REVLKALVYLHAHGHIHRDVKAGNILLDANGSVKMADFGVSACMFDTGDRQRSRNTFVGT 180
Query: 181 PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240
PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY
Sbjct: 181 PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240
Query: 241 ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGER 300
ERDKRFSKSFKELV CLVKDPKKRP++EKL+KHHFFKHAR+ ++L+R+I+D LAPLG+R
Sbjct: 241 ERDKRFSKSFKELVATCLVKDPKKRPSSEKLLKHHFFKHARATEYLSRTILDGLAPLGDR 300
Query: 301 FRMLKAKEADLLVQNKALYEDKEQLS-------------------------QDYDCMSNA 335
FR LKAKEADLL+QNKALYED EQLS QD D MSNA
Sbjct: 301 FRQLKAKEADLLMQNKALYEDMEQLSQKEYIRGISAWNFNLEDLKSQAALIQDED-MSNA 359
Query: 336 EDPNSSGKQNHA--DVEVPAERLSTESGNHSNATTSQD--DGFNNLHDLESSLASFPIKP 391
E+P+ + K D++VP E LS + NHS+ T++ D DGFNNL DLESSLASFP+KP
Sbjct: 360 EEPDMAKKNEDTSNDLKVPVENLS--ASNHSDGTSTLDKEDGFNNLQDLESSLASFPMKP 417
Query: 392 LQALKGCFDVGEDDEGATSPSWKGTAHLETDQFLSKGSLGAIDQESGRNEGENSGRSSSL 451
LQALKGCFDVG+DD TSP +D GRN+ E++G S+
Sbjct: 418 LQALKGCFDVGDDDGNNTSPR-------------------DLDHSYGRNDNESAGPSNLS 458
Query: 452 PRHVILEHKKFLSGSLIPDNAFSSKKAVGEADRDSLQPKNQSERNYSGPLLYRQRRDTNN 511
P++ + KFLSGSL DN F+ K V + DRD LQ K SERN+SGP LYRQRR+ NN
Sbjct: 459 PQNA--QPNKFLSGSLQSDN-FAKK--VTDGDRDYLQTKYPSERNHSGP-LYRQRREINN 512
Query: 512 LPSAEDTSEGAVVQRKGRFKVTSAELSPKGPINSIFSPVSGGSMSPTTP---NFTAASLL 568
PS +DTSEGA+VQR+GRFKVTSA+ S G N+ PV+ S +PT+P N AAS+L
Sbjct: 513 FPSVDDTSEGAIVQRRGRFKVTSADPSSMGLSNNTSGPVA-VSPTPTSPPNQNSMAASIL 571
Query: 569 PSLQFILQQNTMQREEIIRLIKYAEETSGKHAESADAGTNDLLQVTPASTKEKELQSQMI 628
PSLQ ILQQN +QREEI++LIKYAE++ GK+ ES +AG +D LQ +P ST+EKEL Q+I
Sbjct: 572 PSLQCILQQNGLQREEIVKLIKYAEQSYGKNTESIEAGASDALQASPVSTREKELHLQVI 631
Query: 629 TLQQRIASIAEELQRQKIKNAQLEKQLHAVVGE 661
LQQ I S+ EELQRQK+KN QLE+QL ++V +
Sbjct: 632 QLQQSIGSLVEELQRQKLKNVQLERQLSSMVNK 664
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296087657|emb|CBI34913.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 922 bits (2383), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 447/617 (72%), Positives = 501/617 (81%), Gaps = 55/617 (8%)
Query: 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQT 65
EK+FP+DAKDY+LYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQT
Sbjct: 4 EKKFPLDAKDYKLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQT 63
Query: 66 MRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLK 125
M + +HPN+L+AHCSFT+GH LWVVMPYMAGGSCLHIMKS YPEGF+EPVIATLLRE LK
Sbjct: 64 MSLIDHPNLLQAHCSFTSGHTLWVVMPYMAGGSCLHIMKSEYPEGFDEPVIATLLREVLK 123
Query: 126 ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMA 185
ALVYLH HGHIHRDVKAGNILIDSNGA+KLADFGVSACMFDAGDRQRSRNTFVGTPCWMA
Sbjct: 124 ALVYLHNHGHIHRDVKAGNILIDSNGAVKLADFGVSACMFDAGDRQRSRNTFVGTPCWMA 183
Query: 186 PEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245
PEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDK+
Sbjct: 184 PEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKK 243
Query: 246 FSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGERFRMLK 305
FSKSFKE+V CLVKDPKKRPT+EKL KH FFKHARSN++LAR+I++ L PLG+RFR LK
Sbjct: 244 FSKSFKEMVATCLVKDPKKRPTSEKLFKHSFFKHARSNEYLARTILEGLTPLGDRFRTLK 303
Query: 306 AKEADLLVQNKALYEDKEQLS-------------------------QDYDCMSNAEDPNS 340
AKEADLLVQNKALY DKEQLS QDYD +SN +DP+
Sbjct: 304 AKEADLLVQNKALYGDKEQLSQQEYIRGISAWNFNLEDLKNQAALIQDYDVISNVDDPDC 363
Query: 341 SGKQNHADVEVPAERLSTESGNHSNATTSQDDGFNNLHDLESSLASFPIKPLQALKGCFD 400
SNA S +DG N+L +LE+SLASFPI+PLQALKG FD
Sbjct: 364 -----------------------SNAAPSHEDGLNDLSNLENSLASFPIQPLQALKGYFD 400
Query: 401 VGEDDEGATSPSWKGTAHLETDQFLSKGSLGAIDQESGRNEGENSGRSSSLPRHVILEHK 460
V EDD A+S SW+ E++Q ++DQE+ +++GEN GRSSSLPR +I HK
Sbjct: 401 VCEDDGNASSLSWRDVMQSESEQ-------QSVDQEAEKDDGENFGRSSSLPRQIIPGHK 453
Query: 461 KFLSGSLIPDNAFSSKKAVGEADRDSLQPKNQSERNYSGPLLYRQRRDTNNLPSAEDTSE 520
KF SGSL+ DNA S KK G+ DR+++Q + Q ERNYSGPLL+RQ+RDTNN+ S EDT E
Sbjct: 454 KFFSGSLLQDNALSPKKVNGDGDRENIQSRYQPERNYSGPLLHRQKRDTNNISSVEDTPE 513
Query: 521 GAVVQRKGRFKVTSAELSPKGPINSIFSPVSGGSMSPTTPNFTAASLLPSLQFILQQNTM 580
GAVVQ KGRFKVTSAELSPKGP N FS VSGGS SPTTP+ TAAS+LPSLQF+LQQNTM
Sbjct: 514 GAVVQCKGRFKVTSAELSPKGPTNCFFSQVSGGSTSPTTPSLTAASILPSLQFVLQQNTM 573
Query: 581 QREEIIRLIKYAEETSG 597
QRE I++LIKY E++ G
Sbjct: 574 QREGIMKLIKYVEQSCG 590
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 671 | ||||||
| TAIR|locus:2185440 | 674 | AT5G14720 [Arabidopsis thalian | 0.964 | 0.959 | 0.574 | 2.1e-194 | |
| TAIR|locus:2019878 | 687 | AT1G79640 [Arabidopsis thalian | 0.783 | 0.765 | 0.492 | 9.8e-146 | |
| TAIR|locus:2016164 | 594 | AT1G70430 [Arabidopsis thalian | 0.457 | 0.516 | 0.722 | 1.7e-139 | |
| TAIR|locus:2132716 | 711 | AT4G10730 [Arabidopsis thalian | 0.953 | 0.900 | 0.436 | 3.5e-130 | |
| TAIR|locus:2135016 | 709 | AT4G24100 [Arabidopsis thalian | 0.777 | 0.736 | 0.465 | 2.9e-119 | |
| DICTYBASE|DDB_G0276577 | 1028 | fray2 "FRAY subfamily protein | 0.532 | 0.347 | 0.489 | 3e-100 | |
| TAIR|locus:2034888 | 473 | AT1G23700 [Arabidopsis thalian | 0.459 | 0.651 | 0.581 | 5.3e-100 | |
| TAIR|locus:2129780 | 487 | AT4G14480 [Arabidopsis thalian | 0.555 | 0.765 | 0.424 | 1.7e-84 | |
| FB|FBgn0023083 | 552 | fray "frayed" [Drosophila mela | 0.424 | 0.516 | 0.510 | 8.3e-81 | |
| ZFIN|ZDB-GENE-070620-25 | 515 | oxsr1a "oxidative-stress respo | 0.439 | 0.572 | 0.503 | 6e-80 |
| TAIR|locus:2185440 AT5G14720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1883 (667.9 bits), Expect = 2.1e-194, P = 2.1e-194
Identities = 385/670 (57%), Positives = 481/670 (71%)
Query: 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQT 65
EK+FP++AKDY+LYEE+G+GVSATV+RALCIPLN +VAIKVLDLEKCNNDLDGIRREVQT
Sbjct: 6 EKKFPLNAKDYKLYEEIGDGVSATVHRALCIPLNVVVAIKVLDLEKCNNDLDGIRREVQT 65
Query: 66 MRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLK 125
M + NHPNVL+AHCSFTTGH LWVVMPYMAGGSCLHI+KS+YP+GFEEPVIATLLRETLK
Sbjct: 66 MSLINHPNVLQAHCSFTTGHQLWVVMPYMAGGSCLHIIKSSYPDGFEEPVIATLLRETLK 125
Query: 126 ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMA 185
ALVYLH HGHIHRDVKAGNIL+DSNGA+KLADFGVSACMFD GDRQRSRNTFVGTPCWMA
Sbjct: 126 ALVYLHAHGHIHRDVKAGNILLDSNGAVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 185
Query: 186 PEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245
PEVMQQLHGYDFKAD+WSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR
Sbjct: 186 PEVMQQLHGYDFKADVWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245
Query: 246 FSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGERFRMLK 305
FSK+FKE+V CLVKDPKKRPT+EKL+KH FFKHAR D+L ++I++ L PLG+R+R +K
Sbjct: 246 FSKAFKEMVGTCLVKDPKKRPTSEKLLKHPFFKHARPADYLVKTILNGLPPLGDRYRQIK 305
Query: 306 AKEADLLVQNKALYE---DKEQLSQDYDCMS-NAEDPN------SSGKQNHADV----EV 351
+KEADLL+QNK+ YE +++ + + N ED S +HA+ +
Sbjct: 306 SKEADLLMQNKSEYEAHLSQQEYIRGISAWNFNLEDLKTQAALISDDDTSHAEEPDFNQK 365
Query: 352 PAERL--STESGNHSNATTSQDDGFNNLHDLESSLASFPIKPLQALKGCFDVGEDDEGAT 409
ER S S ++++ + + L+D+ +SF P++ L+ + E
Sbjct: 366 QCERQDESALSPERASSSATAPSQDDELNDIHDLESSFASFPIKPLQALKGCFDISEDED 425
Query: 410 SPSWKGTAHLETDQFLSKGSLGAIDQESGRNEGENSGRSSSLPRHVILEHKKFLSGSLIP 469
+ + + + +I + + E++ ++ ++ +K I
Sbjct: 426 NATTPDWKDANVNSGQQLLTKASIGSLAETTKEEDTAAQNTSLPRHVISEQKKYLSGSII 485
Query: 470 DNAFSSKKAVGEADRD-SLQPKNQSERNYSGPLLYRQRRDTNNLPSAEDTSEGAVVQRKG 528
+ S K + +D D Q + LYR +RD S ++TSE V+ KG
Sbjct: 486 PESTFSPKRI-TSDADREFQQRRYQTERSYSGSLYRTKRD-----SVDETSEVPHVEHKG 539
Query: 529 RFKVTSAELSPKGPINSIFSPVSGGSMSPTTPNFTAASLLPSLQFILQQNTMQREEIIRL 588
RFKVTSA+LSPKG NS F+P SGG+ SP+ N T AS+LPS+Q ILQQN MQREEI+RL
Sbjct: 540 RFKVTSADLSPKGSTNSTFTPFSGGTSSPSCLNATTASILPSIQSILQQNAMQREEILRL 599
Query: 589 IKYAEETSGKHAESADAGTNDLLQVTPASTKEKELQSQMITLQQRIASIAEELQRQKIKN 648
IKY E+TS K S + +DLLQ PA+++E+ELQSQ++ LQQ +S+ EEL++QK KN
Sbjct: 600 IKYLEQTSAKQPGSPETNVDDLLQTPPATSRERELQSQVMLLQQSFSSLTEELKKQKQKN 659
Query: 649 AQLEKQLHAV 658
QLE QL+A+
Sbjct: 660 GQLENQLNAL 669
|
|
| TAIR|locus:2019878 AT1G79640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1335 (475.0 bits), Expect = 9.8e-146, Sum P(2) = 9.8e-146
Identities = 275/558 (49%), Positives = 380/558 (68%)
Query: 1 MDLVVEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR 60
M + +K++P+ + Y LYE +G+GVSA V+RALCIP +E+VAIK+LD E+ N DL+ I
Sbjct: 1 MGTMEKKKYPIGPEHYTLYEFIGQGVSALVHRALCIPFDEVVAIKILDFERDNCDLNNIS 60
Query: 61 REVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLL 120
RE QTM + +HPNVL++HCSF + H LWV+MPYM+GGSCLHI+K+AYP+GFEE +IAT+L
Sbjct: 61 REAQTMMLVDHPNVLKSHCSFVSDHNLWVIMPYMSGGSCLHILKAAYPDGFEEAIIATIL 120
Query: 121 RETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGT 180
RE LK L YLH HGHIHRDVKAGNIL+ + GA+KL DFGVSAC+FD+GDRQR+RNTFVGT
Sbjct: 121 REALKGLDYLHQHGHIHRDVKAGNILLGARGAVKLGDFGVSACLFDSGDRQRTRNTFVGT 180
Query: 181 PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240
PCWMAPEVM+QLHGYDFKADIWSFGIT LELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY
Sbjct: 181 PCWMAPEVMEQLHGYDFKADIWSFGITGLELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240
Query: 241 ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGER 300
ERDK+FS+SFK+++ +CLVKDP KRP+A+KL+KH FFK ARS+D++AR ++D L L R
Sbjct: 241 ERDKKFSRSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSSDYIARKLLDGLPDLVNR 300
Query: 301 FRMLKAKEADLLVQNKALYEDKEQLSQ-DYDCMSNAEDPNSSGKQNHADV--EVPAERLS 357
+ +K KE D+L Q K +KE+LSQ +Y + + N + A + ++
Sbjct: 301 VQAIKRKEEDMLAQEKMADGEKEELSQNEYKRGISGWNFNLDDMKAQASLIQDMDCGFSD 360
Query: 358 TESGNHSN--ATTSQDDGFNNLHDLESSLASFPIKPL--QALKGCFDVGEDDEGATSPSW 413
+ SG+ ++ A SQD + + + + + ++PL ++L D +DD SPS+
Sbjct: 361 SLSGSATSLQALDSQDTQ-SEIQEDTGQITNKYLQPLIHRSLSIARDKSDDDSSLASPSY 419
Query: 414 KGTAHLET---DQFLSKGSLGAIDQESGRNEGENSGRSSSLPRHVILEHKKFLSGS-LIP 469
+ D L+ +G+ +G+ ++S+P + + + ++GS ++
Sbjct: 420 DSYVYSSPRHEDLSLNNTHVGSTHANNGKPTD-----ATSIPTN---QPTEIIAGSSVLA 471
Query: 470 DNAFSSKKAVGEADRDSLQPKNQSERNYSGP----------LLYRQRRDTNNLPSAEDTS 519
D + K GE+D+ Q +N S N + P + + + ++L ++D S
Sbjct: 472 DGNGAPNK--GESDKTQEQLQNGSNCNGTHPTVGGDDVPTEMAVKPPKAASSLDESDDKS 529
Query: 520 EGAVVQRKGRFKVTSAEL 537
+ VVQ++GRFKVTS L
Sbjct: 530 KPPVVQQRGRFKVTSENL 547
|
|
| TAIR|locus:2016164 AT1G70430 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1226 (436.6 bits), Expect = 1.7e-139, Sum P(2) = 1.7e-139
Identities = 232/321 (72%), Positives = 264/321 (82%)
Query: 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTM 66
KRFP+ AKDY L+EEVGEGVSATVYRA CI LNEIVA+K+LDLEKC NDL+ IR+EV M
Sbjct: 7 KRFPLYAKDYELFEEVGEGVSATVYRARCIALNEIVAVKILDLEKCRNDLETIRKEVHIM 66
Query: 67 RVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKA 126
+ +HPN+L+AHCSF LW+VMPYM+GGSC H+MKS YPEG E+P+IATLLRE LKA
Sbjct: 67 SLIDHPNLLKAHCSFIDSSSLWIVMPYMSGGSCFHLMKSVYPEGLEQPIIATLLREVLKA 126
Query: 127 LVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAP 186
LVYLH GHIHRDVKAGNILI S G +KL DFGVSACMFD+G+R ++RNTFVGTPCWMAP
Sbjct: 127 LVYLHRQGHIHRDVKAGNILIHSKGVVKLGDFGVSACMFDSGERMQTRNTFVGTPCWMAP 186
Query: 187 EVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246
EVMQQL GYDFK LAHGHAPFSKYPPMKVLLMTLQNAPP LDY+RDK+F
Sbjct: 187 EVMQQLDGYDFKY-----------LAHGHAPFSKYPPMKVLLMTLQNAPPRLDYDRDKKF 235
Query: 247 SKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGERFRMLKA 306
SKSF+EL+ ACLVKDPKKRPTA KL+KH FFKHARS D+L+R I+ L+PLGERF+ LK
Sbjct: 236 SKSFRELIAACLVKDPKKRPTAAKLLKHPFFKHARSTDYLSRKILHGLSPLGERFKKLKE 295
Query: 307 KEADLLVQNKALYEDKEQLSQ 327
EA+L K + DKEQLSQ
Sbjct: 296 AEAELF---KGINGDKEQLSQ 313
|
|
| TAIR|locus:2132716 AT4G10730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1277 (454.6 bits), Expect = 3.5e-130, P = 3.5e-130
Identities = 301/690 (43%), Positives = 415/690 (60%)
Query: 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQT 65
+K F V+ KDY+L EEVG G SA V+RA+ +P NE+VAIK LDL++CN++LD IRRE QT
Sbjct: 37 KKGFSVNPKDYKLMEEVGYGASAVVHRAIYLPTNEVVAIKSLDLDRCNSNLDDIRREAQT 96
Query: 66 MRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLK 125
M + +HPNV+++ CSF H LWVVMP+MA GSCLH+MK+AYP+GFEE I ++L+ETLK
Sbjct: 97 MTLIDHPNVIKSFCSFAVDHHLWVVMPFMAQGSCLHLMKAAYPDGFEEAAICSMLKETLK 156
Query: 126 ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMA 185
AL YLH GHIHRDVKAGNIL+D G IKL DFGVSAC+FD GDRQR+RNTFVGTPCWMA
Sbjct: 157 ALDYLHRQGHIHRDVKAGNILLDDTGEIKLGDFGVSACLFDNGDRQRARNTFVGTPCWMA 216
Query: 186 PEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245
PEV+Q GY+ KADIWSFGITALELAHGHAPFSKYPPMKVLLMT+QNAPPGLDY+RDK+
Sbjct: 217 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 276
Query: 246 FSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGERFRMLK 305
FSKSFKELV CLVKD KRPTAEKL+KH FFK+ + + + + +L PL R + L+
Sbjct: 277 FSKSFKELVALCLVKDQTKRPTAEKLLKHSFFKNVKPPEICVKKLFVDLPPLWTRVKALQ 336
Query: 306 AKEADLLVQNKALYEDKEQLSQ-DYDCMSNAEDPNSSGKQNHADVEVPAERLSTESGNHS 364
AK+A L D++ +SQ +Y +A + N + A + + + + TES
Sbjct: 337 AKDAAQLALKGMASADQDAISQSEYQRGVSAWNFNIEDLKEQASL-LDDDDILTESREEE 395
Query: 365 NATTSQDDGFNNLHDLESSLASFPIKPLQALKGCFDVGEDDEGATSPSWKGTAHLETDQF 424
+ Q N ++D S + + + G + D E P + + L +
Sbjct: 396 ESFGEQLH--NKVNDRGQVSGSQLLS--ENMNGK-EKASDTE-VVEPICEEKSTLNS--- 446
Query: 425 LSKGSLGAIDQESGRNEGENSGRSSSLPRHVILEHKKFLSGSLIPDNAFSSKKAVGEADR 484
+ +++Q + +E ++ ++ P + H LS ++ N+ S K E
Sbjct: 447 ----TTSSVEQPASSSE-QDVPQAKGKPVR-LQTHSGPLSSGVVLINSDSEKVHGYERSE 500
Query: 485 DSLQPKNQSER--NYSGPLLYRQRRDTNNL--P---------SAEDTSEGAVVQRKGRFK 531
Q K+ R ++SGPL R N+L P S +D S+ VVQ KGRF
Sbjct: 501 SERQLKSSVRRAPSFSGPLNLPNRASANSLSAPIKSSGGFRDSIDDKSKANVVQIKGRFS 560
Query: 532 VTSAEL-----SPKGPINSIFSPVSGGSMSPTTPNFTAAS-----LLPSLQFILQQNTMQ 581
VTS L SP S+ + + M PT +S ++P LQ + QQN+MQ
Sbjct: 561 VTSENLDLARASPLRKSASVGNWILDSKM-PTGQAIKESSSHLSFIIPQLQNLFQQNSMQ 619
Query: 582 REEIIRLI----KYAEETSGKHAESAD-----AGTNDLLQVTPASTKEKELQSQMITLQQ 632
++ I+ L+ + AE T G + +N + A+ +E+ L +++ L+
Sbjct: 620 QDLIMNLVNTLQQAAETTDGSQNGKLPPLPRGSDSNGTVVELTAAERERLLLTKITELRA 679
Query: 633 RIASIAEELQRQKIKNAQLEKQLHAVVGED 662
R+ + EEL+ +K K QL+++L +V G +
Sbjct: 680 RMKELTEELEVEKSKQTQLQQKLKSVTGRE 709
|
|
| TAIR|locus:2135016 AT4G24100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1174 (418.3 bits), Expect = 2.9e-119, P = 2.9e-119
Identities = 260/558 (46%), Positives = 352/558 (63%)
Query: 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQT 65
++ F ++ KDY+L EE+G G SA VYRA+ +P NE+VAIK LDL++CN++LD IRRE QT
Sbjct: 23 QRGFSMNPKDYKLMEEIGHGASAVVYRAIYLPTNEVVAIKCLDLDRCNSNLDDIRRESQT 82
Query: 66 MRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLK 125
M + +HPNV+++ CSF+ H LWVVMP+MA GSCLH+MK+AY +GFEE I +L+ETLK
Sbjct: 83 MSLIDHPNVIKSFCSFSVDHSLWVVMPFMAQGSCLHLMKTAYSDGFEESAICCVLKETLK 142
Query: 126 ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMA 185
AL YLH GHIHRDVKAGNIL+D NG IKL DFGVSAC+FD GDRQR+RNTFVGTPCWMA
Sbjct: 143 ALDYLHRQGHIHRDVKAGNILLDDNGEIKLGDFGVSACLFDNGDRQRARNTFVGTPCWMA 202
Query: 186 PEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245
PEV+Q +GY+ KADIWSFGITALELAHGHAPFSKYPPMKVLLMT+QNAPPGLDY+RDK+
Sbjct: 203 PEVLQPGNGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 262
Query: 246 FSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGERFRMLK 305
FSKSFKE+V CLVKD KRPTAEKL+KH FKH + + + + +L PL R + L+
Sbjct: 263 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSCFKHTKPPEQTVKILFSDLPPLWTRVKSLQ 322
Query: 306 AKEADLLVQNKALYEDKEQLSQ-DYDCMSNAEDPNSSGKQNHADVEVPAERLSTESGNHS 364
K+A L + D+E +SQ +Y +A + + + A + + + L ES
Sbjct: 323 DKDAQQLALKRMATADEEAISQSEYQRGVSAWNFDVRDLKTQASLLIDDDDLE-ESKEDE 381
Query: 365 NATTSQDDGFNNLHDLESSLASFPIKPLQALKGCFDVGEDDEGATSPSWKGTAHLETDQF 424
+Q FN ++D E S + + + G V + P+ K ++F
Sbjct: 382 EILCAQ---FNKVNDREQVFDSLQL--YENMNGKEKVSNTE--VEEPTCK-------EKF 427
Query: 425 LSKGSLGAIDQESGRNEGE-NSGRSSSLPRHVILEHKKFLSGSLIPDNAFSSKKAVGEAD 483
+ ++++ S +E + + L R + S +++ +A S K + E
Sbjct: 428 TFVTTTSSLERMSPNSEHDIPEAKVKPLRRQS--QSGPLTSRTVLSHSA-SEKSHIFERS 484
Query: 484 RDSLQ--PKNQSERNYSGPLLYRQRRDTNNL--P---------SAEDTSEGAVVQRKGRF 530
Q P + ++SGPL R +N+L P S +D S+ +VQ KGRF
Sbjct: 485 ESEPQTAPTVRRAPSFSGPLNLSTRASSNSLSAPIKYSGGFRDSLDDKSKANLVQ-KGRF 543
Query: 531 KVTSA--ELSPKGPINSI 546
VTS +L+ P++ +
Sbjct: 544 SVTSGNVDLAKDVPLSIV 561
|
|
| DICTYBASE|DDB_G0276577 fray2 "FRAY subfamily protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 930 (332.4 bits), Expect = 3.0e-100, Sum P(3) = 3.0e-100
Identities = 178/364 (48%), Positives = 247/364 (67%)
Query: 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-DLDGIRREVQT 65
K +P A Y L E +G+G S V RA+C+P E VAIK++DLE C N L+ IR+E+Q
Sbjct: 62 KNYPNSADQYELKETIGKGGSGLVQRAICLPFQENVAIKIIDLEHCKNVSLEEIRKEIQA 121
Query: 66 MRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLK 125
M + +HPNV+ H SF LWV+M +++ GSC IM+ ++P+GFEE VIAT+L+E LK
Sbjct: 122 MSLCHHPNVVAYHTSFVYNESLWVIMDFLSAGSCSDIMRFSFPQGFEEHVIATILKEALK 181
Query: 126 ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMA 185
A+ Y H G IHRD+K+GNILIDSNG I+L+DFGVSA + D G+ SRNTFVGTPCWMA
Sbjct: 182 AICYFHKTGRIHRDIKSGNILIDSNGNIQLSDFGVSATLIDTGET--SRNTFVGTPCWMA 239
Query: 186 PEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245
PE+M+Q++ YD+ DIWSFGITALELA G APF++YPPMKVLL+TLQN PP L+ + + +
Sbjct: 240 PEIMEQVN-YDYAVDIWSFGITALELARGKAPFAEYPPMKVLLLTLQNPPPSLEGDGESK 298
Query: 246 FSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGERFRMLK 305
+S SFK+LV CL KDP KRP KL++H FFK A+ D+L + I+ L PLG+R++ML
Sbjct: 299 WSHSFKDLVEKCLQKDPSKRPLPSKLLEHRFFKQAKKPDYLVQHILAKLPPLGQRYQML- 357
Query: 306 AKEADLLVQNKAL--YEDKEQLSQDYDCMSNAEDPNSSGKQNHADVEVPAERLSTESGNH 363
++++ +++N + ++ S D N + N++ S + N+
Sbjct: 358 SEDSFAMLRNTSSPQFDTGHSNSADEWIFPNENNDNNNSSTTTTTTTTTTTNPSNNNNNN 417
Query: 364 SNAT 367
+N T
Sbjct: 418 NNKT 421
|
|
| TAIR|locus:2034888 AT1G23700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 938 (335.3 bits), Expect = 5.3e-100, Sum P(2) = 5.3e-100
Identities = 190/327 (58%), Positives = 244/327 (74%)
Query: 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQT 65
E RFP+ AKDY + EE+G+GV YRA CI L+EIVAIK+ +LEKC NDL+ IR+EV
Sbjct: 6 ETRFPLVAKDYEILEEIGDGV----YRARCILLDEIVAIKIWNLEKCTNDLETIRKEVHR 61
Query: 66 MRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLK 125
+ + +HPN+LR HCSF LW+VMP+M+ GS L+IMKS YP G EEPVIA LLRE LK
Sbjct: 62 LSLIDHPNLLRVHCSFIDSSSLWIVMPFMSCGSSLNIMKSVYPNGLEEPVIAILLREILK 121
Query: 126 ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR--SRNTFVGTPCW 183
ALVYLH GHIHR+VKAGN+L+DS G +KL DF VSA MFD+ +R R S NTFVG P
Sbjct: 122 ALVYLHGLGHIHRNVKAGNVLVDSEGTVKLGDFEVSASMFDSVERMRTSSENTFVGNPRR 181
Query: 184 MAPEV-MQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP-PGLDYE 241
MAPE MQQ+ GYDFK DIWSFG+TALELAHGH+P + VL + LQN+P P +YE
Sbjct: 182 MAPEKDMQQVDGYDFKVDIWSFGMTALELAHGHSPTT------VLPLNLQNSPFP--NYE 233
Query: 242 RDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGERF 301
D +FSKSF+ELV ACL++DP+KRPTA +L+++ F + S ++LA + +D L+PLGER+
Sbjct: 234 EDTKFSKSFRELVAACLIEDPEKRPTASQLLEYPFLQQTLSTEYLASTFLDGLSPLGERY 293
Query: 302 RMLKAKEADLLVQNKALYEDKEQLSQD 328
R LK ++A L+ K + +KE++SQ+
Sbjct: 294 RKLKEEKAKLV---KGVDGNKEKVSQE 317
|
|
| TAIR|locus:2129780 AT4G14480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 820 (293.7 bits), Expect = 1.7e-84, Sum P(2) = 1.7e-84
Identities = 169/398 (42%), Positives = 256/398 (64%)
Query: 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNE-IVAIKVLDLEKCNNDLDGIRREVQTMR 67
FP+DA+ Y + ++G GVSA+VY+A+CIP+N +VAIK +DL++ D D +RRE +TM
Sbjct: 8 FPLDAEAYEIICKIGVGVSASVYKAICIPMNSMVVAIKAIDLDQSRADFDSLRRETKTMS 67
Query: 68 VTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKAL 127
+ +HPN+L A+CSFT CLWVVMP+M+ GS I+ S++P G E I+ L+ETL A+
Sbjct: 68 LLSHPNILNAYCSFTVDRCLWVVMPFMSCGSLHSIVSSSFPSGLPENCISVFLKETLNAI 127
Query: 128 VYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD-----AGDRQRS-RNTFV-GT 180
YLH GH+HRD+KAGNIL+DS+G++KLADFGVSA +++ +G S R T + GT
Sbjct: 128 SYLHDQGHLHRDIKAGNILVDSDGSVKLADFGVSASIYEPVTSSSGTTSSSLRLTDIAGT 187
Query: 181 PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240
P WMAPEV+ GY FKADIWSFGITALELAHG P S PP+K LLM + DY
Sbjct: 188 PYWMAPEVVHSHTGYGFKADIWSFGITALELAHGRPPLSHLPPLKSLLMKITKRFHFSDY 247
Query: 241 E---------RDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIV 291
E +K+FSK+F+E+V CL +DP KRP+AEKL+KH FFK+ + DF+ ++++
Sbjct: 248 EINTSGSSKKGNKKFSKAFREMVGLCLEQDPTKRPSAEKLLKHPFFKNCKGLDFVVKNVL 307
Query: 292 DNLAPLGERFRMLKAKEADLLVQNKALYEDKEQLSQDYDCMSNAEDPNSSGKQNHADVEV 351
+L+ + F E+ +L+++ +D+E+ +D + + N + +++ D+++
Sbjct: 308 HSLSNAEQMFM-----ESQILIKSVG-DDDEEEEEEDEEIVKNRRISGWNFRED--DLQL 359
Query: 352 PAERLSTESGNHSNATTSQDDGFNNLHDLESSLASFPI 389
+TES + ++ +D + D ++ + +
Sbjct: 360 SPVFPATESDSSESSPREEDQSKDKKEDDNVTITGYEL 397
|
|
| FB|FBgn0023083 fray "frayed" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 760 (272.6 bits), Expect = 8.3e-81, Sum P(2) = 8.3e-81
Identities = 152/298 (51%), Positives = 202/298 (67%)
Query: 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRV 68
+P DY L + +G G +A V+ A CIP NE AIK ++LEK N +D + +E+Q M
Sbjct: 31 WPNSKDDYELRDVIGVGATAVVHGAYCIPRNEKCAIKRINLEKWNTSMDELLKEIQAMSS 90
Query: 69 TNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMK-----SAYPEG-FEEPVIATLLRE 122
H NV+ H SF LW+V+ + GGS L I+K S +G F+E IAT+L+E
Sbjct: 91 CFHENVVTYHTSFVVREELWLVLRLLEGGSLLDIIKHKMRTSNCKQGVFDEATIATVLKE 150
Query: 123 TLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD--RQRSRNTFVGT 180
LK L Y H +G IHRD+KAGNILI +G I++ADFGVSA + D RQ+ R+TFVGT
Sbjct: 151 VLKGLEYFHSNGQIHRDIKAGNILIGDDGTIQIADFGVSAWLATGRDLSRQKVRHTFVGT 210
Query: 181 PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240
PCWMAPEVM+Q HGYDFKADIWSFGITA+E+A G AP+ KYPPMKVL++TLQN PP LD
Sbjct: 211 PCWMAPEVMEQDHGYDFKADIWSFGITAIEMATGTAPYHKYPPMKVLMLTLQNDPPTLDT 270
Query: 241 ERD-----KRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDN 293
D K + K+F++++ CL K+P KRPTA +L+KH FFK A+ +L ++++ +
Sbjct: 271 GADDKDQYKAYGKTFRKMIVECLQKEPSKRPTASELLKHAFFKKAKDRKYLTQTLLQS 328
|
|
| ZFIN|ZDB-GENE-070620-25 oxsr1a "oxidative-stress responsive 1a" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 803 (287.7 bits), Expect = 6.0e-80, P = 6.0e-80
Identities = 155/308 (50%), Positives = 211/308 (68%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN 70
+D DY L E +G G +A V A C P E VAIK ++LEKC +D + +E+Q M +
Sbjct: 12 IDKDDYELQEVIGSGATAVVQAAYCKPRKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71
Query: 71 HPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEG------FEEPVIATLLRETL 124
HPN++ + SF LW+VM ++GGS L +K +G +EP IAT+LRE L
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDFIKYIISKGEHKSGVMDEPSIATILREVL 131
Query: 125 KALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD--RQRSRNTFVGTPC 182
+ L YLH +G IHRDVKAGNIL+ +G++++ADFGVSA + GD R + R TFVGTPC
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDMTRNKVRKTFVGTPC 191
Query: 183 WMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL---- 238
WMAPEVM+Q+ GYDFKAD+WSFGITA+ELA G AP+ KYPPMKVL++TLQN PP L
Sbjct: 192 WMAPEVMEQVRGYDFKADLWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPCLETGV 251
Query: 239 -DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPL 297
D E K++ KSF+++++ CL KDP+KRPTA +L+KH FF A++ D+L +++ +
Sbjct: 252 TDKEMVKKYGKSFRKMISLCLQKDPEKRPTAAELLKHKFFTKAKNTDYLKEKLLERAPTI 311
Query: 298 GERFRMLK 305
GER R ++
Sbjct: 312 GERSRKVR 319
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.I.2413.1 | hypothetical protein (679 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 671 | |||
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-170 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-108 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-100 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-92 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-91 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-84 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-83 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-80 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-79 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-76 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-71 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-70 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-70 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-69 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-68 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-67 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-66 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-65 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-61 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-57 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-56 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-56 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-55 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-55 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-55 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-54 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-53 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-52 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-52 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-51 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-51 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-50 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-50 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-49 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-49 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-49 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-48 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 6e-48 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-47 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-47 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-46 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-46 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-45 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-45 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-45 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-44 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-43 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-43 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-43 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-43 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-42 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-42 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-42 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-41 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-41 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-39 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-39 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-38 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-38 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-38 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-37 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-37 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-37 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-36 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-36 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-36 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-35 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-35 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-35 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-34 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-34 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-34 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-34 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-33 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-32 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-32 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-32 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-31 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-31 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-31 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-31 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-30 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-30 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-30 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-30 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-29 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-29 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-29 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-29 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-29 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-28 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-28 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-28 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-28 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-26 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-26 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-26 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-26 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-25 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-25 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-25 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-25 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-25 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-25 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-25 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-25 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-24 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-24 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-24 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-24 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-24 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-24 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-24 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-24 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-24 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-24 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-23 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-23 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-23 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-23 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-23 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-23 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-23 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-23 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-22 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-22 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-22 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-22 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-22 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-22 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-22 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-22 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-22 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-22 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-21 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-21 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-21 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-21 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-21 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-21 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-20 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-20 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-20 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-20 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-20 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-20 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-19 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-19 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-19 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-19 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-19 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-19 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-19 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-19 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-19 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 5e-19 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-19 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-19 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-19 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-18 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-18 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-18 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-18 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-17 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-17 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-17 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-17 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-17 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-17 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-17 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-17 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-17 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-17 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-16 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-16 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-16 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-16 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-16 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-15 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-15 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-15 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-15 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-15 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-15 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-14 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-14 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-14 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 9e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-13 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-13 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-13 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-13 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-12 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-12 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-12 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-12 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-11 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-10 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-09 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 7e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 4e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 6e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 6e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 9e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 7e-04 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 487 bits (1256), Expect = e-170
Identities = 166/267 (62%), Positives = 210/267 (78%), Gaps = 3/267 (1%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN 73
DY L E +G G +A VY A+C+P NE VAIK +DLEKC +D +R+EVQ M NHPN
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEG-FEEPVIATLLRETLKALVYLHF 132
V++ + SF G LW+VMPY++GGS L IMKS+YP G +E +IAT+L+E LK L YLH
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 133 HGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ-RSRNTFVGTPCWMAPEVMQQ 191
+G IHRD+KAGNIL+ +G++K+ADFGVSA + D GDR + R TFVGTPCWMAPEVM+Q
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 192 LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD-KRFSKSF 250
+HGYDFKADIWSFGITA+ELA G AP+SKYPPMKVL++TLQN PP L+ D K++SKSF
Sbjct: 181 VHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSF 240
Query: 251 KELVTACLVKDPKKRPTAEKLMKHHFF 277
+++++ CL KDP KRPTAE+L+KH FF
Sbjct: 241 RKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 328 bits (844), Expect = e-108
Identities = 128/273 (46%), Positives = 176/273 (64%), Gaps = 10/273 (3%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN 73
+ + L E +G+G VY+A+ N++VAIKV+DLE+ ++++ I++E+Q + P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH 133
+ + + SF G LW++M Y GGSCL ++K P +E IA +LRE L L YLH
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK---PGKLDETYIAFILREVLLGLEYLHEE 117
Query: 134 GHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLH 193
G IHRD+KA NIL+ G +KLADFGVS + RNTFVGTP WMAPEV++Q
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVSGQL---TSTMSKRNTFVGTPFWMAPEVIKQS- 173
Query: 194 GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL 253
GYD KADIWS GITA+ELA G P S PM+VL + +N PP L+ +FSK FK+
Sbjct: 174 GYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE---GNKFSKPFKDF 230
Query: 254 VTACLVKDPKKRPTAEKLMKHHFFKHARSNDFL 286
V+ CL KDPK+RP+A++L+KH F K A+ +L
Sbjct: 231 VSLCLNKDPKERPSAKELLKHKFIKKAKKTSYL 263
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 307 bits (789), Expect = e-100
Identities = 117/262 (44%), Positives = 165/262 (62%), Gaps = 9/262 (3%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNV 74
+ + E++G+G VY+A + VAIKV+ LE + I E+Q ++ HPN+
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKE-KKEKIINEIQILKKCKHPNI 59
Query: 75 LRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHG 134
++ + S+ LW+VM + +GGS ++KS + E IA + +E LK L YLH +G
Sbjct: 60 VKYYGSYLKKDELWIVMEFCSGGSLKDLLKS-TNQTLTESQIAYVCKELLKGLEYLHSNG 118
Query: 135 HIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHG 194
IHRD+KA NIL+ S+G +KL DFG+SA + D ++RNT VGTP WMAPEV+
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT----KARNTMVGTPYWMAPEVINGKP- 173
Query: 195 YDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELV 254
YD+KADIWS GITA+ELA G P+S+ PPMK L N PPGL +++S FK+ +
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLR--NPEKWSDEFKDFL 231
Query: 255 TACLVKDPKKRPTAEKLMKHHF 276
CL K+P+KRPTAE+L+KH F
Sbjct: 232 KKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 285 bits (732), Expect = 4e-92
Identities = 110/264 (41%), Positives = 161/264 (60%), Gaps = 10/264 (3%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN 73
+ + + E++GEG +VY+A+ ++VAIKV+ + DL I +E+ ++ + P
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV---EEDLQEIIKEISILKQCDSPY 59
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH 133
+++ + S+ LW+VM Y GS IMK + E IA +L +TLK L YLH +
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 134 GHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLH 193
IHRD+KAGNIL++ G KLADFGVS + D RNT +GTP WMAPEV+Q++
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLT---DTMAKRNTVIGTPFWMAPEVIQEI- 174
Query: 194 GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL 253
GY+ KADIWS GITA+E+A G P+S PM+ + M PP L +++S F +
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTL--SDPEKWSPEFNDF 232
Query: 254 VTACLVKDPKKRPTAEKLMKHHFF 277
V CLVKDP++RP+A +L++H F
Sbjct: 233 VKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 284 bits (730), Expect = 1e-91
Identities = 97/262 (37%), Positives = 136/262 (51%), Gaps = 8/262 (3%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVL 75
Y + E++GEG VY A ++VAIKV+ +K D + I RE++ ++ HPN++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 76 RAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGH 135
R + F L++VM Y GG ++K E LR+ L AL YLH G
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR--LSEDEARFYLRQILSALEYLHSKGI 118
Query: 136 IHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGY 195
+HRD+K NIL+D +G +KLADFG++ + D TFVGTP +MAPEV+ GY
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQL----DPGEKLTTFVGTPEYMAPEVLLG-KGY 173
Query: 196 DFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVT 255
DIWS G+ EL G PF + L + P S K+L+
Sbjct: 174 GKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWD-ISPEAKDLIR 232
Query: 256 ACLVKDPKKRPTAEKLMKHHFF 277
LVKDP+KR TAE+ ++H FF
Sbjct: 233 KLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 264 bits (677), Expect = 8e-84
Identities = 117/268 (43%), Positives = 156/268 (58%), Gaps = 13/268 (4%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN 73
+DY L + +G G VY+A I E+VAIKV+ LE +D + I++E+ ++ HPN
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP-GDDFEIIQQEISMLKECRHPN 61
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH 133
++ S+ LW+VM Y GGS I + E IA + RETLK L YLH
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQ-VTRGPLSELQIAYVCRETLKGLAYLHET 120
Query: 134 GHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLH 193
G IHRD+K NIL+ +G +KLADFGVSA + + R +F+GTP WMAPEV
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK---RKSFIGTPYWMAPEVAAVER 177
Query: 194 --GYDFKADIWSFGITALELAHGHAPFSKYPPMKVL-LMTLQNA-PPGLDYERDK-RFSK 248
GYD K DIW+ GITA+ELA P PM+ L L++ N PP L +DK ++S
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKL---KDKEKWSP 234
Query: 249 SFKELVTACLVKDPKKRPTAEKLMKHHF 276
F + + CL KDPKKRPTA KL++H F
Sbjct: 235 VFHDFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 263 bits (674), Expect = 4e-83
Identities = 109/275 (39%), Positives = 158/275 (57%), Gaps = 9/275 (3%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVL 75
Y+ E++GEG S VY+A + VAIK + L + + I E+ M+ HPN++
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLR--KQNKELIINEILIMKDCKHPNIV 78
Query: 76 RAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGH 135
+ S+ G LWVVM YM GG L + + EP IA + RE L+ L YLH
Sbjct: 79 DYYDSYLVGDELWVVMEYMDGG-SLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNV 137
Query: 136 IHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGY 195
IHRD+K+ NIL+ +G++KLADFG +A + + RN+ VGTP WMAPEV+++ Y
Sbjct: 138 IHRDIKSDNILLSKDGSVKLADFGFAAQL---TKEKSKRNSVVGTPYWMAPEVIKR-KDY 193
Query: 196 DFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVT 255
K DIWS GI +E+A G P+ + PP++ L + P L +++S FK+ +
Sbjct: 194 GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNP--EKWSPEFKDFLN 251
Query: 256 ACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSI 290
CLVKDP+KRP+AE+L++H F K A + A I
Sbjct: 252 KCLVKDPEKRPSAEELLQHPFLKKACPKEEFAPLI 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 254 bits (651), Expect = 8e-80
Identities = 108/282 (38%), Positives = 157/282 (55%), Gaps = 22/282 (7%)
Query: 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMR- 67
P + L E +GEG VY+A ++VAIK++D+ + + I+ E +R
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEE--EIKEEYNILRK 58
Query: 68 VTNHPNVLRAHCSF------TTGHCLWVVMPYMAGGSCLHIMKSAYPEG--FEEPVIATL 119
+NHPN+ + +F LW+VM GGS ++K +G +E IA +
Sbjct: 59 YSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYI 118
Query: 120 LRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS-RNTFV 178
LRETL+ L YLH + IHRD+K NIL+ N +KL DFGVSA + D RNTF+
Sbjct: 119 LRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL----DSTLGRRNTFI 174
Query: 179 GTPCWMAPEV---MQQLH-GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA 234
GTP WMAPEV +Q YD ++D+WS GITA+ELA G P PM+ L +N
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP 234
Query: 235 PPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHF 276
PP L + + +SK F + ++ CL+K+ ++RP E+L++H F
Sbjct: 235 PPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 253 bits (647), Expect = 3e-79
Identities = 108/272 (39%), Positives = 166/272 (61%), Gaps = 13/272 (4%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQ---TMRVTNHP 72
Y+ E +G G VYR +P +VA+K+++L+ ++D+ I+REV +R + P
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 73 NVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF 132
N+ + + S+ G LW++M Y GGS +MK E I+ ++RE L AL Y+H
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMK---AGPIAEKYISVIIREVLVALKYIHK 119
Query: 133 HGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQL 192
G IHRD+KA NIL+ + G +KL DFGV+A + + +RS TFVGTP WMAPEV+ +
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAA-LLNQNSSKRS--TFVGTPYWMAPEVITEG 176
Query: 193 HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKE 252
YD KADIWS GIT E+A G+ P+S + +++ ++ PP L+ D +SK +E
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLE---DNGYSKLLRE 233
Query: 253 LVTACLVKDPKKRPTAEKLMKHHFFK-HARSN 283
V ACL ++PK+R +AE+L+K + K H+++
Sbjct: 234 FVAACLDEEPKERLSAEELLKSKWIKAHSKTP 265
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 245 bits (626), Expect = 3e-76
Identities = 126/272 (46%), Positives = 175/272 (64%), Gaps = 12/272 (4%)
Query: 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHC 79
E +G+G VY+ + E+VAIK++DLE+ ++++ I++E+ + + P + R +
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 80 SFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRD 139
S+ G LW++M Y+ GGS L ++K P EE IAT+LRE LK L YLH IHRD
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLK---PGPLEETYIATILREILKGLDYLHSERKIHRD 126
Query: 140 VKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKA 199
+KA N+L+ G +KLADFGV+ + D Q RNTFVGTP WMAPEV++Q YDFKA
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLTDT---QIKRNTFVGTPFWMAPEVIKQ-SAYDFKA 182
Query: 200 DIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLV 259
DIWS GITA+ELA G P S PM+VL + +N+PP L + ++SK FKE V ACL
Sbjct: 183 DIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTL----EGQYSKPFKEFVEACLN 238
Query: 260 KDPKKRPTAEKLMKHHFF-KHARSNDFLARSI 290
KDP+ RPTA++L+KH F ++ + FL I
Sbjct: 239 KDPRFRPTAKELLKHKFITRYTKKTSFLTELI 270
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 233 bits (594), Expect = 2e-71
Identities = 126/287 (43%), Positives = 178/287 (62%), Gaps = 20/287 (6%)
Query: 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHC 79
E +G+G V++ + ++VAIK++DLE+ ++++ I++E+ + + P V + +
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 80 SFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRD 139
S+ G LW++M Y+ GGS L ++++ F+E IAT+L+E LK L YLH IHRD
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKKIHRD 126
Query: 140 VKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKA 199
+KA N+L+ G +KLADFGV+ + D Q RNTFVGTP WMAPEV+QQ YD KA
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLTDT---QIKRNTFVGTPFWMAPEVIQQ-SAYDSKA 182
Query: 200 DIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLV 259
DIWS GITA+ELA G P S PM+VL + +N PP L E FSK FKE + ACL
Sbjct: 183 DIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGE----FSKPFKEFIDACLN 238
Query: 260 KDPKKRPTAEKLMKHHFF-KHARSNDFLARSIVDNLAPLGERFRMLK 305
KDP RPTA++L+KH F K+A+ +L I +RF+ K
Sbjct: 239 KDPSFRPTAKELLKHKFIVKNAKKTSYLTELI--------DRFKRWK 277
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 231 bits (590), Expect = 2e-70
Identities = 111/310 (35%), Positives = 159/310 (51%), Gaps = 44/310 (14%)
Query: 18 LYEEVGEGVS--ATVYRALCIPLNEIVAIKVLDLEKCNN-DLDGIRREVQTMRVTNHPNV 74
L +G+ V+ A P N +VA+K ++L+ C+ DL +++E+ T R HPN+
Sbjct: 2 LLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNI 61
Query: 75 LRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHG 134
L SF L+VV P MA GSC ++K+ +PEG E IA +L++ L AL Y+H G
Sbjct: 62 LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG 121
Query: 135 HIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-------WMAPE 187
IHR VKA +IL+ +G + L+ S M G RQR P W++PE
Sbjct: 122 FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR---VVHDFPKSSVKNLPWLSPE 178
Query: 188 VMQQ-LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL-------D 239
V+QQ L GY+ K+DI+S GITA ELA+GH PF P ++LL ++ P L
Sbjct: 179 VLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPL 238
Query: 240 YERD----------------------KRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277
YE + FS+ F + V CL +DP+ RP+A +L+ H FF
Sbjct: 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF 298
Query: 278 KHAR-SNDFL 286
K + N L
Sbjct: 299 KQCKRRNTSL 308
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 227 bits (581), Expect = 9e-70
Identities = 92/269 (34%), Positives = 145/269 (53%), Gaps = 15/269 (5%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPN 73
++ E +G G +VY AL E++A+K ++L + +L+ + RE++ + HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 74 VLRA-HCSFT-TGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLH 131
++R + L + + Y++GGS ++K EPVI R+ L+ L YLH
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLH 118
Query: 132 FHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQ 191
+G +HRD+K NIL+DS+G +KLADFG + + + GTP WMAPEV++
Sbjct: 119 SNGIVHRDIKGANILVDSDGVVKLADFGCAK-RLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 192 LHGYDFKADIWSFGITALELAHGHAPFSKYP-PMKVLL--MTLQNAPPGLDYERDKRFSK 248
Y ADIWS G T +E+A G P+S+ PM L + P ++ S+
Sbjct: 178 -EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEH-----LSE 231
Query: 249 SFKELVTACLVKDPKKRPTAEKLMKHHFF 277
K+ + CL +DPKKRPTA++L++H F
Sbjct: 232 EAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 225 bits (577), Expect = 3e-69
Identities = 97/265 (36%), Positives = 141/265 (53%), Gaps = 8/265 (3%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLD-GIRREVQTMRVTNHPNV 74
Y L ++G G TVY+A +IVA+K+L + D RRE++ +R +HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 75 LRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHG 134
+R +F L++VM Y GG + P E + + L+ L YLH +G
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLEYLHSNG 118
Query: 135 HIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHG 194
IHRD+K NIL+D NG +K+ADFG++ + S TFVGTP +MAPEV+ +G
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKL---LKSSSSLTTFVGTPWYMAPEVLLGGNG 175
Query: 195 YDFKADIWSFGITALELAHGHAPFS--KYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKE 252
Y K D+WS G+ EL G PFS L+ + P D + S+ K+
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKD 235
Query: 253 LVTACLVKDPKKRPTAEKLMKHHFF 277
L+ CL KDP KRPTAE++++H +F
Sbjct: 236 LIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 224 bits (571), Expect = 3e-68
Identities = 119/272 (43%), Positives = 172/272 (63%), Gaps = 12/272 (4%)
Query: 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHC 79
E++G+G V++ + ++VAIK++DLE+ ++++ I++E+ + + P V + +
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 80 SFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRD 139
S+ LW++M Y+ GGS L +++ P +E IAT+LRE LK L YLH IHRD
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLE---PGPLDETQIATILREILKGLDYLHSEKKIHRD 126
Query: 140 VKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKA 199
+KA N+L+ +G +KLADFGV+ + D Q RNTFVGTP WMAPEV++Q YD KA
Sbjct: 127 IKAANVLLSEHGEVKLADFGVAGQLTDT---QIKRNTFVGTPFWMAPEVIKQ-SAYDSKA 182
Query: 200 DIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLV 259
DIWS GITA+ELA G P S+ PMKVL + +N PP L + +SK KE V ACL
Sbjct: 183 DIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTL----EGNYSKPLKEFVEACLN 238
Query: 260 KDPKKRPTAEKLMKHHF-FKHARSNDFLARSI 290
K+P RPTA++L+KH F + A+ +L I
Sbjct: 239 KEPSFRPTAKELLKHKFIVRFAKKTSYLTELI 270
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 219 bits (561), Expect = 5e-67
Identities = 95/264 (35%), Positives = 142/264 (53%), Gaps = 11/264 (4%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEK-CNNDLDGIRREVQTMRVTNHPN 73
+Y+L + +G G VY+ L + + VAIK + LEK L I +E+ ++ HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH 133
+++ S T L++++ Y GS I+K F E ++A + + L+ L YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 134 GHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLH 193
G IHRD+KA NIL +G +KLADFGV+ + D + VGTP WMAPEV+ ++
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK---DDASVVGTPYWMAPEVI-EMS 174
Query: 194 GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL 253
G +DIWS G T +EL G+ P+ PM L +Q+ P L + S K+
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPL----PEGISPELKDF 230
Query: 254 VTACLVKDPKKRPTAEKLMKHHFF 277
+ C KDP RPTA++L+KH +
Sbjct: 231 LMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 215 bits (551), Expect = 5e-66
Identities = 86/255 (33%), Positives = 129/255 (50%), Gaps = 41/255 (16%)
Query: 22 VGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSF 81
+GEG TVY A + VAIK++ E ++ L+ + RE++ ++ NHPN+++ + F
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 82 TTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVK 141
+ L++VM Y GGS ++K E I +L + L+ L YLH +G IHRD+K
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKE-NEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119
Query: 142 AGNILIDS-NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKAD 200
NIL+DS NG +KLADFG+S + T VGTP +MAPEV+ Y K+D
Sbjct: 120 PENILLDSDNGKVKLADFGLSKLLTSDKSL---LKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 201 IWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVK 260
IWS G+ EL K+L+ L K
Sbjct: 177 IWSLGVILYEL------------------------------------PELKDLIRKMLQK 200
Query: 261 DPKKRPTAEKLMKHH 275
DP+KRP+A+++++H
Sbjct: 201 DPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 216 bits (552), Expect = 3e-65
Identities = 107/267 (40%), Positives = 157/267 (58%), Gaps = 11/267 (4%)
Query: 21 EVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCS 80
E+G+G VY+A A K++ +E +L+ E+ + HPN++ + +
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 81 FTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDV 140
+ + LW+++ + GG+ IM G EP I + R+ L+AL +LH H IHRD+
Sbjct: 71 YFYENKLWILIEFCDGGALDSIM-LELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDL 129
Query: 141 KAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQ----QLHGYD 196
KAGNIL+ +G +KLADFGVSA + Q+ R+TF+GTP WMAPEV+ + + YD
Sbjct: 130 KAGNILLTLDGDVKLADFGVSA--KNKSTLQK-RDTFIGTPYWMAPEVVACETFKDNPYD 186
Query: 197 FKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTA 256
+KADIWS GIT +ELA P + PM+VLL L++ PP LD + ++S SF + + +
Sbjct: 187 YKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLD--QPSKWSSSFNDFLKS 244
Query: 257 CLVKDPKKRPTAEKLMKHHFFKHARSN 283
CLVKDP RPTA +L+KH F N
Sbjct: 245 CLVKDPDDRPTAAELLKHPFVSDQSDN 271
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 204 bits (521), Expect = 5e-61
Identities = 99/265 (37%), Positives = 148/265 (55%), Gaps = 19/265 (7%)
Query: 23 GEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDG---IRREVQTMRVTNHPNVLRAHC 79
G+G S VY+ P +I A+K + + D + + RE++T+R P V++ +
Sbjct: 10 GQGSSGVVYKVRHKPTGKIYALKKI---HVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 80 SFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGH-IHR 138
+F + +V+ YM GGS ++K EPV+A + R+ LK L YLH H IHR
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHR 124
Query: 139 DVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFK 198
D+K N+LI+S G +K+ADFG+S + + D+ NTFVGT +M+PE +Q Y +
Sbjct: 125 DIKPSNLLINSKGEVKIADFGISKVLENTLDQ---CNTFVGTVTYMSPERIQGES-YSYA 180
Query: 199 ADIWSFGITALELAHGHAPFSK---YPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVT 255
ADIWS G+T LE A G PF +++ PP L + FS F++ ++
Sbjct: 181 ADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLP---AEEFSPEFRDFIS 237
Query: 256 ACLVKDPKKRPTAEKLMKHHFFKHA 280
ACL KDPKKRP+A +L++H F K A
Sbjct: 238 ACLQKDPKKRPSAAELLQHPFIKKA 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 2e-57
Identities = 101/283 (35%), Positives = 145/283 (51%), Gaps = 24/283 (8%)
Query: 8 RFPVDAKDYRL----YEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRRE- 62
+ VD D R + ++GEG + V A VA+K +DL K RRE
Sbjct: 9 QLVVDPGDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ------RREL 62
Query: 63 ----VQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIAT 118
V MR HPN++ + S+ G LWVVM ++ GG+ I+ E IAT
Sbjct: 63 LFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAT 119
Query: 119 LLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFV 178
+ LKAL +LH G IHRD+K+ +IL+ S+G +KL+DFG A + R++S V
Sbjct: 120 VCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS---LV 176
Query: 179 GTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL 238
GTP WMAPEV+ +L Y + DIWS GI +E+ G P+ PP++ + N PP L
Sbjct: 177 GTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKL 235
Query: 239 DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281
+ + S + + LV+DP +R TA +L+ H F A
Sbjct: 236 --KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 192 bits (489), Expect = 2e-56
Identities = 112/268 (41%), Positives = 154/268 (57%), Gaps = 14/268 (5%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN 73
+D+ L + +G G VY+A + E+ AIKV+ LE D +++E+ M+ H N
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSN 67
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH 133
++ S+ LW+ M + GGS I P E IA + RETL+ L YLH
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP--LSESQIAYVSRETLQGLYYLHSK 125
Query: 134 GHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEV--MQQ 191
G +HRD+K NIL+ NG +KLADFGVSA + +++S F+GTP WMAPEV +++
Sbjct: 126 GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS---FIGTPYWMAPEVAAVER 182
Query: 192 LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVL-LMTLQN-APPGLDYERDK-RFSK 248
GY+ DIW+ GITA+ELA P PM+ L LMT N PP L +DK ++S
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKL---KDKMKWSN 239
Query: 249 SFKELVTACLVKDPKKRPTAEKLMKHHF 276
SF V L K+PKKRPTAEKL++H F
Sbjct: 240 SFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 191 bits (488), Expect = 3e-56
Identities = 98/275 (35%), Positives = 142/275 (51%), Gaps = 16/275 (5%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN 73
D E+G G S V + L P +I+A+K + LE I RE+ + N P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLH-F 132
++ + +F + + M YM GGS I+K E ++ + LK L YLH
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEK 119
Query: 133 HGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQL 192
H IHRDVK NIL++S G IKL DFGVS + ++ TFVGT +MAPE +Q
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS-----LAKTFVGTSSYMAPERIQGN 174
Query: 193 HGYDFKADIWSFGITALELAHGHAPFSK--YPPMKVL-LMT--LQNAPPGLDYERDKRFS 247
Y K+DIWS G++ +ELA G P+ PP + L+ + PP L +FS
Sbjct: 175 D-YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLP---SGKFS 230
Query: 248 KSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282
F++ V CL+KDP++RP+ ++L++H F K S
Sbjct: 231 PDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYES 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 2e-55
Identities = 106/288 (36%), Positives = 144/288 (50%), Gaps = 29/288 (10%)
Query: 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDL--EKCNNDLDGIRREV 63
EK F D R E+G G VY A + NE+VAIK + ++ N I +EV
Sbjct: 14 EKLF----TDLR---EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEV 66
Query: 64 QTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSC--LHIMKSAYPEGFEEPVIATLLR 121
+ ++ HPN + + H W+VM Y G + L + K + +E IA +
Sbjct: 67 RFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHK----KPLQEVEIAAICH 122
Query: 122 ETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTP 181
L+ L YLH H IHRD+KAGNIL+ G +KLADFG ++ + A N+FVGTP
Sbjct: 123 GALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-------NSFVGTP 175
Query: 182 CWMAPEV---MQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL 238
WMAPEV M + YD K D+WS GIT +ELA P M L QN P L
Sbjct: 176 YWMAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL 234
Query: 239 DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFL 286
+S F+ V +CL K P+ RP++E+L+KH F R +
Sbjct: 235 ---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVI 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 190 bits (483), Expect = 3e-55
Identities = 101/268 (37%), Positives = 155/268 (57%), Gaps = 10/268 (3%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN 73
K Y +E++G+G S TVY A+ + + VAIK ++L++ + I E+ MR HPN
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPN 77
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH 133
++ S+ G LWVVM Y+AGGS ++ +E IA + RE L+AL +LH +
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSN 134
Query: 134 GHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLH 193
IHRD+K+ NIL+ +G++KL DFG A + Q R+T VGTP WMAPEV+ +
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAPEVVTR-K 190
Query: 194 GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL 253
Y K DIWS GI A+E+ G P+ P++ L + N P + + ++ S F++
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP--ELQNPEKLSAIFRDF 248
Query: 254 VTACLVKDPKKRPTAEKLMKHHFFKHAR 281
+ CL D +KR +A++L++H F K A+
Sbjct: 249 LNRCLEMDVEKRGSAKELLQHPFLKIAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 188 bits (478), Expect = 7e-55
Identities = 111/277 (40%), Positives = 158/277 (57%), Gaps = 16/277 (5%)
Query: 5 VEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQ 64
+ +R P DY L + VG G VY+A + E+ A+K++ LE +D I++E+
Sbjct: 2 ILRRNP--QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQEIF 58
Query: 65 TMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETL 124
++ H N++ S+ + LW+ M Y GGS I P E IA + RETL
Sbjct: 59 MVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGP--LSELQIAYVCRETL 116
Query: 125 KALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWM 184
+ L YLH G +HRD+K NIL+ NG +KLADFGV+A + +++S F+GTP WM
Sbjct: 117 QGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS---FIGTPYWM 173
Query: 185 APEV--MQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVL-LMTLQN-APPGLDY 240
APEV +++ GY+ DIW+ GITA+ELA P PM+ L LM+ N PP L
Sbjct: 174 APEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKL-- 231
Query: 241 ERDK-RFSKSFKELVTACLVKDPKKRPTAEKLMKHHF 276
+DK ++S +F V L K+PKKRPTAE+L+ H F
Sbjct: 232 -KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 187 bits (475), Expect = 2e-54
Identities = 103/273 (37%), Positives = 156/273 (57%), Gaps = 21/273 (7%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMR-VTNHPNV 74
+ L E VG G VY+ + ++ AIKV+D+ + ++ + I+ E+ ++ ++H N+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNI 75
Query: 75 LRAHCSFTT----GH--CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALV 128
+ +F GH LW+VM + GS ++K+ +E IA + RE L+ L
Sbjct: 76 ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA 135
Query: 129 YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS-RNTFVGTPCWMAPE 187
+LH H IHRD+K N+L+ N +KL DFGVSA + DR RNTF+GTP WMAPE
Sbjct: 136 HLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL----DRTVGRRNTFIGTPYWMAPE 191
Query: 188 VMQQLHG----YDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 243
V+ YD+++DIWS GITA+E+A G P PM+ L + +N PP L +
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL---KS 248
Query: 244 KRFSKSFKELVTACLVKDPKKRPTAEKLMKHHF 276
K++SK F + + CLVK+ RP+ E+L+KH F
Sbjct: 249 KKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF 281
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 1e-53
Identities = 104/314 (33%), Positives = 157/314 (50%), Gaps = 50/314 (15%)
Query: 18 LYEEVGEGVS--ATVYRALCIPLNEIVAIKVLDLEKCNND-LDGIRREVQTMRVTNHPNV 74
L E+G G +VY A P +V +++ DLE C + L ++ EV HPN+
Sbjct: 2 LQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNI 61
Query: 75 LRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHG 134
+ + FTTG LWV+ P+MA GS ++K+ +PEG E +I +L L+ L YLH +G
Sbjct: 62 MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG 121
Query: 135 HIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTF----VGTPCWMAPEVMQ 190
+IHR++KA +ILI +G + L+ + G + + F W++PE+++
Sbjct: 122 YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLR 181
Query: 191 Q-LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTL------------------ 231
Q L+GY+ K+DI+S GITA ELA G PF ++LL L
Sbjct: 182 QDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241
Query: 232 --QNAPPGLD-----------------YER-----DKRFSKSFKELVTACLVKDPKKRPT 267
+N+ G+D ER K FS +F+ LV CL +DP+KRP+
Sbjct: 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPS 301
Query: 268 AEKLMKHHFFKHAR 281
A L+ H FFK +
Sbjct: 302 ASSLLSHAFFKQVK 315
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 182 bits (462), Expect = 1e-52
Identities = 102/272 (37%), Positives = 155/272 (56%), Gaps = 19/272 (6%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMR-VTNHPNV 74
+ L E VG G VY+ + ++ AIKV+D+ ++ + I++E+ ++ ++H N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHHRNI 65
Query: 75 LRAHCSFTTGHC------LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALV 128
+ +F + LW+VM + GS ++K+ +E IA + RE L+ L
Sbjct: 66 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125
Query: 129 YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEV 188
+LH H IHRD+K N+L+ N +KL DFGVSA + R RNTF+GTP WMAPEV
Sbjct: 126 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR---RNTFIGTPYWMAPEV 182
Query: 189 MQQLHG----YDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244
+ YDFK+D+WS GITA+E+A G P PM+ L + +N P L + K
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL---KSK 239
Query: 245 RFSKSFKELVTACLVKDPKKRPTAEKLMKHHF 276
++SK F+ + +CLVK+ +RPT E+LMKH F
Sbjct: 240 KWSKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 181 bits (460), Expect = 4e-52
Identities = 107/286 (37%), Positives = 156/286 (54%), Gaps = 21/286 (7%)
Query: 4 VVEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDG-IRRE 62
++ FP + + + E +G+G V++ L A+K+LD +D+D I E
Sbjct: 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAE 64
Query: 63 VQTMR-VTNHPNVLRAHCSF-----TTGHCLWVVMPYMAGGSCLHIMKSAYPEG--FEEP 114
++ +++HPNV++ + + G LW+V+ GGS ++K G EEP
Sbjct: 65 YNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEP 124
Query: 115 VIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSR 174
+IA +L E L L +LH + IHRDVK NIL+ + G +KL DFGVSA + R R
Sbjct: 125 IIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR---R 181
Query: 175 NTFVGTPCWMAPEVM---QQLHG-YDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMT 230
NT VGTP WMAPEV+ QQL YD + D+WS GITA+EL G P + PM+ L
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI 241
Query: 231 LQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHF 276
+N PP L + + +S F + + CL KD +KRPT L++H F
Sbjct: 242 PRNPPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 1e-51
Identities = 81/266 (30%), Positives = 133/266 (50%), Gaps = 11/266 (4%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPN 73
Y + +++G+G VY ++ +K +DL + + + EV+ ++ NHPN
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEG--FEEPVIATLLRETLKALVYLH 131
+++ + SF L +VM Y GG +K EG F E I + AL YLH
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 132 FHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQ 191
+HRD+K NI + SNG +KL DFG+S + D T VGTP +++PE+ Q
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD---LAKTVVGTPYYLSPELCQN 177
Query: 192 LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251
Y++K+DIWS G EL PF +++ L L+ P + ++S +
Sbjct: 178 K-PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPS----QYSSELR 232
Query: 252 ELVTACLVKDPKKRPTAEKLMKHHFF 277
LV++ L KDP++RP+ ++++ F
Sbjct: 233 NLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 179 bits (454), Expect = 3e-51
Identities = 109/296 (36%), Positives = 164/296 (55%), Gaps = 23/296 (7%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN 73
K Y +E++G+G S TVY A+ I + VAIK ++L++ + I E+ MR +PN
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKNPN 77
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH 133
++ S+ G LWVVM Y+AGGS ++ +E IA + RE L+AL +LH +
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALDFLHSN 134
Query: 134 GHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLH 193
IHRD+K+ NIL+ +G++KL DFG A Q R+T VGTP WMAPEV+ +
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCA---QITPEQSKRSTMVGTPYWMAPEVVTR-K 190
Query: 194 GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL 253
Y K DIWS GI A+E+ G P+ P++ L + N P L + +R S F++
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL--QNPERLSAVFRDF 248
Query: 254 VTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGERFRMLKAKEA 309
+ CL D +R +A++L++H F K A+ + +L PL ++ AKEA
Sbjct: 249 LNRCLEMDVDRRGSAKELLQHPFLKLAKP--------LSSLTPL-----IIAAKEA 291
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 176 bits (447), Expect = 1e-50
Identities = 87/265 (32%), Positives = 135/265 (50%), Gaps = 21/265 (7%)
Query: 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDG------IRREVQTMRVTNHPN 73
E +G G +VY L + + A+K + L ++ G + +E+ + HPN
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLA--DDGQTGQEAVKQLEQEIALLSKLQHPN 63
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH 133
+++ + L++ + + GGS ++K F EPVI R+ L L YLH
Sbjct: 64 IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGS--FPEPVIRLYTRQILLGLEYLHDR 121
Query: 134 GHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLH 193
+HRD+K NIL+D+NG +KLADFG++ + + +F G+P WMAPEV+ Q
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE----FSFAKSFKGSPYWMAPEVIAQQG 177
Query: 194 GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLM--TLQNAPPGLDYERDKRFSKSFK 251
GY ADIWS G T LE+A G P+S+ + + + PP D+ S K
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDH-----LSDEAK 232
Query: 252 ELVTACLVKDPKKRPTAEKLMKHHF 276
+ + CL +DP RPTA +L++H F
Sbjct: 233 DFILKCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 176 bits (447), Expect = 3e-50
Identities = 100/267 (37%), Positives = 150/267 (56%), Gaps = 11/267 (4%)
Query: 21 EVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCS 80
E+G+G VY+A + A KV++ K +L+ E++ + NHP +++ +
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIE-TKSEEELEDYMVEIEILATCNHPYIVKLLGA 77
Query: 81 FTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDV 140
F LW+++ + GG+ IM G EP I + R+ L+AL YLH IHRD+
Sbjct: 78 FYWDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDL 136
Query: 141 KAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVM----QQLHGYD 196
KAGN+L+ +G IKLADFGVSA R R++F+GTP WMAPEV+ + YD
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQR---RDSFIGTPYWMAPEVVMCETMKDTPYD 193
Query: 197 FKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTA 256
+KADIWS GIT +E+A P + PM+VLL ++ PP L + ++S F++ +
Sbjct: 194 YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLS--QPSKWSMEFRDFLKT 251
Query: 257 CLVKDPKKRPTAEKLMKHHFFKHARSN 283
L K P+ RP+A +L++H F SN
Sbjct: 252 ALDKHPETRPSAAQLLEHPFVSSVTSN 278
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 174 bits (442), Expect = 2e-49
Identities = 100/276 (36%), Positives = 148/276 (53%), Gaps = 21/276 (7%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDG-IRREVQTMR-VTNHPN 73
+ + E +G+G VY+ + A+K+LD D+D I E ++ + NHPN
Sbjct: 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPN 80
Query: 74 VLRAHCSF-----TTGHCLWVVMPYMAGGSCLHIMKSAYPEG--FEEPVIATLLRETLKA 126
V++ + F G LW+V+ GGS ++K G +E +I+ +L L
Sbjct: 81 VVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLG 140
Query: 127 LVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAP 186
L +LH + IHRDVK NIL+ + G +KL DFGVSA + R RNT VGTP WMAP
Sbjct: 141 LQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR---RNTSVGTPFWMAP 197
Query: 187 EVM----QQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER 242
EV+ Q + YD + D+WS GITA+EL G P P+K L +N PP L +
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHP- 256
Query: 243 DKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278
+++ +SF ++ CL+KD + RP+ L++H F K
Sbjct: 257 -EKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 3e-49
Identities = 108/296 (36%), Positives = 165/296 (55%), Gaps = 23/296 (7%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN 73
K Y YE++G+G S TV+ A+ + + VAIK ++L+K + I E+ M+ +PN
Sbjct: 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPN 77
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH 133
++ SF G L+VVM Y+AGGS ++ +E IA + RE L+AL +LH +
Sbjct: 78 IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC---MDEAQIAAVCRECLQALEFLHAN 134
Query: 134 GHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLH 193
IHRD+K+ N+L+ +G++KL DFG A Q R+T VGTP WMAPEV+ +
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCA---QITPEQSKRSTMVGTPYWMAPEVVTR-K 190
Query: 194 GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL 253
Y K DIWS GI A+E+ G P+ P++ L + N P L + ++ S F++
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL--QNPEKLSPIFRDF 248
Query: 254 VTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGERFRMLKAKEA 309
+ CL D +KR +A++L++H F K A+ + +L PL +L AKEA
Sbjct: 249 LNRCLEMDVEKRGSAKELLQHPFLKLAKP--------LSSLTPL-----ILAAKEA 291
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 3e-49
Identities = 100/268 (37%), Positives = 154/268 (57%), Gaps = 10/268 (3%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN 73
K Y +E++G+G S TVY A+ + + VAI+ ++L++ + I E+ MR +PN
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPN 78
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH 133
++ S+ G LWVVM Y+AGGS ++ +E IA + RE L+AL +LH +
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSN 135
Query: 134 GHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLH 193
IHRD+K+ NIL+ +G++KL DFG A Q R+T VGTP WMAPEV+ +
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCA---QITPEQSKRSTMVGTPYWMAPEVVTR-K 191
Query: 194 GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL 253
Y K DIWS GI A+E+ G P+ P++ L + N P L + ++ S F++
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL--QNPEKLSAIFRDF 249
Query: 254 VTACLVKDPKKRPTAEKLMKHHFFKHAR 281
+ CL D +KR +A++L++H F K A+
Sbjct: 250 LNRCLDMDVEKRGSAKELLQHQFLKIAK 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 1e-48
Identities = 100/260 (38%), Positives = 150/260 (57%), Gaps = 11/260 (4%)
Query: 21 EVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCS 80
E+G+G VY+A + A KV+D K +L+ E+ + +HPN+++ +
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVID-TKSEEELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 81 FTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDV 140
F + LW+++ + AGG+ +M EP I + ++TL+AL YLH + IHRD+
Sbjct: 71 FYYENNLWILIEFCAGGAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHENKIIHRDL 129
Query: 141 KAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVM----QQLHGYD 196
KAGNIL +G IKLADFGVSA + QR R++F+GTP WMAPEV+ + YD
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAK--NTRTIQR-RDSFIGTPYWMAPEVVMCETSKDRPYD 186
Query: 197 FKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTA 256
+KAD+WS GIT +E+A P + PM+VLL ++ PP L + R+S FK+ +
Sbjct: 187 YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL--AQPSRWSSEFKDFLKK 244
Query: 257 CLVKDPKKRPTAEKLMKHHF 276
CL K+ R T +L++H F
Sbjct: 245 CLEKNVDARWTTTQLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 171 bits (434), Expect = 6e-48
Identities = 97/300 (32%), Positives = 150/300 (50%), Gaps = 47/300 (15%)
Query: 29 TVYRALCIPLNEIVAIKVLDLEKCNNDL-DGIRREVQTMRVTNHPNVLRAHCSFTTGHCL 87
TV A P E V ++ ++LE C N++ ++ E+ ++ NHPN++ +F + L
Sbjct: 15 TVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 74
Query: 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILI 147
WVV +MA GS ++ + + +G E IA +L+ LKAL Y+H G++HR VKA +ILI
Sbjct: 75 WVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI 134
Query: 148 DSNGAIKLADFGVSACMFDAGDRQRSRNTF----VGTPCWMAPEVMQQ-LHGYDFKADIW 202
+G + L+ + M + G R R + F V W++PEV+QQ L GYD K+DI+
Sbjct: 135 SVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIY 194
Query: 203 SFGITALELAHGHAPFSKYPPMKVLL--------------------MTLQNAPPGLDY-- 240
S GITA ELA+GH PF P ++LL +T++ + G +
Sbjct: 195 SVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGL 254
Query: 241 -------------------ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281
++ FS F V CL ++P RP+A L+ H FFK +
Sbjct: 255 GESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 1e-47
Identities = 80/261 (30%), Positives = 123/261 (47%), Gaps = 16/261 (6%)
Query: 22 VGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHC 79
+G+G V ++ A+KVL +K +++ E + NHP +++ H
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 80 SFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRD 139
+F T L++V+ Y GG + F E E + AL YLH G I+RD
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRD 118
Query: 140 VKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKA 199
+K NIL+D++G IKL DFG++ + G R NTF GTP ++APEV+ GY
Sbjct: 119 LKPENILLDADGHIKLTDFGLAKELSSEGSR---TNTFCGTPEYLAPEVLLGK-GYGKAV 174
Query: 200 DIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLV 259
D WS G+ E+ G PF ++ L++ + S ++L++ L
Sbjct: 175 DWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD-----PLRFPEFLSPEARDLISGLLQ 229
Query: 260 KDPKKRPT---AEKLMKHHFF 277
KDP KR AE++ H FF
Sbjct: 230 KDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 171 bits (434), Expect = 2e-47
Identities = 102/398 (25%), Positives = 162/398 (40%), Gaps = 33/398 (8%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVL--DLEKCNNDLDGIRREVQTMR-VTNH 71
YR+ ++GEG VY A ++VA+KVL LE + +++ RE+Q + + +
Sbjct: 1 SYRILRKLGEGSFGEVYLAR---DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 72 PNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEG-FEEPVIATLLRETLKALVYL 130
PN+++ + F L++VM Y+ GGS ++K +G E +L + L AL YL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 131 HFHGHIHRDVKAGNILIDSNG-AIKLADFGVSACMFDAGDRQRSR---NTFVGTPCWMAP 186
H G IHRD+K NIL+D +G +KL DFG++ + D G +T VGTP +MAP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 187 EVMQQLHG--YDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQN--------APP 236
EV+ L +DIWS GIT EL G PF TL+
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 237 GLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAP 296
L + SK+ +L+ L KDPK R ++ + H H + + ++
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDS 297
Query: 297 LGERFRMLKAKEADLLVQNKALYEDKEQLSQDYDCMSNAEDPNSSGKQNHADVEVPAERL 356
R + + EA + + + S +
Sbjct: 298 APLRLSLPPSLEALI------------SSLNSLAISGSDLKLDDSNFSKELAPNGVSSSP 345
Query: 357 STESGNHSNATTSQDDGFNNLHDLESSLASFPIKPLQA 394
S + +S+ + S + QA
Sbjct: 346 HNSSSLLLSTASSKRSSLPKISARSSPSSLSSSSRQQA 383
|
Length = 384 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 2e-46
Identities = 99/265 (37%), Positives = 137/265 (51%), Gaps = 16/265 (6%)
Query: 21 EVGEGVSATVYRALCIPLNEIVAIKVLDL--EKCNNDLDGIRREVQTMRVTNHPNVLRAH 78
E+G G VY A + +E+VAIK + ++ N I +EV+ ++ HPN ++
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 79 CSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHR 138
+ H W+VM Y G + + + + +E IA + L+ L YLH H IHR
Sbjct: 82 GCYLREHTAWLVMEYCLGSAS--DLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 139 DVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLH--GYD 196
DVKAGNIL+ G +KL DFG ++ M A N FVGTP WMAPEV+ + YD
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIMAPA-------NXFVGTPYWMAPEVILAMDEGQYD 192
Query: 197 FKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTA 256
K D+WS GIT +ELA P M L QN P L + +S+ F+ V +
Sbjct: 193 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL---QSGHWSEYFRNFVDS 249
Query: 257 CLVKDPKKRPTAEKLMKHHFFKHAR 281
CL K P+ RPT+E L+KH F R
Sbjct: 250 CLQKIPQDRPTSEVLLKHRFVLRER 274
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 4e-46
Identities = 98/276 (35%), Positives = 141/276 (51%), Gaps = 20/276 (7%)
Query: 21 EVGEGVSATVYRALCIPLNEIVAIKVLDL--EKCNNDLDGIRREVQTMRVTNHPNVLRAH 78
E+G G VY A NE+VA+K + ++ N I +EV+ ++ HPN +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 79 CSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHR 138
+ H W+VM Y G + + + + +E IA + L+ L YLH H IHR
Sbjct: 88 GCYLKEHTAWLVMEYCLGSAS--DLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 145
Query: 139 DVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLH--GYD 196
D+KAGNIL+ G +KLADFG ++ A N+FVGTP WMAPEV+ + YD
Sbjct: 146 DIKAGNILLTEPGQVKLADFGSASKSSPA-------NSFVGTPYWMAPEVILAMDEGQYD 198
Query: 197 FKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTA 256
K D+WS GIT +ELA P M L QN P L + ++ SF+ V
Sbjct: 199 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL---QSNEWTDSFRGFVDY 255
Query: 257 CLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVD 292
CL K P++RP + +L++H F + R AR ++D
Sbjct: 256 CLQKIPQERPASAELLRHDFVRRDRP----ARVLID 287
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 2e-45
Identities = 102/274 (37%), Positives = 144/274 (52%), Gaps = 14/274 (5%)
Query: 11 VDAKDYRLYEE----VGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTM 66
VD D R Y + +GEG + V A ++VA+K +DL K + + EV M
Sbjct: 13 VDPGDPRTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIM 71
Query: 67 RVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKA 126
R H NV+ + S+ G LWVVM ++ GG+ I+ E IA + LKA
Sbjct: 72 RDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLKA 128
Query: 127 LVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAP 186
L LH G IHRD+K+ +IL+ +G +KL+DFG A + R R + VGTP WMAP
Sbjct: 129 LSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR---RKSLVGTPYWMAP 185
Query: 187 EVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246
E++ +L Y + DIWS GI +E+ G P+ PP+K + M N PP L + +
Sbjct: 186 ELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKL--KNLHKV 242
Query: 247 SKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280
S S K + LV+DP +R TA +L+KH F A
Sbjct: 243 SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 2e-45
Identities = 87/282 (30%), Positives = 138/282 (48%), Gaps = 20/282 (7%)
Query: 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTM 66
+++P D D E+G G VY+ ++A+K + + I ++ +
Sbjct: 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVV 67
Query: 67 RVTNH-PNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLK 125
++ P +++ + F T +++ M M+ +CL + E ++ + +K
Sbjct: 68 LKSHDCPYIVKCYGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVK 125
Query: 126 ALVYLHF-HGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWM 184
AL YL HG IHRDVK NIL+D++G +KL DFG+S + D+ + RS G +M
Sbjct: 126 ALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS----AGCAAYM 181
Query: 185 APEVM--QQLHG-YDFKADIWSFGITALELAHGHAPFSKYPPMK----VLLMTLQNAPPG 237
APE + + YD +AD+WS GI+ +ELA G P Y K VL LQ PP
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELATGQFP---YKNCKTEFEVLTKILQEEPPS 238
Query: 238 LDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKH 279
L ++ FS F V CL KD +KRP +L++H F +
Sbjct: 239 LPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 5e-45
Identities = 85/266 (31%), Positives = 128/266 (48%), Gaps = 20/266 (7%)
Query: 25 GVSATVYRALCIPLNEIVAIKVLDLEKCN----NDLDGIRREVQTMRVTNHPNVLRAHCS 80
G V+ A +I AIKV+ +K + N +D + E + P V++ + S
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVI--KKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYS 61
Query: 81 FTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDV 140
F L++VM Y+ GG ++++ +E V + E + AL YLH +G IHRD+
Sbjct: 62 FQGKKNLYLVMEYLPGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRDL 119
Query: 141 KAGNILIDSNGAIKLADFGVSA-----CMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGY 195
K NILIDSNG +KL DFG+S + D ++ VGTP ++APEV+ G+
Sbjct: 120 KPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI-LGQGH 178
Query: 196 DFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVT 255
D WS G E G PF P ++ L +++ D S +L++
Sbjct: 179 SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK---IEWPEDVEVSDEAIDLIS 235
Query: 256 ACLVKDPKKRPTA---EKLMKHHFFK 278
LV DP+KR A E++ H FFK
Sbjct: 236 KLLVPDPEKRLGAKSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 162 bits (410), Expect = 1e-44
Identities = 100/270 (37%), Positives = 138/270 (51%), Gaps = 16/270 (5%)
Query: 21 EVGEGVSATVYRALCIPLNEIVAIKVLDL--EKCNNDLDGIRREVQTMRVTNHPNVLRAH 78
E+G G VY A + NE+VAIK + ++ N I +EV+ ++ HPN +
Sbjct: 32 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91
Query: 79 CSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHR 138
+ H W+VM Y G + + + + +E IA + L+ L YLH H IHR
Sbjct: 92 GCYLREHTAWLVMEYCLGSAS--DLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 149
Query: 139 DVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLH--GYD 196
D+KAGNIL+ G +KLADFG ++ A N+FVGTP WMAPEV+ + YD
Sbjct: 150 DIKAGNILLTEPGQVKLADFGSASIASPA-------NSFVGTPYWMAPEVILAMDEGQYD 202
Query: 197 FKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTA 256
K D+WS GIT +ELA P M L QN P L + +S F+ V +
Sbjct: 203 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL---QSNEWSDYFRNFVDS 259
Query: 257 CLVKDPKKRPTAEKLMKHHFFKHARSNDFL 286
CL K P+ RPT+E+L+KH F R L
Sbjct: 260 CLQKIPQDRPTSEELLKHMFVLRERPETVL 289
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 1e-43
Identities = 78/292 (26%), Positives = 130/292 (44%), Gaps = 40/292 (13%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTM-RVTN 70
D++ + +GEG +TV A N+ AIK+LD + + ++ E + + R+
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 71 HPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYL 130
HP +++ + +F L+ V+ Y G L ++ +E E L AL YL
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYL 118
Query: 131 HFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD------------------RQR 172
H G IHRD+K NIL+D + IK+ DFG +A + D +R
Sbjct: 119 HSKGIIHRDLKPENILLDKDMHIKITDFG-TAKVLDPNSSPESNKGDATNIDSQIEKNRR 177
Query: 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPF---SKYPPMKVLLM 229
+FVGT +++PE++ + +D+W+ G ++ G PF ++Y +
Sbjct: 178 RFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFRGSNEY-------L 229
Query: 230 TLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTA----EKLMKHHFF 277
T Q L+Y F K+L+ LV DP+ R ++L H FF
Sbjct: 230 TFQKILK-LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 2e-43
Identities = 84/269 (31%), Positives = 127/269 (47%), Gaps = 19/269 (7%)
Query: 23 GEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDG-IRREVQTMRVTNHPNVLRAHCSF 81
GEG +V + I A+K + N DL I RE++ + P +++ + +F
Sbjct: 10 GEGAGGSVTKCRLKNTGMIFALKTI-TTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 82 TTGH--CLWVVMPYMAGGSCLHIMKSAYPEG--FEEPVIATLLRETLKALVYLHFHGHIH 137
+ + M Y GGS I K G E V+ + LK L YLH IH
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIH 128
Query: 138 RDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDF 197
RD+K NIL+ G +KL DFGVS + ++ TF GT +MAPE +Q Y
Sbjct: 129 RDIKPSNILLTRKGQVKLCDFGVSGELVNSLA-----GTFTGTSFYMAPERIQGKP-YSI 182
Query: 198 KADIWSFGITALELAHGHAPF-----SKYPPMKVLLMTLQNAPPGL--DYERDKRFSKSF 250
+D+WS G+T LE+A PF P+++L + P L + ++S+ F
Sbjct: 183 TSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEF 242
Query: 251 KELVTACLVKDPKKRPTAEKLMKHHFFKH 279
K+ + CL KDP +RPT +++H + K
Sbjct: 243 KDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 4e-43
Identities = 87/282 (30%), Positives = 139/282 (49%), Gaps = 23/282 (8%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN 70
+ +D ++G G +V + IP ++A KV+ + ++ I RE+Q M
Sbjct: 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECR 61
Query: 71 HPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYL 130
P ++ + +F + + + M +M GS I K P ++ + ++ L YL
Sbjct: 62 SPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGP--IPVEILGKIAVAVVEGLTYL 119
Query: 131 HFHGHI-HRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVM 189
+ I HRD+K NIL++S G IKL DFGVS + ++ +TFVGT +M+PE +
Sbjct: 120 YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-----IADTFVGTSTYMSPERI 174
Query: 190 QQLHGYDFKADIWSFGITALELAHGHAPFSKYP--------PMKVLLM---TLQNAPPGL 238
Q Y K+D+WS GI+ +ELA G PF+ PM +L + +Q PP L
Sbjct: 175 QG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRL 233
Query: 239 DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280
F + ++ V ACL+KDP +RPT ++L F A
Sbjct: 234 PSS---DFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 156 bits (395), Expect = 6e-43
Identities = 100/281 (35%), Positives = 150/281 (53%), Gaps = 14/281 (4%)
Query: 1 MDLVVEKRFPVDAKDY-RLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGI 59
+ LVV P D ++Y + ++GEG + V A + VA+K +DL K + +
Sbjct: 11 LQLVVS---PGDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELL 66
Query: 60 RREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATL 119
EV MR +H NV+ + S+ G LWVVM ++ GG+ I+ E IAT+
Sbjct: 67 FNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATV 123
Query: 120 LRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVG 179
L+AL YLH G IHRD+K+ +IL+ S+G IKL+DFG A R + VG
Sbjct: 124 CLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCA---QVSKEVPKRKSLVG 180
Query: 180 TPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD 239
TP WMAPEV+ +L Y + DIWS GI +E+ G P+ PP++ + N PP +
Sbjct: 181 TPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV- 238
Query: 240 YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280
+ + S + + LV++P +R TA++L++H F K A
Sbjct: 239 -KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLA 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 3e-42
Identities = 83/269 (30%), Positives = 137/269 (50%), Gaps = 16/269 (5%)
Query: 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNND---------LDGIRREVQTMRVTN 70
E +G+G VY AL + E++A+K ++L + +R E++T++ +
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 71 HPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYL 130
H N+++ TT L + + Y+ GGS +++ FEE ++ + L+ L YL
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT--YGRFEEQLVRFFTEQVLEGLAYL 124
Query: 131 HFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQ 190
H G +HRD+KA N+L+D++G K++DFG+S D D + G+ WMAPEV+
Sbjct: 125 HSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDND-QNMSMQGSVFWMAPEVIH 183
Query: 191 QLH-GYDFKADIWSFGITALELAHGHAPFSKYPPMKVL--LMTLQNAPPGLDYERDKRFS 247
GY K DIWS G LE+ G P+S + + L ++APP + + S
Sbjct: 184 SYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPP-IPPDVSMNLS 242
Query: 248 KSFKELVTACLVKDPKKRPTAEKLMKHHF 276
+ + AC +P RPTA +L++H F
Sbjct: 243 PVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 6e-42
Identities = 81/261 (31%), Positives = 134/261 (51%), Gaps = 11/261 (4%)
Query: 22 VGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCS 80
+G G VY A+ + E++A+K + ++ + + I E++ + + HPN+++ +
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 81 FTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDV 140
+++ M Y +GG+ +++ +E VI + L+ L YLH HG +HRD+
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEHGRIL--DEHVIRVYTLQLLEGLAYLHSHGIVHRDI 125
Query: 141 KAGNILIDSNGAIKLADFGVSACMFDAGDRQRSR-NTFVGTPCWMAPEVM--QQLHGYDF 197
K NI +D NG IKL DFG + + + + GTP +MAPEV+ + G+
Sbjct: 126 KPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGR 185
Query: 198 KADIWSFGITALELAHGHAPFSKYPPMKVLLMTL--QNAPPGLDYERDKRFSKSFKELVT 255
ADIWS G LE+A G P+S+ ++ + + PP D + K F +
Sbjct: 186 AADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDR-- 243
Query: 256 ACLVKDPKKRPTAEKLMKHHF 276
CL DPKKRPTA +L++H F
Sbjct: 244 -CLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 7e-42
Identities = 79/291 (27%), Positives = 125/291 (42%), Gaps = 38/291 (13%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR----REVQTMRVTNH 71
Y E++GEG VY+A EIVA+K + L+ N+ +GI RE+ ++ H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLD---NEEEGIPSTALREISLLKELKH 57
Query: 72 PNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLH 131
PN+++ T L++V Y L P +I +++ + L+ L Y H
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYCD--MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115
Query: 132 FHGHIHRDVKAGNILIDSNGAIKLADFGVS-ACMFDAGDRQRSRNTFVGTPCWMAPEVMQ 190
H +HRD+K NILI+ +G +KLADFG++ A R + V T + APE++
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP--LRTYTHE--VVTLWYRAPEILL 171
Query: 191 QLHGYDFKADIWSFGITALELAHGHAPF---------------------SKYP---PMKV 226
Y DIWS G E+ G F +P +
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231
Query: 227 LLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277
T PP + R +L++ L +P KR +A++ +KH +F
Sbjct: 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 4e-41
Identities = 88/268 (32%), Positives = 131/268 (48%), Gaps = 15/268 (5%)
Query: 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQ-TMRVTNHPNVLRAH 78
E+G G TV + L P I+A+K + + + ++ MR ++ P +++ +
Sbjct: 10 GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFY 69
Query: 79 -CSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEG---FEEPVIATLLRETLKALVYLHFHG 134
F G C W+ M M S K Y E ++ + T+KAL YL
Sbjct: 70 GALFREGDC-WICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL 127
Query: 135 HI-HRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQ--Q 191
I HRDVK NIL+D NG IKL DFG+S + D+ + R G +MAPE +
Sbjct: 128 KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD----AGCRPYMAPERIDPSA 183
Query: 192 LHGYDFKADIWSFGITALELAHGHAPFSKY-PPMKVLLMTLQNAPPGLDYERDKRFSKSF 250
GYD ++D+WS GIT E+A G P+ K+ L ++ PP L ++ FS SF
Sbjct: 184 RDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSF 243
Query: 251 KELVTACLVKDPKKRPTAEKLMKHHFFK 278
+ CL+KD KRP ++L++H F K
Sbjct: 244 VNFINLCLIKDESKRPKYKELLEHPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 6e-41
Identities = 97/299 (32%), Positives = 152/299 (50%), Gaps = 22/299 (7%)
Query: 8 RFPVDAKDYRLYEE----VGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREV 63
R VD D R E +GEG + V A VA+K++DL K + + EV
Sbjct: 11 RMVVDQGDPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEV 69
Query: 64 QTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRET 123
MR H NV+ + S+ G LWV+M ++ GG+ I+ E IAT+
Sbjct: 70 VIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR---LNEEQIATVCESV 126
Query: 124 LKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCW 183
L+AL YLH G IHRD+K+ +IL+ +G +KL+DFG A + +++S VGTP W
Sbjct: 127 LQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS---LVGTPYW 183
Query: 184 MAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 243
MAPEV+ + Y + DIWS GI +E+ G P+ P++ + + PP L +
Sbjct: 184 MAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL--KNA 240
Query: 244 KRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGERFR 302
+ S ++ + L ++P++R TA++L+ H F L + + L PL +++R
Sbjct: 241 HKISPVLRDFLERMLTREPQERATAQELLDHPF--------LLQTGLPECLVPLIQQYR 291
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 2e-39
Identities = 80/265 (30%), Positives = 131/265 (49%), Gaps = 14/265 (5%)
Query: 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNND-----LDGIRREVQTMRVTNHPNV 74
E +G+G TVY L +++A+K ++L+ N + ++ EV ++ H N+
Sbjct: 6 EVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 75 LRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHG 134
++ + + + + M ++ GGS I+ P EPV ++ L + YLH +
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGP--LPEPVFCKYTKQILDGVAYLHNNC 122
Query: 135 HIHRDVKAGNILIDSNGAIKLADFGVSA--CMFDA-GDRQRSRNTFVGTPCWMAPEVMQQ 191
+HRD+K N+++ NG IKL DFG + G + GTP WMAPEV+ +
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182
Query: 192 LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251
GY K+DIWS G T E+A G P + + + A GL FS +
Sbjct: 183 -SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI--GAHRGLMPRLPDSFSAAAI 239
Query: 252 ELVTACLVKDPKKRPTAEKLMKHHF 276
+ VT+CL +D +RP+A +L++H F
Sbjct: 240 DFVTSCLTRDQHERPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 79/273 (28%), Positives = 125/273 (45%), Gaps = 20/273 (7%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-DLDGIRREVQTMRVTNHPN 73
DY + E +G+G TV + +I+ K +D + + EV +R HPN
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN 60
Query: 74 VLRAHCSF--TTGHCLWVVMPYMAGGSCLHIMKSAYPEG--FEEPVIATLLRETLKALVY 129
++R + + L++VM Y GG +++ E EE I +L + L AL
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 130 LHFHGH-----IHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWM 184
H +HRD+K NI +D+N +KL DFG++ + G T+VGTP +M
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL---GHDSSFAKTYVGTPYYM 177
Query: 185 APEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP-PGLDYERD 243
+PE + YD K+DIWS G EL PF+ L ++ + Y
Sbjct: 178 SPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTAR-NQLQLASKIKEGKFRRIPY--- 232
Query: 244 KRFSKSFKELVTACLVKDPKKRPTAEKLMKHHF 276
R+S E++ + L DP KRP+ E+L++
Sbjct: 233 -RYSSELNEVIKSMLNVDPDKRPSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 93/302 (30%), Positives = 139/302 (46%), Gaps = 46/302 (15%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNV 74
D+ E+G G V + L P I+A K++ LE + I RE++ + N P +
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYI 61
Query: 75 LRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLH-FH 133
+ + +F + + + M +M GGS ++K A E ++ + L+ L YL H
Sbjct: 62 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKH 119
Query: 134 GHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLH 193
+HRDVK NIL++S G IKL DFGVS + D+ N+FVGT +M+PE +Q H
Sbjct: 120 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH 174
Query: 194 GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG---------------- 237
Y ++DIWS G++ +E+A G P PP L + P
Sbjct: 175 -YTVQSDIWSLGLSLVEMAIGRYPIP--PPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231
Query: 238 -----------LDY--------ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278
LDY FS F++ V CL K+PK+R ++L KH F K
Sbjct: 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291
Query: 279 HA 280
A
Sbjct: 292 RA 293
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 72/269 (26%), Positives = 118/269 (43%), Gaps = 30/269 (11%)
Query: 17 RLYEEVGEGVSATVYRALCIPLNE----IVAIKVLDLEKCNNDLDGIRREVQTMRVTNHP 72
L +++GEG VY+ E VA+K L + + E M+ +HP
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61
Query: 73 NVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF 132
N++R T G L++V YM GG L ++ + E + + + K + YL
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQIAKGMEYLES 120
Query: 133 HGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTP-CWMAPEVMQQ 191
+HRD+ A N L+ N +K++DFG+S +++ ++ + P WMAPE ++
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKL--PIKWMAPESLKD 178
Query: 192 LHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVL--------LMTLQNAPPGLDYER 242
+ K+D+WSFG+ E+ G P+ +VL L +N P L
Sbjct: 179 GK-FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDEL---- 233
Query: 243 DKRFSKSFKELVTACLVKDPKKRPTAEKL 271
EL+ C DP+ RPT +L
Sbjct: 234 --------YELMLQCWAYDPEDRPTFSEL 254
|
Length = 258 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 3e-38
Identities = 79/275 (28%), Positives = 133/275 (48%), Gaps = 26/275 (9%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLN--EIVAIKVLDLEKCN----NDLDGIRREVQTMRV 68
++R + +G+G VY LC ++ +A+K + + + +++ + E+Q ++
Sbjct: 3 NWRRGKLLGQGAFGRVY--LCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKN 60
Query: 69 TNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALV 128
H +++ + L + M YM GGS +K+ E V R+ L+ +
Sbjct: 61 LQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA--LTETVTRKYTRQILEGVE 118
Query: 129 YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSA-----CMFDAGDRQRSRNTFVGTPCW 183
YLH + +HRD+K NIL DS G +KL DFG S C G + + GTP W
Sbjct: 119 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMK-----SVTGTPYW 173
Query: 184 MAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLL-MTLQNAPPGLDYER 242
M+PEV+ GY KAD+WS G T +E+ P++++ M + + Q P L
Sbjct: 174 MSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSH- 231
Query: 243 DKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277
S + + V++ KKRP+AE+L++H F
Sbjct: 232 ---VSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 79/294 (26%), Positives = 125/294 (42%), Gaps = 41/294 (13%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNH 71
D+ + +G G V + A+K+L K ++ + E + ++ H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 72 PNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEG-FEEPVIATLLRETLKALVYL 130
P ++ + SF L++VM Y+ GG ++ + G F EPV + + AL YL
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYL 117
Query: 131 HFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRN-TFVGTPCWMAPEVM 189
H ++RD+K N+L+DS+G IK+ DFG F R + R T GTP ++APE++
Sbjct: 118 HSLDIVYRDLKPENLLLDSDGYIKITDFG-----FAK--RVKGRTYTLCGTPEYLAPEII 170
Query: 190 QQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER----DKR 245
GY D W+ GI E+ G+ PF P+++ YE+ R
Sbjct: 171 -LSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI-------------YEKILEGKVR 216
Query: 246 FSKSF----KELVTACLVKDPKKR-----PTAEKLMKHHFFKHARSNDFLARSI 290
F F K+L+ L D KR + H +F L R I
Sbjct: 217 FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKI 270
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 5e-37
Identities = 83/279 (29%), Positives = 131/279 (46%), Gaps = 27/279 (9%)
Query: 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHC 79
+E+G+G +VY+ L P +A+K + LE + + I E+ + P ++ +
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 80 SFTTGHCLWVVMPYMAGGSCLHIM-KSAYPEGFEEPVIATLLRETLKALVYL-HFHGHIH 137
+F +++ M YM GS + EG E V+ + +K L +L H IH
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIH 126
Query: 138 RDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS-RNTFVGTPCWMAPE-----VMQQ 191
RDVK N+L++ NG +KL DFGVS G+ S T +G +MAPE Q
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVS------GNLVASLAKTNIGCQSYMAPERIKSGGPNQ 180
Query: 192 LHGYDFKADIWSFGITALELAHGHAPFSKYPP------MKVLLMTLQNAPPGLDYERDKR 245
Y ++D+WS G++ LE+A G P YPP L + PP L
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYP---YPPETYANIFAQLSAIVDGDPPTLPSG---- 233
Query: 246 FSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSND 284
+S ++ V CL K P +RPT +L++H + ++ D
Sbjct: 234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNAD 272
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 6e-37
Identities = 85/267 (31%), Positives = 134/267 (50%), Gaps = 20/267 (7%)
Query: 22 VGEGVSATVYRALCIPLNEIVAIKVLDLEKCNND--------LDGIRREVQTMRVTNHPN 73
+G G +VY + E++A+K ++L + LD + RE+ ++ H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 74 VLR-AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF 132
+++ S H L + + Y+ GGS + + + Y FEE ++ +R+ LK L YLH
Sbjct: 68 IVQYLGSSLDADH-LNIFLEYVPGGS-VAALLNNY-GAFEETLVRNFVRQILKGLNYLHN 124
Query: 133 HGHIHRDVKAGNILIDSNGAIKLADFGVSACM---FDAGDRQRSRNTFVGTPCWMAPEVM 189
G IHRD+K NIL+D+ G IK++DFG+S + + +R + G+ WMAPEV+
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVV 184
Query: 190 QQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249
+Q Y KADIWS G +E+ G PF ++ + +NA P E S
Sbjct: 185 KQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASP----EIPSNISSE 239
Query: 250 FKELVTACLVKDPKKRPTAEKLMKHHF 276
+ + D KRPTA +L+KH F
Sbjct: 240 AIDFLEKTFEIDHNKRPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 2e-36
Identities = 73/267 (27%), Positives = 132/267 (49%), Gaps = 25/267 (9%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVA---IKVLDLEKCNNDLDGIRREVQTMRVTNH 71
++++ +++G+G + VY+A+C+ +VA +++ ++ D ++ E+ ++ +H
Sbjct: 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQLDH 61
Query: 72 PNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEG--FEEPVIATLLRETLKALVY 129
PNV++ SF + L +V+ G ++K + E I + AL +
Sbjct: 62 PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121
Query: 130 LHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNT-----FVGTPCWM 184
+H +HRD+K N+ I + G +KL D G+ R S T VGTP +M
Sbjct: 122 MHSKRIMHRDIKPANVFITATGVVKLGDLGLG--------RFFSSKTTAAHSLVGTPYYM 173
Query: 185 APEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYE--R 242
+PE + + +GY+FK+DIWS G E+A +PF K+ L +L DY
Sbjct: 174 SPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYG---DKMNLYSLCKKIEKCDYPPLP 229
Query: 243 DKRFSKSFKELVTACLVKDPKKRPTAE 269
+S+ ++LV+ C+ DP+KRP
Sbjct: 230 ADHYSEELRDLVSRCINPDPEKRPDIS 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 5e-36
Identities = 87/280 (31%), Positives = 139/280 (49%), Gaps = 28/280 (10%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN 73
+D + E +G G TVY+A + I+A+KV+ L+ I E++ + + P
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPY 60
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH 133
++ + +F + + + +M GGS L + + E V+ + +K L YL
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGS-LDVYRK-----IPEHVLGRIAVAVVKGLTYLWSL 114
Query: 134 GHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLH 193
+HRDVK N+L+++ G +KL DFGVS + ++ T+VGT +MAPE ++
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-----IAKTYVGTNAYMAPE---RIS 166
Query: 194 G--YDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQ-------NAPPGLDYERDK 244
G Y +D+WS GI+ +ELA G P+ + + LM LQ PP L
Sbjct: 167 GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLP---VG 223
Query: 245 RFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSND 284
+FS+ F +T C+ K PK+RP E LM H F + ND
Sbjct: 224 QFSEKFVHFITQCMRKQPKERPAPENLMDHPFIV--QYND 261
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 9e-36
Identities = 94/300 (31%), Positives = 142/300 (47%), Gaps = 46/300 (15%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVL-------DLEKCNNDLDGIRREVQTMR 67
D + EE+G G V + +P I+A+K + + ++ DLD +MR
Sbjct: 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLD------ISMR 55
Query: 68 VTNHPNVLRAHCS-FTTGHCLWVVMPYMAGGSCL-HIMKSAYPEG--FEEPVIATLLRET 123
+ P + + + F G +W+ M M + L K Y +G E ++ +
Sbjct: 56 SVDCPYTVTFYGALFREGD-VWICMEVMD--TSLDKFYKKVYDKGLTIPEDILGKIAVSI 112
Query: 124 LKALVYLHFHGH-IHRDVKAGNILIDSNGAIKLADFGVS-------ACMFDAGDRQRSRN 175
+KAL YLH IHRDVK N+LI+ NG +KL DFG+S A DAG +
Sbjct: 113 VKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKP---- 168
Query: 176 TFVGTPCWMAPEVM---QQLHGYDFKADIWSFGITALELAHGHAPFSKY-PPMKVLLMTL 231
+MAPE + GYD K+D+WS GIT +ELA G P+ + P + L +
Sbjct: 169 -------YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV 221
Query: 232 QNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIV 291
+ P L E +FS F++ V CL K+ K+RP +L++H FF+ S + S V
Sbjct: 222 EEPSPQLPAE---KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTDVASFV 278
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 83/305 (27%), Positives = 125/305 (40%), Gaps = 65/305 (21%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEK-----CNNDLDGIRREVQTMRVTN 70
Y+ ++GEG VY+A EIVAIK + L L RE++ ++ N
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTAL----REIKLLKELN 56
Query: 71 HPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYL 130
HPN+++ F L++V +M ++K G E +I + L + L+ L +
Sbjct: 57 HPNIIKLLDVFRHKGDLYLVFEFMDTDLY-KLIK-DRQRGLPESLIKSYLYQLLQGLAFC 114
Query: 131 HFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQ 190
H HG +HRD+K N+LI++ G +KLADFG++ G R +V T + APE++
Sbjct: 115 HSHGILHRDLKPENLLINTEGVLKLADFGLAR---SFGSPVRPYTHYVVTRWYRAPELLL 171
Query: 191 QLHGYDFKADIWSFGITALELAHG--------------------------HAP------- 217
GY DIWS G EL P
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231
Query: 218 -----FSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLM 272
F K M + + +P LD L++ L DP KR TAE+ +
Sbjct: 232 NYKFSFPKKAGMPLPKLFPNASPQALD-------------LLSQMLHYDPHKRITAEQAL 278
Query: 273 KHHFF 277
H +F
Sbjct: 279 AHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 88/268 (32%), Positives = 136/268 (50%), Gaps = 32/268 (11%)
Query: 22 VGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR----REVQTMRVTNHPNVLRA 77
+G G TVY+ + P + A+KV+ N D +R RE++ +R NHPNV++
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVI----YGNHEDTVRRQICREIEILRDVNHPNVVKC 137
Query: 78 HCSFTTGHCLWVVMPYMAGGSC--LHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGH 135
H F + V++ +M GGS HI E +A + R+ L + YLH
Sbjct: 138 HDMFDHNGEIQVLLEFMDGGSLEGTHIAD--------EQFLADVARQILSGIAYLHRRHI 189
Query: 136 IHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQ--LH 193
+HRD+K N+LI+S +K+ADFGVS + D N+ VGT +M+PE + H
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD---PCNSSVGTIAYMSPERINTDLNH 246
Query: 194 G-YD-FKADIWSFGITALELAHGHAPF--SKYPPMKVLLMTL-QNAPPGLDYERDKRFSK 248
G YD + DIWS G++ LE G PF + L+ + + PP E S+
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPP----EAPATASR 302
Query: 249 SFKELVTACLVKDPKKRPTAEKLMKHHF 276
F+ ++ CL ++P KR +A +L++H F
Sbjct: 303 EFRHFISCCLQREPAKRWSAMQLLQHPF 330
|
Length = 353 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 82/309 (26%), Positives = 134/309 (43%), Gaps = 73/309 (23%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVL-----DLEKCNNDLDGIRREVQTMR-VT 69
Y++ +++G+G +VY A E+VAIK + E+C N REV+++R +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-----LREVKSLRKLN 55
Query: 70 NHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVY 129
HPN+++ F L+ V YM G + +MK + F E VI +++ + L+ L +
Sbjct: 56 EHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 130 LHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ-RSRNTF---VGTPCWMA 185
+H HG HRD+K N+L+ +K+ADFG++ R+ RSR + V T + A
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLA--------REIRSRPPYTDYVSTRWYRA 166
Query: 186 PEVMQQLHGYDFKADIWSFGITALELAHGHAPFS-------------------------- 219
PE++ + Y DIW+ G EL F
Sbjct: 167 PEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEG 226
Query: 220 ---------KYPPMKVLLMT--LQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTA 268
++P + + NA P +L+ L DPKKRPTA
Sbjct: 227 YKLASKLGFRFPQFAPTSLHQLIPNASPEA------------IDLIKDMLRWDPKKRPTA 274
Query: 269 EKLMKHHFF 277
+ ++H +F
Sbjct: 275 SQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 1e-34
Identities = 75/268 (27%), Positives = 123/268 (45%), Gaps = 24/268 (8%)
Query: 17 RLYEEVGEGVSATVYRALCIPLN----EIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHP 72
L +++GEG VY+ VA+K L + ++ RE + MR +HP
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 73 NVLRAH--CSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETL---KAL 127
N+++ C T L +VM YM GG L ++ P+ ++ LL L + +
Sbjct: 62 NIVKLLGVC--TEEEPLMIVMEYMPGGDLLDYLRKNRPKELS---LSDLLSFALQIARGM 116
Query: 128 VYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-WMAP 186
YL IHRD+ A N L+ N +K++DFG+S D + + + P WMAP
Sbjct: 117 EYLESKNFIHRDLAARNCLVGENLVVKISDFGLS-RDLYDDDYYKVKGGKL--PIRWMAP 173
Query: 187 EVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245
E +++ + K+D+WSFG+ E+ G P YP M + L+ G +
Sbjct: 174 ESLKEGK-FTSKSDVWSFGVLLWEIFTLGEEP---YPGMSNAEV-LEYLKKGYRLPKPPN 228
Query: 246 FSKSFKELVTACLVKDPKKRPTAEKLMK 273
+L+ C +DP+ RPT +L++
Sbjct: 229 CPPELYKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 74/278 (26%), Positives = 128/278 (46%), Gaps = 43/278 (15%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNND--LDGIRREVQTMRVTNHP 72
D+++ +++G+G +VY+ + N+ A+K +DL + D + E++ + NHP
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-EIRILASVNHP 59
Query: 73 NVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEG--FEEPVIATLLRETLKALVYL 130
N++ +F G+ L +VM Y G + + E I + + L+ L L
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 131 HFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQ 190
H +HRD+K+ NIL+ +N +K+ D G+S + ++ T +GTP +MAPEV +
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKVL-----KKNMAKTQIGTPHYMAPEVWK 174
Query: 191 QLHGYDFKADIWSFGITALELAHGHAPFS--------------KYPPMKVLLMTLQNAPP 236
Y +K+DIWS G E+A PF KYPP+ PP
Sbjct: 175 G-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPI----------PP 223
Query: 237 GLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274
+S+ + + + L PK RP +K++
Sbjct: 224 --------IYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 3e-34
Identities = 82/303 (27%), Positives = 126/303 (41%), Gaps = 57/303 (18%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR----REVQTMRVTNH 71
Y ++GEG VY+A E+VA+K + +E N+ +G RE++ ++ H
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRME---NEKEGFPITAIREIKLLQKLRH 57
Query: 72 PNVLRAHC---SFTTGHCLWVVMPYM----AGGSCLHIMKSAYPEGFEEPVIATLLRETL 124
PN++R S G ++V YM G L F E I +++ L
Sbjct: 58 PNIVRLKEIVTSKGKGSI-YMVFEYMDHDLTG---LLDSPEVK---FTESQIKCYMKQLL 110
Query: 125 KALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWM 184
+ L YLH +G +HRD+K NILI+++G +KLADFG++ V T +
Sbjct: 111 EGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPY--TKRNSADYTNRVITLWYR 168
Query: 185 APEVMQQLHG---YDFKADIWSFGITALELAHGHAPF----------------------- 218
PE+ L G Y + D+WS G EL G F
Sbjct: 169 PPEL---LLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDEN 225
Query: 219 ----SKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274
SK P + L + L S +L+ L DPKKR +A++ ++H
Sbjct: 226 WPGVSKLPWFENLKPK-KPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284
Query: 275 HFF 277
+F
Sbjct: 285 EYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 78/270 (28%), Positives = 123/270 (45%), Gaps = 29/270 (10%)
Query: 17 RLYEEVGEGVSATVYRALCIPLN----EIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHP 72
L +++GEG VY+ VA+K L + ++ RE + MR +HP
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 73 NVLRAH--CSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVI--ATLLRETL---K 125
NV++ C T L++VM YM GG L ++ P + + LL L +
Sbjct: 62 NVVKLLGVC--TEEEPLYIVMEYMEGGDLLSYLRKN------RPKLSLSDLLSFALQIAR 113
Query: 126 ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-WM 184
+ YL IHRD+ A N L+ N +K++DFG+S D R R + P WM
Sbjct: 114 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLS-RDLYDDDYYRKRGGKL--PIRWM 170
Query: 185 APEVMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 243
APE +++ + K+D+WSFG+ E+ G P YP M + L+ G +
Sbjct: 171 APESLKEGK-FTSKSDVWSFGVLLWEIFTLGEQP---YPGMSNEEV-LEYLKNGYRLPQP 225
Query: 244 KRFSKSFKELVTACLVKDPKKRPTAEKLMK 273
+L+ C +DP+ RPT +L++
Sbjct: 226 PNCPPELYDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 77/290 (26%), Positives = 123/290 (42%), Gaps = 32/290 (11%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIK-VLDLEKCNNDLDGIRREVQTMRVTNHPNV 74
Y + VGEG V + EIVAIK + E + REV+ +R H N+
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENI 62
Query: 75 LRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHG 134
+ +F L++V Y + L +++ A P G + + + + L+A+ Y H H
Sbjct: 63 VNLKEAFRRKGRLYLVFEY-VERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCHSHN 120
Query: 135 HIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHG 194
IHRD+K NIL+ +G +KL DFG + + +V T + APE++
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARAL--RARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 195 YDFKADIWSFGITALELAHGHAPF---SKYPPMKVLLMTLQNAPP--GLDYERDKRF--- 246
Y D+W+ G EL G F S + ++ L PP + + RF
Sbjct: 179 YGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238
Query: 247 -------------------SKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277
S + + ACL DPK+R T ++L++H +F
Sbjct: 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 74/268 (27%), Positives = 124/268 (46%), Gaps = 27/268 (10%)
Query: 20 EEVGEGVSATVYRALCIPLNE---IVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLR 76
+++GEG VY+ + VA+K L + + +E + M+ HPNV+R
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 77 --AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETL--------KA 126
C T L++V+ YM GG L ++ + P F P +TL + L K
Sbjct: 61 LLGVC--TEEEPLYLVLEYMEGGDLLDYLRKSRPV-FPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 127 LVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAP 186
+ YL +HRD+ A N L+ + +K++DFG+S ++D ++ + WMAP
Sbjct: 118 MEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAP 176
Query: 187 EVMQQLHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKV--LLMTLQNAPPGLDYERD 243
E ++ + K+D+WSFG+ E+ G P YP + +L L+ G +
Sbjct: 177 ESLKDGI-FTSKSDVWSFGVLLWEIFTLGATP---YPGLSNEEVLEYLRK---GYRLPKP 229
Query: 244 KRFSKSFKELVTACLVKDPKKRPTAEKL 271
+ EL+ +C DP+ RPT +L
Sbjct: 230 EYCPDELYELMLSCWQLDPEDRPTFSEL 257
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 81/273 (29%), Positives = 132/273 (48%), Gaps = 16/273 (5%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEK--CNNDLDGIRREVQTMRVTNH 71
KD+ + VG G V +I A+KV+ + E + ++N
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 72 PNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLH 131
P + + +F L++VM Y GG L ++ + Y + F+E + L E + A+ +H
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL-NRYEDQFDEDMAQFYLAELVLAIHSVH 119
Query: 132 FHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQ 191
G++HRD+K N+LID G IKLADFG +A + ++ + VGTP ++APEV+
Sbjct: 120 QMGYVHRDIKPENVLIDRTGHIKLADFGSAARL--TANKMVNSKLPVGTPDYIAPEVLTT 177
Query: 192 LHG-----YDFKADIWSFGITALELAHGHAPFSKYPPMKVL--LMTLQNAPPGLDYERDK 244
++G Y + D WS G+ A E+ +G +PF + K +M Q L + D
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRF---LKFPEDP 234
Query: 245 RFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277
+ S F +L+ + L+ K+R E L H FF
Sbjct: 235 KVSSDFLDLIQS-LLCGQKERLGYEGLCCHPFF 266
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 5e-32
Identities = 76/256 (29%), Positives = 129/256 (50%), Gaps = 15/256 (5%)
Query: 22 VGEGV--SATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAH 78
+G+G AT+YR + +V K ++L + + + E+ + + HPN++ +
Sbjct: 8 LGKGAFGEATLYRR--TEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 79 CSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHR 138
F + L + M Y GG+ + + FEE ++ L + + A+ Y+H G +HR
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHR 125
Query: 139 DVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFK 198
D+K NI + G IKL DFG+S + G T VGTP +M+PE+ Q + Y+FK
Sbjct: 126 DIKTLNIFLTKAGLIKLGDFGISKIL---GSEYSMAETVVGTPYYMSPELCQGVK-YNFK 181
Query: 199 ADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQ-NAPPGLDYERDKRFSKSFKELVTAC 257
+DIW+ G EL F P+ +++ +Q N P + +S LV +
Sbjct: 182 SDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVS-----VYSSELISLVHSL 236
Query: 258 LVKDPKKRPTAEKLMK 273
L +DP+KRPTA++++
Sbjct: 237 LQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 79/251 (31%), Positives = 126/251 (50%), Gaps = 25/251 (9%)
Query: 39 NEIVAIKVL--DLEKCNNDLDGIRREVQTMR-VTNHPNVLRAHCSFTTGHCLWVVMPYMA 95
+E+ A+KVL D+ ++D++ E + + HP + + H F T L+ VM Y+
Sbjct: 20 DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN 79
Query: 96 GGSCL-HIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIK 154
GG + HI +S F+EP E + L +LH G I+RD+K N+L+DS G IK
Sbjct: 80 GGDLMFHIQRSGR---FDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIK 136
Query: 155 LADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHG 214
+ADFG+ C + TF GTP ++APE++ Y D W+ G+ E+ G
Sbjct: 137 IADFGM--CKEGILGGVTTS-TFCGTPDYIAPEILSYQP-YGPAVDWWALGVLLYEMLAG 192
Query: 215 HAPFSKYPPMKVLLMTLQNAP--PGLDYERDKRFSKSFKELVTACLVKDPKKR----PTA 268
+PF ++ L++ P + SK K ++ + L K+P+KR PT
Sbjct: 193 QSPFEGDDEDELFQSILEDEVRYP-------RWLSKEAKSILKSFLTKNPEKRLGCLPTG 245
Query: 269 EKLMKHH-FFK 278
E+ +K H FF+
Sbjct: 246 EQDIKGHPFFR 256
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 79/292 (27%), Positives = 130/292 (44%), Gaps = 36/292 (12%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR----REVQTMRVTN 70
Y++ +GEG V++A E VA+K + L + GI RE++ ++
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE---GGIPNQALREIKALQACQ 57
Query: 71 HPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYL 130
HP V++ F G +VM YM L + E + + +R LK + Y+
Sbjct: 58 HPYVVKLLDVFPHGSGFVLVMEYMPSD--LSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115
Query: 131 HFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQ 190
H +G +HRD+K N+LI ++G +K+ADFG++ + R S V T + APE++
Sbjct: 116 HANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ--VATRWYRAPELLY 173
Query: 191 QLHGYDFKADIWSFGITALELAHGHAPFSKYPPM-------KVLLMTLQNAPPGL----D 239
YD D+W+ G EL +G F + + L + PGL D
Sbjct: 174 GARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD 233
Query: 240 YER-----------DKRF---SKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277
Y + ++ F S +L+ LV DP KR +A + ++H +F
Sbjct: 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 3e-31
Identities = 93/314 (29%), Positives = 144/314 (45%), Gaps = 54/314 (17%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNV 74
D+ E+G G V++ P I+A K++ LE + I RE+Q + N P +
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 75 LRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYL-HFH 133
+ + +F + + + M +M GGS ++K A E ++ + +K L YL H
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH 123
Query: 134 GHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLH 193
+HRDVK NIL++S G IKL DFGVS + D+ N+FVGT +M+PE +Q H
Sbjct: 124 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH 178
Query: 194 GYDFKADIWSFGITALELAHGH------------------------------------AP 217
Y ++DIWS G++ +E+A G P
Sbjct: 179 -YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRP 237
Query: 218 FSKY-----PPMKV--LLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEK 270
S Y PPM + LL + N PP F F++ V CL+K+P +R ++
Sbjct: 238 LSSYGPDSRPPMAIFELLDYIVNEPP--PKLPSGVFGAEFQDFVNKCLIKNPAERADLKQ 295
Query: 271 LMKHHFFKHARSND 284
LM H F K + + +
Sbjct: 296 LMVHAFIKRSEAEE 309
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 4e-31
Identities = 64/260 (24%), Positives = 124/260 (47%), Gaps = 9/260 (3%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-DLDGIRREVQTMRVTNHPN 73
D+ + ++G+G V++ + + A+K +DL K N + + E + + +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH 133
++R + SF L +VM Y G ++K E + + L L +LH
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 134 GHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLH 193
+HRD+K+ N+ +D+ +K+ D GV+ + D NT VGTP +++PE+ +
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL---SDNTNFANTIVGTPYYLSPELCED-K 176
Query: 194 GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL 253
Y+ K+D+W+ G+ E G PF ++L ++ P + + +S+ +L
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV----SQMYSQQLAQL 232
Query: 254 VTACLVKDPKKRPTAEKLMK 273
+ CL KD ++RP +L++
Sbjct: 233 IDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 94/313 (30%), Positives = 144/313 (46%), Gaps = 56/313 (17%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN 73
D+ E+G G V + P I+A K++ LE + I RE+Q + N P
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYL-HF 132
++ + +F + + + M +M GGS ++K A + E ++ + L+ L YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREK 122
Query: 133 HGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQL 192
H +HRDVK NIL++S G IKL DFGVS + D+ N+FVGT +M+PE +Q
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGT 177
Query: 193 HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLL------------------MTLQNA 234
H Y ++DIWS G++ +ELA G P PP L ++ +
Sbjct: 178 H-YSVQSDIWSMGLSLVELAIGRYPIP--PPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234
Query: 235 PPG-------------------LDYERDKR--------FSKSFKELVTACLVKDPKKRPT 267
PPG LDY ++ F+ F+E V CL+K+P +R
Sbjct: 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERAD 294
Query: 268 AEKLMKHHFFKHA 280
+ LM H F K +
Sbjct: 295 LKMLMNHTFIKRS 307
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 59/171 (34%), Positives = 90/171 (52%), Gaps = 11/171 (6%)
Query: 59 IRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEG-FEEPVIA 117
I E + + NHP +++ + +F ++++M Y GG I++ G F+E
Sbjct: 40 IFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDR---GLFDEYTAR 96
Query: 118 TLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTF 177
+ + A YLH G I+RD+K N+L+DSNG +KL DFG + + Q++ TF
Sbjct: 97 FYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL---KSGQKTW-TF 152
Query: 178 VGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFS--KYPPMKV 226
GTP ++APE++ GYDF D WS GI EL G PF PM++
Sbjct: 153 CGTPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEI 202
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 82/291 (28%), Positives = 123/291 (42%), Gaps = 46/291 (15%)
Query: 22 VGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR----REVQTMRVTNHPNVLRA 77
+GEG A VY+A IVAIK + L + DGI RE++ ++ HPN++
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 78 HCSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHI 136
F + +V +M L ++K I + + TL+ L YLH + +
Sbjct: 68 LDVFGHKSNINLVFEFMETD--LEKVIKDKSIV-LTPADIKSYMLMTLRGLEYLHSNWIL 124
Query: 137 HRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHG-- 194
HRD+K N+LI S+G +KLADFG+ A F G R V T + APE+ L G
Sbjct: 125 HRDLKPNNLLIASDGVLKLADFGL-ARSF--GSPNRKMTHQVVTRWYRAPEL---LFGAR 178
Query: 195 -YDFKADIWSFGITALELAHGHAPF----------------------SKYPPMKVLLMTL 231
Y D+WS G EL PF +P + L +
Sbjct: 179 HYGVGVDMWSVGCIFAELLLR-VPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237
Query: 232 QNAP-PGLDYERDKRFSKSFKE---LVTACLVKDPKKRPTAEKLMKHHFFK 278
+ P P + F + + L+ L +P KR TA + ++H +F
Sbjct: 238 EFKPFPPTP--LKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 86/271 (31%), Positives = 125/271 (46%), Gaps = 29/271 (10%)
Query: 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN----NDLDGIRREVQTMRVTNH-PNV 74
+ + +G +VY A + AIKVL +K + N + ++ E M + P V
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVL--KKSDMIAKNQVTNVKAERAIMMIQGESPYV 59
Query: 75 LRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHG 134
+ + SF + L++VM Y+ GG C ++K+ G E + E + + LH G
Sbjct: 60 AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRG 117
Query: 135 HIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHG 194
IHRD+K N+LID G +KL DFG+S G + FVGTP ++APE + + G
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLS----RNGLENKK---FVGTPDYLAPETILGV-G 169
Query: 195 YDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQ---NAPPGLDYERDKRF-SKSF 250
D +D WS G E G+ PF P V L N P E K F S
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWP-----EEVKEFCSPEA 224
Query: 251 KELVTACLVKDPKKRPTA---EKLMKHHFFK 278
+L+ L DP KR A +++ H FFK
Sbjct: 225 VDLINRLLCMDPAKRLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 81/274 (29%), Positives = 126/274 (45%), Gaps = 46/274 (16%)
Query: 40 EIVAIKVL---DLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAG 96
++ A+KVL D+ K N + +R E + + P +++ + SF L++VM YM G
Sbjct: 27 QVYAMKVLRKSDMIK-RNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPG 85
Query: 97 GSCL-HIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKL 155
G + +++ + F E + E + AL +H G IHRD+K NILID++G IKL
Sbjct: 86 GDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKL 142
Query: 156 ADFGVSACMFDAGD--------------------------RQRSRNTFVGTPCWMAPEVM 189
ADFG+ M A D R+ N+ VGTP ++APEV+
Sbjct: 143 ADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVL 202
Query: 190 QQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM----KVLLMTLQNAPPGLDYERDKR 245
+ Y + D WS G+ E+ +G PF K++ N L + D
Sbjct: 203 RG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKII-----NWKESLRFPPDPP 256
Query: 246 FSKSFKELVTACLVKDPKKR-PTAEKLMKHHFFK 278
S +L+ L DP+ R + E++ H FFK
Sbjct: 257 VSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFK 289
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 2e-29
Identities = 76/259 (29%), Positives = 130/259 (50%), Gaps = 15/259 (5%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIK---VLDLEKCNNDLDGIRREVQTMRVTNH 71
++R+ +++G G + VYRA C+ VA+K + DL D I+ E+ ++ NH
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK-EIDLLKQLNH 61
Query: 72 PNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEG--FEEPVIATLLRETLKALVY 129
PNV++ + SF + L +V+ G ++K + E + + AL +
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 130 LHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVM 189
+H +HRD+K N+ I + G +KL D G+ + + ++ VGTP +M+PE +
Sbjct: 122 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF---SSKTTAAHSLVGTPYYMSPERI 178
Query: 190 QQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYE--RDKRFS 247
+ +GY+FK+DIWS G E+A +PF K+ L +L DY +S
Sbjct: 179 HE-NGYNFKSDIWSLGCLLYEMAALQSPFYG---DKMNLYSLCKKIEQCDYPPLPSDHYS 234
Query: 248 KSFKELVTACLVKDPKKRP 266
+ ++LV C+ DP+KRP
Sbjct: 235 EELRQLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 81/299 (27%), Positives = 126/299 (42%), Gaps = 40/299 (13%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNH 71
K ++ + +G+G V+ ++ A+KVLD ++ N + + E + + +H
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 72 PNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEG-FEEPVIATLLRETLKALVYL 130
P + + SF T L +VM Y GG L + P E V E L AL YL
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGE-LFRLLQRQPGKCLSEEVARFYAAEVLLALEYL 119
Query: 131 HFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSR---------------- 174
H G ++RD+K NIL+ +G I L+DF +S D S+
Sbjct: 120 HLLGIVYRDLKPENILLHESGHIMLSDFDLS-KQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 175 -----------NTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPP 223
N+FVGT ++APEV+ G+ D W+ GI E+ +G PF K
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPF-KGSN 236
Query: 224 MKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKR----PTAEKLMKHHFFK 278
+ + S S ++L+ LVKDP KR A ++ +H FF+
Sbjct: 237 RDETFSNILKKEV--TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 74/259 (28%), Positives = 126/259 (48%), Gaps = 19/259 (7%)
Query: 22 VGEGVSATVYRALCIPLN--EIVAIKVLDLEKCNND-LDGIRREVQTMRVTNHPNVLRAH 78
VG G V+ LC ++V IK + +E+ D + E Q +++ +HPN++ +
Sbjct: 8 VGRGAFGIVH--LCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 79 CSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHR 138
+F L +VM Y GG+ ++ +E I + L AL ++H +HR
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHR 125
Query: 139 DVKAGNILIDSNGAI-KLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDF 197
D+K NIL+D + + K+ DFG+S + + T VGTPC+++PE+ + Y+
Sbjct: 126 DLKTQNILLDKHKMVVKIGDFGISKIL----SSKSKAYTVVGTPCYISPELCEG-KPYNQ 180
Query: 198 KADIWSFGITALELAHGHAPF--SKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVT 255
K+DIW+ G ELA F + P + + +M+ AP R+S ++L+
Sbjct: 181 KSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPIS------DRYSPDLRQLIL 234
Query: 256 ACLVKDPKKRPTAEKLMKH 274
+ L DP KRP ++M
Sbjct: 235 SMLNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 9e-29
Identities = 75/222 (33%), Positives = 110/222 (49%), Gaps = 23/222 (10%)
Query: 61 REVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLL 120
+ +Q R+ + LR T L + M YM GGS +K AY E V
Sbjct: 59 KNLQHERIVQYYGCLRDRAEKT----LTIFMEYMPGGSVKDQLK-AY-GALTESVTRKYT 112
Query: 121 RETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSA-----CMFDAGDRQRSRN 175
R+ L+ + YLH + +HRD+K NIL DS G +KL DFG S CM G R
Sbjct: 113 RQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR----- 167
Query: 176 TFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLL-MTLQNA 234
+ GTP WM+PEV+ GY KAD+WS G T +E+ P+++Y M + + Q
Sbjct: 168 SVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPT 226
Query: 235 PPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHF 276
P L S+ ++ + C+ + + RP+AE+L++H F
Sbjct: 227 NPQL----PSHISEHARDFL-GCIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 76/271 (28%), Positives = 138/271 (50%), Gaps = 20/271 (7%)
Query: 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNND-----LDGIRREVQTMRVTNHPNV 74
+++G G ++ Y+A + ++A+K + + + ++ +R+E++ M NHP++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 75 LRAH-CSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH 133
+R + H + + +MAGGS H++ F+E VI + L+ L YLH +
Sbjct: 66 IRMLGATCEDSH-FNLFVEWMAGGSVSHLLSKYGA--FKEAVIINYTEQLLRGLSYLHEN 122
Query: 134 GHIHRDVKAGNILIDSNGA-IKLADFGVSACMFDAGDRQRS-RNTFVGTPCWMAPEVMQQ 191
IHRDVK N+LIDS G +++ADFG +A + G + +GT +MAPEV++
Sbjct: 123 QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG 182
Query: 192 LHGYDFKADIWSFGITALELAHGHAPFS--KYPPMKVLLMTLQNA--PPGLDYERDKRFS 247
Y D+WS G +E+A P++ K+ L+ + +A P + + S
Sbjct: 183 -EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSI----PEHLS 237
Query: 248 KSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278
+++ CL P+ RP + +L+KH F+
Sbjct: 238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 64/248 (25%), Positives = 104/248 (41%), Gaps = 27/248 (10%)
Query: 38 LNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGG 97
+ + K ++ N + E + ++ NHP ++ SF +++V+ + GG
Sbjct: 30 MKYMNKQKCVEKGSVRN----VLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGG 85
Query: 98 SC-LHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLA 156
H+ + F E + + E + AL YLH G IHRD+K NIL+D G + +
Sbjct: 86 DLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHIT 142
Query: 157 DFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHA 216
DF + A + GTP +MAPEV+ + GY D WS G+TA E G
Sbjct: 143 DFNI-ATKVTPD---TLTTSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKR 197
Query: 217 PF---SKYPPMKVLLMTLQNAP--PGLDYERDKRFSKSFKELVTACLVKDPKKR--PTAE 269
P+ S+ ++ P S + + L +DP+KR +
Sbjct: 198 PYRGHSRTIRDQIRAKQETADVLYPATW-------STEAIDAINKLLERDPQKRLGDNLK 250
Query: 270 KLMKHHFF 277
L H +F
Sbjct: 251 DLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 75/263 (28%), Positives = 120/263 (45%), Gaps = 24/263 (9%)
Query: 39 NEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTN---HPNVLRAHCSFTTGHCLWVVMPY 93
E+ AIK L ++++ + E + N HP ++ F T + VM Y
Sbjct: 24 GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEY 83
Query: 94 MAGG-SCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGA 152
AGG +HI + F EP + L YLH + ++RD+K N+L+D+ G
Sbjct: 84 AAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF 139
Query: 153 IKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELA 212
+K+ADFG+ C G R+ +TF GTP ++APEV+ + Y D W G+ E+
Sbjct: 140 VKIADFGL--CKEGMGFGDRT-STFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEML 195
Query: 213 HGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKR-----PT 267
G +PF +V + + Y R S+ ++ L ++P++R
Sbjct: 196 VGESPFPGDDEEEVFDSIVNDEVR---YPR--FLSREAISIMRRLLRRNPERRLGSGEKD 250
Query: 268 AEKLMKHHFFKHARSNDFLARSI 290
AE + K FF+ +D LAR I
Sbjct: 251 AEDVKKQPFFRDINWDDLLARKI 273
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 8e-28
Identities = 71/259 (27%), Positives = 131/259 (50%), Gaps = 15/259 (5%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIK---VLDLEKCNNDLDGIRREVQTMRVTNH 71
++++ +++G G + VYRA C+ + VA+K + ++ D ++ E+ ++ NH
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK-EIDLLKQLNH 61
Query: 72 PNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEG--FEEPVIATLLRETLKALVY 129
PNV++ SF + L +V+ G ++K + E + + A+ +
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 130 LHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVM 189
+H +HRD+K N+ I + G +KL D G+ + + ++ VGTP +M+PE +
Sbjct: 122 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF---SSKTTAAHSLVGTPYYMSPERI 178
Query: 190 QQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYE--RDKRFS 247
+ +GY+FK+DIWS G E+A +PF K+ L +L DY + +S
Sbjct: 179 HE-NGYNFKSDIWSLGCLLYEMAALQSPFYG---DKMNLFSLCQKIEQCDYPPLPTEHYS 234
Query: 248 KSFKELVTACLVKDPKKRP 266
+ +ELV+ C+ DP +RP
Sbjct: 235 EKLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 68/184 (36%), Positives = 99/184 (53%), Gaps = 11/184 (5%)
Query: 39 NEIVAIKVL--DLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHCSFTTGHCLWVVMPYMA 95
+E+ AIKVL D+ ++D+D E + + + HP + HC F T L+ VM Y+
Sbjct: 20 DEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN 79
Query: 96 GGSCL-HIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIK 154
GG + I +S F+EP E AL++LH HG I+RD+K NIL+D+ G K
Sbjct: 80 GGDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCK 136
Query: 155 LADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHG 214
LADFG+ G + TF GTP ++APE++Q+L Y D W+ G+ E+ G
Sbjct: 137 LADFGMCKEGILNG---VTTTTFCGTPDYIAPEILQELE-YGPSVDWWALGVLMYEMMAG 192
Query: 215 HAPF 218
PF
Sbjct: 193 QPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 76/260 (29%), Positives = 126/260 (48%), Gaps = 13/260 (5%)
Query: 22 VGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSF 81
+G+G VY A + +AIK + E+ + + + E+ H N+++ S
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIP-ERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 82 TTGHCLWVVMPYMAGGSCLHIMKSAY-PEGFEEPVIATLLRETLKALVYLHFHGHIHRDV 140
+ + M + GGS +++S + P E I ++ L+ L YLH + +HRD+
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDI 134
Query: 141 KAGNILIDS-NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQ-LHGYDFK 198
K N+L+++ +G +K++DFG S + AG + TF GT +MAPEV+ + GY
Sbjct: 135 KGDNVLVNTYSGVVKISDFGTSKRL--AGINPCT-ETFTGTLQYMAPEVIDKGPRGYGAP 191
Query: 199 ADIWSFGITALELAHGHAPFSKY--PPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTA 256
ADIWS G T +E+A G PF + P + + + P E + S K +
Sbjct: 192 ADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHP----EIPESLSAEAKNFILR 247
Query: 257 CLVKDPKKRPTAEKLMKHHF 276
C DP KR +A L++ F
Sbjct: 248 CFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 83/266 (31%), Positives = 133/266 (50%), Gaps = 25/266 (9%)
Query: 39 NEIVAIKVLD----LEKCNNDLDGIRREVQTM-RVTNHPNVLRAHCSFTTGHCLWVVMPY 93
++ A+KVL ++K + R E Q + V P ++ H +F T L +++ Y
Sbjct: 28 GKLYAMKVLKKATIVQKAKT-AEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDY 86
Query: 94 MAGGSCL-HIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGA 152
+ GG H+ + E F E + + E + AL +LH G I+RD+K NIL+DS G
Sbjct: 87 VNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGH 143
Query: 153 IKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQ-LHGYDFKADIWSFGITALEL 211
+ L DFG+S F A + +R+ +F GT +MAPEV++ G+D D WS G+ EL
Sbjct: 144 VVLTDFGLSK-EFLAEEEERA-YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFEL 201
Query: 212 AHGHAPFS----KYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKR-- 265
G +PF+ + ++ L++ PP K S ++ + L KDPKKR
Sbjct: 202 LTGASPFTVDGEQNSQSEISRRILKSKPP-----FPKTMSAEARDFIQKLLEKDPKKRLG 256
Query: 266 -PTAEKLMKHHFFKHARSNDFLARSI 290
A+++ H FF+ +D A+ I
Sbjct: 257 ANGADEIKNHPFFQGIDWDDLAAKRI 282
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 84/274 (30%), Positives = 128/274 (46%), Gaps = 22/274 (8%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLD---LEKCNNDLDGIRREVQTMRVTN 70
KD+++ +VG+G V+ A EIVA+K + L K N ++ + E + T
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLN-EVRHVLTERDILTTTK 59
Query: 71 HPNVLRAHCSFTTGHCLWVVMPYMAGGS--CLHIMKSAYPEGFEEPVIATLLRETLKALV 128
+++ +F L++ M Y+ GG L E +A E +A+
Sbjct: 60 SEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMA----EMFEAVD 115
Query: 129 YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEV 188
LH G+IHRD+K N LID++G IKL DFG+S + N+ VG+P +MAPEV
Sbjct: 116 ALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYA------NSVVGSPDYMAPEV 169
Query: 189 MQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER--DKRF 246
++ GYDF D WS G E G PFS P + L+ L D RF
Sbjct: 170 LRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-WENLKYWKETLQRPVYDDPRF 227
Query: 247 SKSFK--ELVTACLVKDPKKRPTAEKLMKHHFFK 278
+ S + +L+T + ++ + E + H FFK
Sbjct: 228 NLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 81/274 (29%), Positives = 133/274 (48%), Gaps = 25/274 (9%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVL----DLEKCNNDLDGIRREVQTMRVTN 70
++RL + +G G VY +A+K + D ++ + +++ + E+Q ++
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 71 HPNVLRAHCSFT--TGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALV 128
H +++ + L + + YM GGS +K AY E V R+ L+ +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLK-AY-GALTENVTRRYTRQILQGVS 120
Query: 129 YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSA-----CMFDAGDRQRSRNTFVGTPCW 183
YLH + +HRD+K NIL DS G +KL DFG S CM G + + GTP W
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIK-----SVTGTPYW 175
Query: 184 MAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLL-MTLQNAPPGLDYER 242
M+PEV+ GY KAD+WS T +E+ P+++Y M + + Q P L
Sbjct: 176 MSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPML---- 230
Query: 243 DKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHF 276
S + ++ + V++ K+RPTAE L++H F
Sbjct: 231 PDGVSDACRDFLKQIFVEE-KRRPTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 81/256 (31%), Positives = 124/256 (48%), Gaps = 35/256 (13%)
Query: 39 NEIVAIKVL--DLEKCNNDLDGIRREVQTMRVTNHPNVLRA-HCSFTTGHCLWVVMPYMA 95
+E+ AIK+L D+ ++D++ E + + + P L H F T L+ VM Y+
Sbjct: 25 DELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 84
Query: 96 GGSCL-HIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIK 154
GG + HI + F+EP E L +LH G I+RD+K N+++D+ G IK
Sbjct: 85 GGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIK 141
Query: 155 LADFGVSAC---MFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALEL 211
+ADFG+ C +F G R TF GTP ++APE++ Y D W+FG+ E+
Sbjct: 142 IADFGM--CKENIFG-GKTTR---TFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEM 194
Query: 212 AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSF-KELVTAC---LVKDPKKR-- 265
G PF ++ + E + + KS KE V+ C L K P KR
Sbjct: 195 LAGQPPFDGEDEDELFQSIM---------EHNVSYPKSLSKEAVSICKGLLTKHPAKRLG 245
Query: 266 --PTAEKLMKHH-FFK 278
PT E+ ++ H FF+
Sbjct: 246 CGPTGERDIREHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 80/279 (28%), Positives = 133/279 (47%), Gaps = 35/279 (12%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLE----KCNNDLDGIRREVQTMRVTN 70
++RL + +G+G VY +A+K + + + + +++ + E+Q ++
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 71 HPNVLRAHCSF--TTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALV 128
H +++ + L + M +M GGS +KS E V R+ L+ +
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVS 120
Query: 129 YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSA-----CMFDAGDRQRSRNTFVGTPCW 183
YLH + +HRD+K NIL DS G +KL DFG S C+ G + + GTP W
Sbjct: 121 YLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMK-----SVTGTPYW 175
Query: 184 MAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLL-MTLQNAPPGL---- 238
M+PEV+ GY KADIWS G T +E+ P++++ M + + Q P L
Sbjct: 176 MSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHV 234
Query: 239 -DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHF 276
D+ RD F K + + K RP+A++L++H F
Sbjct: 235 SDHCRD--FLKR--------IFVEAKLRPSADELLRHTF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 88/304 (28%), Positives = 143/304 (47%), Gaps = 36/304 (11%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRR--------E 62
+ A+D+ + + +G G V ++ A+K+L + + I+R E
Sbjct: 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLL------SKFEMIKRSDSAFFWEE 93
Query: 63 VQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAY--PEGFEEPVIATLL 120
M N +++ H +F L++VM YM GG +++M S Y PE + A
Sbjct: 94 RDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM-SNYDIPEKWARFYTA--- 149
Query: 121 RETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGT 180
E + AL +H G IHRDVK N+L+D +G +KLADFG CM + +T VGT
Sbjct: 150 -EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG--TCMKMDANGMVRCDTAVGT 206
Query: 181 PCWMAPEVM--QQLHG-YDFKADIWSFGITALELAHGHAPF--SKYPPMKVLLMTLQNAP 235
P +++PEV+ Q G Y + D WS G+ E+ G PF +M +N+
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNS- 265
Query: 236 PGLDYERDKRFSKSFKELVTACLVKDPKK--RPTAEKLMKHHFFKHARSNDFLARSIVDN 293
L + D SK K+L+ A L + R +++ H FFK+ + + +I +
Sbjct: 266 --LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN---DQWTFDNIRET 320
Query: 294 LAPL 297
+AP+
Sbjct: 321 VAPV 324
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 75/247 (30%), Positives = 121/247 (48%), Gaps = 21/247 (8%)
Query: 39 NEIVAIKVLD----LEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYM 94
NE AIK L LE + + + R V + HP + C+F T L+ VM Y+
Sbjct: 20 NEFFAIKALKKDVVLEDDDVECTMVERRVLAL-AWEHPFLTHLFCTFQTKEHLFFVMEYL 78
Query: 95 AGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIK 154
GG + ++S+ F+E E + L +LH G I+RD+K N+L+D +G IK
Sbjct: 79 NGGDLMFHIQSSGR--FDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIK 136
Query: 155 LADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHG 214
+ADFG+ C + + + +TF GTP ++APE+++ Y+ D WSFG+ E+ G
Sbjct: 137 IADFGM--CKENM-NGEGKASTFCGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIG 192
Query: 215 HAPFSKYPPMKVLLMTLQNAP--PGLDYERDKRFSKSFKELVTACLVKDPKKR-PTAEKL 271
+PF ++ L + P P + SK K+ ++ +DP KR +
Sbjct: 193 QSPFHGEDEDELFDSILNDRPHFP-------RWISKEAKDCLSKLFERDPTKRLGVDGDI 245
Query: 272 MKHHFFK 278
+H FF+
Sbjct: 246 RQHPFFR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 87/323 (26%), Positives = 154/323 (47%), Gaps = 24/323 (7%)
Query: 22 VGEGVSATVYRALCIPLNEIVAIKVL--DLEKCNNDLDGIRREVQTMRVT-NHPNVLRAH 78
+G+G V+ A N+ AIK L D+ ++D++ E + + + HP + +
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 79 CSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHR 138
C+F T L+ VM Y+ GG + ++S + F+ P E + L +LH G ++R
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHK--FDLPRATFYAAEIICGLQFLHSKGIVYR 120
Query: 139 DVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFK 198
D+K NIL+D++G IK+ADFG+ C + ++ TF GTP ++APE++ Y+
Sbjct: 121 DLKLDNILLDTDGHIKIADFGM--CKENMLGDAKT-CTFCGTPDYIAPEILLG-QKYNTS 176
Query: 199 ADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACL 258
D WSFG+ E+ G +PF + ++ + P Y R ++ K+++
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPC---YPR--WLTREAKDILVKLF 231
Query: 259 VKDPKKRPTAEKLMKHH-FFKHARSNDFLARSIVDNLAPLGERFRMLKAKEADLLVQ-NK 316
V++P++R + ++ H FF+ + R I P K K A+ +K
Sbjct: 232 VREPERRLGVKGDIRQHPFFREIDWSALEEREIEPPFKP--------KVKSANDCSNFDK 283
Query: 317 ALYEDKEQLSQDYDCMSNAEDPN 339
+K +LS + N+ D N
Sbjct: 284 EFLNEKPRLSVTDRMLINSMDQN 306
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 5e-25
Identities = 71/261 (27%), Positives = 122/261 (46%), Gaps = 14/261 (5%)
Query: 15 DYRLYEEVGEGVSATVYRALCIP---LNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNH 71
Y + VGEG + RAL + ++ A+K + L K ++ ++ R+E + H
Sbjct: 1 QYNVLRVVGEG---SFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKH 57
Query: 72 PNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLH 131
PN++ SF L++VM Y GG + +K + F E I + + ++H
Sbjct: 58 PNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH 117
Query: 132 FHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQ 191
+HRD+K+ NI + NG +KL DFG + + G T+VGTP ++ PE+ +
Sbjct: 118 EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA---CTYVGTPYYVPPEIWEN 174
Query: 192 LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251
+ Y+ K+DIWS G EL PF ++L Q + L +S +
Sbjct: 175 M-PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPL----PSHYSYELR 229
Query: 252 ELVTACLVKDPKKRPTAEKLM 272
L+ ++P+ RP+A ++
Sbjct: 230 SLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 76/297 (25%), Positives = 121/297 (40%), Gaps = 45/297 (15%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR----REVQTMR---V 68
Y E+GEG TVY+A + VA+K + + +GI RE+ ++
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVP---LSEEGIPLSTLREIALLKQLES 57
Query: 69 TNHPNVLR-----AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPE-GFEEPVIATLLRE 122
HPN++R L +V ++ L S P+ G I L+R+
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQD--LATYLSKCPKPGLPPETIKDLMRQ 115
Query: 123 TLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC 182
L+ + +LH H +HRD+K NIL+ S+G +K+ADFG++ + + + V T
Sbjct: 116 LLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY----SFEMALTSVVVTLW 171
Query: 183 WMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQ--NAPPGLDY 240
+ APEV+ Q Y D+WS G EL F L P ++
Sbjct: 172 YRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEW 230
Query: 241 ERD---------KRFSKSFKELVTA-----------CLVKDPKKRPTAEKLMKHHFF 277
R+ +SFK V L +P KR +A + ++H +F
Sbjct: 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 83/286 (29%), Positives = 137/286 (47%), Gaps = 35/286 (12%)
Query: 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR----REVQTMRVTNHPNVL 75
E++GEG VY+A E+VA+K + L+ + +G+ RE+ ++ NHPN++
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLD---TETEGVPSTAIREISLLKELNHPNIV 62
Query: 76 RAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGH 135
+ T + L++V ++ M ++ G P+I + L + L+ L + H H
Sbjct: 63 KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRV 121
Query: 136 IHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGY 195
+HRD+K N+LI++ GAIKLADFG++ G R+ V T + APE++ Y
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEILLGCKYY 178
Query: 196 DFKADIWSFGITALELAHGHAPF---SKYPPMKVLLMTL----QNAPPGL----DYERD- 243
DIWS G E+ A F S+ + + TL + PG+ DY+
Sbjct: 179 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF 238
Query: 244 -----KRFSKSF-------KELVTACLVKDPKKRPTAEKLMKHHFF 277
+ FSK ++L++ L DP KR +A+ + H FF
Sbjct: 239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 86/295 (29%), Positives = 139/295 (47%), Gaps = 45/295 (15%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR----REVQTMRVTNH 71
Y+ E++GEG VY+A EIVA+K + LE + +G+ RE+ ++ NH
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLE---TEDEGVPSTAIREISLLKELNH 57
Query: 72 PNVLRAHCSFTTGHCLWVVMPYMAGGSCLHI-----MKSAYPEGFEEPVIATLLRETLKA 126
PN++R + + L++V + L + M S+ G + P+I + L + L+
Sbjct: 58 PNIVRLLDVVHSENKLYLVFEF------LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQG 111
Query: 127 LVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAP 186
+ Y H H +HRD+K N+LID GA+KLADFG+ A F G R+ V T + AP
Sbjct: 112 IAYCHSHRVLHRDLKPQNLLIDREGALKLADFGL-ARAF--GVPVRTYTHEVVTLWYRAP 168
Query: 187 EVMQQLHGYDFKADIWSFGITALELAHGHAPFSK-------YPPMKVLLMTLQNAPPGL- 238
E++ Y DIWS G E+ + F + + L ++ PG+
Sbjct: 169 EILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVT 228
Query: 239 ---DYE------RDKRFSKSFK-------ELVTACLVKDPKKRPTAEKLMKHHFF 277
DY+ + SK +L++ LV DP KR +A+ ++H +F
Sbjct: 229 SLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 80 SFTTGHCLWVVMPYMAGGSC-LHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHR 138
+F T L +VM M GG HI P GF E + + L +LH ++R
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEP-GFPEARAIFYAAQIICGLEHLHQRRIVYR 119
Query: 139 DVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFK 198
D+K N+L+D +G ++++D G+ A G + + R GTP +MAPEV+Q YDF
Sbjct: 120 DLKPENVLLDDHGNVRISDLGL-AVELKGGKKIKGR---AGTPGYMAPEVLQG-EVYDFS 174
Query: 199 ADIWSFGITALELAHGHAPFSKYPPMK----VLLMTLQNAPPGLDYERDKRFSKSFKELV 254
D ++ G T E+ G +PF + + TL+ A E +FS K+L
Sbjct: 175 VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMA-----VEYPDKFSPEAKDLC 229
Query: 255 TACLVKDPKKR-----PTAEKLMKHHFFK 278
A L KDP+KR +A+++ +H FK
Sbjct: 230 EALLQKDPEKRLGCRGGSADEVREHPLFK 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 75/266 (28%), Positives = 124/266 (46%), Gaps = 14/266 (5%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNV 74
Y + +++GEG +Y A +E IK +DL K + + ++EV + HPN+
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 75 LRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHG 134
+ SF L++VM Y GG + + F E I + + L ++H
Sbjct: 62 VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK 121
Query: 135 HIHRDVKAGNILIDSNGAI-KLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLH 193
+HRD+K+ NI + NG + KL DFG++ + D+ + T VGTP +++PE+ Q
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY---TCVGTPYYLSPEICQN-R 177
Query: 194 GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQN--APPGLDYERDKRFSKSFK 251
Y+ K DIWS G EL PF +++L Q AP ++ RD +
Sbjct: 178 PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRD------LR 231
Query: 252 ELVTACLVKDPKKRPTAEKLMKHHFF 277
L++ P+ RP+ ++K F
Sbjct: 232 SLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 81/305 (26%), Positives = 126/305 (41%), Gaps = 47/305 (15%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN----DLDGIR--REVQTMRVT 69
Y L + +G G V A+ VAIK K +N +D R RE++ +R
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIK-----KISNVFDDLIDAKRILREIKLLRHL 56
Query: 70 NHPNVLRAH-----CSFTTGHCLWVVMPYMAGGSCLH-IMKSAYPEGFEEPVIATLLRET 123
H N++ S + +++V M + LH ++KS P+ + I L +
Sbjct: 57 RHENIIGLLDILRPPSPEDFNDVYIVTELM--ETDLHKVIKS--PQPLTDDHIQYFLYQI 112
Query: 124 LKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCW 183
L+ L YLH IHRD+K NIL++SN +K+ DFG++ + D + +V T +
Sbjct: 113 LRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWY 172
Query: 184 MAPEVMQQLHGYDFKADIWSFGITALELAHGHAPF--SKYPPMKVLLMTLQNAPP--GLD 239
APE++ Y DIWS G EL F Y L++ + P L
Sbjct: 173 RAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232
Query: 240 YERDKR---------------FSKSFKE-------LVTACLVKDPKKRPTAEKLMKHHFF 277
+ ++ SK F L+ LV DPKKR TA++ + H +
Sbjct: 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292
Query: 278 KHARS 282
Sbjct: 293 AQLHD 297
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 70/241 (29%), Positives = 107/241 (44%), Gaps = 18/241 (7%)
Query: 62 EVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLL 120
E + ++ T HP + SF T L VM Y GG H+ + F E
Sbjct: 45 ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV---FSEDRARFYG 101
Query: 121 RETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGT 180
E + AL YLH ++RD+K N+++D +G IK+ DFG+ C D + TF GT
Sbjct: 102 AEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGL--CKEGISD-GATMKTFCGT 158
Query: 181 PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240
P ++APEV++ + Y D W G+ E+ G PF K+ + L +
Sbjct: 159 PEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----EI 212
Query: 241 ERDKRFSKSFKELVTACLVKDPKKR-----PTAEKLMKHHFFKHARSNDFLARSIVDNLA 295
+ S K L+ L KDPK+R A+++M+H FF D + + +
Sbjct: 213 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFK 272
Query: 296 P 296
P
Sbjct: 273 P 273
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 80/298 (26%), Positives = 128/298 (42%), Gaps = 52/298 (17%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVL-----DLEKCNNDLDGIRREVQTMR-VT 69
Y++ ++GEG + V +A + AIK + LE+ NN RE+Q +R ++
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-----LREIQALRRLS 55
Query: 70 NHPNVLRAH-CSF--TTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKA 126
HPN+LR F TG L +V M I P E + + + + LK+
Sbjct: 56 PHPNILRLIEVLFDRKTG-RLALVFELMDMNLYELIKGRKRP--LPEKRVKSYMYQLLKS 112
Query: 127 LVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNT-FVGTPCWMA 185
L ++H +G HRD+K NILI + +KLADFG S G + T ++ T + A
Sbjct: 113 LDHMHRNGIFHRDIKPENILIKDD-ILKLADFG-SCR----GIYSKPPYTEYISTRWYRA 166
Query: 186 PEVMQQLHGYDFKADIWSFGITALELAHGHAPF---------SKY------PPMKVLLMT 230
PE + Y K DIW+ G E+ F +K P +VL
Sbjct: 167 PECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF 226
Query: 231 LQNAPPGLDYERDKR-----------FSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277
++ ++Y + S +L+ L DP +R TA++ ++H +F
Sbjct: 227 RKSR--HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 72/243 (29%), Positives = 112/243 (46%), Gaps = 22/243 (9%)
Query: 59 IRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIAT 118
+ R++ T +P V+ CSF T L +VM Y+ GG C ++K+ + +
Sbjct: 50 VERDILTF--AENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVD--MARM 105
Query: 119 LLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVS--ACM----------FD 166
ET+ AL YLH +G +HRD+K N+LI S G IKL DFG+S M +
Sbjct: 106 YFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIE 165
Query: 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKV 226
R+ GTP ++APEV+ + GY D W+ GI E G PF P ++
Sbjct: 166 KDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL 224
Query: 227 LLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKR---PTAEKLMKHHFFKHARSN 283
+ + E D+ ++L++ L ++P +R A ++ +H FF N
Sbjct: 225 FGQVISDDIEWP--EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWN 282
Query: 284 DFL 286
L
Sbjct: 283 GLL 285
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 81/271 (29%), Positives = 131/271 (48%), Gaps = 30/271 (11%)
Query: 22 VGEGVSATVYRALCIPLNEIVAIKVL--DLEKCNNDLDGIRREVQTMRVT-NHPNVLRAH 78
+G+G V A + A+KVL D+ ++D++ E + + + NHP + + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 79 CSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIH 137
C F T L+ VM ++ GG + HI KS F+E E AL++LH G I+
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKGIIY 119
Query: 138 RDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ-RSRNTFVGTPCWMAPEVMQQLHGYD 196
RD+K N+L+D G KLADFG M G ++ +TF GTP ++APE++Q++ Y
Sbjct: 120 RDLKLDNVLLDHEGHCKLADFG----MCKEGIFNGKTTSTFCGTPDYIAPEILQEML-YG 174
Query: 197 FKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA---PPGLDYERDKRFSKSFKEL 253
D W+ G+ E+ GHAPF + L + P L + ++
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAV--------DI 226
Query: 254 VTACLVKDPKKRPTA------EKLMKHHFFK 278
+ A + K+P R + E +++H FFK
Sbjct: 227 LKAFMTKNPTMRLGSLTLGGEEAILRHPFFK 257
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 86/295 (29%), Positives = 128/295 (43%), Gaps = 53/295 (17%)
Query: 22 VGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR----REVQTMRVTNHPNVLRA 77
+GEG VYRA EIVA+K + ++ N+ DGI RE+ + HPN++
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMD---NERDGIPISSLREITLLLNLRHPNIVEL 71
Query: 78 HCSFTTGH--CLWVVMPYMAGGSCLHIMKS---AYPEGFEEPVIATLLRETLKALVYLHF 132
H +++VM Y C + S P F E + L+ + L+ L YLH
Sbjct: 72 KEVVVGKHLDSIFLVMEY-----CEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE 126
Query: 133 HGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQL 192
+ IHRD+K N+L+ G +K+ADFG+ A + G + V T + APE++
Sbjct: 127 NFIIHRDLKVSNLLLTDKGCLKIADFGL-ARTY--GLPAKPMTPKVVTLWYRAPELLLGC 183
Query: 193 HGYDFKADIWSFGITALELAHGHAPFSKYPPMKV------LLMTLQNAP-----PGLD-- 239
Y D+W+ G EL H P P K L++ L P PG
Sbjct: 184 TTYTTAIDMWAVGCILAELL-AHKPLL---PGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239
Query: 240 ------------YERDKR----FSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278
Y K S++ L+ L+ DPKKR TAE+ ++ +FK
Sbjct: 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-23
Identities = 87/293 (29%), Positives = 141/293 (48%), Gaps = 31/293 (10%)
Query: 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRR----- 61
++ + A+DY + + +G G V ++ A+K+L + + I+R
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLL------SKFEMIKRSDSAF 89
Query: 62 ---EVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKS-AYPEGFEEPVIA 117
E M N P V++ C+F L++VM YM GG +++M + PE + + A
Sbjct: 90 FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTA 149
Query: 118 TLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTF 177
E + AL +H G IHRDVK N+L+D +G +KLADFG M + G +T
Sbjct: 150 ----EVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG--MVRCDTA 203
Query: 178 VGTPCWMAPEVMQQLHG---YDFKADIWSFGITALELAHGHAPFSKYPPMKVL--LMTLQ 232
VGTP +++PEV++ G Y + D WS G+ E+ G PF + +M +
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK 263
Query: 233 NAPPGLDYERDKRFSKSFKELVTACLVKDPKK--RPTAEKLMKHHFFKHARSN 283
N+ L++ D SK K L+ A L + R E++ +H FFK+ + N
Sbjct: 264 NS---LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWN 313
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 79/260 (30%), Positives = 122/260 (46%), Gaps = 19/260 (7%)
Query: 39 NEIVAIKVLD---LEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMA 95
+I A+KVL + + D + E + HP ++ +F TG L++++ Y++
Sbjct: 24 GKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLS 83
Query: 96 GGSC-LHIMKSAYPEG-FEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAI 153
GG +H+ + EG F E L E AL +LH G I+RD+K NIL+D+ G +
Sbjct: 84 GGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHV 139
Query: 154 KLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH 213
KL DFG+ G +TF GT +MAPE++ + G+ D WS G ++
Sbjct: 140 KLTDFGLCKESIHEGTVT---HTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLT 195
Query: 214 GHAPFSKYPPMKVLLMTLQ---NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEK 270
G PF+ K + L+ N PP L E K K ++ L P A +
Sbjct: 196 GAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGD---AAE 252
Query: 271 LMKHHFFKHARSNDFLARSI 290
+ H FF+H +D LAR +
Sbjct: 253 VQSHPFFRHVNWDDLLARKV 272
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 74/270 (27%), Positives = 124/270 (45%), Gaps = 21/270 (7%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVL------DLEKCNNDLDGIRREVQTMRVT 69
Y L + +G+G TVY +KVL +L N+ +E Q +
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNP--NETVQANQEAQLLSKL 59
Query: 70 NHPNVLRAHCSFTTGHCLWVVMPYMAGGSC---LHIMKSAYPEGFEEPVIATLLRETLKA 126
+HP +++ H SF ++ Y G L +K + E + + L
Sbjct: 60 DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHT-GKTLSENQVCEWFIQLLLG 118
Query: 127 LVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAP 186
+ Y+H +HRD+KA NI + +N +K+ DFGVS + + D TF GTP +M+P
Sbjct: 119 VHYMHQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLA---TTFTGTPYYMSP 174
Query: 187 EVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246
E ++ GYD K+DIWS G E+ F + V+L ++ P L + +
Sbjct: 175 EALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL----PETY 229
Query: 247 SKSFKELVTACLVKDPKKRPTAEKLMKHHF 276
S+ ++ + L KDP RP+A +++++ F
Sbjct: 230 SRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 81/308 (26%), Positives = 126/308 (40%), Gaps = 50/308 (16%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGI----RREVQTMRVTN 70
DY + ++GEG VY+A I +VA+K + + +N+ DG RE++ ++
Sbjct: 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILM---HNEKDGFPITALREIKILKKLK 65
Query: 71 HPNVL--------RAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRE 122
HPNV+ R S +++V PYM L + E I + +
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD--HDLSGLLENPSVKLTESQIKCYMLQ 123
Query: 123 TLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVS--------ACMFDAGDRQRSR 174
L+ + YLH + +HRD+KA NILID+ G +K+ADFG++ G R
Sbjct: 124 LLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY 183
Query: 175 NTFVGTPCWMAPEVMQQLHGYDFKADIWSFGIT-------------ALELAHGHAPFSKY 221
V T + PE++ Y DIW G ++ H F
Sbjct: 184 TNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243
Query: 222 PPMKVLLMTLQNAPPG-------LDYER--DKRFSKSFKE---LVTACLVKDPKKRPTAE 269
+ PG +Y R ++RF K E L++ L DP KR TA
Sbjct: 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTAS 303
Query: 270 KLMKHHFF 277
++H +F
Sbjct: 304 DALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 79/249 (31%), Positives = 130/249 (52%), Gaps = 22/249 (8%)
Query: 60 RREVQTMR-VTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIA 117
R E Q + + P ++ H +F T L +++ Y+ GG H+ + E F+E +
Sbjct: 52 RTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR---ERFKEQEVQ 108
Query: 118 TLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTF 177
E + AL +LH G I+RD+K NIL+DSNG + L DFG+S F + +R+ + F
Sbjct: 109 IYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFHEDEVERAYS-F 166
Query: 178 VGTPCWMAPEVMQQLH-GYDFKADIWSFGITALELAHGHAPFS----KYPPMKVLLMTLQ 232
GT +MAP++++ G+D D WS G+ EL G +PF+ K ++ L+
Sbjct: 167 CGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK 226
Query: 233 NAPPGLDYERDKRFSKSFKELVTACLVKDPKKR----PT-AEKLMKHHFFKHARSNDFLA 287
+ PP Y ++ S K+++ L+KDPKKR P+ A+++ KH FF+ +D A
Sbjct: 227 SEPP---YPQE--MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAA 281
Query: 288 RSIVDNLAP 296
+ + P
Sbjct: 282 KKVPAPFKP 290
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-23
Identities = 75/284 (26%), Positives = 123/284 (43%), Gaps = 53/284 (18%)
Query: 39 NEIVAIKVLD----LEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYM 94
I A+K L LEK + +R E + ++P V++ + SF + L+++M Y+
Sbjct: 26 GHIYAMKKLRKSEMLEK--EQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYL 83
Query: 95 AGGSCLH-IMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAI 153
GG + +MK + F E + ET+ A+ +H G+IHRD+K N+L+D+ G I
Sbjct: 84 PGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHI 140
Query: 154 KLADFGVSACM-----------------------------FDAGDR----QRSRNTF--- 177
KL+DFG+ C + + +R+R
Sbjct: 141 KLSDFGL--CTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYS 198
Query: 178 -VGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP 236
VGTP ++APEV Q GY+ + D WS G+ E+ G+ PF P + + N
Sbjct: 199 TVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKII-NWKE 256
Query: 237 GLDYERDKRFSKSFKELVT--ACLVKDPKKRPTAEKLMKHHFFK 278
L + + S K+L+ C + ++ H FFK
Sbjct: 257 TLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFK 300
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 8e-23
Identities = 89/300 (29%), Positives = 140/300 (46%), Gaps = 32/300 (10%)
Query: 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRR--------EVQ 64
A+DY + + +G G V ++ A+K+L + + I+R E
Sbjct: 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL------SKFEMIKRSDSAFFWEERD 95
Query: 65 TMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKS-AYPEGFEEPVIATLLRET 123
M N P V++ +F L++VM YM GG +++M + PE + A E
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA----EV 151
Query: 124 LKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCW 183
+ AL +H G IHRDVK N+L+D +G +KLADFG CM + +T VGTP +
Sbjct: 152 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG--TCMKMNKEGMVRCDTAVGTPDY 209
Query: 184 MAPEVMQQLHG---YDFKADIWSFGITALELAHGHAPFSKYPPMKV-LLMTLQNAPPGLD 239
++PEV++ G Y + D WS G+ E+ G PF Y V + N L
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF--YADSLVGTYSKIMNHKNSLT 267
Query: 240 YERDKRFSKSFKELVTACLVKDPKK--RPTAEKLMKHHFFKHARSNDFLARSIVDNLAPL 297
+ D SK K L+ A L + R E++ +H FFK ++ + ++ D +AP+
Sbjct: 268 FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFK---NDQWAWETLRDTVAPV 324
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 9e-23
Identities = 79/268 (29%), Positives = 120/268 (44%), Gaps = 22/268 (8%)
Query: 22 VGEGVSATVYRALCIPLNEIVAIKVLD-----LEKCNNDLDGIRREVQTMRVTNHPNVLR 76
+G+G VY+ I A+KVL +K G R + + P ++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 77 AHCSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEG-FEEPVIATLLRETLKALVYLHFHG 134
SF T L++V YM+GG H+ K EG F E + E + AL +LH +
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYD 116
Query: 135 HIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHG 194
++RD+K NIL+D+ G I L DFG+S + NTF GT ++APEV+ G
Sbjct: 117 IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK---TTNTFCGTTEYLAPEVLLDEKG 173
Query: 195 YDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELV 254
Y D WS G+ E+ G +PF Y M A + + ++ S ++ V
Sbjct: 174 YTKHVDFWSLGVLVFEMCCGWSPF--YAE-DTQQMYRNIAFGKVRFPKNV-LSDEGRQFV 229
Query: 255 TACLVKDPKKR----PTAEKLMKHHFFK 278
L ++P+ R A +L +H FF
Sbjct: 230 KGLLNRNPQHRLGAHRDAVELKEHPFFA 257
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 1e-22
Identities = 74/246 (30%), Positives = 123/246 (50%), Gaps = 19/246 (7%)
Query: 39 NEIVAIKVL--DLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHCSFTTGHCLWVVMPYMA 95
E A+K L D+ ++D++ E + + + +P + +C+F T L+ VM ++
Sbjct: 20 GEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN 79
Query: 96 GGSCL-HIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIK 154
GG + HI + + A E + L +LH G I+RD+K N+++D +G IK
Sbjct: 80 GGDLMFHIQDKGRFDLYRATFYAA---EIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIK 136
Query: 155 LADFGVSACMFDA-GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH 213
+ADFG+ C + GD + S TF GTP ++APE++Q L Y F D WSFG+ E+
Sbjct: 137 IADFGM--CKENVFGDNRAS--TFCGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLI 191
Query: 214 GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273
G +PF ++ + P Y R +K K+++ +DP +R ++
Sbjct: 192 GQSPFHGDDEDELFESIRVDTP---HYPR--WITKESKDILEKLFERDPTRRLGVVGNIR 246
Query: 274 -HHFFK 278
H FFK
Sbjct: 247 GHPFFK 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 1e-22
Identities = 69/261 (26%), Positives = 121/261 (46%), Gaps = 23/261 (8%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEI-VAIKVLDLEKCNNDL--DGIRREVQTMRVTN 70
+++ L ++G G V+ L N + VAIK+L K ++ L ++EVQ ++
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLW--KNRVRVAIKIL---KSDDLLKQQDFQKEVQALKRLR 60
Query: 71 HPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLR---ETLKAL 127
H +++ + G ++++ M GS L ++S PEG PV A+L+ + + +
Sbjct: 61 HKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRS--PEGQVLPV-ASLIDMACQVAEGM 117
Query: 128 VYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPE 187
YL IHRD+ A NIL+ + K+ADFG++ + + D S + + W APE
Sbjct: 118 AYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE--DVYLSSDKKIPYK-WTAPE 174
Query: 188 VMQQLHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246
+ K+D+WSFGI E+ +G P YP M G +
Sbjct: 175 AASHGT-FSTKSDVWSFGILLYEMFTYGQVP---YPGMNN-HEVYDQITAGYRMPCPAKC 229
Query: 247 SKSFKELVTACLVKDPKKRPT 267
+ +++ C +P+ RP+
Sbjct: 230 PQEIYKIMLECWAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 17/219 (7%)
Query: 21 EVGEGVSATVYRALCIPLN----EIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNV-- 74
++GEG V PL E VA+K L+ RE++ +R +H N+
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 75 LRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETL---KALVYLH 131
+ C G L ++M Y+ GS ++ ++ + LL + K + YL
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGS----LRDYLQRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 132 FHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQ 191
+IHRD+ A NIL++S +K++DFG++ + + D + W APE ++
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT 186
Query: 192 LHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLM 229
+ +D+WSFG+T EL +G S+ PP + L M
Sbjct: 187 -SKFSSASDVWSFGVTLYELFTYGDP--SQSPPAEFLRM 222
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 75/283 (26%), Positives = 122/283 (43%), Gaps = 21/283 (7%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN--DLDGIRREVQTMRVTNHP 72
D + VG G V+ A+KV+ + + + E + ++ +HP
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 73 NVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF 132
++R + L+++M Y+ GG ++++ F E + AL YLH
Sbjct: 62 FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHS 119
Query: 133 HGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQL 192
++RD+K NIL+D G IKL DFG F R R+ T GTP ++APEV+Q
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDFG-----FAKKLRDRTW-TLCGTPEYLAPEVIQS- 172
Query: 193 HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKE 252
G++ D W+ GI E+ G+ PF P + L L++ R K+
Sbjct: 173 KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK---LEFPR--HLDLYAKD 227
Query: 253 LVTACLVKDPKKR-----PTAEKLMKHHFFKHARSNDFLARSI 290
L+ LV D +R A+ + H +FK +D R +
Sbjct: 228 LIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKL 270
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 3e-22
Identities = 83/277 (29%), Positives = 134/277 (48%), Gaps = 27/277 (9%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVL--DLEKCNNDLDGIRREVQTMRVTNHP 72
D+ +G+G V A +E+ AIK+L D+ ++D++ E + + ++ P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 73 NVL-RAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLH 131
L + H F T L+ VM Y+ GG ++ ++ F+EP E L +LH
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLH 118
Query: 132 FHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQ 191
G I+RD+K N+++DS G IK+ADFG+ C + D ++ TF GTP ++APE++
Sbjct: 119 SKGIIYRDLKLDNVMLDSEGHIKIADFGM--CKENMWDGVTTK-TFCGTPDYIAPEII-A 174
Query: 192 LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSF- 250
Y D W+FG+ E+ G APF ++ + E + + KS
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM---------EHNVAYPKSMS 225
Query: 251 KELVTAC---LVKDPKKR----PTAEKLMKHH-FFKH 279
KE V C + K P KR P E+ +K H FF++
Sbjct: 226 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 262
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 5e-22
Identities = 82/293 (27%), Positives = 137/293 (46%), Gaps = 27/293 (9%)
Query: 15 DYRLYEEVGEGVSATVY--RALCIP-LNEIVAIKVLD---LEKCNNDLDGIRREVQTMR- 67
++ L + +G G V+ R + ++ A+KVL L + ++ R E +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 68 VTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLLRETLKA 126
V P ++ H +F T L +++ Y++GG H+ + F E + E + A
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDN---FSEDEVRFYSGEIILA 117
Query: 127 LVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAP 186
L +LH G ++RD+K NIL+DS G + L DFG+S F + +++R+ +F GT +MAP
Sbjct: 118 LEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSK-EFLSEEKERTY-SFCGTIEYMAP 175
Query: 187 EVMQQLHGYDFKADIWSFGITALELAHGHAPFS----KYPPMKVLLMTLQNAPPGLDYER 242
E+++ G+ D WS GI EL G +PF+ + +V L+ PP
Sbjct: 176 EIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP-----F 230
Query: 243 DKRFSKSFKELVTACLVKDPKKR-----PTAEKLMKHHFFKHARSNDFLARSI 290
++L+ L KDPKKR A ++ +H FFK R +
Sbjct: 231 PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKV 283
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 5e-22
Identities = 76/292 (26%), Positives = 124/292 (42%), Gaps = 51/292 (17%)
Query: 24 EGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR----REVQTMRVTNHPNVL--RA 77
EG VYRA EIVA+K L +EK + +G RE+ + HPN++ +
Sbjct: 15 EGTYGVVYRARDKKTGEIVALKKLKMEK---EKEGFPITSLREINILLKLQHPNIVTVKE 71
Query: 78 HCSFTTGHCLWVVMPYMAGGSCLHIMKSA---YPEGFEEPVIATLLRETLKALVYLHFHG 134
+ +++VM Y+ H +KS + F + + L+ + L + +LH +
Sbjct: 72 VVVGSNLDKIYMVMEYVE-----HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW 126
Query: 135 HIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHG 194
+HRD+K N+L+++ G +K+ DFG+ A + G + V T + APE++
Sbjct: 127 ILHRDLKTSNLLLNNRGILKICDFGL-AREY--GSPLKPYTQLVVTLWYRAPELLLGAKE 183
Query: 195 YDFKADIWSFG------ITALELAHGHAP---------------------FSKYPPMKVL 227
Y D+WS G +T L G + FS+ P K
Sbjct: 184 YSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK-- 241
Query: 228 LMTLQNAPPGLDYERDKRFSKSFK--ELVTACLVKDPKKRPTAEKLMKHHFF 277
T P ++ S S +L+ L DP KR +AE +KH +F
Sbjct: 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 6e-22
Identities = 72/242 (29%), Positives = 111/242 (45%), Gaps = 20/242 (8%)
Query: 62 EVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLL 120
E + ++ T HP + SF T L VM Y+ GG H+ + F E
Sbjct: 45 ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERV---FSEDRTRFYG 101
Query: 121 RETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGV-SACMFDAGDRQRSRNTFVG 179
E + AL YLH ++RD+K N+++D +G IK+ DFG+ + DA + TF G
Sbjct: 102 AEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA----TMKTFCG 157
Query: 180 TPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD 239
TP ++APEV++ + Y D W G+ E+ G PF K+ + L D
Sbjct: 158 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----D 211
Query: 240 YERDKRFSKSFKELVTACLVKDPKKR-----PTAEKLMKHHFFKHARSNDFLARSIVDNL 294
+ + S K L++ L+KDP KR A+++M+H FF D + +V
Sbjct: 212 IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPF 271
Query: 295 AP 296
P
Sbjct: 272 KP 273
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 6e-22
Identities = 83/314 (26%), Positives = 129/314 (41%), Gaps = 48/314 (15%)
Query: 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR------RE 62
F V ++ Y+ E +G G V A+ + VAIK K + D RE
Sbjct: 1 FDVGSR-YKPIENIGSGAYGVVCSAIDTRSGKKVAIK-----KIPHAFDVPTLAKRTLRE 54
Query: 63 VQTMRVTNHPNVLRAHCSFTT----GHCLWVVMPYMAGGSCLH-IMKSAYPEGFEEPVIA 117
++ +R H N++ ++VVM M S LH I+ S P E I
Sbjct: 55 LKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM--ESDLHHIIHSDQP--LTEEHIR 110
Query: 118 TLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNT- 176
L + L+ L Y+H IHRD+K N+L++ + +++ DFG++ + + + T
Sbjct: 111 YFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTE 170
Query: 177 FVGTPCWMAPEVMQQLHGYDFKADIWSFG-ITALELAHGHA-PFSKY------------- 221
+V T + APE++ L Y D+WS G I A L P Y
Sbjct: 171 YVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGS 230
Query: 222 PPMKVLLMT--------LQNAPPGLDYERDKRFSKSFKE---LVTACLVKDPKKRPTAEK 270
P +VL +QN P K F K+ E L++ L DP++R T E+
Sbjct: 231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQ 290
Query: 271 LMKHHFFKHARSND 284
++H F D
Sbjct: 291 ALQHPFLAQYHDPD 304
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 7e-22
Identities = 69/269 (25%), Positives = 126/269 (46%), Gaps = 22/269 (8%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEI-VAIKVLDLEKCNNDLDGIRREVQTMRVT 69
+D + +E+G G V+ +I VAIK++ E ++ D I E + M
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKW--RGKIDVAIKMIR-EGAMSEDDFIE-EAKVMMKL 56
Query: 70 NHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVY 129
+HPN+++ + T +++V YMA G L+ ++ + + + +A+ Y
Sbjct: 57 SHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLR-ERKGKLGTEWLLDMCSDVCEAMEY 115
Query: 130 LHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGT--PC-WMAP 186
L +G IHRD+ A N L+ + +K++DFG++ + D D+ S GT P W P
Sbjct: 116 LESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD--DQYTSS---QGTKFPVKWAPP 170
Query: 187 EVMQQLHG-YDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244
EV + + K+D+WSFG+ E+ + G P+ ++ +V+ G R K
Sbjct: 171 EVF--DYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA----GYRLYRPK 224
Query: 245 RFSKSFKELVTACLVKDPKKRPTAEKLMK 273
++ +C + P+ RP +KL+
Sbjct: 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLS 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 8e-22
Identities = 72/234 (30%), Positives = 108/234 (46%), Gaps = 32/234 (13%)
Query: 70 NHPNVLRAHCSFTTGHCLWVVMPYMAGGSCL-----HIMKSAYPEGFEEPVIATLLRETL 124
NHP +++ H +F T L++++ ++ GG +M F E + L E
Sbjct: 56 NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM-------FTEEDVKFYLAELA 108
Query: 125 KALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWM 184
AL +LH G I+RD+K NIL+D G IKL DFG+S ++ D ++ +F GT +M
Sbjct: 109 LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYM 165
Query: 185 APEVMQQLHGYDFKADIWSFGITALELAHGHAPF---SKYPPMKVLLMTLQNAPPGLDYE 241
APEV+ + G+ AD WSFG+ E+ G PF + M ++L P L E
Sbjct: 166 APEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPE 224
Query: 242 RDKRFSKSFKELVTACLVKDPKKRPTA-----EKLMKHHFFKHARSNDFLARSI 290
FK ++P R A E++ +H FF N R I
Sbjct: 225 AQSLLRALFK--------RNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREI 270
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 8e-22
Identities = 85/275 (30%), Positives = 131/275 (47%), Gaps = 25/275 (9%)
Query: 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNH 71
AK Y + +G G + TV A + E A+KV+D+E + D + + EV + +
Sbjct: 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDF 90
Query: 72 PNVLRAHCSFTTGH--------CLWVVMPYMAGGSCLHIMKSAYPEG--FEEPVIATLLR 121
++++ H F + +V+ Y G +KS F E L
Sbjct: 91 FSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFI 150
Query: 122 ETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTP 181
+ L A+ ++H IHRD+K+ NIL+ SNG +KL DFG S M+ A TF GTP
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK-MYAATVSDDVGRTFCGTP 209
Query: 182 CWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA----PPG 237
++APE+ ++ Y KAD++S G+ EL PF +V+ TL PP
Sbjct: 210 YYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPS 268
Query: 238 LDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLM 272
+ S +E+VTA L DPK+RP++ KL+
Sbjct: 269 I--------SPEMQEIVTALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 8e-22
Identities = 57/217 (26%), Positives = 105/217 (48%), Gaps = 8/217 (3%)
Query: 60 RREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATL 119
R+EV + HPN+++ SF L++VM Y GG + + F E I
Sbjct: 47 RKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW 106
Query: 120 LRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVG 179
+ AL ++H +HRD+K+ NI + +G IKL DFG++ + + R T +G
Sbjct: 107 FVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR---TCIG 163
Query: 180 TPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD 239
TP +++PE+ + Y+ K+DIW+ G E+ F ++L ++ + P +
Sbjct: 164 TPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV- 221
Query: 240 YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHF 276
+S + LV+ ++P+ RP+ +++ +F
Sbjct: 222 ---SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNF 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 75/296 (25%), Positives = 134/296 (45%), Gaps = 47/296 (15%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR----REVQTMRVTNH 71
Y E++GEG TV++A +EIVA+K + L+ +D +G+ RE+ ++ H
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD---DDDEGVPSSALREICLLKELKH 58
Query: 72 PNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPE---GFEEPVIATLLRETLKALV 128
N++R + + L +V Y C +K + + ++ + + + LK L
Sbjct: 59 KNIVRLYDVLHSDKKLTLVFEY-----CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLA 113
Query: 129 YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEV 188
+ H H +HRD+K N+LI+ NG +KLADFG++ G R + V T + P+V
Sbjct: 114 FCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAF---GIPVRCYSAEVVTLWYRPPDV 170
Query: 189 MQQLHGYDFKADIWSFGITALELAHGHAPFSKYPP----------MKVLLMTLQNAPPGL 238
+ Y D+WS G ELA+ P +P ++L + + PG+
Sbjct: 171 LFGAKLYSTSIDMWSAGCIFAELANAGRPL--FPGNDVDDQLKRIFRLLGTPTEESWPGV 228
Query: 239 DYERDKRFSKSF-----------------KELVTACLVKDPKKRPTAEKLMKHHFF 277
D + + ++L+ LV +P +R +AE+ ++H +F
Sbjct: 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 1e-21
Identities = 68/202 (33%), Positives = 101/202 (50%), Gaps = 13/202 (6%)
Query: 22 VGEGVSATVYRALCIPLNEIVAIKVLDLEKCNND--LDGIRREVQTM-RVTNHPNVLRAH 78
+G G A V I A+KV+ E N+D +D ++ E + +NHP ++ H
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 79 CSFTTGHCLWVVMPYMAGGSCLHIMKS--AYPEGFEEPVIATLLRETLKALVYLHFHGHI 136
F T L+ V+ Y+ GG + M+ PE A E AL YLH G I
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA----EISLALNYLHERGII 118
Query: 137 HRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYD 196
+RD+K N+L+DS G IKL D+G+ GD + +TF GTP ++APE+++ Y
Sbjct: 119 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAPEILRG-EDYG 174
Query: 197 FKADIWSFGITALELAHGHAPF 218
F D W+ G+ E+ G +PF
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 2e-21
Identities = 65/202 (32%), Positives = 101/202 (50%), Gaps = 13/202 (6%)
Query: 22 VGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN--DLDGIRREVQTMR-VTNHPNVLRAH 78
+G G A V I A+KV+ E N+ D+D ++ E +NHP ++ H
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 79 CSFTTGHCLWVVMPYMAGGSCLHIMKSA--YPEGFEEPVIATLLRETLKALVYLHFHGHI 136
F T L+ V+ +++GG + M+ PE A E AL +LH G I
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSA----EISLALNFLHERGII 118
Query: 137 HRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYD 196
+RD+K N+L+D+ G IKL D+G+ GD + +TF GTP ++APE+++ Y
Sbjct: 119 YRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---TTSTFCGTPNYIAPEILRG-EDYG 174
Query: 197 FKADIWSFGITALELAHGHAPF 218
F D W+ G+ E+ G +PF
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 2e-21
Identities = 72/284 (25%), Positives = 117/284 (41%), Gaps = 23/284 (8%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHP 72
D+ + E +G G V A E AIK L + + + +E + +HP
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 73 NVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF 132
++ CSF + ++ ++ ++ GG ++ A F V E + A YLH
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHS 136
Query: 133 HGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRN-TFVGTPCWMAPEVMQQ 191
I+RD+K N+L+D+ G +K+ DFG + + R T GTP ++APEV+Q
Sbjct: 137 KDIIYRDLKPENLLLDNKGHVKVTDFGFA-------KKVPDRTFTLCGTPEYLAPEVIQS 189
Query: 192 LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251
G+ D W+ G+ E G+ PF P ++ L + F +
Sbjct: 190 -KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR-----LKFPNWFDGRAR 243
Query: 252 ELVTACLVKDPKKRPTAEK-----LMKHHFFKHARSNDFLARSI 290
+LV L D KR K + H +F A + AR
Sbjct: 244 DLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYY 287
|
Length = 329 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 71/241 (29%), Positives = 110/241 (45%), Gaps = 20/241 (8%)
Query: 42 VAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLH 101
VA+K L + + +E Q M+ H +++ + + +++V YM+ GS L
Sbjct: 33 VAVKTL--KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLD 90
Query: 102 IMKSAYPEG--FEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFG 159
+KS EG P + + + + + YL +IHRD+ A NIL+ N K+ADFG
Sbjct: 91 FLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFG 148
Query: 160 VSACMFDAGDRQRSRNTFVGTPC-WMAPEVMQQLHG-YDFKADIWSFGITALEL-AHGHA 216
++ + D R F P W APE +G + K+D+WSFGI E+ +G
Sbjct: 149 LARLIEDDEYTAREGAKF---PIKWTAPEAA--NYGRFTIKSDVWSFGILLTEIVTYGRV 203
Query: 217 PFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHF 276
P YP M L+ G R + +L+ C KDP++RPT E L F
Sbjct: 204 P---YPGM-TNREVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYL--QSF 257
Query: 277 F 277
Sbjct: 258 L 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 75/311 (24%), Positives = 120/311 (38%), Gaps = 64/311 (20%)
Query: 22 VGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR-------------REVQTMRV 68
+GEG V +A +IVAIK + + + +ND+ R RE++ M
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 69 TNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEG--FEEPVIATLLRETLKA 126
H N++ + G + +VM MA +K E + +L + L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMASD-----LKKVVDRKIRLTESQVKCILLQILNG 131
Query: 127 LVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSAC---------MFDAGDRQRSRN-- 175
L LH +HRD+ NI I+S G K+ADFG++ + QR
Sbjct: 132 LNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT 191
Query: 176 TFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPF----------------- 218
+ V T + APE++ Y F D+WS G EL G F
Sbjct: 192 SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLG 251
Query: 219 ----SKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK-------ELVTACLVKDPKKRPT 267
+P K L + + P + K F +L+ + L +P +R +
Sbjct: 252 TPNEDNWPQAKKLPLYTEFTP-----RKPKDLKTIFPNASDDAIDLLQSLLKLNPLERIS 306
Query: 268 AEKLMKHHFFK 278
A++ +KH +FK
Sbjct: 307 AKEALKHEYFK 317
|
Length = 335 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 69/267 (25%), Positives = 111/267 (41%), Gaps = 21/267 (7%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN 70
+D +L ++G G V+ L N + V L+ D E Q M+
Sbjct: 3 IDRTSIQLLRKLGAGQFGEVWEGL---WNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLR 59
Query: 71 HPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYL 130
HP +++ + T +++V M GS L ++ + P + + + + YL
Sbjct: 60 HPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL 119
Query: 131 HFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-WMAPEVM 189
+IHRD+ A N+L+ N K+ADFG++ + + R F P W APE
Sbjct: 120 EAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF---PIKWTAPEAA 176
Query: 190 QQLHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQN----APPGLDYERDK 244
+ K+D+WSFGI E+ +G P+ +VL Q PPG
Sbjct: 177 LYNR-FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGC------ 229
Query: 245 RFSKSFKELVTACLVKDPKKRPTAEKL 271
K +++ C +DP RPT E L
Sbjct: 230 --PKELYDIMLDCWKEDPDDRPTFETL 254
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 9e-21
Identities = 59/235 (25%), Positives = 116/235 (49%), Gaps = 17/235 (7%)
Query: 42 VAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLH 101
VAIK++ ++ + D E + M +H +++ + T +++V YM+ G L+
Sbjct: 31 VAIKMI--KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLN 88
Query: 102 IMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVS 161
++ + F+ + + ++ + + YL IHRD+ A N L+D G +K++DFG+S
Sbjct: 89 YLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLS 147
Query: 162 ACMFDAGDRQRSRNTFVGT--PC-WMAPEVMQQLHGYDFKADIWSFGITALEL-AHGHAP 217
+ D D S VG+ P W PEV+ + K+D+W+FG+ E+ + G P
Sbjct: 148 RYVLD--DEYTSS---VGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMP 201
Query: 218 FSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLM 272
+ ++ + + Q GL R S+ ++ +C + ++RPT ++L+
Sbjct: 202 YERFNNSETVEKVSQ----GLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 9e-21
Identities = 81/268 (30%), Positives = 128/268 (47%), Gaps = 28/268 (10%)
Query: 22 VGEGVSATVYRALCIPLNEIVAIKVL--DLEKCNNDLDGIRREVQTMRVTNHPNVL-RAH 78
+G+G V A +E+ AIK+L D+ ++D++ E + + + + P L + H
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 79 CSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIH 137
F T L+ VM Y+ GG + HI + F+EP E L +LH G I+
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRRGIIY 124
Query: 138 RDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDF 197
RD+K N+++DS G IK+ADFG+ C D +R TF GTP ++APE++ Y
Sbjct: 125 RDLKLDNVMLDSEGHIKIADFGM--CKEHMVDGVTTR-TFCGTPDYIAPEII-AYQPYGK 180
Query: 198 KADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSF-KELVTA 256
D W++G+ E+ G PF ++ + E + + KS KE V+
Sbjct: 181 SVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM---------EHNVSYPKSLSKEAVSI 231
Query: 257 C---LVKDPKKR----PTAEKLMKHHFF 277
C + K P KR P E+ ++ H F
Sbjct: 232 CKGLMTKHPSKRLGCGPEGERDIREHAF 259
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 9e-21
Identities = 65/234 (27%), Positives = 116/234 (49%), Gaps = 13/234 (5%)
Query: 42 VAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLH 101
VAIK ++ E ++ D I E + M +HP +++ + T L++V +M G L+
Sbjct: 31 VAIKAIN-EGAMSEEDFIE-EAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLN 88
Query: 102 IMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVS 161
++ + + ++ ++ ++ + + YL + IHRD+ A N L+ S G +K++DFG++
Sbjct: 89 YLRQRQGK-LSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMT 147
Query: 162 ACMFDAGDRQRSRNTFVGTPC-WMAPEVMQQLHGYDFKADIWSFGITALEL-AHGHAPFS 219
+ D S F P W PEV Y K+D+WSFG+ E+ G PF
Sbjct: 148 RYVLDDEYTSSSGAKF---PVKWSPPEVF-NFSKYSSKSDVWSFGVLMWEVFTEGKMPFE 203
Query: 220 KYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273
K +V+ M + G R K S + E++ +C + P+ RPT +L++
Sbjct: 204 KKSNYEVVEMISR----GFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVL 75
++ E++GEG ATVY+ EIVA+K + L+ RE+ M+ H N++
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 76 RAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGH 135
R H T + L +V YM ++ + + + + LK + + H +
Sbjct: 62 RLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRV 121
Query: 136 IHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS----RNTF---VGTPCWMAPEV 188
+HRD+K N+LI+ G +KLADFG++ R+ NTF V T + AP+V
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLA----------RAFGIPVNTFSNEVVTLWYRAPDV 171
Query: 189 MQQLHGYDFKADIWSFGITALELAHGHAPF 218
+ Y DIWS G E+ G F
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITGRPLF 201
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 1e-20
Identities = 70/258 (27%), Positives = 116/258 (44%), Gaps = 16/258 (6%)
Query: 17 RLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLR 76
RL ++G+G V+ N + + L+ + +E Q M+ H +++
Sbjct: 9 RLEVKLGQGCFGEVWMG---TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 65
Query: 77 AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHI 136
+ + + +++V YM+ GS L +K + P + + + + Y+ ++
Sbjct: 66 LY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 124
Query: 137 HRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-WMAPEVMQQLHG- 194
HRD++A NIL+ N K+ADFG++ + D R F P W APE L+G
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF---PIKWTAPEA--ALYGR 179
Query: 195 YDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL 253
+ K+D+WSFGI EL G P YP M V L G +S +L
Sbjct: 180 FTIKSDVWSFGILLTELTTKGRVP---YPGM-VNREVLDQVERGYRMPCPPECPESLHDL 235
Query: 254 VTACLVKDPKKRPTAEKL 271
+ C K+P++RPT E L
Sbjct: 236 MCQCWRKEPEERPTFEYL 253
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 67/272 (24%), Positives = 114/272 (41%), Gaps = 36/272 (13%)
Query: 16 YRLYEEVGEGVSATVYR-------ALCIPLNEIVAIKVLDLEKCNNDLD-GIRREVQTMR 67
Y + E +G G VY+ + L EI + K + D I V +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEI-NVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 68 VT----NHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEG--FEEPVIATLLR 121
+ HPN++R + +F L++VM + G S + F E I +
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 122 ETLKALVYLHFHGHI-HRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTF--- 177
+ + AL YLH I HRD+ NI++ + + + DFG++ +Q+ +
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA--------KQKQPESKLTS 172
Query: 178 -VGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP 236
VGT + PE+++ Y KAD+W+FG ++ PF M L + A
Sbjct: 173 VVGTILYSCPEIVKNE-PYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEA-- 228
Query: 237 GLDYE--RDKRFSKSFKELVTACLVKDPKKRP 266
YE + +S+ +++T+CL D + RP
Sbjct: 229 --VYEPLPEGMYSEDVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 75/291 (25%), Positives = 131/291 (45%), Gaps = 34/291 (11%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR----REVQTMRVTN 70
DY E++GEG VY+ +IVA+K + LE ++ +G+ RE+ ++
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLE---SEEEGVPSTAIREISLLKELQ 57
Query: 71 HPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYL 130
HPN++ L+++ +++ ++ + + ++ + L + L+ +++
Sbjct: 58 HPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117
Query: 131 HFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQ 190
H +HRD+K N+LID+ G IKLADFG++ G R V T + APEV+
Sbjct: 118 HSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF---GIPVRVYTHEVVTLWYRAPEVLL 174
Query: 191 QLHGYDFKADIWSFGITALELA------HGHAPFSKYPPMKVLLMTLQNAP-PGL----D 239
Y DIWS G E+A HG + + + +L T PG+ D
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234
Query: 240 YERD-------------KRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277
Y+ K + +L+ L+ DP KR +A+K + H +F
Sbjct: 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 82/308 (26%), Positives = 128/308 (41%), Gaps = 60/308 (19%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR-REVQTMRVTNHPNV 74
Y E++GEG VY+A NE +A+K + LE+ + + RE+ ++ H N+
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 75 LRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEP-VIATLLRETLKALVYLHFH 133
+R + L++V Y+ H M S+ P+ + P +I T L + L+ + Y H H
Sbjct: 64 VRLQDVVHSEKRLYLVFEYLDLDLKKH-MDSS-PDFAKNPRLIKTYLYQILRGIAYCHSH 121
Query: 134 GHIHRDVKAGNILID-SNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQL 192
+HRD+K N+LID A+KLADFG++ G R+ V T + APE++
Sbjct: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAF---GIPVRTFTHEVVTLWYRAPEILLGS 178
Query: 193 HGYDFKADIWSFGITALELAHGHAP----------------------------------- 217
Y DIWS G E+ + P
Sbjct: 179 RHYSTPVDIWSVGCIFAEMVN-QKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY 237
Query: 218 ---FSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274
F K+PP + + P G+D L++ L DP KR TA ++H
Sbjct: 238 KSAFPKWPPKDLATVVPTLEPAGVD-------------LLSKMLRLDPSKRITARAALEH 284
Query: 275 HFFKHARS 282
+FK
Sbjct: 285 EYFKDLGD 292
|
Length = 294 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 3e-20
Identities = 59/235 (25%), Positives = 109/235 (46%), Gaps = 10/235 (4%)
Query: 44 IKVLDLEKCNN-DLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC-LWVVMPYMAGGSCLH 101
IK L+L + + +E Q + HPN++ S+ L++VM + GG H
Sbjct: 30 IKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYH 89
Query: 102 IMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVS 161
+K + E + + AL YLH +HRD+K N+ + IK+ D G++
Sbjct: 90 KLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIA 149
Query: 162 ACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKY 221
+ + D +T +GTP +M+PE+ Y++K+D+W+ G E+A F+
Sbjct: 150 RVLENQCDMA---STLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAK 205
Query: 222 PPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHF 276
++ ++ P + K +S EL+ L K P+KRP+ + +++ +
Sbjct: 206 DMNSLVYRIIEGKLPPM----PKDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 7e-20
Identities = 75/293 (25%), Positives = 122/293 (41%), Gaps = 40/293 (13%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR----REVQTMRVTNH 71
Y VGEG V + +IVAIK LE + D ++ RE++ ++ H
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKF-LE--SEDDKMVKKIAMREIRMLKQLRH 59
Query: 72 PNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLH 131
N++ F L++V ++ + L ++ YP G +E + L + L+ + + H
Sbjct: 60 ENLVNLIEVFRRKKRLYLVFEFV-DHTVLDDLE-KYPNGLDESRVRKYLFQILRGIEFCH 117
Query: 132 FHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQ 191
H IHRD+K NIL+ +G +KL DFG + + G+ +V T + APE++
Sbjct: 118 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYTDYVATRWYRAPELLVG 174
Query: 192 LHGYDFKADIWSFGITALELAHGHA--P-------------------------FSKYPPM 224
Y DIW+ G E+ G P F K P
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234
Query: 225 KVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277
+ + L+ +R + S +L CL DP RP++ +L+ H FF
Sbjct: 235 AGMRLPEVKEIEPLE-KRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 8e-20
Identities = 68/241 (28%), Positives = 108/241 (44%), Gaps = 18/241 (7%)
Query: 62 EVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLL 120
E + ++ T HP + +F T L VM Y GG H+ + F E
Sbjct: 45 ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV---FTEERARFYG 101
Query: 121 RETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGT 180
E + AL YLH ++RD+K N+++D +G IK+ DFG+ C D + TF GT
Sbjct: 102 AEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL--CKEGISDGATMK-TFCGT 158
Query: 181 PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240
P ++APEV++ + Y D W G+ E+ G PF ++ + L +
Sbjct: 159 PEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-----EI 212
Query: 241 ERDKRFSKSFKELVTACLVKDPKKR-----PTAEKLMKHHFFKHARSNDFLARSIVDNLA 295
+ S K L+ L KDPK+R A+++M+H FF D + + ++
Sbjct: 213 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFK 272
Query: 296 P 296
P
Sbjct: 273 P 273
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 9e-20
Identities = 77/256 (30%), Positives = 124/256 (48%), Gaps = 25/256 (9%)
Query: 22 VGEGVSATVYRALCIPLNEIVAIKVLDLEKCNND--LDGIRREVQTM-RVTNHPNVLRAH 78
+G G A V ++I A+KV+ E ++D +D ++ E + +++P ++ H
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 79 CSFTTGHCLWVVMPYMAGGSCLHIMKS--AYPEGFEEPVIATLLRETLKALVYLHFHGHI 136
F T L++V+ Y+ GG + M+ PE A E AL +LH G I
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAA----EICIALNFLHERGII 118
Query: 137 HRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYD 196
+RD+K N+L+D++G IKL D+G+ GD + +TF GTP ++APE+++ Y
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---TTSTFCGTPNYIAPEILRG-EEYG 174
Query: 197 FKADIWSFGITALELAHGHAPF---SKYPPMKV---LLMTLQNAPPGLDYERDKRF-SKS 249
F D W+ G+ E+ G +PF + P M L + P R RF S
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI-----RIPRFLSVK 229
Query: 250 FKELVTACLVKDPKKR 265
++ L KDPK+R
Sbjct: 230 ASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 50/145 (34%), Positives = 80/145 (55%), Gaps = 7/145 (4%)
Query: 78 HCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIH 137
H +F + L++VM Y GG L ++ S + + E + L E + A+ +H G++H
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLL-SKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVH 125
Query: 138 RDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHG--- 194
RD+K N+L+D NG I+LADFG +C+ D N VGTP +++PE++Q +
Sbjct: 126 RDIKPDNVLLDKNGHIRLADFG--SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183
Query: 195 -YDFKADIWSFGITALELAHGHAPF 218
Y + D WS G+ E+ +G PF
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 71/234 (30%), Positives = 107/234 (45%), Gaps = 22/234 (9%)
Query: 70 NHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEG-FEEPVIATLLRETLKALV 128
N P ++ SF + L++V+ ++ GG H ++ EG F+ E L AL
Sbjct: 51 NCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQR---EGRFDLSRARFYTAELLCALE 107
Query: 129 YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEV 188
LH I+RD+K NIL+D G I L DFG+ C + D ++ NTF GTP ++APE+
Sbjct: 108 NLHKFNVIYRDLKPENILLDYQGHIALCDFGL--CKLNMKDDDKT-NTFCGTPEYLAPEL 164
Query: 189 MQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA---PPGLDYERDKR 245
+ HGY D W+ G+ E+ G PF ++ LQ P G D +
Sbjct: 165 LLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDA--- 220
Query: 246 FSKSFKELVTACLVKDPKKR---PTAEKLMKHHFFKHARSNDFLARSIVDNLAP 296
K+L+ L +DP +R A+++ H FF L + I P
Sbjct: 221 -----KDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKP 269
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-19
Identities = 68/227 (29%), Positives = 107/227 (47%), Gaps = 18/227 (7%)
Query: 60 RREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPE--GFEEPVIA 117
R E+ + +H +++ F + L ++M Y +GG +K E F+E +
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 118 TLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTF 177
L + + AL +H +HRD+K+ NI + G IKL DFG S D+ + ++F
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA-SSF 231
Query: 178 VGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK-----VLLMTLQ 232
GTP ++APE+ ++ Y KAD+WS G+ EL H PF K P + VL
Sbjct: 232 CGTPYYLAPELWERKR-YSKKADMWSLGVILYELLTLHRPF-KGPSQREIMQQVLYGKYD 289
Query: 233 NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKH 279
P + S K L+ L K+P RPT ++L+ F K+
Sbjct: 290 PFPCPV--------SSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328
|
Length = 478 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 81/291 (27%), Positives = 119/291 (40%), Gaps = 61/291 (20%)
Query: 9 FPVDAKDYRLYEEVGEGVSATVYRALCI-PLNEI--VAIKVLDLEKCNNDLDGIRR---- 61
+ + +D L +GEG VY+ + + P NE VA+K C N R
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKT-----CKNCTSPSVREKFL 55
Query: 62 -EVQTMRVTNHPNVLRAHCSFTTGHC----LWVVM---PYMAGGSCLHIMKSAYPEGFEE 113
E MR +HP++++ G +W+VM P S L + K +
Sbjct: 56 QEAYIMRQFDHPHIVK-----LIGVITENPVWIVMELAPLGELRSYLQVNKYSLD----- 105
Query: 114 PVIATLLRETL---KALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR 170
+A+L+ + AL YL +HRD+ A N+L+ S +KL DFG+S + D
Sbjct: 106 --LASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY 163
Query: 171 QRSRNTFVGTPC-WMAPEVMQQLHGYDFKADIWSFGITALE-LAHGHAPFSKYPPMKVL- 227
+ S+ P WMAPE + + +D+W FG+ E L G PF V+
Sbjct: 164 KASKGKL---PIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG 219
Query: 228 -------LMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKL 271
L N PP L Y L+T C DP KRP +L
Sbjct: 220 RIENGERLPMPPNCPPTL-Y-----------SLMTKCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 68/272 (25%), Positives = 114/272 (41%), Gaps = 19/272 (6%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLN----EIVAIKVLDLEKCNNDLDGIRREVQTM 66
+D + + +G G V R + L VAIK L + E M
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRG-RLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIM 59
Query: 67 RVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKA 126
+HPN++R T + ++ YM GS L F + +LR
Sbjct: 60 GQFDHPNIIRLEGVVTKSRPVMIITEYMENGS-LDKFLRENDGKFTVGQLVGMLRGIASG 118
Query: 127 LVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-WMA 185
+ YL ++HRD+ A NIL++SN K++DFG+S + D+ ++ + P W A
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTA 176
Query: 186 PEVMQQLHGYDFKADIWSFGITALE-LAHGHAPFSKYPPMKVL--LMTLQNAPPGLDYER 242
PE + + +D+WSFGI E +++G P+ V+ + PP +D
Sbjct: 177 PEAIAYRK-FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMD--- 232
Query: 243 DKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274
+ +L+ C KD +RPT +++
Sbjct: 233 ---CPSALYQLMLDCWQKDRNERPTFSQIVST 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 79/300 (26%), Positives = 122/300 (40%), Gaps = 51/300 (17%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR--REVQTMRVTNHPN 73
Y+ VG G V A VAIK L + + R RE++ ++ +H N
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS-RPFQSAIHAKRTYRELRLLKHMDHEN 75
Query: 74 VLRAHCSFTTGHCL------WVVMPYMAGGSCLH-IMKSAYPEGFEEPVIATLLRETLKA 126
V+ FT L ++V M G+ L+ I+K + + I L+ + L+
Sbjct: 76 VIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIVKC---QKLSDDHIQFLVYQILRG 130
Query: 127 LVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSR--NTFVGTPCWM 184
L Y+H G IHRD+K NI ++ + +K+ DFG++ R +V T +
Sbjct: 131 LKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA--------RHTDDEMTGYVATRWYR 182
Query: 185 APEVMQQLHGYDFKADIWSFGITALELAHGHAPF--SKYPPMKVLLMTLQNAPP-----G 237
APE+M Y+ DIWS G EL G F S + +M L P
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK 242
Query: 238 LDYERDKRFSKS--------FKELVTAC-----------LVKDPKKRPTAEKLMKHHFFK 278
+ E + + +S FKE+ + LV DP KR TA + + H +
Sbjct: 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 12/207 (5%)
Query: 79 CSFTTGHCLWVVMPYMAGGSCLHIMKSAYPE--GFEEPVIATLLRETLKALVYLHFHGHI 136
+F T L +VM M GG + + + E GF EP + + L +LH I
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRII 119
Query: 137 HRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYD 196
+RD+K N+L+D++G ++++D G++ + D + + + GTP +MAPE++Q YD
Sbjct: 120 YRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG---YAGTPGFMAPELLQG-EEYD 175
Query: 197 FKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTA 256
F D ++ G+T E+ PF KV L+ +FS + K A
Sbjct: 176 FSVDYFALGVTLYEMIAARGPFRARGE-KVENKELKQRILNDSVTYPDKFSPASKSFCEA 234
Query: 257 CLVKDPKKR-----PTAEKLMKHHFFK 278
L KDP+KR + L H F+
Sbjct: 235 LLAKDPEKRLGFRDGNCDGLRTHPLFR 261
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 3e-19
Identities = 72/229 (31%), Positives = 105/229 (45%), Gaps = 25/229 (10%)
Query: 71 HPNVLRAHCSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLLRETLKALVY 129
HP ++ H SF T L+ V+ Y+ GG H+ + F EP E AL Y
Sbjct: 55 HPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERS---FPEPRARFYAAEIASALGY 111
Query: 130 LHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVM 189
LH I+RD+K NIL+DS G + L DFG+ C + ++ +TF GTP ++APEV+
Sbjct: 112 LHSLNIIYRDLKPENILLDSQGHVVLTDFGL--CKEGI-EHSKTTSTFCGTPEYLAPEVL 168
Query: 190 QQLHGYDFKADIWSFGITALELAHGHAPF--SKYPPM--KVLLMTLQNAPPGLDYERDKR 245
++ YD D W G E+ +G PF M +L L+ P +
Sbjct: 169 RK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLR-LKPNI------- 219
Query: 246 FSKSFKELVTACLVKDPKKRPTAEK----LMKHHFFKHARSNDFLARSI 290
S S + L+ L KD KR A+ + H FF +D + + I
Sbjct: 220 -SVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKI 267
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-19
Identities = 49/145 (33%), Positives = 78/145 (53%), Gaps = 7/145 (4%)
Query: 78 HCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIH 137
H +F + L++VM Y GG L ++ S + + E + + E + A+ +H ++H
Sbjct: 67 HYAFQDENYLYLVMDYYVGGDLLTLL-SKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVH 125
Query: 138 RDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHG--- 194
RD+K N+L+D NG I+LADFG M G Q S VGTP +++PE++Q +
Sbjct: 126 RDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSS--VAVGTPDYISPEILQAMEDGMG 183
Query: 195 -YDFKADIWSFGITALELAHGHAPF 218
Y + D WS G+ E+ +G PF
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 79/293 (26%), Positives = 126/293 (43%), Gaps = 40/293 (13%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIK-VLDLEKCNNDLDGIR----REVQTMRVTN 70
Y ++GEG V++ +IVAIK ++ E D I+ RE++ ++
Sbjct: 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESE----DDPVIKKIALREIRMLKQLK 58
Query: 71 HPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYL 130
HPN++ F L +V Y + L+ ++ P G E +I ++ +TL+A+ +
Sbjct: 59 HPNLVNLIEVFRRKRKLHLVFEYC-DHTVLNELE-KNPRGVPEHLIKKIIWQTLQAVNFC 116
Query: 131 HFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQ 190
H H IHRDVK NILI G IKL DFG A + + +V T + APE++
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGF-ARILTGPGDDYT--DYVATRWYRAPELLV 173
Query: 191 QLHGYDFKADIWSFGITALELAHGHAPF---SKYPPMKVLLMTL------------QN-- 233
Y D+W+ G EL G + S + ++ TL N
Sbjct: 174 GDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233
Query: 234 -------APPGLDYERDKRFSKSFKEL--VTACLVKDPKKRPTAEKLMKHHFF 277
P + K + S L + CL DP +R + E+L++H +F
Sbjct: 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 5e-19
Identities = 52/149 (34%), Positives = 77/149 (51%), Gaps = 8/149 (5%)
Query: 71 HPNVLRAHCSFTTGHCLWVVMPYMAGGSC-LHIMKSAYPEGFEEPVIATLLRETLKALVY 129
HP ++ H SF T L+ V+ Y+ GG H+ + F EP E A+ Y
Sbjct: 55 HPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRE---RCFLEPRARFYAAEVASAIGY 111
Query: 130 LHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVM 189
LH I+RD+K NIL+DS G + L DFG+ + + + + +TF GTP ++APEV+
Sbjct: 112 LHSLNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGVEPEETTSTFCGTPEYLAPEVL 168
Query: 190 QQLHGYDFKADIWSFGITALELAHGHAPF 218
++ YD D W G E+ +G PF
Sbjct: 169 RK-EPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 5e-19
Identities = 50/183 (27%), Positives = 74/183 (40%), Gaps = 22/183 (12%)
Query: 105 SAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACM 164
E I + + L AL LH R K+GNIL+ +G +KL G A
Sbjct: 8 EVRGRPLNEEEIWAVCLQCLGALRELH------RQAKSGNILLTWDGLLKL--DGSVAFK 59
Query: 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM 224
R P +MAPEV+Q Y KADI+S GIT E P+++ +
Sbjct: 60 TPEQSRP--------DPYFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEEREL 110
Query: 225 KVLLMTLQNAPPGLDYERDKRF-----SKSFKELVTACLVKDPKKRPTAEKLMKHHFFKH 279
+L L N P D ++SF++ + C + P++R A + H
Sbjct: 111 SAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRALF 170
Query: 280 ARS 282
A +
Sbjct: 171 AET 173
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 6e-19
Identities = 68/225 (30%), Positives = 101/225 (44%), Gaps = 13/225 (5%)
Query: 62 EVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSC-LHIMKSAYPEGFEEPVIATLL 120
E Q + N V+ ++ T L +V+ M GG HI P GF+E
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNP-GFDEERAVFYA 108
Query: 121 RETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGT 180
E L LH ++RD+K NIL+D G I+++D G+ A G+ R R VGT
Sbjct: 109 AEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGL-AVEIPEGETIRGR---VGT 164
Query: 181 PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240
+MAPEV++ Y F D W G E+ G +PF + KV ++
Sbjct: 165 VGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE-KVKREEVERRVKEDQE 222
Query: 241 ERDKRFSKSFKELVTACLVKDPKKR-----PTAEKLMKHHFFKHA 280
E ++FS++ + + L KDP R AE++ H FF+ A
Sbjct: 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 6e-19
Identities = 60/213 (28%), Positives = 106/213 (49%), Gaps = 13/213 (6%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLD----LEKCNNDLDGIRREVQTMRVT 69
+D+ + + +G G V +++ A+K+L+ L++ R E +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC--FREERDVLVNG 58
Query: 70 NHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVY 129
++ + H +F + L++VM Y GG L ++ S + + E + L E + A+
Sbjct: 59 DNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLL-SKFEDRLPEDMARFYLAEMVIAIDS 117
Query: 130 LHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVM 189
+H ++HRD+K NIL+D NG I+LADFG + + G Q S VGTP +++PE++
Sbjct: 118 VHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS--VAVGTPDYISPEIL 175
Query: 190 QQLHG----YDFKADIWSFGITALELAHGHAPF 218
Q + Y + D WS G+ E+ +G PF
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 7e-19
Identities = 70/235 (29%), Positives = 106/235 (45%), Gaps = 15/235 (6%)
Query: 66 MRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLK 125
++ HP ++ H SF T L+ V+ Y+ GG + ++ F EP E
Sbjct: 50 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIAS 107
Query: 126 ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMA 185
AL YLH ++RD+K NIL+DS G I L DFG+ + + + +TF GTP ++A
Sbjct: 108 ALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLA 164
Query: 186 PEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245
PEV+ + YD D W G E+ +G PF ++ L N P L
Sbjct: 165 PEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL-NKPLQL----KPN 218
Query: 246 FSKSFKELVTACLVKDPKKRPTAE----KLMKHHFFKHARSNDFLARSIVDNLAP 296
+ S + L+ L KD KR A+ ++ H FF +D + + I P
Sbjct: 219 ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKITPPFNP 273
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 2e-18
Identities = 69/250 (27%), Positives = 101/250 (40%), Gaps = 52/250 (20%)
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGS--CLHIMKSAYPEGFEEPVIATLLRETLKALVYLH 131
V++ + SF L+ VM Y+ GG L I + E IA E A+ +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA----ELTCAIESVH 118
Query: 132 FHGHIHRDVKAGNILIDSNGAIKLADFG-------------------------------- 159
G IHRD+K NILID +G IKL DFG
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178
Query: 160 -VSACMFDAGDRQRSR-------NTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALEL 211
+ C +R+R R ++ VGTP ++APEV+ + GY D WS G+ E+
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILYEM 237
Query: 212 AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKR---PTA 268
G PF P + + + N L + S+ +L+ L + R A
Sbjct: 238 LVGQPPFLADTPAET-QLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKNGA 295
Query: 269 EKLMKHHFFK 278
+++ H FFK
Sbjct: 296 DEIKAHPFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 70/258 (27%), Positives = 114/258 (44%), Gaps = 16/258 (6%)
Query: 17 RLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLR 76
+L +++G G V+ N + V L+ + E Q M+ H +++
Sbjct: 9 QLIKKLGNGQFGEVWMGT---WNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQ 65
Query: 77 AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHI 136
+ + + +++V YM+ GS L +K + P + + + + Y+ +I
Sbjct: 66 LY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYI 124
Query: 137 HRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-WMAPEVMQQLHG- 194
HRD+++ NIL+ K+ADFG++ + D R F P W APE L+G
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF---PIKWTAPEA--ALYGR 179
Query: 195 YDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL 253
+ K+D+WSFGI EL G P YP M L+ G + S EL
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVP---YPGMNN-REVLEQVERGYRMPCPQDCPISLHEL 235
Query: 254 VTACLVKDPKKRPTAEKL 271
+ C KDP++RPT E L
Sbjct: 236 MLQCWKKDPEERPTFEYL 253
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 75/321 (23%), Positives = 131/321 (40%), Gaps = 67/321 (20%)
Query: 9 FPV--DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR----RE 62
FP + Y ++G+G V++A +IVA+K + +E N+ +G RE
Sbjct: 5 FPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLME---NEKEGFPITALRE 61
Query: 63 VQTMRVTNHPNVLR----AHCSFTTGH----CLWVVMPYMAGGSCLH----IMKSAYPEG 110
++ +++ H NV+ T + ++V + C H ++ + +
Sbjct: 62 IKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEF-----CEHDLAGLLSNKNVK- 115
Query: 111 FEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR 170
F I +++ L L Y+H + +HRD+KA NILI +G +KLADFG++ + +
Sbjct: 116 FTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNS 175
Query: 171 QRSRNT-FVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM----- 224
+ +R T V T + PE++ Y D+W G E+ +++ P M
Sbjct: 176 KPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEM------WTRSPIMQGNTE 229
Query: 225 --------------------KVLLMTLQNA---PPGLDYERDKRFSKSFK-----ELVTA 256
V + L P G + +R K +L+
Sbjct: 230 QHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDK 289
Query: 257 CLVKDPKKRPTAEKLMKHHFF 277
LV DP KR A+ + H FF
Sbjct: 290 LLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 68/224 (30%), Positives = 99/224 (44%), Gaps = 13/224 (5%)
Query: 62 EVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSC-LHIMKSAYPEGFEEPVIATLL 120
E Q + N V+ ++ T L +V+ M GG HI P GFEE
Sbjct: 50 EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP-GFEEERALFYA 108
Query: 121 RETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGT 180
E L L LH ++RD+K NIL+D G I+++D G+ A G+ R R VGT
Sbjct: 109 AEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGL-AVKIPEGESIRGR---VGT 164
Query: 181 PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240
+MAPEV+ Y D W G E+ G +PF + KV + +
Sbjct: 165 VGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPF-RGRKEKVKREEVDRRVLETEE 222
Query: 241 ERDKRFSKSFKELVTACLVKDPKKR-----PTAEKLMKHHFFKH 279
+FS+ K + L KDPK+R A ++ +H FF++
Sbjct: 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRN 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 13/212 (6%)
Query: 61 REVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLL 120
+E Q M+ H ++ + + + +++V +M GS L +K + + P + +
Sbjct: 50 QEAQIMKKLRHDKLVPLY-AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMA 108
Query: 121 RETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGT 180
+ + Y+ +IHRD++A NIL+ N K+ADFG++ + D R F
Sbjct: 109 AQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF--- 165
Query: 181 PC-WMAPEVMQQLHG-YDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPG 237
P W APE L+G + K+D+WSFGI EL G P YP M V L+ G
Sbjct: 166 PIKWTAPEA--ALYGRFTIKSDVWSFGILLTELVTKGRVP---YPGM-VNREVLEQVERG 219
Query: 238 LDYERDKRFSKSFKELVTACLVKDPKKRPTAE 269
+ +S EL+ C KDP +RPT E
Sbjct: 220 YRMPCPQGCPESLHELMKLCWKKDPDERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 5e-18
Identities = 62/221 (28%), Positives = 106/221 (47%), Gaps = 27/221 (12%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR----REVQTMRVTNH 71
+ + ++GEG VY+A E+VA+K + L+ N+ +G RE++ +R NH
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLD---NEKEGFPITAIREIKILRQLNH 65
Query: 72 PNVLRAHCSFTTGH----------CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLR 121
N++ T ++V YM + +++S F E I + ++
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLESGLVH-FSEDHIKSFMK 123
Query: 122 ETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTP 181
+ L+ L Y H +HRD+K NIL+++ G IKLADFG+ A ++++ + + N V T
Sbjct: 124 QLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL-ARLYNSEESRPYTNK-VITL 181
Query: 182 CWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYP 222
+ PE++ Y D+WS G EL F+K P
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGEL------FTKKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 6e-18
Identities = 69/242 (28%), Positives = 108/242 (44%), Gaps = 19/242 (7%)
Query: 62 EVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLL 120
E + ++ + HP + SF T L VM Y GG H+ + F E
Sbjct: 45 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV---FSEDRARFYG 101
Query: 121 RETLKALVYLHFHGHI-HRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVG 179
E + AL YLH ++ +RD+K N+++D +G IK+ DFG+ G + TF G
Sbjct: 102 AEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK---TFCG 158
Query: 180 TPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD 239
TP ++APEV++ + Y D W G+ E+ G PF K+ + L +
Sbjct: 159 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----E 212
Query: 240 YERDKRFSKSFKELVTACLVKDPKKR-----PTAEKLMKHHFFKHARSNDFLARSIVDNL 294
+ S K L++ L KDPK+R A+++M+H FF D + +V
Sbjct: 213 IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPF 272
Query: 295 AP 296
P
Sbjct: 273 KP 274
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 7e-18
Identities = 64/254 (25%), Positives = 115/254 (45%), Gaps = 29/254 (11%)
Query: 40 EIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAH--CSFTTGHCLWVVMPYMAGG 97
E VA+K L E N + +++E++ +R H N+++ C+ G+ + ++M ++ G
Sbjct: 34 EQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSG 93
Query: 98 SCLHIMKSAYPEGFEEPVIATLLR---ETLKALVYLHFHGHIHRDVKAGNILIDSNGAIK 154
S +K P + + L+ + K + YL ++HRD+ A N+L++S +K
Sbjct: 94 S----LKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVK 149
Query: 155 LADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHG 214
+ DFG++ + + ++ W APE + Q Y +D+WSFG+T EL
Sbjct: 150 IGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFY-IASDVWSFGVTLYELLTY 208
Query: 215 HAPFSKYPPMKVLL---------MTLQNAPPGLDYERDKRF------SKSFKELVTACLV 259
S+ PM + L MT+ L E KR + +L+ C
Sbjct: 209 CD--SESSPMTLFLKMIGPTHGQMTVTRLVRVL--EEGKRLPRPPNCPEEVYQLMRKCWE 264
Query: 260 KDPKKRPTAEKLMK 273
P KR T + L++
Sbjct: 265 FQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 8e-18
Identities = 70/274 (25%), Positives = 120/274 (43%), Gaps = 29/274 (10%)
Query: 20 EEVGEGVSATVYRALCIPLN----EIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVL 75
+GEG V P N E+VA+K L E + G ++E+ ++ H N++
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 76 RAH--CSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLL---RETLKALVYL 130
+ CS G L ++M Y+ GS + + +A LL ++ + + YL
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYL 123
Query: 131 HFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQ 190
H +IHRD+ A N+L+D++ +K+ DFG++ + + + R R W A E ++
Sbjct: 124 HSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 191 QLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLM-----TLQNAPPGLD-YERDK 244
+ + + + +D+WSFG+T EL H + PP K M ++ ER
Sbjct: 184 E-NKFSYASDVWSFGVTLYELL-THCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM 241
Query: 245 RFSK------SFKELVTACLVKDPKKRPTAEKLM 272
R L+ C + K RPT L+
Sbjct: 242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLI 275
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 8e-18
Identities = 69/280 (24%), Positives = 123/280 (43%), Gaps = 37/280 (13%)
Query: 21 EVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCS 80
E G+ V AT +R VA+K+L +++L + E ++ NHP+V++ + +
Sbjct: 12 EFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGA 71
Query: 81 FTTGHCLWVVMPYMAGGSC---LHIMKSAYPEGF---------------EEPV----IAT 118
+ L +++ Y GS L + P E + + +
Sbjct: 72 CSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLIS 131
Query: 119 LLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF-DAGDRQRSRNTF 177
+ + + YL +HRD+ A N+L+ +K++DFG+S ++ + +RS+
Sbjct: 132 FAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRI 191
Query: 178 VGTPC-WMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKV--LLMTLQN 233
P WMA E + H Y ++D+WSFG+ E+ G P+ P ++ LL T
Sbjct: 192 ---PVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKT--- 244
Query: 234 APPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273
G ER + S+ L+ C ++P KRPT + K
Sbjct: 245 ---GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 71/271 (26%), Positives = 124/271 (45%), Gaps = 32/271 (11%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVT 69
+++K+ +L +G+G V L + VA+K L K + E M
Sbjct: 3 INSKELKLGATIGKGEFGDVM--LGDYRGQKVAVKCL---KDDSTAAQAFLAEASVMTTL 57
Query: 70 NHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLL---RETLKA 126
HPN+++ G+ L++V YMA GS + ++S G +A L + +
Sbjct: 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRS---RGRAVITLAQQLGFALDVCEG 114
Query: 127 LVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGT-PC-WM 184
+ YL +HRD+ A N+L+ + K++DFG++ ++ S+ G P W
Sbjct: 115 MEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLA--------KEASQGQDSGKLPVKWT 166
Query: 185 APEVMQQLHGYDFKADIWSFGITALEL-AHGHAPFSKYP--PMKVLLMTLQNAPPGLDYE 241
APE + + + K+D+WSFGI E+ + G P YP P+K ++ ++ G E
Sbjct: 167 APEAL-REKKFSTKSDVWSFGILLWEIYSFGRVP---YPRIPLKDVVPHVEK---GYRME 219
Query: 242 RDKRFSKSFKELVTACLVKDPKKRPTAEKLM 272
+ +++ C DP KRPT ++L
Sbjct: 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLR 250
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 1e-17
Identities = 80/299 (26%), Positives = 129/299 (43%), Gaps = 45/299 (15%)
Query: 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHP 72
A Y E++GEG ATVY+ ++VA+KV+ L++ RE ++ H
Sbjct: 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHA 63
Query: 73 NVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF 132
N++ H T L +V Y+ C ++ K +P G + L + L+ L Y+H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 133 HGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTF---VGTPCWMAPEVM 189
+HRD+K N+LI G +KLADFG+ A + +T+ V T + P+V+
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGL------ARAKSVPSHTYSNEVVTLWYRPPDVL 175
Query: 190 QQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK-----------VLLMTLQNAPPG- 237
Y D+W G +E+ G A F P MK VL ++ PG
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQGVAAF---PGMKDIQDQLERIFLVLGTPNEDTWPGV 232
Query: 238 --LDYERDKRF----SKSFKE-------------LVTACLVKDPKKRPTAEKLMKHHFF 277
L + + +RF K+ ++ L + L PK R +A+ + H +F
Sbjct: 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 52/154 (33%), Positives = 76/154 (49%), Gaps = 8/154 (5%)
Query: 66 MRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLLRETL 124
++ HP ++ H SF T L+ V+ ++ GG H+ + F EP E
Sbjct: 50 LKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRE---RSFPEPRARFYAAEIA 106
Query: 125 KALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWM 184
AL YLH ++RD+K NIL+DS G + L DFG+ D + TF GTP ++
Sbjct: 107 SALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD---TTTTFCGTPEYL 163
Query: 185 APEVMQQLHGYDFKADIWSFGITALELAHGHAPF 218
APEV+++ YD D W G E+ +G PF
Sbjct: 164 APEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 67/238 (28%), Positives = 114/238 (47%), Gaps = 19/238 (7%)
Query: 39 NEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGS 98
+ VAIK L++ + + E M+ HP ++R + + T ++++ YM GS
Sbjct: 30 HTKVAIK--SLKQGSMSPEAFLAEANLMKQLQHPRLVRLY-AVVTQEPIYIITEYMENGS 86
Query: 99 CLHIMKSAYPEGFEEPV--IATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLA 156
+ +K+ PEG + + + + + + + ++ +IHRD++A NIL+ K+A
Sbjct: 87 LVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIA 144
Query: 157 DFGVSACMFDAGDRQRSRNTFVGTPC-WMAPEVMQQLHG-YDFKADIWSFGITALEL-AH 213
DFG++ + D R F P W APE + +G + K+D+WSFGI E+ +
Sbjct: 145 DFGLARLIEDNEYTAREGAKF---PIKWTAPEAIN--YGTFTIKSDVWSFGILLTEIVTY 199
Query: 214 GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKL 271
G P YP M +QN G R + EL+ C + P++RPT E L
Sbjct: 200 GRIP---YPGMTN-PEVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYL 253
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 2e-17
Identities = 82/321 (25%), Positives = 128/321 (39%), Gaps = 84/321 (26%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC----NNDLDGIR--REV---Q 64
+ Y + +++G+G V++A+ E+VA+K K N D R RE+ Q
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALK-----KIFDAFRNATDAQRTFREIMFLQ 61
Query: 65 TMRVTNHPN------VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVI-A 117
+ +HPN V++A +++V YM + LH VI A
Sbjct: 62 ELG--DHPNIVKLLNVIKA----ENDKDIYLVFEYME--TDLHA------------VIRA 101
Query: 118 TLLRET---------LKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168
+L + LKAL Y+H IHRD+K NIL++S+ +KLADFG+ A
Sbjct: 102 NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGL-ARSLSEL 160
Query: 169 DRQRSRNT---FVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK 225
+ +V T + APE++ Y D+WS G E+ G F +
Sbjct: 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN 220
Query: 226 VL--LMTLQNAPPGLDYE---------------RDKRFSKSFKE-----------LVTAC 257
L ++ + P D E R K E L+
Sbjct: 221 QLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPR--KPLDELLPKASDDALDLLKKL 278
Query: 258 LVKDPKKRPTAEKLMKHHFFK 278
LV +P KR TAE+ ++H +
Sbjct: 279 LVFNPNKRLTAEEALEHPYVA 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 60/252 (23%), Positives = 107/252 (42%), Gaps = 9/252 (3%)
Query: 20 EEVGEGVSATVYRALCI-PLNEI--VAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLR 76
+++G+G V R ++ VA+K L +K ++ +D +E M +H N++R
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 77 AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHI 136
+ T H L +V GS L ++ F + + + YL I
Sbjct: 61 LYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFI 119
Query: 137 HRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYD 196
HRD+ A NIL+ S+ +K+ DFG+ + D W APE ++ +
Sbjct: 120 HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT-FS 178
Query: 197 FKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVT 255
+D+W FG+T E+ +G P++ ++L + G ER + + ++
Sbjct: 179 HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE---GERLERPEACPQDIYNVML 235
Query: 256 ACLVKDPKKRPT 267
C +P RPT
Sbjct: 236 QCWAHNPADRPT 247
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 83/303 (27%), Positives = 124/303 (40%), Gaps = 45/303 (14%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR--REVQTMRVTNHPN 73
YR ++VG G TV AL VAIK L ++L R RE++ ++ H N
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKHMKHEN 75
Query: 74 VLRAHCSFTTG------HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKAL 127
V+ FT H ++VMP+M G +MK E E I L+ + LK L
Sbjct: 76 VIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGL 131
Query: 128 VYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPE 187
Y+H G IHRD+K GN+ ++ + +K+ DFG+ A +V T + APE
Sbjct: 132 KYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL------ARQTDSEMTGYVVTRWYRAPE 185
Query: 188 VMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVL--LMTLQNAPPG-----LDY 240
V+ Y DIWS G E+ G F + + L +M + P L
Sbjct: 186 VILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245
Query: 241 ERDKRFSKSFKE-------------------LVTACLVKDPKKRPTAEKLMKHHFFKHAR 281
E K + K ++ LV D + R TA + + H +F+
Sbjct: 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305
Query: 282 SND 284
+
Sbjct: 306 DPE 308
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 73/268 (27%), Positives = 117/268 (43%), Gaps = 36/268 (13%)
Query: 22 VGEGVSATVYRALCIPLNEI---VAIKVL----DLEKCNNDLDGIRREVQTMRVTNHPNV 74
+G+G VY I + A+K L DLE +++ +E M+ +HPNV
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLE----EVEQFLKEGIIMKDFSHPNV 58
Query: 75 LRAHCSFTTGHCL------WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETL---K 125
L G CL VV+PYM G + ++S P + L+ L K
Sbjct: 59 LS-----LLGICLPSEGSPLVVLPYMKHGDLRNFIRSET----HNPTVKDLIGFGLQVAK 109
Query: 126 ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-WM 184
+ YL +HRD+ A N ++D + +K+ADFG++ ++D +T P WM
Sbjct: 110 GMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWM 169
Query: 185 APEVMQQLHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 243
A E +Q + K+D+WSFG+ EL G P+ + + LQ G +
Sbjct: 170 ALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ----GRRLLQP 224
Query: 244 KRFSKSFKELVTACLVKDPKKRPTAEKL 271
+ E++ +C P+ RPT +L
Sbjct: 225 EYCPDPLYEVMLSCWHPKPEMRPTFSEL 252
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 54/185 (29%), Positives = 87/185 (47%), Gaps = 14/185 (7%)
Query: 42 VAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC----LWVVMPYMAGG 97
VAIKVL E + D + RE + M ++P ++R G C L +VM MA G
Sbjct: 25 VAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVR-----MIGVCEAEALMLVME-MASG 78
Query: 98 SCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLAD 157
L+ S + + L+ + + YL +HRD+ A N+L+ + K++D
Sbjct: 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISD 138
Query: 158 FGVSACMFDAGDRQRSRNTFVGTPC-WMAPEVMQQLHGYDFKADIWSFGITALE-LAHGH 215
FG+S + A D + P W APE + + ++D+WS+GIT E ++G
Sbjct: 139 FGLSKAL-GADDSYYKARSAGKWPLKWYAPECI-NFRKFSSRSDVWSYGITMWEAFSYGQ 196
Query: 216 APFSK 220
P+ K
Sbjct: 197 KPYKK 201
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 68/226 (30%), Positives = 102/226 (45%), Gaps = 17/226 (7%)
Query: 62 EVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSC-LHI--MKSAYPEGFEEPVIAT 118
E Q + N V+ ++ T L +V+ M GG HI M A GFEE
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEA---GFEEGRAVF 106
Query: 119 LLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFV 178
E L LH ++RD+K NIL+D +G I+++D G+ A G + R V
Sbjct: 107 YAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGL-AVHVPEGQTIKGR---V 162
Query: 179 GTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL 238
GT +MAPEV++ Y F D W+ G E+ G +PF + K+ ++ +
Sbjct: 163 GTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKK-KIKREEVERLVKEV 220
Query: 239 DYERDKRFSKSFKELVTACLVKDPKKR-----PTAEKLMKHHFFKH 279
E ++FS + L L KDPK+R A ++ +H FK
Sbjct: 221 QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 67/271 (24%), Positives = 121/271 (44%), Gaps = 14/271 (5%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN 70
++ D + ++G G VY + + VA+K L + +++ +E M+
Sbjct: 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIK 60
Query: 71 HPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYL 130
HPN+++ T +++ +M G+ L ++ + V+ + + A+ YL
Sbjct: 61 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 120
Query: 131 HFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-WMAPEVM 189
IHRD+ A N L+ N +K+ADFG+S M + F P W APE +
Sbjct: 121 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF---PIKWTAPESL 177
Query: 190 QQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSK 248
+ + K+D+W+FG+ E+A +G +P YP + L + G ER +
Sbjct: 178 -AYNKFSIKSDVWAFGVLLWEIATYGMSP---YPGID-LSQVYELLEKGYRMERPEGCPP 232
Query: 249 SFKELVTACLVKDPKKRPTAEKLMKHHFFKH 279
EL+ AC +P RP+ ++ H F+
Sbjct: 233 KVYELMRACWQWNPSDRPSFAEI--HQAFET 261
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 77/281 (27%), Positives = 127/281 (45%), Gaps = 35/281 (12%)
Query: 18 LYEEVGEGVSATVYRALCIPLNE-----IVAIKVLDLEKCNNDLDGIRREVQTM-RVTNH 71
L + +GEG V +A + L+ VA+K+L + DL + E++ M + H
Sbjct: 16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 75
Query: 72 PNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRE---TLKALV 128
N++ T L+VV+ Y A G+ +++ P G E T K LV
Sbjct: 76 KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135
Query: 129 -----------YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTF 177
+L IHRD+ A N+L+ + +K+ADFG++ D R T
Sbjct: 136 SFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR---DIHHIDYYRKTT 192
Query: 178 VG-TPC-WMAPEVMQQLHGYDFKADIWSFGITALEL-AHGHAPFSKYP--PMKVLLMTLQ 232
G P WMAPE + Y ++D+WSFG+ E+ G +P YP P++ L L+
Sbjct: 193 NGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSP---YPGIPVEELFKLLK 248
Query: 233 NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273
G E+ + ++ L+ C + P +RPT ++L++
Sbjct: 249 E---GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 5e-17
Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 46/214 (21%)
Query: 97 GSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLA 156
G+ LH + ++ P E+ I L + L+ L Y+H G +HRD+K NILI+ N +K+
Sbjct: 93 GTDLHRLLTSRP--LEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKIC 150
Query: 157 DFGVSACMFDAGDRQRSRNT-FVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGH 215
DFG++ Q + T +V T + APE+M YD + DIWS G E+ G
Sbjct: 151 DFGLARI-------QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
Query: 216 APFSKY---------------PPMKVL--------LMTLQNAPPGLDYERDKR-FSKSFK 251
F PP V+ L +Q+ P +R+ FS+ FK
Sbjct: 204 PLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLP-----KREPVPFSEKFK 258
Query: 252 -------ELVTACLVKDPKKRPTAEKLMKHHFFK 278
+L+ LV DP+KR +A + + H +
Sbjct: 259 NADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA 292
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 6e-17
Identities = 57/198 (28%), Positives = 87/198 (43%), Gaps = 18/198 (9%)
Query: 23 GEGVSATVYRALCIPLNE----IVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAH 78
G G TVY+ + IP E VAIKVL E I E M +HP+V+R
Sbjct: 16 GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLL 75
Query: 79 C-SFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLL---RETLKALVYLHFHG 134
++ L + M G L ++ + LL + K + YL
Sbjct: 76 GICLSSQVQL--ITQLMPLGCLLDYVR----NHKDNIGSQYLLNWCVQIAKGMSYLEEKR 129
Query: 135 HIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-WMAPEVMQQLH 193
+HRD+ A N+L+ + +K+ DFG+ A + D +++ P WMA E +
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGL-AKLLDVDEKE-YHAEGGKVPIKWMALESI-LHR 186
Query: 194 GYDFKADIWSFGITALEL 211
Y K+D+WS+G+T EL
Sbjct: 187 IYTHKSDVWSYGVTVWEL 204
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 6e-17
Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 80 SFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRD 139
+F T L ++ M GG LH S + F E + E + L ++H ++RD
Sbjct: 65 AFHTPDKLSFILDLMNGGD-LHYHLSQHGV-FSEAEMRFYAAEIILGLEHMHNRFVVYRD 122
Query: 140 VKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKA 199
+K NIL+D +G ++++D G+ AC F ++ + VGT +MAPEV+Q+ YD A
Sbjct: 123 LKPANILLDEHGHVRISDLGL-ACDFS----KKKPHASVGTHGYMAPEVLQKGVAYDSSA 177
Query: 200 DIWSFGITALELAHGHAPFSKYPP---MKVLLMTLQNAPPGLDYERDKRFSKSFKELVTA 256
D +S G +L GH+PF ++ ++ MTL A E FS + L+
Sbjct: 178 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-----ELPDSFSPELRSLLEG 232
Query: 257 CLVKDPKKR-----PTAEKLMKHHFFK 278
L +D +R A+++ +H FF+
Sbjct: 233 LLQRDVNRRLGCLGRGAQEVKEHPFFR 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 61/205 (29%), Positives = 90/205 (43%), Gaps = 8/205 (3%)
Query: 62 EVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSC-LHIMKSAYPEGFEEPVIATLL 120
E + + N V+ ++ T L +V+ M GG HI P GF+E
Sbjct: 50 EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP-GFDEQRAIFYA 108
Query: 121 RETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGT 180
E L L ++RD+K NIL+D G I+++D G+ A G+ R R VGT
Sbjct: 109 AELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGL-AVQIPEGETVRGR---VGT 164
Query: 181 PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240
+MAPEV+ Y F D W G E+ G +PF K +V +
Sbjct: 165 VGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE-RVKREEVDRRVKEDQE 222
Query: 241 ERDKRFSKSFKELVTACLVKDPKKR 265
E ++FS+ K + L K+PK+R
Sbjct: 223 EYSEKFSEDAKSICRMLLTKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 8e-17
Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 20/207 (9%)
Query: 80 SFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRD 139
+F T L ++ M GG LH S + F E + E + L ++H ++RD
Sbjct: 65 AFHTPDKLCFILDLMNGGD-LHYHLSQHGV-FSEKEMRFYATEIILGLEHMHNRFVVYRD 122
Query: 140 VKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKA 199
+K NIL+D +G ++++D G+ AC F ++ + VGT +MAPEV+Q+ YD A
Sbjct: 123 LKPANILLDEHGHVRISDLGL-ACDFS----KKKPHASVGTHGYMAPEVLQKGTAYDSSA 177
Query: 200 DIWSFGITALELAHGHAPFSKYPPM---KVLLMTLQNAPPGLDYERDKRFSKSFKELVTA 256
D +S G +L GH+PF ++ ++ MTL ++ E FS K L+
Sbjct: 178 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-----VNVELPDSFSPELKSLLEG 232
Query: 257 CLVKDPKKR-----PTAEKLMKHHFFK 278
L +D KR A+++ +H FFK
Sbjct: 233 LLQRDVSKRLGCLGRGAQEVKEHVFFK 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 1e-16
Identities = 68/250 (27%), Positives = 104/250 (41%), Gaps = 49/250 (19%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIK-VLDLEKCNND-LDGIRREVQTMRVTNHP 72
D+ + +G+G V +I A+K +L E D L ++ E + ++ P
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSP 61
Query: 73 NVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF 132
V+ + SF L+++M ++ GG L M Y + F E V + E + A+ +H
Sbjct: 62 WVVSLYYSFQDAQYLYLIMEFLPGGD-LMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHK 119
Query: 133 HGHIHRDVKAGNILIDSNGAIKLADFGVS-----------------------------AC 163
G IHRD+K NILID G IKL+DFG+S +
Sbjct: 120 LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSV 179
Query: 164 MFDA-----------GDRQRSRNTF----VGTPCWMAPEVMQQLHGYDFKADIWSFGITA 208
D+ +++R VGTP ++APE+ Q GY + D WS G
Sbjct: 180 AVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAIM 238
Query: 209 LELAHGHAPF 218
E G PF
Sbjct: 239 FECLIGWPPF 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 64/259 (24%), Positives = 112/259 (43%), Gaps = 17/259 (6%)
Query: 17 RLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLR 76
+L +++G G V+ N + V L+ + E M+ H ++R
Sbjct: 9 KLVKKLGAGQFGEVWMGY---YNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVR 65
Query: 77 AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHI 136
+ T ++++ YMA GS L +KS P + + + + Y+ +I
Sbjct: 66 LYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYI 125
Query: 137 HRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-WMAPEVMQQLHGY 195
HRD++A N+L+ + K+ADFG++ + D R F P W APE + +
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF---PIKWTAPEAI-NFGSF 181
Query: 196 DFKADIWSFGITALEL-AHGHAPFSKYPPMKV--LLMTLQNAPPGLDYERDKRFSKSFKE 252
K+D+WSFGI E+ +G P YP M ++ LQ G R + +
Sbjct: 182 TIKSDVWSFGILLYEIVTYGKIP---YPGMSNSDVMSALQR---GYRMPRMENCPDELYD 235
Query: 253 LVTACLVKDPKKRPTAEKL 271
++ C + ++RPT + L
Sbjct: 236 IMKTCWKEKAEERPTFDYL 254
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 78/298 (26%), Positives = 126/298 (42%), Gaps = 43/298 (14%)
Query: 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHP 72
A Y E++GEG ATVY+ + ++VA+KV+ ++ RE ++ H
Sbjct: 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHA 63
Query: 73 NVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF 132
N++ H T L V YM + L +P G + + + L+ L Y+H
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYMH--TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG 121
Query: 133 HGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS--RNTF---VGTPCWMAPE 187
+HRD+K N+LI G +KLADFG++ R +S T+ V T + P+
Sbjct: 122 QHILHRDLKPQNLLISYLGELKLADFGLA--------RAKSIPSQTYSSEVVTLWYRPPD 173
Query: 188 VMQQLHGYDFKADIWSFGITALELAHGHAPF---SKYPPMKVLLMTLQNAP-----PGL- 238
V+ Y DIW G +E+ G F S + T+ P PG+
Sbjct: 174 VLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233
Query: 239 ---DYERD--------------KRFSKSFK--ELVTACLVKDPKKRPTAEKLMKHHFF 277
+Y+ + KR S+ K +L + L+ PK R +A+ + H +F
Sbjct: 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-16
Identities = 79/274 (28%), Positives = 113/274 (41%), Gaps = 58/274 (21%)
Query: 54 NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGS--CLHIMKSAYPEGF 111
N + ++ E + ++ V++ + SF L+ VM Y+ GG L I +PE
Sbjct: 43 NQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVL 102
Query: 112 EEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFG------------ 159
IA L TL A+ +H G IHRD+K NILID +G IKL DFG
Sbjct: 103 ARFYIAEL---TL-AIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158
Query: 160 ---------------------VSACMFDAGDR-----QRSR--------NTFVGTPCWMA 185
VS C GDR QR+ ++ VGTP ++A
Sbjct: 159 YYQKGSHIRQDSMEPSDLWDDVSNCR--CGDRLKTLEQRATKQHQRCLAHSLVGTPNYIA 216
Query: 186 PEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245
PEV+ + GY D WS G+ E+ G PF P + L + N L +
Sbjct: 217 PEVLLR-KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVI-NWENTLHIPPQVK 274
Query: 246 FSKSFKELVT--ACLVKDPKKRPTAEKLMKHHFF 277
S +L+T C ++ R A+ + H FF
Sbjct: 275 LSPEAVDLITKLCCSAEERLGRNGADDIKAHPFF 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 71/245 (28%), Positives = 112/245 (45%), Gaps = 33/245 (13%)
Query: 42 VAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCL-----WVVMPYMAG 96
VA+K L + + +E M NHPN+++ G CL +++M M G
Sbjct: 29 VAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVK-----LLGVCLLNEPQYIIMELMEG 83
Query: 97 GSCLHIMKSAYPEGFEEPVIATLLRETL-------KALVYLHFHGHIHRDVKAGNILIDS 149
G L ++ A E F P++ L+E L K VYL IHRD+ A N L+
Sbjct: 84 GDLLSYLRDARVERFGPPLLT--LKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSE 141
Query: 150 NG-----AIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHG-YDFKADIWS 203
G +K+ DFG++ ++ + D R + WMAPE + L G + ++D+WS
Sbjct: 142 KGYDADRVVKIGDFGLARDIYKS-DYYRKEGEGLLPVRWMAPESL--LDGKFTTQSDVWS 198
Query: 204 FGITALE-LAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDP 262
FG+ E L G P+ +V LQ+ G ++ + +L+T C +DP
Sbjct: 199 FGVLMWEILTLGQQPYPALNNQEV----LQHVTAGGRLQKPENCPDKIYQLMTNCWAQDP 254
Query: 263 KKRPT 267
+RPT
Sbjct: 255 SERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 63/259 (24%), Positives = 119/259 (45%), Gaps = 18/259 (6%)
Query: 17 RLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLR 76
+L +++G G V+ A N+ + V ++ + ++ E M+ H +++
Sbjct: 9 KLEKKLGAGQFGEVWMA---TYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVK 65
Query: 77 AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHI 136
H + T ++++ +MA GS L +KS P + + + + ++ +I
Sbjct: 66 LH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 124
Query: 137 HRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-WMAPEVMQQLHGY 195
HRD++A NIL+ ++ K+ADFG++ + D R F P W APE + +
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF---PIKWTAPEAI-NFGSF 180
Query: 196 DFKADIWSFGITALEL-AHGHAPFSKYPPMKV--LLMTLQNAPPGLDYERDKRFSKSFKE 252
K+D+WSFGI +E+ +G P YP M ++ L+ G R + +
Sbjct: 181 TIKSDVWSFGILLMEIVTYGRIP---YPGMSNPEVIRALER---GYRMPRPENCPEELYN 234
Query: 253 LVTACLVKDPKKRPTAEKL 271
++ C P++RPT E +
Sbjct: 235 IMMRCWKNRPEERPTFEYI 253
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 5e-16
Identities = 85/300 (28%), Positives = 129/300 (43%), Gaps = 44/300 (14%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIK-VLDLEKCNNDLDGIRREVQTMRVTNHPNV 74
Y++ E +G+G V A+ E VAIK + D+ + +D I RE++ +R+ HP++
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 75 LR-AHC----SFTTGHCLWVVMPYMAGGSCLHIMKSA----YPEGFEEPVIATLLRETLK 125
+ H S ++VV M S LH + A PE + L + L+
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELM--ESDLHQVIKANDDLTPEHHQ-----FFLYQLLR 114
Query: 126 ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMA 185
AL Y+H HRD+K NIL +++ +K+ DFG++ F+ +V T + A
Sbjct: 115 ALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 186 PEVMQQLHG-YDFKADIWSFGITALELAHGHAPFSKYPPMKVL-LMT-LQNAPPG----- 237
PE+ Y DIWS G E+ G F + L L+T L P
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234
Query: 238 ---------LDYERDKR---FSKSFK-------ELVTACLVKDPKKRPTAEKLMKHHFFK 278
L R K+ FS+ F L+ L DPK RPTAE+ + +FK
Sbjct: 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFK 294
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 80/295 (27%), Positives = 124/295 (42%), Gaps = 44/295 (14%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVL 75
Y E++GEG ATV++ +VA+K + LE REV ++ H N++
Sbjct: 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67
Query: 76 RAHCSFTTGHCLWVVMPYMAGG------SCLHIMKSAYPEGFEEPVIATLLRETLKALVY 129
H T L +V Y+ C +IM + L + L+ L Y
Sbjct: 68 TLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHN--------VKIFLYQILRGLAY 119
Query: 130 LHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVM 189
H +HRD+K N+LI+ G +KLADFG++ ++ + V T + P+V+
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLARA---KSVPTKTYSNEVVTLWYRPPDVL 176
Query: 190 QQLHGYDFKADIWSFGITALELAHGHA--PFSKYPPMKVLLMTLQNAP-----PGL---D 239
Y + D+W G E+A G P S L+ L P PG+ D
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236
Query: 240 YERDKRFSKSFK----------------ELVTACLVKDPKKRPTAEKLMKHHFFK 278
++ F K +K EL+T L + KKR +AE+ MKH +F+
Sbjct: 237 EFKNYNFPK-YKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 9e-16
Identities = 80/305 (26%), Positives = 125/305 (40%), Gaps = 46/305 (15%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR--REVQTMRVTNH 71
+ Y ++VG G +V A+ E VAIK L +++ R RE+ ++ H
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLS-RPFQSEIFAKRAYRELTLLKHMQH 73
Query: 72 PNVLRAHCSFTTG------HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLK 125
NV+ FT+ ++VMPYM ++ E + L+ + L
Sbjct: 74 ENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD-----LQKIMGHPLSEDKVQYLVYQMLC 128
Query: 126 ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMA 185
L Y+H G IHRD+K GN+ ++ + +K+ DFG+ A DA +V T + A
Sbjct: 129 GLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGL-ARHADA-----EMTGYVVTRWYRA 182
Query: 186 PEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQ-NAPPGLDYERD- 243
PEV+ Y+ DIWS G E+ G F + L L+ PG ++ +
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242
Query: 244 -----------------KRFSKSFK-------ELVTACLVKDPKKRPTAEKLMKHHFFKH 279
K FS F +L+ L D KR TA + ++H +F
Sbjct: 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS 302
Query: 280 ARSND 284
R D
Sbjct: 303 FRDAD 307
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 69/260 (26%), Positives = 110/260 (42%), Gaps = 36/260 (13%)
Query: 42 VAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLR--AHCSFTTGHCLWVVMPYMAGGS- 98
VA+KVL + +N + +EV+ + + PN+ R C T L ++M YM G
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVC--TVDPPLCMIMEYMENGDL 106
Query: 99 CLHIMKSAYPEGFEEPVIATLLRETLK--------ALVYLHFHGHIHRDVKAGNILIDSN 150
+ K +L TL + YL +HRD+ N L+ N
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKN 166
Query: 151 GAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHG-YDFKADIWSFGITAL 209
IK+ADFG+S ++ + D R + WMA E + L G + K+D+W+FG+T
Sbjct: 167 YTIKIADFGMSRNLY-SSDYYRVQGRAPLPIRWMAWESV--LLGKFTTKSDVWAFGVTLW 223
Query: 210 ELAHGHAPFSKYPPMKVLL--MTLQNAPPGLDYERDKRF---------SKSFKELVTACL 258
E+ + P + L ++NA G + D R K EL+ C
Sbjct: 224 EI----LTLCREQPYEHLTDQQVIENA--GHFFRDDGRQIYLPRPPNCPKDIYELMLECW 277
Query: 259 VKDPKKRPTAEKLMKHHFFK 278
+D + RPT ++ H F +
Sbjct: 278 RRDEEDRPTFREI--HLFLQ 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 76/299 (25%), Positives = 124/299 (41%), Gaps = 44/299 (14%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR----REVQTMRVTNH 71
Y E++GEG VY+A ++VA+K LE D +GI RE+ +++ +
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLE---MDEEGIPPTALREISLLQMLSE 59
Query: 72 -PNVLR----AHCSFTTGH-CLWVVMPYMAGGSCLHIMKSAY---PEGFEEPVIATLLRE 122
++R H G L++V Y+ M S I + + +
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 123 TLKALVYLHFHGHIHRDVKAGNILID-SNGAIKLADFGVSACMFDAGDRQRSRNTFVGTP 181
LK + + H HG +HRD+K N+L+D G +K+AD G+ F + + + T
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA-FSIPVKSYTHE--IVTL 175
Query: 182 CWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLL--MTLQNAP---- 235
+ APEV+ Y DIWS G E++ F ++ LL L P
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235
Query: 236 -PGLDYERD---------KRFSKSFK-------ELVTACLVKDPKKRPTAEKLMKHHFF 277
PG+ RD + S++ +L+ L DP KR +A+ + H +F
Sbjct: 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 66/275 (24%), Positives = 116/275 (42%), Gaps = 28/275 (10%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALC---IPLNE--IVAIKVLDLEKCNNDL-DGIRREVQ 64
V L E+GEG V+ C P N+ +VA+K L E +ND RE +
Sbjct: 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLK-ETASNDARKDFEREAE 60
Query: 65 TMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPE----GFEEPVIATLL 120
+ H N+++ + T G +V YM G ++S P+ + + L
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120
Query: 121 RETL--------KALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172
L +VYL +HRD+ N L+ + +K+ DFG+S ++ D R
Sbjct: 121 LSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVY-TTDYYR 179
Query: 173 SRNTFVGTPCWMAPEVMQQLHG-YDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMT 230
+ WM PE + ++ + ++D+WSFG+ E+ +G P+ +V+
Sbjct: 180 VGGHTMLPIRWMPPESI--MYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237
Query: 231 LQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKR 265
Q G +R + +++ C +DP++R
Sbjct: 238 TQ----GRLLQRPRTCPSEVYDIMLGCWKRDPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 3e-15
Identities = 76/274 (27%), Positives = 114/274 (41%), Gaps = 56/274 (20%)
Query: 54 NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGS--CLHIMKSAYPEGF 111
N + ++ E + ++ V+R + SF L+ VM Y+ GG L I +PE
Sbjct: 43 NQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDL 102
Query: 112 EEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGV--------SAC 163
IA E A+ +H G IHRD+K NILID +G IKL DFG+ +
Sbjct: 103 ARFYIA----ELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158
Query: 164 MFDAGD---------------------------------RQRSR---NTFVGTPCWMAPE 187
+ +GD RQ R ++ VGTP ++APE
Sbjct: 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPE 218
Query: 188 VMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFS 247
V+ + GY D WS G+ E+ G PF P++ M + N L + S
Sbjct: 219 VLLRT-GYTQLCDWWSVGVILYEMLVGQPPFLAQTPLET-QMKVINWQTSLHIPPQAKLS 276
Query: 248 KSFKELVTACLVKDPKKR---PTAEKLMKHHFFK 278
+L+ L + P+ R A+++ H FFK
Sbjct: 277 PEASDLIIK-LCRGPEDRLGKNGADEIKAHPFFK 309
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 5e-15
Identities = 54/230 (23%), Positives = 93/230 (40%), Gaps = 15/230 (6%)
Query: 42 VAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCL---WVVMPYMAGGS 98
VA+K L E RE M +HP ++R G C +++ +A
Sbjct: 26 VAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR-----LIGVCKGEPLMLVMELAPLG 80
Query: 99 CLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADF 158
L E + L + + YL +HRD+ A N+L+ + K++DF
Sbjct: 81 PLLKYLKKRRE-IPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDF 139
Query: 159 GVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALE-LAHGHAP 217
G+S + D R+ W APE + + K+D+WS+G+T E ++G P
Sbjct: 140 GMSRALGAGSDYYRATTAGRWPLKWYAPECI-NYGKFSSKSDVWSYGVTLWEAFSYGAKP 198
Query: 218 FSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPT 267
+ + +V+ M G R + + ++ +C P+ RPT
Sbjct: 199 YGEMKGAEVIAMLES----GERLPRPEECPQEIYSIMLSCWKYRPEDRPT 244
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 6e-15
Identities = 70/260 (26%), Positives = 121/260 (46%), Gaps = 28/260 (10%)
Query: 18 LYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRA 77
L E +GEG V + + VA+K + KC+ E M +H N++R
Sbjct: 10 LGEIIGEGEFGAVLQGEY--TGQKVAVKNI---KCDVTAQAFLEETAVMTKLHHKNLVRL 64
Query: 78 HCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETL---KALVYLHFHG 134
+ L++VM M+ G+ ++ +++ G + LL+ +L + + YL
Sbjct: 65 -LGVILHNGLYIVMELMSKGNLVNFLRT---RGRALVSVIQLLQFSLDVAEGMEYLESKK 120
Query: 135 HIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-WMAPEVMQQLH 193
+HRD+ A NIL+ +G K++DFG++ D + P W APE ++ H
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSK-------LPVKWTAPEALK--H 171
Query: 194 G-YDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251
+ K+D+WS+G+ E+ ++G AP YP M + + + G E +
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRAP---YPKMSLKEVK-ECVEKGYRMEPPEGCPADVY 227
Query: 252 ELVTACLVKDPKKRPTAEKL 271
L+T+C +PKKRP+ KL
Sbjct: 228 VLMTSCWETEPKKRPSFHKL 247
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 6e-15
Identities = 70/281 (24%), Positives = 129/281 (45%), Gaps = 33/281 (11%)
Query: 18 LYEEVGEGVSATVYRALCIPLNE-------IVAIKVLDLEKCNNDLDGIRREVQTMR-VT 69
L + +GEG V A + +++ VA+K+L + DL + E++ M+ +
Sbjct: 19 LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 78
Query: 70 NHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRE---TLKA 126
H N++ + T L+V++ Y + G+ +++ P G E + + T K
Sbjct: 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 127 LV-----------YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRN 175
LV YL IHRD+ A N+L+ N +K+ADFG++ + + +++ N
Sbjct: 139 LVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198
Query: 176 TFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALEL-AHGHAPFSKYP--PMKVLLMTLQ 232
+ WMAPE + Y ++D+WSFG+ E+ G +P YP P++ L L+
Sbjct: 199 GRLPVK-WMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSP---YPGIPVEELFKLLK 253
Query: 233 NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273
G ++ + ++ C P RPT ++L++
Sbjct: 254 E---GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 52/225 (23%), Positives = 102/225 (45%), Gaps = 17/225 (7%)
Query: 62 EVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLR 121
E + + N P ++ +F + L +VM M GG + + + G E +
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102
Query: 122 ETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTP 181
+ +++LH ++RD+K N+L+D G +L+D G++ + D ++ GT
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG----KTITQRAGTN 158
Query: 182 CWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM----KVLLMTLQNAPPG 237
+MAPE++++ Y + D ++ G + E+ G PF + ++ TL++
Sbjct: 159 GYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDE--- 214
Query: 238 LDYERDKRFSKSFKELVTACLVKDPKKR----PTAEKLMKHHFFK 278
+ +E F++ K++ L K P+ R + KH FFK
Sbjct: 215 VKFEHQN-FTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFK 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-15
Identities = 70/278 (25%), Positives = 120/278 (43%), Gaps = 40/278 (14%)
Query: 18 LYEEVGEGVSATVYRALCIPLNEI--VAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNV 74
L + +GEG +V + I VA+K + + C ++++ E M+ +HPNV
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62
Query: 75 LRAHCSFTTGHCLW-----------VVMPYMAGGSC----LHIMKSAYPEGFEEPVIATL 119
+R G CL V++P+M G L+ P+ ++
Sbjct: 63 MR-----LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKF 117
Query: 120 LRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVG 179
+ + + YL IHRD+ A N +++ N + +ADFG+S +++ GD R
Sbjct: 118 MTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYN-GDYYRQGRIAKM 176
Query: 180 TPCWMAPEVMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLM-----TLQN 233
W+A E + Y K+D+WSFG+T E+A G P+ ++ L+
Sbjct: 177 PVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQ 235
Query: 234 APPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKL 271
P LD L+++C + +PK RP+ E L
Sbjct: 236 PPDCLD---------GLYSLMSSCWLLNPKDRPSFETL 264
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 8e-15
Identities = 74/281 (26%), Positives = 130/281 (46%), Gaps = 33/281 (11%)
Query: 18 LYEEVGEGVSATVYRALCIPLNE-------IVAIKVLDLEKCNNDLDGIRREVQTMRVTN 70
L + +GEG V RA +++ VA+K+L + DL + E++ M++
Sbjct: 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG 75
Query: 71 -HPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRE---TLKA 126
H N++ T L+V++ Y A G+ +++ P G + T + E + K
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 127 LV-----------YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRN 175
LV YL IHRD+ A N+L+ + +K+ADFG++ + D +++ N
Sbjct: 136 LVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 176 TFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALEL-AHGHAPFSKYP--PMKVLLMTLQ 232
+ WMAPE + Y ++D+WSFGI E+ G +P YP P++ L L+
Sbjct: 196 GRLPVK-WMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSP---YPGIPVEELFKLLR 250
Query: 233 NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273
G ++ + L+ C P +RPT ++L++
Sbjct: 251 E---GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 8e-15
Identities = 81/312 (25%), Positives = 125/312 (40%), Gaps = 64/312 (20%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR--REVQTMRVTNH 71
K Y+ + +G G V A L VA+K L N R RE+ ++ NH
Sbjct: 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS-RPFQNQTHAKRAYRELVLLKCVNH 79
Query: 72 PNVLRAHCSFTTGHCL------WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLK 125
N++ FT L ++VM M C I + ++ LL + L
Sbjct: 80 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME-----LDHERMSYLLYQMLC 134
Query: 126 ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRN----TFVGTP 181
+ +LH G IHRD+K NI++ S+ +K+ DFG++ R N +V T
Sbjct: 135 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------RTACTNFMMTPYVVTR 186
Query: 182 CWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFS------------------KYPP 223
+ APEV+ + GY DIWS G EL G F
Sbjct: 187 YYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 245
Query: 224 MKVLLMTLQN------APPGL-------------DYERDKRFSKSFKELVTACLVKDPKK 264
M L T++N PG+ + ERDK + ++L++ LV DP K
Sbjct: 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDK 305
Query: 265 RPTAEKLMKHHF 276
R + ++ ++H +
Sbjct: 306 RISVDEALRHPY 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 9e-15
Identities = 66/248 (26%), Positives = 106/248 (42%), Gaps = 41/248 (16%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLD----LEKCNNDLDGIRREVQTMRVT 69
+D+ + +G G V + A+K+L LEK + IR E +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEK--EQVGHIRAERDILVEA 58
Query: 70 NHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVY 129
+ V++ SF L+++M ++ GG + ++ + E + ET+ A+
Sbjct: 59 DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDS 116
Query: 130 LHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRN---------TF--- 177
+H G IHRD+K N+L+DS G +KL+DFG+ + A + RN TF
Sbjct: 117 IHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176
Query: 178 --------------------VGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAP 217
VGTP ++APEV Q GY+ D WS G+ E+ G+ P
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 218 FSKYPPMK 225
F P +
Sbjct: 236 FCSETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 9e-15
Identities = 71/283 (25%), Positives = 131/283 (46%), Gaps = 33/283 (11%)
Query: 18 LYEEVGEGVSATVYRALCIPLNE-------IVAIKVLDLEKCNNDLDGIRREVQTMR-VT 69
L + +GEG V A I +++ VA+K+L + + DL + E++ M+ +
Sbjct: 16 LGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG 75
Query: 70 NHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRE---TLKA 126
H N++ + T L+V++ Y + G+ +++ P G + L E T K
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 127 LV-----------YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRN 175
LV YL IHRD+ A N+L+ + +K+ADFG++ + + +++ N
Sbjct: 136 LVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 176 TFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALEL-AHGHAPFSKYP--PMKVLLMTLQ 232
+ WMAPE + Y ++D+WSFG+ E+ G +P YP P++ L L+
Sbjct: 196 GRLPVK-WMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSP---YPGIPVEELFKLLK 250
Query: 233 NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHH 275
G ++ + ++ C P +RPT ++L++
Sbjct: 251 E---GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 63/236 (26%), Positives = 105/236 (44%), Gaps = 15/236 (6%)
Query: 42 VAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLH 101
VAIK L E M +HPN++ T + +V YM GS
Sbjct: 35 VAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDA 94
Query: 102 IMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVS 161
++ + F + +LR + YL G++HRD+ A NIL++SN K++DFG+S
Sbjct: 95 FLRK-HDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLS 153
Query: 162 ACMFDAGDRQRSRNTFVGT-PC-WMAPEVMQQLHGYDFKADIWSFGITALE-LAHGHAPF 218
+ D D + + T G P W APE + + +D+WS+GI E +++G P+
Sbjct: 154 RVLED--DPEAAYTTRGGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERPY 210
Query: 219 SKYPPMKVLLMTLQN--APPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLM 272
+ V+ + P +D + +L+ C KD +RP E+++
Sbjct: 211 WEMSNQDVIKAIEEGYRLPAPMD------CPAALHQLMLDCWQKDRNERPKFEQIV 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-14
Identities = 75/303 (24%), Positives = 125/303 (41%), Gaps = 46/303 (15%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLD----LEKCNNDLDGIRREVQTMRVTN 70
D+ + +G G V I A+K+L LEK + IR E + +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEK--EQVAHIRAERDILVEAD 59
Query: 71 HPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYL 130
V++ SF L+++M ++ GG + ++ + E + ET+ A+ +
Sbjct: 60 GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAI 117
Query: 131 HFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRN--------------- 175
H G IHRD+K N+L+D+ G +KL+DFG+ + A + RN
Sbjct: 118 HQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 176 -----------------TFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPF 218
+ VGTP ++APEV Q GY+ D WS G+ E+ G+ PF
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 219 SKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKR---PTAEKLMKHH 275
P + + N L + + S+ K+L+ D + R E++ H
Sbjct: 237 CSETPQETYRKVM-NWKETLVFPPEVPISEKAKDLILR-FCTDSENRIGSNGVEEIKSHP 294
Query: 276 FFK 278
FF+
Sbjct: 295 FFE 297
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 60/249 (24%), Positives = 107/249 (42%), Gaps = 29/249 (11%)
Query: 42 VAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLR--AHCSFTTGHCLWVVMPYMAGGSC 99
V +K L ++ +EVQ R NHPNVL+ C + + L V+ + G
Sbjct: 25 VVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLL--VLEFCPLGDL 82
Query: 100 LHIMKSAYPEGFEEPVIATLLR---ETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLA 156
+ ++S + L R E L++LH IH D+ N + ++ ++K+
Sbjct: 83 KNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIG 142
Query: 157 DFGVSACMFDAGDRQRSRNTFVGTPC------WMAPEVMQQLHGYDFKAD------IWSF 204
D+G++ Q + ++ C W+APE+++ D IWS
Sbjct: 143 DYGLALE-------QYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSL 195
Query: 205 GITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYER-DKRFSKSFKELVTACLVKDP 262
G+T EL P+ +VL ++ L + D ++S + E++ C + DP
Sbjct: 196 GVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCWL-DP 254
Query: 263 KKRPTAEKL 271
+ RPTAE++
Sbjct: 255 ETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 74/298 (24%), Positives = 119/298 (39%), Gaps = 41/298 (13%)
Query: 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR--REVQTMRVTN 70
Y+ +GEG V A P VAIK + + R RE++ +R
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIK--KISPFEHQTFCQRTLREIKILRRFK 61
Query: 71 HPN------VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETL 124
H N ++R SF + + +++V M + L+ K + I L + L
Sbjct: 62 HENIIGILDIIRPP-SFESFNDVYIVQELME--TDLY--KLIKTQHLSNDHIQYFLYQIL 116
Query: 125 KALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWM 184
+ L Y+H +HRD+K N+L+++N +K+ DFG++ D +V T +
Sbjct: 117 RGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176
Query: 185 APEVMQQLHGYDFKADIWSFGITALELAHGHAPF--SKYPPMKVLLMTLQNAPPGLDY-- 240
APE+M GY DIWS G E+ F Y L++ + P D
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236
Query: 241 ---ERDKRFSKS--FK-----------------ELVTACLVKDPKKRPTAEKLMKHHF 276
R + + KS FK +L+ L +P KR T E+ + H +
Sbjct: 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 64/255 (25%), Positives = 103/255 (40%), Gaps = 46/255 (18%)
Query: 62 EVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLR 121
E ++ NHP+V+R + +G +V+P+ + ++ K + P ++ +I + +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALI--IEK 164
Query: 122 ETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTP 181
+ L+ L YLH IHRDVK NI I+ + + D G + A GT
Sbjct: 165 QILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL----GLAGTV 220
Query: 182 CWMAPEVMQQLHGYDFKADIWSFGITALE-LAHGHAPFSKYPP------------MKVLL 228
APEV+ + Y+ KADIWS GI E LA+ F P + ++
Sbjct: 221 ETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKII 279
Query: 229 MTLQNAPPGLDYERDKRFSKSFKE--------------------------LVTACLVKDP 262
TL+ P + R + F E LV L D
Sbjct: 280 STLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDA 339
Query: 263 KKRPTAEKLMKHHFF 277
RP+AE+++ + F
Sbjct: 340 AMRPSAEEILNYPMF 354
|
Length = 357 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 68/265 (25%), Positives = 120/265 (45%), Gaps = 14/265 (5%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN 70
+ + L +E+G G V+ + + VAIK + E ++ D I E Q M +
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRK-VAIKTIR-EGAMSEEDFIE-EAQVMMKLS 57
Query: 71 HPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYL 130
HP +++ + T + +V +M G CL A F + + + + + + YL
Sbjct: 58 HPKLVQLYGVCTERSPICLVFEFMEHG-CLSDYLRAQRGKFSQETLLGMCLDVCEGMAYL 116
Query: 131 HFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-WMAPEVM 189
IHRD+ A N L+ N +K++DFG++ + D Q + +T P W +PEV
Sbjct: 117 ESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVL---DDQYTSSTGTKFPVKWSSPEVF 173
Query: 190 QQLHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSK 248
Y K+D+WSFG+ E+ + G P+ +V ++ G + + S+
Sbjct: 174 -SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV----VETINAGFRLYKPRLASQ 228
Query: 249 SFKELVTACLVKDPKKRPTAEKLMK 273
S EL+ C + P+ RP+ L+
Sbjct: 229 SVYELMQHCWKERPEDRPSFSLLLH 253
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 69/273 (25%), Positives = 125/273 (45%), Gaps = 30/273 (10%)
Query: 22 VGEGVSATVYRALCIPLNEI----VAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRA 77
+G GV TV++ + IP + VAIK + I + M +H ++R
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 78 HCSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHI 136
G L +V GS L H+ + + + + + + K + YL H +
Sbjct: 75 -LGICPGASLQLVTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHRMV 131
Query: 137 HRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-WMAPEVMQQLHGY 195
HR++ A NIL+ S+ +++ADFGV+ ++ D++ + TP WMA E + Y
Sbjct: 132 HRNLAARNILLKSDSIVQIADFGVADLLY-PDDKKYFYSE-HKTPIKWMALESI-LFGRY 188
Query: 196 DFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSK------ 248
++D+WS+G+T E+ ++G P++ P +V P L E+ +R ++
Sbjct: 189 THQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV---------PDL-LEKGERLAQPQICTI 238
Query: 249 SFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281
++ C + D RPT ++L + F + AR
Sbjct: 239 DVYMVMVKCWMIDENVRPTFKEL-ANEFTRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 68/277 (24%), Positives = 119/277 (42%), Gaps = 32/277 (11%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALC---IPLNE--IVAIKVLDLEKCNNDLDGIRREVQT 65
+ +D L E+GEG V+ A C +P + +VA+K L + D +RE +
Sbjct: 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD-FQREAEL 60
Query: 66 MRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYP------EGFEEPV---- 115
+ V H +++R + T G L +V YM G ++S P G +
Sbjct: 61 LTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLT 120
Query: 116 ------IATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD 169
IA+ + + L LHF +HRD+ N L+ +K+ DFG+S ++ D
Sbjct: 121 LGQMLAIASQIASGMVYLASLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIYST-D 176
Query: 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLL 228
R + WM PE + + ++DIWSFG+ E+ +G P+ + + +
Sbjct: 177 YYRVGGRTMLPIRWMPPESI-LYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE 235
Query: 229 MTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKR 265
Q G + ER + ++ C ++P++R
Sbjct: 236 CITQ----GRELERPRTCPPEVYAIMQGCWQREPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 73/295 (24%), Positives = 125/295 (42%), Gaps = 43/295 (14%)
Query: 17 RLYEEVGEGVSATVYRALC----------IPLNE------IVAIKVLDLEKCNNDLDGIR 60
RL E++GEG V+ LC E +VA+K+L + +
Sbjct: 8 RLKEKLGEGQFGEVH--LCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFL 65
Query: 61 REVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIM-----KSAYPEGFEEPV 115
+E++ M +PN++R + L ++ YM G + +S + P
Sbjct: 66 KEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPS 125
Query: 116 I--------ATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167
+ A + +K L L+F +HRD+ N L+ ++ IK+ADFG+S ++ +
Sbjct: 126 VSIANLLYMAVQIASGMKYLASLNF---VHRDLATRNCLVGNHYTIKIADFGMSRNLY-S 181
Query: 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH--GHAPFSKYPPMK 225
GD R + V WMA E + L + +D+W+FG+T E+ P+S +
Sbjct: 182 GDYYRIQGRAVLPIRWMAWESI-LLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240
Query: 226 VLLMT---LQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277
V+ T +N + + +L+ C +D K RPT K+ HHF
Sbjct: 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKI--HHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 78/295 (26%), Positives = 121/295 (41%), Gaps = 41/295 (13%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLD-GIRREVQTMR---VTNH 71
Y E+G G TVY+A VA+K + ++ + L REV ++ +H
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 72 PNVLRAH---CSFTTGHCLWVVMPYMAGGSCLHI-MKSAYPEGFEEPVIATLLRETLKAL 127
PN++R + T V + + L + P G I L+R+ L+ L
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 128 VYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVS---ACMFDAGDRQRSRNTFVGTPCWM 184
+LH + +HRD+K NIL+ S G +KLADFG++ +C Q + V T +
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC-------QMALTPVVVTLWYR 174
Query: 185 APEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVL--LMTLQNAPPGLDYER 242
APEV+ Q Y D+WS G E+ F L + L PP D+ R
Sbjct: 175 APEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233
Query: 243 DKRFSKSF--------------------KELVTACLVKDPKKRPTAEKLMKHHFF 277
D + +L+ L +P KR +A + ++H FF
Sbjct: 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 70/258 (27%), Positives = 115/258 (44%), Gaps = 44/258 (17%)
Query: 42 VAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCL-----------WV 89
VA+K + L+ ++++ E M+ +HPNV++ G C V
Sbjct: 30 VAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK-----LIGVCFEASSLQKIPKPMV 84
Query: 90 VMPYMAGGSCLH--IMKSAYPEGFEEPVIATLLR---ETLKALVYLHFHGHIHRDVKAGN 144
++P+M G LH ++ S E+ + TLL+ + + YL IHRD+ A N
Sbjct: 85 ILPFMKHGD-LHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARN 143
Query: 145 ILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSF 204
++ + + +ADFG+S ++ +GD R W+A E + Y K+D+W+F
Sbjct: 144 CMLREDMTVCVADFGLSKKIY-SGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAF 201
Query: 205 GITALELA-HGHAPFSKYPPMKVLLMTLQNAPPGLDYERD-KRFSK------SFKELVTA 256
G+T E+A G P YP ++N DY R R + +L+ +
Sbjct: 202 GVTMWEIATRGQTP---YP-------GVENHEI-YDYLRHGNRLKQPEDCLDELYDLMYS 250
Query: 257 CLVKDPKKRPTAEKLMKH 274
C DPK RPT KL +
Sbjct: 251 CWRADPKDRPTFTKLREV 268
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 28/216 (12%)
Query: 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHC 79
E++G+G VY+ + + N VA+K + +E + ++ +HPN+++
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 80 SFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLLRETLKA---LVYLHFHGH 135
+++VM + GGS L + K + LL+ +L A + YL
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKK-----NRLTVKKLLQMSLDAAAGMEYLESKNC 114
Query: 136 IHRDVKAGNILIDSNGAIKLADFGVS----ACMFDAGDRQRSRNTFVGTPC-WMAPEVMQ 190
IHRD+ A N L+ N +K++DFG+S ++ D + P W APE +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ------IPIKWTAPEALN 168
Query: 191 QLHG-YDFKADIWSFGITALEL-AHGHAPFSKYPPM 224
+G Y ++D+WS+GI E + G P YP M
Sbjct: 169 --YGRYTSESDVWSYGILLWETFSLGDTP---YPGM 199
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 68/269 (25%), Positives = 112/269 (41%), Gaps = 26/269 (9%)
Query: 19 YEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLR-- 76
E GE A +V +K L K N RRE+ R +H NV+R
Sbjct: 15 RGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLL 74
Query: 77 AHCSFTTGHCLWVVMPYMAGGSC---LHIMKSAYPEGFEEPV-------IATLLRETLKA 126
C H + ++ Y G L KS + P+ + T + +
Sbjct: 75 GLCREAEPHYM--ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 127 LVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-WMA 185
L F +HRD+ A N L+ S +K++ +S ++++ + + RN + P W+A
Sbjct: 133 LSNARF---VHRDLAARNCLVSSQREVKVSLLSLSKDVYNS-EYYKLRNALI--PLRWLA 186
Query: 186 PEVMQQLHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244
PE +Q+ + K+D+WSFG+ E+ G PF +V L LQ L+ +
Sbjct: 187 PEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV-LNRLQAGK--LELPVPE 242
Query: 245 RFSKSFKELVTACLVKDPKKRPTAEKLMK 273
+L+T C +PK RP+ +L+
Sbjct: 243 GCPSRLYKLMTRCWAVNPKDRPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 6e-14
Identities = 75/284 (26%), Positives = 111/284 (39%), Gaps = 52/284 (18%)
Query: 18 LYEEVGEGVSATVYRAL---CIPLNEI--VAIKVLDLEKCNNDLDGIRREVQTMRVTNHP 72
L E+G+G VY L + VAIK ++ + E M+ N
Sbjct: 10 LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH 69
Query: 73 NVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPV--IATLLR------ETL 124
+V+R +TG VVM MA G ++S PE P TL + E
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 125 KALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGT-PC- 182
+ YL +HRD+ A N ++ + +K+ DFG++ D + R G P
Sbjct: 130 DGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR---DIYETDYYRKGGKGLLPVR 186
Query: 183 WMAPEVMQQLHG-YDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP-PGLDY 240
WMAPE ++ G + K+D+WSFG+ E+A TL P GL
Sbjct: 187 WMAPESLKD--GVFTTKSDVWSFGVVLWEMA-----------------TLAEQPYQGLSN 227
Query: 241 ERDKRFSKSFK-------------ELVTACLVKDPKKRPTAEKL 271
E +F EL+ C +PK RPT ++
Sbjct: 228 EEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 65/245 (26%), Positives = 106/245 (43%), Gaps = 25/245 (10%)
Query: 42 VAIKVLDLEKC----NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGG 97
VAIK EK +D + E + + NHP + + SF L++V+ ++ GG
Sbjct: 59 VAIK--RFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGG 116
Query: 98 SCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLAD 157
++ + F V + + YL ++RD+K N+L+D +G IK+ D
Sbjct: 117 EFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTD 174
Query: 158 FGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAP 217
FG + + T GTP ++APE++ + G+ AD W+ GI E+ G P
Sbjct: 175 FGFAKVV------DTRTYTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPP 227
Query: 218 FSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKR-----PTAEKLM 272
F P L+ Q G+ Y K + K L+ L D KR A+ +
Sbjct: 228 FYANEP----LLIYQKILEGIIY-FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVK 282
Query: 273 KHHFF 277
+H +F
Sbjct: 283 EHPWF 287
|
Length = 340 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 64/283 (22%), Positives = 123/283 (43%), Gaps = 27/283 (9%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCI---PLNE--IVAIKVLDLEKCNNDLDGIRREVQT 65
+ +D L E+GEG V+ A C P + +VA+K L D +RE +
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD-FQREAEL 60
Query: 66 MRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGF----EEPVIAT--- 118
+ H ++++ + G L +V YM G +++ P+ +P A
Sbjct: 61 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 120
Query: 119 -------LLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171
+ + +VYL +HRD+ N L+ +N +K+ DFG+S ++ +
Sbjct: 121 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR 180
Query: 172 RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMT 230
+T + WM PE + + ++D+WSFG+ E+ +G P+ + +V+
Sbjct: 181 VGGHTMLPIR-WMPPESI-MYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238
Query: 231 LQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273
Q G ER + K +++ C ++P++R +++ K
Sbjct: 239 TQ----GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 8e-14
Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 19/224 (8%)
Query: 62 EVQTMRVTNHPNVLR--AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATL 119
E Q R H N+L+ C+ T + L VM + G ++S P TL
Sbjct: 45 EAQPYRSLQHSNLLQCLGQCTEVTPYLL--VMEFCPLGDLKGYLRSCRKAELMTPDPTTL 102
Query: 120 LR---ETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNT 176
R E L++LH + IH D+ N L+ ++ +K+ D+G+S +
Sbjct: 103 QRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQL 162
Query: 177 FVGTPC-WMAPEVMQQLHGYDFKAD------IWSFGITALELAH-GHAPFSKYPPMKVLL 228
+V P W+APE++ ++HG D +WS G+T EL G P+ +VL
Sbjct: 163 WV--PLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT 220
Query: 229 MTLQNAPPGLDYERDK-RFSKSFKELVTACLVKDPKKRPTAEKL 271
T++ L R K S + E++ C ++ P++RP+AE++
Sbjct: 221 YTVREQQLKLPKPRLKLPLSDRWYEVMQFCWLQ-PEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 9e-14
Identities = 74/297 (24%), Positives = 135/297 (45%), Gaps = 33/297 (11%)
Query: 2 DLVVEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNE-------IVAIKVLDLEKCNN 54
+L + R+ V L + +GEG V A I L++ VA+K+L +
Sbjct: 6 ELPEDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEK 65
Query: 55 DLDGIRREVQTMR-VTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFE- 112
DL + E++ M+ + H N++ + T L+V++ Y + G+ +++ P G E
Sbjct: 66 DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 125
Query: 113 --EPVIATLLRETLKALV-----------YLHFHGHIHRDVKAGNILIDSNGAIKLADFG 159
P + + K LV YL IHRD+ A N+L+ + +K+ADFG
Sbjct: 126 CYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFG 185
Query: 160 VSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALEL-AHGHAPF 218
++ + +++ N + WMAPE + Y ++D+WSFG+ E+ G +P
Sbjct: 186 LARDIHHIDYYKKTTNGRLPVK-WMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSP- 242
Query: 219 SKYP--PMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273
YP P++ L L+ G ++ + ++ C P +RPT ++L++
Sbjct: 243 --YPGVPVEELFKLLKE---GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 62/262 (23%), Positives = 108/262 (41%), Gaps = 34/262 (12%)
Query: 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDL-----DGIRREVQTMRVTNHPNV 74
E +G G V+ N VA+K C L +E + ++ +HPN+
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVK-----SCRETLPPDLKAKFLQEARILKQYSHPNI 55
Query: 75 LRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHG 134
+R T +++VM + GG L +++ P + + ++ + YL
Sbjct: 56 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR-LKVKELIQMVENAAAGMEYLESKH 114
Query: 135 HIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGT------PC-WMAPE 187
IHRD+ A N L+ +K++DFG+S R+ + T P W APE
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMS--------REEEDGVYASTGGMKQIPVKWTAPE 166
Query: 188 VMQQLHG-YDFKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245
+ +G Y ++D+WSFGI E + G P++ + T + G+ +
Sbjct: 167 ALN--YGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ----TREAIEQGVRLPCPEL 220
Query: 246 FSKSFKELVTACLVKDPKKRPT 267
+ L+ C DP +RP+
Sbjct: 221 CPDAVYRLMERCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-13
Identities = 52/162 (32%), Positives = 74/162 (45%), Gaps = 14/162 (8%)
Query: 58 GIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP-YMAGGSCLHIMKSAYPEGFEEPVI 116
G E +R NHP++++ +FT +++P Y C K I
Sbjct: 129 GTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIA-------I 181
Query: 117 ATLL---RETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS 173
+L R L+A+ YLH + IHRD+KA NI I+ G + L DFG +AC F
Sbjct: 182 CDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG-AAC-FPVDINANK 239
Query: 174 RNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGH 215
+ GT APE++ + Y DIWS GI E+A H
Sbjct: 240 YYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 66/247 (26%), Positives = 107/247 (43%), Gaps = 46/247 (18%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNE-----IVAIKVLDLEKCNNDL-DGIRREVQTMRV 68
R EE+GEG VY+ NE VAIK L E + R+E + M
Sbjct: 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLK-ENAEPKVQQEFRQEAELMSD 64
Query: 69 TNHPNV--LRAHCSFTTGHCLWVVMPYMAGGSCLH---IMKSAYPEGFEEPVIATLLRET 123
HPN+ L C+ C ++ Y+A G LH + S + + +
Sbjct: 65 LQHPNIVCLLGVCTKEQPTC--MLFEYLAHGD-LHEFLVRNSPH----SDVGAESGDETV 117
Query: 124 LKALVYLHF----------------HGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167
+L F H +HRD+ A N L+ +K++DFG+S ++ +
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY-S 176
Query: 168 GD--RQRSRNTFVGTPC-WMAPEVMQQLHG-YDFKADIWSFGITALEL-AHGHAPFSKYP 222
D R +S++ P WM PE + L+G + ++DIWSFG+ E+ ++G P+ +
Sbjct: 177 ADYYRVQSKSLL---PVRWMPPEAI--LYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS 231
Query: 223 PMKVLLM 229
+V+ M
Sbjct: 232 NQEVIEM 238
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 73/298 (24%), Positives = 120/298 (40%), Gaps = 52/298 (17%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVL 75
Y +++GEG ATV++ +VA+K + LE REV ++ H N++
Sbjct: 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIV 66
Query: 76 RAHCSFTTGHCLWVVMPYMAGG------SCLHIMKSAYPEGFEEPVIATLLRETLKALVY 129
H T CL +V Y+ +C ++M + + + L+ L Y
Sbjct: 67 TLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHN--------VKIFMFQLLRGLSY 118
Query: 130 LHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTF-----VGTPCWM 184
H +HRD+K N+LI+ G +KLADFG++ R +S T V T +
Sbjct: 119 CHKRKILHRDLKPQNLLINEKGELKLADFGLA--------RAKSVPTKTYSNEVVTLWYR 170
Query: 185 APEVMQQLHGYDFKADIWSFGITALELAHGHA--PFSKYPPMKVLLMTLQNAP-----PG 237
P+V+ Y D+W G E+A G P S L+ L P PG
Sbjct: 171 PPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPG 230
Query: 238 LDYERD------------------KRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277
+ + R +L+++ L+ + K R +AE ++H +F
Sbjct: 231 ITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-13
Identities = 73/232 (31%), Positives = 103/232 (44%), Gaps = 25/232 (10%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN 73
K Y+L +G G VY A+CI +E VAIK K D RE+ M+ NH N
Sbjct: 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIK-----KVLQDPQYKNRELLIMKNLNHIN 120
Query: 74 VLRAHCSFTTGHC---------LWVVMPYMAGGSCLH-IMKSAYPEGFEEPVIATLLR-- 121
++ + T C L VVM ++ +H MK P+ L
Sbjct: 121 IIFLKDYYYT-ECFKKNEKNIFLNVVMEFIP--QTVHKYMKHYARNNHALPLFLVKLYSY 177
Query: 122 ETLKALVYLHFHGHIHRDVKAGNILIDSNG-AIKLADFGVSACMFDAGDRQRSRNTFVGT 180
+ +AL Y+H HRD+K N+LID N +KL DFG SA AG R S ++ +
Sbjct: 178 QLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG-SAKNLLAGQRSVS---YICS 233
Query: 181 PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQ 232
+ APE+M Y D+WS G E+ G+ FS + L+ +Q
Sbjct: 234 RFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ 285
|
Length = 440 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 69/296 (23%), Positives = 123/296 (41%), Gaps = 48/296 (16%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVL 75
Y +++GEG ATVY+ + +VA+K + LE REV ++ H N++
Sbjct: 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67
Query: 76 RAHCSFTTGHCLWVVMPYMAG---------GSCLHIMKSAYPEGFEEPVIATLLRETLKA 126
H T L +V Y+ G+ +++ + L + L+
Sbjct: 68 TLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHN-----------VKLFLFQLLRG 116
Query: 127 LVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAP 186
L Y H +HRD+K N+LI+ G +KLADFG++ ++ + V T + P
Sbjct: 117 LNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA---KSIPTKTYSNEVVTLWYRPP 173
Query: 187 EVMQQLHGYDFKADIWSFGITALELAHGHAPFSK-------YPPMKVLLMTLQNAPPGL- 238
+++ Y + D+W G E++ G F + ++L + PG+
Sbjct: 174 DILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 233
Query: 239 --------DYERDK---------RFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277
+Y + + R EL++ L + +KR +AE+ MKH +F
Sbjct: 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-13
Identities = 64/257 (24%), Positives = 106/257 (41%), Gaps = 41/257 (15%)
Query: 61 REVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLL 120
RE+ ++ +H ++ ++ + +VMP ++ +S P E+ T+
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSG-PLPLEQ--AITIQ 191
Query: 121 RETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGT 180
R L+AL YLH G IHRDVK NI +D L DFG +AC DA + GT
Sbjct: 192 RRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFG-AACKLDAHPDTPQCYGWSGT 250
Query: 181 PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAP-FSKYPP-----MKVLLMTLQNA 234
+PE++ L Y K DIWS G+ E++ + F K ++ ++ +Q
Sbjct: 251 LETNSPELL-ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVH 309
Query: 235 PPGLDYERDK--RFSKSFKE--------------------------LVTACLVKDPKKRP 266
P L++ ++ K FK+ L+ L D + RP
Sbjct: 310 P--LEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRP 367
Query: 267 TAEKLMKHHFFKHARSN 283
+A+ ++ F N
Sbjct: 368 SAQDILSLPLFTKEPIN 384
|
Length = 392 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 5e-13
Identities = 89/356 (25%), Positives = 150/356 (42%), Gaps = 55/356 (15%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR--REVQTMRVTNH 71
K Y+ + +G G V A L+ VAIK L N R RE+ M+ NH
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRELVLMKCVNH 75
Query: 72 PNVLRAHCSFTTGHCL------WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLK 125
N++ FT L ++VM M C I + ++ LL + L
Sbjct: 76 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME-----LDHERMSYLLYQMLC 130
Query: 126 ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTP---- 181
+ +LH G IHRD+K NI++ S+ +K+ DFG++ + + +F+ TP
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---------RTAGTSFMMTPYVVT 181
Query: 182 -CWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240
+ APEV+ + GY DIWS G E+ K+L PG DY
Sbjct: 182 RYYRAPEVILGM-GYKENVDIWSVGCIMGEMVR----------HKILF-------PGRDY 223
Query: 241 ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGER 300
+++K ++L T C K +PT +++ + + + D+L P
Sbjct: 224 --IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN---RPKYAGLTFPKLFPDSLFPADSE 278
Query: 301 FRMLKAKEADLLVQNKALYEDKEQLSQDYDCMSNAEDPNSSGKQNHADVEVPAERL 356
LKA +A L+ + + +++S D + + + P + + A+VE P ++
Sbjct: 279 HNKLKASQARDLLSKMLVIDPAKRISVD-EAL---QHPYINVWYDPAEVEAPPPQI 330
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 75/295 (25%), Positives = 117/295 (39%), Gaps = 43/295 (14%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVL 75
Y+ +++GEG ATVY+ ++VA+K + LE RE ++ H N++
Sbjct: 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIV 66
Query: 76 RAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGH 135
H T L +V Y+ ++ G + L + L+ L Y H
Sbjct: 67 TLHDIIHTKKTLTLVFEYLDTDLKQYM--DDCGGGLSMHNVRLFLFQLLRGLAYCHQRRV 124
Query: 136 IHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS--RNTF---VGTPCWMAPEVMQ 190
+HRD+K N+LI G +KLADFG++ R +S T+ V T + P+V+
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLA--------RAKSVPSKTYSNEVVTLWYRPPDVLL 176
Query: 191 QLHGYDFKADIWSFGITALELAHGHAPF--SKYPP------MKVLLMTLQNAPPGL---- 238
Y D+W G E+A G F S +VL + PG+
Sbjct: 177 GSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236
Query: 239 --------DYERDK---RFSK-----SFKELVTACLVKDPKKRPTAEKLMKHHFF 277
Y + +EL L +PKKR +A + MKH +F
Sbjct: 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 62/269 (23%), Positives = 122/269 (45%), Gaps = 25/269 (9%)
Query: 21 EVGEGVSATVYRAL--CIPLNEIVAIKVLDLEKCNNDL-DGIRREVQTMRVTNHPNVLRA 77
E+G G TV + + + VA+K+L + + L D + RE M+ ++P ++R
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR- 60
Query: 78 HCSFTTGHC---LWVVMPYMAGGSCLH--IMKSAYPEGFEEPVIATLLRETLKALVYLHF 132
G C W+++ +A L+ + K+ + E I L+ + + YL
Sbjct: 61 ----MIGICEAESWMLVMELAELGPLNKFLQKNKH---VTEKNITELVHQVSMGMKYLEE 113
Query: 133 HGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQL 192
+HRD+ A N+L+ + K++DFG+S + + +++ W APE M
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM-NY 172
Query: 193 HGYDFKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251
+ + K+D+WSFG+ E ++G P+ +V M +++ G E +R
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQM-IES---GERMECPQRCPPEMY 228
Query: 252 ELVTACLVKDPKKRP---TAEKLMKHHFF 277
+L+ C +RP E ++++++
Sbjct: 229 DLMKLCWTYGVDERPGFAVVELRLRNYYY 257
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 77/296 (26%), Positives = 123/296 (41%), Gaps = 38/296 (12%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLN-EIVAIKVLDLEKCNNDLD-GIRREVQTMR---V 68
+ Y E+GEG V++A + VA+K + ++ + REV +R
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 69 TNHPNVLRAHCSFTTGHC-----LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRET 123
HPNV+R T L +V ++ ++ K P G I ++ +
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP-GVPTETIKDMMFQL 119
Query: 124 LKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCW 183
L+ L +LH H +HRD+K NIL+ S+G IKLADFG++ Q + + V T +
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY----SFQMALTSVVVTLWY 175
Query: 184 MAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVL--LMTLQNAPPGLDYE 241
APEV+ Q Y D+WS G E+ F + L ++ + P D+
Sbjct: 176 RAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234
Query: 242 RDKRFSKSF--------------------KELVTACLVKDPKKRPTAEKLMKHHFF 277
RD + K+L+ CL +P KR +A + H +F
Sbjct: 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-12
Identities = 47/153 (30%), Positives = 81/153 (52%), Gaps = 10/153 (6%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVL-DLEKCN-NDLDGIRREVQTMRVTNH 71
+++ + + + G VY +++ A+KV+ + N N + ++ E + ++
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 72 PNVLRAHCSFTTGHCLWVVMPYMAGG---SCLHIMKSAYPEGFEEPVIATLLRETLKALV 128
P ++ + S + + +++VM Y+ GG S LHI Y F+E + + E AL
Sbjct: 64 PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIY--GY---FDEEMAVKYISEVALALD 118
Query: 129 YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVS 161
YLH HG IHRD+K N+LI + G IKL DFG+S
Sbjct: 119 YLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 62/264 (23%), Positives = 106/264 (40%), Gaps = 29/264 (10%)
Query: 22 VGEGVSATVYRALCIP--LNEIVAIKVLDLEKCNNDLDGIRREVQTM-RVTNHPNVLRAH 78
+GEG V +A L AIK + +D E++ + ++ +HPN++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 79 CSFTTGHCLWVVMPYMAGGSCLHIMKSAY-----PEGFEEPVIATLL--RETLK------ 125
+ L++ + Y G+ L ++ + P A+ L ++ L
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 126 -ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-W 183
+ YL IHRD+ A NIL+ N K+ADFG+S G + T P W
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS-----RGQEVYVKKTMGRLPVRW 177
Query: 184 MAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYER 242
MA E + Y +D+WS+G+ E+ G P+ ++ + P G E+
Sbjct: 178 MAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL----YEKLPQGYRLEK 232
Query: 243 DKRFSKSFKELVTACLVKDPKKRP 266
+L+ C + P +RP
Sbjct: 233 PLNCDDEVYDLMRQCWREKPYERP 256
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 52/198 (26%), Positives = 94/198 (47%), Gaps = 6/198 (3%)
Query: 22 VGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDL-DGIRREVQTMRVTNHPNVLRAHCS 80
VGEG V + EIVAIK + N ++ + RE++ +R N++ +
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 81 FTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDV 140
F L++V Y+ + L +++ P G + + + + +KA+ + H + +HRD+
Sbjct: 69 FRRRGKLYLVFEYVEK-NMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDI 126
Query: 141 KAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKAD 200
K N+LI N +KL DFG + + + + + +V T + +PE++ Y D
Sbjct: 127 KPENLLISHNDVLKLCDFGFARNLSEGSNANYTE--YVATRWYRSPELLLGA-PYGKAVD 183
Query: 201 IWSFGITALELAHGHAPF 218
+WS G EL+ G F
Sbjct: 184 MWSVGCILGELSDGQPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 68/269 (25%), Positives = 113/269 (42%), Gaps = 26/269 (9%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRA-LCIP--LNEIVAIKVLDLEKCNNDLDGIRREVQTMR 67
+D ++ E +G G V R L +P VAIK L E M
Sbjct: 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMG 60
Query: 68 VTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEG-FEEPVIATLLRETLKA 126
+HPN++ T + ++ +M G+ ++ +G F + +LR
Sbjct: 61 QFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAG 118
Query: 127 LVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGT-----P 181
+ YL ++HRD+ A NIL++SN K++DFG+S + D S T+ + P
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED----DTSDPTYTSSLGGKIP 174
Query: 182 C-WMAPEVMQQLHGYDFKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTLQN--APPG 237
W APE + + +D+WS+GI E +++G P+ V+ Q+ PP
Sbjct: 175 IRWTAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPP 233
Query: 238 LDYERDKRFSKSFKELVTACLVKDPKKRP 266
+D + +L+ C KD RP
Sbjct: 234 MD------CPTALHQLMLDCWQKDRNARP 256
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 59/265 (22%), Positives = 112/265 (42%), Gaps = 24/265 (9%)
Query: 18 LYEEVGEGVSATVYRALCIPL-----NEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHP 72
L E+GEG V+ A C L +VA+K L + +N RE + + H
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLK-DASDNARKDFHREAELLTNLQHE 67
Query: 73 NVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEG-----------FEEPVIATLLR 121
++++ + G L +V YM G +++ P+ + + + +
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 122 ETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTP 181
+ +VYL +HRD+ N L+ N +K+ DFG+S ++ + +T +
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 182 CWMAPEVMQQLHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240
WM PE + + ++D+WS G+ E+ +G P+ + +V+ Q G
Sbjct: 188 -WMPPESI-MYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ----GRVL 241
Query: 241 ERDKRFSKSFKELVTACLVKDPKKR 265
+R + K +L+ C ++P R
Sbjct: 242 QRPRTCPKEVYDLMLGCWQREPHMR 266
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 67/245 (27%), Positives = 115/245 (46%), Gaps = 32/245 (13%)
Query: 42 VAIKVLDLE-KCNNDLDGIRREVQTMRVTNHPNVLR----AHCSFTTGH--CLWVVMPYM 94
VA+K+L + ++D++ RE M+ +HPNV++ + S G V++P+M
Sbjct: 30 VAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFM 89
Query: 95 AGGSCLH---IMKSAYPEGFEEPVIATLLR---ETLKALVYLHFHGHIHRDVKAGNILID 148
G LH +M E F P+ TL+R + + YL IHRD+ A N +++
Sbjct: 90 KHGD-LHTFLLMSRIGEEPFTLPL-QTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN 147
Query: 149 SNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITA 208
N + +ADFG+S ++ +GD R W+A E + + Y +D+W+FG+T
Sbjct: 148 ENMTVCVADFGLSKKIY-SGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTM 205
Query: 209 LELA-HGHAPFSKYPPMKV--LLMT---LQNAPPGLDYERDKRFSKSFKELVTACLVKDP 262
E+ G P++ ++ L+ L+ P L+ EL+ C +P
Sbjct: 206 WEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCLE---------DVYELMCQCWSPEP 256
Query: 263 KKRPT 267
K RP+
Sbjct: 257 KCRPS 261
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 62/275 (22%), Positives = 110/275 (40%), Gaps = 42/275 (15%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNE----IVAIKVLDLEKCNNDLDGIRREVQTM 66
+D K ++ +G G + R C+ L VAI L + G E T+
Sbjct: 2 LDNKSIKIERILGTGRFGELCRG-CLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 67 RVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEG-FEEPVIATLLRETLK 125
+H N++R T G+ + +V YM+ G+ ++ EG + +L
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLAS 118
Query: 126 ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFV-----GT 180
+ YL G++H+ + A +L++S+ K++ F +S +
Sbjct: 119 GMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR-------RLQEDKSEAIYTTMSGKSP 171
Query: 181 PCWMAPEVMQQLHGYDFKADIWSFGITALE-LAHGHAPF---SKYPPMKVL-----LMTL 231
W APE + Q H + +D+WSFGI E +++G P+ S +K + L
Sbjct: 172 VLWAAPEAI-QYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAP 230
Query: 232 QNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRP 266
+N P L +L+ C K+ +RP
Sbjct: 231 RNCPNLL------------HQLMLDCWQKERGERP 253
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 85/328 (25%), Positives = 136/328 (41%), Gaps = 51/328 (15%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR--REVQTMRVTNH 71
K Y+ + +G G V A L VAIK L N R RE+ M+ NH
Sbjct: 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCVNH 82
Query: 72 PNVLRAHCSFTTGHCL------WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLK 125
N++ FT L ++VM M C I + ++ LL + L
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME-----LDHERMSYLLYQMLC 137
Query: 126 ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTP---- 181
+ +LH G IHRD+K NI++ S+ +K+ DFG++ + + +F+ TP
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---------RTAGTSFMMTPYVVT 188
Query: 182 -CWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240
+ APEV+ + GY DIWS G E+ G F PG D+
Sbjct: 189 RYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLF-----------------PGTDH 230
Query: 241 ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGER 300
+++K ++L T C K +PT +++ K+A + + D L P
Sbjct: 231 --IDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR-PKYAGYS--FEKLFPDVLFPADSE 285
Query: 301 FRMLKAKEADLLVQNKALYEDKEQLSQD 328
LKA +A L+ + + +++S D
Sbjct: 286 HNKLKASQARDLLSKMLVIDASKRISVD 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 70/272 (25%), Positives = 118/272 (43%), Gaps = 29/272 (10%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIP--LNEIVAIKVLDLEKCNNDLDGIRREVQTM-RVTN 70
+D + + +GEG V RA+ L AIK+L ND E++ + ++ +
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 71 HPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAY-----PEGFEEPVIATLL--RET 123
HPN++ + L++ + Y G+ L ++ + P +E A+ L ++
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 124 LK-------ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNT 176
L+ + YL IHRD+ A N+L+ N A K+ADFG+S G+ + T
Sbjct: 122 LQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLS-----RGEEVYVKKT 176
Query: 177 FVGTPC-WMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNA 234
P WMA E + Y K+D+WSFG+ E+ G P+ ++ +
Sbjct: 177 MGRLPVRWMAIESL-NYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL----YEKL 231
Query: 235 PPGLDYERDKRFSKSFKELVTACLVKDPKKRP 266
P G E+ + EL+ C P +RP
Sbjct: 232 PQGYRMEKPRNCDDEVYELMRQCWRDRPYERP 263
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 71/254 (27%), Positives = 104/254 (40%), Gaps = 39/254 (15%)
Query: 61 REVQTMRVTNHPNVLRAHCSFTTGHC-----LWVVMPYMAGGSCLH-IMKSAYPEGFEEP 114
RE++ + H NVL A H ++VV M S LH I+ S P+
Sbjct: 48 RELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ--SDLHKIIVS--PQPLSSD 103
Query: 115 VIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSR 174
+ L + L+ L YLH G +HRD+K GN+L++SN +K+ DFG++ + D +
Sbjct: 104 HVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLA--RVEEPDESKHM 161
Query: 175 NTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVL------L 228
V T + APE++ Y DIWS G EL F P++ L L
Sbjct: 162 TQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLL 221
Query: 229 MT-----------------LQNA--PPGLD--YERDKRFSKSFKELVTACLVKDPKKRPT 267
T L+ PP L Y + + L+ LV DP KR +
Sbjct: 222 GTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRIS 281
Query: 268 AEKLMKHHFFKHAR 281
A + H + R
Sbjct: 282 AADALAHPYLDEGR 295
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 46/186 (24%), Positives = 88/186 (47%), Gaps = 12/186 (6%)
Query: 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNIL 146
L++V YMA GS + ++S + + +A+ YL + +HRD+ A N+L
Sbjct: 75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVL 134
Query: 147 IDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGI 206
+ + K++DFG++ +A Q + V W APE +++ + K+D+WSFGI
Sbjct: 135 VSEDNVAKVSDFGLTK---EASSTQDTGKLPVK---WTAPEALRE-KKFSTKSDVWSFGI 187
Query: 207 TALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKR 265
E+ + G P+ + P+K ++ ++ G + +++ C D R
Sbjct: 188 LLWEIYSFGRVPYPRI-PLKDVVPRVEK---GYKMDAPDGCPPVVYDVMKQCWHLDAATR 243
Query: 266 PTAEKL 271
P+ +L
Sbjct: 244 PSFLQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 7e-12
Identities = 75/315 (23%), Positives = 117/315 (37%), Gaps = 63/315 (20%)
Query: 21 EVGEGVSATVYRALCI--PLNEIVAIKVLDLEKCNNDLDGIR----REVQTMRVTNHPNV 74
+G G VY+A + AIK +K GI RE+ +R H NV
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDK--EQYTGISQSACREIALLRELKHENV 64
Query: 75 ---LRAHCSFTTGHCLWVVMPYMAGGSCLHIMK---SAYPEGFEEPVIATLLRETLKALV 128
+ ++++ Y A I+K A ++ +LL + L +
Sbjct: 65 VSLVEVFLEHADK-SVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122
Query: 129 YLHFHGHIHRDVKAGNILI----DSNGAIKLADFGVSACMFDAGDRQ-RSRNTFVGTPCW 183
YLH + +HRD+K NIL+ G +K+ D G+ A +F+A + + V T +
Sbjct: 123 YLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL-ARLFNAPLKPLADLDPVVVTIWY 181
Query: 184 MAPEVMQQLHGYDFKADIWSFG------ITALELAHG-HAPFSKYPP---------MKVL 227
APE++ Y DIW+ G +T + G A K P +VL
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVL 241
Query: 228 LM-TLQNAPPGLDYERDKRFSKSFKE------------------------LVTACLVKDP 262
T ++ P K FK L+ L DP
Sbjct: 242 GTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDP 301
Query: 263 KKRPTAEKLMKHHFF 277
KR TAE+ ++H +F
Sbjct: 302 TKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 8e-12
Identities = 63/219 (28%), Positives = 94/219 (42%), Gaps = 31/219 (14%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR--REVQTMRVTNH 71
K Y+ + +G G V A + VAIK L N R RE+ M++ NH
Sbjct: 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLS-RPFQNVTHAKRAYRELVLMKLVNH 74
Query: 72 PNVLRAHCSFTTGHCL------WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLK 125
N++ FT L ++VM M C I + ++ LL + L
Sbjct: 75 KNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-----LDHERMSYLLYQMLC 129
Query: 126 ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNT------FVG 179
+ +LH G IHRD+K NI++ S+ +K+ DFG++ R+ T +V
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA----------RTAGTSFMMTPYVV 179
Query: 180 TPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPF 218
T + APEV+ + GY DIWS G E+ G F
Sbjct: 180 TRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLF 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 67/280 (23%), Positives = 120/280 (42%), Gaps = 46/280 (16%)
Query: 17 RLYEEVGEGVSATVYRA-LCIPLNE---IVAIKVLDLEKCNNDLDGIRREVQTMRVTNHP 72
R EE+GE +Y+ L +P + +VAIK L ++E M +HP
Sbjct: 8 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHP 67
Query: 73 NVLRAHCSFTTGHCLWVVMPYMAGGSCLH---IMKSAYPE----GFEEPVIATLLR---- 121
N++ T + ++ Y+ G LH IM+S + + E+ + + L
Sbjct: 68 NIVCLLGVVTQEQPVCMLFEYLNQGD-LHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF 126
Query: 122 -----ETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNT 176
+ + YL H +H+D+ A NILI +K++D G+S ++ A + +
Sbjct: 127 LHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186
Query: 177 FVGTPCWMAPEVMQQLHG-YDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTL--- 231
+ WM PE + ++G + +DIWSFG+ E+ + G P+ + +V+ M
Sbjct: 187 LLPIR-WMPPEAI--MYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQ 243
Query: 232 -----QNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRP 266
++ PP + L+T C + P +RP
Sbjct: 244 LLPCSEDCPPRM------------YSLMTECWQEGPSRRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 43/230 (18%)
Query: 66 MRVTNHPNVLRAHCSFTT--GHCLWVVMPYMAGGSCLHIMKSAYPEG-FEEPVIATLLRE 122
M+ ++PN ++ + S TT GH L +M Y+ G ++K EG E + ++R+
Sbjct: 65 MK--DNPNFIKLYYSVTTLKGHVL--IMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQ 117
Query: 123 TLKALVYLHFHGHIHRDVKAGNILID-SNGAIKLADFGVSACMFDAGDRQRSRNTFVGTP 181
++AL LH H IH D+K N+L D + I L D+G+ +GTP
Sbjct: 118 LVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI--------------IGTP 163
Query: 182 C-------WMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYP----PMKVLLMT 230
+ +PE ++ H YD D W+ G+ EL G PF + ++ LL
Sbjct: 164 SCYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKR 222
Query: 231 LQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEK-LMKHHFFKH 279
Q P K SK+ + V + L + R T ++KH F K
Sbjct: 223 QQKKLP-----FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267
|
Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 19/215 (8%)
Query: 22 VGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQ------TMRVTNHPNVL 75
+G G TVY+ + +P E V I V K N+ G + V+ M +HP+++
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAI--KILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 76 R--AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH 133
R C T + +MP+ CL + + ++ + K ++YL
Sbjct: 73 RLLGVCLSPTIQLVTQLMPH----GCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER 128
Query: 134 GHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-WMAPEVMQQL 192
+HRD+ A N+L+ S +K+ DFG++ + GD + P WMA E +
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLL--EGDEKEYNADGGKMPIKWMALECI-HY 185
Query: 193 HGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKV 226
+ ++D+WS+G+T EL G P+ P ++
Sbjct: 186 RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 220
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 22 VGEGVSATVYRA-LCIPLNE--IVAIKVLD---LEKCNNDLDGIRREVQTMRVTNHPNVL 75
+G G V+R L +P + VAIK L EK D E M +H N++
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLS---EASIMGQFSHHNII 69
Query: 76 RAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGH 135
R T ++ YM G+ ++ E F + +LR + YL +
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGE-FSSYQLVGMLRGIAAGMKYLSDMNY 128
Query: 136 IHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGT-PC-WMAPEVMQQLH 193
+HRD+ A NIL++SN K++DFG+S + D D + + T G P W APE +
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLED--DPEGTYTTSGGKIPIRWTAPEAI-AYR 185
Query: 194 GYDFKADIWSFGITALE-LAHGHAPF 218
+ +D+WSFGI E ++ G P+
Sbjct: 186 KFTSASDVWSFGIVMWEVMSFGERPY 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 29/222 (13%)
Query: 16 YRLYEEVGEGVSATVYRALCI--PLNEIVAIKVLDLEKCNNDLDG---IRREVQTMRVTN 70
Y L +E+G+G V A E VAIK K N +R ++ +++
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIK-----KITNVFSKKILAKRALRELKLLR 56
Query: 71 HPNVLRAHCSFTTGHCLWVVMPYMAGGSCLH----------IMKSAYPEGFEEPVIATLL 120
H R H + T + + +V P L+ I++S P + + +
Sbjct: 57 H---FRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQP--LTDAHFQSFI 111
Query: 121 RETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSR--NTFV 178
+ L L Y+H +HRD+K GN+L++++ +K+ DFG+ A F + + +V
Sbjct: 112 YQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGL-ARGFSENPGENAGFMTEYV 170
Query: 179 GTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSK 220
T + APE+M Y D+WS G EL G P K
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAEL-LGRKPVFK 211
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 13/212 (6%)
Query: 22 VGEGVSATVYRALCIPLNE----IVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLR- 76
+G G TVY+ L IP E VAIK L I E M ++P+V R
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 77 -AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGH 135
C +T + +MP+ CL + + + + K + YL
Sbjct: 75 LGICLTSTVQLITQLMPF----GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRL 130
Query: 136 IHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGY 195
+HRD+ A N+L+ + +K+ DFG++ + A +++ WMA E + Y
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAK-LLGADEKEYHAEGGKVPIKWMALESILH-RIY 188
Query: 196 DFKADIWSFGITALEL-AHGHAPFSKYPPMKV 226
++D+WS+G+T EL G P+ P ++
Sbjct: 189 THQSDVWSYGVTVWELMTFGSKPYDGIPASEI 220
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 58/231 (25%), Positives = 94/231 (40%), Gaps = 40/231 (17%)
Query: 62 EVQTMRVTNHPNVLR-AHCSFTTGHCLWVVMPYMAGGSC-LHIMKSAYPEGFEEPVIAT- 118
E + +H N+L H G +V+ PYM G+ L + + E ++T
Sbjct: 58 ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ 117
Query: 119 ----LLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA-----GD 169
+ + + YLH G IH+D+ A N +ID +K+ D +S +F GD
Sbjct: 118 QLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLL 228
+ N V WMA E + Y +D+WSFG+ EL G P+ + P ++
Sbjct: 178 NE---NRPVK---WMALESLVNKE-YSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAA 230
Query: 229 MTLQ--------NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKL 271
N P D+ F ++ C DP++RP+ +L
Sbjct: 231 YLKDGYRLAQPINCP-------DELF-----AVMACCWALDPEERPSFSQL 269
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 64/289 (22%), Positives = 116/289 (40%), Gaps = 42/289 (14%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALC---IPLNE--IVAIKVLDLEKCNNDLDGIRREVQT 65
+ ++G+G V++A +P +VA+K+L E + +RE
Sbjct: 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 61
Query: 66 MRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGG---------------SCLHIMKSAYPEG 110
M +HPN+++ G + ++ YMA G S H SA G
Sbjct: 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 111 FEEPVIATLL-----RETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165
++ ++ + YL +HRD+ N L+ N +K+ADFG+S ++
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 166 DAGDRQRSRNTFVGTPC-WMAPEVMQQLHGYDFKADIWSFGITALEL-AHGHAPFSKYPP 223
A + S N + P WM PE + + Y ++D+W++G+ E+ ++G P+
Sbjct: 182 SADYYKASENDAI--PIRWMPPESI-FYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238
Query: 224 MKVLLM----TLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTA 268
+V+ + + P E L+ C K P RP+
Sbjct: 239 EEVIYYVRDGNVLSCPDNCPLE--------LYNLMRLCWSKLPSDRPSF 279
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 67/285 (23%), Positives = 107/285 (37%), Gaps = 34/285 (11%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEI-----VAIKVLDLEKCNNDLDGIRREVQT 65
V L +G G VY L + VA+K L D E
Sbjct: 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALI 62
Query: 66 MRVTNHPNVLRAHCSFTTGHCL-----WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLL 120
M NH N++ G ++++ MAGG ++ P E P T+
Sbjct: 63 MSKFNHQNIV--RL---IGVSFERLPRFILLELMAGGDLKSFLRENRPRP-ERPSSLTMK 116
Query: 121 ------RETLKALVYLHFHGHIHRDVKAGNILIDSNGA---IKLADFGVSACMFDAGDRQ 171
R+ K YL + IHRD+ A N L+ G K+ADFG++ ++ A +
Sbjct: 117 DLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYR 176
Query: 172 RSRNTFVGTPCWMAPEVMQQLHG-YDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLM 229
+ + WM PE L G + K D+WSFG+ E+ + G+ P+ +V+
Sbjct: 177 KGGRAMLPIK-WMPPEAF--LDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF 233
Query: 230 TLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274
LD + ++T C P+ RP +++
Sbjct: 234 VTGGGR--LDPPKG--CPGPVYRIMTDCWQHTPEDRPNFATILER 274
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 79/310 (25%), Positives = 126/310 (40%), Gaps = 57/310 (18%)
Query: 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR------RE 62
F VD K Y + +G G V A NE VAIK K N D RE
Sbjct: 1 FEVDTK-YVPIKPIGRGAYGIVCSAKNSETNEKVAIK-----KIANAFDNRIDAKRTLRE 54
Query: 63 VQTMRVTNHPNV------LRAHC--SFTTGHCLWVVMPYMAGGSCLH-IMKSAYPEGFEE 113
++ +R +H NV + +F +++V M + LH I++S + +
Sbjct: 55 IKLLRHLDHENVIAIKDIMPPPHREAFND---VYIVYELM--DTDLHQIIRS--SQTLSD 107
Query: 114 PVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS 173
L + L+ L Y+H +HRD+K N+L+++N +K+ DFG++ + GD
Sbjct: 108 DHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM-- 165
Query: 174 RNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPF--SKYPPMKVLLMTL 231
+V T + APE++ Y D+WS G EL F Y L+ L
Sbjct: 166 -TEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITEL 224
Query: 232 QNAPPG-----LDYERDKRFSKSFK-------------------ELVTACLVKDPKKRPT 267
+P + E+ +R+ +S +L+ LV DP KR T
Sbjct: 225 LGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRIT 284
Query: 268 AEKLMKHHFF 277
E+ + H +
Sbjct: 285 VEEALAHPYL 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 56/233 (24%), Positives = 107/233 (45%), Gaps = 9/233 (3%)
Query: 42 VAIKVLDLEKCNNDLDGIRREVQTM-RVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCL 100
VA+K+L +++ + + E++ M + NH N++ + T G + V+ Y G L
Sbjct: 68 VAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLL 127
Query: 101 HIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGV 160
+ ++ + + + K + +L IHRD+ A N+L+ +K+ DFG+
Sbjct: 128 NFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187
Query: 161 SACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHG-YDFKADIWSFGITALEL-AHGHAPF 218
+ + + + N + WMAPE + + Y F++D+WS+GI E+ + G P
Sbjct: 188 ARDIMNDSNYVVKGNARLPVK-WMAPESI--FNCVYTFESDVWSYGILLWEIFSLGSNP- 243
Query: 219 SKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKL 271
YP M V + G + + +++ C DP KRPT +++
Sbjct: 244 --YPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 8e-11
Identities = 61/224 (27%), Positives = 99/224 (44%), Gaps = 31/224 (13%)
Query: 62 EVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLR 121
E + ++ +HPN+++ T +++VM + GG L ++ +E L++
Sbjct: 42 EARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK----DELKTKQLVK 97
Query: 122 ETLKA---LVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFV 178
L A + YL IHRD+ A N L+ N +K++DFG+S D S +
Sbjct: 98 FALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLK 154
Query: 179 GTPC-WMAPEVMQQLHG-YDFKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTLQNAP 235
P W APE + +G Y ++D+WS+GI E + G P YP MT Q A
Sbjct: 155 QIPIKWTAPEALN--YGRYSSESDVWSYGILLWETFSLGVCP---YPG-----MTNQQAR 204
Query: 236 PGLDYERDKRFS------KSFKELVTACLVKDPKKRPTAEKLMK 273
+ E+ R S +++ C P+ RP +L K
Sbjct: 205 EQV--EKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 62/261 (23%), Positives = 110/261 (42%), Gaps = 20/261 (7%)
Query: 21 EVGEGVSATVYRALCIPL-----NEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVL 75
E+G+G VY + + VAIK ++ + E M+ N +V+
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 76 RAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIA--------TLLRETLKAL 127
R + G V+M M G ++S PE PV A + E +
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 128 VYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPE 187
YL+ + +HRD+ A N ++ + +K+ DFG++ +++ D R + WM+PE
Sbjct: 133 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET-DYYRKGGKGLLPVRWMSPE 191
Query: 188 VMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246
++ + +D+WSFG+ E+A P+ +VL ++ GL ++
Sbjct: 192 SLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG---GL-LDKPDNC 246
Query: 247 SKSFKELVTACLVKDPKKRPT 267
EL+ C +PK RP+
Sbjct: 247 PDMLFELMRMCWQYNPKMRPS 267
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 72/276 (26%), Positives = 117/276 (42%), Gaps = 36/276 (13%)
Query: 22 VGEGVSATVYRALCIPLNE----IVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLR- 76
+G G TVY+ + IP E VAIKVL I E M P V R
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 77 -AHCSFTTGHCLWVVMPYMAGGSCL--HIMKSAYPEGFEEPVIATLLRETLKALVYLHFH 133
C +T + +MPY CL ++ ++ G ++ + + K + YL
Sbjct: 75 LGICLTSTVQLVTQLMPY----GCLLDYVRENKDRIGSQD--LLNWCVQIAKGMSYLEEV 128
Query: 134 GHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLH 193
+HRD+ A N+L+ S +K+ DFG+ A + D + + + WMA E + LH
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGL-ARLLDIDETEYHADGGKVPIKWMALESI--LH 185
Query: 194 -GYDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFS---- 247
+ ++D+WS+G+T EL G P+ P ++ P L E+ +R
Sbjct: 186 RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI---------PDL-LEKGERLPQPPI 235
Query: 248 --KSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281
++ C + D + RP +L+ F + AR
Sbjct: 236 CTIDVYMIMVKCWMIDSECRPRFRELV-DEFSRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 8e-11
Identities = 61/255 (23%), Positives = 107/255 (41%), Gaps = 35/255 (13%)
Query: 40 EIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAH-CSFTTGH-CLWVVMPYMAGG 97
E+VA+K L L RE++ ++ H N+++ ++ G L +VM Y+ G
Sbjct: 34 EVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92
Query: 98 SCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLAD 157
L + E + + + K + YL ++HRD+ NIL++S +K+ D
Sbjct: 93 -SLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGD 151
Query: 158 FGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAP 217
FG++ + + + R W APE + + + +D+WSFG+ EL ++
Sbjct: 152 FGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYEL-FTYSD 209
Query: 218 FSKYPPMKVLLMT----------------LQN-----APPGLDYERDKRFSKSFKELVTA 256
S PP + + M L+N APPG E ++
Sbjct: 210 KSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAE--------IYAIMKE 261
Query: 257 CLVKDPKKRPTAEKL 271
C DP +RP+ +L
Sbjct: 262 CWNNDPSQRPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 74/308 (24%), Positives = 123/308 (39%), Gaps = 62/308 (20%)
Query: 17 RLYEEVGEGVSATVYRALC------------IPLNE------IVAIKVLDLEKCNNDLDG 58
E++GEG V+ LC P N +VA+K+L + N +
Sbjct: 8 LFKEKLGEGQFGEVH--LCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARND 65
Query: 59 IRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGG------SCLHIMKSAYPEGFE 112
+EV+ + PN++R L ++ YM G S H+
Sbjct: 66 FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDA 125
Query: 113 EPVIATLLRETLKALV-----------YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVS 161
P L + +L+ YL +HRD+ N L+ N IK+ADFG+S
Sbjct: 126 VPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 162 ACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHG-YDFKADIWSFGITALELAH--GHAPF 218
++ AGD R + V WMA E + L G + +D+W+FG+T E+ P+
Sbjct: 186 RNLY-AGDYYRIQGRAVLPIRWMAWECI--LMGKFTTASDVWAFGVTLWEILMLCKEQPY 242
Query: 219 SKYPPMKVLLMTLQNAPPGLDYERDKRFS----------KSFKELVTACLVKDPKKRPTA 268
+ +V ++NA ++ RD+ + EL+ C +D ++RP+
Sbjct: 243 GELTDEQV----IENAG---EFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSF 295
Query: 269 EKLMKHHF 276
+ H F
Sbjct: 296 SDI--HAF 301
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 60/255 (23%), Positives = 100/255 (39%), Gaps = 40/255 (15%)
Query: 61 REVQTMRVTNHPNVLRAHCSFTTGHCL-----WVVMPYMAGGSCLHIMKSAYPEGFEEPV 115
RE++ ++ H NV+ FT L ++ ++ G +I+K + +
Sbjct: 65 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDH 121
Query: 116 IATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRN 175
+ L+ + L+ L Y+H IHRD+K N+ ++ + +K+ DFG+ A
Sbjct: 122 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL------ARHTDDEMT 175
Query: 176 TFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHA--PFSKYPPMKVLLMTLQN 233
+V T + APE+M Y+ DIWS G EL G P + + L++ L
Sbjct: 176 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 235
Query: 234 APP-----------------GLDYERDKRFSKSF-------KELVTACLVKDPKKRPTAE 269
P L F+ F +L+ LV D KR TA
Sbjct: 236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 295
Query: 270 KLMKHHFFKHARSND 284
+ + H +F D
Sbjct: 296 QALAHAYFAQYHDPD 310
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 47/297 (15%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRR---EVQTMRVTNHP 72
Y+ VG G +V A L + VA+K L + L RR E++ ++ H
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVK--KLSRPFQSLIHARRTYRELRLLKHMKHE 74
Query: 73 NVLRAHCSFTTGHCL------WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKA 126
NV+ FT + ++V M G +I+K + + + L+ + L+
Sbjct: 75 NVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRG 130
Query: 127 LVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAP 186
L Y+H G IHRD+K N+ ++ + +++ DFG+ A +V T + AP
Sbjct: 131 LKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGL------ARQADDEMTGYVATRWYRAP 184
Query: 187 EVMQQLHGYDFKADIWSFGITALELAHGHA--PFSKYPPMKVLLMTLQNAPP-------- 236
E+M Y+ DIWS G EL G A P + Y +M + P
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244
Query: 237 ---------GLDYERDKRFSKSFK-------ELVTACLVKDPKKRPTAEKLMKHHFF 277
L + + K F+ +L+ LV D KR +A + + H +F
Sbjct: 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 62/249 (24%), Positives = 114/249 (45%), Gaps = 24/249 (9%)
Query: 41 IVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGS-- 98
+VA+K+L + N + +E++ M PN++R T L ++ YM G
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 99 ---CLHIMKSAYPEGFEEPVI--------ATLLRETLKALVYLHFHGHIHRDVKAGNILI 147
H + A E + I AT + +K L L+F +HRD+ N L+
Sbjct: 108 QFLSRHEPQEA-AEKADVVTISYSTLIFMATQIASGMKYLSSLNF---VHRDLATRNCLV 163
Query: 148 DSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGIT 207
N IK+ADFG+S ++ +GD R + V WM+ E + L + +D+W+FG+T
Sbjct: 164 GKNYTIKIADFGMSRNLY-SGDYYRIQGRAVLPIRWMSWESI-LLGKFTTASDVWAFGVT 221
Query: 208 ALELAH--GHAPFSKYPPMKVLLMT---LQNAPPGLDYERDKRFSKSFKELVTACLVKDP 262
E+ P+S+ +V+ T ++ + + S +L+ +C ++
Sbjct: 222 LWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNA 281
Query: 263 KKRPTAEKL 271
K+RP+ +++
Sbjct: 282 KERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 2e-10
Identities = 66/247 (26%), Positives = 104/247 (42%), Gaps = 37/247 (14%)
Query: 62 EVQTMRVTNHPNVLRAHCSF--TTGHCLWVVMPYMAGGSCLHIMKSAYPE--GFEEPVIA 117
EV MR H N++R F L+++M + G ++ Y EE I
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 118 TLLRETLKALVYLHF-----HGH--IHRDVKAGNILIDS---------------NG--AI 153
+ R+ L AL Y H +G +HRD+K NI + + NG
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181
Query: 154 KLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVM-QQLHGYDFKADIWSFGITALELA 212
K+ DFG+S + + ++ VGTP + +PE++ + YD K+D+W+ G EL
Sbjct: 182 KIGDFGLSKNI----GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 213 HGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLM 272
G PF K L+ L+ P K SK L+ L K+RP+A + +
Sbjct: 238 SGKTPFHKANNFSQLISELKRGPD----LPIKGKSKELNILIKNLLNLSAKERPSALQCL 293
Query: 273 KHHFFKH 279
+ K+
Sbjct: 294 GYQIIKN 300
|
Length = 1021 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 42/151 (27%), Positives = 73/151 (48%), Gaps = 6/151 (3%)
Query: 125 KALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWM 184
K + +L IHRD+ A NIL+ N +K+ DFG++ ++ D R + + WM
Sbjct: 190 KGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK-WM 248
Query: 185 APEVMQQLHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 243
APE + Y ++D+WSFG+ E+ + G +P YP +K+ + G
Sbjct: 249 APETIFD-RVYTIQSDVWSFGVLLWEIFSLGASP---YPGVKIDEEFCRRLKEGTRMRAP 304
Query: 244 KRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274
+ + + C +P +RPT +L++H
Sbjct: 305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-10
Identities = 51/189 (26%), Positives = 81/189 (42%), Gaps = 23/189 (12%)
Query: 42 VAIKVL--DLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC----LWVVMPYMA 95
VAIK+L D + + RRE HPN++ +G L+ V Y+
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVAL---LDSGEAPPGLLFAVFEYVP 62
Query: 96 GGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGA--- 152
G + ++ + E L+ + L AL H G +HRD+K NI++ G
Sbjct: 63 GRTLREVLAADGALPAGETG--RLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 153 IKLADFGVSACMFDAGDRQRSRNT----FVGTPCWMAPEVMQQLHGYDF--KADIWSFGI 206
K+ DFG+ + D + T +GTP + APE QL G +D++++G+
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE---QLRGEPVTPNSDLYAWGL 177
Query: 207 TALELAHGH 215
LE G
Sbjct: 178 IFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 42/140 (30%), Positives = 72/140 (51%), Gaps = 8/140 (5%)
Query: 136 IHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPE-VMQQLHG 194
IHRD+ A NIL+ N +K+ DFG++ ++ D R + + WMAPE + ++
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK-WMAPESIFDKV-- 252
Query: 195 YDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL 253
Y ++D+WSFG+ E+ + G +P YP +++ Q G + + +
Sbjct: 253 YTTQSDVWSFGVLLWEIFSLGASP---YPGVQINEEFCQRLKDGTRMRAPENATPEIYRI 309
Query: 254 VTACLVKDPKKRPTAEKLMK 273
+ AC DPK+RPT L++
Sbjct: 310 MLACWQGDPKERPTFSALVE 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 55/166 (33%), Positives = 74/166 (44%), Gaps = 19/166 (11%)
Query: 62 EVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLR 121
E + +R +HP VL G +V+P S L+ A + + R
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR--SDLYTYLGARLRPLGLAQVTAVAR 267
Query: 122 ETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNT----- 176
+ L A+ Y+H G IHRD+K N+L++ I L DFG +AC F G S +T
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFG-AAC-FARG----SWSTPFHYG 321
Query: 177 FVGTPCWMAPEVMQQLHG--YDFKADIWSFGITALELA-HGHAPFS 219
GT APEV L G Y DIWS G+ E A H + FS
Sbjct: 322 IAGTVDTNAPEV---LAGDPYTPSVDIWSAGLVIFEAAVHTASLFS 364
|
Length = 461 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 61/264 (23%), Positives = 109/264 (41%), Gaps = 20/264 (7%)
Query: 18 LYEEVGEGVSATVYRALCIPL-----NEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHP 72
L E+G+G VY + VA+K ++ + E M+
Sbjct: 10 LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 69
Query: 73 NVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPE-----GFEEPVIATLLR---ETL 124
+V+R + G VVM MA G ++S PE G P + +++ E
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 125 KALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWM 184
+ YL+ +HRD+ A N ++ + +K+ DFG++ +++ D R + WM
Sbjct: 130 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYET-DYYRKGGKGLLPVRWM 188
Query: 185 APEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERD 243
APE ++ + +D+WSFG+ E+ P+ +VL + G ++
Sbjct: 189 APESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD----GGYLDQP 243
Query: 244 KRFSKSFKELVTACLVKDPKKRPT 267
+ +L+ C +PK RPT
Sbjct: 244 DNCPERVTDLMRMCWQFNPKMRPT 267
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 38/141 (26%), Positives = 71/141 (50%), Gaps = 8/141 (5%)
Query: 136 IHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPE-VMQQLHG 194
IHRD+ A NIL+ N +K+ DFG++ ++ D R + + WMAPE + ++
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK-WMAPESIFDKV-- 251
Query: 195 YDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL 253
Y ++D+WSFG+ E+ + G +P YP +++ + G + + +
Sbjct: 252 YTTQSDVWSFGVLLWEIFSLGASP---YPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSI 308
Query: 254 VTACLVKDPKKRPTAEKLMKH 274
+ C +P+ RPT +L++
Sbjct: 309 MLDCWHNNPEDRPTFSELVEI 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 69/284 (24%), Positives = 116/284 (40%), Gaps = 30/284 (10%)
Query: 9 FPV-DAKDYRLYEEVGEGVSATVYRALCIP--LNEIVAIKVLDLEKCNNDLDGIRREVQT 65
+PV + D + + +GEG V +A L AIK + +D E++
Sbjct: 1 YPVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 60
Query: 66 M-RVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIM-KSAYPEGFEEPVIATLLRET 123
+ ++ +HPN++ + L++ + Y G+ L + KS E IA T
Sbjct: 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120
Query: 124 LKALVYLHFHGH-------------IHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR 170
L + LHF IHRD+ A NIL+ N K+ADFG+S G
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS-----RGQE 175
Query: 171 QRSRNTFVGTPC-WMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLL 228
+ T P WMA E + Y +D+WS+G+ E+ G P+ ++
Sbjct: 176 VYVKKTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-- 232
Query: 229 MTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLM 272
+ P G E+ +L+ C + P +RP+ +++
Sbjct: 233 --YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 49/169 (28%), Positives = 70/169 (41%), Gaps = 31/169 (18%)
Query: 118 TLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGA-------IKLADFGVSACMFDAGDR 170
T+ ++ AL YL +H +V A NIL+ G IKL+D GVS
Sbjct: 121 TVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTAL----- 175
Query: 171 QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELA-HGHAPF-SKYPPMKVLL 228
SR V W+APE + + AD WSFG T LE+ G P + P K
Sbjct: 176 --SREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233
Query: 229 MTLQNAPPGLDYERDKRFS----KSFKELVTACLVKDPKKRPTAEKLMK 273
YE+ R K L++ CL +P +RP+ +++
Sbjct: 234 -----------YEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILR 271
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 49/171 (28%), Positives = 73/171 (42%), Gaps = 48/171 (28%)
Query: 125 KALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-- 182
K + +L IHRD+ A NIL+ K+ DFG+ A D + N V
Sbjct: 225 KGMSFLASKNCIHRDLAARNILLTHGRITKICDFGL------ARDIRNDSNYVVKGNARL 278
Query: 183 ---WMAPEVMQQLHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGL 238
WMAPE + Y F++D+WS+GI E+ + G +P YP M V
Sbjct: 279 PVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSP---YPGMPV------------ 322
Query: 239 DYERDKRFSKSFKE----------------LVTACLVKDPKKRPTAEKLMK 273
D +F K KE ++ +C DP KRPT +++++
Sbjct: 323 ----DSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 45/164 (27%), Positives = 71/164 (43%), Gaps = 14/164 (8%)
Query: 61 REVQTMRVTNHPNVLRAHCSFTT--GHCLWVVMPYMAGGSCLHIMK-------SAYPEGF 111
RE+ +R HPNV+ F + +W++ Y A HI+K + P
Sbjct: 47 REIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQL 105
Query: 112 EEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILI----DSNGAIKLADFGVSACMFDA 167
++ +LL + L + YLH + +HRD+K NIL+ G +K+AD G +
Sbjct: 106 PRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALEL 211
+ V T + APE++ Y DIW+ G EL
Sbjct: 166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 45/164 (27%), Positives = 71/164 (43%), Gaps = 14/164 (8%)
Query: 61 REVQTMRVTNHPNVLRAHCSFTT--GHCLWVVMPYMAGGSCLHIMK-------SAYPEGF 111
RE+ +R HPNV+ F + +W++ Y A HI+K + P
Sbjct: 47 REIALLRELKHPNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQL 105
Query: 112 EEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILI----DSNGAIKLADFGVSACMFDA 167
++ +LL + L + YLH + +HRD+K NIL+ G +K+AD G +
Sbjct: 106 PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALEL 211
+ V T + APE++ Y DIW+ G EL
Sbjct: 166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 57/307 (18%), Positives = 122/307 (39%), Gaps = 53/307 (17%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVL 75
Y +G G + V+ A+ ++ VA+K + L + + RE++ +R +H N++
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQS-VKHALREIKIIRRLDHDNIV 65
Query: 76 RA-HCSFTTGH-------------CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLR 121
+ +G +++V YM + + E + LLR
Sbjct: 66 KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR 125
Query: 122 ETLKALVYLHFHGHIHRDVKAGNILIDSNG-AIKLADFGVSACMFDAGDRQRSRNTF--- 177
L Y+H +HRD+K N+ I++ +K+ DFG++ + D S +
Sbjct: 126 ----GLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIV----DPHYSHKGYLSE 177
Query: 178 -VGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP 236
+ T + +P ++ + Y D+W+ G E+ G F+ ++ + + L++ P
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237
Query: 237 GLDYERDKRFS--------------KSFKEL-----------VTACLVKDPKKRPTAEKL 271
+ +R++ + + ++L + L +P R TAE+
Sbjct: 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEA 297
Query: 272 MKHHFFK 278
+ H +
Sbjct: 298 LMHPYMS 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 7e-08
Identities = 62/242 (25%), Positives = 91/242 (37%), Gaps = 42/242 (17%)
Query: 42 VAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLW----VVMPYMAGG 97
V +KVL + L M +H ++++ + G C+ +V Y+ G
Sbjct: 33 VVLKVLG-SDHRDSLAFFE-TASLMSQLSHKHLVKLY-----GVCVRDENIMVEEYVKFG 85
Query: 98 SC---LHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGA-- 152
LH K+ ++ V L AL YL +H +V NIL+ G
Sbjct: 86 PLDVFLHREKNNVSLHWKLDVAKQLAS----ALHYLEDKKLVHGNVCGKNILVARYGLNE 141
Query: 153 -----IKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGY-DFKADIWSFGI 206
IKL+D G+ + +R R P W+APE ++ AD WSFG
Sbjct: 142 GYVPFIKLSDPGIPITVLSREERV-ER-----IP-WIAPECIRNGQASLTIAADKWSFGT 194
Query: 207 TALEL-AHGHAPFSKYPPM-KVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKK 264
T LE+ ++G P S K Q+ P D L+ C DP K
Sbjct: 195 TLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPD-------CAELANLINQCWTYDPTK 247
Query: 265 RP 266
RP
Sbjct: 248 RP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 43/164 (26%), Positives = 74/164 (45%), Gaps = 11/164 (6%)
Query: 109 EGFEEPVIATLLRETL---KALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165
+G E LL T + + +L +HRD+ A N+L+ +K+ DFG++ +
Sbjct: 229 DGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIM 288
Query: 166 DAGDRQRSRNTFVGTPCWMAPE-VMQQLHGYDFKADIWSFGITALEL-AHGHAPFSKYPP 223
+ +TF+ WMAPE + L Y +D+WS+GI E+ + G P YP
Sbjct: 289 HDSNYVSKGSTFLPVK-WMAPESIFDNL--YTTLSDVWSYGILLWEIFSLGGTP---YPG 342
Query: 224 MKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPT 267
M V G + ++ +++ C +P+KRP+
Sbjct: 343 MIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPS 386
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 50/220 (22%), Positives = 95/220 (43%), Gaps = 22/220 (10%)
Query: 67 RVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSC----LHIMKSAYPEGFEEPVIATLLR- 121
R+ HPN+L+ G C+ + + C L S + L R
Sbjct: 50 RILQHPNILQC-----LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM 104
Query: 122 --ETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVG 179
E + ++H H +H D+ N + S+ +K+ D+G+ + D + +
Sbjct: 105 ACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE-DYIETEDDKCV 163
Query: 180 TPCWMAPEVMQQLHGYDFKAD------IWSFGITALELAHGHA-PFSKYPPMKVLLMTLQ 232
W+APE++ + HG A+ +W+ G+T EL A P+S +VL ++
Sbjct: 164 PLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIK 223
Query: 233 NAPPGL-DYERDKRFSKSFKELVTACLVKDPKKRPTAEKL 271
+ L + + +S+ + E++ C + P+KR TAE++
Sbjct: 224 DQQVKLFKPQLELPYSERWYEVLQFCWLS-PEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 53/236 (22%), Positives = 100/236 (42%), Gaps = 28/236 (11%)
Query: 17 RLYEEVGEGVSATVYRALCI-----PLNEIVAIKVLDLEKCNNDL-DGIRREVQTMRVTN 70
R EE+GE VY+ + VAIK L +K L + + E
Sbjct: 8 RFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-DKAEGPLREEFKHEAMMRSRLQ 66
Query: 71 HPNVLRAHCSFTTGHCLWVVMPYMAGGSCLH---IMKSAYPE------------GFEEPV 115
HPN++ T L ++ Y + LH +M+S + + E
Sbjct: 67 HPNIVCLLGVVTKEQPLSMIFSYCSHSD-LHEFLVMRSPHSDVGSTDDDKTVKSTLEPAD 125
Query: 116 IATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRN 175
++ + + +L H +H+D+ N+L+ +K++D G+ ++ A + N
Sbjct: 126 FVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGN 185
Query: 176 TFVGTPCWMAPEVMQQLHG-YDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLM 229
+ + WM+PE + ++G + +DIWS+G+ E+ ++G P+ Y V+ M
Sbjct: 186 SLLPIR-WMSPEAI--MYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 2e-06
Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 3/93 (3%)
Query: 119 LLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFV 178
++++ L A+ Y+H IHRD+K NI ++ +G I L DFG +A F+ +R+ +V
Sbjct: 272 IMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFG-TAMPFE-KEREAFDYGWV 329
Query: 179 GTPCWMAPEVMQQLHGYDFKADIWSFGITALEL 211
GT +PE++ GY DIWS G+ L++
Sbjct: 330 GTVATNSPEILAG-DGYCEITDIWSCGLILLDM 361
|
Length = 501 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 40/142 (28%), Positives = 60/142 (42%), Gaps = 16/142 (11%)
Query: 136 IHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-----WMAPEVMQ 190
IHRDV A N+L+ K+ DFG+ A D N V WMAPE +
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGL------ARDIMNDSNYVVKGNARLPVKWMAPESIF 287
Query: 191 QLHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249
Y ++D+WS+GI E+ + G +P YP + V + G R
Sbjct: 288 DCV-YTVQSDVWSYGILLWEIFSLGKSP---YPGILVNSKFYKMVKRGYQMSRPDFAPPE 343
Query: 250 FKELVTACLVKDPKKRPTAEKL 271
++ C +P +RPT ++
Sbjct: 344 IYSIMKMCWNLEPTERPTFSQI 365
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 55/213 (25%), Positives = 84/213 (39%), Gaps = 27/213 (12%)
Query: 72 PNVLRAHCSFTTGHCLWVVMPYMAGGSCL-HIMKSAY-PEGFEEPVIATLLRETLKALVY 129
PN++ H + +++V+ + GG HI K PE + E + AL
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEE----CVKRWAAEMVVALDA 100
Query: 130 LHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVM 189
LH G + RD+ NIL+D G I+L F + + D+ D + N + APEV
Sbjct: 101 LHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYC------APEVG 154
Query: 190 QQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249
+ D WS G EL G + P + T N P + S+
Sbjct: 155 GISEETE-ACDWWSLGAILFELLTGKT-LVECHPSGINTHTTLNIPEWV--------SEE 204
Query: 250 FKELVTACLVKDPKKRPTA-----EKLMKHHFF 277
+ L+ L +P +R A E + H FF
Sbjct: 205 ARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 30/142 (21%), Positives = 56/142 (39%), Gaps = 13/142 (9%)
Query: 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRV--TNHPNVLRA 77
+ + G++ VY L + V +K+ + D REV +++ V +
Sbjct: 4 KLLKGGLTNRVYL-LGTKDEDYV-LKINPSREKGADR---EREVAILQLLARKGLPVPKV 58
Query: 78 HCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIH 137
S + +++M ++ G + + E+ IA L E L L L H
Sbjct: 59 LASGESDGWSYLLMEWIEGETLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCH 112
Query: 138 RDVKAGNILIDSNGAIKLADFG 159
D+ GNIL+D + + D+
Sbjct: 113 GDLHPGNILVDDGKILGIIDWE 134
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 5/89 (5%)
Query: 136 IHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPE-VMQQLHG 194
+HRD+ A N+LI +K+ DFG++ + + +TF+ WMAPE + L
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLK-WMAPESIFNNL-- 317
Query: 195 YDFKADIWSFGITALEL-AHGHAPFSKYP 222
Y +D+WSFGI E+ G P+ + P
Sbjct: 318 YTTLSDVWSFGILLWEIFTLGGTPYPELP 346
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 42/155 (27%), Positives = 62/155 (40%), Gaps = 19/155 (12%)
Query: 126 ALVYLHFHGHIHRDVKAGNIL-----IDSNGA--IKLADFGVSACMFDAGDRQRSRNTFV 178
AL YL +H +V NIL ID IKL+D G+ + SR V
Sbjct: 117 ALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVL-------SRQECV 169
Query: 179 GTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL 238
W+APE ++ AD WSFG T E+ ++ P+K + +
Sbjct: 170 ERIPWIAPECVEDSKNLSIAADKWSFGTTLWEIC-----YNGEIPLKDKTLAEKERFYEG 224
Query: 239 DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273
K +L+T C+ DP +RP +M+
Sbjct: 225 QCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMR 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 22/52 (42%), Positives = 32/52 (61%), Gaps = 1/52 (1%)
Query: 112 EEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILID-SNGAIKLADFGVSA 162
E +I T++R+ L AL LH G +HRDVK NI+ +G+ K+ D G +A
Sbjct: 253 ENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAA 304
|
Length = 566 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 6e-05
Identities = 46/151 (30%), Positives = 68/151 (45%), Gaps = 32/151 (21%)
Query: 83 TGHCLWVVMPYMAGGSCL--HIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHI-HRD 139
TGH + +VMP G CL IMK F +A ++ +T AL Y H H+ H D
Sbjct: 204 TGH-MCIVMPKY--GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTELHLMHTD 257
Query: 140 VKAGNILIDSNGA----------------IKLADFGVSACMFDAGDRQRSRNTFVGTPCW 183
+K NIL++++ +++ D G C D + SR V T +
Sbjct: 258 LKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG-GCC-----DERHSRTAIVSTRHY 311
Query: 184 MAPEVMQQLHGYDFKADIWSFGITALELAHG 214
+PEV+ L G+ + D+WS G EL G
Sbjct: 312 RSPEVVLGL-GWMYSTDMWSMGCIIYELYTG 341
|
Length = 467 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 40/155 (25%), Positives = 61/155 (39%), Gaps = 30/155 (19%)
Query: 126 ALVYLHFHGHIHRDVKAGNILIDSNGA--------IKLADFGVSACMFDAGDRQRSRNTF 177
AL +L G H +V A N+L+ IKL+D G+S + +
Sbjct: 112 ALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL-------PKEIL 164
Query: 178 VGTPCWMAPEVMQQLHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPP 236
+ W+ PE ++ AD WSFG T E+ + G P S K L
Sbjct: 165 LERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF------- 217
Query: 237 GLDYE-RDKRFSKSFKEL---VTACLVKDPKKRPT 267
YE R + + + EL + C+ +P RP+
Sbjct: 218 ---YEDRHQLPAPKWTELANLINQCMDYEPDFRPS 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 9e-05
Identities = 28/110 (25%), Positives = 47/110 (42%), Gaps = 3/110 (2%)
Query: 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVL 227
G +GTP ++APE++ + D W+ G+ E G PF+ P +V
Sbjct: 531 GAAPVEGERILGTPDYLAPELLLG-KPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVF 589
Query: 228 LMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277
L P E +++ S + + + L DP KR ++L +H F
Sbjct: 590 QNILNRDIPWP--EGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLF 637
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 9e-05
Identities = 51/198 (25%), Positives = 82/198 (41%), Gaps = 26/198 (13%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR--REVQTMRVTNHPN 73
Y + +G+G VY A + VA+K + + N L R RE + HP
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAY------PEGFEEPVIATLLRETLK-- 125
++ + + G ++ MPY+ G + ++KS + E E+ + L K
Sbjct: 64 IVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 126 -ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGV-----------SACMFDAGDRQRS 173
+ Y+H G +HRD+K NIL+ G + + D+G D + S
Sbjct: 124 ATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 174 RNT----FVGTPCWMAPE 187
T VGTP +MAPE
Sbjct: 184 SMTIPGKIVGTPDYMAPE 201
|
Length = 932 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 20/50 (40%), Positives = 31/50 (62%)
Query: 115 VIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACM 164
VI ++R+ L L LH G +HRD+K N+L+ +G +K+ DFG + M
Sbjct: 310 VIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDM 359
|
Length = 507 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 7e-04
Identities = 16/52 (30%), Positives = 31/52 (59%)
Query: 111 FEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSA 162
+ +I ++++ L L Y+H HG H D+K NI++D N + D+G+++
Sbjct: 123 KNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIAS 174
|
Length = 294 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 671 | |||
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.72 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.6 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.6 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.52 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.45 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.43 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.41 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.39 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.33 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.31 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.26 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.14 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.12 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.12 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.98 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.94 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.93 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.87 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.75 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.69 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.65 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.53 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.41 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.33 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.31 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.27 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.27 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.09 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.06 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.02 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.96 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.91 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.84 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.83 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.67 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.66 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.55 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.47 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.38 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.24 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.24 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.19 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.17 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.13 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.12 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.98 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.57 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.38 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.19 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.13 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.09 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.06 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.02 | |
| PLN02236 | 344 | choline kinase | 95.68 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.57 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.32 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.25 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.23 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.21 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.15 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.32 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.28 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 94.13 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.29 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 92.96 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 92.73 | |
| PTZ00296 | 442 | choline kinase; Provisional | 90.06 | |
| COG4499 | 434 | Predicted membrane protein [Function unknown] | 87.47 |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-64 Score=535.00 Aligned_cols=308 Identities=69% Similarity=1.174 Sum_probs=294.9
Q ss_pred cccccccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEE
Q 005886 3 LVVEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFT 82 (671)
Q Consensus 3 ~~~e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~ 82 (671)
-..+.+|+++.++|++.++||.|..++||+|++.+++.+||||+++++++..+++.+++|++.|+.++||||++++++|.
T Consensus 15 ~~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv 94 (516)
T KOG0582|consen 15 SSSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV 94 (516)
T ss_pred ccccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence 34688999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccc
Q 005886 83 TGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSA 162 (671)
Q Consensus 83 ~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~ 162 (671)
.++.+|+||.||.+|+++++++..++.+|+|..|..|++++++||.|||.+|.||||||+.||||+.+|.|||+|||.+.
T Consensus 95 v~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa 174 (516)
T KOG0582|consen 95 VDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSA 174 (516)
T ss_pred ecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeee
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCccccc-ccccCCCCCCChhH-hhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC----
Q 005886 163 CMFDAGDRQRSR-NTFVGTPCWMAPEV-MQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP---- 236 (671)
Q Consensus 163 ~~~~~~~~~~~~-~~~~GT~~Y~APEv-l~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~---- 236 (671)
++++.+.+...+ .+++|||+|||||+ ++...+|++|+||||||++..||++|+.||..+++++.+.+.+++.++
T Consensus 175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t 254 (516)
T KOG0582|consen 175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLT 254 (516)
T ss_pred eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccc
Confidence 999988777766 88999999999999 667788999999999999999999999999999999999999999998
Q ss_pred -CCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccccchHHHHHHhhhccchHHHHHHHHHHHHH
Q 005886 237 -GLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGERFRMLKAKEAD 310 (671)
Q Consensus 237 -~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~~~~~~~l~~~l~~~~~~~~~lk~~~a~ 310 (671)
.++++....++..++.+|..||.+||.+||||+++|+|+||++++..++....+...+.++..+++..+.+++.
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~~~~~~l~~l~~l~~r~~~~q~~~~~ 329 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEYLVKKLLQSLPPLGTRFKKSQSKEES 329 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhhcchhhhccCCcHHHHHHHHHhhhcc
Confidence 77888889999999999999999999999999999999999999999999999999999999999887766553
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-57 Score=471.59 Aligned_cols=263 Identities=28% Similarity=0.453 Sum_probs=230.7
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcc------cHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN------DLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~------~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 86 (671)
.+.|.+.+.||+|+||.|.+|..+.||+.||||++++.+... ....+++|+++|++|+|||||+++++|....+
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 467888999999999999999999999999999998654221 34557899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCC---CceEEeccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSN---GAIKLADFGVSAC 163 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~---g~vKL~DFGls~~ 163 (671)
.||||||++||+|++.+-.+ +.+.+...+.+++|++.||.|||+.||+||||||+|||+..+ ..+||+|||+|+.
T Consensus 251 ~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred eEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 99999999999999999877 788999999999999999999999999999999999999776 6799999999976
Q ss_pred cccCCCcccccccccCCCCCCChhHhhhc--cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcc
Q 005886 164 MFDAGDRQRSRNTFVGTPCWMAPEVMQQL--HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYE 241 (671)
Q Consensus 164 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~--~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~ 241 (671)
.. ....+.++||||.|.|||++.+. ..|..++||||+||+||.+++|++||++......+...+......+..+
T Consensus 329 ~g----~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~ 404 (475)
T KOG0615|consen 329 SG----EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPL 404 (475)
T ss_pred cc----cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccCh
Confidence 52 34567789999999999999752 2245588999999999999999999988766554555555555556667
Q ss_pred ccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 242 RDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 242 ~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
.|.+++.++++||.+||..||++|||+.++|+||||+.+.
T Consensus 405 ~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 405 QWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 7899999999999999999999999999999999998654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-53 Score=467.25 Aligned_cols=256 Identities=30% Similarity=0.541 Sum_probs=234.6
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
.+|+..+.||+|||+.||.+++..+|+.||+|++.+.... ...+.+.+||++.+.|+|||||+++++|++.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5699999999999999999999999999999999875543 45788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
|+|..++|.+++++. +.++|.+++.+++||+.||.|||+++|+|||||..|||++++.+|||+|||||+.+...+.
T Consensus 98 ELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E-- 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE-- 173 (592)
T ss_pred EecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccc--
Confidence 999999999999965 7899999999999999999999999999999999999999999999999999998854333
Q ss_pred cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHH
Q 005886 172 RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~ 251 (671)
...+.||||.|+|||++.+ .++++.+||||+||+||.||+|++||...+-.+.+..+..+ .|..+..+|.+++
T Consensus 174 -rk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~-----~Y~~P~~ls~~A~ 246 (592)
T KOG0575|consen 174 -RKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN-----EYSMPSHLSAEAK 246 (592)
T ss_pred -ccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc-----CcccccccCHHHH
Confidence 4567899999999999996 78999999999999999999999999987777777666554 5667789999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 252 ELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 252 dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
+||.+||..||.+|||+++||.|+||+..
T Consensus 247 dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 247 DLIRKLLRPNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred HHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence 99999999999999999999999999543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-53 Score=445.37 Aligned_cols=274 Identities=32% Similarity=0.518 Sum_probs=246.2
Q ss_pred ccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q 005886 10 PVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCL 87 (671)
Q Consensus 10 ~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l 87 (671)
.+..++|++++.||+|+||+||.++.+.|++.||+|++++..+- .+..+...|..+|..++||+||+++..|++.+.+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 46789999999999999999999999999999999999887654 3588999999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccC
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~ 167 (671)
|+|+||+.||.|+..|++. +.|+|..++.|+.+|+.||.|||++|||||||||+|||+|.+|+|+|+|||||+.....
T Consensus 101 ylVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EEEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 9999999999999999877 78999999999999999999999999999999999999999999999999999865443
Q ss_pred CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccch
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls 247 (671)
+. ...++|||+.|||||++.+ .+|+..+|+||||+++|+|++|.+||.+.+..+....+.+.... ..+..++
T Consensus 179 ~~---~t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~----~~p~~ls 250 (357)
T KOG0598|consen 179 GD---ATRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLP----LPPGYLS 250 (357)
T ss_pred CC---ccccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCC----CCCccCC
Confidence 33 3456899999999999998 68999999999999999999999999998888877777765422 2244589
Q ss_pred HHHHHHHHHhhhcCCCCCC----CHHHHHhchhccccccchHHHHHHhhh
Q 005886 248 KSFKELVTACLVKDPKKRP----TAEKLMKHHFFKHARSNDFLARSIVDN 293 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRp----Sa~eiL~Hpwfk~~~~~~~~~~~l~~~ 293 (671)
.++++||.++|..||++|. ++.+|-+||||+...|++...+.+...
T Consensus 251 ~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~Pp 300 (357)
T KOG0598|consen 251 EEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPP 300 (357)
T ss_pred HHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCC
Confidence 9999999999999999996 689999999999999987776655443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-53 Score=443.83 Aligned_cols=264 Identities=35% Similarity=0.603 Sum_probs=237.5
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC-EE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH-CL 87 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~-~l 87 (671)
..+...+.+.+..||+|..|+||+++|+.|++.+|+|+|.....+.....+.+|+++++.++|||||.+|+.|.... .+
T Consensus 74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 44556688999999999999999999999999999999966655666788999999999999999999999999999 49
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF-HGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs-~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
+|+||||+||+|..+++.. +.++|..+..++.+|++||.|||. ++||||||||.|||++..|.|||||||.++.+..
T Consensus 154 sI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred EeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 9999999999999999876 789999999999999999999996 8999999999999999999999999999988743
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHhcCCCCCCcc
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKY-----PPMKVLLMTLQNAPPGLDYE 241 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~-----~~~~~~~~~~~~~~~~~~~~ 241 (671)
. ..++++||..|||||.+.+ ..|+.++||||||++++||++|+.||... ...+.+..++.+.++.++..
T Consensus 232 S-----~a~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~ 305 (364)
T KOG0581|consen 232 S-----IANTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG 305 (364)
T ss_pred h-----hcccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc
Confidence 3 4567899999999999998 67999999999999999999999999764 45666777777777666422
Q ss_pred ccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccccc
Q 005886 242 RDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSN 283 (671)
Q Consensus 242 ~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~ 283 (671)
.+|+++++||..||.+||.+||++.++|.|||+++....
T Consensus 306 ---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~ 344 (364)
T KOG0581|consen 306 ---EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDP 344 (364)
T ss_pred ---cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccc
Confidence 589999999999999999999999999999999976543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-52 Score=446.35 Aligned_cols=277 Identities=30% Similarity=0.492 Sum_probs=244.2
Q ss_pred cccccccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeE
Q 005886 3 LVVEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCS 80 (671)
Q Consensus 3 ~~~e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~ 80 (671)
++..+|.-+..++|+++..||+|+||.||+|+-+.||..||+|++++... ..++.+++.|-.+|...++|+||++|..
T Consensus 130 ~lR~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs 209 (550)
T KOG0605|consen 130 YLRLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS 209 (550)
T ss_pred HHHhccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE
Confidence 45567778899999999999999999999999999999999999987653 3568899999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccc
Q 005886 81 FTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGV 160 (671)
Q Consensus 81 ~~~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGl 160 (671)
|.+..++||||||++||++..+|.+. +.+++..++.|+.+++.||+-||.+|+|||||||+|+|||..|++||+||||
T Consensus 210 FQD~~~LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGL 287 (550)
T KOG0605|consen 210 FQDKEYLYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGL 287 (550)
T ss_pred ecCCCeeEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccc
Confidence 99999999999999999999999887 7899999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC---------------------Ccc-----c------------------ccccccCCCCCCChhHhhhccCCC
Q 005886 161 SACMFDAG---------------------DRQ-----R------------------SRNTFVGTPCWMAPEVMQQLHGYD 196 (671)
Q Consensus 161 s~~~~~~~---------------------~~~-----~------------------~~~~~~GT~~Y~APEvl~~~~~~s 196 (671)
|+.+.... +.. . .....+|||-|||||++.+ ++|+
T Consensus 288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~ 366 (550)
T KOG0605|consen 288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYG 366 (550)
T ss_pred cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCC
Confidence 85442100 000 0 0024589999999999998 7799
Q ss_pred ccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCC---HHHHHh
Q 005886 197 FKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPT---AEKLMK 273 (671)
Q Consensus 197 ~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpS---a~eiL~ 273 (671)
..+|+||||||+||||.|.+||.+.++.+.+..++. ....+.++....++++++|||.+||+ ||.+|.. ++||..
T Consensus 367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~n-wr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVN-WRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-HhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 999999999999999999999999999887766554 34455666677889999999999999 9999975 899999
Q ss_pred chhccccccch
Q 005886 274 HHFFKHARSND 284 (671)
Q Consensus 274 Hpwfk~~~~~~ 284 (671)
||||+.+.|+.
T Consensus 445 HPfF~~v~W~~ 455 (550)
T KOG0605|consen 445 HPFFKGVDWDH 455 (550)
T ss_pred CCccccCCcch
Confidence 99999988863
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-52 Score=446.88 Aligned_cols=265 Identities=29% Similarity=0.512 Sum_probs=240.2
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhC-CCCCceeeeeEEEeCCEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVT-NHPNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~~~l~ 88 (671)
..++|.+++.||.|+|++|++|+.+.+++.||||++.++-. ...++.+.+|-.+|..| +||.|++||..|.++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 56899999999999999999999999999999999986643 23467788899999999 8999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
+|+||+++|+|+.+|++. +.|++..++.|+.+|+.||+|||++|||||||||+|||||.+|++||+|||.|+.+.+..
T Consensus 151 FvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred EEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 999999999999999988 889999999999999999999999999999999999999999999999999998874332
Q ss_pred Cc----------ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC
Q 005886 169 DR----------QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL 238 (671)
Q Consensus 169 ~~----------~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~ 238 (671)
.. .....+++||..|.+||++.. ...++.+|||+||||||.|+.|.+||.+.+...++..++. +
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~-----l 302 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA-----L 302 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH-----h
Confidence 11 111256999999999999987 6789999999999999999999999999888877777765 4
Q ss_pred CccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccccch
Q 005886 239 DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSND 284 (671)
Q Consensus 239 ~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~~ 284 (671)
+|.++..+++.+++||+++|..||.+|+|+.+|..||||..+.|.+
T Consensus 303 ~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 303 DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN 348 (604)
T ss_pred cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence 7788899999999999999999999999999999999999998865
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-51 Score=412.87 Aligned_cols=267 Identities=29% Similarity=0.484 Sum_probs=242.5
Q ss_pred ccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q 005886 10 PVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCL 87 (671)
Q Consensus 10 ~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l 87 (671)
+....+|++++.||.|+||+|.+++++.+|.+||+|++++...- ...++..+|..+|+.+.||+++++++.|.+..++
T Consensus 40 ~~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~l 119 (355)
T KOG0616|consen 40 PYSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNL 119 (355)
T ss_pred CcchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeE
Confidence 35678999999999999999999999999999999999876543 4578899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccC
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~ 167 (671)
||||||..||.|+.++++. +.|++..++.|+.||+.||+|||+++|++|||||||||+|.+|.+||+|||+|+...
T Consensus 120 ymvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~-- 195 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS-- 195 (355)
T ss_pred EEEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec--
Confidence 9999999999999999987 789999999999999999999999999999999999999999999999999998662
Q ss_pred CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccch
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls 247 (671)
....+.||||.|+|||++.. ++|+.++|.|+|||++|||+.|.+||....+..+...++... ...+..++
T Consensus 196 ----~rT~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~-----v~fP~~fs 265 (355)
T KOG0616|consen 196 ----GRTWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGK-----VKFPSYFS 265 (355)
T ss_pred ----CcEEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCc-----ccCCcccC
Confidence 22567899999999999998 789999999999999999999999999999988888887753 34567789
Q ss_pred HHHHHHHHHhhhcCCCCC-----CCHHHHHhchhccccccchHHHHHH
Q 005886 248 KSFKELVTACLVKDPKKR-----PTAEKLMKHHFFKHARSNDFLARSI 290 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kR-----pSa~eiL~Hpwfk~~~~~~~~~~~l 290 (671)
.++++||.++|++|-.+| ....+|..||||+...|.....+.+
T Consensus 266 ~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~i 313 (355)
T KOG0616|consen 266 SDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKI 313 (355)
T ss_pred HHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccc
Confidence 999999999999999999 3578999999999988876655543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-50 Score=422.48 Aligned_cols=260 Identities=28% Similarity=0.490 Sum_probs=229.8
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEecccc-CcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEK-CNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~-~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LV 90 (671)
...+|.+.+.||+|+||+||+|+++.++.+||||.|.+.+ ..+..+.+..|+.+|+.++|||||.+++++..++++|||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 4578999999999999999999999999999999998776 345678889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCC------CceEEecccccccc
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSN------GAIKLADFGVSACM 164 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~------g~vKL~DFGls~~~ 164 (671)
||||.||+|.+++... +.++|..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|+.+
T Consensus 88 MEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 9999999999999987 789999999999999999999999999999999999999765 46899999999887
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccc
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (671)
.. .....+.||+|.|||||++.. ..|+.|+|+||+|+|+|+|++|++||...+..+.+..+.+... .....+.
T Consensus 166 ~~----~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~--~~~~~~~ 238 (429)
T KOG0595|consen 166 QP----GSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE--IVPVLPA 238 (429)
T ss_pred Cc----hhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc--ccCchhh
Confidence 42 223456899999999999986 6799999999999999999999999999888887765544321 1222344
Q ss_pred cchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 245 RFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 245 ~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
.++....+|+...|..+|..|.++.+.+.|+++...
T Consensus 239 ~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 239 ELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAAN 274 (429)
T ss_pred hccCchhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence 567778899999999999999999999999998743
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=432.20 Aligned_cols=259 Identities=31% Similarity=0.500 Sum_probs=228.2
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc----ccHHHHHHHHHHHHhCC-CCCceeeeeEEEeCC
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN----NDLDGIRREVQTMRVTN-HPNVLRAHCSFTTGH 85 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~----~~~~~i~~Ei~iL~~L~-HpNIVkl~~~~~~~~ 85 (671)
...+.|++.+.||.|+||+|+.|.+..+|..||||++++.... ...+.+.+|+.+++.+. ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4568999999999999999999999999999999988775322 23567789999999999 999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCC-CceEEecccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSN-GAIKLADFGVSACM 164 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~-g~vKL~DFGls~~~ 164 (671)
.+|+|||||.||+|++.+... +.+.|..++.+++||+.||+|||++||+||||||+|||++.+ +++||+|||+++..
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred eEEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 999999999999999999885 789999999999999999999999999999999999999999 99999999999765
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCC-CccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGY-DFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 243 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~-s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (671)
. .......+.|||+.|+|||++.+...| +.++||||+||+||.|++|+.||.+.........+... .+..+
T Consensus 172 ~---~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~-----~~~~p 243 (370)
T KOG0583|consen 172 P---GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG-----EFKIP 243 (370)
T ss_pred C---CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC-----CccCC
Confidence 2 223456678999999999999984425 58899999999999999999999987666655554333 33445
Q ss_pred ccc-hHHHHHHHHHhhhcCCCCCCCHHHHHhchhccc
Q 005886 244 KRF-SKSFKELVTACLVKDPKKRPTAEKLMKHHFFKH 279 (671)
Q Consensus 244 ~~l-s~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~ 279 (671)
..+ |.++++||.+||..||.+|+++.+|+.||||+.
T Consensus 244 ~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 244 SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 556 999999999999999999999999999999986
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-50 Score=408.02 Aligned_cols=261 Identities=27% Similarity=0.435 Sum_probs=223.2
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
+.|+.+.++|+|+||+||+|+++.||+.||||++--... +.-.+-..||+++|+.++|||+|.++++|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 579999999999999999999999999999999853322 2334566899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
||+. ++.+-+... +.+++...+..++.|++.|+.|||++++|||||||+||||+.+|.+||||||+|+.+...++
T Consensus 82 ~~dh-TvL~eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd--- 156 (396)
T KOG0593|consen 82 YCDH-TVLHELERY-PNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD--- 156 (396)
T ss_pred ecch-HHHHHHHhc-cCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc---
Confidence 9976 555666554 57899999999999999999999999999999999999999999999999999988754443
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--------------
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL-------------- 238 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~-------------- 238 (671)
..+.++.|.||+|||++.|...|+..+|||++||++.||++|.+.|++.++.+.+..+......-+
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 345678999999999999988899999999999999999999999999998887765543221110
Q ss_pred --Ccc----------ccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccc
Q 005886 239 --DYE----------RDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKH 279 (671)
Q Consensus 239 --~~~----------~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~ 279 (671)
..+ ..+.++.-+.+|+++||.+||.+|++.+++|.||||..
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 011 12345677899999999999999999999999999953
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-50 Score=433.80 Aligned_cols=261 Identities=38% Similarity=0.689 Sum_probs=239.0
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
..|....+||+|+.|.||.|+...+++.||||.+++...+ ..+.+.+|+.+|+..+|+|||++++.|..++.+|+||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~-~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP-KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC-chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 5688899999999999999999999999999999877643 357889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS 173 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 173 (671)
|+||+|.+++... .++|.+|+.+++++|.||+|||.+||+|||||.+|||++.+|.+||+|||+++.+... ...
T Consensus 352 m~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~---~~K 425 (550)
T KOG0578|consen 352 MEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE---QSK 425 (550)
T ss_pred cCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc---cCc
Confidence 9999999999876 5999999999999999999999999999999999999999999999999999877443 335
Q ss_pred cccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHH
Q 005886 174 RNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL 253 (671)
Q Consensus 174 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dL 253 (671)
+.+.+|||.|||||+... +.|++++||||||++++||+-|.+||-...+...++.+..+..+.+. .+..+|+.+++|
T Consensus 426 R~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk--~~~klS~~~kdF 502 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLK--NPEKLSPELKDF 502 (550)
T ss_pred cccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcC--CccccCHHHHHH
Confidence 678899999999999988 77999999999999999999999999988888888888888776654 477899999999
Q ss_pred HHHhhhcCCCCCCCHHHHHhchhccccccch
Q 005886 254 VTACLVKDPKKRPTAEKLMKHHFFKHARSND 284 (671)
Q Consensus 254 I~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~~ 284 (671)
+.+||+.|+.+|++|.++|+||||+.+....
T Consensus 503 L~~cL~~dv~~RasA~eLL~HpFl~~a~p~s 533 (550)
T KOG0578|consen 503 LDRCLVVDVEQRASAKELLEHPFLKMAKPES 533 (550)
T ss_pred HHHHhhcchhcCCCHHHHhcChhhhhcCCHH
Confidence 9999999999999999999999998766543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=429.75 Aligned_cols=265 Identities=28% Similarity=0.418 Sum_probs=229.5
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCC-CCCceeeeeEEEeCC-EEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN-HPNVLRAHCSFTTGH-CLWV 89 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~-HpNIVkl~~~~~~~~-~l~L 89 (671)
..++|.++++||.|+||.||+|+.+.+|..||||.++.....-+...-.||++.|++|+ |||||++++++.+.+ .+|+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 45789999999999999999999999999999999976654433344578999999999 999999999999887 9999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCC
Q 005886 90 VMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~ 169 (671)
|||||+. +|+++++.. ...|++..++.|+.||+.||+|+|.+|++|||+||||||+..+..|||+|||+|+....
T Consensus 88 VfE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S--- 162 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS--- 162 (538)
T ss_pred eHHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc---
Confidence 9999965 899999887 67899999999999999999999999999999999999999999999999999986632
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----------
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL----------- 238 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~----------- 238 (671)
....+.++.|+||+|||++.+...|+.++|||++|||++|+.+-++.|.|.+..+.+..+..-.....
T Consensus 163 -kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 163 -KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred -CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 23455679999999999999888899999999999999999999999999999888877764321111
Q ss_pred -----Cccc---------cccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 239 -----DYER---------DKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 239 -----~~~~---------~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
.++. ....+.++.+||.+||.+||.+||||.++|+||||+....
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 1110 1235788999999999999999999999999999986554
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-51 Score=429.31 Aligned_cols=269 Identities=46% Similarity=0.775 Sum_probs=245.3
Q ss_pred ccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q 005886 8 RFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCL 87 (671)
Q Consensus 8 ~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l 87 (671)
........|+.++.||+|+||.||+|.+..+++.||||+++++....+.+.+++|+.+|..++++||.++|+.|..+..+
T Consensus 7 ~~~~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~L 86 (467)
T KOG0201|consen 7 LKIDPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKL 86 (467)
T ss_pred hcCCcccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccH
Confidence 34445677999999999999999999999999999999999998888899999999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccC
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~ 167 (671)
|++||||.||++.++++.. ..+.|..+..++++++.||.|||.++.+|||||+.|||+..+|.|||+|||++..+...
T Consensus 87 wiiMey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred HHHHHHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech
Confidence 9999999999999999876 45589999999999999999999999999999999999999999999999999877433
Q ss_pred CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccch
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls 247 (671)
. ..+.+++|||+|||||++.+ .+|+.++||||||+++|||++|.+||.+..++..++.+.++.||.++ ..++
T Consensus 165 ~---~rr~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~----~~~S 236 (467)
T KOG0201|consen 165 V---KRRKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLD----GDFS 236 (467)
T ss_pred h---hccccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccc----cccC
Confidence 2 23478999999999999996 78999999999999999999999999999999888888888877764 3789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHhchhccccccchHH
Q 005886 248 KSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFL 286 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~~~~ 286 (671)
+.+++||..||.+||+.||+|.++|+|+|++.+.....+
T Consensus 237 ~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~k~s~L 275 (467)
T KOG0201|consen 237 PPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAKKTSEL 275 (467)
T ss_pred HHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcCCchHH
Confidence 999999999999999999999999999999986654433
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=434.38 Aligned_cols=260 Identities=28% Similarity=0.452 Sum_probs=233.0
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEecccc--CcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEK--CNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWV 89 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~--~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~L 89 (671)
..+-|++++.||.|+.|.|.+|+|..||+.+|||+|.+.. .......+.+|+-+|+.+.||||+++|++|++..++|+
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 4577999999999999999999999999999999998763 22346789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCC
Q 005886 90 VMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~ 169 (671)
|.||+.||.|++++..+ +++++..++.+++||+.||.|||..+|+||||||+|+|+|..+++||+|||+|..- .
T Consensus 90 vlEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe----~ 163 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE----V 163 (786)
T ss_pred EEEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc----c
Confidence 99999999999999887 88999999999999999999999999999999999999999999999999998643 2
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHH
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
......+.||+|.|.|||++.|..+.+.++||||+|||||.||+|+.||++.+-...+..+.++ .|+.+..+|.+
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G-----~f~MPs~Is~e 238 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRG-----VFEMPSNISSE 238 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcC-----cccCCCcCCHH
Confidence 2334567899999999999999777789999999999999999999999976655555555444 35567889999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 250 FKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
+++||.+||.+||.+|+|.++|++|||+.....
T Consensus 239 aQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 239 AQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred HHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence 999999999999999999999999999987653
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=388.68 Aligned_cols=262 Identities=27% Similarity=0.364 Sum_probs=225.7
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcc-cHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-DLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~-~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
.+|...+.||+|.||+||+|++..||+.||||.|....... ......|||+.|+.++|+||+.++++|.....+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 57889999999999999999999999999999998775443 24567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
||+ .+|..+++.. ...++...+..|+.++++||+|||.+.|+||||||.|+|++.+|.+||+|||+|+.+......
T Consensus 82 fm~-tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~-- 157 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI-- 157 (318)
T ss_pred ecc-ccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc--
Confidence 996 4888888865 357899999999999999999999999999999999999999999999999999876433322
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--Cccc--------
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL--DYER-------- 242 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~--~~~~-------- 242 (671)
....+-|.||+|||++.|.+.|+..+||||.|||+.||+-|.+-|.|.++.+++..+++..-..- .|+.
T Consensus 158 -~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 158 -QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred -cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 22238899999999999999999999999999999999999999999999888776664321111 1111
Q ss_pred -------------cccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 243 -------------DKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 243 -------------~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
....+.++.||+.+||..||.+|+++.|+|+|+||+..
T Consensus 237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 12235678999999999999999999999999999854
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=430.07 Aligned_cols=272 Identities=31% Similarity=0.512 Sum_probs=240.3
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCC-CCCceeeeeEEEeCC
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTN-HPNVLRAHCSFTTGH 85 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~-HpNIVkl~~~~~~~~ 85 (671)
..+..++|++++.||+|+||+|+++..+.+++.||||++++... ..+++....|.+++.... ||+++.+++.|.+..
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 47788999999999999999999999999999999999987764 356888999999998775 999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
++|+||||+.||++.+++.. +.|++..++.|+..|+.||.|||++||||||||.+|||+|.+|.+||+|||+++...
T Consensus 443 ~l~fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred eEEEEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC
Confidence 99999999999996555543 579999999999999999999999999999999999999999999999999987543
Q ss_pred cCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (671)
.. .....++||||.|||||++.+ ..|+.++|+|||||+||||+.|..||.+.+..+.+..++.. +...+..
T Consensus 520 ~~---g~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d-----~~~yP~~ 590 (694)
T KOG0694|consen 520 GQ---GDRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND-----EVRYPRF 590 (694)
T ss_pred CC---CCccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-----CCCCCCc
Confidence 22 335678999999999999998 67999999999999999999999999998887777766654 2233567
Q ss_pred chHHHHHHHHHhhhcCCCCCCC-----HHHHHhchhccccccchHHHHHHhh
Q 005886 246 FSKSFKELVTACLVKDPKKRPT-----AEKLMKHHFFKHARSNDFLARSIVD 292 (671)
Q Consensus 246 ls~~l~dLI~~cL~~dP~kRpS-----a~eiL~Hpwfk~~~~~~~~~~~l~~ 292 (671)
+|.++.+++.++|.++|++|+. +++|..||||+...|.+...+.+-.
T Consensus 591 ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~P 642 (694)
T KOG0694|consen 591 LSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKP 642 (694)
T ss_pred ccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCC
Confidence 8999999999999999999986 5889999999999987776665433
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=393.78 Aligned_cols=258 Identities=28% Similarity=0.463 Sum_probs=229.1
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
+.|.+.+.||+|.|+.||++.+..||+.+|+|+++..+.. ...+.+.+|+.+-+.|.|||||++++.+...+..|||+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 6789999999999999999999999999999999876643 468899999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcC---CCceEEeccccccccccCCC
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS---NGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~---~g~vKL~DFGls~~~~~~~~ 169 (671)
+|.|++|+.-|-.. ..++|..+-.+++||+.+|.|||.+||||||+||+|+|+-. ..-|||+|||+|..+.
T Consensus 91 ~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~---- 164 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN---- 164 (355)
T ss_pred cccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC----
Confidence 99999998655443 46899999999999999999999999999999999999944 3469999999997664
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHH
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
.......++|||.|||||++.. ..|+..+|||+.|||||.|+.|++||++.+....+..+++.. ..++.+.|..++++
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~-yd~~~~~w~~is~~ 242 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGA-YDYPSPEWDTVTPE 242 (355)
T ss_pred CccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccc-cCCCCcccCcCCHH
Confidence 2223456799999999999987 679999999999999999999999999988777776666653 44555678899999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHhchhccc
Q 005886 250 FKELVTACLVKDPKKRPTAEKLMKHHFFKH 279 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~ 279 (671)
+++||.+||..||.+|+|+.|+|+|||+++
T Consensus 243 Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 243 AKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred HHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 999999999999999999999999999985
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=399.01 Aligned_cols=250 Identities=28% Similarity=0.522 Sum_probs=214.3
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeee-EEEeCCE-EE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHC-SFTTGHC-LW 88 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~-~~~~~~~-l~ 88 (671)
...+|+++++||+|+||+||++.+..+|..||.|.+...... ...+.+..|+.+|+.|+|||||++++ .|.++.. ++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 345799999999999999999999999999999999866543 45678899999999999999999998 6666655 99
Q ss_pred EEEeccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHH--CC--cccccCCCCcEEEcCCCceEEecccccc
Q 005886 89 VVMPYMAGGSCLHIMKSA--YPEGFEEPVIATLLRETLKALVYLHF--HG--HIHRDVKAGNILIDSNGAIKLADFGVSA 162 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~--~~~~l~e~~i~~i~~qIl~aL~yLHs--~g--IVHrDLKPeNILld~~g~vKL~DFGls~ 162 (671)
||||||.+|+|...++.. ....++|..+|.++.|++.||..||. .. |+||||||.|||++.+|.|||+||||++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 999999999999988743 23579999999999999999999999 44 8999999999999999999999999998
Q ss_pred ccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccc
Q 005886 163 CMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER 242 (671)
Q Consensus 163 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~ 242 (671)
.+.. ......+++|||.||+||++.+ .+|++++||||+||++|||+.-++||.+..-......+.+...+. -.
T Consensus 177 ~l~s---~~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~---~p 249 (375)
T KOG0591|consen 177 FLSS---KTTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPP---LP 249 (375)
T ss_pred Hhcc---hhHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCC---Cc
Confidence 6632 2334457899999999999998 789999999999999999999999999986555555554442211 22
Q ss_pred cccchHHHHHHHHHhhhcCCCCCCCH
Q 005886 243 DKRFSKSFKELVTACLVKDPKKRPTA 268 (671)
Q Consensus 243 ~~~ls~~l~dLI~~cL~~dP~kRpSa 268 (671)
...+|..+..||..|+..||+.||+.
T Consensus 250 ~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 250 DEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHhhhHHHHHHHHHccCCcccCCCc
Confidence 36789999999999999999999986
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=407.70 Aligned_cols=264 Identities=32% Similarity=0.548 Sum_probs=223.4
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC--EEEEE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH--CLWVV 90 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~--~l~LV 90 (671)
..+|...+.||+|+||+||++.+..+|..+|||.+....... .+.+.+|+.+|+.++|||||++++...... .++++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 456999999999999999999999999999999998764333 677999999999999999999999855444 69999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcC-CCceEEeccccccccccCCC
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS-NGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~-~g~vKL~DFGls~~~~~~~~ 169 (671)
|||+.||+|.+++..... .++|..++.+.+||+.||+|||++|||||||||+|||++. +|.+||+|||++........
T Consensus 95 mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred eeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 999999999999998743 7999999999999999999999999999999999999999 79999999999876643223
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCC-CChHHHHHHHHhcCCCCCCccccccchH
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSK-YPPMKVLLMTLQNAPPGLDYERDKRFSK 248 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~-~~~~~~~~~~~~~~~~~~~~~~~~~ls~ 248 (671)
.......+.||+.|||||++.......+++|||||||++.||+||..||.. ......+..+.... .....+..+|.
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~---~~P~ip~~ls~ 250 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED---SLPEIPDSLSD 250 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC---CCCCCCcccCH
Confidence 333445679999999999998522234599999999999999999999988 34444444444332 12255677999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 249 SFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 249 ~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
++++||.+|+.++|.+||||+++|.|||.+...
T Consensus 251 ~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 251 EAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 999999999999999999999999999997543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-48 Score=413.10 Aligned_cols=268 Identities=29% Similarity=0.450 Sum_probs=228.1
Q ss_pred ccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeC--
Q 005886 8 RFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTG-- 84 (671)
Q Consensus 8 ~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~-- 84 (671)
..+...+.|+.++.||+|+||.||+|++..||+.||+|.+..+... .......|||.+|++|+||||+++.+...+.
T Consensus 111 w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~ 190 (560)
T KOG0600|consen 111 WGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLS 190 (560)
T ss_pred ccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCC
Confidence 4556677899999999999999999999999999999999877643 3456778999999999999999999998876
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccc
Q 005886 85 HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACM 164 (671)
Q Consensus 85 ~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~ 164 (671)
..+|||+|||+. +|.-++... .-.|++.+|.-|++||+.||+|||.+||+|||||..|||||.+|.+||+|||||+.+
T Consensus 191 ~siYlVFeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 191 GSIYLVFEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred ceEEEEEecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeec
Confidence 689999999976 677766542 346999999999999999999999999999999999999999999999999999866
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CCCCCc--
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA--PPGLDY-- 240 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~--~~~~~~-- 240 (671)
...... ..+..+-|.||+|||++.|...|+.++|+||+||||.||+.|++.|.+.+..+++..|..-. |..-.|
T Consensus 269 ~~~~~~--~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~ 346 (560)
T KOG0600|consen 269 TPSGSA--PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPV 346 (560)
T ss_pred cCCCCc--ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccc
Confidence 433322 24556889999999999999999999999999999999999999999999888776665321 100001
Q ss_pred --------------------cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccc
Q 005886 241 --------------------ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKH 279 (671)
Q Consensus 241 --------------------~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~ 279 (671)
+....++..+.+|+..||..||.+|.||.++|.|+||..
T Consensus 347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 112345778899999999999999999999999999953
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-48 Score=417.40 Aligned_cols=255 Identities=33% Similarity=0.577 Sum_probs=228.7
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
++|.+.+.||+|+||+||+|+.+.|.+.||||++.+... .++...+++|+++++.++|||||.++++|++..++|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 689999999999999999999999999999999987654 3568899999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
||.| +|+.++... +.++|+.++.++.+++.||.|||+++|+|||+||.|||++.+|.+|+||||+|+.+.. ...
T Consensus 82 ~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~---~t~ 155 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST---NTS 155 (808)
T ss_pred hhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc---Cce
Confidence 9987 999999865 7899999999999999999999999999999999999999999999999999988743 222
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHH
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKE 252 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~d 252 (671)
......|||.|||||+..+ ..|+..+|+||||||+|||+.|++||....-......++.... .++...+..+.+
T Consensus 156 vltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v-----~~p~~~S~~f~n 229 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPV-----KPPSTASSSFVN 229 (808)
T ss_pred eeeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCC-----CCcccccHHHHH
Confidence 3445689999999999997 7899999999999999999999999988666555555555422 234578999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 253 LVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 253 LI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
|+..+|.+||.+|++..+++.|||.+..
T Consensus 230 fl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 230 FLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred HHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 9999999999999999999999999854
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=401.82 Aligned_cols=272 Identities=30% Similarity=0.442 Sum_probs=240.5
Q ss_pred ccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC
Q 005886 8 RFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH 85 (671)
Q Consensus 8 ~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~ 85 (671)
.-.+..++|++++.||.|.-|+||+|..+.++..+|+|++++.... +...++..|-+||+.++||.++.+|..|+.++
T Consensus 71 ~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~ 150 (459)
T KOG0610|consen 71 DGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK 150 (459)
T ss_pred CCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence 3456778899999999999999999999999999999999876543 45678888999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
+.|+|||||.||+|..+.++...+.|++..++.|+.+++.||+|||-.|||+||||||||||.++|+|.|+||.|+....
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 99999999999999999999888899999999999999999999999999999999999999999999999999874331
Q ss_pred cC--------------------------------CCc---------------------ccccccccCCCCCCChhHhhhc
Q 005886 166 DA--------------------------------GDR---------------------QRSRNTFVGTPCWMAPEVMQQL 192 (671)
Q Consensus 166 ~~--------------------------------~~~---------------------~~~~~~~~GT~~Y~APEvl~~~ 192 (671)
-. ... ....+.++||..|.|||++.|
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G- 309 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG- 309 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-
Confidence 00 000 012245799999999999998
Q ss_pred cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCC----H
Q 005886 193 HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPT----A 268 (671)
Q Consensus 193 ~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpS----a 268 (671)
.+.+.++|+|+|||++|||+.|..||.+.+..+.+..++..... ++....++..++|||.++|.+||.+|+. |
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~---Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA 386 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLK---FPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGA 386 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCc---CCCCCcchhHHHHHHHHHhccChhhhhccccch
Confidence 78999999999999999999999999999998888888766432 3334478899999999999999999998 9
Q ss_pred HHHHhchhccccccc
Q 005886 269 EKLMKHHFFKHARSN 283 (671)
Q Consensus 269 ~eiL~Hpwfk~~~~~ 283 (671)
.||.+||||+.+.|.
T Consensus 387 ~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 387 AEIKRHPFFEGVNWA 401 (459)
T ss_pred HHhhcCccccCCChh
Confidence 999999999999885
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=401.72 Aligned_cols=262 Identities=26% Similarity=0.428 Sum_probs=226.9
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeC
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG 84 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~ 84 (671)
.......++|++.+.||+|+||.||+|.++.+|+.||||++..... ......+.+|+.+++.++||||++++++|.++
T Consensus 11 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 90 (329)
T PTZ00263 11 DTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE 90 (329)
T ss_pred ccCCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC
Confidence 3445567899999999999999999999999999999999875432 23456788999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccc
Q 005886 85 HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACM 164 (671)
Q Consensus 85 ~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~ 164 (671)
+.+|+||||+.||+|..++... +.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 91 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 168 (329)
T PTZ00263 91 NRVYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV 168 (329)
T ss_pred CEEEEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence 9999999999999999998865 67899999999999999999999999999999999999999999999999998654
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccc
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (671)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+.... ...+.
T Consensus 169 ~~------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~-----~~~p~ 236 (329)
T PTZ00263 169 PD------RTFTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR-----LKFPN 236 (329)
T ss_pred CC------CcceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-----cCCCC
Confidence 21 1234589999999999987 568999999999999999999999998877766555544332 12344
Q ss_pred cchHHHHHHHHHhhhcCCCCCCC-----HHHHHhchhcccccc
Q 005886 245 RFSKSFKELVTACLVKDPKKRPT-----AEKLMKHHFFKHARS 282 (671)
Q Consensus 245 ~ls~~l~dLI~~cL~~dP~kRpS-----a~eiL~Hpwfk~~~~ 282 (671)
.++..+++||.+||..||.+||+ +++++.||||+...+
T Consensus 237 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~ 279 (329)
T PTZ00263 237 WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANW 279 (329)
T ss_pred CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCH
Confidence 57889999999999999999997 799999999987554
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=407.95 Aligned_cols=260 Identities=31% Similarity=0.495 Sum_probs=234.6
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcc--cHHHHHHHHHHHHhCC-CCCceeeeeEEEeCCEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN--DLDGIRREVQTMRVTN-HPNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~--~~~~i~~Ei~iL~~L~-HpNIVkl~~~~~~~~~l~ 88 (671)
....|++.+.||+|.||+||+|+++.||+.+|+|++.+..... ....+.+|+.+|+.+. |||||.++++|++...+|
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3457999999999999999999999999999999998776543 4588999999999998 999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCC----CceEEecccccccc
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSN----GAIKLADFGVSACM 164 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~----g~vKL~DFGls~~~ 164 (671)
+|||+|.||.|++.+... .++|..+..+++||+.++.|||+.||+||||||+|+|+... +.+|++|||++...
T Consensus 113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 999999999999998876 39999999999999999999999999999999999999543 57999999999765
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccc
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (671)
.. .......+||+.|+|||++.+ ..|+..+||||+||++|.|++|.+||.+.........+.... ..+..+.|.
T Consensus 190 ~~----~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~-~~f~~~~w~ 263 (382)
T KOG0032|consen 190 KP----GERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGD-FDFTSEPWD 263 (382)
T ss_pred cC----CceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCC-CCCCCCCcc
Confidence 32 345667899999999999986 679999999999999999999999999998887777666554 356777888
Q ss_pred cchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 245 RFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 245 ~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
.++..+++||..||..||.+|+|+.++|+|||++..
T Consensus 264 ~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 264 DISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred ccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 999999999999999999999999999999999865
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=395.10 Aligned_cols=256 Identities=27% Similarity=0.430 Sum_probs=223.2
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
++|++.+.||+|+||.||+|.+..+|+.||+|++...... .....+.+|+.+++.++||||+++++++.++..+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 4799999999999999999999999999999998754321 23567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
||+.||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~----- 153 (291)
T cd05612 81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD----- 153 (291)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----
Confidence 999999999999875 5789999999999999999999999999999999999999999999999999865422
Q ss_pred cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHH
Q 005886 172 RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~ 251 (671)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..... ..+..++..++
T Consensus 154 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-----~~~~~~~~~~~ 226 (291)
T cd05612 154 -RTWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL-----EFPRHLDLYAK 226 (291)
T ss_pred -CcccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-----CCCccCCHHHH
Confidence 1234579999999999987 6689999999999999999999999998777666555554321 23455788999
Q ss_pred HHHHHhhhcCCCCCCC-----HHHHHhchhccccccc
Q 005886 252 ELVTACLVKDPKKRPT-----AEKLMKHHFFKHARSN 283 (671)
Q Consensus 252 dLI~~cL~~dP~kRpS-----a~eiL~Hpwfk~~~~~ 283 (671)
+||.+||..||.+||+ +++++.||||+...+.
T Consensus 227 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 263 (291)
T cd05612 227 DLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD 263 (291)
T ss_pred HHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence 9999999999999995 9999999999876543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=389.10 Aligned_cols=261 Identities=24% Similarity=0.382 Sum_probs=217.7
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
..++|++.+.||.|+||+||+|.+..++..||+|++...........+.+|+.+++.++||||+++++++.++..+|+||
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 45789999999999999999999999999999999976544444567789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
||+.| +|..++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus 83 e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~---~ 157 (288)
T cd07871 83 EYLDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP---T 157 (288)
T ss_pred eCCCc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC---C
Confidence 99975 888887654 245789999999999999999999999999999999999999999999999998644211 1
Q ss_pred cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-------------
Q 005886 172 RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL------------- 238 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~------------- 238 (671)
.......||+.|+|||++.+...++.++|||||||++|+|++|++||.+....+.+..+........
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 2223457899999999987656689999999999999999999999988776655544432211000
Q ss_pred ---C---------ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 239 ---D---------YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 239 ---~---------~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
. ......++.++++||.+||..||.+|||++++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0 01123467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=391.31 Aligned_cols=264 Identities=26% Similarity=0.391 Sum_probs=214.4
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
.++|++.+.||.|+||.||+|.++.+|+.||||++...........+.+|+.+++.++||||+++++++.++..+|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 57899999999999999999999999999999999755433444567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
|+. ++|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...... ..
T Consensus 84 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~---~~ 158 (303)
T cd07869 84 YVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP---SH 158 (303)
T ss_pred CCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC---Cc
Confidence 996 5777776653 356899999999999999999999999999999999999999999999999998643211 12
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHH-HHHhc--CCC-------------
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLL-MTLQN--APP------------- 236 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~-~~~~~--~~~------------- 236 (671)
......||+.|+|||++.+...++.++|||||||++|+|++|..||.+..+..... .+... .+.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 23345789999999998765668999999999999999999999998765432221 11110 000
Q ss_pred ---CCCcc---------ccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 237 ---GLDYE---------RDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 237 ---~~~~~---------~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
.+... ....++..+++||.+||+.||.+|||+.++|+||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 00000 0012457889999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=387.83 Aligned_cols=266 Identities=24% Similarity=0.344 Sum_probs=220.2
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
.|++.+.||+|+||.||+|.+..+|+.||+|++...... .....+.+|+.+++.++|+||++++++|.+++.+|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 488999999999999999999999999999998754322 223467789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
||.||+|...+.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~----~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE----GE 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC----CC
Confidence 99999998887655445689999999999999999999999999999999999999999999999999865421 11
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHH
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKE 252 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~d 252 (671)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+............... ......+..++..+.+
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~ 234 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK-EDQEEYSEKFSEDAKS 234 (285)
T ss_pred eecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh-cccccCCccCCHHHHH
Confidence 2234579999999999987 5799999999999999999999999987544222111111111 1122335568999999
Q ss_pred HHHHhhhcCCCCCCC-----HHHHHhchhccccccchHH
Q 005886 253 LVTACLVKDPKKRPT-----AEKLMKHHFFKHARSNDFL 286 (671)
Q Consensus 253 LI~~cL~~dP~kRpS-----a~eiL~Hpwfk~~~~~~~~ 286 (671)
||.+||..||.+||+ ++++++||||+...+....
T Consensus 235 li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~ 273 (285)
T cd05631 235 ICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLE 273 (285)
T ss_pred HHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHH
Confidence 999999999999997 8999999999987654433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=398.20 Aligned_cols=253 Identities=28% Similarity=0.446 Sum_probs=217.8
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccCCC
Q 005886 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGG 97 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~gg 97 (671)
+.||+|+||.||+|.++.+|+.||||++..... ......+.+|+.+++.++||||++++++|...+.+|+||||+.||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999999999999999975432 233567788999999999999999999999999999999999999
Q ss_pred CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccccccc
Q 005886 98 SCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTF 177 (671)
Q Consensus 98 sL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~ 177 (671)
+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .......
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~---~~~~~~~ 155 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD---GATMKTF 155 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC---CCcccce
Confidence 999988765 67899999999999999999999999999999999999999999999999998643221 1223456
Q ss_pred cCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHh
Q 005886 178 VGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTAC 257 (671)
Q Consensus 178 ~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~c 257 (671)
+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.... ...+..++.++.+||.+|
T Consensus 156 ~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~-----~~~p~~~~~~~~~li~~~ 229 (323)
T cd05571 156 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-----IRFPRTLSPEAKSLLAGL 229 (323)
T ss_pred ecCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-----CCCCCCCCHHHHHHHHHH
Confidence 89999999999987 678999999999999999999999998876655544443322 223456899999999999
Q ss_pred hhcCCCCCC-----CHHHHHhchhccccccc
Q 005886 258 LVKDPKKRP-----TAEKLMKHHFFKHARSN 283 (671)
Q Consensus 258 L~~dP~kRp-----Sa~eiL~Hpwfk~~~~~ 283 (671)
|..||.+|| ++.++++||||....+.
T Consensus 230 L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~ 260 (323)
T cd05571 230 LKKDPKQRLGGGPEDAKEIMEHRFFASINWQ 260 (323)
T ss_pred ccCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 999999999 89999999999876553
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-47 Score=402.36 Aligned_cols=263 Identities=27% Similarity=0.480 Sum_probs=220.4
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-------------ccHHHHHHHHHHHHhCCCCCceeee
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-------------NDLDGIRREVQTMRVTNHPNVLRAH 78 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-------------~~~~~i~~Ei~iL~~L~HpNIVkl~ 78 (671)
..++|++.+.||+|.||.|.+|++..+++.||||++.+.... ...+.+++||.+|++|+|||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 468999999999999999999999999999999999754321 1247899999999999999999999
Q ss_pred eEEEe--CCEEEEEEeccCCCCHHHHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEE
Q 005886 79 CSFTT--GHCLWVVMPYMAGGSCLHIMKSAYPEG-FEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKL 155 (671)
Q Consensus 79 ~~~~~--~~~l~LVmEy~~ggsL~~~l~~~~~~~-l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL 155 (671)
++..+ .+.+|||+|||..|.+.+.-. .+. +.+.+++.|+++++.||+|||.+|||||||||.|+|++.+|+|||
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEe
Confidence 99986 458999999999987655422 234 899999999999999999999999999999999999999999999
Q ss_pred eccccccccccCC--CcccccccccCCCCCCChhHhhhcc---CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 005886 156 ADFGVSACMFDAG--DRQRSRNTFVGTPCWMAPEVMQQLH---GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMT 230 (671)
Q Consensus 156 ~DFGls~~~~~~~--~~~~~~~~~~GT~~Y~APEvl~~~~---~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~ 230 (671)
+|||.+..+.... .........+|||.|||||+..+.. ..+.+.||||+||+||.|+.|+.||.+....+.+..+
T Consensus 252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KI 331 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKI 331 (576)
T ss_pred eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHH
Confidence 9999985441111 1111223368999999999987622 3467899999999999999999999998877777776
Q ss_pred HhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 231 LQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 231 ~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
+... +.++..+.+...+++||.+||.+||.+|++..+|..|||....
T Consensus 332 vn~p---L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 332 VNDP---LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred hcCc---ccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 6542 3344455688999999999999999999999999999999754
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-47 Score=386.68 Aligned_cols=264 Identities=27% Similarity=0.388 Sum_probs=224.7
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCccc-HHHHHHHHHHHHhCCCCCceeeeeEEEe--CCEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNND-LDGIRREVQTMRVTNHPNVLRAHCSFTT--GHCLW 88 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~-~~~i~~Ei~iL~~L~HpNIVkl~~~~~~--~~~l~ 88 (671)
..++|+.+..|++|+||.||+|+++.|++.||+|.++.++.... --.-.|||.+|..++|||||.+.++... -+.+|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 45789999999999999999999999999999999987663322 1234689999999999999999888764 35799
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
||||||+. +|..++.... ..|....++.++.|++.||+|||.+.|+||||||+|+|++..|.+||+|||+|+.+.
T Consensus 154 ~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg--- 228 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYG--- 228 (419)
T ss_pred eeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhc---
Confidence 99999976 7888888763 689999999999999999999999999999999999999999999999999998763
Q ss_pred CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-------CCCCc-
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP-------PGLDY- 240 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~-------~~~~~- 240 (671)
......+..+-|.||+|||++.+.+.|+.++||||+|||+.||+++.+.|.+....+.+..+.+..- +++..
T Consensus 229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 3334456678999999999999999999999999999999999999999999988888777664321 11110
Q ss_pred cc-------------------cccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 241 ER-------------------DKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 241 ~~-------------------~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
+. ...++....+|+..+|..||.+|.||+++|+|+||...
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 00 01255788999999999999999999999999999864
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-46 Score=399.20 Aligned_cols=264 Identities=25% Similarity=0.401 Sum_probs=227.4
Q ss_pred ccccccCCCCeEEEEEecccCceEEEEEEEcCCC-cEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEE
Q 005886 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLN-EIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFT 82 (671)
Q Consensus 6 e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg-~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~ 82 (671)
++...+..++|++.+.||.|+||.||+|.+..++ ..||+|++..... ......+.+|+.+++.++||||++++++|.
T Consensus 22 ~~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 101 (340)
T PTZ00426 22 KRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK 101 (340)
T ss_pred ccCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 3456678889999999999999999999977665 6899999865432 234567889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccc
Q 005886 83 TGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSA 162 (671)
Q Consensus 83 ~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~ 162 (671)
+...+|+||||+.||+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 102 ~~~~~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~ 179 (340)
T PTZ00426 102 DESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK 179 (340)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCe
Confidence 999999999999999999999876 579999999999999999999999999999999999999999999999999986
Q ss_pred ccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccc
Q 005886 163 CMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER 242 (671)
Q Consensus 163 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~ 242 (671)
.+.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..+......+.... ...
T Consensus 180 ~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~-----~~~ 247 (340)
T PTZ00426 180 VVDT------RTYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI-----IYF 247 (340)
T ss_pred ecCC------CcceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC-----CCC
Confidence 5421 1235689999999999987 568999999999999999999999999877665555444332 123
Q ss_pred cccchHHHHHHHHHhhhcCCCCCC-----CHHHHHhchhccccccc
Q 005886 243 DKRFSKSFKELVTACLVKDPKKRP-----TAEKLMKHHFFKHARSN 283 (671)
Q Consensus 243 ~~~ls~~l~dLI~~cL~~dP~kRp-----Sa~eiL~Hpwfk~~~~~ 283 (671)
+..++..++++|.+||..||.+|+ +++++++||||....+.
T Consensus 248 p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~ 293 (340)
T PTZ00426 248 PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV 293 (340)
T ss_pred CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 456789999999999999999995 89999999999876654
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=398.79 Aligned_cols=265 Identities=25% Similarity=0.425 Sum_probs=220.7
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
++|++.+.||+|+||+||+|.++.+|+.||||++..... ......+.+|+.++..++||||+++++.|.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 479999999999999999999999999999999975432 233567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCc-
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR- 170 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~- 170 (671)
|||.||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.+......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 999999999999765 67999999999999999999999999999999999999999999999999998654221100
Q ss_pred -------------------------------ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCC
Q 005886 171 -------------------------------QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFS 219 (671)
Q Consensus 171 -------------------------------~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~ 219 (671)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 001134589999999999987 679999999999999999999999998
Q ss_pred CCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCC---CCCCHHHHHhchhccccccc
Q 005886 220 KYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPK---KRPTAEKLMKHHFFKHARSN 283 (671)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~---kRpSa~eiL~Hpwfk~~~~~ 283 (671)
+....+....+... ...+.++....++.++++||.+|+. +|. .||++++|++||||+...+.
T Consensus 238 ~~~~~~~~~~i~~~-~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~ 302 (363)
T cd05628 238 SETPQETYKKVMNW-KETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWE 302 (363)
T ss_pred CCCHHHHHHHHHcC-cCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHH
Confidence 87776655554432 1222233334578999999999775 444 45899999999999876543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=382.22 Aligned_cols=259 Identities=24% Similarity=0.385 Sum_probs=213.7
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
++|++.+.||+|+||+||+|+++.+++.||+|++..... ......+.+|+.+++.++||||++++++|..+..+|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 479999999999999999999999999999999875432 2335678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
|+.++.+..+... ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 156 (287)
T cd07848 81 YVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS--NA 156 (287)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc--cc
Confidence 9998766655433 2579999999999999999999999999999999999999999999999999987652211 12
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-------------C--
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP-------------G-- 237 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~-------------~-- 237 (671)
......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+.....+ .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 157 NYTEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred cccccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 2334579999999999987 56899999999999999999999999887654443322211000 0
Q ss_pred -CCc-----------cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 238 -LDY-----------ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 238 -~~~-----------~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
... .....++..+.+||.+||.+||.+|||++++|+||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 000 0112368889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=392.77 Aligned_cols=259 Identities=29% Similarity=0.451 Sum_probs=222.1
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
++|++.+.||+|+||.||+|++..+|+.||||++...... .....+.+|+.++..++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 4799999999999999999999999999999999754322 34567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----- 153 (333)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----
Confidence 999999999999765 5789999999999999999999999999999999999999999999999999865422
Q ss_pred cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccc----cccch
Q 005886 172 RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER----DKRFS 247 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~----~~~ls 247 (671)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.... ..+..+. ...++
T Consensus 154 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~s 230 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK-ETLQRPVYDDPRFNLS 230 (333)
T ss_pred -ccCCcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc-ccccCCCCCccccccC
Confidence 2345689999999999987 579999999999999999999999998877665544333211 1111111 12568
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 248 KSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
.++++||.+||..+|.+||++.++++||||....+
T Consensus 231 ~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~ 265 (333)
T cd05600 231 DEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW 265 (333)
T ss_pred HHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence 99999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=387.74 Aligned_cols=265 Identities=26% Similarity=0.329 Sum_probs=224.2
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEecccc-CcccHHHHHHHHHHHHhCCCCCceeeeeEEEe-----CCE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEK-CNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT-----GHC 86 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~-~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~-----~~~ 86 (671)
...|..++.||.|+||.|+.|.++.+|+.||||.+...- ..-...+..||+++|+.++|+||+.+++.+.. -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 356666899999999999999999999999999986322 12346788999999999999999999999876 357
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
+|+|+|+| +.+|..+++.. ..+++..+..++.||+.||+|+|+.||+||||||.|+|++.+..+||||||+|+....
T Consensus 101 vYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred eEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 99999999 56888888876 4599999999999999999999999999999999999999999999999999987744
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG--------- 237 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~--------- 237 (671)
. ......+.++-|.||+|||++.....|+.++||||+|||+.||++|++.|.|.+....+..++.-....
T Consensus 178 ~-~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 178 F-FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred c-CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 3 334445678999999999999988899999999999999999999999999877666554443222111
Q ss_pred --------------CC---ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 238 --------------LD---YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 238 --------------~~---~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
.. ....+..++.+.+|+++||..||.+|+|++++|.||||....
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 11 112346678999999999999999999999999999998654
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=398.11 Aligned_cols=264 Identities=27% Similarity=0.461 Sum_probs=223.2
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
++|++.+.||+|+||+||+|++..+|+.||||++..... ......+.+|+.+|+.++||||++++++|.++..+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 479999999999999999999999999999999975432 233567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCc-
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR- 170 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~- 170 (671)
|||.||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+......
T Consensus 81 E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 81 EYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 999999999998765 57999999999999999999999999999999999999999999999999998654221100
Q ss_pred ----------------------------------ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCC
Q 005886 171 ----------------------------------QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHA 216 (671)
Q Consensus 171 ----------------------------------~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~ 216 (671)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcCCC
Confidence 001123579999999999976 679999999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCC---HHHHHhchhcccccc
Q 005886 217 PFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPT---AEKLMKHHFFKHARS 282 (671)
Q Consensus 217 PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpS---a~eiL~Hpwfk~~~~ 282 (671)
||.+....+....+... ...+..+....+++.+++||.+||. +|.+|++ +.++|.||||+...+
T Consensus 238 Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~ 304 (364)
T cd05599 238 PFCSDNPQETYRKIINW-KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDW 304 (364)
T ss_pred CCCCCCHHHHHHHHHcC-CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 99988776655544432 2223333344679999999999996 9999998 999999999987654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=399.45 Aligned_cols=264 Identities=27% Similarity=0.451 Sum_probs=219.8
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
++|++++.||+|+||+||+|.+..+|+.||||++..... ......+.+|+.+++.++||||++++++|.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 479999999999999999999999999999999865432 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCc-
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR- 170 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~- 170 (671)
|||.||+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.+......
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 999999999998765 67899999999999999999999999999999999999999999999999998643211100
Q ss_pred -----------c--------------------------------cccccccCCCCCCChhHhhhccCCCccchhhhHHHH
Q 005886 171 -----------Q--------------------------------RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGIT 207 (671)
Q Consensus 171 -----------~--------------------------------~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvI 207 (671)
. ......+||+.|+|||++.+ ..++.++|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvi 237 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAI 237 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecchh
Confidence 0 00013579999999999987 569999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCC---CCHHHHHhchhcccccc
Q 005886 208 ALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKR---PTAEKLMKHHFFKHARS 282 (671)
Q Consensus 208 LyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kR---pSa~eiL~Hpwfk~~~~ 282 (671)
+|||++|..||.+....+.+..+.. ....+.++....++.++++||.+||. +|.+| +++.+++.||||+...+
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~-~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIIN-WRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHc-cCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 9999999999988776555444432 22223333344678999999999997 77775 59999999999986543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=397.97 Aligned_cols=264 Identities=27% Similarity=0.428 Sum_probs=219.4
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
.|++++.||+|+||+||+|++..+++.||||++..... ......+.+|+.+++.++||||++++++|.+...+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 68999999999999999999999999999999975432 2345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCC---
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD--- 169 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~--- 169 (671)
||.||+|..++... ..+++..++.++.||+.||+|||..||+||||||+|||++.+|.+||+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 82 YIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 99999999998765 5789999999999999999999999999999999999999999999999999753210000
Q ss_pred -----------------------------------------cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHH
Q 005886 170 -----------------------------------------RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITA 208 (671)
Q Consensus 170 -----------------------------------------~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvIL 208 (671)
........+||+.|+|||++.+ ..++.++|||||||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~il 238 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVIL 238 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhhHH
Confidence 0001124689999999999987 6689999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhc--CCCCCCCHHHHHhchhcccccc
Q 005886 209 LELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVK--DPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 209 yeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~--dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
|||++|..||....+......++.. ...+..+....+++++++||.+||.. +|..|+++.+++.||||....+
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINW-ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDF 313 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHcc-ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCCh
Confidence 9999999999887765554444321 12223334456899999999996654 5555999999999999986544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=387.34 Aligned_cols=265 Identities=26% Similarity=0.381 Sum_probs=213.3
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeC-----CEEE
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG-----HCLW 88 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~-----~~l~ 88 (671)
+|++.+.||+|+||.||+|.+..+|..||||.+..... ......+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 59999999999999999999999999999999864321 23345688999999999999999999988643 3589
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
+|||||. ++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 81 VVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 157 (338)
T ss_pred EEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence 9999995 6888888765 569999999999999999999999999999999999999999999999999987553322
Q ss_pred CcccccccccCCCCCCChhHhhhc-cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHH----------------
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQL-HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTL---------------- 231 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~-~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~---------------- 231 (671)
.........+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+......+..+.
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 222223456899999999998652 458899999999999999999999998765433221110
Q ss_pred ----------hcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 232 ----------QNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 232 ----------~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
....+.........++..+.+||.+||..||.+|||++++|+||||+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 000000011112346788999999999999999999999999999986554
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=388.39 Aligned_cols=248 Identities=28% Similarity=0.461 Sum_probs=214.7
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEecccc--CcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccCCCCH
Q 005886 22 VGEGVSATVYRALCIPLNEIVAIKVLDLEK--CNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSC 99 (671)
Q Consensus 22 LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~--~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~ggsL 99 (671)
||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++||||++++++|.....+|+||||+.||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999999999999999987543 223456788999999999999999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccccccccC
Q 005886 100 LHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVG 179 (671)
Q Consensus 100 ~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~G 179 (671)
..++... +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...... ......+|
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~g 155 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD---DKTNTFCG 155 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC---CccccccC
Confidence 9998765 579999999999999999999999999999999999999999999999999986432211 22345689
Q ss_pred CCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhh
Q 005886 180 TPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLV 259 (671)
Q Consensus 180 T~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~ 259 (671)
|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+.... ...+..++..+++||.+||.
T Consensus 156 t~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~L~ 229 (312)
T cd05585 156 TPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP-----LRFPDGFDRDAKDLLIGLLS 229 (312)
T ss_pred CcccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC-----CCCCCcCCHHHHHHHHHHcC
Confidence 999999999987 678999999999999999999999998877666555544332 23345688999999999999
Q ss_pred cCCCCCC---CHHHHHhchhcccc
Q 005886 260 KDPKKRP---TAEKLMKHHFFKHA 280 (671)
Q Consensus 260 ~dP~kRp---Sa~eiL~Hpwfk~~ 280 (671)
.||.+|| ++.++|.||||...
T Consensus 230 ~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 230 RDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCHHHcCCCCCHHHHHcCCCcCCC
Confidence 9999997 58999999999865
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=397.57 Aligned_cols=263 Identities=27% Similarity=0.451 Sum_probs=221.1
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
.|++++.||+|+||+||+|++..+++.||+|++..... ......+.+|+.+++.++||||++++++|.++..+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 69999999999999999999999999999999875432 2345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCC---
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD--- 169 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~--- 169 (671)
||.||+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 99999999998765 5789999999999999999999999999999999999999999999999999753211000
Q ss_pred -----------------------------------------cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHH
Q 005886 170 -----------------------------------------RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITA 208 (671)
Q Consensus 170 -----------------------------------------~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvIL 208 (671)
........+||+.|+|||++.+ ..|+.++|||||||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvil 238 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVIL 238 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEechHHH
Confidence 0001124579999999999987 6799999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCC---HHHHHhchhcccccc
Q 005886 209 LELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPT---AEKLMKHHFFKHARS 282 (671)
Q Consensus 209 yeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpS---a~eiL~Hpwfk~~~~ 282 (671)
|+|++|++||.+..+.+....+... ......+....+++++.+||.+|+ .+|.+|++ +.++++||||+...+
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~ 313 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINW-QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDF 313 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHcc-CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence 9999999999987776655544432 222333344568999999999986 59999997 999999999986543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=397.51 Aligned_cols=263 Identities=27% Similarity=0.435 Sum_probs=220.7
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
.+|++++.||+|+||.||+|++..+|+.||||++..... ......+.+|+.+|+.++||||+++++.|.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 479999999999999999999999999999999864322 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCC--
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD-- 169 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~-- 169 (671)
|||.||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+.....
T Consensus 81 E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 81 DYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 999999999999775 5789999999999999999999999999999999999999999999999999743210000
Q ss_pred --------------------------------------cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHH
Q 005886 170 --------------------------------------RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALEL 211 (671)
Q Consensus 170 --------------------------------------~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeL 211 (671)
........+||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceeeeh
Confidence 0001124589999999999987 6789999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCC---CHHHHHhchhccccc
Q 005886 212 AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRP---TAEKLMKHHFFKHAR 281 (671)
Q Consensus 212 ltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRp---Sa~eiL~Hpwfk~~~ 281 (671)
++|+.||.+....+....+.. ....+..+....++..+.+||.+|+ .+|.+|+ ++.++++||||+...
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVIN-WETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhc-cCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 999999988776655444332 2223333444568999999999977 5999999 999999999998654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=389.37 Aligned_cols=254 Identities=28% Similarity=0.463 Sum_probs=227.4
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LV 90 (671)
..+|++.+.||+|.||.|.+|.....|+.||||.|.+.+.. .++-++++||+||+.|+||||+.+|++|+..+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 46899999999999999999999999999999999887755 4567889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCc
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR 170 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~ 170 (671)
|||..||.|++++... +.++|..++.+++||+.|+.|||.+++||||||.+|||+|.|+++||+||||+..+.+
T Consensus 132 MEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~---- 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD---- 205 (668)
T ss_pred EEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc----
Confidence 9999999999999987 7899999999999999999999999999999999999999999999999999976632
Q ss_pred ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHH
Q 005886 171 QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSF 250 (671)
Q Consensus 171 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l 250 (671)
.....++||+|.|.+||++.|...-++.+|-|||||+||.|+.|..||++.+....+.++-... |.. +.-+..+
T Consensus 206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~Ga-----YrE-P~~PSdA 279 (668)
T KOG0611|consen 206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGA-----YRE-PETPSDA 279 (668)
T ss_pred ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccc-----ccC-CCCCchH
Confidence 3345789999999999999996666899999999999999999999999988766655554432 111 2235678
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHhchhcc
Q 005886 251 KELVTACLVKDPKKRPTAEKLMKHHFFK 278 (671)
Q Consensus 251 ~dLI~~cL~~dP~kRpSa~eiL~Hpwfk 278 (671)
.-||.+||.++|++|.|+++|-.|=|+.
T Consensus 280 ~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 280 SGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred HHHHHHHHhcCcccchhHHHHhhhheee
Confidence 8999999999999999999999998885
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=391.15 Aligned_cols=264 Identities=30% Similarity=0.488 Sum_probs=225.2
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
++|++.+.||+|+||+||+|++..+|+.||||++..... ......+.+|+.++..++||||++++++|.++..+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 479999999999999999999999999999999975432 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC---
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG--- 168 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~--- 168 (671)
||+.||+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 999999999999876 679999999999999999999999999999999999999999999999999987653322
Q ss_pred -----------------------CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHH
Q 005886 169 -----------------------DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK 225 (671)
Q Consensus 169 -----------------------~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~ 225 (671)
..........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 00112334679999999999987 578999999999999999999999998877665
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCC-HHHHHhchhcccccc
Q 005886 226 VLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPT-AEKLMKHHFFKHARS 282 (671)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpS-a~eiL~Hpwfk~~~~ 282 (671)
....+.. ....+..+....+++.+.+||.+||. ||.+||+ ++++|+||||+...+
T Consensus 238 ~~~~i~~-~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~ 293 (350)
T cd05573 238 TYNKIIN-WKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDW 293 (350)
T ss_pred HHHHHhc-cCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCH
Confidence 5544443 11222333344479999999999997 9999999 999999999987544
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=407.07 Aligned_cols=267 Identities=36% Similarity=0.674 Sum_probs=239.5
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
+.|+|+..||.|+||.||+|.++.++-..|.|+|.... ...++.+.-||.||..++||+||++++.|..++.+||++||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks-eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS-EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc-hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 45899999999999999999999999888999987543 55678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS 173 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 173 (671)
|.||-...++-.. ...+.+..|..+++|+|.||.|||+++|||||||.+|||++-+|.|+|+|||+++... .....
T Consensus 111 C~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~---~t~qk 186 (1187)
T KOG0579|consen 111 CGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK---STRQK 186 (1187)
T ss_pred cCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch---hHHhh
Confidence 9999998887765 3679999999999999999999999999999999999999999999999999986542 23345
Q ss_pred cccccCCCCCCChhHhh----hccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHH
Q 005886 174 RNTFVGTPCWMAPEVMQ----QLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 174 ~~~~~GT~~Y~APEvl~----~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
+.+++|||+|||||++. ...+|++++||||||++|.||+.+.+|....+++.++..+....||.+. .+..++..
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLl--qPS~Ws~~ 264 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLL--QPSHWSRS 264 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCccc--CcchhhhH
Confidence 67899999999999974 3367999999999999999999999999999999999999888877664 46788999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHhchhccccccchHHH
Q 005886 250 FKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLA 287 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~~~~~ 287 (671)
|.||+++||.+||..||++.++|+||||..+..+..+.
T Consensus 265 F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK~ir 302 (1187)
T KOG0579|consen 265 FSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSNKMIR 302 (1187)
T ss_pred HHHHHHHHHhcCCccCCCHHHHhhCcccccCCcchHHH
Confidence 99999999999999999999999999999888764443
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=389.59 Aligned_cols=253 Identities=28% Similarity=0.444 Sum_probs=216.8
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccCCC
Q 005886 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGG 97 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~gg 97 (671)
+.||+|+||.||++.+..+|..||+|++..... ......+.+|+.+++.++||||++++++|.....+|+||||+.||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 469999999999999999999999999975432 234566778999999999999999999999999999999999999
Q ss_pred CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccccccc
Q 005886 98 SCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTF 177 (671)
Q Consensus 98 sL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~ 177 (671)
+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .......
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~---~~~~~~~ 155 (323)
T cd05595 81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---GATMKTF 155 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC---CCccccc
Confidence 999888765 57899999999999999999999999999999999999999999999999997643221 1223346
Q ss_pred cCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHh
Q 005886 178 VGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTAC 257 (671)
Q Consensus 178 ~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~c 257 (671)
+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.... ...+..+++++++||.+|
T Consensus 156 ~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~-----~~~p~~~~~~~~~li~~~ 229 (323)
T cd05595 156 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-----IRFPRTLSPEAKSLLAGL 229 (323)
T ss_pred cCCcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----CCCCCCCCHHHHHHHHHH
Confidence 89999999999976 568999999999999999999999998876655544443322 123456899999999999
Q ss_pred hhcCCCCCC-----CHHHHHhchhccccccc
Q 005886 258 LVKDPKKRP-----TAEKLMKHHFFKHARSN 283 (671)
Q Consensus 258 L~~dP~kRp-----Sa~eiL~Hpwfk~~~~~ 283 (671)
|..||.+|+ ++.++++||||....+.
T Consensus 230 L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~ 260 (323)
T cd05595 230 LKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 260 (323)
T ss_pred ccCCHHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence 999999998 89999999999876654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=374.79 Aligned_cols=260 Identities=27% Similarity=0.474 Sum_probs=227.3
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc---cc----HHHHHHHHHHHHhC-CCCCceeeeeEEEeCC
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN---ND----LDGIRREVQTMRVT-NHPNVLRAHCSFTTGH 85 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~---~~----~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~~ 85 (671)
..|.-.+.||.|..++|.++.++.+|..+|+|+|...... .. .+.-++|+.+|+++ .||||+.++++|+++.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 5677788999999999999999999999999999754322 11 34456899999877 6999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
.+++|+|.|..|.|++++... -.++|...+++++|++.|++|||.++||||||||+|||++++.++||+|||+|..+.
T Consensus 97 F~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 999999999999999999887 579999999999999999999999999999999999999999999999999987662
Q ss_pred cCCCcccccccccCCCCCCChhHhh-----hccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCc
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQ-----QLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~-----~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~ 240 (671)
........||||.|.|||.+. +..+|+..+|+|++|||||.|+.|.+||+....+-.+..+++ ....+..
T Consensus 175 ----~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime-GkyqF~s 249 (411)
T KOG0599|consen 175 ----PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME-GKYQFRS 249 (411)
T ss_pred ----CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh-cccccCC
Confidence 223445689999999999985 336799999999999999999999999987666555544444 4556677
Q ss_pred cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 241 ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 241 ~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
+.|..++...++||.+||+.||.+|.|++++|.||||...
T Consensus 250 peWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 250 PEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred cchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 8899999999999999999999999999999999999653
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=389.55 Aligned_cols=253 Identities=29% Similarity=0.465 Sum_probs=216.6
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccCCC
Q 005886 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGG 97 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~gg 97 (671)
+.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.+++.++||||+++++++..+..+|+||||+.||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 368999999999999999999999999975432 234567888999999999999999999999999999999999999
Q ss_pred CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccccccc
Q 005886 98 SCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTF 177 (671)
Q Consensus 98 sL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~ 177 (671)
+|...+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .......
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~---~~~~~~~ 155 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD---AATMKTF 155 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc---ccccccc
Confidence 999888765 57999999999999999999999999999999999999999999999999998643211 1223456
Q ss_pred cCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHh
Q 005886 178 VGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTAC 257 (671)
Q Consensus 178 ~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~c 257 (671)
+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+... ....+..++.++.+||.+|
T Consensus 156 ~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~-----~~~~p~~~~~~~~~li~~~ 229 (328)
T cd05593 156 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----DIKFPRTLSADAKSLLSGL 229 (328)
T ss_pred cCCcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC-----CccCCCCCCHHHHHHHHHH
Confidence 89999999999986 56899999999999999999999999887665544443322 1233556899999999999
Q ss_pred hhcCCCCCC-----CHHHHHhchhccccccc
Q 005886 258 LVKDPKKRP-----TAEKLMKHHFFKHARSN 283 (671)
Q Consensus 258 L~~dP~kRp-----Sa~eiL~Hpwfk~~~~~ 283 (671)
|.+||.+|+ ++.++++||||....+.
T Consensus 230 L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 260 (328)
T cd05593 230 LIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQ 260 (328)
T ss_pred cCCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 999999997 89999999999876543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=383.63 Aligned_cols=262 Identities=32% Similarity=0.510 Sum_probs=219.5
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LV 90 (671)
+..++|++.+.||+|+||.||++.+..+|..||+|++...........+.+|+.+|+.++||||+++++++..++.+|+|
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 45689999999999999999999999999999999997654334456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCcEEEcCCCceEEeccccccccccCCC
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH-GHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~-gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~ 169 (671)
|||+.||+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--- 156 (331)
T cd06649 82 MEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 156 (331)
T ss_pred eecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc---
Confidence 9999999999999775 5689999999999999999999986 699999999999999999999999999865422
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-------------
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP------------- 236 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~------------- 236 (671)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+.. ..+.....
T Consensus 157 --~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 157 --SMANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE-AIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred --cccccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHhcccccccccCCccccCcc
Confidence 12234579999999999987 56899999999999999999999999765443321 11110000
Q ss_pred -------------------------------CCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 237 -------------------------------GLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 237 -------------------------------~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
.........++.++++||.+||.+||++|||+.+||+||||+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 000001124678999999999999999999999999999998654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=394.03 Aligned_cols=268 Identities=28% Similarity=0.438 Sum_probs=226.4
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 86 (671)
..+..++|++.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.+++.++||||++++++|.++..
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 45677899999999999999999999999999999999965322 2234567889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
+|+|||||.||+|..++... .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+..
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999999988653 588999999999999999999999999999999999999999999999999865532
Q ss_pred CCCcccccccccCCCCCCChhHhhhc---cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQL---HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 243 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~---~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (671)
.. .......+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.........+... ...+.++..
T Consensus 195 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~ 271 (370)
T cd05596 195 NG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH-KNSLTFPDD 271 (370)
T ss_pred CC--cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-CCcCCCCCc
Confidence 21 1122456899999999998752 23788999999999999999999999987766555555432 222334444
Q ss_pred ccchHHHHHHHHHhhhcCCCC--CCCHHHHHhchhcccccc
Q 005886 244 KRFSKSFKELVTACLVKDPKK--RPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 244 ~~ls~~l~dLI~~cL~~dP~k--RpSa~eiL~Hpwfk~~~~ 282 (671)
..+|.++++||.+||..+|.+ |++++++++||||+...+
T Consensus 272 ~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~ 312 (370)
T cd05596 272 IEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW 312 (370)
T ss_pred CCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence 568999999999999999988 999999999999986543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=393.97 Aligned_cols=269 Identities=30% Similarity=0.472 Sum_probs=225.2
Q ss_pred ccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC
Q 005886 8 RFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH 85 (671)
Q Consensus 8 ~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~ 85 (671)
++.+..++|++.+.||+|+||.||+|.++.+++.||+|++.+... ......+.+|+.+++.++||||++++++|.++.
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 456677899999999999999999999999999999999865322 223456789999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
.+|+|||||.||+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+.
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 999999999999999998654 58999999999999999999999999999999999999999999999999987553
Q ss_pred cCCCcccccccccCCCCCCChhHhhhcc---CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccc
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLH---GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER 242 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~---~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~ 242 (671)
... .......+||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.........+.... ..+.++.
T Consensus 194 ~~~--~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~-~~~~~p~ 270 (370)
T cd05621 194 ETG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK-NSLNFPE 270 (370)
T ss_pred cCC--ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-cccCCCC
Confidence 221 11224568999999999997532 37889999999999999999999998877666555554432 2233444
Q ss_pred cccchHHHHHHHHHhhhcCCCC--CCCHHHHHhchhcccccc
Q 005886 243 DKRFSKSFKELVTACLVKDPKK--RPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 243 ~~~ls~~l~dLI~~cL~~dP~k--RpSa~eiL~Hpwfk~~~~ 282 (671)
...++..++++|..||..++.+ |+++.++++||||+...+
T Consensus 271 ~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~ 312 (370)
T cd05621 271 DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW 312 (370)
T ss_pred cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence 4567999999999999855543 889999999999987543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=379.31 Aligned_cols=265 Identities=29% Similarity=0.433 Sum_probs=224.5
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCC-ceeeeeEEEeCC-----
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPN-VLRAHCSFTTGH----- 85 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpN-IVkl~~~~~~~~----- 85 (671)
...|+.+++||+|+||+||+|+.+.+|+.||+|++...... ..-....+|+.+|+.+.|+| ||++++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 45688889999999999999999999999999999877542 23356689999999999999 999999999887
Q ss_pred -EEEEEEeccCCCCHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccc
Q 005886 86 -CLWVVMPYMAGGSCLHIMKSAYP--EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSA 162 (671)
Q Consensus 86 -~l~LVmEy~~ggsL~~~l~~~~~--~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~ 162 (671)
.+++||||+.. +|..++..... .+++...++.+++||+.||+|||++||+||||||.||||+.+|.+||+|||+|+
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 89999999964 88888887643 368888999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--CCCc
Q 005886 163 CMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP--GLDY 240 (671)
Q Consensus 163 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~--~~~~ 240 (671)
.+. .........++|.||+|||++.|...|+..+||||+|||++||+++++.|.+....+.+..+..-... .-.|
T Consensus 169 a~~---ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 169 AFS---IPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred Hhc---CCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 552 22334566789999999999999888999999999999999999999999999988877766543211 1111
Q ss_pred c-------------cc----------ccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 241 E-------------RD----------KRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 241 ~-------------~~----------~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
+ .+ +..+....+++.+||+.+|.+|.|+..+|.||||....
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 1 11 12234789999999999999999999999999998764
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=384.74 Aligned_cols=257 Identities=28% Similarity=0.473 Sum_probs=219.7
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCC-CceeeeeEEEeCCEEEEEE
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHP-NVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~Hp-NIVkl~~~~~~~~~l~LVm 91 (671)
+|++++.||+|+||.||+|.+..+++.||||++..... ......+..|+.++..+.|+ +|++++++|...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999975432 23456778899999988765 5888999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
||+.||+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...... .
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~---~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG---G 155 (324)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC---C
Confidence 999999999988765 56899999999999999999999999999999999999999999999999997643211 1
Q ss_pred cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHH
Q 005886 172 RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~ 251 (671)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.... ...+..++.++.
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-----~~~~~~~~~~~~ 229 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-----VSYPKSLSKEAV 229 (324)
T ss_pred CceeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----CCCCCCCCHHHH
Confidence 22335689999999999987 568999999999999999999999999877766555554332 223456889999
Q ss_pred HHHHHhhhcCCCCCCCH-----HHHHhchhcccccc
Q 005886 252 ELVTACLVKDPKKRPTA-----EKLMKHHFFKHARS 282 (671)
Q Consensus 252 dLI~~cL~~dP~kRpSa-----~eiL~Hpwfk~~~~ 282 (671)
+||.+||.+||.+|+++ .++++||||+...+
T Consensus 230 ~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 230 SICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred HHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 99999999999999986 89999999987654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=387.90 Aligned_cols=264 Identities=29% Similarity=0.446 Sum_probs=224.1
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
++|.+.+.||+|+||+||+|.++.+|+.||+|++..... ......+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 579999999999999999999999999999999975432 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
||+.||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+.....
T Consensus 81 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-- 157 (330)
T cd05601 81 EYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-- 157 (330)
T ss_pred CCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc--
Confidence 999999999998765 35699999999999999999999999999999999999999999999999999876532221
Q ss_pred cccccccCCCCCCChhHhhh-----ccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Q 005886 172 RSRNTFVGTPCWMAPEVMQQ-----LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~-----~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (671)
.......||+.|+|||++.. ...++.++|||||||++|+|++|..||........+..+... .....++....+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~ 236 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF-QRFLKFPEDPKV 236 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC-CCccCCCCCCCC
Confidence 12233579999999999873 245788999999999999999999999887766655544432 222334445568
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 247 SKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 247 s~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
+..+.+||.+||. +|.+||++.+++.||||....+
T Consensus 237 ~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~ 271 (330)
T cd05601 237 SSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDW 271 (330)
T ss_pred CHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCH
Confidence 9999999999997 9999999999999999986544
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=383.70 Aligned_cols=262 Identities=40% Similarity=0.720 Sum_probs=238.9
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecc
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYM 94 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~ 94 (671)
-|.++++||+|+||.||+|.|+.+|..+|||.+.. ..+++.+.+|+.+|+.++.|+||++|+.|-....+|||||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV---~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV---DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc---cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 47788999999999999999999999999999864 367889999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccc
Q 005886 95 AGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSR 174 (671)
Q Consensus 95 ~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 174 (671)
..|+..+++... .+.+.|..+..+++..++||+|||...-||||||..|||++.+|..||+|||+|..+. +....+
T Consensus 111 GAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT---DTMAKR 186 (502)
T KOG0574|consen 111 GAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT---DTMAKR 186 (502)
T ss_pred CCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhh---hhHHhh
Confidence 999999999865 4789999999999999999999999999999999999999999999999999987764 445667
Q ss_pred ccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHH
Q 005886 175 NTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELV 254 (671)
Q Consensus 175 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI 254 (671)
++++|||+|||||++.. -+|+.++||||||++..||.-|++||.+..++..++++-.+.|+.+ ..+..+|.++.|||
T Consensus 187 NTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF--~KPE~WS~~F~DFi 263 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTF--KKPEEWSSEFNDFI 263 (502)
T ss_pred CccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCC--CChHhhhhHHHHHH
Confidence 88999999999999997 6799999999999999999999999999999888887777666654 45677899999999
Q ss_pred HHhhhcCCCCCCCHHHHHhchhccccccchHH
Q 005886 255 TACLVKDPKKRPTAEKLMKHHFFKHARSNDFL 286 (671)
Q Consensus 255 ~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~~~~ 286 (671)
++||.++|++|-||.++++|||++++..-+.+
T Consensus 264 ~~CLiK~PE~R~TA~~L~~H~FiknA~g~~I~ 295 (502)
T KOG0574|consen 264 RSCLIKKPEERKTALRLCEHTFIKNAPGCDIM 295 (502)
T ss_pred HHHhcCCHHHHHHHHHHhhhhhhcCCCcccHH
Confidence 99999999999999999999999988765443
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-46 Score=365.78 Aligned_cols=259 Identities=28% Similarity=0.434 Sum_probs=231.5
Q ss_pred ccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q 005886 10 PVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCL 87 (671)
Q Consensus 10 ~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l 87 (671)
....++|++.+.||+|.||.||.|+.+.++-.||+|++.+.... .-...+++|+++-+.|+||||+++|++|.+...+
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri 97 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI 97 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence 34678999999999999999999999999999999999876533 2246789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccC
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~ 167 (671)
|+++||..+|+++..+.......|++...+.|+.|++.||.|||.++++||||||+|+|++..|.+||+|||-+..-
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~--- 174 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA--- 174 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec---
Confidence 99999999999999999766688999999999999999999999999999999999999999999999999987532
Q ss_pred CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccch
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls 247 (671)
....+.+.|||..|.+||+..+ ..++..+|+|++|++.||++.|.+||......+....+... ++..+..++
T Consensus 175 --p~~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~-----~~~~p~~is 246 (281)
T KOG0580|consen 175 --PSNKRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV-----DLKFPSTIS 246 (281)
T ss_pred --CCCCceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc-----cccCCcccC
Confidence 2345678899999999999988 67999999999999999999999999887765555555442 344467899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHhchhccc
Q 005886 248 KSFKELVTACLVKDPKKRPTAEKLMKHHFFKH 279 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~ 279 (671)
.+++|+|.+||.++|.+|++..+++.|||+..
T Consensus 247 ~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 247 GGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred hhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 99999999999999999999999999999964
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=385.04 Aligned_cols=255 Identities=26% Similarity=0.439 Sum_probs=216.9
Q ss_pred eEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHH---HhCCCCCceeeeeEEEeCCEEEEE
Q 005886 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTM---RVTNHPNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 16 Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL---~~L~HpNIVkl~~~~~~~~~l~LV 90 (671)
|++++.||+|+||.||+|.+..+|+.||||++..... ....+.+.+|+.++ +.++||||++++++|.....+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 7899999999999999999999999999999975431 23356677777665 466899999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCc
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR 170 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~ 170 (671)
|||+.||+|...+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~--- 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF--- 154 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC---
Confidence 999999999888754 46999999999999999999999999999999999999999999999999997643221
Q ss_pred ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHH
Q 005886 171 QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSF 250 (671)
Q Consensus 171 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l 250 (671)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+..... ..+..++..+
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~-----~~p~~~~~~~ 228 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV-----RYPRFLSREA 228 (324)
T ss_pred CCcccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----CCCCCCCHHH
Confidence 122345689999999999987 5689999999999999999999999998776665554444321 2345678999
Q ss_pred HHHHHHhhhcCCCCCC-----CHHHHHhchhcccccc
Q 005886 251 KELVTACLVKDPKKRP-----TAEKLMKHHFFKHARS 282 (671)
Q Consensus 251 ~dLI~~cL~~dP~kRp-----Sa~eiL~Hpwfk~~~~ 282 (671)
.+||.+||..||.+|| ++.++++||||+...+
T Consensus 229 ~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~ 265 (324)
T cd05589 229 ISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW 265 (324)
T ss_pred HHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence 9999999999999999 7999999999987654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=385.88 Aligned_cols=253 Identities=29% Similarity=0.483 Sum_probs=216.2
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEEEeccCC
Q 005886 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVT-NHPNVLRAHCSFTTGHCLWVVMPYMAG 96 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~~~l~LVmEy~~g 96 (671)
+.||+|+||+||+|+++.+++.||||++..... ......+..|+.++..+ +||||++++++|...+.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 468999999999999999999999999875432 23456677888888766 799999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccccc
Q 005886 97 GSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNT 176 (671)
Q Consensus 97 gsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~ 176 (671)
|+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ......
T Consensus 81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~---~~~~~~ 155 (320)
T cd05590 81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN---GKTTST 155 (320)
T ss_pred chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC---CCcccc
Confidence 9999988765 57999999999999999999999999999999999999999999999999998643211 122345
Q ss_pred ccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHH
Q 005886 177 FVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTA 256 (671)
Q Consensus 177 ~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~ 256 (671)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+..... ..+..++.++++||.+
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~-----~~~~~~~~~~~~li~~ 229 (320)
T cd05590 156 FCGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-----VYPTWLSQDAVDILKA 229 (320)
T ss_pred cccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-----CCCCCCCHHHHHHHHH
Confidence 689999999999986 5689999999999999999999999998877666555544322 2244578999999999
Q ss_pred hhhcCCCCCCCH------HHHHhchhccccccc
Q 005886 257 CLVKDPKKRPTA------EKLMKHHFFKHARSN 283 (671)
Q Consensus 257 cL~~dP~kRpSa------~eiL~Hpwfk~~~~~ 283 (671)
||.+||.+||++ +++++||||+...+.
T Consensus 230 ~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~ 262 (320)
T cd05590 230 FMTKNPTMRLGSLTLGGEEAILRHPFFKELDWE 262 (320)
T ss_pred HcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHH
Confidence 999999999998 999999999876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=391.25 Aligned_cols=265 Identities=26% Similarity=0.452 Sum_probs=222.3
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
++|++.+.||+|+||.||+|.++.+|+.||+|++..... ......+.+|+.++..++||||++++++|.++..+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 479999999999999999999999999999999975332 234577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCC--
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD-- 169 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~-- 169 (671)
|||.||+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+.....
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 999999999998765 5799999999999999999999999999999999999999999999999999864421100
Q ss_pred ------------------------------cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCC
Q 005886 170 ------------------------------RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFS 219 (671)
Q Consensus 170 ------------------------------~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~ 219 (671)
........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCCCC
Confidence 0001124589999999999987 679999999999999999999999998
Q ss_pred CCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCC---CHHHHHhchhccccccc
Q 005886 220 KYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRP---TAEKLMKHHFFKHARSN 283 (671)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRp---Sa~eiL~Hpwfk~~~~~ 283 (671)
+.........+... ...+.++....++.++++||.+|+ .||.+|+ ++.+++.||||+...+.
T Consensus 238 ~~~~~~~~~~i~~~-~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~ 302 (360)
T cd05627 238 SETPQETYRKVMNW-KETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVDWG 302 (360)
T ss_pred CCCHHHHHHHHHcC-CCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCCHH
Confidence 87776655544432 222223333347899999999987 5999998 48999999999977654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=384.08 Aligned_cols=260 Identities=28% Similarity=0.433 Sum_probs=215.6
Q ss_pred CeEEEEEecccCceEEEEEEEc---CCCcEEEEEEeccccC---cccHHHHHHHHHHHHhC-CCCCceeeeeEEEeCCEE
Q 005886 15 DYRLYEEVGEGVSATVYRALCI---PLNEIVAIKVLDLEKC---NNDLDGIRREVQTMRVT-NHPNVLRAHCSFTTGHCL 87 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~---~tg~~VAIKvi~~~~~---~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~~~l 87 (671)
+|++++.||+|+||.||++++. .+|+.||+|++..... ......+.+|+.+++.+ +||||++++++|..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999998864 5789999999865322 23356778899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccC
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~ 167 (671)
|+||||+.||+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+...
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 9999999999999998765 57999999999999999999999999999999999999999999999999998754322
Q ss_pred CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCCCCccccc
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPP---MKVLLMTLQNAPPGLDYERDK 244 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~---~~~~~~~~~~~~~~~~~~~~~ 244 (671)
.. ......+||+.|+|||++.+...++.++|||||||++|+|++|..||..... ...+...+... ....+.
T Consensus 159 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~ 232 (332)
T cd05614 159 EK--ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC----DPPFPS 232 (332)
T ss_pred CC--CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC----CCCCCC
Confidence 21 1223468999999999998755688999999999999999999999964322 22222222222 223345
Q ss_pred cchHHHHHHHHHhhhcCCCCCC-----CHHHHHhchhcccccc
Q 005886 245 RFSKSFKELVTACLVKDPKKRP-----TAEKLMKHHFFKHARS 282 (671)
Q Consensus 245 ~ls~~l~dLI~~cL~~dP~kRp-----Sa~eiL~Hpwfk~~~~ 282 (671)
.++..+++||.+||..||.+|| +++++++||||+...+
T Consensus 233 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 275 (332)
T cd05614 233 FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW 275 (332)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 6889999999999999999999 8899999999986543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=401.45 Aligned_cols=261 Identities=27% Similarity=0.379 Sum_probs=211.7
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeC-------
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG------- 84 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~------- 84 (671)
..++|++++.||+|+||.||+|.+..+++.||||++.... ....+|+.+|+.++||||++++++|...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 4568999999999999999999999999999999885332 3345799999999999999999887542
Q ss_pred -CEEEEEEeccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC-ceEEecccc
Q 005886 85 -HCLWVVMPYMAGGSCLHIMKSA--YPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG-AIKLADFGV 160 (671)
Q Consensus 85 -~~l~LVmEy~~ggsL~~~l~~~--~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g-~vKL~DFGl 160 (671)
..+++||||+.+ +|..++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 257899999975 676666432 235689999999999999999999999999999999999998665 799999999
Q ss_pred ccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---
Q 005886 161 SACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG--- 237 (671)
Q Consensus 161 s~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~--- 237 (671)
|+.+... ......+||+.|+|||++.+...|+.++|||||||++|+|++|.+||.+....+.+..+++.....
T Consensus 218 a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 218 AKNLLAG----QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred chhccCC----CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 8765321 122346889999999999875679999999999999999999999999877666555444321100
Q ss_pred ---------------------CCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 238 ---------------------LDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 238 ---------------------~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
+....+...+.++.+||.+||.+||.+|||+.++|.||||.....
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 001112346789999999999999999999999999999987554
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=372.42 Aligned_cols=258 Identities=28% Similarity=0.376 Sum_probs=210.0
Q ss_pred CCeEEEEEecccCceEEEEEEEcC-CCcEEEEEEeccccCcc-cHHHHHHHHHHHHhC---CCCCceeeeeEEE-----e
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIP-LNEIVAIKVLDLEKCNN-DLDGIRREVQTMRVT---NHPNVLRAHCSFT-----T 83 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~-tg~~VAIKvi~~~~~~~-~~~~i~~Ei~iL~~L---~HpNIVkl~~~~~-----~ 83 (671)
++|++.+.||+|+||+||+|.+.. +|..||+|++....... ....+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999865 46889999987544322 234566777777665 6999999999885 3
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccc
Q 005886 84 GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSAC 163 (671)
Q Consensus 84 ~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~ 163 (671)
...+++||||+. ++|..++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 456999999996 5888888766556689999999999999999999999999999999999999999999999999865
Q ss_pred cccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--Cc-
Q 005886 164 MFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL--DY- 240 (671)
Q Consensus 164 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~--~~- 240 (671)
.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+.+..++....... .+
T Consensus 160 ~~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 160 YSFQ----MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred ccCC----cccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 4221 22345679999999999976 5689999999999999999999999998877666555543211000 00
Q ss_pred -------------------cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 241 -------------------ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 241 -------------------~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
.....++..+++||.+||+.||++|||+.++|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0113467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=379.49 Aligned_cols=278 Identities=28% Similarity=0.448 Sum_probs=246.0
Q ss_pred ccccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEe
Q 005886 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTT 83 (671)
Q Consensus 6 e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~ 83 (671)
..+-.+..++|..++.||+|.||.|.+++.+.+|+.||||+++++.. ..++.+-..|-++|+..+||.+..+..+|..
T Consensus 160 ~~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt 239 (516)
T KOG0690|consen 160 KRKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT 239 (516)
T ss_pred cccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc
Confidence 45567788999999999999999999999999999999999987653 2456777889999999999999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccc
Q 005886 84 GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSAC 163 (671)
Q Consensus 84 ~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~ 163 (671)
.+.+|+||||..||.|+..+... ..|+|+..+.+-.+|+.||.|||+++||+||||.+|+|+|.+|++||+|||+++.
T Consensus 240 ~drlCFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE 317 (516)
T KOG0690|consen 240 QDRLCFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKE 317 (516)
T ss_pred CceEEEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchh
Confidence 99999999999999999888776 7899999999999999999999999999999999999999999999999999864
Q ss_pred cccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 005886 164 MFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 243 (671)
Q Consensus 164 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (671)
-... .....++||||.|.|||++.. ..|+.++|.|.+||++|||+||+.||...+..+.+..++.. +..++
T Consensus 318 ~I~~---g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e-----d~kFP 388 (516)
T KOG0690|consen 318 EIKY---GDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME-----DLKFP 388 (516)
T ss_pred cccc---cceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-----hccCC
Confidence 4332 345678999999999999987 78999999999999999999999999998887766665544 33456
Q ss_pred ccchHHHHHHHHHhhhcCCCCCCC-----HHHHHhchhccccccchHHHHHHhhhc
Q 005886 244 KRFSKSFKELVTACLVKDPKKRPT-----AEKLMKHHFFKHARSNDFLARSIVDNL 294 (671)
Q Consensus 244 ~~ls~~l~dLI~~cL~~dP~kRpS-----a~eiL~Hpwfk~~~~~~~~~~~l~~~l 294 (671)
..++++++.|+..+|.+||.+|+. +.+|.+|+||..+.|.+...+.+...+
T Consensus 389 r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPf 444 (516)
T KOG0690|consen 389 RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPF 444 (516)
T ss_pred ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCC
Confidence 789999999999999999999974 899999999999998877766554433
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=388.80 Aligned_cols=259 Identities=29% Similarity=0.471 Sum_probs=220.9
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcCCCcE-EEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeC
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEI-VAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTG 84 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~-VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~ 84 (671)
..+.++..+..+.+.||.|+||+||+|.+. |.. ||||++...... .....+.+|+.+|.+++|||||+++|++.+.
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP 111 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 346777888888889999999999999987 555 999999754422 2267899999999999999999999999998
Q ss_pred C-EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccccCCCCcEEEcCCC-ceEEeccccc
Q 005886 85 H-CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHG-HIHRDVKAGNILIDSNG-AIKLADFGVS 161 (671)
Q Consensus 85 ~-~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~g-IVHrDLKPeNILld~~g-~vKL~DFGls 161 (671)
. .++|||||+.+|+|.+++.......++...+..++.||+.|+.|||+++ ||||||||+|||++.++ ++||+|||++
T Consensus 112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence 7 7999999999999999998744478999999999999999999999999 99999999999999998 9999999999
Q ss_pred cccccCCCcccccccccCCCCCCChhHhhh-ccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCc
Q 005886 162 ACMFDAGDRQRSRNTFVGTPCWMAPEVMQQ-LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240 (671)
Q Consensus 162 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~-~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~ 240 (671)
+...... ...+...||+.|||||++.+ ...|+.|+|||||||+||||+||..||.+..+.........+.. ..
T Consensus 192 r~~~~~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~---Rp 265 (362)
T KOG0192|consen 192 REKVISK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGL---RP 265 (362)
T ss_pred eeecccc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC---CC
Confidence 7664322 23334789999999999995 25799999999999999999999999999888665555543322 22
Q ss_pred cccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 241 ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 241 ~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
..+..+++.+..||..||..||.+||++.+|+.
T Consensus 266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 234458999999999999999999999999865
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=386.03 Aligned_cols=253 Identities=28% Similarity=0.452 Sum_probs=215.5
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccCCC
Q 005886 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGG 97 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~gg 97 (671)
+.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.+++.++||||++++++|.....+|+||||+.||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 468999999999999999999999999975432 233566778999999999999999999999999999999999999
Q ss_pred CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccccc
Q 005886 98 SCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF-HGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNT 176 (671)
Q Consensus 98 sL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs-~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~ 176 (671)
+|..++... ..+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||++....... .....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~---~~~~~ 155 (325)
T cd05594 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG---ATMKT 155 (325)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC---ccccc
Confidence 999888765 578999999999999999999997 799999999999999999999999999986432211 12334
Q ss_pred ccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHH
Q 005886 177 FVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTA 256 (671)
Q Consensus 177 ~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~ 256 (671)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.... ...+..+++++.+||.+
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~-----~~~p~~~~~~~~~li~~ 229 (325)
T cd05594 156 FCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-----IRFPRTLSPEAKSLLSG 229 (325)
T ss_pred ccCCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC-----CCCCCCCCHHHHHHHHH
Confidence 679999999999987 568999999999999999999999998876655544433321 22345688999999999
Q ss_pred hhhcCCCCCC-----CHHHHHhchhccccccc
Q 005886 257 CLVKDPKKRP-----TAEKLMKHHFFKHARSN 283 (671)
Q Consensus 257 cL~~dP~kRp-----Sa~eiL~Hpwfk~~~~~ 283 (671)
||..||.+|+ ++.++++||||....+.
T Consensus 230 ~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 261 (325)
T cd05594 230 LLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ 261 (325)
T ss_pred HhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence 9999999997 89999999999876543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=382.78 Aligned_cols=252 Identities=32% Similarity=0.514 Sum_probs=215.6
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEEEeccCC
Q 005886 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVT-NHPNVLRAHCSFTTGHCLWVVMPYMAG 96 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~~~l~LVmEy~~g 96 (671)
+.||+|+||.||+|.++.+|+.||||++..... ......+..|..++..+ +||||++++++|...+.+|+||||+.|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 368999999999999999999999999875432 23455677888888765 899999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccccc
Q 005886 97 GSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNT 176 (671)
Q Consensus 97 gsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~ 176 (671)
|+|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....... .....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~---~~~~~ 155 (321)
T cd05591 81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG---VTTTT 155 (321)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC---ccccc
Confidence 9999988765 578999999999999999999999999999999999999999999999999986432211 22345
Q ss_pred ccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHH
Q 005886 177 FVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTA 256 (671)
Q Consensus 177 ~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~ 256 (671)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.... ...+..++.++.+||.+
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~-----~~~p~~~~~~~~~ll~~ 229 (321)
T cd05591 156 FCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD-----VLYPVWLSKEAVSILKA 229 (321)
T ss_pred cccCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-----CCCCCCCCHHHHHHHHH
Confidence 689999999999986 568999999999999999999999999887766665554432 12244578999999999
Q ss_pred hhhcCCCCCC-------CHHHHHhchhcccccc
Q 005886 257 CLVKDPKKRP-------TAEKLMKHHFFKHARS 282 (671)
Q Consensus 257 cL~~dP~kRp-------Sa~eiL~Hpwfk~~~~ 282 (671)
||.+||.+|| ++.++++||||....+
T Consensus 230 ~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~ 262 (321)
T cd05591 230 FMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDW 262 (321)
T ss_pred HhccCHHHcCCCCCCCCCHHHHhcCCccCCCCH
Confidence 9999999999 9999999999986654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=381.78 Aligned_cols=258 Identities=28% Similarity=0.464 Sum_probs=219.8
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEEE
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVT-NHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~~~l~LVm 91 (671)
+|++.+.||+|+||.||+|.+..+++.||||++..... ......+..|..++..+ +|++|+++++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 68999999999999999999999999999999975432 22345567788888776 5899999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
||+.||+|...+... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~---~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD---G 155 (323)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC---C
Confidence 999999999988765 57999999999999999999999999999999999999999999999999998643211 1
Q ss_pred cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHH
Q 005886 172 RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~ 251 (671)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.... ...+..++.++.
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-----~~~p~~~s~~~~ 229 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-----VAYPKSMSKEAV 229 (323)
T ss_pred CccccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----CCCCCcCCHHHH
Confidence 22345689999999999987 679999999999999999999999999887766655554432 123456899999
Q ss_pred HHHHHhhhcCCCCCCC-----HHHHHhchhccccccc
Q 005886 252 ELVTACLVKDPKKRPT-----AEKLMKHHFFKHARSN 283 (671)
Q Consensus 252 dLI~~cL~~dP~kRpS-----a~eiL~Hpwfk~~~~~ 283 (671)
+||.+||.+||.+|++ ..++++||||+...+.
T Consensus 230 ~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~ 266 (323)
T cd05616 230 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 266 (323)
T ss_pred HHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 9999999999999998 4899999999876553
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=388.65 Aligned_cols=260 Identities=28% Similarity=0.445 Sum_probs=233.6
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcc-cHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-DLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~-~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
..-|.+.+.||+|.|++|.+|+|.=||..||||+|++.+... ....+.+|++.|+.+.|||||++|++..+...+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 356899999999999999999999999999999999877553 4578899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEE-cCCCceEEeccccccccccCCCc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILI-DSNGAIKLADFGVSACMFDAGDR 170 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILl-d~~g~vKL~DFGls~~~~~~~~~ 170 (671)
|+-.||+|+++|-+. ..++.|..+.+|++||+.|+.|||...+|||||||+||++ ..-|-|||+|||++..+. .
T Consensus 97 ELGD~GDl~DyImKH-e~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~----P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKH-EEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ----P 171 (864)
T ss_pred EecCCchHHHHHHhh-hccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC----C
Confidence 999999999998765 3789999999999999999999999999999999999976 456899999999987653 2
Q ss_pred ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHH
Q 005886 171 QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSF 250 (671)
Q Consensus 171 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l 250 (671)
.....+.||+..|-|||++.|....-+++||||||||||.|+||++||...++-+.+.+++.. .|..+..++.+.
T Consensus 172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDC-----KYtvPshvS~eC 246 (864)
T KOG4717|consen 172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDC-----KYTVPSHVSKEC 246 (864)
T ss_pred cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcc-----cccCchhhhHHH
Confidence 344567899999999999999654557899999999999999999999999988888877654 466788899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 251 KELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 251 ~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
++||..||..||.+|.+.++|..|+|++....
T Consensus 247 rdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 247 RDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred HHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 99999999999999999999999999997654
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=375.60 Aligned_cols=265 Identities=26% Similarity=0.383 Sum_probs=218.5
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
..++|++.+.||+|+||.||+|.++.+++.||+|.+...........+.+|+.+++.++||||+++++++..+..+|+||
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 45789999999999999999999999999999999976554444456778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
||+.+ +|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 84 e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~---~ 158 (309)
T cd07872 84 EYLDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP---T 158 (309)
T ss_pred eCCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC---c
Confidence 99975 777777654 245889999999999999999999999999999999999999999999999998643221 1
Q ss_pred cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-------------
Q 005886 172 RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL------------- 238 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~------------- 238 (671)
.......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+....+........
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 1223457899999999987656689999999999999999999999987766554433332111000
Q ss_pred ---C---------ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 239 ---D---------YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 239 ---~---------~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
. ......++.++++||.+||..||.+|||+.++|+||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 0 011235688999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=382.03 Aligned_cols=253 Identities=28% Similarity=0.467 Sum_probs=215.7
Q ss_pred EEecccCceEEEEEEEc---CCCcEEEEEEeccccC---cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 20 EEVGEGVSATVYRALCI---PLNEIVAIKVLDLEKC---NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~---~tg~~VAIKvi~~~~~---~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
+.||+|+||.||++++. .+++.||+|++..... ......+.+|+.+|+.++||||++++++|..++.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999864 5788999999875432 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS 173 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 173 (671)
+.||+|..++... +.+.+..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...... ..
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~ 156 (323)
T cd05584 82 LSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG---TV 156 (323)
T ss_pred CCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC---Cc
Confidence 9999999998765 578899999999999999999999999999999999999999999999999986432211 22
Q ss_pred cccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHH
Q 005886 174 RNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL 253 (671)
Q Consensus 174 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dL 253 (671)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.... ...+..++..+.+|
T Consensus 157 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l 230 (323)
T cd05584 157 THTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK-----LNLPPYLTPEARDL 230 (323)
T ss_pred ccccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-----CCCCCCCCHHHHHH
Confidence 334689999999999987 568899999999999999999999999877766555554432 23345678999999
Q ss_pred HHHhhhcCCCCCC-----CHHHHHhchhccccccc
Q 005886 254 VTACLVKDPKKRP-----TAEKLMKHHFFKHARSN 283 (671)
Q Consensus 254 I~~cL~~dP~kRp-----Sa~eiL~Hpwfk~~~~~ 283 (671)
|.+||.+||.+|| ++.+++.||||....+.
T Consensus 231 i~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~ 265 (323)
T cd05584 231 LKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWD 265 (323)
T ss_pred HHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 9999999999999 89999999999876543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=372.51 Aligned_cols=263 Identities=25% Similarity=0.361 Sum_probs=218.8
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
.|++.+.||+|+||.||++.+..+++.||+|++...... .....+.+|+.+++.++||||+++++.+..+..+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 489999999999999999999999999999998654322 223456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
|+.||+|..++.......+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..+.. ..
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~----~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE----GE 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC----CC
Confidence 99999999888655445699999999999999999999999999999999999999999999999999865421 11
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHH
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKE 252 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~d 252 (671)
.....+|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+............... ......+..++..+.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVK-EDQEEYSEKFSEAARS 234 (285)
T ss_pred ccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhh-hcccccCcccCHHHHH
Confidence 2234589999999999986 5689999999999999999999999987654332222211111 1122234568899999
Q ss_pred HHHHhhhcCCCCCC-----CHHHHHhchhccccccc
Q 005886 253 LVTACLVKDPKKRP-----TAEKLMKHHFFKHARSN 283 (671)
Q Consensus 253 LI~~cL~~dP~kRp-----Sa~eiL~Hpwfk~~~~~ 283 (671)
||.+||..||.+|| +++++++||||....+.
T Consensus 235 li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05605 235 ICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK 270 (285)
T ss_pred HHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence 99999999999999 89999999999876554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=381.65 Aligned_cols=253 Identities=28% Similarity=0.490 Sum_probs=211.7
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEEEeccCC
Q 005886 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVT-NHPNVLRAHCSFTTGHCLWVVMPYMAG 96 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~~~l~LVmEy~~g 96 (671)
+.||+|+||.||+|.+..+++.||||++..... ......+.+|..++..+ +||||++++++|.+...+|+|||||.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 468999999999999999999999999976432 23456788999999888 799999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccccc
Q 005886 97 GSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNT 176 (671)
Q Consensus 97 gsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~ 176 (671)
|+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....+ .....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~---~~~~~ 155 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG---DTTST 155 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC---Ccccc
Confidence 9999888765 679999999999999999999999999999999999999999999999999986432211 22345
Q ss_pred ccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHhcCCCCCCccccccchH
Q 005886 177 FVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYP--------PMKVLLMTLQNAPPGLDYERDKRFSK 248 (671)
Q Consensus 177 ~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~--------~~~~~~~~~~~~~~~~~~~~~~~ls~ 248 (671)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ..+.....+.... ...+..++.
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~----~~~p~~~~~ 230 (329)
T cd05588 156 FCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ----IRIPRSLSV 230 (329)
T ss_pred ccCCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC----CCCCCCCCH
Confidence 689999999999987 678999999999999999999999996321 1122222232222 223456889
Q ss_pred HHHHHHHHhhhcCCCCCCC------HHHHHhchhcccccc
Q 005886 249 SFKELVTACLVKDPKKRPT------AEKLMKHHFFKHARS 282 (671)
Q Consensus 249 ~l~dLI~~cL~~dP~kRpS------a~eiL~Hpwfk~~~~ 282 (671)
.+.+||.+||..||.+|++ ++++++||||....+
T Consensus 231 ~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~ 270 (329)
T cd05588 231 KASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270 (329)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 9999999999999999987 789999999976543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=379.55 Aligned_cols=252 Identities=30% Similarity=0.504 Sum_probs=212.4
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHh-CCCCCceeeeeEEEeCCEEEEEEeccCC
Q 005886 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRV-TNHPNVLRAHCSFTTGHCLWVVMPYMAG 96 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~-L~HpNIVkl~~~~~~~~~l~LVmEy~~g 96 (671)
+.||+|+||.||+|.+..+++.||||++..... ......+..|..++.. .+||||+++++++..+..+|+||||+.|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999975432 2334555667777764 5899999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccccc
Q 005886 97 GSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNT 176 (671)
Q Consensus 97 gsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~ 176 (671)
|+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .....
T Consensus 81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---~~~~~ 155 (316)
T cd05592 81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---GKAST 155 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC---Ccccc
Confidence 9999988765 579999999999999999999999999999999999999999999999999986542211 23345
Q ss_pred ccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHH
Q 005886 177 FVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTA 256 (671)
Q Consensus 177 ~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~ 256 (671)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+... .+ ..+..++.++.+||.+
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~----~~~~~~~~~~~~ll~~ 229 (316)
T cd05592 156 FCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND-RP----HFPRWISKEAKDCLSK 229 (316)
T ss_pred ccCCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CC----CCCCCCCHHHHHHHHH
Confidence 689999999999987 56899999999999999999999999988776655544332 22 2245678999999999
Q ss_pred hhhcCCCCCCCH-HHHHhchhcccccc
Q 005886 257 CLVKDPKKRPTA-EKLMKHHFFKHARS 282 (671)
Q Consensus 257 cL~~dP~kRpSa-~eiL~Hpwfk~~~~ 282 (671)
||..||.+||++ .+++.||||....+
T Consensus 230 ~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05592 230 LFERDPTKRLGVDGDIRQHPFFRGIDW 256 (316)
T ss_pred HccCCHHHcCCChHHHHcCcccCCCCH
Confidence 999999999986 58889999986544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=387.08 Aligned_cols=268 Identities=29% Similarity=0.456 Sum_probs=224.1
Q ss_pred ccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC
Q 005886 8 RFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH 85 (671)
Q Consensus 8 ~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~ 85 (671)
...+..++|++.+.||+|+||.||+|.++.+++.||+|++..... ......+.+|+.+++.++||||+++++++.++.
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 356677999999999999999999999999999999999864322 223456788999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
.+|+|||||.||+|..++... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+.
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 999999999999999998754 58999999999999999999999999999999999999999999999999987653
Q ss_pred cCCCcccccccccCCCCCCChhHhhhcc---CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccc
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLH---GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER 242 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~---~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~ 242 (671)
..+ .......+||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+.......+... ...+.++.
T Consensus 194 ~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 270 (371)
T cd05622 194 KEG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH-KNSLTFPD 270 (371)
T ss_pred cCC--cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCcccCCC
Confidence 221 11224568999999999997532 3788999999999999999999999987766655555433 22333444
Q ss_pred cccchHHHHHHHHHhhhcCCCC--CCCHHHHHhchhccccc
Q 005886 243 DKRFSKSFKELVTACLVKDPKK--RPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 243 ~~~ls~~l~dLI~~cL~~dP~k--RpSa~eiL~Hpwfk~~~ 281 (671)
...++..+++||.+||..++.+ |++++++++||||+...
T Consensus 271 ~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 271 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 5578999999999999844433 78999999999998644
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=376.90 Aligned_cols=259 Identities=28% Similarity=0.432 Sum_probs=217.0
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeC-----CEEEE
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG-----HCLWV 89 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~-----~~l~L 89 (671)
.|+-.+.+|.|+||.||+|....+++.||||.+..+.. .-.+|+++|+.++|||||++..+|... -++.+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 47888999999999999999999999999999865542 224899999999999999998888642 25678
Q ss_pred EEeccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCC-CceEEecccccccccc
Q 005886 90 VMPYMAGGSCLHIMKSA--YPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSN-GAIKLADFGVSACMFD 166 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~--~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~-g~vKL~DFGls~~~~~ 166 (671)
|||||+. +|..+++.. ....++.-.++-++.||++||+|||++||+||||||.|+|+|.+ |.+||||||.|+++..
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 9999964 888888742 13568888899999999999999999999999999999999987 8999999999988743
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-----------
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP----------- 235 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~----------- 235 (671)
.. ...++..|+.|+|||++.|...|+.+.||||.||++.||+.|++.|.|.+..+++..+++-..
T Consensus 179 ~e----pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 179 GE----PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred CC----CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 22 234568899999999999999999999999999999999999999999888777665543211
Q ss_pred --------CCCCc-----cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccccc
Q 005886 236 --------PGLDY-----ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSN 283 (671)
Q Consensus 236 --------~~~~~-----~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~ 283 (671)
+.+.. -....+++++.+|+.++|..+|.+|.++.++|.||||+..+..
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 00000 0234568899999999999999999999999999999977654
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=379.54 Aligned_cols=252 Identities=27% Similarity=0.462 Sum_probs=212.4
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHh-CCCCCceeeeeEEEeCCEEEEEEeccCC
Q 005886 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRV-TNHPNVLRAHCSFTTGHCLWVVMPYMAG 96 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~-L~HpNIVkl~~~~~~~~~l~LVmEy~~g 96 (671)
+.||+|+||.||+|.++.+|+.||+|++..... ......+..|..++.. ++||||++++++|.+++.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999999999999999975432 2345566778888865 5899999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccccc
Q 005886 97 GSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNT 176 (671)
Q Consensus 97 gsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~ 176 (671)
|+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~ 155 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG---DNRAST 155 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC---CCceec
Confidence 9999988765 57899999999999999999999999999999999999999999999999997643111 122345
Q ss_pred ccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHH
Q 005886 177 FVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTA 256 (671)
Q Consensus 177 ~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~ 256 (671)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.... + ..+..++.++++||.+
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~-~----~~~~~~~~~~~~li~~ 229 (316)
T cd05620 156 FCGTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT-P----HYPRWITKESKDILEK 229 (316)
T ss_pred cCCCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-C----CCCCCCCHHHHHHHHH
Confidence 689999999999987 568999999999999999999999998877655544443322 2 2234578999999999
Q ss_pred hhhcCCCCCCCH-HHHHhchhcccccc
Q 005886 257 CLVKDPKKRPTA-EKLMKHHFFKHARS 282 (671)
Q Consensus 257 cL~~dP~kRpSa-~eiL~Hpwfk~~~~ 282 (671)
||..||.+||++ +++++||||+...+
T Consensus 230 ~l~~dP~~R~~~~~~~~~h~~f~~~~~ 256 (316)
T cd05620 230 LFERDPTRRLGVVGNIRGHPFFKTINW 256 (316)
T ss_pred HccCCHHHcCCChHHHHcCCCcCCCCH
Confidence 999999999997 58889999986543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=370.25 Aligned_cols=257 Identities=26% Similarity=0.384 Sum_probs=210.9
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccCCCCH
Q 005886 22 VGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSC 99 (671)
Q Consensus 22 LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~ggsL 99 (671)
||+|+||+||+|.++.+|+.||+|++...... .....+..|+.+++.++||||++++++|..+..+|+||||+.||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999998754322 2345677899999999999999999999999999999999999999
Q ss_pred HHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccccccc
Q 005886 100 LHIMKSA--YPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTF 177 (671)
Q Consensus 100 ~~~l~~~--~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~ 177 (671)
...+... ....+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++..+... .......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~---~~~~~~~ 157 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG---QSKTKGY 157 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC---Ccccccc
Confidence 8877432 2246899999999999999999999999999999999999999999999999998654221 1123346
Q ss_pred cCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHh
Q 005886 178 VGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTAC 257 (671)
Q Consensus 178 ~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~c 257 (671)
.||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.................. .....+..++..+.+|+.+|
T Consensus 158 ~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~ 235 (280)
T cd05608 158 AGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILN-DSVTYPDKFSPASKSFCEAL 235 (280)
T ss_pred CCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcc-cCCCCcccCCHHHHHHHHHH
Confidence 89999999999987 56899999999999999999999999765432111111111111 11223456899999999999
Q ss_pred hhcCCCCCC-----CHHHHHhchhccccccc
Q 005886 258 LVKDPKKRP-----TAEKLMKHHFFKHARSN 283 (671)
Q Consensus 258 L~~dP~kRp-----Sa~eiL~Hpwfk~~~~~ 283 (671)
|..||.+|| +++++++||||+...+.
T Consensus 236 l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~ 266 (280)
T cd05608 236 LAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR 266 (280)
T ss_pred hcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence 999999999 88999999999876554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=367.34 Aligned_cols=257 Identities=28% Similarity=0.374 Sum_probs=208.5
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcc-cHHHHHHHHHHHHhC---CCCCceeeeeEEEe-----CC
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-DLDGIRREVQTMRVT---NHPNVLRAHCSFTT-----GH 85 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~-~~~~i~~Ei~iL~~L---~HpNIVkl~~~~~~-----~~ 85 (671)
+|++.+.||+|+||+||+|.++.+|+.||+|.+....... ....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5899999999999999999999999999999987543222 233456777777655 79999999998864 34
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
.+++||||+.+ +|..++.......+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 68999999975 88888876555569999999999999999999999999999999999999999999999999986542
Q ss_pred cCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCC----
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP--PGLD---- 239 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~--~~~~---- 239 (671)
. ........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+......+..+..... ....
T Consensus 160 ~----~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 160 C----QMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred C----cccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 1 112234578999999999986 5689999999999999999999999987766554443332110 0000
Q ss_pred ----------------ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 240 ----------------YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 240 ----------------~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
......++..+++||.+||.+||.+|||+.++|.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 01123567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=359.65 Aligned_cols=264 Identities=63% Similarity=1.115 Sum_probs=230.1
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
++|++.+.||.|+||+||+|.+..++..||+|++...........+.+|+.+++.++|+||+++++.+..++.+|+||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 57999999999999999999999999999999997665555678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc-
Q 005886 94 MAGGSCLHIMKSAYP-EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ- 171 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~-~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~- 171 (671)
+.|++|.+++..... ..+++..++.++.||+.||+|||+.|++||||+|+||+++.++.++|+|||++..+.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 999999999987543 568999999999999999999999999999999999999999999999999987765433221
Q ss_pred cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccc-cccchHHH
Q 005886 172 RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER-DKRFSKSF 250 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~-~~~ls~~l 250 (671)
.......|+..|+|||++.....++.++|+|||||++|+|++|..||...+..+.+.......++.+.... ...++..+
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSF 240 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHH
Confidence 22345679999999999987547899999999999999999999999888777766666665544443322 24678999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 251 KELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 251 ~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
.+||.+||..||.+||++.++++||||
T Consensus 241 ~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 241 RKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=380.03 Aligned_cols=252 Identities=30% Similarity=0.451 Sum_probs=211.8
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHH-HHHhCCCCCceeeeeEEEeCCEEEEEEeccCC
Q 005886 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQ-TMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAG 96 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~-iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~g 96 (671)
+.||+|+||+||+|.+..+|+.||||++..... ......+..|.. +++.++||||++++++|.....+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 469999999999999999999999999875432 122344555554 56789999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccccc
Q 005886 97 GSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNT 176 (671)
Q Consensus 97 gsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~ 176 (671)
|+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... .......
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~---~~~~~~~ 155 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE---HSKTTST 155 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc---CCCcccc
Confidence 9999988765 5789999999999999999999999999999999999999999999999999864321 1122345
Q ss_pred ccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHH
Q 005886 177 FVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTA 256 (671)
Q Consensus 177 ~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~ 256 (671)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+.... . ..+..++..+.+||.+
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~----~~~~~~~~~~~~li~~ 229 (323)
T cd05575 156 FCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP-L----RLKPNISVSARHLLEG 229 (323)
T ss_pred ccCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-C----CCCCCCCHHHHHHHHH
Confidence 689999999999987 568999999999999999999999998877665555444332 1 2245678999999999
Q ss_pred hhhcCCCCCCCH----HHHHhchhcccccc
Q 005886 257 CLVKDPKKRPTA----EKLMKHHFFKHARS 282 (671)
Q Consensus 257 cL~~dP~kRpSa----~eiL~Hpwfk~~~~ 282 (671)
||..||.+||++ .+++.||||....+
T Consensus 230 ~l~~~p~~R~~~~~~~~~il~~~~~~~~~~ 259 (323)
T cd05575 230 LLQKDRTKRLGAKDDFLEIKNHVFFSSINW 259 (323)
T ss_pred HhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 999999999987 69999999987654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=377.42 Aligned_cols=265 Identities=24% Similarity=0.424 Sum_probs=218.1
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
++|++.+.||+|+||+||+++++.+++.||+|++..... ......+.+|+.++..++|+||++++++|.+++++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 579999999999999999999999999999999874321 233566889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
||+.||+|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+.....
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 157 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-- 157 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC--
Confidence 999999999998753 25689999999999999999999999999999999999999999999999999865532221
Q ss_pred cccccccCCCCCCChhHhhh----ccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCc-cccccc
Q 005886 172 RSRNTFVGTPCWMAPEVMQQ----LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY-ERDKRF 246 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~----~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~-~~~~~l 246 (671)
......+||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+....+....+..... .+.. .....+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~ 236 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE-HFQFPPDVTDV 236 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-cccCCCccCCC
Confidence 11223579999999999973 23478899999999999999999999988766555544443221 1111 123457
Q ss_pred hHHHHHHHHHhhhcCCCC--CCCHHHHHhchhcccccc
Q 005886 247 SKSFKELVTACLVKDPKK--RPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 247 s~~l~dLI~~cL~~dP~k--RpSa~eiL~Hpwfk~~~~ 282 (671)
+..+++||.+||..++.+ |+++.++++||||....+
T Consensus 237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~ 274 (331)
T cd05597 237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW 274 (331)
T ss_pred CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence 899999999999764444 789999999999986543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=377.67 Aligned_cols=260 Identities=33% Similarity=0.566 Sum_probs=217.6
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LV 90 (671)
+..++|++.+.||.|+||.||+|.+..+|..||+|++...........+.+|+++++.++||||++++++|.+++.+|+|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 45689999999999999999999999999999999987654334456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCcEEEcCCCceEEeccccccccccCCC
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH-GHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~-gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~ 169 (671)
|||+.||+|.+++... +.+++..+..++.||+.||.|||+. +++||||||+|||++.+|.+||+|||++..+...
T Consensus 82 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 82 MEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred EecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 9999999999999765 5689999999999999999999985 7999999999999999999999999998654221
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHH-------------------
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMT------------------- 230 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~------------------- 230 (671)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||............
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred ---ccccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCC
Confidence 1234579999999999987 56899999999999999999999999764432221110
Q ss_pred -------------------------HhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 231 -------------------------LQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 231 -------------------------~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
....++.. ....++.++++||.+||.+||.+|||+.+++.||||+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKL---PSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCCCccC---CCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 00000000 0123578899999999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=388.18 Aligned_cols=262 Identities=38% Similarity=0.644 Sum_probs=232.4
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
.|.-++.||.|+||.||-|++..+.+.||||.+....- .+....+.+|+.+|+.+.|||++.+.++|..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 46678899999999999999999999999999976542 2447889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
||- |+-.+++.-. .+++.+..|..|+.+.+.||+|||+++.||||||..|||+++.|.|||+|||.|..+.
T Consensus 107 YCl-GSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~------- 177 (948)
T KOG0577|consen 107 YCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA------- 177 (948)
T ss_pred HHh-ccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC-------
Confidence 995 4677776543 3679999999999999999999999999999999999999999999999999886552
Q ss_pred ccccccCCCCCCChhHhhh--ccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHH
Q 005886 173 SRNTFVGTPCWMAPEVMQQ--LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSF 250 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~--~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l 250 (671)
..++|+|||+|||||++.. ...|+-++|||||||+..||.-.++|+...+.+..++-+.++.+|.+.. ..+|..|
T Consensus 178 PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs---~eWS~~F 254 (948)
T KOG0577|consen 178 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQS---NEWSDYF 254 (948)
T ss_pred chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCC---chhHHHH
Confidence 3456899999999999863 2459999999999999999999999998889999999999998887764 4568999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHhchhccccccchHHHH
Q 005886 251 KELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLAR 288 (671)
Q Consensus 251 ~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~~~~~~ 288 (671)
+.||..||.+-|.+|||.+++|+|+|+...++...+..
T Consensus 255 ~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~tvi~d 292 (948)
T KOG0577|consen 255 RNFVDSCLQKIPQERPTSEELLKHRFVLRERPPTVIMD 292 (948)
T ss_pred HHHHHHHHhhCcccCCcHHHHhhcchhccCCCchHHHH
Confidence 99999999999999999999999999988777665543
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=376.55 Aligned_cols=258 Identities=28% Similarity=0.479 Sum_probs=219.6
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCC-CCCceeeeeEEEeCCEEEEEE
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTN-HPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~-HpNIVkl~~~~~~~~~l~LVm 91 (671)
+|++.+.||+|+||.||+|.++.+|+.||+|++..... ......+..|+.++..+. |++|++++++|.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 57889999999999999999999999999999875432 233566778888888775 577889999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
||+.||+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....+
T Consensus 81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~--- 155 (323)
T cd05615 81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--- 155 (323)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC---
Confidence 999999999998765 579999999999999999999999999999999999999999999999999986432211
Q ss_pred cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHH
Q 005886 172 RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~ 251 (671)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.... ...+..++.++.
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-----~~~p~~~~~~~~ 229 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-----VSYPKSLSKEAV 229 (323)
T ss_pred ccccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----CCCCccCCHHHH
Confidence 12334679999999999986 568999999999999999999999999887766655555432 223456789999
Q ss_pred HHHHHhhhcCCCCCCC-----HHHHHhchhccccccc
Q 005886 252 ELVTACLVKDPKKRPT-----AEKLMKHHFFKHARSN 283 (671)
Q Consensus 252 dLI~~cL~~dP~kRpS-----a~eiL~Hpwfk~~~~~ 283 (671)
+|+.+||.++|.+|++ ..++++||||....+.
T Consensus 230 ~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~ 266 (323)
T cd05615 230 SICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWD 266 (323)
T ss_pred HHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHH
Confidence 9999999999999997 5799999999876543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=385.84 Aligned_cols=260 Identities=30% Similarity=0.493 Sum_probs=211.8
Q ss_pred ccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q 005886 10 PVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWV 89 (671)
Q Consensus 10 ~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~L 89 (671)
.....+|++++.||.|+||.||+|++..+|+.||||++...........+.+|+.+++.++|+||++++++|...+.+|+
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 33457899999999999999999999999999999998654433445678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCC
Q 005886 90 VMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~ 169 (671)
|||||.||+|... ....+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 150 v~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~- 222 (353)
T PLN00034 150 LLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM- 222 (353)
T ss_pred EEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence 9999999988542 345678889999999999999999999999999999999999999999999987553211
Q ss_pred cccccccccCCCCCCChhHhhhc----cCCCccchhhhHHHHHHHHHhCCCCCCCCChHH--HHHHHHhcCCCCCCcccc
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQL----HGYDFKADIWSFGITALELAHGHAPFSKYPPMK--VLLMTLQNAPPGLDYERD 243 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~----~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~--~~~~~~~~~~~~~~~~~~ 243 (671)
......+||+.|+|||++... ..++.++|||||||++|+|++|+.||....... .....+.. ......+
T Consensus 223 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~ 297 (353)
T PLN00034 223 --DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM---SQPPEAP 297 (353)
T ss_pred --ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc---cCCCCCC
Confidence 122345899999999987431 234568999999999999999999997432211 11111111 1112234
Q ss_pred ccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 244 KRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 244 ~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
..++.++++||.+||..||.+||++.++|+||||....
T Consensus 298 ~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 298 ATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 56789999999999999999999999999999998653
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=376.83 Aligned_cols=252 Identities=29% Similarity=0.494 Sum_probs=214.9
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEEEeccCC
Q 005886 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVT-NHPNVLRAHCSFTTGHCLWVVMPYMAG 96 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~~~l~LVmEy~~g 96 (671)
+.||+|+||+||+|.+..+++.||||++..... ......+.+|+.++..+ +||||+++++++...+.+|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999975432 23456677888998877 799999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccccc
Q 005886 97 GSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNT 176 (671)
Q Consensus 97 gsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~ 176 (671)
|+|...+... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~---~~~~~~ 155 (318)
T cd05570 81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG---GVTTST 155 (318)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC---CCcccc
Confidence 9999988765 57999999999999999999999999999999999999999999999999998643211 112334
Q ss_pred ccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHH
Q 005886 177 FVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTA 256 (671)
Q Consensus 177 ~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~ 256 (671)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.... ...+..++..+.+||.+
T Consensus 156 ~~g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~-----~~~~~~~~~~~~~li~~ 229 (318)
T cd05570 156 FCGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE-----VRYPRWLSKEAKSILKS 229 (318)
T ss_pred eecCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-----CCCCCcCCHHHHHHHHH
Confidence 679999999999987 568999999999999999999999998877655554443322 12345678999999999
Q ss_pred hhhcCCCCCCCH-----HHHHhchhcccccc
Q 005886 257 CLVKDPKKRPTA-----EKLMKHHFFKHARS 282 (671)
Q Consensus 257 cL~~dP~kRpSa-----~eiL~Hpwfk~~~~ 282 (671)
||..||.+||++ .+++.||||+...+
T Consensus 230 ~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 230 FLTKNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred HccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 999999999999 99999999987544
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=368.05 Aligned_cols=265 Identities=25% Similarity=0.383 Sum_probs=218.9
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
..++|++.+.||.|+||.||+|.+..+++.||+|.+...........+.+|+.+++.++||||+++++++..+..+|+||
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 45789999999999999999999999999999999876554444566788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
||+. ++|..++... ...+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||++...... .
T Consensus 84 e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~---~ 158 (301)
T cd07873 84 EYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP---T 158 (301)
T ss_pred eccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC---C
Confidence 9997 5888877654 246899999999999999999999999999999999999999999999999998644211 1
Q ss_pred cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------------
Q 005886 172 RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG-------------- 237 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~-------------- 237 (671)
.......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+....+.......
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 122344678999999998875668899999999999999999999998876654443322211100
Q ss_pred --CCc---------cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 238 --LDY---------ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 238 --~~~---------~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
..+ .....++..+++||.+||..||.+|||+.++|+||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 000 01235688999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=386.78 Aligned_cols=258 Identities=24% Similarity=0.386 Sum_probs=209.2
Q ss_pred ccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q 005886 10 PVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWV 89 (671)
Q Consensus 10 ~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~L 89 (671)
.+...+|++++.||+|+||.||+|.+..+++.||||... ...+.+|+.+++.++||||++++++|..+...++
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 355678999999999999999999999999999999753 2456789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCC
Q 005886 90 VMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~ 169 (671)
|||++. ++|..++... ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++......
T Consensus 161 v~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-- 235 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-- 235 (391)
T ss_pred EEecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc--
Confidence 999995 6788887665 56899999999999999999999999999999999999999999999999998643221
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHhc---CCCCC-
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPP-------MKVLLMTLQN---APPGL- 238 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~-------~~~~~~~~~~---~~~~~- 238 (671)
........+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||..... ...+..++.. .+..+
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred cccccccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 1122345689999999999987 5699999999999999999999988743211 1111111110 00000
Q ss_pred --------------------------CccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 239 --------------------------DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 239 --------------------------~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
.+.....++.++.+||.+||.+||.+|||+.++|+||||+..
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 001112356789999999999999999999999999999864
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=375.50 Aligned_cols=252 Identities=28% Similarity=0.508 Sum_probs=212.2
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHh-CCCCCceeeeeEEEeCCEEEEEEeccCC
Q 005886 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRV-TNHPNVLRAHCSFTTGHCLWVVMPYMAG 96 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~-L~HpNIVkl~~~~~~~~~l~LVmEy~~g 96 (671)
+.||+|+||+||+|.+..+++.||||++..... .........|..++.. ++||||+++++++.+...+|+||||+.|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999975432 2334566678888875 5999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccccc
Q 005886 97 GSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNT 176 (671)
Q Consensus 97 gsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~ 176 (671)
|+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ......
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~ 155 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG---DAKTCT 155 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC---CCceee
Confidence 9999998765 56899999999999999999999999999999999999999999999999998643211 112335
Q ss_pred ccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHH
Q 005886 177 FVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTA 256 (671)
Q Consensus 177 ~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~ 256 (671)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+... .+. .+..++.++++||.+
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~-~~~----~~~~~~~~~~~li~~ 229 (316)
T cd05619 156 FCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD-NPC----YPRWLTREAKDILVK 229 (316)
T ss_pred ecCCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCC----CCccCCHHHHHHHHH
Confidence 679999999999987 56899999999999999999999999887765544443322 222 234578899999999
Q ss_pred hhhcCCCCCCCHH-HHHhchhcccccc
Q 005886 257 CLVKDPKKRPTAE-KLMKHHFFKHARS 282 (671)
Q Consensus 257 cL~~dP~kRpSa~-eiL~Hpwfk~~~~ 282 (671)
||..||.+||++. +++.||||+...+
T Consensus 230 ~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05619 230 LFVREPERRLGVKGDIRQHPFFREIDW 256 (316)
T ss_pred HhccCHhhcCCChHHHHcCcccCCCCH
Confidence 9999999999996 8999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=377.78 Aligned_cols=253 Identities=30% Similarity=0.496 Sum_probs=210.3
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEEEeccCC
Q 005886 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVT-NHPNVLRAHCSFTTGHCLWVVMPYMAG 96 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~~~l~LVmEy~~g 96 (671)
+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.++..+ +||||++++++|.....+|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999976532 23456678899888766 899999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccccc
Q 005886 97 GSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNT 176 (671)
Q Consensus 97 gsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~ 176 (671)
|+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~---~~~~~ 155 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---DTTST 155 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC---Ccccc
Confidence 9999888765 579999999999999999999999999999999999999999999999999986432211 12345
Q ss_pred ccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHhcCCCCCCccccccchH
Q 005886 177 FVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYP--------PMKVLLMTLQNAPPGLDYERDKRFSK 248 (671)
Q Consensus 177 ~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~--------~~~~~~~~~~~~~~~~~~~~~~~ls~ 248 (671)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ........+.... ...+..++.
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----~~~p~~~~~ 230 (329)
T cd05618 156 FCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----IRIPRSLSV 230 (329)
T ss_pred ccCCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----CCCCCCCCH
Confidence 689999999999987 578999999999999999999999995311 1122222222221 223556789
Q ss_pred HHHHHHHHhhhcCCCCCCC------HHHHHhchhcccccc
Q 005886 249 SFKELVTACLVKDPKKRPT------AEKLMKHHFFKHARS 282 (671)
Q Consensus 249 ~l~dLI~~cL~~dP~kRpS------a~eiL~Hpwfk~~~~ 282 (671)
.+.+||.+||..||.+||+ +.++++||||+...+
T Consensus 231 ~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 231 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred HHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 9999999999999999998 589999999987544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=366.61 Aligned_cols=255 Identities=22% Similarity=0.355 Sum_probs=208.4
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccCCCCH
Q 005886 22 VGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSC 99 (671)
Q Consensus 22 LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~ggsL 99 (671)
||+|+||.||++.++.+|+.||+|++...... .....+..|+.+++.++||||++++++|..+..+|+||||+.|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999998653322 2234556799999999999999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccccccccC
Q 005886 100 LHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVG 179 (671)
Q Consensus 100 ~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~G 179 (671)
..++.......+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++...... .......|
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~ 156 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG----KTITQRAG 156 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC----ceeeccCC
Confidence 98887654456899999999999999999999999999999999999999999999999998654221 12234578
Q ss_pred CCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCccccccchHHHHHHHHHhh
Q 005886 180 TPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP-PGLDYERDKRFSKSFKELVTACL 258 (671)
Q Consensus 180 T~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~-~~~~~~~~~~ls~~l~dLI~~cL 258 (671)
|+.|+|||++.+ ..++.++|||||||++|+|++|..||................. ..... ....++.++++||.+||
T Consensus 157 ~~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L 234 (277)
T cd05607 157 TNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESKDICRLFL 234 (277)
T ss_pred CCCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc-ccccCCHHHHHHHHHHh
Confidence 999999999987 4599999999999999999999999976533211111111111 11111 12457899999999999
Q ss_pred hcCCCCCCCH----HHHHhchhcccccc
Q 005886 259 VKDPKKRPTA----EKLMKHHFFKHARS 282 (671)
Q Consensus 259 ~~dP~kRpSa----~eiL~Hpwfk~~~~ 282 (671)
.+||.+||++ +++++||||+...+
T Consensus 235 ~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 235 AKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred ccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 9999999999 77889999987554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=377.65 Aligned_cols=253 Identities=29% Similarity=0.443 Sum_probs=211.8
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHH-HHHHhCCCCCceeeeeEEEeCCEEEEEEeccCC
Q 005886 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREV-QTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAG 96 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei-~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~g 96 (671)
+.||+|+||+||+|++..+++.||+|++...... .....+..|. .+++.++||||++++++|...+.+|+||||+.|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999998754321 2223444444 456789999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccccc
Q 005886 97 GSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNT 176 (671)
Q Consensus 97 gsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~ 176 (671)
|+|..++... ..+.+..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... ......
T Consensus 81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~---~~~~~~ 155 (325)
T cd05602 81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH---NGTTST 155 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC---CCCccc
Confidence 9999998765 57889999999999999999999999999999999999999999999999998643221 122345
Q ss_pred ccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHH
Q 005886 177 FVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTA 256 (671)
Q Consensus 177 ~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~ 256 (671)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+.+..+.... ...+..++..+.++|.+
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-----~~~~~~~~~~~~~li~~ 229 (325)
T cd05602 156 FCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-----LQLKPNITNSARHLLEG 229 (325)
T ss_pred ccCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-----cCCCCCCCHHHHHHHHH
Confidence 689999999999987 678999999999999999999999999877666555444331 12345688999999999
Q ss_pred hhhcCCCCCCCHH----HHHhchhccccccc
Q 005886 257 CLVKDPKKRPTAE----KLMKHHFFKHARSN 283 (671)
Q Consensus 257 cL~~dP~kRpSa~----eiL~Hpwfk~~~~~ 283 (671)
||.+||.+|+++. ++++|+||....+.
T Consensus 230 ~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~ 260 (325)
T cd05602 230 LLQKDRTKRLGAKDDFMEIKNHIFFSPINWD 260 (325)
T ss_pred HcccCHHHCCCCCCCHHHHhcCcccCCCCHH
Confidence 9999999999865 89999999876554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=375.24 Aligned_cols=265 Identities=24% Similarity=0.419 Sum_probs=219.2
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
++|++.+.||+|+||+||++.++.+++.||+|++..... ......+.+|+.++..++|+||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 479999999999999999999999999999999864321 223456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
||+.||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...+.
T Consensus 81 ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-- 157 (332)
T cd05623 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-- 157 (332)
T ss_pred eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc--
Confidence 999999999999763 24689999999999999999999999999999999999999999999999999865432221
Q ss_pred cccccccCCCCCCChhHhhh----ccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCc-cccccc
Q 005886 172 RSRNTFVGTPCWMAPEVMQQ----LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY-ERDKRF 246 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~----~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~-~~~~~l 246 (671)
......+||+.|+|||++.+ ...++.++|||||||++|+|++|+.||......+....+..... .+.+ .....+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~ 236 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE-RFQFPAQVTDV 236 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc-cccCCCccccC
Confidence 12234579999999999863 24588999999999999999999999998777666655544321 1111 123467
Q ss_pred hHHHHHHHHHhhhcCCCC--CCCHHHHHhchhcccccc
Q 005886 247 SKSFKELVTACLVKDPKK--RPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 247 s~~l~dLI~~cL~~dP~k--RpSa~eiL~Hpwfk~~~~ 282 (671)
+.++++||.+||..++.+ |++++++++||||....+
T Consensus 237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~ 274 (332)
T cd05623 237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW 274 (332)
T ss_pred CHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence 999999999999765544 689999999999987654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=378.30 Aligned_cols=252 Identities=29% Similarity=0.459 Sum_probs=214.8
Q ss_pred EEecccCceEEEEEEE---cCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccC
Q 005886 20 EEVGEGVSATVYRALC---IPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMA 95 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~---~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~ 95 (671)
+.||+|+||.||++++ ..+|+.||+|++...... .....+.+|+.+++.++||||++++++|.....+|+||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999876 357899999999754322 234567789999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccccc
Q 005886 96 GGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRN 175 (671)
Q Consensus 96 ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 175 (671)
||+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .....
T Consensus 82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~---~~~~~ 156 (318)
T cd05582 82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH---EKKAY 156 (318)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC---CCcee
Confidence 99999998765 56899999999999999999999999999999999999999999999999998654221 12233
Q ss_pred cccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHH
Q 005886 176 TFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVT 255 (671)
Q Consensus 176 ~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~ 255 (671)
..+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.... ...+..++..+++||.
T Consensus 157 ~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~-----~~~p~~~~~~~~~li~ 230 (318)
T cd05582 157 SFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK-----LGMPQFLSPEAQSLLR 230 (318)
T ss_pred cccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC-----CCCCCCCCHHHHHHHH
Confidence 5689999999999986 568999999999999999999999999877766655554432 1234567899999999
Q ss_pred HhhhcCCCCCCC-----HHHHHhchhcccccc
Q 005886 256 ACLVKDPKKRPT-----AEKLMKHHFFKHARS 282 (671)
Q Consensus 256 ~cL~~dP~kRpS-----a~eiL~Hpwfk~~~~ 282 (671)
+||..||.+||+ +.+++.||||....+
T Consensus 231 ~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~ 262 (318)
T cd05582 231 ALFKRNPANRLGAGPDGVEEIKRHPFFSTIDW 262 (318)
T ss_pred HHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence 999999999999 788999999986543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=387.05 Aligned_cols=258 Identities=26% Similarity=0.435 Sum_probs=233.2
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE-EEEE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC-LWVV 90 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~-l~LV 90 (671)
.+.|.+++.+|+|+||.+++++++..+..|++|.|...... .......+|+.+++++.|||||.+++.|+.++. ++||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 47899999999999999999999999999999999887643 345578899999999999999999999999888 9999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCc
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR 170 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~ 170 (671)
|+||+||++.+.+.......|+|+.+..|+.||+.||.|||++.|+|||||+.|||++.++.|||+|||+|+.+....
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~-- 160 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED-- 160 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch--
Confidence 999999999999988766789999999999999999999999999999999999999999999999999999884322
Q ss_pred ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHH
Q 005886 171 QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSF 250 (671)
Q Consensus 171 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l 250 (671)
....+.+|||.||.||++.+ ..|+.|+|||||||++|||++-+++|.+.+-......+.+.. -.+.+..++.++
T Consensus 161 -~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~----~~Plp~~ys~el 234 (426)
T KOG0589|consen 161 -SLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL----YSPLPSMYSSEL 234 (426)
T ss_pred -hhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc----CCCCCccccHHH
Confidence 23456799999999999998 679999999999999999999999999988877777777765 234467789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHhchhcc
Q 005886 251 KELVTACLVKDPKKRPTAEKLMKHHFFK 278 (671)
Q Consensus 251 ~dLI~~cL~~dP~kRpSa~eiL~Hpwfk 278 (671)
+.+|+.||.++|..||++.++|.+|.+.
T Consensus 235 ~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 235 RSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred HHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 9999999999999999999999998775
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=377.75 Aligned_cols=259 Identities=27% Similarity=0.396 Sum_probs=209.2
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC-----
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH----- 85 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~----- 85 (671)
..++|++.+.||+|+||.||+|.+..+|..||+|++..... ......+.+|+.+++.++||||++++++|....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 45889999999999999999999999999999999865432 233567789999999999999999999987543
Q ss_pred -EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccc
Q 005886 86 -CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACM 164 (671)
Q Consensus 86 -~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~ 164 (671)
.+|+||||+.+ +|...+. ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 57999999976 4555553 24888999999999999999999999999999999999999999999999998644
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC---------
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP--------- 235 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~--------- 235 (671)
.. ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+........
T Consensus 174 ~~----~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 174 CT----NFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred cc----CccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 21 122334688999999999987 5689999999999999999999999987655433222211100
Q ss_pred ------------CCC---C-------------ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 236 ------------PGL---D-------------YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 236 ------------~~~---~-------------~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
+.. . .......+..+++||.+||..||.+|||+.++|.||||..+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 321 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW 321 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence 000 0 00112346789999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=374.87 Aligned_cols=261 Identities=22% Similarity=0.365 Sum_probs=211.9
Q ss_pred ccccCCCCeEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeeeEE
Q 005886 8 RFPVDAKDYRLYEEVGEGVSATVYRALCI-----PLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHCSF 81 (671)
Q Consensus 8 ~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~-----~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~ 81 (671)
.|.+..++|++.+.||.|+||.||+|.+. .++..||+|++...........+.+|+.+++.+ +||||+++++++
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 1 QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred CcccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 37788899999999999999999999753 345689999987544344456789999999999 899999999988
Q ss_pred EeC-CEEEEEEeccCCCCHHHHHHhhC-----------------------------------------------------
Q 005886 82 TTG-HCLWVVMPYMAGGSCLHIMKSAY----------------------------------------------------- 107 (671)
Q Consensus 82 ~~~-~~l~LVmEy~~ggsL~~~l~~~~----------------------------------------------------- 107 (671)
... ..+|+|||||.||+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 764 46899999999999999887531
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccccccccCC
Q 005886 108 -------PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGT 180 (671)
Q Consensus 108 -------~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT 180 (671)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ........++
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~ 239 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGSARLP 239 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcc-hhcccCCCCC
Confidence 12377888999999999999999999999999999999999999999999999875532211 1122334567
Q ss_pred CCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhh
Q 005886 181 PCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLV 259 (671)
Q Consensus 181 ~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~ 259 (671)
+.|+|||++.+ ..++.++|||||||++|||++ |..||.+..........+.... ....+..++..+.+||.+||.
T Consensus 240 ~~y~aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~ 315 (338)
T cd05102 240 LKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT---RMRAPENATPEIYRIMLACWQ 315 (338)
T ss_pred ccccCcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC---CCCCCCCCCHHHHHHHHHHcc
Confidence 88999999986 568999999999999999997 9999987654444333333221 122345678899999999999
Q ss_pred cCCCCCCCHHHHHh
Q 005886 260 KDPKKRPTAEKLMK 273 (671)
Q Consensus 260 ~dP~kRpSa~eiL~ 273 (671)
.||.+|||+.++++
T Consensus 316 ~dp~~RPs~~el~~ 329 (338)
T cd05102 316 GDPKERPTFSALVE 329 (338)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=376.81 Aligned_cols=252 Identities=28% Similarity=0.403 Sum_probs=211.2
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHH-HHHhCCCCCceeeeeEEEeCCEEEEEEeccCC
Q 005886 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQ-TMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAG 96 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~-iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~g 96 (671)
+.||+|+||+||+|.++.+|+.||+|++..... ......+..|.. +++.++||||++++++|..++.+|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 468999999999999999999999999865432 123345555554 46789999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccccc
Q 005886 97 GSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNT 176 (671)
Q Consensus 97 gsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~ 176 (671)
|+|...+... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..... ......
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~---~~~~~~ 155 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ---SDTTTT 155 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC---CCCccc
Confidence 9999888765 57999999999999999999999999999999999999999999999999998643211 122345
Q ss_pred ccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHH
Q 005886 177 FVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTA 256 (671)
Q Consensus 177 ~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~ 256 (671)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+.... ......++..+.++|.+
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ll~~ 229 (325)
T cd05604 156 FCGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP-----LVLRPGASLTAWSILEE 229 (325)
T ss_pred ccCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC-----ccCCCCCCHHHHHHHHH
Confidence 689999999999987 568999999999999999999999998877666555544432 12234578899999999
Q ss_pred hhhcCCCCCCCH----HHHHhchhcccccc
Q 005886 257 CLVKDPKKRPTA----EKLMKHHFFKHARS 282 (671)
Q Consensus 257 cL~~dP~kRpSa----~eiL~Hpwfk~~~~ 282 (671)
||..+|.+||++ .++++||||....+
T Consensus 230 ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~ 259 (325)
T cd05604 230 LLEKDRQRRLGAKEDFLEIQEHPFFESLSW 259 (325)
T ss_pred HhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence 999999999976 59999999987654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=373.84 Aligned_cols=265 Identities=24% Similarity=0.418 Sum_probs=218.1
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
++|++.+.||+|+||+||+++++.+++.||+|++..... ......+.+|+.++..++|+||+++++++.+++.+|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 579999999999999999999999999999999865321 223456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
||+.||+|..++... ...+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+.....
T Consensus 81 Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-- 157 (331)
T cd05624 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-- 157 (331)
T ss_pred eCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc--
Confidence 999999999999764 24689999999999999999999999999999999999999999999999999865532211
Q ss_pred cccccccCCCCCCChhHhhhc----cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCc-cccccc
Q 005886 172 RSRNTFVGTPCWMAPEVMQQL----HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY-ERDKRF 246 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~~----~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~-~~~~~l 246 (671)
......+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||......+....+.... ..+.+ .....+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~~~~ 236 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE-ERFQFPSHITDV 236 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCC-CcccCCCccccC
Confidence 122345799999999998752 347889999999999999999999998877666555444322 11111 112357
Q ss_pred hHHHHHHHHHhhhcCCCC--CCCHHHHHhchhcccccc
Q 005886 247 SKSFKELVTACLVKDPKK--RPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 247 s~~l~dLI~~cL~~dP~k--RpSa~eiL~Hpwfk~~~~ 282 (671)
+.++++||.+||..++.+ |++++++++||||+...+
T Consensus 237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~ 274 (331)
T cd05624 237 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDW 274 (331)
T ss_pred CHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCH
Confidence 899999999999876544 468999999999986544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=355.93 Aligned_cols=258 Identities=28% Similarity=0.515 Sum_probs=219.2
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc----ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN----NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWV 89 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~----~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~L 89 (671)
+.|++.+.||.|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++..+..+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 6799999999999999999999999999999998654321 234678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCC
Q 005886 90 VMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~ 169 (671)
||||+.|++|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||+++.......
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 99999999999998765 5689999999999999999999999999999999999999999999999999865532211
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHH
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
.........|++.|+|||++.+ ..++.++|||||||++|+|++|+.||................ .....+..++..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 235 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP---TNPQLPSHVSPD 235 (263)
T ss_pred ccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC---CCCCCCccCCHH
Confidence 1111134578899999999987 558999999999999999999999998766555444333221 223345678899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 250 FKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
+.+||.+||.++|.+|||+.++|+||||
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 236 ARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 9999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=360.08 Aligned_cols=259 Identities=27% Similarity=0.402 Sum_probs=213.4
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
+|++.+.||.|+||.||+|.+..+|..||||++...... .....+.+|+.+++.++||||+++++++.++..+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 689999999999999999999999999999998754322 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 94 MAGGSCLHIMKSAYP-EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~-~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
+. ++|..++..... ..+++..++.++.||+.||+|||++|++||||||+|||++.+|.+||+|||++...... ..
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP---VR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC---cc
Confidence 97 578887765432 56899999999999999999999999999999999999999999999999998654221 12
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-----------------
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP----------------- 235 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~----------------- 235 (671)
......+++.|+|||++.+...++.++|||||||++|+|++|++||.+...............
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 223346789999999987655678999999999999999999999987665444333222110
Q ss_pred -------CCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 236 -------PGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 236 -------~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
..........++.++++||.+||..||.+|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 000011123478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=374.18 Aligned_cols=253 Identities=28% Similarity=0.491 Sum_probs=212.4
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEEEeccCC
Q 005886 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVT-NHPNVLRAHCSFTTGHCLWVVMPYMAG 96 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~~~l~LVmEy~~g 96 (671)
+.||+|+||.||+|.+..+++.||+|++...... .....+.+|+.++..+ +||||++++++|.....+|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999765332 3456788899998877 699999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccccc
Q 005886 97 GSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNT 176 (671)
Q Consensus 97 gsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~ 176 (671)
|+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~ 155 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG---DTTST 155 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC---Cceec
Confidence 9999888765 579999999999999999999999999999999999999999999999999986432211 22345
Q ss_pred ccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCC------ChHHHHHHHHhcCCCCCCccccccchHHH
Q 005886 177 FVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKY------PPMKVLLMTLQNAPPGLDYERDKRFSKSF 250 (671)
Q Consensus 177 ~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~------~~~~~~~~~~~~~~~~~~~~~~~~ls~~l 250 (671)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||... ...+.....+...+. ..+..++..+
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~p~~~~~~~ 230 (327)
T cd05617 156 FCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI----RIPRFLSVKA 230 (327)
T ss_pred ccCCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC----CCCCCCCHHH
Confidence 689999999999987 67899999999999999999999999532 222333333333222 2345678999
Q ss_pred HHHHHHhhhcCCCCCCC------HHHHHhchhcccccc
Q 005886 251 KELVTACLVKDPKKRPT------AEKLMKHHFFKHARS 282 (671)
Q Consensus 251 ~dLI~~cL~~dP~kRpS------a~eiL~Hpwfk~~~~ 282 (671)
.++|.+||.+||.+|++ +++++.||||+...+
T Consensus 231 ~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~ 268 (327)
T cd05617 231 SHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDW 268 (327)
T ss_pred HHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence 99999999999999998 579999999987654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=380.48 Aligned_cols=262 Identities=26% Similarity=0.352 Sum_probs=214.7
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC-----EEE
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH-----CLW 88 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~-----~l~ 88 (671)
+|++.+.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.+++.++||||+++++++.... .+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 57889999999999999999999999999999864321 123467889999999999999999999998876 899
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
+||||+. ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE 157 (372)
T ss_pred EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence 9999996 5787777654 579999999999999999999999999999999999999999999999999987542211
Q ss_pred CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--------------
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA-------------- 234 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~-------------- 234 (671)
........+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 158 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 158 --SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred --cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 1223345789999999999875668999999999999999999999998877655443332210
Q ss_pred --------CCCCC-----ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 235 --------PPGLD-----YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 235 --------~~~~~-----~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
+.... +......+.++.+||.+||..||.+|||+.++|+||||....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 00000 012234578899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=377.95 Aligned_cols=252 Identities=28% Similarity=0.440 Sum_probs=209.1
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhC---CCCCceeeeeEEEeCCEEEEEEeccCC
Q 005886 22 VGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVT---NHPNVLRAHCSFTTGHCLWVVMPYMAG 96 (671)
Q Consensus 22 LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L---~HpNIVkl~~~~~~~~~l~LVmEy~~g 96 (671)
||+|+||+||+|+++.+|+.||||++...... ........|..++..+ +||||++++++|.....+|+||||+.|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999998654321 2234455666666654 799999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccccc
Q 005886 97 GSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNT 176 (671)
Q Consensus 97 gsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~ 176 (671)
|+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ......
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~---~~~~~~ 155 (330)
T cd05586 81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD---NKTTNT 155 (330)
T ss_pred ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC---CCCccC
Confidence 9999988765 67999999999999999999999999999999999999999999999999998653221 122345
Q ss_pred ccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHH
Q 005886 177 FVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTA 256 (671)
Q Consensus 177 ~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~ 256 (671)
.+||+.|+|||++.+...++.++|||||||++|+|++|..||.+....+....+.... ..+ ....++.++++||.+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~---~~~~~~~~~~~li~~ 231 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK-VRF---PKNVLSDEGRQFVKG 231 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC-CCC---CCccCCHHHHHHHHH
Confidence 6899999999999765568999999999999999999999998876655444433221 111 123478999999999
Q ss_pred hhhcCCCCCC----CHHHHHhchhcccccc
Q 005886 257 CLVKDPKKRP----TAEKLMKHHFFKHARS 282 (671)
Q Consensus 257 cL~~dP~kRp----Sa~eiL~Hpwfk~~~~ 282 (671)
||..||.+|| ++.++++||||+...+
T Consensus 232 ~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~ 261 (330)
T cd05586 232 LLNRNPQHRLGAHRDAVELKEHPFFADIDW 261 (330)
T ss_pred HcCCCHHHCCCCCCCHHHHhcCccccCCCH
Confidence 9999999998 7999999999986543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=358.51 Aligned_cols=257 Identities=37% Similarity=0.611 Sum_probs=212.4
Q ss_pred eEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCccc-HHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecc
Q 005886 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNND-LDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYM 94 (671)
Q Consensus 16 Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~-~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~ 94 (671)
|++.+.||+|+||+||++.+..+++.||+|++........ .....+|+.+++.++||||+++++++.....+++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 8999999999999999999999999999999986653322 234456999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccc
Q 005886 95 AGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSR 174 (671)
Q Consensus 95 ~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 174 (671)
.+++|.+++... ..+++..++.++.||+.||++||++|++|+||||+||+++.++.++|+|||.+..+ .......
T Consensus 81 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~---~~~~~~~ 155 (260)
T PF00069_consen 81 PGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL---SENNENF 155 (260)
T ss_dssp TTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES---TSTTSEB
T ss_pred cccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccc
Confidence 999999999854 67899999999999999999999999999999999999999999999999998653 1222334
Q ss_pred ccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCc--cccccchHHHHH
Q 005886 175 NTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY--ERDKRFSKSFKE 252 (671)
Q Consensus 175 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~--~~~~~ls~~l~d 252 (671)
....+++.|+|||++.....++.++||||||+++|+|++|..||...................... ......+..+.+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD 235 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence 456889999999999833678999999999999999999999998873222222111111100111 111122489999
Q ss_pred HHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 253 LVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 253 LI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
||.+||..||.+||++.++++||||
T Consensus 236 li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 236 LIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHccCChhHCcCHHHHhcCCCC
Confidence 9999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=374.45 Aligned_cols=259 Identities=26% Similarity=0.365 Sum_probs=211.6
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeC------
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG------ 84 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~------ 84 (671)
..++|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||++++++|...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 45889999999999999999999999999999999875432 23356788999999999999999999988643
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccc
Q 005886 85 HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACM 164 (671)
Q Consensus 85 ~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~ 164 (671)
..+|+||||+.+ .|...+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 357999999975 66666643 4788999999999999999999999999999999999999999999999998654
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC------
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL------ 238 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~------ 238 (671)
.. ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....++.......
T Consensus 177 ~~----~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 177 GT----SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred CC----CCcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 21 122344689999999999987 6789999999999999999999999988776655544433211100
Q ss_pred -------------------------------CccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 239 -------------------------------DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 239 -------------------------------~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
........+..+++||.+||..||.+|||+.++|+||||..+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 000111235678999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=374.10 Aligned_cols=259 Identities=26% Similarity=0.370 Sum_probs=210.0
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeC------
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTG------ 84 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~------ 84 (671)
..++|++.+.||+|+||.||+|.+..+++.||||++...... .....+.+|+.+++.++||||++++++|...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 458999999999999999999999999999999998754322 3356778899999999999999999998654
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccc
Q 005886 85 HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACM 164 (671)
Q Consensus 85 ~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~ 164 (671)
..+|+||||+.+ ++...+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 357999999976 56666543 4888999999999999999999999999999999999999999999999998654
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG------- 237 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~------- 237 (671)
.. ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......+...+......
T Consensus 170 ~~----~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 170 GT----SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred CC----ccccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 21 122345689999999999987 568999999999999999999999998766544333222111000
Q ss_pred ------------------------------CCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 238 ------------------------------LDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 238 ------------------------------~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
.........+..+++||.+||..||.+|||+.++|+||||...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 0001122345678999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=389.33 Aligned_cols=261 Identities=23% Similarity=0.342 Sum_probs=205.6
Q ss_pred ccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCC------CCceeeeeEEEe
Q 005886 10 PVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNH------PNVLRAHCSFTT 83 (671)
Q Consensus 10 ~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~H------pNIVkl~~~~~~ 83 (671)
.+..++|++++.||+|+||+||+|.+..+++.||||++.... .....+..|+.+++.+.| ++|++++++|..
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 345688999999999999999999999999999999986422 223455667777776654 458899999876
Q ss_pred C-CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCcEEEcCCC----------
Q 005886 84 G-HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF-HGHIHRDVKAGNILIDSNG---------- 151 (671)
Q Consensus 84 ~-~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs-~gIVHrDLKPeNILld~~g---------- 151 (671)
+ .++|+||+++ |++|.+++... +.+++..++.++.||+.||+|||. .|||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 4 5789999998 77888888765 579999999999999999999998 5999999999999998765
Q ss_pred ------ceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHH
Q 005886 152 ------AIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK 225 (671)
Q Consensus 152 ------~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~ 225 (671)
.+||+|||++... .......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+....+
T Consensus 280 ~~~~~~~vkl~DfG~~~~~------~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDE------RHSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred cCCCCceEEECCCCccccC------ccccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 4999999986422 122345789999999999987 579999999999999999999999998876654
Q ss_pred HHHHHHhcC---CC-----------------------CCCcc-----------ccccchHHHHHHHHHhhhcCCCCCCCH
Q 005886 226 VLLMTLQNA---PP-----------------------GLDYE-----------RDKRFSKSFKELVTACLVKDPKKRPTA 268 (671)
Q Consensus 226 ~~~~~~~~~---~~-----------------------~~~~~-----------~~~~ls~~l~dLI~~cL~~dP~kRpSa 268 (671)
.+..+.... +. ..... .....+..+.+||.+||.+||.+|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 433222111 00 00000 000113567899999999999999999
Q ss_pred HHHHhchhcccccc
Q 005886 269 EKLMKHHFFKHARS 282 (671)
Q Consensus 269 ~eiL~Hpwfk~~~~ 282 (671)
+++|+||||.....
T Consensus 433 ~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 433 RQMTTHPYVLKYYP 446 (467)
T ss_pred HHHhcCccccccCC
Confidence 99999999987543
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=372.45 Aligned_cols=252 Identities=29% Similarity=0.432 Sum_probs=210.1
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHH-HHHhCCCCCceeeeeEEEeCCEEEEEEeccCC
Q 005886 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQ-TMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAG 96 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~-iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~g 96 (671)
+.||+|+||.||+|++..+|+.||+|++...... .....+.+|.. +++.++||||++++++|.+.+.+|+|||||.|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999998754321 22344555554 57889999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccccc
Q 005886 97 GSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNT 176 (671)
Q Consensus 97 gsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~ 176 (671)
|+|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... ......
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---~~~~~~ 155 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP---EETTST 155 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC---CCcccc
Confidence 9999888765 57899999999999999999999999999999999999999999999999997643221 122345
Q ss_pred ccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHH
Q 005886 177 FVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTA 256 (671)
Q Consensus 177 ~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~ 256 (671)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+... + ...+...+..+.++|.+
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-~----~~~~~~~~~~~~~li~~ 229 (321)
T cd05603 156 FCGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK-P----LQLPGGKTVAACDLLVG 229 (321)
T ss_pred ccCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC-C----CCCCCCCCHHHHHHHHH
Confidence 689999999999976 56899999999999999999999999887665544444332 2 22345678899999999
Q ss_pred hhhcCCCCCCCH----HHHHhchhcccccc
Q 005886 257 CLVKDPKKRPTA----EKLMKHHFFKHARS 282 (671)
Q Consensus 257 cL~~dP~kRpSa----~eiL~Hpwfk~~~~ 282 (671)
||.+||.+||++ .++++|+||....+
T Consensus 230 ~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~ 259 (321)
T cd05603 230 LLHKDQRRRLGAKADFLEIKNHVFFSPINW 259 (321)
T ss_pred HccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence 999999999875 59999999987654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=388.12 Aligned_cols=260 Identities=28% Similarity=0.409 Sum_probs=220.9
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCC-CcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPL-NEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~t-g~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
...|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ......+.+|+.+|+.++|||||+++++|..++.+||||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 45599999999999999999998887 7889999875432 233456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCC
Q 005886 92 PYMAGGSCLHIMKSA--YPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~--~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~ 169 (671)
||+.||+|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~- 223 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV- 223 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc-
Confidence 999999999887542 22468999999999999999999999999999999999999999999999999987653221
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHH
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+.+..+...... +.+..++..
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~----~~~~~~s~~ 298 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD----PFPCPVSSG 298 (478)
T ss_pred ccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----CCCccCCHH
Confidence 1122345689999999999987 57899999999999999999999999887776666555543322 223467899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHhchhccc
Q 005886 250 FKELVTACLVKDPKKRPTAEKLMKHHFFKH 279 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~ 279 (671)
+++||.+||..||.+||++.++|.|+|++.
T Consensus 299 ~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 299 MKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 999999999999999999999999999974
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=387.04 Aligned_cols=256 Identities=29% Similarity=0.448 Sum_probs=214.6
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCC-C-----CCceeeeeEEEeCCEEE
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN-H-----PNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~-H-----pNIVkl~~~~~~~~~l~ 88 (671)
+|++++.||+|+||.|.+|.+..|++.||||+++..+ ........|+.+|..|+ | -|||+++++|...+++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 8999999999999999999999999999999997543 33456677999999886 3 47999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC--ceEEecccccccccc
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG--AIKLADFGVSACMFD 166 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g--~vKL~DFGls~~~~~ 166 (671)
||+|++ +.+|+++++.+...+|+...++.++.||+.||.+||..||||+|||||||||...+ .|||+|||.|...
T Consensus 265 iVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~-- 341 (586)
T KOG0667|consen 265 IVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE-- 341 (586)
T ss_pred eeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc--
Confidence 999999 56899999998888999999999999999999999999999999999999996644 7999999987432
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CC--------
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA--PP-------- 236 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~--~~-------- 236 (671)
.....+++.++.|+|||++.| ..|+.+.||||||||++||++|.+.|.|.+..+++..+++-. |+
T Consensus 342 ----~q~vytYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 342 ----SQRVYTYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred ----CCcceeeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 222337789999999999999 579999999999999999999999999988777665544211 00
Q ss_pred ----------CCCc-----c----------------------cc-----------ccchHHHHHHHHHhhhcCCCCCCCH
Q 005886 237 ----------GLDY-----E----------------------RD-----------KRFSKSFKELVTACLVKDPKKRPTA 268 (671)
Q Consensus 237 ----------~~~~-----~----------------------~~-----------~~ls~~l~dLI~~cL~~dP~kRpSa 268 (671)
++.. . .+ ..-...+.+||++||.+||.+|+|+
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 0000 0 00 0112457899999999999999999
Q ss_pred HHHHhchhcccc
Q 005886 269 EKLMKHHFFKHA 280 (671)
Q Consensus 269 ~eiL~Hpwfk~~ 280 (671)
.++|+||||...
T Consensus 497 ~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 497 AQALNHPFLTGT 508 (586)
T ss_pred HHHhcCcccccc
Confidence 999999999853
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=362.70 Aligned_cols=259 Identities=26% Similarity=0.394 Sum_probs=216.1
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
.|++.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++|+||+++++.+.+...+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 478899999999999999999999999999998654322 223557789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
|+.|++|..++.......+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++...... .
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~----~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG----Q 156 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC----c
Confidence 999999999886654456999999999999999999999999999999999999999999999999998644211 1
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChH---HHHHHHHhcCCCCCCccccccchHH
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM---KVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~---~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ........... ...+..++.+
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 231 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ----EEYSEKFSPD 231 (285)
T ss_pred cccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh----hhcCccCCHH
Confidence 2234579999999999987 56899999999999999999999999865432 12222222211 1224567889
Q ss_pred HHHHHHHhhhcCCCCCCC-----HHHHHhchhcccccc
Q 005886 250 FKELVTACLVKDPKKRPT-----AEKLMKHHFFKHARS 282 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpS-----a~eiL~Hpwfk~~~~ 282 (671)
+++||.+||+.||.+||| ++++++||||+...+
T Consensus 232 ~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05630 232 ARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINF 269 (285)
T ss_pred HHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCH
Confidence 999999999999999999 999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=360.19 Aligned_cols=263 Identities=26% Similarity=0.371 Sum_probs=219.6
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
.|+..+.||.|+||+||+|.+..+|+.||+|++...... .....+.+|+.+++.++|+||+.+++.|..++.+|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 478899999999999999999999999999998654322 223557789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
|+.+++|..++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~----~ 156 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG----E 156 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC----C
Confidence 999999998886654457999999999999999999999999999999999999999999999999998654211 1
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHH
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKE 252 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~d 252 (671)
......|++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.........+...... .....+..++..+.+
T Consensus 157 ~~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 234 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLE-TEEVYSAKFSEEAKS 234 (285)
T ss_pred cccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhc-cccccCccCCHHHHH
Confidence 2234579999999999976 56899999999999999999999999876554333222222211 112234567889999
Q ss_pred HHHHhhhcCCCCCCC-----HHHHHhchhccccccc
Q 005886 253 LVTACLVKDPKKRPT-----AEKLMKHHFFKHARSN 283 (671)
Q Consensus 253 LI~~cL~~dP~kRpS-----a~eiL~Hpwfk~~~~~ 283 (671)
||.+||..||.+||+ +.+++.|+||+.....
T Consensus 235 li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05632 235 ICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK 270 (285)
T ss_pred HHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence 999999999999999 8999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=369.11 Aligned_cols=263 Identities=37% Similarity=0.644 Sum_probs=212.7
Q ss_pred EEEEeccc--CceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecc
Q 005886 18 LYEEVGEG--VSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYM 94 (671)
Q Consensus 18 l~~~LG~G--~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~ 94 (671)
++++||+| +|++||++.++.+|+.||+|.+...... .....+.+|+.+++.++||||++++++|..++.+|+||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789999 7899999999999999999999766543 33467788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc--
Q 005886 95 AGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR-- 172 (671)
Q Consensus 95 ~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~-- 172 (671)
.+|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||.+......+....
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 161 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV 161 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence 999999999765556699999999999999999999999999999999999999999999999987544332221111
Q ss_pred --ccccccCCCCCCChhHhhhc-cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----------
Q 005886 173 --SRNTFVGTPCWMAPEVMQQL-HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL----------- 238 (671)
Q Consensus 173 --~~~~~~GT~~Y~APEvl~~~-~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~----------- 238 (671)
......++..|+|||++.+. ..|+.++|||||||++|+|++|..||.................+..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (327)
T cd08227 162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEEL 241 (327)
T ss_pred ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhc
Confidence 11223577889999999753 3589999999999999999999999987654443333222111100
Q ss_pred ------------------------------CccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 239 ------------------------------DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 239 ------------------------------~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
..+....+++.+.+||.+||+.||.+|||++++|+||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 242 TMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred ccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 001122457789999999999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=365.40 Aligned_cols=255 Identities=26% Similarity=0.366 Sum_probs=196.7
Q ss_pred EEEecccCceEEEEEEEc--CCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe--CCEEEEEEecc
Q 005886 19 YEEVGEGVSATVYRALCI--PLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT--GHCLWVVMPYM 94 (671)
Q Consensus 19 ~~~LG~G~fG~Vyka~~~--~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~--~~~l~LVmEy~ 94 (671)
..+||+|+||+||+|.++ .+++.||+|.+.... ....+.+|+.+|+.++||||++++++|.. +..+|+||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 468999999999999976 467899999986432 23457789999999999999999999864 56789999999
Q ss_pred CCCCHHHHHHhhC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEE----cCCCceEEeccccccc
Q 005886 95 AGGSCLHIMKSAY-------PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILI----DSNGAIKLADFGVSAC 163 (671)
Q Consensus 95 ~ggsL~~~l~~~~-------~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILl----d~~g~vKL~DFGls~~ 163 (671)
. ++|..++.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 5 57888775321 1358999999999999999999999999999999999999 4567899999999876
Q ss_pred cccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHhcC
Q 005886 164 MFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPP---------MKVLLMTLQNA 234 (671)
Q Consensus 164 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~---------~~~~~~~~~~~ 234 (671)
..............+||+.|+|||++.+...++.++|||||||++|+|++|.+||..... ...+..+....
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 533222222334568999999999998756689999999999999999999999964321 01111111100
Q ss_pred --CCCCCc-------------------------------cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 235 --PPGLDY-------------------------------ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 235 --~~~~~~-------------------------------~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
+....+ ......+..+.+||.+||..||.+|||++++|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 000000 0011234578899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=373.19 Aligned_cols=260 Identities=25% Similarity=0.375 Sum_probs=211.7
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeC------
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTG------ 84 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~------ 84 (671)
..++|++++.||.|+||+||+|.+..+++.||||++...... .....+.+|+.+++.++||||++++++|...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 347899999999999999999999999999999998654322 2345677899999999999999999988643
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccc
Q 005886 85 HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACM 164 (671)
Q Consensus 85 ~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~ 164 (671)
..+|++|+++ |++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 4579999998 7788887754 46999999999999999999999999999999999999999999999999998654
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--------
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP-------- 236 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~-------- 236 (671)
.. .....+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+......+..+......
T Consensus 169 ~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 169 DD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred CC------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 21 2234589999999999987556899999999999999999999999876554433332211000
Q ss_pred --------------CCC----ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 237 --------------GLD----YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 237 --------------~~~----~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
... .......++.+.+||.+||..||.+|||+.++|.||||....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 000 001123466789999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=348.19 Aligned_cols=255 Identities=25% Similarity=0.455 Sum_probs=217.8
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEe-CCEEEEEEe
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTT-GHCLWVVMP 92 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~-~~~l~LVmE 92 (671)
.|++.+.||.|+||.||++.++.+++.||+|.+..... ....+.+.+|+.+++.++||||+++++.+.. +..+|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 59999999999999999999999999999999875443 2345678899999999999999999998874 457899999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
|+.+++|.+++.......+++..++.++.+++.||+|||+.|++||||||+||+++.++.++|+|||++..+.... .
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~---~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC---D 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC---C
Confidence 9999999999887544568999999999999999999999999999999999999999999999999987553221 2
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHH
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKE 252 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~d 252 (671)
......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.............+ ..+..++..+.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 232 (257)
T cd08223 158 MASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP----PMPKDYSPELGE 232 (257)
T ss_pred ccccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC----CCccccCHHHHH
Confidence 2334678999999999887 56889999999999999999999999877665554444443322 223567899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 253 LVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 253 LI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
||.+||..+|.+||++.++++||||
T Consensus 233 li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 233 LIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHhccCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=388.44 Aligned_cols=264 Identities=31% Similarity=0.432 Sum_probs=223.4
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC----
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH---- 85 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~---- 85 (671)
...++|++.+.||+|+||+||+|.+..+|+.||||++...... .....+.+|+.++..++|+||+++++.|....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 4568999999999999999999999999999999999765432 34567889999999999999999998876432
Q ss_pred ----EEEEEEeccCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccc
Q 005886 86 ----CLWVVMPYMAGGSCLHIMKSAY--PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFG 159 (671)
Q Consensus 86 ----~l~LVmEy~~ggsL~~~l~~~~--~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFG 159 (671)
.+++||||+.+|+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 4789999999999999886532 2468999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC
Q 005886 160 VSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD 239 (671)
Q Consensus 160 ls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~ 239 (671)
+++.+.... ........+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+....+.+..+......
T Consensus 189 ls~~~~~~~-~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~--- 263 (496)
T PTZ00283 189 FSKMYAATV-SDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD--- 263 (496)
T ss_pred cCeeccccc-cccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC---
Confidence 987553221 1122345689999999999987 56899999999999999999999999987766665555543322
Q ss_pred ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 240 YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 240 ~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
+.+..+++++.+||.+||..||.+||++.++|+|||++..
T Consensus 264 -~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 264 -PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred -CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 2345688999999999999999999999999999999854
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=347.38 Aligned_cols=255 Identities=25% Similarity=0.470 Sum_probs=220.9
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
+|.+.+.||+|+||.||+|.+..+|..|++|.+..... ......+.+|+.+++.++||||+++++++.....+|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 58899999999999999999999999999999875433 34467788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS 173 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 173 (671)
+.|++|.+++.......+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++..+.... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~---~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT---NF 157 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc---ch
Confidence 999999999987645678999999999999999999999999999999999999999999999999987553221 12
Q ss_pred cccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHH
Q 005886 174 RNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL 253 (671)
Q Consensus 174 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dL 253 (671)
.....|++.|+|||++.+ ..++.++|+|||||++|+|++|..||...........+.....+.+ ...++..+.++
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~ 232 (256)
T cd08529 158 ANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV----SQMYSQQLAQL 232 (256)
T ss_pred hhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----ccccCHHHHHH
Confidence 234578999999999987 5688999999999999999999999988776655555544432222 23678899999
Q ss_pred HHHhhhcCCCCCCCHHHHHhchhc
Q 005886 254 VTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 254 I~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
|.+||+.+|++||++.++++|||+
T Consensus 233 i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 233 IDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHccCCcccCcCHHHHhhCCCC
Confidence 999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=354.37 Aligned_cols=260 Identities=48% Similarity=0.865 Sum_probs=224.5
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
++|++.+.||.|+||.||+|.+..+|..||+|++...........+.+|+.+++.++||||+++++++.++..+|+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 47889999999999999999999999999999997665455567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS 173 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 173 (671)
+.+++|.+++... .+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||+++.+.... ..
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~---~~ 154 (274)
T cd06609 81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM---SK 154 (274)
T ss_pred eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc---cc
Confidence 9999999998754 68999999999999999999999999999999999999999999999999987653221 22
Q ss_pred cccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHH
Q 005886 174 RNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL 253 (671)
Q Consensus 174 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dL 253 (671)
.....|++.|+|||++.+ ..++.++|||||||++|+|++|..||....+......+....++... ...++..+.++
T Consensus 155 ~~~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 230 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE---GNKFSKPFKDF 230 (274)
T ss_pred cccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCc---ccccCHHHHHH
Confidence 334578999999999987 45899999999999999999999999877665555444443332221 11278899999
Q ss_pred HHHhhhcCCCCCCCHHHHHhchhccccccc
Q 005886 254 VTACLVKDPKKRPTAEKLMKHHFFKHARSN 283 (671)
Q Consensus 254 I~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~ 283 (671)
|.+||..+|.+|||++++++||||......
T Consensus 231 l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 231 VSLCLNKDPKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred HHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence 999999999999999999999999987665
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=357.42 Aligned_cols=264 Identities=26% Similarity=0.422 Sum_probs=222.2
Q ss_pred cccccCCCCeEEE-EEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHh-CCCCCceeeeeEEEe-
Q 005886 7 KRFPVDAKDYRLY-EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRV-TNHPNVLRAHCSFTT- 83 (671)
Q Consensus 7 ~~~~i~~~~Y~l~-~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~-L~HpNIVkl~~~~~~- 83 (671)
+.+.|. ++|.+- ++||-|-.|.|..|.++.||+.+|+|++.. ....++|++..-. -.|||||.++++|+.
T Consensus 55 k~~~it-edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D------s~KARrEVeLHw~~s~h~~iV~IidVyeNs 127 (400)
T KOG0604|consen 55 KEYSIT-EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD------SPKARREVELHWMASGHPHIVSIIDVYENS 127 (400)
T ss_pred hcccch-hhheehhhhhccccCCceEEEEeccchhhhHHHHHhc------CHHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence 334433 677774 569999999999999999999999999842 3567788887544 469999999999874
Q ss_pred ---CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcC---CCceEEec
Q 005886 84 ---GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS---NGAIKLAD 157 (671)
Q Consensus 84 ---~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~---~g~vKL~D 157 (671)
..++.+|||.|+||.|+..++......|+|..+..|++||..||.|||+.+|.||||||+|+|+.. |..+||+|
T Consensus 128 ~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 128 YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecc
Confidence 467999999999999999999987788999999999999999999999999999999999999965 45799999
Q ss_pred cccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHH---HHHHHHhcC
Q 005886 158 FGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK---VLLMTLQNA 234 (671)
Q Consensus 158 FGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~---~~~~~~~~~ 234 (671)
||+|+... ......+.|-||+|.|||++.. ..|+..+|+||+|||+|.|+||++||....... -....+...
T Consensus 208 fGFAK~t~----~~~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g 282 (400)
T KOG0604|consen 208 FGFAKETQ----EPGDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG 282 (400)
T ss_pred cccccccC----CCccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc
Confidence 99987543 2344566789999999999876 569999999999999999999999996543211 123344555
Q ss_pred CCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 235 PPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 235 ~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
...|+.+.|..+|+.++++|.++|..+|.+|+|+.+++.|||+.....
T Consensus 283 qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 283 QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA 330 (400)
T ss_pred CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence 566777788999999999999999999999999999999999987543
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=360.97 Aligned_cols=265 Identities=29% Similarity=0.430 Sum_probs=224.7
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcc--cHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN--DLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~--~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
++|++.+.||+|+||.||+|.+..+++.||||.+....... ....+.+|+.+++.++||||+++++.+.....+|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999997654432 4567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCc-
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR- 170 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~- 170 (671)
||+.|++|..++.......+++..++.++.||+.||+|||+.|++||||||+||+++.++.++|+|||++.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 9999999999987654567999999999999999999999999999999999999999999999999997644221110
Q ss_pred -------------------------ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHH
Q 005886 171 -------------------------QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK 225 (671)
Q Consensus 171 -------------------------~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~ 225 (671)
......+.||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 011224578999999999987 568999999999999999999999998877665
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCC----HHHHHhchhcccccc
Q 005886 226 VLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPT----AEKLMKHHFFKHARS 282 (671)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpS----a~eiL~Hpwfk~~~~ 282 (671)
.+..+..... .+.....++..+++||.+||..||.+||+ ++++|.||||+...+
T Consensus 240 ~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~ 297 (316)
T cd05574 240 TFSNILKKEV---TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNW 297 (316)
T ss_pred HHHHHhcCCc---cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCCh
Confidence 5554443321 22223337899999999999999999999 999999999987654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=360.12 Aligned_cols=260 Identities=33% Similarity=0.523 Sum_probs=215.6
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
++|++.+.||+|+||.||++.+..+|..||+|.+...........+.+|+++++.++||||++++++|..++.+|+||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 47999999999999999999999999999999987543333456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF-HGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs-~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
+.|++|..++... ..+++..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----- 153 (308)
T cd06615 81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----- 153 (308)
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-----
Confidence 9999999999876 678999999999999999999997 59999999999999999999999999998654221
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-------------
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD------------- 239 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~------------- 239 (671)
.....+|++.|+|||++.+ ..++.++|||||||++|+|++|..||........ ...+........
T Consensus 154 ~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 154 MANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL-EAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred ccccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH-HHhhcCccccccccCCcccccCCCC
Confidence 1234688999999999876 5688999999999999999999999975443222 111111100000
Q ss_pred ---------------------ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 240 ---------------------YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 240 ---------------------~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
......++.++++||.+||..+|.+||++.++++||||..+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 295 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAEL 295 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhccc
Confidence 0001136788999999999999999999999999999986543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=352.86 Aligned_cols=259 Identities=27% Similarity=0.430 Sum_probs=214.5
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
++|++.+.||+|+||.||+|.++.+|+.||+|++..... ......+.+|+.+++.++||||+++++++.....+++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 479999999999999999999999999999999865432 2234567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
|+.++.|..++... ..+++..++.++.||+.||+|||+.|++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--- 155 (286)
T cd07847 81 YCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--- 155 (286)
T ss_pred ccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc---
Confidence 99998887776543 5689999999999999999999999999999999999999999999999999875532211
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------------
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG--------------- 237 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~--------------- 237 (671)
......++..|+|||++.+...++.++|||||||++|+|++|..||.+....+....+.......
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 22345688999999998765568899999999999999999999998876655443332111000
Q ss_pred -CCc----------cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 238 -LDY----------ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 238 -~~~----------~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
... .....++..+.+||.+||..+|.+||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000 0123567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=352.96 Aligned_cols=258 Identities=39% Similarity=0.674 Sum_probs=213.4
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.++||||+++++++..+..+|+|||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 467999999999999999999999999999999986443 2345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
|+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..+... ..
T Consensus 87 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~---~~ 161 (267)
T cd06646 87 YCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT---IA 161 (267)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc---cc
Confidence 99999999988765 57899999999999999999999999999999999999999999999999998755321 11
Q ss_pred ccccccCCCCCCChhHhhh--ccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHH
Q 005886 173 SRNTFVGTPCWMAPEVMQQ--LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSF 250 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~--~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l 250 (671)
......|++.|+|||.+.+ ...++.++|+|||||++|+|++|..||....+......................++..+
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF 241 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHH
Confidence 2234578999999999853 23477899999999999999999999976554333222211111111111223568899
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHhchh
Q 005886 251 KELVTACLVKDPKKRPTAEKLMKHHF 276 (671)
Q Consensus 251 ~dLI~~cL~~dP~kRpSa~eiL~Hpw 276 (671)
.+||.+||..+|.+||+++++|+|+|
T Consensus 242 ~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 242 HNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 99999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=358.62 Aligned_cols=265 Identities=28% Similarity=0.433 Sum_probs=226.3
Q ss_pred eEE-EEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEEEec
Q 005886 16 YRL-YEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 16 Y~l-~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
|++ .+.||+|+||.|--+....+|.+||||+|++. ......++.+|++++..+ .|+||+.++++|+++..+|||||.
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEK 157 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEK 157 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEec
Confidence 444 35799999999999999999999999999866 345578899999999887 699999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC---ceEEeccccccccccCCCc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG---AIKLADFGVSACMFDAGDR 170 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g---~vKL~DFGls~~~~~~~~~ 170 (671)
|.||+|...|.+. ..|+|..+.+++++|+.||.|||.+||.||||||+|||..... -||||||.|..-+...++.
T Consensus 158 m~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 158 MRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred ccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 9999999988877 7899999999999999999999999999999999999996544 4899999987544322221
Q ss_pred ----ccccccccCCCCCCChhHhh----hccCCCccchhhhHHHHHHHHHhCCCCCCCCCh--------------HHHHH
Q 005886 171 ----QRSRNTFVGTPCWMAPEVMQ----QLHGYDFKADIWSFGITALELAHGHAPFSKYPP--------------MKVLL 228 (671)
Q Consensus 171 ----~~~~~~~~GT~~Y~APEvl~----~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~--------------~~~~~ 228 (671)
.....+.+|+..|||||+.. ....|+.++|.||||||||.|++|++||.+... .+.++
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF 315 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF 315 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence 11234568999999999974 234589999999999999999999999976432 23556
Q ss_pred HHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccccc
Q 005886 229 MTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSN 283 (671)
Q Consensus 229 ~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~ 283 (671)
..++.....++-..|..+|.+++++|..+|..||..|.++.++++|||++....+
T Consensus 316 esIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 316 ESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 6777777777777789999999999999999999999999999999999976654
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=352.56 Aligned_cols=257 Identities=39% Similarity=0.687 Sum_probs=215.2
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeeeEEEeC------C
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHCSFTTG------H 85 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~------~ 85 (671)
.+.|++.+.||.|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||++++++|... .
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 356889999999999999999999999999999986543 3346788999999988 799999999998753 4
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
.+|+||||+.+++|..++.......+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~ 162 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence 68999999999999999887544568999999999999999999999999999999999999999999999999986542
Q ss_pred cCCCcccccccccCCCCCCChhHhhh----ccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcc
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQ----LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYE 241 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~----~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~ 241 (671)
. .........|++.|+|||++.+ ...++.++|||||||++|+|++|..||................. ...
T Consensus 163 ~---~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~---~~~ 236 (272)
T cd06637 163 R---TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA---PRL 236 (272)
T ss_pred c---ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCC---CCC
Confidence 1 1122345679999999999863 13578899999999999999999999987665554443333221 122
Q ss_pred ccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 242 RDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 242 ~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
....++..+.+||.+||..+|.+|||+.++++||||
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 237 KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 234678899999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=375.53 Aligned_cols=270 Identities=28% Similarity=0.410 Sum_probs=231.8
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 86 (671)
.++..+.|...+.||+|+||.||-+..+.||+.||+|.+.+++.. .......+|-.+|.+++.++||.+-..|++.+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 789999999999999999999999999999999999999866543 234567889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
+++||..|.||+|...|.....++|++..++.|+.+|+.||++||+.+||+|||||+|||+|+.|+|+|+|+|||..+..
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 99999999999999888887667999999999999999999999999999999999999999999999999999876532
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHH---HHHHHHhcCCCCCCcccc
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK---VLLMTLQNAPPGLDYERD 243 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~---~~~~~~~~~~~~~~~~~~ 243 (671)
+. .....+||.+|||||++.. ..|+...|.|||||++|||+.|+.||....... .+...+... .-+.+
T Consensus 340 -g~---~~~~rvGT~GYMAPEvl~n-e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~----~~ey~ 410 (591)
T KOG0986|consen 340 -GK---PIRGRVGTVGYMAPEVLQN-EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED----PEEYS 410 (591)
T ss_pred -CC---ccccccCcccccCHHHHcC-CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc----hhhcc
Confidence 22 2223499999999999998 459999999999999999999999997654322 222222222 22335
Q ss_pred ccchHHHHHHHHHhhhcCCCCCCC-----HHHHHhchhccccccchHHH
Q 005886 244 KRFSKSFKELVTACLVKDPKKRPT-----AEKLMKHHFFKHARSNDFLA 287 (671)
Q Consensus 244 ~~ls~~l~dLI~~cL~~dP~kRpS-----a~eiL~Hpwfk~~~~~~~~~ 287 (671)
.++|+++++|...+|.+||.+|+. +.++.+||||+...|....+
T Consensus 411 ~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rlea 459 (591)
T KOG0986|consen 411 DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEA 459 (591)
T ss_pred cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhc
Confidence 789999999999999999999975 67999999999887754443
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=355.73 Aligned_cols=263 Identities=40% Similarity=0.710 Sum_probs=222.7
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
.++|++++.||.|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++..+..+|+|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 467999999999999999999999899999999986442 2345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
|+.|++|..++... ...+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++...... ..
T Consensus 83 ~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~---~~ 158 (280)
T cd06611 83 FCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST---LQ 158 (280)
T ss_pred ccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc---cc
Confidence 99999999988764 246899999999999999999999999999999999999999999999999987644221 12
Q ss_pred ccccccCCCCCCChhHhhh----ccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchH
Q 005886 173 SRNTFVGTPCWMAPEVMQQ----LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSK 248 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~----~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~ 248 (671)
......|++.|+|||++.. ...++.++|||||||++|+|++|..||.................+.+ ..+..++.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 236 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTL--DQPSKWSS 236 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCc--CCcccCCH
Confidence 2334578999999999853 23467899999999999999999999988776665555444333222 23456789
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 249 SFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 249 ~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
++.+||.+||..+|.+||++.++|+||||.....
T Consensus 237 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (280)
T cd06611 237 SFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSD 270 (280)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhcChhhcccch
Confidence 9999999999999999999999999999987644
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=356.60 Aligned_cols=266 Identities=36% Similarity=0.658 Sum_probs=223.0
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
..+.|++++.||+|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++..+..+|+||
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 4477999999999999999999999999999999986442 334567888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
||+.|++|..++.... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++...... .
T Consensus 89 e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~---~ 164 (292)
T cd06644 89 EFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT---L 164 (292)
T ss_pred ecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc---c
Confidence 9999999988776542 56899999999999999999999999999999999999999999999999987643221 1
Q ss_pred cccccccCCCCCCChhHhhh----ccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccch
Q 005886 172 RSRNTFVGTPCWMAPEVMQQ----LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~----~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls 247 (671)
.......|++.|+|||++.+ ...++.++|||||||++|+|++|..||.................+. ...+..++
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 242 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT--LSQPSKWS 242 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCcc--CCCCcccC
Confidence 22234578999999999852 2346889999999999999999999998876655554444332222 22345678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHhchhccccccch
Q 005886 248 KSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSND 284 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~~ 284 (671)
.++.+||.+||..+|.+||+++++++||||....+..
T Consensus 243 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 279 (292)
T cd06644 243 MEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR 279 (292)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence 8999999999999999999999999999998776654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=357.15 Aligned_cols=258 Identities=26% Similarity=0.389 Sum_probs=208.7
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
+|++.+.||.|+||.||+|.+..+|+.||+|.+...... .....+.+|+.+++.++||||+++++++.+...+|+|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 589999999999999999999999999999998754322 2245677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS 173 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 173 (671)
+.+ +|..++... ...+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++..+.. ....
T Consensus 81 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~---~~~~ 155 (284)
T cd07839 81 CDQ-DLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI---PVRC 155 (284)
T ss_pred CCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCC---CCCC
Confidence 975 777776643 25689999999999999999999999999999999999999999999999999865421 1122
Q ss_pred cccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCC-CCCChHHHHHHHHhcC--------------CCCC
Q 005886 174 RNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPF-SKYPPMKVLLMTLQNA--------------PPGL 238 (671)
Q Consensus 174 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF-~~~~~~~~~~~~~~~~--------------~~~~ 238 (671)
.....+++.|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+.+..+.... +...
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence 234578899999999887556899999999999999999988875 4433333222221110 0000
Q ss_pred C----------ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 239 D----------YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 239 ~----------~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
. ......++.++++||.+||..||.+|||++++|.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 01123568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=352.43 Aligned_cols=268 Identities=31% Similarity=0.557 Sum_probs=234.5
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCC-CCCceeeeeEEEeCC
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN-HPNVLRAHCSFTTGH 85 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~-HpNIVkl~~~~~~~~ 85 (671)
.++..+.++.+.+..||.|+.|.||+++++.+|...|||.+.+....++..++...+.++...+ .|+||+.+++|..+.
T Consensus 85 ~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~ 164 (391)
T KOG0983|consen 85 QRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT 164 (391)
T ss_pred cccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc
Confidence 5788899999999999999999999999999999999999988776777888999998886664 999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCcEEEcCCCceEEecccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF-HGHIHRDVKAGNILIDSNGAIKLADFGVSACM 164 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs-~gIVHrDLKPeNILld~~g~vKL~DFGls~~~ 164 (671)
.++|.||.|. .+.+.+.+...+.++|..+-.+...++.||.||.. +||+|||+||.|||+|..|++|+||||++-++
T Consensus 165 dV~IcMelMs--~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrl 242 (391)
T KOG0983|consen 165 DVFICMELMS--TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRL 242 (391)
T ss_pred hHHHHHHHHH--HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccccccee
Confidence 9999999983 46665554445779999999999999999999986 59999999999999999999999999999888
Q ss_pred ccCCCcccccccccCCCCCCChhHhhh--ccCCCccchhhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhcCCCCCCcc
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQ--LHGYDFKADIWSFGITALELAHGHAPFSKY-PPMKVLLMTLQNAPPGLDYE 241 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~--~~~~s~ksDIWSLGvILyeLltG~~PF~~~-~~~~~~~~~~~~~~~~~~~~ 241 (671)
.+... .....|.+.|||||.+.- ...|+-++||||||++|+||+||+.||.+. .+++.+..++.+.|+.++..
T Consensus 243 vdSkA----htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~ 318 (391)
T KOG0983|consen 243 VDSKA----HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGH 318 (391)
T ss_pred ecccc----cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcc
Confidence 65432 233479999999999864 245899999999999999999999999885 56778888888888777654
Q ss_pred ccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 242 RDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 242 ~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
.++|+.+++|+..||++|+.+||...++|+|||+.....
T Consensus 319 --~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~ 357 (391)
T KOG0983|consen 319 --MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYET 357 (391)
T ss_pred --cCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecch
Confidence 449999999999999999999999999999999987654
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=356.66 Aligned_cols=258 Identities=27% Similarity=0.446 Sum_probs=222.9
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
++|++.+.||.|+||.||++.+..+++.||+|++..... ......+.+|+++++.++||||+++++++..+..+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 479999999999999999999999999999999865432 234577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
||+.+++|.+++... ..+++..+..++.||+.||+|||+.|++||||+|.|||++.+|.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 999999999998876 67999999999999999999999999999999999999999999999999998655321
Q ss_pred cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHH
Q 005886 172 RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~ 251 (671)
....+|++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+.... ...+..++..++
T Consensus 155 --~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~ 226 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK-----VRFPSFFSPDAK 226 (290)
T ss_pred --CCCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----ccCCccCCHHHH
Confidence 334578999999999876 468889999999999999999999998776554444444321 223455789999
Q ss_pred HHHHHhhhcCCCCCC-----CHHHHHhchhccccccchH
Q 005886 252 ELVTACLVKDPKKRP-----TAEKLMKHHFFKHARSNDF 285 (671)
Q Consensus 252 dLI~~cL~~dP~kRp-----Sa~eiL~Hpwfk~~~~~~~ 285 (671)
++|.+||..||.+|+ +++++++||||....+...
T Consensus 227 ~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~ 265 (290)
T cd05580 227 DLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIAL 265 (290)
T ss_pred HHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHH
Confidence 999999999999999 9999999999987765443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=353.91 Aligned_cols=260 Identities=27% Similarity=0.450 Sum_probs=217.5
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
+|++.+.||.|+||.||+|.+..+|..||+|++..... ......+.+|+.+++.++||||+++++++..+..+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 58999999999999999999999999999999876543 23356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS 173 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 173 (671)
+ |++|..++.... ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~ 156 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP--RL 156 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC--Cc
Confidence 9 999999887643 5699999999999999999999999999999999999999999999999999875533221 22
Q ss_pred cccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---------------
Q 005886 174 RNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL--------------- 238 (671)
Q Consensus 174 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~--------------- 238 (671)
.....|+..|+|||++.+...++.++|||||||++|+|++|.+||.+..+...+..+........
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK 236 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhc
Confidence 33457899999999987655678999999999999999999999987766554444332211000
Q ss_pred -C---------ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcc
Q 005886 239 -D---------YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278 (671)
Q Consensus 239 -~---------~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk 278 (671)
. .......+..+.+||.+||..+|.+||+++++|+||||.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0 001134578899999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=353.75 Aligned_cols=259 Identities=39% Similarity=0.680 Sum_probs=215.0
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++..+..+|+||
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 3468999999999999999999999999999999986543 233456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
||+.+++|.+++... +.+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++..... ..
T Consensus 86 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~---~~ 160 (267)
T cd06645 86 EFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA---TI 160 (267)
T ss_pred eccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC---cc
Confidence 999999999998765 5799999999999999999999999999999999999999999999999999865422 11
Q ss_pred cccccccCCCCCCChhHhh--hccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHH
Q 005886 172 RSRNTFVGTPCWMAPEVMQ--QLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~--~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
.......|++.|+|||++. ....++.++|+|||||++|+|++|..||....+......................++..
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNS 240 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHH
Confidence 2233457999999999974 22458889999999999999999999997655444333222221111111112346789
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHhchh
Q 005886 250 FKELVTACLVKDPKKRPTAEKLMKHHF 276 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpSa~eiL~Hpw 276 (671)
+.+||.+||..+|++||++++++.|||
T Consensus 241 ~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 241 FHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=376.86 Aligned_cols=257 Identities=25% Similarity=0.412 Sum_probs=222.0
Q ss_pred ccccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC
Q 005886 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH 85 (671)
Q Consensus 6 e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~ 85 (671)
.++|.+....+++++.||+|.||.||.|....+ ..||+|.+.... ...+.+.+|+++|++|.|+|||++++++..++
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~--m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~ 274 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGS--MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE 274 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccc--cChhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence 466788888889999999999999999998743 369999986543 23367789999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
.+|||||||+.|+|.++++......+.......++.||++|++||+++++|||||...|||+++++.|||+|||||+...
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC
Confidence 99999999999999999998555789999999999999999999999999999999999999999999999999998443
Q ss_pred cCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccc
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (671)
+.. ........-...|.|||.+.. ..++.++|||||||+||||+| |+.||.+.+..+.+..+-+ ++..+.+.
T Consensus 355 d~~--Y~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~----GyRlp~P~ 427 (468)
T KOG0197|consen 355 DDE--YTASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLER----GYRLPRPE 427 (468)
T ss_pred CCc--eeecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhc----cCcCCCCC
Confidence 222 222222334567999999987 569999999999999999999 9999999988776655443 56778899
Q ss_pred cchHHHHHHHHHhhhcCCCCCCCHHHHH
Q 005886 245 RFSKSFKELVTACLVKDPKKRPTAEKLM 272 (671)
Q Consensus 245 ~ls~~l~dLI~~cL~~dP~kRpSa~eiL 272 (671)
.+|+++.+++..||..+|++|||++.+.
T Consensus 428 ~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 428 GCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 9999999999999999999999998654
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=353.26 Aligned_cols=254 Identities=31% Similarity=0.552 Sum_probs=211.8
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+|+.+++.++||||++++++|...+.+++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 47889999999999999999999999999999987554334456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS 173 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 173 (671)
+.+++|..+ ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++..+.. ..
T Consensus 81 ~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~-----~~ 149 (279)
T cd06619 81 MDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN-----SI 149 (279)
T ss_pred CCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc-----cc
Confidence 999988643 3478889999999999999999999999999999999999999999999999865422 12
Q ss_pred cccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChH-------HHHHHHHhcCCCCCCccccccc
Q 005886 174 RNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM-------KVLLMTLQNAPPGLDYERDKRF 246 (671)
Q Consensus 174 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~-------~~~~~~~~~~~~~~~~~~~~~l 246 (671)
....+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||...... .....+....++.. ....+
T Consensus 150 ~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 225 (279)
T cd06619 150 AKTYVGTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL---PVGQF 225 (279)
T ss_pred ccCCCCChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCC---CCCcC
Confidence 234689999999999986 56899999999999999999999999653221 11111111111111 12346
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 247 SKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 247 s~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
+.++.+||.+||..+|.+||++++++.||||.....
T Consensus 226 ~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~ 261 (279)
T cd06619 226 SEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYND 261 (279)
T ss_pred CHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccC
Confidence 789999999999999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=345.34 Aligned_cols=259 Identities=43% Similarity=0.736 Sum_probs=219.6
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
.++|++.+.||.|+||.||+|.+..+++.+|+|++..... .....+.+|+.+++.++||||+++++++...+.+|++||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch-hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 4789999999999999999999999999999999875532 256788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
|+.+++|..++... ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++...... ..
T Consensus 81 ~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~---~~ 156 (262)
T cd06613 81 YCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT---IA 156 (262)
T ss_pred CCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh---hh
Confidence 99999999988764 246899999999999999999999999999999999999999999999999998654321 11
Q ss_pred ccccccCCCCCCChhHhhhc--cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHH
Q 005886 173 SRNTFVGTPCWMAPEVMQQL--HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSF 250 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~--~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l 250 (671)
......|+..|+|||.+.+. ..++.++|+|||||++|+|++|..||.+..+.+....................++.++
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVF 236 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHH
Confidence 23345789999999998752 2578899999999999999999999988776655544443321111222344568899
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHhchh
Q 005886 251 KELVTACLVKDPKKRPTAEKLMKHHF 276 (671)
Q Consensus 251 ~dLI~~cL~~dP~kRpSa~eiL~Hpw 276 (671)
.+||.+||..+|..|||+.+++.|+|
T Consensus 237 ~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 237 HDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 99999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=355.11 Aligned_cols=261 Identities=38% Similarity=0.694 Sum_probs=221.1
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
..++|++.+.||+|+||.||+|.+..++..||+|.+...... ....+.+|+.+++.++||||+++++.|.....+|+||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 457899999999999999999999999999999998765433 3467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
||+.|++|..++... .+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++...... .
T Consensus 97 e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~---~ 170 (296)
T cd06654 97 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---Q 170 (296)
T ss_pred cccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc---c
Confidence 999999999988653 5789999999999999999999999999999999999999999999999987654221 1
Q ss_pred cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHH
Q 005886 172 RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~ 251 (671)
.......|++.|+|||.+.+ ..++.++|||||||++|+|++|..||....+............+ ....+..++..+.
T Consensus 171 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~ 247 (296)
T cd06654 171 SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP--ELQNPEKLSAIFR 247 (296)
T ss_pred cccCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCC--CCCCccccCHHHH
Confidence 12234578999999999876 56889999999999999999999999877654443333322221 1223456788999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 252 ELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 252 dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
+||.+||..+|.+||++.+++.||||...+.
T Consensus 248 ~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 278 (296)
T cd06654 248 DFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278 (296)
T ss_pred HHHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence 9999999999999999999999999986544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=405.70 Aligned_cols=267 Identities=28% Similarity=0.445 Sum_probs=233.6
Q ss_pred ccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q 005886 10 PVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCL 87 (671)
Q Consensus 10 ~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l 87 (671)
-+..++|++++.||+|+||.|..++++.|++.||+|++++..+ ..+..-|..|-.+|...+.+-|+.++..|.++.++
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 3567899999999999999999999999999999999976322 23456788899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccC
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~ 167 (671)
|+|||||.||+|..++.+. ..+++..++.|+..|+.||.-||+.|+|||||||+|||||..|++||+|||.+..+...
T Consensus 151 YlVMdY~pGGDlltLlSk~--~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKF--DRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EEEEecccCchHHHHHhhc--CCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 9999999999999999887 47999999999999999999999999999999999999999999999999988776443
Q ss_pred CCcccccccccCCCCCCChhHhhhc----cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQL----HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 243 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~----~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (671)
|.. .....+|||-|++||++... ..|+..+|+||+||++|||+.|..||...+-.+.+..|+.. ...+.++..
T Consensus 229 G~V--~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h-k~~l~FP~~ 305 (1317)
T KOG0612|consen 229 GTV--RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH-KESLSFPDE 305 (1317)
T ss_pred CcE--EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch-hhhcCCCcc
Confidence 332 33456999999999999731 45899999999999999999999999987777777666654 334555555
Q ss_pred ccchHHHHHHHHHhhhcCCCCCCC---HHHHHhchhcccccc
Q 005886 244 KRFSKSFKELVTACLVKDPKKRPT---AEKLMKHHFFKHARS 282 (671)
Q Consensus 244 ~~ls~~l~dLI~~cL~~dP~kRpS---a~eiL~Hpwfk~~~~ 282 (671)
..+|.++++||.++++ +|+.|.. ++++..||||.+..|
T Consensus 306 ~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 306 TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 6799999999999986 7899998 999999999998887
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=352.82 Aligned_cols=260 Identities=37% Similarity=0.653 Sum_probs=220.2
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecc
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYM 94 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~ 94 (671)
.|++.+.||.|+||.||+|.+..++..+|+|.+.... ......+.+|+.+++.++||||++++++|..+..+|+||||+
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 3688899999999999999999999999999986433 234567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccc
Q 005886 95 AGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSR 174 (671)
Q Consensus 95 ~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 174 (671)
.+++|..++... ...+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++...... ....
T Consensus 85 ~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~---~~~~ 160 (282)
T cd06643 85 AGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT---IQRR 160 (282)
T ss_pred CCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc---cccc
Confidence 999998887653 256899999999999999999999999999999999999999999999999998654321 1223
Q ss_pred ccccCCCCCCChhHhhh----ccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHH
Q 005886 175 NTFVGTPCWMAPEVMQQ----LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSF 250 (671)
Q Consensus 175 ~~~~GT~~Y~APEvl~~----~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l 250 (671)
....|++.|+|||++.. ...++.++|||||||++|+|++|.+||................++.. ..+..++..+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 238 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL--AQPSRWSSEF 238 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC--CCccccCHHH
Confidence 34578999999999842 24477899999999999999999999988777666555554433322 2345678999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 251 KELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 251 ~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
++||.+||..||.+||++.++++||||+...
T Consensus 239 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 239 KDFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 9999999999999999999999999998654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=354.00 Aligned_cols=261 Identities=38% Similarity=0.669 Sum_probs=222.6
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LV 90 (671)
-..++|++.+.||.|+||.||+|.+..+|+.||+|.+..... .....+.+|+.+++.++||||+++++++.....+|+|
T Consensus 16 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred CCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 344679999999999999999999999999999999875432 3357788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCc
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR 170 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~ 170 (671)
|||+.|++|..++... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 95 ~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~-- 169 (296)
T cd06655 95 MEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ-- 169 (296)
T ss_pred EEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc--
Confidence 9999999999988653 58999999999999999999999999999999999999999999999999986543221
Q ss_pred ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHH
Q 005886 171 QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSF 250 (671)
Q Consensus 171 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l 250 (671)
.......|++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.........+.....+. ...+..++..+
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 245 (296)
T cd06655 170 -SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE--LQNPEKLSPIF 245 (296)
T ss_pred -ccCCCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcc--cCCcccCCHHH
Confidence 12234578999999999876 568899999999999999999999998877655544443322222 22345678899
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 251 KELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 251 ~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
.+||.+||..||.+||++.+++.||||+.+.
T Consensus 246 ~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 246 RDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred HHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 9999999999999999999999999998655
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=346.62 Aligned_cols=256 Identities=32% Similarity=0.569 Sum_probs=216.6
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcc--------cHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN--------DLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~--------~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 86 (671)
+|.+...||.|+||.||+|.+..+++.||+|.+....... ..+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4788899999999999999999899999999986543221 23568899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
+++||||+.+++|..++... +.+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 99999999999999999765 5689999999999999999999999999999999999999999999999999876642
Q ss_pred CCCc---ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 005886 167 AGDR---QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 243 (671)
Q Consensus 167 ~~~~---~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (671)
.... ........|++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+...............+ ..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~ 233 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASP----EIP 233 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCC----cCC
Confidence 2111 112234568999999999986 56889999999999999999999999887665544443332222 234
Q ss_pred ccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 244 KRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 244 ~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
..++..+.++|.+||..||.+||++.++++||||
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 234 SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred cccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 5678999999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=356.65 Aligned_cols=261 Identities=39% Similarity=0.697 Sum_probs=220.1
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
..++|++.+.||.|+||.||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.++||||++++++|..+..+|+||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 34789999999999999999999999999999999875443 23467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
||+.|++|..++... .+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++...... .
T Consensus 96 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~---~ 169 (297)
T cd06656 96 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---Q 169 (297)
T ss_pred cccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC---c
Confidence 999999999988653 5889999999999999999999999999999999999999999999999998654221 1
Q ss_pred cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHH
Q 005886 172 RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~ 251 (671)
.......|++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.................+ ....+..++..++
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 246 (297)
T cd06656 170 SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP--ELQNPERLSAVFR 246 (297)
T ss_pred cCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCC--CCCCccccCHHHH
Confidence 12234578999999999986 66889999999999999999999999776554333222222111 1223456788999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 252 ELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 252 dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
+||.+||..+|.+||++.++|+||||+..+.
T Consensus 247 ~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 247 DFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred HHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 9999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=352.44 Aligned_cols=259 Identities=28% Similarity=0.429 Sum_probs=214.3
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
+|++.+.||.|+||.||+|++..+|..||||.+...... .....+.+|+++++.++||||+++++++.++..+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 489999999999999999999999999999998754322 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS 173 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 173 (671)
+. ++|..++.......+++..++.++.||+.||+|||+.|++||||+|+||+++.++.+||+|||++...... ...
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~---~~~ 156 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRT 156 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC---ccc
Confidence 96 57888887654567899999999999999999999999999999999999999999999999998654211 112
Q ss_pred cccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--------------
Q 005886 174 RNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD-------------- 239 (671)
Q Consensus 174 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~-------------- 239 (671)
.....+++.|+|||++.+...++.++|||||||++|+|++|..||...+.................
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 233467899999999876555788999999999999999999999877665544443322111100
Q ss_pred ----------ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 240 ----------YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 240 ----------~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
......++.++++||.+||..||.+|||++++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 01123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=347.19 Aligned_cols=258 Identities=28% Similarity=0.518 Sum_probs=213.6
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc----ccHHHHHHHHHHHHhCCCCCceeeeeEEEe--CCEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN----NDLDGIRREVQTMRVTNHPNVLRAHCSFTT--GHCL 87 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~----~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~--~~~l 87 (671)
.+|++.+.||+|+||.||+|.+..+|..||+|.+...... .....+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 5799999999999999999999999999999998654321 235678899999999999999999999876 4678
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccC
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~ 167 (671)
+++|||+.+++|..++... ..+++..++.++.||+.||+|||+.|++||||||+||+++.++.+||+|||+++.+...
T Consensus 82 ~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 9999999999999998765 46899999999999999999999999999999999999999999999999998654221
Q ss_pred CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccch
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls 247 (671)
...........|+..|+|||++.+ ..++.++|||||||++|+|++|+.||................ .....+..++
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~~ 235 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP---TNPQLPSHIS 235 (266)
T ss_pred cccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCC---CCCCCchhcC
Confidence 111112233568999999999987 568899999999999999999999998776555443332211 1122345578
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHhchhcc
Q 005886 248 KSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk 278 (671)
+.+++|| .||..+|.+||+++++++||||+
T Consensus 236 ~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 236 EHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 8899999 67778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=343.25 Aligned_cols=251 Identities=27% Similarity=0.472 Sum_probs=216.5
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecc
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYM 94 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~ 94 (671)
+|++.+.||.|+||.||++.+..+++.||+|.+.........+.+.+|+.+++.++||||++++++|.++..+|+||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 58999999999999999999999999999999876554455678889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccc
Q 005886 95 AGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSR 174 (671)
Q Consensus 95 ~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 174 (671)
.+|+|..++.......+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..+.... ...
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~---~~~ 157 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG---AYA 157 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc---ccc
Confidence 99999998876544568999999999999999999999999999999999999999999999999986553221 122
Q ss_pred ccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHH
Q 005886 175 NTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELV 254 (671)
Q Consensus 175 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI 254 (671)
....|++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+.............. +.+..++..+.+||
T Consensus 158 ~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li 232 (255)
T cd08219 158 CTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK----PLPSHYSYELRSLI 232 (255)
T ss_pred ccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC----CCCcccCHHHHHHH
Confidence 34578999999999877 56899999999999999999999999887665554444433222 22446788999999
Q ss_pred HHhhhcCCCCCCCHHHHHh
Q 005886 255 TACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 255 ~~cL~~dP~kRpSa~eiL~ 273 (671)
.+||..||.+||++.+++.
T Consensus 233 ~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 233 KQMFKRNPRSRPSATTILS 251 (255)
T ss_pred HHHHhCCcccCCCHHHHhh
Confidence 9999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=345.93 Aligned_cols=261 Identities=40% Similarity=0.710 Sum_probs=218.3
Q ss_pred ccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeeeEEEeCC---
Q 005886 10 PVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHCSFTTGH--- 85 (671)
Q Consensus 10 ~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~~--- 85 (671)
+-..++|++.+.||.|+||.||+|.+..+++.|++|++.... ...+.+.+|+.+++.+ +||||++++++|....
T Consensus 2 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred CCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 445689999999999999999999999999999999986543 2346788999999998 7999999999997644
Q ss_pred ---EEEEEEeccCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccc
Q 005886 86 ---CLWVVMPYMAGGSCLHIMKSAY--PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGV 160 (671)
Q Consensus 86 ---~l~LVmEy~~ggsL~~~l~~~~--~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGl 160 (671)
.+|+||||+.+++|.+++.... ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 5899999999999999887543 45789999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCcccccccccCCCCCCChhHhhhc----cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC
Q 005886 161 SACMFDAGDRQRSRNTFVGTPCWMAPEVMQQL----HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP 236 (671)
Q Consensus 161 s~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~----~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~ 236 (671)
+...... ........|++.|+|||++... ..++.++|||||||++|+|++|..||...........+.....+
T Consensus 160 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 236 (275)
T cd06608 160 SAQLDST---LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP 236 (275)
T ss_pred ceecccc---hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC
Confidence 7654221 1223345789999999998542 34678999999999999999999999876665555555544332
Q ss_pred CCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 237 GLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 237 ~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
.. .....++..+++||.+||..||.+|||+.++++|||+
T Consensus 237 ~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 237 TL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 22 2233478899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=351.62 Aligned_cols=258 Identities=39% Similarity=0.703 Sum_probs=215.4
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeeeEEEe------C
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHCSFTT------G 84 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~------~ 84 (671)
..+.|++.+.||.|+||.||+|.+..+++.||+|++.... .....+..|+.+++.+ +||||++++++|.. .
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 91 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence 3478999999999999999999999999999999986543 3345678899999888 79999999999853 5
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccc
Q 005886 85 HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACM 164 (671)
Q Consensus 85 ~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~ 164 (671)
..+|++|||+.+|+|.+++.......+++..++.++.||+.||.|||++||+||||+|+||+++.++.++|+|||++...
T Consensus 92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171 (282)
T ss_pred CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence 68999999999999999998755556889999999999999999999999999999999999999999999999997644
Q ss_pred ccCCCcccccccccCCCCCCChhHhhh----ccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCc
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQ----LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~----~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~ 240 (671)
... ........|++.|+|||++.. ...++.++|||||||++|+|++|..||....+...............
T Consensus 172 ~~~---~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 246 (282)
T cd06636 172 DRT---VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL-- 246 (282)
T ss_pred hcc---ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCC--
Confidence 211 122344679999999999852 24578899999999999999999999987766554444333322221
Q ss_pred cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 241 ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 241 ~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
....++..+.+||.+||..||.+||++.+||+||||
T Consensus 247 -~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 247 -KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred -cccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 234578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=370.53 Aligned_cols=261 Identities=22% Similarity=0.309 Sum_probs=208.6
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEc--CCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCI--PLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~--~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~ 88 (671)
+...+|++++.||.|+||.||+|... .++..||+|.+... ....+|+.+|+.++||||++++++|.....+|
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 34457999999999999999999764 45678999987543 23568999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
+|||++. ++|..++... ..+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||++..+....
T Consensus 163 lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EEehhcC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 9999995 5788887544 679999999999999999999999999999999999999999999999999986553221
Q ss_pred CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChH---HHHHHHHh---cCCCCCC---
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM---KVLLMTLQ---NAPPGLD--- 239 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~---~~~~~~~~---~~~~~~~--- 239 (671)
.........||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.... ..+..++. ..+..+.
T Consensus 240 -~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 240 -DTPQCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred -ccccccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 1222335689999999999986 56899999999999999999999999764321 11111111 1000000
Q ss_pred ------------------cc-----ccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 240 ------------------YE-----RDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 240 ------------------~~-----~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
+. ....++.++++||.+||..||.+|||+.++|.||||+...+
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence 00 11235678999999999999999999999999999986544
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=348.29 Aligned_cols=262 Identities=32% Similarity=0.567 Sum_probs=212.0
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHH-HHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQT-MRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~i-L~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
++|++.+.||+|+||.||+|.+..+|+.||||.+...........+..|+.+ ++.++||||+++++++..+..+|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 4799999999999999999999999999999998765433333455556654 677899999999999999999999999
Q ss_pred ccCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCcEEEcCCCceEEeccccccccccCCC
Q 005886 93 YMAGGSCLHIMKSAY--PEGFEEPVIATLLRETLKALVYLHFH-GHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 93 y~~ggsL~~~l~~~~--~~~l~e~~i~~i~~qIl~aL~yLHs~-gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~ 169 (671)
|+. |+|..++.... ...+++..++.++.||+.||+|||++ +++||||||+|||++.++.+||+|||++..+...
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-- 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS-- 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc--
Confidence 996 57877765432 24689999999999999999999998 9999999999999999999999999998654221
Q ss_pred cccccccccCCCCCCChhHhhhc---cCCCccchhhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcCCCCCCcccccc
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQL---HGYDFKADIWSFGITALELAHGHAPFSKYP-PMKVLLMTLQNAPPGLDYERDKR 245 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~---~~~s~ksDIWSLGvILyeLltG~~PF~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 245 (671)
.......|+..|+|||++.+. ..++.++|+|||||++|+|++|..||.... ..+.+........+.+. ...
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~ 232 (283)
T cd06617 158 --VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLP---AEK 232 (283)
T ss_pred --cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCC---ccc
Confidence 112235789999999998642 347889999999999999999999997543 33333344433322221 235
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccccc
Q 005886 246 FSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSN 283 (671)
Q Consensus 246 ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~ 283 (671)
+|.++.+||.+||..+|.+||++.+++.||||......
T Consensus 233 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 270 (283)
T cd06617 233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK 270 (283)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence 78999999999999999999999999999999876543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=350.59 Aligned_cols=260 Identities=27% Similarity=0.395 Sum_probs=209.5
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
.++|++.+.||.|+||.||+|.++.+++.||||.+...........+.+|+.+++.++||||+++++++.++..+|+|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 47899999999999999999999999999999998755433334556789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
|+.+ +|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...... .
T Consensus 84 ~~~~-~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~---~ 158 (291)
T cd07844 84 YLDT-DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS---K 158 (291)
T ss_pred cCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC---c
Confidence 9975 8988876542 468999999999999999999999999999999999999999999999999976432111 1
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhcCC---CC-----------
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPP-MKVLLMTLQNAP---PG----------- 237 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~-~~~~~~~~~~~~---~~----------- 237 (671)
......++..|+|||++.+...++.++|||||||++|+|++|..||.+... .+.+..+..... +.
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 122335788999999987655688999999999999999999999976552 222211111000 00
Q ss_pred ----CCc-------cccccch--HHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 238 ----LDY-------ERDKRFS--KSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 238 ----~~~-------~~~~~ls--~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
... .....++ ..+.++|.+||..+|.+|||+.++|.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 0011234 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=372.49 Aligned_cols=254 Identities=29% Similarity=0.456 Sum_probs=225.1
Q ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccCCC
Q 005886 19 YEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGG 97 (671)
Q Consensus 19 ~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~gg 97 (671)
-+.||.|.||+||-|+++.+|+.||||+|++.+.+ +....+++|+.||+.++||.||.+...|++.+.+++|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 36799999999999999999999999999988765 4457889999999999999999999999999999999999965
Q ss_pred CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC---ceEEeccccccccccCCCccccc
Q 005886 98 SCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG---AIKLADFGVSACMFDAGDRQRSR 174 (671)
Q Consensus 98 sL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g---~vKL~DFGls~~~~~~~~~~~~~ 174 (671)
++.+.|-....+.+++.....++.||+.||.|||.++|||+||||+|||+.... .+||||||+|++... ...+
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE----ksFR 723 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE----KSFR 723 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch----hhhh
Confidence 666666555568899999999999999999999999999999999999996543 799999999988732 3345
Q ss_pred ccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHH
Q 005886 175 NTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELV 254 (671)
Q Consensus 175 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI 254 (671)
.+.+|||.|.|||++.. ++|+..-||||.|||+|.-+.|..||....+ +...+++..-.++...|..++.++.|||
T Consensus 724 rsVVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd---IndQIQNAaFMyPp~PW~eis~~AidlI 799 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDED---INDQIQNAAFMYPPNPWSEISPEAIDLI 799 (888)
T ss_pred hhhcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCccc---hhHHhhccccccCCCchhhcCHHHHHHH
Confidence 67899999999999997 7899999999999999999999999976443 4456677766666777999999999999
Q ss_pred HHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 255 TACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 255 ~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
..+|+..-.+|.+.++.|.|||++...
T Consensus 800 n~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 800 NNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred HHHHHHHHHHhcchHhhccchhhhcch
Confidence 999999999999999999999998653
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=342.89 Aligned_cols=255 Identities=25% Similarity=0.459 Sum_probs=219.6
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
+|++.+.||+|+||.||++.+..+|+.||+|.+..... ......+.+|+.+++.++||||+++++++...+.+|+||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 58999999999999999999999999999999875432 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS 173 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 173 (671)
+.+++|.+.+.......+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~ 157 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV---EL 157 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch---hh
Confidence 999999998876544468999999999999999999999999999999999999999999999999986542211 11
Q ss_pred cccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHH
Q 005886 174 RNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL 253 (671)
Q Consensus 174 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dL 253 (671)
.....|++.|+|||++.+ ..++.++|+|||||++|+|++|..||...........++....+ ..+..++.++.++
T Consensus 158 ~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l 232 (256)
T cd08218 158 ARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYP----PVSSHYSYDLRNL 232 (256)
T ss_pred hhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCC----CCcccCCHHHHHH
Confidence 223568999999999876 56888999999999999999999999877766665555544322 2245678899999
Q ss_pred HHHhhhcCCCCCCCHHHHHhchhc
Q 005886 254 VTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 254 I~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
|.+||..+|.+||++.++|+||||
T Consensus 233 i~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 233 VSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHhhCChhhCcCHHHHhhCcCC
Confidence 999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=344.35 Aligned_cols=259 Identities=28% Similarity=0.483 Sum_probs=215.0
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC----cccHHHHHHHHHHHHhCCCCCceeeeeEEEe--CCE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC----NNDLDGIRREVQTMRVTNHPNVLRAHCSFTT--GHC 86 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~----~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~--~~~ 86 (671)
.++|++.+.||+|+||.||+|.+..+|..||||.+..... ......+.+|+.+++.++||||+++++++.+ ...
T Consensus 1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence 3689999999999999999999999999999999864321 1235678899999999999999999999876 357
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
+|+||||+.|++|.+++... ..+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++..+..
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 89999999999999998765 4688999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (671)
............|+..|+|||++.+ ..++.++|||||||++|+|++|+.||................ .....+..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~ 234 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP---TNPVLPPHV 234 (265)
T ss_pred ccccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCC---CCCCCchhh
Confidence 2111122334578999999999976 568999999999999999999999998776555443333221 112234567
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHhchhcc
Q 005886 247 SKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278 (671)
Q Consensus 247 s~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk 278 (671)
+..+.++|.+||. +|.+||+++++++|||+.
T Consensus 235 ~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 235 SDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred CHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 8889999999994 999999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=349.42 Aligned_cols=258 Identities=45% Similarity=0.800 Sum_probs=220.9
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
..|+..+.||.|+||.||+|.+..++..||||++...........+.+|+.+++.++||||+++++++.++..+|+||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 46888899999999999999999999999999987655445567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS 173 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 173 (671)
+.||+|.+++.. ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 84 ~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~ 157 (277)
T cd06640 84 LGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ---IK 157 (277)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc---cc
Confidence 999999998865 368899999999999999999999999999999999999999999999999986553211 12
Q ss_pred cccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHH
Q 005886 174 RNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL 253 (671)
Q Consensus 174 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dL 253 (671)
.....++..|+|||++.+ ..++.++|+|||||++|+|++|..||....+......+....++ .....++..+.+|
T Consensus 158 ~~~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l 232 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPP----TLTGEFSKPFKEF 232 (277)
T ss_pred cccccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCC----CCchhhhHHHHHH
Confidence 234578999999999876 56899999999999999999999999877665544433222222 2344578899999
Q ss_pred HHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 254 VTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 254 I~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
|.+||..+|.+||++.+++.||||.....
T Consensus 233 i~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 233 IDACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred HHHHcccCcccCcCHHHHHhChHhhhcch
Confidence 99999999999999999999999976554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=346.36 Aligned_cols=261 Identities=28% Similarity=0.523 Sum_probs=214.9
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-----ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-----NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWV 89 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-----~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~L 89 (671)
+|+..+.||+|+||.||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++.+...+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 488889999999999999999999999999998754321 135678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC-ceEEeccccccccccCC
Q 005886 90 VMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG-AIKLADFGVSACMFDAG 168 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g-~vKL~DFGls~~~~~~~ 168 (671)
||||+.|++|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .+||+|||++..+....
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999999998765 5789999999999999999999999999999999999998776 59999999986653321
Q ss_pred Cc-ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccch
Q 005886 169 DR-QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 169 ~~-~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls 247 (671)
.. ........|+..|+|||++.+ ..++.++|+|||||++|+|++|..||...........+............+..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred ccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 11 111234578999999999876 5689999999999999999999999975443222222211111112223345678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHhchhcc
Q 005886 248 KSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk 278 (671)
..+.++|.+||..+|.+||++.++++||||+
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 9999999999999999999999999999994
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=352.63 Aligned_cols=264 Identities=28% Similarity=0.490 Sum_probs=217.6
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
++|++++.||+|+||.||+|.+..+|..||+|.+...........+.+|+.+++.++||||+++++++...+.+|+||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 47899999999999999999999999999999987543334457788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 94 MAGGSCLHIMKSAY-PEGFEEPVIATLLRETLKALVYLHF-HGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 94 ~~ggsL~~~l~~~~-~~~l~e~~i~~i~~qIl~aL~yLHs-~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
+.|++|..++.... ...+++..+..++.||+.||.|||. .|++||||||+||+++.++.+||+|||++..+..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 155 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA----- 155 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC-----
Confidence 99999998887532 2368999999999999999999997 5999999999999999999999999999865421
Q ss_pred cccccccCCCCCCChhHhhhcc-----CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Q 005886 172 RSRNTFVGTPCWMAPEVMQQLH-----GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~~~-----~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (671)
.......|++.|+|||++.+.. .++.++|||||||++|+|++|..||............ ...........+..+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 234 (286)
T cd06622 156 SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL-SAIVDGDPPTLPSGY 234 (286)
T ss_pred CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH-HHHhhcCCCCCCccc
Confidence 1223457889999999986422 3578999999999999999999999765443332221 111111122334558
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccccc
Q 005886 247 SKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSN 283 (671)
Q Consensus 247 s~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~ 283 (671)
+.++.+||.+||..+|.+||++.+++.||||......
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 8999999999999999999999999999999866543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=349.57 Aligned_cols=261 Identities=25% Similarity=0.345 Sum_probs=212.0
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCC-CCCceeeeeEEEeCCE-----
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTN-HPNVLRAHCSFTTGHC----- 86 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~-HpNIVkl~~~~~~~~~----- 86 (671)
++|++.+.||.|+||.||+|.+..+|+.||||++...... .....+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4799999999999999999999999999999998755322 23457788999999995 6999999999987665
Q ss_pred EEEEEeccCCCCHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcC-CCceEEecccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAY---PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS-NGAIKLADFGVSA 162 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~---~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~-~g~vKL~DFGls~ 162 (671)
+|+||||+.+ +|..++.... ...+++..++.++.||+.||.|||++|++||||||+||+++. ++.+||+|||++.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 8999999986 7888776542 235899999999999999999999999999999999999998 8899999999986
Q ss_pred ccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCCc
Q 005886 163 CMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP--PGLDY 240 (671)
Q Consensus 163 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~--~~~~~ 240 (671)
.+.... .......+++.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+..... ....+
T Consensus 160 ~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 160 AFSIPV---KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred ecCCCc---cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 542211 1122336789999999987656689999999999999999999999988776665544433211 00000
Q ss_pred ---------------------cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcc
Q 005886 241 ---------------------ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278 (671)
Q Consensus 241 ---------------------~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk 278 (671)
.....++..+.+||.+||..||.+||++.++|.||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 01134788999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=347.51 Aligned_cols=257 Identities=37% Similarity=0.631 Sum_probs=217.1
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
++|++.+.||.|+||.||+|.++.+++.||+|.+...........+.+|+.+++.++||||+++++++..+..+|+||||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 47888999999999999999999999999999987655444556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF-HGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs-~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
+.|++|.+++.... ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~---- 155 (265)
T cd06605 81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL---- 155 (265)
T ss_pred cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH----
Confidence 99999999987643 578999999999999999999999 999999999999999999999999999976542211
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHhcCCCCCCccccccch
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYP-----PMKVLLMTLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ls 247 (671)
.....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.... .............+... ...++
T Consensus 156 -~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 230 (265)
T cd06605 156 -AKTFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLP---SGKFS 230 (265)
T ss_pred -hhcccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCC---hhhcC
Confidence 112678999999999987 578999999999999999999999996542 22222223333222221 11278
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 248 KSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
..+.+||.+||..||.+|||+.+++.||||+..
T Consensus 231 ~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 231 PDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 899999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=350.02 Aligned_cols=260 Identities=26% Similarity=0.362 Sum_probs=208.5
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
.++|++.+.||+|+||.||+|.+..+|..||+|++...........+.+|+.+++.++|+||+++++++..+...|+|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 47899999999999999999999999999999998755433434567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
|+. +++...+... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus 84 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~ 158 (291)
T cd07870 84 YMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS---Q 158 (291)
T ss_pred ccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC---C
Confidence 996 5677666543 2467888899999999999999999999999999999999999999999999986542211 1
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHhc--------------CCCC
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM-KVLLMTLQN--------------APPG 237 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~-~~~~~~~~~--------------~~~~ 237 (671)
......+++.|+|||++.+...++.++|||||||++|+|++|..||.+.... +.+..+... .+..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence 2234467999999999876456888999999999999999999999766542 222221110 0000
Q ss_pred CC-----------ccccc--cchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 238 LD-----------YERDK--RFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 238 ~~-----------~~~~~--~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
.. ...+. ..+..+.+|+.+||..||.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00 00001 125688999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=354.21 Aligned_cols=255 Identities=25% Similarity=0.357 Sum_probs=195.3
Q ss_pred EEEecccCceEEEEEEEcC--CCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe--CCEEEEEEecc
Q 005886 19 YEEVGEGVSATVYRALCIP--LNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT--GHCLWVVMPYM 94 (671)
Q Consensus 19 ~~~LG~G~fG~Vyka~~~~--tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~--~~~l~LVmEy~ 94 (671)
..+||+|+||.||+|.++. ++..||+|.+.... ....+.+|+.+++.++||||+++++++.. +..+|+||||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 3579999999999999764 56889999986432 23457789999999999999999999854 56889999998
Q ss_pred CCCCHHHHHHhhC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEE----cCCCceEEeccccccc
Q 005886 95 AGGSCLHIMKSAY-------PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILI----DSNGAIKLADFGVSAC 163 (671)
Q Consensus 95 ~ggsL~~~l~~~~-------~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILl----d~~g~vKL~DFGls~~ 163 (671)
.+ +|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 65 7777765321 2358899999999999999999999999999999999999 4567899999999876
Q ss_pred cccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChH---------HHHHHHHhcC
Q 005886 164 MFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM---------KVLLMTLQNA 234 (671)
Q Consensus 164 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~---------~~~~~~~~~~ 234 (671)
...............||+.|+|||++.+...++.++|||||||++|+|++|.+||...... ..+..+....
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence 5332222223345688999999999987566899999999999999999999999643211 0111111000
Q ss_pred --CCCCC-------------------------------ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 235 --PPGLD-------------------------------YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 235 --~~~~~-------------------------------~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
+.... .......+..+.+||.+||..||.+|||+.++|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00000 00011234568899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=339.99 Aligned_cols=255 Identities=27% Similarity=0.454 Sum_probs=220.5
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
+|++++.||.|+||.||.+++..++..+++|.+..... ......+.+|+.+++.++|+||+++++++.+...++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 59999999999999999999999999999999876543 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS 173 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 173 (671)
|.|++|.+++.......+++..+..++.|++.||+|||+.|++||||+|+||+++.++.+||+|||++........ .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~---~ 157 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS---M 157 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc---c
Confidence 9999999999875445689999999999999999999999999999999999999999999999999865532221 2
Q ss_pred cccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHH
Q 005886 174 RNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL 253 (671)
Q Consensus 174 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dL 253 (671)
.....|++.|+|||++.+ ..++.++|+||||+++|+|++|..||......+....+...... .....++..+.++
T Consensus 158 ~~~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 232 (256)
T cd08221 158 AETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT----PVVSVYSSELISL 232 (256)
T ss_pred ccccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC----CCccccCHHHHHH
Confidence 334578999999999886 45888999999999999999999999887766655555443222 1235678899999
Q ss_pred HHHhhhcCCCCCCCHHHHHhchhc
Q 005886 254 VTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 254 I~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
|.+||..+|.+||++.++|+|||+
T Consensus 233 i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 233 VHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHcccCcccCCCHHHHhhCcCC
Confidence 999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=395.31 Aligned_cols=266 Identities=26% Similarity=0.419 Sum_probs=220.2
Q ss_pred ccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEe--C
Q 005886 8 RFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTT--G 84 (671)
Q Consensus 8 ~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~--~ 84 (671)
..++..++|++++.||+|+||+||+|.++.++..||+|++...... .....+..|+.+|+.++|||||+++++|.. .
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 3456678999999999999999999999999999999998765433 345678899999999999999999999864 4
Q ss_pred CEEEEEEeccCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHC-------CcccccCCCCcEEEcC------
Q 005886 85 HCLWVVMPYMAGGSCLHIMKSAY--PEGFEEPVIATLLRETLKALVYLHFH-------GHIHRDVKAGNILIDS------ 149 (671)
Q Consensus 85 ~~l~LVmEy~~ggsL~~~l~~~~--~~~l~e~~i~~i~~qIl~aL~yLHs~-------gIVHrDLKPeNILld~------ 149 (671)
..+|||||||.+|+|..+|.... ...+++..++.|+.||+.||.|||.. +||||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 57999999999999999887532 24699999999999999999999985 4999999999999964
Q ss_pred -----------CCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhc-cCCCccchhhhHHHHHHHHHhCCCC
Q 005886 150 -----------NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQL-HGYDFKADIWSFGITALELAHGHAP 217 (671)
Q Consensus 150 -----------~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~~s~ksDIWSLGvILyeLltG~~P 217 (671)
.+.+||+|||++..+... ......+||+.|+|||++.+. ..++.++||||||||||+|++|..|
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~----s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P 242 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIE----SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242 (1021)
T ss_pred cccccccccCCCCceEEccCCcccccccc----ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 235899999998654221 122345899999999998642 4588999999999999999999999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 218 FSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 218 F~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
|........+...+...+. + ....++.++.+||..||..+|.+||++.++|.||||+...
T Consensus 243 F~~~~~~~qli~~lk~~p~-l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 243 FHKANNFSQLISELKRGPD-L---PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred CCcCCcHHHHHHHHhcCCC-C---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 9877666555555544321 1 1234688999999999999999999999999999998543
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=352.33 Aligned_cols=265 Identities=28% Similarity=0.462 Sum_probs=220.5
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
++|++.+.||+|+||.||++.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++.+..+..+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 479999999999999999999999999999999875432 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC---
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG--- 168 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~--- 168 (671)
||+.|++|..++... +.+++..+..++.|++.||.|||++|++||||||+||+++.+|.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 999999999999775 568999999999999999999999999999999999999999999999999876321100
Q ss_pred ---------CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC
Q 005886 169 ---------DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD 239 (671)
Q Consensus 169 ---------~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~ 239 (671)
..........|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.+....+............ .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~ 236 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW-P 236 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC-C
Confidence 00011123468889999999876 568999999999999999999999998877665555444332111 1
Q ss_pred ccccccchHHHHHHHHHhhhcCCCCCCC---HHHHHhchhccccccc
Q 005886 240 YERDKRFSKSFKELVTACLVKDPKKRPT---AEKLMKHHFFKHARSN 283 (671)
Q Consensus 240 ~~~~~~ls~~l~dLI~~cL~~dP~kRpS---a~eiL~Hpwfk~~~~~ 283 (671)
. ....++..+.+||.+||..||.+||+ +.++|.||||....+.
T Consensus 237 ~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~ 282 (305)
T cd05609 237 E-GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWN 282 (305)
T ss_pred C-ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHH
Confidence 1 12257889999999999999999998 7999999999876554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=341.86 Aligned_cols=255 Identities=43% Similarity=0.768 Sum_probs=218.2
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
.++|++.+.||.|+||.||+|.+..++..||+|.+..... ...+.+|+.+++.++||||+++++++..+..+|+++|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 3689999999999999999999998899999999864432 6789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
|+.+++|.+++... ...+++..++.++.|++.||.|||..|++||||+|+||+++.++.+||+|||++....... .
T Consensus 79 ~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~---~ 154 (256)
T cd06612 79 YCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM---A 154 (256)
T ss_pred cCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc---c
Confidence 99999999998653 2568999999999999999999999999999999999999999999999999986553221 1
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHH
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKE 252 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~d 252 (671)
......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||....+......+...... ....+..++..+.+
T Consensus 155 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 231 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPP--TLSDPEKWSPEFND 231 (256)
T ss_pred ccccccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCC--CCCchhhcCHHHHH
Confidence 2234568999999999987 56899999999999999999999999877665544333332222 22234567889999
Q ss_pred HHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 253 LVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 253 LI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
||.+||..||.+|||+.++|.||||
T Consensus 232 ~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 232 FVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHhcChhhCcCHHHHhcCCCC
Confidence 9999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=360.46 Aligned_cols=266 Identities=24% Similarity=0.342 Sum_probs=213.1
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeC-----CEE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG-----HCL 87 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~-----~~l 87 (671)
.++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+|+.+++.++||||+++++++... ..+
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 378999999999999999999999999999999986433334456678899999999999999999887654 358
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccC
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~ 167 (671)
|+||||+.+ +|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 84 ~lv~e~~~~-~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 84 YIVQELMET-DLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred EEEehhccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 999999964 78777754 46899999999999999999999999999999999999999999999999998765332
Q ss_pred CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-------------
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA------------- 234 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~------------- 234 (671)
..........+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.........+....
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 2222223346789999999998765568999999999999999999999997755433222111100
Q ss_pred ----------CCCCCc---cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 235 ----------PPGLDY---ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 235 ----------~~~~~~---~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
+..... .....++.++.+||.+||..+|.+|||+.++++||||+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 000000 011345788999999999999999999999999999986653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=349.14 Aligned_cols=258 Identities=24% Similarity=0.381 Sum_probs=215.8
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCC-----cEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLN-----EIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH 85 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg-----~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~ 85 (671)
+...+|++++.||+|+||.||+|.+...+ ..||+|.+...........+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 34578999999999999999999877655 6799999875443444567889999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYP--------------EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG 151 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~--------------~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g 151 (671)
..|++|||+.+|+|.+++..... ..+++..++.++.||+.||+|||++|++||||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 99999999999999999876422 4578889999999999999999999999999999999999999
Q ss_pred ceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 005886 152 AIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMT 230 (671)
Q Consensus 152 ~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~ 230 (671)
.+||+|||++....... .........+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+
T Consensus 162 ~~~L~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05048 162 TVKISDFGLSRDIYSAD-YYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239 (283)
T ss_pred cEEECCCcceeeccccc-cccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999999987553222 1122334467889999999876 568999999999999999998 99999987776655444
Q ss_pred HhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 231 LQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 231 ~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
...... ..+..++.++.+|+.+||..||.+||++.+++++
T Consensus 240 ~~~~~~----~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 240 RSRQLL----PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HcCCcC----CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 433222 2345689999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=346.44 Aligned_cols=258 Identities=41% Similarity=0.743 Sum_probs=218.7
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCC---CCCceeeeeEEEeCCEEEEEE
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN---HPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~---HpNIVkl~~~~~~~~~l~LVm 91 (671)
.|++.+.||.|+||.||+|.+..+|+.||+|.+...........+.+|+.+++.+. ||||+++++++..+..+|+||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 58889999999999999999999999999999876544555678889999999886 999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
||+.|++|.+++... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+....
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--- 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--- 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc---
Confidence 999999999988653 68999999999999999999999999999999999999999999999999987653322
Q ss_pred cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHH
Q 005886 172 RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~ 251 (671)
.......|++.|+|||.+.+...++.++|+|||||++|+|++|..||.+..............++.+. ...++.++.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 232 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLE---DNGYSKLLR 232 (277)
T ss_pred cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCC---cccCCHHHH
Confidence 22334579999999999876556789999999999999999999999877655443322222222211 123788999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 252 ELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 252 dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
+||.+||..||.+||++.++++||||+...
T Consensus 233 ~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 233 EFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 999999999999999999999999997654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=352.03 Aligned_cols=260 Identities=22% Similarity=0.335 Sum_probs=208.1
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcC----------------CCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCc
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIP----------------LNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNV 74 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~----------------tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNI 74 (671)
+..++|++.+.||+|+||.||+|.+.. ++..||+|++...........+.+|+.++..++||||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCe
Confidence 356789999999999999999997532 3457999998755434445678899999999999999
Q ss_pred eeeeeEEEeCCEEEEEEeccCCCCHHHHHHhhCC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 005886 75 LRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYP-----------------EGFEEPVIATLLRETLKALVYLHFHGHIH 137 (671)
Q Consensus 75 Vkl~~~~~~~~~l~LVmEy~~ggsL~~~l~~~~~-----------------~~l~e~~i~~i~~qIl~aL~yLHs~gIVH 137 (671)
+++++++.+.+.+|+||||+.+|+|.+++..... ..+++..++.++.||+.||.|||++||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 9999999999999999999999999998865321 23677889999999999999999999999
Q ss_pred ccCCCCcEEEcCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh--CC
Q 005886 138 RDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH--GH 215 (671)
Q Consensus 138 rDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt--G~ 215 (671)
|||||+|||++.++.+||+|||+++.+.... .........++..|+|||++.+ ..++.++|||||||++|+|++ +.
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGD-YYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCc-eeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999987553221 1122233456889999999876 568999999999999999986 67
Q ss_pred CCCCCCChHHHHHHHHh---cCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHH
Q 005886 216 APFSKYPPMKVLLMTLQ---NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLM 272 (671)
Q Consensus 216 ~PF~~~~~~~~~~~~~~---~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL 272 (671)
.||.+............ ..........+..++..+.+||.+||..||.+|||+.+|.
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 78887766554432221 1111111223456788999999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=349.66 Aligned_cols=259 Identities=26% Similarity=0.435 Sum_probs=213.5
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcc-cHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-DLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~-~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
++|++.+.||+|+||.||+|.+..+++.||+|++....... ..+.+.+|+.+++.++||||++++++|..+..+|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 47999999999999999999999999999999986543222 34567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
|+.++.|..+.... ..+++..+..++.||+.||+|||+.|++||||+|+||+++.++.++|+|||++..+.... .
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~---~ 155 (286)
T cd07846 81 FVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG---E 155 (286)
T ss_pred cCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc---c
Confidence 99998888776543 458999999999999999999999999999999999999999999999999986543221 2
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-----------------
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP----------------- 235 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~----------------- 235 (671)
......|+..|+|||++.+...++.++|||||||++|+|++|.+||......+....+.....
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 223457899999999987655678899999999999999999999976654433222221000
Q ss_pred ----CCCC-----ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 236 ----PGLD-----YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 236 ----~~~~-----~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
+... ......++..+.+||.+||..+|.+||++.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0000 01134568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=339.20 Aligned_cols=254 Identities=27% Similarity=0.460 Sum_probs=218.0
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
+|++.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++.+..+..+++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 589999999999999999999999999999999765432 3467788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC-ceEEeccccccccccCCCccc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG-AIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g-~vKL~DFGls~~~~~~~~~~~ 172 (671)
+.|++|.+++.......+++..+..++.+++.||+|||++|++|+||+|+||+++.++ .+||+|||++...... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~----~ 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK----S 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC----c
Confidence 9999999999876445689999999999999999999999999999999999998654 6899999998655221 1
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHH
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKE 252 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~d 252 (671)
......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+...... ..+..++..+++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~ 231 (256)
T cd08220 157 KAYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA----PISDRYSPDLRQ 231 (256)
T ss_pred cccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC----CCCCCcCHHHHH
Confidence 2233578999999999986 56889999999999999999999999887766555554443222 223457889999
Q ss_pred HHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 253 LVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 253 LI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
+|.+||..+|.+|||+.+++.||||
T Consensus 232 li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 232 LILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHccCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=346.61 Aligned_cols=259 Identities=26% Similarity=0.369 Sum_probs=214.3
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecc
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYM 94 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~ 94 (671)
+|++.+.||.|++|.||+|++..+|..||||++...........+.+|+.+++.++||||+++++++.+...+|+||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 58999999999999999999999999999999976654444567788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccc
Q 005886 95 AGGSCLHIMKSAY-PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS 173 (671)
Q Consensus 95 ~ggsL~~~l~~~~-~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 173 (671)
.+ +|.+++.... ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++..+... ...
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~---~~~ 156 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP---VNT 156 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC---ccc
Confidence 85 7888776542 245899999999999999999999999999999999999999999999999998654221 112
Q ss_pred cccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------------CCc
Q 005886 174 RNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG-------------LDY 240 (671)
Q Consensus 174 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~-------------~~~ 240 (671)
.....+++.|++||++.+...++.++|||||||++|+|++|..||.+.+..+....+....... +..
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 2345678999999998765567899999999999999999999998776555444333211000 000
Q ss_pred -----------cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 241 -----------ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 241 -----------~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
.....++..+.++|.+||..||.+||++.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0112457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=365.53 Aligned_cols=254 Identities=24% Similarity=0.328 Sum_probs=201.7
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
...+|++++.||+|+||.||+|.+..++..||+|+.... ....|+.+++.++||||+++++++......|+||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 445799999999999999999999999999999985322 2356999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
||+. ++|..++... ...+++..++.++.||+.||.|||.+|||||||||+|||++.++.+||+|||++..... .
T Consensus 137 e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~----~ 210 (357)
T PHA03209 137 PHYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV----A 210 (357)
T ss_pred EccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc----C
Confidence 9995 5777777653 35689999999999999999999999999999999999999999999999999864321 1
Q ss_pred cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCC-CCCCCChH---------HHHHHHHh---cCCCCC
Q 005886 172 RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHA-PFSKYPPM---------KVLLMTLQ---NAPPGL 238 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~-PF~~~~~~---------~~~~~~~~---~~~~~~ 238 (671)
.......||+.|+|||++.+ ..++.++|||||||++|+|+++.. +|...... ..+..++. ..+..+
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 289 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF 289 (357)
T ss_pred cccccccccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence 12234679999999999987 568999999999999999998544 44432111 01111111 011111
Q ss_pred C--------------------------ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccc
Q 005886 239 D--------------------------YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKH 279 (671)
Q Consensus 239 ~--------------------------~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~ 279 (671)
. ......++..+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 0 0011245677888999999999999999999999999975
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=352.04 Aligned_cols=267 Identities=31% Similarity=0.520 Sum_probs=215.1
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCC-CCCceeeeeEEEeCCEEEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN-HPNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~-HpNIVkl~~~~~~~~~l~LV 90 (671)
+.++|+..+.||+|+||.||++.+..+|+.||+|.+...........+.+|+.++.++. ||||+++++++..+...|++
T Consensus 2 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 2 TAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred cHHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 34678888999999999999999999999999999876544445667889999999886 99999999999999999999
Q ss_pred EeccCCCCHHHH---HHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 91 MPYMAGGSCLHI---MKSAYPEGFEEPVIATLLRETLKALVYLHFH-GHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 91 mEy~~ggsL~~~---l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~-gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
|||+.+ ++..+ +.......+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++..+..
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 999864 44443 3322235699999999999999999999975 999999999999999999999999999865532
Q ss_pred CCCcccccccccCCCCCCChhHhhhc--cCCCccchhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCCCCCcccc
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQL--HGYDFKADIWSFGITALELAHGHAPFSKYPPM-KVLLMTLQNAPPGLDYERD 243 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~--~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~-~~~~~~~~~~~~~~~~~~~ 243 (671)
.. ......|++.|+|||++.+. ..++.++|||||||++|+|++|..||...... +.........++.+....+
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd06616 161 SI----AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEE 236 (288)
T ss_pred CC----ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCC
Confidence 21 12234689999999999864 36899999999999999999999999765421 2222222222233333333
Q ss_pred ccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccccc
Q 005886 244 KRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSN 283 (671)
Q Consensus 244 ~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~ 283 (671)
..++.++.+||.+||.++|.+|||++++++||||+...+.
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~ 276 (288)
T cd06616 237 REFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEER 276 (288)
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhc
Confidence 4588999999999999999999999999999999865543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=352.07 Aligned_cols=258 Identities=47% Similarity=0.835 Sum_probs=218.7
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
+.|+..+.||.|+||.||+|.+..++..||+|++...........+.+|+.+++.++||||++++++|..+..+|+||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 45777788999999999999999999999999987655445567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS 173 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 173 (671)
+.|++|..++.. ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..+... ...
T Consensus 84 ~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~---~~~ 157 (277)
T cd06642 84 LGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT---QIK 157 (277)
T ss_pred cCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc---chh
Confidence 999999998864 46899999999999999999999999999999999999999999999999998655321 112
Q ss_pred cccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHH
Q 005886 174 RNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL 253 (671)
Q Consensus 174 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dL 253 (671)
.....|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||....+......+....++ .....++..+.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l 232 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPP----TLEGQYSKPFKEF 232 (277)
T ss_pred hhcccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCC----CCCcccCHHHHHH
Confidence 233578999999999987 56889999999999999999999999876555444333222222 2234578899999
Q ss_pred HHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 254 VTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 254 I~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
|.+||..+|.+||++.++++||||.....
T Consensus 233 i~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06642 233 VEACLNKDPRFRPTAKELLKHKFITRYTK 261 (277)
T ss_pred HHHHccCCcccCcCHHHHHHhHHHHHHhh
Confidence 99999999999999999999999986543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=346.24 Aligned_cols=264 Identities=38% Similarity=0.676 Sum_probs=216.0
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeeeEEE---
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHCSFT--- 82 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~--- 82 (671)
+.++...++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 556667899999999999999999999999999999999875422 2235678899999998 7999999999884
Q ss_pred --eCCEEEEEEeccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecc
Q 005886 83 --TGHCLWVVMPYMAGGSCLHIMKSA--YPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADF 158 (671)
Q Consensus 83 --~~~~l~LVmEy~~ggsL~~~l~~~--~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DF 158 (671)
.+..+|+||||+.|++|.+++... ....+++..++.++.|++.||.|||+++++||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccC
Confidence 456799999999999999987642 2246889999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCcccccccccCCCCCCChhHhhh----ccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC
Q 005886 159 GVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQ----LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA 234 (671)
Q Consensus 159 Gls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~----~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~ 234 (671)
|++..+... ........|++.|+|||++.. ...++.++|||||||++|+|++|..||................
T Consensus 169 g~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~ 245 (286)
T cd06638 169 GVSAQLTST---RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP 245 (286)
T ss_pred CceeecccC---CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC
Confidence 998655321 112234579999999999853 1347889999999999999999999998776544443332222
Q ss_pred CCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 235 PPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 235 ~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
.+. ...+..++..+.+||.+||..||.+|||+.++|+|+||
T Consensus 246 ~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 246 PPT--LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCc--ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 111 12234467889999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=347.42 Aligned_cols=264 Identities=27% Similarity=0.374 Sum_probs=214.9
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
++|++.+.||.|+||+||+|.++.+|+.||+|.+...... .....+.+|+.+++.++||||+++++++.....+|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 6899999999999999999999999999999998654322 234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcC-CCceEEeccccccccccCCCcc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS-NGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~-~g~vKL~DFGls~~~~~~~~~~ 171 (671)
|+. ++|...+.......+++..++.++.||+.||+|||++|++||||+|+||+++. ++.+||+|||++...... .
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~---~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP---V 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC---c
Confidence 996 47877776554445788899999999999999999999999999999999985 457999999998644211 1
Q ss_pred cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC------------
Q 005886 172 RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD------------ 239 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~------------ 239 (671)
.......|++.|+|||++.+...++.++|||||||++|+|++|.+||......+....+.........
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY 237 (294)
T ss_pred cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh
Confidence 12233467899999999876556889999999999999999999999877665554443321110000
Q ss_pred ------------ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 240 ------------YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 240 ------------~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
......++..++++|.+||..+|.+||++.++|.||||....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 001235688899999999999999999999999999998654
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=344.48 Aligned_cols=255 Identities=20% Similarity=0.327 Sum_probs=212.3
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEc---CCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCI---PLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCL 87 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~---~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l 87 (671)
++.++|++.+.||+|+||.||+|.++ ..+..||+|.+...........+.+|+.+++.++||||+++++++..+..+
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 56789999999999999999999875 456789999987654344456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccC
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~ 167 (671)
|+||||+.+|+|..++... ...+++..++.++.||+.||+|||++|++||||||+|||++.++.+|++|||.+.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~- 159 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS- 159 (266)
T ss_pred EEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc-
Confidence 9999999999999988764 24689999999999999999999999999999999999999999999999998643311
Q ss_pred CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (671)
..........++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+.... ..+.+..+
T Consensus 160 -~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~ 233 (266)
T cd05064 160 -EAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF----RLPAPRNC 233 (266)
T ss_pred -cchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC----CCCCCCCC
Confidence 11111122345678999999987 678999999999999999775 999998877665544443322 22345668
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 247 SKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 247 s~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
+..+.+++.+||..+|.+||++.+|++
T Consensus 234 ~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 234 PNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred CHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=349.57 Aligned_cols=260 Identities=32% Similarity=0.544 Sum_probs=218.5
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LV 90 (671)
+..++|++++.||+|+||+||+|.+..+|+.||+|++...........+.+|+++++.++||||+++++++.....+|+|
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 34578999999999999999999999999999999987654444567889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCcEEEcCCCceEEeccccccccccCCC
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF-HGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs-~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~ 169 (671)
|||+.+++|..++... +.+++..+..++.+++.||.|||+ +|++||||||+||+++.++.++|+|||++..+...
T Consensus 82 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-- 157 (284)
T cd06620 82 MEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-- 157 (284)
T ss_pred EecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence 9999999999988765 568999999999999999999997 69999999999999999999999999997644221
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChH-----------HHHHHHHhcCCCCC
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM-----------KVLLMTLQNAPPGL 238 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~-----------~~~~~~~~~~~~~~ 238 (671)
......|+..|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+....++.+
T Consensus 158 ---~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd06620 158 ---IADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRL 233 (284)
T ss_pred ---ccCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCC
Confidence 1234579999999999876 46889999999999999999999999765432 12222222222221
Q ss_pred CccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 239 DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 239 ~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
. ...++..+.+||.+||..||.+||++.++++|+||....
T Consensus 234 ~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 234 P---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred C---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 1 123678899999999999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=351.30 Aligned_cols=264 Identities=26% Similarity=0.390 Sum_probs=215.6
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcc-cHHHHHHHHHHHHhCCCCCceeeeeEEEeC--CEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-DLDGIRREVQTMRVTNHPNVLRAHCSFTTG--HCLW 88 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~-~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~--~~l~ 88 (671)
..++|++.+.||.|+||.||+|.+..+|+.||+|++....... ....+.+|+.+++.++|+||+++++++... +.+|
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 5688999999999999999999999999999999987544222 233566899999999999999999999765 5789
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
+||||+.+ +|..++... ...+++..++.++.||+.||+|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 85 lv~e~~~~-~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEecCCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 99999965 788877654 2568999999999999999999999999999999999999999999999999987553221
Q ss_pred CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG----------- 237 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~----------- 237 (671)
.......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.++...+..+.......
T Consensus 163 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 163 ---KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred ---CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 122233568899999998765668999999999999999999999998877766555444321100
Q ss_pred -----CCcc---------ccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 238 -----LDYE---------RDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 238 -----~~~~---------~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
+... ....+++.+.+||.+||..||.+|||+.++|.||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 0000 012357889999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=345.37 Aligned_cols=255 Identities=25% Similarity=0.356 Sum_probs=206.4
Q ss_pred eEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCC-CCCceeeeeEEEeC--CEEEEEEe
Q 005886 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN-HPNVLRAHCSFTTG--HCLWVVMP 92 (671)
Q Consensus 16 Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~-HpNIVkl~~~~~~~--~~l~LVmE 92 (671)
|++.+.||+|+||.||+|.+..++..||+|++.............+|+.++..+. ||||+++++++.+. +.+++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 7889999999999999999999999999999875432222334457888888885 99999999999987 89999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
|+.| ++.+.+.... ..+++..++.++.||+.||+|||..|++||||+|+||+++. +.+||+|||++..+....
T Consensus 81 ~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~---- 153 (282)
T cd07831 81 LMDM-NLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP---- 153 (282)
T ss_pred cCCc-cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC----
Confidence 9975 7777776532 46899999999999999999999999999999999999999 999999999987553211
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC---------------CC
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP---------------PG 237 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~---------------~~ 237 (671)
......+++.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+..... ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 123356899999999876545678899999999999999999999987765544333221110 00
Q ss_pred CCcc---------ccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 238 LDYE---------RDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 238 ~~~~---------~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
+.++ ....++..+.+||.+||.++|.+||++.++|.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1110 113568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=339.43 Aligned_cols=260 Identities=30% Similarity=0.540 Sum_probs=216.6
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
+|.+.+.||+|+||.||+|.+..+++.||+|++...... .....+.+|+.+++.++|+||+++++++...+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 589999999999999999999999999999998765433 3577899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS 173 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 173 (671)
+.+++|.+++... ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.+||+|||++............
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 81 CSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred CCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 9999999998765 45889999999999999999999999999999999999999999999999998765332222111
Q ss_pred -cccccCCCCCCChhHhhhcc--CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHH
Q 005886 174 -RNTFVGTPCWMAPEVMQQLH--GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSF 250 (671)
Q Consensus 174 -~~~~~GT~~Y~APEvl~~~~--~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l 250 (671)
.....+++.|+|||++.+.. .++.++||||||+++|+|++|+.||............+.. ......+....++..+
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 237 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPPIPDSLQLSPEG 237 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCCCCcccccCHHH
Confidence 22457889999999987632 2788999999999999999999999765432222222222 1111223334568899
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 251 KELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 251 ~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
.+||.+||..+|.+||++.+++.|||+
T Consensus 238 ~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 238 KDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=342.86 Aligned_cols=257 Identities=30% Similarity=0.584 Sum_probs=213.8
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-----ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-----NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWV 89 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-----~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~L 89 (671)
+|++.+.||.|+||.||+|.+ .+|+.+|+|.+...... .....+.+|+.+++.++|+||+++++++.+...+|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 588999999999999999986 47889999998754321 224568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC-
Q 005886 90 VMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG- 168 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~- 168 (671)
||||+.|++|..++... ..+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 80 FMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 99999999999999765 568999999999999999999999999999999999999999999999999986542111
Q ss_pred --CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Q 005886 169 --DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246 (671)
Q Consensus 169 --~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (671)
..........|+..|+|||++.+ ..++.++|+|||||++|+|++|..||...........+.... ......+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 234 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHR--GLMPRLPDSF 234 (265)
T ss_pred cccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhcc--CCCCCCCCCC
Confidence 11112234578999999999986 568899999999999999999999998765544333222211 1112234568
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 247 SKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 247 s~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
+.++.+||.+||..+|.+||++.++|.||||
T Consensus 235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 8999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=349.34 Aligned_cols=262 Identities=26% Similarity=0.333 Sum_probs=216.1
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc----ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN----NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~----~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LV 90 (671)
+|++.+.||.|+||.||+|.+..+|+.||||.+...... .....+..|+.+++.++|+||+++++++.+...+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 588999999999999999999999999999999755432 1234567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCc
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR 170 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~ 170 (671)
|||+ +|+|..++.... ..+++..++.++.||+.||.|||++|++|+||||+|||++.+|.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-- 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN-- 156 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC--
Confidence 9999 899999987652 368999999999999999999999999999999999999999999999999986553221
Q ss_pred ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC------------
Q 005886 171 QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL------------ 238 (671)
Q Consensus 171 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~------------ 238 (671)
.......+++.|+|||.+.+...++.++|||||||++|+|++|.+||.+..+.+.+..+........
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 157 -RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred -ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence 1223346788999999987656688999999999999999999988987766554443332110000
Q ss_pred -----------CccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 239 -----------DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 239 -----------~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
.......++..+.+||.+||.+||.+|||+.++|.||||.+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 0011234578899999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=345.32 Aligned_cols=257 Identities=44% Similarity=0.791 Sum_probs=219.1
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecc
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYM 94 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~ 94 (671)
-|++.+.||.|+||.||+|.+..++..||||++...........+.+|+.+++.++||||++++++|..+..+|+||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 47788999999999999999999999999999875554455678889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccc
Q 005886 95 AGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSR 174 (671)
Q Consensus 95 ~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 174 (671)
.+++|..++.. ..+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++..+... ....
T Consensus 85 ~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~---~~~~ 158 (277)
T cd06641 85 GGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT---QIKR 158 (277)
T ss_pred CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc---hhhh
Confidence 99999998864 35889999999999999999999999999999999999999999999999997654221 1122
Q ss_pred ccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHH
Q 005886 175 NTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELV 254 (671)
Q Consensus 175 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI 254 (671)
....|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+.....+ .....++.++.++|
T Consensus 159 ~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~i 233 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPP----TLEGNYSKPLKEFV 233 (277)
T ss_pred ccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCC----CCCcccCHHHHHHH
Confidence 34578999999999876 56788999999999999999999999877665544443322222 22446788999999
Q ss_pred HHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 255 TACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 255 ~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
.+||..+|.+||++.++++||||.....
T Consensus 234 ~~~l~~~p~~Rp~~~~~l~~~~~~~~~~ 261 (277)
T cd06641 234 EACLNKEPSFRPTAKELLKHKFIVRFAK 261 (277)
T ss_pred HHHccCChhhCcCHHHHHhCHHHhhhhh
Confidence 9999999999999999999999987544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=343.03 Aligned_cols=260 Identities=30% Similarity=0.544 Sum_probs=215.0
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc---------ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN---------NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH 85 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~---------~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~ 85 (671)
+|.+.+.||.|+||.||+|.+..+|+.||+|.+...... ...+.+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 588999999999999999999999999999998643211 12356788999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
.+++||||+.|++|.+++... ..+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 999999999999999998776 578999999999999999999999999999999999999999999999999986542
Q ss_pred cCCCcccccccccCCCCCCChhHhhhcc-CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh-cCCCCCCcccc
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLH-GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQ-NAPPGLDYERD 243 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~-~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~-~~~~~~~~~~~ 243 (671)
.. ..........|+..|+|||++.... .++.++|+||||+++|+|++|..||.............. .....+.....
T Consensus 160 ~~-~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06629 160 DI-YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS 238 (272)
T ss_pred cc-ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence 21 1111223457899999999987633 478999999999999999999999976555443333221 11222222233
Q ss_pred ccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 244 KRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 244 ~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
..++..+++||.+||..+|.+||++.++|+||||
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 239 MNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 4678999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=344.55 Aligned_cols=260 Identities=36% Similarity=0.636 Sum_probs=215.1
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeeeEEEeC-----C
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHCSFTTG-----H 85 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~-----~ 85 (671)
..++|.+.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||++++++|... .
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 3578999999999999999999999999999999986432 2345678899999988 899999999998753 4
Q ss_pred EEEEEEeccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSA--YPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSAC 163 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~--~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~ 163 (671)
.+|+||||+.|++|.+++... ....+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++..
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 689999999999999988642 224689999999999999999999999999999999999999999999999999875
Q ss_pred cccCCCcccccccccCCCCCCChhHhhhcc----CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC
Q 005886 164 MFDAGDRQRSRNTFVGTPCWMAPEVMQQLH----GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD 239 (671)
Q Consensus 164 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~----~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~ 239 (671)
...... ......|++.|+|||++.... .++.++|||||||++|+|++|+.||........+..+.....+.+
T Consensus 178 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~- 253 (291)
T cd06639 178 LTSTRL---RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTL- 253 (291)
T ss_pred cccccc---cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCC-
Confidence 532111 123457899999999986422 367899999999999999999999988766555555444333222
Q ss_pred ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcc
Q 005886 240 YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278 (671)
Q Consensus 240 ~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk 278 (671)
.....++..+.+||.+||..+|.+||++.+++.||||+
T Consensus 254 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 254 -LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred -CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 22345678899999999999999999999999999994
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=346.17 Aligned_cols=267 Identities=22% Similarity=0.373 Sum_probs=217.3
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIP-----LNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT 83 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~-----tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~ 83 (671)
|.++.++|++.+.||+|+||.||+|.++. .+..||+|.+...........+.+|+.+++.++||||+++++++.+
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 56788999999999999999999997652 3457999998654433334567889999999999999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEE
Q 005886 84 GHCLWVVMPYMAGGSCLHIMKSAYP--------EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKL 155 (671)
Q Consensus 84 ~~~l~LVmEy~~ggsL~~~l~~~~~--------~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL 155 (671)
....|+||||+.+|+|..++..... ..+....+..++.||+.||.|||++||+||||||+||+++.++.++|
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999999975321 23456778999999999999999999999999999999999999999
Q ss_pred eccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcC
Q 005886 156 ADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNA 234 (671)
Q Consensus 156 ~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~ 234 (671)
+|||+++....... ........++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+....
T Consensus 161 ~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 238 (288)
T cd05061 161 GDFGMTRDIYETDY-YRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 238 (288)
T ss_pred CcCCcccccccccc-ccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999875432221 111223356778999999876 568999999999999999998 899998877665544443322
Q ss_pred CCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh------chhccccc
Q 005886 235 PPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK------HHFFKHAR 281 (671)
Q Consensus 235 ~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~------Hpwfk~~~ 281 (671)
. ...+..++..++++|.+||..||.+|||+.++++ ||||..+.
T Consensus 239 ~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 239 Y----LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred C----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 1 1224456889999999999999999999999986 89998654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=347.94 Aligned_cols=252 Identities=16% Similarity=0.258 Sum_probs=209.8
Q ss_pred cccCCCCeEEE--EEecccCceEEEEEEEcCCCcEEEEEEeccccCcc--cHHHHHHHHHHHHhCCCCCceeeeeEEEe-
Q 005886 9 FPVDAKDYRLY--EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN--DLDGIRREVQTMRVTNHPNVLRAHCSFTT- 83 (671)
Q Consensus 9 ~~i~~~~Y~l~--~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~--~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~- 83 (671)
..++.++++.. ..||+|++|.||+|.+ +|+.||||.+....... ..+.+.+|+.+|+.++||||+++++++.+
T Consensus 13 ~~i~~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~ 90 (283)
T PHA02988 13 KCIESDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI 90 (283)
T ss_pred eecCHHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec
Confidence 44556666665 6799999999999987 58999999987543222 25678899999999999999999999977
Q ss_pred ---CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCcEEEcCCCceEEeccc
Q 005886 84 ---GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH-GHIHRDVKAGNILIDSNGAIKLADFG 159 (671)
Q Consensus 84 ---~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~-gIVHrDLKPeNILld~~g~vKL~DFG 159 (671)
...+++|||||.||+|.+++... ..+++.....++.+++.||.|||.. +++||||||+|||++.++.+||+|||
T Consensus 91 ~~~~~~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg 168 (283)
T PHA02988 91 VDDLPRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHG 168 (283)
T ss_pred ccCCCceEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccc
Confidence 45789999999999999999865 5688999999999999999999984 99999999999999999999999999
Q ss_pred cccccccCCCcccccccccCCCCCCChhHhhhc-cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC
Q 005886 160 VSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQL-HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL 238 (671)
Q Consensus 160 ls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~ 238 (671)
+++.+... .....||+.|+|||++.+. ..|+.++|||||||++|||++|..||.+.+..+....+.....
T Consensus 169 ~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~--- 239 (283)
T PHA02988 169 LEKILSSP------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNN--- 239 (283)
T ss_pred hHhhhccc------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC---
Confidence 98755221 1234789999999999752 4689999999999999999999999998877665555443321
Q ss_pred CccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 239 DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 239 ~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
....+..++..+++||.+||..||.+|||+.+++.
T Consensus 240 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 12233457899999999999999999999999985
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=372.70 Aligned_cols=256 Identities=23% Similarity=0.304 Sum_probs=204.9
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
...|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|+.+|+.++|||||++++++..+...++||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 457999999999999999999999999999999642 2235689999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
++. ++|..++... ...+++..++.|+.||+.||.|||++|||||||||+|||++.++.+||+|||+++.+... ....
T Consensus 241 ~~~-~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~-~~~~ 317 (461)
T PHA03211 241 KYR-SDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS-WSTP 317 (461)
T ss_pred ccC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccc-cccc
Confidence 995 6788877653 246899999999999999999999999999999999999999999999999998654221 1112
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHhcCC---CCC----
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYP-------PMKVLLMTLQNAP---PGL---- 238 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~-------~~~~~~~~~~~~~---~~~---- 238 (671)
.....+||+.|+|||++.+ ..++.++|||||||+||||++|..|+.... ....+..++.... ..+
T Consensus 318 ~~~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred cccccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 2234679999999999987 568999999999999999999876543211 1112222222110 000
Q ss_pred -----------------------CccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccc
Q 005886 239 -----------------------DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKH 279 (671)
Q Consensus 239 -----------------------~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~ 279 (671)
.+.....++..+.+||.+||..||.+|||+.|+|+||||+.
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 01111245668999999999999999999999999999963
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=344.68 Aligned_cols=260 Identities=28% Similarity=0.468 Sum_probs=213.8
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
++|++.+.||+|+||.||+|.+..+++.||+|++...... .....+.+|+++++.++|+||+++++++..++.+|+|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 4799999999999999999999999999999998754332 335778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
|+.++.+..+.... ..+++..++.++.||+.||.|||.+|++||||+|+||+++.++.+||+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~--~ 156 (288)
T cd07833 81 YVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA--S 156 (288)
T ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc--c
Confidence 99987666555443 5689999999999999999999999999999999999999999999999999865532221 1
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC---CC-------------
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA---PP------------- 236 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~---~~------------- 236 (671)
......|+..|+|||++.+...++.++||||||+++|+|++|.+||.+....+.+..+.... ++
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence 23346789999999999874478999999999999999999999998766544333221100 00
Q ss_pred CCC-----------ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 237 GLD-----------YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 237 ~~~-----------~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
+.. ...+..++.++++||.+||..+|.+||+++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 000 01122358899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=364.55 Aligned_cols=261 Identities=21% Similarity=0.366 Sum_probs=212.2
Q ss_pred ccccCCCCeEEEEEecccCceEEEEEEE-----cCCCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeeeEE
Q 005886 8 RFPVDAKDYRLYEEVGEGVSATVYRALC-----IPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHCSF 81 (671)
Q Consensus 8 ~~~i~~~~Y~l~~~LG~G~fG~Vyka~~-----~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~ 81 (671)
.+.+..++|++.+.||+|+||.||+|++ ..++..||||++.........+.+.+|+.+++.+ +||||++++++|
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 4556677999999999999999999974 3456789999987554444567788999999999 899999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhC------------------------------------------------------
Q 005886 82 TTGHCLWVVMPYMAGGSCLHIMKSAY------------------------------------------------------ 107 (671)
Q Consensus 82 ~~~~~l~LVmEy~~ggsL~~~l~~~~------------------------------------------------------ 107 (671)
......|+|||||.||+|.+++....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 99999999999999999999886531
Q ss_pred -------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 108 -------------------PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 108 -------------------~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 0146788899999999999999999999999999999999999999999999987553221
Q ss_pred CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccch
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls 247 (671)
. ........++..|+|||++.+ ..++.++|||||||++|+|++ |..||............+.... ....+...+
T Consensus 269 ~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 343 (375)
T cd05104 269 N-YVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY---RMLSPECAP 343 (375)
T ss_pred c-ccccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCc---cCCCCCCCC
Confidence 1 111223345678999999987 568999999999999999998 9999987655444444443321 122234567
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 248 KSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.++++||.+||..||.+||++.++++
T Consensus 344 ~~l~~li~~cl~~dP~~RPs~~eil~ 369 (375)
T cd05104 344 SEMYDIMKSCWDADPLKRPTFKQIVQ 369 (375)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHH
Confidence 89999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=365.24 Aligned_cols=260 Identities=20% Similarity=0.357 Sum_probs=211.7
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCC-----cEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeeeEEE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLN-----EIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHCSFT 82 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg-----~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~ 82 (671)
|.+..++|++.+.||+|+||.||+|.+..+| ..||+|++...........+.+|+.+++.+ +||||++++++|.
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 4456778999999999999999999875544 479999997654444567788999999999 8999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHhhC-------------------------------------------------------
Q 005886 83 TGHCLWVVMPYMAGGSCLHIMKSAY------------------------------------------------------- 107 (671)
Q Consensus 83 ~~~~l~LVmEy~~ggsL~~~l~~~~------------------------------------------------------- 107 (671)
....+|+|||||.+|+|.+++....
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 9999999999999999999886431
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccc
Q 005886 108 -------------PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSR 174 (671)
Q Consensus 108 -------------~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 174 (671)
...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..... ....
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~-~~~~ 271 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN-YVVK 271 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc-eeec
Confidence 12477888999999999999999999999999999999999999999999999875532211 1112
Q ss_pred ccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHH
Q 005886 175 NTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL 253 (671)
Q Consensus 175 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dL 253 (671)
....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||................ .....+..++.++.++
T Consensus 272 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~l 347 (374)
T cd05106 272 GNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG---YQMSRPDFAPPEIYSI 347 (374)
T ss_pred cCCCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcc---cCccCCCCCCHHHHHH
Confidence 23345678999999976 569999999999999999997 999998765544443333322 2222344568999999
Q ss_pred HHHhhhcCCCCCCCHHHHHh
Q 005886 254 VTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 254 I~~cL~~dP~kRpSa~eiL~ 273 (671)
|.+||..||.+|||+.++++
T Consensus 348 i~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 348 MKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=339.71 Aligned_cols=256 Identities=23% Similarity=0.417 Sum_probs=216.5
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~ 88 (671)
|.+...+|.+.+.||.|+||.||+|.+..++..||+|++.... .....+.+|+.+++.++||||+++++++..+..++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 5677889999999999999999999999999999999986432 33567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
+||||+.+++|.+++.......+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 99999999999999876555568999999999999999999999999999999999999999999999999986542211
Q ss_pred CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccch
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls 247 (671)
........+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+........ +....+..++
T Consensus 159 --~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~ 231 (263)
T cd05052 159 --YTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG----YRMERPEGCP 231 (263)
T ss_pred --eeccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC----CCCCCCCCCC
Confidence 111122344678999999876 568999999999999999998 99999887665544433332 2233456788
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 248 KSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.++.++|.+||..||.+||++.++++
T Consensus 232 ~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 232 PKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHHH
Confidence 99999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=369.45 Aligned_cols=264 Identities=29% Similarity=0.425 Sum_probs=231.3
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcc-cHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-DLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCL 87 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~-~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l 87 (671)
.......|.+.+.||+|.|++|.+|++..+|..||||+|++..... ....+.+|+++|+.++|||||+++.+.+....+
T Consensus 51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 4456678999999999999999999999999999999998776443 346689999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccC
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~ 167 (671)
|+||||+.||.+++++.+. +.+.+..++.++.|++.|++|||+++|||||||++||||+.+.++||+|||++..+.
T Consensus 131 ylV~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-- 206 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD-- 206 (596)
T ss_pred EEEEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec--
Confidence 9999999999999999987 778889999999999999999999999999999999999999999999999997663
Q ss_pred CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccch
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls 247 (671)
......++||++.|.|||++.+....++.+|+||+|++||-|++|.+||++..-.+.....+.. .+..+-.++
T Consensus 207 --~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g-----k~rIp~~ms 279 (596)
T KOG0586|consen 207 --YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG-----KYRIPFYMS 279 (596)
T ss_pred --ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheee-----eecccceee
Confidence 2334567899999999999999777789999999999999999999999986544333222222 233455678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHhchhccccccc
Q 005886 248 KSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSN 283 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~ 283 (671)
.+..++|.++|.++|.+|++.+++.+|.|.......
T Consensus 280 ~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 280 CDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred chhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 899999999999999999999999999999865544
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=341.27 Aligned_cols=252 Identities=27% Similarity=0.472 Sum_probs=216.6
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
.|++.+.||.|+||.||+|.+..++..||+|++...... .....+.+|+++++.++||||+++++++..+..+|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 589999999999999999999999999999999755422 346788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
|+.|++|..++... ..+++..+..++.||+.||.|||.+|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc----
Confidence 99999999998765 578999999999999999999999999999999999999999999999999986553221
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhcCCCCCCccccccchHHH
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPP--MKVLLMTLQNAPPGLDYERDKRFSKSF 250 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~--~~~~~~~~~~~~~~~~~~~~~~ls~~l 250 (671)
......|+..|+|||++.+ ..++.++|+||||+++|+|++|..||..... ........... ....+..++..+
T Consensus 155 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 229 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETA----DVLYPATWSTEA 229 (258)
T ss_pred cccccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccc----cccCcccCcHHH
Confidence 2234578999999999987 5589999999999999999999999987653 22222222211 223345678999
Q ss_pred HHHHHHhhhcCCCCCCCH--HHHHhchhc
Q 005886 251 KELVTACLVKDPKKRPTA--EKLMKHHFF 277 (671)
Q Consensus 251 ~dLI~~cL~~dP~kRpSa--~eiL~Hpwf 277 (671)
.++|.+||..||.+||++ .+++.||||
T Consensus 230 ~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 230 IDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=348.05 Aligned_cols=260 Identities=26% Similarity=0.365 Sum_probs=213.6
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcc-cHHHHHHHHHHHHhCCCCCceeeeeEEEeC--CEEEE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-DLDGIRREVQTMRVTNHPNVLRAHCSFTTG--HCLWV 89 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~-~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~--~~l~L 89 (671)
.++|++.+.||.|+||.||+|.+..+++.||+|.+....... ....+.+|+.+++.++||||+++++++... ..+|+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 468999999999999999999999999999999987544322 234567899999999999999999999887 89999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCC
Q 005886 90 VMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~ 169 (671)
||||+.+ +|..++.... ..+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||++..+....
T Consensus 84 v~e~~~~-~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 160 (293)
T cd07843 84 VMEYVEH-DLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL- 160 (293)
T ss_pred EehhcCc-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-
Confidence 9999975 8888887642 468999999999999999999999999999999999999999999999999987653321
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC------------
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG------------ 237 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~------------ 237 (671)
.......+++.|+|||.+.+...++.++|||||||++|+|++|.+||...........+.......
T Consensus 161 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 161 --KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred --cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 222345688999999998765557899999999999999999999998877655444333211100
Q ss_pred --------------CCcccccc-chHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 238 --------------LDYERDKR-FSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 238 --------------~~~~~~~~-ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
+....+.. +++.+.+||.+||..+|++|||+.++|.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 00011111 58889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=339.68 Aligned_cols=252 Identities=29% Similarity=0.480 Sum_probs=213.7
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccCCCCH
Q 005886 22 VGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSC 99 (671)
Q Consensus 22 LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~ggsL 99 (671)
||.|+||.||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++.++..+|+||||+.|++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999999999999999755432 3457789999999999999999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccccccccC
Q 005886 100 LHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVG 179 (671)
Q Consensus 100 ~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~G 179 (671)
.+++... ..+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++....... ......|
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----~~~~~~~ 154 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----KTWTFCG 154 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc----ccccccC
Confidence 9999765 468999999999999999999999999999999999999999999999999986553221 2234578
Q ss_pred CCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhcCCCCCCccccccchHHHHHHHHHh
Q 005886 180 TPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYP--PMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTAC 257 (671)
Q Consensus 180 T~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~--~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~c 257 (671)
++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.... ..+....+... .. ....+..++.++++||.+|
T Consensus 155 ~~~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~i~~~ 230 (262)
T cd05572 155 TPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKG-NG--KLEFPNYIDKAAKDLIKQL 230 (262)
T ss_pred CcCccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhcc-CC--CCCCCcccCHHHHHHHHHH
Confidence 999999999876 568999999999999999999999998766 44444333321 11 1223444588999999999
Q ss_pred hhcCCCCCCC-----HHHHHhchhccccccc
Q 005886 258 LVKDPKKRPT-----AEKLMKHHFFKHARSN 283 (671)
Q Consensus 258 L~~dP~kRpS-----a~eiL~Hpwfk~~~~~ 283 (671)
|..+|.+||+ +.++++||||+...++
T Consensus 231 l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 231 LRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred ccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence 9999999999 9999999999876553
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=336.23 Aligned_cols=257 Identities=37% Similarity=0.635 Sum_probs=219.9
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
++|++.+.||.|+||.||+|.+..+|+.||+|++...........+.+|+..+..++||||+++++++.....+|+||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 47899999999999999999999999999999987654434467889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF-HGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs-~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
+.|++|.+++... ..+++..++.++.||+.||+|||+ .|++||||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~---~ 155 (264)
T cd06623 81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL---D 155 (264)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC---C
Confidence 9999999999875 678999999999999999999999 999999999999999999999999999986553211 1
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhcCCCCCCcccccc-chH
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYP---PMKVLLMTLQNAPPGLDYERDKR-FSK 248 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~---~~~~~~~~~~~~~~~~~~~~~~~-ls~ 248 (671)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.... ..+....+.....+ ..... ++.
T Consensus 156 ~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 230 (264)
T cd06623 156 QCNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPP----SLPAEEFSP 230 (264)
T ss_pred cccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCC----CCCcccCCH
Confidence 1234578999999999877 568899999999999999999999997764 22333333322222 22334 788
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 249 SFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 249 ~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
.+.++|.+||..+|.+||++.+++.||||+.+
T Consensus 231 ~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 231 EFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 99999999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=346.62 Aligned_cols=251 Identities=26% Similarity=0.364 Sum_probs=203.7
Q ss_pred EecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHH---hCCCCCceeeeeEEEeCCEEEEEEeccC
Q 005886 21 EVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMR---VTNHPNVLRAHCSFTTGHCLWVVMPYMA 95 (671)
Q Consensus 21 ~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~---~L~HpNIVkl~~~~~~~~~l~LVmEy~~ 95 (671)
.||+|+||.||++.+..+|+.||+|++...... .......+|..+++ ..+||||+.+++++..++.+|+||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999998755432 11233344544443 4579999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccccc
Q 005886 96 GGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRN 175 (671)
Q Consensus 96 ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 175 (671)
||+|..++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++...... ...
T Consensus 81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-----~~~ 153 (279)
T cd05633 81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPH 153 (279)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc-----Ccc
Confidence 99999988765 56999999999999999999999999999999999999999999999999998644211 122
Q ss_pred cccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChH--HHHHHHHhcCCCCCCccccccchHHHHHH
Q 005886 176 TFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM--KVLLMTLQNAPPGLDYERDKRFSKSFKEL 253 (671)
Q Consensus 176 ~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~--~~~~~~~~~~~~~~~~~~~~~ls~~l~dL 253 (671)
...||+.|+|||.+.+...++.++|||||||++|+|++|..||...... ......... .....+..++.++++|
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l 229 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT----VNVELPDSFSPELKSL 229 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhc----CCcCCccccCHHHHHH
Confidence 3479999999999875456889999999999999999999999754322 222222111 2223355688999999
Q ss_pred HHHhhhcCCCCCC-----CHHHHHhchhcccccc
Q 005886 254 VTACLVKDPKKRP-----TAEKLMKHHFFKHARS 282 (671)
Q Consensus 254 I~~cL~~dP~kRp-----Sa~eiL~Hpwfk~~~~ 282 (671)
|.+||..||.+|| ++.++++||||+...+
T Consensus 230 i~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~ 263 (279)
T cd05633 230 LEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDW 263 (279)
T ss_pred HHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCH
Confidence 9999999999999 6999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=335.63 Aligned_cols=254 Identities=33% Similarity=0.594 Sum_probs=215.6
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC----cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC----NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~----~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LV 90 (671)
+|+..+.||+|+||.||+|.+..++..|++|.+..... ......+.+|+.+++.++||||+++++++..+..+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47788999999999999999998999999999865432 12456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCc
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR 170 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~ 170 (671)
|||+.|++|.+++... ..+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence 9999999999998765 468899999999999999999999999999999999999999999999999986542221
Q ss_pred ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHH
Q 005886 171 QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSF 250 (671)
Q Consensus 171 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l 250 (671)
......|++.|+|||.+.....++.++|+|||||++|+|++|..||................. ....+..++..+
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 231 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE---LPPIPDHLSDEA 231 (258)
T ss_pred --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc---CCCcCCCcCHHH
Confidence 233467899999999987633388999999999999999999999987765554444332111 112345678999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 251 KELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 251 ~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
.+||.+||..+|.+||++.++|.||||
T Consensus 232 ~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 232 KDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=349.75 Aligned_cols=260 Identities=36% Similarity=0.615 Sum_probs=218.0
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
+.|.....||.|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++||||+++++.+...+..|+||||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 44666788999999999999999999999999986433 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS 173 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 173 (671)
+.|++|..++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++...... ...
T Consensus 101 ~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~---~~~ 174 (292)
T cd06658 101 LEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE---VPK 174 (292)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc---ccc
Confidence 999999988754 35899999999999999999999999999999999999999999999999998644221 122
Q ss_pred cccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHH
Q 005886 174 RNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL 253 (671)
Q Consensus 174 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dL 253 (671)
.....|++.|+|||++.+ ..++.++|||||||++|+|++|..||........+..+....+... .....++..+.+|
T Consensus 175 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l 251 (292)
T cd06658 175 RKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV--KDSHKVSSVLRGF 251 (292)
T ss_pred CceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc--ccccccCHHHHHH
Confidence 234578999999999876 5688999999999999999999999987766555444333222221 2233568899999
Q ss_pred HHHhhhcCCCCCCCHHHHHhchhccccccc
Q 005886 254 VTACLVKDPKKRPTAEKLMKHHFFKHARSN 283 (671)
Q Consensus 254 I~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~ 283 (671)
|.+||..||.+|||++++|+||||......
T Consensus 252 i~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 252 LDLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred HHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 999999999999999999999999866543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=344.84 Aligned_cols=270 Identities=24% Similarity=0.351 Sum_probs=212.2
Q ss_pred ccccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcc-cHHHHHHHHHHHHhCCCCCceeeeeEEEeC
Q 005886 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-DLDGIRREVQTMRVTNHPNVLRAHCSFTTG 84 (671)
Q Consensus 6 e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~-~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~ 84 (671)
+-.+.-..++|++.+.||+|+||.||+|.+..+++.||||.+....... ....+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (310)
T cd07865 4 EFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK 83 (310)
T ss_pred cCcccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence 3445566789999999999999999999999999999999986543222 234567899999999999999999998764
Q ss_pred C--------EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEe
Q 005886 85 H--------CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLA 156 (671)
Q Consensus 85 ~--------~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~ 156 (671)
. .+|+||||+.+ +|...+... ...+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~ 161 (310)
T cd07865 84 ATPYNRYKGSFYLVFEFCEH-DLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLA 161 (310)
T ss_pred cccccCCCceEEEEEcCCCc-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEEC
Confidence 3 46999999964 777777653 2468999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCc-ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh---
Q 005886 157 DFGVSACMFDAGDR-QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQ--- 232 (671)
Q Consensus 157 DFGls~~~~~~~~~-~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~--- 232 (671)
|||++..+...... ........++..|+|||++.+...++.++||||||+++|+|++|+.||.+.........+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T cd07865 162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG 241 (310)
T ss_pred cCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99998755332211 11223456889999999987655578899999999999999999999987665443322211
Q ss_pred cCCCCC-------------Cc------c-----ccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 233 NAPPGL-------------DY------E-----RDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 233 ~~~~~~-------------~~------~-----~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
..++.. .. . .....+..+.+||.+||..||.+|||++++|.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 111000 00 0 011135678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=337.48 Aligned_cols=255 Identities=23% Similarity=0.401 Sum_probs=214.9
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~ 88 (671)
|.+..++|++.++||+|+||.||+|.+. .+..||+|.+.... ...+.+.+|+.+++.++||||+++++++...+.+|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 6788999999999999999999999865 56779999876433 23568889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
+||||+.+|+|.+++.......+++..++.++.||+.||+|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 99999999999999977655678999999999999999999999999999999999999999999999999987653211
Q ss_pred CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccch
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls 247 (671)
........++..|+|||++.+ ..++.++|||||||++|+|++ |..||...........+.... ..+....++
T Consensus 158 --~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~ 230 (261)
T cd05072 158 --YTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY----RMPRMENCP 230 (261)
T ss_pred --eeccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC----CCCCCCCCC
Confidence 111223356778999999876 568899999999999999998 999998876655544443322 233345688
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 248 KSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
..+.+||.+||..+|++||+++++++
T Consensus 231 ~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 231 DELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHH
Confidence 99999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=340.41 Aligned_cols=263 Identities=31% Similarity=0.527 Sum_probs=213.8
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe--CCEEEEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT--GHCLWVVM 91 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~--~~~l~LVm 91 (671)
++|+..+.||.|++|.||+|.+..+++.||+|.+...........+.+|+++++.++||||++++++|.. ...+|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 4799999999999999999999999999999998755444446778999999999999999999999865 44799999
Q ss_pred eccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCC
Q 005886 92 PYMAGGSCLHIMKSA--YPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~--~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~ 169 (671)
||+.|++|.+++... ....+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~-- 158 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS-- 158 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc--
Confidence 999999998876542 2345889999999999999999999999999999999999999999999999997644221
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHhcCCCCCCccc--
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYP-----PMKVLLMTLQNAPPGLDYER-- 242 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~-----~~~~~~~~~~~~~~~~~~~~-- 242 (671)
......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.... ..+..........+.+....
T Consensus 159 ---~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd06621 159 ---LAGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234 (287)
T ss_pred ---ccccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCC
Confidence 1123567899999999876 568999999999999999999999997652 22222222221111111111
Q ss_pred cccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 243 DKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 243 ~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
...+++.+.+||.+||..+|.+|||+.++++||||+....
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 274 (287)
T cd06621 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274 (287)
T ss_pred CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence 1345788999999999999999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=343.17 Aligned_cols=258 Identities=29% Similarity=0.434 Sum_probs=213.1
Q ss_pred eEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecc
Q 005886 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYM 94 (671)
Q Consensus 16 Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~ 94 (671)
|++.+.||.|++|.||+|.+..+|..||+|++...... .....+.+|+.+++.++||||+++++++.++...|+||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 67889999999999999999999999999998765432 23456888999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccc
Q 005886 95 AGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSR 174 (671)
Q Consensus 95 ~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 174 (671)
. ++|..++.......+++..++.++.||+.||+|||++|++||||+|+||+++.++.++|+|||++..+... ....
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~---~~~~ 156 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP---VRTY 156 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC---cccc
Confidence 5 68999887664346899999999999999999999999999999999999999999999999998654221 1122
Q ss_pred ccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC------------------
Q 005886 175 NTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP------------------ 236 (671)
Q Consensus 175 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~------------------ 236 (671)
....+++.|+|||++.+...++.++|||||||++|+|++|.+||........+..+......
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 23367899999998876455788999999999999999999999877665544433221100
Q ss_pred ------CCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 237 ------GLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 237 ------~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
.........++..+.+||.+||..||.+|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 00011134567899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=341.16 Aligned_cols=260 Identities=22% Similarity=0.375 Sum_probs=212.2
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIP-----LNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT 83 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~-----tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~ 83 (671)
|.+..++|++.+.||+|+||.||+|.+.. ++..||||++...........+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 56778899999999999999999998652 3567999998644333344568899999999999999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEE
Q 005886 84 GHCLWVVMPYMAGGSCLHIMKSAYP--------EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKL 155 (671)
Q Consensus 84 ~~~l~LVmEy~~ggsL~~~l~~~~~--------~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL 155 (671)
....++||||+.+|+|.+++..... ..++...+..++.|++.||+|||+.|++||||||+||+++.++.++|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 9999999999999999999875321 23567788999999999999999999999999999999999999999
Q ss_pred eccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcC
Q 005886 156 ADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNA 234 (671)
Q Consensus 156 ~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~ 234 (671)
+|||+++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+....
T Consensus 161 ~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 238 (277)
T cd05062 161 GDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG 238 (277)
T ss_pred CCCCCccccCCccee-ecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999998654322111 11122356788999999986 568999999999999999999 789998877665554444332
Q ss_pred CCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 235 PPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 235 ~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
.. ..+..++..+++||.+||..||.+|||+.+++++
T Consensus 239 ~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 239 LL----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred cC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 21 2245678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=339.40 Aligned_cols=259 Identities=24% Similarity=0.395 Sum_probs=215.4
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCC-----cEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLN-----EIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT 83 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg-----~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~ 83 (671)
|.+..++|++.+.||.|+||.||+|.++..+ ..||+|.+...........+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 5788899999999999999999999887544 78999998654433445678899999999999999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEE
Q 005886 84 GHCLWVVMPYMAGGSCLHIMKSAYP--------EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKL 155 (671)
Q Consensus 84 ~~~l~LVmEy~~ggsL~~~l~~~~~--------~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL 155 (671)
...+|+||||+.+|+|..++..... ..+++..++.++.||+.||.|||++|++||||||+|||++.++.+||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 9999999999999999999865321 23678889999999999999999999999999999999999999999
Q ss_pred eccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcC
Q 005886 156 ADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNA 234 (671)
Q Consensus 156 ~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~ 234 (671)
+|||+++.+..... ........++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+.........
T Consensus 161 ~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 238 (277)
T cd05032 161 GDFGMTRDIYETDY-YRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG 238 (277)
T ss_pred CCcccchhhccCcc-cccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC
Confidence 99999875533221 112234467889999999876 568999999999999999998 999998877666554444222
Q ss_pred CCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 235 PPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 235 ~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
....+..++..+.+||.+||..+|.+|||+.+++.
T Consensus 239 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 239 ----HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 22234556899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=342.04 Aligned_cols=255 Identities=26% Similarity=0.365 Sum_probs=210.8
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccCCCCH
Q 005886 22 VGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSC 99 (671)
Q Consensus 22 LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~ggsL 99 (671)
||+|+||+||+|.+..+|+.||+|++..... ......+.+|+.+++.++||||++++++|...+.+|+||||+.|++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6999999999999999999999999875432 22345667899999999999999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccccccccC
Q 005886 100 LHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVG 179 (671)
Q Consensus 100 ~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~G 179 (671)
.+++.......+++..++.++.|++.||.|||..|++||||+|+||+++.++.+||+|||++..... ........|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~~~ 156 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG----GKKIKGRAG 156 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc----CCccccccC
Confidence 9998776445799999999999999999999999999999999999999999999999998865422 122234568
Q ss_pred CCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhh
Q 005886 180 TPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLV 259 (671)
Q Consensus 180 T~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~ 259 (671)
+..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+... ........+..+++.+.++|.+||.
T Consensus 157 ~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~ 234 (277)
T cd05577 157 TPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR-TLEMAVEYPDKFSPEAKDLCEALLQ 234 (277)
T ss_pred CCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc-cccccccCCccCCHHHHHHHHHHcc
Confidence 889999999887 45889999999999999999999999765431111111111 1112223345678999999999999
Q ss_pred cCCCCCC-----CHHHHHhchhcccccc
Q 005886 260 KDPKKRP-----TAEKLMKHHFFKHARS 282 (671)
Q Consensus 260 ~dP~kRp-----Sa~eiL~Hpwfk~~~~ 282 (671)
.||.+|| ++.+++.||||+...+
T Consensus 235 ~~p~~R~~~~~~~~~~ll~h~~~~~~~~ 262 (277)
T cd05577 235 KDPEKRLGCRGGSADEVREHPLFKDLNW 262 (277)
T ss_pred CChhHccCCCcccHHHHHhChhhhcCCh
Confidence 9999999 8999999999986554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=334.65 Aligned_cols=255 Identities=29% Similarity=0.485 Sum_probs=216.8
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
+|.+.+.||.|+||.||+|.+..+|..||+|.+...... ...+.+.+|+.+++.++|+||+++++.+.....+|+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 589999999999999999999999999999998765332 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC-ceEEeccccccccccCCCccc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG-AIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g-~vKL~DFGls~~~~~~~~~~~ 172 (671)
+.+++|.+++.......+++..+..++.|++.||.|||+.|++|+||||.||+++.++ .+||+|||++....... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~---~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM---E 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc---c
Confidence 9999999998765444689999999999999999999999999999999999998886 46999999886553221 1
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHH
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKE 252 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~d 252 (671)
......|++.|+|||++.+ ..++.++|+|||||++|+|++|..||......+........... +....++..+.+
T Consensus 158 ~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 232 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA----PISPNFSRDLRS 232 (257)
T ss_pred cccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCC----CCCCCCCHHHHH
Confidence 1223468999999999876 45889999999999999999999999877666555544443221 223467889999
Q ss_pred HHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 253 LVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 253 LI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
+|.+||..+|.+|||+.++++||||
T Consensus 233 ~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 233 LISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHhccChhhCcCHHHHhhCCCC
Confidence 9999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=346.20 Aligned_cols=262 Identities=24% Similarity=0.326 Sum_probs=208.1
Q ss_pred CeEEEEEecccCceEEEEEEEcC--CCcEEEEEEecccc--CcccHHHHHHHHHHHHhCCCCCceeeeeEEEeC--CEEE
Q 005886 15 DYRLYEEVGEGVSATVYRALCIP--LNEIVAIKVLDLEK--CNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG--HCLW 88 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~--tg~~VAIKvi~~~~--~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~--~~l~ 88 (671)
+|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 89999999987633 122346778899999999999999999999988 8899
Q ss_pred EEEeccCCCCHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcC----CCceEEeccccc
Q 005886 89 VVMPYMAGGSCLHIMKSAY---PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS----NGAIKLADFGVS 161 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~---~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~----~g~vKL~DFGls 161 (671)
+||||+.+ ++..++.... ...+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 6776664332 136899999999999999999999999999999999999999 899999999998
Q ss_pred cccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHH---------HHHHHHh
Q 005886 162 ACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK---------VLLMTLQ 232 (671)
Q Consensus 162 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~---------~~~~~~~ 232 (671)
..+..............+++.|+|||++.+...++.++|||||||++|+|++|++||.+..... .+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 7653332222233455789999999998775668999999999999999999999997544321 0100000
Q ss_pred cC-------------------------CCCCC-------ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 233 NA-------------------------PPGLD-------YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 233 ~~-------------------------~~~~~-------~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
.. ...+. .+.+...+..+.++|.+||..||.+|||+.+++.||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 00 00000 00011456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=333.59 Aligned_cols=255 Identities=29% Similarity=0.489 Sum_probs=214.3
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEe--CCEEEEEE
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTT--GHCLWVVM 91 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~--~~~l~LVm 91 (671)
+|++.+.||.|+||.||+|.+..+|..||+|++..... ....+.+..|+.+++.++||||+++++++.. +..+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 58999999999999999999999999999999875443 2345678899999999999999999998764 45789999
Q ss_pred eccCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHH-----HCCcccccCCCCcEEEcCCCceEEecccccccc
Q 005886 92 PYMAGGSCLHIMKSAY--PEGFEEPVIATLLRETLKALVYLH-----FHGHIHRDVKAGNILIDSNGAIKLADFGVSACM 164 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~--~~~l~e~~i~~i~~qIl~aL~yLH-----s~gIVHrDLKPeNILld~~g~vKL~DFGls~~~ 164 (671)
||+.+++|..++.... ...+++..++.++.||+.||+||| +.+++|+||+|+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999999999886532 356899999999999999999999 889999999999999999999999999998765
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccc
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (671)
.... .......|++.|+|||++.+ ..++.++|+||||+++|+|++|..||...........+..... ...+.
T Consensus 161 ~~~~---~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~ 232 (265)
T cd08217 161 GHDS---SFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF----RRIPY 232 (265)
T ss_pred cCCc---ccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCC----CCCcc
Confidence 3221 11234578999999999987 5588999999999999999999999988764443333322221 22345
Q ss_pred cchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 245 RFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 245 ~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
.++..+.+++.+||..+|.+||++.+||+|||+
T Consensus 233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 678999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=353.77 Aligned_cols=266 Identities=24% Similarity=0.352 Sum_probs=215.1
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEe----CCEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTT----GHCLW 88 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~----~~~l~ 88 (671)
.+|++.+.||.|+||.||+|.++.+|..||+|++..... ......+.+|+.+|+.++||||++++++|.. ...+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 789999999999999999999999999999999875432 2345677889999999999999999998863 45789
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
+||||+. ++|..++... ..+++..++.++.||+.||.|||.+||+||||||+|||++.+|.+||+|||++.......
T Consensus 85 lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 85 VVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred EEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 9999995 5888888654 569999999999999999999999999999999999999999999999999987653322
Q ss_pred Ccc-cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--------------
Q 005886 169 DRQ-RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQN-------------- 233 (671)
Q Consensus 169 ~~~-~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~-------------- 233 (671)
... .......|+..|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~ 241 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence 211 11234578999999999876556899999999999999999999999776543322211110
Q ss_pred ---------CCCCCCc---cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 234 ---------APPGLDY---ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 234 ---------~~~~~~~---~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
.+..... .....++..+.+||.+||+.+|.+||++.+++.||||.....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~ 302 (334)
T cd07855 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302 (334)
T ss_pred hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence 0000000 112346889999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=341.76 Aligned_cols=257 Identities=23% Similarity=0.385 Sum_probs=214.1
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIP-----LNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH 85 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~-----tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~ 85 (671)
+...+|.+.+.||+|+||.||+|.+.. ++..||||++...........+.+|+++++.++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 345789999999999999999998753 357899999875544444678999999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCce
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAY------------PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAI 153 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~------------~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~v 153 (671)
.+|+||||+.|++|.+++.... ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 9999999999999999987542 1347888999999999999999999999999999999999999999
Q ss_pred EEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 005886 154 KLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQ 232 (671)
Q Consensus 154 KL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~ 232 (671)
||+|||++........ ........+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 162 kl~d~g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05049 162 KIGDFGMSRDVYTTDY-YRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239 (280)
T ss_pred EECCcccceecccCcc-eecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 9999999865422211 111223456788999999987 568999999999999999998 9999988776665555443
Q ss_pred cCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 233 NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 233 ~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.... ..+..++..+.+||.+||..||.+||++.++++
T Consensus 240 ~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 240 GRLL----QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCcC----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 3222 223467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=346.20 Aligned_cols=260 Identities=38% Similarity=0.702 Sum_probs=219.5
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
..++|++.+.||+|+||.||++.+..++..||+|.+.... ....+.+.+|+.+++.++||||++++++|...+.+|+|+
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 4578999999999999999999999899999999986443 233567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
||+.|++|..++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 96 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~--- 169 (293)
T cd06647 96 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 169 (293)
T ss_pred ecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc---
Confidence 999999999988753 57899999999999999999999999999999999999999999999999876543221
Q ss_pred cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHH
Q 005886 172 RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~ 251 (671)
.......|++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.................+ ....+..++..++
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~ 246 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP--ELQNPEKLSAIFR 246 (293)
T ss_pred cccccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCC--CCCCccccCHHHH
Confidence 22334578999999999876 56889999999999999999999999876554433322222221 1223445788999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 252 ELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 252 dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
+||.+||..+|.+||++.+++.||||+..+
T Consensus 247 ~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 247 DFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 999999999999999999999999998765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=347.29 Aligned_cols=256 Identities=39% Similarity=0.675 Sum_probs=206.2
Q ss_pred CceEEEEEEEcCCCcEEEEEEecccc-CcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccCCCCHHHHHH
Q 005886 26 VSATVYRALCIPLNEIVAIKVLDLEK-CNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMK 104 (671)
Q Consensus 26 ~fG~Vyka~~~~tg~~VAIKvi~~~~-~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~ggsL~~~l~ 104 (671)
++|.||.+++..+|+.||||++.... .......+.+|+.+++.++||||++++++|...+.+|++|||+.+|+|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 44556666667789999999997652 34557789999999999999999999999999999999999999999999998
Q ss_pred hhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCc----ccccccccCC
Q 005886 105 SAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR----QRSRNTFVGT 180 (671)
Q Consensus 105 ~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~----~~~~~~~~GT 180 (671)
......+++..+..++.||+.||+|||++||+||||||+||+++.+|.+||+|||.+..+...+.. ........++
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (314)
T cd08216 92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN 171 (314)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccccc
Confidence 765567999999999999999999999999999999999999999999999999988655432221 1112344678
Q ss_pred CCCCChhHhhhc-cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----------------------
Q 005886 181 PCWMAPEVMQQL-HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG---------------------- 237 (671)
Q Consensus 181 ~~Y~APEvl~~~-~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~---------------------- 237 (671)
..|+|||++.+. ..++.++|||||||++|+|++|..||.................+.
T Consensus 172 ~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
T cd08216 172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNE 251 (314)
T ss_pred ccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccccccc
Confidence 899999998753 358899999999999999999999998766544433322211100
Q ss_pred -------CCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 238 -------LDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 238 -------~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
........++.++.+||.+||..||.+|||+.++|+||||+..+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 252 HPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred ccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 00111223467899999999999999999999999999998765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=352.46 Aligned_cols=262 Identities=37% Similarity=0.688 Sum_probs=209.7
Q ss_pred EEeccc--CceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccCC
Q 005886 20 EEVGEG--VSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAG 96 (671)
Q Consensus 20 ~~LG~G--~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~g 96 (671)
..||.| +||+||+|.+..+|+.||+|++...... ...+.+.+|+.+++.++||||++++++|..+..+|+||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456776 9999999999999999999998765432 3457889999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccc---
Q 005886 97 GSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS--- 173 (671)
Q Consensus 97 gsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~--- 173 (671)
++|..++.......+++..+..++.||+.||+|||+.|++||||||+|||++.++.++++|||.+......+.....
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence 99999988765567999999999999999999999999999999999999999999999999865443222211111
Q ss_pred -cccccCCCCCCChhHhhhc-cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC---------------
Q 005886 174 -RNTFVGTPCWMAPEVMQQL-HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP--------------- 236 (671)
Q Consensus 174 -~~~~~GT~~Y~APEvl~~~-~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~--------------- 236 (671)
.....++..|+|||++.+. ..++.++|||||||++|+|++|..||............+...+.
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (328)
T cd08226 164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRM 243 (328)
T ss_pred ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhh
Confidence 1112356679999998753 34789999999999999999999999876554433332221110
Q ss_pred ---------------------------CCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 237 ---------------------------GLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 237 ---------------------------~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
....+....++..+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 244 KNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred ccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 001111234677899999999999999999999999999997554
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=353.55 Aligned_cols=260 Identities=25% Similarity=0.360 Sum_probs=209.9
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeC------
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG------ 84 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~------ 84 (671)
..++|++.+.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.+++.++||||++++++|...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 45889999999999999999999999999999999864332 23345677899999999999999999998644
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccc
Q 005886 85 HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACM 164 (671)
Q Consensus 85 ~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~ 164 (671)
..+|+||||+.+ +|...+... +++..+..++.||+.||+|||.+|++||||||+||+++.++.+||+|||++...
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 357999999964 777777542 889999999999999999999999999999999999999999999999998654
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG------- 237 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~------- 237 (671)
.. ........|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+.......
T Consensus 169 ~~----~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 169 GT----SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred CC----CCCCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 22 112334578999999999987 678999999999999999999999998765443332222111000
Q ss_pred --------------C------------Cc-----cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 238 --------------L------------DY-----ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 238 --------------~------------~~-----~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
. .+ ......+..+++||.+||..||.+|||+.++|.||||+.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~ 318 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWY 318 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhcc
Confidence 0 00 00123466789999999999999999999999999998544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=329.95 Aligned_cols=255 Identities=31% Similarity=0.534 Sum_probs=220.6
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
+|.+.+.||.|+||.||++.+..++..||+|++...... .....+.+|+++++.++|||++++++.+.....+++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 589999999999999999999999999999999765432 4567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 94 MAGGSCLHIMKSAY--PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 94 ~~ggsL~~~l~~~~--~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
+.|++|..++.... ...+++..+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--- 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--- 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc---
Confidence 99999999987653 3678999999999999999999999999999999999999999999999999986543221
Q ss_pred cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHH
Q 005886 172 RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~ 251 (671)
.......|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||................... .+..++..+.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 232 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP----IPSQYSSELR 232 (258)
T ss_pred ceecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCC----CCCCCCHHHH
Confidence 12334578999999999876 558899999999999999999999998877665555554443222 2346789999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 252 ELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 252 dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
++|.+||..+|.+||++.++|.||||
T Consensus 233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 233 NLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=341.55 Aligned_cols=263 Identities=24% Similarity=0.435 Sum_probs=217.6
Q ss_pred ccccccCCCCeEEEEEecccCceEEEEEEEcCCC-----cEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeee
Q 005886 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLN-----EIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHC 79 (671)
Q Consensus 6 e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg-----~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~ 79 (671)
+..+.+..++|++.+.||+|+||.||++.+...+ ..||+|.+...........+.+|+.+++.+ +||||+++++
T Consensus 4 ~~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 4 DPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred CcccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 4567888999999999999999999999887543 689999987554444456788999999999 8999999999
Q ss_pred EEEeCCEEEEEEeccCCCCHHHHHHhh--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcE
Q 005886 80 SFTTGHCLWVVMPYMAGGSCLHIMKSA--------------YPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNI 145 (671)
Q Consensus 80 ~~~~~~~l~LVmEy~~ggsL~~~l~~~--------------~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNI 145 (671)
++..+..+|+||||+.+|+|..++... ....+++..++.++.||+.||+|||++||+||||||+||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 999999999999999999999998653 124688999999999999999999999999999999999
Q ss_pred EEcCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChH
Q 005886 146 LIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPM 224 (671)
Q Consensus 146 Lld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~ 224 (671)
|++.++.+||+|||+++.+..... ........++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDY-YRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred EEcCCCeEEeCccccccccccccc-eeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 999999999999999875532211 111122345678999999876 568999999999999999997 99999887765
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 225 KVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
+......... ....+..++..+.+||.+||..||.+|||+.+++++
T Consensus 242 ~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 242 ELFKLLKEGY----RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHHcCC----cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 5554443332 223345678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=352.55 Aligned_cols=263 Identities=19% Similarity=0.326 Sum_probs=212.3
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeC--------
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG-------- 84 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~-------- 84 (671)
..+|++.+.||.|+||.||+|.+..+|..||+|++..... .....+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 4789999999999999999999999999999999865543 4456788999999999999999999776653
Q ss_pred ------CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcC-CCceEEec
Q 005886 85 ------HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS-NGAIKLAD 157 (671)
Q Consensus 85 ------~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~-~g~vKL~D 157 (671)
..+|+||||+. ++|..++.. ..+++..++.++.||+.||.|||++|++||||||+||+++. ++.+||+|
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 36899999997 588887754 36899999999999999999999999999999999999974 55789999
Q ss_pred cccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC
Q 005886 158 FGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG 237 (671)
Q Consensus 158 FGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~ 237 (671)
||++..+..............|+..|+|||++.+...++.++|||||||++|+|++|+.||.+..+.......+...+..
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99986542211111122334689999999988665668899999999999999999999998776655544443322111
Q ss_pred CC-------------------------ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 238 LD-------------------------YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 238 ~~-------------------------~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
.. ......++.++.+||.+||+.||.+|||+.++|.||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 00 01123467889999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=335.40 Aligned_cols=254 Identities=33% Similarity=0.537 Sum_probs=213.7
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccCCCCH
Q 005886 22 VGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSC 99 (671)
Q Consensus 22 LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~ggsL 99 (671)
||.|+||.||+|.+..+|+.||+|++..... ......+.+|+.+++.++||||+++++.+..+..+|+||||+.|++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6999999999999999999999999865432 23467788999999999999999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCc-----cccc
Q 005886 100 LHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR-----QRSR 174 (671)
Q Consensus 100 ~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~-----~~~~ 174 (671)
.+++... +.+++..+..++.||+.||.|||..|++||||+|+||+++.++.++|+|||++......... ....
T Consensus 81 ~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 158 (265)
T cd05579 81 ASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158 (265)
T ss_pred HHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccc
Confidence 9999875 47899999999999999999999999999999999999999999999999998654322110 1122
Q ss_pred ccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHH
Q 005886 175 NTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELV 254 (671)
Q Consensus 175 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI 254 (671)
....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||................ ..++....++..+.+||
T Consensus 159 ~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~i 234 (265)
T cd05579 159 KRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK---IEWPEDVEVSDEAIDLI 234 (265)
T ss_pred cCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---cCCCccccCCHHHHHHH
Confidence 34578899999999876 458889999999999999999999998877666554443321 12222223589999999
Q ss_pred HHhhhcCCCCCCCH---HHHHhchhccccc
Q 005886 255 TACLVKDPKKRPTA---EKLMKHHFFKHAR 281 (671)
Q Consensus 255 ~~cL~~dP~kRpSa---~eiL~Hpwfk~~~ 281 (671)
.+||+.+|.+|||+ .++|+||||+...
T Consensus 235 ~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 235 SKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred HHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence 99999999999999 9999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=354.90 Aligned_cols=262 Identities=21% Similarity=0.356 Sum_probs=212.5
Q ss_pred ccccCCCCeEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeeeEE
Q 005886 8 RFPVDAKDYRLYEEVGEGVSATVYRALCIP-----LNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHCSF 81 (671)
Q Consensus 8 ~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~-----tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~ 81 (671)
+|.+..++|++.+.||.|+||.||+|.+.. +++.||+|++...........+.+|+.+++.+ +||||+++++++
T Consensus 1 ~~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred CcccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 467788899999999999999999997543 45789999987544334456788899999999 899999999987
Q ss_pred Ee-CCEEEEEEeccCCCCHHHHHHhhCC----------------------------------------------------
Q 005886 82 TT-GHCLWVVMPYMAGGSCLHIMKSAYP---------------------------------------------------- 108 (671)
Q Consensus 82 ~~-~~~l~LVmEy~~ggsL~~~l~~~~~---------------------------------------------------- 108 (671)
.. +..++++|||+.|++|.+++.....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 64 4678999999999999998864321
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccccccccCCC
Q 005886 109 -------EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTP 181 (671)
Q Consensus 109 -------~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~ 181 (671)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.... .........++.
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~-~~~~~~~~~~~~ 239 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP-DYVRKGDARLPL 239 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCc-chhhccCCCCCc
Confidence 257889999999999999999999999999999999999999999999999987653322 112223446678
Q ss_pred CCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhc
Q 005886 182 CWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVK 260 (671)
Q Consensus 182 ~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~ 260 (671)
.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+.+...+.... ....+..++.++.+++.+||+.
T Consensus 240 ~y~aPE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~~cl~~ 315 (337)
T cd05054 240 KWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT---RMRAPEYATPEIYSIMLDCWHN 315 (337)
T ss_pred cccCcHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccC---CCCCCccCCHHHHHHHHHHccC
Confidence 8999999987 679999999999999999998 9999987554444433333321 1122445788999999999999
Q ss_pred CCCCCCCHHHHHhc
Q 005886 261 DPKKRPTAEKLMKH 274 (671)
Q Consensus 261 dP~kRpSa~eiL~H 274 (671)
+|++||++.++++|
T Consensus 316 ~p~~RPs~~ell~~ 329 (337)
T cd05054 316 NPEDRPTFSELVEI 329 (337)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=334.01 Aligned_cols=257 Identities=28% Similarity=0.488 Sum_probs=215.1
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEecccc----CcccHHHHHHHHHHHHhCCCCCceeeeeEEEeC--CEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEK----CNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG--HCL 87 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~----~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~--~~l 87 (671)
.+|++.+.||+|+||.||+|.+..+|..||+|.+.... .......+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 58999999999999999999999999999999985432 123456788999999999999999999998764 568
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccC
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~ 167 (671)
++||||+.|++|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||+++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 9999999999999998765 45889999999999999999999999999999999999999999999999998755321
Q ss_pred CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccch
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls 247 (671)
...........|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||................ .....+..++
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~p~~~~ 235 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQP---TKPMLPDGVS 235 (264)
T ss_pred cccCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCC---CCCCCCcccC
Confidence 111122234578999999999987 568899999999999999999999998876655544433221 1223456788
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 248 KSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
..+.++|.+||. +|..||++.++|.|||.
T Consensus 236 ~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 236 DACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 999999999998 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=339.58 Aligned_cols=258 Identities=22% Similarity=0.368 Sum_probs=212.7
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEc----CCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCI----PLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~----~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 86 (671)
+...+|++.+.||+|+||+||+|... .++..||+|.+...........+.+|+.+++.++||||+++++++..+..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 34578999999999999999999853 45578999998754434445678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC
Q 005886 87 LWVVMPYMAGGSCLHIMKSAY---------------PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG 151 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~---------------~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g 151 (671)
.|+||||+.+++|.+++.... ...+++..+..++.||+.||+|||++|++||||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 999999999999999885331 12478888999999999999999999999999999999999999
Q ss_pred ceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 005886 152 AIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMT 230 (671)
Q Consensus 152 ~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~ 230 (671)
.+||+|||+++....... ........++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+
T Consensus 162 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~ 239 (283)
T cd05090 162 HVKISDLGLSREIYSADY-YRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239 (283)
T ss_pred cEEeccccccccccCCcc-eecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999999876533221 122234456788999999976 568999999999999999998 99999887665544444
Q ss_pred HhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 231 LQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 231 ~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
..... ...+..++..+.++|.+||..||.+||++.+|+++
T Consensus 240 ~~~~~----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 240 RKRQL----LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HcCCc----CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 33222 22345678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=340.42 Aligned_cols=252 Identities=25% Similarity=0.355 Sum_probs=205.1
Q ss_pred EecccCceEEEEEEEcCCCcEEEEEEeccccCccc--HHHHHHHH---HHHHhCCCCCceeeeeEEEeCCEEEEEEeccC
Q 005886 21 EVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNND--LDGIRREV---QTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMA 95 (671)
Q Consensus 21 ~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~--~~~i~~Ei---~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~ 95 (671)
.||+|+||.||+|.+..+++.||+|++........ ......|. ..++..+||||++++++|.....+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999999999999999876543211 12233333 34455689999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccccc
Q 005886 96 GGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRN 175 (671)
Q Consensus 96 ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 175 (671)
||+|..++... +.+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++..+... ...
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~ 153 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPH 153 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-----CCc
Confidence 99999888754 57999999999999999999999999999999999999999999999999998644211 123
Q ss_pred cccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChH--HHHHHHHhcCCCCCCccccccchHHHHHH
Q 005886 176 TFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM--KVLLMTLQNAPPGLDYERDKRFSKSFKEL 253 (671)
Q Consensus 176 ~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~--~~~~~~~~~~~~~~~~~~~~~ls~~l~dL 253 (671)
...|+..|+|||++.+...++.++||||+||++|+|++|..||.+.... ......... .....+..++..+.++
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~s~~~~~l 229 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT----MAVELPDSFSPELRSL 229 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc----cCCCCCCcCCHHHHHH
Confidence 4579999999999975456899999999999999999999999765322 111111111 1223345678999999
Q ss_pred HHHhhhcCCCCCC-----CHHHHHhchhccccccc
Q 005886 254 VTACLVKDPKKRP-----TAEKLMKHHFFKHARSN 283 (671)
Q Consensus 254 I~~cL~~dP~kRp-----Sa~eiL~Hpwfk~~~~~ 283 (671)
|.+||..+|.+|| ++.++++||||+...+.
T Consensus 230 i~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~ 264 (278)
T cd05606 230 LEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQ 264 (278)
T ss_pred HHHHhhcCHHhccCCCCCCHHHHHhCccccCCCch
Confidence 9999999999999 99999999999887654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=338.87 Aligned_cols=258 Identities=24% Similarity=0.378 Sum_probs=212.7
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIP-----LNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH 85 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~-----tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~ 85 (671)
+..+.|.+.+.||+|+||.||+|.+.. ++..||+|.+...........+.+|+.+++.++|+||+++++++.+..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 355789999999999999999999987 778899998864443334467888999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC---ceEEec
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYP-----EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG---AIKLAD 157 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~-----~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g---~vKL~D 157 (671)
..|+||||+.|++|..++..... ..+++..+..++.||+.||+|||++|++||||||+|||++.++ .+||+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 99999999999999999876532 2588999999999999999999999999999999999998765 599999
Q ss_pred cccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCC
Q 005886 158 FGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPP 236 (671)
Q Consensus 158 FGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~ 236 (671)
||+++.+...... .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+.....
T Consensus 163 fg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~- 239 (277)
T cd05036 163 FGMARDIYRASYY-RKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGR- 239 (277)
T ss_pred CccccccCCccce-ecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-
Confidence 9998765221111 11112234567999999976 569999999999999999997 9999998776665544443322
Q ss_pred CCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 237 GLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 237 ~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
...+..++..+.+||.+||..+|.+||++.++++|
T Consensus 240 ---~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 240 ---LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 22345678999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=364.98 Aligned_cols=250 Identities=27% Similarity=0.506 Sum_probs=219.5
Q ss_pred cccccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeC
Q 005886 5 VEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG 84 (671)
Q Consensus 5 ~e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~ 84 (671)
-++-|.|..+...-++.||.|+-|.||+|+.. ++.||||+++. .-..+|+-|++|+||||+.+.++|...
T Consensus 115 q~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~e--------lkETdIKHLRkLkH~NII~FkGVCtqs 184 (904)
T KOG4721|consen 115 QEELWEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVRE--------LKETDIKHLRKLKHPNIITFKGVCTQS 184 (904)
T ss_pred hhhhccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhh--------hhhhhHHHHHhccCcceeeEeeeecCC
Confidence 35567888888888899999999999999876 88999998742 224578889999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccc
Q 005886 85 HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACM 164 (671)
Q Consensus 85 ~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~ 164 (671)
-+++||||||..|.|+.+++.. ..+.......|.++|+.|+.|||.+.|||||||.-||||..+..|||+|||.++.+
T Consensus 185 PcyCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 185 PCYCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKEL 262 (904)
T ss_pred ceeEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhh
Confidence 9999999999999999999987 67888889999999999999999999999999999999999999999999998766
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccc
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (671)
.+ ......|+||..|||||++.. ...+.|+|||||||+|||||||..||.+.+...+++- -....+..+.+.
T Consensus 263 ~~----~STkMSFaGTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwG---VGsNsL~LpvPs 334 (904)
T KOG4721|consen 263 SD----KSTKMSFAGTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWG---VGSNSLHLPVPS 334 (904)
T ss_pred hh----hhhhhhhhhhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchheeEEe---ccCCcccccCcc
Confidence 33 245667899999999999987 6789999999999999999999999988765544332 223345567788
Q ss_pred cchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 245 RFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 245 ~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
.+++.|+=||+.||.-.|..||++.+||.|
T Consensus 335 tcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 335 TCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred cCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 899999999999999999999999999999
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=335.49 Aligned_cols=252 Identities=31% Similarity=0.484 Sum_probs=207.4
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHH-HhCCCCCceeeeeEEEeCCEEEEEEeccCC
Q 005886 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTM-RVTNHPNVLRAHCSFTTGHCLWVVMPYMAG 96 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL-~~L~HpNIVkl~~~~~~~~~l~LVmEy~~g 96 (671)
+.||.|+||.||+|.+..+|+.||+|++...... .....+..|..++ ...+||||+++++++..++.+|+||||+.|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999998654321 2223344554444 456899999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccccc
Q 005886 97 GSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNT 176 (671)
Q Consensus 97 gsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~ 176 (671)
++|..++... ..+++..+..++.||+.||.|||+.|++||||+|.||+++.++.+||+|||++..... ...
T Consensus 82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-------~~~ 152 (260)
T cd05611 82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-------NKK 152 (260)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-------ccc
Confidence 9999999765 5689999999999999999999999999999999999999999999999998764321 234
Q ss_pred ccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHH
Q 005886 177 FVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTA 256 (671)
Q Consensus 177 ~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~ 256 (671)
..|++.|+|||.+.+ ..++.++||||||+++|+|++|..||................. .........++..+.++|.+
T Consensus 153 ~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~ 230 (260)
T cd05611 153 FVGTPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRI-NWPEEVKEFCSPEAVDLINR 230 (260)
T ss_pred CCCCcCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc-CCCCcccccCCHHHHHHHHH
Confidence 578999999999987 4589999999999999999999999988766554444333221 12222234578999999999
Q ss_pred hhhcCCCCCCC---HHHHHhchhcccccc
Q 005886 257 CLVKDPKKRPT---AEKLMKHHFFKHARS 282 (671)
Q Consensus 257 cL~~dP~kRpS---a~eiL~Hpwfk~~~~ 282 (671)
||..+|.+||+ ++++|.||||+...|
T Consensus 231 ~l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 231 LLCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred HccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 99999999995 589999999987655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=369.87 Aligned_cols=253 Identities=28% Similarity=0.496 Sum_probs=219.0
Q ss_pred EecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccCCCCHH
Q 005886 21 EVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCL 100 (671)
Q Consensus 21 ~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~ggsL~ 100 (671)
.||+|.||+||.|+++.|...+|||.|.-. .....+-+..||.+.+.|.|.|||+++|++..++++-|.||-.+||+|.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek-dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK-DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc-cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 699999999999999999999999998643 3445678899999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCC--CHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEc-CCCceEEeccccccccccCCCcccccccc
Q 005886 101 HIMKSAYPEGF--EEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILID-SNGAIKLADFGVSACMFDAGDRQRSRNTF 177 (671)
Q Consensus 101 ~~l~~~~~~~l--~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld-~~g~vKL~DFGls~~~~~~~~~~~~~~~~ 177 (671)
.++.... +++ +|..+..|.+||+.||.|||.+.|||||||-+|||++ ..|.+||+|||.++++. .......++
T Consensus 661 sLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA---ginP~TETF 736 (1226)
T KOG4279|consen 661 SLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA---GINPCTETF 736 (1226)
T ss_pred HHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhc---cCCcccccc
Confidence 9998764 566 8999999999999999999999999999999999995 47899999999998873 233456678
Q ss_pred cCCCCCCChhHhh-hccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHH
Q 005886 178 VGTPCWMAPEVMQ-QLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTA 256 (671)
Q Consensus 178 ~GT~~Y~APEvl~-~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~ 256 (671)
.||..|||||++. |..+|+.++|||||||++.||+||++||.........+..+. -.....+.+..++.+++.||.+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG--myKvHP~iPeelsaeak~Filr 814 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG--MYKVHPPIPEELSAEAKNFILR 814 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc--ceecCCCCcHHHHHHHHHHHHH
Confidence 9999999999996 456799999999999999999999999976644333222221 1122445678899999999999
Q ss_pred hhhcCCCCCCCHHHHHhchhcccc
Q 005886 257 CLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 257 cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
|+..||.+||+|.++|..||++..
T Consensus 815 cFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 815 CFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HcCCCcccCccHHHhccCcccccC
Confidence 999999999999999999999865
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=339.27 Aligned_cols=248 Identities=25% Similarity=0.395 Sum_probs=201.5
Q ss_pred CCeEEEEEe--cccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHh-CCCCCceeeeeEEEeCCEEEEE
Q 005886 14 KDYRLYEEV--GEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRV-TNHPNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 14 ~~Y~l~~~L--G~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~-L~HpNIVkl~~~~~~~~~l~LV 90 (671)
++|++.+.+ |.|+||.||++.++.++..+|+|++....... .|+..... .+||||++++++|...+.+|+|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv 87 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLI 87 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence 566676665 99999999999999999999999986543221 12222222 2799999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC-ceEEeccccccccccCCC
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG-AIKLADFGVSACMFDAGD 169 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g-~vKL~DFGls~~~~~~~~ 169 (671)
|||++|++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~---- 161 (267)
T PHA03390 88 MDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG---- 161 (267)
T ss_pred EEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC----
Confidence 9999999999999876 4799999999999999999999999999999999999999988 99999999986542
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHH
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
......|++.|+|||++.+ ..++.++|||||||++|+|++|..||................. ......+..++..
T Consensus 162 ---~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 236 (267)
T PHA03390 162 ---TPSCYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKN 236 (267)
T ss_pred ---CCccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHH
Confidence 1123468999999999987 5689999999999999999999999975543322111111111 1122334568999
Q ss_pred HHHHHHHhhhcCCCCCCC-HHHHHhchhcc
Q 005886 250 FKELVTACLVKDPKKRPT-AEKLMKHHFFK 278 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpS-a~eiL~Hpwfk 278 (671)
+.+||.+||+.+|.+||+ ++++|+||||+
T Consensus 237 ~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 237 ANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 999999999999999996 69999999996
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=339.80 Aligned_cols=258 Identities=36% Similarity=0.627 Sum_probs=217.6
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecc
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYM 94 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~ 94 (671)
.|.....||.|+||.||++.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..|+|+||+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 5666789999999999999999999999999986443 223456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccc
Q 005886 95 AGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSR 174 (671)
Q Consensus 95 ~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 174 (671)
.|++|.+++.. ..+++..+..++.||+.||+|||++|++||||+|+||+++.++.++|+|||++...... ....
T Consensus 99 ~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~---~~~~ 172 (285)
T cd06648 99 EGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE---VPRR 172 (285)
T ss_pred CCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC---Cccc
Confidence 99999998876 36899999999999999999999999999999999999999999999999987544221 1122
Q ss_pred ccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHH
Q 005886 175 NTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELV 254 (671)
Q Consensus 175 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI 254 (671)
....|++.|+|||++.+ ..++.++|||||||++|+|++|..||....+...........++.. .....++..+.+||
T Consensus 173 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li 249 (285)
T cd06648 173 KSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKL--KNLHKVSPRLRSFL 249 (285)
T ss_pred ccccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCC--cccccCCHHHHHHH
Confidence 34578999999999876 5689999999999999999999999987666555444433322222 22334788999999
Q ss_pred HHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 255 TACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 255 ~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
.+||..+|.+||++.++++||||+.+..
T Consensus 250 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 250 DRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred HHHcccChhhCcCHHHHccCcccccCCC
Confidence 9999999999999999999999987664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=338.37 Aligned_cols=256 Identities=29% Similarity=0.483 Sum_probs=219.1
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCC-CCCceeeeeEEEeCCEEEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTN-HPNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~-HpNIVkl~~~~~~~~~l~LV 90 (671)
++|.+.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.+++.+. ||||+++++++..+..+++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 579999999999999999999999999999999875432 233467889999999998 99999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCc
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR 170 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~ 170 (671)
|||+.+++|.+++... +.+++..++.++.|++.||.|||++|++|+||+|+||+++.+|.++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 81 LEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 9999999999999876 57999999999999999999999999999999999999999999999999998655322210
Q ss_pred -----------------ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 005886 171 -----------------QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQN 233 (671)
Q Consensus 171 -----------------~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~ 233 (671)
........|+..|+|||++.+ ..++.++||||||+++|+|++|..||........+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence 122345578999999999876 55888999999999999999999999887655544443321
Q ss_pred CCCCCCccccccchHHHHHHHHHhhhcCCCCCCCH----HHHHhchhc
Q 005886 234 APPGLDYERDKRFSKSFKELVTACLVKDPKKRPTA----EKLMKHHFF 277 (671)
Q Consensus 234 ~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa----~eiL~Hpwf 277 (671)
.+..+..+++.+.+||.+||..+|.+||++ +++|+||||
T Consensus 238 -----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 238 -----EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred -----CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 223345678899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=334.20 Aligned_cols=257 Identities=24% Similarity=0.354 Sum_probs=213.9
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCC---CcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPL---NEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCL 87 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~t---g~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l 87 (671)
++.++|++.+.||+|+||+||+|.+..+ ...||||.+...........+.+|+.+++.++||||+++++++.....+
T Consensus 1 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred CChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 3567899999999999999999998654 4579999987554444566788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccC
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~ 167 (671)
|+||||+.+++|.+++.... +.+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++..+...
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 81 MIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999987642 46899999999999999999999999999999999999999999999999998766311
Q ss_pred CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (671)
... .......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||......+....+.... ..+.+..+
T Consensus 160 ~~~-~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~ 233 (266)
T cd05033 160 EAT-YTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY----RLPPPMDC 233 (266)
T ss_pred ccc-eeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC----CCCCCCCC
Confidence 111 11112345678999999876 568999999999999999998 999998877665554443322 12234567
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 247 SKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 247 s~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
+..+.+|+.+||..+|.+||++.+++++
T Consensus 234 ~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 234 PSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 8999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=334.87 Aligned_cols=259 Identities=27% Similarity=0.455 Sum_probs=209.1
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
..+.......||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++|+||+++++++..++.+|+||
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 3444445578999999999999999999999999886443 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCC--CHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcC-CCceEEeccccccccccCC
Q 005886 92 PYMAGGSCLHIMKSAYPEGF--EEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS-NGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l--~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~-~g~vKL~DFGls~~~~~~~ 168 (671)
||+.|++|..++.... ..+ ++..+..++.||+.||+|||++||+||||||+||+++. ++.++|+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 85 EQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred ecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 9999999999987642 234 78889999999999999999999999999999999976 6799999999986542211
Q ss_pred CcccccccccCCCCCCChhHhhhc-cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccch
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQL-HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~-~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls 247 (671)
.......|++.|+|||++.+. ..++.++|+||||+++|+|++|..||................ ......+..++
T Consensus 164 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 238 (268)
T cd06624 164 ---PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF--KIHPEIPESLS 238 (268)
T ss_pred ---CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh--ccCCCCCcccC
Confidence 122334689999999998652 347889999999999999999999997654322221111110 11112345678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 248 KSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
.++++||.+||..+|.+|||+.+++.||||
T Consensus 239 ~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 239 AEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=346.56 Aligned_cols=256 Identities=23% Similarity=0.369 Sum_probs=209.4
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcE----EEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEI----VAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~----VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 86 (671)
+...+|++.+.||+|+||.||+|.+..+|.. ||+|++...........+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 3567899999999999999999998766654 8999986544344467788999999999999999999998875 5
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
.++|++|+.+|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred ceeeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 77899999999999998764 24588999999999999999999999999999999999999999999999999876532
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (671)
... ........++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+.. .++... ...+.+..
T Consensus 162 ~~~-~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~---~~~~~~~~ 235 (316)
T cd05108 162 DEK-EYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKG---ERLPQPPI 235 (316)
T ss_pred CCc-ceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCC---CCCCCCCC
Confidence 211 111122345678999999986 568999999999999999997 99999887665433 233221 12223456
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 246 FSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 246 ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
++..+.++|.+||..+|.+||++.+++.+
T Consensus 236 ~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 236 CTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 78899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=338.56 Aligned_cols=263 Identities=41% Similarity=0.738 Sum_probs=223.7
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
..+.|++...||+|+||.||+|.+..++..||+|++..... ....+.+|+.+++.++|+||+++++++.....+|+|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 34668999999999999999999998999999999875432 4567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
||+.|++|.+++.... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 95 e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--- 170 (286)
T cd06614 95 EYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK--- 170 (286)
T ss_pred eccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch---
Confidence 9999999999998762 378999999999999999999999999999999999999999999999999876543221
Q ss_pred cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHH
Q 005886 172 RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~ 251 (671)
.......|++.|+|||++.+ ..++.++|+|||||++|+|++|..||....+......+.....+.. .....++..++
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~ 247 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPL--KNPEKWSPEFK 247 (286)
T ss_pred hhhccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--cchhhCCHHHH
Confidence 12234568899999999876 5689999999999999999999999988776655544433332222 22344788999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHhchhccccccc
Q 005886 252 ELVTACLVKDPKKRPTAEKLMKHHFFKHARSN 283 (671)
Q Consensus 252 dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~ 283 (671)
+||.+||..+|.+||++.++|.||||+.+.+.
T Consensus 248 ~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 279 (286)
T cd06614 248 DFLNKCLVKDPEKRPSAEELLQHPFLKKACPK 279 (286)
T ss_pred HHHHHHhccChhhCcCHHHHhhChHhhccCch
Confidence 99999999999999999999999999986554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=359.82 Aligned_cols=263 Identities=19% Similarity=0.357 Sum_probs=215.5
Q ss_pred ccccccCCCCeEEEEEecccCceEEEEEEEcCC-----CcEEEEEEeccccCcccHHHHHHHHHHHHhCC-CCCceeeee
Q 005886 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPL-----NEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN-HPNVLRAHC 79 (671)
Q Consensus 6 e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~t-----g~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~-HpNIVkl~~ 79 (671)
+.+|.+..++|++++.||.|+||.||+|.+... +..||||++.........+.+.+|+.+|+.+. ||||+++++
T Consensus 29 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 29 DSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred CCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 458999999999999999999999999987543 34699999975544444678899999999996 999999999
Q ss_pred EEEeCCEEEEEEeccCCCCHHHHHHhhC----------------------------------------------------
Q 005886 80 SFTTGHCLWVVMPYMAGGSCLHIMKSAY---------------------------------------------------- 107 (671)
Q Consensus 80 ~~~~~~~l~LVmEy~~ggsL~~~l~~~~---------------------------------------------------- 107 (671)
+|.....+|||||||.+|+|.+++....
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 9999999999999999999998876431
Q ss_pred ------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcE
Q 005886 108 ------------------------------------------PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNI 145 (671)
Q Consensus 108 ------------------------------------------~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNI 145 (671)
...+++..+..++.||+.||+|||+.||+||||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 12477888899999999999999999999999999999
Q ss_pred EEcCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChH
Q 005886 146 LIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPM 224 (671)
Q Consensus 146 Lld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~ 224 (671)
|++.++.+||+|||+++...... .........+++.|+|||++.+ ..++.++|||||||++|+|++ |..||......
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDS-NYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccc-cccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 99999999999999987553221 1122334467889999999976 568999999999999999997 99999875443
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 225 KVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
......+... .....+..++..+.++|.+||..||.+||++.++.+
T Consensus 347 ~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 347 STFYNKIKSG---YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHHHhcC---CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 3333333322 222334567899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=343.01 Aligned_cols=263 Identities=23% Similarity=0.412 Sum_probs=214.8
Q ss_pred cccccccCCCCeEEEEEecccCceEEEEEEEcC-------CCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCcee
Q 005886 5 VEKRFPVDAKDYRLYEEVGEGVSATVYRALCIP-------LNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLR 76 (671)
Q Consensus 5 ~e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~-------tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVk 76 (671)
..++|.+..++|.+.+.||+|+||.||+|.+.. ++..||+|.+...........+.+|+.+++.+ +||||++
T Consensus 9 ~~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~ 88 (307)
T cd05098 9 EDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIIN 88 (307)
T ss_pred CCCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEee
Confidence 456888999999999999999999999998653 23469999987554344456788899999999 7999999
Q ss_pred eeeEEEeCCEEEEEEeccCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCC
Q 005886 77 AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYP--------------EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKA 142 (671)
Q Consensus 77 l~~~~~~~~~l~LVmEy~~ggsL~~~l~~~~~--------------~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKP 142 (671)
+++++...+.+|+||||+.+|+|.+++..... ..++...+..++.||+.||+|||++|++||||||
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp 168 (307)
T cd05098 89 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAA 168 (307)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccH
Confidence 99999999999999999999999999976422 2478889999999999999999999999999999
Q ss_pred CcEEEcCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCC
Q 005886 143 GNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKY 221 (671)
Q Consensus 143 eNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~ 221 (671)
+|||++.++.+||+|||++........ ........+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccch-hhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 999999999999999999865422111 111112234578999999986 568999999999999999998 89999876
Q ss_pred ChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 222 PPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
+..+......... ....+..++.++++||.+||..+|.+||++.++++
T Consensus 247 ~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 247 PVEELFKLLKEGH----RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred CHHHHHHHHHcCC----CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 6544443333222 22334567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=349.83 Aligned_cols=264 Identities=27% Similarity=0.343 Sum_probs=217.8
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC-----EEE
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH-----CLW 88 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~-----~l~ 88 (671)
+|++.+.||.|+||.||+|.+..+|+.||||++..... ......+.+|+.+++.++||||+++++++.... .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 58999999999999999999999999999999875432 334577899999999999999999999998875 799
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
+||+|+. ++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 81 lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 81 IVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157 (330)
T ss_pred EEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence 9999997 4788888765 479999999999999999999999999999999999999999999999999987653322
Q ss_pred CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---------
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD--------- 239 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~--------- 239 (671)
..........+++.|+|||++.+...++.++|||||||++|+|++|.+||.+....+....+.........
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE 237 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence 11122344578999999999987547899999999999999999999999887765544433321110000
Q ss_pred -----------------ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 240 -----------------YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 240 -----------------~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
......++..+.+||.+||.++|.+||+++++|.||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 001233678899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=344.43 Aligned_cols=258 Identities=33% Similarity=0.597 Sum_probs=216.9
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
..|.....||.|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||++++++|..++.+|+||||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 445566789999999999999999999999999865432 3356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS 173 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 173 (671)
+.+++|..++.. ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++..+... ...
T Consensus 100 ~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~---~~~ 173 (297)
T cd06659 100 LQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD---VPK 173 (297)
T ss_pred CCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc---ccc
Confidence 999999987754 35899999999999999999999999999999999999999999999999998644221 112
Q ss_pred cccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHH
Q 005886 174 RNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL 253 (671)
Q Consensus 174 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dL 253 (671)
.....|++.|+|||++.+ ..++.++|||||||++|+|++|..||.................. .......++..+.++
T Consensus 174 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~ 250 (297)
T cd06659 174 RKSLVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP--KLKNAHKISPVLRDF 250 (297)
T ss_pred ccceecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC--CccccCCCCHHHHHH
Confidence 234679999999999976 56899999999999999999999999876655544433222211 222345678899999
Q ss_pred HHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 254 VTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 254 I~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
|.+||..+|.+||++.+++.||||.+..
T Consensus 251 i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 251 LERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred HHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 9999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=331.51 Aligned_cols=252 Identities=25% Similarity=0.417 Sum_probs=209.6
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LV 90 (671)
++.++|++.+.||+|+||.||++..+ .+..+|+|.+.... .....+.+|+.+++.++||||+++++++.....+|+|
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 1 INPSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred CCHHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 35678999999999999999999875 45679999876432 2346788899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCc
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR 170 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~ 170 (671)
|||+.||+|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~- 155 (256)
T cd05114 78 TEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY- 155 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-
Confidence 99999999999887542 4589999999999999999999999999999999999999999999999998865422111
Q ss_pred ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHH
Q 005886 171 QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 171 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
.......++..|+|||++.+ ..++.++||||||+++|+|++ |+.||......+....+...... ..+...+..
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~----~~~~~~~~~ 229 (256)
T cd05114 156 -TSSSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL----YRPKLASMT 229 (256)
T ss_pred -eccCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC----CCCCCCCHH
Confidence 11122345678999999876 568999999999999999999 99999887766665555443221 223446788
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 250 FKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
+.+||.+||..+|.+||++.++++
T Consensus 230 ~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 230 VYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=324.97 Aligned_cols=253 Identities=46% Similarity=0.804 Sum_probs=216.7
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecc
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYM 94 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~ 94 (671)
+|++.+.||.|+||.||++.+..+++.|++|++..... .....+.+|+..++.++||||+++++++..+...++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 58999999999999999999999999999999875543 35678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccc
Q 005886 95 AGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSR 174 (671)
Q Consensus 95 ~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 174 (671)
.|++|.+++.... ..+++..++.++.|++.||.|||.+|++||||+|+||+++.++.++|+|||++........ .
T Consensus 80 ~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~----~ 154 (253)
T cd05122 80 SGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA----R 154 (253)
T ss_pred CCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc----c
Confidence 9999999887642 5689999999999999999999999999999999999999999999999998865432111 3
Q ss_pred ccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHH
Q 005886 175 NTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELV 254 (671)
Q Consensus 175 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI 254 (671)
....|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.............+.. .....++..+.+||
T Consensus 155 ~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~i 231 (253)
T cd05122 155 NTMVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGL--RNPEKWSDEFKDFL 231 (253)
T ss_pred cceecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCc--CcccccCHHHHHHH
Confidence 45678999999999986 4588999999999999999999999988765555444443322222 22333588999999
Q ss_pred HHhhhcCCCCCCCHHHHHhchh
Q 005886 255 TACLVKDPKKRPTAEKLMKHHF 276 (671)
Q Consensus 255 ~~cL~~dP~kRpSa~eiL~Hpw 276 (671)
.+||..||.+|||+.++|+|||
T Consensus 232 ~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 232 KKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHccCChhhCCCHHHHhcCCC
Confidence 9999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=342.24 Aligned_cols=257 Identities=39% Similarity=0.653 Sum_probs=214.8
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
+.|.+.+.||+|+||.||+|.+..+|+.||+|++...... .....+.+|+.+++.++||||++++++|.+++..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 5699999999999999999999999999999998644322 33467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
||+. |++.+++... ...+++..+..++.||+.||.|||+.|++||||+|+||+++.++.+||+|||++....
T Consensus 95 e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~------ 166 (307)
T cd06607 95 EYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS------ 166 (307)
T ss_pred HhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecC------
Confidence 9997 4676666543 2468999999999999999999999999999999999999999999999999875432
Q ss_pred cccccccCCCCCCChhHhhh--ccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHH
Q 005886 172 RSRNTFVGTPCWMAPEVMQQ--LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~--~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
......|++.|+|||++.+ ...++.++||||||+++|+|++|..||...........+....++... ...++..
T Consensus 167 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 242 (307)
T cd06607 167 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLS---SNDWSDY 242 (307)
T ss_pred -CCCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCC---chhhCHH
Confidence 1224578899999998752 245888999999999999999999999887665554444433322221 2346789
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 250 FKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
+.+||.+||..+|.+||++.+++.||||.....
T Consensus 243 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 275 (307)
T cd06607 243 FRNFVDSCLQKIPQDRPSSEELLKHRFVLRERP 275 (307)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhcChhhcccCC
Confidence 999999999999999999999999999986554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=342.09 Aligned_cols=263 Identities=26% Similarity=0.399 Sum_probs=209.6
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcc-cHHHHHHHHHHHHhCCCCCceeeeeEEEeC-------
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-DLDGIRREVQTMRVTNHPNVLRAHCSFTTG------- 84 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~-~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~------- 84 (671)
.++|++.+.||.|+||.||+|.++.+++.||||++....... ....+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 589999999999999999999999999999999986543322 234567899999999999999999987543
Q ss_pred -CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccc
Q 005886 85 -HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSAC 163 (671)
Q Consensus 85 -~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~ 163 (671)
..+|+||+|+.+ ++...+... ...+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++..
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 357999999965 566666543 24699999999999999999999999999999999999999999999999999876
Q ss_pred cccCCCcc--------cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Q 005886 164 MFDAGDRQ--------RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP 235 (671)
Q Consensus 164 ~~~~~~~~--------~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~ 235 (671)
........ .......|++.|+|||++.+...++.++|||||||++|+|++|.+||.+.........+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 53322111 1123446789999999987655689999999999999999999999988776554433322110
Q ss_pred C--CCCc-----------------------cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 236 P--GLDY-----------------------ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 236 ~--~~~~-----------------------~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
. ...+ .....++..+.+||.+||..||.+|||+.+++.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 0 0000 0012345678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=326.92 Aligned_cols=253 Identities=37% Similarity=0.672 Sum_probs=219.5
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
+|++.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+++++.++||||+++++++.+...+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 589999999999999999999999999999998765432 3467889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS 173 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 173 (671)
+.+++|.+++... ..+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~---~~ 155 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS---KD 155 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCc---cc
Confidence 9999999998766 678999999999999999999999999999999999999999999999999987653221 11
Q ss_pred cccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHH
Q 005886 174 RNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL 253 (671)
Q Consensus 174 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dL 253 (671)
.....|+..|+|||.+.+ ..++.++|||+||+++|+|++|..||................. ...+..++..+.++
T Consensus 156 ~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~ 230 (254)
T cd06627 156 DASVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDH----PPLPEGISPELKDF 230 (254)
T ss_pred ccccccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCC----CCCCCCCCHHHHHH
Confidence 234578999999999876 4588999999999999999999999987766555544443322 22345678999999
Q ss_pred HHHhhhcCCCCCCCHHHHHhchhc
Q 005886 254 VTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 254 I~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
|.+||..+|++||++.+++.||||
T Consensus 231 i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 231 LMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHHhCChhhCcCHHHHhcCCCC
Confidence 999999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=341.74 Aligned_cols=266 Identities=23% Similarity=0.411 Sum_probs=219.3
Q ss_pred ccccccccccCCCCeEEEEEecccCceEEEEEEEc-------CCCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCC
Q 005886 2 DLVVEKRFPVDAKDYRLYEEVGEGVSATVYRALCI-------PLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPN 73 (671)
Q Consensus 2 ~~~~e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~-------~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpN 73 (671)
|+.-..+|.+...+|.+.+.||+|+||.||+|.+. ..+..||+|.+...........+.+|+.+++.+ +|||
T Consensus 3 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~ 82 (304)
T cd05101 3 ELPEDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82 (304)
T ss_pred ccccCCcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCC
Confidence 45556789999999999999999999999999753 234579999987544345567889999999999 8999
Q ss_pred ceeeeeEEEeCCEEEEEEeccCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccc
Q 005886 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYP--------------EGFEEPVIATLLRETLKALVYLHFHGHIHRD 139 (671)
Q Consensus 74 IVkl~~~~~~~~~l~LVmEy~~ggsL~~~l~~~~~--------------~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrD 139 (671)
|+++++++.....+|+||||+.+|+|.+++..... ..++...+..++.||+.||.|||++|++|||
T Consensus 83 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~d 162 (304)
T cd05101 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRD 162 (304)
T ss_pred chheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence 99999999999999999999999999999876422 2467788999999999999999999999999
Q ss_pred CCCCcEEEcCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCC
Q 005886 140 VKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPF 218 (671)
Q Consensus 140 LKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF 218 (671)
|||+|||++.++.+||+|||++..+...... .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||
T Consensus 163 lkp~Nili~~~~~~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~ 240 (304)
T cd05101 163 LAARNVLVTENNVMKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPY 240 (304)
T ss_pred cccceEEEcCCCcEEECCCccceeccccccc-ccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence 9999999999999999999998755322111 11223356778999999976 568999999999999999998 88999
Q ss_pred CCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 219 SKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.+.+..+.......... ...+..++..+++||.+||..+|.+||++.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~ 291 (304)
T cd05101 241 PGIPVEELFKLLKEGHR----MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291 (304)
T ss_pred ccCCHHHHHHHHHcCCc----CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 88776665544433221 2234567899999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=367.38 Aligned_cols=251 Identities=26% Similarity=0.468 Sum_probs=214.1
Q ss_pred EEEEEecccCceEEEEEEEcCCCcEEEEEEecc---ccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE--EEEEE
Q 005886 17 RLYEEVGEGVSATVYRALCIPLNEIVAIKVLDL---EKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC--LWVVM 91 (671)
Q Consensus 17 ~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~---~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~--l~LVm 91 (671)
+...+||+|+|-+||+|.+..+|..||.-.+.. .+.+...+++..|+.+|+.|.|||||++|++|.+... +.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 445789999999999999999999999655543 3445567999999999999999999999999997654 88999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccccCCCCcEEEcCC-CceEEeccccccccccCC
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH--GHIHRDVKAGNILIDSN-GAIKLADFGVSACMFDAG 168 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~--gIVHrDLKPeNILld~~-g~vKL~DFGls~~~~~~~ 168 (671)
|++..|+|..+.++. +..+...+..|++||++||.|||++ -|||||||-+||||+.+ |.|||+|+|||+.+..
T Consensus 123 EL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~-- 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK-- 198 (632)
T ss_pred ecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc--
Confidence 999999999999988 7789999999999999999999998 59999999999999765 8999999999987732
Q ss_pred CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhcCCCCCCccccccch
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPP-MKVLLMTLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~-~~~~~~~~~~~~~~~~~~~~~~ls 247 (671)
......+|||.|||||++.. .|+..+||||||++|+||+|+..||..... ..++..+..+.+|..-. +.=.
T Consensus 199 ---s~aksvIGTPEFMAPEmYEE--~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~---kV~d 270 (632)
T KOG0584|consen 199 ---SHAKSVIGTPEFMAPEMYEE--NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALS---KVKD 270 (632)
T ss_pred ---cccceeccCccccChHHHhh--hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhh---ccCC
Confidence 22234799999999999984 699999999999999999999999988754 44555555555443222 2226
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 248 KSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
+++++||.+||.. ...|||+.|+|+||||...
T Consensus 271 Pevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 271 PEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 7999999999998 9999999999999999864
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=348.71 Aligned_cols=262 Identities=24% Similarity=0.342 Sum_probs=212.1
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEecccc-CcccHHHHHHHHHHHHhCCCCCceeeeeEEEeC-----CEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEK-CNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG-----HCL 87 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~-~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~-----~~l 87 (671)
++|.+.+.||.|+||+||+|.+..+|..||||.+.... .......+.+|+.+++.++||||+++++++... ..+
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 57999999999999999999999999999999986532 223355677899999999999999999988654 358
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccC
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~ 167 (671)
|+||||+. ++|..++... +.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 85 ~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred EEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 99999995 6888888765 57999999999999999999999999999999999999999999999999998654221
Q ss_pred CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh---------------
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQ--------------- 232 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~--------------- 232 (671)
. .......|+..|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+..
T Consensus 162 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 162 G---DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred c---ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 1 2233457899999999987645688999999999999999999999976543322211110
Q ss_pred --------cCCCCC--C-ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 233 --------NAPPGL--D-YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 233 --------~~~~~~--~-~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
..+... . ......++..+.+||.+||..+|.+|||+.++|+||||....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 000000 0 011245788999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=335.60 Aligned_cols=255 Identities=22% Similarity=0.381 Sum_probs=216.1
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~ 88 (671)
|+....+|++.+.||.|+||.||+|.+.. +..+|+|++.... ......+.+|+.+++.++||||+++++++.....+|
T Consensus 1 ~~~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 78 (261)
T cd05148 1 WERPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVY 78 (261)
T ss_pred CcCcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc-hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeE
Confidence 34556789999999999999999999887 8889999986543 223567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
+||||+.+++|.+++.......+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 99999999999999987655678999999999999999999999999999999999999999999999999986553211
Q ss_pred CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccch
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls 247 (671)
.......++..|+|||++.+ ..++.++||||||+++|+|++ |+.||......+.+..+... .....+..++
T Consensus 159 ---~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~ 230 (261)
T cd05148 159 ---YLSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG----YRMPCPAKCP 230 (261)
T ss_pred ---ccccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC----CcCCCCCCCC
Confidence 11223456778999999876 568999999999999999998 89999887766655554432 2233356778
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 248 KSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
..+.++|.+||..||.+|||+.++++
T Consensus 231 ~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 231 QEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=331.48 Aligned_cols=247 Identities=22% Similarity=0.346 Sum_probs=203.1
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccCCCCH
Q 005886 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSC 99 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~ggsL 99 (671)
+.||+|+||.||+|.++.+|+.||+|.+...........+.+|+.+++.++||||+++++++.....+|+||||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46899999999999999999999999876443334456789999999999999999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccccccccC
Q 005886 100 LHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVG 179 (671)
Q Consensus 100 ~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~G 179 (671)
..++... ...+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++...... ..........+
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~ 158 (252)
T cd05084 81 LTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDG-VYASTGGMKQI 158 (252)
T ss_pred HHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccc-cccccCCCCCC
Confidence 9998754 246899999999999999999999999999999999999999999999999998654211 11111111123
Q ss_pred CCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhh
Q 005886 180 TPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACL 258 (671)
Q Consensus 180 T~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL 258 (671)
+..|+|||.+.+ ..++.++|||||||++|+|++ |..||................. ...+..++..+.+||.+||
T Consensus 159 ~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l 233 (252)
T cd05084 159 PVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR----LPCPELCPDAVYRLMERCW 233 (252)
T ss_pred ceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC----CCCcccCCHHHHHHHHHHc
Confidence 456999999876 568999999999999999997 9999987666544333333222 2334567899999999999
Q ss_pred hcCCCCCCCHHHHHh
Q 005886 259 VKDPKKRPTAEKLMK 273 (671)
Q Consensus 259 ~~dP~kRpSa~eiL~ 273 (671)
..+|.+|||+.++++
T Consensus 234 ~~~p~~Rps~~~~~~ 248 (252)
T cd05084 234 EYDPGQRPSFSTVHQ 248 (252)
T ss_pred CCChhhCcCHHHHHH
Confidence 999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=331.58 Aligned_cols=253 Identities=24% Similarity=0.399 Sum_probs=210.5
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LV 90 (671)
++.++|++++.||.|+||.||+|.+.. +..||+|.+.... .....+.+|+.+++.++||||+++++++.....+|+|
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 1 IDPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred CChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 456889999999999999999998754 4469999986433 2346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCc
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR 170 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~ 170 (671)
|||+.+|+|.+++.... ..+++..++.++.||+.||.|||++|++|+||||.|||++.++.+||+|||+++.......
T Consensus 78 ~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~- 155 (256)
T cd05113 78 TEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY- 155 (256)
T ss_pred EEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-
Confidence 99999999999987642 3689999999999999999999999999999999999999999999999999875533211
Q ss_pred ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHH
Q 005886 171 QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 171 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
.......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...........+...... ..+...+..
T Consensus 156 -~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 229 (256)
T cd05113 156 -TSSVGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL----YRPHLASEK 229 (256)
T ss_pred -eecCCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC----CCCCCCCHH
Confidence 11122345678999999976 458999999999999999998 99999887766555555443221 223456889
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 250 FKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
+++++.+||..+|.+||++.+++.+
T Consensus 230 ~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 230 VYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHHh
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=339.74 Aligned_cols=263 Identities=26% Similarity=0.382 Sum_probs=212.7
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC----
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH---- 85 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~---- 85 (671)
...++|++.+.||.|+||.||+|.++.+|+.||+|++...... .....+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 4567899999999999999999999999999999999754322 23456778999999999999999999987655
Q ss_pred ------EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccc
Q 005886 86 ------CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFG 159 (671)
Q Consensus 86 ------~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFG 159 (671)
.+|+||||+.+ ++...+... ...+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 89999999976 676666544 3468999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CCC
Q 005886 160 VSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA--PPG 237 (671)
Q Consensus 160 ls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~--~~~ 237 (671)
++..+..... .......+++.|+|||++.+...++.++|||||||++|+|++|++||........+..+.... +..
T Consensus 162 ~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (302)
T cd07864 162 LARLYNSEES--RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239 (302)
T ss_pred ccccccCCcc--cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 9876533221 112223568889999998764557899999999999999999999998766554443332211 000
Q ss_pred CCc-----------------------cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 238 LDY-----------------------ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 238 ~~~-----------------------~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
..+ .....++..+.+||.+||..||.+||++.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 000 1123468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=338.30 Aligned_cols=270 Identities=30% Similarity=0.561 Sum_probs=218.3
Q ss_pred cccccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeeeEEEe
Q 005886 5 VEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHCSFTT 83 (671)
Q Consensus 5 ~e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~ 83 (671)
....+.+..++|++.+.||+|+||.||+|.+..+++.||||.+...........+.+|+.++..+ +||||+++++++.+
T Consensus 6 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 85 (296)
T cd06618 6 DGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT 85 (296)
T ss_pred cceeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec
Confidence 45668889999999999999999999999999999999999997554333445666777766666 59999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCcEEEcCCCceEEecccccc
Q 005886 84 GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF-HGHIHRDVKAGNILIDSNGAIKLADFGVSA 162 (671)
Q Consensus 84 ~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs-~gIVHrDLKPeNILld~~g~vKL~DFGls~ 162 (671)
+..+|+||||+. +.+..++... ...+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++.
T Consensus 86 ~~~~~~v~e~~~-~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~ 163 (296)
T cd06618 86 DSDVFICMELMS-TCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG 163 (296)
T ss_pred CCeEEEEeeccC-cCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccch
Confidence 999999999985 5777776653 2478999999999999999999997 599999999999999999999999999986
Q ss_pred ccccCCCcccccccccCCCCCCChhHhhhc---cCCCccchhhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhcCCCCC
Q 005886 163 CMFDAGDRQRSRNTFVGTPCWMAPEVMQQL---HGYDFKADIWSFGITALELAHGHAPFSKYPP-MKVLLMTLQNAPPGL 238 (671)
Q Consensus 163 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~---~~~s~ksDIWSLGvILyeLltG~~PF~~~~~-~~~~~~~~~~~~~~~ 238 (671)
.+.... ......|++.|+|||.+.+. ..++.++||||||+++|+|++|+.||..... .+.+........+..
T Consensus 164 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T cd06618 164 RLVDSK----AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL 239 (296)
T ss_pred hccCCC----cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCC
Confidence 553211 11233678899999998753 2378899999999999999999999976433 233333333322222
Q ss_pred CccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 239 DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 239 ~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
+....++.++.+||.+||..||.+||++.+++.||||.....
T Consensus 240 --~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 281 (296)
T cd06618 240 --PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET 281 (296)
T ss_pred --CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence 222357889999999999999999999999999999986554
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=330.48 Aligned_cols=255 Identities=25% Similarity=0.405 Sum_probs=212.4
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~ 88 (671)
|.+..++|++.+.||+|+||.||+|.+. .++.||+|.+.... .....+.+|+.+++.++||||+++++++...+.+|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 4677889999999999999999999865 45779999986543 23467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
+||||+.|++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999999999976544568999999999999999999999999999999999999999999999999987653211
Q ss_pred CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccch
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls 247 (671)
. .......++..|+|||++.+ ..++.++||||||+++|+|++ |+.||.+.........+..... ......++
T Consensus 158 ~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~ 230 (261)
T cd05068 158 Y--EAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR----MPCPPGCP 230 (261)
T ss_pred c--cccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----CCCCCcCC
Confidence 1 11111223457999999876 568999999999999999999 9999988776655544433322 22345678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 248 KSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
..+.++|.+||..+|.+||++.+++.
T Consensus 231 ~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 231 KELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 89999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=325.03 Aligned_cols=257 Identities=36% Similarity=0.630 Sum_probs=216.7
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeC--CEEEEEE
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG--HCLWVVM 91 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~--~~l~LVm 91 (671)
+|.+.+.||+|+||.||+|.+..++..|++|++..... ....+.+.+|+.+++.++||||+++++.+... ..+++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 58899999999999999999999999999999875542 24467889999999999999999999999998 8999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
||+.+++|.+++... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 157 (260)
T cd06606 81 EYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG- 157 (260)
T ss_pred EecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc-
Confidence 999999999998876 47899999999999999999999999999999999999999999999999998665332211
Q ss_pred cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHH
Q 005886 172 RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~ 251 (671)
.......++..|+|||.+.+ ..++.++||||||+++|+|++|..||............+.. .......+..++..++
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~ 234 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS--SGEPPEIPEHLSEEAK 234 (260)
T ss_pred ccccCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc--cCCCcCCCcccCHHHH
Confidence 11334578999999999876 45889999999999999999999999876632222222221 1112233456689999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 252 ELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 252 dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
+||.+||..+|.+||++.+++.||||
T Consensus 235 ~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 235 DFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=341.11 Aligned_cols=262 Identities=21% Similarity=0.383 Sum_probs=215.8
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeeeE
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCI-----PLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHCS 80 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~-----~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~ 80 (671)
-.+++..++|.+.+.||+|+||.||+|.+. .++..||+|++.........+.+.+|+.+++.+ +||||++++++
T Consensus 28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred ccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 356778889999999999999999999863 345689999987554344456789999999999 79999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccc
Q 005886 81 FTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGV 160 (671)
Q Consensus 81 ~~~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGl 160 (671)
+.....+|+||||+.+|+|.+++.......+++..+..++.||+.||+|||++|++|+||||+|||++.++.++|+|||+
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 99999999999999999999999765444589999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCC
Q 005886 161 SACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLD 239 (671)
Q Consensus 161 s~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~ 239 (671)
++.+..... ........+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.............. ..
T Consensus 188 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~---~~ 262 (302)
T cd05055 188 ARDIMNDSN-YVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG---YR 262 (302)
T ss_pred cccccCCCc-eeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC---Cc
Confidence 875532211 111223456788999999876 568999999999999999998 999998766554443333322 12
Q ss_pred ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 240 YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 240 ~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
...+...+..+.+||.+||..+|.+||++.+++.
T Consensus 263 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 263 MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 2234456889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=337.61 Aligned_cols=256 Identities=22% Similarity=0.407 Sum_probs=211.9
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCI-----PLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH 85 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~-----~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~ 85 (671)
|..++|.+.+.||+|+||.||++.+. .++..||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 56789999999999999999999863 345678999886432 234567889999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceE
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAY-----------PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIK 154 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~-----------~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vK 154 (671)
.+|+||||+.+++|..++.... ...+++..++.++.||+.||+|||++|++||||||+|||++.++.+|
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 9999999999999999987542 12489999999999999999999999999999999999999999999
Q ss_pred EeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q 005886 155 LADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQN 233 (671)
Q Consensus 155 L~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~ 233 (671)
|+|||++....... .........+++.|+|||++.+ ..++.++|||||||++|+|++ |..||......+....+...
T Consensus 161 l~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~ 238 (288)
T cd05093 161 IGDFGMSRDVYSTD-YYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 238 (288)
T ss_pred eccCCccccccCCc-eeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99999986543221 1112223456788999999976 568999999999999999998 99999887766655555443
Q ss_pred CCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 234 APPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 234 ~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
... ..+..++.++.+|+.+||..||.+|||+.+++.
T Consensus 239 ~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 239 RVL----QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CcC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 221 223457889999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=327.82 Aligned_cols=249 Identities=26% Similarity=0.448 Sum_probs=212.0
Q ss_pred EEecccCceEEEEEEEcCC---CcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccCC
Q 005886 20 EEVGEGVSATVYRALCIPL---NEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAG 96 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~t---g~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~g 96 (671)
+.||+|+||.||+|.+... +..||+|++...........+.+|+..++.++|+||+++++++.....+++||||+.+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4689999999999999866 8899999997655444467889999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCC
Q 005886 97 GSCLHIMKSAY-------PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 97 gsL~~~l~~~~-------~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~ 169 (671)
++|.+++.... ...+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||.+........
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 160 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence 99999987642 25689999999999999999999999999999999999999999999999999876543221
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchH
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSK 248 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~ 248 (671)
........+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||............... .....+..++.
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~ 234 (262)
T cd00192 161 -YRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG----YRLPKPEYCPD 234 (262)
T ss_pred -cccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC----CCCCCCccCCh
Confidence 122344568899999999886 468999999999999999999 69999988766555444432 22334556789
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 249 SFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 249 ~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
++.++|.+||..+|.+||++.+++++
T Consensus 235 ~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 235 ELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=374.48 Aligned_cols=260 Identities=23% Similarity=0.380 Sum_probs=215.9
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCC-CCCceeeeeE-EEe-
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN-HPNVLRAHCS-FTT- 83 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~-HpNIVkl~~~-~~~- 83 (671)
..+.|...++++.+.|-+|||+.||+|.+...|..||+|.+-.. .......+.+||.+|++|. |+|||.+++. ...
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~ 108 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR 108 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence 45788889999999999999999999999988899999998654 4556888999999999996 9999999993 321
Q ss_pred -----CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCCcEEEcCCCceEEe
Q 005886 84 -----GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHG--HIHRDVKAGNILIDSNGAIKLA 156 (671)
Q Consensus 84 -----~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~g--IVHrDLKPeNILld~~g~vKL~ 156 (671)
...++|.||||.||.|.++|......+|+|.++++|+.|++.||++||... |||||||-|||||+.+|..|||
T Consensus 109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeC
Confidence 246889999999999999998776677999999999999999999999997 9999999999999999999999
Q ss_pred ccccccccccCCCccccc------ccccCCCCCCChhHhh--hccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 005886 157 DFGVSACMFDAGDRQRSR------NTFVGTPCWMAPEVMQ--QLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLL 228 (671)
Q Consensus 157 DFGls~~~~~~~~~~~~~------~~~~GT~~Y~APEvl~--~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~ 228 (671)
|||.+.-........... .....|+.|+|||++. +....++|+|||+|||+||-|+....||.+.....++
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl- 267 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL- 267 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE-
Confidence 999874332221110000 1235799999999986 3356899999999999999999999999876443321
Q ss_pred HHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 229 MTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 229 ~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
...+.++....++..+++||..||+.||.+||++-+++.+
T Consensus 268 ------ng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 268 ------NGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred ------eccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 2234445556899999999999999999999999999874
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=339.02 Aligned_cols=257 Identities=19% Similarity=0.320 Sum_probs=212.3
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCC-----CcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPL-----NEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH 85 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~t-----g~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~ 85 (671)
++..+|++.+.||.|+||.||+|.+..+ +..||||++...........+.+|+.+++.++||||+++++++....
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 4566788999999999999999987643 57899999875443333567889999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAY--------------PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG 151 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~--------------~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g 151 (671)
.+++++||+.+++|..++.... ...+++..+..++.|++.||.|||++||+||||||+|||++.++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 9999999999999999885321 13478888999999999999999999999999999999999999
Q ss_pred ceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 005886 152 AIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMT 230 (671)
Q Consensus 152 ~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~ 230 (671)
.+||+|||+++.+..... ........+++.|+|||.+.+ ..++.++|||||||++|||++ |..||.+....+....+
T Consensus 162 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05091 162 NVKISDLGLFREVYAADY-YKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239 (283)
T ss_pred ceEecccccccccccchh-eeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999999876533221 122233456789999999876 458999999999999999998 88999887776655554
Q ss_pred HhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 231 LQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 231 ~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
...... ..+..++..+.+||..||+.+|.+||++.+|+.
T Consensus 240 ~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 240 RNRQVL----PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred HcCCcC----CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 443222 224568899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=330.76 Aligned_cols=254 Identities=26% Similarity=0.481 Sum_probs=208.0
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
++|++.+.||.|+||.||+|++..+++.||||.+..... ......+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 689999999999999999999999999999998864322 233456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCC
Q 005886 92 PYMAGGSCLHIMKSAY--PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~--~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~ 169 (671)
||+.+|+|..++.... ...+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~-- 159 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch--
Confidence 9999999998875421 245889999999999999999999999999999999999999999999999998654221
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhcCCCCCCccccccchH
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPP-MKVLLMTLQNAPPGLDYERDKRFSK 248 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~-~~~~~~~~~~~~~~~~~~~~~~ls~ 248 (671)
........|++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||..... .......+... .........++.
T Consensus 160 -~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 235 (267)
T cd08228 160 -TTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC--DYPPLPTEHYSE 235 (267)
T ss_pred -hHHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcC--CCCCCChhhcCH
Confidence 112234578999999999986 5688999999999999999999999965432 12222222211 111112335678
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 249 SFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 249 ~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.+.+||.+||..+|.+||++.++++
T Consensus 236 ~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 236 KLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred HHHHHHHHHCCCCcccCcCHHHHHH
Confidence 8999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=333.24 Aligned_cols=257 Identities=24% Similarity=0.368 Sum_probs=212.1
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCc---EEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNE---IVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCL 87 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~---~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l 87 (671)
++..+|++.+.||.|+||.||+|.++.++. .||+|.+...........+.+|+.+++.++||||+++++++..++.+
T Consensus 1 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred CCHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 356789999999999999999999875543 69999986544344456789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccC
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~ 167 (671)
|+||||+.|++|..++... ...+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++..+...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 9999999999999998764 246899999999999999999999999999999999999999999999999998765332
Q ss_pred CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (671)
...........++..|+|||.+.+ ..++.++|+|||||++|++++ |..||.+....+....+.... ..+....+
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~ 234 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY----RLPAPMDC 234 (267)
T ss_pred cceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC----cCCCCCCC
Confidence 221111122234568999999986 568999999999999999886 999998876655444443321 22334567
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 247 SKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 247 s~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
+..+.+++.+||+.+|.+||++.++++
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 235 PAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=341.31 Aligned_cols=255 Identities=22% Similarity=0.356 Sum_probs=207.6
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcE--EEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeeeEEEeCCEE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEI--VAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHCSFTTGHCL 87 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~--VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~~~l 87 (671)
+..++|++.+.||+|+||.||+|.+..+|.. +|+|.+...........+.+|+.++..+ +||||+++++++..+..+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~ 83 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 83 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence 4567999999999999999999999887765 4677665333233456788999999999 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCce
Q 005886 88 WVVMPYMAGGSCLHIMKSAY--------------PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAI 153 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~--------------~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~v 153 (671)
|+||||+.+|+|..++.... ...+++..++.++.||+.||+|||++|++||||||+|||++.++.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcE
Confidence 99999999999999987542 1257899999999999999999999999999999999999999999
Q ss_pred EEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 005886 154 KLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQ 232 (671)
Q Consensus 154 KL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~ 232 (671)
||+|||++.... .........++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+.......
T Consensus 164 kl~dfg~~~~~~----~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 238 (303)
T cd05088 164 KIADFGLSRGQE----VYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 238 (303)
T ss_pred EeCccccCcccc----hhhhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence 999999875221 1111112234667999999876 568999999999999999998 9999987666554433322
Q ss_pred cCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 233 NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 233 ~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
......+..++..+.+||.+||..+|.+||++.++|.+
T Consensus 239 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 239 ----GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred ----CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 22223344578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=331.12 Aligned_cols=257 Identities=22% Similarity=0.342 Sum_probs=212.5
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCc---EEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNE---IVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCL 87 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~---~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l 87 (671)
|..++|+..+.||+|+||.||+|.++.++. .+|+|.+...........+.+|+.+++.++||||+++++++.....+
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 566789999999999999999999876664 69999986544344456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccC
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~ 167 (671)
|+||||+.+++|..++... .+.+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 82 MIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 9999999999999998764 256899999999999999999999999999999999999999999999999998765332
Q ss_pred CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (671)
............++.|+|||++.+ ..++.++|||||||++|+|++ |..||......+....+... ...+....+
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~----~~~~~~~~~ 235 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG----FRLPAPMDC 235 (268)
T ss_pred cccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC----CCCCCCCCC
Confidence 221111112233457999999976 568999999999999999997 99999877765555444332 222334457
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 247 SKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 247 s~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
+..+++|+.+||..+|.+||++.++++
T Consensus 236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 236 PSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=355.99 Aligned_cols=267 Identities=25% Similarity=0.433 Sum_probs=210.3
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEec-cccCcccHHHHHHHHHHHHhC-CCCCceeeeeEEEeC
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLD-LEKCNNDLDGIRREVQTMRVT-NHPNVLRAHCSFTTG 84 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~-~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~ 84 (671)
..+.+..+.|++++.||.||.+.||++..-.. +.||+|.+. .......++.+.+|+..|.+| .|.+||++++|-..+
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d 432 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD 432 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC
Confidence 45778889999999999999999999986544 456666554 344445688999999999988 599999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccc
Q 005886 85 HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACM 164 (671)
Q Consensus 85 ~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~ 164 (671)
+++||||||= .-+|..+++... ...+.-.++.|+.|+|.|+.++|.+||||.||||.|+|+- .|.+||+|||+|..+
T Consensus 433 ~~lYmvmE~G-d~DL~kiL~k~~-~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 433 GYLYMVMECG-DIDLNKILKKKK-SIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAI 509 (677)
T ss_pred ceEEEEeecc-cccHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhccc
Confidence 9999999964 458888888763 3344348899999999999999999999999999999996 589999999999766
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhcc----------CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLH----------GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA 234 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~----------~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~ 234 (671)
... .....+.+-+||+.||+||.+.... ..+.++||||||||||+|+.|++||..+......+..+...
T Consensus 510 ~~D-TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P 588 (677)
T KOG0596|consen 510 QPD-TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDP 588 (677)
T ss_pred Ccc-ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCC
Confidence 332 2223345669999999999986421 14578999999999999999999998765433333333332
Q ss_pred CCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccc
Q 005886 235 PPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKH 279 (671)
Q Consensus 235 ~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~ 279 (671)
.-.+.|+.... ..++.++++.||..||.+||++.++|+|||++.
T Consensus 589 ~~~Iefp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 589 NHEIEFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred CccccccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 22222322111 123999999999999999999999999999985
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=345.46 Aligned_cols=265 Identities=26% Similarity=0.345 Sum_probs=212.8
Q ss_pred CCeE-EEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcc-------------cHHHHHHHHHHHHhCCCCCceeeee
Q 005886 14 KDYR-LYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-------------DLDGIRREVQTMRVTNHPNVLRAHC 79 (671)
Q Consensus 14 ~~Y~-l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~-------------~~~~i~~Ei~iL~~L~HpNIVkl~~ 79 (671)
++|. +.+.||.|+||+||+|.+..+|+.||||++....... ....+.+|+.+++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4454 4577999999999999999999999999986543221 0125778999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccc
Q 005886 80 SFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFG 159 (671)
Q Consensus 80 ~~~~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFG 159 (671)
+|..+..+|+||||+. |+|..++... ..+++..+..++.||+.||.|||++|++||||+|+||+++.++.+||+|||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 9999999999999996 5888888764 568999999999999999999999999999999999999999999999999
Q ss_pred cccccccCC-----------CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 005886 160 VSACMFDAG-----------DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLL 228 (671)
Q Consensus 160 ls~~~~~~~-----------~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~ 228 (671)
++....... ..........+++.|+|||++.+...++.++|||||||++|+|++|.+||.+..+.+.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 244 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 986553111 011122234678899999999875567899999999999999999999998877665544
Q ss_pred HHHhcC--CCCCCc---------------------cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 229 MTLQNA--PPGLDY---------------------ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 229 ~~~~~~--~~~~~~---------------------~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
.+.... +....+ .....++..+.+||.+||..+|.+||+++++|.||||+...
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~ 320 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP 320 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence 333211 100000 01234578899999999999999999999999999998543
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=337.50 Aligned_cols=266 Identities=29% Similarity=0.444 Sum_probs=214.7
Q ss_pred CeEEEEEecccCceEEEEEEEc---CCCcEEEEEEeccccC---cccHHHHHHHHHHHHhC-CCCCceeeeeEEEeCCEE
Q 005886 15 DYRLYEEVGEGVSATVYRALCI---PLNEIVAIKVLDLEKC---NNDLDGIRREVQTMRVT-NHPNVLRAHCSFTTGHCL 87 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~---~tg~~VAIKvi~~~~~---~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~~~l 87 (671)
.|++.+.||.|+||.||+|.+. .+|..||+|++..... ....+.+.+|+.+++.+ +|+||++++++|..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999875 4789999999865332 22346788899999999 699999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccC
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~ 167 (671)
|+||||+.+++|.+++... ..+++..+..++.||+.||.|||+.|++||||+|+|||++.++.+||+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 9999999999999998765 56899999999999999999999999999999999999999999999999998654221
Q ss_pred CCcccccccccCCCCCCChhHhhhc-cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQL-HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~-~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (671)
. ........|+..|+|||.+.+. ..++.++||||||+++|+|++|..||...........+...... ...+.+..+
T Consensus 159 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 235 (290)
T cd05613 159 E--VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQEM 235 (290)
T ss_pred c--ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc-cCCCCCccC
Confidence 1 1222346789999999998642 24678999999999999999999999643221111111111100 011224557
Q ss_pred hHHHHHHHHHhhhcCCCCCC-----CHHHHHhchhccccccchH
Q 005886 247 SKSFKELVTACLVKDPKKRP-----TAEKLMKHHFFKHARSNDF 285 (671)
Q Consensus 247 s~~l~dLI~~cL~~dP~kRp-----Sa~eiL~Hpwfk~~~~~~~ 285 (671)
+..+.+|+.+||..||.+|| ++++++.||||+...+++.
T Consensus 236 ~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~ 279 (290)
T cd05613 236 SALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDL 279 (290)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHH
Confidence 88999999999999999997 8999999999998776443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=327.41 Aligned_cols=255 Identities=26% Similarity=0.413 Sum_probs=214.3
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~ 88 (671)
|++..++|++.+.||.|+||.||+|.+. .+..||||.+.... .....+.+|+.+++.++||||+++++++.....+|
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT--MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc--cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 5788899999999999999999999875 45779999987443 23467889999999999999999999999989999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
+||||+.+++|.+++.......+++..+..++.+|+.||.|||++|++|+||||+||+++.++.+||+|||++..+...
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~- 156 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD- 156 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch-
Confidence 9999999999999998764457899999999999999999999999999999999999999999999999998655321
Q ss_pred CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccch
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls 247 (671)
.........++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.........+.... ....+..++
T Consensus 157 -~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~ 230 (261)
T cd05034 157 -EYTAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY----RMPRPPNCP 230 (261)
T ss_pred -hhhhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----CCCCCCCCC
Confidence 1111122345678999999986 568999999999999999998 999998877665555544332 223344568
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 248 KSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
..+.+++.+||..+|.+||++.+++.
T Consensus 231 ~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 231 EELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHH
Confidence 89999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=336.09 Aligned_cols=261 Identities=23% Similarity=0.356 Sum_probs=212.6
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCC----------------cEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCc
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLN----------------EIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNV 74 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg----------------~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNI 74 (671)
+...+|++++.||+|+||.||+|.+..++ ..||+|++...........+.+|+.+++.++||||
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCE
Confidence 35678999999999999999999877544 45899998765544556788999999999999999
Q ss_pred eeeeeEEEeCCEEEEEEeccCCCCHHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcE
Q 005886 75 LRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYP---------EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNI 145 (671)
Q Consensus 75 Vkl~~~~~~~~~l~LVmEy~~ggsL~~~l~~~~~---------~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNI 145 (671)
+++++++..+..+++||||+.+++|..++..... ..+++..++.++.|++.||+|||++|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 9999999999999999999999999999876521 2589999999999999999999999999999999999
Q ss_pred EEcCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh--CCCCCCCCCh
Q 005886 146 LIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH--GHAPFSKYPP 223 (671)
Q Consensus 146 Lld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt--G~~PF~~~~~ 223 (671)
+++.++.++|+|||+++....... ........+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDY-YRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eecCCCceEEccccceeecccCcc-eeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 999999999999999875533221 122334467789999999886 568999999999999999998 7889987666
Q ss_pred HHHHHHHHhcC---CCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 224 MKVLLMTLQNA---PPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 224 ~~~~~~~~~~~---~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
...+....... ........+..++.++.+||.+||..||.+|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 55443333210 111112234456789999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=329.24 Aligned_cols=254 Identities=26% Similarity=0.410 Sum_probs=210.2
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~ 88 (671)
|.+..++|++.+.||+|+||.||+|.+. .+..||+|.+..... ..+.+.+|+.+++.++||||+++++++.. ...|
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIY 76 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcE
Confidence 4567789999999999999999999765 566799999865432 34678899999999999999999998854 5689
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
++|||+.+++|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++..+....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 99999999999999876544568999999999999999999999999999999999999999999999999986543221
Q ss_pred CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccch
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls 247 (671)
. .......++..|+|||++.+ ..++.++||||||+++|+|++ |.+||.+....+....+.... ..+.+...+
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~ 229 (260)
T cd05070 157 Y--TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY----RMPCPQDCP 229 (260)
T ss_pred c--ccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC----CCCCCCcCC
Confidence 1 11222345678999999876 568899999999999999999 999998877665554443322 223345678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 248 KSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
..+.+||.+||.++|.+|||+.+++.
T Consensus 230 ~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 230 ISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHH
Confidence 89999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=329.85 Aligned_cols=252 Identities=24% Similarity=0.409 Sum_probs=209.0
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LV 90 (671)
++..+|++.+.||+|+||.||+|.+. ++..+|+|++.... .....+.+|+.+++.++||||+++++++.....+|+|
T Consensus 1 ~~~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 1 IDPSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA--MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred CChHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 35678999999999999999999876 46679999986432 2335678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCc
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR 170 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~ 170 (671)
|||++|++|.+++.... ..+++..++.++.||+.||+|||+.|++||||||+||+++.++.+||+|||+++...+...
T Consensus 78 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~- 155 (256)
T cd05059 78 TEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY- 155 (256)
T ss_pred EecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc-
Confidence 99999999999987642 4689999999999999999999999999999999999999999999999999865432111
Q ss_pred ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHH
Q 005886 171 QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 171 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
.......++..|+|||++.+ ..++.++|||||||++|+|++ |..||....+.+....+... .....+..++..
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 229 (256)
T cd05059 156 -TSSQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG----YRLYRPKLAPTE 229 (256)
T ss_pred -cccCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC----CcCCCCCCCCHH
Confidence 11112234457999999986 568999999999999999999 89999887766555444332 222334567999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 250 FKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
+.+++.+||..+|.+|||+.++++
T Consensus 230 ~~~li~~cl~~~p~~Rpt~~~~l~ 253 (256)
T cd05059 230 VYTIMYSCWHEKPEDRPAFKKLLS 253 (256)
T ss_pred HHHHHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=328.55 Aligned_cols=254 Identities=24% Similarity=0.400 Sum_probs=211.0
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~ 88 (671)
|.+..++|++.++||+|+||.||+|... +++.||+|.+.... .....+.+|+.+++.++||||+++++++. ...+|
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS--MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC--CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 5677889999999999999999999865 57889999986443 23467889999999999999999999875 45689
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
+||||+.+++|.+++.......+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 99999999999999876555678999999999999999999999999999999999999999999999999986543111
Q ss_pred CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccch
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls 247 (671)
........++..|+|||++.+ ..++.++||||||+++|+|++ |++||.+.............. ..+.+..++
T Consensus 157 --~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~ 229 (260)
T cd05067 157 --YTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY----RMPRPDNCP 229 (260)
T ss_pred --cccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC----CCCCCCCCC
Confidence 111223356778999999876 568899999999999999999 999998877655544433322 223345678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 248 KSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.++.++|.+||..+|.+||++++++.
T Consensus 230 ~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 230 EELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHH
Confidence 89999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=329.89 Aligned_cols=254 Identities=26% Similarity=0.406 Sum_probs=209.1
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~ 88 (671)
|.+..++|++.+.||+|+||.||+|.+..++ .||+|++..... ....+.+|+.+++.++||||+++++++.. ...|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 76 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcE
Confidence 4567788999999999999999999887654 599999875332 34578899999999999999999998754 5689
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
+||||+.+|+|.+++.......+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++..+....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999999999986544568999999999999999999999999999999999999999999999999986553221
Q ss_pred CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccch
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls 247 (671)
. .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+..... ......++
T Consensus 157 ~--~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~ 229 (262)
T cd05071 157 Y--TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR----MPCPPECP 229 (262)
T ss_pred c--ccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC----CCCccccC
Confidence 1 11223456778999999876 568999999999999999999 8999987766555444433221 22245678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 248 KSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
..+.+||.+||..||.+||++.+++.
T Consensus 230 ~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 230 ESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHHH
Confidence 89999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=338.42 Aligned_cols=267 Identities=27% Similarity=0.387 Sum_probs=214.7
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCc----EEEEEEeccccCcc-cHHHHHHHHHHHHhCCCCCceeeeeEEEe-CCE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNE----IVAIKVLDLEKCNN-DLDGIRREVQTMRVTNHPNVLRAHCSFTT-GHC 86 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~----~VAIKvi~~~~~~~-~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~-~~~ 86 (671)
...|++.+.||+|+||.||+|..+.++. .+|||.++-++... .-...-||+.+++.+.||||+.+..+|.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3579999999999999999997776654 68999987654322 23567799999999999999999999988 889
Q ss_pred EEEEEeccCCCCHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCC----CceEEeccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYP---EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSN----GAIKLADFG 159 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~---~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~----g~vKL~DFG 159 (671)
+|+++||.+. +|+++|+.... ..++...+..++.||+.|+.|||++-|+||||||.|||+..+ |.|||+|||
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 9999999976 79998875432 458899999999999999999999999999999999999887 899999999
Q ss_pred cccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCCh---------HHHHHHH
Q 005886 160 VSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPP---------MKVLLMT 230 (671)
Q Consensus 160 ls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~---------~~~~~~~ 230 (671)
+++.+...-........++-|.||+|||++.|.+.|+.++|||++|||+.||++-.+.|.+... ...+..+
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI 261 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI 261 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence 9988755444444566778999999999999999999999999999999999999888854211 1122222
Q ss_pred Hh--cCCCCCCccc------------------------------cccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcc
Q 005886 231 LQ--NAPPGLDYER------------------------------DKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278 (671)
Q Consensus 231 ~~--~~~~~~~~~~------------------------------~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk 278 (671)
+. ..|..-+|+. ++.-++.+.+|+.+||+.||.+|.|++++|+|+||.
T Consensus 262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~ 341 (438)
T KOG0666|consen 262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFT 341 (438)
T ss_pred HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccc
Confidence 21 1111111111 111234578999999999999999999999999998
Q ss_pred cc
Q 005886 279 HA 280 (671)
Q Consensus 279 ~~ 280 (671)
..
T Consensus 342 ~d 343 (438)
T KOG0666|consen 342 ED 343 (438)
T ss_pred cC
Confidence 54
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=332.80 Aligned_cols=258 Identities=28% Similarity=0.442 Sum_probs=211.4
Q ss_pred eEEEEEecccCceEEEEEEEcCCCcEEEEEEecccc-CcccHHHHHHHHHHHHhCCCCCceeeeeEEEeC--CEEEEEEe
Q 005886 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEK-CNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG--HCLWVVMP 92 (671)
Q Consensus 16 Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~-~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~--~~l~LVmE 92 (671)
|++.+.||.|+||.||+|.+..+|+.||+|.+.... .......+.+|+.+++.++||||+++++++... ..+|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 788999999999999999999999999999997653 223346688899999999999999999999988 89999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
|+.+ +|..++.... ..+++..++.++.||+.||+|||..|++|+||+|+||+++.++.+||+|||++........ .
T Consensus 81 ~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~--~ 156 (287)
T cd07840 81 YMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS--A 156 (287)
T ss_pred cccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc--c
Confidence 9975 7888776542 4689999999999999999999999999999999999999999999999999876533221 1
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--CCCcc---------
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP--GLDYE--------- 241 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~--~~~~~--------- 241 (671)
......++..|+|||.+.+...++.++||||||+++|+|++|..||........+..+...... ...+.
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE 236 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence 2233467889999998876556889999999999999999999999887765544433321110 00000
Q ss_pred --------------cccc-chHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 242 --------------RDKR-FSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 242 --------------~~~~-ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
.... ++..+.++|.+||..+|.+||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0111 37889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=348.57 Aligned_cols=279 Identities=28% Similarity=0.462 Sum_probs=238.9
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhC-CCCCceeeeeEEEe
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVT-NHPNVLRAHCSFTT 83 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~ 83 (671)
.+..+...+|.++..||+|+||.|.+|..+.+.+.||||++++...- .+++--..|-++|... +-|.+++++..|.+
T Consensus 342 ~~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT 421 (683)
T KOG0696|consen 342 KRDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT 421 (683)
T ss_pred cccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh
Confidence 34467788999999999999999999999999999999999876532 3344445677777766 47899999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccc
Q 005886 84 GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSAC 163 (671)
Q Consensus 84 ~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~ 163 (671)
-+.+|+||||+.||+|-..|+.. +.|.|..+..|+.+|+-||-|||++|||+||||.+|||++.+|++||+|||+++.
T Consensus 422 mDRLyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 422 MDRLYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred hhheeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc
Confidence 99999999999999999988877 7899999999999999999999999999999999999999999999999999864
Q ss_pred cccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 005886 164 MFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 243 (671)
Q Consensus 164 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (671)
-. .......++||||.|+|||++.. ..|+.++|+||+||+||||+.|++||++.+..+.+..+.... ...+
T Consensus 500 ni---~~~~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn-----vsyP 570 (683)
T KOG0696|consen 500 NI---FDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN-----VSYP 570 (683)
T ss_pred cc---cCCcceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc-----CcCc
Confidence 32 22345678999999999999986 789999999999999999999999999988877766665542 2336
Q ss_pred ccchHHHHHHHHHhhhcCCCCCCCH-----HHHHhchhccccccchHHHHHHhhhccc
Q 005886 244 KRFSKSFKELVTACLVKDPKKRPTA-----EKLMKHHFFKHARSNDFLARSIVDNLAP 296 (671)
Q Consensus 244 ~~ls~~l~dLI~~cL~~dP~kRpSa-----~eiL~Hpwfk~~~~~~~~~~~l~~~l~~ 296 (671)
+.+|.++.++++.+|.+.|.+|+.+ .+|-.||||+.+.|.....+.+...+.|
T Consensus 571 KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkP 628 (683)
T KOG0696|consen 571 KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKP 628 (683)
T ss_pred ccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCC
Confidence 7899999999999999999999764 6899999999998887766655444443
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=361.83 Aligned_cols=270 Identities=26% Similarity=0.420 Sum_probs=241.0
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~ 88 (671)
+...+++++..||-|+||.|=++........+|+|++++...- ...+++..|-.+|..++.|+||++|-.|.+..++|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 4556788899999999999999987766666899998765432 44688999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
+.||-|-||.++.++... +.|++..++.++..++.|++|||++|||+|||||+|++++.+|-+||.|||+|+.+.
T Consensus 497 mLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~--- 571 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG--- 571 (732)
T ss_pred hhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc---
Confidence 999999999999999887 889999999999999999999999999999999999999999999999999998763
Q ss_pred CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchH
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSK 248 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~ 248 (671)
......++||||.|.|||++.. ++.+.++|.||||+++|||++|.+||.+.+++..+..++.... .+.++..+++
T Consensus 572 -~g~KTwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid---~i~~Pr~I~k 646 (732)
T KOG0614|consen 572 -SGRKTWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID---KIEFPRRITK 646 (732)
T ss_pred -cCCceeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh---hhhcccccch
Confidence 3344568999999999999987 7899999999999999999999999999999999988887653 2455788999
Q ss_pred HHHHHHHHhhhcCCCCCCC-----HHHHHhchhccccccchHHHHHH
Q 005886 249 SFKELVTACLVKDPKKRPT-----AEKLMKHHFFKHARSNDFLARSI 290 (671)
Q Consensus 249 ~l~dLI~~cL~~dP~kRpS-----a~eiL~Hpwfk~~~~~~~~~~~l 290 (671)
.+.+||++++..+|.+|+. +.+|.+|.||....|..+..+.+
T Consensus 647 ~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L 693 (732)
T KOG0614|consen 647 TATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTL 693 (732)
T ss_pred hHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccC
Confidence 9999999999999999986 78999999999888876655544
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=339.11 Aligned_cols=263 Identities=24% Similarity=0.424 Sum_probs=215.0
Q ss_pred cccccccCCCCeEEEEEecccCceEEEEEEEcC-------CCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCcee
Q 005886 5 VEKRFPVDAKDYRLYEEVGEGVSATVYRALCIP-------LNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLR 76 (671)
Q Consensus 5 ~e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~-------tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVk 76 (671)
.+..|.+...+|.+.+.||+|+||.||+|.+.. .+..||+|.+...........+.+|+.+++.+ +||||++
T Consensus 3 ~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (314)
T cd05099 3 LDPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIIN 82 (314)
T ss_pred CcccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeee
Confidence 356778888999999999999999999998643 34569999987544444567788999999999 6999999
Q ss_pred eeeEEEeCCEEEEEEeccCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCC
Q 005886 77 AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYP--------------EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKA 142 (671)
Q Consensus 77 l~~~~~~~~~l~LVmEy~~ggsL~~~l~~~~~--------------~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKP 142 (671)
+++++.....+|+||||+.+|+|..++..... ..+++..+..++.||+.||.|||++|++||||||
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp 162 (314)
T cd05099 83 LLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAA 162 (314)
T ss_pred EEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 99999999999999999999999999876421 3478889999999999999999999999999999
Q ss_pred CcEEEcCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCC
Q 005886 143 GNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKY 221 (671)
Q Consensus 143 eNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~ 221 (671)
+|||++.++.+||+|||+++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHDIDYY-KKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred eeEEEcCCCcEEEccccccccccccccc-cccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999998654321111 11112234568999999976 568999999999999999999 89999887
Q ss_pred ChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 222 PPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
+..+....+..... ...+..++.++++||.+||..+|.+||++.++++
T Consensus 241 ~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 241 PVEELFKLLREGHR----MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred CHHHHHHHHHcCCC----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 76555544433221 2234567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=333.68 Aligned_cols=257 Identities=30% Similarity=0.451 Sum_probs=213.0
Q ss_pred eEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecc
Q 005886 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYM 94 (671)
Q Consensus 16 Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~ 94 (671)
|++.+.||.|++|.||+|.+..+|+.+|+|.+...... .....+.+|+.+++.++||||+++++++..+..+|+||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 67889999999999999999999999999998755432 34567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccc
Q 005886 95 AGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSR 174 (671)
Q Consensus 95 ~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 174 (671)
.+ ++..++.... ..+++..+..++.||+.||.|||.+|++|+||||+||+++.++.++|+|||.+....... ...
T Consensus 81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~---~~~ 155 (283)
T cd05118 81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV---RPY 155 (283)
T ss_pred CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc---ccc
Confidence 75 7888776642 578999999999999999999999999999999999999999999999999986553322 122
Q ss_pred ccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---------------
Q 005886 175 NTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD--------------- 239 (671)
Q Consensus 175 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~--------------- 239 (671)
....++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+..+....+.........
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence 33568899999999987547899999999999999999999999877765544333322111000
Q ss_pred ----------ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 240 ----------YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 240 ----------~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
......++..+.+||.+||..||.+||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 01123467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=313.34 Aligned_cols=262 Identities=26% Similarity=0.401 Sum_probs=220.1
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCccc-HHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNND-LDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~-~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
.+|.-+++||+|.||+||+|+++.+++.||+|.+......+. -....+|+-+|+.+.|.|||+++++...+..+-+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 357778999999999999999999999999999987654332 4567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
||.. +|..+.... .+.++...++.++.|++.||.|||+++++||||||.|+||+.+|.+|++|||+++.+ +-..+
T Consensus 82 ~cdq-dlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglaraf---gipvr 156 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAF---GIPVR 156 (292)
T ss_pred HhhH-HHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhc---CCceE
Confidence 9954 676666554 367999999999999999999999999999999999999999999999999999865 23334
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCC--CCCCccc-------
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAP--PGLDYER------- 242 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~--~~~~~~~------- 242 (671)
.....+-|.||++|.++.|.+-|+...|+||.|||+.|+.. |++.|.+.+-.+.+..+..-.. ..-.|+.
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 45556789999999999998889999999999999999998 8999999887777666553211 1111110
Q ss_pred ---------------cccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 243 ---------------DKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 243 ---------------~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
-++++..-++|++++|.-+|..|++++.+|+||||...
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 11234456899999999999999999999999999754
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=326.62 Aligned_cols=253 Identities=26% Similarity=0.509 Sum_probs=208.5
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
++|++.+.||.|+||.||+|.+..+|+.||+|.+..... ......+.+|+.+++.++|+||+++++++...+.+++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 689999999999999999999999999999999864322 233678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCC
Q 005886 92 PYMAGGSCLHIMKSAY--PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~--~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~ 169 (671)
||+.||+|..++.... ...+++..++.++.+|+.||.|||+.|++||||+|+||+++.++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-- 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC--
Confidence 9999999999886532 245899999999999999999999999999999999999999999999999997654221
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhcCCCCCCccccccch
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPP--MKVLLMTLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~--~~~~~~~~~~~~~~~~~~~~~~ls 247 (671)
........|++.|+|||.+.+ ..++.++|||||||++|+|++|..||..... .+..........+.. ....++
T Consensus 160 -~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 234 (267)
T cd08224 160 -TTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPL---PADHYS 234 (267)
T ss_pred -CcccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCC---ChhhcC
Confidence 112234578999999999876 5689999999999999999999999965431 122222222111111 123578
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 248 KSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
..+.++|.+||..+|.+||++.+|++
T Consensus 235 ~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 235 EELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 89999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=328.77 Aligned_cols=245 Identities=23% Similarity=0.349 Sum_probs=201.0
Q ss_pred EecccCceEEEEEEE--cCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccCCC
Q 005886 21 EVGEGVSATVYRALC--IPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGG 97 (671)
Q Consensus 21 ~LG~G~fG~Vyka~~--~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~gg 97 (671)
+||+|+||.||+|.+ ..++..||+|++...... ...+.+.+|+.+++.++||||+++++++.. ..+++||||+.+|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 689999999999964 467889999998654322 235678899999999999999999998864 5678999999999
Q ss_pred CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccccccc
Q 005886 98 SCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTF 177 (671)
Q Consensus 98 sL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~ 177 (671)
+|.+++... ..+++..+..++.|++.||+|||++|++||||||.||+++.++.+||+|||++..+.............
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence 999998765 568999999999999999999999999999999999999999999999999987653322211112223
Q ss_pred cCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHH
Q 005886 178 VGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTA 256 (671)
Q Consensus 178 ~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~ 256 (671)
.+++.|+|||++.. ..++.++|||||||++|||++ |..||...........+..... .+.+..++.++++||.+
T Consensus 159 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~----~~~~~~~~~~l~~li~~ 233 (257)
T cd05116 159 KWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER----MECPQRCPPEMYDLMKL 233 (257)
T ss_pred CCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC----CCCCCCCCHHHHHHHHH
Confidence 45678999999875 568889999999999999998 9999988776655544433222 23355689999999999
Q ss_pred hhhcCCCCCCCHHHHHh
Q 005886 257 CLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 257 cL~~dP~kRpSa~eiL~ 273 (671)
||+.||.+||++.+|..
T Consensus 234 ~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 234 CWTYGVDERPGFAVVEL 250 (257)
T ss_pred HhccCchhCcCHHHHHH
Confidence 99999999999998854
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=327.65 Aligned_cols=246 Identities=24% Similarity=0.388 Sum_probs=203.3
Q ss_pred EEecccCceEEEEEEEcCCC---cEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccCC
Q 005886 20 EEVGEGVSATVYRALCIPLN---EIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAG 96 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~tg---~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~g 96 (671)
+.||+|+||.||+|.+...+ ..||+|.+...........+.+|+.+++.++||||+++++++. ...+++||||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999877655 7899999876654445567889999999999999999999876 4568999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccccc
Q 005886 97 GSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNT 176 (671)
Q Consensus 97 gsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~ 176 (671)
|+|.+++... ..+++..++.++.|++.||+|||..|++||||||+|||++.++.+||+|||+++.+............
T Consensus 80 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 80 GPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 9999999876 46899999999999999999999999999999999999999999999999998765332222111222
Q ss_pred ccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHH
Q 005886 177 FVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVT 255 (671)
Q Consensus 177 ~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~ 255 (671)
..++..|+|||.+.+ ..++.++|||||||++|+|++ |..||......+....+.... ....+..++..++++|.
T Consensus 158 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~ 232 (257)
T cd05060 158 GRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE----RLPRPEECPQEIYSIML 232 (257)
T ss_pred ccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC----cCCCCCCCCHHHHHHHH
Confidence 234567999999876 568999999999999999998 999998877655544443332 12345567899999999
Q ss_pred HhhhcCCCCCCCHHHHHh
Q 005886 256 ACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 256 ~cL~~dP~kRpSa~eiL~ 273 (671)
+||..+|.+||++.++++
T Consensus 233 ~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 233 SCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHhcCChhhCcCHHHHHH
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=361.01 Aligned_cols=262 Identities=24% Similarity=0.389 Sum_probs=218.7
Q ss_pred ccccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeC
Q 005886 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG 84 (671)
Q Consensus 6 e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~ 84 (671)
+..|.|..++..+.+.||+|.||+||+|++..+ ||||+++.... ++..+.|++|+..+++-+|.||+=+.|++...
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred ccccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 467899999999999999999999999998743 99999987653 45688999999999999999999999999988
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccc
Q 005886 85 HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACM 164 (671)
Q Consensus 85 ~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~ 164 (671)
.. .||+-+|+|-+|+.++.-.. ..|.....+.|++||+.|+.|||.++|||||||..|||+.+++.|||+||||+...
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred ce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeee
Confidence 77 89999999999999886542 46899999999999999999999999999999999999999999999999998654
Q ss_pred ccCCCcccccccccCCCCCCChhHhhh--ccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccc
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQ--LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER 242 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~--~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~ 242 (671)
.-. ..........|...|||||++.. ...|++.+|||||||++|||++|..||.......+++++-+.....-....
T Consensus 539 ~~w-~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~ 617 (678)
T KOG0193|consen 539 TRW-SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKI 617 (678)
T ss_pred eee-ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhh
Confidence 222 11122334568889999999863 356899999999999999999999999965555555444333211112233
Q ss_pred cccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 243 DKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 243 ~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
...+++++++|+..||.+++++||.+.+||.
T Consensus 618 ~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 618 RSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred hccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 4567889999999999999999999999976
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=331.63 Aligned_cols=255 Identities=23% Similarity=0.345 Sum_probs=207.9
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCc----EEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNE----IVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~----~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 86 (671)
+..++|++.+.||.|+||+||+|.+..+|. .||+|++...........+.+|+.+++.++||||+++++++... .
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~ 82 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-T 82 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence 356789999999999999999999887776 48999986554444466788999999999999999999998764 5
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
.+++|+|+.+|+|.+++... ...+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||+++.+..
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 78899999999999998764 24689999999999999999999999999999999999999999999999999875532
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (671)
... ........+++.|+|||.+.+ ..++.++|||||||++|||++ |..||...........+.... ..+.+..
T Consensus 162 ~~~-~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~ 235 (279)
T cd05109 162 DET-EYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE----RLPQPPI 235 (279)
T ss_pred ccc-eeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC----cCCCCcc
Confidence 111 111112245678999999976 568999999999999999998 999998766544433222221 1222456
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 246 FSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 246 ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
++..+.++|.+||..||.+||++.+++.
T Consensus 236 ~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 236 CTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7889999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=333.99 Aligned_cols=257 Identities=29% Similarity=0.452 Sum_probs=210.6
Q ss_pred eEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCC-CCCceeeeeEEEeCCEEEEEEecc
Q 005886 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN-HPNVLRAHCSFTTGHCLWVVMPYM 94 (671)
Q Consensus 16 Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~-HpNIVkl~~~~~~~~~l~LVmEy~ 94 (671)
|.+.+.||.|+||+||+|....+++.||||.+.............+|+..++.+. ||||+++++++..+..+|+||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 7889999999999999999998999999999865443333344567999999999 999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccc
Q 005886 95 AGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSR 174 (671)
Q Consensus 95 ~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 174 (671)
+|+|.+.+.......+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~----~~~ 155 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR----PPY 155 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC----CCc
Confidence 789998887764457899999999999999999999999999999999999999999999999998654221 122
Q ss_pred ccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--------------C-
Q 005886 175 NTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL--------------D- 239 (671)
Q Consensus 175 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~--------------~- 239 (671)
....|+..|+|||++.+...++.++|+||||+++|+|++|++||......+....+........ .
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 3457899999999986656688999999999999999999999987765544433322110000 0
Q ss_pred ----------ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 240 ----------YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 240 ----------~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
.......+..+.+||.+||..+|.+||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00011235789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=358.45 Aligned_cols=271 Identities=28% Similarity=0.433 Sum_probs=231.3
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeC
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG 84 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~ 84 (671)
+|-..+..-|..++.||-|+||.|.++....|...||.|.+.+... .+.+..+..|-.||..-+.+-||+||..|.++
T Consensus 622 kRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDk 701 (1034)
T KOG0608|consen 622 KRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDK 701 (1034)
T ss_pred HHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccC
Confidence 3455677889999999999999999999999999999999876542 45678889999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccc
Q 005886 85 HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACM 164 (671)
Q Consensus 85 ~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~ 164 (671)
+++|+||+|+.||++-.+|.+. +.|+|..++.|+.++.+|+++.|..|+|||||||+|||||.+|++||+||||++-+
T Consensus 702 dnLYFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 702 DNLYFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred CceEEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccc
Confidence 9999999999999999988877 78999999999999999999999999999999999999999999999999998543
Q ss_pred c--------cCCCcc-------------------------------cccccccCCCCCCChhHhhhccCCCccchhhhHH
Q 005886 165 F--------DAGDRQ-------------------------------RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFG 205 (671)
Q Consensus 165 ~--------~~~~~~-------------------------------~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLG 205 (671)
- ..++.. ......+||+.|+|||++.. .+|+..+|+||.|
T Consensus 780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~g 858 (1034)
T KOG0608|consen 780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVG 858 (1034)
T ss_pred eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhh
Confidence 1 111100 01134589999999999997 7899999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCC---HHHHHhchhcccccc
Q 005886 206 ITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPT---AEKLMKHHFFKHARS 282 (671)
Q Consensus 206 vILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpS---a~eiL~Hpwfk~~~~ 282 (671)
||||||+.|++||-..++.+.-.. +.+....+++....++|+++.+||.++++ +++.|+. ++++..||||+.+.+
T Consensus 859 vil~em~~g~~pf~~~tp~~tq~k-v~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgIDf 936 (1034)
T KOG0608|consen 859 VILYEMLVGQPPFLADTPGETQYK-VINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGIDF 936 (1034)
T ss_pred HHHHHHhhCCCCccCCCCCcceee-eeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccch
Confidence 999999999999987766554332 33445556677788999999999999774 7889975 778999999997764
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=328.64 Aligned_cols=253 Identities=23% Similarity=0.388 Sum_probs=207.0
Q ss_pred eEEEEEecccCceEEEEEEEcCC---CcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE-----
Q 005886 16 YRLYEEVGEGVSATVYRALCIPL---NEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC----- 86 (671)
Q Consensus 16 Y~l~~~LG~G~fG~Vyka~~~~t---g~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~----- 86 (671)
|++.+.||+|+||.||+|.+..+ +..||+|.+...... .....+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 67889999999999999987653 478999998754432 345678999999999999999999998866544
Q ss_pred -EEEEEeccCCCCHHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccc
Q 005886 87 -LWVVMPYMAGGSCLHIMKSAY----PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVS 161 (671)
Q Consensus 87 -l~LVmEy~~ggsL~~~l~~~~----~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls 161 (671)
.++||||+.+|+|..++.... ...+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 899999999999998875432 235899999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCc
Q 005886 162 ACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDY 240 (671)
Q Consensus 162 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~ 240 (671)
+.+...... .......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+....+...........
T Consensus 161 ~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---- 234 (273)
T cd05035 161 KKIYSGDYY-RQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL---- 234 (273)
T ss_pred eeccccccc-cccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----
Confidence 765332211 11222345678999999876 568999999999999999999 99999887776665544443322
Q ss_pred cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 241 ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 241 ~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
..+..++..+.++|.+||..||.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 235 KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2345678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=344.44 Aligned_cols=261 Identities=28% Similarity=0.375 Sum_probs=213.4
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC-----
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH----- 85 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~----- 85 (671)
..++|++++.||+|+||.||+|.+..+|..||||.+...... .....+.+|+.+|+.++||||++++++|..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 357899999999999999999999999999999998644322 23456889999999999999999999997654
Q ss_pred -EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccc
Q 005886 86 -CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACM 164 (671)
Q Consensus 86 -~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~ 164 (671)
.+++||+|+ |++|..++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 468999999 7788888764 46899999999999999999999999999999999999999999999999998643
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG------- 237 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~------- 237 (671)
.. ......+++.|+|||++.+...++.++|+|||||++|+|++|..||.+.........+.......
T Consensus 169 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07880 169 DS------EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242 (343)
T ss_pred cc------CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 21 12345779999999998764458899999999999999999999998766544433332211100
Q ss_pred ---------------CC----ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 238 ---------------LD----YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 238 ---------------~~----~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
.. ......++..+.++|.+||..||.+|||+.+++.||||+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 00 0112456788999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=372.88 Aligned_cols=149 Identities=28% Similarity=0.483 Sum_probs=136.6
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWV 89 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~L 89 (671)
..++|.+++.||+|+||+||+|.+..+++.||||++...... .....+.+|+.+++.++||||+++++++.....+||
T Consensus 2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 357899999999999999999999999999999999754322 234678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccc
Q 005886 90 VMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSA 162 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~ 162 (671)
||||+.|++|..++... +.+++..++.|+.||+.||+|||.+|||||||||+|||++.++.+||+|||+++
T Consensus 82 VmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999998765 568999999999999999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=329.45 Aligned_cols=256 Identities=26% Similarity=0.357 Sum_probs=208.0
Q ss_pred eEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcc-cHHHHHHHHHHHHhC---CCCCceeeeeEEEeCCE-----
Q 005886 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-DLDGIRREVQTMRVT---NHPNVLRAHCSFTTGHC----- 86 (671)
Q Consensus 16 Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~-~~~~i~~Ei~iL~~L---~HpNIVkl~~~~~~~~~----- 86 (671)
|++.+.||.|+||.||+|.+..++..||+|.+....... ....+.+|+.+++.+ +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 788999999999999999999889999999997543222 234566787777655 69999999999998776
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
++++|||+.+ +|.+++.......+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++..+..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 9999999975 788888765444689999999999999999999999999999999999999999999999999865522
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG--------- 237 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~--------- 237 (671)
. .......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+....+.......
T Consensus 160 ~----~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 160 E----MALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred C----cccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 1 12223467899999999987 568899999999999999999999998877666554443321100
Q ss_pred ------CC-------ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 238 ------LD-------YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 238 ------~~-------~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
+. ......++..+.+||.+||..||.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00 00112456788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=332.96 Aligned_cols=256 Identities=23% Similarity=0.412 Sum_probs=211.4
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCI-----PLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH 85 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~-----~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~ 85 (671)
+..++|.+.++||+|+||.||++... .++..+|+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 45678999999999999999999753 346679999875332 334567899999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYP-------------EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGA 152 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~-------------~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~ 152 (671)
.+|+||||+.+|+|.+++....+ ..+++..++.++.||+.||+|||++|++||||||+|||++.++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 99999999999999999876432 24788999999999999999999999999999999999999999
Q ss_pred eEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 005886 153 IKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTL 231 (671)
Q Consensus 153 vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~ 231 (671)
+||+|||++..+.... .........+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||......+....+.
T Consensus 161 ~kL~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05092 161 VKIGDFGMSRDIYSTD-YYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238 (280)
T ss_pred EEECCCCceeEcCCCc-eeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 9999999986543211 1112233456788999999887 568999999999999999998 999998777666555444
Q ss_pred hcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 232 QNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 232 ~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.... ...+..++..+.+||.+||..||.+||++.+++.
T Consensus 239 ~~~~----~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 239 QGRE----LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred cCcc----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 4322 2234567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=325.86 Aligned_cols=249 Identities=22% Similarity=0.390 Sum_probs=207.9
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEE-eCCEE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFT-TGHCL 87 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~-~~~~l 87 (671)
|.++.++|++.+.||+|+||.||++... |..||+|.+... ...+.+.+|+.+++.++|+||+++++++. .+..+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC---chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 4677889999999999999999999765 778999998533 23467889999999999999999998754 55679
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccC
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~ 167 (671)
|+||||+.+++|.+++.......+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999999999988764456899999999999999999999999999999999999999999999999998644221
Q ss_pred CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (671)
.....++..|+|||++.+ ..++.++|||||||++|+|++ |..||...........+.... .......+
T Consensus 156 ------~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~ 224 (256)
T cd05082 156 ------QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----KMDAPDGC 224 (256)
T ss_pred ------CCCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC----CCCCCCCC
Confidence 122345678999999876 568999999999999999997 999998766544443333322 22334567
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 247 SKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 247 s~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
+..+.++|.+||..+|.+|||+.++++
T Consensus 225 ~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 225 PPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=335.54 Aligned_cols=252 Identities=24% Similarity=0.365 Sum_probs=206.4
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCc--EEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNE--IVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~--~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~~~l~LV 90 (671)
++|++.+.||+|+||.||+|....++. .+++|.+...........+.+|+.++.++ +||||+++++++.....+|+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 689999999999999999999887765 46888876333333456788999999988 799999999999999999999
Q ss_pred EeccCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEe
Q 005886 91 MPYMAGGSCLHIMKSAY--------------PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLA 156 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~--------------~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~ 156 (671)
|||+.+|+|.+++.... ...+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEEC
Confidence 99999999999986532 1348889999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCC
Q 005886 157 DFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAP 235 (671)
Q Consensus 157 DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~ 235 (671)
|||++.... .........++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.............
T Consensus 162 dfg~~~~~~----~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~-- 234 (297)
T cd05089 162 DFGLSRGEE----VYVKKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-- 234 (297)
T ss_pred CcCCCcccc----ceeccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--
Confidence 999875321 0111111233557999999876 568999999999999999997 99999887766555444332
Q ss_pred CCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 236 PGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 236 ~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
.....+..++..+.+||.+||..+|.+||+++++++.
T Consensus 235 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 235 --YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2223345688999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=336.39 Aligned_cols=256 Identities=37% Similarity=0.644 Sum_probs=213.8
Q ss_pred eEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 16 Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
|...+.||+|+||+||+|++..+|..||+|++...... .....+.+|+.+++.++||||+++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999999999999999998754322 2345788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS 173 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 173 (671)
+. |++.+++... ...+++..++.++.||+.||.|||++|++||||+|+||+++.++.+||+|||++... ..
T Consensus 103 ~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~-------~~ 173 (313)
T cd06633 103 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKS-------SP 173 (313)
T ss_pred CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCccc-------CC
Confidence 96 5777776543 246899999999999999999999999999999999999999999999999987432 12
Q ss_pred cccccCCCCCCChhHhhh--ccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHH
Q 005886 174 RNTFVGTPCWMAPEVMQQ--LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251 (671)
Q Consensus 174 ~~~~~GT~~Y~APEvl~~--~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~ 251 (671)
.....|+..|+|||++.. ...++.++|||||||++|+|++|..||.................+.. ....++..++
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~ 250 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL---QSNEWTDSFR 250 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---CccccCHHHH
Confidence 234678999999999852 24578899999999999999999999988776665555444333222 2345678899
Q ss_pred HHHHHhhhcCCCCCCCHHHHHhchhccccccc
Q 005886 252 ELVTACLVKDPKKRPTAEKLMKHHFFKHARSN 283 (671)
Q Consensus 252 dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~ 283 (671)
+||.+||..+|.+||++.+++.||||......
T Consensus 251 ~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~ 282 (313)
T cd06633 251 GFVDYCLQKIPQERPASAELLRHDFVRRDRPA 282 (313)
T ss_pred HHHHHHccCChhhCcCHHHHhcCcccCCCchh
Confidence 99999999999999999999999999875543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=336.67 Aligned_cols=255 Identities=37% Similarity=0.632 Sum_probs=214.3
Q ss_pred EEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccCCC
Q 005886 18 LYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGG 97 (671)
Q Consensus 18 l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~gg 97 (671)
....||+|+||.||++.+..+|..||||++.... ......+.+|+.+++.++||||++++++|...+..|+||||+.++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 3467999999999999999999999999986433 234567889999999999999999999999999999999999999
Q ss_pred CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccccccc
Q 005886 98 SCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTF 177 (671)
Q Consensus 98 sL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~ 177 (671)
+|.+++.. ..+++..++.++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++...... .......
T Consensus 103 ~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~---~~~~~~~ 176 (292)
T cd06657 103 ALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE---VPRRKSL 176 (292)
T ss_pred cHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccc---ccccccc
Confidence 99987754 35899999999999999999999999999999999999999999999999987544221 1122345
Q ss_pred cCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHh
Q 005886 178 VGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTAC 257 (671)
Q Consensus 178 ~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~c 257 (671)
.|++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+..............+..+ .....++..+.++|.+|
T Consensus 177 ~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~ 253 (292)
T cd06657 177 VGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKL--KNLHKVSPSLKGFLDRL 253 (292)
T ss_pred ccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCccc--CCcccCCHHHHHHHHHH
Confidence 78999999999876 5678999999999999999999999987666554444433333222 12345788999999999
Q ss_pred hhcCCCCCCCHHHHHhchhcccccc
Q 005886 258 LVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 258 L~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
|..+|.+||++.++|.||||.++..
T Consensus 254 l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 254 LVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred HhCCcccCcCHHHHhcChHHhccCC
Confidence 9999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=364.56 Aligned_cols=266 Identities=39% Similarity=0.718 Sum_probs=237.1
Q ss_pred ccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeeeEEEe---
Q 005886 8 RFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHCSFTT--- 83 (671)
Q Consensus 8 ~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~--- 83 (671)
.++.....|++.+.||.|.+|.||+++++.+|+.+|+|++.... ..-+.+..|+++|+.+ +|||++.+|++|..
T Consensus 13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~--d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE--DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred hCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc--cccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 45666788999999999999999999999999999999987654 3336788899999866 79999999999974
Q ss_pred --CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccc
Q 005886 84 --GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVS 161 (671)
Q Consensus 84 --~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls 161 (671)
++.+|||||||.||+..++++.-....+.|..|..|++.++.||.+||.+.++|||||-.|||++.+|.|||+|||++
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvS 170 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVS 170 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeee
Confidence 568999999999999999999876778999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCCCCChhHhhhc----cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC
Q 005886 162 ACMFDAGDRQRSRNTFVGTPCWMAPEVMQQL----HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG 237 (671)
Q Consensus 162 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~----~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~ 237 (671)
+.+.. ....+++++|||+|||||++.-. ..|+..+|+||||++..||.-|.+|+.+.-++..++.+.++.|+.
T Consensus 171 aQlds---T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPk 247 (953)
T KOG0587|consen 171 AQLDS---TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK 247 (953)
T ss_pred eeeec---ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcc
Confidence 87732 33456788999999999998632 347789999999999999999999999999999999998887776
Q ss_pred CCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 238 LDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 238 ~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
+ ..+.+++.++.+||..||.+|..+||+..++|+|||+++.
T Consensus 248 L--krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 248 L--KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred c--cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 5 4577899999999999999999999999999999999843
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=345.61 Aligned_cols=267 Identities=27% Similarity=0.373 Sum_probs=217.7
Q ss_pred ccccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeC
Q 005886 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG 84 (671)
Q Consensus 6 e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~ 84 (671)
+..+.+ .++|++...||.|+||.||+|.+..++..||||++..... ......+.+|+.+++.++||||+++++++...
T Consensus 8 ~~~~~~-~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (343)
T cd07851 8 KTVWEV-PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPA 86 (343)
T ss_pred cceecc-cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcc
Confidence 344444 5789999999999999999999999999999999865322 22345677899999999999999999988766
Q ss_pred CE------EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecc
Q 005886 85 HC------LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADF 158 (671)
Q Consensus 85 ~~------l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DF 158 (671)
.. +|+|+||+ |++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+||
T Consensus 87 ~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 87 SSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred ccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccc
Confidence 54 89999999 6789888865 46999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC
Q 005886 159 GVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL 238 (671)
Q Consensus 159 Gls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~ 238 (671)
|++..... ......+++.|+|||++.+...++.++|||||||++|+|++|+.||.+......+..+........
T Consensus 163 g~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 236 (343)
T cd07851 163 GLARHTDD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD 236 (343)
T ss_pred cccccccc------cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Confidence 99865421 123457899999999987644678999999999999999999999987766554443332211000
Q ss_pred -------------------------C-ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccccc
Q 005886 239 -------------------------D-YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSN 283 (671)
Q Consensus 239 -------------------------~-~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~ 283 (671)
. ......++..+.+||.+||..||.+|||+.+|+.||||..+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 0 01112458899999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=325.71 Aligned_cols=254 Identities=26% Similarity=0.400 Sum_probs=208.5
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~ 88 (671)
|.+..++|++.+.||.|+||.||+|.+..++ .+|+|.+.... ...+.+.+|+.+++.++||||+++++++.. ...|
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIY 76 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcE
Confidence 3566688999999999999999999876554 58999875433 234678899999999999999999998864 5688
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
+||||+.+|+|.+++.......+++..+..++.||+.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 99999999999999976544568999999999999999999999999999999999999999999999999986542211
Q ss_pred CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccch
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls 247 (671)
........++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+..+.+....+..... ...+..++
T Consensus 157 --~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~ 229 (260)
T cd05069 157 --YTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR----MPCPQGCP 229 (260)
T ss_pred --ccccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----CCCCcccC
Confidence 111223346778999999876 568999999999999999999 9999988776655444433322 22345678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 248 KSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
..+.+||.+||.+||.+||+++++++
T Consensus 230 ~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 230 ESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHH
Confidence 99999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.86 Aligned_cols=261 Identities=25% Similarity=0.352 Sum_probs=210.6
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeC------
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG------ 84 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~------ 84 (671)
..++|.+.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 34789999999999999999999999999999999865432 22346678899999999999999999988643
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccc
Q 005886 85 HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACM 164 (671)
Q Consensus 85 ~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~ 164 (671)
..+|++++++ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++...
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 3478888887 7788887764 35899999999999999999999999999999999999999999999999998643
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--------
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP-------- 236 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~-------- 236 (671)
. .......|++.|+|||++.+...++.++|||||||++|+|++|..||........+..+......
T Consensus 171 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T cd07877 171 D------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 244 (345)
T ss_pred c------ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 1 12234578999999999876556889999999999999999999999776554433222211000
Q ss_pred -----------------CCC-ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 237 -----------------GLD-YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 237 -----------------~~~-~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
... .......++.+.+||.+||..||.+||++.++|.||||+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 000 0011235788999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=332.36 Aligned_cols=251 Identities=30% Similarity=0.494 Sum_probs=204.8
Q ss_pred EEEEEecccCceEEEEEEEc----CCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 17 RLYEEVGEGVSATVYRALCI----PLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 17 ~l~~~LG~G~fG~Vyka~~~----~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
++.+.||.|.||.||+|... ..+..|+||.+.........+.+.+|++.++.++||||+++++++.....+++|||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 57889999999999999988 45678999999654444457889999999999999999999999998888999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
||.+|+|.+++.......+++..++.|+.||+.||.|||+++++|++|++.|||++.++.+||+|||++...... ....
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~-~~~~ 160 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK-SKYK 160 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS-SSEE
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccc
Confidence 999999999998875567999999999999999999999999999999999999999999999999998655211 1112
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHH
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~ 251 (671)
......+...|+|||++.+ ..++.++||||||+++|||++ |..||......+.......... ...+..++..+.
T Consensus 161 ~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 235 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR----LPIPDNCPKDIY 235 (259)
T ss_dssp ESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE----TTSBTTSBHHHH
T ss_pred ccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccc----ceeccchhHHHH
Confidence 2233456778999999987 458999999999999999999 7899998877665555533322 233556899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHh
Q 005886 252 ELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 252 dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
++|..||..||.+||++.+|++
T Consensus 236 ~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 236 SLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHh
Confidence 9999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=344.21 Aligned_cols=260 Identities=28% Similarity=0.385 Sum_probs=210.0
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeC------C
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG------H 85 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~------~ 85 (671)
.++|.+...||+|+||.||+|.+..+|+.||||++..... ......+.+|+.+++.++||||++++++|... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 3689999999999999999999999999999999865432 22345678999999999999999999998754 3
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
.+|+||||+.+ +|..++. ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++....
T Consensus 94 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred eEEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 56999999964 6665542 368999999999999999999999999999999999999999999999999976431
Q ss_pred cCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC----------
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP---------- 235 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~---------- 235 (671)
.......|++.|+|||++.+...++.++|||||||++|+|++|+.||.+......+..++....
T Consensus 169 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07879 169 ------AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242 (342)
T ss_pred ------CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 1223457899999999987645688999999999999999999999988765544433322110
Q ss_pred ------------CCCC----ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccccc
Q 005886 236 ------------PGLD----YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSN 283 (671)
Q Consensus 236 ------------~~~~----~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~ 283 (671)
+... ......++..+.+||.+||+.||.+||++.++|.||||+..+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 0000 00123467789999999999999999999999999999876643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=332.58 Aligned_cols=254 Identities=23% Similarity=0.381 Sum_probs=200.2
Q ss_pred eEEEEEecccCceEEEEEE----EcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe--CCEEEE
Q 005886 16 YRLYEEVGEGVSATVYRAL----CIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT--GHCLWV 89 (671)
Q Consensus 16 Y~l~~~LG~G~fG~Vyka~----~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~--~~~l~L 89 (671)
|++.+.||+|+||+||++. ...++..||+|++...........+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 4999999999999998865 3457889999998755433445678899999999999999999998865 346899
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCC
Q 005886 90 VMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~ 169 (671)
||||+.+++|.+++... .+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||+++.+.....
T Consensus 86 v~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred EecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 99999999999998764 589999999999999999999999999999999999999999999999999875532221
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHH-HH----------HHHhcCCCCC
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKV-LL----------MTLQNAPPGL 238 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~-~~----------~~~~~~~~~~ 238 (671)
.........++..|+|||++.+ ..++.++|||||||++|+|++|..||......-. .. ..........
T Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T cd05080 163 YYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM 241 (283)
T ss_pred hhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCC
Confidence 1111222345677999999876 5689999999999999999999999865332100 00 0000000111
Q ss_pred CccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 239 DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 239 ~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
..+.+..++..+.+|+.+||..+|.+|||+.+++.
T Consensus 242 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 12234567889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=323.37 Aligned_cols=253 Identities=27% Similarity=0.465 Sum_probs=216.6
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
+|++.+.||.|+||.||++.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++.....+|+||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 58999999999999999999999999999999875442 23456778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 94 MAGGSCLHIMKSAY--PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 94 ~~ggsL~~~l~~~~--~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
+.+++|..++.... ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC----
Confidence 99999999886521 246899999999999999999999999999999999999999999999999998665332
Q ss_pred cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHH
Q 005886 172 RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~ 251 (671)
......|++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+..+..........+. ....++.+++
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 230 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPP----IPPIYSQDLQ 230 (256)
T ss_pred -CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC----CchhhCHHHH
Confidence 2223468999999999976 568889999999999999999999998877655544444333222 2346788999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 252 ELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 252 dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
++|.+||..+|.+||++.+++.||++
T Consensus 231 ~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 231 NFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 99999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=331.08 Aligned_cols=254 Identities=23% Similarity=0.392 Sum_probs=205.5
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcE----EEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEI----VAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCL 87 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~----VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l 87 (671)
..++|++.+.||.|+||+||+|.+..+|.. |++|.+...........+..|+..++.++||||+++++++.. ..+
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~ 83 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL 83 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence 457899999999999999999999887764 677776533323345677788889999999999999998764 467
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccC
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~ 167 (671)
++++||+.+|+|.+++... ...+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 8899999999999998764 256899999999999999999999999999999999999999999999999998765322
Q ss_pred CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (671)
. .........|+..|+|||.+.+ ..++.++|||||||++|||++ |..||.+....... ..+.... ....+..+
T Consensus 163 ~-~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-~~~~~~~---~~~~~~~~ 236 (279)
T cd05111 163 D-KKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP-DLLEKGE---RLAQPQIC 236 (279)
T ss_pred C-cccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHCCC---cCCCCCCC
Confidence 2 2222234567788999999976 568999999999999999998 99999887654432 2222211 11223446
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 247 SKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 247 s~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
+..+.+++.+||..||.+|||+.++++
T Consensus 237 ~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 237 TIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 778999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=327.92 Aligned_cols=256 Identities=23% Similarity=0.366 Sum_probs=211.1
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCc---EEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNE---IVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~---~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~ 88 (671)
+..+|++.+.||+|+||.||+|.++.+++ .||||++...........+..|+.+++.++||||+++++++..+..++
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 55789999999999999999999887665 599999875443445678899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
+||||+.+|+|..++... .+.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 82 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 82 IITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999999999988764 3568999999999999999999999999999999999999999999999999986543222
Q ss_pred Cccccccccc--CCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Q 005886 169 DRQRSRNTFV--GTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245 (671)
Q Consensus 169 ~~~~~~~~~~--GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (671)
.......... ++..|+|||.+.+ ..++.++|||||||++|||++ |..||......+....+... ...+.+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~----~~~~~~~~ 235 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD----YRLPPPMD 235 (269)
T ss_pred cccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC----CcCCCccc
Confidence 1111111111 2457999999876 568999999999999999886 99999887766554444322 22233456
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 246 FSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 246 ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
++..+.+++.+||..+|.+||++.+++.
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 236 CPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=340.50 Aligned_cols=264 Identities=22% Similarity=0.421 Sum_probs=215.6
Q ss_pred cccccccCCCCeEEEEEecccCceEEEEEEEcCC-------CcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCcee
Q 005886 5 VEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPL-------NEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLR 76 (671)
Q Consensus 5 ~e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~t-------g~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVk 76 (671)
...+|.+...+|++.+.||+|+||.||+|.+... +..||+|.+...........+.+|+.+++.+ +||||++
T Consensus 3 ~~~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (334)
T cd05100 3 ADPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIIN 82 (334)
T ss_pred CCcccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 3567889999999999999999999999986532 2368999887544344567889999999999 8999999
Q ss_pred eeeEEEeCCEEEEEEeccCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCC
Q 005886 77 AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYP--------------EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKA 142 (671)
Q Consensus 77 l~~~~~~~~~l~LVmEy~~ggsL~~~l~~~~~--------------~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKP 142 (671)
+++++.....+|++|||+.+|+|.+++..... ..++...+..++.||+.||+|||++|++||||||
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp 162 (334)
T cd05100 83 LLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA 162 (334)
T ss_pred eeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence 99999999999999999999999999875421 2367788899999999999999999999999999
Q ss_pred CcEEEcCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCC
Q 005886 143 GNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKY 221 (671)
Q Consensus 143 eNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~ 221 (671)
+|||++.++.+||+|||+++....... ........++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDY-YKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccc-cccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 999999999999999999865422111 111122344567999999976 568999999999999999998 89999887
Q ss_pred ChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 222 PPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
+..+....+.... ....+..++..+.+||.+||..+|.+||++.+++.+
T Consensus 241 ~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 241 PVEELFKLLKEGH----RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred CHHHHHHHHHcCC----CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 7666554443322 222345678899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=331.92 Aligned_cols=257 Identities=21% Similarity=0.377 Sum_probs=210.5
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIP-----LNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH 85 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~-----tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~ 85 (671)
++.++|++...||+|+||.||+|.+.. ++..||+|++...........+.+|+.+++.++||||+++++++..+.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 466889999999999999999998753 678899999875443344567889999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCC--------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcE
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYP--------------------EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNI 145 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~--------------------~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNI 145 (671)
.+|+||||+.+|+|.+++..... ..+++..++.++.||+.||+|||.+|++||||||.||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 99999999999999999875321 2477888999999999999999999999999999999
Q ss_pred EEcCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChH
Q 005886 146 LIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPM 224 (671)
Q Consensus 146 Lld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~ 224 (671)
|++.++.++|+|||++........ ........+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADY-YKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred EecCCCceEECccccceecccCcc-ccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999865422211 111122345677999999876 568999999999999999997 88899877766
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 225 KVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
+....+..... ...+..++.++.+||.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 240 EVIYYVRDGNV----LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHhcCCC----CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 55444332221 1224467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=344.98 Aligned_cols=262 Identities=22% Similarity=0.360 Sum_probs=209.6
Q ss_pred ccccCCCCeEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeeeEE
Q 005886 8 RFPVDAKDYRLYEEVGEGVSATVYRALCI-----PLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHCSF 81 (671)
Q Consensus 8 ~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~-----~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~ 81 (671)
+|.+..++|++.+.||+|+||.||+|.+. .+++.||||++...........+.+|+.++..+ +||||+++++++
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred CcccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 36677889999999999999999999853 467889999997554444566788999999999 689999999987
Q ss_pred Ee-CCEEEEEEeccCCCCHHHHHHhhC-----------------------------------------------------
Q 005886 82 TT-GHCLWVVMPYMAGGSCLHIMKSAY----------------------------------------------------- 107 (671)
Q Consensus 82 ~~-~~~l~LVmEy~~ggsL~~~l~~~~----------------------------------------------------- 107 (671)
.. +..+++|||||.+|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 65 457899999999999999886531
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccccc
Q 005886 108 ------------PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRN 175 (671)
Q Consensus 108 ------------~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 175 (671)
...++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~ 239 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKG 239 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcc-hhhcC
Confidence 12367778889999999999999999999999999999999999999999999875532211 11222
Q ss_pred cccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHH
Q 005886 176 TFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELV 254 (671)
Q Consensus 176 ~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI 254 (671)
...+++.|+|||++.+ ..++.++|||||||++|+|++ |..||............+.... ....+..+++.+.+++
T Consensus 240 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 315 (343)
T cd05103 240 DARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT---RMRAPDYTTPEMYQTM 315 (343)
T ss_pred CCCCCcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccC---CCCCCCCCCHHHHHHH
Confidence 3346678999999876 568999999999999999997 9999987654433333333221 1222344678999999
Q ss_pred HHhhhcCCCCCCCHHHHHhc
Q 005886 255 TACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 255 ~~cL~~dP~kRpSa~eiL~H 274 (671)
..||..||.+||++.+|++|
T Consensus 316 ~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 316 LDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHccCChhhCcCHHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=324.12 Aligned_cols=250 Identities=24% Similarity=0.404 Sum_probs=211.7
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~ 88 (671)
|.++.++|++.+.||.|+||.||+|... |+.||+|.+..... ....+.+|+.+++.++|+||+++++++......|
T Consensus 1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 1 WAINSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred CccChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 4567889999999999999999999875 88999999875542 4678889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
+||||+.+++|.+++.......+++..+..++.|++.||.|||.+|++||||||+||+++.++.+||+|||++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~- 155 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG- 155 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc-
Confidence 9999999999999998764447899999999999999999999999999999999999999999999999998655211
Q ss_pred CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccch
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls 247 (671)
.....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...+............ ....+..++
T Consensus 156 -----~~~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~ 225 (256)
T cd05039 156 -----QDSGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY----RMEAPEGCP 225 (256)
T ss_pred -----cccCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC----CCCCccCCC
Confidence 112345667999999876 568889999999999999997 999998876655443333221 122345678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 248 KSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
..+.+||.+||..+|.+||++.++++
T Consensus 226 ~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 226 PEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHH
Confidence 99999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=344.69 Aligned_cols=265 Identities=25% Similarity=0.394 Sum_probs=213.7
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEecccc-CcccHHHHHHHHHHHHhC-CCCCceeeeeEEEe--CCEEE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEK-CNNDLDGIRREVQTMRVT-NHPNVLRAHCSFTT--GHCLW 88 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~-~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~--~~~l~ 88 (671)
.++|++.+.||+|+||.||+|.+..+|..||+|.+.... .......+.+|+.+++.+ +||||++++++|.. ...+|
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 478999999999999999999999999999999885432 123345677899999999 99999999999865 34789
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
+||||+. ++|..++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+....
T Consensus 86 lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred EEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 9999997 4888887653 67888999999999999999999999999999999999999999999999987664322
Q ss_pred Cc--ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC----------
Q 005886 169 DR--QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP---------- 236 (671)
Q Consensus 169 ~~--~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~---------- 236 (671)
.. ........||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.........+......
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence 21 122334678999999998876566889999999999999999999999876654433322221100
Q ss_pred ----------------CCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 237 ----------------GLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 237 ----------------~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
.........++.++.+||.+||..||.+|||+.++++||||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 000111233688999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=332.68 Aligned_cols=256 Identities=23% Similarity=0.408 Sum_probs=210.1
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIP-----LNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH 85 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~-----tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~ 85 (671)
+..++|.+.+.||+|+||.||+|.+.. ++..+++|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 345789999999999999999998643 45668899875332 223467889999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYP--------------EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG 151 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~--------------~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g 151 (671)
.+++||||+.+++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 99999999999999999875421 3478999999999999999999999999999999999999999
Q ss_pred ceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 005886 152 AIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMT 230 (671)
Q Consensus 152 ~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~ 230 (671)
.++|+|||++....... .........|++.|+|||.+.+ ..++.++|||||||++|+|++ |..||......+....+
T Consensus 161 ~~~l~dfg~a~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 238 (291)
T cd05094 161 LVKIGDFGMSRDVYSTD-YYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238 (291)
T ss_pred cEEECCCCcccccCCCc-eeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999986543221 1112233467889999999887 568999999999999999998 99999877765554443
Q ss_pred HhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 231 LQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 231 ~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
...... ..+..++..+.+||.+||..+|.+||++.++++
T Consensus 239 ~~~~~~----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 239 TQGRVL----ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred hCCCCC----CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 332221 224457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=327.74 Aligned_cols=252 Identities=23% Similarity=0.367 Sum_probs=199.7
Q ss_pred EEecccCceEEEEEEEcC--CCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccCCC
Q 005886 20 EEVGEGVSATVYRALCIP--LNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGG 97 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~--tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~gg 97 (671)
++||+|+||.||+|.... ....+|+|.+...........+.+|+.+++.++||||+++++++.....+|+||||+.+|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999996543 345688888764443344567788999999999999999999999999999999999999
Q ss_pred CHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccc
Q 005886 98 SCLHIMKSAYP---EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSR 174 (671)
Q Consensus 98 sL~~~l~~~~~---~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 174 (671)
+|.+++..... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~ 159 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY-YITK 159 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchh-eecc
Confidence 99999876432 2356788899999999999999999999999999999999999999999999864322111 1112
Q ss_pred ccccCCCCCCChhHhhh------ccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCc-cccccc
Q 005886 175 NTFVGTPCWMAPEVMQQ------LHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDY-ERDKRF 246 (671)
Q Consensus 175 ~~~~GT~~Y~APEvl~~------~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~-~~~~~l 246 (671)
....+++.|+|||++.. ...++.++|||||||++|+|++ |..||....+.+.+...+......+.. .....+
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd05042 160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKY 239 (269)
T ss_pred CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccC
Confidence 33456778999999853 1346789999999999999999 889998877766655555443322221 234567
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 247 SKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 247 s~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
+..+.+++..|| .||.+|||++++++
T Consensus 240 ~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 240 SDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 889999999998 59999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=351.86 Aligned_cols=263 Identities=20% Similarity=0.342 Sum_probs=216.0
Q ss_pred ccccccCCCCeEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeccccCcccHHHHHHHHHHHHhCC-CCCceeeee
Q 005886 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCI-----PLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN-HPNVLRAHC 79 (671)
Q Consensus 6 e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~-----~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~-HpNIVkl~~ 79 (671)
+..|.+..++|.+.+.||+|+||.||+|++. .+++.||+|++...........+.+|+.+|..+. ||||+++++
T Consensus 29 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 29 DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred CCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 4458888899999999999999999999854 3557899999976544444567889999999997 999999999
Q ss_pred EEEeCCEEEEEEeccCCCCHHHHHHhhCC---------------------------------------------------
Q 005886 80 SFTTGHCLWVVMPYMAGGSCLHIMKSAYP--------------------------------------------------- 108 (671)
Q Consensus 80 ~~~~~~~l~LVmEy~~ggsL~~~l~~~~~--------------------------------------------------- 108 (671)
++.....+|+|||||.+|+|.+++.....
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 99999999999999999999999865311
Q ss_pred ---------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCC
Q 005886 109 ---------------------------------------------EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAG 143 (671)
Q Consensus 109 ---------------------------------------------~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPe 143 (671)
..+++..++.++.||+.||+|||+.|++||||||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~ 268 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAAR 268 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcc
Confidence 13567778899999999999999999999999999
Q ss_pred cEEEcCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCC
Q 005886 144 NILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYP 222 (671)
Q Consensus 144 NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~ 222 (671)
|||++.++.+||+|||+++....... ........+++.|+|||++.+ ..++.++|||||||++|||++ |..||....
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSN-YISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccc-cccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999875432211 112234467889999999976 568999999999999999998 899998766
Q ss_pred hHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 223 PMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
..+.....+... .....+..++..+.+||.+||..+|.+||++.+|++
T Consensus 347 ~~~~~~~~~~~~---~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 347 MNEQFYNAIKRG---YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred chHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 555444433322 122234567899999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=324.45 Aligned_cols=249 Identities=24% Similarity=0.392 Sum_probs=206.7
Q ss_pred EEecccCceEEEEEEEcC-CCc--EEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccCC
Q 005886 20 EEVGEGVSATVYRALCIP-LNE--IVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAG 96 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~-tg~--~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~g 96 (671)
+.||+|+||.||+|.+.. .+. .||||.+.........+.+.+|+.+++.++||||+++++++.. ..+++||||+.+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999865 333 6899999766544556788999999999999999999999998 899999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccccc
Q 005886 97 GSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNT 176 (671)
Q Consensus 97 gsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~ 176 (671)
++|..++.......+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++..+............
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 159 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH 159 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccC
Confidence 99999998753346899999999999999999999999999999999999999999999999998766432222122223
Q ss_pred ccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHH
Q 005886 177 FVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVT 255 (671)
Q Consensus 177 ~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~ 255 (671)
..++..|+|||.+.+ ..++.++|||||||++|+|++ |..||......+....+.... .....+..++..+.+++.
T Consensus 160 ~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~ 235 (257)
T cd05040 160 LKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG---ERLERPEACPQDIYNVML 235 (257)
T ss_pred CCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC---CcCCCCccCCHHHHHHHH
Confidence 467889999999876 568999999999999999998 999998777666544443321 122234467889999999
Q ss_pred HhhhcCCCCCCCHHHHHh
Q 005886 256 ACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 256 ~cL~~dP~kRpSa~eiL~ 273 (671)
+||..+|.+||++.+++.
T Consensus 236 ~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 236 QCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHCCCCcccCCCHHHHHH
Confidence 999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=326.20 Aligned_cols=246 Identities=24% Similarity=0.366 Sum_probs=200.4
Q ss_pred EecccCceEEEEEEEc--CCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccCCCC
Q 005886 21 EVGEGVSATVYRALCI--PLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGS 98 (671)
Q Consensus 21 ~LG~G~fG~Vyka~~~--~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~ggs 98 (671)
.||+|+||.||+|.+. ..+..||+|++.........+.+.+|+.+++.++||||+++++++.. ..+|+||||+.+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999775 44567999998755434445678999999999999999999998864 57899999999999
Q ss_pred HHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccccccc
Q 005886 99 CLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFV 178 (671)
Q Consensus 99 L~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~ 178 (671)
|.+++... ...+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||++..+..............
T Consensus 81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05115 81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK 159 (257)
T ss_pred HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCC
Confidence 99988753 25689999999999999999999999999999999999999999999999999865432221111122223
Q ss_pred CCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHh
Q 005886 179 GTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTAC 257 (671)
Q Consensus 179 GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~c 257 (671)
+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+...... ..+..++.++.++|.+|
T Consensus 160 ~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~c 234 (257)
T cd05115 160 WPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL----DCPAECPPEMYALMKDC 234 (257)
T ss_pred CCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC----CCCCCCCHHHHHHHHHH
Confidence 4578999999876 568999999999999999996 99999887776655444433322 23456789999999999
Q ss_pred hhcCCCCCCCHHHHHh
Q 005886 258 LVKDPKKRPTAEKLMK 273 (671)
Q Consensus 258 L~~dP~kRpSa~eiL~ 273 (671)
|..+|++||++.++++
T Consensus 235 ~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 235 WIYKWEDRPNFAKVEE 250 (257)
T ss_pred cCCChhhCcCHHHHHH
Confidence 9999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=331.87 Aligned_cols=253 Identities=24% Similarity=0.414 Sum_probs=208.7
Q ss_pred CeEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q 005886 15 DYRLYEEVGEGVSATVYRALCIP-----LNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWV 89 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~-----tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~L 89 (671)
+|++.+.||+|+||.||+|.+.. ....+|+|.+...........+.+|+.+++.++||||+++++.+..++..|+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 58899999999999999998753 2356899988655444446778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEE
Q 005886 90 VMPYMAGGSCLHIMKSAY----------------------PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILI 147 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~~----------------------~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILl 147 (671)
||||+.+|+|..++.... ...+++..++.++.|++.||+|||++|++||||||+|||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 999999999999886431 1247888999999999999999999999999999999999
Q ss_pred cCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHH
Q 005886 148 DSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKV 226 (671)
Q Consensus 148 d~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~ 226 (671)
+.++.+||+|||++......... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+..+.+.
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~ 238 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSY-VKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238 (290)
T ss_pred cCCCcEEeccccccccccCccch-hcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 99999999999998755332221 11223356778999999876 568999999999999999998 9999988776655
Q ss_pred HHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 227 LLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
....... .....+..++.++.+||.+||..+|.+||++.++++
T Consensus 239 ~~~~~~~----~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 239 FNLLKTG----YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHhCC----CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 4433322 223345667899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=326.94 Aligned_cols=254 Identities=27% Similarity=0.469 Sum_probs=211.4
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC----cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC----NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~----~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LV 90 (671)
+|.+.+.||+|+||.||++.+..++..+++|++..... ......+.+|+.+++.++||||+++++++.+...+++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58999999999999999999988877777777653221 22344577899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 91 MPYMAGGSCLHIMKSA--YPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~--~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
|||+.+++|..++... ....+++..++.++.|++.||.|||++|++|+||+|+||+++. +.+||+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 9999999999888642 2256899999999999999999999999999999999999974 679999999986653322
Q ss_pred CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchH
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSK 248 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~ 248 (671)
.......|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.................+ ..+..++.
T Consensus 160 ---~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 231 (260)
T cd08222 160 ---DLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTP----SLPETYSR 231 (260)
T ss_pred ---ccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCC----CCcchhcH
Confidence 12334568999999999876 56888999999999999999999999876665555444443222 22456788
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 249 SFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 249 ~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
++.++|.+||..+|.+||++.++++||||
T Consensus 232 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 232 QLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=334.71 Aligned_cols=261 Identities=23% Similarity=0.333 Sum_probs=208.3
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCC--------------cEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCcee
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLN--------------EIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLR 76 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg--------------~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVk 76 (671)
+..++|++.+.||+|+||.||+|.+..++ ..||+|.+...........+.+|+++++.++||||++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 34578999999999999999999875432 3589999875543444567899999999999999999
Q ss_pred eeeEEEeCCEEEEEEeccCCCCHHHHHHhhC----------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEE
Q 005886 77 AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAY----------PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNIL 146 (671)
Q Consensus 77 l~~~~~~~~~l~LVmEy~~ggsL~~~l~~~~----------~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNIL 146 (671)
+++++.....+|+||||+.+++|..++.... ...+++..++.++.||+.||.|||++|++||||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999886431 123678889999999999999999999999999999999
Q ss_pred EcCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh--CCCCCCCCChH
Q 005886 147 IDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH--GHAPFSKYPPM 224 (671)
Q Consensus 147 ld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt--G~~PF~~~~~~ 224 (671)
++.++.+||+|||++..+.... .........+++.|+|||++.+ ..++.++|||||||++|+|++ |..||......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGD-YYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EcCCCcEEecccccccccccCc-ceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 9999999999999987553321 1122233456778999999876 568999999999999999988 67898876655
Q ss_pred HHHHHHHhcC---CCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 225 KVLLMTLQNA---PPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 225 ~~~~~~~~~~---~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
+......... ........+..++..+.+||.+||..||.+||++.+|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 240 QVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 5443322111 011111224457889999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=338.22 Aligned_cols=264 Identities=23% Similarity=0.319 Sum_probs=209.8
Q ss_pred CeEEEEEecccCceEEEEEEEcCC--CcEEEEEEeccccCc-ccHHHHHHHHHHHHhC-CCCCceeeeeEEEe----CCE
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPL--NEIVAIKVLDLEKCN-NDLDGIRREVQTMRVT-NHPNVLRAHCSFTT----GHC 86 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~t--g~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~----~~~ 86 (671)
+|++.+.||.|+||.||++.+..+ +..||||.+...... .....+.+|+.+++.+ +||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999999988 899999998643222 2345678899999988 59999999987543 246
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
+|++|+|+. ++|..++... ..+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||++..+..
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 889999985 5888888654 6799999999999999999999999999999999999999999999999999876532
Q ss_pred CCCc-ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC----------
Q 005886 167 AGDR-QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP---------- 235 (671)
Q Consensus 167 ~~~~-~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~---------- 235 (671)
.... ........||+.|+|||++.+...++.++|||||||++|+|++|.+||........+..++....
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 2211 11223457999999999987655689999999999999999999999987654433322221110
Q ss_pred ---------------CCCCc-cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 236 ---------------PGLDY-ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 236 ---------------~~~~~-~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
+...+ .....++..+.+||.+||..||.+|||+.+++.||||..+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 00000 11234578899999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=372.67 Aligned_cols=259 Identities=20% Similarity=0.326 Sum_probs=209.8
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LV 90 (671)
.++|++.+.||+|+||.||+|.+..+|+.||||++...... .....+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 36899999999999999999999999999999998754322 2346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccc
Q 005886 91 MPYMAGGSCLHIMKSAY---------PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVS 161 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~---------~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls 161 (671)
|||+.||+|.+++.... ...++...+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 99999999999886421 123556778899999999999999999999999999999999999999999998
Q ss_pred cccccCCC---------------cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHH
Q 005886 162 ACMFDAGD---------------RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKV 226 (671)
Q Consensus 162 ~~~~~~~~---------------~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~ 226 (671)
........ ........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+.
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 76521110 0111234579999999999987 5689999999999999999999999987655443
Q ss_pred HHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 227 LLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
........+ ........+++.+.+++.+||..||.+||+..+.|.+
T Consensus 240 ~~~~~i~~P--~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 240 SYRDVILSP--IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhhccCh--hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 322211111 1112234678899999999999999999887776654
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=329.29 Aligned_cols=257 Identities=28% Similarity=0.415 Sum_probs=211.8
Q ss_pred eEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecc
Q 005886 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYM 94 (671)
Q Consensus 16 Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~ 94 (671)
|++.+.||.|+||.||+|++..+++.||+|++..... ......+.+|+.+++.++||||+++++++.....+|+||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 6788999999999999999999999999999976542 233467788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccc
Q 005886 95 AGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSR 174 (671)
Q Consensus 95 ~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 174 (671)
. ++|.+++.... ..+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++...... ....
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~---~~~~ 155 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP---LRTY 155 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCC---cccc
Confidence 7 58999887652 46899999999999999999999999999999999999999999999999998654221 1122
Q ss_pred ccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-------------------
Q 005886 175 NTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP------------------- 235 (671)
Q Consensus 175 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~------------------- 235 (671)
....++..|+|||.+.+...++.++|||||||++|+|++|.+||.+....+.+..+.....
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT 235 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence 3346688899999987754789999999999999999999999987765544433322110
Q ss_pred -CCC----CccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 236 -PGL----DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 236 -~~~----~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
+.. .....+.++..+.++|.+||..||.+||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 000 001122347789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=327.07 Aligned_cols=253 Identities=24% Similarity=0.420 Sum_probs=203.3
Q ss_pred eEEEEEecccCceEEEEEEEcCCCc--EEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeC------CE
Q 005886 16 YRLYEEVGEGVSATVYRALCIPLNE--IVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG------HC 86 (671)
Q Consensus 16 Y~l~~~LG~G~fG~Vyka~~~~tg~--~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~------~~ 86 (671)
|.+.+.||+|+||.||+|.+..++. .||+|.+..... ......+.+|+.+++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999887775 589999875432 23467788999999999999999999876432 25
Q ss_pred EEEEEeccCCCCHHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSA----YPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSA 162 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~----~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~ 162 (671)
.++||||+.+|+|..++... ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 78999999999999877432 12348899999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCcc
Q 005886 163 CMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYE 241 (671)
Q Consensus 163 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~ 241 (671)
.+..... ........+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+..... ..
T Consensus 161 ~~~~~~~-~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----~~ 234 (272)
T cd05075 161 KIYNGDY-YRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR----LK 234 (272)
T ss_pred ccCcccc-eecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC----CC
Confidence 6532211 111223356778999999886 568999999999999999999 8999988766555444433221 12
Q ss_pred ccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 242 RDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 242 ~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
.+..++..++++|.+||..||.+|||+.+++++
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 235 QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 244678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=362.73 Aligned_cols=264 Identities=20% Similarity=0.291 Sum_probs=195.8
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCC-cEEEEEEec--------------cc--cCcccHHHHHHHHHHHHhCCCCCce
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLN-EIVAIKVLD--------------LE--KCNNDLDGIRREVQTMRVTNHPNVL 75 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg-~~VAIKvi~--------------~~--~~~~~~~~i~~Ei~iL~~L~HpNIV 75 (671)
.++|++++.||+|+||+||+|..+... ..+++|.+. +. ........+.+|+.+|+.++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 368999999999999999998765432 222222111 00 0112245678999999999999999
Q ss_pred eeeeEEEeCCEEEEEEeccCCCCHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCc
Q 005886 76 RAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAY---PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGA 152 (671)
Q Consensus 76 kl~~~~~~~~~l~LVmEy~~ggsL~~~l~~~~---~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~ 152 (671)
++++++......|+||+++. ++|..++.... ........++.++.||+.||+|||++|||||||||+|||++.+|.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 99999999999999999995 46776664331 122345678889999999999999999999999999999999999
Q ss_pred eEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCC-CCCC--ChHHHHHH
Q 005886 153 IKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAP-FSKY--PPMKVLLM 229 (671)
Q Consensus 153 vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~P-F~~~--~~~~~~~~ 229 (671)
+||+|||++..+... ........+||+.|+|||++.+ ..|+.++|||||||++|||++|..+ |... .....+..
T Consensus 306 vkL~DFGla~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 306 IVLGDFGTAMPFEKE--REAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred EEEEeCCCceecCcc--cccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 999999998765321 1122334689999999999987 5799999999999999999998754 4322 22222222
Q ss_pred HHhcCC---CCCC------------------------ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 230 TLQNAP---PGLD------------------------YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 230 ~~~~~~---~~~~------------------------~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
++.... ..+. ......++..+.++|.+||..||.+|||+.|+|.||||...
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 222110 0000 00112356678889999999999999999999999999754
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=333.17 Aligned_cols=257 Identities=23% Similarity=0.361 Sum_probs=205.9
Q ss_pred CCCCeEEEEEecccCceEEEEEEE----cCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeC--C
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALC----IPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG--H 85 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~----~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~--~ 85 (671)
+.+-|++++.||+|+||.||+|++ ..++..||+|.+...........+.+|+.+++.+.||||+++++++... .
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 2 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred chhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 345689999999999999999974 4578899999987554444567889999999999999999999999875 6
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
.+|+||||++|++|..++.... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||+++.+.
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 7899999999999999986542 358999999999999999999999999999999999999999999999999987653
Q ss_pred cCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCC--------------hHHHHHHHH
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYP--------------PMKVLLMTL 231 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~--------------~~~~~~~~~ 231 (671)
.............|+..|+|||++.+ ..++.++|||||||++|+|+++..|+.... ........+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 32222222334567788999999876 568999999999999999999876643210 001111111
Q ss_pred hcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 232 QNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 232 ~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.. +...+.+..++..+.+||.+||..+|.+||++.++++
T Consensus 240 ~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 240 EE---GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred Hc---CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 11 1122234567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=326.95 Aligned_cols=254 Identities=27% Similarity=0.479 Sum_probs=207.7
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
++|++.+.||.|+||.||+|.+..+|..||||.+..... ......+.+|+.+++.++||||++++++|..++.++++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 578999999999999999999999999999998865332 223467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCC
Q 005886 92 PYMAGGSCLHIMKSA--YPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~--~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~ 169 (671)
||+.|++|.+++... ....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..+....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC-
Confidence 999999999988642 12458999999999999999999999999999999999999999999999999876542211
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCCCCCccccccchH
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM-KVLLMTLQNAPPGLDYERDKRFSK 248 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~-~~~~~~~~~~~~~~~~~~~~~ls~ 248 (671)
.......|++.|+|||++.+ ..++.++|+||||+++|+|++|..||.+.... ......+... ......+..++.
T Consensus 161 --~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 235 (267)
T cd08229 161 --TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDHYSE 235 (267)
T ss_pred --cccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC--CCCCCCcccccH
Confidence 12234578999999999976 56889999999999999999999999754321 1111111111 111112345788
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 249 SFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 249 ~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.+++||.+||..||.+|||+.+|++
T Consensus 236 ~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 236 ELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHHH
Confidence 9999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=332.06 Aligned_cols=263 Identities=29% Similarity=0.466 Sum_probs=212.8
Q ss_pred CeEEEEEecccCceEEEEEEEc---CCCcEEEEEEeccccC---cccHHHHHHHHHHHHhC-CCCCceeeeeEEEeCCEE
Q 005886 15 DYRLYEEVGEGVSATVYRALCI---PLNEIVAIKVLDLEKC---NNDLDGIRREVQTMRVT-NHPNVLRAHCSFTTGHCL 87 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~---~tg~~VAIKvi~~~~~---~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~~~l 87 (671)
+|++.+.||.|+||.||++.+. .++..||||++..... ......+.+|+.++..+ +||||+++++.+..+..+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 5899999999999999999864 4678899999864322 22345678899999999 699999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccC
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~ 167 (671)
|+||||+.||+|...+... ..+++..++.++.|++.||.|||..|++||||+|.||+++.++.++|+|||++..+...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 9999999999999988765 56899999999999999999999999999999999999999999999999998655332
Q ss_pred CCcccccccccCCCCCCChhHhhhcc-CCCccchhhhHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhcCCCCCCccc
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLH-GYDFKADIWSFGITALELAHGHAPFSKYPP----MKVLLMTLQNAPPGLDYER 242 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~-~~s~ksDIWSLGvILyeLltG~~PF~~~~~----~~~~~~~~~~~~~~~~~~~ 242 (671)
.. .......|++.|+|||.+.+.. .++.++||||||+++|+|++|..||..... .+........ ....
T Consensus 159 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~ 231 (288)
T cd05583 159 EE--ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS-----KPPF 231 (288)
T ss_pred cc--cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc-----CCCC
Confidence 11 1223457899999999987532 367899999999999999999999964322 1111122211 1223
Q ss_pred cccchHHHHHHHHHhhhcCCCCCCC---HHHHHhchhccccccchHH
Q 005886 243 DKRFSKSFKELVTACLVKDPKKRPT---AEKLMKHHFFKHARSNDFL 286 (671)
Q Consensus 243 ~~~ls~~l~dLI~~cL~~dP~kRpS---a~eiL~Hpwfk~~~~~~~~ 286 (671)
+..++..+.++|.+||+.||.+||| +.++|+||||+...+....
T Consensus 232 ~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~~ 278 (288)
T cd05583 232 PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLA 278 (288)
T ss_pred CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHHh
Confidence 4557889999999999999999998 5678999999987765443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=327.66 Aligned_cols=258 Identities=21% Similarity=0.348 Sum_probs=212.4
Q ss_pred ccCCCCeEEEEEecccCceEEEEEEEcC----CCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe-C
Q 005886 10 PVDAKDYRLYEEVGEGVSATVYRALCIP----LNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT-G 84 (671)
Q Consensus 10 ~i~~~~Y~l~~~LG~G~fG~Vyka~~~~----tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~-~ 84 (671)
.++.++|++.+.||+|+||.||+|.+.. ++..||+|.+...........+.+|+.+++.++||||+++++++.. .
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 4678899999999999999999999876 3578999988644334456778899999999999999999998765 5
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecc
Q 005886 85 HCLWVVMPYMAGGSCLHIMKSAYP------EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADF 158 (671)
Q Consensus 85 ~~l~LVmEy~~ggsL~~~l~~~~~------~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DF 158 (671)
...+++++|+.+|+|..++..... ..+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence 778999999999999999876432 35889999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCC
Q 005886 159 GVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPG 237 (671)
Q Consensus 159 Gls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~ 237 (671)
|+++.+...... .......++..|+|||++.+ ..++.++|||||||++|++++ |..||......+........
T Consensus 162 g~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---- 235 (280)
T cd05043 162 ALSRDLFPMDYH-CLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG---- 235 (280)
T ss_pred CCcccccCCceE-EeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC----
Confidence 998765332211 11123356778999999976 568999999999999999998 99999887665544333322
Q ss_pred CCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 238 LDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 238 ~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.....+..++.++.+++.+||..||.+|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 236 YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 222234567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=330.90 Aligned_cols=260 Identities=22% Similarity=0.357 Sum_probs=207.1
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcC----------------CCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCce
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIP----------------LNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVL 75 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~----------------tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIV 75 (671)
..++|++.+.||+|+||.||++.+.. ++..||+|++...........+.+|+.+++.++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 34679999999999999999986432 34568999987544334456788999999999999999
Q ss_pred eeeeEEEeCCEEEEEEeccCCCCHHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEE
Q 005886 76 RAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYP---------EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNIL 146 (671)
Q Consensus 76 kl~~~~~~~~~l~LVmEy~~ggsL~~~l~~~~~---------~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNIL 146 (671)
++++++.....+|+||||+.+|+|..++..... ..+++..++.++.||+.||+|||++|++||||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 999999999999999999999999998876421 23677889999999999999999999999999999999
Q ss_pred EcCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh--CCCCCCCCChH
Q 005886 147 IDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH--GHAPFSKYPPM 224 (671)
Q Consensus 147 ld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt--G~~PF~~~~~~ 224 (671)
++.++.++|+|||+++.+..... ........+++.|+|||+..+ ..++.++|||||||++|+|++ |..||......
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EcCCCCEEeccCcccccccCCcc-eeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999875532221 112223345678999998876 568999999999999999998 78899876655
Q ss_pred HHHHHHH---hcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 225 KVLLMTL---QNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 225 ~~~~~~~---~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
+...... .........+.+..++..+.+||.+||..||.+||++.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 5432221 111111112334557889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=325.79 Aligned_cols=256 Identities=24% Similarity=0.368 Sum_probs=210.0
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCC---CcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPL---NEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH 85 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~t---g~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~ 85 (671)
|.+..++|.+.+.||+|+||.||+|.+... ...||||.+.........+.+.+|+.+++.++||||+++++++.+.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~- 79 (270)
T cd05056 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN- 79 (270)
T ss_pred CeechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-
Confidence 456778899999999999999999987654 3468999886544344566889999999999999999999998764
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
..|+||||+.+|+|.+++.... ..+++..++.++.||+.||+|||+.|++||||||+||+++.++.+||+|||++....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 5789999999999999997642 358999999999999999999999999999999999999999999999999986553
Q ss_pred cCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccc
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (671)
.... .......+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+..... ...+.
T Consensus 159 ~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~----~~~~~ 231 (270)
T cd05056 159 DESY--YKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGER----LPMPP 231 (270)
T ss_pred cccc--eecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCc----CCCCC
Confidence 2211 11112334568999999876 568999999999999999986 9999988776655544433221 23356
Q ss_pred cchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 245 RFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 245 ~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.++..+.+||.+||..+|.+|||+.+++.
T Consensus 232 ~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 232 NCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 78899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=320.26 Aligned_cols=251 Identities=27% Similarity=0.470 Sum_probs=210.4
Q ss_pred eEEEEEecccCceEEEEEEEcCCC----cEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 16 YRLYEEVGEGVSATVYRALCIPLN----EIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 16 Y~l~~~LG~G~fG~Vyka~~~~tg----~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
+++.+.||.|+||.||+|.+...+ ..||+|++...........+..|+.+++.++|+||+++++++.+....|++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 357789999999999999998766 8899999865544435678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
||+.|++|.+++.......+++..++.++.||+.||+|||+.|++||||||+||+++.++.++|+|||++..........
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence 99999999999876533338999999999999999999999999999999999999999999999999986553321111
Q ss_pred cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHH
Q 005886 172 RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSF 250 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l 250 (671)
.....+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||...........+...... .....++..+
T Consensus 161 --~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 233 (258)
T smart00219 161 --KKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRL----PKPENCPPEI 233 (258)
T ss_pred --cccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC----CCCCcCCHHH
Confidence 112237789999999865 568999999999999999998 89999876665555444433222 2244578999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHh
Q 005886 251 KELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 251 ~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.+++.+||..||.+|||+.++++
T Consensus 234 ~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 234 YKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHCcCChhhCcCHHHHHh
Confidence 99999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=321.88 Aligned_cols=254 Identities=23% Similarity=0.423 Sum_probs=210.2
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~ 88 (671)
|.+..++|++.+.||+|+||.||+|.+. .+..+|+|.+.... .....+.+|+.+++.++|+||+++++++.. ..+|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 5788899999999999999999999855 45669999876432 235678899999999999999999999988 7789
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
++|||+.+++|.+++.......+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++..+....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999999999977544567888999999999999999999999999999999999999999999999986553211
Q ss_pred CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccch
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls 247 (671)
........++..|+|||++.+ ..++.++|+|||||++|+|++ |..||.+.........+... ...+....++
T Consensus 157 --~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~ 229 (260)
T cd05073 157 --YTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG----YRMPRPENCP 229 (260)
T ss_pred --cccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC----CCCCCcccCC
Confidence 112223346678999999976 568999999999999999998 99999887665444333322 2223345678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 248 KSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.++.+++.+||..+|.+||++.+++.
T Consensus 230 ~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 230 EELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHH
Confidence 89999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=321.37 Aligned_cols=245 Identities=32% Similarity=0.517 Sum_probs=211.0
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccCCCCH
Q 005886 22 VGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSC 99 (671)
Q Consensus 22 LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~ggsL 99 (671)
||.|+||.||++.+..+++.||+|++...... .....+..|+.+++.++||||+++++.+..+..+|+||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999989999999998765432 2456888999999999999999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccccccccC
Q 005886 100 LHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVG 179 (671)
Q Consensus 100 ~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~G 179 (671)
.+++... ..+++..+..++.|++.||.|||..|++|+||+|+||+++.++.++|+|||++....... .......|
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~ 155 (250)
T cd05123 81 FSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG---SRTNTFCG 155 (250)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC---CcccCCcC
Confidence 9999866 468999999999999999999999999999999999999999999999999986543221 12344578
Q ss_pred CCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhh
Q 005886 180 TPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLV 259 (671)
Q Consensus 180 T~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~ 259 (671)
+..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+... ....+..++..+.+||.+||.
T Consensus 156 ~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~~i~~~l~ 229 (250)
T cd05123 156 TPEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD-----PLRFPEFLSPEARDLISGLLQ 229 (250)
T ss_pred CccccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC-----CCCCCCCCCHHHHHHHHHHhc
Confidence 999999999876 45788999999999999999999999877654444444331 223455668999999999999
Q ss_pred cCCCCCCCH---HHHHhchhc
Q 005886 260 KDPKKRPTA---EKLMKHHFF 277 (671)
Q Consensus 260 ~dP~kRpSa---~eiL~Hpwf 277 (671)
.||.+||++ +++++||||
T Consensus 230 ~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 230 KDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred CCHhhCCCcccHHHHHhCCCC
Confidence 999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=332.88 Aligned_cols=258 Identities=39% Similarity=0.651 Sum_probs=215.3
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
+.|...+.||+|+||.||+|++..+|..||+|++..... ......+.+|+.+++.++|||++++++++..+...|+||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 458889999999999999999999999999999875432 233457889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
||+.| ++.+++... ...+++..+..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++....
T Consensus 105 e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~------ 176 (317)
T cd06635 105 EYCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS------ 176 (317)
T ss_pred eCCCC-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC------
Confidence 99975 777766543 2568999999999999999999999999999999999999999999999999875431
Q ss_pred cccccccCCCCCCChhHhhh--ccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHH
Q 005886 172 RSRNTFVGTPCWMAPEVMQQ--LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~--~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
......|++.|+|||++.. ...++.++|||||||++|+|++|..||...........+.....+.. ....++..
T Consensus 177 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 252 (317)
T cd06635 177 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL---QSNEWSDY 252 (317)
T ss_pred -CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC---CCccccHH
Confidence 1234578999999999852 24578899999999999999999999988766555555544332221 23456788
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHhchhccccccc
Q 005886 250 FKELVTACLVKDPKKRPTAEKLMKHHFFKHARSN 283 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~ 283 (671)
+++||.+||..+|.+||++.++++|+|+......
T Consensus 253 l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 286 (317)
T cd06635 253 FRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPE 286 (317)
T ss_pred HHHHHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence 9999999999999999999999999999765543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=333.38 Aligned_cols=257 Identities=39% Similarity=0.635 Sum_probs=213.5
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
+.|...+.||.|+||.||+|+++.++..||+|.+..... ......+.+|+.+++.++|+|++++++++......|+||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 457788999999999999999999999999999865322 233456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
||+. |++.+++... ...+++..++.++.|++.||.|||++|++||||+|.||+++.++.+||+|||++....
T Consensus 95 e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~------ 166 (308)
T cd06634 95 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------ 166 (308)
T ss_pred EccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeec------
Confidence 9996 5777766543 2468999999999999999999999999999999999999999999999999875432
Q ss_pred cccccccCCCCCCChhHhhh--ccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHH
Q 005886 172 RSRNTFVGTPCWMAPEVMQQ--LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~--~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
......|++.|+|||++.+ ...++.++|||||||++|+|++|..||.................+. .....++..
T Consensus 167 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 242 (308)
T cd06634 167 -PANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA---LQSGHWSEY 242 (308)
T ss_pred -CcccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCC---cCcccccHH
Confidence 1234578999999999853 2347889999999999999999999998766555444444333222 123457889
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 250 FKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
+.+||.+||..+|.+||++.++++||||.....
T Consensus 243 ~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~ 275 (308)
T cd06634 243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275 (308)
T ss_pred HHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence 999999999999999999999999999987554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=325.95 Aligned_cols=258 Identities=22% Similarity=0.346 Sum_probs=212.3
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCC-----CcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPL-----NEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH 85 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~t-----g~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~ 85 (671)
+..++|++...||.|+||.||+|+.+.+ .+.||+|.+...........+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 3457899999999999999999997643 46799998865443334678999999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYP-------EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADF 158 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~-------~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DF 158 (671)
..|+||||+.+|+|.+++..... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999999976531 15899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCC
Q 005886 159 GVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPG 237 (671)
Q Consensus 159 Gls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~ 237 (671)
|++...... .........+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||.+..............
T Consensus 162 ~~~~~~~~~--~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~--- 235 (275)
T cd05046 162 SLSKDVYNS--EYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK--- 235 (275)
T ss_pred ccccccCcc--cccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC---
Confidence 987643221 1122334467788999999876 458899999999999999998 889998766655444333221
Q ss_pred CCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 238 LDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 238 ~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
..+.....++..+.++|.+||..+|.+||++.+++.+
T Consensus 236 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 236 LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 1223345678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=324.87 Aligned_cols=252 Identities=23% Similarity=0.346 Sum_probs=198.0
Q ss_pred EEecccCceEEEEEEEc--CCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccCCC
Q 005886 20 EEVGEGVSATVYRALCI--PLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGG 97 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~--~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~gg 97 (671)
+.||+|+||.||+|... .++..+|+|.+...........+.+|+.+++.++||||+++++++.+...+|+||||+.+|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 36899999999999864 3556799999865543334457888999999999999999999999999999999999999
Q ss_pred CHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccc
Q 005886 98 SCLHIMKSAYP---EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSR 174 (671)
Q Consensus 98 sL~~~l~~~~~---~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 174 (671)
+|.+++..... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++...... ......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~-~~~~~~ 159 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE-DYYVTP 159 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCc-ceeecC
Confidence 99999875321 24567788899999999999999999999999999999999999999999998543221 111222
Q ss_pred ccccCCCCCCChhHhhhcc------CCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCc-cccccc
Q 005886 175 NTFVGTPCWMAPEVMQQLH------GYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDY-ERDKRF 246 (671)
Q Consensus 175 ~~~~GT~~Y~APEvl~~~~------~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~-~~~~~l 246 (671)
....|++.|+|||++.+.. .++.++|||||||++|+|++ |..||......+............+.. .....+
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd05087 160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPL 239 (269)
T ss_pred CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCC
Confidence 3456788999999986421 35789999999999999996 999998776655443333322211111 112346
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 247 SKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 247 s~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
+..+.+++.+|| .+|.+|||+++|+.
T Consensus 240 ~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 240 SDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 788999999999 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=385.49 Aligned_cols=263 Identities=30% Similarity=0.506 Sum_probs=223.8
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
+|.-.-.||.|.||.||-|.+..+|...|+|.+..... ......+.+|..++..++|||+|++|++-.+.+.++|.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 46667889999999999999999999999999875443 34467788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC-Cccc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG-DRQR 172 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~-~~~~ 172 (671)
|.||+|.+++... +..+|.....|..|++.|++|||++|||||||||.|||++.+|.+|++|||.|....... +...
T Consensus 1316 C~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred hccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence 9999999999875 567888899999999999999999999999999999999999999999999987664432 2223
Q ss_pred ccccccCCCCCCChhHhhhc--cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHH
Q 005886 173 SRNTFVGTPCWMAPEVMQQL--HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSF 250 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~--~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l 250 (671)
.....+|||.|||||++.+. ++...++|||||||++.||+||+.||...+..-.++..+. .+-....+.++|.+.
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~---~gh~Pq~P~~ls~~g 1470 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVA---AGHKPQIPERLSSEG 1470 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHh---ccCCCCCchhhhHhH
Confidence 34567999999999999874 3567789999999999999999999988776544333332 222334466799999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 251 KELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 251 ~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
++||..||..||..|.++.|||.|.|-+....
T Consensus 1471 ~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d 1502 (1509)
T KOG4645|consen 1471 RDFLEHCLEQDPKMRWTASQLLEHAFGKSCTD 1502 (1509)
T ss_pred HHHHHHHHhcCchhhhHHHHHHHhhccccccc
Confidence 99999999999999999999999999875443
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=336.32 Aligned_cols=260 Identities=26% Similarity=0.359 Sum_probs=210.5
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEe-CCEEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTT-GHCLWV 89 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~-~~~l~L 89 (671)
..++|++.+.||.|+||.||+|.+..+|..||||.+..... ......+.+|+.+++.++||||++++++|.. ...+|+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 34679999999999999999999999999999998865332 2335678899999999999999999999876 567899
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCC
Q 005886 90 VMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~ 169 (671)
||||+ +++|..++.. ..+++..+..++.||+.||.|||+.|++||||+|.||+++.++.+||+|||++....
T Consensus 88 v~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~---- 159 (328)
T cd07856 88 VTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD---- 159 (328)
T ss_pred Eeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccC----
Confidence 99999 5688887764 357888899999999999999999999999999999999999999999999986431
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh-----------------
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQ----------------- 232 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~----------------- 232 (671)
.......+++.|+|||++.+...++.++|||||||++|+|++|..||...........+..
T Consensus 160 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd07856 160 --PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237 (328)
T ss_pred --CCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh
Confidence 1123457889999999986645689999999999999999999999987654322211110
Q ss_pred ------cCCCCCCc---cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 233 ------NAPPGLDY---ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 233 ------~~~~~~~~---~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
..+..... .....++..+.++|.+||+.+|.+||++++++.||||....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence 00000000 11235678999999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=324.41 Aligned_cols=255 Identities=24% Similarity=0.379 Sum_probs=210.3
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCc----EEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNE----IVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~----~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 86 (671)
+...+|++.+.||+|+||.||+|.++.+|. .||+|.+...........+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 355789999999999999999999887765 5899988765544456778899999999999999999999987 78
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
.++||||+.+|+|.+++.... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||+++....
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred eEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 899999999999999987642 4589999999999999999999999999999999999999999999999999876532
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (671)
... ........++..|+|||.+.. ..++.++|+|||||++|+|++ |..||.+....+......... ....+..
T Consensus 162 ~~~-~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~ 235 (279)
T cd05057 162 DEK-EYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE----RLPQPPI 235 (279)
T ss_pred ccc-ceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC----CCCCCCC
Confidence 111 111112234668999999875 568899999999999999998 999998877655444333322 2233445
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 246 FSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 246 ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
++..+.+++.+||..+|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 236 CTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 7789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=317.88 Aligned_cols=252 Identities=23% Similarity=0.391 Sum_probs=208.1
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LV 90 (671)
++..+|++.+.||.|+||.||+|.+. .+..+|+|.+.... .....+.+|+++++.++||||+++++++.....+|+|
T Consensus 1 ~~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 1 IHPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA--MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred CChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC--CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 35678999999999999999999875 46789999886433 2245788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCc
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR 170 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~ 170 (671)
|||+.+++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++......
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 154 (256)
T cd05112 78 FEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-- 154 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc--
Confidence 99999999999887542 458899999999999999999999999999999999999999999999999986542211
Q ss_pred ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHH
Q 005886 171 QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 171 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
........++..|+|||++.+ ..++.++|||||||++|+|++ |..||................ ....+...+..
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~ 229 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF----RLYKPRLASQS 229 (256)
T ss_pred ccccCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC----CCCCCCCCCHH
Confidence 111122345678999999986 568999999999999999998 999998766655444433221 11223446889
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 250 FKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
+.+|+.+||..+|.+||++.++++
T Consensus 230 ~~~l~~~~l~~~p~~Rp~~~~~l~ 253 (256)
T cd05112 230 VYELMQHCWKERPEDRPSFSLLLH 253 (256)
T ss_pred HHHHHHHHcccChhhCCCHHHHHH
Confidence 999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=317.70 Aligned_cols=245 Identities=22% Similarity=0.349 Sum_probs=201.7
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccCCCCH
Q 005886 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSC 99 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~ggsL 99 (671)
+.||+|+||.||+|... ++..||+|++...........+.+|+.+++.++||||+++++++......++||||+.+++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 46899999999999854 68889999987554334445788999999999999999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccccccccC
Q 005886 100 LHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVG 179 (671)
Q Consensus 100 ~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~G 179 (671)
..++.... ..+++..++.++.+++.||.|||++|++||||||+||+++.++.+||+|||++...... .........+
T Consensus 80 ~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~ 156 (250)
T cd05085 80 LSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG--IYSSSGLKQI 156 (250)
T ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccc--ccccCCCCCC
Confidence 99887542 46889999999999999999999999999999999999999999999999998643211 1111122244
Q ss_pred CCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhh
Q 005886 180 TPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACL 258 (671)
Q Consensus 180 T~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL 258 (671)
++.|+|||++.+ ..++.++||||||+++|+|++ |..||.+.........+.... ....+..++..+.+|+.+||
T Consensus 157 ~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l 231 (250)
T cd05085 157 PIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY----RMSCPQKCPDDVYKVMQRCW 231 (250)
T ss_pred cccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC----CCCCCCCCCHHHHHHHHHHc
Confidence 677999999876 568899999999999999998 999998776555444333322 22234567899999999999
Q ss_pred hcCCCCCCCHHHHHh
Q 005886 259 VKDPKKRPTAEKLMK 273 (671)
Q Consensus 259 ~~dP~kRpSa~eiL~ 273 (671)
..+|.+||++.++++
T Consensus 232 ~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 232 DYKPENRPKFSELQK 246 (250)
T ss_pred ccCcccCCCHHHHHH
Confidence 999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=326.32 Aligned_cols=256 Identities=22% Similarity=0.378 Sum_probs=201.0
Q ss_pred CCCCeEEEEEecccCceEEEEEEE----cCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe--CC
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALC----IPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT--GH 85 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~----~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~--~~ 85 (671)
..++|++.+.||+|+||.||+|.. ..++..||+|.+.... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 346899999999999999999974 4578899999986432 2335678899999999999999999998753 45
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
.+|+||||+.+|+|..++... ...+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++..+.
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 789999999999999998754 2458999999999999999999999999999999999999999999999999987653
Q ss_pred cCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHH---------------HHHHH
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK---------------VLLMT 230 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~---------------~~~~~ 230 (671)
.............++..|+|||++.+ ..++.++|||||||++|||++|..|+....... .+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 22211111112234556999999976 568999999999999999999877764322110 00011
Q ss_pred HhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 231 LQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 231 ~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
+.. ....+.+..++..+.+||.+||..+|.+|||+.++++
T Consensus 239 ~~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 239 LKN---NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred Hhc---CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 111 1122234567889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=323.73 Aligned_cols=245 Identities=22% Similarity=0.348 Sum_probs=199.5
Q ss_pred EEecccCceEEEEEEEcCCCc--EEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEEEeccCC
Q 005886 20 EEVGEGVSATVYRALCIPLNE--IVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHCSFTTGHCLWVVMPYMAG 96 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~tg~--~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~~~l~LVmEy~~g 96 (671)
+.||+|+||.||+|.+..+|. .+|+|.+...........+.+|+.++..+ +||||+++++++.....+|+||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999988876 46888876433334456788999999999 899999999999999999999999999
Q ss_pred CCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccc
Q 005886 97 GSCLHIMKSAY--------------PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSA 162 (671)
Q Consensus 97 gsL~~~l~~~~--------------~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~ 162 (671)
|+|.+++.... ...+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++.
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 99999987542 1247899999999999999999999999999999999999999999999999975
Q ss_pred ccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCcc
Q 005886 163 CMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYE 241 (671)
Q Consensus 163 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~ 241 (671)
... ..........+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+... ....
T Consensus 161 ~~~----~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~----~~~~ 231 (270)
T cd05047 161 GQE----VYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG----YRLE 231 (270)
T ss_pred ccc----hhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC----CCCC
Confidence 221 1111111234567999999876 568999999999999999997 99999876655544433322 2223
Q ss_pred ccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 242 RDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 242 ~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.+..++.++.+|+.+||..+|.+|||+.+++.
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 232 KPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 34557889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=370.11 Aligned_cols=261 Identities=28% Similarity=0.426 Sum_probs=206.5
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEE---------
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFT--------- 82 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~--------- 82 (671)
...+|+.++.||+||||.||+++++-+|+.||||.|...........+.+|+.+|.+|+|||||++|..|.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 34788899999999999999999999999999999988765556788999999999999999999886550
Q ss_pred ---------------------------------------------------------------------e----------
Q 005886 83 ---------------------------------------------------------------------T---------- 83 (671)
Q Consensus 83 ---------------------------------------------------------------------~---------- 83 (671)
+
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 0
Q ss_pred -----------------------C--------CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 005886 84 -----------------------G--------HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF 132 (671)
Q Consensus 84 -----------------------~--------~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs 132 (671)
+ ..+||-||||+..++.+++..+.... .....|+++++|+.||+|+|+
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHh
Confidence 0 24789999999988888887762211 467799999999999999999
Q ss_pred CCcccccCCCCcEEEcCCCceEEeccccccccc------cC---------CCcccccccccCCCCCCChhHhhhcc--CC
Q 005886 133 HGHIHRDVKAGNILIDSNGAIKLADFGVSACMF------DA---------GDRQRSRNTFVGTPCWMAPEVMQQLH--GY 195 (671)
Q Consensus 133 ~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~------~~---------~~~~~~~~~~~GT~~Y~APEvl~~~~--~~ 195 (671)
.|||||||||.|||++.++.|||+|||+|.... +. +......+..+||..|+|||++.+.. .|
T Consensus 716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 999999999999999999999999999997621 00 11112335679999999999998755 59
Q ss_pred CccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcc---ccccchHHHHHHHHHhhhcCCCCCCCHHHHH
Q 005886 196 DFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYE---RDKRFSKSFKELVTACLVKDPKKRPTAEKLM 272 (671)
Q Consensus 196 s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~---~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL 272 (671)
+.|+||||||||++||+. ||...-........++. +.++.+ ..+.+ +.-..+|.+||+.||.+||||.++|
T Consensus 796 n~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~--g~iP~~~~f~~~~~-~~e~slI~~Ll~hdP~kRPtA~eLL 869 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRK--GSIPEPADFFDPEH-PEEASLIRWLLSHDPSKRPTATELL 869 (1351)
T ss_pred cchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhccc--CCCCCCcccccccc-hHHHHHHHHHhcCCCccCCCHHHHh
Confidence 999999999999999994 57543222222233332 222222 22223 3456899999999999999999999
Q ss_pred hchhccc
Q 005886 273 KHHFFKH 279 (671)
Q Consensus 273 ~Hpwfk~ 279 (671)
++.||-.
T Consensus 870 ~s~llpp 876 (1351)
T KOG1035|consen 870 NSELLPP 876 (1351)
T ss_pred hccCCCc
Confidence 9999974
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=319.34 Aligned_cols=248 Identities=25% Similarity=0.381 Sum_probs=197.5
Q ss_pred EEecccCceEEEEEEEcC---CCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEE-eCCEEEEEEeccC
Q 005886 20 EEVGEGVSATVYRALCIP---LNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFT-TGHCLWVVMPYMA 95 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~---tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~-~~~~l~LVmEy~~ 95 (671)
+.||+|+||.||+|.+.. .+..||||.+...........+.+|+.+++.++||||+++++++. .+...|+||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 368999999999998753 345799999854333344677889999999999999999999765 4567899999999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc-ccc
Q 005886 96 GGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ-RSR 174 (671)
Q Consensus 96 ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~-~~~ 174 (671)
+|+|..++.... ...++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++.+....... ...
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 159 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH 159 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence 999999987642 346777888999999999999999999999999999999999999999999986553321111 111
Q ss_pred ccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHH
Q 005886 175 NTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL 253 (671)
Q Consensus 175 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dL 253 (671)
....+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||................. ...+..++..+.++
T Consensus 160 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l 234 (262)
T cd05058 160 TGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR----LLQPEYCPDPLYEV 234 (262)
T ss_pred ccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC----CCCCCcCCHHHHHH
Confidence 23356778999999876 568999999999999999999 5777877666554444333221 22234568899999
Q ss_pred HHHhhhcCCCCCCCHHHHHh
Q 005886 254 VTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 254 I~~cL~~dP~kRpSa~eiL~ 273 (671)
+.+||..+|.+||++.++++
T Consensus 235 i~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 235 MLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred HHHHcCCChhhCCCHHHHHH
Confidence 99999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=318.54 Aligned_cols=247 Identities=24% Similarity=0.374 Sum_probs=205.8
Q ss_pred ccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q 005886 10 PVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWV 89 (671)
Q Consensus 10 ~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~L 89 (671)
.+..++|++.+.||+|+||.||++. .+++.||+|.+... .....+.+|+.+++.++||||+++++++..+ .+|+
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 2 LLNLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD---VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cccHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCc---chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 4566889999999999999999986 46888999998543 2346788999999999999999999998765 4799
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCC
Q 005886 90 VMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~ 169 (671)
||||+.|++|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999999999998764456899999999999999999999999999999999999999999999999998643211
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchH
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSK 248 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~ 248 (671)
......+..|+|||.+.+ ..++.++|+|||||++|+|++ |++||......+....+.... ....+..++.
T Consensus 154 ----~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 224 (254)
T cd05083 154 ----VDNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY----RMEPPEGCPA 224 (254)
T ss_pred ----CCCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC----CCCCCCcCCH
Confidence 112344678999999876 568899999999999999997 999998876655444333321 2223456789
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 249 SFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 249 ~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.+.+||.+||..+|.+||++.+++.
T Consensus 225 ~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 225 DVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=321.52 Aligned_cols=247 Identities=25% Similarity=0.448 Sum_probs=202.7
Q ss_pred EecccCceEEEEEEEcCCC------cEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecc
Q 005886 21 EVGEGVSATVYRALCIPLN------EIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYM 94 (671)
Q Consensus 21 ~LG~G~fG~Vyka~~~~tg------~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~ 94 (671)
.||+|+||.||+|+++..+ ..||||.+...........+.+|+.+++.++||||+++++++......|+||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 6899999999999986544 6799999865443345677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC-----ceEEecccccccc
Q 005886 95 AGGSCLHIMKSAY-----PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG-----AIKLADFGVSACM 164 (671)
Q Consensus 95 ~ggsL~~~l~~~~-----~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g-----~vKL~DFGls~~~ 164 (671)
.|++|..++.... ...+++..+..++.||+.||.|||+.+++|+||||+||+++.++ .++|+|||++...
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~ 161 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI 161 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccccc
Confidence 9999999887532 23478899999999999999999999999999999999999877 8999999998655
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERD 243 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (671)
..... ........++..|+|||++.+ ..++.++|||||||++|+|++ |..||......+....+.... ....+
T Consensus 162 ~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~----~~~~~ 235 (269)
T cd05044 162 YKSDY-YRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG----RLQKP 235 (269)
T ss_pred ccccc-cccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC----ccCCc
Confidence 32211 112223456788999999986 568999999999999999998 999998776655444332221 22334
Q ss_pred ccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 244 KRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 244 ~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
..++..+.+||.+||..+|.+||++.++++
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 236 ENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 567899999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=315.78 Aligned_cols=246 Identities=22% Similarity=0.354 Sum_probs=203.1
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccCCCCH
Q 005886 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSC 99 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~ggsL 99 (671)
+.||.|+||.||+|.+.. ++.||+|.+...........+.+|+.+++.++||||+++++++......|+||||+.|++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 468999999999999887 9999999987654444567889999999999999999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccccccccC
Q 005886 100 LHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVG 179 (671)
Q Consensus 100 ~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~G 179 (671)
..++... ...+++..+..++.+++.||+|||++|++||||||+|||++.++.+||+|||++...... ..........+
T Consensus 80 ~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~ 157 (251)
T cd05041 80 LTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGG-IYTVSDGLKQI 157 (251)
T ss_pred HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCC-cceeccccCcc
Confidence 9998654 246789999999999999999999999999999999999999999999999998644211 11111112234
Q ss_pred CCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhh
Q 005886 180 TPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACL 258 (671)
Q Consensus 180 T~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL 258 (671)
+..|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+.... ....+..++..+.+||.+||
T Consensus 158 ~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l 232 (251)
T cd05041 158 PIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY----RMPAPQLCPEEIYRLMLQCW 232 (251)
T ss_pred eeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC----CCCCCccCCHHHHHHHHHHh
Confidence 567999999876 568999999999999999998 899998876554443332221 22234567889999999999
Q ss_pred hcCCCCCCCHHHHHh
Q 005886 259 VKDPKKRPTAEKLMK 273 (671)
Q Consensus 259 ~~dP~kRpSa~eiL~ 273 (671)
..+|.+||++.++++
T Consensus 233 ~~~p~~Rp~~~ell~ 247 (251)
T cd05041 233 AYDPENRPSFSEIYN 247 (251)
T ss_pred ccChhhCcCHHHHHH
Confidence 999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=352.22 Aligned_cols=244 Identities=29% Similarity=0.460 Sum_probs=207.7
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHH-hCCCCCceeeeeEEEeCCEEEEEE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMR-VTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~-~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
...|++...+|.|+|+.|..+.+..+++..++|++.+.. ....+|+.++. .-+||||+++++.+.++.+.|+||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 578999999999999999999999999999999997663 22346775554 447999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEE-cCCCceEEeccccccccccCCCc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILI-DSNGAIKLADFGVSACMFDAGDR 170 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILl-d~~g~vKL~DFGls~~~~~~~~~ 170 (671)
|++.|+.|.+.+... ..+. ..+..|+++|+.|+.|||.+|+|||||||+|||+ +..|+++|+|||.+......
T Consensus 396 e~l~g~ell~ri~~~--~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--- 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSK--PEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--- 469 (612)
T ss_pred hhccccHHHHHHHhc--chhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence 999999999888765 3333 6788899999999999999999999999999999 58899999999987654221
Q ss_pred ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHH
Q 005886 171 QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSF 250 (671)
Q Consensus 171 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l 250 (671)
..+.+-|..|.|||++.. .+|++++||||||++||+|++|+.||...+....+...++..+ ....+|..+
T Consensus 470 ---~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~------~s~~vS~~A 539 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPK------FSECVSDEA 539 (612)
T ss_pred ---hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCc------cccccCHHH
Confidence 234466889999999985 7899999999999999999999999988776634433333321 126789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 251 KELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 251 ~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
++||.+||+.||.+||++.+++.||||
T Consensus 540 KdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 540 KDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHHHHhccCChhhCcChhhhccCcch
Confidence 999999999999999999999999999
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=319.51 Aligned_cols=265 Identities=26% Similarity=0.361 Sum_probs=212.8
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeC--
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG-- 84 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~-- 84 (671)
...-|+.++|++.+.||.|||+.||+++...++..||+|.+.... .++.+...+|++..++++||||++++++...+
T Consensus 14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 345678899999999999999999999999999999999987655 45678899999999999999999998877543
Q ss_pred ---CEEEEEEeccCCCCHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCCcEEEcCCCceEEec
Q 005886 85 ---HCLWVVMPYMAGGSCLHIMKSAYP--EGFEEPVIATLLRETLKALVYLHFHG--HIHRDVKAGNILIDSNGAIKLAD 157 (671)
Q Consensus 85 ---~~l~LVmEy~~ggsL~~~l~~~~~--~~l~e~~i~~i~~qIl~aL~yLHs~g--IVHrDLKPeNILld~~g~vKL~D 157 (671)
+..||+++|...|+|.+.+..... ..++|..+.+|+.+|+.||++||... ++||||||.|||+.+.+.++|.|
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEe
Confidence 359999999999999998865433 25899999999999999999999998 99999999999999999999999
Q ss_pred cccccccccC--CCc----ccccccccCCCCCCChhHhhh--ccCCCccchhhhHHHHHHHHHhCCCCCCCCChHH-HHH
Q 005886 158 FGVSACMFDA--GDR----QRSRNTFVGTPCWMAPEVMQQ--LHGYDFKADIWSFGITALELAHGHAPFSKYPPMK-VLL 228 (671)
Q Consensus 158 FGls~~~~~~--~~~----~~~~~~~~GT~~Y~APEvl~~--~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~-~~~ 228 (671)
||.+....-. +.. ......-..|..|+|||++.- ....+.++|||||||+||.|+.|..||....... .+
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl- 251 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL- 251 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE-
Confidence 9987543110 000 001112356889999999863 1236789999999999999999999996421100 00
Q ss_pred HHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 229 MTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 229 ~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
.+.-..+.+.++....+|..+.+||++||+.||.+||++.+++.+
T Consensus 252 -aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 252 -ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred -EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 011112334556667799999999999999999999999999863
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=359.77 Aligned_cols=258 Identities=24% Similarity=0.428 Sum_probs=223.8
Q ss_pred ccccCCCCeEEEEEecccCceEEEEEEEcCC-----CcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEE
Q 005886 8 RFPVDAKDYRLYEEVGEGVSATVYRALCIPL-----NEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFT 82 (671)
Q Consensus 8 ~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~t-----g~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~ 82 (671)
...+...+-++.++||+|+||+||+|+...- ...||||.++..........|+||+.+|..++|||||+++|++.
T Consensus 480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR 559 (774)
T ss_pred eeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence 3556677888899999999999999986633 35699999987766657889999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHhhCC------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCC
Q 005886 83 TGHCLWVVMPYMAGGSCLHIMKSAYP------------EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSN 150 (671)
Q Consensus 83 ~~~~l~LVmEy~~ggsL~~~l~~~~~------------~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~ 150 (671)
.++.+|||+|||..|+|.+++....+ ..++..+...|+.||+.|++||-++.+|||||-..|+||.++
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN 639 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc
Confidence 99999999999999999999975532 237888999999999999999999999999999999999999
Q ss_pred CceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 005886 151 GAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLM 229 (671)
Q Consensus 151 g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~ 229 (671)
..|||+||||++..+...... ......-..+|||||.|.. ..|+.++|||||||+|||+++ |..||.+..+.+++..
T Consensus 640 l~VKIsDfGLsRdiYssDYYk-~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~ 717 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYK-VRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC 717 (774)
T ss_pred eEEEecccccchhhhhhhhhc-ccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence 999999999998775543322 2222244678999999987 579999999999999999999 9999999999888777
Q ss_pred HHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHH
Q 005886 230 TLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKL 271 (671)
Q Consensus 230 ~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~ei 271 (671)
+.... -.+.+..+|.++.+|+..||+..|.+||++.+|
T Consensus 718 i~~g~----lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 718 IRAGQ----LLSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred HHcCC----cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 66543 256788999999999999999999999999998
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=326.28 Aligned_cols=255 Identities=22% Similarity=0.381 Sum_probs=206.0
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCc----EEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNE----IVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~----~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 86 (671)
+..++|+..+.||+|+||.||+|.+..+|. .||+|.+...........+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 356789999999999999999999987776 46888876544333345688999999999999999999998765 4
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
.+++++|+.+|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.+..
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred ceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 67899999999999988764 24588999999999999999999999999999999999999999999999999875532
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (671)
.. .........++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+........ .+.... ....+..
T Consensus 162 ~~-~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~---~~~~~~~ 235 (303)
T cd05110 162 DE-KEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD-LLEKGE---RLPQPPI 235 (303)
T ss_pred cc-cccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHCCC---CCCCCCC
Confidence 21 1111223456778999999876 568999999999999999997 999998765544332 222211 1222345
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 246 FSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 246 ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
++..+.+++..||..+|++||++.++++
T Consensus 236 ~~~~~~~li~~c~~~~p~~Rp~~~~l~~ 263 (303)
T cd05110 236 CTIDVYMVMVKCWMIDADSRPKFKELAA 263 (303)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 6789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=323.26 Aligned_cols=276 Identities=21% Similarity=0.309 Sum_probs=221.5
Q ss_pred cccccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcc-cHHHHHHHHHHHHhCCCCCceeeeeEEEe
Q 005886 5 VEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-DLDGIRREVQTMRVTNHPNVLRAHCSFTT 83 (671)
Q Consensus 5 ~e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~-~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~ 83 (671)
....|......|+-+.+||+|.||.||+|+++.+|+.||+|++-.+.... .-....+|+++|..+.|+|++.+++.|..
T Consensus 8 ~~~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~t 87 (376)
T KOG0669|consen 8 MYEPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 87 (376)
T ss_pred ccCCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhh
Confidence 45667888899999999999999999999999999999998875543221 23456789999999999999999877753
Q ss_pred --------CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEE
Q 005886 84 --------GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKL 155 (671)
Q Consensus 84 --------~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL 155 (671)
...+|+||.+|+. +|+-++... ...|+...|.+++++++.||.|+|+..|+|||+||.|+||+.+|.+||
T Consensus 88 k~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilkl 165 (376)
T KOG0669|consen 88 KATPTNRDRATFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKL 165 (376)
T ss_pred ccCCcccccceeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEe
Confidence 3469999999976 677777543 256899999999999999999999999999999999999999999999
Q ss_pred eccccccccccCCCcc-cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh--
Q 005886 156 ADFGVSACMFDAGDRQ-RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQ-- 232 (671)
Q Consensus 156 ~DFGls~~~~~~~~~~-~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~-- 232 (671)
+|||+++.+....... ......+-|.+|++||.+.|...|+++.|||..|||+.||++|.+-|.+.+....+..+-+
T Consensus 166 ADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~Lc 245 (376)
T KOG0669|consen 166 ADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLC 245 (376)
T ss_pred eccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHh
Confidence 9999997764433222 2234457799999999999999999999999999999999999999998877665543321
Q ss_pred -cCCCCC-----Ccccccc----------------------chHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 233 -NAPPGL-----DYERDKR----------------------FSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 233 -~~~~~~-----~~~~~~~----------------------ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
+..+.. .++.+.. -.+++.+|+.+||..||.+|+++.++|+|.||+....
T Consensus 246 Gs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~ 323 (376)
T KOG0669|consen 246 GSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM 323 (376)
T ss_pred ccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence 111100 0010000 1246889999999999999999999999999986543
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=321.34 Aligned_cols=257 Identities=24% Similarity=0.405 Sum_probs=206.6
Q ss_pred CCCCeEEEEEecccCceEEEEEEEc----CCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe--CC
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCI----PLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT--GH 85 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~----~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~--~~ 85 (671)
..++|++.+.||+|+||.||+|... .++..||||++...........+.+|+.+++.+.||||+++++++.. ..
T Consensus 2 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred chhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 3467889999999999999999865 34789999998755433346788999999999999999999999887 66
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
..++||||+.+++|..++.... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 8999999999999999987652 358999999999999999999999999999999999999999999999999987653
Q ss_pred cCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHH--------------HHHHHH
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK--------------VLLMTL 231 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~--------------~~~~~~ 231 (671)
.............++..|+|||.+.+ ..++.++|||||||++|+|++|..||....... .....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 22221112222345667999999876 468899999999999999999999986532211 111112
Q ss_pred hcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 232 QNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 232 ~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.. ......+..++.++.+|+.+||..+|.+||++.+++.
T Consensus 240 ~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 240 KE---GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred Hc---CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 21 1222334567789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=365.09 Aligned_cols=257 Identities=24% Similarity=0.447 Sum_probs=222.4
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCc-----EEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNE-----IVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH 85 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~-----~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~ 85 (671)
+....-++...||+|+||.||.|....... .||||.+.......+...|.+|..+|+.++|||||+++|++.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 456778899999999999999998875433 389999877666677889999999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYP-----EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGV 160 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~-----~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGl 160 (671)
..+|++|||+||+|..+|++..+ ..+.......++.+|++|+.||+++++|||||...|+|++....|||+|||+
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999999987632 4578889999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCC
Q 005886 161 SACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLD 239 (671)
Q Consensus 161 s~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~ 239 (671)
|+.+.+...... .....-...|||||.+.. ..++.++|||||||+|||+++ |..||.+....+++...+... .
T Consensus 849 ArDiy~~~yyr~-~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg----R 922 (1025)
T KOG1095|consen 849 ARDIYDKDYYRK-HGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG----R 922 (1025)
T ss_pred hHhhhhchheec-cCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC----c
Confidence 986644332211 111223457999999987 579999999999999999999 999999999988877666554 4
Q ss_pred ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 240 YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 240 ~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.+.+..++..+.++|..||..+|++||++..|++
T Consensus 923 L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 923 LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred cCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 4567889999999999999999999999999987
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=322.42 Aligned_cols=239 Identities=22% Similarity=0.347 Sum_probs=194.4
Q ss_pred EEecccCceEEEEEEEcCCCcE-------EEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 20 EEVGEGVSATVYRALCIPLNEI-------VAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~tg~~-------VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
+.||.|+||.||+|.+...+.. ||+|.+.... ....+.+.+|+.+++.++||||+++++++..+...++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 4689999999999998765543 8888875332 2335678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCc--------eEEecccccccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGA--------IKLADFGVSACM 164 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~--------vKL~DFGls~~~ 164 (671)
|+.+|+|..++.... ..+++..++.++.||+.||+|||++||+||||||+||+++.++. ++++|||++...
T Consensus 80 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~ 158 (258)
T cd05078 80 YVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158 (258)
T ss_pred cCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence 999999999987652 36899999999999999999999999999999999999987764 699999987543
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHG-HAPFSKYPPMKVLLMTLQNAPPGLDYERD 243 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG-~~PF~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (671)
. ......+++.|+|||++.+...++.++|||||||++|+|++| .+||.......... .... .. ..+
T Consensus 159 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~-~~----~~~ 225 (258)
T cd05078 159 L-------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYED-RH----QLP 225 (258)
T ss_pred C-------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHc-cc----cCC
Confidence 2 123357889999999998655689999999999999999998 57776655543322 1111 11 123
Q ss_pred ccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 244 KRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 244 ~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
...+.++.+||.+||..||.+|||++++++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 255 (258)
T cd05078 226 APKWTELANLINQCMDYEPDFRPSFRAIIR 255 (258)
T ss_pred CCCcHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 345678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=318.02 Aligned_cols=251 Identities=19% Similarity=0.347 Sum_probs=197.6
Q ss_pred EecccCceEEEEEEEcCCC--cEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccCCCC
Q 005886 21 EVGEGVSATVYRALCIPLN--EIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGS 98 (671)
Q Consensus 21 ~LG~G~fG~Vyka~~~~tg--~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~ggs 98 (671)
+||+|+||.||+|.....+ ..+++|.+...........+.+|+.+++.++||||+++++++.....+|+||||+.+|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 6999999999999754332 34667776554433446788999999999999999999999999999999999999999
Q ss_pred HHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccccc
Q 005886 99 CLHIMKSAY--PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNT 176 (671)
Q Consensus 99 L~~~l~~~~--~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~ 176 (671)
|..++.... ...+++..++.++.||+.||+|||+.+++||||||+|||++.++.+||+|||++...... ........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~ 160 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE-DYIETEDD 160 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcc-hhhhcccC
Confidence 999987542 234677788899999999999999999999999999999999999999999987533211 11122234
Q ss_pred ccCCCCCCChhHhhhc------cCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCC-CCccccccchH
Q 005886 177 FVGTPCWMAPEVMQQL------HGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPG-LDYERDKRFSK 248 (671)
Q Consensus 177 ~~GT~~Y~APEvl~~~------~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~-~~~~~~~~ls~ 248 (671)
.+|++.|+|||++... ..++.++|||||||++|+|++ |..||....+.+.....+...... ........++.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (268)
T cd05086 161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSE 240 (268)
T ss_pred CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcH
Confidence 5789999999998531 235778999999999999997 678998777766655554433222 12223345788
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 249 SFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 249 ~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.+.+++..|| .+|.+||++.++++
T Consensus 241 ~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 241 RWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred HHHHHHHHHh-hCcccCCCHHHHHH
Confidence 9999999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=317.44 Aligned_cols=229 Identities=24% Similarity=0.279 Sum_probs=191.4
Q ss_pred cCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccCCCCHHHHHH
Q 005886 25 GVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMK 104 (671)
Q Consensus 25 G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~ggsL~~~l~ 104 (671)
|.||.||++.++.+|+.||+|.+.... ...+|...+....||||+++++++.....+|+||||+.||+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 899999999999999999999986542 23345555556679999999999999999999999999999999887
Q ss_pred hhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccccccccCCCCCC
Q 005886 105 SAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWM 184 (671)
Q Consensus 105 ~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~ 184 (671)
.. ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++++|||++..+.. ......++..|+
T Consensus 78 ~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~------~~~~~~~~~~y~ 149 (237)
T cd05576 78 KF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED------SCDGEAVENMYC 149 (237)
T ss_pred Hh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc------ccccCCcCcccc
Confidence 65 4689999999999999999999999999999999999999999999999998754421 112345678899
Q ss_pred ChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCC
Q 005886 185 APEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKK 264 (671)
Q Consensus 185 APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~k 264 (671)
|||.+.+ ..++.++|+||+||++|+|++|..||....... . .......+..++..+++||.+||+.||.+
T Consensus 150 aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~ 219 (237)
T cd05576 150 APEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSGI------N---THTTLNIPEWVSEEARSLLQQLLQFNPTE 219 (237)
T ss_pred CCcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------c---cccccCCcccCCHHHHHHHHHHccCCHHH
Confidence 9999865 568899999999999999999999886543210 0 01112234567899999999999999999
Q ss_pred CCCH-----HHHHhchhc
Q 005886 265 RPTA-----EKLMKHHFF 277 (671)
Q Consensus 265 RpSa-----~eiL~Hpwf 277 (671)
||++ +++++||||
T Consensus 220 R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 220 RLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred hcCCCccchHHHHcCCCC
Confidence 9985 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=318.34 Aligned_cols=240 Identities=24% Similarity=0.343 Sum_probs=191.9
Q ss_pred EEecccCceEEEEEEEcCC------------CcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q 005886 20 EEVGEGVSATVYRALCIPL------------NEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCL 87 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~t------------g~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l 87 (671)
+.||+|+||.||+|+.... ...||+|++.... ......+.+|+.+++.++||||+++++++..+...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 4689999999999985322 2358889875432 23345778899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCc-------eEEecccc
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGA-------IKLADFGV 160 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~-------vKL~DFGl 160 (671)
++||||+.+|+|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++. ++++|||+
T Consensus 80 ~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred EEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 9999999999998887654 245899999999999999999999999999999999999987664 89999998
Q ss_pred ccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHH-hCCCCCCCCChHHHHHHHHhcCCCCCC
Q 005886 161 SACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQNAPPGLD 239 (671)
Q Consensus 161 s~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLl-tG~~PF~~~~~~~~~~~~~~~~~~~~~ 239 (671)
+.... ......|+..|+|||++.....++.++|||||||++|+|+ .|..||......+... .....
T Consensus 159 ~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~----- 225 (262)
T cd05077 159 PITVL-------SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQ----- 225 (262)
T ss_pred Ccccc-------CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcC-----
Confidence 75442 1223468889999999875467899999999999999998 5899987655433221 11111
Q ss_pred ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 240 YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 240 ~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
.......+.++.+||.+||..||.+||++.+|+++
T Consensus 226 ~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 226 CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 11122346789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=322.53 Aligned_cols=267 Identities=28% Similarity=0.480 Sum_probs=229.6
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhC-CCCCceeeeeEEEe
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVT-NHPNVLRAHCSFTT 83 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~ 83 (671)
-.+.+...+|.++..||+|+|++|.++++++|.+.||+|+++++-.. ++.+-++.|-.+...- +||.+|-++..|.+
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 45778889999999999999999999999999999999999876543 4577788888877654 79999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccc
Q 005886 84 GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSAC 163 (671)
Q Consensus 84 ~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~ 163 (671)
+..+++|.||..||+|-..++.. ..++|+.++.|..+|+.||.|||++|||+||||.+|+|+|..|++||+|+|+++.
T Consensus 323 esrlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred cceEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc
Confidence 99999999999999998877766 6799999999999999999999999999999999999999999999999999865
Q ss_pred cccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCC-------CChHHHHHHHHhcCCC
Q 005886 164 MFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSK-------YPPMKVLLMTLQNAPP 236 (671)
Q Consensus 164 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~-------~~~~~~~~~~~~~~~~ 236 (671)
-...+ ....++||||.|+|||++.+ ..|++.+|.|+|||+++||+.|+.||+- .+..+.+++++-...
T Consensus 401 ~l~~g---d~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq- 475 (593)
T KOG0695|consen 401 GLGPG---DTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ- 475 (593)
T ss_pred CCCCC---cccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc-
Confidence 43333 34578999999999999998 6799999999999999999999999952 233445555554332
Q ss_pred CCCccccccchHHHHHHHHHhhhcCCCCCCC------HHHHHhchhccccccc
Q 005886 237 GLDYERDKRFSKSFKELVTACLVKDPKKRPT------AEKLMKHHFFKHARSN 283 (671)
Q Consensus 237 ~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpS------a~eiL~Hpwfk~~~~~ 283 (671)
...+..+|..+..+++..|++||.+|.. +.++..|+||+...|.
T Consensus 476 ---iriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd 525 (593)
T KOG0695|consen 476 ---IRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWD 525 (593)
T ss_pred ---ccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHH
Confidence 2335567888889999999999999964 7899999999877664
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=313.54 Aligned_cols=237 Identities=23% Similarity=0.335 Sum_probs=192.5
Q ss_pred EEecccCceEEEEEEEcCCC----------cEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q 005886 20 EEVGEGVSATVYRALCIPLN----------EIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWV 89 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~tg----------~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~L 89 (671)
+.||+|+||.||+|.+..++ ..|++|++...... ...+.+|+.+++.++||||+++++++.. ...|+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 46899999999999998777 34788876543322 5788899999999999999999999988 77899
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC-------ceEEecccccc
Q 005886 90 VMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG-------AIKLADFGVSA 162 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g-------~vKL~DFGls~ 162 (671)
||||+.+|+|..++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 78 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 78 VEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 999999999999987652 3689999999999999999999999999999999999999887 79999999986
Q ss_pred ccccCCCcccccccccCCCCCCChhHhhhc-cCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCc
Q 005886 163 CMFDAGDRQRSRNTFVGTPCWMAPEVMQQL-HGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDY 240 (671)
Q Consensus 163 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~ 240 (671)
.... .....++..|+|||++.+. ..++.++|||||||++|+|++ |..||............... ...
T Consensus 157 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~--~~~-- 225 (259)
T cd05037 157 TVLS-------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ--HRL-- 225 (259)
T ss_pred cccc-------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC--CCC--
Confidence 5422 2234677889999999863 368899999999999999999 68888776433322211111 111
Q ss_pred cccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 241 ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 241 ~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
+......+.+||.+||..+|.+||++.++++
T Consensus 226 --~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 226 --PMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred --CCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1112378999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=319.95 Aligned_cols=239 Identities=24% Similarity=0.338 Sum_probs=190.8
Q ss_pred EecccCceEEEEEEEcCCC------------------------cEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCcee
Q 005886 21 EVGEGVSATVYRALCIPLN------------------------EIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLR 76 (671)
Q Consensus 21 ~LG~G~fG~Vyka~~~~tg------------------------~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVk 76 (671)
+||+|+||.||+|....++ ..||+|++.... ......+.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence 6999999999999754221 348888886432 223456778899999999999999
Q ss_pred eeeEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC-----
Q 005886 77 AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG----- 151 (671)
Q Consensus 77 l~~~~~~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g----- 151 (671)
+++++......|+||||+.+|+|..++... .+.+++..+..++.||+.||+|||++||+||||||.|||++..+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~ 159 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT 159 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence 999999999999999999999999888653 25689999999999999999999999999999999999997643
Q ss_pred --ceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHH-hCCCCCCCCChHHHHH
Q 005886 152 --AIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLL 228 (671)
Q Consensus 152 --~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLl-tG~~PF~~~~~~~~~~ 228 (671)
.+|++|||++..... .....++..|+|||.+.+...++.++|||||||++|+|+ +|..||....+.....
T Consensus 160 ~~~~kl~d~g~~~~~~~-------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 160 SPFIKLSDPGVSFTALS-------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred cceeeecCCcccccccc-------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 489999998753321 122367888999999876556899999999999999985 6999998765544322
Q ss_pred HHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 229 MTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 229 ~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
...... . .+...+..+.+||.+||..+|.+|||+.++|++
T Consensus 233 -~~~~~~-~----~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 -FYEKKH-R----LPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred -HHHhcc-C----CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 222111 1 122345789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=342.77 Aligned_cols=259 Identities=27% Similarity=0.443 Sum_probs=218.8
Q ss_pred ccccccCCCCeEEEEEecccCceEEEEEEEcCCCc---E-EEEEEeccc--cCcccHHHHHHHHHHHHhCCCCCceeeee
Q 005886 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNE---I-VAIKVLDLE--KCNNDLDGIRREVQTMRVTNHPNVLRAHC 79 (671)
Q Consensus 6 e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~---~-VAIKvi~~~--~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~ 79 (671)
...|.+..++-.+.++||+|+||.||+|..+..+. . ||||....+ ........+.+|+++|+.++|||||++||
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 34577778888888999999999999999876533 3 899998752 23456788999999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccc
Q 005886 80 SFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFG 159 (671)
Q Consensus 80 ~~~~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFG 159 (671)
+......+|||||+|.||+|.+++++.. ..++......++.+.+.||+|||++++|||||-..|+|++.++.+||+|||
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccc
Confidence 9999999999999999999999999872 359999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCcccccccc-cCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCC
Q 005886 160 VSACMFDAGDRQRSRNTF-VGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPG 237 (671)
Q Consensus 160 ls~~~~~~~~~~~~~~~~-~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~ 237 (671)
+++.- ......... .-...|+|||.+.. ..|++++|||||||++||+++ |..||.+....+....+..+ +
T Consensus 308 Ls~~~----~~~~~~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~---~ 379 (474)
T KOG0194|consen 308 LSRAG----SQYVMKKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKN---G 379 (474)
T ss_pred cccCC----cceeeccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhc---C
Confidence 97533 111111111 23568999999987 479999999999999999999 89999999988777777443 2
Q ss_pred CCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 238 LDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 238 ~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
+....+...+..+..++.+||..+|++||++.++.+
T Consensus 380 ~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 380 YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 334445577899999999999999999999999865
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.94 Aligned_cols=257 Identities=18% Similarity=0.277 Sum_probs=192.5
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCC---CcEEEEEEeccccCcccH----------HHHHHHHHHHHhCCCCCceee
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPL---NEIVAIKVLDLEKCNNDL----------DGIRREVQTMRVTNHPNVLRA 77 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~t---g~~VAIKvi~~~~~~~~~----------~~i~~Ei~iL~~L~HpNIVkl 77 (671)
+..++|++.+.||+|+||+||+|.+..+ +..+|+|+.......... .....+...+..++|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 5568999999999999999999998887 677888875433321111 111223344566789999999
Q ss_pred eeEEEeCC----EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCce
Q 005886 78 HCSFTTGH----CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAI 153 (671)
Q Consensus 78 ~~~~~~~~----~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~v 153 (671)
++.+.... ..+++|+++. .++...+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred EEeeeEecCCceEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 98766543 4578888874 4666666554 346888899999999999999999999999999999999999999
Q ss_pred EEeccccccccccCCCc----ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 005886 154 KLADFGVSACMFDAGDR----QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLM 229 (671)
Q Consensus 154 KL~DFGls~~~~~~~~~----~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~ 229 (671)
+|+|||+|+.+...+.. ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 99999998766432211 112233579999999999987 5689999999999999999999999987643221111
Q ss_pred -----HHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 230 -----TLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 230 -----~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.+.....+ . .....+++.+.+++..||..+|.+||++.++++
T Consensus 245 ~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 245 AAKCDFIKRLHEG-K-IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HhHHHHHHHhhhh-h-hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 11111111 0 112346789999999999999999999999875
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=331.53 Aligned_cols=258 Identities=26% Similarity=0.371 Sum_probs=210.9
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCC--CC----ceeeeeEEEeCCE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNH--PN----VLRAHCSFTTGHC 86 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~H--pN----IVkl~~~~~~~~~ 86 (671)
.++|+++..+|+|+||.|..+.+..++..||||+++ ......+...-|+++|.++.+ |+ +|.+.++|...++
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik--~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIK--NVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHH--HHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 588999999999999999999999999999999985 233555667779999999842 33 7888899999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcC-----------------
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS----------------- 149 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~----------------- 149 (671)
.+||+|.+ |-+++++++.+....|+...++.++.||+.+++|||+.+++|.||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r 244 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIR 244 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceec
Confidence 99999998 679999999987788999999999999999999999999999999999999942
Q ss_pred ---CCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHH
Q 005886 150 ---NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKV 226 (671)
Q Consensus 150 ---~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~ 226 (671)
+..|||+|||.|+.- .....+.+.|..|+|||++.+ -+++.++||||+||||+||.+|...|.+.++.+.
T Consensus 245 ~~ks~~I~vIDFGsAtf~------~e~hs~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 245 PLKSTAIKVIDFGSATFD------HEHHSTIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred cCCCcceEEEecCCccee------ccCcceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 235899999987532 222367799999999999998 6799999999999999999999999988876653
Q ss_pred H---HHHHhcCCCC---------------CCccc-------------cc----------cchHHHHHHHHHhhhcCCCCC
Q 005886 227 L---LMTLQNAPPG---------------LDYER-------------DK----------RFSKSFKELVTACLVKDPKKR 265 (671)
Q Consensus 227 ~---~~~~~~~~~~---------------~~~~~-------------~~----------~ls~~l~dLI~~cL~~dP~kR 265 (671)
+ ..+++..|.. ++|+. +. .--..+.|||++||..||.+|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 3 2222211111 11000 00 001347899999999999999
Q ss_pred CCHHHHHhchhcccc
Q 005886 266 PTAEKLMKHHFFKHA 280 (671)
Q Consensus 266 pSa~eiL~Hpwfk~~ 280 (671)
+|+.|+|.||||+..
T Consensus 398 iTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 398 ITLREALSHPFFARL 412 (415)
T ss_pred ccHHHHhcCHHhhcC
Confidence 999999999999854
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=312.08 Aligned_cols=251 Identities=23% Similarity=0.434 Sum_probs=205.7
Q ss_pred CeEEEEEecccCceEEEEEEEcC-CCcEEEEEEecccc---------CcccHHHHHHHHHHHHh-CCCCCceeeeeEEEe
Q 005886 15 DYRLYEEVGEGVSATVYRALCIP-LNEIVAIKVLDLEK---------CNNDLDGIRREVQTMRV-TNHPNVLRAHCSFTT 83 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~-tg~~VAIKvi~~~~---------~~~~~~~i~~Ei~iL~~-L~HpNIVkl~~~~~~ 83 (671)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+.... .......+.+|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999987 68899999986432 11234567778888864 799999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCcEEEcCCCceEEecccc
Q 005886 84 GHCLWVVMPYMAGGSCLHIMKSA--YPEGFEEPVIATLLRETLKALVYLHF-HGHIHRDVKAGNILIDSNGAIKLADFGV 160 (671)
Q Consensus 84 ~~~l~LVmEy~~ggsL~~~l~~~--~~~~l~e~~i~~i~~qIl~aL~yLHs-~gIVHrDLKPeNILld~~g~vKL~DFGl 160 (671)
++.+|+||||+.|++|.+++... ....+++..++.++.|++.||.|||. .|++|+||+|+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 99999999999999999887542 23468999999999999999999996 6899999999999999999999999999
Q ss_pred ccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCc
Q 005886 161 SACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240 (671)
Q Consensus 161 s~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~ 240 (671)
+....... ......|+..|+|||++.+ ..++.++|+||||+++|+|++|..||...........+.......
T Consensus 161 ~~~~~~~~----~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--- 232 (269)
T cd08528 161 AKQKQPES----KLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP--- 232 (269)
T ss_pred eeeccccc----ccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc---
Confidence 86543221 2344578999999999986 558999999999999999999999997766554444333322111
Q ss_pred cccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 241 ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 241 ~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.....++..+.+||.+||..||.+||++.++..
T Consensus 233 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~ 265 (269)
T cd08528 233 LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSA 265 (269)
T ss_pred CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHH
Confidence 112357889999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=311.58 Aligned_cols=252 Identities=23% Similarity=0.396 Sum_probs=201.3
Q ss_pred eEEEEEecccCceEEEEEEEcC---CCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC------
Q 005886 16 YRLYEEVGEGVSATVYRALCIP---LNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH------ 85 (671)
Q Consensus 16 Y~l~~~LG~G~fG~Vyka~~~~---tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~------ 85 (671)
|++.+.||+|+||.||+|.... ++..||||++..... ....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 6788999999999999998653 578999999865432 234567889999999999999999999886532
Q ss_pred EEEEEEeccCCCCHHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAY----PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVS 161 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~----~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls 161 (671)
..+++++|+.+|+|..++.... ...+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 3478999999999988765321 124788899999999999999999999999999999999999999999999998
Q ss_pred cccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCc
Q 005886 162 ACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDY 240 (671)
Q Consensus 162 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~ 240 (671)
+.+.... .........+++.|++||.+.+ ..++.++|||||||++|+|++ |.+||.+....+....+..... .
T Consensus 161 ~~~~~~~-~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----~ 234 (273)
T cd05074 161 KKIYSGD-YYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR----L 234 (273)
T ss_pred ccccCCc-ceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc----C
Confidence 7552211 1111223355678999999876 568899999999999999999 8999987766554443333221 1
Q ss_pred cccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 241 ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 241 ~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.....++..+.+++.+||..+|.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 235 KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 223456789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=320.15 Aligned_cols=269 Identities=28% Similarity=0.493 Sum_probs=222.2
Q ss_pred ccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHH-HhCCCCCceeeeeEEEeCCE
Q 005886 8 RFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTM-RVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 8 ~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL-~~L~HpNIVkl~~~~~~~~~ 86 (671)
-|+....+.+-++.||.|+||+|++-.++++|+..|||.|.......+..++..|..+. +.-+.||||++||..-.++.
T Consensus 58 ~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd 137 (361)
T KOG1006|consen 58 LHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD 137 (361)
T ss_pred ccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc
Confidence 35666677777889999999999999999999999999998777666678888888765 55679999999999999999
Q ss_pred EEEEEeccCCCCHHHHH---HhhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCcEEEcCCCceEEecccccc
Q 005886 87 LWVVMPYMAGGSCLHIM---KSAYPEGFEEPVIATLLRETLKALVYLHFH-GHIHRDVKAGNILIDSNGAIKLADFGVSA 162 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l---~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~-gIVHrDLKPeNILld~~g~vKL~DFGls~ 162 (671)
.||.||+|. .+|..+. .......++|..+..|....+.||.||-.. .|||||+||+|||++..|.|||||||++-
T Consensus 138 cWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcG 216 (361)
T KOG1006|consen 138 CWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICG 216 (361)
T ss_pred eeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchH
Confidence 999999995 3444332 222235699999999999999999999864 89999999999999999999999999987
Q ss_pred ccccCCCcccccccccCCCCCCChhHhhhc-cCCCccchhhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhcCCCCCCc
Q 005886 163 CMFDAGDRQRSRNTFVGTPCWMAPEVMQQL-HGYDFKADIWSFGITALELAHGHAPFSKYPP-MKVLLMTLQNAPPGLDY 240 (671)
Q Consensus 163 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~~s~ksDIWSLGvILyeLltG~~PF~~~~~-~~~~~~~~~~~~~~~~~ 240 (671)
.+.+.-. .+.-.|...|||||.+... .+|+-++|+||||++|||++||..||.++.. ++.+.++...-++.+..
T Consensus 217 qLv~SiA----kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~ 292 (361)
T KOG1006|consen 217 QLVDSIA----KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLF 292 (361)
T ss_pred hHHHHHH----hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecC
Confidence 6643221 2234788999999999743 3599999999999999999999999998865 45555566666665554
Q ss_pred cc-cccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 241 ER-DKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 241 ~~-~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
.. ...++..+..||..||.+|-..||.+.+++++||++...
T Consensus 293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred cccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 33 245899999999999999999999999999999998543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=327.14 Aligned_cols=254 Identities=28% Similarity=0.384 Sum_probs=197.2
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC-EEEEEEe
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH-CLWVVMP 92 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~-~l~LVmE 92 (671)
+.|.-...||+|+||.||+|... .|..||||.+....... ...|.+|+.++..++|||+|+++|||.+.+ ..+||+|
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYE 152 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYE 152 (361)
T ss_pred hCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEE
Confidence 46666689999999999999865 45889999876554332 455999999999999999999999999998 5999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCCCcEEEcCCCceEEeccccccccccCCC
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHG---HIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~g---IVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~ 169 (671)
||.+|+|.+.+.......+++....+|+.+++.||+|||... ||||||||.|||+|.++..||+|||+|+.....
T Consensus 153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~-- 230 (361)
T KOG1187|consen 153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG-- 230 (361)
T ss_pred ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc--
Confidence 999999999987653227899999999999999999999964 999999999999999999999999998433110
Q ss_pred cccccccc-cCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCC---h---HHHHHHHHhc--CCCCCCc
Q 005886 170 RQRSRNTF-VGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYP---P---MKVLLMTLQN--APPGLDY 240 (671)
Q Consensus 170 ~~~~~~~~-~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~---~---~~~~~~~~~~--~~~~~~~ 240 (671)
.....+. .||..|+|||.+.. ...+.++|||||||+|.||++|+.|.+... . .+.....+.. ...-++.
T Consensus 231 -~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~ 308 (361)
T KOG1187|consen 231 -DTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDP 308 (361)
T ss_pred -ccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCC
Confidence 1222222 89999999999976 568999999999999999999998886432 1 1111112221 1111111
Q ss_pred ccc-ccch-----HHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 241 ERD-KRFS-----KSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 241 ~~~-~~ls-----~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
... ..++ ..+..+...|+..+|.+||++.++++
T Consensus 309 ~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 309 RLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 111 1222 23667888999999999999999754
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=340.47 Aligned_cols=249 Identities=28% Similarity=0.487 Sum_probs=201.5
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC------EE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH------CL 87 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~------~l 87 (671)
.-|...+.||+|+||.||+++++.+|+.||||.++........+..-+|+++|++++|||||+++++=++.. ..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 457788999999999999999999999999999988776677889999999999999999999998876544 46
Q ss_pred EEEEeccCCCCHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEc--CCC--ceEEecccccc
Q 005886 88 WVVMPYMAGGSCLHIMKSA-YPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILID--SNG--AIKLADFGVSA 162 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~-~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld--~~g--~vKL~DFGls~ 162 (671)
.+|||||.||+|+.++... +..+++|..++.++.++..||.|||.+|||||||||+||++- .+| .-||+|||.|+
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 8999999999999999753 236899999999999999999999999999999999999983 334 46999999998
Q ss_pred ccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChH----HHHHHHHhcCCCCC
Q 005886 163 CMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM----KVLLMTLQNAPPGL 238 (671)
Q Consensus 163 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~----~~~~~~~~~~~~~~ 238 (671)
.+.+ .....+++||+.|.+||++...+.|+..+|.|||||++|+++||..||-..... ++...++...+.+.
T Consensus 173 el~d----~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 173 ELDD----NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV 248 (732)
T ss_pred cCCC----CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence 7733 235667899999999999985467999999999999999999999999543222 23333333322221
Q ss_pred ----------------CccccccchHH----HHHHHHHhhhcCCCCCC
Q 005886 239 ----------------DYERDKRFSKS----FKELVTACLVKDPKKRP 266 (671)
Q Consensus 239 ----------------~~~~~~~ls~~----l~dLI~~cL~~dP~kRp 266 (671)
..+.+..++.. +-..+..+|..+|.+|.
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 11222233333 44677889999999998
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=324.93 Aligned_cols=256 Identities=23% Similarity=0.417 Sum_probs=224.2
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 86 (671)
+.|+++..+.....+||-|.||.||.|.+++..-.||||.++-+. ..++.|..|..+|+.++|||+|+++++|..+-.
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt--MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc--hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 678888888999999999999999999999988899999986443 457899999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
+|||+|||-.|+|++++.......++...+..++.||..|++||..+++|||||-..|+|+.++..|||+||||++.|..
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 99999999999999999998777788888999999999999999999999999999999999999999999999998753
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (671)
.. .+......-..-|.|||-+.- ..++.++|||+|||+|||+.| |..||.+.+-..++ ..+. .++....+..
T Consensus 418 DT--YTAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY-~LLE---kgyRM~~PeG 490 (1157)
T KOG4278|consen 418 DT--YTAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-GLLE---KGYRMDGPEG 490 (1157)
T ss_pred Cc--eecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHH-HHHh---ccccccCCCC
Confidence 32 222222233567999999875 568999999999999999999 99999997654433 3333 3566777899
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHH
Q 005886 246 FSKSFKELVTACLVKDPKKRPTAEKL 271 (671)
Q Consensus 246 ls~~l~dLI~~cL~~dP~kRpSa~ei 271 (671)
|++.+.+|+..||++.|.+||++.+|
T Consensus 491 CPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 491 CPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred CCHHHHHHHHHHhcCCcccCccHHHH
Confidence 99999999999999999999999998
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=326.34 Aligned_cols=269 Identities=24% Similarity=0.355 Sum_probs=222.7
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC------cccHHHHHHHHHHHHhCCCCCceeeeeEEE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC------NNDLDGIRREVQTMRVTNHPNVLRAHCSFT 82 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~------~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~ 82 (671)
.+...++|-++.+||+|+|+.||+|.+...+++||+|+-...+. .+.....-+|..|.+.|+||-||++|++|.
T Consensus 458 HptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs 537 (775)
T KOG1151|consen 458 HPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS 537 (775)
T ss_pred CcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee
Confidence 34556788899999999999999999999999999999754431 233567789999999999999999999997
Q ss_pred -eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccccCCCCcEEEcC---CCceEEe
Q 005886 83 -TGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH--GHIHRDVKAGNILIDS---NGAIKLA 156 (671)
Q Consensus 83 -~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~--gIVHrDLKPeNILld~---~g~vKL~ 156 (671)
+.+.+|-|+|||+|.+|..+++.. ..++|..++.|+-||+.||.||... .|||-||||.|||+-. .|.+||+
T Consensus 538 lDtdsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 538 LDTDSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred eccccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEee
Confidence 556799999999999999999877 7899999999999999999999987 5999999999999954 4789999
Q ss_pred ccccccccccCCCc----ccccccccCCCCCCChhHhhh---ccCCCccchhhhHHHHHHHHHhCCCCCCCCCh-HHHHH
Q 005886 157 DFGVSACMFDAGDR----QRSRNTFVGTPCWMAPEVMQQ---LHGYDFKADIWSFGITALELAHGHAPFSKYPP-MKVLL 228 (671)
Q Consensus 157 DFGls~~~~~~~~~----~~~~~~~~GT~~Y~APEvl~~---~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~-~~~~~ 228 (671)
||||+++|.+..+. ........||.||++||++.- ....+.++||||+|||+|.++.|+.||..... .+++.
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq 695 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ 695 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence 99999998654432 223455789999999999863 23468899999999999999999999976533 33332
Q ss_pred HHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccc
Q 005886 229 MTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKH 279 (671)
Q Consensus 229 ~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~ 279 (671)
....-......++..+.++.++++||.+||.+--++|..+.++-.||||..
T Consensus 696 eNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 696 ENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred hhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 221112233456667789999999999999999999999999999999963
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=334.16 Aligned_cols=265 Identities=24% Similarity=0.365 Sum_probs=225.1
Q ss_pred ccCCCCeEEEEEecccCceEEEEEEEcCC-Cc--EEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q 005886 10 PVDAKDYRLYEEVGEGVSATVYRALCIPL-NE--IVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 10 ~i~~~~Y~l~~~LG~G~fG~Vyka~~~~t-g~--~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 86 (671)
-|..++.+++++||+|+||+|++|.+... |+ .||||++.........+.|.+|+.+|-+|+|||++++||+..+ ..
T Consensus 106 lIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 106 LIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QP 184 (1039)
T ss_pred eccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence 45567788899999999999999988753 33 4899999877766678999999999999999999999999988 67
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
+.||||++.+|+|.+.+.+.....|-...+..|+.||+.|+.||..+++|||||-..|||+-....||||||||.+.+..
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 88999999999999999885567788889999999999999999999999999999999999989999999999988754
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (671)
..+.........-...|+|||.+.. ..++.++|+|+|||++|||++ |..||.+.....++..+- .+-..++++.
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD----~~erLpRPk~ 339 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID----AGERLPRPKY 339 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc----ccccCCCCCC
Confidence 4433322222233457999999987 569999999999999999999 999999988866554433 4456677889
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 246 FSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 246 ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
++..+.++++.||..+|.+|||+..|...-+...+
T Consensus 340 csedIY~imk~cWah~paDRptFsair~~~~l~ea 374 (1039)
T KOG0199|consen 340 CSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEA 374 (1039)
T ss_pred ChHHHHHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence 99999999999999999999999998765555433
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=292.23 Aligned_cols=244 Identities=37% Similarity=0.597 Sum_probs=205.5
Q ss_pred CceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccCCCCHHHHHHh
Q 005886 26 VSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKS 105 (671)
Q Consensus 26 ~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~ggsL~~~l~~ 105 (671)
+||.||+|.+..+|+.||+|++.........+.+.+|+..++.++|+||+++++++......+++|||+.+++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999999999999999987655433368899999999999999999999999999999999999999999999876
Q ss_pred hCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccccccccCCCCCCC
Q 005886 106 AYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMA 185 (671)
Q Consensus 106 ~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~A 185 (671)
. ..++...++.++.+++.++.|||..|++|+||+|.||+++.++.++|+|||++....... ......|+..|++
T Consensus 81 ~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~ 154 (244)
T smart00220 81 R--GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTFVGTPEYMA 154 (244)
T ss_pred c--cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc----ccccccCCcCCCC
Confidence 5 338999999999999999999999999999999999999999999999999986653221 2344578999999
Q ss_pred hhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCC
Q 005886 186 PEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKR 265 (671)
Q Consensus 186 PEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kR 265 (671)
||.+.+ ..++.++|||+||+++|+|++|..||............+........ .....++..+.+++.+||..+|.+|
T Consensus 155 pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R 232 (244)
T smart00220 155 PEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP-PPEWKISPEAKDLIRKLLVKDPEKR 232 (244)
T ss_pred HHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc-cccccCCHHHHHHHHHHccCCchhc
Confidence 999875 56888999999999999999999999874444444444433222211 1111278899999999999999999
Q ss_pred CCHHHHHhchhc
Q 005886 266 PTAEKLMKHHFF 277 (671)
Q Consensus 266 pSa~eiL~Hpwf 277 (671)
|++.++++||||
T Consensus 233 p~~~~~~~~~~~ 244 (244)
T smart00220 233 LTAEEALQHPFF 244 (244)
T ss_pred cCHHHHhhCCCC
Confidence 999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=339.01 Aligned_cols=265 Identities=22% Similarity=0.258 Sum_probs=183.6
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCC----CcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeE----
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPL----NEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCS---- 80 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~t----g~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~---- 80 (671)
.....++|++.+.||+|+||.||+|.+..+ +..||||.+.... ..+....+ .++...+.+++.+...
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~---~~e~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG---AVEIWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc---hhHHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 344678999999999999999999999988 8999999875322 11111111 1222223333322222
Q ss_pred --EEeCCEEEEEEeccCCCCHHHHHHhhCCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccC
Q 005886 81 --FTTGHCLWVVMPYMAGGSCLHIMKSAYPE------------------GFEEPVIATLLRETLKALVYLHFHGHIHRDV 140 (671)
Q Consensus 81 --~~~~~~l~LVmEy~~ggsL~~~l~~~~~~------------------~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDL 140 (671)
...+..+|+||||+.+++|.+++...... ...+..+..++.||+.||+|||++||+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 24566899999999999999988754211 1123457789999999999999999999999
Q ss_pred CCCcEEEcC-CCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhcc---------------------CCCcc
Q 005886 141 KAGNILIDS-NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLH---------------------GYDFK 198 (671)
Q Consensus 141 KPeNILld~-~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~---------------------~~s~k 198 (671)
||+|||++. ++.+||+|||+|+.+... .......++||+.|+|||.+.... .++.+
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~--~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVG--INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccc--cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 999999986 579999999998755221 122334678999999999764311 23456
Q ss_pred chhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-----------CCCC------ccccccchHHHHHHHHHhhhcC
Q 005886 199 ADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP-----------PGLD------YERDKRFSKSFKELVTACLVKD 261 (671)
Q Consensus 199 sDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~-----------~~~~------~~~~~~ls~~l~dLI~~cL~~d 261 (671)
+|||||||+||||+++..|+.. ....+...+.... .... +.........+++||.+||++|
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 7999999999999997776543 2222222221110 0000 0001112334669999999999
Q ss_pred CCCCCCHHHHHhchhcccccc
Q 005886 262 PKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 262 P~kRpSa~eiL~Hpwfk~~~~ 282 (671)
|.+|||+.++|+||||+....
T Consensus 438 P~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 438 GRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred cccCCCHHHHhCCcCcCCCCc
Confidence 999999999999999987544
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=325.02 Aligned_cols=257 Identities=24% Similarity=0.388 Sum_probs=216.3
Q ss_pred ccccCCCCeEEEEEecccCceEEEEEEEcCC--C--cEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe
Q 005886 8 RFPVDAKDYRLYEEVGEGVSATVYRALCIPL--N--EIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT 83 (671)
Q Consensus 8 ~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~t--g--~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~ 83 (671)
.|.+.....++.++||.|.||.||+|.+..- | --||||.-+........+.|..|..+|+.++|||||+++|++.+
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 4556666666778899999999999987643 3 24889988776666778999999999999999999999999986
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccc
Q 005886 84 GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSAC 163 (671)
Q Consensus 84 ~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~ 163 (671)
. ..|||||++..|.|.++++.. ...++......|+.||+.||+|||+..+|||||-..|||+.....|||+|||+++.
T Consensus 463 ~-P~WivmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 463 Q-PMWIVMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred c-ceeEEEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhh
Confidence 4 789999999999999999875 35688899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccc
Q 005886 164 MFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYER 242 (671)
Q Consensus 164 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~ 242 (671)
+.+......+ ...-..-|||||-+.- ..++.++|||.|||++||++. |..||.+..+.+++. ....+-..+.
T Consensus 541 ~ed~~yYkaS--~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~----~iEnGeRlP~ 613 (974)
T KOG4257|consen 541 LEDDAYYKAS--RGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG----HIENGERLPC 613 (974)
T ss_pred ccccchhhcc--ccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCccccccccceEE----EecCCCCCCC
Confidence 8654433222 1223457999999875 569999999999999999988 999999877655433 2333445677
Q ss_pred cccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 243 DKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 243 ~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
++.+++.+..|+.+||..+|.+||.+.+|..
T Consensus 614 P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 614 PPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred CCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 8899999999999999999999999998853
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=315.12 Aligned_cols=262 Identities=27% Similarity=0.436 Sum_probs=203.2
Q ss_pred ccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCC-----C---CCceeeeeEE
Q 005886 10 PVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN-----H---PNVLRAHCSF 81 (671)
Q Consensus 10 ~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~-----H---pNIVkl~~~~ 81 (671)
.....+|.+.++||+|.|++||+|.+..+.++||+|+++.. +...+....||++|+.+. | .+||++++.|
T Consensus 74 ~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 74 VFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred cccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 44568999999999999999999999999999999998633 345677788999998763 3 3599999999
Q ss_pred Ee----CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCcEEEcCC------
Q 005886 82 TT----GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH-GHIHRDVKAGNILIDSN------ 150 (671)
Q Consensus 82 ~~----~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~-gIVHrDLKPeNILld~~------ 150 (671)
.. +.+++||+|++ |..|+.+|+.....+++...++.|++|||.||.|||.. ||||.||||+|||+..+
T Consensus 152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~ 230 (590)
T KOG1290|consen 152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAK 230 (590)
T ss_pred eecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhh
Confidence 75 56899999999 77899999988889999999999999999999999986 99999999999999400
Q ss_pred --------------------------------------------------------------------------------
Q 005886 151 -------------------------------------------------------------------------------- 150 (671)
Q Consensus 151 -------------------------------------------------------------------------------- 150 (671)
T Consensus 231 ~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n 310 (590)
T KOG1290|consen 231 DAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRIN 310 (590)
T ss_pred hhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCC
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 005886 151 -------------------------------------------------------------------------------- 150 (671)
Q Consensus 151 -------------------------------------------------------------------------------- 150 (671)
T Consensus 311 ~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~d 390 (590)
T KOG1290|consen 311 GNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECD 390 (590)
T ss_pred ccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccc
Confidence
Q ss_pred CceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCC-----CChHH
Q 005886 151 GAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSK-----YPPMK 225 (671)
Q Consensus 151 g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~-----~~~~~ 225 (671)
-.|||+|||-| |+. ...+..-+.|..|+||||+.| .+|++.+||||++|++|||+||...|.- ++..+
T Consensus 391 i~vKIaDlGNA-CW~-----~khFT~DIQTRQYRapEVllG-sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDE 463 (590)
T KOG1290|consen 391 IRVKIADLGNA-CWV-----HKHFTEDIQTRQYRAPEVLLG-SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDE 463 (590)
T ss_pred eeEEEeeccch-hhh-----hhhhchhhhhhhccCcceeec-CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccH
Confidence 01455566543 332 122333467899999999998 6799999999999999999999998842 22222
Q ss_pred HH----HHHHhcCCCCC----------------------------------CccccccchHHHHHHHHHhhhcCCCCCCC
Q 005886 226 VL----LMTLQNAPPGL----------------------------------DYERDKRFSKSFKELVTACLVKDPKKRPT 267 (671)
Q Consensus 226 ~~----~~~~~~~~~~~----------------------------------~~~~~~~ls~~l~dLI~~cL~~dP~kRpS 267 (671)
.. ...+...|..+ .|.+...-..++.+|+.-||+.+|++|||
T Consensus 464 DHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~t 543 (590)
T KOG1290|consen 464 DHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPT 543 (590)
T ss_pred HHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccccc
Confidence 22 11121111110 01111122356789999999999999999
Q ss_pred HHHHHhchhccccc
Q 005886 268 AEKLMKHHFFKHAR 281 (671)
Q Consensus 268 a~eiL~Hpwfk~~~ 281 (671)
|.++|+|||+....
T Consensus 544 A~~cl~hPwLn~~~ 557 (590)
T KOG1290|consen 544 AAQCLKHPWLNPVA 557 (590)
T ss_pred HHHHhcCccccCCC
Confidence 99999999998654
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=333.19 Aligned_cols=263 Identities=24% Similarity=0.347 Sum_probs=232.0
Q ss_pred cccccccCCCCeEEEEEecccCceEEEEEEEcCCCc---EEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEE
Q 005886 5 VEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNE---IVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSF 81 (671)
Q Consensus 5 ~e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~---~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~ 81 (671)
.|...+|+....++.+.||.|-||.||+|+.+..|+ .||||.++-....+....|..|+.||-+++||||++|.|+.
T Consensus 620 reFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVV 699 (996)
T KOG0196|consen 620 REFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVV 699 (996)
T ss_pred HHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEE
Confidence 455678899999999999999999999999987774 59999998777777788999999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccc
Q 005886 82 TTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVS 161 (671)
Q Consensus 82 ~~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls 161 (671)
.....+.||.|||++|+|..+++.+. +.|..-++.-+++.|+.|+.||-+.|+|||||-..|||++.+-.+|++||||+
T Consensus 700 Tks~PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 700 TKSKPVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred ecCceeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccce
Confidence 99999999999999999999998764 67999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCc
Q 005886 162 ACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDY 240 (671)
Q Consensus 162 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~ 240 (671)
+.+.+..........-.-...|.|||.+.. ..++.++||||+||+|||.+. |..||++.++.+++..+.+ ++..
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~----gyRL 853 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQ----GYRL 853 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHh----ccCC
Confidence 988665533222221122468999999986 669999999999999999887 9999999999888776655 4566
Q ss_pred cccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 241 ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 241 ~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
+.+..+|..+..|+..||++|-.+||.+.+|+.
T Consensus 854 PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 854 PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 678889999999999999999999999999976
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=333.29 Aligned_cols=263 Identities=40% Similarity=0.690 Sum_probs=235.3
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
...+|+++..+|.|+||.||+|+++.+++..|+|+++++. ..+...+++|+-+++.++|||||.+++.|.....+|+.|
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep-~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP-GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccC-CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 4678999999999999999999999999999999998876 344678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
|||.||+|.++..-- +.++|.++..+++..+.||+|||+.|-+|||||-.|||+++.|.||++|||.++.+. ...
T Consensus 92 EycgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqit---ati 166 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT---ATI 166 (829)
T ss_pred EecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhh---hhh
Confidence 999999999876544 789999999999999999999999999999999999999999999999999987653 334
Q ss_pred cccccccCCCCCCChhHhh--hccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHH
Q 005886 172 RSRNTFVGTPCWMAPEVMQ--QLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~--~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
..+..+.|||.|||||+.. ...+|...+|||++|++..|+---++|....-++..++..-.............++++.
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~ 246 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEF 246 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHH
Confidence 4567889999999999963 44579999999999999999999999987778888777776666655566667788999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 250 FKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
|.+|++.+|.++|.+||+++.+|.|||....
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 9999999999999999999999999999754
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=315.81 Aligned_cols=258 Identities=23% Similarity=0.361 Sum_probs=217.1
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
......++++||+|.||.|.+|... .+..||+|.++-.........|.+|+++|.+|+|||||+++++|..++.+++|+
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred chhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 4456778999999999999999854 368899999987776667789999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
|||+.|+|..++.++...........+++.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++-++. ++..
T Consensus 615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys-g~yy 693 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS-GDYY 693 (807)
T ss_pred HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccccccc-CCce
Confidence 999999999999887555555666778999999999999999999999999999999999999999999987643 3333
Q ss_pred cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh--CCCCCCCCChHHHHHHHHh---cCCCCCCccccccc
Q 005886 172 RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH--GHAPFSKYPPMKVLLMTLQ---NAPPGLDYERDKRF 246 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt--G~~PF~~~~~~~~~~~~~~---~~~~~~~~~~~~~l 246 (671)
+.....+-...|||||.+.- ..++.++|+|+||+++||+++ ...||....+.......-. ......-...+.-+
T Consensus 694 ~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~c 772 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPAC 772 (807)
T ss_pred eeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcC
Confidence 44445566789999999886 569999999999999999764 8899988877665543322 12222223456778
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHH
Q 005886 247 SKSFKELVTACLVKDPKKRPTAEKLM 272 (671)
Q Consensus 247 s~~l~dLI~~cL~~dP~kRpSa~eiL 272 (671)
+..+.++|..||..+-.+||+++++-
T Consensus 773 p~~lyelml~Cw~~es~~RPsFe~lh 798 (807)
T KOG1094|consen 773 PQGLYELMLRCWRRESEQRPSFEQLH 798 (807)
T ss_pred cHHHHHHHHHHhchhhhcCCCHHHHH
Confidence 99999999999999999999999983
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=321.37 Aligned_cols=267 Identities=18% Similarity=0.264 Sum_probs=192.7
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEc----------------CCCcEEEEEEeccccCcc-------------cHHHHHH
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCI----------------PLNEIVAIKVLDLEKCNN-------------DLDGIRR 61 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~----------------~tg~~VAIKvi~~~~~~~-------------~~~~i~~ 61 (671)
+..++|++.++||+|+||+||+|... ..++.||||.+....... ..+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 36789999999999999999999752 235679999986443211 1122334
Q ss_pred HHHHHHhCCCCCc-----eeeeeEEEe--------CCEEEEEEeccCCCCHHHHHHhhCC--------------------
Q 005886 62 EVQTMRVTNHPNV-----LRAHCSFTT--------GHCLWVVMPYMAGGSCLHIMKSAYP-------------------- 108 (671)
Q Consensus 62 Ei~iL~~L~HpNI-----Vkl~~~~~~--------~~~l~LVmEy~~ggsL~~~l~~~~~-------------------- 108 (671)
|+.++.++.|.++ ++++++|.. +...|+||||+.+++|.+++.....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6677777766554 666676653 3568999999999999998864311
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccccccccCCCCCCCh
Q 005886 109 --EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAP 186 (671)
Q Consensus 109 --~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~AP 186 (671)
..+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++..+... .........+|+.|+||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~--~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG--INFNPLYGMLDPRYSPP 379 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccC--CccCccccCCCcceeCh
Confidence 12356778899999999999999999999999999999999999999999998654221 11111223458999999
Q ss_pred hHhhhccC-------------------C--CccchhhhHHHHHHHHHhCCC-CCCCCChHHHHHHH--------HhcCCC
Q 005886 187 EVMQQLHG-------------------Y--DFKADIWSFGITALELAHGHA-PFSKYPPMKVLLMT--------LQNAPP 236 (671)
Q Consensus 187 Evl~~~~~-------------------~--s~ksDIWSLGvILyeLltG~~-PF~~~~~~~~~~~~--------~~~~~~ 236 (671)
|++..... | ..+.||||+||++|+|++|.. ||.+.......... ......
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 99853210 1 234799999999999999876 77543211111000 011122
Q ss_pred CCCccccccchHHHHHHHHHhhhcCC---CCCCCHHHHHhchhccc
Q 005886 237 GLDYERDKRFSKSFKELVTACLVKDP---KKRPTAEKLMKHHFFKH 279 (671)
Q Consensus 237 ~~~~~~~~~ls~~l~dLI~~cL~~dP---~kRpSa~eiL~Hpwfk~ 279 (671)
.+.+..+..++..+++||.+||.++| .+|+|+.++|+||||..
T Consensus 460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 33445566789999999999999876 68999999999999953
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=327.55 Aligned_cols=251 Identities=27% Similarity=0.378 Sum_probs=197.7
Q ss_pred EEEecccCceE-EEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEEEeccCC
Q 005886 19 YEEVGEGVSAT-VYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHCSFTTGHCLWVVMPYMAG 96 (671)
Q Consensus 19 ~~~LG~G~fG~-Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~~~l~LVmEy~~g 96 (671)
.+.+|.|+-|+ ||+|... |+.||||.+- ..-.+.+.+|+..|+.. +|||||++||.-.+...+||..|+|.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll----~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~- 586 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE--GREVAVKRLL----EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA- 586 (903)
T ss_pred HHHcccCCCCcEEEEEeeC--CceehHHHHh----hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-
Confidence 35679999986 6999876 8899999863 23356788999999988 59999999999999999999999996
Q ss_pred CCHHHHHHhh-CC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcC---CC--ceEEeccccccccccCCC
Q 005886 97 GSCLHIMKSA-YP-EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS---NG--AIKLADFGVSACMFDAGD 169 (671)
Q Consensus 97 gsL~~~l~~~-~~-~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~---~g--~vKL~DFGls~~~~~~~~ 169 (671)
.+|.++++.. .. ........+.++.|++.||++||+.+||||||||.||||+. ++ .++|+|||+++.+.....
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 4899999874 11 11111446789999999999999999999999999999976 34 689999999998855444
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchH
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSK 248 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~ 248 (671)
......+..||-+|+|||++... .-..++|||||||++|+.++ |.+||.+....+. .++.+...-........+
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~-~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L~~~~d~-- 741 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLRED-RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHLEPLPDC-- 741 (903)
T ss_pred hhhcccCCCCcccccCHHHHhcc-ccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeeeccCchH--
Confidence 44446677899999999999873 45668999999999999999 5999977543322 223222222222211212
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 249 SFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 249 ~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
++.+||.+||.++|..||+|.++|.||||+...
T Consensus 742 eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~e 774 (903)
T KOG1027|consen 742 EAKDLISRMLNPDPQLRPSATDVLNHPLFWDSE 774 (903)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHhCCCccCChH
Confidence 899999999999999999999999999998654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=285.83 Aligned_cols=257 Identities=25% Similarity=0.426 Sum_probs=207.3
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCC-CCCceeeeeEEEeC--CEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN-HPNVLRAHCSFTTG--HCLW 88 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~-HpNIVkl~~~~~~~--~~l~ 88 (671)
..++|++..++|+|.|+.||.|.+..+++.++||+++. -....+.+|+.+|..|. ||||+++++...+. ....
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 56889999999999999999999999999999999863 33578999999999986 99999999999875 4578
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCC-CceEEeccccccccccC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSN-GAIKLADFGVSACMFDA 167 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~-g~vKL~DFGls~~~~~~ 167 (671)
+|+||..+.+...+. ..++...++.++.+++.||.|||+.||+|||+||.|++||.. ..++|+|+|+|.... +
T Consensus 112 LiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH-p 185 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-P 185 (338)
T ss_pred hHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC-C
Confidence 999999887765554 357788899999999999999999999999999999999865 479999999986542 2
Q ss_pred CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCC-CCCChHHHHHHHHhc-------------
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPF-SKYPPMKVLLMTLQN------------- 233 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF-~~~~~~~~~~~~~~~------------- 233 (671)
+ ...+..+.+..|.-||++.....|+..-|+|||||+|..|+..+-|| .|.+..+.+..+..-
T Consensus 186 ~---~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 186 G---KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY 262 (338)
T ss_pred C---ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence 2 22344577889999999998888999999999999999999988887 444444444332211
Q ss_pred ---CCCCCC----------------ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 234 ---APPGLD----------------YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 234 ---~~~~~~----------------~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
..+.+. .+...-.++++.||+.++|..|-.+|+||.|++.||||....
T Consensus 263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~ 329 (338)
T KOG0668|consen 263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR 329 (338)
T ss_pred ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence 111110 001112468999999999999999999999999999997543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=308.48 Aligned_cols=259 Identities=24% Similarity=0.363 Sum_probs=206.6
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCC------CCCceeeeeEEEeCC
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN------HPNVLRAHCSFTTGH 85 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~------HpNIVkl~~~~~~~~ 85 (671)
.-.+|.+....|+|-|++|.+|.+..-|..||||+|.... .-...=.+|+++|++|. --|+++++-.|...+
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE--~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE--VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch--HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 3478999999999999999999999999999999996321 11233467999999985 347999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC-ceEEeccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAY-PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG-AIKLADFGVSAC 163 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~-~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g-~vKL~DFGls~~ 163 (671)
++|||+|-+. .+|.+++++.. .-++....++.|+.|++.||..|-..||+|.||||+|||++... .+||||||.|..
T Consensus 508 HLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~ 586 (752)
T KOG0670|consen 508 HLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASF 586 (752)
T ss_pred eeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccc
Confidence 9999999884 58999998753 24688889999999999999999999999999999999998764 689999998754
Q ss_pred cccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHH--hcCCCC----
Q 005886 164 MFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTL--QNAPPG---- 237 (671)
Q Consensus 164 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~--~~~~~~---- 237 (671)
... .....+.-+.+|.|||++.| ..|+...|+||+||+||||.||+..|+|.+....+...+ ....+.
T Consensus 587 ~~e-----neitPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR 660 (752)
T KOG0670|consen 587 ASE-----NEITPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR 660 (752)
T ss_pred ccc-----ccccHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence 321 12334566789999999999 679999999999999999999999999887655443222 111000
Q ss_pred ----CCccc---------------------------------------------cccchHHHHHHHHHhhhcCCCCCCCH
Q 005886 238 ----LDYER---------------------------------------------DKRFSKSFKELVTACLVKDPKKRPTA 268 (671)
Q Consensus 238 ----~~~~~---------------------------------------------~~~ls~~l~dLI~~cL~~dP~kRpSa 268 (671)
.+..+ ...+-..+++|+.+||..||.+|.|+
T Consensus 661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~ 740 (752)
T KOG0670|consen 661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV 740 (752)
T ss_pred hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence 00000 00112358899999999999999999
Q ss_pred HHHHhchhccc
Q 005886 269 EKLMKHHFFKH 279 (671)
Q Consensus 269 ~eiL~Hpwfk~ 279 (671)
.++|+||||..
T Consensus 741 nqAL~HpFi~~ 751 (752)
T KOG0670|consen 741 NQALKHPFITE 751 (752)
T ss_pred HHHhcCCcccC
Confidence 99999999963
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=292.60 Aligned_cols=258 Identities=26% Similarity=0.369 Sum_probs=208.9
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC----
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH---- 85 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~---- 85 (671)
....+|.-+..+|.|+- .|..|-+..+++.||+|.+..... .....+..+|...+..+.|+||++++.+|.-..
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 45578999999999999 788899999999999999866532 233678889999999999999999999997543
Q ss_pred --EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccc
Q 005886 86 --CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSAC 163 (671)
Q Consensus 86 --~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~ 163 (671)
.+|+|||||. ++|..++.. .++-..+..++.|+++|+.|||+.||+||||||+||++..++.+||+|||+|+.
T Consensus 93 ~~e~y~v~e~m~-~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 93 FQEVYLVMELMD-ANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHhHHHHHHhhh-hHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcc
Confidence 5899999996 477777763 367788999999999999999999999999999999999999999999999864
Q ss_pred cccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-------
Q 005886 164 MFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP------- 236 (671)
Q Consensus 164 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~------- 236 (671)
-. ..-..+.++.|..|.|||++.+ .+|.+.+||||+|||+.||++|...|.|.+..+.+.++......
T Consensus 168 e~----~~~~mtpyVvtRyyrapevil~-~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 168 ED----TDFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred cC----cccccCchhheeeccCchheec-cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 31 1134566789999999999998 45999999999999999999999999887665554433321100
Q ss_pred --------------------------CCCcc----ccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccc
Q 005886 237 --------------------------GLDYE----RDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKH 279 (671)
Q Consensus 237 --------------------------~~~~~----~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~ 279 (671)
...+. ..+.-+..+++++.+||..||++|.+++++|+||||+-
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~v 315 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKV 315 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeee
Confidence 00000 00111345889999999999999999999999999983
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=292.91 Aligned_cols=259 Identities=24% Similarity=0.345 Sum_probs=205.5
Q ss_pred EEEEEecccCceEEEEEEEcCCCcEEEEEEecccc-CcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC-----EEEEE
Q 005886 17 RLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEK-CNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH-----CLWVV 90 (671)
Q Consensus 17 ~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~-~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~-----~l~LV 90 (671)
+--+.||.|+||+||.+.+..+|+.||+|++..-. .-....++.+|+++|..++|.||+..++...-.+ .+|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 33468999999999999999999999999874221 1123578899999999999999999888776543 46788
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCc
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR 170 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~ 170 (671)
+|+|.. +|-.+|-. +..++.+.+.-++.||++||+|||+.||+||||||.|+|++.|..+||||||+++..... .
T Consensus 136 TELmQS-DLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d--~ 210 (449)
T KOG0664|consen 136 TELMQS-DLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR--D 210 (449)
T ss_pred HHHHHh-hhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh--h
Confidence 888854 56555543 367899999999999999999999999999999999999999999999999999866332 2
Q ss_pred ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC----------------
Q 005886 171 QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA---------------- 234 (671)
Q Consensus 171 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~---------------- 234 (671)
.......+-|-.|+|||++.|...|+.++||||.|||+.||+..+..|....+.+.+..+..-.
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 2334445778999999999998899999999999999999999999998877776655443211
Q ss_pred -------CCCCCccc------cccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 235 -------PPGLDYER------DKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 235 -------~~~~~~~~------~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
....+... +..-..+..+++.++|..||++|.+.++++.|+|+...
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 10001100 01112457789999999999999999999999998754
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=334.42 Aligned_cols=240 Identities=18% Similarity=0.295 Sum_probs=186.9
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecc
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYM 94 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~ 94 (671)
.|.....||+|+||.||+|.++.+|..||||.+..... ....|+.+++.++|||||++++++.+....|+|||||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 45566789999999999999999999999999864321 1235688999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 95 AGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLH---FHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 95 ~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLH---s~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
+||+|.+++. .+++..+..++.||+.||+||| ..+|+||||||+||+++.++..++. ||......
T Consensus 766 ~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~------ 833 (968)
T PLN00113 766 EGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC------ 833 (968)
T ss_pred CCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc------
Confidence 9999999985 3788899999999999999999 6699999999999999998887775 66543221
Q ss_pred cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChH-----HHHHHHHhcC------CCCC--
Q 005886 172 RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM-----KVLLMTLQNA------PPGL-- 238 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~-----~~~~~~~~~~------~~~~-- 238 (671)
......||+.|+|||++.+ ..|+.++|||||||++|||++|+.||...... +......... .+..
T Consensus 834 -~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 834 -TDTKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred -cCCCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence 1123378999999999886 56999999999999999999999998542111 1100000000 0000
Q ss_pred CccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 239 DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 239 ~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
..........++.+++.+||..||.+||++.++++
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 946 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHH
Confidence 00111223346788999999999999999999976
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=312.31 Aligned_cols=260 Identities=26% Similarity=0.465 Sum_probs=216.9
Q ss_pred ccccCCCCeEEEEEecccCceEEEEEEEcC---C----CcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeee
Q 005886 8 RFPVDAKDYRLYEEVGEGVSATVYRALCIP---L----NEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHC 79 (671)
Q Consensus 8 ~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~---t----g~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~ 79 (671)
.|++..+...+.+.||.|+||.||+|.... . ...||||.+.......+.+.+..|+.+|+.+ .||||+.+.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 677888888888899999999999997441 1 3469999987666566788999999999988 5999999999
Q ss_pred EEEeCCEEEEEEeccCCCCHHHHHHhhC------C--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcE
Q 005886 80 SFTTGHCLWVVMPYMAGGSCLHIMKSAY------P--------EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNI 145 (671)
Q Consensus 80 ~~~~~~~l~LVmEy~~ggsL~~~l~~~~------~--------~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNI 145 (671)
++..+..+++|+|||..|+|.++++... . ..+.......++.||+.|++||++..+|||||-..||
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV 449 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV 449 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence 9999999999999999999999998774 0 1288889999999999999999999999999999999
Q ss_pred EEcCCCceEEeccccccccccCCCcccccccccC--CCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCC
Q 005886 146 LIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVG--TPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYP 222 (671)
Q Consensus 146 Lld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~G--T~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~ 222 (671)
|+..+..+||+|||+|+.......... ....| ...|||||.+.. ..|+.++|||||||+||||++ |..||.+..
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~~--~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYRT--KSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceEe--cCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 999999999999999975433222211 11122 335999999998 779999999999999999999 999999866
Q ss_pred hHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 223 PMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
....+... ...+.....+..++.++.+++..||..+|++||++.++..
T Consensus 527 ~~~~l~~~---l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 527 PTEELLEF---LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred cHHHHHHH---HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 33333333 3345566778889999999999999999999999999865
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=266.67 Aligned_cols=228 Identities=27% Similarity=0.458 Sum_probs=189.0
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHH-hCCCCCceeeeeEEEeCC
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMR-VTNHPNVLRAHCSFTTGH 85 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~-~L~HpNIVkl~~~~~~~~ 85 (671)
+.|.+..++...+..||+|++|.|-+.++..+|...|+|.+...-......++.+|+.+.. ....|++|.+|+.+.+..
T Consensus 39 ~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 39 RNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred CccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 4478888888889999999999999999999999999999875554455677788888764 457999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCcEEEcCCCceEEecccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSA--YPEGFEEPVIATLLRETLKALVYLHFH-GHIHRDVKAGNILIDSNGAIKLADFGVSA 162 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~--~~~~l~e~~i~~i~~qIl~aL~yLHs~-gIVHrDLKPeNILld~~g~vKL~DFGls~ 162 (671)
.+||.||.|.. +|..+.+.. ..+.++|..+-+++..++.||.|||++ .++|||+||.||||+.+|.|||||||++-
T Consensus 119 dvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 119 DVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred cEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 99999999953 565443322 136789999999999999999999997 89999999999999999999999999987
Q ss_pred ccccCCCcccccccccCCCCCCChhHhhh---ccCCCccchhhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhcCCCCC
Q 005886 163 CMFDAGDRQRSRNTFVGTPCWMAPEVMQQ---LHGYDFKADIWSFGITALELAHGHAPFSKY-PPMKVLLMTLQNAPPGL 238 (671)
Q Consensus 163 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~---~~~~s~ksDIWSLGvILyeLltG~~PF~~~-~~~~~~~~~~~~~~~~~ 238 (671)
.+.+.-. .+--.|...|||||.+.. ..+|+.++||||||+++.||++++.||..+ ++++.+.++....++.+
T Consensus 198 ~L~dSiA----kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~L 273 (282)
T KOG0984|consen 198 YLVDSIA----KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQL 273 (282)
T ss_pred eehhhhH----HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCC
Confidence 7744221 122367888999999863 246999999999999999999999999765 67777777777766655
Q ss_pred C
Q 005886 239 D 239 (671)
Q Consensus 239 ~ 239 (671)
.
T Consensus 274 p 274 (282)
T KOG0984|consen 274 P 274 (282)
T ss_pred c
Confidence 4
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=298.00 Aligned_cols=202 Identities=27% Similarity=0.431 Sum_probs=179.7
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-------ccHHHHHHHHHHHHhCC---CCCceeeeeEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-------NDLDGIRREVQTMRVTN---HPNVLRAHCSF 81 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-------~~~~~i~~Ei~iL~~L~---HpNIVkl~~~~ 81 (671)
...+|..++.+|.|+||.|++|.++.....|+||.|.+++.- ..+..+--||+||..++ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 345799999999999999999999999999999999877632 22445678999999997 99999999999
Q ss_pred EeCCEEEEEEecc-CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccc
Q 005886 82 TTGHCLWVVMPYM-AGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGV 160 (671)
Q Consensus 82 ~~~~~l~LVmEy~-~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGl 160 (671)
++++++||+||-- +|-+|+++|..+ ..++|..+..|++||+.|+++||+.||||||||-+|+.++.+|.+||+|||.
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence 9999999999975 456999999887 7899999999999999999999999999999999999999999999999998
Q ss_pred ccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCC
Q 005886 161 SACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSK 220 (671)
Q Consensus 161 s~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~ 220 (671)
|+.. .......++||..|.|||++.|.+..+..-|||+||++||.++....||..
T Consensus 717 aa~~-----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYT-----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhh-----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 7643 233456789999999999999977678889999999999999999999864
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=287.82 Aligned_cols=250 Identities=22% Similarity=0.349 Sum_probs=191.6
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHh--CCCCCceeeeeEEEeCC----
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRV--TNHPNVLRAHCSFTTGH---- 85 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~--L~HpNIVkl~~~~~~~~---- 85 (671)
+....++++.||+|.||.||+|... ++.||||++.. .+.+.+..|-.+.+. +.|+||++++++-....
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhcc--CceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 3455678899999999999999765 79999999864 345677778777764 58999999998877655
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CcccccCCCCcEEEcCCCceEEe
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH---------GHIHRDVKAGNILIDSNGAIKLA 156 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~---------gIVHrDLKPeNILld~~g~vKL~ 156 (671)
.+|||++|.+.|+|.++++.+ .+++....+++..++.||+|||.. +|+|||||..|||+.+|+++.|+
T Consensus 282 eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 899999999999999999986 689999999999999999999972 59999999999999999999999
Q ss_pred ccccccccccCCCcccccccccCCCCCCChhHhhhccCCC-----ccchhhhHHHHHHHHHhCCC------------CCC
Q 005886 157 DFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYD-----FKADIWSFGITALELAHGHA------------PFS 219 (671)
Q Consensus 157 DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s-----~ksDIWSLGvILyeLltG~~------------PF~ 219 (671)
|||||.++... ........-+||.+|||||++.|.-.+. .+.||||+|.+||||++... ||.
T Consensus 359 DFGLAl~~~p~-~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 359 DFGLALRLEPG-KPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred ccceeEEecCC-CCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 99999887543 3333334479999999999999865554 35899999999999998543 232
Q ss_pred ---CC-ChHHHHHH--HHhcCCCCCCccc-cccchHHHHHHHHHhhhcCCCCCCCHHHH
Q 005886 220 ---KY-PPMKVLLM--TLQNAPPGLDYER-DKRFSKSFKELVTACLVKDPKKRPTAEKL 271 (671)
Q Consensus 220 ---~~-~~~~~~~~--~~~~~~~~~~~~~-~~~ls~~l~dLI~~cL~~dP~kRpSa~ei 271 (671)
+. +..+.+.. ......|.+.-.+ ....-..+++.++-||..||+-|+|+.=+
T Consensus 438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 01 11111111 1122222222111 11224568899999999999999997543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=248.28 Aligned_cols=214 Identities=40% Similarity=0.639 Sum_probs=187.3
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccCCCCHHH
Q 005886 22 VGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLH 101 (671)
Q Consensus 22 LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~ggsL~~ 101 (671)
||.|++|.||++.+..+|+.+++|++...........+.+|+..++.+.|++|+++++++......+++|||+.|++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999888999999998765433245789999999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcC-CCceEEeccccccccccCCCcccccccccCC
Q 005886 102 IMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS-NGAIKLADFGVSACMFDAGDRQRSRNTFVGT 180 (671)
Q Consensus 102 ~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~-~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT 180 (671)
++.... ..++...++.++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~ 156 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLKTIVGT 156 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---hhhcccCC
Confidence 987642 35889999999999999999999999999999999999999 89999999999865432211 12335678
Q ss_pred CCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhc
Q 005886 181 PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVK 260 (671)
Q Consensus 181 ~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~ 260 (671)
..|++||.+.....++.+.|+|++|+++|+| ..+.+++.+||..
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------~~~~~~l~~~l~~ 200 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------PELKDLIRKMLQK 200 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------HHHHHHHHHHhhC
Confidence 8999999987633688999999999999999 5788999999999
Q ss_pred CCCCCCCHHHHHhch
Q 005886 261 DPKKRPTAEKLMKHH 275 (671)
Q Consensus 261 dP~kRpSa~eiL~Hp 275 (671)
+|.+||++.++++|+
T Consensus 201 ~p~~R~~~~~l~~~~ 215 (215)
T cd00180 201 DPEKRPSAKEILEHL 215 (215)
T ss_pred CcccCcCHHHHhhCC
Confidence 999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=283.00 Aligned_cols=265 Identities=29% Similarity=0.426 Sum_probs=206.8
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcC---CCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeeeEEEeC
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIP---LNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHCSFTTG 84 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~---tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~ 84 (671)
++-..+.|.++.+||.|+|++||+|.+.. ..++||+|.+..... ..++.+|+++|..+ .+.||+++.+.+...
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~---p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS---PSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC---chHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 55566889999999999999999999887 788999999876543 45799999999887 599999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCC-CceEEeccccccc
Q 005886 85 HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSN-GAIKLADFGVSAC 163 (671)
Q Consensus 85 ~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~-g~vKL~DFGls~~ 163 (671)
+.+.+||||++.....++.. .++...++.|++.++.||+++|.+|||||||||.|+|++.. +.-.|+|||+|..
T Consensus 108 d~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred CeeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence 99999999999988877764 36688899999999999999999999999999999999764 6788999999852
Q ss_pred cc-----------------c-CC-----------------------CcccccccccCCCCCCChhHhhhccCCCccchhh
Q 005886 164 MF-----------------D-AG-----------------------DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIW 202 (671)
Q Consensus 164 ~~-----------------~-~~-----------------------~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIW 202 (671)
.. . .+ ......-...||++|+|||++.+...-++++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 10 0 00 0000112346999999999999988889999999
Q ss_pred hHHHHHHHHHhCCCCCCCCChH-HHHHHHH-----------hcCCCC---------------------------------
Q 005886 203 SFGITALELAHGHAPFSKYPPM-KVLLMTL-----------QNAPPG--------------------------------- 237 (671)
Q Consensus 203 SLGvILyeLltG~~PF~~~~~~-~~~~~~~-----------~~~~~~--------------------------------- 237 (671)
|.|||+..+++++.||-...+. ..+..+. ......
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~ 342 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP 342 (418)
T ss_pred eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence 9999999999999998432211 1100000 000000
Q ss_pred -CC-ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 238 -LD-YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 238 -~~-~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
.. ......++..+.+|+.+||..||.+|.||+++|+||||..+.
T Consensus 343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD 388 (418)
T ss_pred ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence 00 001122345789999999999999999999999999998543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=296.84 Aligned_cols=250 Identities=25% Similarity=0.370 Sum_probs=210.3
Q ss_pred eEEEEEecccCceEEEEEEEcCCCc----EEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 16 YRLYEEVGEGVSATVYRALCIPLNE----IVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 16 Y~l~~~LG~G~fG~Vyka~~~~tg~----~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
.+..+.||+|+||+||+|.+.+.|+ +||||++......+....+.+|+.+|..++|||++++++++.... +.||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 3446789999999999999887664 689999877666666788999999999999999999999998776 88999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
+||++|.|.++++... ..+-......|+.||++|+.|||.+.+|||||-..|||+..-..|||.|||+++.+...+...
T Consensus 777 q~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred HhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 9999999999998753 567888899999999999999999999999999999999999999999999998764433322
Q ss_pred cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHH
Q 005886 172 RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSF 250 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l 250 (671)
. .....-.+-|||=|.+.. ..|+.++|||||||++||++| |..||.+.+..++-...-. +.....++.++.++
T Consensus 856 ~-~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~----geRLsqPpiCtiDV 929 (1177)
T KOG1025|consen 856 S-APGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK----GERLSQPPICTIDV 929 (1177)
T ss_pred c-ccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc----cccCCCCCCccHHH
Confidence 2 222233566899998876 679999999999999999999 9999999887665432222 22355678899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHh
Q 005886 251 KELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 251 ~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
+.++.+||..|+..||+++++-.
T Consensus 930 y~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 930 YMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHHhccCcccCccHHHHHH
Confidence 99999999999999999998743
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=276.18 Aligned_cols=251 Identities=27% Similarity=0.397 Sum_probs=192.4
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHH--hCCCCCceeeeeEEEeCC----E
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMR--VTNHPNVLRAHCSFTTGH----C 86 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~--~L~HpNIVkl~~~~~~~~----~ 86 (671)
.++..+.+.||+|.||.||+|.+. |+.||||++... +...+.+|.++.+ .|+|+||+.+++.-..++ .
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hheeEEEEEecCccccceeecccc--CCceEEEEeccc----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 467889999999999999999987 889999998632 3356677777775 569999999988765443 5
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccccCCCCcEEEcCCCceEEecc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH--------GHIHRDVKAGNILIDSNGAIKLADF 158 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~--------gIVHrDLKPeNILld~~g~vKL~DF 158 (671)
+|||.+|-+.|+|++++... .++.....+++..++.||++||.. .|.|||||..|||+..+|.+.|+|+
T Consensus 284 LwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 89999999999999999874 789999999999999999999963 4999999999999999999999999
Q ss_pred ccccccccC-CCcccccccccCCCCCCChhHhhhccCC-----CccchhhhHHHHHHHHHhC----------CCCCCCCC
Q 005886 159 GVSACMFDA-GDRQRSRNTFVGTPCWMAPEVMQQLHGY-----DFKADIWSFGITALELAHG----------HAPFSKYP 222 (671)
Q Consensus 159 Gls~~~~~~-~~~~~~~~~~~GT~~Y~APEvl~~~~~~-----s~ksDIWSLGvILyeLltG----------~~PF~~~~ 222 (671)
|||...... ..-....+..+||..|||||++...-.. -..+||||||.++||++.. ++||.+.-
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 998665333 2233445677999999999999753221 1358999999999999753 57886542
Q ss_pred h----HHHHHHHH--hcCCCCCCccccccch--HHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 223 P----MKVLLMTL--QNAPPGLDYERDKRFS--KSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 223 ~----~~~~~~~~--~~~~~~~~~~~~~~ls--~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
+ .+.....+ +...|.++ ..|...+ ..+..|++.||..+|.-|.||-.|.+
T Consensus 441 p~DPs~eeMrkVVCv~~~RP~ip-nrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 441 PSDPSFEEMRKVVCVQKLRPNIP-NRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CCCCCHHHHhcceeecccCCCCC-cccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 2 23332221 22222222 1222222 34667999999999999999876643
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-29 Score=247.09 Aligned_cols=214 Identities=35% Similarity=0.545 Sum_probs=181.7
Q ss_pred eEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccC
Q 005886 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMA 95 (671)
Q Consensus 16 Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~ 95 (671)
|.+...||.|++|.||++.+..+++.+|+|.+...........+.+|+..++.++|+|++++++++......++++||+.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 67889999999999999999988999999998755433256788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccc
Q 005886 96 GGSCLHIMKSAYPEG-FEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSR 174 (671)
Q Consensus 96 ggsL~~~l~~~~~~~-l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 174 (671)
+++|..++... .. +++..++.++.+++.++.+||.+|++|+||+|.||+++.++.++|+|||++....... ....
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~--~~~~ 156 (225)
T smart00221 81 GGDLFDYLRKK--GGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL--AALL 156 (225)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc--cccc
Confidence 99999998875 33 8899999999999999999999999999999999999999999999999987663322 0123
Q ss_pred ccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCC-CChHHHHHHHHhc
Q 005886 175 NTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSK-YPPMKVLLMTLQN 233 (671)
Q Consensus 175 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~-~~~~~~~~~~~~~ 233 (671)
....++..|++||.+.+...++.++|+|+||+++|+|++|+.||.. ..+.......+..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~ 216 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSF 216 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhc
Confidence 4457889999999984335678899999999999999999999977 4444444444433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=298.78 Aligned_cols=204 Identities=12% Similarity=0.108 Sum_probs=148.2
Q ss_pred hCCC-CCceeeeeEE-------EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccc
Q 005886 68 VTNH-PNVLRAHCSF-------TTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRD 139 (671)
Q Consensus 68 ~L~H-pNIVkl~~~~-------~~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrD 139 (671)
.+.| +||++++++| .....++++|||+ +++|.+++... ...+++..++.+++||+.||+|||++||||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 4445 5778888877 3345688889987 66999999753 35699999999999999999999999999999
Q ss_pred CCCCcEEEcCC-------------------CceEEeccccccccccCCC-------------cccccccccCCCCCCChh
Q 005886 140 VKAGNILIDSN-------------------GAIKLADFGVSACMFDAGD-------------RQRSRNTFVGTPCWMAPE 187 (671)
Q Consensus 140 LKPeNILld~~-------------------g~vKL~DFGls~~~~~~~~-------------~~~~~~~~~GT~~Y~APE 187 (671)
|||+||||+.. +.+||+|||+++....... ........+||++|||||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 99999999643 4566666666643211000 000112246899999999
Q ss_pred HhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCC
Q 005886 188 VMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPT 267 (671)
Q Consensus 188 vl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpS 267 (671)
++.+ ..|+.++|||||||+||||++|.+||..... ..........+. . .........+++.+||.++|.+||+
T Consensus 186 ~~~~-~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~---~-~~~~~~~~~~~~~~~L~~~P~~Rps 258 (793)
T PLN00181 186 EDNG-SSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPP---Q-ILLNWPKEASFCLWLLHPEPSCRPS 258 (793)
T ss_pred hhcc-CCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcCh---h-hhhcCHHHHHHHHHhCCCChhhCcC
Confidence 9987 5689999999999999999999988764221 111111111110 0 1111345678999999999999999
Q ss_pred HHHHHhchhcccc
Q 005886 268 AEKLMKHHFFKHA 280 (671)
Q Consensus 268 a~eiL~Hpwfk~~ 280 (671)
+.++|+||||...
T Consensus 259 ~~eil~h~~~~~~ 271 (793)
T PLN00181 259 MSELLQSEFINEP 271 (793)
T ss_pred hHHHhhchhhhhh
Confidence 9999999999864
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=255.61 Aligned_cols=259 Identities=22% Similarity=0.342 Sum_probs=212.9
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCC-----cEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLN-----EIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT 83 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg-----~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~ 83 (671)
..+...++++...+-+|.||.||.|++.... +.|.+|.++....+-++..+..|.-.+..+.|||++.+.++...
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 4456677888899999999999999776433 23556766655555567888899999999999999999998865
Q ss_pred C-CEEEEEEeccCCCCHHHHHHhh------CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEe
Q 005886 84 G-HCLWVVMPYMAGGSCLHIMKSA------YPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLA 156 (671)
Q Consensus 84 ~-~~l~LVmEy~~ggsL~~~l~~~------~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~ 156 (671)
+ ...++++.++.-|+|..++... +...+...++..++.|+..|++|||++|+||.||-..|++|++.-.|||+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 4 4678889999999999998733 22346667788899999999999999999999999999999999999999
Q ss_pred ccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCC
Q 005886 157 DFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAP 235 (671)
Q Consensus 157 DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~ 235 (671)
|=.+++.+++.....- .....-...||+||.+.. ..|+.++|+|||||+||||+| |+.||...++.+.......
T Consensus 439 DsaLSRDLFP~DYhcL-GDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd--- 513 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCL-GDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD--- 513 (563)
T ss_pred cchhccccCccccccc-CCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc---
Confidence 9999998876543221 112233567999999987 679999999999999999999 9999999999887655443
Q ss_pred CCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 236 PGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 236 ~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
++....+-++|+++..++..||..+|++||+++++..
T Consensus 514 -GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 514 -GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred -cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 4556667889999999999999999999999999854
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-29 Score=249.67 Aligned_cols=241 Identities=23% Similarity=0.329 Sum_probs=187.3
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeee-EEEeCCEEEEE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHC-SFTTGHCLWVV 90 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~-~~~~~~~l~LV 90 (671)
.+.|.+.+.||+|.||.+.+|.|+.++..+++|.+.... .....|.+|...--.| .|.||+.-|+ .|++.+.++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~--tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ--TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch--hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 367889999999999999999999999999999987554 3457788888765444 5899998765 57888899999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEc-CC-CceEEeccccccccccCC
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILID-SN-GAIKLADFGVSACMFDAG 168 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld-~~-g~vKL~DFGls~~~~~~~ 168 (671)
|||++.|+|..-+.. .++-|.....++.|++.||.|||++++||||||.+||||- .+ -+|||||||+.+.. +
T Consensus 101 qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~---g 174 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV---G 174 (378)
T ss_pred eccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc---C
Confidence 999999999887765 4789999999999999999999999999999999999983 33 38999999987533 1
Q ss_pred CcccccccccCCCCCCChhHhhhcc----CCCccchhhhHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhcCCCCCCc
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQLH----GYDFKADIWSFGITALELAHGHAPFSKYP----PMKVLLMTLQNAPPGLDY 240 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~~----~~s~ksDIWSLGvILyeLltG~~PF~~~~----~~~~~~~~~~~~~~~~~~ 240 (671)
. .-...--+..|.+||+..... ...+.+|||.||+|+|.+++|.+||.... +.-....-.+...+..+
T Consensus 175 ~---tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P- 250 (378)
T KOG1345|consen 175 T---TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALP- 250 (378)
T ss_pred c---eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCc-
Confidence 1 111223356799999876422 14677899999999999999999997432 11222222333333222
Q ss_pred cccccchHHHHHHHHHhhhcCCCCC
Q 005886 241 ERDKRFSKSFKELVTACLVKDPKKR 265 (671)
Q Consensus 241 ~~~~~ls~~l~dLI~~cL~~dP~kR 265 (671)
.....+++.+..+.++-|..+|++|
T Consensus 251 ~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 251 KKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred hhhcccCHHHHHHHHHhcCCccccc
Confidence 2235678899999999999999999
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-26 Score=231.98 Aligned_cols=261 Identities=35% Similarity=0.533 Sum_probs=210.8
Q ss_pred eEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcc--cHHHHHHHHHHHHhCCCC-CceeeeeEEEeCCEEEEEEe
Q 005886 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN--DLDGIRREVQTMRVTNHP-NVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 16 Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~--~~~~i~~Ei~iL~~L~Hp-NIVkl~~~~~~~~~l~LVmE 92 (671)
|.+.+.||.|+||.||++.+. ..+++|.+....... ....+.+|+.+++.+.|+ +|+++++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 889999999999999999987 778999997665444 377899999999999988 79999999988888999999
Q ss_pred ccCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC-ceEEeccccccccccCCCc
Q 005886 93 YMAGGSCLHIMKSAYP-EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG-AIKLADFGVSACMFDAGDR 170 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~-~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g-~vKL~DFGls~~~~~~~~~ 170 (671)
|+.++++..++..... ..+.+..+..++.|++.++.|+|..|++|||+||+||+++..+ .++++|||++..+......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999999977765421 2689999999999999999999999999999999999999988 7999999998754332222
Q ss_pred c---cccccccCCCCCCChhHhhhc--cCCCccchhhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCC-CCcc
Q 005886 171 Q---RSRNTFVGTPCWMAPEVMQQL--HGYDFKADIWSFGITALELAHGHAPFSKYPP---MKVLLMTLQNAPPG-LDYE 241 (671)
Q Consensus 171 ~---~~~~~~~GT~~Y~APEvl~~~--~~~s~ksDIWSLGvILyeLltG~~PF~~~~~---~~~~~~~~~~~~~~-~~~~ 241 (671)
. ......+||+.|+|||.+.+. ..+....|+|++|++++++++|..||..... .......+...... ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 1 134677999999999999874 4688899999999999999999999877663 23333333333222 2222
Q ss_pred ccccc----hHHHHHHHHHhhhcCCCCCCCHHHHHhchhccc
Q 005886 242 RDKRF----SKSFKELVTACLVKDPKKRPTAEKLMKHHFFKH 279 (671)
Q Consensus 242 ~~~~l----s~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~ 279 (671)
..... ...+.+++..|+..+|..|.+......++|+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 22222 267899999999999999999999988866654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-27 Score=227.46 Aligned_cols=164 Identities=29% Similarity=0.385 Sum_probs=129.6
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccccc
Q 005886 97 GSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNT 176 (671)
Q Consensus 97 gsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~ 176 (671)
|+|.+++... ...+++..++.++.||+.||.|||+++ ||+|||++.++.+|+ ||++..... ..
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~--------~~ 63 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP--------EQ 63 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc--------cc
Confidence 6888988764 256999999999999999999999999 999999999999999 999865422 12
Q ss_pred ccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHH-HHHHHhcCCCCCCc--cccccchH--HHH
Q 005886 177 FVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKV-LLMTLQNAPPGLDY--ERDKRFSK--SFK 251 (671)
Q Consensus 177 ~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~-~~~~~~~~~~~~~~--~~~~~ls~--~l~ 251 (671)
..||+.|||||++.+ ..|+.++|||||||++|||++|..||........ +............. .....++. .++
T Consensus 64 ~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (176)
T smart00750 64 SRVDPYFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFA 142 (176)
T ss_pred CCCcccccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHH
Confidence 268999999999987 5689999999999999999999999976544322 22222222111110 11233444 699
Q ss_pred HHHHHhhhcCCCCCCCHHHHHhchhcc
Q 005886 252 ELVTACLVKDPKKRPTAEKLMKHHFFK 278 (671)
Q Consensus 252 dLI~~cL~~dP~kRpSa~eiL~Hpwfk 278 (671)
+||.+||..+|.+||++.+++.|+|+.
T Consensus 143 ~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 143 DFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHHHhcccccccCHHHHHHHHHHH
Confidence 999999999999999999999999986
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-25 Score=236.33 Aligned_cols=255 Identities=22% Similarity=0.250 Sum_probs=198.2
Q ss_pred CeEEEEEecccCceEEEEEEEcCCC-cEEEEEEeccccCcccHHHHHHHHHHHHhCC----CCCceeeeeEE-EeCCEEE
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLN-EIVAIKVLDLEKCNNDLDGIRREVQTMRVTN----HPNVLRAHCSF-TTGHCLW 88 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg-~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~----HpNIVkl~~~~-~~~~~l~ 88 (671)
+|++.+.||+|+||.||.|.+..++ ..+|+|+.......... .+..|+.++..+. .+++..+++.+ ..+.+.|
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 8999999999999999999988775 67899987654333322 6778888888876 36899999999 5888999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCC-----CceEEecccccc-
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSN-----GAIKLADFGVSA- 162 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~-----g~vKL~DFGls~- 162 (671)
|||+.+ |.+|.++......+.|+..++..++.|++.+|++||+.|+|||||||.|+++... ..+.|.|||+++
T Consensus 98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~ 176 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR 176 (322)
T ss_pred EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence 999988 8899998876655789999999999999999999999999999999999999765 359999999998
Q ss_pred -ccccCCCc----ccc-cccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC
Q 005886 163 -CMFDAGDR----QRS-RNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP 236 (671)
Q Consensus 163 -~~~~~~~~----~~~-~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~ 236 (671)
.+...... .+. ...+.||..|+++.++.+ ...+.+.|+||++.++.+|+.|..||.+...............
T Consensus 177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~- 254 (322)
T KOG1164|consen 177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR- 254 (322)
T ss_pred ccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh-
Confidence 43322221 111 234679999999999988 6689999999999999999999999977654322221111111
Q ss_pred CCCcc-ccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 237 GLDYE-RDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 237 ~~~~~-~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
..... .....+.++..+...+-..+...+|....+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 11111 22334677888888888889999999887755
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.6e-27 Score=267.18 Aligned_cols=262 Identities=19% Similarity=0.242 Sum_probs=200.2
Q ss_pred EEEEEecccCceEEEEEEEcCCCcEEEEEEeccc--cCc---ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 17 RLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLE--KCN---NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 17 ~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~--~~~---~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
.....+|.|++|.|+.+.....+..++.|.+... ... .....+..|+-+-..+.|||++.....+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3467899999998888887777776776655421 111 11223666777778899999988777777666666669
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCc-
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR- 170 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~- 170 (671)
|||++ +|+.++... ..+....+-.+++|++.||.|||..||.||||||+|+++..+|.+||+|||.+..+......
T Consensus 401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 99999 999998875 56888889999999999999999999999999999999999999999999998766433332
Q ss_pred ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc----CCCCCCccccccc
Q 005886 171 QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQN----APPGLDYERDKRF 246 (671)
Q Consensus 171 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~----~~~~~~~~~~~~l 246 (671)
.......+|+..|+|||++.+.......+||||.|++++.|++|+.||......+........ ....-.+..+..+
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 557 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLL 557 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhc
Confidence 134567899999999999998543445689999999999999999999654333221111110 0011112335567
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 247 SKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 247 s~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
+...+.+|.+||+.||.+|.|+++|++.+||+...
T Consensus 558 p~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 558 PRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred hhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 88899999999999999999999999999998643
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.2e-25 Score=237.78 Aligned_cols=182 Identities=18% Similarity=0.182 Sum_probs=139.0
Q ss_pred ccccCCCCeEEEEEecccCceEEEEEEEcC-CCcEEEEEEeccccC----cccHHHHHHHHHHHHhCCCCCcee-eeeEE
Q 005886 8 RFPVDAKDYRLYEEVGEGVSATVYRALCIP-LNEIVAIKVLDLEKC----NNDLDGIRREVQTMRVTNHPNVLR-AHCSF 81 (671)
Q Consensus 8 ~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~-tg~~VAIKvi~~~~~----~~~~~~i~~Ei~iL~~L~HpNIVk-l~~~~ 81 (671)
..+.-.++|.+.+.||+|+||+||+|.++. ++..||||++..... ......+.+|+.+|+.+.|+||+. ++++
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 345566889999999999999999999886 678889998753311 123567899999999999999985 4432
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccC-CCCcEEEcCCCceEEecccc
Q 005886 82 TTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDV-KAGNILIDSNGAIKLADFGV 160 (671)
Q Consensus 82 ~~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDL-KPeNILld~~g~vKL~DFGl 160 (671)
...|+|||||.|++|... .. .. ...++.+++.||.|||++||+|||| ||+|||++.++.+||+|||+
T Consensus 91 ---~~~~LVmE~~~G~~L~~~-~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHLA-RP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred ---CCcEEEEEccCCCCHHHh-Cc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 457999999999999632 11 11 1467899999999999999999999 99999999999999999999
Q ss_pred ccccccCCCccc-----ccccccCCCCCCChhHhhhcc-----CCCccchhh
Q 005886 161 SACMFDAGDRQR-----SRNTFVGTPCWMAPEVMQQLH-----GYDFKADIW 202 (671)
Q Consensus 161 s~~~~~~~~~~~-----~~~~~~GT~~Y~APEvl~~~~-----~~s~ksDIW 202 (671)
|+.+...+.... ...+.++++.|+|||.+.... ..+...|-|
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 987654332111 113567899999999986421 133446766
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-24 Score=220.55 Aligned_cols=254 Identities=19% Similarity=0.260 Sum_probs=202.9
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCC-CCCceeeeeEEEeCCEEEE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN-HPNVLRAHCSFTTGHCLWV 89 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~-HpNIVkl~~~~~~~~~l~L 89 (671)
+..-.|+++++||.|+||+++.|++.-+|++||||+=. ...+...++.|.+..+.|. .++|..+|.+...+.+-.|
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP---rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP---RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEecc---ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence 55568999999999999999999999999999999743 3345567889999998884 7999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC-----ceEEecccccccc
Q 005886 90 VMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG-----AIKLADFGVSACM 164 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g-----~vKL~DFGls~~~ 164 (671)
|||++ |.+|.++..-+ ...|+..++..++.|++.-++|+|.+.+|+|||||+|+||...+ .|.|+|||+|+.+
T Consensus 102 VidLL-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhhhh-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 99998 78888887755 46799999999999999999999999999999999999997644 5899999999888
Q ss_pred ccCCCcc----cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhcCC-CC
Q 005886 165 FDAGDRQ----RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPP--MKVLLMTLQNAP-PG 237 (671)
Q Consensus 165 ~~~~~~~----~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~--~~~~~~~~~~~~-~~ 237 (671)
.+..... +......||..||+-....| ..-+.+.|+-|||-+++++|-|.+||.+... .+...+.+.... ..
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST 258 (449)
T ss_pred cCccccccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence 6654432 34467789999999999888 5678899999999999999999999987642 222222222221 11
Q ss_pred CCccccccchHHHHHHHHHhhhcCCCCCCCHHH
Q 005886 238 LDYERDKRFSKSFKELVTACLVKDPKKRPTAEK 270 (671)
Q Consensus 238 ~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~e 270 (671)
.......++|.++...+.-.-..+-.+-|..+-
T Consensus 259 ~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdy 291 (449)
T KOG1165|consen 259 PIEVLCEGFPEEFATYLRYVRRLDFFETPDYDY 291 (449)
T ss_pred CHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHH
Confidence 122334567777777777766666666666543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.2e-26 Score=249.83 Aligned_cols=256 Identities=28% Similarity=0.407 Sum_probs=210.5
Q ss_pred EecccCceEEEEEEE---cCCCcEEEEEEeccccCcc-cHHHHHHHHHHHHhCC-CCCceeeeeEEEeCCEEEEEEeccC
Q 005886 21 EVGEGVSATVYRALC---IPLNEIVAIKVLDLEKCNN-DLDGIRREVQTMRVTN-HPNVLRAHCSFTTGHCLWVVMPYMA 95 (671)
Q Consensus 21 ~LG~G~fG~Vyka~~---~~tg~~VAIKvi~~~~~~~-~~~~i~~Ei~iL~~L~-HpNIVkl~~~~~~~~~l~LVmEy~~ 95 (671)
.+|+|+||.|+++.- ...|.-||+|++.+..... ....-..|-.++..++ ||.+|+++..|..+..+|+++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999987642 2456779999987654322 2224556778888887 9999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccccc
Q 005886 96 GGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRN 175 (671)
Q Consensus 96 ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 175 (671)
||+|+..+... ..+.+.....+...++.+++++|..||+|||+|++||+++.+|++++.|||+++...+...
T Consensus 81 gg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~------ 152 (612)
T KOG0603|consen 81 GGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI------ 152 (612)
T ss_pred cchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh------
Confidence 99999887765 6788999999999999999999999999999999999999999999999999876643221
Q ss_pred cccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHH
Q 005886 176 TFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVT 255 (671)
Q Consensus 176 ~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~ 255 (671)
.|||..|||||++. ++...+|.||||+++++|++|..||.+ ++...++... ...+..++..+++++.
T Consensus 153 -~cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~-----~~~p~~l~~~a~~~~~ 219 (612)
T KOG0603|consen 153 -ACGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE-----LEMPRELSAEARSLFR 219 (612)
T ss_pred -cccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc-----cCCchhhhHHHHHHHH
Confidence 19999999999997 378899999999999999999999988 3444444322 2335678899999999
Q ss_pred HhhhcCCCCCCC-----HHHHHhchhccccccchHHHHHHhhhccch
Q 005886 256 ACLVKDPKKRPT-----AEKLMKHHFFKHARSNDFLARSIVDNLAPL 297 (671)
Q Consensus 256 ~cL~~dP~kRpS-----a~eiL~Hpwfk~~~~~~~~~~~l~~~l~~~ 297 (671)
.++..+|.+|.. +.++++|+||+...|.....+.+...+.|.
T Consensus 220 ~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~ 266 (612)
T KOG0603|consen 220 QLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPG 266 (612)
T ss_pred HHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCc
Confidence 999999999975 579999999999988877666655555543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-24 Score=211.62 Aligned_cols=256 Identities=20% Similarity=0.246 Sum_probs=202.7
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCC-CCCceeeeeEEEeCCEE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN-HPNVLRAHCSFTTGHCL 87 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~-HpNIVkl~~~~~~~~~l 87 (671)
-.+....|+++++||.|+||.+|.|.+..+|..||||+=. .......+..|..+.+.|. ...|..+..++.+..+-
T Consensus 10 ~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es---~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 10 ELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLES---SKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred hheeccceEEEEeecCCchhheeeeeeccCCceEEEEeec---ccCCCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 3467899999999999999999999999999999999842 2233456778888888886 46788888889999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCC---CceEEecccccccc
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSN---GAIKLADFGVSACM 164 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~---g~vKL~DFGls~~~ 164 (671)
.+||+++ |.+|.++..-. ...|+..++.-++-|++.-|+|+|.+++|||||||+|+|+.-+ ..+.++|||+|+.+
T Consensus 87 vlVMdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eeeeecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 9999998 78888877654 3579999999999999999999999999999999999999654 36899999999887
Q ss_pred ccCCCcc----cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHH---HHHHHHhcCCCC
Q 005886 165 FDAGDRQ----RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK---VLLMTLQNAPPG 237 (671)
Q Consensus 165 ~~~~~~~----~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~---~~~~~~~~~~~~ 237 (671)
.+..... +......||..|.+-..+.+ ..-+.+.|+-|+|.+|.++.-|..||.+..... ....+.......
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~ 243 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST 243 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence 6654322 23345689999998877766 346778999999999999999999998875432 223333322222
Q ss_pred CCccccccchHHHHHHHHHhhhcCCCCCCCHHH
Q 005886 238 LDYERDKRFSKSFKELVTACLVKDPKKRPTAEK 270 (671)
Q Consensus 238 ~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~e 270 (671)
..-.....+|.++.-.+..|-..--++-|...-
T Consensus 244 ~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~y 276 (341)
T KOG1163|consen 244 PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMY 276 (341)
T ss_pred CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHH
Confidence 222335678899999999998888888887543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-24 Score=246.75 Aligned_cols=233 Identities=27% Similarity=0.433 Sum_probs=182.4
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
...+|..++.|..|+||.||..+|+.+.+.+|+|+ ++.. -.+++ ++..-..|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~-----lilRn---ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-----LILRN---ILTFAGNPFVV---------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcc-cccc-----hhhhc---cccccCCccee----------------
Confidence 34789999999999999999999999999999954 3222 11111 33444555554
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC---
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG--- 168 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~--- 168 (671)
|++...++.. +.++.. ++.+++|||+.||+|||+||+|.+|+.-|++|++|||+++.....-
T Consensus 136 -----gDc~tllk~~--g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -----GDCATLLKNI--GPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -----chhhhhcccC--CCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 6777777664 444433 2789999999999999999999999999999999999985432110
Q ss_pred ---------CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC
Q 005886 169 ---------DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD 239 (671)
Q Consensus 169 ---------~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~ 239 (671)
.+.-.....||||.|+|||++.. .+|+..+|+|++|+|+|+++.|..||.+.++.+.+...+.......
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp- 278 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP- 278 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc-
Confidence 11112245699999999999987 7899999999999999999999999999999888777766543322
Q ss_pred ccccccchHHHHHHHHHhhhcCCCCCC---CHHHHHhchhccccccchHHH
Q 005886 240 YERDKRFSKSFKELVTACLVKDPKKRP---TAEKLMKHHFFKHARSNDFLA 287 (671)
Q Consensus 240 ~~~~~~ls~~l~dLI~~cL~~dP~kRp---Sa~eiL~Hpwfk~~~~~~~~~ 287 (671)
+.+..++++++++|.++|..+|..|. .+-++..|+||+...|...+.
T Consensus 279 -E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llR 328 (1205)
T KOG0606|consen 279 -EEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLR 328 (1205)
T ss_pred -ccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhh
Confidence 33566889999999999999999994 577899999999988875543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.7e-23 Score=238.20 Aligned_cols=249 Identities=24% Similarity=0.263 Sum_probs=185.8
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHH---HHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGI---RREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i---~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
+|...+.||.+.|=+|.+|++.. |. |+||++-+..-.-.+..+ .+|++ ...++|||++.+.-+...+...|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 78899999999999999998763 44 889998654423233333 33444 56779999999998888888999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
+|... +|++.+... +.+...+.++|+.||+.||..||..||+|||||.+||||+.-.-+.|+||...+..+-+.+..
T Consensus 101 qyvkh-nLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHhh-hhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 99854 788888765 567888899999999999999999999999999999999999999999998765554444544
Q ss_pred cccccccCC----CCCCChhHhhhccC----------CCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCC
Q 005886 172 RSRNTFVGT----PCWMAPEVMQQLHG----------YDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPP 236 (671)
Q Consensus 172 ~~~~~~~GT----~~Y~APEvl~~~~~----------~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~ 236 (671)
.....++.| .||+|||.+....+ .+++-||||+||+++||++ |++||.-. .+.....+...
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~aYr~~~~~ 253 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLAYRSGNAD 253 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHhHhccCcc
Confidence 444445544 47999999875221 4578899999999999999 89999421 11111000000
Q ss_pred CCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 237 GLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 237 ~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
........-=+..++.||..|++.||.+|.+|++.|+
T Consensus 254 ~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~ 290 (1431)
T KOG1240|consen 254 DPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQ 290 (1431)
T ss_pred CHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHH
Confidence 0000000011347899999999999999999999987
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.5e-22 Score=195.58 Aligned_cols=139 Identities=17% Similarity=0.168 Sum_probs=109.9
Q ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-cc------------------------HHHHHHHHHHHHhCCCCC
Q 005886 19 YEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-ND------------------------LDGIRREVQTMRVTNHPN 73 (671)
Q Consensus 19 ~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~------------------------~~~i~~Ei~iL~~L~HpN 73 (671)
.+.||+|+||.||+|.+. +|+.||||+++..... .. .....+|+..+..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999987 8999999999754211 01 122345999999998888
Q ss_pred ceeeeeEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH-HHCCcccccCCCCcEEEcCCCc
Q 005886 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYL-HFHGHIHRDVKAGNILIDSNGA 152 (671)
Q Consensus 74 IVkl~~~~~~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yL-Hs~gIVHrDLKPeNILld~~g~ 152 (671)
+...+.+.... .+|||||+.|+++...+... ..+++..+..++.|++.+|.|| |+.||+||||||+|||++ ++.
T Consensus 81 v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 81 IPCPEPILLKS--HVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCCcEEEecC--CEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 75544433332 38999999988776543332 5789999999999999999999 799999999999999998 578
Q ss_pred eEEeccccccc
Q 005886 153 IKLADFGVSAC 163 (671)
Q Consensus 153 vKL~DFGls~~ 163 (671)
++|+|||+|..
T Consensus 156 v~LiDFG~a~~ 166 (190)
T cd05147 156 LYIIDVSQSVE 166 (190)
T ss_pred EEEEEcccccc
Confidence 99999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.1e-21 Score=200.67 Aligned_cols=236 Identities=22% Similarity=0.355 Sum_probs=151.7
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCC----------CCceeeeeEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNH----------PNVLRAHCSF 81 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~H----------pNIVkl~~~~ 81 (671)
..+...+.||.|+|+.||.+++..||+.+|+|++..... ....+.+++|.-....+.+ -.++-.++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 356678899999999999999999999999999865442 2346777777655544322 1222222222
Q ss_pred ---------EeC---C-----EEEEEEeccCCCCHHHHHHh---hCCCC--CCHHHHHHHHHHHHHHHHHHHHCCccccc
Q 005886 82 ---------TTG---H-----CLWVVMPYMAGGSCLHIMKS---AYPEG--FEEPVIATLLRETLKALVYLHFHGHIHRD 139 (671)
Q Consensus 82 ---------~~~---~-----~l~LVmEy~~ggsL~~~l~~---~~~~~--l~e~~i~~i~~qIl~aL~yLHs~gIVHrD 139 (671)
... . +.+++|+-+. ++|..++.. ..... +.......+..|++..+++||..|+||+|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgd 170 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGD 170 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecc
Confidence 111 1 2467888774 577776542 21111 12222345568999999999999999999
Q ss_pred CCCCcEEEcCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhc-------cCCCccchhhhHHHHHHHHH
Q 005886 140 VKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQL-------HGYDFKADIWSFGITALELA 212 (671)
Q Consensus 140 LKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~-------~~~s~ksDIWSLGvILyeLl 212 (671)
|+|+|+|++.+|.+.|+||+..... +..... ...+..|.+||+.... ..++.+.|.|+||+++|.|+
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~---g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRA---GTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEET---TEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cceeeEEEcCCCCEEEcChHHHeec---Cceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 9999999999999999999976433 221111 2446789999987542 23788899999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCC
Q 005886 213 HGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKR 265 (671)
Q Consensus 213 tG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kR 265 (671)
||..||........ ....+.....+|..++.||..+|..+|.+|
T Consensus 245 C~~lPf~~~~~~~~---------~~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEAD---------PEWDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGST---------SGGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCcccc---------ccccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 99999986533211 110233334789999999999999999988
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.9e-21 Score=195.28 Aligned_cols=171 Identities=15% Similarity=0.203 Sum_probs=132.1
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCccc--HHH------HHHHHHHHHhCCCCCceeeeeEEEe
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNND--LDG------IRREVQTMRVTNHPNVLRAHCSFTT 83 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~--~~~------i~~Ei~iL~~L~HpNIVkl~~~~~~ 83 (671)
..++|++.+.||.|+||.||++.. ++..+|||++........ ... +.+|+..+.++.||+|..+.+++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 458999999999999999999754 466899999864432221 122 6799999999999999999988764
Q ss_pred C--------CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEE
Q 005886 84 G--------HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKL 155 (671)
Q Consensus 84 ~--------~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL 155 (671)
. ...+|||||++|.+|.++.. +++ ..+.+++.+|..||..|++|||+||+||+++.+| ++|
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~l 175 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRI 175 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEE
Confidence 3 35789999999999977631 333 3466999999999999999999999999999988 999
Q ss_pred eccccccccccCCCcccccccccCCCCCCChh-HhhhccCCCccchhhhHHHHHHHHH
Q 005886 156 ADFGVSACMFDAGDRQRSRNTFVGTPCWMAPE-VMQQLHGYDFKADIWSFGITALELA 212 (671)
Q Consensus 156 ~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APE-vl~~~~~~s~ksDIWSLGvILyeLl 212 (671)
+|||....... .. |-+ +... ..|+.++|+|+||+++..+.
T Consensus 176 iDfg~~~~~~e--~~--------------a~d~~vle-r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 176 IDLSGKRCTAQ--RK--------------AKDRIDLE-RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EECCCcccccc--hh--------------hHHHHHHH-hHhcccccccceeEeehHHH
Confidence 99997643311 00 111 2222 45778999999999887654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.3e-21 Score=187.72 Aligned_cols=139 Identities=18% Similarity=0.211 Sum_probs=111.8
Q ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--------------------cc-----HHHHHHHHHHHHhCCCCC
Q 005886 19 YEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--------------------ND-----LDGIRREVQTMRVTNHPN 73 (671)
Q Consensus 19 ~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--------------------~~-----~~~i~~Ei~iL~~L~HpN 73 (671)
.+.||+|+||.||+|.+. +|+.||||+++..... .. ...+.+|+..+..+.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 478999999999999987 8999999998754211 00 123467899999999999
Q ss_pred ceeeeeEEEeCCEEEEEEeccCCCCHHHH-HHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCcEEEcCCC
Q 005886 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLHI-MKSAYPEGFEEPVIATLLRETLKALVYLHF-HGHIHRDVKAGNILIDSNG 151 (671)
Q Consensus 74 IVkl~~~~~~~~~l~LVmEy~~ggsL~~~-l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs-~gIVHrDLKPeNILld~~g 151 (671)
|.....+.... .||||||+.|+++... +.. ..+++..+..++.|++.+|.+||. .||+||||||+|||++ ++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC
Confidence 86555544433 4799999998855433 332 457888899999999999999999 9999999999999998 89
Q ss_pred ceEEecccccccc
Q 005886 152 AIKLADFGVSACM 164 (671)
Q Consensus 152 ~vKL~DFGls~~~ 164 (671)
.++|+|||++..+
T Consensus 155 ~~~liDFG~a~~~ 167 (190)
T cd05145 155 KPYIIDVSQAVEL 167 (190)
T ss_pred CEEEEEcccceec
Confidence 9999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-21 Score=195.71 Aligned_cols=251 Identities=21% Similarity=0.368 Sum_probs=199.8
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH 85 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~ 85 (671)
+---|+.....++-+|.....|..|+|++. |..+++|++....+. ..-..|..|.-.|+.+.||||+.+++.+...-
T Consensus 183 r~~gid~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp 260 (448)
T KOG0195|consen 183 RYTGIDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP 260 (448)
T ss_pred cccCcchhhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC
Confidence 334566777778889999999999999877 444667888655433 23456788888999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC-ccc-ccCCCCcEEEcCCCceEEe--ccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHG-HIH-RDVKAGNILIDSNGAIKLA--DFGVS 161 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~g-IVH-rDLKPeNILld~~g~vKL~--DFGls 161 (671)
++.++..||+.|+|+.++.....--.+..++.+++.+|+.|++|||+.. ++- --|....+++|++-+.+|. |--++
T Consensus 261 nlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs 340 (448)
T KOG0195|consen 261 NLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS 340 (448)
T ss_pred CceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee
Confidence 9999999999999999998764444677889999999999999999973 443 4688999999998776654 33222
Q ss_pred cccccCCCcccccccccCCCCCCChhHhhhccC--CCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC
Q 005886 162 ACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHG--YDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD 239 (671)
Q Consensus 162 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~--~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~ 239 (671)
. . .....-.|.||+||.++.... --.++|+|||++++|||.|...||.+.++++.-..+.- .++.
T Consensus 341 f---q-------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial---eglr 407 (448)
T KOG0195|consen 341 F---Q-------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL---EGLR 407 (448)
T ss_pred e---e-------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh---cccc
Confidence 1 0 112245789999999987432 23578999999999999999999999999887655533 4566
Q ss_pred ccccccchHHHHHHHHHhhhcCCCCCCCHHHHH
Q 005886 240 YERDKRFSKSFKELVTACLVKDPKKRPTAEKLM 272 (671)
Q Consensus 240 ~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL 272 (671)
...+++++..+..|+.-|++.||.+||.+..|+
T Consensus 408 v~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 408 VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred ccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 677889999999999999999999999987663
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.1e-20 Score=183.05 Aligned_cols=189 Identities=15% Similarity=0.121 Sum_probs=140.9
Q ss_pred EEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc---ccHHHHHHHHHHHHhCC-CCCceeeeeEEEeCCEEEEEEe
Q 005886 17 RLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN---NDLDGIRREVQTMRVTN-HPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 17 ~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~---~~~~~i~~Ei~iL~~L~-HpNIVkl~~~~~~~~~l~LVmE 92 (671)
.+...|++|+||+||.+.. .+..++.+.+.....- -....+.+|+++|+.|. |++|++++++ +..|++|+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3568899999999997765 5777877766544321 11236789999999995 5889999886 34689999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccC-CCCcEEEcCCCceEEeccccccccccCCC--
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDV-KAGNILIDSNGAIKLADFGVSACMFDAGD-- 169 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDL-KPeNILld~~g~vKL~DFGls~~~~~~~~-- 169 (671)
|+.|.+|...+.. . ...++.|++.+|.+||.+||+|||| ||+|||++.+|.++|+|||+|......+.
T Consensus 79 yI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 79 YLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred eecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 9999998654321 1 1357889999999999999999999 79999999999999999999874422211
Q ss_pred ---cccc-----cccccCCCCCCChhHhhhccCCC-ccchhhhHHHHHHHHHhCCCCCCC
Q 005886 170 ---RQRS-----RNTFVGTPCWMAPEVMQQLHGYD-FKADIWSFGITALELAHGHAPFSK 220 (671)
Q Consensus 170 ---~~~~-----~~~~~GT~~Y~APEvl~~~~~~s-~ksDIWSLGvILyeLltG~~PF~~ 220 (671)
.... ..-...++.|++|+...-....+ ...+.++.|+-+|.++|+..|+.+
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0000 01123688999999765433344 567888999999999999998754
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.2e-21 Score=211.38 Aligned_cols=181 Identities=23% Similarity=0.380 Sum_probs=133.0
Q ss_pred EEEEEEeccCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAY-PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACM 164 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~-~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~ 164 (671)
++||.|++|.-++|.+++.... ....+...+..++.|+..|++| +|.+|||+||.||++..+..+||.|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 3666888888889999887432 2346677789999999999999 99999999999999999999999999998665
Q ss_pred ccCC---CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCc
Q 005886 165 FDAG---DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDY 240 (671)
Q Consensus 165 ~~~~---~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~ 240 (671)
.... .........+||.+||+||.+.+ ..|+.++||||||+||+||+. -..+|.... ....++.. .++.
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~f~T~~er~~----t~~d~r~g--~ip~ 479 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQFSTQFERIA----TLTDIRDG--IIPP 479 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHHhccHHHHHH----hhhhhhcC--CCCh
Confidence 3322 11234456789999999999998 679999999999999999997 223322111 11111111 0110
Q ss_pred cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 241 ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 241 ~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
..+..+ +.-.+|+.+||.+.|.+||++.+.-.|+|.
T Consensus 480 ~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 480 EFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred HHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 111222 234689999999999999988777777765
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-20 Score=196.51 Aligned_cols=191 Identities=29% Similarity=0.387 Sum_probs=139.4
Q ss_pred CCCCceeeeeEEEe---------------------------CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHH
Q 005886 70 NHPNVLRAHCSFTT---------------------------GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRE 122 (671)
Q Consensus 70 ~HpNIVkl~~~~~~---------------------------~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~q 122 (671)
.|||||++..+|.+ ...+|+||..... +|..++-.. ..+-...+-++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~---~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR---HRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC---CCchHHHHHHHHH
Confidence 59999999888743 2468999987754 788877654 4566778889999
Q ss_pred HHHHHHHHHHCCcccccCCCCcEEE--cCCC--ceEEeccccccccccCCCcc-----cccccccCCCCCCChhHhhhcc
Q 005886 123 TLKALVYLHFHGHIHRDVKAGNILI--DSNG--AIKLADFGVSACMFDAGDRQ-----RSRNTFVGTPCWMAPEVMQQLH 193 (671)
Q Consensus 123 Il~aL~yLHs~gIVHrDLKPeNILl--d~~g--~vKL~DFGls~~~~~~~~~~-----~~~~~~~GT~~Y~APEvl~~~~ 193 (671)
+++|+.|||.+||.|||+|.+|||+ ++++ .+.|+|||.+ +.+..... ......-|...-||||+.....
T Consensus 350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCc--LAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCC--LADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccccee--eeccccccccccccccccCCCcceecchhhhhcCC
Confidence 9999999999999999999999998 4444 5789999965 32222111 1112235778899999987533
Q ss_pred CC-----CccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCH
Q 005886 194 GY-----DFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTA 268 (671)
Q Consensus 194 ~~-----s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa 268 (671)
+. -.++|.|+.|.+.||+++...||.+...+..-....+.. --...+..+++.++++|-.+|+.||.+|+++
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~---qLPalp~~vpp~~rqlV~~lL~r~pskRvsp 504 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQES---QLPALPSRVPPVARQLVFDLLKRDPSKRVSP 504 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhh---hCCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence 32 247999999999999999999998743322111111111 1123356789999999999999999999985
Q ss_pred H
Q 005886 269 E 269 (671)
Q Consensus 269 ~ 269 (671)
.
T Consensus 505 ~ 505 (598)
T KOG4158|consen 505 N 505 (598)
T ss_pred c
Confidence 3
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.8e-19 Score=180.25 Aligned_cols=134 Identities=19% Similarity=0.158 Sum_probs=108.3
Q ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhC-----CCCCceeeeeEEEeCC---E-EEE
Q 005886 19 YEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-----NHPNVLRAHCSFTTGH---C-LWV 89 (671)
Q Consensus 19 ~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-----~HpNIVkl~~~~~~~~---~-l~L 89 (671)
.+.||+|+||.||. +..++.. +||++..... ...+.+.+|+.+++.+ +||||++++++++++. . +.+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~-~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD-GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc-chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 46899999999995 7777665 6999876432 2356789999999999 6799999999999874 4 347
Q ss_pred EEec--cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHH-HHHHHCCcccccCCCCcEEEcCC----CceEEeccccc
Q 005886 90 VMPY--MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKAL-VYLHFHGHIHRDVKAGNILIDSN----GAIKLADFGVS 161 (671)
Q Consensus 90 VmEy--~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL-~yLHs~gIVHrDLKPeNILld~~----g~vKL~DFGls 161 (671)
|||| +.+|+|.+++... .+++. ..++.+++.++ +|||+++||||||||+|||++.. +.++|+||+-+
T Consensus 83 I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 8999 5579999999763 46666 36688888888 99999999999999999999743 37999995543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.3e-19 Score=209.54 Aligned_cols=201 Identities=21% Similarity=0.290 Sum_probs=162.0
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCC---CCCceeeeeEEEe
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN---HPNVLRAHCSFTT 83 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~---HpNIVkl~~~~~~ 83 (671)
.-+++....|.|-++||+|+||.||+|.+.. |+.||+|+=.....-+ +.--.+++.+|+ -+-|..++..+.-
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE----fYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE----FYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee----eeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 4477888999999999999999999999887 9999999843322111 111223344444 3445666666666
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcC-------CCceEEe
Q 005886 84 GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS-------NGAIKLA 156 (671)
Q Consensus 84 ~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~-------~g~vKL~ 156 (671)
.+..+||++|...|+|.+++... +.+++..+..+..|+|..|++||..+|||+||||+|+||.. ...++|+
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~--~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTN--KVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred CCcceeeeeccccccHHHhhccC--CCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEE
Confidence 77788999999999999999844 78999999999999999999999999999999999999943 2369999
Q ss_pred ccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCC
Q 005886 157 DFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHA 216 (671)
Q Consensus 157 DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~ 216 (671)
|||-+..|.-..+. ......++|-.+-.+|+..| ..+++.+|.|.|+-++|.||.|+.
T Consensus 844 DfG~siDm~lfp~~-~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDG-TKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ecccceeeeEcCCC-cEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHHH
Confidence 99988666433332 45667789999999999988 789999999999999999999853
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4e-21 Score=220.54 Aligned_cols=267 Identities=21% Similarity=0.321 Sum_probs=216.9
Q ss_pred CCCeEEEEEecccCceEEEEEEEcC-CCcEEEEEEecccc-CcccHHHHHHHHHHHHhCC-CCCceeeeeEEEeCCEEEE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIP-LNEIVAIKVLDLEK-CNNDLDGIRREVQTMRVTN-HPNVLRAHCSFTTGHCLWV 89 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~-tg~~VAIKvi~~~~-~~~~~~~i~~Ei~iL~~L~-HpNIVkl~~~~~~~~~l~L 89 (671)
...|.+.+.||+|+|+.|-.+.... +...+|.|.+.... .......+..|..+-+.+. |+|++.+++........++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 4678899999999999999887643 34456777765543 2334566677888877787 9999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccccCCCCcEEEcCCC-ceEEeccccccccccC
Q 005886 90 VMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLH-FHGHIHRDVKAGNILIDSNG-AIKLADFGVSACMFDA 167 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLH-s~gIVHrDLKPeNILld~~g-~vKL~DFGls~~~~~~ 167 (671)
+++|..|++++..+........+...+..++.|+..++.|+| ..++.||||||+|.+++..+ .++++|||+|..+...
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 999999999999883222226777788999999999999999 99999999999999999999 9999999999877553
Q ss_pred CCcccccccccC-CCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Q 005886 168 GDRQRSRNTFVG-TPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246 (671)
Q Consensus 168 ~~~~~~~~~~~G-T~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (671)
..........+| ++.|+|||...+.....+..|+||+|+++.-+++|..||...................+.+..+..+
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSI 258 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccC
Confidence 344445566788 9999999999875556888999999999999999999997554433322222233333455668889
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHhchhccc
Q 005886 247 SKSFKELVTACLVKDPKKRPTAEKLMKHHFFKH 279 (671)
Q Consensus 247 s~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~ 279 (671)
+....+++.+++..+|..|.+.+++..+||+..
T Consensus 259 ~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 259 SDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ChhhhhcccccccCCchhccccccccccccccc
Confidence 999999999999999999999999999999976
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.3e-19 Score=180.55 Aligned_cols=141 Identities=20% Similarity=0.164 Sum_probs=111.8
Q ss_pred CeEEEEEecccCceEEEEEE-EcCCCcEEEEEEeccccCc-------------------c----cHHHHHHHHHHHHhCC
Q 005886 15 DYRLYEEVGEGVSATVYRAL-CIPLNEIVAIKVLDLEKCN-------------------N----DLDGIRREVQTMRVTN 70 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~-~~~tg~~VAIKvi~~~~~~-------------------~----~~~~i~~Ei~iL~~L~ 70 (671)
.|.+.+.||+|+||.||+|. +..+|+.||||++...... . ....+.+|+.++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58899999999999999998 7789999999998754211 0 0123578999999997
Q ss_pred CCC--ceeeeeEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccccCCCCcEEE
Q 005886 71 HPN--VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHG-HIHRDVKAGNILI 147 (671)
Q Consensus 71 HpN--IVkl~~~~~~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~g-IVHrDLKPeNILl 147 (671)
+.+ +.+++++ . ..|+||||+.|++|...+... ..+....+..++.||+.+|.+||.+| ++||||||+||++
T Consensus 109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe---c-CceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 633 3344432 2 348999999998876654332 34566677899999999999999999 9999999999999
Q ss_pred cCCCceEEecccccc
Q 005886 148 DSNGAIKLADFGVSA 162 (671)
Q Consensus 148 d~~g~vKL~DFGls~ 162 (671)
+ ++.++|+|||.+.
T Consensus 183 ~-~~~i~LiDFg~a~ 196 (237)
T smart00090 183 H-DGKVVIIDVSQSV 196 (237)
T ss_pred E-CCCEEEEEChhhh
Confidence 9 8899999999875
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.6e-18 Score=171.57 Aligned_cols=134 Identities=25% Similarity=0.320 Sum_probs=113.7
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeccccCcc-------cHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-------DLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~-------~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
+.||+|++|.||+|.+ .|..|++|+........ ....+.+|+.++..+.|++|+....++......++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999987 57789999865332211 12457789999999999999888888877788999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSA 162 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~ 162 (671)
|++|++|.+++.... . ....++.+++.+|.+||..|++|||++|.|||++ ++.++|+|||++.
T Consensus 80 ~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~ 142 (211)
T PRK14879 80 YIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAE 142 (211)
T ss_pred EeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCccc
Confidence 999999999886531 1 7789999999999999999999999999999999 7899999999875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.4e-18 Score=167.41 Aligned_cols=131 Identities=21% Similarity=0.293 Sum_probs=107.6
Q ss_pred EecccCceEEEEEEEcCCCcEEEEEEeccccCcc-------cHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 21 EVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-------DLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 21 ~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~-------~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
.||+|+||.||+|.. +|..|++|+........ ....+.+|+.+++.+.|+++.....++......++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999984 57789999865432211 135677899999999988876666666667778999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSAC 163 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~ 163 (671)
++|++|.+++... .. .++.+++.+|.+||+.|++|||++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~--~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEG--ND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhc--HH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999887543 11 7899999999999999999999999999999 88999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.4e-17 Score=182.59 Aligned_cols=205 Identities=25% Similarity=0.416 Sum_probs=157.5
Q ss_pred HHhCCCCCceeeeeEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc-ccccCCCCc
Q 005886 66 MRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGH-IHRDVKAGN 144 (671)
Q Consensus 66 L~~L~HpNIVkl~~~~~~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gI-VHrDLKPeN 144 (671)
|+.+.|.|+.++++.+.++..+++|.+||..|+|.+.+... ...++.-....++++|+.||+|||...| .|+.++..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 45789999999999999999999999999999999999873 3568888899999999999999999865 999999999
Q ss_pred EEEcCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccC------CCccchhhhHHHHHHHHHhCCCCC
Q 005886 145 ILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHG------YDFKADIWSFGITALELAHGHAPF 218 (671)
Q Consensus 145 ILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~------~s~ksDIWSLGvILyeLltG~~PF 218 (671)
++++....+||+|||+......... ........-...|.|||++.+... .+.+.||||||+++||+++...||
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~-~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAE-PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred ceeeeeEEEEechhhhccccccccc-ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 9999999999999999765532111 011111123456999999986311 356799999999999999999999
Q ss_pred CCC----ChHHHHHHHHhcCCCCCCccc--cccchHHHHHHHHHhhhcCCCCCCCHHHHH
Q 005886 219 SKY----PPMKVLLMTLQNAPPGLDYER--DKRFSKSFKELVTACLVKDPKKRPTAEKLM 272 (671)
Q Consensus 219 ~~~----~~~~~~~~~~~~~~~~~~~~~--~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL 272 (671)
... .+.++...+.......+.... ...+.+++..+++.||..+|..||+++++-
T Consensus 159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHH
Confidence 652 233344443331222222111 114566899999999999999999999874
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.5e-17 Score=163.80 Aligned_cols=137 Identities=24% Similarity=0.237 Sum_probs=108.1
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc---------------------ccHHHHHHHHHHHHhCCCCC
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN---------------------NDLDGIRREVQTMRVTNHPN 73 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~---------------------~~~~~i~~Ei~iL~~L~HpN 73 (671)
.|.+.+.||.|+||.||+|... +|+.||||++...... .......+|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 4888899999999999999874 7999999997643210 01123567888998888874
Q ss_pred --ceeeeeEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC
Q 005886 74 --VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG 151 (671)
Q Consensus 74 --IVkl~~~~~~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g 151 (671)
++.+++ ....++||||+.|++|..+... .....++.+|+.++.++|..|++||||||+||+++.++
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC
Confidence 444443 2345899999999988765321 34567889999999999999999999999999999999
Q ss_pred ceEEecccccccc
Q 005886 152 AIKLADFGVSACM 164 (671)
Q Consensus 152 ~vKL~DFGls~~~ 164 (671)
.++|+|||++...
T Consensus 163 ~~~liDfg~~~~~ 175 (198)
T cd05144 163 KIYIIDWPQMVST 175 (198)
T ss_pred cEEEEECCccccC
Confidence 9999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.5e-16 Score=181.76 Aligned_cols=135 Identities=18% Similarity=0.220 Sum_probs=109.9
Q ss_pred eEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-------ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q 005886 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-------NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 16 Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-------~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~ 88 (671)
|...+.||+|+||+||+|.+.. ..+++|+....... .....+.+|+.+++.+.|++|+.++.++......+
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 4557899999999999998753 33455543221111 12356889999999999999998888887777889
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccc
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSAC 163 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~ 163 (671)
+||||++|++|.+++. ....++.+++.+|.|||+.|++||||||+|||+ .++.++|+|||+++.
T Consensus 413 lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999999998875 246789999999999999999999999999999 678999999999753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.4e-16 Score=151.39 Aligned_cols=136 Identities=21% Similarity=0.254 Sum_probs=98.1
Q ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHH----------------------HHHHHHHHHhCCCCC--
Q 005886 19 YEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDG----------------------IRREVQTMRVTNHPN-- 73 (671)
Q Consensus 19 ~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~----------------------i~~Ei~iL~~L~HpN-- 73 (671)
.+.||+|+||+||+|.+. +|+.||||++...... ..... ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999876 8999999998643211 11111 135666666664433
Q ss_pred ceeeeeEEEeCCEEEEEEeccCCCCHHH-HHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCcEEEcCCC
Q 005886 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLH-IMKSAYPEGFEEPVIATLLRETLKALVYLHF-HGHIHRDVKAGNILIDSNG 151 (671)
Q Consensus 74 IVkl~~~~~~~~~l~LVmEy~~ggsL~~-~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs-~gIVHrDLKPeNILld~~g 151 (671)
+.++++. ...++||||+.|+.+.. .+... .. ...+..++.+++.++.++|. .||+||||||+||+++ ++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhh---hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence 4444443 23589999999854322 12211 01 15678999999999999999 9999999999999999 89
Q ss_pred ceEEecccccccc
Q 005886 152 AIKLADFGVSACM 164 (671)
Q Consensus 152 ~vKL~DFGls~~~ 164 (671)
.++|+|||.+...
T Consensus 152 ~~~liDfg~a~~~ 164 (187)
T cd05119 152 KVYIIDVPQAVEI 164 (187)
T ss_pred cEEEEECcccccc
Confidence 9999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.2e-15 Score=137.59 Aligned_cols=131 Identities=18% Similarity=0.213 Sum_probs=110.8
Q ss_pred EEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCC--CCceeeeeEEEeCCEEEEEEeccC
Q 005886 18 LYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNH--PNVLRAHCSFTTGHCLWVVMPYMA 95 (671)
Q Consensus 18 l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~H--pNIVkl~~~~~~~~~l~LVmEy~~ 95 (671)
+++.||.|.++.||++.... ..+++|.+..... ...+.+|+.+++.+.| .++++++.++...+..|++|||+.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 45789999999999998753 6799999754432 4678899999999976 589999999888889999999998
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCCCcEEEcCCCceEEecccccc
Q 005886 96 GGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH---GHIHRDVKAGNILIDSNGAIKLADFGVSA 162 (671)
Q Consensus 96 ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~---gIVHrDLKPeNILld~~g~vKL~DFGls~ 162 (671)
|+.+..+ +......++.+++.+|++||.. +++|+|++|.||+++..+.++++|||.++
T Consensus 77 g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 77 GETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred CeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 8766533 4456678899999999999985 79999999999999998999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=8.9e-15 Score=150.50 Aligned_cols=133 Identities=17% Similarity=0.171 Sum_probs=102.0
Q ss_pred Eec-ccCceEEEEEEEcCCCcEEEEEEeccccC------------cccHHHHHHHHHHHHhCCCCCc--eeeeeEEEeCC
Q 005886 21 EVG-EGVSATVYRALCIPLNEIVAIKVLDLEKC------------NNDLDGIRREVQTMRVTNHPNV--LRAHCSFTTGH 85 (671)
Q Consensus 21 ~LG-~G~fG~Vyka~~~~tg~~VAIKvi~~~~~------------~~~~~~i~~Ei~iL~~L~HpNI--Vkl~~~~~~~~ 85 (671)
.|| .|+.|+||.+... +..++||.+..... ......+.+|+.++..+.|++| ++++++.....
T Consensus 38 ~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 38 VVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred eeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 466 7777888887654 77899998853221 1223567889999999998875 66776654322
Q ss_pred ----EEEEEEeccCC-CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccc
Q 005886 86 ----CLWVVMPYMAG-GSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGV 160 (671)
Q Consensus 86 ----~l~LVmEy~~g-gsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGl 160 (671)
..++|||++.| .+|.+++... .+++. .+.+|+.+|.+||.+||+||||||+|||++.++.++|+|||.
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 23599999997 6888887542 45554 367899999999999999999999999999999999999998
Q ss_pred cc
Q 005886 161 SA 162 (671)
Q Consensus 161 s~ 162 (671)
+.
T Consensus 189 ~~ 190 (239)
T PRK01723 189 GE 190 (239)
T ss_pred cc
Confidence 64
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.4e-16 Score=182.58 Aligned_cols=271 Identities=24% Similarity=0.369 Sum_probs=216.2
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 86 (671)
|-...+.+.+.+-+-+|.|+.++.+.-..+|...++|+..+... ..+.+.++++-.++-...+|.++.....|.-...
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence 55688899999999999999999998888887777777643321 1234555555555555677888887777777888
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc-
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF- 165 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~- 165 (671)
.+|||+|+.|++|...+... ++.+++.++.+...+..+++|||...+.|||++|.|+|+..+|..++.|||......
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNS--GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred cchhhHHhccCCchhhhhcC--CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccc
Confidence 99999999999999999876 567888889999999999999999999999999999999999999999998332110
Q ss_pred -----cCC----------------------CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCC
Q 005886 166 -----DAG----------------------DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPF 218 (671)
Q Consensus 166 -----~~~----------------------~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF 218 (671)
+.. +........+||+.|.+||.+.+ ......+|+|++|+++++.++|.+||
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 000 00022345689999999999988 56788999999999999999999999
Q ss_pred CCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHH---HHHhchhccccccch
Q 005886 219 SKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAE---KLMKHHFFKHARSND 284 (671)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~---eiL~Hpwfk~~~~~~ 284 (671)
....+.+++..+.....+.. .-+...+.++++++..+|..+|.+|..+. ++..|+||+...|..
T Consensus 1036 na~tpq~~f~ni~~~~~~~p--~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIPWP--EGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred CCcchhhhhhccccCCCCCC--CCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccc
Confidence 99888887766555443322 22456789999999999999999999877 899999999887753
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=9.9e-15 Score=162.17 Aligned_cols=259 Identities=22% Similarity=0.242 Sum_probs=195.2
Q ss_pred CCCCeEEEEEecc--cCceEEEEEEE--cCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCC-CCCceeeeeEEEeCC
Q 005886 12 DAKDYRLYEEVGE--GVSATVYRALC--IPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTN-HPNVLRAHCSFTTGH 85 (671)
Q Consensus 12 ~~~~Y~l~~~LG~--G~fG~Vyka~~--~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~-HpNIVkl~~~~~~~~ 85 (671)
-...+-+...+|. |.+|.||.+.+ ..++..+|+|.-+.... +....+=.+|+.....++ |+|.++.+..|+..+
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence 3445667788999 99999999998 88899999997322211 122233345666666664 999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHH----HHHHHHHCCcccccCCCCcEEEcCC-CceEEecccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLK----ALVYLHFHGHIHRDVKAGNILIDSN-GAIKLADFGV 160 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~----aL~yLHs~gIVHrDLKPeNILld~~-g~vKL~DFGl 160 (671)
.+|+-+|+|. .+|..+.... ...+++..++.++.+... ||.++|+.+++|-|+||.||++..+ ..++++|||+
T Consensus 192 ~lfiqtE~~~-~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 192 ILFIQTELCG-ESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred cceeeecccc-chhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence 9999999995 6777666543 244888999999999999 9999999999999999999999999 8899999999
Q ss_pred ccccccCCCcccc--cccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC
Q 005886 161 SACMFDAGDRQRS--RNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL 238 (671)
Q Consensus 161 s~~~~~~~~~~~~--~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~ 238 (671)
...+.+....... .....|...|++||++.+ -++...|||++|.+..+..+|..++....... +..+.... +
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--W~~~r~~~--i 343 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSS--WSQLRQGY--I 343 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCC--cccccccc--C
Confidence 8766443322111 122367888999999986 48899999999999999999877664321100 11111111 2
Q ss_pred CccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcc
Q 005886 239 DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278 (671)
Q Consensus 239 ~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk 278 (671)
..+.....+.++...+..|+..+|..|+++..++.|+++.
T Consensus 344 p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~ 383 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH 383 (524)
T ss_pred chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence 2233445567777899999999999999999999999986
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.6e-14 Score=148.19 Aligned_cols=212 Identities=23% Similarity=0.324 Sum_probs=147.5
Q ss_pred HHHHhCCCCCceeeeeEEEeCCE-----EEEEEeccCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHC--C
Q 005886 64 QTMRVTNHPNVLRAHCSFTTGHC-----LWVVMPYMAGGSCLHIMKSAY--PEGFEEPVIATLLRETLKALVYLHFH--G 134 (671)
Q Consensus 64 ~iL~~L~HpNIVkl~~~~~~~~~-----l~LVmEy~~ggsL~~~l~~~~--~~~l~e~~i~~i~~qIl~aL~yLHs~--g 134 (671)
.-|-.+.|.|||++|.||.+..+ ..++.|||..|++..++++.. ...+....+.+|+.||+.||.|||+. -
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 44556789999999999986543 788999999999999987542 24578888999999999999999997 5
Q ss_pred cccccCCCCcEEEcCCCceEEeccccccccccC-CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh
Q 005886 135 HIHRDVKAGNILIDSNGAIKLADFGVSACMFDA-GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH 213 (671)
Q Consensus 135 IVHrDLKPeNILld~~g~vKL~DFGls~~~~~~-~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt 213 (671)
|+|+.+..+-|++..+|-+||+----....... ......+....|-+.|.|||.=.- ...+.++|||+||++..+|..
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc-cccccchhhhhhhHHHHHHHH
Confidence 999999999999999998887522111000000 001111223456789999985332 335668999999999999998
Q ss_pred CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccccc
Q 005886 214 GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSN 283 (671)
Q Consensus 214 G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~ 283 (671)
|..--......-.....+.+..-++. ..--+++|.+||+-.|..||++..+|.||.+-++...
T Consensus 278 lEiq~tnseS~~~~ee~ia~~i~~le-------n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhsl 340 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANVIIGLE-------NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHSL 340 (458)
T ss_pred heeccCCCcceeehhhhhhhheeecc-------CccccCcCcccccCCCCCCcchhhhhcCceeeecchH
Confidence 86643221111111222222221111 1123568999999999999999999999988765543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.9e-12 Score=145.45 Aligned_cols=184 Identities=18% Similarity=0.237 Sum_probs=140.3
Q ss_pred eEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccC
Q 005886 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMA 95 (671)
Q Consensus 16 Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~ 95 (671)
|++ +...-++.+.+-.|..+.++.+|.|.+++.... .....+.+-++.|+.++||||+++++.++.+..+|||+|-+.
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~ 92 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR 92 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc
Confidence 555 445555555333577888999999999876654 446678889999999999999999999999999999999884
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccc
Q 005886 96 GGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF-HGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSR 174 (671)
Q Consensus 96 ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs-~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 174 (671)
.|..+++.. ....+..-+.||+.||.|||. .+++|++|.-..|+++..|.+||++|-++......+. ..
T Consensus 93 --Pl~~~lk~l-----~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~---~~ 162 (690)
T KOG1243|consen 93 --PLETVLKEL-----GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA---PA 162 (690)
T ss_pred --cHHHHHHHh-----HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc---cc
Confidence 566666654 366777889999999999985 5899999999999999999999999988643322211 11
Q ss_pred ccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhC
Q 005886 175 NTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHG 214 (671)
Q Consensus 175 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG 214 (671)
....---.|..|+.+.. -.-..|.|-|||++++++.|
T Consensus 163 ~~~~~~~s~~~P~~~~~---s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 163 KSLYLIESFDDPEEIDP---SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccchhhhcccChhhcCc---cccchhhhhHHHHHHHHhCc
Confidence 11122234677776543 11357999999999999999
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.1e-12 Score=146.36 Aligned_cols=140 Identities=24% Similarity=0.303 Sum_probs=95.4
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeccccCc---ccH------------------------------H------HHH
Q 005886 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN---NDL------------------------------D------GIR 60 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~---~~~------------------------------~------~i~ 60 (671)
+.||.|++|.||+|+.+ +|+.||||+....-.. .+. . .+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999864 7999999997532100 000 0 133
Q ss_pred HHHHHHHhC-----CCCCceeeeeEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHH-HHHHHHHCC
Q 005886 61 REVQTMRVT-----NHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLK-ALVYLHFHG 134 (671)
Q Consensus 61 ~Ei~iL~~L-----~HpNIVkl~~~~~~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~-aL~yLHs~g 134 (671)
+|...+..+ ++++|.-..-++......+|||||+.|++|.++..... .+.. ...++..++. .+.++|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-AGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-cCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 444444443 24443322222233345689999999999988765321 1222 2345555555 478899999
Q ss_pred cccccCCCCcEEEcCCCceEEecccccccc
Q 005886 135 HIHRDVKAGNILIDSNGAIKLADFGVSACM 164 (671)
Q Consensus 135 IVHrDLKPeNILld~~g~vKL~DFGls~~~ 164 (671)
++|+|++|+||+++.+|.++++|||++..+
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 999999999999999999999999987544
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.5e-13 Score=153.94 Aligned_cols=143 Identities=19% Similarity=0.220 Sum_probs=93.1
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc---------------------------------ccHHHHH
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN---------------------------------NDLDGIR 60 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~---------------------------------~~~~~i~ 60 (671)
..|+. +.||.|++|.||+|+.+.+|+.||||++...-.. +....+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45665 7899999999999999888999999998632100 0112233
Q ss_pred HHHHHHH------hC----CCCCceeeeeEEE-eCCEEEEEEeccCCCCHHHHH--HhhCC--CCCCHHHHHHHHHHHHH
Q 005886 61 REVQTMR------VT----NHPNVLRAHCSFT-TGHCLWVVMPYMAGGSCLHIM--KSAYP--EGFEEPVIATLLRETLK 125 (671)
Q Consensus 61 ~Ei~iL~------~L----~HpNIVkl~~~~~-~~~~l~LVmEy~~ggsL~~~l--~~~~~--~~l~e~~i~~i~~qIl~ 125 (671)
+|+.+++ ++ .+.+.+.+-.+|. -....+|||||+.|+.+.++. ..... ..+.+..+..++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 3343332 22 2333233222222 234567999999999997743 22200 013344444455554
Q ss_pred HHHHHHHCCcccccCCCCcEEEcCCC----ceEEecccccccc
Q 005886 126 ALVYLHFHGHIHRDVKAGNILIDSNG----AIKLADFGVSACM 164 (671)
Q Consensus 126 aL~yLHs~gIVHrDLKPeNILld~~g----~vKL~DFGls~~~ 164 (671)
+..|++|+|+||+||+++.+| .++++|||++..+
T Consensus 277 -----f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 277 -----FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred -----HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 459999999999999999888 9999999998655
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.33 E-value=5.1e-12 Score=121.41 Aligned_cols=127 Identities=17% Similarity=0.201 Sum_probs=95.6
Q ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCce-eeeeEEEeCCEEEEEEeccCCC
Q 005886 19 YEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVL-RAHCSFTTGHCLWVVMPYMAGG 97 (671)
Q Consensus 19 ~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIV-kl~~~~~~~~~l~LVmEy~~gg 97 (671)
++.|+.|.++.||++... +..|++|+...... ....+.+|+.+++.+.+.+++ +++.+.. ...++||||++|.
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCC
Confidence 467899999999999865 77899999754321 123467899999888655544 4554443 2347899999998
Q ss_pred CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----ccccCCCCcEEEcCCCceEEecccccc
Q 005886 98 SCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGH-----IHRDVKAGNILIDSNGAIKLADFGVSA 162 (671)
Q Consensus 98 sL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gI-----VHrDLKPeNILld~~g~vKL~DFGls~ 162 (671)
++... ......++.+++.+|+.||..++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 77 ~l~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 77 ELLTE----------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccccc----------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 76542 01123467899999999999885 9999999999998 6789999999763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.8e-12 Score=144.36 Aligned_cols=251 Identities=22% Similarity=0.189 Sum_probs=182.8
Q ss_pred CCCCeEEEEEecccCceEEEEEEEc-CCCcEEEEEEeccccCcc-cHHHHHHHHHHHHhC-CCCCceeeeeEEEeCCEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCI-PLNEIVAIKVLDLEKCNN-DLDGIRREVQTMRVT-NHPNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~-~tg~~VAIKvi~~~~~~~-~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~~~l~ 88 (671)
...+|-++..||.|.|+.|+..... .++..|++|.+....... .-..-..|+.+...+ -|.+++.++..|......|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 4467889999999999999987655 567789999875433221 111223455555444 5899999999998888888
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCC-CceEEeccccccccccC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSN-GAIKLADFGVSACMFDA 167 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~-g~vKL~DFGls~~~~~~ 167 (671)
+--|||+|+++...+.-. ..+.+...+++..|++.++.++|+..++|+|+||.||++..+ +..++.|||..+.+..
T Consensus 343 ip~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~- 419 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF- 419 (524)
T ss_pred CchhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce-
Confidence 999999999887655332 568888999999999999999999999999999999999876 7889999998754211
Q ss_pred CCcccccccccCCCCCC-ChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Q 005886 168 GDRQRSRNTFVGTPCWM-APEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~-APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (671)
......+.-+++ .+|++.....+..++|++|||..+++.++|.+.-..... ...+..+ .++.....
T Consensus 420 -----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~-----~~p~~~~~ 486 (524)
T KOG0601|consen 420 -----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSG-----DTPNLPGL 486 (524)
T ss_pred -----ecccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeecc-----cccCCCch
Confidence 111223344455 366666556788999999999999999998653221111 1111111 12223344
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHhchhcc
Q 005886 247 SKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278 (671)
Q Consensus 247 s~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk 278 (671)
...+..+.+.++..++..||.+.++..|+=|.
T Consensus 487 ~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 487 KLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred HHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 57889999999999999999999998877654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.26 E-value=5.1e-11 Score=118.84 Aligned_cols=136 Identities=17% Similarity=0.176 Sum_probs=99.7
Q ss_pred EEEecccCceEEEEEEEcC------CCcEEEEEEecccc---------------C------cccHHHHH----HHHHHHH
Q 005886 19 YEEVGEGVSATVYRALCIP------LNEIVAIKVLDLEK---------------C------NNDLDGIR----REVQTMR 67 (671)
Q Consensus 19 ~~~LG~G~fG~Vyka~~~~------tg~~VAIKvi~~~~---------------~------~~~~~~i~----~Ei~iL~ 67 (671)
...||.|--+.||.|.... .+..+|||+..... . ......+. +|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999997653 35789999985210 0 11123344 8999998
Q ss_pred hCCC--CCceeeeeEEEeCCEEEEEEeccCCCCHH-HHHHhhCCCCCCHHHHHHHHHHHHHHHHHH-HHCCcccccCCCC
Q 005886 68 VTNH--PNVLRAHCSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLLRETLKALVYL-HFHGHIHRDVKAG 143 (671)
Q Consensus 68 ~L~H--pNIVkl~~~~~~~~~l~LVmEy~~ggsL~-~~l~~~~~~~l~e~~i~~i~~qIl~aL~yL-Hs~gIVHrDLKPe 143 (671)
++.. -++.+++++ ..-+|||||+.++.+. ..++. ..+++..+..++.+++.+|..| |..|+||+||++.
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~ 154 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEY 154 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 8853 456666654 3457899999775442 22322 2355666778899999999999 8999999999999
Q ss_pred cEEEcCCCceEEecccccc
Q 005886 144 NILIDSNGAIKLADFGVSA 162 (671)
Q Consensus 144 NILld~~g~vKL~DFGls~ 162 (671)
||+++ ++.+.|+|||.+.
T Consensus 155 NIL~~-~~~v~iIDF~qav 172 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSV 172 (197)
T ss_pred HEEEE-CCcEEEEECCCce
Confidence 99997 5789999999764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.1e-10 Score=109.91 Aligned_cols=131 Identities=21% Similarity=0.285 Sum_probs=102.2
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeccccCcc-------cHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-------DLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~-------~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
..+++|+-+.+|.+... |..+++|.=..+.... ...+-.+|+.++..+.--.|.-..-++.+.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 45789999999999654 5557777643332221 13456789999998876677666667777778889999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSA 162 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~ 162 (671)
|.+|..|.+.+... ...+++.+-.-+.-||..||||+||.+.||++...+ +.++||||+.
T Consensus 80 ~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 80 YIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred EeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccc
Confidence 99998888888654 256788888899999999999999999999997654 9999999974
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=7.5e-10 Score=107.75 Aligned_cols=143 Identities=22% Similarity=0.258 Sum_probs=110.7
Q ss_pred EEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcc-------cHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q 005886 18 LYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-------DLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 18 l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~-------~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LV 90 (671)
.+..|-+|+-+.|+++... |+.+.||.-..+.... ...+..+|++.|.++.--.|.-..-+|.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 6788999999999999765 8888888754333321 145677899999988766776666777777777889
Q ss_pred EeccCCC-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC---ceEEecccccc
Q 005886 91 MPYMAGG-SCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG---AIKLADFGVSA 162 (671)
Q Consensus 91 mEy~~gg-sL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g---~vKL~DFGls~ 162 (671)
|||++|. ++.+++...............+++.|-..|.-||..+|||+||..+||++..+| .+.++|||++.
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 9999873 566666554333333444478999999999999999999999999999997665 35899999974
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.7e-10 Score=113.66 Aligned_cols=139 Identities=16% Similarity=0.177 Sum_probs=103.7
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCC--CCceeeeeEEEeC---CEEEEEEecc
Q 005886 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNH--PNVLRAHCSFTTG---HCLWVVMPYM 94 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~H--pNIVkl~~~~~~~---~~l~LVmEy~ 94 (671)
+.||.|.++.||++.... |..|++|+............+.+|+.+++.+.+ .++.+++.+.... +..|+||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 678999999999998643 578999997644322234578899999999875 3456777776654 2678999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 005886 95 AGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF------------------------------------------ 132 (671)
Q Consensus 95 ~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs------------------------------------------ 132 (671)
.|.++...+.. ..+++.....++.+++.+|.+||+
T Consensus 83 ~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 83 DGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 99877654321 235666666777777777777773
Q ss_pred --------------CCcccccCCCCcEEEcC--CCceEEecccccc
Q 005886 133 --------------HGHIHRDVKAGNILIDS--NGAIKLADFGVSA 162 (671)
Q Consensus 133 --------------~gIVHrDLKPeNILld~--~g~vKL~DFGls~ 162 (671)
.+++|+|+.|.||+++. ++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 24689999999999998 5678999999753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.3e-08 Score=110.03 Aligned_cols=215 Identities=17% Similarity=0.213 Sum_probs=155.1
Q ss_pred CceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe----CCEEEEEEeccCC-CCHH
Q 005886 26 VSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT----GHCLWVVMPYMAG-GSCL 100 (671)
Q Consensus 26 ~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~----~~~l~LVmEy~~g-gsL~ 100 (671)
--.+.|++....+|..|++|.++..+.... .....-++.++++.|+|||++.++|.. +..+++|++|.++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~-nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST-NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc-ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 346789999999999999999854332211 122345678999999999999999983 5679999999875 4666
Q ss_pred HHHHhhC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccC
Q 005886 101 HIMKSAY-------------PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167 (671)
Q Consensus 101 ~~l~~~~-------------~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~ 167 (671)
++-.... ....+|..+|.|+.||..||.++|+.|+.-+-|.|.+||++.+-+++|...|+.-.+...
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 6442221 134788999999999999999999999999999999999998888999888765433211
Q ss_pred CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCC-CCCCChHHHHHHHHhcCCCCCCccccccc
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAP-FSKYPPMKVLLMTLQNAPPGLDYERDKRF 246 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~P-F~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (671)
. .+| +.+ -.+-|.-.||.+++-|.||..- +......+.....+ -..+
T Consensus 447 ~---------------~~~--le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I-----------~~~y 494 (655)
T KOG3741|consen 447 P---------------TEP--LES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI-----------TTTY 494 (655)
T ss_pred C---------------Ccc--hhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-----------hhhh
Confidence 1 111 222 1146888999999999999653 22222222211111 2346
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 247 SKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 247 s~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
+.+++++|.-+...++++ -++.+++.|
T Consensus 495 S~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 495 STDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred hHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 889999999999999987 678888765
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.8e-08 Score=108.45 Aligned_cols=244 Identities=17% Similarity=0.218 Sum_probs=154.7
Q ss_pred eEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHH-hCCCCCceeeee------EEEeC-CEE
Q 005886 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMR-VTNHPNVLRAHC------SFTTG-HCL 87 (671)
Q Consensus 16 Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~-~L~HpNIVkl~~------~~~~~-~~l 87 (671)
......||+|+-+.+|-.-.. +..| .|++........ .+.+..|. .-+||-+-.-+. +..+. ..+
T Consensus 13 i~~gr~LgqGgea~ly~l~e~--~d~V-AKIYh~Pppa~~----aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEV--RDQV-AKIYHAPPPAAQ----AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred cCCCccccCCccceeeecchh--hchh-heeecCCCchHH----HHHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 345678999999999954322 2334 488865432221 11222232 335654332011 11122 237
Q ss_pred EEEEeccCCCCHHHHHH-----hhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccc
Q 005886 88 WVVMPYMAGGSCLHIMK-----SAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSA 162 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~-----~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~ 162 (671)
.+.|+.+.|..=-..+. +.....+.+..+.++++.|+.+.+-||.+|.+-+|+.++|+|+.+++.|.|.|-..-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence 78899887753222221 1122457889999999999999999999999999999999999999999998755322
Q ss_pred ccccCCCcccccccccCCCCCCChhHhh-h---ccCCCccchhhhHHHHHHHHHhC-CCCCCCCC-------hHHHHHH-
Q 005886 163 CMFDAGDRQRSRNTFVGTPCWMAPEVMQ-Q---LHGYDFKADIWSFGITALELAHG-HAPFSKYP-------PMKVLLM- 229 (671)
Q Consensus 163 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~-~---~~~~s~ksDIWSLGvILyeLltG-~~PF~~~~-------~~~~~~~- 229 (671)
.. ......-..+|.+.|.+||.-. + ..+-+...|.|.||+++++|+.| ++||.+.. +.+....
T Consensus 166 i~----~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 166 IN----ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred ec----cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 11 2233344568999999999854 1 12345678999999999999985 99997642 1121100
Q ss_pred --------HHhcCCCCCCccccccchHHHHHHHHHhhhc--CCCCCCCHHH
Q 005886 230 --------TLQNAPPGLDYERDKRFSKSFKELVTACLVK--DPKKRPTAEK 270 (671)
Q Consensus 230 --------~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~--dP~kRpSa~e 270 (671)
.-....+......+.-+++.+..|..+|+.. .+.-|||++-
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 0001111111122456788999999999875 3568999864
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.2e-08 Score=104.85 Aligned_cols=131 Identities=11% Similarity=0.046 Sum_probs=94.1
Q ss_pred EEEEEEEcCCCcEEEEEEeccccCc----------ccHHHHHHHHHHHHhCCCCC--ceeeeeEEEe-----CCEEEEEE
Q 005886 29 TVYRALCIPLNEIVAIKVLDLEKCN----------NDLDGIRREVQTMRVTNHPN--VLRAHCSFTT-----GHCLWVVM 91 (671)
Q Consensus 29 ~Vyka~~~~tg~~VAIKvi~~~~~~----------~~~~~i~~Ei~iL~~L~HpN--IVkl~~~~~~-----~~~l~LVm 91 (671)
.|+++.. .|+.|.||........ .....+.+|...+..|..-+ ++.+.++++. ...-+|||
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 3556543 4778999976322211 11124778999888774333 3344555543 23578999
Q ss_pred eccCCC-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcC-------CCceEEeccccc
Q 005886 92 PYMAGG-SCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS-------NGAIKLADFGVS 161 (671)
Q Consensus 92 Ey~~gg-sL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~-------~g~vKL~DFGls 161 (671)
|++.|. +|.+++........+......++.+++..+..||.+||+|+|+++.|||++. ++.+.|+||+.+
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 999886 7888876432244567778899999999999999999999999999999975 457999999975
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=9.8e-10 Score=124.36 Aligned_cols=157 Identities=18% Similarity=0.261 Sum_probs=112.6
Q ss_pred HHHHHHHHHHHC-CcccccCCCCcEEEcCCCceEEeccccccccccCCCccc------ccccccCCCCCCChhHhhhccC
Q 005886 122 ETLKALVYLHFH-GHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR------SRNTFVGTPCWMAPEVMQQLHG 194 (671)
Q Consensus 122 qIl~aL~yLHs~-gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~------~~~~~~GT~~Y~APEvl~~~~~ 194 (671)
++..|+.|+|++ ++||+.|.|++|+++.+|.+||+.|+++........... ...-..-...|.|||++.+ ..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TT 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cc
Confidence 344899999986 899999999999999999999999998754432111000 0011123457999999987 55
Q ss_pred CCccchhhhHHHHHHHHH-hCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 195 YDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 195 ~s~ksDIWSLGvILyeLl-tG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.+.++|+||+||++|.+. .|+.-|......... ..-.+....-.......++.++++-+.++|..++..||++..++.
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-SFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchh-hhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 788999999999999998 466555544322211 111111111112224678999999999999999999999999999
Q ss_pred chhcccc
Q 005886 274 HHFFKHA 280 (671)
Q Consensus 274 Hpwfk~~ 280 (671)
.|||...
T Consensus 265 ~~ff~D~ 271 (700)
T KOG2137|consen 265 IPFFSDP 271 (700)
T ss_pred ccccCCc
Confidence 9999864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.75 E-value=5.3e-08 Score=96.72 Aligned_cols=124 Identities=24% Similarity=0.359 Sum_probs=81.2
Q ss_pred EEEEEEEcCCCcEEEEEEecccc--------------C------c-c----cHHHHHHHHHHHHhCCCC--CceeeeeEE
Q 005886 29 TVYRALCIPLNEIVAIKVLDLEK--------------C------N-N----DLDGIRREVQTMRVTNHP--NVLRAHCSF 81 (671)
Q Consensus 29 ~Vyka~~~~tg~~VAIKvi~~~~--------------~------~-~----~~~~i~~Ei~iL~~L~Hp--NIVkl~~~~ 81 (671)
.||.|.. ..|..+|+|+..... . . . ......+|.+.|..+..- ++.+++++
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 3888876 467899999985310 0 0 0 134567899999999766 45666644
Q ss_pred EeCCEEEEEEeccC--CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH-HHHCCcccccCCCCcEEEcCCCceEEecc
Q 005886 82 TTGHCLWVVMPYMA--GGSCLHIMKSAYPEGFEEPVIATLLRETLKALVY-LHFHGHIHRDVKAGNILIDSNGAIKLADF 158 (671)
Q Consensus 82 ~~~~~l~LVmEy~~--ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~y-LHs~gIVHrDLKPeNILld~~g~vKL~DF 158 (671)
..+ +|||||+. |..+..+.... ++......++.+++..+.. +|..||||+||.+.||+++.+ .+.|+||
T Consensus 79 -~~~--~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 79 -NRN--VIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp -ETT--EEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred -eCC--EEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence 233 58999998 65554443322 2234567788888885555 579999999999999999876 8999999
Q ss_pred cccc
Q 005886 159 GVSA 162 (671)
Q Consensus 159 Gls~ 162 (671)
|.+.
T Consensus 151 ~qav 154 (188)
T PF01163_consen 151 GQAV 154 (188)
T ss_dssp TTEE
T ss_pred Ccce
Confidence 9764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.4e-09 Score=119.98 Aligned_cols=245 Identities=24% Similarity=0.296 Sum_probs=172.5
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCC-ceeeeeEEEeCCEEEEEEec
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN-VLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpN-IVkl~~~~~~~~~l~LVmEy 93 (671)
-|.....+++|+++.+++.+..++...+ .+++... ....-++++|.+++||| .+..++.+..+.+.+++|++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 3555667899999999999877766655 6776433 34556888999999999 88888888888999999999
Q ss_pred cCCC-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 94 MAGG-SCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 94 ~~gg-sL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
+.++ +....+... ...+.+-....+++.-+.+++|+|+.--+||| ||+..+ +.+|..||+....+.. ..
T Consensus 316 ~s~~rs~~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~----~~ 385 (829)
T KOG0576|consen 316 CSTGRSSALEMTVS-EIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTR----TM 385 (829)
T ss_pred hcCCccccccCChh-hHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCc----cc
Confidence 9887 221111100 12344555667778888999999998778999 777654 7899999998765522 22
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHH-
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK- 251 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~- 251 (671)
...+..+|+.|+|||+... ..+..+.|.|++|+-..+|.-|-+|-.. +..... .+.+.+...........+..+.
T Consensus 386 ~~~t~~~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~~~-~~g~~p~s~~L~~~~aw~~~~~~ 461 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPRSS--PPAVLP-MIGNGPNSPMLTDKSAWSPVFHR 461 (829)
T ss_pred ccccCCCCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCCCC--CccccC-CCCCCCCccccchhhhcCccccc
Confidence 4667899999999999886 5688899999999988888888777543 111110 0111110000000011122222
Q ss_pred HHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 252 ELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 252 dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
++...|+..-|..|+....++.|.+|...
T Consensus 462 ~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 462 DFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred CCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 48889999999999999999999999754
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.65 E-value=4.5e-07 Score=91.22 Aligned_cols=105 Identities=16% Similarity=0.204 Sum_probs=82.6
Q ss_pred HHHHHHHHHHHHhCCCC--CceeeeeEEEeC----CEEEEEEeccCCC-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHH
Q 005886 56 LDGIRREVQTMRVTNHP--NVLRAHCSFTTG----HCLWVVMPYMAGG-SCLHIMKSAYPEGFEEPVIATLLRETLKALV 128 (671)
Q Consensus 56 ~~~i~~Ei~iL~~L~Hp--NIVkl~~~~~~~----~~l~LVmEy~~gg-sL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~ 128 (671)
.....+|...+..|..- .+.+++++.+.. ...++|+|+++|. +|.+++.... ..+......++.++...++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHH
Confidence 45677888887766432 345566666553 2468999999885 7888887642 2666778899999999999
Q ss_pred HHHHCCcccccCCCCcEEEcCCC---ceEEecccccc
Q 005886 129 YLHFHGHIHRDVKAGNILIDSNG---AIKLADFGVSA 162 (671)
Q Consensus 129 yLHs~gIVHrDLKPeNILld~~g---~vKL~DFGls~ 162 (671)
-||.+||+|+|+++.|||++.++ .+.++||+-++
T Consensus 133 ~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~ 169 (206)
T PF06293_consen 133 KLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR 169 (206)
T ss_pred HHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence 99999999999999999998887 79999999654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=3.6e-07 Score=94.35 Aligned_cols=134 Identities=21% Similarity=0.244 Sum_probs=99.4
Q ss_pred eEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-----------------cc----cHHHHHHHHHHHHhCCCC--
Q 005886 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-----------------NN----DLDGIRREVQTMRVTNHP-- 72 (671)
Q Consensus 16 Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-----------------~~----~~~~i~~Ei~iL~~L~Hp-- 72 (671)
+.+...||-|--+.||.|.+. .|.++|||+-..... .. .....++|.++|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456788999999999999866 688899998542110 00 134567899999998755
Q ss_pred CceeeeeEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCc
Q 005886 73 NVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGA 152 (671)
Q Consensus 73 NIVkl~~~~~~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~ 152 (671)
.|.+.+++- .-.+||||..|..|...- +....+..++..|+.-+.-+-..|+||+|+.+-||+++.+|.
T Consensus 172 ~VP~P~~~n----RHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 172 KVPKPIAWN----RHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCCccccc----cceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence 677776653 346799999997765432 123345566666777776666899999999999999999999
Q ss_pred eEEeccccc
Q 005886 153 IKLADFGVS 161 (671)
Q Consensus 153 vKL~DFGls 161 (671)
+.++||--+
T Consensus 241 ~~vIDwPQ~ 249 (304)
T COG0478 241 IVVIDWPQA 249 (304)
T ss_pred EEEEeCccc
Confidence 999999643
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.41 E-value=4.6e-06 Score=84.05 Aligned_cols=138 Identities=15% Similarity=0.063 Sum_probs=100.4
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEecc--cc---CcccHHHHHHHHHHHHhCCCCC--ceeeeeEEE-e----CCEEEE
Q 005886 22 VGEGVSATVYRALCIPLNEIVAIKVLDL--EK---CNNDLDGIRREVQTMRVTNHPN--VLRAHCSFT-T----GHCLWV 89 (671)
Q Consensus 22 LG~G~fG~Vyka~~~~tg~~VAIKvi~~--~~---~~~~~~~i~~Ei~iL~~L~HpN--IVkl~~~~~-~----~~~l~L 89 (671)
-|+||.+-|++.... |..+-+|.-.. .. .+.....+.+|+..|..|..-+ +.++. ++. . ...-+|
T Consensus 26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 367899999987654 44677887531 11 1334678999999998875322 44444 332 1 234688
Q ss_pred EEeccCC-CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCc--eEEecccccc
Q 005886 90 VMPYMAG-GSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGA--IKLADFGVSA 162 (671)
Q Consensus 90 VmEy~~g-gsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~--vKL~DFGls~ 162 (671)
|+|-+.| -+|.+++........+......++.+|...+.-||..|+.|+|+.+.|||++.+|. |+++||--++
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 9997754 47777776543345677777899999999999999999999999999999987777 9999997654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.33 E-value=3.2e-06 Score=96.01 Aligned_cols=141 Identities=28% Similarity=0.314 Sum_probs=93.0
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEecccc---------------------Cc----cc--------HHH------HH
Q 005886 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEK---------------------CN----ND--------LDG------IR 60 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~---------------------~~----~~--------~~~------i~ 60 (671)
..|+.++-|.||+|+.+ +|+.||||+....- .+ -. .+. +.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 56889999999999866 49999999974210 00 00 011 22
Q ss_pred HHHHHHHhC-----CCCCceeeeeEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 005886 61 REVQTMRVT-----NHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGH 135 (671)
Q Consensus 61 ~Ei~iL~~L-----~HpNIVkl~~~~~~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gI 135 (671)
+|...+..+ +.|+|.-..=+++-...-.|+|||+.|-.+.++..... .+++...+.....++ -+..+-..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcCc
Confidence 344444333 34555544445555566789999999998888743222 456644333322222 2334445899
Q ss_pred ccccCCCCcEEEcCCCceEEecccccccc
Q 005886 136 IHRDVKAGNILIDSNGAIKLADFGVSACM 164 (671)
Q Consensus 136 VHrDLKPeNILld~~g~vKL~DFGls~~~ 164 (671)
+|.|..|.||+++.+|.+.+.|||+...+
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecC
Confidence 99999999999999999999999987544
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.31 E-value=8.7e-06 Score=82.46 Aligned_cols=137 Identities=18% Similarity=0.215 Sum_probs=87.3
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCccc--H------HHHHHHHHHHHhC---CCCCceeeeeE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNND--L------DGIRREVQTMRVT---NHPNVLRAHCS 80 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~--~------~~i~~Ei~iL~~L---~HpNIVkl~~~ 80 (671)
..++|++.+.+-......|.+..- .|+.+++|...-+....+ . ....+++..+..+ .--.+..++.+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 457788888888887777776653 467788998653221111 0 1122333333333 22222232322
Q ss_pred EE-----eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEE
Q 005886 81 FT-----TGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKL 155 (671)
Q Consensus 81 ~~-----~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL 155 (671)
.+ --...+|+|||++|..|.++.. +++ .+...|..++.-||..|++|+|..|.|++++.++ +++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~i 175 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRI 175 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEE
Confidence 22 2345678999999987765432 233 2445677889999999999999999999998554 999
Q ss_pred eccccc
Q 005886 156 ADFGVS 161 (671)
Q Consensus 156 ~DFGls 161 (671)
+||+..
T Consensus 176 ID~~~k 181 (229)
T PF06176_consen 176 IDTQGK 181 (229)
T ss_pred EECccc
Confidence 999853
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.27 E-value=9.5e-06 Score=82.98 Aligned_cols=134 Identities=17% Similarity=0.213 Sum_probs=84.2
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCC--ceeeeeEEEeCCEEEEEEeccCCC
Q 005886 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN--VLRAHCSFTTGHCLWVVMPYMAGG 97 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpN--IVkl~~~~~~~~~l~LVmEy~~gg 97 (671)
..||+|..+.||+. .|..+++|..... .....+.+|.++++.+..-. +.+++++....+..++||+++.|.
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~---~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPG---FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCC---CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 57899999999984 2555778987532 23456789999998886433 467788888888889999999996
Q ss_pred C-HH--------------HHH----HhhCC---CCCCHHH-HHHHHH----------HHHH-HHHHHHH----CCccccc
Q 005886 98 S-CL--------------HIM----KSAYP---EGFEEPV-IATLLR----------ETLK-ALVYLHF----HGHIHRD 139 (671)
Q Consensus 98 s-L~--------------~~l----~~~~~---~~l~e~~-i~~i~~----------qIl~-aL~yLHs----~gIVHrD 139 (671)
. +. ..+ ..-.. ....... ...+.. .+.. ...+|.. ..++|+|
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 3 11 111 10000 1111111 011100 0111 1222221 2468999
Q ss_pred CCCCcEEEcCCCceEEeccccc
Q 005886 140 VKAGNILIDSNGAIKLADFGVS 161 (671)
Q Consensus 140 LKPeNILld~~g~vKL~DFGls 161 (671)
+.|.||+++.++ +.|+||+.+
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a 180 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDF 180 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhc
Confidence 999999999888 999999975
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.27 E-value=5.8e-06 Score=98.76 Aligned_cols=203 Identities=18% Similarity=0.227 Sum_probs=141.5
Q ss_pred HHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEE----EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 005886 56 LDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLW----VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLH 131 (671)
Q Consensus 56 ~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~----LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLH 131 (671)
.....-|+..+.++.|+|++.++.|........ +..++|.+.++...+... +..+....+.+..++++||+|+|
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHH
Confidence 344455677788889999999998887654433 345688888998888876 67888999999999999999999
Q ss_pred HCCcccccCCCC---cEEEcCCCceEEe--ccccccccccCCCcccccccccCCCCCCChhHhhhccCCCc--cchhhhH
Q 005886 132 FHGHIHRDVKAG---NILIDSNGAIKLA--DFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDF--KADIWSF 204 (671)
Q Consensus 132 s~gIVHrDLKPe---NILld~~g~vKL~--DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~--ksDIWSL 204 (671)
+....|.-+... +.-.+..+.+.++ ||+.+..+.+... .....-+..|.|||.... +.+.. ..|+|.+
T Consensus 304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~----~~~~~~~~~~~~~e~~~~-~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK----SFSDLLAEIRNADEDLKE-NTAKKSRLTDLWCL 378 (1351)
T ss_pred HhccceeEEecccccccccCccceeecchhhhcccccCCCccc----chhhcCcccccccccccc-ccchhhhhhHHHHH
Confidence 996655555444 3333455667776 8887765533221 112344667888887764 33333 3699999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccc
Q 005886 205 GITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKH 279 (671)
Q Consensus 205 GvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~ 279 (671)
|..+.-+..|..+-.... ...... +........++..+|+.-++++|+++.+++.|+|.+.
T Consensus 379 gll~~~~~~~~~i~~~~~-------~~~~~l-------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSA-------VPVSLL-------DVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRF 439 (1351)
T ss_pred HHHHhhhhhcCccccccc-------chhhhh-------ccccchhhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence 999999988755421110 000000 1111226788999999999999999999999999874
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.09 E-value=2.5e-05 Score=80.11 Aligned_cols=136 Identities=19% Similarity=0.216 Sum_probs=94.2
Q ss_pred EEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc------------------cc-----HHHHHHHHHHHHhCC--CC
Q 005886 18 LYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN------------------ND-----LDGIRREVQTMRVTN--HP 72 (671)
Q Consensus 18 l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~------------------~~-----~~~i~~Ei~iL~~L~--Hp 72 (671)
+...|+.|--+.||+|.. ..+..||+|++...... .. ..-..+|+.-|+++. +-
T Consensus 52 ~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 52 LVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 355788999999999975 46889999998532110 00 122356777777774 34
Q ss_pred CceeeeeEEEeCCEEEEEEeccCCCC-HHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCcEEEcCC
Q 005886 73 NVLRAHCSFTTGHCLWVVMPYMAGGS-CLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF-HGHIHRDVKAGNILIDSN 150 (671)
Q Consensus 73 NIVkl~~~~~~~~~l~LVmEy~~ggs-L~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs-~gIVHrDLKPeNILld~~ 150 (671)
.+.+.+.++. -.|||||+.... -.-.|+. -++....+..+..+++..+.-|-. .|+||+||..-|||+. +
T Consensus 131 rvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 131 RVPEPIAFRN----NVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-D 202 (268)
T ss_pred CCCCceeecC----CeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-C
Confidence 4555655543 468999985431 0111211 123333678888999999988877 8999999999999999 8
Q ss_pred CceEEecccccc
Q 005886 151 GAIKLADFGVSA 162 (671)
Q Consensus 151 g~vKL~DFGls~ 162 (671)
|.+.|+|||-|.
T Consensus 203 ~~p~iID~~QaV 214 (268)
T COG1718 203 GEPYIIDVSQAV 214 (268)
T ss_pred CeEEEEECcccc
Confidence 899999999764
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.06 E-value=3.5e-05 Score=77.00 Aligned_cols=138 Identities=26% Similarity=0.328 Sum_probs=81.6
Q ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCC--CceeeeeEEE---eCCEEEEEEec
Q 005886 19 YEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHP--NVLRAHCSFT---TGHCLWVVMPY 93 (671)
Q Consensus 19 ~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~Hp--NIVkl~~~~~---~~~~l~LVmEy 93 (671)
++.|+.|..+.||++.... ..+++|+.... .....+.+|..+++.+... .+.+++.+.. .....+++|++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~ 76 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY 76 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence 4689999999999998764 47899996533 3456788899888877533 3456665443 33457999999
Q ss_pred cCCCCHHH----------------HHH---hh-CC-CCCCHHH------HHHH---------------HHHHHH-HHHHH
Q 005886 94 MAGGSCLH----------------IMK---SA-YP-EGFEEPV------IATL---------------LRETLK-ALVYL 130 (671)
Q Consensus 94 ~~ggsL~~----------------~l~---~~-~~-~~l~e~~------i~~i---------------~~qIl~-aL~yL 130 (671)
+.|..+.. .+. .. .. ..+.... ...+ ...+.. .+..+
T Consensus 77 i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (239)
T PF01636_consen 77 IPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQEL 156 (239)
T ss_dssp ESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_pred eccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHH
Confidence 99987776 111 11 00 1111000 0000 111222 23333
Q ss_pred HH-------CCcccccCCCCcEEEc-CCCceEEeccccc
Q 005886 131 HF-------HGHIHRDVKAGNILID-SNGAIKLADFGVS 161 (671)
Q Consensus 131 Hs-------~gIVHrDLKPeNILld-~~g~vKL~DFGls 161 (671)
+. .+++|+|+.|.|||++ .++.+-|+||+.+
T Consensus 157 ~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a 195 (239)
T PF01636_consen 157 EALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDA 195 (239)
T ss_dssp HHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred HhhhccCCCcEEEEeccccccceeeeccceeEEEecccc
Confidence 32 3599999999999999 6677789999865
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.02 E-value=5.8e-05 Score=91.19 Aligned_cols=81 Identities=19% Similarity=0.249 Sum_probs=58.1
Q ss_pred EEEEecccCceEEEEEEEcCCC--cEEEEEEeccccCcccHHHHHHHHHHHHhCC-CCCc--eeeeeEEEeC---CEEEE
Q 005886 18 LYEEVGEGVSATVYRALCIPLN--EIVAIKVLDLEKCNNDLDGIRREVQTMRVTN-HPNV--LRAHCSFTTG---HCLWV 89 (671)
Q Consensus 18 l~~~LG~G~fG~Vyka~~~~tg--~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~-HpNI--Vkl~~~~~~~---~~l~L 89 (671)
.+..|+.|.+..+|+......+ ..+++|+............+.+|+.+|+.+. |++| .+++.++.+. +..|+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 3677899999999998765332 3577787644332233457889999999985 6665 7777777654 46789
Q ss_pred EEeccCCCC
Q 005886 90 VMPYMAGGS 98 (671)
Q Consensus 90 VmEy~~ggs 98 (671)
||||+.|..
T Consensus 122 VME~v~G~~ 130 (822)
T PLN02876 122 IMEYLEGRI 130 (822)
T ss_pred EEEecCCcc
Confidence 999998864
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.96 E-value=7.1e-05 Score=76.72 Aligned_cols=75 Identities=23% Similarity=0.186 Sum_probs=52.6
Q ss_pred EecccCc-eEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCC-CCCceeeeeEEEeCCEEEEEEeccCCCC
Q 005886 21 EVGEGVS-ATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN-HPNVLRAHCSFTTGHCLWVVMPYMAGGS 98 (671)
Q Consensus 21 ~LG~G~f-G~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~-HpNIVkl~~~~~~~~~l~LVmEy~~ggs 98 (671)
.|-.|.+ +.||++... +..+.+|+..... ...+.+|+.+++.+. +--+.++++++...+..++||++++|.+
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~ 78 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVP 78 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCcc
Confidence 3444555 789998643 4568888864332 345678999988774 3446677888777777899999999977
Q ss_pred HHH
Q 005886 99 CLH 101 (671)
Q Consensus 99 L~~ 101 (671)
+..
T Consensus 79 l~~ 81 (244)
T cd05150 79 AAA 81 (244)
T ss_pred HhH
Confidence 653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.91 E-value=1.9e-06 Score=104.43 Aligned_cols=256 Identities=10% Similarity=0.032 Sum_probs=165.9
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEec---cccCcc-cHHHHHHHHHHHHhCCCCCceeeeeEEEe--CC
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLD---LEKCNN-DLDGIRREVQTMRVTNHPNVLRAHCSFTT--GH 85 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~---~~~~~~-~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~--~~ 85 (671)
....|++.--+|.|.++.--.-+.+..+ +.+|+.. .+...+ ..+.+..|...++...|+++...+.-... ..
T Consensus 1227 ~~e~~EV~l~i~~~~~~R~k~Lr~kid~--Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ 1304 (2724)
T KOG1826|consen 1227 AMEHSEVNLGISNHFHFRNKWLRSKIDW--FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSEST 1304 (2724)
T ss_pred HhhhhheeeecccceeeccchHhhhhce--eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCCh
Confidence 3455666666666666544332222222 2344432 222111 23445556666677889998877665553 33
Q ss_pred EEEEEEeccCCCCHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHC-----CcccccCCCCcEEEcCCCceEEecc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYP--EGFEEPVIATLLRETLKALVYLHFH-----GHIHRDVKAGNILIDSNGAIKLADF 158 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~--~~l~e~~i~~i~~qIl~aL~yLHs~-----gIVHrDLKPeNILld~~g~vKL~DF 158 (671)
..|.+++|+.+|.+++++-+... ..+.+..+.....+.+.+..-+|+. -.+|+++|+-|.+|..+-.||++++
T Consensus 1305 ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~ 1384 (2724)
T KOG1826|consen 1305 EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKG 1384 (2724)
T ss_pred HHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccc
Confidence 56889999999999998876533 2344444545555557777777764 2689999999999999999999999
Q ss_pred ccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC
Q 005886 159 GVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL 238 (671)
Q Consensus 159 Gls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~ 238 (671)
|+.++.. ......+...+++.|++|++... -.++.++|+|..|+.+|++..|..+|-... ...+++....-
T Consensus 1385 gLdKIkn---p~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~rs~~n~~fi~fl-----q~~Lkgiidn~ 1455 (2724)
T KOG1826|consen 1385 GLDKIKN---PVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLRSDGNAYFIFFL-----QPALKGIIDNH 1455 (2724)
T ss_pred ccccccC---chHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHHhcccHHHHHHH-----HHHHcCccccc
Confidence 9987332 22234456788999999999887 457888999999999999999988874322 22222221111
Q ss_pred C-ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcc
Q 005886 239 D-YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278 (671)
Q Consensus 239 ~-~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk 278 (671)
. ...+...|.++...+..+|-+.-..||.-...+.-+.|.
T Consensus 1456 tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1456 TFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred ccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 1 122223344555566666777778889888888777665
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.84 E-value=8.6e-05 Score=72.60 Aligned_cols=128 Identities=16% Similarity=0.217 Sum_probs=90.7
Q ss_pred EEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCcee-eeeEEEeCCEEEEEEeccC
Q 005886 17 RLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLR-AHCSFTTGHCLWVVMPYMA 95 (671)
Q Consensus 17 ~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVk-l~~~~~~~~~l~LVmEy~~ 95 (671)
.+.+.||+|++|.||+|... |..+|+|+-.. ......+..|+++|..+...++.. +|.+..+ ++.|||+.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~---ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~ 95 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRR---DSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYID 95 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEecC---CcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhc
Confidence 45678999999999999865 67899998543 345678999999999998777654 4444332 34599999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCC-CCcEEEcCCCceEEecccccc
Q 005886 96 GGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVK-AGNILIDSNGAIKLADFGVSA 162 (671)
Q Consensus 96 ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLK-PeNILld~~g~vKL~DFGls~ 162 (671)
|-.|...-... + +.-+..++..---|-..||-|+.|. |..+++..++.+.|+||.-|+
T Consensus 96 G~~L~~~~~~~-----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 96 GRPLGKLEIGG-----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred Ccchhhhhhcc-----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 97776554311 2 2334455566555667899999986 555555566699999999764
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00026 Score=71.04 Aligned_cols=130 Identities=21% Similarity=0.286 Sum_probs=91.7
Q ss_pred cccCCCCeEEEEEecccCc-eEEEEEEEcCCCcEEEEEEecc---cc-------Cc----------ccHHHHHHHHHHHH
Q 005886 9 FPVDAKDYRLYEEVGEGVS-ATVYRALCIPLNEIVAIKVLDL---EK-------CN----------NDLDGIRREVQTMR 67 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~f-G~Vyka~~~~tg~~VAIKvi~~---~~-------~~----------~~~~~i~~Ei~iL~ 67 (671)
|..-..+++.++.||.|.- |.||++... |+.||+|++.. .. .. ...+-+..|.+...
T Consensus 32 F~~h~~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfg 109 (207)
T PF13095_consen 32 FTHHGDDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFG 109 (207)
T ss_pred cCCCCCcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhH
Confidence 3334478999999999999 999999765 88999999321 11 00 11335667777665
Q ss_pred hC---CCCCc--eeeeeEEEeC------------------CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q 005886 68 VT---NHPNV--LRAHCSFTTG------------------HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETL 124 (671)
Q Consensus 68 ~L---~HpNI--Vkl~~~~~~~------------------~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl 124 (671)
+| ++.++ |++|||+.-. -...||.||..... .+. ..-+.+|+
T Consensus 110 RLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~~~ 174 (207)
T PF13095_consen 110 RLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQML 174 (207)
T ss_pred HHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHHHH
Confidence 55 56666 9999998422 12467788775532 122 23466788
Q ss_pred HHHHHHHHCCcccccCCCCcEEEcCCCceEEecccc
Q 005886 125 KALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGV 160 (671)
Q Consensus 125 ~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGl 160 (671)
.-+..+|..||+-+|+++.|.. + -||+|||.
T Consensus 175 ~dl~~~~k~gI~~~Dv~~~ny~---~--G~lvDfs~ 205 (207)
T PF13095_consen 175 RDLKILHKLGIVPRDVKPRNYR---G--GKLVDFSS 205 (207)
T ss_pred HHHHHHHHCCeeeccCcccccc---C--CEEEeccc
Confidence 8899999999999999999985 2 37899985
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00019 Score=81.70 Aligned_cols=136 Identities=24% Similarity=0.262 Sum_probs=85.5
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeccccCc---cc---------------------------HHHHHHHHHHH---
Q 005886 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN---ND---------------------------LDGIRREVQTM--- 66 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~---~~---------------------------~~~i~~Ei~iL--- 66 (671)
+.||.-+.|.|++|+.+. |+.||||+-+..-.. .+ .+.+..|+..+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 678999999999999776 999999995421000 00 11222232222
Q ss_pred -------HhCCCCC------ceeeeeEEEeCCEEEEEEeccCCCCHHHH--HHhhCCCCCCHHHHHHHHHHHHHH-HHHH
Q 005886 67 -------RVTNHPN------VLRAHCSFTTGHCLWVVMPYMAGGSCLHI--MKSAYPEGFEEPVIATLLRETLKA-LVYL 130 (671)
Q Consensus 67 -------~~L~HpN------IVkl~~~~~~~~~l~LVmEy~~ggsL~~~--l~~~~~~~l~e~~i~~i~~qIl~a-L~yL 130 (671)
+.+.|-+ |.++|-.+. ....|+||||.|..+.++ |.+ .+++...+. ..+..+ ++.|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~---~gi~~~~i~---~~l~~~~~~qI 317 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDK---RGISPHDIL---NKLVEAYLEQI 317 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHH---cCCCHHHHH---HHHHHHHHHHH
Confidence 2233444 444433333 347889999999877654 333 346555333 333332 2334
Q ss_pred HHCCcccccCCCCcEEEcC----CCceEEecccccccc
Q 005886 131 HFHGHIHRDVKAGNILIDS----NGAIKLADFGVSACM 164 (671)
Q Consensus 131 Hs~gIVHrDLKPeNILld~----~g~vKL~DFGls~~~ 164 (671)
-..|++|+|=.|.||++.. ++.+.+-|||+.+.+
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 4579999999999999984 568999999997544
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00094 Score=67.07 Aligned_cols=130 Identities=21% Similarity=0.279 Sum_probs=92.1
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEecccc---------------CcccHHHHHHHHHHHHhCC------CCCceeee
Q 005886 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEK---------------CNNDLDGIRREVQTMRVTN------HPNVLRAH 78 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~---------------~~~~~~~i~~Ei~iL~~L~------HpNIVkl~ 78 (671)
..||+|+.-.||.- +.+...+||++.... .........+|+.....+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 56899999999943 334446789987554 0112456667777666555 88899999
Q ss_pred eEEEeCCEEEEEEeccCC------CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC-
Q 005886 79 CSFTTGHCLWVVMPYMAG------GSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG- 151 (671)
Q Consensus 79 ~~~~~~~~l~LVmEy~~g------gsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g- 151 (671)
|+.+++.-+.+|+|.... -+|.+++... .+++ .+...+-.-..||-.++|+.+|++|.||++..++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 999999999999998642 3577777543 4555 3334444556788889999999999999995432
Q ss_pred ---ceEEec-cc
Q 005886 152 ---AIKLAD-FG 159 (671)
Q Consensus 152 ---~vKL~D-FG 159 (671)
.+.|+| ||
T Consensus 157 ~~~~lvlIDG~G 168 (199)
T PF10707_consen 157 GEFRLVLIDGLG 168 (199)
T ss_pred CceEEEEEeCCC
Confidence 467776 44
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00033 Score=71.61 Aligned_cols=72 Identities=15% Similarity=0.250 Sum_probs=45.6
Q ss_pred EEecccCce-EEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCC---CceeeeeEEEeC---CEEEEEEe
Q 005886 20 EEVGEGVSA-TVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHP---NVLRAHCSFTTG---HCLWVVMP 92 (671)
Q Consensus 20 ~~LG~G~fG-~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~Hp---NIVkl~~~~~~~---~~l~LVmE 92 (671)
+.|+.|+.. .||+. +..+++|+.... .....+.+|..+|..+... -+.++++..... ...|++|+
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~---~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~ 74 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAA---GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR 74 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCcc---chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence 567777776 48875 234677875431 2345788999999877532 344444444332 24588999
Q ss_pred ccCCCCH
Q 005886 93 YMAGGSC 99 (671)
Q Consensus 93 y~~ggsL 99 (671)
++.|.++
T Consensus 75 ~i~G~~l 81 (235)
T cd05155 75 WLEGETA 81 (235)
T ss_pred eecCCCC
Confidence 9998665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0014 Score=66.58 Aligned_cols=75 Identities=9% Similarity=0.229 Sum_probs=48.0
Q ss_pred EEEecccCceEEEEEEEcC-CCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCC-ceeeeeEEEeCCEEEEEEeccCC
Q 005886 19 YEEVGEGVSATVYRALCIP-LNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN-VLRAHCSFTTGHCLWVVMPYMAG 96 (671)
Q Consensus 19 ~~~LG~G~fG~Vyka~~~~-tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpN-IVkl~~~~~~~~~l~LVmEy~~g 96 (671)
++.|..|-...+|++.... .++.|++|+..... .. .-...+|+.+++.+...+ ++++++.+. + .+||||++|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~-~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G 76 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT-EL-IIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPG 76 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCc-cc-eecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCC
Confidence 4678889999999986443 25678899765321 11 123357888888885433 344544433 2 379999988
Q ss_pred CCH
Q 005886 97 GSC 99 (671)
Q Consensus 97 gsL 99 (671)
.++
T Consensus 77 ~~l 79 (235)
T cd05157 77 RTL 79 (235)
T ss_pred CcC
Confidence 654
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0032 Score=69.74 Aligned_cols=78 Identities=19% Similarity=0.130 Sum_probs=55.3
Q ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEecc------ccCcccHHHHHHHHHHHHhCC---CCCceeeeeEEEeCCEEEE
Q 005886 19 YEEVGEGVSATVYRALCIPLNEIVAIKVLDL------EKCNNDLDGIRREVQTMRVTN---HPNVLRAHCSFTTGHCLWV 89 (671)
Q Consensus 19 ~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~------~~~~~~~~~i~~Ei~iL~~L~---HpNIVkl~~~~~~~~~l~L 89 (671)
.+.||.|.+..||++.....++.|+||.-.. +..+...++...|...|+.+. ..++++++.+. ....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence 5789999999999998764335799998431 112334677888888887753 34577777763 355789
Q ss_pred EEeccCCCC
Q 005886 90 VMPYMAGGS 98 (671)
Q Consensus 90 VmEy~~ggs 98 (671)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999997643
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.00074 Score=67.22 Aligned_cols=96 Identities=19% Similarity=0.153 Sum_probs=76.2
Q ss_pred HHHHHHHHhCCC-CCceeeeeEEEeCCEEEEEEeccCCCCHHHH---HHhhCCCCCCHHHHHHHHHHHHHHHHHHHH---
Q 005886 60 RREVQTMRVTNH-PNVLRAHCSFTTGHCLWVVMPYMAGGSCLHI---MKSAYPEGFEEPVIATLLRETLKALVYLHF--- 132 (671)
Q Consensus 60 ~~Ei~iL~~L~H-pNIVkl~~~~~~~~~l~LVmEy~~ggsL~~~---l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs--- 132 (671)
..|.-+|+.+.+ +++++++|++.. ++|.||...+++... +... ...++..+..++.+++..+++|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 358888888876 699999999853 568899987766432 1111 235788899999999999999997
Q ss_pred CCcccccCCCCcEEEcCCCceEEeccccc
Q 005886 133 HGHIHRDVKAGNILIDSNGAIKLADFGVS 161 (671)
Q Consensus 133 ~gIVHrDLKPeNILld~~g~vKL~DFGls 161 (671)
..+.-.|++|+|+-++.+|.+|++|...+
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v 109 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDV 109 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhc
Confidence 34566899999999999999999999865
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0039 Score=66.45 Aligned_cols=78 Identities=9% Similarity=-0.062 Sum_probs=55.8
Q ss_pred EEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCC---CCceeeeeEEEe---CCEEEEE
Q 005886 17 RLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNH---PNVLRAHCSFTT---GHCLWVV 90 (671)
Q Consensus 17 ~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~H---pNIVkl~~~~~~---~~~l~LV 90 (671)
.-.+.||.|..+.||+.... .+ .+.+|+.+ . ......+..|...|+.+.- ..|.++++++.. .+..+||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~-~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 17 SRVECISEQPYAALWALYDS-QG-NPMPLMAR-S--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred heeeecCCccceeEEEEEcC-CC-CEEEEEec-c--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 34578999999999988533 23 46677743 2 1123588899999988853 357788887754 3668999
Q ss_pred EeccCCCCH
Q 005886 91 MPYMAGGSC 99 (671)
Q Consensus 91 mEy~~ggsL 99 (671)
||+++|+++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998754
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0025 Score=67.22 Aligned_cols=140 Identities=15% Similarity=0.133 Sum_probs=83.5
Q ss_pred eEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCC--ceeeee------EEEeCCEE
Q 005886 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN--VLRAHC------SFTTGHCL 87 (671)
Q Consensus 16 Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpN--IVkl~~------~~~~~~~l 87 (671)
..-.+.|..|....+|+.... +..+++|+... .....+..|+.++..+.+-+ +.+++. +....+..
T Consensus 16 ~~~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~ 89 (296)
T cd05153 16 LLSFEGISAGIENTNYFVTTD--SGRYVLTLFEK----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP 89 (296)
T ss_pred hhheecccCccccceEEEEeC--CCcEEEEEcCC----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence 334677888888999988643 44688898753 22356777888887774322 444433 22334567
Q ss_pred EEEEeccCCCCHHH-----------HH---Hhh---CCCC----CCHHHHH------------HHHHHHHHHHHHHHH--
Q 005886 88 WVVMPYMAGGSCLH-----------IM---KSA---YPEG----FEEPVIA------------TLLRETLKALVYLHF-- 132 (671)
Q Consensus 88 ~LVmEy~~ggsL~~-----------~l---~~~---~~~~----l~e~~i~------------~i~~qIl~aL~yLHs-- 132 (671)
++|++|++|..+.. .+ ... .... ....... .....+..++.++..
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 89999999866411 11 110 0000 0000000 011112233444443
Q ss_pred -----CCcccccCCCCcEEEcCCCceEEeccccc
Q 005886 133 -----HGHIHRDVKAGNILIDSNGAIKLADFGVS 161 (671)
Q Consensus 133 -----~gIVHrDLKPeNILld~~g~vKL~DFGls 161 (671)
.++||+|+.|.||+++.++.+.|+||+.+
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a 203 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFA 203 (296)
T ss_pred hhcCCCcCCccCcCcccEEEeCCceEEEeehhhh
Confidence 47999999999999998877889999865
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0046 Score=63.96 Aligned_cols=133 Identities=14% Similarity=0.175 Sum_probs=75.8
Q ss_pred EecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCc-eeeeeEEEeCCEEEEEEeccCCCCH
Q 005886 21 EVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNV-LRAHCSFTTGHCLWVVMPYMAGGSC 99 (671)
Q Consensus 21 ~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNI-Vkl~~~~~~~~~l~LVmEy~~ggsL 99 (671)
.+..|-.+.+|+.. ..|..+++|........-. -...+|..+++.+..-.+ .+++..+. -++||+|++|..+
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~ 75 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALG-VDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVI 75 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCccccccc-CcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccc
Confidence 35678888999886 3466788887543221111 134678888888864333 33443332 2689999998654
Q ss_pred HH--------------HHHhhCC-----CCCCH-HHHHHHHHHH---------HHHHHHHHH--------CCcccccCCC
Q 005886 100 LH--------------IMKSAYP-----EGFEE-PVIATLLRET---------LKALVYLHF--------HGHIHRDVKA 142 (671)
Q Consensus 100 ~~--------------~l~~~~~-----~~l~e-~~i~~i~~qI---------l~aL~yLHs--------~gIVHrDLKP 142 (671)
.. .+.+-.. ..++. ..+..+..++ ...+..+-. ..++|+|+.|
T Consensus 76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~ 155 (256)
T TIGR02721 76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA 155 (256)
T ss_pred ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence 21 1111111 11111 1122222222 111222221 2589999999
Q ss_pred CcEEEcCCCceEEeccccc
Q 005886 143 GNILIDSNGAIKLADFGVS 161 (671)
Q Consensus 143 eNILld~~g~vKL~DFGls 161 (671)
.||+++.++ +.|+||..+
T Consensus 156 ~Nil~~~~~-~~lIDwE~a 173 (256)
T TIGR02721 156 YNLVVTPQG-LKLIDWEYA 173 (256)
T ss_pred CcEEEeCCC-CEEEecccc
Confidence 999999877 789999875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0079 Score=64.22 Aligned_cols=136 Identities=14% Similarity=0.156 Sum_probs=74.4
Q ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCC--Cceeeee------EEEeCCEEEEE
Q 005886 19 YEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHP--NVLRAHC------SFTTGHCLWVV 90 (671)
Q Consensus 19 ~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~Hp--NIVkl~~------~~~~~~~l~LV 90 (671)
.+.|+.|....+|+.... .| .+++|++. .. ....+..|+.++..|... .+.+++. +....+..+++
T Consensus 27 ~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~-~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l 100 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT-QG-EYVLTLFE-RL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAI 100 (319)
T ss_pred cchhccccccceEEEEeC-CC-cEEEEEec-cC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEE
Confidence 456778888899988643 33 58889875 21 223444555555554211 1333332 22335668899
Q ss_pred EeccCCCCHH-----------HHHH---hhCCCCC--------C--H--HHHHH-----------HHHHH-HHHHHHHH-
Q 005886 91 MPYMAGGSCL-----------HIMK---SAYPEGF--------E--E--PVIAT-----------LLRET-LKALVYLH- 131 (671)
Q Consensus 91 mEy~~ggsL~-----------~~l~---~~~~~~l--------~--e--~~i~~-----------i~~qI-l~aL~yLH- 131 (671)
++|++|..+. ..+. ... ..+ . . ..+.. .+.+. -..++.+.
T Consensus 101 ~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~-~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 179 (319)
T PRK05231 101 VTFLEGKWPRAPTAAHCAEVGEMLARMHLAG-RDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLAS 179 (319)
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHhhh-hcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhc
Confidence 9999986431 1111 100 001 0 0 00000 11111 11222322
Q ss_pred ------HCCcccccCCCCcEEEcCCCceEEeccccc
Q 005886 132 ------FHGHIHRDVKAGNILIDSNGAIKLADFGVS 161 (671)
Q Consensus 132 ------s~gIVHrDLKPeNILld~~g~vKL~DFGls 161 (671)
..|+||+|+.|.||+++.+...-|+||+.+
T Consensus 180 ~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~ 215 (319)
T PRK05231 180 AAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFA 215 (319)
T ss_pred cccccCCcccCCCCCCCCcEEEECCceEEEEecccc
Confidence 238999999999999986666689999975
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.009 Score=63.63 Aligned_cols=142 Identities=18% Similarity=0.157 Sum_probs=82.7
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCC--CceeeeeE------EEeCC
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHP--NVLRAHCS------FTTGH 85 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~Hp--NIVkl~~~------~~~~~ 85 (671)
.....+..++.|....+|++.. ..| .+++|+..... ....+..|+.++..|... .+.+++.. ....+
T Consensus 22 ~~~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~---~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g 96 (307)
T TIGR00938 22 GELLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV---KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG 96 (307)
T ss_pred CCceeccccCCccccceEEEEe-CCC-cEEEEEecCCC---CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC
Confidence 3455577788888889998864 334 57789875422 234556677777666322 23444331 12245
Q ss_pred EEEEEEeccCCCCHH-----------HH---HHhhCCCCC--------CHHH-----HH----------HHHHHHHHHHH
Q 005886 86 CLWVVMPYMAGGSCL-----------HI---MKSAYPEGF--------EEPV-----IA----------TLLRETLKALV 128 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~-----------~~---l~~~~~~~l--------~e~~-----i~----------~i~~qIl~aL~ 128 (671)
..+++|+|++|..+. .. +.... ..+ .... .. .....+...++
T Consensus 97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~-~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~ 175 (307)
T TIGR00938 97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAG-AHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELD 175 (307)
T ss_pred eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhh-ccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHH
Confidence 678999999885431 11 11100 111 0010 00 01112333455
Q ss_pred HHHH-------CCcccccCCCCcEEEcCCCceEEeccccc
Q 005886 129 YLHF-------HGHIHRDVKAGNILIDSNGAIKLADFGVS 161 (671)
Q Consensus 129 yLHs-------~gIVHrDLKPeNILld~~g~vKL~DFGls 161 (671)
++.. .++||+|+.+.||+++.++.+.|+||+.+
T Consensus 176 ~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~ 215 (307)
T TIGR00938 176 YLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFA 215 (307)
T ss_pred HHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccc
Confidence 5542 58999999999999998887789999975
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0041 Score=65.85 Aligned_cols=75 Identities=13% Similarity=0.150 Sum_probs=48.3
Q ss_pred EEEecccCceEEEEEEEcC------CCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCc-eeeeeEEEeCCEEEEEE
Q 005886 19 YEEVGEGVSATVYRALCIP------LNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNV-LRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 19 ~~~LG~G~fG~Vyka~~~~------tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNI-Vkl~~~~~~~~~l~LVm 91 (671)
++.|..|-...||++.... .++.|++|+..... .......+|..++..+....+ .++++++.. .+|+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~ 76 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV--ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIE 76 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC--cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchh
Confidence 4567778888999987543 25788899965332 222356788888887753333 345555542 3589
Q ss_pred eccCCCCH
Q 005886 92 PYMAGGSC 99 (671)
Q Consensus 92 Ey~~ggsL 99 (671)
+|++|..+
T Consensus 77 e~i~G~~l 84 (302)
T cd05156 77 EFIPSRTL 84 (302)
T ss_pred heeCCCcC
Confidence 99888655
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.0014 Score=69.78 Aligned_cols=133 Identities=20% Similarity=0.207 Sum_probs=93.9
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-----------------ccc--H--HHHHHHHHHHHhCC-CC
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-----------------NND--L--DGIRREVQTMRVTN-HP 72 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-----------------~~~--~--~~i~~Ei~iL~~L~-Hp 72 (671)
-|.++..||-|.-+-||.+-+. .|.+.++|+-.+.+. ..+ + -...+|...|+.|. |-
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 3567788999999999999765 578888887542211 011 1 22457888888774 32
Q ss_pred C-ceeeeeEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC
Q 005886 73 N-VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG 151 (671)
Q Consensus 73 N-IVkl~~~~~~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g 151 (671)
. |.+.+++ +.-++|||++.|-.|..+-.- ..+..+...+..-+.-|-.+|+||+|..-=||++..++
T Consensus 172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v--------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRHV--------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD 239 (465)
T ss_pred CCCCCcccc----cceeeHHHhhcccceeeeeec--------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCC
Confidence 2 4444443 334679999988777654321 12345666677777888899999999999999999999
Q ss_pred ceEEecccc
Q 005886 152 AIKLADFGV 160 (671)
Q Consensus 152 ~vKL~DFGl 160 (671)
.++++||--
T Consensus 240 ~i~vIDFPQ 248 (465)
T KOG2268|consen 240 KIVVIDFPQ 248 (465)
T ss_pred CEEEeechH
Confidence 999999963
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.037 Score=60.50 Aligned_cols=74 Identities=22% Similarity=0.157 Sum_probs=49.7
Q ss_pred EecccCceEEEEEEEcCCCcEEEEEEec----c--ccCcccHHHHHHHHHHHHhCC--CC-CceeeeeEEEeCCEEEEEE
Q 005886 21 EVGEGVSATVYRALCIPLNEIVAIKVLD----L--EKCNNDLDGIRREVQTMRVTN--HP-NVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 21 ~LG~G~fG~Vyka~~~~tg~~VAIKvi~----~--~~~~~~~~~i~~Ei~iL~~L~--Hp-NIVkl~~~~~~~~~l~LVm 91 (671)
+||.|....||++.....++.|+||.-. . +..+-..++..-|...|+... -| .+.++|. .+.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 6899999999999975433679999742 1 223445677778888887653 34 3444433 3444556899
Q ss_pred eccCC
Q 005886 92 PYMAG 96 (671)
Q Consensus 92 Ey~~g 96 (671)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.037 Score=58.44 Aligned_cols=29 Identities=31% Similarity=0.514 Sum_probs=24.2
Q ss_pred CcccccCCCCcEEEcCCCc-eEEecccccc
Q 005886 134 GHIHRDVKAGNILIDSNGA-IKLADFGVSA 162 (671)
Q Consensus 134 gIVHrDLKPeNILld~~g~-vKL~DFGls~ 162 (671)
.+||+|+.|.|||++.++. +-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 4899999999999987555 5699999763
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.015 Score=65.37 Aligned_cols=165 Identities=24% Similarity=0.252 Sum_probs=102.6
Q ss_pred HHHHHHHHHHhCCCCCceeeeeEEEeC-CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 005886 58 GIRREVQTMRVTNHPNVLRAHCSFTTG-HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHI 136 (671)
Q Consensus 58 ~i~~Ei~iL~~L~HpNIVkl~~~~~~~-~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIV 136 (671)
.+.--.++++.+.|+|...++++-... ....+|||++ +.+|.+.+.... .- +..+. .+|+.
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~---l~---~~s~~-----------~~~~~ 89 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN---LK---DESLL-----------AHGVL 89 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc---cc---hhhhc-----------ccccc
Confidence 445566788999999999988877654 3478899998 668888877652 11 11111 22222
Q ss_pred cccCCCCcEEEcCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCC
Q 005886 137 HRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHA 216 (671)
Q Consensus 137 HrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~ 216 (671)
|- +.++++|- +.+.. | ...++|+|||++|.++.++.-|..
T Consensus 90 ~~------------~~~~~td~-----~~t~~-----------------~------~~~~pKsdVwsl~~i~~el~L~~~ 129 (725)
T KOG1093|consen 90 HL------------NIIYITDH-----FLTKY-----------------P------SPIGPKSDVWSLGFIILELYLGIS 129 (725)
T ss_pred ee------------hhhhcccc-----ccccC-----------------C------CCCCcchhhhhHHHHHHHHHHhhH
Confidence 21 12333330 00000 1 011248999999999999999988
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCc-------cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 217 PFSKYPPMKVLLMTLQNAPPGLDY-------ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 217 PF~~~~~~~~~~~~~~~~~~~~~~-------~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
-|......+.+..+..-....... .+...++..+..+..+|+...|..||...++.+|+-|...
T Consensus 130 l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 130 LEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 776554444333332211111000 1122345667889999999999999999999999999765
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.032 Score=60.68 Aligned_cols=137 Identities=18% Similarity=0.255 Sum_probs=93.3
Q ss_pred EEEEecccCceEEEEEEEcCCCcEEEEEEeccc--------c------------Cc-ccHH----HHHHHHHHHHhCCCC
Q 005886 18 LYEEVGEGVSATVYRALCIPLNEIVAIKVLDLE--------K------------CN-NDLD----GIRREVQTMRVTNHP 72 (671)
Q Consensus 18 l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~--------~------------~~-~~~~----~i~~Ei~iL~~L~Hp 72 (671)
+-..|..|--+.||.|. ...|..+|||+++.. + +. +... -...|++-|++++..
T Consensus 148 inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 44678899999999987 456888999998521 0 10 1111 235788888888776
Q ss_pred CceeeeeEEEeCCEEEEEEeccCCCCHH-HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccccCCCCcEEEcCC
Q 005886 73 NVLRAHCSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLLRETLKALVYLH-FHGHIHRDVKAGNILIDSN 150 (671)
Q Consensus 73 NIVkl~~~~~~~~~l~LVmEy~~ggsL~-~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLH-s~gIVHrDLKPeNILld~~ 150 (671)
.|.-.--..... -+|||+|+.+.... -.|+. ..++...+..+-.+++.-+.-|- ..++||.||.--|+|+. +
T Consensus 227 GIP~PePIlLk~--hVLVM~FlGrdgw~aPkLKd---~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-d 300 (520)
T KOG2270|consen 227 GIPCPEPILLKN--HVLVMEFLGRDGWAAPKLKD---ASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-D 300 (520)
T ss_pred CCCCCCceeeec--ceEeeeeccCCCCcCccccc---ccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-C
Confidence 654433333332 35799999542211 12322 34677778888888888777774 45899999999999995 6
Q ss_pred CceEEeccccc
Q 005886 151 GAIKLADFGVS 161 (671)
Q Consensus 151 g~vKL~DFGls 161 (671)
|.+.|+|.+-+
T Consensus 301 G~lyiIDVSQS 311 (520)
T KOG2270|consen 301 GKLYIIDVSQS 311 (520)
T ss_pred CEEEEEEcccc
Confidence 88999999865
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.03 Score=60.20 Aligned_cols=145 Identities=17% Similarity=0.217 Sum_probs=84.1
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEec-cccCcccHHHHHHHHHHHHhCCCC--CceeeeeEEEeCC--EEEE
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLD-LEKCNNDLDGIRREVQTMRVTNHP--NVLRAHCSFTTGH--CLWV 89 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~-~~~~~~~~~~i~~Ei~iL~~L~Hp--NIVkl~~~~~~~~--~l~L 89 (671)
...+++.+-.|..-.+|..... ++.+++. .. ............+|+.+|+.+.-- -+...++.+.++. ..|.
T Consensus 26 ~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~ 102 (321)
T COG3173 26 GLLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY 102 (321)
T ss_pred CCceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence 3445555545555556655544 7778888 33 223334456777888888877542 2344566666655 6799
Q ss_pred EEeccCCCCH------------------HHHHHhhCC------------CCCCHHHHHHHHHHH--------------HH
Q 005886 90 VMPYMAGGSC------------------LHIMKSAYP------------EGFEEPVIATLLRET--------------LK 125 (671)
Q Consensus 90 VmEy~~ggsL------------------~~~l~~~~~------------~~l~e~~i~~i~~qI--------------l~ 125 (671)
||+|++|..+ .+++..-.. ..+....+..+..+. ..
T Consensus 103 v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~ 182 (321)
T COG3173 103 VMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR 182 (321)
T ss_pred EEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence 9999988322 111111000 001111122222211 12
Q ss_pred HHHHHHHC--------CcccccCCCCcEEEcCCCceEEecccccc
Q 005886 126 ALVYLHFH--------GHIHRDVKAGNILIDSNGAIKLADFGVSA 162 (671)
Q Consensus 126 aL~yLHs~--------gIVHrDLKPeNILld~~g~vKL~DFGls~ 162 (671)
-..+++.+ .++|+|+.+.||+++.++-+-|.||+++.
T Consensus 183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~ 227 (321)
T COG3173 183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELAT 227 (321)
T ss_pred HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccc
Confidence 23444432 58999999999999998889999999864
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.02 E-value=0.07 Score=56.46 Aligned_cols=28 Identities=29% Similarity=0.500 Sum_probs=24.6
Q ss_pred CCcccccCCCCcEEEcCCCceEEeccccc
Q 005886 133 HGHIHRDVKAGNILIDSNGAIKLADFGVS 161 (671)
Q Consensus 133 ~gIVHrDLKPeNILld~~g~vKL~DFGls 161 (671)
.++||+|+.+.||+++. +.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 47899999999999987 67889999954
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.68 E-value=0.089 Score=57.29 Aligned_cols=141 Identities=17% Similarity=0.224 Sum_probs=80.1
Q ss_pred CCeEEEEEecccCceEEEEEEEcC----CCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCc-eeeeeEEEeCCEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIP----LNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNV-LRAHCSFTTGHCLW 88 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~----tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNI-Vkl~~~~~~~~~l~ 88 (671)
+... +..|-.|-.-.+|++.... .++.|++|+..... ....++ .+|..+++.+..-++ .++++.+..+
T Consensus 37 ~~~~-i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g---- 109 (344)
T PLN02236 37 EALQ-VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG---- 109 (344)
T ss_pred CcEE-EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-Ceeech-HHHHHHHHHHHHcCCCCceEEEECCc----
Confidence 3444 4456568889999986432 24678899875432 222232 678888887754444 3456666433
Q ss_pred EEEeccCCCCHHH--------------HHHhhCC----C---CCCHHHHHHHHHHH-----------------HHHHHHH
Q 005886 89 VVMPYMAGGSCLH--------------IMKSAYP----E---GFEEPVIATLLRET-----------------LKALVYL 130 (671)
Q Consensus 89 LVmEy~~ggsL~~--------------~l~~~~~----~---~l~e~~i~~i~~qI-----------------l~aL~yL 130 (671)
.|.+|+.|.++.. .+.+-.. . ......+..++.++ ...+..|
T Consensus 110 ~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L 189 (344)
T PLN02236 110 RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLL 189 (344)
T ss_pred eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHH
Confidence 4788887765521 1111100 0 01122233332221 1111111
Q ss_pred ----H----HCCcccccCCCCcEEEcC-CCceEEeccccc
Q 005886 131 ----H----FHGHIHRDVKAGNILIDS-NGAIKLADFGVS 161 (671)
Q Consensus 131 ----H----s~gIVHrDLKPeNILld~-~g~vKL~DFGls 161 (671)
. ...++|+|+++.|||++. ++.+.|+||..+
T Consensus 190 ~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya 229 (344)
T PLN02236 190 EKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYA 229 (344)
T ss_pred HHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhc
Confidence 1 225899999999999976 468999999875
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.11 Score=57.52 Aligned_cols=76 Identities=20% Similarity=0.224 Sum_probs=52.3
Q ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEec----c-ccCcccHHHHHHHHHHHHhCC--CC-CceeeeeEEEeCCEEEEE
Q 005886 19 YEEVGEGVSATVYRALCIPLNEIVAIKVLD----L-EKCNNDLDGIRREVQTMRVTN--HP-NVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 19 ~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~----~-~~~~~~~~~i~~Ei~iL~~L~--Hp-NIVkl~~~~~~~~~l~LV 90 (671)
++.||.|.-..||++.+...++.|+||.-. . +..+-..++..-|...|+... .| ++.++|.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 788999999999999874335678898732 1 223455788888999888663 34 45555443 34456678
Q ss_pred EeccCC
Q 005886 91 MPYMAG 96 (671)
Q Consensus 91 mEy~~g 96 (671)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998854
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.32 E-value=0.22 Score=53.11 Aligned_cols=28 Identities=14% Similarity=0.208 Sum_probs=26.2
Q ss_pred CcccccCCCCcEEEcCCCceEEeccccc
Q 005886 134 GHIHRDVKAGNILIDSNGAIKLADFGVS 161 (671)
Q Consensus 134 gIVHrDLKPeNILld~~g~vKL~DFGls 161 (671)
++||+|+.++|||++.++.+.|+||..+
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~ 224 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKA 224 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhc
Confidence 7999999999999999999999999875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.25 E-value=0.072 Score=54.32 Aligned_cols=115 Identities=16% Similarity=0.100 Sum_probs=72.7
Q ss_pred cCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccCCCCHHHHHH
Q 005886 25 GVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMK 104 (671)
Q Consensus 25 G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~ggsL~~~l~ 104 (671)
|+-++.-.++.+- | ...+|++..-.+.-....+..+.+++.+++ .|+++..- ....+.++.|+|-..
T Consensus 73 ~gNsTl~~~kt~i-G-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~------- 139 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-G-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKI------- 139 (308)
T ss_pred CCceEEEEecccc-c-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCc-------
Confidence 3334444443332 3 245666654444423355678888888875 47777633 556788999998431
Q ss_pred hhCCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccccCCCCcEEEcCCCceEEecccc
Q 005886 105 SAYPEGFEEPVIATLLRETLKALVYLHFH--GHIHRDVKAGNILIDSNGAIKLADFGV 160 (671)
Q Consensus 105 ~~~~~~l~e~~i~~i~~qIl~aL~yLHs~--gIVHrDLKPeNILld~~g~vKL~DFGl 160 (671)
.-... .++..=+.+|.-.|+. +.+|+|-.|+||+-|..|.+||.|=+.
T Consensus 140 ----~i~~~----N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 140 ----KINFS----NFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred ----ccchh----HHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 11111 1122224677788853 789999999999999999999999773
|
The function of this family is unknown. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.23 E-value=0.13 Score=55.62 Aligned_cols=141 Identities=13% Similarity=0.239 Sum_probs=78.4
Q ss_pred CCeEEEEEecccCceEEEEEEEcCC---CcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCc-eeeeeEEEeCCEEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPL---NEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNV-LRAHCSFTTGHCLWV 89 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~t---g~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNI-Vkl~~~~~~~~~l~L 89 (671)
++.++ +.|..|-...+|++..... +..|++|+..... . ..-.-.+|..+++.+..-++ .++++++..+ +
T Consensus 15 ~~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t-~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~ 87 (330)
T PLN02421 15 SDFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT-D-YVIDRERELQAIKYLSAAGFGAKLLGVFGNG----M 87 (330)
T ss_pred CceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCc-C-eEechHHHHHHHHHHHhcCCCCceeEEeCCc----E
Confidence 34444 5555588888999875432 2378899875322 1 11223578888888765444 3556666322 4
Q ss_pred EEeccCCCCHHH--------------HHHhhCCCC------C-CHHHHHHHHHHH----------------------HHH
Q 005886 90 VMPYMAGGSCLH--------------IMKSAYPEG------F-EEPVIATLLRET----------------------LKA 126 (671)
Q Consensus 90 VmEy~~ggsL~~--------------~l~~~~~~~------l-~e~~i~~i~~qI----------------------l~a 126 (671)
|.+|+.|..+.. .+.+-.... + ....+..++.++ ..-
T Consensus 88 i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 167 (330)
T PLN02421 88 IQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDE 167 (330)
T ss_pred eehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHH
Confidence 888887765411 111111111 1 112222232221 111
Q ss_pred HHHH---H-HC----CcccccCCCCcEEEcC-CCceEEeccccc
Q 005886 127 LVYL---H-FH----GHIHRDVKAGNILIDS-NGAIKLADFGVS 161 (671)
Q Consensus 127 L~yL---H-s~----gIVHrDLKPeNILld~-~g~vKL~DFGls 161 (671)
+..+ . .. .++|+|+.+.|||++. ++.++++||..|
T Consensus 168 ~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYa 211 (330)
T PLN02421 168 IVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYG 211 (330)
T ss_pred HHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEccccc
Confidence 2221 1 11 2799999999999975 578999999976
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.21 E-value=0.23 Score=55.34 Aligned_cols=75 Identities=19% Similarity=0.076 Sum_probs=52.7
Q ss_pred EEEEecccCceEEEEEEEcCCCcEEEEEEeccc------cCcccHHHHHHHHHHHHhCC---CCCceeeeeEEEeCCEEE
Q 005886 18 LYEEVGEGVSATVYRALCIPLNEIVAIKVLDLE------KCNNDLDGIRREVQTMRVTN---HPNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 18 l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~------~~~~~~~~i~~Ei~iL~~L~---HpNIVkl~~~~~~~~~l~ 88 (671)
..+.||.|....||+..+. +..|+||.-... ..+....+...|...|+.+. ..++.+++.++.+. .+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--AL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CE
Confidence 3678999999999998863 456889985411 11234566667777777654 35778888887744 56
Q ss_pred EEEeccCC
Q 005886 89 VVMPYMAG 96 (671)
Q Consensus 89 LVmEy~~g 96 (671)
++|||+++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 78999976
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.15 E-value=0.065 Score=56.99 Aligned_cols=75 Identities=15% Similarity=0.110 Sum_probs=49.0
Q ss_pred EEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCC---CCCceeeeeEEEeCCEEEEEEec
Q 005886 17 RLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN---HPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 17 ~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~---HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
+-.+.++-|....+|+.. .+++.+.||+-. ......+..|..-|+.|. .-.+.+++++....+.-||||||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~----~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~ 93 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNS----ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEF 93 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEE----GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecC----hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEe
Confidence 346779999999999886 667889999865 222357888988888773 44577889988877777999999
Q ss_pred cCCC
Q 005886 94 MAGG 97 (671)
Q Consensus 94 ~~gg 97 (671)
++.+
T Consensus 94 l~~~ 97 (288)
T PF03881_consen 94 LEMG 97 (288)
T ss_dssp ----
T ss_pred ecCC
Confidence 8776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.32 E-value=0.48 Score=48.79 Aligned_cols=75 Identities=16% Similarity=0.176 Sum_probs=51.3
Q ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCC---CCCceeeeeEEEeCCEEEEEEeccC
Q 005886 19 YEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN---HPNVLRAHCSFTTGHCLWVVMPYMA 95 (671)
Q Consensus 19 ~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~---HpNIVkl~~~~~~~~~l~LVmEy~~ 95 (671)
.+.+.-|.--..|...+- ..+|.+|+-. ......+..|+.-|+.+. .-.|.+++++.....+.|+||||++
T Consensus 21 r~~v~gG~inea~~v~dg--~~~~FvK~n~----~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~ 94 (286)
T COG3001 21 REEVSGGDINEAWRLRDG--TDPFFVKCNQ----REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLP 94 (286)
T ss_pred ccccCCccccceeEeecC--CcceEEEecc----hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeecc
Confidence 344555555555554432 3457788732 234567888888777664 4567889999999999999999998
Q ss_pred CCCH
Q 005886 96 GGSC 99 (671)
Q Consensus 96 ggsL 99 (671)
.|.+
T Consensus 95 ~~~~ 98 (286)
T COG3001 95 TGPL 98 (286)
T ss_pred CCCC
Confidence 7544
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.28 E-value=0.12 Score=56.20 Aligned_cols=87 Identities=21% Similarity=0.219 Sum_probs=60.5
Q ss_pred CCCCCceeeeeEE-EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCcEE
Q 005886 69 TNHPNVLRAHCSF-TTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH-GHIHRDVKAGNIL 146 (671)
Q Consensus 69 L~HpNIVkl~~~~-~~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~-gIVHrDLKPeNIL 146 (671)
...++..+++-+- ....+.|++|++- |+++. .++ .-..+++..++.+.+..++-+..+ ..-|||+.-+|||
T Consensus 282 ~g~~~~e~~~vv~~de~~y~yl~~kdh-gt~is-~ik-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niL 354 (488)
T COG5072 282 CGSVFLETLKVVSLDETLYLYLHFKDH-GTPIS-IIK-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNIL 354 (488)
T ss_pred ccchhhhcceEEecCCceEEEEEEecC-Cceee-eee-----cccHHHHHHHHHHHHHHHhhhhhcCCccccccccccee
Confidence 3444444444333 3345778888875 44443 222 234566778888877777777655 6789999999999
Q ss_pred EcCCCceEEeccccccc
Q 005886 147 IDSNGAIKLADFGVSAC 163 (671)
Q Consensus 147 ld~~g~vKL~DFGls~~ 163 (671)
|+ +|+|-|+||-+++.
T Consensus 355 Id-~GnvtLIDfklsRl 370 (488)
T COG5072 355 ID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ee-cCceEEEEeeeeec
Confidence 99 99999999999873
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.13 E-value=0.15 Score=56.26 Aligned_cols=61 Identities=28% Similarity=0.408 Sum_probs=45.1
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH-HHCCcccccCCCCcEEEcCC
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYL-HFHGHIHRDVKAGNILIDSN 150 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yL-Hs~gIVHrDLKPeNILld~~ 150 (671)
..|+=+|..|-++..+++.. ..+|+....++.-.+.|+-.+ --.+++|.|+.|.||++-.+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~---~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK---SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhhcc---cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 45667788888888888764 456666777776666665544 44689999999999999543
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.29 E-value=1.2 Score=49.39 Aligned_cols=76 Identities=14% Similarity=0.215 Sum_probs=44.9
Q ss_pred EEEEecccCceEEEEEEEcCC-CcE-----EEEEEeccccCcccHHHHHHHHHHHHhCCCCCc-eeeeeEEEeCCEEEEE
Q 005886 18 LYEEVGEGVSATVYRALCIPL-NEI-----VAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNV-LRAHCSFTTGHCLWVV 90 (671)
Q Consensus 18 l~~~LG~G~fG~Vyka~~~~t-g~~-----VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNI-Vkl~~~~~~~~~l~LV 90 (671)
.++.|..|-...+|++..... +.. |.+++... . ....-.-.+|+.+++.+...++ .++++.|.. ++|
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~-~-~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l 127 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST-Y-NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTI 127 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC-C-CceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEE
Confidence 345666688899999865432 122 33333211 1 1111123568889988865544 456666653 589
Q ss_pred EeccCCCCH
Q 005886 91 MPYMAGGSC 99 (671)
Q Consensus 91 mEy~~ggsL 99 (671)
.||++|..|
T Consensus 128 ~efIeGr~l 136 (383)
T PTZ00384 128 QEWVEGNTM 136 (383)
T ss_pred EEEeccccC
Confidence 999988665
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.96 E-value=1.2 Score=55.61 Aligned_cols=148 Identities=16% Similarity=0.215 Sum_probs=79.4
Q ss_pred cccccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhC-------CCCCceee
Q 005886 5 VEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-------NHPNVLRA 77 (671)
Q Consensus 5 ~e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-------~HpNIVkl 77 (671)
+++.|.+.. .+..|+. ..-.+|+... .+|..|++|+.+... ....+..|...|..| .-|.+++-
T Consensus 20 ~~~~ygl~~----~~~~L~s-~~d~nf~v~~-~~g~~yVLKi~~~~~---~~~~~~~q~~~L~hL~~~~~glpvP~~i~t 90 (1013)
T PRK06148 20 LAQHFGISA----TATPLDG-ERDLNFRLTT-DDGADYILKIVNPSE---PRVESDFQTAALDHLAAVAPDLPVPRLIPS 90 (1013)
T ss_pred HHHHcCCce----EEeecCC-cCCceEEEEe-CCCCeEEEEEcCCcc---chhHHHHHHHHHHHHHhhCCCCCcCeeeec
Confidence 445566642 2356753 4577888864 457779999987542 223344455555433 22333332
Q ss_pred e-----eEEEe-CC--EEEEEEeccCCCCHHHH-----------------HHh---hC-CC----CCCH-----------
Q 005886 78 H-----CSFTT-GH--CLWVVMPYMAGGSCLHI-----------------MKS---AY-PE----GFEE----------- 113 (671)
Q Consensus 78 ~-----~~~~~-~~--~l~LVmEy~~ggsL~~~-----------------l~~---~~-~~----~l~e----------- 113 (671)
. ..... ++ .++.+++|++|..+... +.. .. .. .+.+
T Consensus 91 ~~G~~~~~v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~ 170 (1013)
T PRK06148 91 LSGASLASAQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDR 170 (1013)
T ss_pred CCCCeEEEeecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhh
Confidence 1 11111 22 56778999999776541 000 00 00 0101
Q ss_pred ------HHHHHHHHHHHHHHHH-----HH--HCCcccccCCCCcEEEcCCC--ceE-Eeccccc
Q 005886 114 ------PVIATLLRETLKALVY-----LH--FHGHIHRDVKAGNILIDSNG--AIK-LADFGVS 161 (671)
Q Consensus 114 ------~~i~~i~~qIl~aL~y-----LH--s~gIVHrDLKPeNILld~~g--~vK-L~DFGls 161 (671)
...+.++.+++....- +. ..++||+|+.+.|||++.++ .+. |+|||-+
T Consensus 171 l~~i~d~~~r~~l~~~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa 234 (1013)
T PRK06148 171 LHFIDDPEDRALVERFLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDA 234 (1013)
T ss_pred hhhcCCHHHHHHHHHHHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccc
Confidence 1112223333333221 11 25799999999999998875 554 9999975
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.73 E-value=2.2 Score=45.99 Aligned_cols=70 Identities=14% Similarity=0.016 Sum_probs=42.0
Q ss_pred CceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCC--Cceeee---e--EEEeCCEEEEEEeccCCCC
Q 005886 26 VSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHP--NVLRAH---C--SFTTGHCLWVVMPYMAGGS 98 (671)
Q Consensus 26 ~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~Hp--NIVkl~---~--~~~~~~~l~LVmEy~~ggs 98 (671)
.-..||+... ..|..+++|+..... .....+..|+..+..|... .|+... + ....++..+.+++++.|..
T Consensus 37 ~eN~vy~v~~-~~~~~~vlKv~r~~~--~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 37 YENRVYQFGD-EDGRRVVAKFYRPER--WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred ccceEEEEec-CCCCEEEEEEcCccc--CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 3456888864 346678999875322 2346677888887765321 122211 1 2233567888999998754
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.06 E-value=2.8 Score=47.35 Aligned_cols=78 Identities=9% Similarity=0.149 Sum_probs=47.8
Q ss_pred CCeEEEEEecccCceEEEEEEEcCC--------CcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCce-eeeeEEEeC
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPL--------NEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVL-RAHCSFTTG 84 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~t--------g~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIV-kl~~~~~~~ 84 (671)
++. -++.|..|-.-.+|++..... ++.|.+++.-... ...-.-..|..+++.+..-+|- ++++.|.
T Consensus 106 ~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t--e~lIdR~~E~~v~~~ls~~gi~P~l~~~f~-- 180 (442)
T PTZ00296 106 DDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV--DELYNPISEFEVYKTMSKYRIAPQLLNTFS-- 180 (442)
T ss_pred ccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc--cceeCHHHHHHHHHHHHHCCCCCceEEEeC--
Confidence 344 567788888888999875421 4678888874322 1112334677777777544443 4555553
Q ss_pred CEEEEEEeccCCCC
Q 005886 85 HCLWVVMPYMAGGS 98 (671)
Q Consensus 85 ~~l~LVmEy~~ggs 98 (671)
-+.|.+|++|..
T Consensus 181 --gg~I~efi~g~~ 192 (442)
T PTZ00296 181 --GGRIEEWLYGDP 192 (442)
T ss_pred --CCEEEEeeCCcc
Confidence 234788888763
|
|
| >COG4499 Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Probab=87.47 E-value=6.5 Score=42.94 Aligned_cols=124 Identities=15% Similarity=0.140 Sum_probs=79.5
Q ss_pred HHHHHHhCCCCCceeeeeEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCC
Q 005886 62 EVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVK 141 (671)
Q Consensus 62 Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLK 141 (671)
+..++.. ..|+|+.-+. .+.+.+.|-++....-.-+..+++ +....-++++.+.+..|.-+. +--.|-=|.
T Consensus 41 ~~~lld~-~~~f~~~eit--~~~Ds~vIsy~i~~~~~~F~~~k~-----~~k~~Klr~a~~~I~~l~e~~-~tr~~~~la 111 (434)
T COG4499 41 LAELLDK-SPPFIVAEIT--EDNDSFVISYPIPEAAKSFASAKR-----KEKTRKLRLALQNIATLSELN-NTRYTFFLA 111 (434)
T ss_pred HHHHhcc-CCCccceeec--ccCceeEEEecCccccchHHHHHH-----HHHHHHHHHHHHHHHHHHHhh-ccceeEEec
Confidence 3444544 4566665332 344455555554443333334432 456667777888888877643 334455578
Q ss_pred CCcEEEcCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCC
Q 005886 142 AGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSK 220 (671)
Q Consensus 142 PeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~ 220 (671)
|+||+++.++.+-+.-||+-.. -.|.=|.||.+.. .+-+++..++.|..+|..
T Consensus 112 PeNilf~~~l~p~~vH~Glk~~---------------lpPye~tee~f~~-----------~ykA~~~~~fn~k~~Fe~ 164 (434)
T COG4499 112 PENILFDGGLTPFFVHRGLKNS---------------LPPYEMTEERFLK-----------EYKALAIYAFNGKFSFES 164 (434)
T ss_pred chheEEcCCCceEEEecchhcc---------------CCCCCCCHHHHHH-----------HHHHHHHHHHcCCccHHH
Confidence 9999999999999999997422 2455578887764 345677788899999854
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 671 | ||||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-87 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-85 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-60 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-59 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-58 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-58 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-58 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-57 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-54 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-47 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-46 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-45 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-45 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-45 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-45 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-42 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-42 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-42 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-41 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-41 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-41 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-41 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-41 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-41 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-40 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-40 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-39 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-39 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-39 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-39 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-39 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-37 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-37 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-32 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-32 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-31 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-30 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-29 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-29 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-29 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-29 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-29 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-29 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-29 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-27 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-27 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-27 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-26 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-26 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-26 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-26 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-26 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-26 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-26 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-26 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-26 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-25 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-25 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-25 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-25 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-24 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-24 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-24 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-23 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-23 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-23 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-23 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-23 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-23 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-23 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-23 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-23 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-23 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-23 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-23 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-23 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-23 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-23 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-23 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-23 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-23 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 8e-23 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-23 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-23 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-23 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-23 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-23 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-23 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 9e-23 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-22 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-22 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-22 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-22 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-22 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-22 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-22 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-22 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-22 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-22 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-22 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-22 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-22 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-22 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-22 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-22 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-22 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-22 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-22 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-22 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-22 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-22 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-22 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-22 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-22 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-22 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-21 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-21 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-21 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-21 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-21 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-21 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-21 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-21 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-21 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-21 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-21 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-21 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-21 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-21 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-21 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-21 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-21 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-21 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-21 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-21 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-21 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-21 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-21 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-21 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-21 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-21 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-21 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-21 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-21 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-21 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-21 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-21 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-21 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-21 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-21 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-21 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-21 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-21 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-21 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-21 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-21 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-21 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-21 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-21 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-21 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-21 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-21 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-21 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-21 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-21 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-21 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-21 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-21 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-21 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-21 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-21 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-21 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-21 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-21 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-21 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-21 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-21 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-21 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-21 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-21 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-21 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-21 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-21 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-21 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-20 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-20 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-20 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-20 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-20 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-20 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-20 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-20 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-20 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-20 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-20 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-20 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-20 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-20 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-20 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-20 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-20 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-20 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-20 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-20 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-20 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-20 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-20 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-20 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-20 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-20 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-20 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-20 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-20 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-20 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-20 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-20 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-20 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-20 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-20 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-20 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-20 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-20 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-20 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-20 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-20 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-20 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-20 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-20 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-20 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-20 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-20 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-20 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-20 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-20 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-20 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-20 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-20 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-20 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-20 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-20 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-20 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-20 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-20 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-20 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-20 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-20 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-19 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-19 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-19 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-19 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-19 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-19 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-19 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-19 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-19 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-19 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-19 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-19 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-19 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-19 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-19 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-19 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-19 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-19 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-19 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-19 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-19 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-19 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-19 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-19 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-19 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-19 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-19 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-19 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-19 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-18 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-18 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-18 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-18 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-18 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-18 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-18 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-18 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-18 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-18 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-18 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-18 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-18 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-18 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-18 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-18 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-18 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-18 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-18 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-18 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-18 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-18 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-18 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-18 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-18 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-18 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-18 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-18 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-18 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-18 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-18 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-18 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-18 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-18 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-18 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-18 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-17 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-17 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-17 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-17 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-17 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-17 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-17 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-17 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-17 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-17 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-17 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-17 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-17 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-17 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-17 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-17 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-17 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-17 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-17 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-17 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-17 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-17 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-17 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-17 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-17 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-17 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-17 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-17 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-17 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-17 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-17 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-17 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-17 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-17 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-17 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-17 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-17 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-17 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-17 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-17 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-17 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-17 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-17 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-17 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-17 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-17 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 8e-17 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-17 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-17 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-17 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-17 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-17 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-17 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-17 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-17 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-17 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-16 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-16 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-16 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-16 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-16 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-16 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-16 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-16 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-16 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-16 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-16 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-16 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-16 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-16 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-16 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-16 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-16 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-16 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-16 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-16 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-16 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-16 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-16 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-16 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-16 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-16 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-16 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-16 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-16 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-16 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-16 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-16 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-16 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-16 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-16 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-16 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-16 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 7e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-16 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-16 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-16 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-16 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-16 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-16 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-15 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-15 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-15 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-15 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-15 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-15 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-15 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-15 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-15 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-15 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-15 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-15 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-15 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-15 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-15 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-15 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-15 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-15 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-15 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-14 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-14 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-14 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-14 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-14 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-14 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-13 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-13 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-13 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-13 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-13 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-13 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-13 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-13 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-13 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-13 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-13 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-13 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-13 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-13 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-13 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-12 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-12 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-12 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-12 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-12 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-12 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-12 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-11 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-11 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-11 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-11 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-11 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-11 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-11 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-11 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-11 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-11 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-11 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-11 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-11 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-11 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 9e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-10 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 8e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-09 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 4e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-09 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 6e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-09 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 6e-09 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 8e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-08 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-08 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-08 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-08 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-08 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-08 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-08 |
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 495 bits (1277), Expect = e-173
Identities = 150/294 (51%), Positives = 203/294 (69%), Gaps = 13/294 (4%)
Query: 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQT 65
+ ++ DY L E +G G +A V A C P E VAIK ++LEKC +D + +E+Q
Sbjct: 7 ALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQA 66
Query: 66 MRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEG------FEEPVIATL 119
M +HPN++ + SF LW+VM ++GGS L I+K +G +E IAT+
Sbjct: 67 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 120 LRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD--RQRSRNTF 177
LRE L+ L YLH +G IHRDVKAGNIL+ +G++++ADFGVSA + GD R + R TF
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 178 VGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG 237
VGTPCWMAPEVM+Q+ GYDFKADIWSFGITA+ELA G AP+ KYPPMKVL++TLQN PP
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246
Query: 238 L-----DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFL 286
L D E K++ KSF+++++ CL KDP+KRPTA +L++H FF+ A++ +FL
Sbjct: 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFL 300
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 445 bits (1147), Expect = e-152
Identities = 108/374 (28%), Positives = 165/374 (44%), Gaps = 55/374 (14%)
Query: 8 RFPVDAKDYRLYEEVGEGVS--ATVYRALCIPLNEIVAIKVLDLEKCNND-LDGIRREVQ 64
F + Y L +G+G TV A P E V ++ ++LE C+N+ + ++ E+
Sbjct: 19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELH 78
Query: 65 TMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETL 124
++ NHPN++ +F + LWVV +MA GS ++ + + +G E IA +L+ L
Sbjct: 79 VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL 138
Query: 125 KALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNT----FVGT 180
KAL Y+H G++HR VKA +ILI +G + L+ + M G RQR + V
Sbjct: 139 KALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198
Query: 181 PCWMAPEVMQQ-LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL- 238
W++PEV+QQ L GYD K+DI+S GITA ELA+GH PF P ++LL L P L
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258
Query: 239 ----------------------------------------DYERDKRFSKSFKELVTACL 258
+ + FS F V CL
Sbjct: 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCL 318
Query: 259 VKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGERFRMLKAKEADLLVQNKAL 318
++P RP+A L+ H FFK + R + L L + E + +
Sbjct: 319 QRNPDARPSASTLLNHSFFKQIK------RRASEALPELLRPVTPITNFEGSQSQDHSGI 372
Query: 319 YEDKEQLSQDYDCM 332
+ L +
Sbjct: 373 FGLVTNLEELEVDD 386
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 419 bits (1080), Expect = e-143
Identities = 120/297 (40%), Positives = 179/297 (60%), Gaps = 18/297 (6%)
Query: 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHP 72
+ + E++G+G V++ + ++VAIK++DLE+ ++++ I++E+ + + P
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 73 NVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF 132
V + + S+ LW++M Y+ GGS L +++ P +E IAT+LRE LK L YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE---PGPLDETQIATILREILKGLDYLHS 137
Query: 133 HGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQL 192
IHRD+KA N+L+ +G +KLADFGV+ + D + RNTFVGTP WMAPEV++Q
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK---RNTFVGTPFWMAPEVIKQ- 193
Query: 193 HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKE 252
YD KADIWS GITA+ELA G P S+ PMKVL + +N PP L + +SK KE
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTL----EGNYSKPLKE 249
Query: 253 LVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGERFRMLKAKEA 309
V ACL K+P RPTA++L+KH F L L +R++ KA+++
Sbjct: 250 FVEACLNKEPSFRPTAKELLKHKFILRNAKK-------TSYLTELIDRYKRWKAEQS 299
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 357 bits (918), Expect = e-119
Identities = 85/286 (29%), Positives = 135/286 (47%), Gaps = 15/286 (5%)
Query: 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQT 65
+R+ + D E+G G V++ ++A+K + + I ++
Sbjct: 17 GQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDV 76
Query: 66 -MRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETL 124
++ + P +++ +F T +++ M M G+C +K E ++ + +
Sbjct: 77 VLKSHDCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIV 134
Query: 125 KALVYLHF-HGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCW 183
KAL YL HG IHRDVK NIL+D G IKL DFG+S + D ++++ G +
Sbjct: 135 KALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD----KAKDRSAGCAAY 190
Query: 184 MAPEVMQQLH----GYDFKADIWSFGITALELAHGHAPFSKY-PPMKVLLMTLQNAPPGL 238
MAPE + YD +AD+WS GI+ +ELA G P+ +VL LQ PP L
Sbjct: 191 MAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL 250
Query: 239 DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSND 284
FS F+ V CL KD +KRP KL++H F K + +
Sbjct: 251 --PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLE 294
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 342 bits (880), Expect = e-114
Identities = 97/300 (32%), Positives = 157/300 (52%), Gaps = 19/300 (6%)
Query: 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHP 72
+ + + E+G+G VY+A + A KV++ + +L+ E++ + +HP
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHP 76
Query: 73 NVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF 132
+++ ++ LW+++ + GG+ IM G EP I + R+ L+AL +LH
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 133 HGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVM--- 189
IHRD+KAGN+L+ G I+LADFGVSA + R++F+GTP WMAPEV+
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK---RDSFIGTPYWMAPEVVMCE 192
Query: 190 -QQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSK 248
+ YD+KADIWS GIT +E+A P + PM+VLL ++ PP L ++S
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL--LTPSKWSV 250
Query: 249 SFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGERFRMLKAKE 308
F++ + L K+P+ RP+A +L++H F SN L L + +E
Sbjct: 251 EFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKA--------LRELVAEAKAEVMEE 302
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 342 bits (878), Expect = e-113
Identities = 114/295 (38%), Positives = 171/295 (57%), Gaps = 18/295 (6%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN 73
+ + + E++GEG +VY+A+ +IVAIK + +E +DL I +E+ M+ + P+
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE---SDLQEIIKEISIMQQCDSPH 85
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH 133
V++ + S+ LW+VM Y GS I++ + E IAT+L+ TLK L YLHF
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR-LRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 134 GHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLH 193
IHRD+KAGNIL+++ G KLADFGV+ + D + RNT +GTP WMAPEV+Q+
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK---RNTVIGTPFWMAPEVIQE-I 200
Query: 194 GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL 253
GY+ ADIWS GITA+E+A G P++ PM+ + M N PP + + +S +F +
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTF--RKPELWSDNFTDF 258
Query: 254 VTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGERFRMLKAKE 308
V CLVK P++R TA +L++H F + A+ L L +K K
Sbjct: 259 VKQCLVKSPEQRATATQLLQHPFVRSAKGVSI--------LRDLINEAMDVKLKR 305
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 339 bits (872), Expect = e-112
Identities = 103/291 (35%), Positives = 160/291 (54%), Gaps = 19/291 (6%)
Query: 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMR-VTNH 71
A + L E VG G VY+ + ++ AIKV+D+ ++ + I++E+ ++ ++H
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHH 80
Query: 72 PNVLRAHCSFTTGHC------LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLK 125
N+ + +F + LW+VM + GS ++K+ +E IA + RE L+
Sbjct: 81 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 140
Query: 126 ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMA 185
L +LH H IHRD+K N+L+ N +KL DFGVSA + R RNTF+GTP WMA
Sbjct: 141 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR---RNTFIGTPYWMA 197
Query: 186 PEVMQQLH----GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYE 241
PEV+ YDFK+D+WS GITA+E+A G P PM+ L + +N P L
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL--- 254
Query: 242 RDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVD 292
+ K++SK F+ + +CLVK+ +RP E+LMKH F + + + + D
Sbjct: 255 KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKD 305
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 338 bits (868), Expect = e-112
Identities = 102/294 (34%), Positives = 159/294 (54%), Gaps = 18/294 (6%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN 73
K Y +E++G+G S TVY A+ + + VAI+ ++L++ + I E+ MR +PN
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPN 78
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH 133
++ S+ G LWVVM Y+AGGS ++ +E IA + RE L+AL +LH +
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 134 GHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLH 193
IHRD+K+ NIL+ +G++KL DFG A + + R+T VGTP WMAPEV+ +
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTR-K 191
Query: 194 GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL 253
Y K DIWS GI A+E+ G P+ P++ L + N P L + ++ S F++
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL--QNPEKLSAIFRDF 249
Query: 254 VTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGERFRMLKAK 307
+ CL D +KR +A++L++H F K A+ L PL +
Sbjct: 250 LNRCLEMDVEKRGSAKELLQHQFLKIAKPLSS--------LTPLIAAAKEATKN 295
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 338 bits (868), Expect = e-111
Identities = 84/293 (28%), Positives = 140/293 (47%), Gaps = 14/293 (4%)
Query: 1 MDLVVEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR 60
+ + E+ + A+D + E+G G +V + + P +I+A+K + + +
Sbjct: 9 LKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLL 68
Query: 61 REVQT-MRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAY---PEGFEEPVI 116
++ MR ++ P +++ + + W+ M M S K Y + E ++
Sbjct: 69 MDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEIL 127
Query: 117 ATLLRETLKALVYLHFHGHI-HRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRN 175
+ T+KAL +L + I HRD+K NIL+D +G IKL DFG+S + D+ ++
Sbjct: 128 GKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS----IAKT 183
Query: 176 TFVGTPCWMAPEVMQQ---LHGYDFKADIWSFGITALELAHGHAPFSKYPPM-KVLLMTL 231
G +MAPE + GYD ++D+WS GIT ELA G P+ K+ + L +
Sbjct: 184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV 243
Query: 232 QNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSND 284
+ PP L ++ FS SF V CL KD KRP ++L+KH F
Sbjct: 244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERA 296
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 334 bits (859), Expect = e-110
Identities = 93/293 (31%), Positives = 146/293 (49%), Gaps = 18/293 (6%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN 73
Y ++GEG + V A VA+K++DL K + + EV MR H N
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHFN 103
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH 133
V+ + S+ G LWV+M ++ GG+ I+ E IAT+ L+AL YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQALAYLHAQ 160
Query: 134 GHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLH 193
G IHRD+K+ +IL+ +G +KL+DFG A + + R + VGTP WMAPEV+ +
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK---RKSLVGTPYWMAPEVISR-S 216
Query: 194 GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL 253
Y + DIWS GI +E+ G P+ P++ + + PP L + + S ++
Sbjct: 217 LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL--KNSHKVSPVLRDF 274
Query: 254 VTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGERFRMLKA 306
+ LV+DP++R TA++L+ H F + L PL + +R +
Sbjct: 275 LERMLVRDPQERATAQELLDHPFLLQTGLPEC--------LVPLIQLYRKQTS 319
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 334 bits (858), Expect = e-110
Identities = 105/315 (33%), Positives = 153/315 (48%), Gaps = 26/315 (8%)
Query: 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDL--EKCNNDLDGIRREVQTMRVTN 70
K + E+G G VY A + +E+VAIK + ++ N I +EV+ ++
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 71 HPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYL 130
HPN ++ + H W+VM Y GS +++ + + +E IA + L+ L YL
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLE-VHKKPLQEVEIAAVTHGALQGLAYL 170
Query: 131 HFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEV-- 188
H H IHRDVKAGNIL+ G +KL DFG ++ M N+FVGTP WMAPEV
Sbjct: 171 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-------APANSFVGTPYWMAPEVIL 223
Query: 189 MQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSK 248
YD K D+WS GIT +ELA P M L QN P L + +S+
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL---QSGHWSE 280
Query: 249 SFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGERFRMLKAKE 308
F+ V +CL K P+ RPT+E L+KH F R + L +R + +
Sbjct: 281 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTV--------IMDLIQRTKDAVREL 332
Query: 309 ADLLVQ--NKALYED 321
+L + K L+++
Sbjct: 333 DNLQYRKMKKILFQE 347
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 304 bits (782), Expect = 4e-99
Identities = 81/284 (28%), Positives = 132/284 (46%), Gaps = 16/284 (5%)
Query: 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQ-TMR 67
V A D E+G G V + +P +I+A+K + + + + ++ +MR
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 68 VTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEG--FEEPVIATLLRETLK 125
+ P + + + +W+ M M S K +G E ++ + +K
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 126 ALVYLHFHGH-IHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWM 184
AL +LH IHRDVK N+LI++ G +K+ DFG+S + D +++ G +M
Sbjct: 121 ALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD----VAKDIDAGCKPYM 176
Query: 185 APEVMQ---QLHGYDFKADIWSFGITALELAHGHAPFSKY-PPMKVLLMTLQNAPPGLDY 240
APE + GY K+DIWS GIT +ELA P+ + P + L ++ P L
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP- 235
Query: 241 ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSND 284
+FS F + + CL K+ K+RPT +LM+H FF S
Sbjct: 236 --ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKG 277
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 288 bits (740), Expect = 2e-92
Identities = 68/298 (22%), Positives = 114/298 (38%), Gaps = 14/298 (4%)
Query: 5 VEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQ 64
V+ + + VG G V+R A+K + LE E+
Sbjct: 49 VDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR------VEELV 102
Query: 65 TMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETL 124
+ P ++ + + G + + M + GGS ++K E L + L
Sbjct: 103 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQAL 160
Query: 125 KALVYLHFHGHIHRDVKAGNILIDSNGA-IKLADFGVSACMFDAGDRQ--RSRNTFVGTP 181
+ L YLH +H DVKA N+L+ S+G+ L DFG + C+ G + + + GT
Sbjct: 161 EGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 220
Query: 182 CWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYE 241
MAPEV+ D K DIWS L + +G P+++Y + L PP +
Sbjct: 221 THMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIP 279
Query: 242 RDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGE 299
+ + + L K+P R +A +L + + + P G
Sbjct: 280 PS--CAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPRGN 335
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 2e-89
Identities = 88/322 (27%), Positives = 140/322 (43%), Gaps = 54/322 (16%)
Query: 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQT 65
+K + D+ E+G G V++ P ++A K++ LE + I RE+Q
Sbjct: 25 QKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQV 84
Query: 66 MRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLK 125
+ N P ++ + +F + + + M +M GGS ++K A E ++ + +K
Sbjct: 85 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIK 142
Query: 126 ALVYLHFHGHI-HRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWM 184
L YL I HRDVK NIL++S G IKL DFGVS + D+ N+FVGT +M
Sbjct: 143 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYM 197
Query: 185 APEVMQQLHGYDFKADIWSFGITALELAHGHAPF-------------------------- 218
+PE +Q Y ++DIWS G++ +E+A G P
Sbjct: 198 SPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256
Query: 219 ------------SKYPPMKVLLMTLQ----NAPPGLDYERDKRFSKSFKELVTACLVKDP 262
P + L PP L FS F++ V CL+K+P
Sbjct: 257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP---SGVFSLEFQDFVNKCLIKNP 313
Query: 263 KKRPTAEKLMKHHFFKHARSND 284
+R ++LM H F K + + +
Sbjct: 314 AERADLKQLMVHAFIKRSDAEE 335
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 264 bits (677), Expect = 1e-83
Identities = 73/270 (27%), Positives = 121/270 (44%), Gaps = 13/270 (4%)
Query: 22 VGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSF 81
+G+G VY + +AIK + + + E+ + H N+++ SF
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 82 TTGHCLWVVMPYMAGGSCLHIMKSAY-PEGFEEPVIATLLRETLKALVYLHFHGHIHRDV 140
+ + + M + GGS +++S + P E I ++ L+ L YLH + +HRD+
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDI 148
Query: 141 KAGNILIDS-NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQ-LHGYDFK 198
K N+LI++ +G +K++DFG S + TF GT +MAPE++ + GY
Sbjct: 149 KGDNVLINTYSGVLKISDFGTSKRLAGINPC---TETFTGTLQYMAPEIIDKGPRGYGKA 205
Query: 199 ADIWSFGITALELAHGHAPFSKYP-PMKVLLM-TLQNAPPGLDYERDKRFSKSFKELVTA 256
ADIWS G T +E+A G PF + P + + P + + S K +
Sbjct: 206 ADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEI----PESMSAEAKAFILK 261
Query: 257 CLVKDPKKRPTAEKLMKHHFFKHARSNDFL 286
C DP KR A L+ F K +
Sbjct: 262 CFEPDPDKRACANDLLVDEFLKVSSKKKKT 291
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 258 bits (660), Expect = 4e-81
Identities = 64/292 (21%), Positives = 108/292 (36%), Gaps = 37/292 (12%)
Query: 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRV-TN 70
++ E++G G +V++ + I AIK D REV V
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 71 HPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEG--FEEPVIATLLRETLKALV 128
H +V+R ++ + + Y GGS + Y F+E + LL + + L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 129 YLHFHGHIHRDVKAGNILIDSNGAI-------------------KLADFGVSACMFDAGD 169
Y+H +H D+K NI I K+ D G +
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI----- 184
Query: 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLM 229
S G ++A EV+Q+ + + KADI++ +T + A +
Sbjct: 185 --SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI-- 240
Query: 230 TLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281
Q P + + S+ F EL+ + DP++RP+A L+KH A
Sbjct: 241 -RQGRLPRI----PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 6e-80
Identities = 72/278 (25%), Positives = 125/278 (44%), Gaps = 23/278 (8%)
Query: 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTN 70
D + + E+G G TVY+ L VA L K ++ + E + ++
Sbjct: 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ 83
Query: 71 HPNVLRAHCSFTTGH----CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKA 126
HPN++R + S+ + C+ +V M G+ +K + V+ + R+ LK
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKG 141
Query: 127 LVYLHFHGH--IHRDVKAGNILIDS-NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCW 183
L +LH IHRD+K NI I G++K+ D G++ R +GTP +
Sbjct: 142 LQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-----RASFAKAVIGTPEF 196
Query: 184 MAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLM--TLQNAPPGLDYE 241
MAPE+ ++ YD D+++FG+ LE+A P+S+ + T P
Sbjct: 197 MAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF--- 251
Query: 242 RDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKH 279
DK KE++ C+ ++ +R + + L+ H FF+
Sbjct: 252 -DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 254 bits (652), Expect = 8e-80
Identities = 71/302 (23%), Positives = 126/302 (41%), Gaps = 30/302 (9%)
Query: 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHP 72
A D+ +G+G V +A + AIK + + L I EV + NH
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EKLSTILSEVMLLASLNHQ 62
Query: 73 NVLRAHCSF-------------TTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATL 119
V+R + ++ L++ M Y G+ ++ S + L
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRL 121
Query: 120 LRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS------ 173
R+ L+AL Y+H G IHRD+K NI ID + +K+ DFG++ + + D +
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 174 -----RNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLL 228
+ +GT ++A EV+ Y+ K D++S GI E+ + PFS +L
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL 238
Query: 229 MTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLAR 288
L++ + D K K+++ + DP KRP A L+ + ++ +
Sbjct: 239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIKE 298
Query: 289 SI 290
++
Sbjct: 299 AL 300
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 248 bits (636), Expect = 3e-77
Identities = 66/268 (24%), Positives = 103/268 (38%), Gaps = 16/268 (5%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-DLDGIRREVQTM-RVTNH 71
+ ++ +G G V++ + A+K D EV + +V H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 72 PNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLH 131
P +R ++ G L++ H + E + LR+TL AL +LH
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCGPSLQQHCEA--WGASLPEAQVWGYLRDTLLALAHLH 174
Query: 132 FHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQ 191
G +H DVK NI + G KL DFG+ + + G P +MAPE++Q
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL----GTAGAGEVQEGDPRYMAPELLQ- 229
Query: 192 LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251
Y AD++S G+T LE+A + L PP S +
Sbjct: 230 -GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQ--GYLPPEF----TAGLSSELR 282
Query: 252 ELVTACLVKDPKKRPTAEKLMKHHFFKH 279
++ L DPK R TAE L+ +
Sbjct: 283 SVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 2e-74
Identities = 64/281 (22%), Positives = 126/281 (44%), Gaps = 10/281 (3%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-DLDGIRREVQTMRVTNHP 72
+ Y +++GEG IK +++ + ++ + + RREV + HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 73 NVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF 132
N+++ SF L++VM Y GG + + F+E I + AL ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 133 HGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQL 192
+HRD+K+ NI + +G ++L DFG++ + + +GTP +++PE+ +
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL---ARACIGTPYYLSPEICEN- 199
Query: 193 HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKE 252
Y+ K+DIW+ G EL F ++L + + P + +S +
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV----SLHYSYDLRS 255
Query: 253 LVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDN 293
LV+ ++P+ RP+ +++ F R FL+ ++
Sbjct: 256 LVSQLFKRNPRDRPSVNSILEKGFIAK-RIEKFLSPQLIAE 295
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 3e-74
Identities = 58/290 (20%), Positives = 111/290 (38%), Gaps = 38/290 (13%)
Query: 5 VEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQ 64
V+KRF D++ E +G G V++A + IK + + REV+
Sbjct: 5 VDKRF---GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVK 56
Query: 65 TMRVTNHPNVLRAHCSF----------------TTGHCLWVVMPYMAGGSCLHIMKSAYP 108
+ +H N++ + + + CL++ M + G+ ++
Sbjct: 57 ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 116
Query: 109 EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168
E ++ + L + K + Y+H I+RD+K NI + +K+ DFG+ +
Sbjct: 117 EKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---- 172
Query: 169 DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLL 228
R GT +M+PE + Y + D+++ G+ EL H +
Sbjct: 173 KNDGKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFE---TSKFF 228
Query: 229 MTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278
L++ F K K L+ L K P+ RP ++++
Sbjct: 229 TDLRDGII------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 7e-74
Identities = 73/283 (25%), Positives = 130/283 (45%), Gaps = 15/283 (5%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN--DLDGIRREVQTMRVTNH 71
++R+ +++G G + VYRA C+ VA+K + + + +E+ ++ NH
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 72 PNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEG--FEEPVIATLLRETLKALVY 129
PNV++ + SF + L +V+ G ++K + E + + AL +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 130 LHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVM 189
+H +HRD+K N+ I + G +KL D G+ ++ VGTP +M+PE +
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA---AHSLVGTPYYMSPERI 208
Query: 190 QQLHGYDFKADIWSFGITALELAHGHAPF-SKYPPMKVLLMTLQNAPPGLDYER--DKRF 246
+ +GY+FK+DIWS G E+A +PF + L ++ DY +
Sbjct: 209 HE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC----DYPPLPSDHY 263
Query: 247 SKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARS 289
S+ ++LV C+ DP+KRP + HA + L
Sbjct: 264 SEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHH 306
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 2e-71
Identities = 76/347 (21%), Positives = 147/347 (42%), Gaps = 23/347 (6%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-DLDGIRREVQTMRVT 69
V + Y + +++G G S+ V++ L +I AIK ++LE+ +N LD R E+ +
Sbjct: 6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL 64
Query: 70 NHPN--VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKAL 127
+ ++R + T +++VM +K + + + + L+A+
Sbjct: 65 QQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAV 121
Query: 128 VYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPE 187
+H HG +H D+K N LI +G +KL DFG++ M +++ VGT +M PE
Sbjct: 122 HTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM-QPDTTSVVKDSQVGTVNYMPPE 179
Query: 188 VMQQ----------LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG 237
++ K+D+WS G + +G PF + L + + P
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID--PN 237
Query: 238 LDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK-HARSNDFLARSIVDNLAP 296
+ E K ++++ CL +DPK+R + +L+ H + + + +A+ + +
Sbjct: 238 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKY 297
Query: 297 LGERFRMLKAKEADLLVQNKALYEDKEQLSQDYDCMSNAEDPNSSGK 343
+ + L + +L K LYE S + K
Sbjct: 298 VLGQLVGLNSPN-SILKAAKTLYEHYSGGESHNSSSSKTFEKKRGKK 343
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 2e-69
Identities = 67/285 (23%), Positives = 130/285 (45%), Gaps = 21/285 (7%)
Query: 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-DLDGIRREVQT 65
+ V + Y + +++G G S+ V++ L +I AIK ++LE+ +N LD R E+
Sbjct: 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 66 MRVTNHPN--VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRET 123
+ + ++R + T +++VM +K + + + +
Sbjct: 80 LNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNM 136
Query: 124 LKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCW 183
L+A+ +H HG +H D+K N LI +G +KL DFG++ M +++ VGT +
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM-QPDTTSVVKDSQVGTVNY 194
Query: 184 MAPEVMQQL----------HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQN 233
M PE ++ + K+D+WS G + +G PF + L + +
Sbjct: 195 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 254
Query: 234 APPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278
P + E K ++++ CL +DPK+R + +L+ H + +
Sbjct: 255 --PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 8e-68
Identities = 75/351 (21%), Positives = 146/351 (41%), Gaps = 23/351 (6%)
Query: 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-DLDGIRREVQT 65
+ V + Y + +++G G S+ V++ L +I AIK ++LE+ +N LD R E+
Sbjct: 49 ECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAY 107
Query: 66 MRVTNHPN--VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRET 123
+ + ++R + T +++VM +K + + +
Sbjct: 108 LNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNM 164
Query: 124 LKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCW 183
L+A+ +H HG +H D+K N LI +G +KL DFG++ M +++ VG +
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM-QPDTTSVVKDSQVGAVNY 222
Query: 184 MAPEVMQQ----------LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQN 233
M PE ++ K+D+WS G + +G PF + L + +
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 282
Query: 234 APPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK-HARSNDFLARSIVD 292
P + E K ++++ CL +DPK+R + +L+ H + + + +A+ +
Sbjct: 283 --PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTE 340
Query: 293 NLAPLGERFRMLKAKEADLLVQNKALYEDKEQLSQDYDCMSNAEDPNSSGK 343
+ + + L + +L K LYE S + K
Sbjct: 341 EMKYVLGQLVGLNSPN-SILKAAKTLYEHYSGGESHNSSSSKTFEKKRGKK 390
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 8e-65
Identities = 65/289 (22%), Positives = 112/289 (38%), Gaps = 33/289 (11%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN 73
D+ + +G G V+ A + AIK + L + + REV+ + HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 74 VLRAHCSFTTGHC------------LWVVMPYMAGGSCLHIMKSA-YPEGFEEPVIATLL 120
++R ++ + L++ M + M E E V +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 121 RETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR-------- 172
+ +A+ +LH G +HRD+K NI + +K+ DFG+ M + Q
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 173 -SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTL 231
VGT +M+PE + + Y K DI+S G+ EL + PFS L +
Sbjct: 185 ARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDV 240
Query: 232 QNA--PPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278
+N PP + +V L P +RP A ++++ F+
Sbjct: 241 RNLKFPPLFT-----QKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE 284
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 4e-62
Identities = 69/282 (24%), Positives = 118/282 (41%), Gaps = 19/282 (6%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMR-VTNHPN 73
+ + +G G T+ + N VA+K + E REVQ +R HPN
Sbjct: 25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPEC----FSFADREVQLLRESDEHPN 79
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH 133
V+R C+ ++ + A ++ + + TLL++T L +LH
Sbjct: 80 VIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFA--HLGLEPITLLQQTTSGLAHLHSL 137
Query: 134 GHIHRDVKAGNILIDSNGA-----IKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEV 188
+HRD+K NILI A ++DFG+ + R+ GT W+APE+
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 189 MQQL--HGYDFKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245
+ + + DI+S G ++ G PF K + ++ + L E+
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH-- 255
Query: 246 FSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK-HARSNDFL 286
+EL+ + DP+KRP+A+ ++KH FF + F
Sbjct: 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFF 297
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 4e-61
Identities = 70/279 (25%), Positives = 119/279 (42%), Gaps = 18/279 (6%)
Query: 10 PVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRV 68
P A+DY + +G G + +I+ K LD + + EV +R
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 69 TNHPNVLRAHCSF--TTGHCLWVVMPYMAGGSCLHIMKSAYPEG--FEEPVIATLLRETL 124
HPN++R + T L++VM Y GG ++ E +E + ++ +
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 125 KALVYLH-----FHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVG 179
AL H H +HRD+K N+ +D +KL DFG++ + TFVG
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF---AKTFVG 178
Query: 180 TPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD 239
TP +M+PE M + Y+ K+DIWS G EL PF+ + ++ + +
Sbjct: 179 TPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI- 236
Query: 240 YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278
R+S E++T L RP+ E+++++
Sbjct: 237 ---PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 2e-60
Identities = 65/283 (22%), Positives = 111/283 (39%), Gaps = 19/283 (6%)
Query: 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTM 66
+D K Y +++GEG + V + A+K + + D + +RE
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMH 80
Query: 67 RVTNHPNVLRAHCSF----TTGHCLWVVMPYMAGGSCLHIMKSAYPEG--FEEPVIATLL 120
R+ NHPN+LR H W+++P+ G+ + ++ +G E I LL
Sbjct: 81 RLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLL 140
Query: 121 RETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRN----- 175
+ L +H G+ HRD+K NIL+ G L D G + R
Sbjct: 141 LGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200
Query: 176 -TFVGTPCWMAPEVMQQL--HGYDFKADIWSFGITALELAHGHAPF-SKYPPMKVLLMTL 231
T + APE+ D + D+WS G + G P+ + + + +
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV 260
Query: 232 QNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274
QN L + R S + +L+ + + DP +RP L+
Sbjct: 261 QN---QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 4e-60
Identities = 71/272 (26%), Positives = 120/272 (44%), Gaps = 15/272 (5%)
Query: 10 PVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLD---LEKCNNDLDGIRREVQTM 66
P + Y +G+G A + E+ A K++ L K + + + E+
Sbjct: 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK-PHQREKMSMEISIH 69
Query: 67 RVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKA 126
R H +V+ H F ++VV+ S L + K + EP LR+ +
Sbjct: 70 RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLG 127
Query: 127 LVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAP 186
YLH + IHRD+K GN+ ++ + +K+ DFG++ + G+R + GTP ++AP
Sbjct: 128 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKVLCGTPNYIAP 184
Query: 187 EVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246
EV+ + G+ F+ D+WS G L G PF +K + ++ +Y K
Sbjct: 185 EVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKN----EYSIPKHI 238
Query: 247 SKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278
+ L+ L DP RPT +L+ FF
Sbjct: 239 NPVAASLIQKMLQTDPTARPTINELLNDEFFT 270
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 3e-59
Identities = 71/272 (26%), Positives = 120/272 (44%), Gaps = 15/272 (5%)
Query: 10 PVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLD---LEKCNNDLDGIRREVQTM 66
P + Y +G+G A + E+ A K++ L K + + + E+
Sbjct: 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK-PHQREKMSMEISIH 95
Query: 67 RVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKA 126
R H +V+ H F ++VV+ S L + K + EP LR+ +
Sbjct: 96 RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLG 153
Query: 127 LVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAP 186
YLH + IHRD+K GN+ ++ + +K+ DFG++ + G+R + GTP ++AP
Sbjct: 154 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKVLCGTPNYIAP 210
Query: 187 EVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246
EV+ + G+ F+ D+WS G L G PF +K + ++ +Y K
Sbjct: 211 EVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKN----EYSIPKHI 264
Query: 247 SKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278
+ L+ L DP RPT +L+ FF
Sbjct: 265 NPVAASLIQKMLQTDPTARPTINELLNDEFFT 296
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 198 bits (507), Expect = 5e-59
Identities = 71/268 (26%), Positives = 128/268 (47%), Gaps = 14/268 (5%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLD---LEKCNNDLDGIRREVQTMRVTN 70
+D+++ +G+G A VYRA I VAIK++D + K + ++ EV+
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYK-AGMVQRVQNEVKIHCQLK 69
Query: 71 HPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYL 130
HP++L + F + +++V+ G +K+ + F E + + + ++YL
Sbjct: 70 HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYL 128
Query: 131 HFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQ 190
H HG +HRD+ N+L+ N IK+ADFG++ + ++ T GTP +++PE+
Sbjct: 129 HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK---HYTLCGTPNYISPEIAT 185
Query: 191 QLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSF 250
+ + ++D+WS G L G PF +K L + A DYE S
Sbjct: 186 R-SAHGLESDVWSLGCMFYTLLIGRPPFDT-DTVKNTLNKVVLA----DYEMPSFLSIEA 239
Query: 251 KELVTACLVKDPKKRPTAEKLMKHHFFK 278
K+L+ L ++P R + ++ H F
Sbjct: 240 KDLIHQLLRRNPADRLSLSSVLDHPFMS 267
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 198 bits (507), Expect = 6e-59
Identities = 69/267 (25%), Positives = 121/267 (45%), Gaps = 15/267 (5%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNH 71
+D+ + +G+G VY A I+A+KVL + +RREV+ H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 72 PNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLH 131
PN+LR + F +++++ Y G+ ++ F+E AT + E AL Y H
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH 126
Query: 132 FHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQ 191
IHRD+K N+L+ S G +K+ADFG S R GT ++ PE+++
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-----SRRTDLCGTLDYLPPEMIEG 181
Query: 192 LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251
+D K D+WS G+ E G PF + T + ++ ++ +
Sbjct: 182 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE----TYKRISRV-EFTFPDFVTEGAR 235
Query: 252 ELVTACLVKDPKKRPTAEKLMKHHFFK 278
+L++ L +P +RP ++++H +
Sbjct: 236 DLISRLLKHNPSQRPMLREVLEHPWIT 262
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 4e-57
Identities = 61/299 (20%), Positives = 114/299 (38%), Gaps = 42/299 (14%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN 73
+ L + +G+G +A V+R ++ AIKV + +D RE + ++ NH N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 74 VLRAHCSF--TTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLLRETLKALVYL 130
+++ TT ++M + GS + + + G E +LR+ + + +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 131 HFHGHIHRDVKAGNILI----DSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAP 186
+G +HR++K GNI+ D KL DFG + + + + GT ++ P
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL----EDDEQFVSLYGTEEYLHP 184
Query: 187 EVMQQL-------HGYDFKADIWSFGITALELAHGHAPFS------------------KY 221
++ ++ Y D+WS G+T A G PF K
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 222 PPMKVLLMTLQNAPPGLDYE--RDKRFSKSFKELVT----ACLVKDPKKRPTAEKLMKH 274
+ +N P + S+ + L+T L D +K ++
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 6e-56
Identities = 49/269 (18%), Positives = 97/269 (36%), Gaps = 30/269 (11%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNND-LDGIRREVQTMRVT 69
+D K ++ E S +++ + +KVL + + E +R+
Sbjct: 7 IDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64
Query: 70 NHPNVLR--AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKAL 127
+HPNVL C ++ +M GS +++ ++ + + +
Sbjct: 65 SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124
Query: 128 VYLHFHGH--IHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMA 185
+LH + + +++ID + +++ V + P W+A
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK--------FSFQSPGRMYAPAWVA 176
Query: 186 PEVMQ--QLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQN-----APPGL 238
PE +Q AD+WSF + EL PF+ M++ + PPG+
Sbjct: 177 PEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGI 236
Query: 239 DYERDKRFSKSFKELVTACLVKDPKKRPT 267
+L+ C+ +DP KRP
Sbjct: 237 S--------PHVSKLMKICMNEDPAKRPK 257
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-55
Identities = 73/269 (27%), Positives = 123/269 (45%), Gaps = 29/269 (10%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNND-LDGIRREVQTMRVT 69
+ D + E++G G TV+RA VA+K+L + + + ++ REV M+
Sbjct: 34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL 91
Query: 70 NHPNVLR--AHCSFTTGHCLWVVMPYMAGGSCLH--IMKSAYPEGFEEPVIATLLRETLK 125
HPN++ T L +V Y++ GS L+ + KS E +E ++ + K
Sbjct: 92 RHPNIVLFMGAV--TQPPNLSIVTEYLSRGS-LYRLLHKSGAREQLDERRRLSMAYDVAK 148
Query: 126 ALVYLHFHGH--IHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCW 183
+ YLH +HR++K+ N+L+D +K+ DFG+S S + GTP W
Sbjct: 149 GMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL---SSKSAAGTPEW 205
Query: 184 MAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQN-----APPGL 238
MAPEV++ + K+D++SFG+ ELA P+ P +V+ P L
Sbjct: 206 MAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNL 264
Query: 239 DYERDKRFSKSFKELVTACLVKDPKKRPT 267
+ ++ C +P KRP+
Sbjct: 265 N--------PQVAAIIEGCWTNEPWKRPS 285
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-55
Identities = 72/267 (26%), Positives = 117/267 (43%), Gaps = 17/267 (6%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHP 72
D+ + +G+G VY A I+A+KVL + +RRE++ HP
Sbjct: 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74
Query: 73 NVLRAHCSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLLRETLKALVYLH 131
N+LR + F +++++ + G + K F+E AT + E AL Y H
Sbjct: 75 NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALHYCH 131
Query: 132 FHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQ 191
IHRD+K N+L+ G +K+ADFG S R R T GT ++ PE+++
Sbjct: 132 ERKVIHRDIKPENLLMGYKGELKIADFGWSV--HAPSLR---RRTMCGTLDYLPPEMIEG 186
Query: 192 LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251
+D K D+W G+ E G PF + T + D + S K
Sbjct: 187 -KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE----THRRIVNV-DLKFPPFLSDGSK 240
Query: 252 ELVTACLVKDPKKRPTAEKLMKHHFFK 278
+L++ L P +R + +M+H + K
Sbjct: 241 DLISKLLRYHPPQRLPLKGVMEHPWVK 267
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-55
Identities = 70/290 (24%), Positives = 121/290 (41%), Gaps = 31/290 (10%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNND-LDGIRREVQTMRVT 69
+ + + E +G+G VY + VAI+++D+E+ N D L +REV R T
Sbjct: 30 IPFEQLEIGELIGKGRFGQVYHGRW---HGEVAIRLIDIERDNEDQLKAFKREVMAYRQT 86
Query: 70 NHPNVLR--AHCSFTTGHCLWVVMPYMAGGS---CLHIMKSAYPEGFEEPVIATLLRETL 124
H NV+ C + L ++ G + + K + + +E +
Sbjct: 87 RHENVVLFMGAC--MSPPHLAIITSLCKGRTLYSVVRDAKIV----LDVNKTRQIAQEIV 140
Query: 125 KALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVS--ACMFDAGDRQRSRNTFVGTPC 182
K + YLH G +H+D+K+ N+ D NG + + DFG+ + + AG R+ G C
Sbjct: 141 KGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLC 199
Query: 183 WMAPEVMQQLHG--------YDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA 234
+APE+++QL + +D+++ G EL PF P ++
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM 259
Query: 235 PPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH--HFFKHARS 282
P L K +++ C + ++RPT KLM K R
Sbjct: 260 KPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 4e-55
Identities = 68/305 (22%), Positives = 110/305 (36%), Gaps = 50/305 (16%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLD----------------LEKCNNDLDG 58
DYR+ + +G + LC N+ A+K + + D
Sbjct: 32 DYRIIRTLNQGKFNKII--LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 59 IRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGG------SCLHIMKSAYPEGFE 112
+ E+Q + + L T ++++ YM ++ Y
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 113 EPVIATLLRETLKALVYLHFHGHI-HRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171
VI +++ L + Y+H +I HRDVK NIL+D NG +KL+DFG S M D
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK---- 205
Query: 172 RSRNTFVGTPCWMAPEVMQ-QLHGYDFKADIWSFGITALELAHGHAPFS----------- 219
GT +M PE + K DIWS GI + + PFS
Sbjct: 206 -KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264
Query: 220 ------KYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273
+YP + + + S + + L K+P +R T+E +K
Sbjct: 265 IRTKNIEYPLDRNHFLYPLTNKK--STCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322
Query: 274 HHFFK 278
H +
Sbjct: 323 HEWLA 327
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 5e-55
Identities = 72/396 (18%), Positives = 147/396 (37%), Gaps = 55/396 (13%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN 73
+ L + +G+G +A V+R ++ AIKV + +D RE + ++ NH N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 74 VLRAHCSF--TTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLLRETLKALVYL 130
+++ TT ++M + GS + + + G E +LR+ + + +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 131 HFHGHIHRDVKAGNILI----DSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAP 186
+G +HR++K GNI+ D KL DFG + + + + GT ++ P
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL----EDDEQFVSLYGTEEYLHP 184
Query: 187 EVMQQL-------HGYDFKADIWSFGITALELAHGHAPFS------------------KY 221
++ ++ Y D+WS G+T A G PF K
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 222 PPMKVLLMTLQNAPPGLDYE--RDKRFSKSFKELVTA----CLVKDPKKRPTAEKLMKHH 275
+ +N P + S+ + L+T L D +K ++
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE- 303
Query: 276 FFKHARSNDFLARSIVDNLA-PLGERFRMLKAKEADLLVQNKALYEDKEQLSQDYDCMSN 334
++D L R ++ + ++ + ++ +Y+ + +S + + +
Sbjct: 304 ------TSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYE 357
Query: 335 AE----DPNSSGKQ-NHADVEVPAERLSTESGNHSN 365
+P + E P +S E +H +
Sbjct: 358 GRRLVLEPGRLAQHFPKTTEENPIFVVSREGNSHHH 393
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 4e-54
Identities = 69/273 (25%), Positives = 126/273 (46%), Gaps = 15/273 (5%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN 73
+ ++G G V+ IK ++ ++ ++ I E++ ++ +HPN
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLH--IMKSAYPEGFEEPVIATLLRETLKALVYLH 131
+++ F H +++VM GG L + A + E +A L+++ + AL Y H
Sbjct: 82 IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 132 FHGHIHRDVKAGNILIDS---NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEV 188
+H+D+K NIL + IK+ DFG++ +F + + GT +MAPEV
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE-LFKSDEHS---TNAAGTALYMAPEV 197
Query: 189 MQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD-KRFS 247
++ FK DIWS G+ L G PF+ +V +Y + + +
Sbjct: 198 FKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE---PNYAVECRPLT 252
Query: 248 KSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280
+L+ L KDP++RP+A +++ H +FK A
Sbjct: 253 PQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 1e-53
Identities = 71/271 (26%), Positives = 122/271 (45%), Gaps = 16/271 (5%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNND-LDGIRREVQTMRVT 69
+ + + +G G TVY+ + VA+K+L++ L + EV +R T
Sbjct: 21 IPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 77
Query: 70 NHPNVLR--AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKAL 127
H N+L + T L +V + G S H + ++ + FE + + R+T + +
Sbjct: 78 RHVNILLFMGYS---TAPQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGM 133
Query: 128 VYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPE 187
YLH IHRD+K+ NI + + +K+ DFG+ A G+ WMAPE
Sbjct: 134 DYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGL-ATEKSRWSGSHQFEQLSGSILWMAPE 192
Query: 188 VMQQLHG--YDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTL--QNAPPGLDYERD 243
V++ Y F++D+++FGI EL G P+S ++ + + P L R
Sbjct: 193 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRS 252
Query: 244 KRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274
K K L+ CL K +RP+ +++
Sbjct: 253 N-CPKRMKRLMAECLKKKRDERPSFPRILAE 282
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 4e-53
Identities = 40/306 (13%), Positives = 82/306 (26%), Gaps = 43/306 (14%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEK--CNNDLDGIRREVQTMRVTNH 71
+ +L E + G + V+ + E A+KV + ++L+ +
Sbjct: 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG 121
Query: 72 PNVLRAHCSF--------------------------TTGHCLWVVMPYMAG--GSCLHIM 103
+ A ++MP + +
Sbjct: 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTL 181
Query: 104 KSAYPEGFEEPVIAT--LLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVS 161
Y +E ++A L + ++ L G +H N+ I +G + L D
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSAL 241
Query: 162 ACMFDAGDRQRSRNTFVGTPCWMAPEVMQ-QLHGYDFKADIWSFGITALELAHGHAPFSK 220
G R + E + + + W G++ + PF
Sbjct: 242 W---KVGTR---GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295
Query: 221 YPPMKVLLMTL----QNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHF 276
P L + K L+ L D ++R + M+
Sbjct: 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE 355
Query: 277 FKHARS 282
F ++
Sbjct: 356 FLQLQN 361
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 5e-53
Identities = 73/303 (24%), Positives = 127/303 (41%), Gaps = 38/303 (12%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMR-VTNHP 72
+ +G G S TV VA+K + ++ D E++ + +HP
Sbjct: 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHP 69
Query: 73 NVLRAHCSFTTGHCLWVVMPYMAGGSCLH---IMKSAYPEG---FEEPVIATLLRETLKA 126
NV+R +CS TT L++ + L K+ E +E +LLR+
Sbjct: 70 NVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 127 LVYLHFHGHIHRDVKAGNILIDS-------------NGAIKLADFGVSACMFDAGDR--Q 171
+ +LH IHRD+K NIL+ + N I ++DFG+ D+G +
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC-KKLDSGQSSFR 186
Query: 172 RSRNTFVGTPCWMAPEVMQQLH------GYDFKADIWSFG-ITALELAHGHAPFSKYPPM 224
+ N GT W APE++++ + DI+S G + L+ G PF
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 225 KVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK-HARSN 283
+ ++ + + D+ +L++ + DP KRPTA K+++H F ++
Sbjct: 247 ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKL 306
Query: 284 DFL 286
+FL
Sbjct: 307 EFL 309
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 1e-52
Identities = 80/356 (22%), Positives = 153/356 (42%), Gaps = 32/356 (8%)
Query: 2 DLVVEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN--DLDGI 59
+ V+ + + Y+ +G+G V + A+KV+ + D + +
Sbjct: 14 GMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL 73
Query: 60 RREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIAT 118
REVQ ++ +HPN+++ + F ++V GG I+ F E A
Sbjct: 74 LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR---FSEVDAAR 130
Query: 119 LLRETLKALVYLHFHGHIHRDVKAGNILIDS---NGAIKLADFGVSACMFDAGDRQRSRN 175
++R+ L + Y+H + +HRD+K N+L++S + I++ DFG+S F+A + +
Sbjct: 131 IIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS-THFEASKKMK--- 186
Query: 176 TFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP 235
+GT ++APEV+ YD K D+WS G+ L G PF+ +L
Sbjct: 187 DKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE-KGK 243
Query: 236 PGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDF-----LARSI 290
+ + K+ S+S K+L+ L P R +A + H + + +
Sbjct: 244 YTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNA 303
Query: 291 VDNLAPLGERFR-MLKAKEADL--LVQNKALYEDKEQLSQDYDCMSNAEDPNSSGK 343
+ N+ +F+ K +A L + ++ ++L+ + M D N G+
Sbjct: 304 ILNI----RQFQGTQKLAQAALLYMGSKLTSQDETKELTAIFHKM----DKNGDGQ 351
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-52
Identities = 66/291 (22%), Positives = 117/291 (40%), Gaps = 50/291 (17%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGI------RREVQ 64
+ + +++G+G V++ + +VAIK L L + + I +REV
Sbjct: 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 65 TMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETL 124
M NHPN+++ + + VM ++ G H + + V L+ +
Sbjct: 76 IMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIA 132
Query: 125 KALVYLHFHGH--IHRDVKAGNILIDSNGA-----IKLADFGVSACMFDAGDRQRSRNT- 176
+ Y+ +HRD+++ NI + S K+ADFG+S +Q +
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS--------QQSVHSVS 184
Query: 177 -FVGTPCWMAPEVMQQLHG-YDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTL--- 231
+G WMAPE + Y KAD +SF + + G PF +Y K+ + +
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244
Query: 232 --------QNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274
++ PP L + ++ C DPKKRP ++K
Sbjct: 245 EGLRPTIPEDCPPRL------------RNVIELCWSGDPKKRPHFSYIVKE 283
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 4e-52
Identities = 75/273 (27%), Positives = 124/273 (45%), Gaps = 25/273 (9%)
Query: 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRV 68
+D K+ + E VG G V +A + VAIK ++ E + E++ +
Sbjct: 3 HMIDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESES---ERKAFIVELRQLSR 57
Query: 69 TNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYP-EGFEEPVIATLLRETLKAL 127
NHPN+++ + + CL VM Y GGS +++ A P + + + + +
Sbjct: 58 VNHPNIVKLYGACLNPVCL--VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 128 VYLHFHGH---IHRDVKAGNILIDSNG-AIKLADFGVSACMFDAGDRQRSRNTFVGTPCW 183
YLH IHRD+K N+L+ + G +K+ DFG + D Q G+ W
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA------CDIQTHMTNNKGSAAW 169
Query: 184 MAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKY--PPMKVLLMTLQNAPPGLDYE 241
MAPEV + + Y K D++S+GI E+ PF + P +++ P
Sbjct: 170 MAPEVFEGSN-YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP----P 224
Query: 242 RDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274
K K + L+T C KDP +RP+ E+++K
Sbjct: 225 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 5e-52
Identities = 66/269 (24%), Positives = 125/269 (46%), Gaps = 17/269 (6%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVL 75
+ L + +GEG V A+ E VA+K++D+++ + + I++E+ ++ NH NV+
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 76 RAHCSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLLRETLKALVYLHFHG 134
+ + G+ ++ + Y +GG I G EP + + +VYLH G
Sbjct: 69 KFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 135 HIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHG 194
HRD+K N+L+D +K++DFG++ +F +R+R N GT ++APE++++
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELLKR-RE 183
Query: 195 YD-FKADIWSFGITALELAHGHAPF-SKYPPMKVLLMTLQN---APPGLDYERDKRFSKS 249
+ D+WS GI + G P+ + + P K+ +
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP------WKKIDSA 237
Query: 250 FKELVTACLVKDPKKRPTAEKLMKHHFFK 278
L+ LV++P R T + K ++
Sbjct: 238 PLALLHKILVENPSARITIPDIKKDRWYN 266
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 6e-52
Identities = 80/344 (23%), Positives = 153/344 (44%), Gaps = 32/344 (9%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-DLDGIRREVQTMRVTNHP 72
+ Y+ +++G G V + AIK++ + + EV +++ +HP
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 73 NVLRAHCSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLLRETLKALVYLH 131
N+++ + F ++VM GG I+ F E A ++++ L + YLH
Sbjct: 97 NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK---FNEVDAAVIIKQVLSGVTYLH 153
Query: 132 FHGHIHRDVKAGNILIDS---NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEV 188
H +HRD+K N+L++S + IK+ DFG+S +F+ + + +GT ++APEV
Sbjct: 154 KHNIVHRDLKPENLLLESKEKDALIKIVDFGLS-AVFENQKKMK---ERLGTAYYIAPEV 209
Query: 189 MQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSK 248
+++ YD K D+WS G+ L G+ PF ++L ++ D K S+
Sbjct: 210 LRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRK-VEKGKYTFDSPEWKNVSE 266
Query: 249 SFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGERFRMLKA-- 306
K+L+ L D ++R +A++ ++H + K + L L ++
Sbjct: 267 GAKDLIKQMLQFDSQRRISAQQALEHPWIK----EMCSKKESGIELPSLANAIENMRKFQ 322
Query: 307 -----KEADLLVQNKALY--EDKEQLSQDYDCMSNAEDPNSSGK 343
+A LL L E+ ++L+ + + D N G+
Sbjct: 323 NSQKLAQAALLYMASKLTSQEETKELTDIFRHI----DKNGDGQ 362
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 6e-52
Identities = 85/344 (24%), Positives = 147/344 (42%), Gaps = 32/344 (9%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-DLDGIRREVQTMRVTNHP 72
+ Y + +G+G V + + A+KV++ N D I REV+ ++ +HP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 73 NVLRAHCSFTTGHCLWVVMPYMAGGSCLH-IMKSAYPEGFEEPVIATLLRETLKALVYLH 131
N+++ ++V GG I+K F E A ++++ + Y+H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMH 138
Query: 132 FHGHIHRDVKAGNILIDS---NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEV 188
H +HRD+K NIL++S + IK+ DFG+S F + +GT ++APEV
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS-TCFQQNTKM---KDRIGTAYYIAPEV 194
Query: 189 MQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSK 248
++ YD K D+WS G+ L G PF +L ++ D + + S
Sbjct: 195 LRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR-VETGKYAFDLPQWRTISD 251
Query: 249 SFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLA------RSIVDNLAPLGERFR 302
K+L+ L P R TA + ++H + + S S + N+ +F+
Sbjct: 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNI----RQFQ 307
Query: 303 -MLKAKEADLLVQNKALYEDKE--QLSQDYDCMSNAEDPNSSGK 343
K +A LL L E QL++ + + D N+ G
Sbjct: 308 AEKKLAQAALLYMASKLTTLDETKQLTEIFRKL----DTNNDGM 347
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 6e-52
Identities = 76/333 (22%), Positives = 121/333 (36%), Gaps = 36/333 (10%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNV 74
+ + E +G G V R + E VAIK E + + E+Q M+ NHPNV
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 75 LRAH------CSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLLRETLKAL 127
+ A + M Y GG ++ + G +E I TLL + AL
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 128 VYLHFHGHIHRDVKAGNILIDSNG---AIKLADFGVSACMFDAGDRQRSRNTFVGTPCWM 184
YLH + IHRD+K NI++ K+ D G + D G+ FVGT ++
Sbjct: 135 RYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK-ELDQGELCT---EFVGTLQYL 190
Query: 185 APEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244
APE+++Q Y D WSFG A E G PF ++ D
Sbjct: 191 APELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD 249
Query: 245 R-------------------FSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDF 285
+ + + L+ ++R T + F+ +
Sbjct: 250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL--DSI 307
Query: 286 LARSIVDNLAPLGERFRMLKAKEADLLVQNKAL 318
L+ ++ + + R E + L K+
Sbjct: 308 LSLKLLSVMNMVSGRVHTYPVTENENLQNLKSW 340
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 8e-52
Identities = 69/292 (23%), Positives = 122/292 (41%), Gaps = 38/292 (13%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLD-------------------------LE 50
Y L +E+G+G V A N A+KVL
Sbjct: 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 51 KCNNDLDGIRREVQTMRVTNHPNVLRAHC--SFTTGHCLWVVMPYMAGGSCLHIMKSAYP 108
+ ++ + +E+ ++ +HPNV++ L++V + G + +
Sbjct: 75 QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--- 131
Query: 109 EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168
+ E ++ +K + YLH+ IHRD+K N+L+ +G IK+ADFGVS F
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSN-EFKGS 190
Query: 169 DRQRSRNTFVGTPCWMAPEVMQQLH-GYD-FKADIWSFGITALELAHGHAPFSKYPPMKV 226
D S VGTP +MAPE + + + D+W+ G+T G PF +
Sbjct: 191 DALLS--NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIMC 247
Query: 227 LLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278
L +++ L++ ++ K+L+T L K+P+ R ++ H +
Sbjct: 248 LHSKIKSQA--LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 1e-51
Identities = 43/323 (13%), Positives = 88/323 (27%), Gaps = 59/323 (18%)
Query: 3 LVVEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEK--CNNDLDGIR 60
VE + +G+ A E + V + +N + ++
Sbjct: 62 FRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMK 121
Query: 61 REVQTMR-------------------------VTNHPNVLRAHCSFTTGHCLWVVMPYMA 95
EV +R ++R L Y
Sbjct: 122 EEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPR 181
Query: 96 GGSCLHIM------KSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS 149
S L S+ + L + ++ L LH +G +H ++ +I++D
Sbjct: 182 MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQ 241
Query: 150 NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHG----------YDFKA 199
G + L F R +R + + PE+ + F
Sbjct: 242 RGGVFLTGFEHLV-------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSF 294
Query: 200 DIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLV 259
D W+ G+ + P +K + + K + + L+ L
Sbjct: 295 DAWALGLVIYWIWCADLPITKDAALGGS---------EWIFRSCKNIPQPVRALLEGFLR 345
Query: 260 KDPKKRPTAEKLMKHHFFKHARS 282
+ R + M+ ++ R+
Sbjct: 346 YPKEDRLLPLQAMETPEYEQLRT 368
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-51
Identities = 70/278 (25%), Positives = 122/278 (43%), Gaps = 19/278 (6%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-DLDGIRREVQTMRVTNHP 72
+ Y + +G+G V + + A+KV++ N D I REV+ ++ +HP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 73 NVLRAHCSFTTGHCLWVVMPYMAGGSCLH-IMKSAYPEGFEEPVIATLLRETLKALVYLH 131
N+++ ++V GG I+K F E A ++++ + Y+H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMH 138
Query: 132 FHGHIHRDVKAGNILIDS---NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEV 188
H +HRD+K NIL++S + IK+ DFG+S F + +GT ++APEV
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKM---KDRIGTAYYIAPEV 194
Query: 189 MQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD--KRF 246
++ YD K D+WS G+ L G PF +L ++ +
Sbjct: 195 LRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK---YAFDLPQWRTI 249
Query: 247 SKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSND 284
S K+L+ L P R TA + ++H + + S +
Sbjct: 250 SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSEE 287
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 3e-51
Identities = 64/272 (23%), Positives = 113/272 (41%), Gaps = 19/272 (6%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLD---LEKCNNDLDGIRREVQTMRVTNHP 72
Y + + +GEG V L A+K+L L + N +++E+Q +R H
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 73 NVLRAH--CSFTTGHCLWVVMPYMAGGSCL---HIMKSAYPEGFEEPVIATLLRETLKAL 127
NV++ +++VM Y G + + + F + + L
Sbjct: 67 NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE----KRFPVCQAHGYFCQLIDGL 122
Query: 128 VYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPE 187
YLH G +H+D+K GN+L+ + G +K++ GV+ + R T G+P + PE
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR-TSQGSPAFQPPE 181
Query: 188 VMQQLHGYD-FKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246
+ L + FK DIWS G+T + G PF + L + Y
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGKG----SYAIPGDC 236
Query: 247 SKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278
+L+ L +P KR + ++ +H +F+
Sbjct: 237 GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFR 268
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 5e-51
Identities = 76/290 (26%), Positives = 136/290 (46%), Gaps = 20/290 (6%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-DLDGIRREVQTMRVTNHP 72
+Y + EE+G+G + V R + A K+++ +K + D + RE + R HP
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 73 NVLRAHCSFTTGHCLWVVMPYMAGGSCLH-IMKSAYPEGFEEPVIATLLRETLKALVYLH 131
N++R H S ++V + GG I+ + + E + +++ L+++ Y H
Sbjct: 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCH 122
Query: 132 FHGHIHRDVKAGNILIDS---NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEV 188
+G +HR++K N+L+ S A+KLADFG++ + + + F GTP +++PEV
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEA---WHGFAGTPGYLSPEV 178
Query: 189 MQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD--KRF 246
+++ Y DIW+ G+ L G+ PF ++ A DY
Sbjct: 179 LKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA---YDYPSPEWDTV 234
Query: 247 SKSFKELVTACLVKDPKKRPTAEKLMKHHFFK-HARSNDFLAR-SIVDNL 294
+ K L+ + L +PKKR TA++ +K + R + R VD L
Sbjct: 235 TPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCL 284
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 6e-51
Identities = 70/280 (25%), Positives = 116/280 (41%), Gaps = 32/280 (11%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGI---RREVQTMR 67
+D + L E +G G VYRA + + VA+K + + I R+E +
Sbjct: 4 IDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 68 VTNHPNV--LRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLK 125
+ HPN+ LR C L +VM + GG ++ + ++ + +
Sbjct: 62 MLKHPNIIALRGVC--LKEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIAR 116
Query: 126 ALVYLHFHGH---IHRDVKAGNILID--------SNGAIKLADFGVSACMFDAGDRQRSR 174
+ YLH IHRD+K+ NILI SN +K+ DFG++ + ++
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW-----HRTTK 171
Query: 175 NTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA 234
+ G WMAPEV++ + +D+WS+G+ EL G PF + V N
Sbjct: 172 MSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN- 229
Query: 235 PPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274
L + F +L+ C DP RP+ ++
Sbjct: 230 --KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 1e-50
Identities = 70/269 (26%), Positives = 125/269 (46%), Gaps = 15/269 (5%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN 73
+ Y L +G G V A+ A K + D+D ++E++ M+ +HPN
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-DVDRFKQEIEIMKSLDHPN 67
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLH-IMKSAYPEGFEEPVIATLLRETLKALVYLHF 132
++R + +F +++VM GG ++ F E A ++++ L A+ Y H
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRV---FRESDAARIMKDVLSAVAYCHK 124
Query: 133 HGHIHRDVKAGNILIDS---NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVM 189
HRD+K N L + + +KL DFG++A F G T VGTP +++P+V+
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA-RFKPGKMM---RTKVGTPYYVSPQVL 180
Query: 190 QQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249
+ Y + D WS G+ L G+ PFS P +++ ++ + S
Sbjct: 181 EG--LYGPECDEWSAGVMMYVLLCGYPPFSA-PTDSEVMLKIREGTFTFPEKDWLNVSPQ 237
Query: 250 FKELVTACLVKDPKKRPTAEKLMKHHFFK 278
+ L+ L K PK+R T+ + ++H +F+
Sbjct: 238 AESLIRRLLTKSPKQRITSLQALEHEWFE 266
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-50
Identities = 68/320 (21%), Positives = 121/320 (37%), Gaps = 38/320 (11%)
Query: 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTM 66
+ + R+ + EG A VY A + A+K L + I +EV M
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFM 79
Query: 67 R-VTNHPNVLRAHCSFT-------TGHCLWVVMPYMAGGSCLHIMKSAYPEG-FEEPVIA 117
+ ++ HPN+++ + + TG ++++ + G + +K G +
Sbjct: 80 KKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVL 139
Query: 118 TLLRETLKALVYLHFHGH--IHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSR- 174
+ +T +A+ ++H IHRD+K N+L+ + G IKL DFG + + D S
Sbjct: 140 KIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ 199
Query: 175 --------NTFVGTPCWMAPEVMQQLHG--YDFKADIWSFGITALELAHGHAPFSKYPPM 224
T TP + PE++ K DIW+ G L PF +
Sbjct: 200 RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259
Query: 225 KVLLMTLQNA----PPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280
+++ N PP F L+ A L +P++R + +++ A
Sbjct: 260 RIV-----NGKYSIPPHDTQ------YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308
Query: 281 RSNDFLARSIVDNLAPLGER 300
N I + L G
Sbjct: 309 ARNVNPKSPITELLEQNGGY 328
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 3e-50
Identities = 81/338 (23%), Positives = 151/338 (44%), Gaps = 27/338 (7%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-DLDGIRREVQTMRVTNHP 72
+Y + EE+G+G + V R + A K+++ +K + D + RE + R HP
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88
Query: 73 NVLRAHCSFTTGHCLWVVMPYMAGGSCLH-IMKSAYPEGFEEPVIATLLRETLKALVYLH 131
N++R H S ++V + GG I+ + + E + +++ L+++ Y H
Sbjct: 89 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCH 145
Query: 132 FHGHIHRDVKAGNILIDS---NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEV 188
+G +HR++K N+L+ S A+KLADFG++ + + + F GTP +++PEV
Sbjct: 146 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEA---WHGFAGTPGYLSPEV 201
Query: 189 MQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD--KRF 246
+++ Y DIW+ G+ L G+ PF ++ A DY
Sbjct: 202 LKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA---YDYPSPEWDTV 257
Query: 247 SKSFKELVTACLVKDPKKRPTAEKLMKHHFFKH--ARSNDFLARSIVDNLAPLGERFR-M 303
+ K L+ + L +PKKR TA++ +K + + ++ + VD L ++F
Sbjct: 258 TPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCL----KKFNAR 313
Query: 304 LKAKEADLLVQNKALYEDKEQLSQDYDCMSNAEDPNSS 341
K K A L + L ++ P++
Sbjct: 314 RKLKGAILTTM--IATRNLSNLGRNLLNKKEQGPPSTI 349
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 3e-50
Identities = 74/316 (23%), Positives = 123/316 (38%), Gaps = 47/316 (14%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEK----CNNDLDGIRREVQTMRVT 69
K Y L +G+G V A+ I AIK+++ K D++ I+ EV+ M+
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 70 NHPNVLRAHCSFTTGHCLWVVMPYMAGG-------------------------------- 97
+HPN+ R + + + +VM GG
Sbjct: 86 HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 98 ------SCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS-- 149
+H + + E +I+ ++R+ AL YLH G HRD+K N L +
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205
Query: 150 NGAIKLADFGVSACMFDAGDRQRSR-NTFVGTPCWMAPEVMQQL-HGYDFKADIWSFGIT 207
+ IKL DFG+S + + + T GTP ++APEV+ Y K D WS G+
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 208 ALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPT 267
L G PF + L N + S ++L++ L ++ +R
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVL-NKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFD 324
Query: 268 AEKLMKHHFFKHARSN 283
A + ++H +
Sbjct: 325 AMRALQHPWISQFSDK 340
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 3e-50
Identities = 73/322 (22%), Positives = 138/322 (42%), Gaps = 18/322 (5%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVL 75
+ L + +GEG V A+ E VA+K++D+++ + + I++E+ ++ NH NV+
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 76 RAHCSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLLRETLKALVYLHFHG 134
+ + G+ ++ + Y +GG I G EP + + +VYLH G
Sbjct: 69 KFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 135 HIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHG 194
HRD+K N+L+D +K++DFG++ +F +R+R N GT ++APE++++
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELLKR-RE 183
Query: 195 YD-FKADIWSFGITALELAHGHAPF-SKYPPMKVLLMTLQN---APPGLDYERDKRFSKS 249
+ D+WS GI + G P+ + + P K+ +
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP------WKKIDSA 237
Query: 250 FKELVTACLVKDPKKRPTAEKLMKHHFF-KHARSNDFLARSIVDNLAPLGERFRMLKAKE 308
L+ LV++P R T + K ++ K + R ++ F
Sbjct: 238 PLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSN 297
Query: 309 ADLLVQNKALYEDKEQLSQDYD 330
D N A S+++
Sbjct: 298 LDFSPVNSASRTPGSGWSKEHH 319
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 3e-50
Identities = 85/344 (24%), Positives = 147/344 (42%), Gaps = 37/344 (10%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN----DLDGIRREVQTMRVTNH 71
Y L E +G+G + V R + + A+K++D+ K + + ++RE + H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 72 PNVLRAHCSFTTGHCLWVVMPYMAGGSCLH--IMKSAYPEGFEEPVIATLLRETLKALVY 129
P+++ ++++ L++V +M G + ++ + E V + +R+ L+AL Y
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 130 LHFHGHIHRDVKAGNILIDS---NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAP 186
H + IHRDVK +L+ S + +KL FGV+ + ++G VGTP +MAP
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG---GRVGTPHFMAP 202
Query: 187 EVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG-LDYERD-- 243
EV+++ Y D+W G+ L G PF + G
Sbjct: 203 EVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMNPRQW 256
Query: 244 KRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK--HARSNDFLARSIVDNLAPLGERF 301
S+S K+LV L+ DP +R T + + H + K + V+ L +F
Sbjct: 257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQL----RKF 312
Query: 302 R-MLKAKEADLLV----QNKALYEDKEQLSQDYDCMSNAEDPNS 340
K K A L + + Y D + D+ EDP S
Sbjct: 313 NARRKLKGAVLAAVSSHKFNSFYGDPPEELPDFS-----EDPTS 351
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 6e-50
Identities = 82/344 (23%), Positives = 162/344 (47%), Gaps = 29/344 (8%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-DLDGIRREVQTMRVTNHP 72
++Y+L+EE+G+G + V R + + + A +++ +K + D + RE + R+ HP
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 73 NVLRAHCSFTTGHCLWVVMPYMAGGSCLH-IMKSAYPEGFEEPVIATLLRETLKALVYLH 131
N++R H S + +++ + GG I+ Y + E + +++ L+A+++ H
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY---YSEADASHCIQQILEAVLHCH 127
Query: 132 FHGHIHRDVKAGNILIDS---NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEV 188
G +HR++K N+L+ S A+KLADFG++ + Q++ F GTP +++PEV
Sbjct: 128 QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI-EVEGE--QQAWFGFAGTPGYLSPEV 184
Query: 189 MQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD--KRF 246
+++ Y D+W+ G+ L G+ PF ++ A D+
Sbjct: 185 LRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA---YDFPSPEWDTV 240
Query: 247 SKSFKELVTACLVKDPKKRPTAEKLMKHHFFKH--ARSNDFLARSIVDNLAPLGERFR-M 303
+ K+L+ L +P KR TA + +KH + H ++ + VD L ++F
Sbjct: 241 TPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCL----KKFNAR 296
Query: 304 LKAKEADL--LVQNKALYEDKEQLSQDYDCMSNAEDPNSSGKQN 345
K K A L ++ + K+++ + + S+G
Sbjct: 297 RKLKGAILTVMLATRNFSVRKQEIIKV---TEQLIEAISNGDFE 337
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 7e-50
Identities = 81/288 (28%), Positives = 132/288 (45%), Gaps = 27/288 (9%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEK--------CNNDLDGIRREVQT 65
++Y E +G GVS+ V R + P + A+K++D+ + +EV
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 66 MR-VTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLH-IMKSAYPEGFEEPVIATLLRET 123
+R V+ HPN+++ ++ T ++V M G + + E ++R
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRAL 133
Query: 124 LKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCW 183
L+ + LH +HRD+K NIL+D + IKL DFG S C D G++ R GTP +
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS-CQLDPGEKLR---EVCGTPSY 189
Query: 184 MAPEV-----MQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL 238
+APE+ GY + D+WS G+ L G PF M +L M +
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN---Y 246
Query: 239 DYERD--KRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSND 284
+ +S + K+LV+ LV P+KR TAE+ + H FF+ +
Sbjct: 247 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEE 294
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 6e-49
Identities = 83/366 (22%), Positives = 150/366 (40%), Gaps = 42/366 (11%)
Query: 2 DLVVEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN------- 54
+ V K+ + Y ++G G V + AIKV+ + +
Sbjct: 24 GMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDN 83
Query: 55 -----DLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLH-IMKSAYP 108
+ I E+ ++ +HPN+++ F ++V + GG I+
Sbjct: 84 KNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK- 142
Query: 109 EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS---NGAIKLADFGVSACMF 165
F+E A ++++ L + YLH H +HRD+K NIL+++ IK+ DFG+S F
Sbjct: 143 --FDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLS-SFF 199
Query: 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK 225
+ +GT ++APEV+++ Y+ K D+WS G+ L G+ PF
Sbjct: 200 SKDYKL---RDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD 254
Query: 226 VLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH-----HFFKHA 280
++ ++ D+ K S KEL+ L D KR TAE+ + +
Sbjct: 255 IIKK-VEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNIN 313
Query: 281 RSNDFLARSIVDNLAPLGERFR-MLKAKEADLLVQNKALYEDKE--QLSQDYDCMSNAED 337
+S+ + N+ +F K +A +L L +E +L+ + + D
Sbjct: 314 KSDQKTLCGALSNM----RKFEGSQKLAQAAILFIGSKLTTLEERKELTDIFKKL----D 365
Query: 338 PNSSGK 343
N G+
Sbjct: 366 KNGDGQ 371
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 1e-48
Identities = 75/298 (25%), Positives = 130/298 (43%), Gaps = 32/298 (10%)
Query: 14 KDYRLYEEV-GEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTM-RVTNH 71
Y+L E+V GEG A V + + ++ A+K+++ + + + REV+ + + H
Sbjct: 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR-VFREVEMLYQCQGH 70
Query: 72 PNVLRAHCSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLLRETLKALVYL 130
NVL F ++V M GGS L HI K + F E + ++++ AL +L
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH---FNELEASVVVQDVASALDFL 127
Query: 131 HFHGHIHRDVKAGNILI---DSNGAIKLADFGVSACMFDAGDRQRSRN----TFVGTPCW 183
H G HRD+K NIL + +K+ DF + + + GD T G+ +
Sbjct: 128 HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 184 MAPEV----MQQLHGYDFKADIWSFGITALELAHGHAPF---SKYPPMKVLLMTLQNAPP 236
MAPEV ++ YD + D+WS G+ L G+ PF
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247
Query: 237 GL---------DYERD--KRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSN 283
L ++ S + K+L++ LV+D K+R +A ++++H + +
Sbjct: 248 MLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPE 305
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-48
Identities = 86/288 (29%), Positives = 135/288 (46%), Gaps = 16/288 (5%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-DLDGIRREVQTMRVTNHPN 73
+YRL + +G+G A V A I VAIK++D + N L + REV+ M++ NHPN
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLLRETLKALVYLHF 132
+++ T L+++M Y +GG +++ +E + R+ + A+ Y H
Sbjct: 76 IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR---MKEKEARSKFRQIVSAVQYCHQ 132
Query: 133 HGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQL 192
+HRD+KA N+L+D++ IK+ADFG S F G + F G P + APE+ Q
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSN-EFTVGGKLD---AFCGAPPYAAPELFQG- 187
Query: 193 HGYD-FKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251
YD + D+WS G+ L G PF +K L + Y S +
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLRG----KYRIPFYMSTDCE 242
Query: 252 ELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGE 299
L+ LV +P KR T E++MK + D L + L +
Sbjct: 243 NLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQ 290
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 5e-48
Identities = 72/274 (26%), Positives = 110/274 (40%), Gaps = 16/274 (5%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN 70
D E +G+G + E++ +K L + +EV+ MR
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKEL-IRFDEETQRTFLKEVKVMRCLE 65
Query: 71 HPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYL 130
HPNVL+ L + Y+ GG+ I+KS + + ++ + YL
Sbjct: 66 HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYL 124
Query: 131 HFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR-----------QRSRNTFVG 179
H IHRD+ + N L+ N + +ADFG++ M D + ++ R T VG
Sbjct: 125 HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 180 TPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD 239
P WMAPE++ YD K D++SFGI E+ Y P + LD
Sbjct: 185 NPYWMAPEMINGRS-YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG--FLD 241
Query: 240 YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273
SF + C DP+KRP+ KL
Sbjct: 242 RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 5e-48
Identities = 73/327 (22%), Positives = 131/327 (40%), Gaps = 38/327 (11%)
Query: 14 KDYRLY---EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTM-RVT 69
+ Y L + +GEG + + + N+ A+K++ ++E+ +
Sbjct: 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM----EANTQKEITALKLCE 63
Query: 70 NHPNVLRAHCSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLLRETLKALV 128
HPN+++ H F ++VM + GG I K + F E + ++R+ + A+
Sbjct: 64 GHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH---FSETEASYIMRKLVSAVS 120
Query: 129 YLHFHGHIHRDVKAGNILI---DSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMA 185
++H G +HRD+K N+L + N IK+ DFG + + T T + A
Sbjct: 121 HMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK---TPCFTLHYAA 177
Query: 186 PEVMQQLHGYDFKADIWSFGITALELAHGHAPF------SKYPPMKVLLMTLQNAPPGLD 239
PE++ Q +GYD D+WS G+ + G PF ++ ++
Sbjct: 178 PELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD--FS 234
Query: 240 YERD--KRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA--------RSNDFLARS 289
+E + K S+ K+L+ L DP KR L + + + + D L S
Sbjct: 235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSS 294
Query: 290 IVDNLAPLGERFR-MLKAKEADLLVQN 315
+ F K K +QN
Sbjct: 295 GAAVHTCVKATFHAFNKYKREGFCLQN 321
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 6e-48
Identities = 73/281 (25%), Positives = 132/281 (46%), Gaps = 26/281 (9%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-------DLDGIRREVQTM 66
+ Y + +G GVS+ V R + A+K++++ + RRE +
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 67 R-VTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLH-IMKSAYPEGFEEPVIATLLRETL 124
R V HP+++ S+ + +++V M G + + E +++R L
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA---LSEKETRSIMRSLL 210
Query: 125 KALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWM 184
+A+ +LH + +HRD+K NIL+D N I+L+DFG S C + G++ GTP ++
Sbjct: 211 EAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFS-CHLEPGEK---LRELCGTPGYL 266
Query: 185 APEV-----MQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD 239
APE+ + GY + D+W+ G+ L G PF + +L M ++
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQ---YQ 323
Query: 240 YERD--KRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278
+ S + K+L++ L DP+ R TAE+ ++H FF+
Sbjct: 324 FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 6e-48
Identities = 76/267 (28%), Positives = 129/267 (48%), Gaps = 17/267 (6%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPN 73
Y L + +G G V VA+K+L+ +K + + I+RE+Q +++ HP+
Sbjct: 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLLRETLKALVYLHF 132
+++ + +T ++VM Y++GG +I K EE L ++ L A+ Y H
Sbjct: 73 IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR---VEEMEARRLFQQILSAVDYCHR 129
Query: 133 HGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQL 192
H +HRD+K N+L+D++ K+ADFG+S M D + T G+P + APEV+
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR----TSCGSPNYAAPEVISG- 184
Query: 193 HGYD-FKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251
Y + DIWS G+ L G PF + L ++ + + ++S
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGG----VFYIPEYLNRSVA 239
Query: 252 ELVTACLVKDPKKRPTAEKLMKHHFFK 278
L+ L DP KR T + + +H +FK
Sbjct: 240 TLLMHMLQVDPLKRATIKDIREHEWFK 266
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 8e-48
Identities = 49/230 (21%), Positives = 90/230 (39%), Gaps = 21/230 (9%)
Query: 62 EVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKS-AYPEGFEEPVIATLL 120
+++ M + N + + L++ M + M E E V +
Sbjct: 111 KIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIF 170
Query: 121 RETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS------- 173
+ +A+ +LH G +HRD+K NI + +K+ DFG+ M + Q
Sbjct: 171 IQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 230
Query: 174 --RNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTL 231
VGT +M+PE + + Y K DI+S G+ EL + FS ++ +
Sbjct: 231 ATHTGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDV 286
Query: 232 QNA--PPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKH 279
+N P + +V L P +RP A ++++ F++
Sbjct: 287 RNLKFPLLFT-----QKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 15/81 (18%), Positives = 29/81 (35%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN 73
D+ + +G G V+ A + AIK + L + + REV+ + HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 74 VLRAHCSFTTGHCLWVVMPYM 94
++R ++
Sbjct: 66 IVRYFNAWLETPPEKWQEEMD 86
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 9e-48
Identities = 70/275 (25%), Positives = 114/275 (41%), Gaps = 29/275 (10%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNND-------LDGIRREVQTM 66
+ Y +G G V+ A+ N+ V +K + EK D L + E+ +
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 67 RVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCL--HIMKSAYPEGFEEPVIATLLRETL 124
H N+++ F +VM G L I + +EP+ + + R+ +
Sbjct: 84 SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLV 140
Query: 125 KALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWM 184
A+ YL IHRD+K NI+I + IKL DFG +A + +R + TF GT +
Sbjct: 141 SAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL----ERGKLFYTFCGTIEYC 196
Query: 185 APEVMQQLHGYD-FKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 243
APEV+ + Y + ++WS G+T L PF + + +
Sbjct: 197 APEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPFCELE--ETV---------EAAIHPP 244
Query: 244 KRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278
SK LV+ L P++R T EKL+ +
Sbjct: 245 YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVT 279
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-47
Identities = 75/277 (27%), Positives = 125/277 (45%), Gaps = 24/277 (8%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTM-RVTNHP 72
Y + E++G G + R + N A+K++D K + E++ + R HP
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP-----TEEIEILLRYGQHP 76
Query: 73 NVLRAHCSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLLRETLKALVYLH 131
N++ + G ++VV M GG L I++ + F E + +L K + YLH
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF---FSEREASAVLFTITKTVEYLH 133
Query: 132 FHGHIHRDVKAGNILIDSNG----AIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPE 187
G +HRD+K NIL +I++ DFG A A + T T ++APE
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESIRICDFGF-AKQLRAENGLLM--TPCYTANFVAPE 190
Query: 188 VMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM--KVLLMTLQNAPPGLDYERD-- 243
V+++ GYD DIWS G+ + G+ PF+ P + +L + +
Sbjct: 191 VLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK--FSLSGGYW 247
Query: 244 KRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280
S + K+LV+ L DP +R TA +++H + H
Sbjct: 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 4e-47
Identities = 41/313 (13%), Positives = 85/313 (27%), Gaps = 53/313 (16%)
Query: 11 VDAKDYRLY---EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQT 65
+ R +G+ A E + V + N + ++ EV
Sbjct: 72 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLR 131
Query: 66 MR----------------------VTNHPNVLRAHCSFTTGHCLWV-----VMPYMAG-- 96
+R + P + +WV + P M
Sbjct: 132 LRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNL 191
Query: 97 GSCLHIMKSAYPEG--FEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIK 154
+ ++ S L + ++ L LH +G +H ++ +I++D G +
Sbjct: 192 QTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVF 251
Query: 155 LADFGVSACMFDAGDRQRSR-NTFVGTPCWMAPEVMQ----QLHGYDFKADIWSFGITAL 209
L F G S P A ++ F D W+ G+
Sbjct: 252 LTGFEHLV---RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308
Query: 210 ELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAE 269
+ P + + + K + + L+ L + R
Sbjct: 309 WIWCADLPNTDDAALGGS---------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPL 359
Query: 270 KLMKHHFFKHARS 282
+ M+ ++ R+
Sbjct: 360 QAMETPEYEQLRT 372
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 5e-47
Identities = 71/278 (25%), Positives = 122/278 (43%), Gaps = 21/278 (7%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-------NDLDGIRREVQTM 66
+Y + + +G G V A + VAI+++ K + + E++ +
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 67 RVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLH-IMKSAYPEGFEEPVIATLLRETLK 125
+ NHP +++ F ++V+ M GG ++ + +E + L
Sbjct: 195 KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKR---LKEATCKLYFYQMLL 250
Query: 126 ALVYLHFHGHIHRDVKAGNILIDS---NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC 182
A+ YLH +G IHRD+K N+L+ S + IK+ DFG S + T GTP
Sbjct: 251 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSLMRTLCGTPT 306
Query: 183 WMAPEVMQQLH--GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240
++APEV+ + GY+ D WS G+ G+ PFS++ L + +
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 366
Query: 241 ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278
E S+ +LV LV DPK R T E+ ++H + +
Sbjct: 367 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 404
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 8e-47
Identities = 71/283 (25%), Positives = 123/283 (43%), Gaps = 23/283 (8%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-----DLDGIRREVQTMRV 68
Y + EE+G G A V + + A K + + ++ + I REV +R
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 69 TNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLH-IMKSAYPEGFEEPVIATLLRETLKAL 127
HPN++ H F + +++ ++GG + + E L++ L +
Sbjct: 65 IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILDGV 121
Query: 128 VYLHFHGHIHRDVKAGNILIDS----NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCW 183
YLH H D+K NI++ N IKL DFG++ +AG+ + GTP +
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA-HKIEAGNEFK---NIFGTPEF 177
Query: 184 MAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 243
+APE++ +AD+WS G+ L G +PF + L D++ +
Sbjct: 178 VAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVN---YDFDEE 233
Query: 244 --KRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSND 284
S+ K+ + LVKDPK+R T + ++H + K R +
Sbjct: 234 YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-46
Identities = 74/327 (22%), Positives = 127/327 (38%), Gaps = 27/327 (8%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-----DLDGIRREVQTMRV 68
Y EE+G G A V + A K + + + + I REV ++
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 69 TNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLH-IMKSAYPEGFEEPVIATLLRETLKAL 127
HPNV+ H + + +++ +AGG + + E L++ L +
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGV 127
Query: 128 VYLHFHGHIHRDVKAGNILIDS----NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCW 183
YLH H D+K NI++ IK+ DFG++ D G+ + GTP +
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-HKIDFGNEFK---NIFGTPEF 183
Query: 184 MAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 243
+APE++ +AD+WS G+ L G +PF + L ++E +
Sbjct: 184 VAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN---YEFEDE 239
Query: 244 --KRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIV----DNLAPL 297
S K+ + LVKDPKKR T + ++H + K + L+R +
Sbjct: 240 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEKFKKF 299
Query: 298 GERFRMLKAKEADLLVQNKALYEDKEQ 324
R + L +A + +
Sbjct: 300 AARKKSNNGSGGGLNDIFEAQKIEWHE 326
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 2e-46
Identities = 73/361 (20%), Positives = 141/361 (39%), Gaps = 27/361 (7%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-----DLDGIRREVQTMRV 68
Y + EE+G G A V + A K + + + I REV +R
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 69 TNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCL--HIMKSAYPEGFEEPVIATLLRETLKA 126
HPN++ H + + +++ ++GG L + + E + +++ L
Sbjct: 72 VLHPNIITLHDVYENRTDVVLILELVSGGE-LFDFLAQKES---LSEEEATSFIKQILDG 127
Query: 127 LVYLHFHGHIHRDVKAGNILIDS----NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC 182
+ YLH H D+K NI++ IKL DFG++ + G + GTP
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEFK---NIFGTPE 183
Query: 183 WMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER 242
++APE++ +AD+WS G+ L G +PF + L + D++
Sbjct: 184 FVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVS---YDFDE 239
Query: 243 D--KRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK-HARSNDFLARSIVDNLAPLGE 299
+ + S+ K+ + LVK+ +KR T ++ ++H + + R V NL +
Sbjct: 240 EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKK 299
Query: 300 RFRMLKAKEADLLVQNKALYEDKEQLSQDYDCMSNAEDPNSSGKQNHADVEVPAERLSTE 359
++ + K + +V + + + + + S S + +
Sbjct: 300 QYVRRRWKLSFSIVS-LCNHLTRSLMKKVHLRTSEDLRNCESDTEENIARRKALHPRRRS 358
Query: 360 S 360
S
Sbjct: 359 S 359
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-46
Identities = 70/315 (22%), Positives = 129/315 (40%), Gaps = 26/315 (8%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-----DLDGIRREVQTMRV 68
Y + EE+G G A V + A K + + + I REV +R
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 69 TNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCL--HIMKSAYPEGFEEPVIATLLRETLKA 126
H NV+ H + + +++ ++GG L + + E + +++ L
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGE-LFDFLAQKES---LSEEEATSFIKQILDG 127
Query: 127 LVYLHFHGHIHRDVKAGNILIDS----NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC 182
+ YLH H D+K NI++ IKL DFG++ + G + GTP
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-HEIEDGVEFK---NIFGTPE 183
Query: 183 WMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER 242
++APE++ +AD+WS G+ L G +PF + L + D++
Sbjct: 184 FVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVS---YDFDE 239
Query: 243 D--KRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK-HARSNDFLARSIVDNLAPLGE 299
+ S+ K+ + LVK+ +KR T ++ ++H + + R V NL +
Sbjct: 240 EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRK 299
Query: 300 RFRMLKAKEADLLVQ 314
++ + K + +V
Sbjct: 300 QYVRRRWKLSFSIVS 314
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 5e-46
Identities = 77/306 (25%), Positives = 133/306 (43%), Gaps = 25/306 (8%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-------NDLDGIRREVQTM 66
+Y + + +G G V A + VAIK++ K + + E++ +
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 67 RVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLH-IMKSAYPEGFEEPVIATLLRETLK 125
+ NHP +++ F ++V+ M GG ++ + +E + L
Sbjct: 70 KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKR---LKEATCKLYFYQMLL 125
Query: 126 ALVYLHFHGHIHRDVKAGNILIDS---NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC 182
A+ YLH +G IHRD+K N+L+ S + IK+ DFG S + R T GTP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMR---TLCGTPT 181
Query: 183 WMAPEVMQQLH--GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240
++APEV+ + GY+ D WS G+ G+ PFS++ L + +
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 241
Query: 241 ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGER 300
E S+ +LV LV DPK R T E+ ++H + + ++ + R D L+ E
Sbjct: 242 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ----DEDMKRKFQDLLSEENES 297
Query: 301 FRMLKA 306
+ +
Sbjct: 298 TALPQV 303
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 5e-46
Identities = 64/270 (23%), Positives = 114/270 (42%), Gaps = 17/270 (6%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN 73
+ Y + E++G G V+R + + K + D +++E+ + + H N
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHRN 62
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLLRETLKALVYLHF 132
+L H SF + L ++ +++G I SA+ E I + + + +AL +LH
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQFLHS 120
Query: 133 HGHIHRDVKAGNILIDS--NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQ 190
H H D++ NI+ + + IK+ +FG + GD R P + APEV Q
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR-QLKPGDNFR---LLFTAPEYYAPEVHQ 176
Query: 191 QLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD--KRFSK 248
D+WS G L G PF +++ + ++ + K S
Sbjct: 177 H-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE---YTFDEEAFKEISI 232
Query: 249 SFKELVTACLVKDPKKRPTAEKLMKHHFFK 278
+ V LVK+ K R TA + ++H + K
Sbjct: 233 EAMDFVDRLLVKERKSRMTASEALQHPWLK 262
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-45
Identities = 68/297 (22%), Positives = 106/297 (35%), Gaps = 44/297 (14%)
Query: 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHP 72
A+D L E VG+G V+R E VA+K+ + E+ + H
Sbjct: 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWF--RETELYNTVMLRHE 62
Query: 73 NVLR--AHCSFTTGHC--LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALV 128
N+L A + LW++ Y GS ++ + ++ L
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLA 119
Query: 129 YLHFHGH--------IHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR--QRSRNTFV 178
+LH HRD+K+ NIL+ NG +AD G+ A M N V
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL-AVMHSQSTNQLDVGNNPRV 178
Query: 179 GTPCWMAPEVMQ-----QLHGYDFKADIWSFGITALELAHGHA----------PFSKYPP 223
GT +MAPEV+ + DIW+FG+ E+A PF P
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238
Query: 224 MKVLLMTLQNA-------PPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273
++ P + S +L+ C ++P R TA ++ K
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-45
Identities = 82/335 (24%), Positives = 147/335 (43%), Gaps = 40/335 (11%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPN 73
Y + E +GEG V A + VA+K + + + + RE+ +++ HP+
Sbjct: 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLLRETLKALVYLHF 132
+++ + TT + +V+ Y AGG +I++ + E ++ + A+ Y H
Sbjct: 71 IIKLYDVITTPTDIVMVIEY-AGGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHR 126
Query: 133 HGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQL 192
H +HRD+K N+L+D N +K+ADFG+S M D T G+P + APEV+
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN----FLKTSCGSPNYAAPEVING- 181
Query: 193 HGYD-FKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251
Y + D+WS GI + G PF + L + + Y S +
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVGRLPFDD-EFIPNLFKKVNSC----VYVMPDFLSPGAQ 236
Query: 252 ELVTACLVKDPKKRPTAEKLMKHHFFK-----HARSNDFLARSIVDN--LAPLGERF--- 301
L+ +V DP +R T +++ + +F + R + + S D+ ++ LGE
Sbjct: 237 SLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEAMGFS 296
Query: 302 -----RMLKAKEAD-------LLVQNKALYEDKEQ 324
L++ E + LL +N+ + E E
Sbjct: 297 EDYIVEALRSDENNEVKEAYNLLHENQVIQEKLEH 331
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 3e-45
Identities = 80/307 (26%), Positives = 137/307 (44%), Gaps = 24/307 (7%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN 73
+ + E+G G ++ VYR + A+KVL D +R E+ + +HPN
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPN 109
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLLRETLKALVYLHF 132
+++ F T + +V+ + GG I++ Y + E A +++ L+A+ YLH
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY---YSERDAADAVKQILEAVAYLHE 166
Query: 133 HGHIHRDVKAGNILI---DSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVM 189
+G +HRD+K N+L + +K+ADFG+S + + + T GTP + APE++
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSK-IVEHQVLMK---TVCGTPGYCAPEIL 222
Query: 190 QQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD--KRFS 247
+ Y + D+WS GI L G PF + + + N + S
Sbjct: 223 RG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE--YYFISPWWDEVS 279
Query: 248 KSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGERFR-MLKA 306
+ K+LV +V DPKKR T + ++H + +N + L + F K
Sbjct: 280 LNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMDTAQKKL----QEFNARRKL 335
Query: 307 KEADLLV 313
K A V
Sbjct: 336 KAAVKAV 342
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 6e-45
Identities = 59/275 (21%), Positives = 122/275 (44%), Gaps = 16/275 (5%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN 73
Y + EE+G G V+R + + K ++ D ++ E+ M +HP
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL-DKYTVKNEISIMNQLHHPK 109
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLLRETLKALVYLHF 132
++ H +F + + +++ +++GG I Y E + +R+ + L ++H
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMHE 167
Query: 133 HGHIHRDVKAGNILIDS--NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQ 190
H +H D+K NI+ ++ ++K+ DFG++ + + + T + APE++
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLAT-KLNPDEIVK---VTTATAEFAAPEIVD 223
Query: 191 QLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD--KRFSK 248
+ F D+W+ G+ L G +PF+ ++ L + +++ D S
Sbjct: 224 R-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD---WEFDEDAFSSVSP 279
Query: 249 SFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSN 283
K+ + L K+P+KR T ++H + K SN
Sbjct: 280 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 314
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 7e-45
Identities = 49/334 (14%), Positives = 109/334 (32%), Gaps = 44/334 (13%)
Query: 2 DLVVEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLN-----EIVAIKVLDLEKCNNDL 56
+ + F + +K ++ +GEG A VY A LN + +KV +
Sbjct: 53 AIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK-PANPWEF 111
Query: 57 DGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIM---KSAYPEGFEE 113
+ ++ ++ + ++ + + + +V + G+ L+ + K+ + +
Sbjct: 112 YIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQ 171
Query: 114 PVIATLLRETLKALVYLHFHGHIHRDVKAGNILI-----------DSNGAIKLADFGVSA 162
++ + L + +H IH D+K N ++ D + + L D G S
Sbjct: 172 GLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 163 CMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYP 222
M T + E++ ++++ D + T + G K
Sbjct: 232 DMKLFPKGTI-FTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289
Query: 223 PMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282
+ L P LD + E L + L++ K +
Sbjct: 290 GGECKPEGLFRRLPHLDM---------WNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340
Query: 283 NDFLARSIVDNLAPLGERFRMLKAKEADLLVQNK 316
+ + R L+ + LL++ K
Sbjct: 341 H-------------YTNKIRALRNRLIVLLLECK 361
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 8e-45
Identities = 68/295 (23%), Positives = 120/295 (40%), Gaps = 15/295 (5%)
Query: 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-DLDGIRREVQTMR-VTNHPNVLRA 77
+E+G G A V + + + A K L + I E+ + + P V+
Sbjct: 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94
Query: 78 HCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIH 137
H + + +++ Y AGG + E E + L+++ L+ + YLH + +H
Sbjct: 95 HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVH 154
Query: 138 RDVKAGNILI---DSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHG 194
D+K NIL+ G IK+ DFG+S R +GTP ++APE++
Sbjct: 155 LDLKPQNILLSSIYPLGDIKIVDFGMSR-KIGHACELR---EIMGTPEYLAPEILNY-DP 209
Query: 195 YDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD--KRFSKSFKE 252
D+W+ GI A L +PF + L Q +DY + S+ +
Sbjct: 210 ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN---VDYSEETFSSVSQLATD 266
Query: 253 LVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGERFRMLKAK 307
+ + LVK+P+KRPTAE + H + + + + + +
Sbjct: 267 FIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQDHSVRSSED 321
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 9e-45
Identities = 68/299 (22%), Positives = 114/299 (38%), Gaps = 44/299 (14%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN 70
AK ++ +++G+G V+ E VA+KV + + E+ +
Sbjct: 34 TIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFR--ETEIYQTVLMR 89
Query: 71 HPNVLR--AHCSFTTGHC--LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKA 126
H N+L A TG L+++ Y GS +KS + + L ++
Sbjct: 90 HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSG 146
Query: 127 LVYLHFHGH--------IHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR--SRNT 176
L +LH HRD+K+ NIL+ NG +AD G+ A F + + NT
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL-AVKFISDTNEVDIPPNT 205
Query: 177 FVGTPCWMAPEVMQQLHG-----YDFKADIWSFGITALELAHG----------HAPFSKY 221
VGT +M PEV+ + AD++SFG+ E+A P+
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265
Query: 222 PPMKVLLMTLQNA-------PPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273
P ++ P + + +L+T C +P R TA ++ K
Sbjct: 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-44
Identities = 76/320 (23%), Positives = 126/320 (39%), Gaps = 24/320 (7%)
Query: 14 KDYRLYEEV-GEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTM-RVTNH 71
DY+L ++V G GV+ V + A+K+L D R+EV + +
Sbjct: 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY------DSPKARQEVDHHWQASGG 81
Query: 72 PNVLRAHCSFTTGH----CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKAL 127
P+++ + H CL ++M M GG ++ + F E A ++R+ A+
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 128 VYLHFHGHIHRDVKAGNILI---DSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWM 184
+LH H HRDVK N+L + + +KL DFG + Q T TP ++
Sbjct: 142 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK-ETTQNALQ----TPCYTPYYV 196
Query: 185 APEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG-LDYERD 243
APEV+ YD D+WS G+ L G PF + + G +
Sbjct: 197 APEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255
Query: 244 --KRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGERF 301
S+ K+L+ L DP +R T + M H + + L + +
Sbjct: 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHW 315
Query: 302 RMLKAKEADLLVQNKALYED 321
+K + L + Y+
Sbjct: 316 DEVKEEMTSALATMRVDYDQ 335
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-44
Identities = 74/279 (26%), Positives = 127/279 (45%), Gaps = 27/279 (9%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNH 71
+D++ + +GEG +TV A + + AIK+L+ N + + RE M +H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 72 PNVLRAHCSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPV----IATLLRETLKA 126
P ++ + +F L+ + Y G L +I K F+E A E + A
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTA----EIVSA 142
Query: 127 LVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAP 186
L YLH G IHRD+K NIL++ + I++ DFG + + + R+ N+FVGT +++P
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NSFVGTAQYVSP 201
Query: 187 EVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246
E++ + +D+W+ G +L G PF + ++ +Y+ ++F
Sbjct: 202 ELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-----EYDFPEKF 255
Query: 247 SKSFKELVTACLVKDPKKRPT------AEKLMKHHFFKH 279
++LV LV D KR L H FF+
Sbjct: 256 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 3e-44
Identities = 75/267 (28%), Positives = 128/267 (47%), Gaps = 17/267 (6%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPN 73
Y L + +G G V VA+K+L+ +K + + IRRE+Q +++ HP+
Sbjct: 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLLRETLKALVYLHF 132
+++ + +T +++VM Y++GG +I K+ +E L ++ L + Y H
Sbjct: 78 IIKLYQVISTPSDIFMVMEYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHR 134
Query: 133 HGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQL 192
H +HRD+K N+L+D++ K+ADFG+S M D T G+P + APEV+
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE----FLRTSCGSPNYAAPEVISG- 189
Query: 193 HGYD-FKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251
Y + DIWS G+ L G PF + L + + + + + S
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDG----IFYTPQYLNPSVI 244
Query: 252 ELVTACLVKDPKKRPTAEKLMKHHFFK 278
L+ L DP KR T + + +H +FK
Sbjct: 245 SLLKHMLQVDPMKRATIKDIREHEWFK 271
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 4e-44
Identities = 69/294 (23%), Positives = 121/294 (41%), Gaps = 31/294 (10%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-----DLDGIRREVQTMRV 68
Y++ +G G +VY + + N VAIK ++ ++ ++ + + EV ++
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 69 TNH--PNVLRAHCSFTTGHCLWVVMPYMAGGSCL--HIMKSAYPEGFEEPVIATLLRETL 124
+ V+R F +++ L I + +E + + + L
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVL 159
Query: 125 KALVYLHFHGHIHRDVKAGNILIDSN-GAIKLADFGVSACMFDAGDRQRSRNTFVGTPCW 183
+A+ + H G +HRD+K NILID N G +KL DFG A + D F GT +
Sbjct: 160 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-----TVYTDFDGTRVY 214
Query: 184 MAPEVMQQLHGYD-FKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER 242
PE ++ H Y A +WS GI ++ G PF +++
Sbjct: 215 SPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEII---------RGQVFF 262
Query: 243 DKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAP 296
+R S + L+ CL P RPT E++ H + + A + +L+P
Sbjct: 263 RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 316
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 6e-44
Identities = 69/278 (24%), Positives = 106/278 (38%), Gaps = 33/278 (11%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-----DLDGIRREVQTMRV 68
+YRL +G+G TV+ + VAIKV+ + D EV +
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 69 TN----HPNVLRAHCSFTTGHCLWVVMPYMAGGSCL--HIMKSAYPEGFEEPVIATLLRE 122
HP V+R F T +V+ L +I + E +
Sbjct: 91 VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCFFGQ 147
Query: 123 TLKALVYLHFHGHIHRDVKAGNILIDS-NGAIKLADFGVSACMFDAGDRQRSRNTFVGTP 181
+ A+ + H G +HRD+K NILID G KL DFG A + D F GT
Sbjct: 148 VVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE-----PYTDFDGTR 202
Query: 182 CWMAPEVMQQLHGYD-FKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240
+ PE + + H Y A +WS GI ++ G PF + ++L +
Sbjct: 203 VYSPPEWISR-HQYHALPATVWSLGILLYDMVCGDIPFERD--QEIL---------EAEL 250
Query: 241 ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278
S L+ CL P RP+ E+++ + +
Sbjct: 251 HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQ 288
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 8e-44
Identities = 71/269 (26%), Positives = 114/269 (42%), Gaps = 17/269 (6%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVL 75
Y +++G G E+VA+K ++ ++ ++RE+ R HPN++
Sbjct: 22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE--NVQREIINHRSLRHPNIV 79
Query: 76 RAHCSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLLRETLKALVYLHFHG 134
R T L ++M Y +GG I + F E ++ L + Y H
Sbjct: 80 RFKEVILTPTHLAIIMEYASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSMQ 136
Query: 135 HIHRDVKAGNILIDSNGA--IKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQL 192
HRD+K N L+D + A +K+ DFG S + + VGTP ++APEV+ +
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTPAYIAPEVLLR- 191
Query: 193 HGYD-FKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYE--RDKRFSKS 249
YD AD+WS G+T + G PF + T+Q Y D R S
Sbjct: 192 QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV-KYSIPDDIRISPE 250
Query: 250 FKELVTACLVKDPKKRPTAEKLMKHHFFK 278
L++ V DP R + ++ H +F
Sbjct: 251 CCHLISRIFVADPATRISIPEIKTHSWFL 279
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-43
Identities = 66/339 (19%), Positives = 131/339 (38%), Gaps = 19/339 (5%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN 73
Y ++EE+G G V+R A K + + D + +R+E+QTM V HP
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES-DKETVRKEIQTMSVLRHPT 215
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLH-IMKSAYPEGFEEPVIATLLRETLKALVYLHF 132
++ H +F + + ++ +M+GG + E +R+ K L ++H
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHE 273
Query: 133 HGHIHRDVKAGNILIDSNG--AIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQ 190
+ ++H D+K NI+ + +KL DFG++ D + GT + APEV +
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNELKLIDFGLT-AHLDPKQSVK---VTTGTAEFAAPEVAE 329
Query: 191 QLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD--KRFSK 248
+ D+WS G+ + L G +PF + L + + S+
Sbjct: 330 G-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD---WNMDDSAFSGISE 385
Query: 249 SFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGERFRMLKAKE 308
K+ + L+ DP R T + ++H + + ++ + + +
Sbjct: 386 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAW 445
Query: 309 ADLLVQN---KALYEDKEQLSQDYDCMSNAEDPNSSGKQ 344
+ L ++ Q+Y D + + +
Sbjct: 446 PEPLPPLGRISNYSSLRKHRPQEYSIRDAFWDRSEAQPR 484
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-43
Identities = 66/298 (22%), Positives = 111/298 (37%), Gaps = 44/298 (14%)
Query: 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNH 71
A+ L E +G+G V+R E VA+K+ + + E+ + H
Sbjct: 40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFR--EAEIYQTVMLRH 95
Query: 72 PNVLR--AHCSFTTGHC--LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKAL 127
N+L A + G LW+V Y GS + + L T L
Sbjct: 96 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGL 152
Query: 128 VYLHFHGH--------IHRDVKAGNILIDSNGAIKLADFGVSACMFDAG--DRQRSRNTF 177
+LH HRD+K+ NIL+ NG +AD G+ A D+ + N
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL-AVRHDSATDTIDIAPNHR 211
Query: 178 VGTPCWMAPEVMQQLHG-----YDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQ 232
VGT +MAPEV+ +ADI++ G+ E+A + + ++ L
Sbjct: 212 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271
Query: 233 NAPPGLDY------ERDKR-----------FSKSFKELVTACLVKDPKKRPTAEKLMK 273
+ P ++ E+ R + +++ C + R TA ++ K
Sbjct: 272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 6e-43
Identities = 77/343 (22%), Positives = 136/343 (39%), Gaps = 31/343 (9%)
Query: 12 DAKDYRLYEEV-GEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTM-RVT 69
DY++ +V G G++ V + E A+K+L D RREV+ R +
Sbjct: 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ------DCPKARREVELHWRAS 112
Query: 70 NHPNVLRAHCSF----TTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLK 125
P+++R + CL +VM + GG ++ + F E + +++ +
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 126 ALVYLHFHGHIHRDVKAGNILIDS---NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC 182
A+ YLH HRDVK N+L S N +KL DFG + + + T TP
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLT---TPCYTPY 228
Query: 183 WMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPF---SKYPPMKVLLMTLQNAPPGLD 239
++APEV+ YD D+WS G+ L G+ PF + ++
Sbjct: 229 YVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 287
Query: 240 YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGE 299
S+ K L+ L +P +R T + M H + + + ++ + L E
Sbjct: 288 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ---STKVPQTPLHTSRVLKE 344
Query: 300 RFRMLKAKEADLLVQNKALYEDKEQLSQDYDCMSNAEDPNSSG 342
+ + ++ + D EQ+ + ED ++
Sbjct: 345 DKERWEDVKEEMTSALATMRVDYEQIK-----IKKIEDASNPL 382
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 7e-43
Identities = 68/261 (26%), Positives = 118/261 (45%), Gaps = 10/261 (3%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNND--LDGIRREVQTMRVTNHPN 73
Y++ +++G G +TVY A LN VAIK + + + L REV +H N
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH 133
++ C ++VM Y+ G + ++S P + + L + + H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDT--AINFTNQILDGIKHAHDM 130
Query: 134 GHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLH 193
+HRD+K NILIDSN +K+ DFG++ + + Q N +GT + +PE Q
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ--TNHVLGTVQYFSPE--QAKG 186
Query: 194 GY-DFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKE 252
D DI+S GI E+ G PF+ + + + +Q++ P + + K +S
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSN 246
Query: 253 LVTACLVKDPKKRP-TAEKLM 272
++ KD R T +++
Sbjct: 247 VILRATEKDKANRYKTIQEMK 267
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-42
Identities = 64/301 (21%), Positives = 112/301 (37%), Gaps = 48/301 (15%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRRE--VQTMRV 68
+ +L E G V++A LNE VA+K+ D + E V ++
Sbjct: 21 FQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFP----IQDKQSWQNEYEVYSLPG 74
Query: 69 TNHPNVLR--AHCSFTTGHC--LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETL 124
H N+L+ T LW++ + GS +K+ + +
Sbjct: 75 MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMA 131
Query: 125 KALVYLHFHGH----------IHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSR 174
+ L YLH HRD+K+ N+L+ +N +ADFG+ A F+AG
Sbjct: 132 RGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL-ALKFEAGKSAGDT 190
Query: 175 NTFVGTPCWMAPEVMQQLHGYDF----KADIWSFGITALELAHGHAPFSKYPP------- 223
+ VGT +MAPEV++ + + D+++ G+ ELA
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250
Query: 224 -----------MKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLM 272
M+ +++ + P DY + E + C D + R +A +
Sbjct: 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310
Query: 273 K 273
+
Sbjct: 311 E 311
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 4e-42
Identities = 65/288 (22%), Positives = 127/288 (44%), Gaps = 16/288 (5%)
Query: 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHC 79
E +G G V++ +A K++ D + ++ E+ M +H N+++ +
Sbjct: 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK-DKEEVKNEISVMNQLDHANLIQLYD 153
Query: 80 SFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHR 138
+F + + + +VM Y+ GG I+ +Y E +++ + + ++H +H
Sbjct: 154 AFESKNDIVLVMEYVDGGELFDRIIDESYN--LTELDTILFMKQICEGIRHMHQMYILHL 211
Query: 139 DVKAGNILIDS--NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYD 196
D+K NIL + IK+ DFG++ + ++ + GTP ++APEV+
Sbjct: 212 DLKPENILCVNRDAKQIKIIDFGLAR-RYKPREKLK---VNFGTPEFLAPEVVNY-DFVS 266
Query: 197 FKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD--KRFSKSFKELV 254
F D+WS G+ A L G +PF + L L D E + + S+ KE +
Sbjct: 267 FPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACR---WDLEDEEFQDISEEAKEFI 323
Query: 255 TACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGERFR 302
+ L+K+ R +A + +KH + + + L+ N + F
Sbjct: 324 SKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKKKNRGSDAQDFV 371
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 8e-42
Identities = 63/311 (20%), Positives = 109/311 (35%), Gaps = 57/311 (18%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT- 69
+D + +L E +G G VY+ VA+KV + E RV
Sbjct: 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA----NRQNFINEKNIYRVPL 63
Query: 70 -NHPNVLR--AHCSFTTGHC---LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRET 123
H N+ R T +VM Y GS + + L
Sbjct: 64 MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSV 120
Query: 124 LKALVYLH----FHGH-----IHRDVKAGNILIDSNGAIKLADFGVS-----ACMFDAGD 169
+ L YLH H HRD+ + N+L+ ++G ++DFG+S + G+
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE 180
Query: 170 RQRSRNTFVGTPCWMAPEV------MQQLHGYDFKADIWSFGITALELAHG---HAPFSK 220
+ + VGT +MAPEV ++ + D+++ G+ E+ P
Sbjct: 181 EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240
Query: 221 YPPMKVLLMTLQNAPPGLD------------------YERDKRFSKSFKELVTACLVKDP 262
P ++ T P + ++ + +S KE + C +D
Sbjct: 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDA 300
Query: 263 KKRPTAEKLMK 273
+ R TA+ +
Sbjct: 301 EARLTAQXAEE 311
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 71/265 (26%), Positives = 123/265 (46%), Gaps = 13/265 (4%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNND--LDGIRREVQTMRVTNHPN 73
Y L E +G G + V+ A + + VA+KVL + + RRE Q NHP
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 74 VLRAH----CSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVY 129
++ + G ++VM Y+ G + I+ + P + ++ + +AL +
Sbjct: 74 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKR--AIEVIADACQALNF 131
Query: 130 LHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVM 189
H +G IHRDVK NI+I + A+K+ DFG++ + D+G+ +GT +++PE
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE-- 189
Query: 190 QQLHGY-DFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSK 248
Q D ++D++S G E+ G PF+ P+ V ++ P R + S
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS-ARHEGLSA 248
Query: 249 SFKELVTACLVKDPKKRP-TAEKLM 272
+V L K+P+ R TA ++
Sbjct: 249 DLDAVVLKALAKNPENRYQTAAEMR 273
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-41
Identities = 65/254 (25%), Positives = 115/254 (45%), Gaps = 29/254 (11%)
Query: 39 NEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAG 96
++ A+K ++ +KC N++ + +E+Q M+ HP ++ SF +++V+ + G
Sbjct: 40 KKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLG 99
Query: 97 GSCL--HIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIK 154
G L H+ ++ + F+E + + E + AL YL IHRD+K NIL+D +G +
Sbjct: 100 GD-LRYHLQQNVH---FKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVH 155
Query: 155 LADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVM--QQLHGYDFKADIWSFGITALELA 212
+ DF + A M + T GT +MAPE+ ++ GY F D WS G+TA EL
Sbjct: 156 ITDFNI-AAMLPRETQI---TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELL 211
Query: 213 HGHAPF---SKYPPMKVLLMTLQNA---PPGLDYERDKRFSKSFKELVTACLVKDPKKR- 265
G P+ S +++ P +S+ L+ L +P +R
Sbjct: 212 RGRRPYHIRSSTSSKEIVHTFETTVVTYPSA--------WSQEMVSLLKKLLEPNPDQRF 263
Query: 266 PTAEKLMKHHFFKH 279
+ +
Sbjct: 264 SQLSDVQNFPYMND 277
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-41
Identities = 75/284 (26%), Positives = 114/284 (40%), Gaps = 21/284 (7%)
Query: 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVL--DLEKCNNDLDGIRREVQ 64
+R PV +R Y +G+G V ++ A K L K E Q
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236
Query: 65 TMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETL 124
+ N V+ ++ T L +V+ M GG + GF E E
Sbjct: 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEIC 296
Query: 125 KALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWM 184
L LH ++RD+K NIL+D +G I+++D G+ A G VGT +M
Sbjct: 297 CGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL-AVHVPEGQTI---KGRVGTVGYM 352
Query: 185 APEVMQQLHGYDFKADIWSFGITALELAHGHAPF----SKYPPMKVLLMTLQNAPPGLDY 240
APEV++ Y F D W+ G E+ G +PF K +V + +
Sbjct: 353 APEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE----- 406
Query: 241 ERDKRFSKSFKELVTACLVKDPKKR-----PTAEKLMKHHFFKH 279
E +RFS + L + L KDP +R +A ++ +H FK
Sbjct: 407 EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 7e-41
Identities = 64/255 (25%), Positives = 104/255 (40%), Gaps = 13/255 (5%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNND--LDGIRREVQTMRVTNHPN 73
YRL VG G VY A IVA+K++ ++ ++RE +T P+
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH 133
V+ H L+V M + G +++ P V ++R+ AL H
Sbjct: 96 VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAV--AIVRQIGSALDAAHAA 153
Query: 134 GHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLH 193
G HRDVK NIL+ ++ L DFG+++ D Q VGT +MAPE +
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ--LGNTVGTLYYMAPE---RFS 208
Query: 194 GY--DFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251
++ADI++ E G P+ + V+ + A P +F
Sbjct: 209 ESHATYRADIYALTCVLYECLTGSPPYQG-DQLSVMGAHINQAIPRPS-TVRPGIPVAFD 266
Query: 252 ELVTACLVKDPKKRP 266
++ + K+P+ R
Sbjct: 267 AVIARGMAKNPEDRY 281
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 5e-40
Identities = 77/261 (29%), Positives = 119/261 (45%), Gaps = 15/261 (5%)
Query: 39 NEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAG 96
++ A+K+L + +D E M N P V++ +F L++VM YM G
Sbjct: 94 RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG 153
Query: 97 GSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLA 156
G +++M + E E + AL +H G IHRDVK N+L+D +G +KLA
Sbjct: 154 GDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLA 210
Query: 157 DFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHG---YDFKADIWSFGITALELAH 213
DFG CM + +T VGTP +++PEV++ G Y + D WS G+ E+
Sbjct: 211 DFGT--CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268
Query: 214 GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKR---PTAEK 270
G PF + + N L + D SK K L+ A + D + R E+
Sbjct: 269 GDTPFYADSLVG-TYSKIMNHKNSLTFPDDNDISKEAKNLICA-FLTDREVRLGRNGVEE 326
Query: 271 LMKHHFFKHARSNDFLARSIV 291
+ +H FFK+ + R V
Sbjct: 327 IKRHLFFKNDQWAWETLRDTV 347
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-40
Identities = 79/385 (20%), Positives = 142/385 (36%), Gaps = 35/385 (9%)
Query: 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQ 64
+ P+ + + +G G V+ ++ A K L+ ++ G E +
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 65 TMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSC-LHIMKSAYPEG-FEEPVIATLLRE 122
+ + ++ +F T L +VM M GG HI F+EP +
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 123 TLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC 182
+ L +LH I+RD+K N+L+D +G ++++D G++ + + + GTP
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT---KGYAGTPG 354
Query: 183 WMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPF----SKYPPMKVLLMTLQNAPPGL 238
+MAPE++ YDF D ++ G+T E+ PF K ++ L+ A
Sbjct: 355 FMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV--- 410
Query: 239 DYERDKRFSKSFKELVTACLVKDPKKR-----PTAEKLMKHHFFKHARSNDFLARSIVDN 293
+FS + K+ A L KDP+KR + + L H F+ A +
Sbjct: 411 --TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPP 468
Query: 294 LAPLGERFRMLKAKEADLLVQNKALYEDKEQLSQDYDCMSNAEDPNSSGKQNHADVEVPA 353
P D +D S D + +P
Sbjct: 469 FVP-------------DSRTVYAKNIQDVGAFSTVKGVAFEKADTEFFQEFASGTCPIPW 515
Query: 354 ERLSTESGNHSNATTSQDDGFNNLH 378
+ E+G + + DG ++ H
Sbjct: 516 QEEMIETGVFGDLNVWRPDGVDHHH 540
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-39
Identities = 68/287 (23%), Positives = 124/287 (43%), Gaps = 21/287 (7%)
Query: 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLD----LEKCNNDLDGIRRE 62
K + D+ + + +G G + V ++ A+K+++ L++ ++ R E
Sbjct: 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKR--GEVSCFREE 111
Query: 63 VQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLLR 121
+ + + + H +F + L++VM Y GG L + K + E + L
Sbjct: 112 RDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSK--FGERIPAEMARFYLA 169
Query: 122 ETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTP 181
E + A+ +H G++HRD+K NIL+D G I+LADFG C+ D VGTP
Sbjct: 170 EIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGS--CLKLRADGTVRSLVAVGTP 227
Query: 182 CWMAPEVMQQLHG------YDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP 235
+++PE++Q + G Y + D W+ G+ A E+ +G PF + +
Sbjct: 228 DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE 287
Query: 236 PGLDYERDKRFSKSFKELVTACLVKDPKKR---PTAEKLMKHHFFKH 279
D+ + ++ + L+ P+ R A H FF
Sbjct: 288 HLSLPLVDEGVPEEARDFIQR-LLCPPETRLGRGGAGDFRTHPFFFG 333
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 4e-39
Identities = 65/252 (25%), Positives = 117/252 (46%), Gaps = 17/252 (6%)
Query: 39 NEIVAIKVLD----LEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYM 94
+++ A+K+L+ L++ + R E + + + H +F + L++VM Y
Sbjct: 99 DKVFAMKILNKWEMLKR--AETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYY 156
Query: 95 AGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIK 154
GG L ++ S + + E + L E + A+ +H ++HRD+K NIL+D NG I+
Sbjct: 157 VGGDLLTLL-SKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIR 215
Query: 155 LADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLH----GYDFKADIWSFGITALE 210
LADFG C+ D + VGTP +++PE++Q + Y + D WS G+ E
Sbjct: 216 LADFGS--CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYE 273
Query: 211 LAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKR---PT 267
+ +G PF ++ + + + S++ K+L+ L+ + R
Sbjct: 274 MLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRR-LICSREHRLGQNG 332
Query: 268 AEKLMKHHFFKH 279
E KH FF
Sbjct: 333 IEDFKKHPFFSG 344
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 70/260 (26%), Positives = 114/260 (43%), Gaps = 20/260 (7%)
Query: 39 NEIVAIKVL--DLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAG 96
A+K+L ++ +++ E + ++ T HP + +F T L VM Y G
Sbjct: 30 GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89
Query: 97 GSCL-HIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKL 155
G H+ + F E E + AL YLH ++RD+K N+++D +G IK+
Sbjct: 90 GELFFHLSRERV---FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKI 146
Query: 156 ADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGH 215
DFG+ G TF GTP ++APEV++ + Y D W G+ E+ G
Sbjct: 147 TDFGLCKEGISDGATM---KTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGR 202
Query: 216 APFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKR----PT-AEK 270
PF + L + + S K L+ L KDPK+R P+ A++
Sbjct: 203 LPFYN-QDHERLFELILMEEIRF----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE 257
Query: 271 LMKHHFFKHARSNDFLARSI 290
+M+H FF D + + +
Sbjct: 258 VMEHRFFLSINWQDVVQKKL 277
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 74/301 (24%), Positives = 128/301 (42%), Gaps = 51/301 (16%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGI----RREVQTMRVT 69
+ Y E++GEG TV++A +EIVA+K + L+ +D +G+ RE+ ++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD---DDDEGVPSSALREICLLKEL 58
Query: 70 NHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLH----IMKSAYPEGFEEPVIATLLRETLK 125
H N++R H + L +V + S + ++ + L + LK
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCD-----QDLKKYFDS-CNGDLDPEIVKSFLFQLLK 112
Query: 126 ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMA 185
L + H +HRD+K N+LI+ NG +KLA+FG+ A F G R + V T +
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGL-ARAF--GIPVRCYSAEVVTLWYRP 169
Query: 186 PEVMQQLHGYDFKADIWSFGITALELAHGHAP---------------------------- 217
P+V+ Y D+WS G ELA+ P
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229
Query: 218 FSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277
+K P K + A L + + + ++L+ L +P +R +AE+ ++H +F
Sbjct: 230 MTKLPDYKP--YPMYPATTSLV-NVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286
Query: 278 K 278
Sbjct: 287 S 287
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-38
Identities = 69/289 (23%), Positives = 122/289 (42%), Gaps = 27/289 (9%)
Query: 5 VEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGI----- 59
VE + D+ ++ +G G VY ++ A+K LD ++ G
Sbjct: 180 VELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALN 238
Query: 60 -RREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIA 117
R + + + P ++ +F T L ++ M GG H+ + F E +
Sbjct: 239 ERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEADMR 295
Query: 118 TLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTF 177
E + L ++H ++RD+K NIL+D +G ++++D G+ AC F +
Sbjct: 296 FYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGL-ACDFSKK----KPHAS 350
Query: 178 VGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMT--LQNAP 235
VGT +MAPEV+Q+ YD AD +S G +L GH+PF ++ +
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 410
Query: 236 PGLDYERDKRFSKSFKELVTACLVKDPKKR-----PTAEKLMKHHFFKH 279
L FS + L+ L +D +R A+++ + FF+
Sbjct: 411 VEL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-37
Identities = 74/286 (25%), Positives = 122/286 (42%), Gaps = 27/286 (9%)
Query: 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVL--DLEKCNNDLDGIRREV 63
+ + V ++ + +G+G V A+K+L ++ +++ E
Sbjct: 140 KPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN 199
Query: 64 QTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCL-HIMKSAYPEGFEEPVIATLLRE 122
+ ++ + HP + SF T L VM Y GG H+ + F E E
Sbjct: 200 RVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV---FSEDRARFYGAE 256
Query: 123 TLKALVYLH-FHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTP 181
+ AL YLH ++RD+K N+++D +G IK+ DFG+ G TF GTP
Sbjct: 257 IVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KTFCGTP 313
Query: 182 CWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPF---SKYPPMKVLLMTLQNAPPGL 238
++APEV++ + Y D W G+ E+ G PF +++LM P L
Sbjct: 314 EYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTL 372
Query: 239 DYERDKRFSKSFKELVTACLVKDPKKR----PT-AEKLMKHHFFKH 279
K L++ L KDPK+R A+++M+H FF
Sbjct: 373 --------GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 9e-37
Identities = 78/266 (29%), Positives = 121/266 (45%), Gaps = 33/266 (12%)
Query: 39 NEIVAIKVLDLEKCNNDLDGI--RREVQTM---RV---TNHPNVLRAHCSFTTGHCLWVV 90
++ A+KVL +K + R V+T + NHP +++ H +F T L+++
Sbjct: 52 RQLYAMKVL--KK-----ATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI 104
Query: 91 MPYMAGGSC-LHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS 149
+ ++ GG + K F E + L E AL +LH G I+RD+K NIL+D
Sbjct: 105 LDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDE 161
Query: 150 NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITAL 209
G IKL DFG+S D + +F GT +MAPEV+ + G+ AD WSFG+
Sbjct: 162 EGHIKLTDFGLSKESIDHEKKA---YSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMF 217
Query: 210 ELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKR---- 265
E+ G PF K + + A G+ + S + L+ ++P R
Sbjct: 218 EMLTGTLPFQG-KDRKETMTMILKAKLGM----PQFLSPEAQSLLRMLFKRNPANRLGAG 272
Query: 266 PT-AEKLMKHHFFKHARSNDFLARSI 290
P E++ +H FF N R I
Sbjct: 273 PDGVEEIKRHSFFSTIDWNKLYRREI 298
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 73/309 (23%), Positives = 114/309 (36%), Gaps = 68/309 (22%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR----REVQTMRVTN 70
Y ++GEG V++ +IVAIK D I+ RE++ ++
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLES---EDDPVIKKIALREIRMLKQLK 60
Query: 71 HPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYL 130
HPN++ F L +V Y + LH + Y G E ++ ++ +TL+A+ +
Sbjct: 61 HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDR-YQRGVPEHLVKSITWQTLQAVNFC 118
Query: 131 HFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWM-APEVM 189
H H IHRDVK NILI + IKL DFG A + + V T W +PE++
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGF-ARLL--TGPSDYYDDEVAT-RWYRSPELL 174
Query: 190 QQLHGYDFKADIWSFG---------------------------------------ITALE 210
Y D+W+ G + +
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234
Query: 211 LAHGHAPFSKYPPMKVLLMTLQNAPP-GLDYERDKRFSKSFKELVTACLVKDPKKRPTAE 269
G M+ L + N L L+ CL DP +R T E
Sbjct: 235 YFSGV-KIPDPEDMEPLELKFPNISYPALG-------------LLKGCLHMDPTERLTCE 280
Query: 270 KLMKHHFFK 278
+L+ H +F+
Sbjct: 281 QLLHHPYFE 289
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 68/296 (22%), Positives = 114/296 (38%), Gaps = 42/296 (14%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR----REVQTMRVTN 70
Y VGEG V + IVAIK +D ++ RE++ ++
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES---DDDKMVKKIAMREIKLLKQLR 82
Query: 71 HPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYL 130
H N++ ++V ++ + L ++ +P G + V+ L + + + +
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLEL-FPNGLDYQVVQKYLFQIINGIGFC 140
Query: 131 HFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQ 190
H H IHRD+K NIL+ +G +KL DFG A + V T + APE++
Sbjct: 141 HSHNIIHRDIKPENILVSQSGVVKLCDFGF-ARTL--AAPGEVYDDEVATRWYRAPELLV 197
Query: 191 QLHGYDFKADIWSFG-ITALELAHGHAPF---------------------------SKYP 222
Y D+W+ G + E+ G F +K P
Sbjct: 198 GDVKYGKAVDVWAIGCLVT-EMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256
Query: 223 PMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278
+ + L+ R + S+ +L CL DP KRP +L+ H FF+
Sbjct: 257 VFAGVRLPEIKEREPLE-RRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 65/275 (23%), Positives = 104/275 (37%), Gaps = 44/275 (16%)
Query: 12 DAKDYRLYEEV-GEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTM-RVT 69
DY++ +V G G++ V + E A+K+L D RREV+ R +
Sbjct: 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ------DCPKARREVELHWRAS 68
Query: 70 NHPNVLRAHCSF----TTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLK 125
P+++R + CL +VM + GG ++ + F E + +++ +
Sbjct: 69 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 126 ALVYLHFHGHIHRDVKAGNILIDS---NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC 182
A+ YLH HRDVK N+L S N +KL DFG
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG----------------------- 165
Query: 183 WMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPF---SKYPPMKVLLMTLQNAPPGLD 239
A E + YD D+WS G+ L G+ PF + ++
Sbjct: 166 -FAKETTGE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 222
Query: 240 YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274
S+ K L+ L +P +R T + M H
Sbjct: 223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 68/261 (26%), Positives = 118/261 (45%), Gaps = 21/261 (8%)
Query: 39 NEIVAIKVL---DLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMA 95
+I A+KVL + + D + E + HP ++ +F TG L++++ Y++
Sbjct: 45 GKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLS 104
Query: 96 GGSC-LHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIK 154
GG + + + F E L E AL +LH G I+RD+K NI+++ G +K
Sbjct: 105 GGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVK 161
Query: 155 LADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHG 214
L DFG+ G +TF GT +MAPE++ + G++ D WS G ++ G
Sbjct: 162 LTDFGLCKESIHDGTVT---HTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTG 217
Query: 215 HAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKR----PT-AE 269
PF+ K + + L ++ ++L+ L ++ R P A
Sbjct: 218 APPFTG-ENRKKTIDKILKCKLNL----PPYLTQEARDLLKKLLKRNAASRLGAGPGDAG 272
Query: 270 KLMKHHFFKHARSNDFLARSI 290
++ H FF+H + LAR +
Sbjct: 273 EVQAHPFFRHINWEELLARKV 293
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 84/312 (26%), Positives = 124/312 (39%), Gaps = 70/312 (22%)
Query: 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR----REVQTMRV 68
AK Y + +GEG ATVY+A N+IVAIK + L + DGI RE++ ++
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 69 TNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLH----IMKSAYPEGFEEPVIATLLRETL 124
+HPN++ +F + +V +M I+K I + TL
Sbjct: 69 LSHPNIIGLLDAFGHKSNISLVFDFM-----ETDLEVIIKD-NSLVLTPSHIKAYMLMTL 122
Query: 125 KALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWM 184
+ L YLH H +HRD+K N+L+D NG +KLADFG+ A F G R+ V T +
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGL-AKSF--GSPNRAYTHQVVTRWYR 179
Query: 185 APEVMQQLHGYDFKADIWSFG-ITALELAHGHA--------------------------- 216
APE++ Y D+W+ G I A EL
Sbjct: 180 APELLFGARMYGVGVDMWAVGCILA-ELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238
Query: 217 ---------PFSKYPPMKVLLMTLQNAPP-GLDYERDKRFSKSFKELVTACLVKDPKKRP 266
F +P + L A LD L+ + +P R
Sbjct: 239 DMCSLPDYVTFKSFPGIP-LHHIFSAAGDDLLD-------------LIQGLFLFNPCARI 284
Query: 267 TAEKLMKHHFFK 278
TA + +K +F
Sbjct: 285 TATQALKMKYFS 296
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 71/287 (24%), Positives = 118/287 (41%), Gaps = 29/287 (10%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHP 72
+ + +G G V A+K+LD +K ++ E + ++ N P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 73 NVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPV----IATLLRETLKALV 128
+++ SF L++VM Y+AGG ++ F EP A + +
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAA----QIVLTFE 155
Query: 129 YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEV 188
YLH I+RD+K N+LID G I++ DFG F + R+ T GTP +APE+
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG-----FAKRVKGRT-WTLCGTPEALAPEI 209
Query: 189 MQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSK 248
+ GY+ D W+ G+ E+A G+ PF P+++ + + + FS
Sbjct: 210 ILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK---VRFPSH--FSS 263
Query: 249 SFKELVTACLVKDPKKR-----PTAEKLMKHHFFKHARSNDFLARSI 290
K+L+ L D KR + H +F R +
Sbjct: 264 DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKV 310
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 78/267 (29%), Positives = 129/267 (48%), Gaps = 25/267 (9%)
Query: 39 NEIVAIKVL---DLEKCNNDLDGIRREVQTM-RVTNHPNVLRAHCSFTTGHCLWVVMPYM 94
++ A+KVL + + + R E Q + + P ++ H +F T L +++ Y+
Sbjct: 82 GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYI 141
Query: 95 AGGSC-LHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAI 153
GG H+ + E F E + + E + AL +LH G I+RD+K NIL+DSNG +
Sbjct: 142 NGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHV 198
Query: 154 KLADFGVS-ACMFDAGDRQRSRNTFVGTPCWMAPEVMQ-QLHGYDFKADIWSFGITALEL 211
L DFG+S + D +R F GT +MAP++++ G+D D WS G+ EL
Sbjct: 199 VLTDFGLSKEFVADETERA---YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYEL 255
Query: 212 AHGHAPFSKYPPMKVLLMTLQN---APPGLDYERDKRFSKSFKELVTACLVKDPKKR--- 265
G +PF+ + + P + S K+L+ L+KDPKKR
Sbjct: 256 LTGASPFTVDGEKNSQAEISRRILKSEPPY----PQEMSALAKDLIQRLLMKDPKKRLGC 311
Query: 266 -PT-AEKLMKHHFFKHARSNDFLARSI 290
P A+++ +H FF+ +D A+ +
Sbjct: 312 GPRDADEIKEHLFFQKINWDDLAAKKV 338
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-36
Identities = 68/300 (22%), Positives = 109/300 (36%), Gaps = 50/300 (16%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGI----RREVQTMRVT 69
+ Y +++GEG ATVY+ + +VA+K + LE +G REV ++
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLE----HEEGAPCTAIREVSLLKDL 57
Query: 70 NHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLH----IMKSAYPEGFEEPVIATLLRETLK 125
H N++ H T L +V Y+ + + L + L+
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLD-----KDLKQYLDD-CGNIINMHNVKLFLFQLLR 111
Query: 126 ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMA 185
L Y H +HRD+K N+LI+ G +KLADFG+ A ++ + V T +
Sbjct: 112 GLAYCHRQKVLHRDLKPQNLLINERGELKLADFGL-ARAK--SIPTKTYDNEVVTLWYRP 168
Query: 186 PEVMQQLHGYDFKADIWSFGITALELAHGHAPF--------------------------- 218
P+++ Y + D+W G E+A G F
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 228
Query: 219 SKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278
K R +L+T L + + R +AE MKH FF
Sbjct: 229 LSNEEFK--TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-36
Identities = 67/318 (21%), Positives = 119/318 (37%), Gaps = 67/318 (21%)
Query: 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR----REVQTMR 67
+ Y ++G+G V++A + VA+K + +E N+ +G RE++ ++
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME---NEKEGFPITALREIKILQ 71
Query: 68 VTNHPNVLR--------AHCSFTTGHCLWVVMPYM----AGGSCLHIMKSAYPEGFEEPV 115
+ H NV+ A +++V + AG ++ + F
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG-----LLSNV-LVKFTLSE 125
Query: 116 IATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRN 175
I +++ L L Y+H + +HRD+KA N+LI +G +KLADFG+ A F +
Sbjct: 126 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL-ARAFSLAKNSQPNR 184
Query: 176 TFVGTPC----WM-APEVMQQLHGYDFKADIWSFG-ITALELAHGHAPF----------- 218
T W PE++ Y D+W G I A E+
Sbjct: 185 Y---TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMA-EMWTRSPIMQGNTEQHQLAL 240
Query: 219 ----------------SKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK--ELVTACLVK 260
Y + + L +R K + + +L+ LV
Sbjct: 241 ISQLCGSITPEVWPNVDNYELYE--KLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 298
Query: 261 DPKKRPTAEKLMKHHFFK 278
DP +R ++ + H FF
Sbjct: 299 DPAQRIDSDDALNHDFFW 316
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-36
Identities = 72/300 (24%), Positives = 120/300 (40%), Gaps = 51/300 (17%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGI----RREVQTMRVT 69
+ Y E++GEG VY+A E A+K + LE + +GI RE+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLE---KEDEGIPSTTIREISILKEL 57
Query: 70 NHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLH----IMKSAYPEGFEEPVIATLLRETLK 125
H N+++ + T L +V ++ ++ G E + L + L
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLD-----QDLKKLLDV-CEGGLESVTAKSFLLQLLN 111
Query: 126 ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMA 185
+ Y H +HRD+K N+LI+ G +K+ADFG+ A F G R + T + A
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGL-ARAF--GIPVRKYTHEIVTLWYRA 168
Query: 186 PEVMQQLHGYDFKADIWSFGITALELAHGHAPF--------------------------- 218
P+V+ Y DIWS G E+ +G F
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228
Query: 219 SKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278
++ P P K +S +L++ L DP +R TA++ ++H +FK
Sbjct: 229 TELPKYDP---NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-36
Identities = 71/270 (26%), Positives = 119/270 (44%), Gaps = 29/270 (10%)
Query: 39 NEIVAIKVL--DLEKCNNDLDGIRREVQTM-RVTNHPNVLRAHCSFTTGHCLWVVMPYMA 95
+ I A+KV+ +L + D+D ++ E + +NHP ++ H F T L+ V+ Y+
Sbjct: 34 DRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 93
Query: 96 GGSCL-HIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIK 154
GG + H+ + E E AL YLH G I+RD+K N+L+DS G IK
Sbjct: 94 GGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIK 150
Query: 155 LADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHG 214
L D+G+ C + +TF GTP ++APE+++ Y F D W+ G+ E+ G
Sbjct: 151 LTDYGM--CKEGLRPGDTT-STFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAG 206
Query: 215 HAPFSKYPPM--------KVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKR- 265
+PF L + + + S ++ + L KDPK+R
Sbjct: 207 RSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI----PRSLSVKAASVLKSFLNKDPKERL 262
Query: 266 -----PTAEKLMKHHFFKHARSNDFLARSI 290
+ H FF++ + + +
Sbjct: 263 GCHPQTGFADIQGHPFFRNVDWDMMEQKQV 292
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-36
Identities = 82/300 (27%), Positives = 126/300 (42%), Gaps = 50/300 (16%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGI----RREVQTMRVT 69
+ Y+ E+VGEG VY+A IVA+K + L+ + +GI RE+ ++
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLD---AEDEGIPSTAIREISLLKEL 76
Query: 70 NHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLH----IMKSAYPEGFEEPVIATLLRETLK 125
+HPN++ + CL +V +M ++ G ++ I L + L+
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFME-----KDLKKVLDE-NKTGLQDSQIKIYLYQLLR 130
Query: 126 ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMA 185
+ + H H +HRD+K N+LI+S+GA+KLADFG+ A F G RS V T + A
Sbjct: 131 GVAHCHQHRILHRDLKPQNLLINSDGALKLADFGL-ARAF--GIPVRSYTHEVVTLWYRA 187
Query: 186 PEVMQQLHGYDFKADIWSFGITALELAHGHAPF--------------------------- 218
P+V+ Y DIWS G E+ G F
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247
Query: 219 SKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278
+ P K T Q F + +L++ L DP KR +A M H +FK
Sbjct: 248 QELPLWK--QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 78/265 (29%), Positives = 116/265 (43%), Gaps = 33/265 (12%)
Query: 39 NEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAG 96
A+KVL E ++ E + + HP ++R +F ++++M Y+ G
Sbjct: 31 GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG 90
Query: 97 GSCL--HIMKSAYPEGFEEPV----IATLLRETLKALVYLHFHGHIHRDVKAGNILIDSN 150
G L + KS F PV A E AL YLH I+RD+K NIL+D N
Sbjct: 91 GE-LFSLLRKSQR---FPNPVAKFYAA----EVCLALEYLHSKDIIYRDLKPENILLDKN 142
Query: 151 GAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALE 210
G IK+ DFG + D T GTP ++APEV+ Y+ D WSFGI E
Sbjct: 143 GHIKITDFGFAK---YVPDVT---YTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYE 195
Query: 211 LAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKR----- 265
+ G+ PF MK L L + F++ K+L++ + +D +R
Sbjct: 196 MLAGYTPFYDSNTMKTYEKILNAE---LRFPPF--FNEDVKDLLSRLITRDLSQRLGNLQ 250
Query: 266 PTAEKLMKHHFFKHARSNDFLARSI 290
E + H +FK L+R+I
Sbjct: 251 NGTEDVKNHPWFKEVVWEKLLSRNI 275
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 1e-35
Identities = 74/257 (28%), Positives = 120/257 (46%), Gaps = 17/257 (6%)
Query: 39 NEIVAIKVL--DLEKCNNDLDGIRREVQTM-RVTNHPNVLRAHCSFTTGHCLWVVMPYMA 95
N+ AIK L D+ ++D++ E + + HP + C+F T L+ VM Y+
Sbjct: 42 NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 101
Query: 96 GGSC-LHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIK 154
GG HI F+ E + L +LH G ++RD+K NIL+D +G IK
Sbjct: 102 GGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIK 158
Query: 155 LADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHG 214
+ADFG+ C + ++ NTF GTP ++APE++ Y+ D WSFG+ E+ G
Sbjct: 159 IADFGM--CKENMLGDAKT-NTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIG 214
Query: 215 HAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKR-PTAEKLMK 273
+PF ++ + P Y R K K+L+ V++P+KR + +
Sbjct: 215 QSPFHGQDEEELFHSIRMDNPF---YPRW--LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269
Query: 274 HHFFKHARSNDFLARSI 290
H F+ + + I
Sbjct: 270 HPLFREINWEELERKEI 286
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 73/261 (27%), Positives = 116/261 (44%), Gaps = 21/261 (8%)
Query: 39 NEIVAIKVL--DLEKCNNDLDGIRREVQTM-RVTNHPNVLRAHCSFTTGHCLWVVMPYMA 95
+E+ A+K+L D+ ++D++ E + + P + + H F T L+ VM Y+
Sbjct: 45 DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 104
Query: 96 GGSCLHIMKSAYPEG-FEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIK 154
GG +M G F+EP E L +L G I+RD+K N+++DS G IK
Sbjct: 105 GG---DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIK 161
Query: 155 LADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHG 214
+ADFG+ C + D + TF GTP ++APE++ Y D W+FG+ E+ G
Sbjct: 162 IADFGM--CKENIWDGVTT-KTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAG 217
Query: 215 HAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKR----PT-AE 269
APF L ++ K SK + + K P KR P
Sbjct: 218 QAPFEG-EDEDELFQSIMEHNVAYP----KSMSKEAVAICKGLMTKHPGKRLGCGPEGER 272
Query: 270 KLMKHHFFKHARSNDFLARSI 290
+ +H FF++ + I
Sbjct: 273 DIKEHAFFRYIDWEKLERKEI 293
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-35
Identities = 87/401 (21%), Positives = 147/401 (36%), Gaps = 72/401 (17%)
Query: 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIK--VLDLEKCNNDLDGIRREVQTM 66
P + Y + +G G VY+A E+VAIK + D N RE+Q M
Sbjct: 50 RPQEVS-YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIM 101
Query: 67 RVTNHPNVLR-AHCSFTTGH-----CLWVVMPYMAGGSCLH-IMKSAYPEG--FEEPVIA 117
R +H N++R + +++G L +V+ Y+ ++ + + +
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVK 159
Query: 118 TLLRETLKALVYLHFHGHIHRDVKAGNILIDSN-GAIKLADFGVSACMFDAGDRQRSRNT 176
+ + ++L Y+H G HRD+K N+L+D + +KL DFG SA G+ S
Sbjct: 160 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG-SAKQLVRGEPNVS--- 215
Query: 177 FVGTPCWMAPEVMQQLHGYDFKADIWSFG-ITALELAHGHAPFSKYPP-----------M 224
++ + + APE++ Y D+WS G + A EL G F P +
Sbjct: 216 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLA-ELLLGQPIF----PGDSGVDQLVEII 270
Query: 225 KVL---------LMTLQNAPPGLDYERDKRFSKSFK--------ELVTACLVKDPKKRPT 267
KVL M + ++K F+ L + L P R T
Sbjct: 271 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 330
Query: 268 AEKLMKHHFFKHARS-NDFLARSIVDNLAPLGERFRMLKAKEADLLVQNKALYEDKEQLS 326
+ H FF R N L N F + + L ++
Sbjct: 331 PLEACAHSFFDELRDPNVKL-----PNGRDTPALFNFTTQELSSNPPLATILIPPHARIQ 385
Query: 327 QDYDCMSNAEDPNSSGKQNHADVEVPAERLSTESGNHSNAT 367
A P ++ + A+ + + S + SN+T
Sbjct: 386 A------AASTPTNATAASDANTGDRGQTNNAASASASNST 420
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 6e-35
Identities = 70/270 (25%), Positives = 119/270 (44%), Gaps = 29/270 (10%)
Query: 39 NEIVAIKVL--DLEKCNNDLDGIRREVQTM-RVTNHPNVLRAHCSFTTGHCLWVVMPYMA 95
+ I A++V+ +L + D+D ++ E + +NHP ++ H F T L+ V+ Y+
Sbjct: 77 DRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 136
Query: 96 GGSCL-HIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIK 154
GG + H+ + E E AL YLH G I+RD+K N+L+DS G IK
Sbjct: 137 GGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIK 193
Query: 155 LADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHG 214
L D+G+ C + +TF GTP ++APE+++ Y F D W+ G+ E+ G
Sbjct: 194 LTDYGM--CKEGLRPGDTT-STFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAG 249
Query: 215 HAPFSKYPPM--------KVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKR- 265
+PF L + + + S ++ + L KDPK+R
Sbjct: 250 RSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI----PRSLSVKAASVLKSFLNKDPKERL 305
Query: 266 -----PTAEKLMKHHFFKHARSNDFLARSI 290
+ H FF++ + + +
Sbjct: 306 GCHPQTGFADIQGHPFFRNVDWDMMEQKQV 335
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-35
Identities = 76/265 (28%), Positives = 123/265 (46%), Gaps = 28/265 (10%)
Query: 39 NEIVAIKVL--DLEKCNNDLDGIRREVQTM-RVTNHPNVLRAHCSFTTGHCLWVVMPYMA 95
++ A+KVL D+ ++D++ E + + NHP + + C F T L+ VM ++
Sbjct: 48 GDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVN 107
Query: 96 GGSC-LHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIK 154
GG HI KS F+E E + AL++LH G I+RD+K N+L+D G K
Sbjct: 108 GGDLMFHIQKSRR---FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCK 164
Query: 155 LADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHG 214
LADFG+ C + + TF GTP ++APE++Q+ Y D W+ G+ E+ G
Sbjct: 165 LADFGM--CKEGICNGVTT-ATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCG 220
Query: 215 HAPF---SKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKR------ 265
HAPF ++ + +L P L + ++ + + K+P R
Sbjct: 221 HAPFEAENEDDLFEAILNDEVVYPTWL--------HEDATGILKSFMTKNPTMRLGSLTQ 272
Query: 266 PTAEKLMKHHFFKHARSNDFLARSI 290
+++H FFK R I
Sbjct: 273 GGEHAILRHPFFKEIDWAQLNHRQI 297
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 68/302 (22%), Positives = 119/302 (39%), Gaps = 43/302 (14%)
Query: 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGI----RREVQTMRV 68
+ ++ E++G G ATVY+ L VA+K + L+ +G RE+ M+
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS----EEGTPSTAIREISLMKE 59
Query: 69 TNHPNVLRAHCSFTTGHCLWVVMPYMA---GGSCLHIMKSAYPEGFEEPVIATLLRETLK 125
H N++R + T + L +V +M P G E ++ + L+
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 126 ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMA 185
L + H + +HRD+K N+LI+ G +KL DFG+ A F G + ++ V T + A
Sbjct: 120 GLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGL-ARAF--GIPVNTFSSEVVTLWYRA 176
Query: 186 PEVMQQLHGYDFKADIWSFGITALELAHGHAPF--------------------------- 218
P+V+ Y DIWS G E+ G F
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236
Query: 219 SKYPPMKVLLM--TLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHF 276
+K P + ++ L + + + + L +P R +A++ + H +
Sbjct: 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296
Query: 277 FK 278
F
Sbjct: 297 FA 298
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 2e-34
Identities = 71/261 (27%), Positives = 118/261 (45%), Gaps = 21/261 (8%)
Query: 39 NEIVAIKVL--DLEKCNNDLDGIRREVQTM-RVTNHPNVLRAHCSFTTGHCLWVVMPYMA 95
+E+ A+K+L D+ ++D++ E + + P + + H F T L+ VM Y+
Sbjct: 366 DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 425
Query: 96 GGSCLHIMKSAYPEG-FEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIK 154
GG +M G F+EP E L +L G I+RD+K N+++DS G IK
Sbjct: 426 GG---DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIK 482
Query: 155 LADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHG 214
+ADFG+ C + D + TF GTP ++APE++ Y D W+FG+ E+ G
Sbjct: 483 IADFGM--CKENIWDGVTT-KTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAG 538
Query: 215 HAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKR-----PTAE 269
APF ++ +++ Y + SK + + K P KR
Sbjct: 539 QAPFEGEDEDELFQSIMEHNVA---YPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGER 593
Query: 270 KLMKHHFFKHARSNDFLARSI 290
+ +H FF++ + I
Sbjct: 594 DIKEHAFFRYIDWEKLERKEI 614
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-34
Identities = 58/257 (22%), Positives = 93/257 (36%), Gaps = 31/257 (12%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNE-IVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNV 74
Y + + G +Y AL +N V +K L E Q + HP++
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSI 141
Query: 75 LR-----AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVY 129
++ H ++VM Y+ G S +K + + L E L AL Y
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQS----LKRSKGQKLPVAEAIAYLLEILPALSY 197
Query: 130 LHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVM 189
LH G ++ D+K NI++ +KL D G + + G GTP + APE
Sbjct: 198 LHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFG-------YLYGTPGFQAPE-- 247
Query: 190 QQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249
G DI++ G T L + + L P L + S
Sbjct: 248 IVRTGPTVATDIYTVGRTLAALTLDLPTRN-----GRYVDGLPEDDPVL------KTYDS 296
Query: 250 FKELVTACLVKDPKKRP 266
+ L+ + DP++R
Sbjct: 297 YGRLLRRAIDPDPRQRF 313
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-34
Identities = 75/260 (28%), Positives = 110/260 (42%), Gaps = 20/260 (7%)
Query: 39 NEIVAIKVLDLEKC--NNDLDGIRREVQTM-RVTNHPNVLRAHCSFTTGHCLWVVMPYMA 95
A+KVL + + I E + + HP ++ H SF T L+ V+ Y+
Sbjct: 63 EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 122
Query: 96 GGSC-LHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIK 154
GG H+ + F EP E AL YLH ++RD+K NIL+DS G I
Sbjct: 123 GGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIV 179
Query: 155 LADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHG 214
L DFG+ + +TF GTP ++APEV+ + YD D W G E+ +G
Sbjct: 180 LTDFGLCKENIEHNSTT---STFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYG 235
Query: 215 HAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKR----PTAEK 270
PF ++ L N P L + S + L+ L KD KR +
Sbjct: 236 LPPFYSRNTAEMYDNIL-NKPLQL----KPNITNSARHLLEGLLQKDRTKRLGAKDDFME 290
Query: 271 LMKHHFFKHARSNDFLARSI 290
+ H FF +D + + I
Sbjct: 291 IKSHVFFSLINWDDLINKKI 310
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 70/305 (22%), Positives = 113/305 (37%), Gaps = 57/305 (18%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGI----RREVQTMRVTN 70
YR ++GEG VY+A+ NE VAIK + LE ++ +G+ REV ++
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLE---HEEEGVPGTAIREVSLLKELQ 91
Query: 71 HPNVLRAHCSFTTGHCLWVVMPYMAGGSCLH----IMKSAYPEGFEEPVIATLLRETLKA 126
H N++ H L ++ Y + M VI + L + +
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEYAE-----NDLKKYMDKNPD--VSMRVIKSFLYQLING 144
Query: 127 LVYLHFHGHIHRDVKAGNILIDSN-----GAIKLADFGVSACMFDAGDRQRSRNTFVGTP 181
+ + H +HRD+K N+L+ + +K+ DFG+ A F G R + T
Sbjct: 145 VNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL-ARAF--GIPIRQFTHEIITL 201
Query: 182 CWMAPEVMQQLHGYDFKADIWSFG-ITALELAHGHAPF---------------------- 218
+ PE++ Y DIWS I A E+ F
Sbjct: 202 WYRPPEILLGSRHYSTSVDIWSIACIWA-EMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT 260
Query: 219 -----SKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273
+ P K + L +L+TA L DP KR +A+ ++
Sbjct: 261 TWPGVTALPDWKQSF--PKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318
Query: 274 HHFFK 278
H +F
Sbjct: 319 HPYFS 323
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 8e-33
Identities = 37/259 (14%), Positives = 64/259 (24%), Gaps = 41/259 (15%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNND--LDGIRREVQTMRVTNHPN 73
YRL G ++AL L+ VA+ +D + D L + + P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH 133
V R T VV ++ GGS ++ ++ A H
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGS----LQEVADTSPSPVGAIRAMQSLAAAADAAHRA 148
Query: 134 GHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLH 193
G + + +G + LA M
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPAT-----------------------MPDA------ 179
Query: 194 GYDFKADIWSFGITALELAHGHAPF---SKYPPMKVLLMTLQNAPPGLDYERDKRFSKSF 250
+ + DI G + L P + P + D+
Sbjct: 180 --NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPA-DIDRDIPFQI 236
Query: 251 KELVTACLVKDPKKRPTAE 269
+ + D R +
Sbjct: 237 SAVAARSVQGDGGIRSAST 255
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 8e-33
Identities = 81/309 (26%), Positives = 128/309 (41%), Gaps = 57/309 (18%)
Query: 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRV 68
+ Y + +G G V++A + +E VAIK + +K + RE+Q MR+
Sbjct: 36 EQREIA-YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKN-----RELQIMRI 88
Query: 69 TNHPNVLR-AHCSFTTGH-----CLWVVMPYMAGGSCLH-IMKSAYPEG--FEEPVIATL 119
HPNV+ ++ G L +V+ Y+ ++ + +I
Sbjct: 89 VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV--PETVYRASRHYAKLKQTMPMLLIKLY 146
Query: 120 LRETLKALVYLHFHGHIHRDVKAGNILIDSN-GAIKLADFGVSACMFDAGDRQRSRNTFV 178
+ + L++L Y+H G HRD+K N+L+D G +KL DFG SA + AG+ S ++
Sbjct: 147 MYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG-SAKILIAGEPNVS---YI 202
Query: 179 GTPCWMAPEVMQQLHGYDFKADIWSFG-ITALELAHGHAPFSKYPP-----------MKV 226
+ + APE++ Y DIWS G + A EL G F P +KV
Sbjct: 203 CSRYYRAPELIFGATNYTTNIDIWSTGCVMA-ELMQGQPLF----PGESGIDQLVEIIKV 257
Query: 227 L---------LMTLQNAPPGLDYERDKRFSKSFK--------ELVTACLVKDPKKRPTAE 269
L M R FSK F+ +L++ L P R TA
Sbjct: 258 LGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAI 317
Query: 270 KLMKHHFFK 278
+ + H FF
Sbjct: 318 EALCHPFFD 326
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 76/310 (24%), Positives = 115/310 (37%), Gaps = 64/310 (20%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR----REV---QTMR 67
Y E+G G TVY+A VA+K + + G+ REV + +
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 68 VTNHPNVLRAHCSFTTGHC-----LWVVMPYMAGGSCLH----IMKSAYPEGFEEPVIAT 118
HPNV+R T + +V ++ + A P G I
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-----QDLRTYLDKAPPPGLPAETIKD 124
Query: 119 LLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFV 178
L+R+ L+ L +LH + +HRD+K NIL+ S G +KLADFG+ A ++ +
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL-ARIYS------YQMAL- 176
Query: 179 GTPC----WM-APEVMQQLHG--YDFKADIWSFG-ITALELAHGHAPF------------ 218
TP W APEV L Y D+WS G I A E+ F
Sbjct: 177 -TPVVVTLWYRAPEV---LLQSTYATPVDMWSVGCIFA-EMFRRKPLFCGNSEADQLGKI 231
Query: 219 ---------SKYPPMKVL-LMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTA 268
+P L P +S +L+ L +P KR +A
Sbjct: 232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISA 291
Query: 269 EKLMKHHFFK 278
+ ++H +
Sbjct: 292 FRALQHSYLH 301
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 69/306 (22%), Positives = 119/306 (38%), Gaps = 58/306 (18%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMR-VTNHP 72
DY+L ++G G + V+ A+ I NE V +K+L K I+RE++ + + P
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK----KKIKREIKILENLRGGP 91
Query: 73 N------VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKA 126
N +++ S T +V ++ + ++ + I + E LKA
Sbjct: 92 NIITLADIVKDPVSRT----PALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKA 142
Query: 127 LVYLHFHGHIHRDVKAGNILIDS-NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMA 185
L Y H G +HRDVK N++ID + ++L D+G++ + + N V + +
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA----EFYHPGQEYNVRVASRYFKG 198
Query: 186 PEVMQQLHGYDFKADIWSFGITALELAHGHAPF---SKYPPMKVLLMTLQNAPPGLDY-- 240
PE++ YD+ D+WS G + PF V + + DY
Sbjct: 199 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258
Query: 241 ----ERDKRFSKSFKE------------------------LVTACLVKDPKKRPTAEKLM 272
E D RF+ + L D + R TA + M
Sbjct: 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 318
Query: 273 KHHFFK 278
+H +F
Sbjct: 319 EHPYFY 324
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-32
Identities = 71/315 (22%), Positives = 122/315 (38%), Gaps = 66/315 (20%)
Query: 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIK-VLDLEKCNNDLDGIR--REVQTMRVT 69
+++ G+G TV VAIK V+ + R + +Q + V
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ-----DPRFRNRELQIMQDLAVL 76
Query: 70 NHPNVLR-AHCSFTTGH------CLWVVMPYMAGGSCLH-IMKSAYPEGFEEPV--IATL 119
+HPN+++ +T G L VVM Y+ LH ++ Y P I
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV--PDTLHRCCRNYYRRQVAPPPILIKVF 134
Query: 120 LRETLKALVYLHFHGH--IHRDVKAGNILID-SNGAIKLADFGVSACMFDAGDRQRSRNT 176
L + ++++ LH HRD+K N+L++ ++G +KL DFG SA + N
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG-SAKKLSPSE----PNV 189
Query: 177 -FVGTPCWMAPEVMQQLHGYDFKADIWSFG-ITALELAHGHAPFSKYPP----------- 223
++ + + APE++ Y DIWS G I A E+ G F
Sbjct: 190 AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFA-EMMLGEPIF----RGDNSAGQLHEI 244
Query: 224 MKVL---------LMTLQNAPPGLDYERDKRFSKSFKE-----------LVTACLVKDPK 263
++VL + + L + +S F + L++A L P+
Sbjct: 245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPE 304
Query: 264 KRPTAEKLMKHHFFK 278
+R + + H +F
Sbjct: 305 ERMKPYEALCHPYFD 319
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-31
Identities = 62/281 (22%), Positives = 110/281 (39%), Gaps = 42/281 (14%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR---REVQTMR 67
++ +D L E++G G V+ N +VA+K + D +E + ++
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC---RETLPPDLKAKFLQEARILK 167
Query: 68 VTNHPNVLRAH--CSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLK 125
+HPN++R C T +++VM + GG L +++ + ++ +
Sbjct: 168 QYSHPNIVRLIGVC--TQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAA 224
Query: 126 ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-WM 184
+ YL IHRD+ A N L+ +K++DFG+S D V P W
Sbjct: 225 GMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV--PVKWT 282
Query: 185 APEVMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMK---VLLMTLQ-------- 232
APE + Y ++D+WSFGI E G +P YP + +
Sbjct: 283 APEALNYGR-YSSESDVWSFGILLWETFSLGASP---YPNLSNQQTREFVEKGGRLPCPE 338
Query: 233 NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273
P + L+ C +P +RP+ + +
Sbjct: 339 LCPDAV------------FRLMEQCWAYEPGQRPSFSTIYQ 367
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 75/311 (24%), Positives = 117/311 (37%), Gaps = 68/311 (21%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPL-NEIVAIKVLDLEKCNNDLDGI----RREVQTMR-- 67
Y E+GEG V++A + VA+K + ++ +G+ REV +R
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ---TGEEGMPLSTIREVAVLRHL 68
Query: 68 -VTNHPNVLRAHCSFTTGHC-----LWVVMPYMAGGSCLH----IMKSAYPEGFEEPVIA 117
HPNV+R T L +V ++ + G I
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-----QDLTTYLDKVPEPGVPTETIK 123
Query: 118 TLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTF 177
++ + L+ L +LH H +HRD+K NIL+ S+G IKLADFG+ A ++ +
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL-ARIYS------FQMAL 176
Query: 178 VGTPC----WM-APEVMQQLHG--YDFKADIWSFG-ITALELAHGHAPF----------- 218
T W APEV L Y D+WS G I A E+ F
Sbjct: 177 --TSVVVTLWYRAPEV---LLQSSYATPVDLWSVGCIFA-EMFRRKPLFRGSSDVDQLGK 230
Query: 219 ----------SKYPPMKVL-LMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPT 267
+P L + + + K+L+ CL +P KR +
Sbjct: 231 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 290
Query: 268 AEKLMKHHFFK 278
A + H +F+
Sbjct: 291 AYSALSHPYFQ 301
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-30
Identities = 64/287 (22%), Positives = 127/287 (44%), Gaps = 24/287 (8%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-DLDGIRREVQTMRVT 69
++ D + ++G G VY + + VA+K L K + +++ +E M+
Sbjct: 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEI 273
Query: 70 NHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVY 129
HPN+++ T +++ +M G+ L ++ + V+ + + A+ Y
Sbjct: 274 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 333
Query: 130 LHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-WMAPEV 188
L IHR++ A N L+ N +K+ADFG+S M + F P W APE
Sbjct: 334 LEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF---PIKWTAPES 390
Query: 189 MQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQN----APPGLDYERD 243
+ + + K+D+W+FG+ E+A +G +P+ +V + ++ P G
Sbjct: 391 LAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG------ 443
Query: 244 KRFSKSFKELVTACLVKDPKKRPTAEKLMKH--HFFKHARSNDFLAR 288
+ EL+ AC +P RP+ ++ + F+ + +D + +
Sbjct: 444 --CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEK 488
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 62/276 (22%), Positives = 108/276 (39%), Gaps = 41/276 (14%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNE----IVAIKVLDLEKCNNDLDGIRREVQTM 66
+ +++ + +G G TVY+ L IP E VAIK L I E M
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 67 RVTNHPNVLR--AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETL 124
++P+V R C + ++ M G L ++ + + + +
Sbjct: 72 ASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIA 127
Query: 125 KALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGT--PC 182
K + YL +HRD+ A N+L+ + +K+ DFG++ + A +++ G P
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-GAEEKEYHAE---GGKVPI 183
Query: 183 -WMAPEVMQQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKVL--------LMTL 231
WMA E + H Y ++D+WS+G+T EL G P+ P ++ L
Sbjct: 184 KWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 241
Query: 232 QNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPT 267
+ Y ++ C + D RP
Sbjct: 242 PICTIDV-Y-----------MIMRKCWMIDADSRPK 265
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-30
Identities = 65/291 (22%), Positives = 126/291 (43%), Gaps = 32/291 (10%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-DLDGIRREVQTMRVT 69
++ D + ++G G VY + + VA+K L K + +++ +E M+
Sbjct: 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEI 66
Query: 70 NHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVY 129
HPN+++ T +++ +M G+ L ++ + V+ + + A+ Y
Sbjct: 67 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 130 LHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-WMAPEV 188
L IHRD+ A N L+ N +K+ADFG+S M + F P W APE
Sbjct: 127 LEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF---PIKWTAPES 183
Query: 189 MQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ--------NAPPGLD 239
+ + + K+D+W+FG+ E+A +G +P+ +V + + P +
Sbjct: 184 LAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV- 241
Query: 240 YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH--HFFKHARSNDFLAR 288
Y EL+ AC +P RP+ ++ + F+ + +D + +
Sbjct: 242 Y-----------ELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEK 281
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 65/276 (23%), Positives = 107/276 (38%), Gaps = 36/276 (13%)
Query: 10 PVDAKDYRLYEEVGEGVSATVYRALCIPLNEI---VAIKVLDLEKCNNDLDGIRREVQTM 66
+ E +G G VY + + A+K L+ ++ E M
Sbjct: 21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 80
Query: 67 RVTNHPNVLRAH-CSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLL---RE 122
+ +HPNVL + VV+PYM G + +++ P + L+ +
Sbjct: 81 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGFGLQ 136
Query: 123 TLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGT-P 181
K + YL +HRD+ A N ++D +K+ADFG++ M+D + N P
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD-KEYYSVHNKTGAKLP 195
Query: 182 C-WMAPEVMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ------- 232
WMA E +Q + K+D+WSFG+ EL G P+ + + LQ
Sbjct: 196 VKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 254
Query: 233 -NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPT 267
P L Y E++ C + RP+
Sbjct: 255 EYCPDPL-Y-----------EVMLKCWHPKAEMRPS 278
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 70/341 (20%), Positives = 117/341 (34%), Gaps = 89/341 (26%)
Query: 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRV 68
+K Y L + +G G V I + A+K K D RE+ M+V
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALK-----KVLQDPRYKNRELDIMKV 56
Query: 69 TNHPNVLRAHCSFTTGHC--------------------------------------LWVV 90
+H N+++ F T L V+
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 91 MPYMAGGSCLH-IMKSAYPEG--FEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILI 147
M Y+ LH ++KS G +I+ + + +A+ ++H G HRD+K N+L+
Sbjct: 117 MEYV--PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV 174
Query: 148 DSN-GAIKLADFGVSACMFDAGDRQRSRNT-FVGTPCWMAPEVMQQLHGYDFKADIWSFG 205
+S +KL DFG SA + + ++ + + APE+M Y D+WS G
Sbjct: 175 NSKDNTLKLCDFG-SAKKLIPSE----PSVAYICSRFYRAPELMLGATEYTPSIDLWSIG 229
Query: 206 -ITALELAHGHAPFSKYPP-----------MKVL---------LMTLQNAPPGLDYERDK 244
+ EL G F ++++ M + K
Sbjct: 230 CVFG-ELILGKPLF----SGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAK 284
Query: 245 RFSKSFK--------ELVTACLVKDPKKRPTAEKLMKHHFF 277
+ K +L+ L +P R + M H FF
Sbjct: 285 DWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 59/274 (21%), Positives = 108/274 (39%), Gaps = 35/274 (12%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEI----VAIKVLDLEKCNNDLDGIRREVQTM 66
+ + +G G VY+ + + VAIK L E M
Sbjct: 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 100
Query: 67 RVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKA 126
+H N++R + + ++ YM G+ ++ E F + +LR
Sbjct: 101 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAG 159
Query: 127 LVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC---W 183
+ YL ++HRD+ A NIL++SN K++DFG+S + D + + + G W
Sbjct: 160 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS---GGKIPIRW 216
Query: 184 MAPEVMQQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ--------N 233
APE + + + +D+WSFGI E+ +G P+ + +V+ +
Sbjct: 217 TAPEAIS--YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD 274
Query: 234 APPGLDYERDKRFSKSFKELVTACLVKDPKKRPT 267
P + Y +L+ C ++ +RP
Sbjct: 275 CPSAI-Y-----------QLMMQCWQQERARRPK 296
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 67/272 (24%), Positives = 108/272 (39%), Gaps = 32/272 (11%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNE---IVAIKVLDLEKCNNDLDGIRREVQTMR 67
++A + + +G G S V + VAIK L E M
Sbjct: 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMG 105
Query: 68 VTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKAL 127
+HPN++R T G +V YM GS +++ + F + +LR +
Sbjct: 106 QFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGM 164
Query: 128 VYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC---WM 184
YL G++HRD+ A N+L+DSN K++DFG+S + D D + G W
Sbjct: 165 RYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT---GGKIPIRWT 221
Query: 185 APEVMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ--------NAP 235
APE + + +D+WSFG+ E+ +G P+ V+ + P
Sbjct: 222 APEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCP 280
Query: 236 PGLDYERDKRFSKSFKELVTACLVKDPKKRPT 267
L + +L+ C KD +RP
Sbjct: 281 HAL-H-----------QLMLDCWHKDRAQRPR 300
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 68/317 (21%), Positives = 125/317 (39%), Gaps = 44/317 (13%)
Query: 2 DLVVEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNE-----IVAIKVLDLEKCNNDL 56
D+ V + V + + E+G+G VY + + + VAIK ++ +
Sbjct: 13 DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER 72
Query: 57 DGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVI 116
E M+ N +V+R + G V+M M G ++S P PV+
Sbjct: 73 IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 132
Query: 117 ATLLRETL--------KALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168
A + + YL+ + +HRD+ A N ++ + +K+ DFG++ +++
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE-T 191
Query: 169 D--RQRSRNTFVGTP-CWMAPEVMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPM 224
D R+ + P WM+PE ++ + +D+WSFG+ E+A P+
Sbjct: 192 DYYRKGGKGLL---PVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 247
Query: 225 KVLLMTLQ--------NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHF 276
+VL ++ N P L + EL+ C +PK RP+ ++
Sbjct: 248 QVLRFVMEGGLLDKPDNCPDML-F-----------ELMRMCWQYNPKMRPSFLEI--ISS 293
Query: 277 FKHARSNDFLARSIVDN 293
K F S +
Sbjct: 294 IKEEMEPGFREVSFYYS 310
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 62/291 (21%), Positives = 108/291 (37%), Gaps = 39/291 (13%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEI---VAIKVLDLEKCNNDLDGIRREVQTMR 67
+ +D L +GEG VY + VA+K + ++ + E M+
Sbjct: 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 68
Query: 68 VTNHPNVLRAH--CSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLK 125
+HP++++ W++M G H ++ + + + K
Sbjct: 69 NLDHPHIVKLIGII---EEEPTWIIMELYPYGELGHYLERNKNS-LKVLTLVLYSLQICK 124
Query: 126 ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-WM 184
A+ YL +HRD+ NIL+ S +KL DFG+S + D + S P WM
Sbjct: 125 AMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL---PIKWM 181
Query: 185 APEVMQQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ--------NA 234
+PE + + +D+W F + E+ G PF V+ + +
Sbjct: 182 SPESIN--FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLC 239
Query: 235 PPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH--HFFKHARSN 283
PP L Y L+T C DP RP +L+ ++ +
Sbjct: 240 PPVL-Y-----------TLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDI 278
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 69/307 (22%), Positives = 121/307 (39%), Gaps = 34/307 (11%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNE---IVAIKVLDLEKCNNDLDGIRREVQTMR 67
+DA + + + VG G V ++ VAIK L + E M
Sbjct: 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 68 VTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKAL 127
+HPN++R T + +V YM GS ++ + F + +LR +
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGM 160
Query: 128 VYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC---WM 184
YL G++HRD+ A NILI+SN K++DFG+ + D + + G W
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR---GGKIPIRWT 217
Query: 185 APEVMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ--------NAP 235
+PE + + +D+WS+GI E+ +G P+ + V+ + + P
Sbjct: 218 SPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 276
Query: 236 PGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK--HHFFKHARSNDFLARSIVDN 293
L Y +L+ C KD RP E+++ ++ S + +
Sbjct: 277 AAL-Y-----------QLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARP 324
Query: 294 LAPLGER 300
L ++
Sbjct: 325 SNLLLDQ 331
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 73/288 (25%), Positives = 111/288 (38%), Gaps = 42/288 (14%)
Query: 1 MDLVVEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNE---IVAIKVLDLEKCNNDLD 57
+ V + P + +G+G VY I + AIK L ++
Sbjct: 8 LAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVE 67
Query: 58 GIRREVQTMRVTNHPNVLR--AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPV 115
RE MR NHPNVL G V++PYM G L ++S P
Sbjct: 68 AFLREGLLMRGLNHPNVLALIGIMLPPEGLP-HVLLPYMCHGDLLQFIRSPQRN----PT 122
Query: 116 IATLLRETL---KALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA---GD 169
+ L+ L + + YL +HRD+ A N ++D + +K+ADFG++ + D
Sbjct: 123 VKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSV 182
Query: 170 RQRSRNTFVGTPC-WMAPEVMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVL 227
+Q P W A E +Q + + K+D+WSFG+ EL G P+ P +
Sbjct: 183 QQHRHARL---PVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT 238
Query: 228 LMTLQ--------NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPT 267
Q P L Y +++ C DP RPT
Sbjct: 239 HFLAQGRRLPQPEYCPDSL-Y-----------QVMQQCWEADPAVRPT 274
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 66/317 (20%), Positives = 123/317 (38%), Gaps = 45/317 (14%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNE---IVAIKVLDLEKCN-NDLDGIRREVQTM 66
+ + + L +G+G +V A + VA+K+L + +D++ RE M
Sbjct: 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACM 79
Query: 67 RVTNHPNVLR--AHCS----FTTGHCLWVVMPYMAGGSCLH-IMKSAYPEGFEEPVIATL 119
+ +HP+V + V++P+M G ++ S E + TL
Sbjct: 80 KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL 139
Query: 120 LRETL---KALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD--RQRSR 174
+R + + YL IHRD+ A N ++ + + +ADFG+S ++ GD RQ
Sbjct: 140 VRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYS-GDYYRQGCA 198
Query: 175 NTFVGTPC-WMAPEVMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ 232
+ P W+A E + + Y +D+W+FG+T E+ G P++ ++ +
Sbjct: 199 SKL---PVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254
Query: 233 --------NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH--HFFKHARS 282
+ Y +L+ C DPK+RP+ L + H
Sbjct: 255 GNRLKQPPECMEEV-Y-----------DLMYQCWSADPKQRPSFTCLRMELENILGHLSV 302
Query: 283 NDFLARSIVDNLAPLGE 299
+ N+
Sbjct: 303 LSTSQDPLYINIERAHH 319
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 64/276 (23%), Positives = 107/276 (38%), Gaps = 36/276 (13%)
Query: 10 PVDAKDYRLYEEVGEGVSATVYRALCIPLNEI---VAIKVLDLEKCNNDLDGIRREVQTM 66
+ E +G G VY + + A+K L+ ++ E M
Sbjct: 85 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 144
Query: 67 RVTNHPNVLRAH-CSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLL---RE 122
+ +HPNVL + VV+PYM G + +++ P + L+ +
Sbjct: 145 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGFGLQ 200
Query: 123 TLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGT-P 181
K + +L +HRD+ A N ++D +K+ADFG++ M+D + N P
Sbjct: 201 VAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD-KEFDSVHNKTGAKLP 259
Query: 182 C-WMAPEVMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ------- 232
WMA E +Q + K+D+WSFG+ EL G P+ + + LQ
Sbjct: 260 VKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 318
Query: 233 -NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPT 267
P L Y E++ C + RP+
Sbjct: 319 EYCPDPL-Y-----------EVMLKCWHPKAEMRPS 342
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 78/315 (24%), Positives = 122/315 (38%), Gaps = 67/315 (21%)
Query: 8 RFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN----NDLDGIR--R 61
+ + Y VG G +V A+ E VAIK K + +++ R R
Sbjct: 19 AWELPKT-YVSPTHVGSGAYGSVCSAIDKRSGEKVAIK-----KLSRPFQSEIFAKRAYR 72
Query: 62 EVQTMRVTNHPN------VLRAHCSFTTGHCLWVVMPYMAGGSCLH-IMKSAYPEGFEEP 114
E+ ++ H N V S + ++VMP+M + L IM F E
Sbjct: 73 ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM--QTDLQKIMGLK----FSEE 126
Query: 115 VIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSR 174
I L+ + LK L Y+H G +HRD+K GN+ ++ + +K+ DFG++ R
Sbjct: 127 KIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA----------RHA 176
Query: 175 NT----FVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPF--SKY------- 221
+ +V T + APEV+ Y+ DIWS G E+ G F Y
Sbjct: 177 DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 236
Query: 222 -----PPMKVLLMTLQNAPPGLDYERDKRFS--KSFKE-----------LVTACLVKDPK 263
P + L + Y + + K F + L+ L D
Sbjct: 237 LKVTGVPGTEFVQKLND-KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVD 295
Query: 264 KRPTAEKLMKHHFFK 278
KR TA + + H FF+
Sbjct: 296 KRLTAAQALTHPFFE 310
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 82/315 (26%), Positives = 126/315 (40%), Gaps = 66/315 (20%)
Query: 8 RFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN----NDLDGIR--R 61
+ V A YR + VG G V A+ VAIK K ++L R R
Sbjct: 20 AWEVRAV-YRDLQPVGSGAYGAVCSAVDGRTGAKVAIK-----KLYRPFQSELFAKRAYR 73
Query: 62 EVQTMRVTNHPN------VLRAHCSFTTGHCLWVVMPYMAGGSCLH-IMKSAYPEGFEEP 114
E++ ++ H N V + ++VMP+M G+ L +MK E E
Sbjct: 74 ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKH---EKLGED 128
Query: 115 VIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSR 174
I L+ + LK L Y+H G IHRD+K GN+ ++ + +K+ DFG++ R
Sbjct: 129 RIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA----------RQA 178
Query: 175 NTF----VGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPF--SKY------- 221
++ V T + APEV+ Y DIWS G E+ G F S +
Sbjct: 179 DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 238
Query: 222 -----PPMKVLLMTLQNAPPGLDYERDKRFS--KSFKE-----------LVTACLVKDPK 263
P + LQ+ +Y + K F L+ LV D +
Sbjct: 239 MKVTGTPPAEFVQRLQS-DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAE 297
Query: 264 KRPTAEKLMKHHFFK 278
+R TA + + H +F+
Sbjct: 298 QRVTAGEALAHPYFE 312
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 77/345 (22%), Positives = 137/345 (39%), Gaps = 47/345 (13%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNE----IVAIKVLDLEKCNNDLDGIRREVQTM 66
+ R + +G GV TV++ + IP E V IKV++ + + + +
Sbjct: 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAI 69
Query: 67 RVTNHPNVLRAH--CSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETL 124
+H +++R C G L +V Y+ GS L ++ ++ +
Sbjct: 70 GSLDHAHIVRLLGLC---PGSSLQLVTQYLPLGSLLDHVRQHRGA-LGPQLLLNWGVQIA 125
Query: 125 KALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGT--PC 182
K + YL HG +HR++ A N+L+ S +++ADFGV+ + D+Q + P
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL-PPDDKQLLYS---EAKTPI 181
Query: 183 -WMAPEVMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ-------- 232
WMA E + Y ++D+WS+G+T EL G P++ +V + +
Sbjct: 182 KWMALESI-HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQ 240
Query: 233 NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVD 292
+ Y ++ C + D RPT ++L + F +AR
Sbjct: 241 ICTIDV-Y-----------MVMVKCWMIDENIRPTFKEL--ANEF------TRMARDPPR 280
Query: 293 NLAPLGERFRMLKAKEADLLVQNKALYEDKEQLSQDYDCMSNAED 337
L E + + NK L E + + D D AE+
Sbjct: 281 YLVIKRESGPGIAPGPEPHGLTNKKLEEVELEPELDLDLDLEAEE 325
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 66/294 (22%), Positives = 112/294 (38%), Gaps = 34/294 (11%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEI---VAIKVL--DLEKCNNDLDGIRREVQT 65
+ KD RL E++G+G V R + VA+K L D+ +D REV
Sbjct: 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 66 MRVTNHPNVLRAH--CSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRET 123
M +H N++R + + +V GS L ++ F ++ +
Sbjct: 75 MHSLDHRNLIRLYGVV---LTPPMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQV 130
Query: 124 LKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGT--P 181
+ + YL IHRD+ A N+L+ + +K+ DFG+ + D + P
Sbjct: 131 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ---EHRKVP 187
Query: 182 C-WMAPEVMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQN-----A 234
W APE ++ + +D W FG+T E+ +G P+ ++L +
Sbjct: 188 FAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 246
Query: 235 PPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLAR 288
P + ++ C P+ RPT L F A+ D A
Sbjct: 247 PEDC--------PQDIYNVMVQCWAHKPEDRPTFVAL--RDFLLEAQPTDMRAE 290
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-28
Identities = 61/287 (21%), Positives = 111/287 (38%), Gaps = 42/287 (14%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN 70
++ K+ +L + +G+G V VA+K + K + E M
Sbjct: 190 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCI---KNDATAQAFLAEASVMTQLR 244
Query: 71 HPNVLR--AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALV 128
H N+++ L++V YMA GS + ++S + + +A+
Sbjct: 245 HSNLVQLLGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 303
Query: 129 YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC------ 182
YL + +HRD+ A N+L+ + K++DFG+ ++
Sbjct: 304 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL------------TKEASSTQDTGKLPVK 351
Query: 183 WMAPEVMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQN----APPG 237
W APE +++ + K+D+WSFGI E+ G P+ + P V+ + AP G
Sbjct: 352 WTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG 410
Query: 238 LDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH--HFFKHARS 282
+ +++ C D RPT +L + H H
Sbjct: 411 C--------PPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHELH 449
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 56/281 (19%), Positives = 110/281 (39%), Gaps = 25/281 (8%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNE----IVAIKVLDLEKCNNDLDGIRREVQTM 66
+ + + ++GEG V P + VA+K L E N + +++E++ +
Sbjct: 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEIL 77
Query: 67 RVTNHPNV--LRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETL 124
R H N+ + C+ G+ + ++M ++ GS + +
Sbjct: 78 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQIC 136
Query: 125 KALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGT--P- 181
K + YL ++HRD+ A N+L++S +K+ DFG++ + + ++ P
Sbjct: 137 KGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD---DRDSPV 193
Query: 182 CWMAPEVMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQNAPPGLD- 239
W APE + Q + +D+WSFG+T EL + + S ++
Sbjct: 194 FWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252
Query: 240 ---YERDKRFSK------SFKELVTACLVKDPKKRPTAEKL 271
+ KR +L+ C P R + + L
Sbjct: 253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNL 293
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 69/287 (24%), Positives = 118/287 (41%), Gaps = 35/287 (12%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNE----IVAIKVLDLEKCNNDLDGIRREVQTM 66
+ + ++GEG V P N+ +VA+K L + G ++E+ +
Sbjct: 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDIL 87
Query: 67 RVTNHPNV--LRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLL---R 121
R H ++ + C L +VM Y+ GS + +A LL +
Sbjct: 88 RTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR------HSIGLAQLLLFAQ 141
Query: 122 ETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD--RQRSRNTFVG 179
+ + + YLH +IHRD+ A N+L+D++ +K+ DFG++ + + + R R
Sbjct: 142 QICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS-- 199
Query: 180 TP-CWMAPEVMQQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQNAPP 236
P W APE + + + +D+WSFG+T EL H + S L+ Q
Sbjct: 200 -PVFWYAPECL--KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT 256
Query: 237 GLDY----ERDKRFSK------SFKELVTACLVKDPKKRPTAEKLMK 273
L ER +R + L+ C + RPT E L+
Sbjct: 257 VLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 69/289 (23%), Positives = 119/289 (41%), Gaps = 42/289 (14%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEI---VAIKVLDLEKCN-NDLDGIRREVQTM 66
+D L + +GEG +V + VA+K + L+ + +++ E M
Sbjct: 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACM 90
Query: 67 RVTNHPNVLR--AHCSFTTGHC---LWVVMPYMAGGSCLH-IMKSAYPEGFEEPVIATLL 120
+ +HPNV+R C + V++P+M G ++ S G + + TLL
Sbjct: 91 KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLL 150
Query: 121 RETL---KALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD--RQRSRN 175
+ + + YL +HRD+ A N ++ + + +ADFG+S ++ GD RQ
Sbjct: 151 KFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYS-GDYYRQGRIA 209
Query: 176 TFVGTPC-WMAPEVMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ- 232
P W+A E + Y K+D+W+FG+T E+A G P+ ++ L
Sbjct: 210 KM---PVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG 265
Query: 233 -------NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274
+ L Y E++ +C DP RPT L
Sbjct: 266 HRLKQPEDCLDEL-Y-----------EIMYSCWRTDPLDRPTFSVLRLQ 302
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 70/277 (25%), Positives = 114/277 (41%), Gaps = 37/277 (13%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEI---VAIKVLDLEKCNNDLDGIRREVQTMR 67
+ + L +GEG V++ + + VAIK ++ + +E TMR
Sbjct: 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 71
Query: 68 VTNHPNVLRAH--CSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLK 125
+HP++++ T + +W++M G ++ + + +
Sbjct: 72 QFDHPHIVKLIGVI---TENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLST 127
Query: 126 ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-WM 184
AL YL +HRD+ A N+L+ SN +KL DFG+S M D+ + S+ P WM
Sbjct: 128 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL---PIKWM 184
Query: 185 APEVMQQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKVL--------LMTLQNA 234
APE + + +D+W FG+ E+ HG PF V+ L N
Sbjct: 185 APESIN--FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 242
Query: 235 PPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKL 271
PP L Y L+T C DP +RP +L
Sbjct: 243 PPTL-Y-----------SLMTKCWAYDPSRRPRFTEL 267
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 61/293 (20%), Positives = 113/293 (38%), Gaps = 52/293 (17%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN 70
++ K+ +L + +G+G V VA+K + K + E M
Sbjct: 18 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCI---KNDATAQAFLAEASVMTQLR 72
Query: 71 HPNVLR--AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALV 128
H N+++ G L++V YMA GS + ++S + + +A+
Sbjct: 73 HSNLVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 131
Query: 129 YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC------ 182
YL + +HRD+ A N+L+ + K++DFG+ ++
Sbjct: 132 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL------------TKEASSTQDTGKLPVK 179
Query: 183 WMAPEVMQQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ-------- 232
W APE + + K+D+WSFGI E+ G P+ + P V+ +
Sbjct: 180 WTAPEAL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD 237
Query: 233 NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDF 285
PP + Y E++ C D RP+ +L +H ++++
Sbjct: 238 GCPPAV-Y-----------EVMKNCWHLDAAMRPSFLQL--REQLEHIKTHEL 276
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 60/273 (21%), Positives = 104/273 (38%), Gaps = 35/273 (12%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNE----IVAIKVLDLEKCNNDLDGIRREVQTM 66
+ +++ + +G G TVY+ L IP E VAIK L I E M
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 67 RVTNHPNVLR--AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETL 124
++P+V R C + ++ M G L ++ + + + +
Sbjct: 72 ASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIA 127
Query: 125 KALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-W 183
K + YL +HRD+ A N+L+ + +K+ DFG++ + + V P W
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKW 185
Query: 184 MAPEVMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVL--------LMTLQNA 234
MA E + Y ++D+WS+G+T EL G P+ P ++ L
Sbjct: 186 MALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC 244
Query: 235 PPGLDYERDKRFSKSFKELVTACLVKDPKKRPT 267
+ Y ++ C + D RP
Sbjct: 245 TIDV-Y-----------MIMVKCWMIDADSRPK 265
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-28
Identities = 59/284 (20%), Positives = 108/284 (38%), Gaps = 32/284 (11%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNE----IVAIKVLDLEKCNNDLDGIRREVQTM 66
+ + + ++G+G +V PL + +VA+K L + +RE+Q +
Sbjct: 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQREIQIL 78
Query: 67 RVTNHPNV--LRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETL 124
+ + + R L +VM Y+ G ++ + + +
Sbjct: 79 KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQIC 137
Query: 125 KALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-- 182
K + YL +HRD+ A NIL++S +K+ADFG++ + D R P
Sbjct: 138 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR-----EPGQS 192
Query: 183 ---WMAPEVMQQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQNAPPG 237
W APE + + ++D+WSFG+ EL + S ++ ++ P
Sbjct: 193 PIFWYAPESL--SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL 250
Query: 238 LDY----ERDKRFSK------SFKELVTACLVKDPKKRPTAEKL 271
E +R EL+ C P+ RP+ L
Sbjct: 251 SRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 294
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 8e-28
Identities = 70/284 (24%), Positives = 118/284 (41%), Gaps = 28/284 (9%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN 70
+ + RL ++G+G V+ VAIK L + + +E Q M+
Sbjct: 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTL--KPGTMSPEAFLQEAQVMKKLR 237
Query: 71 HPNVLRAH--CSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALV 128
H +++ + + +++V YM+ GS L +K + P + + + +
Sbjct: 238 HEKLVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 294
Query: 129 YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-WMAPE 187
Y+ ++HRD++A NIL+ N K+ADFG++ + D R F P W APE
Sbjct: 295 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF---PIKWTAPE 351
Query: 188 VMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQN----APPGLDYER 242
+ K+D+WSFGI EL G P+ +VL + PP
Sbjct: 352 AALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE----- 405
Query: 243 DKRFSKSFKELVTACLVKDPKKRPTAEKLMKH--HFFKHARSND 284
+S +L+ C K+P++RPT E L +F
Sbjct: 406 ---CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 446
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-28
Identities = 71/314 (22%), Positives = 121/314 (38%), Gaps = 64/314 (20%)
Query: 8 RFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN----NDLDGIR--R 61
+ V + Y+ VG G +V A VA+K K + + + R R
Sbjct: 24 IWEVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVK-----KLSRPFQSIIHAKRTYR 77
Query: 62 EVQTMRVTNHPN------VLRAHCSFTTGHCLWVVMPYMAGGSCLH-IMKSAYPEGFEEP 114
E++ ++ H N V S + +++V M G+ L+ I+K + +
Sbjct: 78 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKC---QKLTDD 132
Query: 115 VIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSR 174
+ L+ + L+ L Y+H IHRD+K N+ ++ + +K+ DFG++ R
Sbjct: 133 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA----------RHT 182
Query: 175 NTF----VGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPF--SKYPPMKVLL 228
V T + APE+M Y+ DIWS G EL G F + + L+
Sbjct: 183 ADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 242
Query: 229 MTLQNAPP-----GLDYERDKRF--------SKSFKE-----------LVTACLVKDPKK 264
+ L P + E + + +F L+ LV D K
Sbjct: 243 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 302
Query: 265 RPTAEKLMKHHFFK 278
R TA + + H +F
Sbjct: 303 RITAAQALAHAYFA 316
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 66/297 (22%), Positives = 117/297 (39%), Gaps = 39/297 (13%)
Query: 6 EKRFPVDAKDYRLYE-EVGEGVSATVYRALCIPLNEI--VAIKVLDLEKCNNDLDGIRRE 62
+K+ + + + + E+G G +V + + + VAIKVL D + + RE
Sbjct: 1 DKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMRE 60
Query: 63 VQTMRVTNHPNVLRAH--CSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLL 120
Q M ++P ++R C L +VM GG + E +A LL
Sbjct: 61 AQIMHQLDNPYIVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELL 116
Query: 121 RETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGT 180
+ + YL +HRD+ A N+L+ + K++DFG+S + +R
Sbjct: 117 HQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR---SAG 173
Query: 181 --PC-WMAPEVMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVL--------L 228
P W APE + + ++D+WS+G+T E +G P+ K +V+ +
Sbjct: 174 KWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM 232
Query: 229 MTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH--HFFKHARSN 283
PP L Y L++ C + + RP + + + S
Sbjct: 233 ECPPECPPEL-Y-----------ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 63/306 (20%), Positives = 115/306 (37%), Gaps = 53/306 (17%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPL----NEIVAIKVLDLEKCNNDLDGIRREVQTM 66
+ + + +++G+G +V PL E+VA+K L L RE++ +
Sbjct: 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEIL 65
Query: 67 RVTNHPNV--LRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETL 124
+ H N+ + C L ++M Y+ GS ++ + E + + +
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQIC 124
Query: 125 KALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGT--P- 181
K + YL +IHRD+ NIL+++ +K+ DFG++ + + + + P
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE---PGESPI 181
Query: 182 CWMAPEVMQQLHG-YDFKADIWSFGITALEL----------------AHGHAPFSKYPPM 224
W APE + + +D+WSFG+ EL G+ M
Sbjct: 182 FWYAPESL--TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK---QGQM 236
Query: 225 KV--LLMTLQN-----APPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277
V L+ L+N P G ++T C + +RP+ L
Sbjct: 237 IVFHLIELLKNNGRLPRPDGC--------PDEIYMIMTECWNNNVNQRPSFRDL--ALRV 286
Query: 278 KHARSN 283
R N
Sbjct: 287 DQIRDN 292
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 73/326 (22%), Positives = 119/326 (36%), Gaps = 77/326 (23%)
Query: 8 RFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN----NDLDGIR--R 61
F V + Y+ + +G G V A L VAIK K + N R R
Sbjct: 20 TFTVLKR-YQNLKPIGSGAQGIVCAAYDAILERNVAIK-----KLSRPFQNQTHAKRAYR 73
Query: 62 EVQTMRVTNHPN------VLRAHCSFTTGHCLWVVMPYMAGGSCLH-IMKSAYPEGFEEP 114
E+ M+ NH N V S +++VM M + L +++ +
Sbjct: 74 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM--DANLCQVIQM----ELDHE 127
Query: 115 VIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSR 174
++ LL + L + +LH G IHRD+K NI++ S+ +K+ DFG++ R
Sbjct: 128 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------RTAGT 179
Query: 175 NTF----VGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPF------------ 218
+ V T + APEV+ + Y DIWS G E+ G F
Sbjct: 180 SFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 238
Query: 219 --------------------------SKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKE 252
KY + D E +K + ++
Sbjct: 239 IEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYS-FEKLFPDVLFPADSEHNKLKASQARD 297
Query: 253 LVTACLVKDPKKRPTAEKLMKHHFFK 278
L++ LV D KR + ++ ++H +
Sbjct: 298 LLSKMLVIDASKRISVDEALQHPYIN 323
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 57/272 (20%), Positives = 108/272 (39%), Gaps = 32/272 (11%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN 70
+D + +E+G G V+ + ++ VAIK + + + E + M +
Sbjct: 5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTI--REGAMSEEDFIEEAEVMMKLS 61
Query: 71 HPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYL 130
HP +++ + + +V +M G +++ F + + + + + YL
Sbjct: 62 HPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAYL 120
Query: 131 HFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-WMAPEVM 189
IHRD+ A N L+ N IK++DFG++ + D + F P W +PEV
Sbjct: 121 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF---PVKWASPEVF 177
Query: 190 QQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ--------NAPPGLD 239
Y K+D+WSFG+ E+ G P+ +V+ A +
Sbjct: 178 --SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHV- 234
Query: 240 YERDKRFSKSFKELVTACLVKDPKKRPTAEKL 271
Y +++ C + P+ RP +L
Sbjct: 235 Y-----------QIMNHCWRERPEDRPAFSRL 255
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 80/317 (25%), Positives = 128/317 (40%), Gaps = 60/317 (18%)
Query: 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN---NDLDGIR--REV 63
+ + + ++L +GEG V A P EIVAIK K L +R RE+
Sbjct: 7 YNISSD-FQLKSLLGEGAYGVVCSATHKPTGEIVAIK-----KIEPFDKPLFALRTLREI 60
Query: 64 QTMRVTNHPNVLRAHCSFTTGHC-----LWVVMPYMAGGSCLH-IMKSAYPEGFEEPVIA 117
+ ++ H N++ ++++ M + LH ++ + + + I
Sbjct: 61 KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVIST---QMLSDDHIQ 115
Query: 118 TLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNT- 176
+ +TL+A+ LH IHRD+K N+LI+SN +K+ DFG+ A + D S T
Sbjct: 116 YFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGL-ARIIDESAADNSEPTG 174
Query: 177 -------FVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPF--SKY------ 221
FV T + APEVM Y D+WS G EL F Y
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234
Query: 222 -------PPMKVLLMTLQNAPPGLDY-----ERDKR-FSKSFK-------ELVTACLVKD 261
P L +++ P +Y K F +L+ LV D
Sbjct: 235 IFGIIGTPHSDNDLRCIES-PRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFD 293
Query: 262 PKKRPTAEKLMKHHFFK 278
P KR TA++ ++H + +
Sbjct: 294 PAKRITAKEALEHPYLQ 310
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 68/309 (22%), Positives = 120/309 (38%), Gaps = 50/309 (16%)
Query: 8 RFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN---NDLDGIR--RE 62
F V + Y +GEG V A VAIK K + + R RE
Sbjct: 22 VFDVGPR-YTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-----KISPFEHQTYCQRTLRE 75
Query: 63 VQTMRVTNHPNVLRAH-----CSFTTGHCLWVVMPYMAGGSCLH-IMKSAYPEGFEEPVI 116
++ + H N++ + + +++V M + L+ ++K+ + I
Sbjct: 76 IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKT---QHLSNDHI 130
Query: 117 ATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNT 176
L + L+ L Y+H +HRD+K N+L+++ +K+ DFG++ D
Sbjct: 131 CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190
Query: 177 FVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPF--SKY------------P 222
+V T + APE+M GY DIWS G E+ F Y
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 250
Query: 223 PMKVLLMTLQNAPPGLDY-----ERDKR-FSKSFK-------ELVTACLVKDPKKRPTAE 269
P + L + N +Y ++K +++ F +L+ L +P KR E
Sbjct: 251 PSQEDLNCIIN-LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 309
Query: 270 KLMKHHFFK 278
+ + H + +
Sbjct: 310 QALAHPYLE 318
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 58/280 (20%), Positives = 115/280 (41%), Gaps = 31/280 (11%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPL----NEIVAIKVLDLEKCNNDLDGIRREVQTM 66
+ + + +++G+G +V PL E+VA+K L L RE++ +
Sbjct: 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEIL 96
Query: 67 RVTNHPNV--LRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETL 124
+ H N+ + C L ++M Y+ GS ++ + E + + +
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQIC 155
Query: 125 KALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGT--P- 181
K + YL +IHRD+ NIL+++ +K+ DFG++ + + + + P
Sbjct: 156 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKE---PGESPI 212
Query: 182 CWMAPEVMQQLHG-YDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD- 239
W APE + + +D+WSFG+ EL + SK PP + + M + +
Sbjct: 213 FWYAPESL--TESKFSVASDVWSFGVVLYELF-TYIEKSKSPPAEFMRMIGNDKQGQMIV 269
Query: 240 ------YERDKRFSK------SFKELVTACLVKDPKKRPT 267
+ + R + ++T C + +RP+
Sbjct: 270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPS 309
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-27
Identities = 69/276 (25%), Positives = 113/276 (40%), Gaps = 35/276 (12%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEI---VAIKVLDLEKCNNDLDGIRREVQTMR 67
+ + L +GEG V++ + + VAIK ++ + +E TMR
Sbjct: 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMR 446
Query: 68 VTNHPNVLRAH--CSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLK 125
+HP++++ T + +W++M G ++ + + +
Sbjct: 447 QFDHPHIVKLIGVI---TENPVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLST 502
Query: 126 ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-WM 184
AL YL +HRD+ A N+L+ SN +KL DFG+S M D+ + S+ P WM
Sbjct: 503 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL---PIKWM 559
Query: 185 APEVMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ--------NAP 235
APE + + +D+W FG+ E+ HG PF V+ N P
Sbjct: 560 APESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP 618
Query: 236 PGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKL 271
P L Y L+T C DP +RP +L
Sbjct: 619 PTL-Y-----------SLMTKCWAYDPSRRPRFTEL 642
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 8e-27
Identities = 70/284 (24%), Positives = 118/284 (41%), Gaps = 28/284 (9%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN 70
+ + RL ++G+G V+ VAIK L + + +E Q M+
Sbjct: 264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTL--KPGTMSPEAFLQEAQVMKKLR 320
Query: 71 HPNVLRAH--CSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALV 128
H +++ + + +++V YM+ GS L +K + P + + + +
Sbjct: 321 HEKLVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 377
Query: 129 YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-WMAPE 187
Y+ ++HRD++A NIL+ N K+ADFG++ + D R F P W APE
Sbjct: 378 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF---PIKWTAPE 434
Query: 188 VMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQN----APPGLDYER 242
+ K+D+WSFGI EL G P+ +VL + PP
Sbjct: 435 AALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE----- 488
Query: 243 DKRFSKSFKELVTACLVKDPKKRPTAEKLMKH--HFFKHARSND 284
+S +L+ C K+P++RPT E L +F
Sbjct: 489 ---CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 529
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 66/273 (24%), Positives = 126/273 (46%), Gaps = 34/273 (12%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEI-VAIKVLDLEKCNNDLDGIRREVQTMRVT 69
+ ++ L +E+G G V + VA+K++ ++ + D +E QTM
Sbjct: 5 LKREEITLLKELGSGQFGVVKLGKW--KGQYDVAVKMI--KEGSMSEDEFFQEAQTMMKL 60
Query: 70 NHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVY 129
+HP +++ + + + +++V Y++ G L+ ++S E + + + + + +
Sbjct: 61 SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAF 119
Query: 130 LHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-WMAPEV 188
L H IHRD+ A N L+D + +K++DFG++ + D F P W APEV
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKF---PVKWSAPEV 176
Query: 189 MQQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ--------NAPPGL 238
+ Y K+D+W+FGI E+ G P+ Y +V+L Q A +
Sbjct: 177 F--HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTI 234
Query: 239 DYERDKRFSKSFKELVTACLVKDPKKRPTAEKL 271
Y +++ +C + P+KRPT ++L
Sbjct: 235 -Y-----------QIMYSCWHELPEKRPTFQQL 255
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 56/300 (18%), Positives = 105/300 (35%), Gaps = 43/300 (14%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEI-------VAIKVLDLEKCNNDLDGIRREV 63
+ +D E +G+G +++ + + + V +KVLD + N +
Sbjct: 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD-KAHRNYSESFFEAA 63
Query: 64 QTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRET 123
M +H +++ + G +V ++ GS +K + ++
Sbjct: 64 SMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC-INILWKLEVAKQL 122
Query: 124 LKALVYLHFHGHIHRDVKAGNILIDS--------NGAIKLADFGVSACMFDAGD-RQRSR 174
A+ +L + IH +V A NIL+ IKL+D G+S + ++R
Sbjct: 123 AAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP 182
Query: 175 NTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQN 233
W+ PE ++ + D WSFG T E+ G P S + L
Sbjct: 183 --------WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF---- 230
Query: 234 APPGLDYERDKRFSK----SFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARS 289
YE + L+ C+ +P RP+ + + D + R
Sbjct: 231 ------YEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAI--IRDLNSLFTPDLVPRG 282
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 68/287 (23%), Positives = 117/287 (40%), Gaps = 36/287 (12%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN 70
V + +L E +G G V+ + VA+K L ++ + D E M+
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSL--KQGSMSPDAFLAEANLMKQLQ 66
Query: 71 HPNVLR--AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALV 128
H ++R A T ++++ YM GS + +K+ + + + + +
Sbjct: 67 HQRLVRLYAVV---TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 129 YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-WMAPE 187
++ +IHRD++A NIL+ + K+ADFG++ + D R F P W APE
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF---PIKWTAPE 180
Query: 188 VMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ--------NAPPGL 238
+ + K+D+WSFGI E+ HG P+ +V+ + N P L
Sbjct: 181 AINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL 239
Query: 239 DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH--HFFKHARSN 283
Y +L+ C + P+ RPT + L FF
Sbjct: 240 -Y-----------QLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 59/289 (20%), Positives = 110/289 (38%), Gaps = 41/289 (14%)
Query: 4 VVEKRFPVDAKDYRLYEEV-GEGVSATVYRALCIPLNEI--VAIKVLDLEKCN-NDLDGI 59
+ K +D K L ++ G G TV + + VA+K+L E + D +
Sbjct: 6 IRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDEL 65
Query: 60 RREVQTMRVTNHPNVLRAH--CSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIA 117
E M+ ++P ++R C +VM G ++ ++ I
Sbjct: 66 LAEANVMQQLDNPYIVRMIGIC---EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNII 120
Query: 118 TLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTF 177
L+ + + YL +HRD+ A N+L+ + K++DFG+S + + +++
Sbjct: 121 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ--- 177
Query: 178 VGT--PC-WMAPEVMQQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKVL----- 227
P W APE + + + K+D+WSFG+ E +G P+ +V
Sbjct: 178 THGKWPVKWYAPECIN--YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 235
Query: 228 ---LMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273
+ P + Y +L+ C D + RP +
Sbjct: 236 GERMGCPAGCPREM-Y-----------DLMNLCWTYDVENRPGFAAVEL 272
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-26
Identities = 66/285 (23%), Positives = 116/285 (40%), Gaps = 37/285 (12%)
Query: 4 VVEKRFPVDAKDYRLYE-EVGEGVSATVYRALCIPLNEI--VAIKVLDLEKCNNDLDGIR 60
+ +K+ + + + + E+G G +V + + + VAIKVL D + +
Sbjct: 325 LKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM 384
Query: 61 REVQTMRVTNHPNVLRAH--CSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIAT 118
RE Q M ++P ++R C L +VM GG + E +A
Sbjct: 385 REAQIMHQLDNPYIVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAE 440
Query: 119 LLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD--RQRSRNT 176
LL + + YL +HR++ A N+L+ + K++DFG+S + RS
Sbjct: 441 LLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 500
Query: 177 FVGTPC-WMAPEVMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ-- 232
+ P W APE + + ++D+WS+G+T E +G P+ K +V+ Q
Sbjct: 501 W---PLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK 556
Query: 233 ------NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKL 271
PP L Y L++ C + + RP +
Sbjct: 557 RMECPPECPPEL-Y-----------ALMSDCWIYKWEDRPDFLTV 589
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 60/314 (19%), Positives = 120/314 (38%), Gaps = 54/314 (17%)
Query: 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR--REVQTM 66
F + ++ Y + +G G + V+ A+ ++ VAIK + L + RE++ +
Sbjct: 7 FDLGSR-YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKII 62
Query: 67 RVTNHPNVLR--------------AHCSFTTGHCLWVVMPYMAGGSCLH-IMKSAYPEGF 111
R +H N+++ S T + +++V YM + L +++
Sbjct: 63 RRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQ---GPL 117
Query: 112 EEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS-NGAIKLADFGVSACMFDAGDR 170
E + + L+ L Y+H +HRD+K N+ I++ + +K+ DFG++ M
Sbjct: 118 LEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177
Query: 171 QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFG-ITALELAHGHAPF--SKY------ 221
+ + + T + +P ++ + Y D+W+ G I A E+ G F +
Sbjct: 178 KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFA-EMLTGKTLFAGAHELEQMQL 236
Query: 222 -------PPMKVLLMTLQNAP---PGLDYERDKRFSKSFKE-------LVTACLVKDPKK 264
+ L P E K ++ + L P
Sbjct: 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMD 296
Query: 265 RPTAEKLMKHHFFK 278
R TAE+ + H +
Sbjct: 297 RLTAEEALSHPYMS 310
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-26
Identities = 73/329 (22%), Positives = 123/329 (37%), Gaps = 75/329 (22%)
Query: 4 VVEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN----NDLDGI 59
V + F V + Y+ + +G G V A L+ VAIK K + N
Sbjct: 53 VGDSTFTVLKR-YQNLKPIGSGAQGIVCAAYDAVLDRNVAIK-----KLSRPFQNQTHAK 106
Query: 60 R--REVQTMRVTNHPN------VLRAHCSFTTGHCLWVVMPYMAGGSCLH-IMKSAYPEG 110
R RE+ M+ NH N V + +++VM M + L +++
Sbjct: 107 RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQM----E 160
Query: 111 FEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR 170
+ ++ LL + L + +LH G IHRD+K NI++ S+ +K+ DFG++ R
Sbjct: 161 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------R 212
Query: 171 QRSRNTF----VGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPF-------- 218
+ V T + APEV+ + Y DIWS G E+ F
Sbjct: 213 TAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 271
Query: 219 ---------------------------SKYPPM-KVLLMTL-QNAPPGLDYERDKRFSKS 249
P + L ++ D E +K +
Sbjct: 272 WNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ 331
Query: 250 FKELVTACLVKDPKKRPTAEKLMKHHFFK 278
++L++ LV DP KR + + ++H +
Sbjct: 332 ARDLLSKMLVIDPAKRISVDDALQHPYIN 360
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-26
Identities = 60/269 (22%), Positives = 117/269 (43%), Gaps = 26/269 (9%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN 70
+ + +L +++G G V+ A + VA+K + + + ++ E M+
Sbjct: 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTM--KPGSMSVEAFLAEANVMKTLQ 241
Query: 71 HPNVLRAH--CSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALV 128
H +++ H T ++++ +MA GS L +KS P + + + +
Sbjct: 242 HDKLVKLHAVV---TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 298
Query: 129 YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-WMAPE 187
++ +IHRD++A NIL+ ++ K+ADFG++ + D R F P W APE
Sbjct: 299 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF---PIKWTAPE 355
Query: 188 VMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQN----APPGLDYER 242
+ + K+D+WSFGI +E+ +G P+ +V+ + P
Sbjct: 356 AINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENC---- 410
Query: 243 DKRFSKSFKELVTACLVKDPKKRPTAEKL 271
+ ++ C P++RPT E +
Sbjct: 411 ----PEELYNIMMRCWKNRPEERPTFEYI 435
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 8e-26
Identities = 62/273 (22%), Positives = 118/273 (43%), Gaps = 34/273 (12%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-DLDGIRREVQTMRVT 69
+D KD +E+G G V + VAIK++ K + D E + M
Sbjct: 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMI---KEGSMSEDEFIEEAKVMMNL 76
Query: 70 NHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVY 129
+H +++ + T ++++ YMA G L+ ++ F+ + + ++ +A+ Y
Sbjct: 77 SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEY 135
Query: 130 LHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC-WMAPEV 188
L +HRD+ A N L++ G +K++DFG+S + D + F P W PEV
Sbjct: 136 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF---PVRWSPPEV 192
Query: 189 MQQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQ--------NAPPGL 238
+ ++ + K+DIW+FG+ E+ G P+ ++ + Q A +
Sbjct: 193 L--MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKV 250
Query: 239 DYERDKRFSKSFKELVTACLVKDPKKRPTAEKL 271
Y ++ +C + +RPT + L
Sbjct: 251 -Y-----------TIMYSCWHEKADERPTFKIL 271
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 67/320 (20%), Positives = 108/320 (33%), Gaps = 63/320 (19%)
Query: 17 RLYEEVGEGVSATVYRALCIPL--NEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNV 74
+VG G VY+A ++ A+K ++ + R E+ +R HPNV
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACR-EIALLRELKHPNV 80
Query: 75 LRAH--CSFTTGHCLWVVMPYMAG------GSCLHIMKSAYPEGFEEPVIATLLRETLKA 126
+ +W++ Y + P ++ +LL + L
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140
Query: 127 LVYLHFHGHIHRDVKAGNILIDS----NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC 182
+ YLH + +HRD+K NIL+ G +K+AD G A +F++ + + V
Sbjct: 141 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF-ARLFNSPLKPLADLDPVVVTF 199
Query: 183 WM-APEVMQQLHGYDFKADIWSFG-ITALELAHGHAPF---------------------- 218
W APE++ Y DIW+ G I A EL F
Sbjct: 200 WYRAPELLLGARHYTKAIDIWAIGCIFA-ELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 258
Query: 219 --------------SKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK------ELVTACL 258
K P L+ + K L+ L
Sbjct: 259 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLL 318
Query: 259 VKDPKKRPTAEKLMKHHFFK 278
DP KR T+E+ M+ +F
Sbjct: 319 TMDPIKRITSEQAMQDPYFL 338
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 67/297 (22%), Positives = 118/297 (39%), Gaps = 54/297 (18%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNE-----IVAIKVLDLEKCNNDLDGIRREVQT 65
+ +D L E+GEG V+ A C L +VA+K L E + +RE +
Sbjct: 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQREAEL 96
Query: 66 MRVTNHPNVLR--AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRE- 122
+ + H +++R C T G L +V YM G ++S P+ +
Sbjct: 97 LTMLQHQHIVRFFGVC--TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154
Query: 123 -TLKALV-----------YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD- 169
L L+ YL +HRD+ N L+ +K+ DFG+S ++ D
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST-DY 213
Query: 170 -RQRSRNTFVGTP-CWMAPEVMQQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMK 225
R R P WM PE + L+ + ++D+WSFG+ E+ +G P+ + +
Sbjct: 214 YRVGGRTML---PIRWMPPESI--LYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 268
Query: 226 VLLMTLQ--------NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274
+ Q PP + Y ++ C ++P++R + + +
Sbjct: 269 AIDCITQGRELERPRACPPEV-Y-----------AIMRGCWQREPQQRHSIKDVHAR 313
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 66/338 (19%), Positives = 119/338 (35%), Gaps = 83/338 (24%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNND-LDGIRREVQTMRV------ 68
Y L ++G G +TV+ A + N VA+K++ + + + E++ ++
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV---RGDKVYTEAAEDEIKLLQRVNDADN 77
Query: 69 -----TNHPNVLRAHCSFT-----TGH-CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIA 117
++L+ F H + V + G + L ++K G +
Sbjct: 78 TKEDSMGANHILKLLDHFNHKGPNGVHVVM--VFEVL-GENLLALIKKYEHRGIPLIYVK 134
Query: 118 TLLRETLKALVYLHFHGH-IHRDVKAGNILID------SNGAIKLADFGVSACMFDAGDR 170
+ ++ L L Y+H IH D+K N+L++ + IK+AD G +AC +D
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG-NACWYD---- 189
Query: 171 QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFS----------- 219
+ T + +PEV+ + ADIWS EL G F
Sbjct: 190 -EHYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247
Query: 220 ----------KYPPMKVL-----------------------LMTLQNAPPGLDYERDKRF 246
P +L L++ Y+ K
Sbjct: 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEK-YKFSKDE 306
Query: 247 SKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSND 284
+K + ++ L DP+KR A L+ H + K +
Sbjct: 307 AKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGME 344
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 63/323 (19%), Positives = 120/323 (37%), Gaps = 62/323 (19%)
Query: 4 VVEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--------ND 55
++ + + + Y + + G V + VAIK + + +
Sbjct: 13 LIAELHAMQSP-YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDS 70
Query: 56 LDGIR--REVQTMRVTNHPNVLRAHCSFTTGHC-----LWVVMPYMAGGSCLH-IMKSAY 107
R RE++ + +HPN+L F L++V M + L ++
Sbjct: 71 FLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM--RTDLAQVIHDQR 128
Query: 108 PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167
I + L L LH G +HRD+ GNIL+ N I + DF ++
Sbjct: 129 IV-ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA------ 181
Query: 168 GDRQRSRNTF----VGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPF--SKY 221
R+ + + V + APE++ Q G+ D+WS G E+ + A F S +
Sbjct: 182 --REDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF 239
Query: 222 ------------PPMKVLLMTLQNAPPGLDYERD---KRFSKSFKE-----------LVT 255
P ++ + P DY R+ ++++ L+
Sbjct: 240 YNQLNKIVEVVGTPKIEDVVMFSS-PSARDYLRNSLSNVPARAWTAVVPTADPVALDLIA 298
Query: 256 ACLVKDPKKRPTAEKLMKHHFFK 278
L +P++R + E+ ++H +F+
Sbjct: 299 KMLEFNPQRRISTEQALRHPYFE 321
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 65/284 (22%), Positives = 114/284 (40%), Gaps = 34/284 (11%)
Query: 17 RLYEEVGEGVSATVYRALCIPLNE-----IVAIKVLDLEKCNNDLDGIRREVQTM-RVTN 70
+ +G G V A L + VA+K+L + + + E++ + + N
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 71 HPNVLR--AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRE-----T 123
H N++ C T G V+ Y G L+ ++ ++ +
Sbjct: 86 HMNIVNLLGAC--TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 124 LKALV-----------YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172
L+ L+ +L IHRD+ A NIL+ K+ DFG++ + + +
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 173 SRNTFVGTPC-WMAPEVMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMT 230
N + P WMAPE + Y F++D+WS+GI EL G +P YP M V
Sbjct: 204 KGNARL--PVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSP---YPGMPVDSKF 257
Query: 231 LQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274
+ G + +++ C DP KRPT +++++
Sbjct: 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 64/296 (21%), Positives = 105/296 (35%), Gaps = 56/296 (18%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNE-----IVAIKVLDLEKCNNDLDGIRREVQT 65
V K+ L +G G VY + VA+K L D E
Sbjct: 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 86
Query: 66 MRVTNHPNVLR--AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRET 123
+ NH N++R +++M MAGG ++ P + +
Sbjct: 87 ISKFNHQNIVRCIGVS--LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSL------A 138
Query: 124 LKALV-----------YLHFHGHIHRDVKAGNILIDSNGA---IKLADFGVSACMFDAGD 169
+ L+ YL + IHRD+ A N L+ G K+ DFG++ ++ A
Sbjct: 139 MLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 198
Query: 170 RQRSRNTFVGTP-CWMAPEVMQQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKV 226
++ + P WM PE + G + K D WSFG+ E+ G+ P+ +V
Sbjct: 199 YRKGGCAML--PVKWMPPEAF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 254
Query: 227 LLMTLQ--------NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274
L N P + Y ++T C P+ RP +++
Sbjct: 255 LEFVTSGGRMDPPKNCPGPV-Y-----------RIMTQCWQHQPEDRPNFAIILER 298
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 5e-25
Identities = 69/276 (25%), Positives = 114/276 (41%), Gaps = 51/276 (18%)
Query: 22 VGEGVSATVYRALCIPLNE-IVAIKVLDLEKCNNDLDGIR---REVQTMRVTNHPNV--L 75
+GEG VY+ +N VA+K L + + +E++ M H N+ L
Sbjct: 39 MGEGGFGVVYKGY---VNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 76 RAHCSFTTGHCLWVVMPYMAGGS---CLHIMKSAYP----------EGFEEPVIATLLRE 122
+ G L +V YM GS L + P +G A
Sbjct: 96 LGFS--SDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQG-----AA----- 143
Query: 123 TLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC 182
+ +LH + HIHRD+K+ NIL+D K++DFG+ A + + + VGT
Sbjct: 144 --NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGL-ARASEKFAQTVMTSRIVGTTA 200
Query: 183 WMAPEVMQQLHGY-DFKADIWSFGITALELAHGHAPFSKYPPMKVLL---MTLQNAPPGL 238
+MAPE + G K+DI+SFG+ LE+ G ++ ++LL +++ +
Sbjct: 201 YMAPEAL---RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTI 257
Query: 239 DYERDKRFSK-SFKELVTA------CLVKDPKKRPT 267
+ DK+ + + CL + KRP
Sbjct: 258 EDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPD 293
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 61/295 (20%), Positives = 118/295 (40%), Gaps = 55/295 (18%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNE-----IVAIKVLDLEKCNNDLDGIRREVQT 65
+ +D L E+GEG V+ A C L+ +VA+K L + +RE +
Sbjct: 12 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQREAEL 70
Query: 66 MRVTNHPNVLR--AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRE- 122
+ H ++++ C G L +V YM G +++ P+ +
Sbjct: 71 LTNLQHEHIVKFYGVC--GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128
Query: 123 --TLKALV-----------YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD 169
L ++ YL +HRD+ N L+ +N +K+ DFG+S ++ D
Sbjct: 129 ELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS-TD 187
Query: 170 --RQRSRNTFVGTP-CWMAPEVMQQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPM 224
R P WM PE + ++ + ++D+WSFG+ E+ +G P+ +
Sbjct: 188 YYRVGGHTML---PIRWMPPESI--MYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 242
Query: 225 KVLLMTLQ--------NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKL 271
+V+ Q P + Y +++ C ++P++R +++
Sbjct: 243 EVIECITQGRVLERPRVCPKEV-Y-----------DVMLGCWQREPQQRLNIKEI 285
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-25
Identities = 64/296 (21%), Positives = 106/296 (35%), Gaps = 56/296 (18%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNE-----IVAIKVLDLEKCNNDLDGIRREVQT 65
V K+ L +G G VY + VA+K L D E
Sbjct: 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 127
Query: 66 MRVTNHPNVLR--AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRET 123
+ NH N++R ++++ MAGG ++ P + +
Sbjct: 128 ISKFNHQNIVRCIGVS--LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL------A 179
Query: 124 LKALV-----------YLHFHGHIHRDVKAGNILIDSNG---AIKLADFGVSACMFDAGD 169
+ L+ YL + IHRD+ A N L+ G K+ DFG++ ++ AG
Sbjct: 180 MLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY 239
Query: 170 RQRSRNTFVGTP-CWMAPEVMQQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKV 226
++ + P WM PE + G + K D WSFG+ E+ G+ P+ +V
Sbjct: 240 YRKGGCAML--PVKWMPPEAF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 295
Query: 227 LLMTLQ--------NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274
L N P + Y ++T C P+ RP +++
Sbjct: 296 LEFVTSGGRMDPPKNCPGPV-Y-----------RIMTQCWQHQPEDRPNFAIILER 339
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 49/236 (20%), Positives = 83/236 (35%), Gaps = 46/236 (19%)
Query: 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN----DLDGIR- 60
+ + + Y + +G G V A +VAIK K +D R
Sbjct: 46 HSDWQIPDR-YEIRHLIGTGSYGHVCEAYDKLEKRVVAIK-----KILRVFEDLIDCKRI 99
Query: 61 -REVQTMRVTNHPNVLRAH-----CSFTTGHCLWVVMPYMAGGSCLH-IMKSAYPEGFEE 113
RE+ + NH +V++ L+VV+ S + ++ P E
Sbjct: 100 LREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLFRT--PVYLTE 155
Query: 114 PVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS 173
I TLL L + Y+H G +HRD+K N L++ + ++K+ DFG++ + +
Sbjct: 156 LHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215
Query: 174 RNTFVGTPCWM------------------------APEVMQQLHGYDFKADIWSFG 205
APE++ Y D+WS G
Sbjct: 216 LPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG 271
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 67/291 (23%), Positives = 122/291 (41%), Gaps = 55/291 (18%)
Query: 17 RLYEEVGEGVSATVYRALCIPLNE-----IVAIKVLDLEKCNNDLDGIRREVQTM-RVTN 70
+L + +G G V A +++ VA+K+L +++ + E++ + + +
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 71 HPNVLR--AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRE---TLK 125
H NV+ C+ G L V++ + G+ ++S E V L + TL+
Sbjct: 90 HLNVVNLLGACT-KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 126 ALV-----------YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSR 174
L+ +L IHRD+ A NIL+ +K+ DFG++ ++ D R
Sbjct: 149 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 175 NTFVGTP-CWMAPEVMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKV---LLM 229
+ + P WMAPE + Y ++D+WSFG+ E+ G +P YP +K+
Sbjct: 209 DARL--PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASP---YPGVKIDEEFCR 262
Query: 230 TLQ---------NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKL 271
L+ P + Y + + C +P +RPT +L
Sbjct: 263 RLKEGTRMRAPDYTTPEM-Y-----------QTMLDCWHGEPSQRPTFSEL 301
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 66/357 (18%), Positives = 109/357 (30%), Gaps = 97/357 (27%)
Query: 8 RFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN----DLDGIR--R 61
V Y + +G G VY A + VAIK K N +D R R
Sbjct: 21 NVHVPDN-YIIKHLIGRGSYGYVYLAYDKNTEKNVAIK-----KVNRMFEDLIDCKRILR 74
Query: 62 EVQTMRVTNHPNVLRAH-----CSFTTGHCLWVVMPYMAGGSCLH-IMKSAYPEGFEEPV 115
E+ + ++R + L++V+ S L + K+ P E
Sbjct: 75 EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLFKT--PIFLTEEH 130
Query: 116 IATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRN 175
I T+L L ++H G IHRD+K N L++ + ++K+ DFG++ + D +
Sbjct: 131 IKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 176 TFVGTPCWM-------------------APEVMQQLHGYDFKADIWSFG-ITALELAHGH 215
APE++ Y DIWS G I A EL +
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFA-ELLNML 249
Query: 216 APFSKYPP-----------MKVLLMTLQNAPPGLDY------------------------ 240
P +
Sbjct: 250 QSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINK 309
Query: 241 ERDKRF--------SKSFKE-----------LVTACLVKDPKKRPTAEKLMKHHFFK 278
++ + K+ L+ + L +P KR T ++ + H + K
Sbjct: 310 PEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLK 366
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 61/289 (21%), Positives = 101/289 (34%), Gaps = 50/289 (17%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNE-----IVAIKVLDLEKCNNDLDGIRREVQT 65
+ R EE+GE VY+ VAIK L + + R E
Sbjct: 6 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAML 65
Query: 66 MRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRE--- 122
HPNV+ T L ++ Y + G + P +
Sbjct: 66 RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 123 TLKALV-----------YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD-- 169
V YL H +H+D+ N+L+ +K++D G+ ++ A D
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA-DYY 184
Query: 170 RQRSRNTFVGTP-CWMAPEVMQQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKV 226
+ + P WMAPE + ++G + +DIWS+G+ E+ +G P+ Y V
Sbjct: 185 KLLGNSLL---PIRWMAPEAI--MYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 239
Query: 227 LLMTLQ--------NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPT 267
+ M + P + Y L+ C + P +RP
Sbjct: 240 VEMIRNRQVLPCPDDCPAWV-Y-----------ALMIECWNEFPSRRPR 276
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 71/292 (24%), Positives = 127/292 (43%), Gaps = 51/292 (17%)
Query: 17 RLYEEVGEGVSATVYRALCIPLNE-------IVAIKVLDLEKCNNDLDGIRREVQTM-RV 68
L + +GEG V A + +++ VA+K+L + DL + E++ M +
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 69 TNHPNVLR--AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRE---T 123
H N++ C T L+V++ Y + G+ +++ P G E + E T
Sbjct: 98 GKHKNIINLLGAC--TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 124 LKALV-----------YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172
K LV YL IHRD+ A N+L+ N +K+ADFG++ + + ++
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 173 SRNTFVGTPC-WMAPEVMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMT 230
+ N + P WMAPE + Y ++D+WSFG+ E+ G +P+ P ++ +
Sbjct: 216 TTNGRL--PVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272
Query: 231 LQ--------NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274
+ N L Y ++ C P +RPT ++L++
Sbjct: 273 KEGHRMDKPANCTNEL-Y-----------MMMRDCWHAVPSQRPTFKQLVED 312
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 70/341 (20%), Positives = 119/341 (34%), Gaps = 82/341 (24%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNND--LDGIRREVQTMRV----- 68
Y + + +G+G V +A +++ VA+K++ N E++ +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR----NEKRFHRQAAEEIRILEHLRKQD 154
Query: 69 -TNHPNVLRAHCSFT-TGH-CLWVVMPYMAGGSCLH-IMKSAYPEGFEEPVIATLLRETL 124
N NV+ +FT H C+ + L+ ++K +GF P++ L
Sbjct: 155 KDNTMNVIHMLENFTFRNHICM--TFELL--SMNLYELIKKNKFQGFSLPLVRKFAHSIL 210
Query: 125 KALVYLHFHGHIHRDVKAGNILIDSNG--AIKLADFGVSACMFDAGDRQRSRNTFVGTPC 182
+ L LH + IH D+K NIL+ G IK+ DFG S+C + T++ +
Sbjct: 211 QCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG-SSCYEH-----QRVYTYIQSRF 264
Query: 183 WMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPF------------------------ 218
+ APEV+ Y D+WS G EL G+
Sbjct: 265 YRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323
Query: 219 -----------SKYPPMKVLLMTLQNAPPGLDYERDKRFS-------------------K 248
SK P + TL + L+ R +R
Sbjct: 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDP 383
Query: 249 SFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARS 289
F + + CL DP R T + ++H + +
Sbjct: 384 LFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEK 424
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 64/293 (21%), Positives = 115/293 (39%), Gaps = 56/293 (19%)
Query: 17 RLYEEVGEGVSATVYRALCIPLNE-----IVAIKVLDLEKCNNDLDGIRREVQTM-RVTN 70
+ + +G G V A L + VA+K+L ++ + + E++ M +
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 71 HPNVLR--AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRE-TLKAL 127
H N++ C T G + V+ Y G L+ ++ +P A + + L
Sbjct: 109 HENIVNLLGAC--THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 128 V-----------YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNT 176
+ +L IHRDV A N+L+ + K+ DFG++ + + + N
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 177 FVGTPC-WMAPEVMQQLHG-YDFKADIWSFGITALELA-HGHAPFSKYPPMKV---LLMT 230
+ P WMAPE + Y ++D+WS+GI E+ G P YP + V
Sbjct: 227 RL--PVKWMAPESI--FDCVYTVQSDVWSYGILLWEIFSLGLNP---YPGILVNSKFYKL 279
Query: 231 LQ---------NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274
++ AP + Y ++ AC +P RPT +++
Sbjct: 280 VKDGYQMAQPAFAPKNI-Y-----------SIMQACWALEPTHRPTFQQICSF 320
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 71/289 (24%), Positives = 125/289 (43%), Gaps = 51/289 (17%)
Query: 17 RLYEEVGEGVSATVYRALCIPLNE-------IVAIKVLDLEKCNNDLDGIRREVQTM-RV 68
L + +GEG V A + +++ VA+K+L + DL + E++ M +
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 143
Query: 69 TNHPNVLR--AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRE---T 123
H N++ C T L+V++ Y + G+ +++ P G E + E T
Sbjct: 144 GKHKNIINLLGAC--TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201
Query: 124 LKALV-----------YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172
K LV YL IHRD+ A N+L+ N +K+ADFG++ + + ++
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 173 SRNTFVGTPC-WMAPEVMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMT 230
+ N + P WMAPE + Y ++D+WSFG+ E+ G +P+ P ++ +
Sbjct: 262 TTNGRL--PVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 318
Query: 231 LQ--------NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKL 271
+ N L Y ++ C P +RPT ++L
Sbjct: 319 KEGHRMDKPANCTNEL-Y-----------MMMRDCWHAVPSQRPTFKQL 355
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 71/292 (24%), Positives = 126/292 (43%), Gaps = 51/292 (17%)
Query: 17 RLYEEVGEGVSATVYRALCIPLNEI-------VAIKVLDLEKCNNDLDGIRREVQTM-RV 68
L + +GEG V A I L++ VA+K+L + DL + E++ M +
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 131
Query: 69 TNHPNVLR--AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRE---T 123
H N++ C T L+V++ Y + G+ +++ P G E + E +
Sbjct: 132 GKHKNIINLLGAC--TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189
Query: 124 LKALV-----------YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172
K LV YL IHRD+ A N+L+ + +K+ADFG++ + ++
Sbjct: 190 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 173 SRNTFVGTP-CWMAPEVMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMT 230
+ N + P WMAPE + Y ++D+WSFG+ E+ G +P+ P ++ +
Sbjct: 250 TTNGRL--PVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 306
Query: 231 LQ--------NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274
+ N L Y ++ C P +RPT ++L++
Sbjct: 307 KEGHRMDKPSNCTNEL-Y-----------MMMRDCWHAVPSQRPTFKQLVED 346
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 65/320 (20%), Positives = 127/320 (39%), Gaps = 69/320 (21%)
Query: 4 VVEKRFPVDAK------DYRLYEEVGEGVSATVYRALCIPLNE-----IVAIKVLDLEKC 52
V + + D K + + +G G V A +++ VA+K+L +
Sbjct: 29 VDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD 88
Query: 53 NNDLDGIRREVQTM-RVTNHPNVLR--AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPE 109
+++ + + E++ M ++ +H N++ C T ++++ Y G L+ ++S +
Sbjct: 89 SSEREALMSELKMMTQLGSHENIVNLLGAC--TLSGPIYLIFEYCCYGDLLNYLRSKREK 146
Query: 110 GFEEPVIATLLRE----------TLKALV-----------YLHFHGHIHRDVKAGNILID 148
E+ + + T + L+ +L F +HRD+ A N+L+
Sbjct: 147 FSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT 206
Query: 149 SNGAIKLADFGVSACMFDAGDRQRSRNTFVGTP-CWMAPEVMQQLHGYDFKADIWSFGIT 207
+K+ DFG++ + + N + P WMAPE + + Y K+D+WS+GI
Sbjct: 207 HGKVVKICDFGLARDIMSDSNYVVRGNARL--PVKWMAPESLFE-GIYTIKSDVWSYGIL 263
Query: 208 ALELA-HGHAPFSKYPPMKV---LLMTLQ---------NAPPGLDYERDKRFSKSFKELV 254
E+ G P YP + V +Q A + Y ++
Sbjct: 264 LWEIFSLGVNP---YPGIPVDANFYKLIQNGFKMDQPFYATEEI-Y-----------IIM 308
Query: 255 TACLVKDPKKRPTAEKLMKH 274
+C D +KRP+ L
Sbjct: 309 QSCWAFDSRKRPSFPNLTSF 328
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 7e-23
Identities = 60/291 (20%), Positives = 107/291 (36%), Gaps = 59/291 (20%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNE--IVAIKVLDLEKCNNDLDGIRREVQTM-R 67
+D D + + +GEG V +A AIK + +D E++ + +
Sbjct: 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 81
Query: 68 VTNHPNVLR--AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRE--- 122
+ +HPN++ C L++ + Y G+ L ++ + +
Sbjct: 82 LGHHPNIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 139
Query: 123 TLKALV-----------YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171
+ + L+ YL IHRD+ A NIL+ N K+ADFG+S
Sbjct: 140 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS---------- 189
Query: 172 RSRNTFVGTPC------WMAPEVMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPM 224
R + +V WMA E + Y +D+WS+G+ E+ G P+
Sbjct: 190 RGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 248
Query: 225 KVLLMTLQ--------NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPT 267
++ Q N + Y +L+ C + P +RP+
Sbjct: 249 ELYEKLPQGYRLEKPLNCDDEV-Y-----------DLMRQCWREKPYERPS 287
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 9e-23
Identities = 71/337 (21%), Positives = 115/337 (34%), Gaps = 89/337 (26%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNND--LDGIRREVQTMRVTNHP- 72
Y + +G+G V +A E VAIK++ N L+ + EV+ + + N
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK----NKKAFLNQAQIEVRLLELMNKHD 111
Query: 73 -----NVLRAHCSFT-TGH-CLWVVMPYMAGGSCLH-IMKSAYPEGFEEPVIATLLRETL 124
++ F H CL V + L+ ++++ G + ++
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCL--VFEML--SYNLYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 125 KALVYLHFH--GHIHRDVKAGNILI--DSNGAIKLADFGVSACMFDAGDRQRSRNTFVGT 180
AL++L IH D+K NIL+ AIK+ DFG S+C + ++ +
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQLG-----QRIYQYIQS 221
Query: 181 PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFS---------------KYPPMK 225
+ +PEV+ + YD D+WS G +E+ G FS PP
Sbjct: 222 RFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH 280
Query: 226 VL-----------------------------------------LMTLQNAPPGLDY---E 241
+L L P G
Sbjct: 281 ILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESG 340
Query: 242 RDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278
FK+L+ L DPK R ++H FFK
Sbjct: 341 HTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFK 377
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 1e-22
Identities = 69/342 (20%), Positives = 124/342 (36%), Gaps = 83/342 (24%)
Query: 8 RFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN----NDLDGIR--R 61
V K Y L +++G+G V++++ E+VA+K K N D R R
Sbjct: 4 DRHVLRK-YELVKKLGKGAYGIVWKSIDRRTGEVVAVK-----KIFDAFQNSTDAQRTFR 57
Query: 62 EVQTMR-VTNHPNVLRAHCSFT--TGHCLWVVMPYMAGGSCLH-IMKSAYPEGFEEPVIA 117
E+ + ++ H N++ +++V YM + LH ++++ E
Sbjct: 58 EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIRA---NILEPVHKQ 112
Query: 118 TLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTF 177
++ + +K + YLH G +HRD+K NIL+++ +K+ADFG+S + +
Sbjct: 113 YVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172
Query: 178 VGTPCWM------------------APEVMQQLHGYDFKADIWSFG-ITALELAHGHAPF 218
+ APE++ Y D+WS G I E+ G F
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG-EILCGKPIF 231
Query: 219 --SKY-------------PPMKVL-----------LMTLQNAPPGLDYERDKRFSKSFKE 252
S P + + + +L+ + F+K
Sbjct: 232 PGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNL 291
Query: 253 ----------------LVTACLVKDPKKRPTAEKLMKHHFFK 278
L+ L +P KR +A +KH F
Sbjct: 292 LLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVS 333
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 63/300 (21%), Positives = 112/300 (37%), Gaps = 62/300 (20%)
Query: 17 RLYEEVGEGVSATVYRALCIPLNE-----IVAIKVLDLEKCNNDLDGIRREVQTMRVTNH 71
++GEG V++A L +VA+K+L E + +RE M ++
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 72 PNVLR--AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRE------- 122
PN+++ C G + ++ YMA G ++S P + L
Sbjct: 110 PNIVKLLGVC--AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 123 ----TLKALV-----------YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167
+ + YL +HRD+ N L+ N +K+ADFG+S ++
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS- 226
Query: 168 GD--RQRSRNTFVGTP-CWMAPEVMQQLHG-YDFKADIWSFGITALELA-HGHAPFSKYP 222
D + + P WM PE + + Y ++D+W++G+ E+ +G P+
Sbjct: 227 ADYYKADGNDAI---PIRWMPPESI--FYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281
Query: 223 PMKVLLMTLQ--------NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274
+V+ N P L Y L+ C K P RP+ + +
Sbjct: 282 HEEVIYYVRDGNILACPENCPLEL-Y-----------NLMRLCWSKLPADRPSFCSIHRI 329
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 65/297 (21%), Positives = 114/297 (38%), Gaps = 56/297 (18%)
Query: 17 RLYEEVGEGVSATVYRALCIPLNE-----IVAIKVLDLEKCNNDLDGIRREVQTMRVTNH 71
L + +GEG V +A L VA+K+L ++L + E ++ NH
Sbjct: 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNH 85
Query: 72 PNVLR--AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRE------- 122
P+V++ C + L +++ Y GS ++ + G
Sbjct: 86 PHVIKLYGAC--SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 123 ----TLKALV-----------YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167
T+ L+ YL +HRD+ A NIL+ +K++DFG+S +++
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 168 GDRQRSRNTFVGTPC-WMAPEVMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMK 225
+ + P WMA E + H Y ++D+WSFG+ E+ G P+ PP +
Sbjct: 204 DSYVKRSQGRI--PVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260
Query: 226 VLLMTLQ--------NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274
+ + N + Y L+ C ++P KRP + K
Sbjct: 261 LFNLLKTGHRMERPDNCSEEM-Y-----------RLMLQCWKQEPDKRPVFADISKD 305
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 2e-21
Identities = 71/373 (19%), Positives = 124/373 (33%), Gaps = 125/373 (33%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMR-----VT 69
Y + ++G G +TV+ + I + VA+KV+ K + + E++ ++
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV---KSAEHYTETALDEIRLLKSVRNSDP 95
Query: 70 NHPNVLRAHC-----SFT-TG----H-CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIAT 118
N PN R F +G H C+ V + G L + + +G P +
Sbjct: 96 NDPN--REMVVQLLDDFKISGVNGTHICM--VFEVL-GHHLLKWIIKSNYQGLPLPCVKK 150
Query: 119 LLRETLKALVYLHFHGH-IHRDVKAGNILI------------------------------ 147
++++ L+ L YLH IH D+K NIL+
Sbjct: 151 IIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210
Query: 148 -------------------DSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEV 188
+K+AD G +A + + T + + EV
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLG------NACWVHKHFTEDIQTRQYRSLEV 264
Query: 189 MQQLHGYDFKADIWSFGITALELAHGHAPFSKY---------------------PPMKVL 227
+ GY+ ADIWS A ELA G F + P K++
Sbjct: 265 LIG-SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI 323
Query: 228 LM------------TLQNAPPGLD----------YERDKRFSKSFKELVTACLVKDPKKR 265
+ L++ YE + + F + + L P+KR
Sbjct: 324 VAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKR 383
Query: 266 PTAEKLMKHHFFK 278
TA + ++H +
Sbjct: 384 ATAAECLRHPWLN 396
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 7e-21
Identities = 73/340 (21%), Positives = 114/340 (33%), Gaps = 93/340 (27%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNND--LDGIRREVQTMRVTNHPN 73
+ + ++G+G V I + A+KV+ N + E ++ + +
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV----RNIKKYTRSAKIEADILKKIQNDD 92
Query: 74 VLRAHC-----SFT-TGH-CLWVVMPYMAGGSCLH--IMKSAYPEGFEEPVIATLLRETL 124
+ + F H CL + + G L+ I ++ Y GF I E L
Sbjct: 93 INNNNIVKYHGKFMYYDHMCL--IFEPL--GPSLYEIITRNNY-NGFHIEDIKLYCIEIL 147
Query: 125 KALVYLHFHGHIHRDVKAGNILIDSNG-------------------------AIKLADFG 159
KAL YL H D+K NIL+D IKL DFG
Sbjct: 148 KALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207
Query: 160 VSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPF- 218
A F + + T + APEV+ L G+D +D+WSFG EL G F
Sbjct: 208 -CAT-FK----SDYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFR 260
Query: 219 -------------------------------SKYPPMKVLLMTLQNAPPGLDYERDKRFS 247
SKY L + ++ + +
Sbjct: 261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKC 320
Query: 248 KS---------FKELVTACLVKDPKKRPTAEKLMKHHFFK 278
F + + + L DP RP+ +L+KH F +
Sbjct: 321 LPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 4e-20
Identities = 75/272 (27%), Positives = 110/272 (40%), Gaps = 37/272 (13%)
Query: 22 VGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAH--C 79
+G G VY+ + +VA+K L E+ + EV+ + + H N+LR C
Sbjct: 38 LGRGGFGKVYKG-RLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96
Query: 80 SFTTGHCLWVVMPYMAGGS---CLHIMKSAYPEGFEEPV---IATLLRETLKALVYLHFH 133
T +V PYMA GS CL + P + P IA + + L YLH H
Sbjct: 97 --MTPTERLLVYPYMANGSVASCLRERPESQPP-LDWPKRQRIAL---GSARGLAYLHDH 150
Query: 134 GH---IHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQ 190
IHRDVKA NIL+D + DFG+ A + D D + GT +APE +
Sbjct: 151 CDPKIIHRDVKAANILLDEEFEAVVGDFGL-AKLMDYKDTHVT-TAVRGTIGHIAPEYLS 208
Query: 191 QLHGY-DFKADIWSFGITALELAHGHAPF-SKYPPMKVLLMTLQNAPPGLDYER-----D 243
G K D++ +G+ LEL G F +M L L ++ D
Sbjct: 209 --TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVD 266
Query: 244 KRFSKSF--KELVTA------CLVKDPKKRPT 267
++ +E+ C P +RP
Sbjct: 267 VDLQGNYKDEEVEQLIQVALLCTQSSPMERPK 298
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 9e-20
Identities = 69/333 (20%), Positives = 113/333 (33%), Gaps = 85/333 (25%)
Query: 16 YRLYEEVGEGVSATVYRALC-IPLNEIVAIKVLDLEKCNND--LDGIRREVQTMRV---- 68
Y + +GEG V L VA+K++ N + R E+ ++
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR----NVGKYREAARLEINVLKKIKEK 76
Query: 69 --TNHPNVLRAHCSFT-TGH-CLWVVMPYMAGGSCLH-IMKSAYPEGFEEPVIATLLRET 123
N + F GH C+ + G +K + + P + + +
Sbjct: 77 DKENKFLCVLMSDWFNFHGHMCI--AFELL--GKNTFEFLKENNFQPYPLPHVRHMAYQL 132
Query: 124 LKALVYLHFHGHIHRDVKAGNILIDSNG-------------------AIKLADFGVSACM 164
AL +LH + H D+K NIL ++ +I++ADFG SA
Sbjct: 133 CHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-SAT- 190
Query: 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFS----- 219
FD T V T + PEV+ +L G+ D+WS G E G F
Sbjct: 191 FD----HEHHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245
Query: 220 ----------KYPPMKVL-------------LMTLQNAPPGLDYERDKRFSKS------- 249
P ++ L+ +N+ G + + + KS
Sbjct: 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSL 305
Query: 250 ----FKELVTACLVKDPKKRPTAEKLMKHHFFK 278
+L+ L DP +R T + + H FF
Sbjct: 306 EHVQLFDLMRRMLEFDPAQRITLAEALLHPFFA 338
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-19
Identities = 70/339 (20%), Positives = 116/339 (34%), Gaps = 87/339 (25%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLN-EIVAIKVLDLEKCNND--LDGIRREVQTMRV---- 68
Y + + +GEG V + VA+K++ N D + R E+Q +
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK----NVDRYCEAARSEIQVLEHLNTT 71
Query: 69 --TNHPNVLRAHCSFT-TGH-CLWVVMPYMAGGSCLH--IMKSAYPEGFEEPVIATLLRE 122
+ ++ F GH C+ V + G + I ++ + F I + +
Sbjct: 72 DPNSTFRCVQMLEWFEHHGHICI--VFELL--GLSTYDFIKENGF-LPFRLDHIRKMAYQ 126
Query: 123 TLKALVYLHFHGHIHRDVKAGNILIDSNG-------------------AIKLADFGVSAC 163
K++ +LH + H D+K NIL + IK+ DFG SA
Sbjct: 127 ICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-SAT 185
Query: 164 MFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFS---- 219
+D +T V T + APEV+ L G+ D+WS G +E G F
Sbjct: 186 -YD----DEHHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239
Query: 220 -----------KYPPMKVLLMTLQN---APPGLDYERDKRFSKSFKE------------- 252
P ++ T + LD++ +
Sbjct: 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQD 299
Query: 253 --------LVTACLVKDPKKRPTAEKLMKHHFFKHARSN 283
L+ L DP KR T + +KH FF + +
Sbjct: 300 VEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 69/279 (24%), Positives = 105/279 (37%), Gaps = 56/279 (20%)
Query: 22 VGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR---REVQTMRVTNHPNV--LR 76
+G GV VY+ + VA+K GI E++T+ HP++ L
Sbjct: 47 IGHGVFGKVYKG-VLRDGAKVALKRRT----PESSQGIEEFETEIETLSFCRHPHLVSLI 101
Query: 77 AHCSFTTGHCLWVVMPYMAGGS---CLHIMKSAYPEGFEEPV----------IATLLRET 123
C L + YM G+ L+ G + P I
Sbjct: 102 GFCDERNEMIL--IYKYMENGNLKRHLY--------GSDLPTMSMSWEQRLEICI---GA 148
Query: 124 LKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFV-GTPC 182
+ L YLH IHRDVK+ NIL+D N K+ DFG+S + S T V GT
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS--TVVKGTLG 206
Query: 183 WMAPE-VM-QQLHGYDFKADIWSFGITALELAHGHAPFSKY-PPMKVLL----MTLQN-- 233
++ PE + +L K+D++SFG+ E+ + + P V L + N
Sbjct: 207 YIDPEYFIKGRL---TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263
Query: 234 -----APPGLDYERDKRFSKSFKELVTACLVKDPKKRPT 267
P L + + F + CL + RP+
Sbjct: 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS 302
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 45/229 (19%), Positives = 85/229 (37%), Gaps = 27/229 (11%)
Query: 1 MDLVVEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR 60
+ VV Y++ +GEG ++ + N+ VAIK E +D +R
Sbjct: 4 QNNVVGVH-------YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF---EPRRSDAPQLR 53
Query: 61 REVQTMRV-TNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATL 119
E +T ++ + + G +V+ + G L + F +A
Sbjct: 54 DEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMA 111
Query: 120 LRETLKALVYLHFHGHIHRDVKAGNILIDSNGA-----IKLADFGVSACMFDAGDRQ--- 171
++ L + +H ++RD+K N LI + I + DFG+ D +Q
Sbjct: 112 AKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP 171
Query: 172 -RSRNTFVGTPCWMAPEVMQQLHGYD--FKADIWSFGITALELAHGHAP 217
R + GT +M+ + G + + D+ + G + G P
Sbjct: 172 YREKKNLSGTARYMS---INTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 43/160 (26%), Positives = 72/160 (45%), Gaps = 32/160 (20%)
Query: 129 YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTP-CWMAPE 187
+L IHRD+ A NIL+ +K+ DFG++ ++ D R + + P WMAPE
Sbjct: 208 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL--PLKWMAPE 265
Query: 188 VMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKV---LLMTLQ---------NA 234
+ Y ++D+WSFG+ E+ G +P YP +K+ L+
Sbjct: 266 TIFD-RVYTIQSDVWSFGVLLWEIFSLGASP---YPGVKIDEEFCRRLKEGTRMRAPDYT 321
Query: 235 PPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274
P + Y + + C +P +RPT +L++H
Sbjct: 322 TPEM-Y-----------QTMLDCWHGEPSQRPTFSELVEH 349
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 23/116 (19%), Positives = 49/116 (42%), Gaps = 16/116 (13%)
Query: 9 FPVDAKDY-------RLYEEVGEGVSATVYRALCIPLNE-----IVAIKVLDLEKCNNDL 56
P DA + +L + +G G V A +++ VA+K+L +++
Sbjct: 10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 69
Query: 57 DGIRREVQTM-RVTNHPNVLR--AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPE 109
+ E++ + + +H NV+ C+ G L V++ + G+ ++S E
Sbjct: 70 RALMSELKILIHIGHHLNVVNLLGACT-KPGGPLMVIVEFCKFGNLSTYLRSKRNE 124
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 42/215 (19%), Positives = 82/215 (38%), Gaps = 22/215 (10%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMR-VTNHPNV 74
+R+ +++G G + + NE VAIK LE + + E + + + + +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIK---LEPMKSRAPQLHLEYRFYKQLGSGDGI 67
Query: 75 LRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHG 134
+ + G +V+ + G L + F + + + + + Y+H
Sbjct: 68 PQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN 125
Query: 135 HIHRDVKAGNILIDSNGA-----IKLADFGVSACMFDAGDRQ----RSRNTFVGTPCWMA 185
I+RDVK N LI G I + DF ++ D ++ R + GT +M+
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMS 185
Query: 186 PEVMQQLH-GYD--FKADIWSFGITALELAHGHAP 217
H G + + D+ + G + G P
Sbjct: 186 INT----HLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 50/227 (22%), Positives = 80/227 (35%), Gaps = 25/227 (11%)
Query: 1 MDLVVEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR 60
M+L V R YRL ++G G +Y I E VAIK+ E +
Sbjct: 3 MELRVGNR-------YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLH 52
Query: 61 REVQTMRV-TNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATL 119
E + ++ + G +VM + G L + + F + L
Sbjct: 53 IESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLL 110
Query: 120 LRETLKALVYLHFHGHIHRDVKAGNILIDSNG---AIKLADFGVSACMFDAGDRQ----R 172
+ + + Y+H IHRDVK N L+ + + DFG++ DA Q R
Sbjct: 111 ADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYR 170
Query: 173 SRNTFVGTPCWMAPEVMQQLHGYD--FKADIWSFGITALELAHGHAP 217
GT + + G + + D+ S G + G P
Sbjct: 171 ENKNLTGTARYASINTHL---GIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 75.8 bits (186), Expect = 1e-14
Identities = 89/537 (16%), Positives = 156/537 (29%), Gaps = 95/537 (17%)
Query: 1 MDLVVEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR 60
M+ V + +RL ++G G +Y I NE VAIK+ E +
Sbjct: 1 MEPRVGNK-------FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLL 50
Query: 61 REVQTMRV-TNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATL 119
E + R+ + G +VM + G L + + + L
Sbjct: 51 YESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLML 108
Query: 120 LRETLKALVYLHFHGHIHRDVKAGNILIDSNG---AIKLADFGVSACMFDAGDRQ----R 172
+ + + ++H +HRD+K N L+ + + DFG++ D Q R
Sbjct: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168
Query: 173 SRNTFVGTPCWMAPEVMQQLHGYD--FKADIWSFGITALELAHGHAPFSKYPPMKVLLMT 230
GT + + + G + + D+ S G + G P+
Sbjct: 169 ENKNLTGTARYAS---VNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG---------- 215
Query: 231 LQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHH------FFKHARSND 284
L+ YE+ + + K + E L + + +F + RS
Sbjct: 216 LKAGTKKQKYEK----------------ISEKKVATSIEALCRGYPTEFASYFHYCRSLR 259
Query: 285 FLARSIVDNLAPLGERFRMLKAKEADLLVQNKALYEDKEQLSQDYDCMSNAEDPNSSGKQ 344
F + L L FR L +E Q +D +
Sbjct: 260 FDDKPDYSYLKRL---FRDLFIRE-------------GFQFDYVFDWTILKYQQSQIASA 303
Query: 345 NHADVEVPAERLSTESGNHSNATTSQDDGFNNLHDLESSLASFPIKPLQALKGCFDVGED 404
V A N S D P
Sbjct: 304 PPRAVGHGAGPSGLAPPALQNDRQSGVDEGRTSGWSSMDRRRAPPPI------------- 350
Query: 405 DEGATSPSWKGTAHLETDQFLSKGSLGAIDQESGRNEGENSGRSSSLPRHVILEHKKFLS 464
+ K A + D SK + + GR+ S S R + + +
Sbjct: 351 --ASVGTLAKQKAPVGNDASFSKEPVISASNFLGRS-------SGSSRRPAVSSSRDVMP 401
Query: 465 GSLIPDNAFSSKKAVGEADRDSLQPKNQSERNYSGPLLYRQRRDTNNLPSAEDTSEG 521
+ + A A R + P+ S N + P R ++N+ + E +G
Sbjct: 402 IDTSEPSRTRATDASPGAFRRTSGPQKSSPVNSAEPKHSSSARHSSNVKNYESALKG 458
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.5 bits (169), Expect = 7e-13
Identities = 52/328 (15%), Positives = 98/328 (29%), Gaps = 76/328 (23%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLE-------KCNNDLDGIRREVQTMR 67
+ E++GEGV V++ + + VAIK++ +E + I E+ +
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 68 ---------VTNHPNVLR---AHC---------------------------SFTTGHCLW 88
+ HC F L+
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF-HGHIHRDVKAGNILI 147
+V+ + GG L M++ ++L + +L HRD+ GN+L+
Sbjct: 139 IVLEFEFGGIDLEQMRTKLSSLAT---AKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 148 DSNGAIKLAD-----------FGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQL-HG- 194
KL G+ + D SR G + + + L G
Sbjct: 196 KKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYT---LSRLERDGIVVFCDVSMDEDLFTGD 252
Query: 195 YDFKADIWSFGITALEL-AHGHAPFSKYPPMKVL---LMTLQNAPPGLDYERDKRFSKSF 250
D++ DI+ + P+S + L ++ + K+ +
Sbjct: 253 GDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKI 312
Query: 251 KELVTACLVKDPKKRPTAEKLMKHHFFK 278
+E L + L +H FK
Sbjct: 313 QEFHRTML----NFSSATDLLCQHSLFK 336
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 35/198 (17%), Positives = 69/198 (34%), Gaps = 35/198 (17%)
Query: 16 YRLYEEVGEGVSATVYRALCI--------PLNEIVAIKVLDLEKCNNDLDGIRREVQTMR 67
++L +Y A P + ++K L+ + L + Q R
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK---LDAKDGRLFNEQNFFQ--R 98
Query: 68 VTNHPNVLRAHCSFTTGH-----CLW----------VVMPYMAGGSCLHIMKSAYPEGFE 112
V + ++T C+ +V+P + G S + +
Sbjct: 99 AAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLS 157
Query: 113 EPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGA--IKLADFGVSACMFDAGD- 169
E + + L AL +LH + ++H +V A NI +D + LA +G + +G
Sbjct: 158 ERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKH 217
Query: 170 ---RQRSRNTFVGTPCWM 184
+ SR+ G ++
Sbjct: 218 VAYVEGSRSPHEGDLEFI 235
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 2e-08
Identities = 105/668 (15%), Positives = 190/668 (28%), Gaps = 188/668 (28%)
Query: 78 HCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIH 137
H F TG Y L + + A+ + F+ + + + L HI
Sbjct: 6 HMDFETGE-----HQY-QYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEI----DHI- 54
Query: 138 RDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDF 197
+ + + +G ++L + + + FV EV++ Y F
Sbjct: 55 --IMSKD---AVSGTLRLFW-----TLLSKQEEMVQK--FVE-------EVLRI--NYKF 93
Query: 198 KADIWSF------GITAL------ELAHGHAPFSKY-----PPMKVL---LMTLQNAP-- 235
+T + L + + F+KY P L L+ L+ A
Sbjct: 94 LMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNV 153
Query: 236 -----PG-------LDYERDKRFSKSFKELV---TACLVKDPKKRPTAEKLMKHHFFKHA 280
G LD + + P+ + + + +
Sbjct: 154 LIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNW 213
Query: 281 RSNDFLARSIVDNLAPLGERFRML---KAKEADLL----VQNKALYEDKEQLSQDYDCMS 333
S + +I + + R L K E LL VQN + + + C
Sbjct: 214 TSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWN-----AFNLSC-- 266
Query: 334 NAEDPNSSGK-------QNHADVEVPAERLSTESGNHSNATTSQDDGFNNLHDLESSLAS 386
K + D + A + S +H + T + D+ +S L
Sbjct: 267 ---------KILLTTRFKQVTDF-LSAATTTHISLDHHSMTLTPDEV-------KSLLLK 309
Query: 387 F---PIK--PLQALKG----CFDVGE--DDEGATSPSWKGTAHLETDQFLS--KGSLGAI 433
+ + P + L + E D AT +WK H+ D+ + + SL +
Sbjct: 310 YLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWK---HVNCDKLTTIIESSLNVL 366
Query: 434 DQESGRNEGENSGRSSSLPRHVILEHKKFLSGSLIPDNAFS----------SKKAVGEAD 483
+ E L + F + IP S V +
Sbjct: 367 E------PAEYRKMFDRL---SV-----FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLH 412
Query: 484 RDSLQPKNQSERNYSGPLLYRQ-RRDTNNLPSAEDTSEGAVVQRKGRFKVTSAELSPKGP 542
+ SL K E S P +Y + + N + + V S +L P
Sbjct: 413 KYSLVEKQPKESTISIPSIYLELKVKLENEYALHRS---IVDHYNIPKTFDSDDLIPPYL 469
Query: 543 INSIFSPV----SGGSMSPTTPNFTAASLLPSLQFILQQ---------------NTMQRE 583
+S + F + +F+ Q+ NT+Q
Sbjct: 470 DQYFYSHIGHHLKNIEHPERMTLFR--MVFLDFRFLEQKIRHDSTAWNASGSILNTLQ-- 525
Query: 584 EIIRLIKYAEETSGKHAESADAGTNDLLQVTPA------STKEKEL-QSQMITLQQRIAS 636
+L Y + + N +L P +K +L + I L +
Sbjct: 526 ---QLKFYKPYIC-DNDPKYERLVNAILDFLPKIEENLICSKYTDLLR---IALMAEDEA 578
Query: 637 IAEELQRQ 644
I EE +Q
Sbjct: 579 IFEEAHKQ 586
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 2e-04
Identities = 49/373 (13%), Positives = 111/373 (29%), Gaps = 111/373 (29%)
Query: 1 MDLVVEKRFPVDAKDYRLYEEVGEGVSATV--YRALCIPLNEIVAIKVLDL----EKCNN 54
+ +D L + + + R +P E++ L E +
Sbjct: 281 LSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLP-REVLTTNPRRLSIIAESIRD 339
Query: 55 DLDGIR--REVQTMRVTN---------HPNVLRAH---CS-FTTGHCLWVVMPYMAGGSC 99
L + V ++T P R S F +P +
Sbjct: 340 GLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPS----AHIPTIL---- 391
Query: 100 LHIMKSAYPEGFEEPVIATLLRETL------KALVYLHFHGHIHRDVKAGNILIDSNGAI 153
L ++ + V+ L + +L ++ + + I+ ++K +++ A+
Sbjct: 392 LSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIP---SIYLELKV---KLENEYAL 445
Query: 154 --KLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALEL 211
+ D FD+ D + L Y +S +
Sbjct: 446 HRSIVDHYNIPKTFDSDD-----------------LIPPYLDQY-----FYSH------I 477
Query: 212 AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL--VTACLVKDPKKRPTAE 269
H H L +++ ER F F + + + D +
Sbjct: 478 GH-H------------LKNIEHP------ERMTLFRMVFLDFRFLEQKIRHDSTAWNASG 518
Query: 270 KLM---------KHHFFKHARSNDFLARSIVDNLAPLGERFRMLKAKEADLLVQ------ 314
++ K + + + L +I+D L + E ++ +K D L++
Sbjct: 519 SILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEE--NLICSKYTD-LLRIALMAE 575
Query: 315 NKALYEDKEQLSQ 327
++A++E+ + Q
Sbjct: 576 DEAIFEEAHKQVQ 588
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 37/206 (17%), Positives = 72/206 (34%), Gaps = 37/206 (17%)
Query: 1 MDLVVEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR 60
+D + + + L +++G G +Y A E A V+ +E N +
Sbjct: 31 LDDMEGNQ-------WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGP--LF 81
Query: 61 REVQTMRVTNHPNVLRAHCSFTTG------HCLW-------------VVMPYMAGGSCLH 101
E++ + + ++ +VM + G
Sbjct: 82 SELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQK 140
Query: 102 IMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGA--IKLADFG 159
I F++ + L L L Y+H + ++H D+KA N+L+ + LAD+G
Sbjct: 141 ISGQNGT--FKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYG 198
Query: 160 VSACMFDAGD----RQRSRNTFVGTP 181
+S G+ ++ R GT
Sbjct: 199 LSYRYCPNGNHKQYQENPRKGHNGTI 224
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 17/67 (25%), Positives = 31/67 (46%), Gaps = 6/67 (8%)
Query: 124 LKALVYLHFHGHIHRDVKAGNILIDSNGA--IKLADFGVSACMFDAGDRQ----RSRNTF 177
L L Y+H H ++H D+KA N+L++ + L D+G++ G + +
Sbjct: 162 LDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCH 221
Query: 178 VGTPCWM 184
GT +
Sbjct: 222 DGTIEFT 228
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 671 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.81 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.68 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.14 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.09 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.99 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.62 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.46 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.39 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.2 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.16 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.09 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.04 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.95 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.56 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.51 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.35 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.22 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.15 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.08 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.96 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.87 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.87 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.66 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.57 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.43 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.94 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.62 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.5 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.54 | |
| 1nkp_B | 83 | MAX protein, MYC proto-oncogene protein; transcrip | 88.87 | |
| 3m91_A | 51 | Proteasome-associated ATPase; coil COIL alpha heli | 82.21 | |
| 1nkp_A | 88 | C-MYC, MYC proto-oncogene protein; transcription, | 80.79 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-61 Score=510.62 Aligned_cols=265 Identities=27% Similarity=0.455 Sum_probs=236.1
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWV 89 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~L 89 (671)
..++|++++.||+|+||+||+|+++.+|+.||||++.+... ......+.+|+.+|+.++|||||+++++|.+++++||
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34679999999999999999999999999999999976532 3456889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCC
Q 005886 90 VMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~ 169 (671)
|||||.||+|++++... +.+++..++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.+... .
T Consensus 110 vmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~-~ 186 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE-S 186 (311)
T ss_dssp EECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT-T
T ss_pred EEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC-C
Confidence 99999999999999887 68999999999999999999999999999999999999999999999999999876332 2
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHH
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
......+++||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+.... +..+..+|++
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-----~~~p~~~s~~ 260 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE-----YDFPEKFFPK 260 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-----CCCCTTCCHH
T ss_pred CcccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----CCCCcccCHH
Confidence 2334567899999999999988 679999999999999999999999999988877777666543 2335678999
Q ss_pred HHHHHHHhhhcCCCCCCCHHH------HHhchhccccccchH
Q 005886 250 FKELVTACLVKDPKKRPTAEK------LMKHHFFKHARSNDF 285 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpSa~e------iL~Hpwfk~~~~~~~ 285 (671)
+++||.+||.+||.+|||++| |++||||+...|...
T Consensus 261 ~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l 302 (311)
T 4aw0_A 261 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302 (311)
T ss_dssp HHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred HHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence 999999999999999999887 689999998887643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-60 Score=513.26 Aligned_cols=259 Identities=36% Similarity=0.612 Sum_probs=232.7
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
..|++++.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|+.+|+.++|||||+++++|.+++.+||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 569999999999999999999999999999999976543 3356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS 173 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 173 (671)
|.||+|.+++.. ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+... ...
T Consensus 153 ~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~---~~~ 226 (346)
T 4fih_A 153 LEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE---VPR 226 (346)
T ss_dssp CTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS---SCC
T ss_pred CCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC---CCc
Confidence 999999999876 46999999999999999999999999999999999999999999999999999866332 223
Q ss_pred cccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHH
Q 005886 174 RNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL 253 (671)
Q Consensus 174 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dL 253 (671)
..+.+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+....++.+ ..+..+|+++++|
T Consensus 227 ~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~--~~~~~~s~~~~dl 303 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL--KNLHKVSPSLKGF 303 (346)
T ss_dssp BCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC--SCGGGSCHHHHHH
T ss_pred ccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC--CccccCCHHHHHH
Confidence 456799999999999987 6799999999999999999999999999888887777776655443 3456799999999
Q ss_pred HHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 254 VTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 254 I~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
|.+||.+||.+|||++|+|+||||++...
T Consensus 304 i~~~L~~dP~~R~ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 304 LDRLLVRDPAQRATAAELLKHPFLAKAGP 332 (346)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence 99999999999999999999999987654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-61 Score=514.90 Aligned_cols=266 Identities=23% Similarity=0.445 Sum_probs=230.6
Q ss_pred ccccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeC
Q 005886 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTG 84 (671)
Q Consensus 6 e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~ 84 (671)
|.-|-...++|++++.||+|+||+||+|+++.+|+.||||++...... ...+.+.+|+.+|+.|+|||||+++++|.++
T Consensus 16 en~~f~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~ 95 (350)
T 4b9d_A 16 ENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN 95 (350)
T ss_dssp CCCBCSCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cccCCCcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence 344445678999999999999999999999999999999999866543 3467899999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccc
Q 005886 85 HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACM 164 (671)
Q Consensus 85 ~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~ 164 (671)
+.+|||||||.||+|.+++.......+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+
T Consensus 96 ~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 175 (350)
T 4b9d_A 96 GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175 (350)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceee
Confidence 99999999999999999998765567899999999999999999999999999999999999999999999999999765
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccc
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (671)
... .....+.+||+.|||||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+..+.....+. .+.
T Consensus 176 ~~~---~~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~----~~~ 247 (350)
T 4b9d_A 176 NST---VELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP----VSL 247 (350)
T ss_dssp CHH---HHHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC----CCT
T ss_pred cCC---cccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC----CCc
Confidence 321 122345789999999999987 679999999999999999999999999988888887777765432 345
Q ss_pred cchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccc
Q 005886 245 RFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKH 279 (671)
Q Consensus 245 ~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~ 279 (671)
.+|.++++||.+||.+||.+|||++++|+||||+.
T Consensus 248 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 248 HYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 78999999999999999999999999999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-59 Score=516.40 Aligned_cols=260 Identities=36% Similarity=0.609 Sum_probs=233.7
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
+.|+++++||+|+||+||+|+++.+|+.||||++..... ...+.+.+|+.+|+.++|||||+++++|.+++.+||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC-SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 569999999999999999999999999999999986543 3356789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS 173 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 173 (671)
|.||+|.+++.. ..+++..++.|++||+.||+|||++|||||||||+||||+.+|.|||+|||+|+.+... ...
T Consensus 230 ~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~---~~~ 303 (423)
T 4fie_A 230 LEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE---VPR 303 (423)
T ss_dssp CTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS---CCC
T ss_pred CCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC---Ccc
Confidence 999999999975 36999999999999999999999999999999999999999999999999999866332 223
Q ss_pred cccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHH
Q 005886 174 RNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL 253 (671)
Q Consensus 174 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dL 253 (671)
..+.+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+....++.+ ..+..+|+++++|
T Consensus 304 ~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~--~~~~~~s~~~~dl 380 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL--KNLHKVSPSLKGF 380 (423)
T ss_dssp BCCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--SCTTSSCHHHHHH
T ss_pred ccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC--cccccCCHHHHHH
Confidence 456799999999999987 6799999999999999999999999999888888877777655443 3456789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHhchhccccccc
Q 005886 254 VTACLVKDPKKRPTAEKLMKHHFFKHARSN 283 (671)
Q Consensus 254 I~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~ 283 (671)
|.+||.+||.+|||+.|+|+||||+.....
T Consensus 381 i~~~L~~dP~~R~ta~ell~Hp~~~~~~~p 410 (423)
T 4fie_A 381 LDRLLVRDPAQRATAAELLKHPFLAKAGPP 410 (423)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred HHHHcCCChhHCcCHHHHhcCHHhcCCCCC
Confidence 999999999999999999999999976543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-59 Score=489.25 Aligned_cols=255 Identities=24% Similarity=0.398 Sum_probs=211.4
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LV 90 (671)
.++|++++.||+|+||+||+|+++.+|+.||||++++.... .....+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 36899999999999999999999999999999999765432 3467899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCc
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR 170 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~ 170 (671)
|||| +|+|.+++... +.+++..++.+++||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 92 mEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---- 164 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD---- 164 (275)
T ss_dssp EECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred EeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC----
Confidence 9999 67999998876 6799999999999999999999999999999999999999999999999999976532
Q ss_pred ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHH
Q 005886 171 QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSF 250 (671)
Q Consensus 171 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l 250 (671)
.....+.+||+.|||||++.+...++.++|||||||++|+|++|++||.+.+....+..+.... +..+..+|+++
T Consensus 165 ~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~-----~~~p~~~s~~~ 239 (275)
T 3hyh_A 165 GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV-----YTLPKFLSPGA 239 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-----CCCCTTSCHHH
T ss_pred CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-----CCCCCCCCHHH
Confidence 2233467999999999999884445789999999999999999999999877766555554432 22356789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHhchhccc
Q 005886 251 KELVTACLVKDPKKRPTAEKLMKHHFFKH 279 (671)
Q Consensus 251 ~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~ 279 (671)
++||.+||.+||.+|||++|+|+||||+.
T Consensus 240 ~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 240 AGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 99999999999999999999999999974
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-60 Score=500.90 Aligned_cols=268 Identities=29% Similarity=0.455 Sum_probs=228.0
Q ss_pred ccccCCCCeEEEEEecccCceEEEEEEEc---CCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEe
Q 005886 8 RFPVDAKDYRLYEEVGEGVSATVYRALCI---PLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTT 83 (671)
Q Consensus 8 ~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~---~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~ 83 (671)
...+++++|++++.||+|+||+||+|++. .+++.||||++++.... .....+.+|+.+|+.++|||||+++++|.+
T Consensus 18 ~~~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 97 (304)
T 3ubd_A 18 HEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT 97 (304)
T ss_dssp CCCCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE
T ss_pred cccCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 34556789999999999999999999984 46889999999765432 234568889999999999999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccc
Q 005886 84 GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSAC 163 (671)
Q Consensus 84 ~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~ 163 (671)
++.+|||||||.||+|.+++... +.+++..++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 99999999999999999999887 6799999999999999999999999999999999999999999999999999976
Q ss_pred cccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 005886 164 MFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 243 (671)
Q Consensus 164 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (671)
.... .....+.+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+..... ..+
T Consensus 176 ~~~~---~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-----~~p 246 (304)
T 3ubd_A 176 SIDH---EKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-----GMP 246 (304)
T ss_dssp --------CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----CCC
T ss_pred ccCC---CccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC-----CCC
Confidence 5332 223456799999999999987 6799999999999999999999999999888877777766432 235
Q ss_pred ccchHHHHHHHHHhhhcCCCCCCC-----HHHHHhchhccccccchHH
Q 005886 244 KRFSKSFKELVTACLVKDPKKRPT-----AEKLMKHHFFKHARSNDFL 286 (671)
Q Consensus 244 ~~ls~~l~dLI~~cL~~dP~kRpS-----a~eiL~Hpwfk~~~~~~~~ 286 (671)
..+|+++++||.+||.+||.+||| ++++|+||||+...|....
T Consensus 247 ~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~ 294 (304)
T 3ubd_A 247 QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLY 294 (304)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHH
T ss_pred CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHH
Confidence 678999999999999999999998 5899999999988765443
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-58 Score=484.18 Aligned_cols=253 Identities=27% Similarity=0.463 Sum_probs=219.6
Q ss_pred eEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEe----CCEEEEE
Q 005886 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTT----GHCLWVV 90 (671)
Q Consensus 16 Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~----~~~l~LV 90 (671)
|++.++||+|+||+||+|.++.+|..||||++...... ...+.+.+|+.+|+.++|||||+++++|.+ +..+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 57888999999999999999999999999999765433 346789999999999999999999999975 4578999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCCcEEEcC-CCceEEeccccccccccC
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHG--HIHRDVKAGNILIDS-NGAIKLADFGVSACMFDA 167 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~g--IVHrDLKPeNILld~-~g~vKL~DFGls~~~~~~ 167 (671)
||||.||+|.+++... +.+++..++.|+.||+.||+|||++| ||||||||+|||++. +|.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~-- 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-- 183 (290)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC--
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC--
Confidence 9999999999999877 67999999999999999999999998 999999999999974 7999999999996431
Q ss_pred CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccch
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls 247 (671)
.....+.+||+.|||||++.+ .|+.++|||||||+||||+||++||.+......+...+..... ....+..++
T Consensus 184 ---~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~ 256 (290)
T 3fpq_A 184 ---ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAI 256 (290)
T ss_dssp ---TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGCCC
T ss_pred ---CCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC--CCCCCccCC
Confidence 123346799999999999875 5999999999999999999999999877666555555544322 233456688
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHhchhccc
Q 005886 248 KSFKELVTACLVKDPKKRPTAEKLMKHHFFKH 279 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~ 279 (671)
+++++||.+||.+||.+|||++++|+||||++
T Consensus 257 ~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 99999999999999999999999999999974
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-58 Score=492.08 Aligned_cols=262 Identities=26% Similarity=0.334 Sum_probs=224.8
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~ 88 (671)
+....+.|++.++||+|+||+||+|+++.+|+.||||+++.+... .+|+.+|+.++|||||+++++|.++..+|
T Consensus 53 ~~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~------~~E~~il~~l~HpnIV~l~~~~~~~~~~~ 126 (336)
T 4g3f_A 53 YREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLYGAVREGPWVN 126 (336)
T ss_dssp CCBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC------THHHHTTTTCCCTTBCCEEEEEEETTEEE
T ss_pred hhcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH------HHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 444567899999999999999999999999999999999765432 46999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC-ceEEeccccccccccC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG-AIKLADFGVSACMFDA 167 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g-~vKL~DFGls~~~~~~ 167 (671)
||||||.||+|.++++.. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+| .+||+|||+|+.+...
T Consensus 127 ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp EEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred EEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999999999999877 6799999999999999999999999999999999999999988 6999999999876433
Q ss_pred CCc--ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Q 005886 168 GDR--QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245 (671)
Q Consensus 168 ~~~--~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (671)
+.. ......++||+.|||||++.+ ..|+.++|||||||++|||++|++||.+......+..+....++. ...+..
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~ 281 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPI--REIPPS 281 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGG--GGSCTT
T ss_pred CcccceecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCc--hhcCcc
Confidence 221 122345689999999999988 679999999999999999999999998877666666666543321 234677
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHH-------------Hhchhccccc
Q 005886 246 FSKSFKELVTACLVKDPKKRPTAEKL-------------MKHHFFKHAR 281 (671)
Q Consensus 246 ls~~l~dLI~~cL~~dP~kRpSa~ei-------------L~Hpwfk~~~ 281 (671)
+++.+++||.+||.+||.+|||+.|+ |+|||+....
T Consensus 282 ~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 282 CAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 89999999999999999999999998 5689987654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-56 Score=485.84 Aligned_cols=266 Identities=23% Similarity=0.321 Sum_probs=224.2
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEe------CCE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTT------GHC 86 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~------~~~ 86 (671)
++|++++.||+|+||+||+|+++.+|+.||||++..... ......+.+|+.+|+.++|||||++++++.. ...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 679999999999999999999999999999999975543 2345678899999999999999999998764 367
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
+|||||||. |+|+.++... +.+++..++.|++||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.+..
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred EEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 999999996 5799988765 6899999999999999999999999999999999999999999999999999986643
Q ss_pred CCC-cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------
Q 005886 167 AGD-RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG-------- 237 (671)
Q Consensus 167 ~~~-~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~-------- 237 (671)
... ......+.+||++|||||++.+...|+.++||||+|||+|||++|++||.+.+..+.+..+.......
T Consensus 211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~ 290 (398)
T 4b99_A 211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV 290 (398)
T ss_dssp -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC--
T ss_pred CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhh
Confidence 322 22344578999999999999886678999999999999999999999999988877766554321110
Q ss_pred ---------------CCc---cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 238 ---------------LDY---ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 238 ---------------~~~---~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
... .....+++++++||.+||.+||.+|||+.++|+||||+....
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353 (398)
T ss_dssp ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence 000 112356899999999999999999999999999999987643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-56 Score=467.85 Aligned_cols=262 Identities=24% Similarity=0.342 Sum_probs=205.3
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC--------
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH-------- 85 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~-------- 85 (671)
++|++++.||+|+||+||+|+++.+|+.||||++.........+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 469999999999999999999999999999999986654455678999999999999999999999997644
Q ss_pred ----EEEEEEeccCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccc
Q 005886 86 ----CLWVVMPYMAGGSCLHIMKSAYP-EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGV 160 (671)
Q Consensus 86 ----~l~LVmEy~~ggsL~~~l~~~~~-~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGl 160 (671)
++|||||||.||+|.+++..... ...++..++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence 47999999999999999986522 2355677899999999999999999999999999999999999999999999
Q ss_pred ccccccCCCc---------ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 005886 161 SACMFDAGDR---------QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTL 231 (671)
Q Consensus 161 s~~~~~~~~~---------~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~ 231 (671)
|+.+...... .....+.+||+.|||||++.+ ..|+.++|||||||++|||++ ||.+..........+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~ 240 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDV 240 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHH
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHH
Confidence 9876432211 112345689999999999987 679999999999999999996 886533222222222
Q ss_pred hcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 232 QNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 232 ~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
.... + .+.+...++.+.+||.+||.+||.+|||+.++|+||||+...+
T Consensus 241 ~~~~--~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 241 RNLK--F-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp HTTC--C-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred hcCC--C-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence 2211 1 1233455677899999999999999999999999999987643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-55 Score=503.26 Aligned_cols=272 Identities=25% Similarity=0.366 Sum_probs=229.8
Q ss_pred cccccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHH---HHHHHhCCCCCceeeee
Q 005886 5 VEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRRE---VQTMRVTNHPNVLRAHC 79 (671)
Q Consensus 5 ~e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~E---i~iL~~L~HpNIVkl~~ 79 (671)
+|...++..++|++++.||+|+||+||+|+++.+|+.||||++.+... ......+.+| +.+++.++|||||++++
T Consensus 180 ~e~~~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~ 259 (689)
T 3v5w_A 180 VELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 259 (689)
T ss_dssp HHTTCCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred cccCCCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEE
Confidence 345668889999999999999999999999999999999999975432 1223344444 56667789999999999
Q ss_pred EEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccc
Q 005886 80 SFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFG 159 (671)
Q Consensus 80 ~~~~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFG 159 (671)
+|.+.+.+|||||||.||+|+.++... +.|++..++.|+.||+.||+|||++|||||||||+||||+.+|.|||+|||
T Consensus 260 ~f~~~~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFG 337 (689)
T 3v5w_A 260 AFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337 (689)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEEECCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccc
Confidence 999999999999999999999999887 679999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCC
Q 005886 160 VSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPP---MKVLLMTLQNAPP 236 (671)
Q Consensus 160 ls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~---~~~~~~~~~~~~~ 236 (671)
+|+.+.. ....+.+||+.|||||++.+...|+.++||||||||||||++|++||.+... ..+...+... .
T Consensus 338 lA~~~~~-----~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~-~- 410 (689)
T 3v5w_A 338 LACDFSK-----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-A- 410 (689)
T ss_dssp TCEECSS-----CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC-C-
T ss_pred eeeecCC-----CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC-C-
Confidence 9976522 2235679999999999997546799999999999999999999999976432 2223333332 2
Q ss_pred CCCccccccchHHHHHHHHHhhhcCCCCCCC-----HHHHHhchhccccccchHHHH
Q 005886 237 GLDYERDKRFSKSFKELVTACLVKDPKKRPT-----AEKLMKHHFFKHARSNDFLAR 288 (671)
Q Consensus 237 ~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpS-----a~eiL~Hpwfk~~~~~~~~~~ 288 (671)
...+..+|+++++||.+||.+||.+|++ +++|++||||+...|.....+
T Consensus 411 ---~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~ 464 (689)
T 3v5w_A 411 ---VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQ 464 (689)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTT
T ss_pred ---CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcC
Confidence 2335678999999999999999999998 799999999999887654433
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-54 Score=468.37 Aligned_cols=263 Identities=28% Similarity=0.415 Sum_probs=213.3
Q ss_pred ccCCCCeEEEEEecccCceEEEEEEEc---CCCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeeeEEEeCC
Q 005886 10 PVDAKDYRLYEEVGEGVSATVYRALCI---PLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHCSFTTGH 85 (671)
Q Consensus 10 ~i~~~~Y~l~~~LG~G~fG~Vyka~~~---~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~~ 85 (671)
|-..++|++.+.||+|+||+||+|+++ .+++.||||++... .....+.+|+++|+.+ +|||||+++++|.+.+
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~---~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT---SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT---SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc---cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 434578999999999999999999885 46789999998644 2346788999999988 6999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCC-CceEEecccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSN-GAIKLADFGVSACM 164 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~-g~vKL~DFGls~~~ 164 (671)
++|||||||+||+|.+++. .+++..++.+++||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+..
T Consensus 94 ~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 9999999999999999883 48999999999999999999999999999999999999877 79999999999755
Q ss_pred ccCCC-------------------------cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCC
Q 005886 165 FDAGD-------------------------RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFS 219 (671)
Q Consensus 165 ~~~~~-------------------------~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~ 219 (671)
.+... ......+.+||++|||||++.+...|+.++||||+|||+|+|++|++||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 33211 01123456899999999999886679999999999999999999999995
Q ss_pred CC-ChHHHHHHHHhc----------------------CC---------------------------CCCCccccccchHH
Q 005886 220 KY-PPMKVLLMTLQN----------------------AP---------------------------PGLDYERDKRFSKS 249 (671)
Q Consensus 220 ~~-~~~~~~~~~~~~----------------------~~---------------------------~~~~~~~~~~ls~~ 249 (671)
.. +....+..+... .+ .....+.+..+|++
T Consensus 249 ~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~ 328 (361)
T 4f9c_A 249 KASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE 328 (361)
T ss_dssp CCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred CCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence 44 333333222110 00 00011234568899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 250 FKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
++|||.+||.+||.+|||++|+|+||||++.
T Consensus 329 a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 329 AYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-54 Score=458.84 Aligned_cols=261 Identities=22% Similarity=0.413 Sum_probs=223.0
Q ss_pred ccCCCCeEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeC
Q 005886 10 PVDAKDYRLYEEVGEGVSATVYRALCI-----PLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG 84 (671)
Q Consensus 10 ~i~~~~Y~l~~~LG~G~fG~Vyka~~~-----~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~ 84 (671)
.|..++|.+.+.||+|+||+||+|++. .+|..||||+++... ....+.+.+|+.+|+.++|||||+++++|.++
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 87 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEG 87 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 467789999999999999999999875 367889999997442 34467899999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhhC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCce
Q 005886 85 HCLWVVMPYMAGGSCLHIMKSAY-----------PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAI 153 (671)
Q Consensus 85 ~~l~LVmEy~~ggsL~~~l~~~~-----------~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~v 153 (671)
+.+|||||||+||+|.+++.... ...+++..++.|+.||+.||+|||+++||||||||+|||++.++.+
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcE
Confidence 99999999999999999997642 2469999999999999999999999999999999999999999999
Q ss_pred EEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 005886 154 KLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQ 232 (671)
Q Consensus 154 KL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~ 232 (671)
||+|||+|+...... ........+||+.|||||++.+ ..|+.++|||||||+||||+| |+.||.+.+..+.+..+..
T Consensus 168 Ki~DFGla~~~~~~~-~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 245 (299)
T 4asz_A 168 KIGDFGMSRDVYSTD-YYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 245 (299)
T ss_dssp EECCCSCHHHHTGGG-CEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred EECCcccceecCCCC-ceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999997653322 2223344579999999999987 679999999999999999998 9999999988887777666
Q ss_pred cCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccc
Q 005886 233 NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKH 279 (671)
Q Consensus 233 ~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~ 279 (671)
...+ +.+..+|+++.+||.+||..||.+|||+.+| |+|++.
T Consensus 246 ~~~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 246 GRVL----QRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred CCCC----CCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 5432 3456789999999999999999999999999 567753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-54 Score=454.32 Aligned_cols=262 Identities=26% Similarity=0.419 Sum_probs=215.5
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH 85 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~ 85 (671)
..|+|+.++|++.+.||+|+||+||+|++. ..||||+++.... ....+.+.+|+.+|+.++|||||++++++.+ +
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~ 104 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D 104 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C
Confidence 358899999999999999999999999854 3599999875432 3446789999999999999999999998765 5
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
.+|||||||+||+|.+++... ...+++..+..|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|+...
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred eEEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 689999999999999999764 3569999999999999999999999999999999999999999999999999997653
Q ss_pred cCCCcccccccccCCCCCCChhHhhhc--cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCccc
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQL--HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP-PGLDYER 242 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~--~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~-~~~~~~~ 242 (671)
... ........+||+.|||||++.+. ..|+.++|||||||+||||+||+.||.+......+...+.... .......
T Consensus 184 ~~~-~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 262 (307)
T 3omv_A 184 RWS-GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKL 262 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTS
T ss_pred cCC-cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Confidence 222 22234567899999999999752 3589999999999999999999999998777665555554322 2112234
Q ss_pred cccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 243 DKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 243 ~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
+..++.++++||.+||..||.+|||+.+|+.+
T Consensus 263 ~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 263 YKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 56789999999999999999999999988654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-54 Score=454.28 Aligned_cols=260 Identities=22% Similarity=0.344 Sum_probs=223.7
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCI-----PLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT 83 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~-----~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~ 83 (671)
.++...++++.++||+|+||+||+|... .+++.||||++.........+.+.+|+.+|+.++|||||++++++.+
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 3567789999999999999999999864 46789999999765545557889999999999999999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcC
Q 005886 84 GHCLWVVMPYMAGGSCLHIMKSAY--------------PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS 149 (671)
Q Consensus 84 ~~~l~LVmEy~~ggsL~~~l~~~~--------------~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~ 149 (671)
+..+|||||||++|+|.+++.... ...+++..+..|+.||+.||+|||+++||||||||+|||++.
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence 999999999999999999997542 135899999999999999999999999999999999999999
Q ss_pred CCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 005886 150 NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLL 228 (671)
Q Consensus 150 ~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~ 228 (671)
++.+||+|||+|+.+.... ........+||+.|||||++.+ ..|+.++|||||||+||||+| |..||.+.+..+...
T Consensus 181 ~~~~Ki~DFGlar~~~~~~-~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAAD-YYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp GGCEEECCSCCBCGGGGGG-CBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCEEECCcccceeccCCC-ceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999998664322 2233455689999999999987 679999999999999999998 899999998877766
Q ss_pred HHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 229 MTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 229 ~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
.+..... .+.+..++..+.+||.+||..||.+|||+.+|+++
T Consensus 259 ~i~~~~~----~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 259 MIRNRQV----LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCC----CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 6654432 23456789999999999999999999999999764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=456.62 Aligned_cols=258 Identities=23% Similarity=0.406 Sum_probs=215.7
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCI-----PLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT 83 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~-----~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~ 83 (671)
..+..++|.+.++||+|+||+||+|++. .++..||||+++... ....+.+.+|+.+|+.++|||||+++++|.+
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 114 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVRFFGVCTE 114 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 4567789999999999999999999875 368899999996432 3446789999999999999999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCC
Q 005886 84 GHCLWVVMPYMAGGSCLHIMKSAY-------------PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSN 150 (671)
Q Consensus 84 ~~~l~LVmEy~~ggsL~~~l~~~~-------------~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~ 150 (671)
...+|||||||+||+|.+++.... ...+++..++.|+.||+.||+|||+++||||||||+|||++.+
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG 194 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC
Confidence 999999999999999999997642 2458999999999999999999999999999999999999999
Q ss_pred CceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 005886 151 GAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLM 229 (671)
Q Consensus 151 g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~ 229 (671)
+.+||+|||+|+.+... .........+||+.|||||++.+ ..|+.++|||||||+||||+| |+.||.+.+..+.+..
T Consensus 195 ~~~Ki~DFGla~~~~~~-~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 272 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYST-DYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272 (329)
T ss_dssp TEEEECCCC-----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred CcEEEcccccceeccCC-CcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999765332 22223345689999999999987 679999999999999999999 9999999888877766
Q ss_pred HHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 230 TLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 230 ~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
+..... .+.+..+++++.+||.+||..||.+|||+.+|+.
T Consensus 273 i~~g~~----~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 312 (329)
T 4aoj_A 273 ITQGRE----LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHA 312 (329)
T ss_dssp HHHTCC----CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred HHcCCC----CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 665432 3345678999999999999999999999999976
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-53 Score=486.84 Aligned_cols=262 Identities=24% Similarity=0.393 Sum_probs=231.1
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
.++|++++.||+|+||+||+|.++.+|+.||||++.... ....+.+.+|+.+|+.++|||||+++++|.++..+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 368999999999999999999999999999999997543 3346788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCC--CceEEeccccccccccCCCc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSN--GAIKLADFGVSACMFDAGDR 170 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~--g~vKL~DFGls~~~~~~~~~ 170 (671)
||.||+|++++... ...+++..++.|++||+.||+|||++||+||||||+|||++.+ |.+||+|||+|+.+..
T Consensus 235 ~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~---- 309 (573)
T 3uto_A 235 FMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---- 309 (573)
T ss_dssp CCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT----
T ss_pred ecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC----
Confidence 99999999988643 2569999999999999999999999999999999999999854 8999999999986632
Q ss_pred ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHH
Q 005886 171 QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSF 250 (671)
Q Consensus 171 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l 250 (671)
.......+||+.|||||++.+ ..|+.++|||||||++|+|++|.+||.+....+.+..+... ...+....+..+|.++
T Consensus 310 ~~~~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~s~~~ 387 (573)
T 3uto_A 310 KQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC-DWNMDDSAFSGISEDG 387 (573)
T ss_dssp TSEEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT-CCCCCSGGGTTSCHHH
T ss_pred CCceeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhC-CCCCCcccccCCCHHH
Confidence 223346799999999999988 67999999999999999999999999998887776665543 3334445567899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 251 KELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 251 ~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
++||.+||.+||.+|||+.++|+||||+...+
T Consensus 388 ~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 388 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 99999999999999999999999999986544
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-53 Score=457.01 Aligned_cols=263 Identities=21% Similarity=0.358 Sum_probs=223.7
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcCCC-----cEEEEEEeccccCcccHHHHHHHHHHHHhCCC-CCceeeeeE
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLN-----EIVAIKVLDLEKCNNDLDGIRREVQTMRVTNH-PNVLRAHCS 80 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg-----~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~H-pNIVkl~~~ 80 (671)
++|+|..++|++.+.||+|+||+||+|.+..++ +.||||++...........+.+|+.+|+.+.| ||||+++++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 357889999999999999999999999987544 67999999766555567789999999999965 999999999
Q ss_pred EEe-CCEEEEEEeccCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcE
Q 005886 81 FTT-GHCLWVVMPYMAGGSCLHIMKSAY--------------PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNI 145 (671)
Q Consensus 81 ~~~-~~~l~LVmEy~~ggsL~~~l~~~~--------------~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNI 145 (671)
|.. +..+|||||||.||+|.++++... ...+++..+..|+.||+.||+|||+++||||||||+||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI 216 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 216 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence 976 467999999999999999997532 23489999999999999999999999999999999999
Q ss_pred EEcCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChH
Q 005886 146 LIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPM 224 (671)
Q Consensus 146 Lld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~ 224 (671)
|++.++.+||+|||+|+.+..... .......+||+.|||||++.+ ..|+.++|||||||+||||+| |..||.+....
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred eeCCCCCEEECcchhhhhcccCCC-ceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999986643322 223456789999999999987 679999999999999999998 99999987655
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 225 KVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
+.+...+... ...+.+..+++++++||.+||..||.+|||+.+|++|
T Consensus 295 ~~~~~~i~~g---~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 295 EEFCRRLKEG---TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHHHHT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcC---CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 5554444432 1233456789999999999999999999999999986
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-50 Score=426.40 Aligned_cols=260 Identities=30% Similarity=0.463 Sum_probs=229.2
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWV 89 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~L 89 (671)
...++|++++.||+|+||.||+|.+..+|+.||||++...... .....+.+|+.+|+.++||||+++++++.+...+|+
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 3457899999999999999999999999999999999765432 346778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCC
Q 005886 90 VMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~ 169 (671)
|||||.||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 92 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-- 167 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-- 167 (328)
T ss_dssp EECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--
T ss_pred EEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC--
Confidence 99999999999999876 67999999999999999999999999999999999999999999999999998755322
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHH
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.........+..... ..+..++.+
T Consensus 168 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----~~p~~~s~~ 240 (328)
T 3fe3_A 168 --GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-----RIPFYMSTD 240 (328)
T ss_dssp --CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----CCCTTSCHH
T ss_pred --CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----CCCCCCCHH
Confidence 2345578999999999998854446899999999999999999999999887776666655432 234567999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 250 FKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
+.+||.+||..||.+|||++++|+||||+...
T Consensus 241 ~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 241 CENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 99999999999999999999999999998654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=428.70 Aligned_cols=265 Identities=28% Similarity=0.448 Sum_probs=232.3
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEecccc--CcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEK--CNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~--~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~ 88 (671)
+..++|++++.||+|+||+||+|+++.+|+.||||++.... .......+.+|+.+|+.++||||++++++|.+...+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 45689999999999999999999999999999999997543 2345678899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
+||||+.||+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 82 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 158 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD- 158 (337)
T ss_dssp EEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC-
Confidence 999999999999999876 67999999999999999999999999999999999999999999999999998653222
Q ss_pred CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchH
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSK 248 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~ 248 (671)
.......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.........+..... ..+..++.
T Consensus 159 --~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-----~~p~~~s~ 230 (337)
T 1o6l_A 159 --GATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-----RFPRTLSP 230 (337)
T ss_dssp --TCCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----CCCTTSCH
T ss_pred --CCcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-----CCCCCCCH
Confidence 223456789999999999987 6799999999999999999999999998777666655554322 23456899
Q ss_pred HHHHHHHHhhhcCCCCCC-----CHHHHHhchhccccccchHH
Q 005886 249 SFKELVTACLVKDPKKRP-----TAEKLMKHHFFKHARSNDFL 286 (671)
Q Consensus 249 ~l~dLI~~cL~~dP~kRp-----Sa~eiL~Hpwfk~~~~~~~~ 286 (671)
++++||.+||.+||.+|| ++.++++||||+...|....
T Consensus 231 ~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~ 273 (337)
T 1o6l_A 231 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVV 273 (337)
T ss_dssp HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHH
T ss_pred HHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence 999999999999999999 89999999999987765433
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=433.74 Aligned_cols=267 Identities=26% Similarity=0.463 Sum_probs=226.1
Q ss_pred ccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEecccc--CcccHHHHHHHHHHHHhC-CCCCceeeeeEEEeC
Q 005886 8 RFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEK--CNNDLDGIRREVQTMRVT-NHPNVLRAHCSFTTG 84 (671)
Q Consensus 8 ~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~--~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~ 84 (671)
.-.+..++|++++.||+|+||+||+|+++.+|+.||||++.... .......+.+|..+++.+ +||||++++++|.+.
T Consensus 17 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 96 (353)
T 3txo_A 17 SNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP 96 (353)
T ss_dssp ------CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred cCCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC
Confidence 34567789999999999999999999999999999999997543 124467788999999987 799999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccc
Q 005886 85 HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACM 164 (671)
Q Consensus 85 ~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~ 164 (671)
..+|+|||||.||+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999999999877 67999999999999999999999999999999999999999999999999998643
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccc
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (671)
.. ........+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+..+....+..... ..+.
T Consensus 175 ~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-----~~p~ 245 (353)
T 3txo_A 175 IC---NGVTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-----VYPT 245 (353)
T ss_dssp CC------------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----CCCT
T ss_pred cc---CCccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----CCCC
Confidence 22 1223456789999999999987 5699999999999999999999999999888777766665432 2245
Q ss_pred cchHHHHHHHHHhhhcCCCCCCCH------HHHHhchhccccccchH
Q 005886 245 RFSKSFKELVTACLVKDPKKRPTA------EKLMKHHFFKHARSNDF 285 (671)
Q Consensus 245 ~ls~~l~dLI~~cL~~dP~kRpSa------~eiL~Hpwfk~~~~~~~ 285 (671)
.++..+++||.+||.+||.+||++ .++++||||+...|...
T Consensus 246 ~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l 292 (353)
T 3txo_A 246 WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQL 292 (353)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHH
T ss_pred CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHH
Confidence 689999999999999999999998 99999999998776433
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=414.51 Aligned_cols=261 Identities=38% Similarity=0.696 Sum_probs=230.3
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
..++|++++.||+|+||+||+|.+..+|+.||||++..... ...+.+.+|+.+++.++||||++++++|...+.+|+||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc-cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 34789999999999999999999999999999999975543 33577899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
|||.||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 97 e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~ 170 (297)
T 3fxz_A 97 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---Q 170 (297)
T ss_dssp ECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST---T
T ss_pred ECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc---c
Confidence 999999999999764 6999999999999999999999999999999999999999999999999998765322 2
Q ss_pred cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHH
Q 005886 172 RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~ 251 (671)
......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.........+.....+.+ ..+..++..++
T Consensus 171 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 247 (297)
T 3fxz_A 171 SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL--QNPEKLSAIFR 247 (297)
T ss_dssp CCBCCCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC--SCGGGSCHHHH
T ss_pred cccCCccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--CCccccCHHHH
Confidence 23445689999999999987 6799999999999999999999999998887776666655544333 33567899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 252 ELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 252 dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
+||.+||..||.+|||+.++|+||||+....
T Consensus 248 ~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 278 (297)
T 3fxz_A 248 DFLNRCLEMDVEKRGSAKELLQHQFLKIAKP 278 (297)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence 9999999999999999999999999987654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=427.86 Aligned_cols=263 Identities=25% Similarity=0.384 Sum_probs=230.4
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-----ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-----NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCL 87 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-----~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l 87 (671)
.+.|++.+.||+|+||+||+|.++.+|+.||+|++...... ...+.+.+|+.+|+.++||||++++++|.+...+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 36799999999999999999999999999999999765432 2357899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC----ceEEeccccccc
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG----AIKLADFGVSAC 163 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g----~vKL~DFGls~~ 163 (671)
|+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 91 ~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 9999999999999999765 6799999999999999999999999999999999999998877 799999999876
Q ss_pred cccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 005886 164 MFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 243 (671)
Q Consensus 164 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (671)
+... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+....+.+..+... ...+....+
T Consensus 169 ~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~ 242 (361)
T 2yab_A 169 IEDG----VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV-SYDFDEEFF 242 (361)
T ss_dssp CCTT----CCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT-CCCCCHHHH
T ss_pred cCCC----CccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCCCchhc
Confidence 5321 22345689999999999987 57999999999999999999999999988777666555443 334444556
Q ss_pred ccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccccc
Q 005886 244 KRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSN 283 (671)
Q Consensus 244 ~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~ 283 (671)
..++..+++||.+||.+||.+|||+.++|+||||+...+.
T Consensus 243 ~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~ 282 (361)
T 2yab_A 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQ 282 (361)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSHH
T ss_pred cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCchh
Confidence 7889999999999999999999999999999999866543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=420.45 Aligned_cols=264 Identities=29% Similarity=0.482 Sum_probs=232.9
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~ 88 (671)
+..++|++++.||+|+||.||+|+++.+|+.||+|++..... ....+.+.+|+.+++.++||||++++++|.+...+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 356899999999999999999999999999999999975432 244678889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
+||||+.||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 83 lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 158 (318)
T ss_dssp EEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred EEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence 999999999999999876 6799999999999999999999999999999999999999999999999999875421
Q ss_pred CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchH
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSK 248 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~ 248 (671)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.........+..... ..+..++.
T Consensus 159 ----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----~~p~~~~~ 228 (318)
T 1fot_A 159 ----VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-----RFPPFFNE 228 (318)
T ss_dssp ----CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-----CCCTTSCH
T ss_pred ----ccccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----CCCCCCCH
Confidence 2345689999999999987 6799999999999999999999999998887777666665432 23456899
Q ss_pred HHHHHHHHhhhcCCCCCC-----CHHHHHhchhccccccchHHHH
Q 005886 249 SFKELVTACLVKDPKKRP-----TAEKLMKHHFFKHARSNDFLAR 288 (671)
Q Consensus 249 ~l~dLI~~cL~~dP~kRp-----Sa~eiL~Hpwfk~~~~~~~~~~ 288 (671)
++++||.+||..||.+|| +++++++||||+...+.....+
T Consensus 229 ~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~ 273 (318)
T 1fot_A 229 DVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSR 273 (318)
T ss_dssp HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTT
T ss_pred HHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhC
Confidence 999999999999999999 8999999999998877554433
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=426.46 Aligned_cols=268 Identities=28% Similarity=0.500 Sum_probs=230.7
Q ss_pred ccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhC-CCCCceeeeeEEEeC
Q 005886 8 RFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVT-NHPNVLRAHCSFTTG 84 (671)
Q Consensus 8 ~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~ 84 (671)
...+..++|++.+.||+|+||.||+|+++.+|+.||||++..... ......+..|..++..+ +||||++++++|.+.
T Consensus 11 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~ 90 (345)
T 1xjd_A 11 QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 90 (345)
T ss_dssp -----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred cCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC
Confidence 345678999999999999999999999999999999999975432 34467788899999876 999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccc
Q 005886 85 HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACM 164 (671)
Q Consensus 85 ~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~ 164 (671)
..+|+|||||.||+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 9999999999999999999876 57999999999999999999999999999999999999999999999999998653
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccc
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (671)
... .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+..+....+....+ ..+.
T Consensus 169 ~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-----~~p~ 239 (345)
T 1xjd_A 169 MLG---DAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP-----FYPR 239 (345)
T ss_dssp CCT---TCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----CCCT
T ss_pred ccC---CCcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCC-----CCCc
Confidence 221 123456799999999999987 6799999999999999999999999998887766665554432 2245
Q ss_pred cchHHHHHHHHHhhhcCCCCCCCHH-HHHhchhccccccchHH
Q 005886 245 RFSKSFKELVTACLVKDPKKRPTAE-KLMKHHFFKHARSNDFL 286 (671)
Q Consensus 245 ~ls~~l~dLI~~cL~~dP~kRpSa~-eiL~Hpwfk~~~~~~~~ 286 (671)
.++.++++||.+||..||.+||++. ++++||||+...|....
T Consensus 240 ~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l~ 282 (345)
T 1xjd_A 240 WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELE 282 (345)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHH
T ss_pred ccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHHHHh
Confidence 6899999999999999999999998 99999999988775443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=430.71 Aligned_cols=268 Identities=28% Similarity=0.477 Sum_probs=226.0
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhC-CCCCceeeeeEEEeCC
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVT-NHPNVLRAHCSFTTGH 85 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~~ 85 (671)
..+..++|++++.||+|+||+||+|+++.+++.||+|++.+.... .....+.+|..++..+ +||||++++++|.+..
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 456778999999999999999999999999999999999765432 3345688899999876 8999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
.+|+|||||.||+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 999999999999999999876 679999999999999999999999999999999999999999999999999987532
Q ss_pred cCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHhcCCCC
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYP--------PMKVLLMTLQNAPPG 237 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~--------~~~~~~~~~~~~~~~ 237 (671)
.. .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.... ....+...+.....
T Consensus 205 ~~---~~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~- 279 (396)
T 4dc2_A 205 RP---GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI- 279 (396)
T ss_dssp CT---TCCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-
T ss_pred cC---CCccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-
Confidence 22 223456799999999999987 679999999999999999999999996431 12223333333222
Q ss_pred CCccccccchHHHHHHHHHhhhcCCCCCCCH------HHHHhchhccccccchHH
Q 005886 238 LDYERDKRFSKSFKELVTACLVKDPKKRPTA------EKLMKHHFFKHARSNDFL 286 (671)
Q Consensus 238 ~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa------~eiL~Hpwfk~~~~~~~~ 286 (671)
..+..++.++++||.+||.+||.+||++ ++|++||||+...|....
T Consensus 280 ---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~ 331 (396)
T 4dc2_A 280 ---RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMME 331 (396)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHH
T ss_pred ---CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHH
Confidence 2345689999999999999999999985 899999999988775443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=425.04 Aligned_cols=275 Identities=36% Similarity=0.621 Sum_probs=228.7
Q ss_pred cccccCCCCeEEEEEeccc--CceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEe
Q 005886 7 KRFPVDAKDYRLYEEVGEG--VSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTT 83 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G--~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~ 83 (671)
.+|....++|++++.||+| +||+||+|+++.+|+.||||++...... .....+.+|+.+++.++|||||+++++|.+
T Consensus 18 s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 97 (389)
T 3gni_B 18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA 97 (389)
T ss_dssp CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE
Confidence 4678889999999999999 9999999999999999999999766533 345778899999999999999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccc
Q 005886 84 GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSAC 163 (671)
Q Consensus 84 ~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~ 163 (671)
++.+|+|||||.||+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 99999999999999999999887667799999999999999999999999999999999999999999999999998865
Q ss_pred cccCCCcc----cccccccCCCCCCChhHhhhc-cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-
Q 005886 164 MFDAGDRQ----RSRNTFVGTPCWMAPEVMQQL-HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG- 237 (671)
Q Consensus 164 ~~~~~~~~----~~~~~~~GT~~Y~APEvl~~~-~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~- 237 (671)
....+... ......+||+.|+|||++.+. ..|+.++|||||||++|+|++|+.||.+..........+....+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 54332211 122335899999999999863 468999999999999999999999998776655444333221110
Q ss_pred ----------------------------------------CCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 238 ----------------------------------------LDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 238 ----------------------------------------~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
...+.+..+++.+++||.+||..||.+|||+.++|+||||
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f 337 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 337 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence 0112345678899999999999999999999999999999
Q ss_pred cccc
Q 005886 278 KHAR 281 (671)
Q Consensus 278 k~~~ 281 (671)
+...
T Consensus 338 ~~~~ 341 (389)
T 3gni_B 338 KQIK 341 (389)
T ss_dssp GGC-
T ss_pred HHHh
Confidence 8654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=423.77 Aligned_cols=269 Identities=26% Similarity=0.430 Sum_probs=232.0
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhC-CCCCceeeeeEEEeCC
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVT-NHPNVLRAHCSFTTGH 85 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~~ 85 (671)
-.+..++|++++.||+|+||.||+|+++.+|+.||||++..... ......+.+|..++..+ +||||++++++|.+..
T Consensus 15 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 94 (353)
T 2i0e_A 15 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 94 (353)
T ss_dssp ----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred CCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence 45678899999999999999999999999999999999975432 24467788999999887 8999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
.+|+|||||.||+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 999999999999999999876 579999999999999999999999999999999999999999999999999987532
Q ss_pred cCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (671)
.. .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+..+....+..... ..+..
T Consensus 173 ~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-----~~p~~ 243 (353)
T 2i0e_A 173 WD---GVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-----AYPKS 243 (353)
T ss_dssp CT---TCCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----CCCTT
T ss_pred cC---CcccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC-----CCCCC
Confidence 21 223456789999999999987 6799999999999999999999999998887776666665432 23457
Q ss_pred chHHHHHHHHHhhhcCCCCCCC-----HHHHHhchhccccccchHHHH
Q 005886 246 FSKSFKELVTACLVKDPKKRPT-----AEKLMKHHFFKHARSNDFLAR 288 (671)
Q Consensus 246 ls~~l~dLI~~cL~~dP~kRpS-----a~eiL~Hpwfk~~~~~~~~~~ 288 (671)
++.++++||.+||.+||.+||+ +++|++||||+...|.....+
T Consensus 244 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~ 291 (353)
T 2i0e_A 244 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERK 291 (353)
T ss_dssp SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTT
T ss_pred CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhC
Confidence 8999999999999999999994 799999999998877655443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=419.63 Aligned_cols=265 Identities=30% Similarity=0.507 Sum_probs=225.9
Q ss_pred ccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhC-CCCCceeeeeEEEeCCE
Q 005886 10 PVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVT-NHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 10 ~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~~~ 86 (671)
++..++|++++.||+|+||.||+|+++.+|+.||||++...... .....+.+|+.+++.+ +||||++++++|.+...
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 45678999999999999999999999999999999999865433 3456788999999887 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
+|+|||||.||+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999999999999876 5799999999999999999999999999999999999999999999999999875422
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHhcCCCCC
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYP--------PMKVLLMTLQNAPPGL 238 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~--------~~~~~~~~~~~~~~~~ 238 (671)
.+ ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.... ........+.....
T Consensus 163 ~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~-- 236 (345)
T 3a8x_A 163 PG---DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-- 236 (345)
T ss_dssp TT---CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC--
T ss_pred CC---CcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC--
Confidence 22 23456789999999999987 678999999999999999999999996521 11222222322222
Q ss_pred CccccccchHHHHHHHHHhhhcCCCCCCCH------HHHHhchhccccccch
Q 005886 239 DYERDKRFSKSFKELVTACLVKDPKKRPTA------EKLMKHHFFKHARSND 284 (671)
Q Consensus 239 ~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa------~eiL~Hpwfk~~~~~~ 284 (671)
..+..++..+++||.+||.+||.+||++ .++++||||+...|..
T Consensus 237 --~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~ 286 (345)
T 3a8x_A 237 --RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDM 286 (345)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHH
T ss_pred --CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHH
Confidence 2345689999999999999999999995 8999999999876643
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=418.82 Aligned_cols=253 Identities=24% Similarity=0.308 Sum_probs=194.5
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC----EEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH----CLWV 89 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~----~l~L 89 (671)
++|.+.+.||+|+||+||+|++ +|+.||||+++... ........|+..+..++|||||++++++.+++ .+||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 5799999999999999999987 48999999986432 11223345666667899999999999998654 6899
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccccCCCCcEEEcCCCceEEeccccc
Q 005886 90 VMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH--------GHIHRDVKAGNILIDSNGAIKLADFGVS 161 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~--------gIVHrDLKPeNILld~~g~vKL~DFGls 161 (671)
|||||+||+|.+++... .+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+|
T Consensus 79 V~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 99999999999999764 689999999999999999999987 9999999999999999999999999999
Q ss_pred cccccCCCc-ccccccccCCCCCCChhHhhhcc-----CCCccchhhhHHHHHHHHHhCCCCCCCCC-------------
Q 005886 162 ACMFDAGDR-QRSRNTFVGTPCWMAPEVMQQLH-----GYDFKADIWSFGITALELAHGHAPFSKYP------------- 222 (671)
Q Consensus 162 ~~~~~~~~~-~~~~~~~~GT~~Y~APEvl~~~~-----~~s~ksDIWSLGvILyeLltG~~PF~~~~------------- 222 (671)
+........ .......+||+.|||||++.+.. .|+.++|||||||+||||+||.+||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 766433322 12234568999999999997532 26779999999999999999977663211
Q ss_pred -hHHHHHHHH-hc-CCCCCCcc-ccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 223 -PMKVLLMTL-QN-APPGLDYE-RDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 223 -~~~~~~~~~-~~-~~~~~~~~-~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
....+...+ .. ..+.++.. .....+..+.+||.+||..||.+|||+.+|++
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 112222222 11 11222111 11234567899999999999999999999976
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=421.52 Aligned_cols=261 Identities=26% Similarity=0.424 Sum_probs=231.5
Q ss_pred ccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q 005886 10 PVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCL 87 (671)
Q Consensus 10 ~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l 87 (671)
....++|++++.||+|+||.||+|+++.+|+.||||++..... ......+.+|+.+|+.++||||++++++|.+...+
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 4566899999999999999999999999999999999975432 24467889999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccC
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~ 167 (671)
|+||||+.||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 117 ~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~- 193 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC-
Confidence 9999999999999999876 5799999999999999999999999999999999999999999999999999875521
Q ss_pred CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccch
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls 247 (671)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.........+..... ..+..++
T Consensus 194 -----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-----~~p~~~~ 262 (350)
T 1rdq_E 194 -----RTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFS 262 (350)
T ss_dssp -----CBCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----CCCTTCC
T ss_pred -----CcccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC-----CCCCCCC
Confidence 2345689999999999987 6799999999999999999999999998887776666665422 2345689
Q ss_pred HHHHHHHHHhhhcCCCCCCC-----HHHHHhchhccccccch
Q 005886 248 KSFKELVTACLVKDPKKRPT-----AEKLMKHHFFKHARSND 284 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRpS-----a~eiL~Hpwfk~~~~~~ 284 (671)
.++++||.+||..||.+||+ +++|++||||+...|..
T Consensus 263 ~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~ 304 (350)
T 1rdq_E 263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304 (350)
T ss_dssp HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHH
T ss_pred HHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHH
Confidence 99999999999999999998 99999999999776643
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=404.15 Aligned_cols=263 Identities=25% Similarity=0.379 Sum_probs=217.0
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
++|++++.||+|+||+||+|.+..+|+.||||++...... .....+.+|+.+++.++||||+++++++.++..+|+|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 6899999999999999999999999999999999765533 335778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
||.| ++...+... .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 82 ~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~---~~~ 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI---PVR 156 (292)
T ss_dssp CCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS---CCS
T ss_pred cCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCC---ccc
Confidence 9976 555555443 26799999999999999999999999999999999999999999999999999875522 222
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCC-CCCCChHHHHHHHHhcC--CCCCC----------
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAP-FSKYPPMKVLLMTLQNA--PPGLD---------- 239 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~P-F~~~~~~~~~~~~~~~~--~~~~~---------- 239 (671)
.....+||+.|+|||++.+...++.++|||||||++|+|++|..| |.+......+..+.... +....
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 334568999999999998755689999999999999999987777 55555444444333211 10000
Q ss_pred ------------ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 240 ------------YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 240 ------------~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
......++..+++||.+||..||.+|||++++|+||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 011235789999999999999999999999999999998643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=413.69 Aligned_cols=270 Identities=26% Similarity=0.434 Sum_probs=223.4
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEc---CCCcEEEEEEeccccC---cccHHHHHHHHHHHHhCCCCCceeeeeEEE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCI---PLNEIVAIKVLDLEKC---NNDLDGIRREVQTMRVTNHPNVLRAHCSFT 82 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~---~tg~~VAIKvi~~~~~---~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~ 82 (671)
..+..++|++.+.||+|+||.||+|++. .+|+.||+|++..... ......+.+|+.+|+.++||||++++++|.
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 4567789999999999999999999985 6899999999976532 233566789999999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccc
Q 005886 83 TGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSA 162 (671)
Q Consensus 83 ~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~ 162 (671)
....+|+|||||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999999999876 579999999999999999999999999999999999999999999999999986
Q ss_pred ccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccc
Q 005886 163 CMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER 242 (671)
Q Consensus 163 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~ 242 (671)
...... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..... ..
T Consensus 170 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-----~~ 240 (327)
T 3a62_A 170 ESIHDG---TVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-----NL 240 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-----CC
T ss_pred ccccCC---ccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-----CC
Confidence 542221 22345689999999999987 5689999999999999999999999998877776666655422 23
Q ss_pred cccchHHHHHHHHHhhhcCCCCCC-----CHHHHHhchhccccccchHHHHH
Q 005886 243 DKRFSKSFKELVTACLVKDPKKRP-----TAEKLMKHHFFKHARSNDFLARS 289 (671)
Q Consensus 243 ~~~ls~~l~dLI~~cL~~dP~kRp-----Sa~eiL~Hpwfk~~~~~~~~~~~ 289 (671)
+..++..+++||.+||..||.+|| ++.++++||||+...+.....+.
T Consensus 241 p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~~ 292 (327)
T 3a62_A 241 PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARK 292 (327)
T ss_dssp CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTTC
T ss_pred CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhcc
Confidence 456899999999999999999999 89999999999988776554433
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=414.43 Aligned_cols=259 Identities=23% Similarity=0.370 Sum_probs=226.7
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
.++|++.+.||+|+||+||+|.+..+|+.||+|++.... .....+.+|+.+++.++||||++++++|.+...+|+|||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 478999999999999999999999999999999986442 345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcC--CCceEEeccccccccccCCCc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS--NGAIKLADFGVSACMFDAGDR 170 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~--~g~vKL~DFGls~~~~~~~~~ 170 (671)
||.||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..+...
T Consensus 82 ~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~--- 157 (321)
T 1tki_A 82 FISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--- 157 (321)
T ss_dssp CCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT---
T ss_pred eCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC---
Confidence 99999999998654 246999999999999999999999999999999999999987 789999999998765321
Q ss_pred ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHH
Q 005886 171 QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSF 250 (671)
Q Consensus 171 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l 250 (671)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.... ..+....+..++.++
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~s~~~ 234 (321)
T 1tki_A 158 -DNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE-YTFDEEAFKEISIEA 234 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CCCCHHHHTTSCHHH
T ss_pred -CccccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCC-CCCChhhhccCCHHH
Confidence 22345689999999999987 558999999999999999999999999888776666555543 333444456789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 251 KELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 251 ~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
++||.+||..||.+|||+.++|+||||+..
T Consensus 235 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 235 MDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 999999999999999999999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=409.54 Aligned_cols=261 Identities=26% Similarity=0.387 Sum_probs=227.4
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-----ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-----NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-----~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~ 88 (671)
+.|++.+.||+|+||.||+|.++.+|+.||+|++...... ...+.+.+|+.+|+.++||||++++++|.+...+|
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 5799999999999999999999999999999999765432 24678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC----ceEEecccccccc
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG----AIKLADFGVSACM 164 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g----~vKL~DFGls~~~ 164 (671)
+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..+
T Consensus 91 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 999999999999999765 6799999999999999999999999999999999999998887 7999999998765
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccc
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (671)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+.+..+... ...+....+.
T Consensus 169 ~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~ 242 (326)
T 2y0a_A 169 DFG----NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV-NYEFEDEYFS 242 (326)
T ss_dssp CTT----SCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHT-CCCCCHHHHT
T ss_pred CCC----CccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhc-CCCcCccccc
Confidence 321 12345689999999999986 56999999999999999999999999987776665554433 2333344456
Q ss_pred cchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 245 RFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 245 ~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
.++..+++||.+||..||.+|||+.++|+||||+....
T Consensus 243 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 280 (326)
T 2y0a_A 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 280 (326)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSH
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcc
Confidence 78999999999999999999999999999999986543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=418.99 Aligned_cols=258 Identities=27% Similarity=0.461 Sum_probs=225.8
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
++|++.+.||+|+||.||+|.++.+|+.||+|++...... .....+.+|+.+++.++||||++++++|.+...+|+|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 4799999999999999999999999999999999765433 346788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCC---CceEEeccccccccccCCC
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSN---GAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~---g~vKL~DFGls~~~~~~~~ 169 (671)
||.||+|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 109 ~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~-- 184 (362)
T 2bdw_A 109 LVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-- 184 (362)
T ss_dssp CCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC--
T ss_pred cCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC--
Confidence 99999999988765 579999999999999999999999999999999999999765 45999999998755321
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHH
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.........+.... ..+....+..++.+
T Consensus 185 --~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~ 260 (362)
T 2bdw_A 185 --EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA-YDYPSPEWDTVTPE 260 (362)
T ss_dssp --CSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCTTGGGGSCHH
T ss_pred --cccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-CCCCcccccCCCHH
Confidence 22345689999999999987 579999999999999999999999999887766655554433 33344456778999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHhchhccc
Q 005886 250 FKELVTACLVKDPKKRPTAEKLMKHHFFKH 279 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~ 279 (671)
+++||.+||..||.+||++.++|+||||+.
T Consensus 261 ~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 261 AKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 999999999999999999999999999975
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=411.17 Aligned_cols=268 Identities=24% Similarity=0.373 Sum_probs=211.2
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
..++|++++.||+|+||.||+|.++.+|+.||||++...........+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 45789999999999999999999999999999999986655555678889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccC
Q 005886 92 PYMAGGSCLHIMKSAY----PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~----~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~ 167 (671)
||+. |+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+...
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 9998 58988886542 245899999999999999999999999999999999999999999999999998755221
Q ss_pred CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CCCCC------
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA--PPGLD------ 239 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~--~~~~~------ 239 (671)
.......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+....+.+..+.... +....
T Consensus 162 ---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 162 ---VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp ---CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred ---cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 1223456899999999999875668999999999999999999999999887766555443211 10000
Q ss_pred ---------------------ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccccc
Q 005886 240 ---------------------YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSN 283 (671)
Q Consensus 240 ---------------------~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~ 283 (671)
......++.++++||.+||..||.+|||+.++|+||||+.....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence 01122578899999999999999999999999999999976553
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=433.72 Aligned_cols=271 Identities=30% Similarity=0.449 Sum_probs=231.4
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 86 (671)
+.+..++|++++.||+|+||+||+|+++.+|+.||+|++..... ......+.+|+.+++.++|||||+++++|.++..
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 55677899999999999999999999999999999999965321 1234567899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
+|+|||||.||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.+..
T Consensus 144 ~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp EEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 99999999999999998763 699999999999999999999999999999999999999999999999999876532
Q ss_pred CCCcccccccccCCCCCCChhHhhhccC---CCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHG---YDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 243 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~---~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (671)
.+ .....+.+||+.|+|||++.+... |+.++|||||||++|+|++|++||.+.+.......++... ..+.++.+
T Consensus 221 ~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~ 297 (410)
T 3v8s_A 221 EG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK-NSLTFPDD 297 (410)
T ss_dssp TS--EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH-HHCCCCTT
T ss_pred CC--cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc-ccccCCCc
Confidence 21 122346789999999999986321 7889999999999999999999999888777666665431 11233344
Q ss_pred ccchHHHHHHHHHhhhcCCCC--CCCHHHHHhchhccccccchH
Q 005886 244 KRFSKSFKELVTACLVKDPKK--RPTAEKLMKHHFFKHARSNDF 285 (671)
Q Consensus 244 ~~ls~~l~dLI~~cL~~dP~k--RpSa~eiL~Hpwfk~~~~~~~ 285 (671)
..++.++++||.+||..+|.+ ||++++|++||||+...|...
T Consensus 298 ~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~ 341 (410)
T 3v8s_A 298 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWE 341 (410)
T ss_dssp CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCST
T ss_pred ccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHH
Confidence 578999999999999999988 999999999999998776543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=415.94 Aligned_cols=264 Identities=24% Similarity=0.418 Sum_probs=221.6
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
.++|++++.||+|+||+||+|.+..+|+.||||++.........+.+.+|+.+++.++||||+++++++.++..+|+|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 47899999999999999999999999999999999766544445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
||.||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+... ....
T Consensus 86 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~~~~ 162 (323)
T 3tki_A 86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN-NRER 162 (323)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET-TEEC
T ss_pred cCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccC-Cccc
Confidence 99999999988654 57999999999999999999999999999999999999999999999999998755322 2223
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHH
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKE 252 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~d 252 (671)
.....+||+.|+|||++.+...++.++|||||||++|+|++|..||.................. ....+..++..+.+
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 240 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--YLNPWKKIDSAPLA 240 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT--TSTTGGGSCHHHHH
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc--cCCccccCCHHHHH
Confidence 3445789999999999987444578999999999999999999999876554333333322221 22335678999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 253 LVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 253 LI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
||.+||..||.+|||+.++|+||||+...
T Consensus 241 li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 241 LLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 99999999999999999999999998643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=430.87 Aligned_cols=259 Identities=26% Similarity=0.464 Sum_probs=226.2
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
++|++.+.||+|+||+||+|.++.+|+.||+|++...... .....+.+|+.+++.++||||++++++|.++..+|+|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 6899999999999999999999999999999999765533 345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEc---CCCceEEeccccccccccCCC
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILID---SNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld---~~g~vKL~DFGls~~~~~~~~ 169 (671)
||.||+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++......
T Consensus 91 ~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~-- 166 (444)
T 3soa_A 91 LVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-- 166 (444)
T ss_dssp CCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT--
T ss_pred eCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC--
Confidence 99999999999876 6799999999999999999999999999999999999998 4578999999998655322
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHH
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
.......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.........+.... ..+..+.+..++++
T Consensus 167 -~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~s~~ 243 (444)
T 3soa_A 167 -QQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA-YDFPSPEWDTVTPE 243 (444)
T ss_dssp -CCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCCCTTTTTTSCHH
T ss_pred -CceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC-CCCCccccccCCHH
Confidence 222345689999999999987 579999999999999999999999999887776666555443 33344456678999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHhchhccc
Q 005886 250 FKELVTACLVKDPKKRPTAEKLMKHHFFKH 279 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~ 279 (671)
+++||.+||..||.+|||+.++|+||||+.
T Consensus 244 ~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 244 AKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred HHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 999999999999999999999999999975
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=425.21 Aligned_cols=273 Identities=25% Similarity=0.449 Sum_probs=230.8
Q ss_pred ccccccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEE
Q 005886 4 VVEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSF 81 (671)
Q Consensus 4 ~~e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~ 81 (671)
++.....+..++|++++.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.+|+.++|||||+++++|
T Consensus 5 ~~~~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 84 (384)
T 4fr4_A 5 VFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF 84 (384)
T ss_dssp ---CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccCCCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 3445667788999999999999999999999999999999999975432 24567889999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccc
Q 005886 82 TTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVS 161 (671)
Q Consensus 82 ~~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls 161 (671)
.+...+|+|||||.||+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a 162 (384)
T 4fr4_A 85 QDEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIA 162 (384)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EeCCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEecccee
Confidence 9999999999999999999999875 67999999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCcccccccccCCCCCCChhHhhhc--cCCCccchhhhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhcCCCC
Q 005886 162 ACMFDAGDRQRSRNTFVGTPCWMAPEVMQQL--HGYDFKADIWSFGITALELAHGHAPFSKYPP--MKVLLMTLQNAPPG 237 (671)
Q Consensus 162 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~--~~~s~ksDIWSLGvILyeLltG~~PF~~~~~--~~~~~~~~~~~~~~ 237 (671)
..+.. .......+||+.|+|||++.+. ..|+.++|||||||++|+|++|..||..... .......+....
T Consensus 163 ~~~~~----~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~-- 236 (384)
T 4fr4_A 163 AMLPR----ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV-- 236 (384)
T ss_dssp EECCT----TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC--
T ss_pred eeccC----CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc--
Confidence 75522 2234567899999999999742 4589999999999999999999999975332 222222222222
Q ss_pred CCccccccchHHHHHHHHHhhhcCCCCCCC-HHHHHhchhccccccchHH
Q 005886 238 LDYERDKRFSKSFKELVTACLVKDPKKRPT-AEKLMKHHFFKHARSNDFL 286 (671)
Q Consensus 238 ~~~~~~~~ls~~l~dLI~~cL~~dP~kRpS-a~eiL~Hpwfk~~~~~~~~ 286 (671)
...+..++..+.+||.+||..||.+||+ ++++++||||+...|....
T Consensus 237 --~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~~ 284 (384)
T 4fr4_A 237 --VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVF 284 (384)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHHH
T ss_pred --cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHHH
Confidence 2234568999999999999999999998 9999999999988775443
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=407.96 Aligned_cols=266 Identities=28% Similarity=0.415 Sum_probs=217.8
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWV 89 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~L 89 (671)
.-.++|++++.||+|+||+||+|.+. +|+.||+|++...... .....+.+|+.+++.++||||+++++++.++..+|+
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 34588999999999999999999985 5899999999755433 235678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCC
Q 005886 90 VMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~ 169 (671)
|||||.| +|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 97 v~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~--- 171 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI--- 171 (311)
T ss_dssp EEECCSE-EHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS---
T ss_pred EEcCCCC-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC---
Confidence 9999975 788877654 35699999999999999999999999999999999999999999999999999875522
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CCCCCc-------
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA--PPGLDY------- 240 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~--~~~~~~------- 240 (671)
........+||+.|+|||++.+...++.++|||||||++|+|++|..||.+......+..+.... +....+
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP 251 (311)
T ss_dssp CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence 12233445899999999999876678999999999999999999999998876655544443211 111000
Q ss_pred ----------------cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 241 ----------------ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 241 ----------------~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
.....++.++.+||.+||.+||.+|||++++|+||||+...+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 309 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence 112346789999999999999999999999999999987643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=400.82 Aligned_cols=260 Identities=26% Similarity=0.397 Sum_probs=216.3
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
++|++++.||+|+||+||+|.+ .+|+.||+|++...... .....+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 6899999999999999999998 67999999999765432 335778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
|+.+ +|..++... .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...... ..
T Consensus 81 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~ 155 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP---VR 155 (288)
T ss_dssp CCSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred ecCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc---cc
Confidence 9976 888888754 357999999999999999999999999999999999999999999999999998755221 12
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CCCCC-----------
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA--PPGLD----------- 239 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~--~~~~~----------- 239 (671)
......||+.|+|||++.+...++.++|||||||++|+|++|..||.+......+..+.... +....
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 23345889999999999875668999999999999999999999999887766655544311 00000
Q ss_pred -----------ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccc
Q 005886 240 -----------YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKH 279 (671)
Q Consensus 240 -----------~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~ 279 (671)
......++.++.+||.+||..||.+|||+.++|+||||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 0112457899999999999999999999999999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=422.42 Aligned_cols=268 Identities=28% Similarity=0.441 Sum_probs=225.0
Q ss_pred ccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHH-HHhCCCCCceeeeeEEEeCCE
Q 005886 10 PVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQT-MRVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 10 ~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~i-L~~L~HpNIVkl~~~~~~~~~ 86 (671)
.+..++|++++.||+|+||.||+|+++.+++.||||++...... .....+.+|..+ ++.++||||++++++|.+...
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 35668999999999999999999999999999999999765432 234556677776 577899999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
+|+|||||.||+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 99999999999999999876 6799999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (671)
. .......+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+..+....++.... ..+..+
T Consensus 192 ~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-----~~~~~~ 262 (373)
T 2r5t_A 192 H---NSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-----QLKPNI 262 (373)
T ss_dssp C---CCCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC-----CCCSSS
T ss_pred C---CCccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-----CCCCCC
Confidence 2 223456799999999999987 6799999999999999999999999998877776666665421 234568
Q ss_pred hHHHHHHHHHhhhcCCCCCCCH----HHHHhchhccccccchHHHH
Q 005886 247 SKSFKELVTACLVKDPKKRPTA----EKLMKHHFFKHARSNDFLAR 288 (671)
Q Consensus 247 s~~l~dLI~~cL~~dP~kRpSa----~eiL~Hpwfk~~~~~~~~~~ 288 (671)
+..+++||.+||.+||.+||++ .++++||||+...|.....+
T Consensus 263 ~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~ 308 (373)
T 2r5t_A 263 TNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINK 308 (373)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTT
T ss_pred CHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHhC
Confidence 9999999999999999999986 69999999998877655443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=414.34 Aligned_cols=262 Identities=26% Similarity=0.429 Sum_probs=221.3
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC----cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC----NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~----~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~ 88 (671)
.++|++.+.||+|+||+||+|.++.+|+.||||++..... ....+.+.+|+.+++.++||||++++++|.++..+|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 3679999999999999999999999999999999864321 224678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCc---eEEeccccccc
Q 005886 89 VVMPYMAGGSCLHIMKSA--YPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGA---IKLADFGVSAC 163 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~--~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~---vKL~DFGls~~ 163 (671)
+|||||.||+|.+.+... ....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999998877543 2235899999999999999999999999999999999999987654 99999999876
Q ss_pred cccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 005886 164 MFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 243 (671)
Q Consensus 164 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (671)
+... .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.. ......+... ........+
T Consensus 183 ~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~-~~~~~~~~~ 256 (351)
T 3c0i_A 183 LGES---GLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKG-KYKMNPRQW 256 (351)
T ss_dssp CCTT---SCBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHT-CCCCCHHHH
T ss_pred ecCC---CeeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcC-CCCCCcccc
Confidence 5332 122345689999999999987 568999999999999999999999998743 3333333332 223333445
Q ss_pred ccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 244 KRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 244 ~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
..++.++++||.+||..||.+|||+.++|+||||+..
T Consensus 257 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 6789999999999999999999999999999999853
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=416.53 Aligned_cols=263 Identities=26% Similarity=0.387 Sum_probs=211.5
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~ 88 (671)
.....++|++++.||+|+||+||+|++..+|+.||||++.... .....+.+|+.+++.++||||++++++|.+...+|
T Consensus 15 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 15 IMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA--AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST--TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc--cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 4456789999999999999999999999999999999997543 22367889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCc--eEEecccccccccc
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGA--IKLADFGVSACMFD 166 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~--vKL~DFGls~~~~~ 166 (671)
+|||||.||+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++....
T Consensus 93 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 93 IIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred EEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999999999876 57999999999999999999999999999999999999987765 99999999864321
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChH----HHHHHHHhcCCCCCCccc
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM----KVLLMTLQNAPPGLDYER 242 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~----~~~~~~~~~~~~~~~~~~ 242 (671)
.......+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.... .....+.. . ....+.
T Consensus 171 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~-~--~~~~~~ 243 (361)
T 3uc3_A 171 ----HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS-V--KYSIPD 243 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHT-T--CCCCCT
T ss_pred ----cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhc-C--CCCCCC
Confidence 122345689999999999987433344589999999999999999999875432 22222222 1 223334
Q ss_pred cccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 243 DKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 243 ~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
+..++..+++||.+||..||.+|||+.++|+||||.....
T Consensus 244 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 283 (361)
T 3uc3_A 244 DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLP 283 (361)
T ss_dssp TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence 4568999999999999999999999999999999976543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=430.04 Aligned_cols=266 Identities=27% Similarity=0.432 Sum_probs=221.6
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEecccc--CcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEK--CNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~--~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 86 (671)
..+..++|++++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||++++++|.+.+.
T Consensus 143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 222 (446)
T 4ejn_A 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR 222 (446)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence 4456688999999999999999999999999999999997542 22345677889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF-HGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs-~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
+|+|||||.||+|..++... ..+++..++.++.||+.||+|||+ +|||||||||+|||++.+|.+||+|||+++...
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999999999876 679999999999999999999998 999999999999999999999999999986542
Q ss_pred cCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (671)
.. .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.........+..... ..+..
T Consensus 301 ~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-----~~p~~ 371 (446)
T 4ejn_A 301 KD---GATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-----RFPRT 371 (446)
T ss_dssp C--------CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----CCCTT
T ss_pred CC---CcccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-----CCCcc
Confidence 22 223445789999999999987 6799999999999999999999999998877766666555432 23456
Q ss_pred chHHHHHHHHHhhhcCCCCCC-----CHHHHHhchhccccccchH
Q 005886 246 FSKSFKELVTACLVKDPKKRP-----TAEKLMKHHFFKHARSNDF 285 (671)
Q Consensus 246 ls~~l~dLI~~cL~~dP~kRp-----Sa~eiL~Hpwfk~~~~~~~ 285 (671)
+++++++||.+||.+||.+|| +++++|+||||+...+...
T Consensus 372 ~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~ 416 (446)
T 4ejn_A 372 LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHV 416 (446)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHH
Confidence 899999999999999999999 9999999999998765443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=413.23 Aligned_cols=260 Identities=28% Similarity=0.419 Sum_probs=210.6
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+.+++.++||||++++++|.+...+|+|||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 467999999999999999999999999999999987542 34567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcC---CCceEEeccccccccccCCC
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS---NGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~---~g~vKL~DFGls~~~~~~~~ 169 (671)
|+.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 129 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~--- 203 (349)
T 2w4o_A 129 LVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--- 203 (349)
T ss_dssp CCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred eCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc---
Confidence 99999999998765 56999999999999999999999999999999999999975 78999999999875422
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHH
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..........+......+..+.+..++..
T Consensus 204 -~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 281 (349)
T 2w4o_A 204 -QVLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN 281 (349)
T ss_dssp ----------CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred -ccccccccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHH
Confidence 122345689999999999987 568999999999999999999999998776655444444444333334445678999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 250 FKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
+++||.+||..||.+|||+.++|+||||.....
T Consensus 282 ~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 282 AKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA 314 (349)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence 999999999999999999999999999986554
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=402.26 Aligned_cols=267 Identities=25% Similarity=0.368 Sum_probs=218.0
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
.++|++++.||+|+||+||+|.+..+|+.||||++...... .....+.+|+.+++.++||||+++++++.....+|+||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 37899999999999999999999999999999998655432 23567789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
|||.|++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 82 e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 156 (311)
T 4agu_A 82 EYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS--- 156 (311)
T ss_dssp ECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc---
Confidence 999999998888755 679999999999999999999999999999999999999999999999999987653221
Q ss_pred cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------------
Q 005886 172 RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG-------------- 237 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~-------------- 237 (671)
......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+....+....+.......
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 223455899999999999876678999999999999999999999999887766554333211000
Q ss_pred --CC----------ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccccch
Q 005886 238 --LD----------YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSND 284 (671)
Q Consensus 238 --~~----------~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~~ 284 (671)
.. ......++..+.+||.+||..||.+|||++++|+||||+......
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence 00 011245788999999999999999999999999999999876543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=432.29 Aligned_cols=272 Identities=24% Similarity=0.418 Sum_probs=230.3
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 86 (671)
..+..++|++++.||+|+||+||+|+++.+|+.||+|++..... ......+.+|+.++..++||||++++++|.++..
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 148 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence 34667899999999999999999999999999999999975321 1223458899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
+|+|||||.||+|..++... ...+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.+..
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 99999999999999999863 35799999999999999999999999999999999999999999999999999876533
Q ss_pred CCCcccccccccCCCCCCChhHhhh----ccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCc-c
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQ----LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY-E 241 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~----~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~-~ 241 (671)
... ......+||+.|+|||++.. ...|+.++|||||||++|||++|+.||.+....+....++.... .+.+ .
T Consensus 228 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~ 304 (437)
T 4aw2_A 228 DGT--VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE-RFQFPT 304 (437)
T ss_dssp TSC--EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH-HCCCCS
T ss_pred CCC--cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc-cccCCc
Confidence 222 22345689999999999973 24589999999999999999999999999887777666653211 0111 1
Q ss_pred ccccchHHHHHHHHHhhhcCCCC--CCCHHHHHhchhccccccch
Q 005886 242 RDKRFSKSFKELVTACLVKDPKK--RPTAEKLMKHHFFKHARSND 284 (671)
Q Consensus 242 ~~~~ls~~l~dLI~~cL~~dP~k--RpSa~eiL~Hpwfk~~~~~~ 284 (671)
....+++++++||.+||+.+|.+ |++++++++||||+...|..
T Consensus 305 ~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~ 349 (437)
T 4aw2_A 305 QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDN 349 (437)
T ss_dssp SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTT
T ss_pred ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHH
Confidence 22458999999999999988888 99999999999999887754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=399.94 Aligned_cols=265 Identities=28% Similarity=0.381 Sum_probs=216.5
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc----ccHHHHHHHHHHHHhC---CCCCceeeeeEEEe
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN----NDLDGIRREVQTMRVT---NHPNVLRAHCSFTT 83 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~----~~~~~i~~Ei~iL~~L---~HpNIVkl~~~~~~ 83 (671)
+..++|++.+.||+|+||+||+|.+..+|+.||||++...... .....+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3467999999999999999999999999999999998754321 2235667788877766 49999999999987
Q ss_pred CC-----EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecc
Q 005886 84 GH-----CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADF 158 (671)
Q Consensus 84 ~~-----~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DF 158 (671)
.. .+++||||+. |+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 65 6899999996 59999998775556999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CC
Q 005886 159 GVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA--PP 236 (671)
Q Consensus 159 Gls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~--~~ 236 (671)
|++..... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.........+.... ++
T Consensus 165 g~a~~~~~----~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (308)
T 3g33_A 165 GLARIYSY----QMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239 (308)
T ss_dssp SCTTTSTT----CCCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred ccccccCC----CcccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99865421 223345689999999999987 569999999999999999999999999888777665554321 11
Q ss_pred CCCc--------------------cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 237 GLDY--------------------ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 237 ~~~~--------------------~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
...+ .....++..+.+||.+||.+||.+|||+.++|+||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 1111 11235788999999999999999999999999999998643
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=404.04 Aligned_cols=261 Identities=26% Similarity=0.444 Sum_probs=215.6
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-------------------------ccHHHHHHHH
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-------------------------NDLDGIRREV 63 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-------------------------~~~~~i~~Ei 63 (671)
..+..++|++.+.||+|+||.||+|.+..+|+.||||++...... ...+.+.+|+
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 87 (298)
T 2zv2_A 8 DCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEI 87 (298)
T ss_dssp --CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHH
T ss_pred CceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHH
Confidence 345668999999999999999999999999999999999754321 1235688999
Q ss_pred HHHHhCCCCCceeeeeEEEe--CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCC
Q 005886 64 QTMRVTNHPNVLRAHCSFTT--GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVK 141 (671)
Q Consensus 64 ~iL~~L~HpNIVkl~~~~~~--~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLK 141 (671)
.+++.++||||+++++++.+ ...+|+||||+.+++|.+++.. ..+++..++.++.||+.||+|||++||+|||||
T Consensus 88 ~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 164 (298)
T 2zv2_A 88 AILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIK 164 (298)
T ss_dssp HHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence 99999999999999999987 6789999999999998876432 469999999999999999999999999999999
Q ss_pred CCcEEEcCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccC--CCccchhhhHHHHHHHHHhCCCCCC
Q 005886 142 AGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHG--YDFKADIWSFGITALELAHGHAPFS 219 (671)
Q Consensus 142 PeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~--~s~ksDIWSLGvILyeLltG~~PF~ 219 (671)
|+|||++.++.+||+|||++..+.... ......+||+.|+|||++.+... ++.++|||||||++|+|++|..||.
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSD---ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSS---CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred HHHEEECCCCCEEEecCCCcccccccc---ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 999999999999999999987653221 22344689999999999876332 4778999999999999999999998
Q ss_pred CCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcc
Q 005886 220 KYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278 (671)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk 278 (671)
+.........+.... ..++....++..+++||.+||..||.+|||+.++|+||||+
T Consensus 242 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 242 DERIMCLHSKIKSQA---LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp CSSHHHHHHHHHHCC---CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred CccHHHHHHHHhccc---CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 876655544444332 22233457899999999999999999999999999999996
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=427.51 Aligned_cols=271 Identities=24% Similarity=0.394 Sum_probs=228.1
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 86 (671)
..+..++|++++.||+|+||.||+|+++.+|+.||||++.+... ......+.+|..++..++||||++++++|.+.+.
T Consensus 56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 135 (412)
T 2vd5_A 56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY 135 (412)
T ss_dssp HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 45677899999999999999999999999999999999965321 1234568899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
+|+|||||.||+|..++.... ..+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+++.+..
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccC
Confidence 999999999999999998652 4699999999999999999999999999999999999999999999999999876532
Q ss_pred CCCcccccccccCCCCCCChhHhhh------ccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCc
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQ------LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~------~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~ 240 (671)
... ......+||+.|+|||++.+ ...|+.++|||||||++|||++|+.||.+....+....+..... .+.+
T Consensus 215 ~~~--~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~~~ 291 (412)
T 2vd5_A 215 DGT--VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE-HLSL 291 (412)
T ss_dssp TSC--EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH-HCCC
T ss_pred CCc--cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-CcCC
Confidence 221 12335689999999999974 24589999999999999999999999998887776665553210 0111
Q ss_pred -cccccchHHHHHHHHHhhhcCCCCC---CCHHHHHhchhccccccch
Q 005886 241 -ERDKRFSKSFKELVTACLVKDPKKR---PTAEKLMKHHFFKHARSND 284 (671)
Q Consensus 241 -~~~~~ls~~l~dLI~~cL~~dP~kR---pSa~eiL~Hpwfk~~~~~~ 284 (671)
..+..++.++++||.+||. +|.+| |+++++++||||+...|..
T Consensus 292 p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~ 338 (412)
T 2vd5_A 292 PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDG 338 (412)
T ss_dssp C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTT
T ss_pred CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence 1235689999999999999 99998 5999999999999887754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-48 Score=407.95 Aligned_cols=266 Identities=24% Similarity=0.361 Sum_probs=215.2
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWV 89 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~L 89 (671)
...++|++++.||+|+||+||+|.+..+|+.||||++...... .....+.+|+.+++.++||||+++++++.++..+|+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 4557899999999999999999999999999999999755432 234567899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEc-----CCCceEEecccccccc
Q 005886 90 VMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILID-----SNGAIKLADFGVSACM 164 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld-----~~g~vKL~DFGls~~~ 164 (671)
|||||.| +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++..+
T Consensus 111 v~e~~~~-~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EEECCSE-EHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EEecCCC-CHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 9999975 899998876 5699999999999999999999999999999999999994 4456999999998765
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CCCCCcc-
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA--PPGLDYE- 241 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~--~~~~~~~- 241 (671)
... .......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+......+..+.... +....+.
T Consensus 188 ~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 188 GIP---IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264 (329)
T ss_dssp C--------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred CCc---ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence 221 2223445889999999999875668999999999999999999999999888777666554321 1111100
Q ss_pred ----------------------ccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 242 ----------------------RDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 242 ----------------------~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
....++.++.+||.+||..||.+|||+.++|+||||+...+
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 11226789999999999999999999999999999997654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=395.72 Aligned_cols=259 Identities=27% Similarity=0.472 Sum_probs=218.5
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
++|.+.+.||+|+||.||+|.+..+|..||+|++.........+.+.+|+.+++.++||||+++++++.+...+|+||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 67999999999999999999999999999999998776566678999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEE---cCCCceEEeccccccccccCC
Q 005886 94 MAGGSCLHIMKSA--YPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILI---DSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 94 ~~ggsL~~~l~~~--~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILl---d~~g~vKL~DFGls~~~~~~~ 168 (671)
+.||+|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..+...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~- 180 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD- 180 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc-
Confidence 9999999988543 23569999999999999999999999999999999999999 44678999999998654221
Q ss_pred CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchH
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSK 248 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~ 248 (671)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..............+ .+.. ....+++
T Consensus 181 ---~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~ 253 (285)
T 3is5_A 181 ---EHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP-NYAV-ECRPLTP 253 (285)
T ss_dssp ---------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCC---CCCCH
T ss_pred ---ccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCc-cccc-ccCcCCH
Confidence 22345689999999999864 589999999999999999999999998876665544443322 2221 1234789
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 249 SFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 249 ~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
.+.+||.+||..||.+|||+.++|+||||+++
T Consensus 254 ~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~a 285 (285)
T 3is5_A 254 QAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285 (285)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC-
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHHhhcC
Confidence 99999999999999999999999999999853
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=402.37 Aligned_cols=280 Identities=52% Similarity=0.944 Sum_probs=206.5
Q ss_pred cccccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeC
Q 005886 5 VEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG 84 (671)
Q Consensus 5 ~e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~ 84 (671)
....+.+..++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 85 (303)
T 2vwi_A 6 SALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK 85 (303)
T ss_dssp -------CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESS
T ss_pred cccccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec
Confidence 34568889999999999999999999999999999999999987665555567788999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhh------CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecc
Q 005886 85 HCLWVVMPYMAGGSCLHIMKSA------YPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADF 158 (671)
Q Consensus 85 ~~l~LVmEy~~ggsL~~~l~~~------~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DF 158 (671)
..+|+||||+.|++|.+++... ....+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+||
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEec
Confidence 9999999999999999988742 2356899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCC--cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC
Q 005886 159 GVSACMFDAGD--RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP 236 (671)
Q Consensus 159 Gls~~~~~~~~--~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~ 236 (671)
|++........ .........||+.|+|||++.+...++.++|||||||++|+|++|..||.................+
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 245 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC
Confidence 99876533221 1122345689999999999986556899999999999999999999999988877766666555443
Q ss_pred CCC-----ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccccch
Q 005886 237 GLD-----YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSND 284 (671)
Q Consensus 237 ~~~-----~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~~ 284 (671)
... ......++..+.+||.+||..||.+||++.++++||||+.....+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~ 298 (303)
T 2vwi_A 246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKE 298 (303)
T ss_dssp CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-------
T ss_pred ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCCc
Confidence 322 122356789999999999999999999999999999998766543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=418.01 Aligned_cols=265 Identities=23% Similarity=0.368 Sum_probs=210.8
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCC-CCCceeeeeEEEeCC--EEE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTN-HPNVLRAHCSFTTGH--CLW 88 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~-HpNIVkl~~~~~~~~--~l~ 88 (671)
.++|++++.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.+++.+. ||||++++++|...+ .+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 3789999999999999999999999999999999864432 234667889999999997 999999999998644 799
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
+|||||. |+|..++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+....
T Consensus 88 lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 9999997 5888888763 68999999999999999999999999999999999999999999999999997653211
Q ss_pred ------------------CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 005886 169 ------------------DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMT 230 (671)
Q Consensus 169 ------------------~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~ 230 (671)
.........+||++|+|||++.+...|+.++|||||||++|+|++|++||.+.+....+..+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 01122345689999999999987667999999999999999999999999998877766555
Q ss_pred HhcCCCCCC--------------------------------c----------cccccchHHHHHHHHHhhhcCCCCCCCH
Q 005886 231 LQNAPPGLD--------------------------------Y----------ERDKRFSKSFKELVTACLVKDPKKRPTA 268 (671)
Q Consensus 231 ~~~~~~~~~--------------------------------~----------~~~~~ls~~l~dLI~~cL~~dP~kRpSa 268 (671)
+........ + ..+..+++++.+||.+||..||.+|||+
T Consensus 244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~ 323 (388)
T 3oz6_A 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323 (388)
T ss_dssp HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence 432111000 0 0012568899999999999999999999
Q ss_pred HHHHhchhccccc
Q 005886 269 EKLMKHHFFKHAR 281 (671)
Q Consensus 269 ~eiL~Hpwfk~~~ 281 (671)
+++|+||||+...
T Consensus 324 ~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 324 NDALKHPFVSIFH 336 (388)
T ss_dssp HHHTTSTTTTTTC
T ss_pred HHHhCCHHHHHhc
Confidence 9999999998654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=425.44 Aligned_cols=260 Identities=26% Similarity=0.458 Sum_probs=227.2
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
++|++++.||+|+||+||+|.++.+|+.||||++..... ......+.+|+.+|+.++||||+++++++.+...+|+|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 679999999999999999999999999999999965432 3456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEc---CCCceEEeccccccccccCCC
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILID---SNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld---~~g~vKL~DFGls~~~~~~~~ 169 (671)
||.||+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.+...
T Consensus 102 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-- 177 (486)
T 3mwu_A 102 LYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-- 177 (486)
T ss_dssp CCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC--
Confidence 99999999988776 6799999999999999999999999999999999999995 4567999999998765321
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHH
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+....+.+..+... ...+..+.+..++.+
T Consensus 178 --~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~s~~ 252 (486)
T 3mwu_A 178 --TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG-KYAFDLPQWRTISDD 252 (486)
T ss_dssp ------CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-CCCSCSGGGGGSCHH
T ss_pred --CccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCcccCCCCHH
Confidence 22345689999999999976 4999999999999999999999999998877766555543 334455667789999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 250 FKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
+++||.+||..||.+|||+.++|+||||+....
T Consensus 253 ~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 999999999999999999999999999987654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=414.02 Aligned_cols=257 Identities=25% Similarity=0.381 Sum_probs=219.5
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWV 89 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~L 89 (671)
..++|++.+.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.+++.++||||+++++++.+...+|+
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34789999999999999999999999999999999875421 2234678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCC
Q 005886 90 VMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~ 169 (671)
||||+ +|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 87 v~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~--- 160 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD--- 160 (336)
T ss_dssp EECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT---
T ss_pred EEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC---
Confidence 99999 78899988776 6799999999999999999999999999999999999999999999999999875532
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHH
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
.......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+....... .......+..+..+++.
T Consensus 161 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-----~~i~~~~~~~p~~~s~~ 234 (336)
T 3h4j_B 161 -GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-----KKVNSCVYVMPDFLSPG 234 (336)
T ss_dssp -SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-----CCCCSSCCCCCTTSCHH
T ss_pred -CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-----HHHHcCCCCCcccCCHH
Confidence 122345689999999999987443478999999999999999999999875432211 11111223445678999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 250 FKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
+++||.+||..||.+|||++++++||||+..
T Consensus 235 ~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 235 AQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 9999999999999999999999999999854
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=390.00 Aligned_cols=262 Identities=26% Similarity=0.450 Sum_probs=227.3
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
.++|++.+.||+|+||.||+|.+..+|+.||+|++...... .....+.+|+.+++.++||||+++++++..+...|+||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 47899999999999999999999999999999999765433 34677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCc---eEEeccccccccccCC
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGA---IKLADFGVSACMFDAG 168 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~---vKL~DFGls~~~~~~~ 168 (671)
||+.|++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++.....
T Consensus 85 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~-- 160 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND-- 160 (284)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS--
T ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc--
Confidence 999999999988876 67999999999999999999999999999999999999987654 99999999865532
Q ss_pred CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchH
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSK 248 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~ 248 (671)
........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.... .....+.+..+++
T Consensus 161 --~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 236 (284)
T 3kk8_A 161 --SEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA-YDYPSPEWDTVTP 236 (284)
T ss_dssp --SCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCTTTTTTSCH
T ss_pred --CccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcc-ccCCchhhcccCH
Confidence 122345689999999999987 568999999999999999999999999877766655554433 2333344567899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 249 SFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 249 ~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
++.+||.+||..||.+|||+.++|+||||+....
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 237 EAKSLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 9999999999999999999999999999986543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=411.41 Aligned_cols=256 Identities=28% Similarity=0.441 Sum_probs=216.2
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEEE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~~~l~LVm 91 (671)
.++|++.+.||+|+||.||+|.++.+|+.||||++..... ...+|+.++..+ +||||++++++|.++..+|+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3679999999999999999999999999999999975542 234688888777 7999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCC----CceEEeccccccccccC
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSN----GAIKLADFGVSACMFDA 167 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~----g~vKL~DFGls~~~~~~ 167 (671)
|||.||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+... +.+||+|||++......
T Consensus 96 E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 96 ELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp CCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 999999999999765 679999999999999999999999999999999999998443 35999999998765322
Q ss_pred CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhcCCCCCCccccc
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKY---PPMKVLLMTLQNAPPGLDYERDK 244 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~---~~~~~~~~~~~~~~~~~~~~~~~ 244 (671)
. ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+. ...+....+. .....+....+.
T Consensus 174 ~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~-~~~~~~~~~~~~ 248 (342)
T 2qr7_A 174 N---GLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG-SGKFSLSGGYWN 248 (342)
T ss_dssp T---CCBCCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH-HCCCCCCSTTTT
T ss_pred C---CceeccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc-cCCcccCccccc
Confidence 2 22345689999999999987 45899999999999999999999999763 3333333333 333333334467
Q ss_pred cchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 245 RFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 245 ~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
.++.++++||.+||..||.+|||+.++|+||||..+
T Consensus 249 ~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 249 SVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 789999999999999999999999999999999754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=425.44 Aligned_cols=269 Identities=26% Similarity=0.306 Sum_probs=203.2
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEe-----CCE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTT-----GHC 86 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~-----~~~ 86 (671)
.++|++++.||+|+||+||+|.++.+|+.||||++..... ......+.+|+.+|+.++|||||+++++|.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 4789999999999999999999999999999999865432 2345788999999999999999999999954 357
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
+|+||||+ +|+|..++... ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++....
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred EEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 99999998 56899988765 6799999999999999999999999999999999999999999999999999976532
Q ss_pred CCCc------------------------ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh---------
Q 005886 167 AGDR------------------------QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH--------- 213 (671)
Q Consensus 167 ~~~~------------------------~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt--------- 213 (671)
.... .......+||++|+|||++.....|+.++||||||||+|||++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~ 288 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence 2111 1123456899999999998655679999999999999999998
Q ss_pred --CCCCCCCCCh--------------------HHHHHHHHh-----------------------cCCCC---CCcccccc
Q 005886 214 --GHAPFSKYPP--------------------MKVLLMTLQ-----------------------NAPPG---LDYERDKR 245 (671)
Q Consensus 214 --G~~PF~~~~~--------------------~~~~~~~~~-----------------------~~~~~---~~~~~~~~ 245 (671)
|.++|.+... ...+..+.. ..+.. ........
T Consensus 289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (458)
T 3rp9_A 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA 368 (458)
T ss_dssp GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence 7777766431 111111110 00000 01122345
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccccch
Q 005886 246 FSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSND 284 (671)
Q Consensus 246 ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~~ 284 (671)
++.++.+||.+||.+||.+|||++++|+||||+...+..
T Consensus 369 ~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~ 407 (458)
T 3rp9_A 369 SSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE 407 (458)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred CCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCc
Confidence 689999999999999999999999999999999876543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=425.33 Aligned_cols=261 Identities=25% Similarity=0.426 Sum_probs=230.3
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LV 90 (671)
.++|++.+.||+|+||.||+|.++.+|+.||||++..... ......+.+|+.+++.++||||++++++|.+...+|+|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 3679999999999999999999999999999999976543 34578899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEE---cCCCceEEeccccccccccC
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILI---DSNGAIKLADFGVSACMFDA 167 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILl---d~~g~vKL~DFGls~~~~~~ 167 (671)
||||.||+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+...
T Consensus 105 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp ECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 9999999999998765 679999999999999999999999999999999999999 46789999999998765322
Q ss_pred CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccch
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls 247 (671)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+....+.+..+... ...+..+.+..++
T Consensus 183 ----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~s 255 (484)
T 3nyv_A 183 ----KKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKG-KYTFELPQWKKVS 255 (484)
T ss_dssp ----CSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCCCSGGGGGSC
T ss_pred ----cccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC-CCCCCCcccccCC
Confidence 22345689999999999976 5899999999999999999999999998877766655544 3344556677899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 248 KSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
..+++||.+||.+||.+|||+.++|+||||+....
T Consensus 256 ~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 256 ESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 99999999999999999999999999999986544
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=408.92 Aligned_cols=264 Identities=25% Similarity=0.367 Sum_probs=214.1
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
++|++++.||+|+||+||+|.+..+|+.||||++...........+.+|+.+++.++||||+++++++.++..+|+||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 68999999999999999999999999999999997554333223455799999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS 173 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 173 (671)
+.| +|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... ...
T Consensus 82 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~---~~~ 156 (324)
T 3mtl_A 82 LDK-DLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP---TKT 156 (324)
T ss_dssp CSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred ccc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC---ccc
Confidence 974 888888765 346999999999999999999999999999999999999999999999999998654221 222
Q ss_pred cccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--CCC------------
Q 005886 174 RNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP--GLD------------ 239 (671)
Q Consensus 174 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~--~~~------------ 239 (671)
....+||+.|+|||++.+...++.++|||||||++|+|++|..||.+....+.+..+...... ...
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcc
Confidence 344588999999999987667899999999999999999999999998876665554432111 100
Q ss_pred -----------ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 240 -----------YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 240 -----------~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
......++.++.+||.+||..||.+|||++++|+||||.....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 0112356889999999999999999999999999999986543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=399.33 Aligned_cols=258 Identities=34% Similarity=0.597 Sum_probs=225.6
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEecc
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYM 94 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy~ 94 (671)
.|...+.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.....+|+||||+
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 124 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL 124 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecC
Confidence 4888999999999999999999999999999997544 344677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccccc
Q 005886 95 AGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSR 174 (671)
Q Consensus 95 ~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~ 174 (671)
.||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 125 ~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---~~~ 198 (321)
T 2c30_A 125 QGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV---PKR 198 (321)
T ss_dssp CSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS---CCB
T ss_pred CCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc---ccc
Confidence 99999998864 469999999999999999999999999999999999999999999999999987653221 223
Q ss_pred ccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHH
Q 005886 175 NTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELV 254 (671)
Q Consensus 175 ~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI 254 (671)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+....++.+ .....++..+++||
T Consensus 199 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li 275 (321)
T 2c30_A 199 KSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL--KNSHKVSPVLRDFL 275 (321)
T ss_dssp CCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC--TTGGGSCHHHHHHH
T ss_pred ccccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc--CccccCCHHHHHHH
Confidence 45689999999999987 5689999999999999999999999998877766655555444332 23456889999999
Q ss_pred HHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 255 TACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 255 ~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
.+||..||.+|||+.++|+||||.....
T Consensus 276 ~~~l~~dp~~Rps~~ell~hp~~~~~~~ 303 (321)
T 2c30_A 276 ERMLVRDPQERATAQELLDHPFLLQTGL 303 (321)
T ss_dssp HHHSCSSTTTSCCHHHHHTSGGGGGCCC
T ss_pred HHHccCChhhCcCHHHHhcChhhccCCC
Confidence 9999999999999999999999986554
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=399.65 Aligned_cols=266 Identities=27% Similarity=0.414 Sum_probs=213.9
Q ss_pred CCeEEE-EEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHh-CCCCCceeeeeEEEeCCEEEEEE
Q 005886 14 KDYRLY-EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRV-TNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 14 ~~Y~l~-~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~-L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
+.|++. +.||+|+||.||+|.+..+|+.||||++.... ......+.+|+.++.. ++||||+++++++.+++.+|+||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 679885 68999999999999999999999999997543 3446788999999988 47999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCc---eEEeccccccccccCC
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGA---IKLADFGVSACMFDAG 168 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~---vKL~DFGls~~~~~~~ 168 (671)
|||.||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++......+
T Consensus 91 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 168 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168 (316)
T ss_dssp ECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred EcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence 999999999999876 57999999999999999999999999999999999999988775 9999999986553222
Q ss_pred C----cccccccccCCCCCCChhHhhh----ccCCCccchhhhHHHHHHHHHhCCCCCCCCCh--------------HHH
Q 005886 169 D----RQRSRNTFVGTPCWMAPEVMQQ----LHGYDFKADIWSFGITALELAHGHAPFSKYPP--------------MKV 226 (671)
Q Consensus 169 ~----~~~~~~~~~GT~~Y~APEvl~~----~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~--------------~~~ 226 (671)
. ........+||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+... ...
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 248 (316)
T 2ac3_A 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248 (316)
T ss_dssp -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence 1 1112234579999999999974 13478899999999999999999999976542 122
Q ss_pred HHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 227 LLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
+...+......+....+..++..+++||.+||..||.+|||+.++|+||||+...+
T Consensus 249 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 304 (316)
T 2ac3_A 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304 (316)
T ss_dssp HHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred HHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence 23333333333333334568999999999999999999999999999999987544
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=400.20 Aligned_cols=263 Identities=25% Similarity=0.380 Sum_probs=228.4
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcc-----cHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-----DLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCL 87 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~-----~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l 87 (671)
.++|++.+.||+|+||.||+|.++.+|+.||+|++....... ..+.+.+|+.+++.+.||||+++++++.+...+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 367999999999999999999999999999999997654322 367899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC----ceEEeccccccc
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG----AIKLADFGVSAC 163 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g----~vKL~DFGls~~ 163 (671)
|+||||+.|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 9999999999999999865 6789999999999999999999999999999999999999888 799999999876
Q ss_pred cccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 005886 164 MFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 243 (671)
Q Consensus 164 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (671)
.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+... ...+....+
T Consensus 169 ~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~ 242 (321)
T 2a2a_A 169 IEDG----VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV-SYDFDEEFF 242 (321)
T ss_dssp CCTT----CCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT-CCCCCHHHH
T ss_pred cCcc----ccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc-ccccChhhh
Confidence 5321 22345679999999999987 56899999999999999999999999987776665544433 333333445
Q ss_pred ccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccccc
Q 005886 244 KRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSN 283 (671)
Q Consensus 244 ~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~ 283 (671)
..++..+++||.+||..||.+|||+.++|+||||+...+.
T Consensus 243 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~~ 282 (321)
T 2a2a_A 243 SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQ 282 (321)
T ss_dssp TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSHH
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCcc
Confidence 6789999999999999999999999999999999876544
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=424.86 Aligned_cols=261 Identities=26% Similarity=0.435 Sum_probs=226.0
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc------------ccHHHHHHHHHHHHhCCCCCceeeeeE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN------------NDLDGIRREVQTMRVTNHPNVLRAHCS 80 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~------------~~~~~i~~Ei~iL~~L~HpNIVkl~~~ 80 (671)
.++|++++.||+|+||+||+|.++.+++.||||++...... ...+.+.+|+.+|+.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 47899999999999999999999999999999999754322 335788999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC---ceEEec
Q 005886 81 FTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG---AIKLAD 157 (671)
Q Consensus 81 ~~~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g---~vKL~D 157 (671)
|.+...+|+|||||.||+|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 99999999999999999999998876 6799999999999999999999999999999999999998876 699999
Q ss_pred cccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC
Q 005886 158 FGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG 237 (671)
Q Consensus 158 FGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~ 237 (671)
||++..+... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+....+.+..+... ...
T Consensus 193 fg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-~~~ 265 (504)
T 3q5i_A 193 FGLSSFFSKD----YKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG-KYY 265 (504)
T ss_dssp CTTCEECCTT----SCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCC
T ss_pred CCCCEEcCCC----CccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCC
Confidence 9998765321 22345689999999999875 5899999999999999999999999998877766655543 334
Q ss_pred CCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 238 LDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 238 ~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
+..+.+..++.++++||.+||.+||.+|||+.++|+||||+....
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 266 FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 455566789999999999999999999999999999999987653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=387.62 Aligned_cols=257 Identities=27% Similarity=0.410 Sum_probs=225.1
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
++|++.+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|+.+++.++||||++++++|.+...+|+||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF-VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc-cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 57999999999999999999999999999999987543 34467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEE---cCCCceEEeccccccccccCCCc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILI---DSNGAIKLADFGVSACMFDAGDR 170 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILl---d~~g~vKL~DFGls~~~~~~~~~ 170 (671)
+.|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..+...
T Consensus 88 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~--- 162 (277)
T 3f3z_A 88 CTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--- 162 (277)
T ss_dssp CCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT---
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc---
Confidence 9999999998876 679999999999999999999999999999999999999 77889999999998755321
Q ss_pred ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHH
Q 005886 171 QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSF 250 (671)
Q Consensus 171 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l 250 (671)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||......+....+.... ..+....+..+++.+
T Consensus 163 -~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 238 (277)
T 3f3z_A 163 -KMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGT-FTFPEKDWLNVSPQA 238 (277)
T ss_dssp -SCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCHHHHTTSCHHH
T ss_pred -cchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-CCCCchhhhcCCHHH
Confidence 22345689999999999876 48999999999999999999999999887776666555543 223333344689999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 251 KELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 251 ~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
.+||.+||..||.+|||+.++|+||||+..
T Consensus 239 ~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 239 ESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 999999999999999999999999999754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=405.12 Aligned_cols=258 Identities=26% Similarity=0.374 Sum_probs=217.0
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCC-----CCCceeeeeEEEeCC
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN-----HPNVLRAHCSFTTGH 85 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~-----HpNIVkl~~~~~~~~ 85 (671)
+..++|++++.||+|+||+||+|.+..+|+.||||++... ......+..|+.+++.+. ||||++++++|....
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~ 109 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD 109 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence 3457999999999999999999999999999999998632 234566788999999886 999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcC----------------
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS---------------- 149 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~---------------- 149 (671)
.+|+||||+ |++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 110 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~ 188 (360)
T 3llt_A 110 HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188 (360)
T ss_dssp EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTC
T ss_pred eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccc
Confidence 999999999 899999998875567999999999999999999999999999999999999975
Q ss_pred ---------CCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCC
Q 005886 150 ---------NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSK 220 (671)
Q Consensus 150 ---------~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~ 220 (671)
++.+||+|||++..... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+
T Consensus 189 ~~~~~~~~~~~~~kl~DFG~a~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 189 KKIQIYRTKSTGIKLIDFGCATFKSD------YHGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp CEEEEEEESCCCEEECCCTTCEETTS------CCCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccCCCCEEEEeccCceecCC------CCcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 78999999999865321 2235689999999999987 5699999999999999999999999988
Q ss_pred CChHHHHHHHHhcCCCCCCc-----------------------------------------cccccchHHHHHHHHHhhh
Q 005886 221 YPPMKVLLMTLQNAPPGLDY-----------------------------------------ERDKRFSKSFKELVTACLV 259 (671)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~ls~~l~dLI~~cL~ 259 (671)
....+.+..+.....+.... ......++.+.+||.+||.
T Consensus 262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 341 (360)
T 3llt_A 262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ 341 (360)
T ss_dssp SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence 77666554433321111000 0001123678899999999
Q ss_pred cCCCCCCCHHHHHhchhcc
Q 005886 260 KDPKKRPTAEKLMKHHFFK 278 (671)
Q Consensus 260 ~dP~kRpSa~eiL~Hpwfk 278 (671)
.||.+|||+.++|+||||+
T Consensus 342 ~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 342 IDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp SSGGGSCCHHHHTTSGGGC
T ss_pred CChhhCCCHHHHhcCcccC
Confidence 9999999999999999995
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=391.99 Aligned_cols=260 Identities=26% Similarity=0.418 Sum_probs=223.6
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 86 (671)
-....++|++.+.||+|+||+||+|.+..++..||+|++..... ......+.+|+.+++.++||||++++++|.+...
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 83 (279)
T 3fdn_A 4 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR 83 (279)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence 35577899999999999999999999999999999999865432 1235678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
+|+||||+.+|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 99999999999999999876 6799999999999999999999999999999999999999999999999998753321
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (671)
.......||+.|+|||++.+ ..++.++||||||+++|+|++|..||...........+.... ...+..+
T Consensus 162 -----~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~ 230 (279)
T 3fdn_A 162 -----SRRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-----FTFPDFV 230 (279)
T ss_dssp -----------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-----CCCCTTS
T ss_pred -----ccccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC-----CCCCCcC
Confidence 12344689999999999987 568999999999999999999999999877766555444432 2234567
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 247 SKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 247 s~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
+..+++||.+||..||.+|||+.++|+||||+...
T Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 231 TEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred CHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 89999999999999999999999999999998543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=404.11 Aligned_cols=277 Identities=22% Similarity=0.309 Sum_probs=225.4
Q ss_pred ccccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEe-
Q 005886 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTT- 83 (671)
Q Consensus 6 e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~- 83 (671)
+..+.-..++|++++.||+|+||.||+|.+..+|+.||||++...... .....+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 88 (351)
T 3mi9_A 9 ECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK 88 (351)
T ss_dssp CCTTSCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC
T ss_pred cccccccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecc
Confidence 445556678999999999999999999999999999999998655433 335677899999999999999999999987
Q ss_pred -------CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEe
Q 005886 84 -------GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLA 156 (671)
Q Consensus 84 -------~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~ 156 (671)
.+.+|+|||||.| +|...+... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~ 166 (351)
T 3mi9_A 89 ASPYNRCKGSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLA 166 (351)
T ss_dssp --------CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEEC
T ss_pred ccccccCCceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEc
Confidence 4578999999975 777776654 2569999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCC-cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--
Q 005886 157 DFGVSACMFDAGD-RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQN-- 233 (671)
Q Consensus 157 DFGls~~~~~~~~-~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~-- 233 (671)
|||++..+..... ........+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.........+...
T Consensus 167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 246 (351)
T 3mi9_A 167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 246 (351)
T ss_dssp CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9999876532222 2223345689999999999987567899999999999999999999999988776655444321
Q ss_pred -CCCCCCccccc-------------------------cchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccccchH
Q 005886 234 -APPGLDYERDK-------------------------RFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDF 285 (671)
Q Consensus 234 -~~~~~~~~~~~-------------------------~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~~~ 285 (671)
.++.. ++... ..++.+.+||.+||..||.+|||++++|+||||+.......
T Consensus 247 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 323 (351)
T 3mi9_A 247 SITPEV-WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD 323 (351)
T ss_dssp CCCTTT-STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCC
T ss_pred CCChhh-ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCccc
Confidence 11111 11000 12678999999999999999999999999999987554433
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=405.55 Aligned_cols=265 Identities=22% Similarity=0.300 Sum_probs=223.4
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeC-----CEE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG-----HCL 87 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~-----~~l 87 (671)
.++|++++.||+|+||.||+|.+..++..||||++...........+.+|+.+++.++||||+++++++... ..+
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 478999999999999999999999999999999997554444567889999999999999999999999765 479
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccC
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~ 167 (671)
|+||||+. |+|..++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 106 ~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 99999997 4899988763 6999999999999999999999999999999999999999999999999999766433
Q ss_pred CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----------
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG---------- 237 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~---------- 237 (671)
..........+||+.|+|||++.+...++.++|||||||++|+|++|..||.+....+.+..+.......
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 261 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 3333334556899999999998776678999999999999999999999998877665554443211100
Q ss_pred ---------------CC-ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 238 ---------------LD-YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 238 ---------------~~-~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
.. ......++.++.+||.+||..||.+|||+.++|+||||+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 00 011245788999999999999999999999999999998754
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=421.72 Aligned_cols=258 Identities=26% Similarity=0.444 Sum_probs=222.0
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
++|++++.||+|+||+||+|.++.++..||||++..... ......+.+|+.+++.++||||++++++|.+...+|+|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 369999999999999999999999999999999976543 2346788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCC---CceEEeccccccccccCCC
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSN---GAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~---g~vKL~DFGls~~~~~~~~ 169 (671)
||.||+|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.. +.+||+|||+++.+...
T Consensus 117 ~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~-- 192 (494)
T 3lij_A 117 CYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-- 192 (494)
T ss_dssp CCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT--
T ss_pred cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC--
Confidence 99999999988776 679999999999999999999999999999999999999764 45999999998765321
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHH
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+....+.+..+.... ..+..+.+..++..
T Consensus 193 --~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~s~~ 267 (494)
T 3lij_A 193 --KKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGK-YTFDSPEWKNVSEG 267 (494)
T ss_dssp --BCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCSGGGTTSCHH
T ss_pred --ccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCchhcccCCHH
Confidence 22345689999999999874 58999999999999999999999999988877666555443 33444556789999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 250 FKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
+++||.+||..||.+|||+.++|+||||+..
T Consensus 268 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 268 AKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 9999999999999999999999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=434.64 Aligned_cols=269 Identities=26% Similarity=0.392 Sum_probs=230.7
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 86 (671)
.++..++|++++.||+|+||.||+|.++.+|+.||||++..... ......+.+|+.+|+.++||||++++++|.+...
T Consensus 179 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 258 (576)
T 2acx_A 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA 258 (576)
T ss_dssp SCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCE
Confidence 45788999999999999999999999999999999999975432 2345778899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
+|+|||||.||+|..++.......+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||++..+..
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999999999876445699999999999999999999999999999999999999999999999999876532
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCCCCcccc
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPP---MKVLLMTLQNAPPGLDYERD 243 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~---~~~~~~~~~~~~~~~~~~~~ 243 (671)
. ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+... ...+...+...+.. .+
T Consensus 339 ~----~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~----~p 409 (576)
T 2acx_A 339 G----QTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE----YS 409 (576)
T ss_dssp T----CCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCC----CC
T ss_pred C----ccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccccc----CC
Confidence 1 12334689999999999987 5689999999999999999999999987532 23333333333322 24
Q ss_pred ccchHHHHHHHHHhhhcCCCCCC-----CHHHHHhchhccccccchHH
Q 005886 244 KRFSKSFKELVTACLVKDPKKRP-----TAEKLMKHHFFKHARSNDFL 286 (671)
Q Consensus 244 ~~ls~~l~dLI~~cL~~dP~kRp-----Sa~eiL~Hpwfk~~~~~~~~ 286 (671)
..++.++++||.+||.+||.+|| +++++++||||+...|....
T Consensus 410 ~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~ 457 (576)
T 2acx_A 410 ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLG 457 (576)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHH
T ss_pred ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHh
Confidence 67899999999999999999999 89999999999987765443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=418.60 Aligned_cols=257 Identities=27% Similarity=0.439 Sum_probs=207.5
Q ss_pred CCCeEEE-EEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHH-HhCCCCCceeeeeEEEe----CCE
Q 005886 13 AKDYRLY-EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTM-RVTNHPNVLRAHCSFTT----GHC 86 (671)
Q Consensus 13 ~~~Y~l~-~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL-~~L~HpNIVkl~~~~~~----~~~ 86 (671)
.++|.+. +.||+|+||+||+|.++.+|+.||||++.. ...+.+|+.++ +..+||||++++++|.. ..+
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 4678887 689999999999999999999999999853 24677888887 56689999999999876 678
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcC---CCceEEeccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS---NGAIKLADFGVSAC 163 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~---~g~vKL~DFGls~~ 163 (671)
+|||||||.||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 999999999999999998754456999999999999999999999999999999999999987 78999999999875
Q ss_pred cccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHH---HHHHHhcCCCCCCc
Q 005886 164 MFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKV---LLMTLQNAPPGLDY 240 (671)
Q Consensus 164 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~---~~~~~~~~~~~~~~ 240 (671)
... .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+...... ....+......+..
T Consensus 214 ~~~----~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~ 288 (400)
T 1nxk_A 214 TTS----HNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 288 (400)
T ss_dssp CC---------------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred cCC----CCccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence 422 122345689999999999976 6799999999999999999999999976543210 11122222222333
Q ss_pred cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 241 ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 241 ~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
..+..++.++++||.+||..||.+|||+.++|+||||...
T Consensus 289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 3456789999999999999999999999999999999854
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=425.21 Aligned_cols=261 Identities=28% Similarity=0.403 Sum_probs=227.7
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 86 (671)
-.+..++|.+.+.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.+++.++||||+++++++.+...
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 90 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD 90 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 34566899999999999999999999999999999999975432 2345789999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
+|+|||||.||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 91 ~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999999998764 6799999999999999999999999999999999999999999999999999876532
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (671)
. ......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.........+..... ..+..+
T Consensus 169 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-----~~p~~~ 239 (476)
T 2y94_A 169 G----EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF-----YTPQYL 239 (476)
T ss_dssp T----CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC-----CCCTTC
T ss_pred c----ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc-----CCCccC
Confidence 1 2234568999999999998744457899999999999999999999998776666555554322 234567
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 247 SKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 247 s~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
++++.+||.+||..||.+|||+.++++||||+..
T Consensus 240 s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 240 NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 8999999999999999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=398.96 Aligned_cols=259 Identities=22% Similarity=0.333 Sum_probs=211.4
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC--------
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH-------- 85 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~-------- 85 (671)
++|++.+.||+|+||.||+|+++.+|+.||||++.........+.+.+|+.+|+.++||||++++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 579999999999999999999999999999999986665556788999999999999999999999986543
Q ss_pred -------------------------------------------------EEEEEEeccCCCCHHHHHHhhCC-CCCCHHH
Q 005886 86 -------------------------------------------------CLWVVMPYMAGGSCLHIMKSAYP-EGFEEPV 115 (671)
Q Consensus 86 -------------------------------------------------~l~LVmEy~~ggsL~~~l~~~~~-~~l~e~~ 115 (671)
.+|+|||||.||+|.+++..... ...++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 48999999999999999986532 2356677
Q ss_pred HHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCc---------ccccccccCCCCCCCh
Q 005886 116 IATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR---------QRSRNTFVGTPCWMAP 186 (671)
Q Consensus 116 i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~---------~~~~~~~~GT~~Y~AP 186 (671)
++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ .......+||+.|+||
T Consensus 166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 245 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCH
T ss_pred HHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccCh
Confidence 8999999999999999999999999999999999999999999998766432211 1223456899999999
Q ss_pred hHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCC
Q 005886 187 EVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRP 266 (671)
Q Consensus 187 Evl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRp 266 (671)
|++.+ ..++.++|||||||++|+|++|..|+... .......... . ........++.+.+||.+||..||.+||
T Consensus 246 E~~~~-~~~~~~~Di~slG~il~el~~~~~~~~~~---~~~~~~~~~~--~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp 318 (332)
T 3qd2_B 246 EQIHG-NNYSHKVDIFSLGLILFELLYSFSTQMER---VRIITDVRNL--K-FPLLFTQKYPQEHMMVQDMLSPSPTERP 318 (332)
T ss_dssp HHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCHHHH---HHHHHHHHTT--C-CCHHHHHHCHHHHHHHHHHHCSSGGGSC
T ss_pred HHhcC-CCCcchhhHHHHHHHHHHHHHcCCChhHH---HHHHHHhhcc--C-CCcccccCChhHHHHHHHHccCCCCcCC
Confidence 99987 57999999999999999999987775321 1111122221 1 1122345678889999999999999999
Q ss_pred CHHHHHhchhccc
Q 005886 267 TAEKLMKHHFFKH 279 (671)
Q Consensus 267 Sa~eiL~Hpwfk~ 279 (671)
|+.++|+||||++
T Consensus 319 s~~~~l~~~~f~~ 331 (332)
T 3qd2_B 319 EATDIIENAIFEN 331 (332)
T ss_dssp CHHHHHHSTTCCC
T ss_pred CHHHHhhchhhhc
Confidence 9999999999975
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=403.40 Aligned_cols=268 Identities=28% Similarity=0.430 Sum_probs=223.2
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEecccc----CcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEK----CNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWV 89 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~----~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~L 89 (671)
++|++.+.||+|+||+||+|.+..+++.||+|++.... .......+.+|+.+++.++||||++++++|.+...+|+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 67999999999999999999999999999999987543 23456789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhC--------------------------------------CCCCCHHHHHHHHHHHHHHHHHHH
Q 005886 90 VMPYMAGGSCLHIMKSAY--------------------------------------PEGFEEPVIATLLRETLKALVYLH 131 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~~--------------------------------------~~~l~e~~i~~i~~qIl~aL~yLH 131 (671)
|||||.||+|.+++.... ...+++..++.++.||+.||+|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 999999999999884210 112467789999999999999999
Q ss_pred HCCcccccCCCCcEEEcCCC--ceEEeccccccccccCCC-cccccccccCCCCCCChhHhhhc-cCCCccchhhhHHHH
Q 005886 132 FHGHIHRDVKAGNILIDSNG--AIKLADFGVSACMFDAGD-RQRSRNTFVGTPCWMAPEVMQQL-HGYDFKADIWSFGIT 207 (671)
Q Consensus 132 s~gIVHrDLKPeNILld~~g--~vKL~DFGls~~~~~~~~-~~~~~~~~~GT~~Y~APEvl~~~-~~~s~ksDIWSLGvI 207 (671)
++||+||||||+|||++.++ .+||+|||++..+..... .........||+.|+|||++.+. ..++.++|||||||+
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 265 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence 99999999999999998776 899999999876543222 11223456899999999999742 468899999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 208 ALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 208 LyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
+|+|++|..||.+....+....+..... .+..+....+++.+++||.+||..||.+||++.++|+||||+...+
T Consensus 266 l~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 266 LHLLLMGAVPFPGVNDADTISQVLNKKL-CFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHCCC-CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred HHHHHHCCCCCCCCChHHHHHHHHhccc-ccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence 9999999999999888777766665433 3334445568999999999999999999999999999999987653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=421.76 Aligned_cols=259 Identities=25% Similarity=0.352 Sum_probs=211.1
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeC------C
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG------H 85 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~------~ 85 (671)
.++|++++.||+|+||+||+|.+..+|+.||||++..... ......+.+|+.+|+.++||||++++++|... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 4789999999999999999999999999999999975432 23467788999999999999999999999754 4
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
.+|+|||||.++ |...+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 141 ~~~lv~E~~~~~-l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred eEEEEEeCCCCC-HHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 689999999765 666553 348999999999999999999999999999999999999999999999999987542
Q ss_pred cCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG-------- 237 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~-------- 237 (671)
. .......+||++|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..++......
T Consensus 216 ~----~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 216 T----SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp -----CCCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred C----CcccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 2 223445789999999999988 579999999999999999999999999988766665554321110
Q ss_pred --------------CCccc---------------cccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 238 --------------LDYER---------------DKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 238 --------------~~~~~---------------~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
..... ....+.++++||.+||.+||.+|||++++|+||||+...
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 363 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 363 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence 00000 011267899999999999999999999999999998654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=390.76 Aligned_cols=258 Identities=44% Similarity=0.790 Sum_probs=228.3
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
+.|++++.||+|+||.||+|.+..+|+.||||++...........+.+|+.+++.++||||+++++++.....+|+||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 56999999999999999999999999999999998776566678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS 173 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 173 (671)
+.|++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 102 ~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~ 175 (303)
T 3a7i_A 102 LGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT---QIK 175 (303)
T ss_dssp CTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT---BCC
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc---ccc
Confidence 999999999864 46999999999999999999999999999999999999999999999999998765322 122
Q ss_pred cccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHH
Q 005886 174 RNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL 253 (671)
Q Consensus 174 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dL 253 (671)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+....++. ....++..+.+|
T Consensus 176 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~l 250 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT----LEGNYSKPLKEF 250 (303)
T ss_dssp BCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC----CCSSCCHHHHHH
T ss_pred cCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCC----CccccCHHHHHH
Confidence 345689999999999987 568999999999999999999999999887776665555544332 245678999999
Q ss_pred HHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 254 VTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 254 I~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
|.+||..||.+|||+.++|+||||.....
T Consensus 251 i~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 279 (303)
T 3a7i_A 251 VEACLNKEPSFRPTAKELLKHKFILRNAK 279 (303)
T ss_dssp HHHHCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred HHHHcCCChhhCcCHHHHhhChhhhcCCC
Confidence 99999999999999999999999976543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=415.57 Aligned_cols=269 Identities=23% Similarity=0.308 Sum_probs=214.1
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeC-----CE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG-----HC 86 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~-----~~ 86 (671)
.++|++++.||+|+||+||+|.++.+|+.||||++..... ......+.+|+.+|+.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4889999999999999999999999999999999975432 23457889999999999999999999999876 57
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
+|+||||+. |+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred EEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 999999996 5999999765 6799999999999999999999999999999999999999999999999999976533
Q ss_pred CCCc-------------------ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhC-----------CC
Q 005886 167 AGDR-------------------QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHG-----------HA 216 (671)
Q Consensus 167 ~~~~-------------------~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG-----------~~ 216 (671)
.... .......+||++|+|||++.....|+.++||||||||+|||++| .+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p 261 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence 2211 01235679999999999986657799999999999999999984 44
Q ss_pred CCCCCCh-----------------HHHHHHH-----------------------HhcCCCCCC---ccccccchHHHHHH
Q 005886 217 PFSKYPP-----------------MKVLLMT-----------------------LQNAPPGLD---YERDKRFSKSFKEL 253 (671)
Q Consensus 217 PF~~~~~-----------------~~~~~~~-----------------------~~~~~~~~~---~~~~~~ls~~l~dL 253 (671)
+|.+... ...+..+ +...+.... ......+++++.+|
T Consensus 262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 341 (432)
T 3n9x_A 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL 341 (432)
T ss_dssp SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence 4544321 1111111 111111111 01124578999999
Q ss_pred HHHhhhcCCCCCCCHHHHHhchhccccccch
Q 005886 254 VTACLVKDPKKRPTAEKLMKHHFFKHARSND 284 (671)
Q Consensus 254 I~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~~ 284 (671)
|.+||..||.+|||++++|+||||+...+..
T Consensus 342 l~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 372 (432)
T 3n9x_A 342 LESMLKFNPNKRITIDQALDHPYLKDVRKKK 372 (432)
T ss_dssp HHHHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred HHHHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence 9999999999999999999999999876543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=441.58 Aligned_cols=270 Identities=26% Similarity=0.436 Sum_probs=234.0
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEecccc--CcccHHHHHHHHHHHHhC-CCCCceeeeeEEEeCC
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEK--CNNDLDGIRREVQTMRVT-NHPNVLRAHCSFTTGH 85 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~--~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~~ 85 (671)
..+..++|++++.||+|+||.||+|.++.+|+.||||++.... .......+..|..++..+ +||||++++++|.+..
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~ 415 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence 3456789999999999999999999999999999999997543 224467788899999877 7999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
.+||||||+.||+|..++... +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+++...
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 999999999999999999877 679999999999999999999999999999999999999999999999999987543
Q ss_pred cCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (671)
..+ ......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+..++.... ..+..
T Consensus 494 ~~~---~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-----~~p~~ 564 (674)
T 3pfq_A 494 WDG---VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-----AYPKS 564 (674)
T ss_dssp CTT---CCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC-----CCCTT
T ss_pred cCC---cccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC-----CCCcc
Confidence 222 23456799999999999987 6799999999999999999999999999888777766665432 23457
Q ss_pred chHHHHHHHHHhhhcCCCCCCCH-----HHHHhchhccccccchHHHHH
Q 005886 246 FSKSFKELVTACLVKDPKKRPTA-----EKLMKHHFFKHARSNDFLARS 289 (671)
Q Consensus 246 ls~~l~dLI~~cL~~dP~kRpSa-----~eiL~Hpwfk~~~~~~~~~~~ 289 (671)
++.++++||.+||.+||.+||++ ++|++||||+...|.....+.
T Consensus 565 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~ 613 (674)
T 3pfq_A 565 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKE 613 (674)
T ss_dssp SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTC
T ss_pred CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCC
Confidence 89999999999999999999997 999999999988876554443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=400.61 Aligned_cols=268 Identities=24% Similarity=0.345 Sum_probs=221.0
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCL 87 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l 87 (671)
|-...++|++++.||+|+||.||+|.+..+|+.||||++...... .....+.+|+.+++.++||||+++++++.+...+
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 99 (331)
T 4aaa_A 20 YFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRW 99 (331)
T ss_dssp CCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEE
Confidence 445678999999999999999999999999999999998655433 2345678999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccC
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~ 167 (671)
|+||||+.|++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 100 ~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp EEEEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999999999888876654 67999999999999999999999999999999999999999999999999998655322
Q ss_pred CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----------
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG---------- 237 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~---------- 237 (671)
. .......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.........+.......
T Consensus 178 ~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 178 G---EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred c---cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 2 223445899999999999875578999999999999999999999999887766554443211000
Q ss_pred ------C----------CccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 238 ------L----------DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 238 ------~----------~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
. .......++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 314 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence 0 0011235789999999999999999999999999999998543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=389.10 Aligned_cols=263 Identities=24% Similarity=0.417 Sum_probs=223.9
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
++|++.+.||+|+||.||+|.+..+|+.||||++.........+.+.+|+.+++.++||||+++++++.+...+|+||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 67999999999999999999999999999999997665555568899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS 173 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 173 (671)
+.|++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++..+.... ....
T Consensus 87 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~ 163 (276)
T 2yex_A 87 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN-RERL 163 (276)
T ss_dssp CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT-EECC
T ss_pred cCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc-chhc
Confidence 9999999988654 569999999999999999999999999999999999999999999999999986553222 1223
Q ss_pred cccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHH
Q 005886 174 RNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL 253 (671)
Q Consensus 174 ~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dL 253 (671)
.....||+.|+|||++.+...++.++|||||||++|+|++|..||.................. ....+..++..+.+|
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l 241 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--YLNPWKKIDSAPLAL 241 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT--TSTTGGGSCHHHHHH
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc--ccCchhhcCHHHHHH
Confidence 345689999999999987443578899999999999999999999876543322222222221 122346789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 254 VTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 254 I~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
|.+||..||.+|||+.++++||||+...
T Consensus 242 i~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 242 LHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHCCCCchhCCCHHHHhcCccccChh
Confidence 9999999999999999999999998654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=411.70 Aligned_cols=261 Identities=21% Similarity=0.385 Sum_probs=225.0
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
.++|++++.||+|+||.||+|.++.+|+.||+|++.... ......+.+|+.+|+.++||||++++++|.+...+|+|||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 368999999999999999999999999999999987543 2335678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcC--CCceEEeccccccccccCCCc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS--NGAIKLADFGVSACMFDAGDR 170 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~--~g~vKL~DFGls~~~~~~~~~ 170 (671)
||.||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..+...
T Consensus 129 ~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~--- 204 (387)
T 1kob_A 129 FLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--- 204 (387)
T ss_dssp CCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT---
T ss_pred cCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC---
Confidence 99999999988654 246899999999999999999999999999999999999974 468999999998765321
Q ss_pred ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHH
Q 005886 171 QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSF 250 (671)
Q Consensus 171 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l 250 (671)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+......+..+.... ..+....+..++.++
T Consensus 205 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~s~~~ 281 (387)
T 1kob_A 205 -EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD-WEFDEDAFSSVSPEA 281 (387)
T ss_dssp -SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC-CCCCSSTTTTSCHHH
T ss_pred -cceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCccccccCCHHH
Confidence 12234589999999999987 568999999999999999999999999887766665554432 223334456789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 251 KELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 251 ~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
++||.+||..||.+|||+.++|+||||+...
T Consensus 282 ~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 282 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 9999999999999999999999999998643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=402.87 Aligned_cols=258 Identities=24% Similarity=0.433 Sum_probs=200.1
Q ss_pred CCeEEE---EEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCC-CCCceeeeeEEEeCCEEEE
Q 005886 14 KDYRLY---EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN-HPNVLRAHCSFTTGHCLWV 89 (671)
Q Consensus 14 ~~Y~l~---~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~-HpNIVkl~~~~~~~~~l~L 89 (671)
++|++. +.||+|+||+||+|.++.+|+.||||++... ....+.+|+.+++.+. ||||++++++|.++..+|+
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l 83 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL 83 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence 456664 7899999999999999999999999998643 3467789999999997 9999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC---ceEEecccccccccc
Q 005886 90 VMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG---AIKLADFGVSACMFD 166 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g---~vKL~DFGls~~~~~ 166 (671)
|||||.||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 161 (325)
T 3kn6_A 84 VMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161 (325)
T ss_dssp EECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred EEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence 99999999999999876 6799999999999999999999999999999999999997765 899999999875432
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcCCCCCCc
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPP------MKVLLMTLQNAPPGLDY 240 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~------~~~~~~~~~~~~~~~~~ 240 (671)
. .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+... .......+......+..
T Consensus 162 ~---~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 237 (325)
T 3kn6_A 162 D---NQPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG 237 (325)
T ss_dssp --------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCS
T ss_pred C---CCcccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCc
Confidence 2 222345689999999999987 6799999999999999999999999976432 12223333333333444
Q ss_pred cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 241 ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 241 ~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
..+..++.++++||.+||..||.+|||+.++++||||+...
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 55567899999999999999999999999999999998643
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=418.94 Aligned_cols=262 Identities=27% Similarity=0.433 Sum_probs=212.2
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-------ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-------NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH 85 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-------~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~ 85 (671)
.++|++.+.||+|+||+||+|.+..+++.||||++...... .....+.+|+.+|+.++||||+++++++.. .
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 47899999999999999999999999999999999764321 122357899999999999999999999864 4
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC---ceEEecccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG---AIKLADFGVSA 162 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g---~vKL~DFGls~ 162 (671)
.+|+|||||.||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred ceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 589999999999999888655 6799999999999999999999999999999999999997654 59999999987
Q ss_pred ccccCCCcccccccccCCCCCCChhHhhh--ccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCc
Q 005886 163 CMFDAGDRQRSRNTFVGTPCWMAPEVMQQ--LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240 (671)
Q Consensus 163 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~--~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~ 240 (671)
.... .......+||+.|+|||++.+ ...|+.++|||||||++|+|++|..||.+......+...+......+..
T Consensus 291 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~ 366 (419)
T 3i6u_A 291 ILGE----TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 366 (419)
T ss_dssp SCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCH
T ss_pred ecCC----CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCc
Confidence 5522 223345689999999999853 3568889999999999999999999998765443344444444434444
Q ss_pred cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 241 ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 241 ~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
..+..++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 367 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 407 (419)
T 3i6u_A 367 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 407 (419)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence 45567899999999999999999999999999999998543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=385.70 Aligned_cols=260 Identities=27% Similarity=0.455 Sum_probs=222.7
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEe----
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTT---- 83 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~---- 83 (671)
+..+.+.|++.+.||+|+||.||+|.+..++..||+|++..... ......+.+|+.+++.++||||++++++|..
T Consensus 21 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (290)
T 1t4h_A 21 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100 (290)
T ss_dssp ECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS
T ss_pred cccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCC
Confidence 45566779999999999999999999999999999999876543 2346788999999999999999999999875
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCCcEEEc-CCCceEEecccc
Q 005886 84 GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHG--HIHRDVKAGNILID-SNGAIKLADFGV 160 (671)
Q Consensus 84 ~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~g--IVHrDLKPeNILld-~~g~vKL~DFGl 160 (671)
...+|+||||+.||+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+
T Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 101 KKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred CceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 46799999999999999999876 67999999999999999999999999 99999999999997 789999999999
Q ss_pred ccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCc
Q 005886 161 SACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240 (671)
Q Consensus 161 s~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~ 240 (671)
+..... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..........+..... ..
T Consensus 179 ~~~~~~-----~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~ 249 (290)
T 1t4h_A 179 ATLKRA-----SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PA 249 (290)
T ss_dssp GGGCCT-----TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CG
T ss_pred cccccc-----cccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC--cc
Confidence 854321 12334579999999999875 4899999999999999999999999886665555544443322 23
Q ss_pred cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccc
Q 005886 241 ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKH 279 (671)
Q Consensus 241 ~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~ 279 (671)
..+..+++++.+||.+||..||.+|||+.++|+||||+.
T Consensus 250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 345667889999999999999999999999999999974
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=388.35 Aligned_cols=259 Identities=26% Similarity=0.393 Sum_probs=225.6
Q ss_pred ccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q 005886 10 PVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCL 87 (671)
Q Consensus 10 ~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l 87 (671)
.+..++|++.+.||+|+||.||+|.+..++..||||++..... ......+.+|+.+++.++||||+++++++.+...+
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence 3466899999999999999999999999999999999865432 22356789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccC
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~ 167 (671)
|+||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~- 166 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS- 166 (284)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS-
T ss_pred EEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc-
Confidence 9999999999999999876 5799999999999999999999999999999999999999999999999999854421
Q ss_pred CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccch
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls 247 (671)
.......||+.|+|||++.+ ..++.++||||||+++|+|++|..||...........+.... ...+..++
T Consensus 167 ----~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-----~~~~~~~~ 236 (284)
T 2vgo_A 167 ----LRRRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD-----LKFPPFLS 236 (284)
T ss_dssp ----SCBCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-----CCCCTTSC
T ss_pred ----cccccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc-----cCCCCcCC
Confidence 12235689999999999987 568999999999999999999999998877666555444322 22345688
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 248 KSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
..+++||.+||..||.+||++.++++||||+...
T Consensus 237 ~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 237 DGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred HHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 9999999999999999999999999999998543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=402.75 Aligned_cols=262 Identities=32% Similarity=0.552 Sum_probs=222.5
Q ss_pred ccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q 005886 10 PVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWV 89 (671)
Q Consensus 10 ~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~L 89 (671)
.+..++|++++.||+|+||.||+|.+..+|..||+|++...........+.+|+.+++.++||||+++++++..+..+|+
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence 45678999999999999999999999999999999999866544556788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 90 VMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH-GHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~-gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
||||+.|++|.+++... ..+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+||+|||++..+...
T Consensus 109 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp EECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 99999999999999876 5799999999999999999999996 9999999999999999999999999998655221
Q ss_pred CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHH------------------
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMT------------------ 230 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~------------------ 230 (671)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||............
T Consensus 186 ----~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 186 ----MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp ----C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred ----cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 2234689999999999987 56899999999999999999999999876544322111
Q ss_pred ------------------------HhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 231 ------------------------LQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 231 ------------------------~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
.....+. .....++.++.+||.+||..||.+|||+.++|+||||+...+
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 333 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPK---LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 333 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCC---CCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCC---CCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence 1111111 112347889999999999999999999999999999986543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=427.76 Aligned_cols=266 Identities=25% Similarity=0.401 Sum_probs=227.8
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 86 (671)
-++..++|++++.||+|+||.||+|+++.+|+.||||++..... ......+.+|+.+|+.++||||++++++|.+...
T Consensus 180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 259 (543)
T 3c4z_A 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD 259 (543)
T ss_dssp SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence 35677899999999999999999999999999999999975432 2346788999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAY--PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACM 164 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~--~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~ 164 (671)
+|+|||||.||+|..++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 999999999999999987643 346999999999999999999999999999999999999999999999999998765
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhcCCCCCCc
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYP----PMKVLLMTLQNAPPGLDY 240 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~----~~~~~~~~~~~~~~~~~~ 240 (671)
... .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.. .......+.... .
T Consensus 340 ~~~---~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~-~---- 410 (543)
T 3c4z_A 340 KAG---QTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA-V---- 410 (543)
T ss_dssp CTT---CCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC-C----
T ss_pred cCC---CcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc-c----
Confidence 322 122345689999999999987 679999999999999999999999997753 233333333322 1
Q ss_pred cccccchHHHHHHHHHhhhcCCCCCCC-----HHHHHhchhccccccc
Q 005886 241 ERDKRFSKSFKELVTACLVKDPKKRPT-----AEKLMKHHFFKHARSN 283 (671)
Q Consensus 241 ~~~~~ls~~l~dLI~~cL~~dP~kRpS-----a~eiL~Hpwfk~~~~~ 283 (671)
..+..++..+++||.+||.+||.+||+ +++|++||||+...|.
T Consensus 411 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~ 458 (543)
T 3c4z_A 411 TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR 458 (543)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence 234678999999999999999999996 5899999999987664
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=387.59 Aligned_cols=265 Identities=42% Similarity=0.752 Sum_probs=223.9
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LV 90 (671)
...++|++.+.||+|+||.||+|.+..+|+.||||++.... ....+.+|+.+++.++||||+++++++.....+|+|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 44678999999999999999999999999999999987543 356788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCc
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR 170 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~ 170 (671)
|||+.|++|.+++... ...+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 103 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 178 (314)
T 3com_A 103 MEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT--- 178 (314)
T ss_dssp EECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT---
T ss_pred eecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh---
Confidence 9999999999998743 257999999999999999999999999999999999999999999999999998655322
Q ss_pred ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHH
Q 005886 171 QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSF 250 (671)
Q Consensus 171 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l 250 (671)
........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.................+.+ ..+..++..+
T Consensus 179 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l 255 (314)
T 3com_A 179 MAKRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTF--RKPELWSDNF 255 (314)
T ss_dssp BSCBCCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--SSGGGSCHHH
T ss_pred ccccCccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCccc--CCcccCCHHH
Confidence 222345689999999999987 5689999999999999999999999998877666655555443332 3355689999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHhchhccccccchH
Q 005886 251 KELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDF 285 (671)
Q Consensus 251 ~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~~~ 285 (671)
.+||.+||..||.+|||+.++|+||||+.......
T Consensus 256 ~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~~ 290 (314)
T 3com_A 256 TDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSI 290 (314)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCGGG
T ss_pred HHHHHHHccCChhhCcCHHHHHhCHHHhcCCcchH
Confidence 99999999999999999999999999997765433
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=388.37 Aligned_cols=265 Identities=30% Similarity=0.498 Sum_probs=207.8
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCccc-HHHHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNND-LDGIRREVQTMRVTNHPNVLRAHCSFTTGHCL 87 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~-~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l 87 (671)
+.+..++|++.+.||+|+||+||+|.+..+|+.||||++........ ...+.++...++.++||||+++++++.++..+
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 46778999999999999999999999999999999999975543332 33444555567889999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCcEEEcCCCceEEecccccccc
Q 005886 88 WVVMPYMAGGSCLHIMKSA--YPEGFEEPVIATLLRETLKALVYLHFH-GHIHRDVKAGNILIDSNGAIKLADFGVSACM 164 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~--~~~~l~e~~i~~i~~qIl~aL~yLHs~-gIVHrDLKPeNILld~~g~vKL~DFGls~~~ 164 (671)
|+||||+.| +|.+++... ....+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999975 787766541 235799999999999999999999998 9999999999999999999999999998655
Q ss_pred ccCCCcccccccccCCCCCCChhHhh---hccCCCccchhhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhcCCCCCCc
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQ---QLHGYDFKADIWSFGITALELAHGHAPFSKY-PPMKVLLMTLQNAPPGLDY 240 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~---~~~~~s~ksDIWSLGvILyeLltG~~PF~~~-~~~~~~~~~~~~~~~~~~~ 240 (671)
... .......||+.|+|||++. ....++.++|||||||++|+|++|..||... ..............+..
T Consensus 161 ~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 234 (290)
T 3fme_A 161 VDD----VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL-- 234 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC--
T ss_pred ccc----ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc--
Confidence 321 2223347999999999972 3356899999999999999999999999864 33344444444433322
Q ss_pred cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 241 ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 241 ~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
....++.++.+||.+||..||.+|||+.++|+||||+...
T Consensus 235 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 235 -PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp -CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred -ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 2346789999999999999999999999999999998543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=385.49 Aligned_cols=260 Identities=27% Similarity=0.422 Sum_probs=223.2
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-----ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-----NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-----~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~ 88 (671)
++|++.+.||+|+||.||+|.+..+|+.||+|++...... ...+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 5799999999999999999999999999999999765432 23678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC----ceEEecccccccc
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG----AIKLADFGVSACM 164 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g----~vKL~DFGls~~~ 164 (671)
+||||+.|++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++.++ .+||+|||++...
T Consensus 85 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 999999999999999876 5799999999999999999999999999999999999998877 8999999998755
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccc
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (671)
... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+.. ....+....+.
T Consensus 163 ~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 236 (283)
T 3bhy_A 163 EAG----NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISA-VNYDFDEEYFS 236 (283)
T ss_dssp C------------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT-TCCCCCHHHHT
T ss_pred cCC----CcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHh-cccCCcchhcc
Confidence 321 12334579999999999986 5689999999999999999999999998776655544433 33333444456
Q ss_pred cchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 245 RFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 245 ~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
.++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 237 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 237 NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp TCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 7899999999999999999999999999999998654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=404.84 Aligned_cols=260 Identities=28% Similarity=0.355 Sum_probs=214.3
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC------
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH------ 85 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~------ 85 (671)
.++|++++.||+|+||.||+|.+..+|+.||||++...... .....+.+|+.+|+.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 47899999999999999999999999999999998654322 33567889999999999999999999998763
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
.+|+||||+ |++|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 469999999 8899999876 469999999999999999999999999999999999999999999999999987542
Q ss_pred cCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC---------
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP--------- 236 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~--------- 236 (671)
. .....+||++|+|||++.+...|+.++|||||||++|+|++|+.||.+......+..+......
T Consensus 180 ~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 253 (367)
T 1cm8_A 180 S------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 253 (367)
T ss_dssp S------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred c------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 1 2345689999999999987567999999999999999999999999988776655544321110
Q ss_pred -----------------CCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 237 -----------------GLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 237 -----------------~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
.........+++.+.+||.+||..||.+|||+.++|+||||+....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred hhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 0001123456899999999999999999999999999999987653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=401.21 Aligned_cols=265 Identities=27% Similarity=0.378 Sum_probs=216.1
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcc----cHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN----DLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCL 87 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~----~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l 87 (671)
..++|++.+.||+|+||.||+|.+..+|+.||||++....... ....+.+|+.+++.++||||++++++|.+...+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4588999999999999999999999999999999997543221 134678999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccC
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~ 167 (671)
|+||||+.+ +|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.+...
T Consensus 88 ~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp EEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred EEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 999999986 788877654 346889999999999999999999999999999999999999999999999998765322
Q ss_pred CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CCCCCc-----
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA--PPGLDY----- 240 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~--~~~~~~----- 240 (671)
.......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+......+..+.... +....+
T Consensus 166 ---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 242 (346)
T 1ua2_A 166 ---NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 242 (346)
T ss_dssp ---CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred ---cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence 2233456899999999999875668999999999999999999999999988777665554321 111000
Q ss_pred ----------------cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 241 ----------------ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 241 ----------------~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
.....++.++++||.+||..||.+|||+.++|+||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 01245678999999999999999999999999999998654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=389.23 Aligned_cols=266 Identities=35% Similarity=0.660 Sum_probs=224.0
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.++||||+++++++..+..+|+||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 4578999999999999999999999999999999986543 345678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
||+.|++|..++... ...+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++...... .
T Consensus 96 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~ 171 (302)
T 2j7t_A 96 EFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT---L 171 (302)
T ss_dssp ECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH---H
T ss_pred EeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc---c
Confidence 999999999988764 256999999999999999999999999999999999999999999999999987543211 1
Q ss_pred cccccccCCCCCCChhHhh----hccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccch
Q 005886 172 RSRNTFVGTPCWMAPEVMQ----QLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~----~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls 247 (671)
.......||+.|+|||++. ....++.++|||||||++|+|++|..||.................+.. ..+..++
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 249 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL--LTPSKWS 249 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--SSGGGSC
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc--CCccccC
Confidence 1223457999999999985 235688999999999999999999999998887776666655543322 3356789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHhchhccccccch
Q 005886 248 KSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSND 284 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~~ 284 (671)
..+.+||.+||..||.+|||+.++++||||+...+..
T Consensus 250 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~ 286 (302)
T 2j7t_A 250 VEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNK 286 (302)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCCH
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccch
Confidence 9999999999999999999999999999999877653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=397.80 Aligned_cols=264 Identities=25% Similarity=0.398 Sum_probs=218.5
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC----
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH---- 85 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~---- 85 (671)
..++|++.+.||+|+||.||+|.+..+|+.||||++...... .....+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 457899999999999999999999999999999999765432 23567889999999999999999999987654
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
.+|+||||+.|++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred ccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 459999999999999999876 579999999999999999999999999999999999999999999999999987664
Q ss_pred cCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (671)
............+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+................ ........
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~ 245 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI-PPSARHEG 245 (311)
T ss_dssp --------------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC-CHHHHSTT
T ss_pred ccccccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC-CcccccCC
Confidence 43333334445689999999999987 57999999999999999999999999988877766666554322 22233456
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHhchhccc
Q 005886 246 FSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKH 279 (671)
Q Consensus 246 ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~ 279 (671)
++.++.+||.+||..||.+||++.++|.|+|++.
T Consensus 246 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 246 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 8999999999999999999999999999999974
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=391.13 Aligned_cols=267 Identities=38% Similarity=0.681 Sum_probs=221.8
Q ss_pred ccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeeeEEEe---
Q 005886 8 RFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHCSFTT--- 83 (671)
Q Consensus 8 ~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~--- 83 (671)
.+....++|++.+.||+|+||.||+|.+..+|+.||||++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 34456789999999999999999999999999999999987543 3457888999999998 89999999999987
Q ss_pred ---CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccc
Q 005886 84 ---GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGV 160 (671)
Q Consensus 84 ---~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGl 160 (671)
...+|+||||+.||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 175 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 175 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcC
Confidence 56899999999999999999875445799999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCcccccccccCCCCCCChhHhhh----ccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC
Q 005886 161 SACMFDAGDRQRSRNTFVGTPCWMAPEVMQQ----LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP 236 (671)
Q Consensus 161 s~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~----~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~ 236 (671)
+...... ........||+.|+|||++.. ...++.++|||||||++|+|++|..||.+.........+.....+
T Consensus 176 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 252 (326)
T 2x7f_A 176 SAQLDRT---VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP 252 (326)
T ss_dssp TC----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred ceecCcC---ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc
Confidence 8654221 122345689999999999862 245889999999999999999999999988877666655554433
Q ss_pred CCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 237 GLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 237 ~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
.. ....++..+++||.+||..||.+||++.++|+||||+....
T Consensus 253 ~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 295 (326)
T 2x7f_A 253 RL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN 295 (326)
T ss_dssp CC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred cC---CccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence 22 24567899999999999999999999999999999986543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=397.62 Aligned_cols=264 Identities=25% Similarity=0.431 Sum_probs=214.8
Q ss_pred ccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCC--CCceeeeeEEEeC
Q 005886 8 RFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNH--PNVLRAHCSFTTG 84 (671)
Q Consensus 8 ~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~H--pNIVkl~~~~~~~ 84 (671)
-+.+..++|++++.||+|+||.||+|.+ .+++.||||++...... .....+.+|+.+|+.+.| |||+++++++.++
T Consensus 3 ~i~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 81 (343)
T 3dbq_A 3 CISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 81 (343)
T ss_dssp CEESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred eeeeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC
Confidence 3567888999999999999999999987 46899999999765433 345778999999999976 9999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccc
Q 005886 85 HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACM 164 (671)
Q Consensus 85 ~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~ 164 (671)
..+|+||| +.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++.+
T Consensus 82 ~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 82 QYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp SEEEEEEC-CCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred CEEEEEEe-CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 99999999 5578999999876 6799999999999999999999999999999999999997 688999999998765
Q ss_pred ccCCCcccccccccCCCCCCChhHhhh----------ccCCCccchhhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHhc
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQ----------LHGYDFKADIWSFGITALELAHGHAPFSKYPPMK-VLLMTLQN 233 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~----------~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~-~~~~~~~~ 233 (671)
... .........+||+.|+|||++.+ ...++.++|||||||++|+|++|..||....... .+...+.
T Consensus 158 ~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~- 235 (343)
T 3dbq_A 158 QPD-TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID- 235 (343)
T ss_dssp -------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC-
T ss_pred Ccc-cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc-
Confidence 322 11222345689999999999964 1458899999999999999999999998754432 2222222
Q ss_pred CCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 234 APPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 234 ~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
+......+...+..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 236 --~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 236 --PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp --TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred --CCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 122233455678899999999999999999999999999999854
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=389.54 Aligned_cols=261 Identities=25% Similarity=0.390 Sum_probs=222.5
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LV 90 (671)
.++|++++.||+|+||.||+|.+..++..||+|++...... .....+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 47899999999999999999999999999999998654432 3357889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCc
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR 170 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~ 170 (671)
|||+.|++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 90 ~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 165 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-- 165 (294)
T ss_dssp EECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc--
Confidence 9999999999999877 579999999999999999999999999999999999999999999999999987553221
Q ss_pred ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHH
Q 005886 171 QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSF 250 (671)
Q Consensus 171 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l 250 (671)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..........+....+.........++..+
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSL 244 (294)
T ss_dssp ---------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHH
T ss_pred ccccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHH
Confidence 122345679999999999987 6689999999999999999999999999888777767666655544444566789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHhchhcc
Q 005886 251 KELVTACLVKDPKKRPTAEKLMKHHFFK 278 (671)
Q Consensus 251 ~dLI~~cL~~dP~kRpSa~eiL~Hpwfk 278 (671)
.++|.+||.+||.+||+..+.+.+.|..
T Consensus 245 ~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 245 SNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred HHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 9999999999999999766777777765
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=383.66 Aligned_cols=261 Identities=28% Similarity=0.404 Sum_probs=217.2
Q ss_pred ccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q 005886 10 PVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCL 87 (671)
Q Consensus 10 ~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l 87 (671)
.+..++|++.+.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.+++.++||||+++++++.....+
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 4566899999999999999999999999999999999865431 23467889999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccC
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~ 167 (671)
|+||||+.|++|.+++... ..+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 9999999999999999876 57999999999999999999999999999999999999999999999999998654221
Q ss_pred CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccch
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls 247 (671)
.......||+.|+|||++.+...++.++||||||+++|+|++|..||...........+..... ..+..++
T Consensus 165 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~ 235 (276)
T 2h6d_A 165 ----EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF-----YIPEYLN 235 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----CCCTTSC
T ss_pred ----cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-----cCchhcC
Confidence 1223457999999999998744346899999999999999999999988766555544443321 2245678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 248 KSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
..+.+||.+||..||.+|||+.++++||||+...
T Consensus 236 ~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 236 RSVATLLMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence 9999999999999999999999999999998543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=406.95 Aligned_cols=259 Identities=24% Similarity=0.344 Sum_probs=217.7
Q ss_pred CeEE--EEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 15 DYRL--YEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 15 ~Y~l--~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
.|.+ .+.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.+|+.++||||++++++|.+...+|+|||
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 166 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4555 678999999999999999999999999997543 2345778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEE--cCCCceEEeccccccccccCCCc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILI--DSNGAIKLADFGVSACMFDAGDR 170 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILl--d~~g~vKL~DFGls~~~~~~~~~ 170 (671)
||.||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+...
T Consensus 167 ~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~--- 242 (373)
T 2x4f_A 167 YVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR--- 242 (373)
T ss_dssp CCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT---
T ss_pred CCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc---
Confidence 99999999888653 2468999999999999999999999999999999999999 56789999999998765321
Q ss_pred ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHH
Q 005886 171 QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSF 250 (671)
Q Consensus 171 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l 250 (671)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+......+..+..... .+....+..++.++
T Consensus 243 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~ 319 (373)
T 2x4f_A 243 -EKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW-DLEDEEFQDISEEA 319 (373)
T ss_dssp -CBCCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-CSCSGGGTTSCHHH
T ss_pred -cccccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCChhhhccCCHHH
Confidence 12334579999999999976 5689999999999999999999999999887777666665432 23334456789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 251 KELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 251 ~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
++||.+||..||.+|||+.++|+||||+...
T Consensus 320 ~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 320 KEFISKLLIKEKSWRISASEALKHPWLSDHK 350 (373)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence 9999999999999999999999999998643
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=406.07 Aligned_cols=263 Identities=24% Similarity=0.367 Sum_probs=214.6
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe-----
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT----- 83 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~----- 83 (671)
+....++|++.+.||+|+||+||+|.+..+|+.||||++...... ..+|+.+|+.++||||++++++|..
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-----KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-----HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 345678999999999999999999999999999999998654322 2379999999999999999999944
Q ss_pred ---------------------------------CCEEEEEEeccCCCCHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHH
Q 005886 84 ---------------------------------GHCLWVVMPYMAGGSCLHIMKS--AYPEGFEEPVIATLLRETLKALV 128 (671)
Q Consensus 84 ---------------------------------~~~l~LVmEy~~ggsL~~~l~~--~~~~~l~e~~i~~i~~qIl~aL~ 128 (671)
..++++|||||.| +|...+.. .....+++..++.++.||+.||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 3458999999985 77776653 22367999999999999999999
Q ss_pred HHHHCCcccccCCCCcEEEc-CCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHH
Q 005886 129 YLHFHGHIHRDVKAGNILID-SNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGIT 207 (671)
Q Consensus 129 yLHs~gIVHrDLKPeNILld-~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvI 207 (671)
|||++||+||||||+|||++ .++.+||+|||+++.+... ......+||+.|+|||++.+...|+.++|||||||+
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS----EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT----SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC----CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99999999999999999997 6889999999998765322 223456889999999999876669999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHhcCCCC------------------------CCccccccchHHHHHHHHHhhhcCCC
Q 005886 208 ALELAHGHAPFSKYPPMKVLLMTLQNAPPG------------------------LDYERDKRFSKSFKELVTACLVKDPK 263 (671)
Q Consensus 208 LyeLltG~~PF~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~ls~~l~dLI~~cL~~dP~ 263 (671)
+|+|++|+.||.+....+.+..++...... .....+..++.++.+||.+||..||.
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 999999999999988777666554321100 00012345788999999999999999
Q ss_pred CCCCHHHHHhchhccccc
Q 005886 264 KRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 264 kRpSa~eiL~Hpwfk~~~ 281 (671)
+|||+.++|+||||+..+
T Consensus 312 ~R~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 312 LRINPYEAMAHPFFDHLR 329 (383)
T ss_dssp GSCCHHHHHTSGGGHHHH
T ss_pred hCCCHHHHhcCHHHHHHH
Confidence 999999999999998643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=396.54 Aligned_cols=264 Identities=27% Similarity=0.407 Sum_probs=224.3
Q ss_pred CCeEEE-EEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEE
Q 005886 14 KDYRLY-EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVT-NHPNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 14 ~~Y~l~-~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~~~l~LV 90 (671)
++|.+. +.||+|+||+||+|.+..+|+.||||++...... .....+.+|+.+++.+ +||||++++++|.....+|+|
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 567887 8899999999999999999999999999765433 3467889999999988 569999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcC---CCceEEeccccccccccC
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS---NGAIKLADFGVSACMFDA 167 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~---~g~vKL~DFGls~~~~~~ 167 (671)
||||.||+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 99999999999886655567999999999999999999999999999999999999987 789999999998765321
Q ss_pred CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccch
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls 247 (671)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+... ...+....+..++
T Consensus 188 ----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~ 261 (327)
T 3lm5_A 188 ----CELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV-NVDYSEETFSSVS 261 (327)
T ss_dssp ----------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-CCCCCTTTTTTSC
T ss_pred ----cccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc-ccccCchhhcccC
Confidence 12334689999999999987 56899999999999999999999999988776665554443 3333444556789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHhchhccccccc
Q 005886 248 KSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSN 283 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~ 283 (671)
..+++||.+||..||.+|||++++|+||||+...+.
T Consensus 262 ~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~ 297 (327)
T 3lm5_A 262 QLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE 297 (327)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence 999999999999999999999999999999977654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=396.16 Aligned_cols=260 Identities=28% Similarity=0.443 Sum_probs=214.2
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-------ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-------NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-------~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 86 (671)
++|++.+.||+|+||.||+|.+..+|+.||||++...... .....+.+|+.+++.++||||+++++++..+.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 6799999999999999999999999999999999754321 22345789999999999999999999998765
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCc---eEEeccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGA---IKLADFGVSAC 163 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~---vKL~DFGls~~ 163 (671)
+|+||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 89999999999999988755 67999999999999999999999999999999999999987664 99999999865
Q ss_pred cccCCCcccccccccCCCCCCChhHhhh--ccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcc
Q 005886 164 MFDAGDRQRSRNTFVGTPCWMAPEVMQQ--LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYE 241 (671)
Q Consensus 164 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~--~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~ 241 (671)
... ........||+.|+|||++.+ ...++.++|||||||++|+|++|..||........+...+......+...
T Consensus 167 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (322)
T 2ycf_A 167 LGE----TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 242 (322)
T ss_dssp CCC----CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHH
T ss_pred ccc----ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCch
Confidence 521 112234579999999999853 35688999999999999999999999976554333333333333233333
Q ss_pred ccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 242 RDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 242 ~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
.+..++..+.+||.+||..||.+||++.++|+||||+..
T Consensus 243 ~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 456789999999999999999999999999999999753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=383.34 Aligned_cols=264 Identities=29% Similarity=0.473 Sum_probs=226.3
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--------ccHHHHHHHHHHHHhCC-CCCceeeeeEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--------NDLDGIRREVQTMRVTN-HPNVLRAHCSFT 82 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--------~~~~~i~~Ei~iL~~L~-HpNIVkl~~~~~ 82 (671)
-.++|++.+.||+|+||.||+|.++.+|+.||||++...... ...+.+.+|+.+++.+. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 458999999999999999999999999999999999754311 12456789999999995 999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccc
Q 005886 83 TGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSA 162 (671)
Q Consensus 83 ~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~ 162 (671)
....+|+||||+.|++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++.
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence 999999999999999999999876 579999999999999999999999999999999999999999999999999986
Q ss_pred ccccCCCcccccccccCCCCCCChhHhhh-----ccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC
Q 005886 163 CMFDAGDRQRSRNTFVGTPCWMAPEVMQQ-----LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG 237 (671)
Q Consensus 163 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~-----~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~ 237 (671)
.+... .......||+.|+|||++.+ ...++.++|||||||++|+|++|..||...........+.... ..
T Consensus 173 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~ 247 (298)
T 1phk_A 173 QLDPG----EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN-YQ 247 (298)
T ss_dssp ECCTT----CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CC
T ss_pred hcCCC----cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCC-cc
Confidence 55321 22344689999999999863 2457889999999999999999999998877766555554433 22
Q ss_pred CCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 238 LDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 238 ~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
+..+.+..++..+.+||.+||..||.+|||+.++|+||||+....
T Consensus 248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (298)
T 1phk_A 248 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV 292 (298)
T ss_dssp CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence 333445678999999999999999999999999999999987553
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=398.13 Aligned_cols=258 Identities=27% Similarity=0.496 Sum_probs=222.9
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-------ccHHHHHHHHHHHHhC-CCCCceeeeeEEEeCC
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-------NDLDGIRREVQTMRVT-NHPNVLRAHCSFTTGH 85 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-------~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~~ 85 (671)
++|++.+.||.|+||.||+|.++.+|+.||||++...... .....+.+|+.+++.+ +||||++++++|....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 5799999999999999999999999999999998754321 1145678999999998 8999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
.+|+||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+.
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 999999999999999999876 579999999999999999999999999999999999999999999999999987653
Q ss_pred cCCCcccccccccCCCCCCChhHhhhc-----cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCc
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQL-----HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~-----~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~ 240 (671)
.. ......+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.........+... ...+..
T Consensus 252 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~~ 326 (365)
T 2y7j_A 252 PG----EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEG-QYQFSS 326 (365)
T ss_dssp TT----CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-CCCCCH
T ss_pred CC----cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC-CCCCCC
Confidence 21 223456899999999998742 24788999999999999999999999887766655544443 223334
Q ss_pred cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcc
Q 005886 241 ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278 (671)
Q Consensus 241 ~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk 278 (671)
+.+..++..+.+||.+||..||.+|||+.++|+||||+
T Consensus 327 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 44567899999999999999999999999999999996
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=396.58 Aligned_cols=258 Identities=38% Similarity=0.643 Sum_probs=222.9
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
+.|++++.||+|+||+||+|.+..+|+.||||++...... .....+.+|+.+++.++||||++++++|..+..+|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4599999999999999999999999999999999755322 23567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
|||. |+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 134 e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~------ 205 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------ 205 (348)
T ss_dssp ECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS------
T ss_pred ecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecC------
Confidence 9997 5788777644 2579999999999999999999999999999999999999999999999999986542
Q ss_pred cccccccCCCCCCChhHhhh--ccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHH
Q 005886 172 RSRNTFVGTPCWMAPEVMQQ--LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~--~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
.....+||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+......+..+.....+.. ....++..
T Consensus 206 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 281 (348)
T 1u5q_A 206 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL---QSGHWSEY 281 (348)
T ss_dssp -SBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC---CCTTSCHH
T ss_pred -CCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---CCCCCCHH
Confidence 1234689999999999863 24689999999999999999999999998887776666666544332 24567899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHhchhccccccc
Q 005886 250 FKELVTACLVKDPKKRPTAEKLMKHHFFKHARSN 283 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~ 283 (671)
+++||.+||..||.+|||++++|+||||......
T Consensus 282 l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~ 315 (348)
T 1u5q_A 282 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 315 (348)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred HHHHHHHHcccChhhCcCHHHHhhChhhhccCCc
Confidence 9999999999999999999999999999876543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=387.67 Aligned_cols=259 Identities=25% Similarity=0.398 Sum_probs=222.3
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3679999999999999999999999999999999975432 234578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEE---cCCCceEEeccccccccccCCC
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILI---DSNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILl---d~~g~vKL~DFGls~~~~~~~~ 169 (671)
|+.|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 87 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~--- 161 (304)
T 2jam_A 87 LVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--- 161 (304)
T ss_dssp CCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC---
T ss_pred cCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC---
Confidence 99999999998776 579999999999999999999999999999999999999 7788999999999854311
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHH
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.... ..+....+..++..
T Consensus 162 --~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~ 237 (304)
T 2jam_A 162 --GIMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGY-YEFESPFWDDISES 237 (304)
T ss_dssp --BTTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCC-CCCCTTTTTTSCHH
T ss_pred --CccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-CCCCccccccCCHH
Confidence 12334579999999999986 568999999999999999999999999877766655554432 22333445678999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 250 FKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
+.+||.+||..||.+|||+.++|+||||+...
T Consensus 238 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 238 AKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp HHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 99999999999999999999999999998643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=384.25 Aligned_cols=259 Identities=26% Similarity=0.432 Sum_probs=226.1
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~ 88 (671)
...++|++.+.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 4567899999999999999999999999999999998755422 34577889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
+||||+.|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 92 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 999999999999998876 579999999999999999999999999999999999999999999999999987553222
Q ss_pred CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchH
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSK 248 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~ 248 (671)
.......||+.|+|||++.+ ..++.++||||||+++|+|++|..||......+....+.... ...+..++.
T Consensus 170 ---~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~ 240 (294)
T 2rku_A 170 ---ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-----YSIPKHINP 240 (294)
T ss_dssp ---CCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-----CCCCTTSCH
T ss_pred ---cccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc-----CCCccccCH
Confidence 22334679999999999987 568999999999999999999999999877666555444332 223456789
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 249 SFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 249 ~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
.+.+||.+||..||.+|||+.++|+||||...
T Consensus 241 ~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 241 VAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp HHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 99999999999999999999999999999754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=391.01 Aligned_cols=252 Identities=27% Similarity=0.339 Sum_probs=206.6
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHH-hCCCCCceeeeeEEEeCCEEEEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMR-VTNHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~-~L~HpNIVkl~~~~~~~~~l~LVm 91 (671)
++|++.+.||+|+||+||+|.+..+|+.||||++...... ........|+..+. ...||||++++++|.++..+|+||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 5799999999999999999999999999999998654322 22334445555554 449999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
||| +++|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 137 e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~----~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT----A 210 (311)
T ss_dssp ECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred ecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc----C
Confidence 999 67888888765 25699999999999999999999999999999999999999999999999999865422 1
Q ss_pred cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHH
Q 005886 172 RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~ 251 (671)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.... ...... ......+..++.++.
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~~~---~~~~~~~~~~~~~l~ 282 (311)
T 3p1a_A 211 GAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGW---QQLRQG---YLPPEFTAGLSSELR 282 (311)
T ss_dssp ----CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH---HHHTTT---CCCHHHHTTSCHHHH
T ss_pred CCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHhcc---CCCcccccCCCHHHH
Confidence 22334579999999999876 5899999999999999999997776553221 122221 123344567899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHhchhccc
Q 005886 252 ELVTACLVKDPKKRPTAEKLMKHHFFKH 279 (671)
Q Consensus 252 dLI~~cL~~dP~kRpSa~eiL~Hpwfk~ 279 (671)
+||.+||..||.+|||+.++|+||||++
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 283 SVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 9999999999999999999999999974
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=385.19 Aligned_cols=260 Identities=26% Similarity=0.458 Sum_probs=199.5
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWV 89 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~L 89 (671)
..++|++.+.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.+++.++||||+++++++.+...+|+
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 44789999999999999999999999999999999965432 2335788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCC
Q 005886 90 VMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~ 169 (671)
||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 89 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~- 166 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH- 166 (278)
T ss_dssp EEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC-
Confidence 99999999999998764 3568999999999999999999999999999999999999999999999999986553221
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHH
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.............. ..+..+..++.+
T Consensus 167 --~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 238 (278)
T 3cok_A 167 --EKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL-----ADYEMPSFLSIE 238 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS-----SCCCCCTTSCHH
T ss_pred --CcceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh-----cccCCccccCHH
Confidence 12234679999999999987 5689999999999999999999999987654443322221 122345668999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 250 FKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
+.+||.+||..||.+|||+.++|+||||....
T Consensus 239 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 239 AKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 99999999999999999999999999998543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=392.98 Aligned_cols=258 Identities=26% Similarity=0.436 Sum_probs=226.1
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWV 89 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~L 89 (671)
..++|++.+.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 457899999999999999999999999999999998755422 346778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCC
Q 005886 90 VMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~ 169 (671)
||||+.|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 119 v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~- 195 (335)
T 2owb_A 119 VLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG- 195 (335)
T ss_dssp EECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred EEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc-
Confidence 99999999999998876 679999999999999999999999999999999999999999999999999987653222
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHH
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+.... +..+..++..
T Consensus 196 --~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-----~~~~~~~~~~ 267 (335)
T 2owb_A 196 --ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-----YSIPKHINPV 267 (335)
T ss_dssp --CCBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-----CCCCTTSCHH
T ss_pred --ccccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC-----CCCCccCCHH
Confidence 22345689999999999987 568999999999999999999999998877666555544432 1234567899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 250 FKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
+.+||.+||..||.+|||+.++|+||||...
T Consensus 268 ~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 268 AASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp HHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 9999999999999999999999999999754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=388.36 Aligned_cols=265 Identities=20% Similarity=0.312 Sum_probs=214.2
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEE----------
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFT---------- 82 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~---------- 82 (671)
.++|++++.||+|+||.||+|.+..+|+.||||++.... ......+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 478999999999999999999999999999999986543 344677889999999999999999999873
Q ss_pred ----eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEc-CCCceEEec
Q 005886 83 ----TGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILID-SNGAIKLAD 157 (671)
Q Consensus 83 ----~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld-~~g~vKL~D 157 (671)
....+|+||||+. |+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 4578999999997 589988864 4689999999999999999999999999999999999997 567999999
Q ss_pred cccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC
Q 005886 158 FGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG 237 (671)
Q Consensus 158 FGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~ 237 (671)
||++.................||+.|+|||++.+...++.++|||||||++|+|++|..||.+.........+....+..
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99987653322222334456789999999998765678999999999999999999999999887766655554433211
Q ss_pred C-------------------------CccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 238 L-------------------------DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 238 ~-------------------------~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
. .......++.++++||.+||..||.+|||+.++|+||||+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF 314 (320)
T ss_dssp CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence 0 01123457899999999999999999999999999999986654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=401.11 Aligned_cols=250 Identities=26% Similarity=0.401 Sum_probs=215.4
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcc-------cHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-------DLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~-------~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 86 (671)
++|++.+.||+|+||+||+|.++.+|+.||||++....... ....+.+|+.+++.++||||++++++|.+...
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 67999999999999999999999999999999997654221 23457789999999999999999999999999
Q ss_pred EEEEEeccCCC-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 87 LWVVMPYMAGG-SCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 87 l~LVmEy~~gg-sL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
+|+||||+.+| +|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 99999999776 999999865 579999999999999999999999999999999999999999999999999987553
Q ss_pred cCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (671)
. .......+||+.|+|||++.+...++.++|||||||++|+|++|..||...... .. .....+..
T Consensus 182 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~-----~~~~~~~~ 246 (335)
T 3dls_A 182 R----GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VE-----AAIHPPYL 246 (335)
T ss_dssp T----TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TT-----TCCCCSSC
T ss_pred C----CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hh-----hccCCCcc
Confidence 2 122345689999999999987444488999999999999999999999763221 11 11223445
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 246 FSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 246 ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
++.++.+||.+||..||.+|||+.++|+||||+..
T Consensus 247 ~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 247 VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 78999999999999999999999999999999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=391.55 Aligned_cols=258 Identities=24% Similarity=0.378 Sum_probs=213.6
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCC-CCCceeeeeEEEe--CCEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN-HPNVLRAHCSFTT--GHCLW 88 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~-HpNIVkl~~~~~~--~~~l~ 88 (671)
..++|++.+.||+|+||+||+|.+..+|+.||||++.. .....+.+|+.+++.+. ||||+++++++.+ ...++
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 35789999999999999999999999999999999863 33577899999999997 9999999999998 67899
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC-ceEEeccccccccccC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG-AIKLADFGVSACMFDA 167 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g-~vKL~DFGls~~~~~~ 167 (671)
+||||+.+++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..+...
T Consensus 110 lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp EEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred EEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 9999999999998874 388999999999999999999999999999999999999777 8999999998755322
Q ss_pred CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHh------------cC
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKY-PPMKVLLMTLQ------------NA 234 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~-~~~~~~~~~~~------------~~ 234 (671)
.......||+.|+|||++.+...++.++|||||||++|+|++|..||... .....+..+.. ..
T Consensus 185 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 185 ----QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp ----CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred ----CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence 22345589999999999987667999999999999999999999999543 22222221111 00
Q ss_pred CCC--------------------CCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 235 PPG--------------------LDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 235 ~~~--------------------~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
... .....+..++.++.+||.+||..||.+|||++++|+||||+...+
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence 000 011112347899999999999999999999999999999997654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=380.52 Aligned_cols=253 Identities=25% Similarity=0.329 Sum_probs=211.9
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVT-NHPNVLRAHCSFTTGHCLWVVM 91 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~~~l~LVm 91 (671)
++|++.+.||+|+||+||+|.+..+|+.||||++..... ......+.+|+..+..+ +||||+++++++.+...+|+||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 679999999999999999999999999999999976533 23456788899999988 9999999999999999999999
Q ss_pred eccCCCCHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCC-------------------
Q 005886 92 PYMAGGSCLHIMKSAYP--EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSN------------------- 150 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~--~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~------------------- 150 (671)
||+.|++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 170 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence 99999999999876422 568999999999999999999999999999999999999844
Q ss_pred CceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 005886 151 GAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMT 230 (671)
Q Consensus 151 g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~ 230 (671)
+.+||+|||++..... .....||+.|+|||++.+...++.++|||||||++|+|++|.+||..... ...+
T Consensus 171 ~~~kl~Dfg~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~ 240 (289)
T 1x8b_A 171 VMFKIGDLGHVTRISS-------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEI 240 (289)
T ss_dssp CCEEECCCTTCEETTC-------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHH
T ss_pred eEEEEcccccccccCC-------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHH
Confidence 4799999999865422 12346999999999998754677899999999999999999988755432 2223
Q ss_pred HhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 231 LQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 231 ~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
.....+ ..+..++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 241 ~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 241 RQGRLP----RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HTTCCC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HcCCCC----CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 332222 2345689999999999999999999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=398.52 Aligned_cols=268 Identities=30% Similarity=0.470 Sum_probs=221.3
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEc---CCCcEEEEEEeccccC---cccHHHHHHHHHHHHhC-CCCCceeeeeEE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCI---PLNEIVAIKVLDLEKC---NNDLDGIRREVQTMRVT-NHPNVLRAHCSF 81 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~---~tg~~VAIKvi~~~~~---~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~ 81 (671)
..+..++|++++.||+|+||.||+|++. .+|+.||||++..... ......+.+|+.+++.+ +||||+++++++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 128 (355)
T 1vzo_A 49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 128 (355)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence 3455689999999999999999999984 5899999999875432 12345677899999999 799999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccc
Q 005886 82 TTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVS 161 (671)
Q Consensus 82 ~~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls 161 (671)
.....+|+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeCceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999999999876 57999999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCcccccccccCCCCCCChhHhhhc-cCCCccchhhhHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhcCCC
Q 005886 162 ACMFDAGDRQRSRNTFVGTPCWMAPEVMQQL-HGYDFKADIWSFGITALELAHGHAPFSKYP----PMKVLLMTLQNAPP 236 (671)
Q Consensus 162 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~~s~ksDIWSLGvILyeLltG~~PF~~~~----~~~~~~~~~~~~~~ 236 (671)
+.+.... .......+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.... .......+... .+
T Consensus 207 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~ 283 (355)
T 1vzo_A 207 KEFVADE--TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EP 283 (355)
T ss_dssp EECCGGG--GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-CC
T ss_pred eecccCC--CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc-CC
Confidence 7553221 1223456899999999999852 347899999999999999999999997532 22222223222 21
Q ss_pred CCCccccccchHHHHHHHHHhhhcCCCCCC-----CHHHHHhchhccccccchH
Q 005886 237 GLDYERDKRFSKSFKELVTACLVKDPKKRP-----TAEKLMKHHFFKHARSNDF 285 (671)
Q Consensus 237 ~~~~~~~~~ls~~l~dLI~~cL~~dP~kRp-----Sa~eiL~Hpwfk~~~~~~~ 285 (671)
..+..++..+++||.+||..||.+|| ++.++++||||+...+...
T Consensus 284 ----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l 333 (355)
T 1vzo_A 284 ----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDL 333 (355)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHH
T ss_pred ----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHh
Confidence 23456889999999999999999999 9999999999997765443
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=388.82 Aligned_cols=263 Identities=22% Similarity=0.373 Sum_probs=219.1
Q ss_pred ccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC--EE
Q 005886 10 PVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH--CL 87 (671)
Q Consensus 10 ~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~--~l 87 (671)
.+..++|++.+.||+|+||+||+|.+..+|+.||||++.........+.+.+|+.+++.++||||+++++++.... .+
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 3456889999999999999999999999999999999986655556788899999999999999999999998765 78
Q ss_pred EEEEeccCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEE----cCCCceEEecccccc
Q 005886 88 WVVMPYMAGGSCLHIMKSAYP-EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILI----DSNGAIKLADFGVSA 162 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~-~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILl----d~~g~vKL~DFGls~ 162 (671)
|+||||+.||+|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999999986532 239999999999999999999999999999999999999 777889999999987
Q ss_pred ccccCCCcccccccccCCCCCCChhHhhh-------ccCCCccchhhhHHHHHHHHHhCCCCCCCCCh----HHHHHHHH
Q 005886 163 CMFDAGDRQRSRNTFVGTPCWMAPEVMQQ-------LHGYDFKADIWSFGITALELAHGHAPFSKYPP----MKVLLMTL 231 (671)
Q Consensus 163 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~-------~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~----~~~~~~~~ 231 (671)
.+... ......+||+.|+|||++.. ...++.++|||||||++|+|++|..||..... .+....++
T Consensus 165 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 165 ELEDD----EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp ECCTT----CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred ecCCC----CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 65322 22334679999999999873 25689999999999999999999999965432 33444444
Q ss_pred hcCCCCC--------------------CccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchh
Q 005886 232 QNAPPGL--------------------DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHF 276 (671)
Q Consensus 232 ~~~~~~~--------------------~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpw 276 (671)
...+... .......++..+.+||.+||..||.+|||++++|+||=
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 4333211 01123456788999999999999999999999999973
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=402.72 Aligned_cols=263 Identities=24% Similarity=0.427 Sum_probs=214.7
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCC--CCCceeeeeEEEeCC
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTN--HPNVLRAHCSFTTGH 85 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~--HpNIVkl~~~~~~~~ 85 (671)
..+..++|++++.||+|+||+||+|.+.. |+.||||++...... .....+.+|+.+|+.+. ||||+++++++..+.
T Consensus 51 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 51 ISVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129 (390)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred ccccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence 34555679999999999999999999765 899999999765432 34678899999999996 599999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
.+|+||| +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+.
T Consensus 130 ~~~lv~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred EEEEEEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 9999999 5688999999876 5789999999999999999999999999999999999995 6899999999987653
Q ss_pred cCCCcccccccccCCCCCCChhHhhhc----------cCCCccchhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcC
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQL----------HGYDFKADIWSFGITALELAHGHAPFSKYPPM-KVLLMTLQNA 234 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~----------~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~-~~~~~~~~~~ 234 (671)
... ........+||+.|+|||++.+. ..|+.++|||||||++|+|++|..||...... ..+..++..
T Consensus 206 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~- 283 (390)
T 2zmd_A 206 PDT-TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP- 283 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT-
T ss_pred CCC-ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc-
Confidence 221 11223456899999999999751 35889999999999999999999999876443 333333321
Q ss_pred CCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 235 PPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 235 ~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
......+...+..+++||.+||..||.+|||+.++|+||||+..
T Consensus 284 --~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 284 --NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp --TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred --cccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 12223345568899999999999999999999999999999854
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=398.22 Aligned_cols=259 Identities=25% Similarity=0.358 Sum_probs=208.7
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC------
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH------ 85 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~------ 85 (671)
.++|++++.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.+++.++||||++++++|....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 4789999999999999999999999999999999975432 234567889999999999999999999998765
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
.+|+|||||.| +|...+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 104 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred ceEEEEEcCCC-CHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 79999999975 6877775 358999999999999999999999999999999999999999999999999986542
Q ss_pred cCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC------
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD------ 239 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~------ 239 (671)
. .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+......+..++........
T Consensus 179 ~----~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 179 T----SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ---------------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred c----ccccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 1 122345689999999999987 57999999999999999999999999988776666555443211100
Q ss_pred -------------------------------ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 240 -------------------------------YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 240 -------------------------------~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
.......+..+++||.+||..||.+|||++++|+||||+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 326 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 326 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence 000112367899999999999999999999999999998643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=402.37 Aligned_cols=260 Identities=25% Similarity=0.366 Sum_probs=202.9
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeC------C
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG------H 85 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~------~ 85 (671)
.++|++++.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.+++.++||||++++++|... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 3789999999999999999999999999999999865432 23456788999999999999999999999754 5
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
.+|+||||+ |++|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 689999999 7888888865 469999999999999999999999999999999999999999999999999986542
Q ss_pred cCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC---------
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP--------- 236 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~--------- 236 (671)
. .....+||++|+|||++.+...|+.++|||||||++|+|++|+.||.+.+....+..+......
T Consensus 184 ~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 257 (367)
T 2fst_X 184 D------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257 (367)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred c------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 1 2345689999999999987567999999999999999999999999988776655544331100
Q ss_pred ----------------CCC-ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 237 ----------------GLD-YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 237 ----------------~~~-~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
... ......+++.+.+||.+||..||.+|||+.++|.||||+....
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320 (367)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence 000 0112346789999999999999999999999999999987554
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=392.67 Aligned_cols=267 Identities=26% Similarity=0.339 Sum_probs=219.4
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeC-----CE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG-----HC 86 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~-----~~ 86 (671)
..++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+|+.+++.++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3589999999999999999999999999999999996544344466788999999999999999999988764 67
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
+|+||||+. |+|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 89 ~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 999999997 589888876 3699999999999999999999999999999999999999999999999999876532
Q ss_pred CCCcc-------cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CCC-
Q 005886 167 AGDRQ-------RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQN--APP- 236 (671)
Q Consensus 167 ~~~~~-------~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~--~~~- 236 (671)
..... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+......+..+... .+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCS
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCch
Confidence 21111 12234689999999999876567899999999999999999999999987765544333221 000
Q ss_pred ------------------------CCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 237 ------------------------GLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 237 ------------------------~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
......+..++..+.+||.+||..||.+|||+.++|+||||+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 0001123467899999999999999999999999999999987654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=406.50 Aligned_cols=259 Identities=24% Similarity=0.374 Sum_probs=211.7
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe------CCEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT------GHCL 87 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~------~~~l 87 (671)
.+|++.+.||+|+||+||+|++..+|+.||||++..... ...+|+.+|+.++|||||+++++|.. ..++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 469999999999999999999999999999999865432 23479999999999999999999854 2357
Q ss_pred EEEEeccCCCCHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCC-CceEEecccccccc
Q 005886 88 WVVMPYMAGGSCLHIMKS--AYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSN-GAIKLADFGVSACM 164 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~--~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~-g~vKL~DFGls~~~ 164 (671)
++||||+.+ ++..++.. .....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.+
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 899999976 56665543 223679999999999999999999999999999999999999965 57899999999765
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC---------
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP--------- 235 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~--------- 235 (671)
... ......+||+.|+|||++.+...|+.++|||||||++|||++|+.||.+....+.+..++....
T Consensus 208 ~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 208 VRG----EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp CTT----CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred ccC----CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 322 1233568999999999998756799999999999999999999999998887666655543210
Q ss_pred -----CCCCcc----------ccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 236 -----PGLDYE----------RDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 236 -----~~~~~~----------~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
..+.++ ....++.++.+||.+||.+||.+|||+.++|+||||+....
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 345 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence 000110 12356899999999999999999999999999999986543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=406.14 Aligned_cols=259 Identities=24% Similarity=0.351 Sum_probs=215.5
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhC------CCCCceeeeeEEEeCCE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT------NHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L------~HpNIVkl~~~~~~~~~ 86 (671)
..+|++++.||+|+||+||+|.+..+++.||||++.... .....+.+|+.+++.+ +|+||++++++|.....
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc--chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 467999999999999999999999999999999986432 3345677888888776 67899999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCc--eEEecccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGA--IKLADFGVSACM 164 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~--vKL~DFGls~~~ 164 (671)
+|+||||+. ++|.+++.......+++..++.++.||+.||+|||++|||||||||+|||++.++. +||+|||++...
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~ 252 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence 999999996 68999988775567999999999999999999999999999999999999999887 999999998543
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD----- 239 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~----- 239 (671)
. ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+....+.+..+.........
T Consensus 253 ~------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~ 325 (429)
T 3kvw_A 253 H------QRVYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325 (429)
T ss_dssp T------CCCCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred C------CcccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence 1 22345689999999999987 56999999999999999999999999988776665444422100000
Q ss_pred ------------c-------------------------------------cccccchHHHHHHHHHhhhcCCCCCCCHHH
Q 005886 240 ------------Y-------------------------------------ERDKRFSKSFKELVTACLVKDPKKRPTAEK 270 (671)
Q Consensus 240 ------------~-------------------------------------~~~~~ls~~l~dLI~~cL~~dP~kRpSa~e 270 (671)
+ ......++.+.+||.+||.+||.+|||+.+
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e 405 (429)
T 3kvw_A 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405 (429)
T ss_dssp BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence 0 001123678999999999999999999999
Q ss_pred HHhchhccccc
Q 005886 271 LMKHHFFKHAR 281 (671)
Q Consensus 271 iL~Hpwfk~~~ 281 (671)
+|+||||+...
T Consensus 406 ~L~Hpw~~~~~ 416 (429)
T 3kvw_A 406 ALRHPWLRRRL 416 (429)
T ss_dssp HHTSTTTC---
T ss_pred HhCChhhccCC
Confidence 99999998643
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=403.51 Aligned_cols=261 Identities=26% Similarity=0.403 Sum_probs=211.1
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC------E
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH------C 86 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~------~ 86 (671)
..+|++.+.||+|+||+||+|++..++. ||+|++...... ..+|+.+|+.++||||++++++|.... .
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 3579999999999999999999987776 888887543322 237999999999999999999996433 4
Q ss_pred EEEEEeccCCCCHHHHHH-hhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEc-CCCceEEecccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMK-SAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILID-SNGAIKLADFGVSACM 164 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~-~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld-~~g~vKL~DFGls~~~ 164 (671)
+|+|||||.++.+..+.. ......+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++.+
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 899999998754433322 12236799999999999999999999999999999999999998 7899999999998765
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--------
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP-------- 236 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~-------- 236 (671)
... ......+||+.|+|||++.+...|+.++|||||||++|+|++|+.||.+....+.+..++.....
T Consensus 193 ~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 193 IAG----EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp CTT----CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred cCC----CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 322 22335689999999999987667999999999999999999999999998877666555432100
Q ss_pred -----------CC-----CccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccccc
Q 005886 237 -----------GL-----DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSN 283 (671)
Q Consensus 237 -----------~~-----~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~ 283 (671)
.. ....+..+++++.+||.+||.+||.+|||+.++|+||||+..++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 331 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG 331 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence 00 011233478899999999999999999999999999999976653
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=381.05 Aligned_cols=264 Identities=27% Similarity=0.391 Sum_probs=211.6
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe----------
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT---------- 83 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~---------- 83 (671)
++|++++.||+|+||.||+|.+..+|+.||||++... ......+.+|+.+++.++||||++++++|.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 5799999999999999999999999999999998543 2345778899999999999999999999865
Q ss_pred ---CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccc
Q 005886 84 ---GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGV 160 (671)
Q Consensus 84 ---~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGl 160 (671)
...+|+||||+.||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 45789999999999999999864 24678899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC-----------cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 005886 161 SACMFDAGD-----------RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLM 229 (671)
Q Consensus 161 s~~~~~~~~-----------~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~ 229 (671)
+........ .........||+.|+|||++.+...++.++|||||||++|+|++ ||...........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~ 239 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHH
Confidence 865532110 01223456799999999999875568999999999999999998 5543333233333
Q ss_pred HHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccccc
Q 005886 230 TLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSN 283 (671)
Q Consensus 230 ~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~ 283 (671)
.+......+........+..+++||.+||..||.+|||+.++|+||||+.....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 293 (303)
T 1zy4_A 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQD 293 (303)
T ss_dssp HHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCHH
T ss_pred hccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCChH
Confidence 344333333334456678889999999999999999999999999999865543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=384.29 Aligned_cols=268 Identities=27% Similarity=0.358 Sum_probs=220.6
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEc-CCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhC---CCCCceeeeeEEE-
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCI-PLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVT---NHPNVLRAHCSFT- 82 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~-~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L---~HpNIVkl~~~~~- 82 (671)
+....++|++.+.||+|+||.||+|.+. .+|+.||+|++...... .....+.+|+.+++.+ .||||+++++++.
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 6 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp CCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred ccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 4445589999999999999999999995 67899999998754322 2233566777777665 8999999999997
Q ss_pred ----eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecc
Q 005886 83 ----TGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADF 158 (671)
Q Consensus 83 ----~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DF 158 (671)
....+|+||||+. |+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecC
Confidence 5678999999997 59999998765566999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CC
Q 005886 159 GVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA--PP 236 (671)
Q Consensus 159 Gls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~--~~ 236 (671)
|++..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+......+..++... +.
T Consensus 165 g~~~~~~~----~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (326)
T 1blx_A 165 GLARIYSF----QMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239 (326)
T ss_dssp CSCCCCCG----GGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccC----CCCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 99865421 123345689999999999987 568999999999999999999999999887766655554321 10
Q ss_pred CC--------------------CccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 237 GL--------------------DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 237 ~~--------------------~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
.. .......++..+++||.+||..||.+|||+.++|+||||+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 00 01123467899999999999999999999999999999987654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=379.28 Aligned_cols=260 Identities=27% Similarity=0.459 Sum_probs=224.9
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
++|++.+.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.+++.++||||+++++++.....+|+|||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 579999999999999999999999999999999975543 3457789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCC---CceEEeccccccccccCCC
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSN---GAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~---g~vKL~DFGls~~~~~~~~ 169 (671)
|+.|++|.+.+... ..+++..++.++.||+.||.|||++|++||||||+||+++.+ +.+||+|||++......
T Consensus 102 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~-- 177 (287)
T 2wei_A 102 LYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-- 177 (287)
T ss_dssp CCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC--
T ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC--
Confidence 99999999988766 579999999999999999999999999999999999999764 46999999998755321
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHH
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
.......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+... ...+..+.+..++.+
T Consensus 178 --~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 252 (287)
T 2wei_A 178 --TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG-KYAFDLPQWRTISDD 252 (287)
T ss_dssp --SSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCCCSGGGTTSCHH
T ss_pred --CccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCCchhhhhcCHH
Confidence 12234568999999999876 4899999999999999999999999988776655544443 333344455678999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 250 FKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
+.+||.+||..||.+|||+.++|+||||+...+
T Consensus 253 ~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 285 (287)
T 2wei_A 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred HHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence 999999999999999999999999999986544
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=396.72 Aligned_cols=260 Identities=23% Similarity=0.414 Sum_probs=221.4
Q ss_pred ccccCCCCeEEEEEecccCceEEEEEEEc-------CCCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeee
Q 005886 8 RFPVDAKDYRLYEEVGEGVSATVYRALCI-------PLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHC 79 (671)
Q Consensus 8 ~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~-------~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~ 79 (671)
.+.+..++|++.+.||+|+||.||+|.+. .++..||||++...........+.+|+.+|+.+ +||||+++++
T Consensus 75 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 75 KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp TTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred cccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 35667789999999999999999999975 345679999997655445567899999999999 8999999999
Q ss_pred EEEeCCEEEEEEeccCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcE
Q 005886 80 SFTTGHCLWVVMPYMAGGSCLHIMKSAYP--------------EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNI 145 (671)
Q Consensus 80 ~~~~~~~l~LVmEy~~ggsL~~~l~~~~~--------------~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNI 145 (671)
+|.+...+|+||||+.||+|.+++..... ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 234 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence 99999999999999999999999987532 3588999999999999999999999999999999999
Q ss_pred EEcCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChH
Q 005886 146 LIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPM 224 (671)
Q Consensus 146 Lld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~ 224 (671)
|++.+|.+||+|||+++...... .........||+.|+|||++.+ ..|+.++|||||||++|+|++ |..||.+....
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNID-YYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCC-TTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred EECCCCCEEEccccCCcccCccc-ceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999999999987553322 1222334567899999999987 679999999999999999999 99999988776
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 225 KVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
+....+..... ...+..++..+.+||.+||..||.+||++.++++
T Consensus 313 ~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 357 (370)
T 2psq_A 313 ELFKLLKEGHR----MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357 (370)
T ss_dssp GHHHHHHTTCC----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcCCC----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 66554444332 2335578899999999999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=385.11 Aligned_cols=260 Identities=24% Similarity=0.317 Sum_probs=215.3
Q ss_pred CCCCeEEEEEecccCceEEEEEEE-cCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCC------CceeeeeEEEeC
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALC-IPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHP------NVLRAHCSFTTG 84 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~-~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~Hp------NIVkl~~~~~~~ 84 (671)
..++|++.+.||+|+||.||+|.+ ..+|+.||||++... ......+.+|+.+++.+.|+ +|++++++|...
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 357999999999999999999998 568899999998643 23456788999999888665 499999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcC---------------
Q 005886 85 HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS--------------- 149 (671)
Q Consensus 85 ~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~--------------- 149 (671)
..+|+||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 9999999999 889999998775557899999999999999999999999999999999999987
Q ss_pred ----CCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHH
Q 005886 150 ----NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK 225 (671)
Q Consensus 150 ----~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~ 225 (671)
++.+||+|||++.... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~------~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDD------EHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEESCCCEEECCCSSCEETT------SCCCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccCCCceEeeCcccccCc------cccccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 6689999999986432 12335689999999999987 569999999999999999999999998877655
Q ss_pred HHHHHHhcCCCCCC---------------------------------------ccccccchHHHHHHHHHhhhcCCCCCC
Q 005886 226 VLLMTLQNAPPGLD---------------------------------------YERDKRFSKSFKELVTACLVKDPKKRP 266 (671)
Q Consensus 226 ~~~~~~~~~~~~~~---------------------------------------~~~~~~ls~~l~dLI~~cL~~dP~kRp 266 (671)
....+.....+... .......+..+.+||.+||..||.+||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 44332211100000 001123467899999999999999999
Q ss_pred CHHHHHhchhccccc
Q 005886 267 TAEKLMKHHFFKHAR 281 (671)
Q Consensus 267 Sa~eiL~Hpwfk~~~ 281 (671)
|+.++|+||||+..+
T Consensus 322 t~~ell~hp~f~~~~ 336 (339)
T 1z57_A 322 TLREALKHPFFDLLK 336 (339)
T ss_dssp CHHHHTTSGGGGGGG
T ss_pred CHHHHhcCHHHHHHh
Confidence 999999999998654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=409.15 Aligned_cols=254 Identities=14% Similarity=0.162 Sum_probs=204.9
Q ss_pred ccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHH---HHHhCCCCCceeee----
Q 005886 8 RFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQ---TMRVTNHPNVLRAH---- 78 (671)
Q Consensus 8 ~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~---iL~~L~HpNIVkl~---- 78 (671)
.+....++|++.+.||+|+||+||+|++..+|+.||||++..... ....+.+.+|+. +++.++|||||+++
T Consensus 67 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~ 146 (377)
T 3byv_A 67 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146 (377)
T ss_dssp SSSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred ecCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhh
Confidence 344556889999999999999999999999999999999975432 234678899994 55566899999998
Q ss_pred ---eEEEeCC-----------------EEEEEEeccCCCCHHHHHHhhCCCCCCH-------HHHHHHHHHHHHHHHHHH
Q 005886 79 ---CSFTTGH-----------------CLWVVMPYMAGGSCLHIMKSAYPEGFEE-------PVIATLLRETLKALVYLH 131 (671)
Q Consensus 79 ---~~~~~~~-----------------~l~LVmEy~~ggsL~~~l~~~~~~~l~e-------~~i~~i~~qIl~aL~yLH 131 (671)
+++.+.+ ..||||||| +|+|.+++... +.+++ ..++.++.||+.||+|||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~--~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 223 (377)
T 3byv_A 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL--LSHSSTHKSLVHHARLQLTLQVIRLLASLH 223 (377)
T ss_dssp CCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH--HHTTTTTHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc--cccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 6666553 289999999 67999999865 33444 788889999999999999
Q ss_pred HCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhc----------cCCCccchh
Q 005886 132 FHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQL----------HGYDFKADI 201 (671)
Q Consensus 132 s~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~----------~~~s~ksDI 201 (671)
++||+||||||+|||++.+|.+||+|||+++... ......+| +.|+|||++.+. ..|+.++||
T Consensus 224 ~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv 296 (377)
T 3byv_A 224 HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG------ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA 296 (377)
T ss_dssp HTTEECSCCCGGGEEECTTCCEEECCGGGCEETT------CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred hCCeecCCCCHHHEEEcCCCCEEEEechhheecC------CcccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence 9999999999999999999999999999986431 12345578 999999999874 269999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 202 WSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 202 WSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
|||||++|+|++|..||.+.........+ ...+..++.++.+||.+||..||.+|||+.++|+||||+..
T Consensus 297 wSlG~il~elltg~~Pf~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 297 WALGLVIYWIWCADLPITKDAALGGSEWI---------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp HHHHHHHHHHHHSSCCC------CCSGGG---------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCcccccccchhhh---------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 99999999999999999765432211111 11235678999999999999999999999999999999754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=395.56 Aligned_cols=258 Identities=30% Similarity=0.378 Sum_probs=215.0
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEE-----
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCL----- 87 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l----- 87 (671)
++|.+.+.||+|+||.||+|.+..+|+.||||++...... .....+.+|+.+++.++||||++++++|......
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 7999999999999999999999999999999999754322 2357788999999999999999999999887654
Q ss_pred -EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 88 -WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 88 -~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
|+||||+. ++|..++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 122 ~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~- 195 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD- 195 (371)
T ss_dssp CEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred EEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc-
Confidence 99999997 57777663 459999999999999999999999999999999999999999999999999986442
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC----------
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP---------- 236 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~---------- 236 (671)
......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+....+.+..+......
T Consensus 196 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 270 (371)
T 4exu_A 196 -----AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 270 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred -----cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence 12345689999999999987567999999999999999999999999988766655544331110
Q ss_pred -------------CC---CccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 237 -------------GL---DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 237 -------------~~---~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
.. ....+..+++.+.+||.+||..||.+|||+.++|+||||+....
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 332 (371)
T 4exu_A 271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 332 (371)
T ss_dssp CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCC
Confidence 00 01123456899999999999999999999999999999986554
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=389.88 Aligned_cols=259 Identities=25% Similarity=0.365 Sum_probs=220.6
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCc---EEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNE---IVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH 85 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~---~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~ 85 (671)
..+..++|++.+.||+|+||.||+|.+..+|. .||||++...........+.+|+.+++.++||||+++++++.+..
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 123 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR 123 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 45677899999999999999999999986655 499999976554555678999999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
.+|+||||+.||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred ccEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 999999999999999999754 3579999999999999999999999999999999999999999999999999997664
Q ss_pred cCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccc
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (671)
.............||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+.... ..+.+.
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~ 277 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY----RLPAPM 277 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC----CCCCCT
T ss_pred cCccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC----CCCCCC
Confidence 43333333344567889999999987 568999999999999999999 999999888777666555442 223456
Q ss_pred cchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 245 RFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 245 ~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.++..+.+||.+||..||.+|||+.++++
T Consensus 278 ~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 278 GCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 78999999999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=397.18 Aligned_cols=256 Identities=25% Similarity=0.401 Sum_probs=209.1
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCC--------CCCceeeeeEEE--
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN--------HPNVLRAHCSFT-- 82 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~--------HpNIVkl~~~~~-- 82 (671)
.++|++.+.||+|+||+||+|++..+|+.||||++... ......+.+|+.+++.+. ||||++++++|.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 47899999999999999999999999999999998643 234567889999998885 788999999998
Q ss_pred --eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCcEEEcCCC--------
Q 005886 83 --TGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH-GHIHRDVKAGNILIDSNG-------- 151 (671)
Q Consensus 83 --~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~-gIVHrDLKPeNILld~~g-------- 151 (671)
....+|+||||+ +++|...+.......+++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence 566899999999 66777766665456799999999999999999999999 999999999999998775
Q ss_pred -----------------------------------------ceEEeccccccccccCCCcccccccccCCCCCCChhHhh
Q 005886 152 -----------------------------------------AIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQ 190 (671)
Q Consensus 152 -----------------------------------------~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~ 190 (671)
.+||+|||++..... .....+||+.|+|||++.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~------~~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK------HFTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB------CSCSCCSCGGGCCHHHHH
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc------cCccCCCCCcccCChhhc
Confidence 799999999865421 233458999999999998
Q ss_pred hccCCCccchhhhHHHHHHHHHhCCCCCCCCCh------HHHHHHHHh---cCCCC------C-----------------
Q 005886 191 QLHGYDFKADIWSFGITALELAHGHAPFSKYPP------MKVLLMTLQ---NAPPG------L----------------- 238 (671)
Q Consensus 191 ~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~------~~~~~~~~~---~~~~~------~----------------- 238 (671)
+ ..|+.++|||||||++|+|++|..||..... ...+..+.. ..+.. .
T Consensus 267 ~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 267 G-SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp T-SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred C-CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 7 5699999999999999999999999976542 122211111 10000 0
Q ss_pred -----------CccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcc
Q 005886 239 -----------DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278 (671)
Q Consensus 239 -----------~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk 278 (671)
.+..+...+..+.+||.+||..||.+|||+.++|+||||+
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 0012344567899999999999999999999999999996
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=378.02 Aligned_cols=263 Identities=25% Similarity=0.429 Sum_probs=222.3
Q ss_pred ccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEe--CCE
Q 005886 10 PVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTT--GHC 86 (671)
Q Consensus 10 ~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~--~~~ 86 (671)
|...++|++.+.||+|+||.||+|.+..+|+.||+|++...... ...+.+.+|+.+++.++||||+++++++.. ...
T Consensus 2 p~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp -CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred CCchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence 44568999999999999999999999999999999999765432 346778999999999999999999998854 678
Q ss_pred EEEEEeccCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccccCCCCcEEEcCCCceEEeccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAY--PEGFEEPVIATLLRETLKALVYLHFHG-----HIHRDVKAGNILIDSNGAIKLADFG 159 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~--~~~l~e~~i~~i~~qIl~aL~yLHs~g-----IVHrDLKPeNILld~~g~vKL~DFG 159 (671)
+|+||||+.|++|.+++.... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999999987542 234899999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC
Q 005886 160 VSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD 239 (671)
Q Consensus 160 ls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~ 239 (671)
++...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.......
T Consensus 162 ~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~-- 235 (279)
T 2w5a_A 162 LARILNHD---TSFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR-- 235 (279)
T ss_dssp HHHHC------CHHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--
T ss_pred hheeeccc---cccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccccc--
Confidence 98655221 111234579999999999987 568999999999999999999999999887766555555443322
Q ss_pred ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 240 YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 240 ~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
.+..++.++.+||.+||..||.+||++.++|+|+|+...
T Consensus 236 --~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 236 --IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred --CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 245678999999999999999999999999999999754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=382.34 Aligned_cols=263 Identities=24% Similarity=0.408 Sum_probs=219.8
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEecccc---CcccHHHHHHHHHHHHhCCCCCceeeeeEEE--eCCEE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEK---CNNDLDGIRREVQTMRVTNHPNVLRAHCSFT--TGHCL 87 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~---~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~--~~~~l 87 (671)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++. ....+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999999999999999997543 2344678999999999999999999999984 45689
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccC
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~ 167 (671)
|+||||+.++ |.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999887 777777655567999999999999999999999999999999999999999999999999998755322
Q ss_pred CCcccccccccCCCCCCChhHhhhcc-CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLH-GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~-~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (671)
. .........||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.........+.... +..+..+
T Consensus 163 ~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-----~~~~~~~ 236 (305)
T 2wtk_C 163 A-ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS-----YAIPGDC 236 (305)
T ss_dssp C-SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-----CCCCSSS
T ss_pred c-cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC-----CCCCCcc
Confidence 1 122234567999999999997632 24779999999999999999999999877666555444432 2234568
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 247 SKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 247 s~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
+..+.+||.+||..||.+|||+.++++||||+....
T Consensus 237 ~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 237 GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 899999999999999999999999999999986543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=373.19 Aligned_cols=257 Identities=21% Similarity=0.370 Sum_probs=220.7
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 86 (671)
..|.++.++|++.+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 79 (269)
T ss_dssp --CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred ccEEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc--cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence 568899999999999999999999999987 57789999997543 334678999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
+|+||||+.|++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred eEEEEEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 99999999999999999764 35689999999999999999999999999999999999999999999999999875532
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (671)
. .........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+..... ...+..
T Consensus 159 ~--~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~ 231 (269)
T 4hcu_A 159 D--QYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR----LYKPRL 231 (269)
T ss_dssp H--HHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC----CCCCTT
T ss_pred c--ccccccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc----CCCCCc
Confidence 1 1122334567888999999987 569999999999999999999 9999998887766655554422 233456
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 246 FSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 246 ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
++..+.+||.+||..||.+||++.++++|
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 232 ASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 78999999999999999999999999875
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=384.27 Aligned_cols=263 Identities=27% Similarity=0.439 Sum_probs=213.7
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH 85 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~ 85 (671)
..+.+...+|++.+.||+|+||+||+|.+ +|..||||++...... .....+.+|+.+++.++||||+++++++.+..
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 45678889999999999999999999987 4889999998755432 34567889999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCCcEEEcCCCceEEecccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYP-EGFEEPVIATLLRETLKALVYLHFHG--HIHRDVKAGNILIDSNGAIKLADFGVSA 162 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~-~~l~e~~i~~i~~qIl~aL~yLHs~g--IVHrDLKPeNILld~~g~vKL~DFGls~ 162 (671)
.+|+||||+.||+|.+++..... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 99999999999999999976421 13899999999999999999999999 9999999999999999999999999986
Q ss_pred ccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccc
Q 005886 163 CMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER 242 (671)
Q Consensus 163 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~ 242 (671)
.... .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..... ....
T Consensus 188 ~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~---~~~~ 260 (309)
T 3p86_A 188 LKAS---TFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK---RLEI 260 (309)
T ss_dssp -----------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCC---CCCC
T ss_pred cccc---cccccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC---CCCC
Confidence 4422 1122345689999999999987 5689999999999999999999999998887666554433221 2234
Q ss_pred cccchHHHHHHHHHhhhcCCCCCCCHHHHHh--chhcc
Q 005886 243 DKRFSKSFKELVTACLVKDPKKRPTAEKLMK--HHFFK 278 (671)
Q Consensus 243 ~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~--Hpwfk 278 (671)
+..+++.+.+||.+||..||.+|||+.++++ ++|++
T Consensus 261 ~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 261 PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 5678999999999999999999999999987 34444
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=396.55 Aligned_cols=264 Identities=23% Similarity=0.352 Sum_probs=223.7
Q ss_pred cccCCCCeEEEEEecccCceEEEEEE-----EcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRAL-----CIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT 83 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~-----~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~ 83 (671)
..+..++|++.+.||+|+||+||+|. +..++..||||++...........+.+|+.+++.++||||+++++++..
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 35667899999999999999999999 4567889999999755444556678899999999999999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC---ceEE
Q 005886 84 GHCLWVVMPYMAGGSCLHIMKSAYP-----EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG---AIKL 155 (671)
Q Consensus 84 ~~~l~LVmEy~~ggsL~~~l~~~~~-----~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g---~vKL 155 (671)
....|+|||||.||+|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||++.+| .+||
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence 9999999999999999999987532 3589999999999999999999999999999999999999655 5999
Q ss_pred eccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcC
Q 005886 156 ADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNA 234 (671)
Q Consensus 156 ~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~ 234 (671)
+|||+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+....
T Consensus 226 ~DFG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~ 303 (367)
T 3l9p_A 226 GDFGMARDIYRAGY-YRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 303 (367)
T ss_dssp CCCHHHHHHHHHSS-CTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred CCCccccccccccc-cccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999875533222 223345678999999999987 579999999999999999998 999999988777666555543
Q ss_pred CCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcc
Q 005886 235 PPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278 (671)
Q Consensus 235 ~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk 278 (671)
.. ..+..++..+.+||.+||..||.+|||+.++++|.|+.
T Consensus 304 ~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 304 RM----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC----CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 22 23556889999999999999999999999999998875
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=393.44 Aligned_cols=263 Identities=21% Similarity=0.330 Sum_probs=220.9
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEE-----EcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeeeE
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRAL-----CIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHCS 80 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~-----~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~ 80 (671)
..|++..++|++.+.||+|+||.||+|. +..+++.||||++...........+.+|+.+++.+ +||||++++++
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~ 94 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 94 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence 4577889999999999999999999999 55677899999997655445567899999999999 89999999999
Q ss_pred EEeCC-EEEEEEeccCCCCHHHHHHhhCC---------------------------------------------------
Q 005886 81 FTTGH-CLWVVMPYMAGGSCLHIMKSAYP--------------------------------------------------- 108 (671)
Q Consensus 81 ~~~~~-~l~LVmEy~~ggsL~~~l~~~~~--------------------------------------------------- 108 (671)
+...+ .+|+|||||.||+|.+++.....
T Consensus 95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 98754 49999999999999999986532
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccccc
Q 005886 109 -------------EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRN 175 (671)
Q Consensus 109 -------------~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 175 (671)
..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.... ......
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~ 253 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-DYVRKG 253 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT-TCEEC-
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc-cchhcc
Confidence 128999999999999999999999999999999999999999999999999987553322 222334
Q ss_pred cccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHH
Q 005886 176 TFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELV 254 (671)
Q Consensus 176 ~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI 254 (671)
...||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+..........+.... ....+..+++++.+||
T Consensus 254 ~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li 329 (359)
T 3vhe_A 254 DARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT---RMRAPDYTTPEMYQTM 329 (359)
T ss_dssp -CEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC---CCCCCTTCCHHHHHHH
T ss_pred ccCCCceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCC---CCCCCCCCCHHHHHHH
Confidence 5678999999999987 679999999999999999998 9999988765555544444322 2233456889999999
Q ss_pred HHhhhcCCCCCCCHHHHHhc
Q 005886 255 TACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 255 ~~cL~~dP~kRpSa~eiL~H 274 (671)
.+||..||.+|||+.++++|
T Consensus 330 ~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 330 LDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHccCChhhCCCHHHHHHH
Confidence 99999999999999999885
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=382.42 Aligned_cols=265 Identities=23% Similarity=0.407 Sum_probs=224.8
Q ss_pred ccccccccCCCCeEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeee
Q 005886 4 VVEKRFPVDAKDYRLYEEVGEGVSATVYRALCI-----PLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAH 78 (671)
Q Consensus 4 ~~e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~-----~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~ 78 (671)
.-...+.+..++|++.+.||+|+||.||+|.+. .++..||||++...........+.+|+.+++.++||||++++
T Consensus 13 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 92 (314)
T 2ivs_A 13 LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLY 92 (314)
T ss_dssp -CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cCCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEE
Confidence 345668888999999999999999999999984 456889999997655445567899999999999999999999
Q ss_pred eEEEeCCEEEEEEeccCCCCHHHHHHhhCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 005886 79 CSFTTGHCLWVVMPYMAGGSCLHIMKSAYP----------------------EGFEEPVIATLLRETLKALVYLHFHGHI 136 (671)
Q Consensus 79 ~~~~~~~~l~LVmEy~~ggsL~~~l~~~~~----------------------~~l~e~~i~~i~~qIl~aL~yLHs~gIV 136 (671)
+++.+...+|+||||+.||+|.+++..... ..+++..++.++.||+.||.|||++||+
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv 172 (314)
T 2ivs_A 93 GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLV 172 (314)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 999999999999999999999999986532 2389999999999999999999999999
Q ss_pred cccCCCCcEEEcCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CC
Q 005886 137 HRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GH 215 (671)
Q Consensus 137 HrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~ 215 (671)
||||||+|||++.++.+||+|||++....... .........||+.|+|||++.+ ..++.++|||||||++|+|++ |.
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~ 250 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEED-SYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGG 250 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTS-CEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSC
T ss_pred ccccchheEEEcCCCCEEEccccccccccccc-cceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999987553322 2222344567889999999987 568999999999999999999 99
Q ss_pred CCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 216 APFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 216 ~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
.||.+.........+..... ...+..++..+.+||.+||..||.+||++.+++++
T Consensus 251 ~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 251 NPYPGIPPERLFNLLKTGHR----MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp CSSTTCCGGGHHHHHHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHhhcCCc----CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99998877665544443322 23356789999999999999999999999999874
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=384.68 Aligned_cols=269 Identities=20% Similarity=0.362 Sum_probs=203.8
Q ss_pred ccccCCCCeEEEEEecccCceEEEEEEEcCCCc---EEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEe
Q 005886 8 RFPVDAKDYRLYEEVGEGVSATVYRALCIPLNE---IVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTT 83 (671)
Q Consensus 8 ~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~---~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~ 83 (671)
.+.+..++|++.+.||+|+||+||+|.+..++. .||||++..... ....+.+.+|+.+++.++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 466788999999999999999999999887775 899999875532 3446789999999999999999999999988
Q ss_pred CCEE------EEEEeccCCCCHHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCce
Q 005886 84 GHCL------WVVMPYMAGGSCLHIMKSAYP----EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAI 153 (671)
Q Consensus 84 ~~~l------~LVmEy~~ggsL~~~l~~~~~----~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~v 153 (671)
.... |+||||+.||+|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCE
Confidence 7665 999999999999998865421 258999999999999999999999999999999999999999999
Q ss_pred EEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 005886 154 KLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQ 232 (671)
Q Consensus 154 KL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~ 232 (671)
||+|||++....... .........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 177 kl~Dfg~a~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~ 254 (323)
T 3qup_A 177 CVADFGLSRKIYSGD-YYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254 (323)
T ss_dssp EECCCCC------------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred EEeeccccccccccc-cccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc
Confidence 999999987553322 2222334467889999999987 569999999999999999999 9999998887776665555
Q ss_pred cCCCCCCccccccchHHHHHHHHHhhhcCCCCCCC-------HHHHHhchhcccccc
Q 005886 233 NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPT-------AEKLMKHHFFKHARS 282 (671)
Q Consensus 233 ~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpS-------a~eiL~Hpwfk~~~~ 282 (671)
.... ..+..++..+.+||.+||..||.+||| +++++.|||+.....
T Consensus 255 ~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~ 307 (323)
T 3qup_A 255 GNRL----KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307 (323)
T ss_dssp TCCC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred CCCC----CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence 4322 335568899999999999999999999 778899999986544
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=403.20 Aligned_cols=264 Identities=25% Similarity=0.349 Sum_probs=195.1
Q ss_pred CCeEE-EEEecccCceEEEEEEEc--CCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe--CCEEE
Q 005886 14 KDYRL-YEEVGEGVSATVYRALCI--PLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT--GHCLW 88 (671)
Q Consensus 14 ~~Y~l-~~~LG~G~fG~Vyka~~~--~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~--~~~l~ 88 (671)
+.|++ .++||+|+||+||+|+++ .+++.||||++.... ....+.+|+.+|+.++||||++++++|.. ...+|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS---CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC---CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 44666 457999999999999976 578899999986443 23568899999999999999999999954 77899
Q ss_pred EEEeccCCCCHHHHHHhhC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEE----cCCCceEEec
Q 005886 89 VVMPYMAGGSCLHIMKSAY-------PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILI----DSNGAIKLAD 157 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~-------~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILl----d~~g~vKL~D 157 (671)
+||||+.| +|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 99999965 7877775321 1249999999999999999999999999999999999999 6778999999
Q ss_pred cccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChH---------HHHH
Q 005886 158 FGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM---------KVLL 228 (671)
Q Consensus 158 FGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~---------~~~~ 228 (671)
||+++.+.............+||+.|+|||++.+...|+.++|||||||++|+|++|.+||.+.... ..+.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 9999766433222234456789999999999987566999999999999999999999999765431 2222
Q ss_pred HHHh--cCCCCCCcccc-------------------------------ccchHHHHHHHHHhhhcCCCCCCCHHHHHhch
Q 005886 229 MTLQ--NAPPGLDYERD-------------------------------KRFSKSFKELVTACLVKDPKKRPTAEKLMKHH 275 (671)
Q Consensus 229 ~~~~--~~~~~~~~~~~-------------------------------~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hp 275 (671)
.++. ..+....+... ...+..+.+||.+||..||.+|||++++|+||
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 2221 11111111110 11267889999999999999999999999999
Q ss_pred hccccc
Q 005886 276 FFKHAR 281 (671)
Q Consensus 276 wfk~~~ 281 (671)
||+...
T Consensus 336 ~f~~~~ 341 (405)
T 3rgf_A 336 YFLEDP 341 (405)
T ss_dssp GGTSSS
T ss_pred hhccCC
Confidence 998654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=392.72 Aligned_cols=266 Identities=21% Similarity=0.280 Sum_probs=204.7
Q ss_pred ccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC----
Q 005886 10 PVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH---- 85 (671)
Q Consensus 10 ~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~---- 85 (671)
....++|++.+.||+|+||+||+|.+..+|+.||||++.... .......+++..++.++||||++++++|....
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP--RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT--TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc--cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 345579999999999999999999999999999999986543 22345667888889999999999999997533
Q ss_pred ---EEEEEEeccCCCCHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCCCcEEEcC-CCceEEec
Q 005886 86 ---CLWVVMPYMAGGSCLHIMKS--AYPEGFEEPVIATLLRETLKALVYLH--FHGHIHRDVKAGNILIDS-NGAIKLAD 157 (671)
Q Consensus 86 ---~l~LVmEy~~ggsL~~~l~~--~~~~~l~e~~i~~i~~qIl~aL~yLH--s~gIVHrDLKPeNILld~-~g~vKL~D 157 (671)
.+|+||||+.|+ |...+.. .....+++..++.++.||+.||.||| ++||+||||||+|||++. ++.+||+|
T Consensus 97 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~D 175 (360)
T 3e3p_A 97 RDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD 175 (360)
T ss_dssp TCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred cceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEee
Confidence 389999999874 4444332 22357899999999999999999999 999999999999999997 89999999
Q ss_pred cccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC
Q 005886 158 FGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG 237 (671)
Q Consensus 158 FGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~ 237 (671)
||++..+... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+......+..+.......
T Consensus 176 fg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 251 (360)
T 3e3p_A 176 FGSAKKLSPS----EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251 (360)
T ss_dssp CTTCBCCCTT----SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred CCCceecCCC----CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCC
Confidence 9998755322 223356899999999999875668999999999999999999999999887766655544321100
Q ss_pred ----------------------CC-----ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 238 ----------------------LD-----YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 238 ----------------------~~-----~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
.. ......++.++++||.+||..||.+|||+.++|+||||+....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 00 0011225789999999999999999999999999999997654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=390.56 Aligned_cols=266 Identities=21% Similarity=0.281 Sum_probs=211.5
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcc----------cHHHHHHHHHHHHhCCCCCceeeeeE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN----------DLDGIRREVQTMRVTNHPNVLRAHCS 80 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~----------~~~~i~~Ei~iL~~L~HpNIVkl~~~ 80 (671)
...++|++.+.||+|+||.||+|.+.. |..||||++....... ....+.+|+.+++.++||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 456899999999999999999998765 9999999986543221 13788999999999999999999999
Q ss_pred EEe-----CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEE
Q 005886 81 FTT-----GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKL 155 (671)
Q Consensus 81 ~~~-----~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL 155 (671)
|.. ...+|+||||+. |+|...+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEE
Confidence 954 347999999997 5788877654 356999999999999999999999999999999999999999999999
Q ss_pred eccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Q 005886 156 ADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP 235 (671)
Q Consensus 156 ~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~ 235 (671)
+|||++..... ........||+.|+|||++.+...++.++|||||||++|+|++|..||.+......+..+.....
T Consensus 176 ~Dfg~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 251 (362)
T 3pg1_A 176 CDFNLAREDTA----DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG 251 (362)
T ss_dssp CCTTC-------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EecCccccccc----ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 99999864322 12234468999999999998756799999999999999999999999998776655544432110
Q ss_pred ---------------------------CCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccccc
Q 005886 236 ---------------------------PGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSN 283 (671)
Q Consensus 236 ---------------------------~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~ 283 (671)
..........+++.+.+||.+||..||.+|||+.++|+||||+.....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 326 (362)
T 3pg1_A 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP 326 (362)
T ss_dssp CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence 000111234567889999999999999999999999999999976543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=391.71 Aligned_cols=265 Identities=25% Similarity=0.385 Sum_probs=220.5
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCccc----------------HHHHHHHHHHHHhCCCCCc
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNND----------------LDGIRREVQTMRVTNHPNV 74 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~----------------~~~i~~Ei~iL~~L~HpNI 74 (671)
+..++|++.+.||+|+||.||+|.+ +|+.||||++........ ...+.+|+.+++.++||||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 3458999999999999999999998 899999999875432211 2789999999999999999
Q ss_pred eeeeeEEEeCCEEEEEEeccCCCCHHHH------HHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCcEEE
Q 005886 75 LRAHCSFTTGHCLWVVMPYMAGGSCLHI------MKSAYPEGFEEPVIATLLRETLKALVYLHF-HGHIHRDVKAGNILI 147 (671)
Q Consensus 75 Vkl~~~~~~~~~l~LVmEy~~ggsL~~~------l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs-~gIVHrDLKPeNILl 147 (671)
+++++++.+.+.+|+||||+.||+|.++ +.......+++..++.++.||+.||.|||+ +||+||||||+|||+
T Consensus 106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185 (348)
T ss_dssp CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence 9999999999999999999999999988 655334679999999999999999999999 999999999999999
Q ss_pred cCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCc-cchhhhHHHHHHHHHhCCCCCCCCChHHH
Q 005886 148 DSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDF-KADIWSFGITALELAHGHAPFSKYPPMKV 226 (671)
Q Consensus 148 d~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~-ksDIWSLGvILyeLltG~~PF~~~~~~~~ 226 (671)
+.++.+||+|||++...... ......||+.|+|||++.+...++. ++|||||||++|+|++|..||........
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred cCCCcEEEeccccccccccc-----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 99999999999998654221 3345689999999999987435666 99999999999999999999988766333
Q ss_pred HHHHHhcCCCCCCcc---------------ccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 227 LLMTLQNAPPGLDYE---------------RDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 227 ~~~~~~~~~~~~~~~---------------~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
....+......+... ....++..+.+||.+||..||.+|||+.++|+||||+....
T Consensus 261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~ 331 (348)
T 2pml_X 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI 331 (348)
T ss_dssp HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCH
T ss_pred HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCH
Confidence 333333322222110 11568899999999999999999999999999999987654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=384.98 Aligned_cols=259 Identities=22% Similarity=0.376 Sum_probs=221.4
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCI-----PLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT 83 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~-----~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~ 83 (671)
+.+..++|++.+.||+|+||.||+|.+. .+++.||||++...........+.+|+.+++.++||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 5667789999999999999999999997 45589999999765544556789999999999999999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCC
Q 005886 84 GHCLWVVMPYMAGGSCLHIMKSAYP----------------------EGFEEPVIATLLRETLKALVYLHFHGHIHRDVK 141 (671)
Q Consensus 84 ~~~l~LVmEy~~ggsL~~~l~~~~~----------------------~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLK 141 (671)
...+|+||||+.||+|.+++..... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 201 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 201 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 9999999999999999999986421 468999999999999999999999999999999
Q ss_pred CCcEEEcCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCC
Q 005886 142 AGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSK 220 (671)
Q Consensus 142 PeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~ 220 (671)
|+|||++.++.+||+|||++....... .........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSAD-YYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGG-CBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred cceEEECCCCeEEEeecCCCcccccCc-cccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999987653222 1122344578999999999987 569999999999999999999 9999998
Q ss_pred CChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 221 YPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
....+....+...... ..+..++..+.+||.+||..||.+||++.++++
T Consensus 280 ~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 280 MAHEEVIYYVRDGNIL----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp SCHHHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CChHHHHHHHhCCCcC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 8877666555544322 234578899999999999999999999999976
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=375.73 Aligned_cols=261 Identities=28% Similarity=0.451 Sum_probs=213.1
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
.++|.....||+|+||.||+|.+..++..||||++.... ......+.+|+.+++.++||||+++++++.....+++|||
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence 344444558999999999999999999999999987543 3345778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcC-CCceEEeccccccccccCCCc
Q 005886 93 YMAGGSCLHIMKSAY-PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS-NGAIKLADFGVSACMFDAGDR 170 (671)
Q Consensus 93 y~~ggsL~~~l~~~~-~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~-~g~vKL~DFGls~~~~~~~~~ 170 (671)
|+.|++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~--- 176 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI--- 176 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC---
Confidence 999999999997653 235679999999999999999999999999999999999987 899999999998755321
Q ss_pred ccccccccCCCCCCChhHhhhc-cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHH-H-HHhcCCCCCCccccccch
Q 005886 171 QRSRNTFVGTPCWMAPEVMQQL-HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLL-M-TLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 171 ~~~~~~~~GT~~Y~APEvl~~~-~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~-~-~~~~~~~~~~~~~~~~ls 247 (671)
........||+.|+|||++.+. ..++.++|||||||++|+|++|..||.......... . ...... ...+..++
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 252 (295)
T 2clq_A 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH----PEIPESMS 252 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCC----CCCCTTSC
T ss_pred CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccc----ccccccCC
Confidence 1223456899999999999763 248899999999999999999999997654333221 1 122221 22345689
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 248 KSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
.++.+||.+||..||.+||++.++|+||||+...
T Consensus 253 ~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 253 AEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp HHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 9999999999999999999999999999998544
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=386.20 Aligned_cols=266 Identities=21% Similarity=0.364 Sum_probs=221.5
Q ss_pred ccccccCCCCeEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeee
Q 005886 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCI-----PLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHC 79 (671)
Q Consensus 6 e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~-----~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~ 79 (671)
+..|.+..++|++.+.||+|+||.||+|.+. .++..||||++...........+.+|+.+++.+ +||||+++++
T Consensus 37 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 37 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 3457788899999999999999999999973 456789999997654445567899999999999 9999999999
Q ss_pred EEEeCCEEEEEEeccCCCCHHHHHHhhCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 005886 80 SFTTGHCLWVVMPYMAGGSCLHIMKSAYP---------------------EGFEEPVIATLLRETLKALVYLHFHGHIHR 138 (671)
Q Consensus 80 ~~~~~~~l~LVmEy~~ggsL~~~l~~~~~---------------------~~l~e~~i~~i~~qIl~aL~yLHs~gIVHr 138 (671)
++...+.+|+||||+.||+|.+++..... ..+++..++.++.||+.||+|||++||+||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 99999999999999999999999986532 237899999999999999999999999999
Q ss_pred cCCCCcEEEcCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCC
Q 005886 139 DVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAP 217 (671)
Q Consensus 139 DLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~P 217 (671)
||||+|||++.++.+||+|||++....... .........||+.|+|||++.+ ..++.++|||||||++|+|++ |..|
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDS-NYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCT-TSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCc-cceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999987653322 2223345578899999999987 569999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchh
Q 005886 218 FSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHF 276 (671)
Q Consensus 218 F~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpw 276 (671)
|.+..........+... .....+..++..+.+||.+||..||.+|||+.++++|-.
T Consensus 275 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQNG---FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp STTCCCSHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cccCCcHHHHHHHHhcC---CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 98877655555555442 222335567999999999999999999999999998643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=383.28 Aligned_cols=261 Identities=22% Similarity=0.319 Sum_probs=214.4
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCC-cEEEEEEeccccCcccHHHHHHHHHHHHhCCCCC------ceeeeeEEEeC
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLN-EIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN------VLRAHCSFTTG 84 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg-~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpN------IVkl~~~~~~~ 84 (671)
..++|++.+.||+|+||+||+|.+..++ ..||+|++... ......+.+|+.+++.+.|++ ++.+++++...
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 3578999999999999999999998877 68999998643 234567888999999887665 99999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEE-----------------
Q 005886 85 HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILI----------------- 147 (671)
Q Consensus 85 ~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILl----------------- 147 (671)
..+|+||||+ ++++.+.+.......+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccc
Confidence 9999999999 6677777776644579999999999999999999999999999999999999
Q ss_pred --cCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHH
Q 005886 148 --DSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK 225 (671)
Q Consensus 148 --d~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~ 225 (671)
+.++.+||+|||++.... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~------~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDH------EHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp EEESCCCEEECCCTTCEETT------SCCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccCCCcEEEeecCcccccc------ccccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 567899999999986432 12234689999999999987 569999999999999999999999999877655
Q ss_pred HHHHHHhcCCCCCC---------------------------------------ccccccchHHHHHHHHHhhhcCCCCCC
Q 005886 226 VLLMTLQNAPPGLD---------------------------------------YERDKRFSKSFKELVTACLVKDPKKRP 266 (671)
Q Consensus 226 ~~~~~~~~~~~~~~---------------------------------------~~~~~~ls~~l~dLI~~cL~~dP~kRp 266 (671)
.+..+.....+... .......+..+.+||.+||..||.+||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 44332221110000 001122356899999999999999999
Q ss_pred CHHHHHhchhcccccc
Q 005886 267 TAEKLMKHHFFKHARS 282 (671)
Q Consensus 267 Sa~eiL~Hpwfk~~~~ 282 (671)
|+.++|+||||+...+
T Consensus 327 t~~e~l~hp~f~~~~~ 342 (355)
T 2eu9_A 327 TLAEALLHPFFAGLTP 342 (355)
T ss_dssp CHHHHTTSGGGGGCCH
T ss_pred CHHHHhcChhhcCCCh
Confidence 9999999999997654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=400.70 Aligned_cols=265 Identities=14% Similarity=0.144 Sum_probs=199.1
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhC--CCCCceeee------
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVT--NHPNVLRAH------ 78 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L--~HpNIVkl~------ 78 (671)
+.....+|++.+.||+|+||+||+|.+..+|+.||||++...... .....+.+|+.+++.+ +||||++++
T Consensus 57 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p 136 (371)
T 3q60_A 57 LSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLP 136 (371)
T ss_dssp TTCCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCC
T ss_pred CCCCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEee
Confidence 334455699999999999999999999999999999999875532 3456778886555444 699988755
Q ss_pred -eEEEeC-----------------CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHH------HHHHHHHHHHHHHHHHCC
Q 005886 79 -CSFTTG-----------------HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVI------ATLLRETLKALVYLHFHG 134 (671)
Q Consensus 79 -~~~~~~-----------------~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i------~~i~~qIl~aL~yLHs~g 134 (671)
+++... ..+|||||||. |+|.+++.... ..+.+..+ ..++.||+.||+|||++|
T Consensus 137 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ 214 (371)
T 3q60_A 137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKG 214 (371)
T ss_dssp CEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC
Confidence 444433 34899999998 89999998642 23444445 677799999999999999
Q ss_pred cccccCCCCcEEEcCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhh-ccCCCccchhhhHHHHHHHHHh
Q 005886 135 HIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQ-LHGYDFKADIWSFGITALELAH 213 (671)
Q Consensus 135 IVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~-~~~~s~ksDIWSLGvILyeLlt 213 (671)
|+||||||+|||++.+|.+||+|||+++.... ......||+.|+|||++.+ ...|+.++|||||||++|+|++
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTC------EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCC------CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 99999999999999999999999999875421 1114567799999999974 2458999999999999999999
Q ss_pred CCCCCCCCChHHHH--H--HHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 214 GHAPFSKYPPMKVL--L--MTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 214 G~~PF~~~~~~~~~--~--~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
|+.||.+..+.... . .........+.++.+..++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 289 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 289 LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp SSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred CCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence 99999876432100 0 00111122333344567899999999999999999999999999999998654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=390.91 Aligned_cols=259 Identities=24% Similarity=0.345 Sum_probs=212.6
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCC-CC-----CceeeeeEEEeCCE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN-HP-----NVLRAHCSFTTGHC 86 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~-Hp-----NIVkl~~~~~~~~~ 86 (671)
.++|++.+.||+|+||+||+|.+..+|+.||||++.... .....+.+|+.+++.+. |+ +|++++++|.....
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH--HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 478999999999999999999999999999999986432 33566778898888775 55 49999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCCCcEEEc--CCCceEEecccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLH--FHGHIHRDVKAGNILID--SNGAIKLADFGVSA 162 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLH--s~gIVHrDLKPeNILld--~~g~vKL~DFGls~ 162 (671)
+|+||||+. |+|.+++.......+++..++.++.||+.||.||| ..|||||||||+|||++ .++.+||+|||++.
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 999999996 59999998775567999999999999999999999 46999999999999995 47789999999986
Q ss_pred ccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---
Q 005886 163 CMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD--- 239 (671)
Q Consensus 163 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~--- 239 (671)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+....+.+..+.........
T Consensus 210 ~~~~------~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (382)
T 2vx3_A 210 QLGQ------RIYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282 (382)
T ss_dssp ETTC------CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eccc------ccccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 5521 2335689999999999987 56999999999999999999999999988777666555432110000
Q ss_pred -----------------cc------------c--c-------------------------ccchHHHHHHHHHhhhcCCC
Q 005886 240 -----------------YE------------R--D-------------------------KRFSKSFKELVTACLVKDPK 263 (671)
Q Consensus 240 -----------------~~------------~--~-------------------------~~ls~~l~dLI~~cL~~dP~ 263 (671)
+. . . ...+..+++||.+||..||.
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 362 (382)
T 2vx3_A 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK 362 (382)
T ss_dssp TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence 00 0 0 00124789999999999999
Q ss_pred CCCCHHHHHhchhccccc
Q 005886 264 KRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 264 kRpSa~eiL~Hpwfk~~~ 281 (671)
+|||+.++|+||||+...
T Consensus 363 ~Rpta~e~L~hp~f~~~~ 380 (382)
T 2vx3_A 363 TRIQPYYALQHSFFKKTA 380 (382)
T ss_dssp TSCCHHHHTTSGGGCC--
T ss_pred hCCCHHHHhcCcccccCC
Confidence 999999999999998653
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=378.58 Aligned_cols=268 Identities=31% Similarity=0.552 Sum_probs=207.0
Q ss_pred ccccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCccc-HHHHHHHHHHHHhCCCCCceeeeeEEEeC
Q 005886 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNND-LDGIRREVQTMRVTNHPNVLRAHCSFTTG 84 (671)
Q Consensus 6 e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~-~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~ 84 (671)
..+|.+..++|++++.||+|+||.||+|.+..+|+.||||++........ ...+.++..+++.++||||+++++++...
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~ 96 (318)
T 2dyl_A 17 GQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN 96 (318)
T ss_dssp SSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred chhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Confidence 35688888999999999999999999999999999999999976544333 33444555678889999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCcEEEcCCCceEEeccccccc
Q 005886 85 HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH-GHIHRDVKAGNILIDSNGAIKLADFGVSAC 163 (671)
Q Consensus 85 ~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~-gIVHrDLKPeNILld~~g~vKL~DFGls~~ 163 (671)
..+|+||||+ ++.+..+.... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++..
T Consensus 97 ~~~~lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 97 TDVFIAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp SEEEEEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred CcEEEEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 9999999999 55666655543 35799999999999999999999995 999999999999999999999999999865
Q ss_pred cccCCCcccccccccCCCCCCChhHhhh----ccCCCccchhhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhcCCCCC
Q 005886 164 MFDAGDRQRSRNTFVGTPCWMAPEVMQQ----LHGYDFKADIWSFGITALELAHGHAPFSKY-PPMKVLLMTLQNAPPGL 238 (671)
Q Consensus 164 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~----~~~~s~ksDIWSLGvILyeLltG~~PF~~~-~~~~~~~~~~~~~~~~~ 238 (671)
+... .......||+.|+|||++.+ ...++.++|||||||++|+|++|..||... ........+....++.+
T Consensus 175 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (318)
T 2dyl_A 175 LVDD----KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL 250 (318)
T ss_dssp ----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCC
T ss_pred ccCC----ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCC
Confidence 5321 12234579999999999852 245889999999999999999999999874 34444555555443332
Q ss_pred CccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 239 DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 239 ~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
+....++..+.+||.+||..||.+||++.++|+||||+...
T Consensus 251 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 251 --PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp --CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred --CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 22346889999999999999999999999999999998543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=386.47 Aligned_cols=259 Identities=30% Similarity=0.384 Sum_probs=213.5
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE-----
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC----- 86 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~----- 86 (671)
.++|.+.+.||+|+||.||+|.++.+|+.||||++...... .....+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 37899999999999999999999999999999999754322 235678899999999999999999999987654
Q ss_pred -EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 87 -LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 87 -l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
+|+||||+. ++|..++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 103 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred eEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 599999997 57766653 359999999999999999999999999999999999999999999999999986432
Q ss_pred cCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-----------
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA----------- 234 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~----------- 234 (671)
......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+......+..+....
T Consensus 178 ------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 251 (353)
T 3coi_A 178 ------AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 251 (353)
T ss_dssp ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTC
T ss_pred ------CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHH
Confidence 123346899999999999875678999999999999999999999999877655544433210
Q ss_pred ------------CCC---CCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 235 ------------PPG---LDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 235 ------------~~~---~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
+.. ........++..+.+||.+||..||.+|||+.++|+||||+....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 314 (353)
T 3coi_A 252 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 314 (353)
T ss_dssp SCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence 000 001123467899999999999999999999999999999986543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=370.79 Aligned_cols=257 Identities=23% Similarity=0.391 Sum_probs=218.8
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 86 (671)
..|.+..++|++++.||+|+||+||+|.+. ++..||||++.... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 93 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 93 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC--CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence 467889999999999999999999999876 67789999997543 234678999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
+|+||||+.|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred eEEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999999999999763 25699999999999999999999999999999999999999999999999999875532
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (671)
. .........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||...........+..... ...+..
T Consensus 173 ~--~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~ 245 (283)
T 3gen_A 173 D--EYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR----LYRPHL 245 (283)
T ss_dssp H--HHHSTTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC----CCCCTT
T ss_pred c--ccccccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC----CCCCCc
Confidence 1 1122334467888999999987 568999999999999999998 9999998887766665554432 223456
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 246 FSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 246 ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
++..+.+||.+||..||.+|||+.++++|
T Consensus 246 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 246 ASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 78999999999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=377.91 Aligned_cols=265 Identities=21% Similarity=0.361 Sum_probs=225.0
Q ss_pred cccccccCCCCeEEEEEecccCceEEEEEEE-----cCCCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeee
Q 005886 5 VEKRFPVDAKDYRLYEEVGEGVSATVYRALC-----IPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAH 78 (671)
Q Consensus 5 ~e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~-----~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~ 78 (671)
.+..|.+..++|++.+.||+|+||.||+|.+ ..+++.||||++.........+.+.+|+.+++.+ +||||++++
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 93 (313)
T 1t46_A 14 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLL 93 (313)
T ss_dssp CCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEE
Confidence 4667888899999999999999999999985 4577899999997655445567899999999999 999999999
Q ss_pred eEEEeCCEEEEEEeccCCCCHHHHHHhhCCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCC
Q 005886 79 CSFTTGHCLWVVMPYMAGGSCLHIMKSAYPE----------------GFEEPVIATLLRETLKALVYLHFHGHIHRDVKA 142 (671)
Q Consensus 79 ~~~~~~~~l~LVmEy~~ggsL~~~l~~~~~~----------------~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKP 142 (671)
+++..+..+|+||||+.||+|.+++...... .+++..++.++.||+.||.|||++||+||||||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 173 (313)
T 1t46_A 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (313)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence 9999999999999999999999999875321 489999999999999999999999999999999
Q ss_pred CcEEEcCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCC
Q 005886 143 GNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKY 221 (671)
Q Consensus 143 eNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~ 221 (671)
+|||++.++.+||+|||++....... .........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~ 251 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDS-NYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCT-TSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ceEEEcCCCCEEEccccccccccccc-cceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence 99999999999999999987553322 1222334567889999999987 579999999999999999998 99999887
Q ss_pred ChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 222 PPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
.........+.... ....+..++..+.+||.+||..||.+|||+.+++++
T Consensus 252 ~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 252 PVDSKFYKMIKEGF---RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp CSSHHHHHHHHHTC---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cchhHHHHHhccCC---CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 66555555444332 222345688999999999999999999999999873
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=389.26 Aligned_cols=264 Identities=23% Similarity=0.426 Sum_probs=225.5
Q ss_pred cccccccCCCCeEEEEEecccCceEEEEEEEcCCC-------cEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCcee
Q 005886 5 VEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLN-------EIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLR 76 (671)
Q Consensus 5 ~e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg-------~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVk 76 (671)
...++.+..++|++.+.||+|+||+||+|.+..++ ..||||++...........+.+|+.+++.+ +||||++
T Consensus 60 ~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~ 139 (382)
T 3tt0_A 60 EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIIN 139 (382)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhh
Confidence 34567888899999999999999999999976433 579999997665555567899999999999 9999999
Q ss_pred eeeEEEeCCEEEEEEeccCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCC
Q 005886 77 AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYP--------------EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKA 142 (671)
Q Consensus 77 l~~~~~~~~~l~LVmEy~~ggsL~~~l~~~~~--------------~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKP 142 (671)
+++++..+..+|+||||+.||+|.+++..... ..+++..++.++.||+.||+|||++||+||||||
T Consensus 140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 219 (382)
T 3tt0_A 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 219 (382)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence 99999999999999999999999999987642 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCC
Q 005886 143 GNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKY 221 (671)
Q Consensus 143 eNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~ 221 (671)
+|||++.++.+||+|||+++...... .........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHID-YYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCC-TTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceEEEcCCCcEEEcccCccccccccc-ccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999987553222 1223344567889999999987 679999999999999999999 99999988
Q ss_pred ChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 222 PPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
...+....+..... ...+..++.++.+||.+||..||.+|||+.+++++
T Consensus 298 ~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 298 PVEELFKLLKEGHR----MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp CHHHHHHHHHTTCC----CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHcCCC----CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 77666555544332 23356789999999999999999999999999873
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=385.74 Aligned_cols=271 Identities=31% Similarity=0.529 Sum_probs=202.3
Q ss_pred cccccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHH-HHHhCCCCCceeeeeEEEe
Q 005886 5 VEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQ-TMRVTNHPNVLRAHCSFTT 83 (671)
Q Consensus 5 ~e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~-iL~~L~HpNIVkl~~~~~~ 83 (671)
-+..|.+..++|++++.||+|+||.||+|.++.+|+.||||++...........+.+|+. +++.++||||+++++++..
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp CCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred hHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 456688899999999999999999999999999999999999976544444455556665 6778899999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCcEEEcCCCceEEeccc
Q 005886 84 GHCLWVVMPYMAGGSCLHIMKS---AYPEGFEEPVIATLLRETLKALVYLHFH-GHIHRDVKAGNILIDSNGAIKLADFG 159 (671)
Q Consensus 84 ~~~l~LVmEy~~ggsL~~~l~~---~~~~~l~e~~i~~i~~qIl~aL~yLHs~-gIVHrDLKPeNILld~~g~vKL~DFG 159 (671)
.+.+|+||||+.| +|.+++.. .....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence 9999999999986 77776653 2246799999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCCcccccccccCCCCCCChhHhh---hccCCCccchhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCC
Q 005886 160 VSACMFDAGDRQRSRNTFVGTPCWMAPEVMQ---QLHGYDFKADIWSFGITALELAHGHAPFSKYPPM-KVLLMTLQNAP 235 (671)
Q Consensus 160 ls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~---~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~-~~~~~~~~~~~ 235 (671)
++..+... .......||+.|+|||++. ....++.++|||||||++|+|++|..||.+.... ..........+
T Consensus 172 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 247 (327)
T 3aln_A 172 ISGQLVDS----IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDP 247 (327)
T ss_dssp SSCC----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCC
T ss_pred Cceecccc----cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCC
Confidence 98655321 1223347999999999984 2245899999999999999999999999875432 22222222222
Q ss_pred CCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 236 PGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 236 ~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
+.+.......++..+.+||.+||..||.+|||+.++++||||...
T Consensus 248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 333333345689999999999999999999999999999999754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=372.70 Aligned_cols=258 Identities=23% Similarity=0.420 Sum_probs=225.2
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 86 (671)
+.|.+..++|++.+.||+|+||.||+|.+..++..||+|++.... ...+.+.+|+.+++.++||||+++++++.++..
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS--THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 568889999999999999999999999999999999999986443 446788999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
+|+||||+.|++|.+++.......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 99999999999999999876556799999999999999999999999999999999999999999999999999875532
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (671)
. .........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.............. ....+..
T Consensus 164 ~--~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~ 236 (288)
T 3kfa_A 164 D--TYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY----RMERPEG 236 (288)
T ss_dssp S--SSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC----CCCCCTT
T ss_pred C--ccccccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC----CCCCCCC
Confidence 2 2223344567889999999987 568999999999999999999 999998877665554444332 2234567
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 246 FSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 246 ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
++..+.+||.+||..||.+|||+.++++
T Consensus 237 ~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 237 CPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 8999999999999999999999999976
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=388.64 Aligned_cols=263 Identities=25% Similarity=0.354 Sum_probs=212.1
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCC-----------CCCceee
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN-----------HPNVLRA 77 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~-----------HpNIVkl 77 (671)
-++..++|++.+.||+|+||+||+|.+..+|+.||||++.... .....+.+|+.+++.+. ||||+++
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc--cchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 3456789999999999999999999999999999999986432 33567888999998876 8999999
Q ss_pred eeEEEeCC----EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCCCcEEEc----
Q 005886 78 HCSFTTGH----CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH-GHIHRDVKAGNILID---- 148 (671)
Q Consensus 78 ~~~~~~~~----~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~-gIVHrDLKPeNILld---- 148 (671)
++++.... .+++||||+ |++|.+++.......+++..++.++.||+.||+|||++ ||+||||||+|||++
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence 99998754 899999999 89999999876556799999999999999999999998 999999999999994
Q ss_pred --CCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCCh---
Q 005886 149 --SNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPP--- 223 (671)
Q Consensus 149 --~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~--- 223 (671)
..+.+||+|||++..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+...
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~------~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 243 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDE------HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSY 243 (373)
T ss_dssp TTTEEEEEECCCTTCEETTB------CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CcCcceEEEcccccccccCC------CCCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCccccc
Confidence 344799999999865421 2234589999999999987 5689999999999999999999999976542
Q ss_pred ---HHHHHHHHh---cCCC-----------------------CC-----------CccccccchHHHHHHHHHhhhcCCC
Q 005886 224 ---MKVLLMTLQ---NAPP-----------------------GL-----------DYERDKRFSKSFKELVTACLVKDPK 263 (671)
Q Consensus 224 ---~~~~~~~~~---~~~~-----------------------~~-----------~~~~~~~ls~~l~dLI~~cL~~dP~ 263 (671)
...+..+.. ..+. .. .+..+..++.++.+||.+||..||.
T Consensus 244 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 323 (373)
T 1q8y_A 244 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 323 (373)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred CChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcc
Confidence 112222111 1000 00 0112345678899999999999999
Q ss_pred CCCCHHHHHhchhccccc
Q 005886 264 KRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 264 kRpSa~eiL~Hpwfk~~~ 281 (671)
+|||+.++|+||||+...
T Consensus 324 ~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 324 KRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp TCBCHHHHHTCGGGTTCT
T ss_pred ccCCHHHHhhChhhhccc
Confidence 999999999999998653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=380.20 Aligned_cols=264 Identities=21% Similarity=0.363 Sum_probs=224.2
Q ss_pred cccccccCCCCeEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeee
Q 005886 5 VEKRFPVDAKDYRLYEEVGEGVSATVYRALCI-----PLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHC 79 (671)
Q Consensus 5 ~e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~-----~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~ 79 (671)
.-..+.+..++|++.+.||+|+||.||+|.+. .+++.||||++...........+.+|+.+++.++||||+++++
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 44567888899999999999999999999887 4678899999976554445667889999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCCHHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC
Q 005886 80 SFTTGHCLWVVMPYMAGGSCLHIMKSAY--------PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG 151 (671)
Q Consensus 80 ~~~~~~~l~LVmEy~~ggsL~~~l~~~~--------~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g 151 (671)
++.+...+|+||||+.||+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence 9999999999999999999999987532 13578999999999999999999999999999999999999999
Q ss_pred ceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 005886 152 AIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMT 230 (671)
Q Consensus 152 ~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~ 230 (671)
.+||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+
T Consensus 176 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 253 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253 (322)
T ss_dssp CEEECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred eEEECcCccccccccccc-cccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence 999999999875533221 122334567899999999987 568999999999999999999 89999988776665555
Q ss_pred HhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 231 LQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 231 ~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
...... ..+..++..+.+||.+||..||.+|||+.++++|
T Consensus 254 ~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 254 MEGGLL----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCcC----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 443322 2345788999999999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=387.06 Aligned_cols=258 Identities=26% Similarity=0.411 Sum_probs=188.2
Q ss_pred CCCCeEEEE-EecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe----CCE
Q 005886 12 DAKDYRLYE-EVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT----GHC 86 (671)
Q Consensus 12 ~~~~Y~l~~-~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~----~~~ 86 (671)
..++|.+.+ .||+|+||+||+|.++.+|+.||||++... .....+....++.+.||||++++++|.. +..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 347899965 699999999999999999999999998542 1222333344678899999999999986 556
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcC---CCceEEeccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS---NGAIKLADFGVSAC 163 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~---~g~vKL~DFGls~~ 163 (671)
+|+|||||.||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 999999999999999998765567999999999999999999999999999999999999976 45699999999865
Q ss_pred cccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHH---HHHhcCCCCCCc
Q 005886 164 MFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLL---MTLQNAPPGLDY 240 (671)
Q Consensus 164 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~---~~~~~~~~~~~~ 240 (671)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......... ..+......+..
T Consensus 181 ~~~-----~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (336)
T 3fhr_A 181 TTQ-----NALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPN 254 (336)
T ss_dssp C----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCT
T ss_pred ccc-----cccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCc
Confidence 421 22335688999999999876 568899999999999999999999997655433211 111112222233
Q ss_pred cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 241 ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 241 ~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
+.+..++..+++||.+||..||.+|||+.++|+||||+..
T Consensus 255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 255 PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 3446789999999999999999999999999999999864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=366.45 Aligned_cols=255 Identities=26% Similarity=0.416 Sum_probs=218.8
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~ 88 (671)
+.+..++|++.+.||+|+||.||+|.+. ++..||+|++.... .....+.+|+.+++.++||||+++++++.+...+|
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS--MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY 79 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT--BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred eEechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC--CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence 5677899999999999999999999776 57789999987543 33467899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
+||||+.|++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 80 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 999999999999999765 2459999999999999999999999999999999999999999999999999987553322
Q ss_pred CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccch
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls 247 (671)
........||+.|+|||++.+ ..++.++||||||+++|+|++ |..||.................. ..+..++
T Consensus 159 --~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~ 231 (268)
T 3sxs_A 159 --YVSSVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL----YRPHLAS 231 (268)
T ss_dssp --EEECCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC----CCCTTSC
T ss_pred --hhcccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC----CCCCcCh
Confidence 122234466788999999987 568999999999999999999 99999988877766555544322 2345578
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 248 KSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
+.+.+||.+||..||.+|||+.++++|
T Consensus 232 ~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 232 DTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=372.52 Aligned_cols=259 Identities=24% Similarity=0.370 Sum_probs=209.2
Q ss_pred ccccccCCCCeEEEEEecccCceEEEEEEEcCC---CcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEE
Q 005886 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPL---NEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFT 82 (671)
Q Consensus 6 e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~t---g~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~ 82 (671)
.+.|.+..++|++.+.||+|+||.||+|.+..+ +..||+|++.........+.+.+|+.+++.++||||+++++++.
T Consensus 7 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 7 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 86 (281)
T ss_dssp --CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence 457889999999999999999999999998754 45699999875544445678899999999999999999999985
Q ss_pred eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccc
Q 005886 83 TGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSA 162 (671)
Q Consensus 83 ~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~ 162 (671)
++.+|+||||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred -cCccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccc
Confidence 45689999999999999999765 2468999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCcc
Q 005886 163 CMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYE 241 (671)
Q Consensus 163 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~ 241 (671)
...... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+..... ..
T Consensus 165 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~----~~ 237 (281)
T 1mp8_A 165 YMEDST--YYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER----LP 237 (281)
T ss_dssp ----------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----CC
T ss_pred ccCccc--ccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC----CC
Confidence 653221 112233467889999999987 678999999999999999996 9999998877666555544332 22
Q ss_pred ccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 242 RDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 242 ~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.+..++..+.+||.+||..||.+|||+.++++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 238 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 35678999999999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=371.97 Aligned_cols=262 Identities=23% Similarity=0.352 Sum_probs=221.8
Q ss_pred cccccCCCCeEEEE-EecccCceEEEEEEEc--CCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe
Q 005886 7 KRFPVDAKDYRLYE-EVGEGVSATVYRALCI--PLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT 83 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~-~LG~G~fG~Vyka~~~--~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~ 83 (671)
+.+.+..++|.+.+ .||+|+||.||+|.+. .++..||||++.........+.+.+|+.+++.++||||+++++++ .
T Consensus 2 ~~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~ 80 (287)
T 1u59_A 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-Q 80 (287)
T ss_dssp CCCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred CcccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-c
Confidence 45677889999988 9999999999999864 467889999997655445577899999999999999999999999 4
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccc
Q 005886 84 GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSAC 163 (671)
Q Consensus 84 ~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~ 163 (671)
...+|+||||+.|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCCcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceee
Confidence 55689999999999999998643 35699999999999999999999999999999999999999999999999999876
Q ss_pred cccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccc
Q 005886 164 MFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYER 242 (671)
Q Consensus 164 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~ 242 (671)
...............||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+...... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~----~~ 234 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM----EC 234 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC----CC
T ss_pred eccCcceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC----CC
Confidence 6433332233344567899999999986 568999999999999999998 99999988776665555443322 23
Q ss_pred cccchHHHHHHHHHhhhcCCCCCCCHHHHHhch
Q 005886 243 DKRFSKSFKELVTACLVKDPKKRPTAEKLMKHH 275 (671)
Q Consensus 243 ~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hp 275 (671)
+..++..+.+||.+||..||.+||++.++++|.
T Consensus 235 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 235 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 567899999999999999999999999998864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=393.49 Aligned_cols=261 Identities=21% Similarity=0.363 Sum_probs=220.9
Q ss_pred ccccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC
Q 005886 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH 85 (671)
Q Consensus 6 e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~ 85 (671)
...|.+..++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+|+.+|+.++||||+++++++..+.
T Consensus 106 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp CCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred ccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence 34677888999999999999999999999999999999999875433334556889999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
.+|+|||||.||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred CcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 999999999999999999765 2358999999999999999999999999999999999999999999999999986542
Q ss_pred cCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccc
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (671)
.. ..........+++.|+|||++.+ ..++.++|||||||++|||++ |..||.+.........+.... ..+.+.
T Consensus 265 ~~-~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~----~~~~~~ 338 (377)
T 3cbl_A 265 DG-VYAASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG----RLPCPE 338 (377)
T ss_dssp TS-EEECCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC----CCCCCT
T ss_pred CC-ceeecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----CCCCCC
Confidence 21 11111122345778999999987 568999999999999999998 999999887766554444332 233456
Q ss_pred cchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 245 RFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 245 ~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.++..+.+||.+||..||.+|||+.++++
T Consensus 339 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 339 LCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 68999999999999999999999999975
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=379.47 Aligned_cols=267 Identities=22% Similarity=0.407 Sum_probs=224.3
Q ss_pred ccccccccccCCCCeEEEEEecccCceEEEEEEEc-------CCCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCC
Q 005886 2 DLVVEKRFPVDAKDYRLYEEVGEGVSATVYRALCI-------PLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPN 73 (671)
Q Consensus 2 ~~~~e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~-------~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpN 73 (671)
|+-....|.+..++|++.+.||+|+||.||+|.+. .++..||||++...........+.+|+.+++.+ +|||
T Consensus 23 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~ 102 (334)
T 2pvf_A 23 ELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102 (334)
T ss_dssp CCCCCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred cCCCCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCC
Confidence 34455678889999999999999999999999986 457789999997655445567899999999999 8999
Q ss_pred ceeeeeEEEeCCEEEEEEeccCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccc
Q 005886 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYP--------------EGFEEPVIATLLRETLKALVYLHFHGHIHRD 139 (671)
Q Consensus 74 IVkl~~~~~~~~~l~LVmEy~~ggsL~~~l~~~~~--------------~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrD 139 (671)
|+++++++...+.+|+||||+.||+|.+++..... ..+++..++.++.||+.||+|||++||+|||
T Consensus 103 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~D 182 (334)
T 2pvf_A 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRD 182 (334)
T ss_dssp BCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred EeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCC
Confidence 99999999999999999999999999999986532 2489999999999999999999999999999
Q ss_pred CCCCcEEEcCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCC
Q 005886 140 VKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPF 218 (671)
Q Consensus 140 LKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF 218 (671)
|||+|||++.++.+||+|||++....... .........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||
T Consensus 183 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~ 260 (334)
T 2pvf_A 183 LAARNVLVTENNVMKIADFGLARDINNID-YYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPY 260 (334)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECTTTS-SEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CccceEEEcCCCCEEEccccccccccccc-cccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCc
Confidence 99999999999999999999987553222 1122334567889999999987 568999999999999999999 99999
Q ss_pred CCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 219 SKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
.+....+....+...... ..+..++..+.+||.+||..||.+|||+.+++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 261 PGIPVEELFKLLKEGHRM----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp TTCCHHHHHHHHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcCCHHHHHHHHhcCCCC----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 988776655554443322 2345688999999999999999999999999873
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=378.09 Aligned_cols=256 Identities=17% Similarity=0.199 Sum_probs=210.1
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHCSFTTGHCLWV 89 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~~~l~L 89 (671)
+..++|++.+.||+|+||.||+|.+..+|+.||||++..... ...+.+|+.+++.+ +||||+++++++..+..+|+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 345889999999999999999999999999999999875432 23578999999999 99999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCc-----eEEecccccccc
Q 005886 90 VMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGA-----IKLADFGVSACM 164 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~-----vKL~DFGls~~~ 164 (671)
||||+ |++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.+
T Consensus 83 v~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99999 99999999864 357999999999999999999999999999999999999998887 999999999765
Q ss_pred ccCCCcc----cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChH---HHHHHHHhcCCCC
Q 005886 165 FDAGDRQ----RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM---KVLLMTLQNAPPG 237 (671)
Q Consensus 165 ~~~~~~~----~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~---~~~~~~~~~~~~~ 237 (671)
....... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... +.+..+.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 4332211 12346789999999999987 67899999999999999999999999875332 2222221111100
Q ss_pred CCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 238 LDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 238 ~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
........++ ++.+||..||..||.+||++.+|++
T Consensus 240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 0111123355 9999999999999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=371.38 Aligned_cols=264 Identities=22% Similarity=0.317 Sum_probs=215.0
Q ss_pred ccccccccccCCCCeEEEE-EecccCceEEEEEEE--cCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceee
Q 005886 2 DLVVEKRFPVDAKDYRLYE-EVGEGVSATVYRALC--IPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRA 77 (671)
Q Consensus 2 ~~~~e~~~~i~~~~Y~l~~-~LG~G~fG~Vyka~~--~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl 77 (671)
+.+......++.++|++.+ .||+|+||.||+|.+ ..+++.||||++...... ...+.+.+|+.+++.++||||+++
T Consensus 4 ~~i~~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 83 (291)
T 1xbb_A 4 EEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83 (291)
T ss_dssp -------CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred cccCcceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 4455667788889999999 999999999999954 567889999999755432 236789999999999999999999
Q ss_pred eeEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEec
Q 005886 78 HCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLAD 157 (671)
Q Consensus 78 ~~~~~~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~D 157 (671)
++++ ....+|+||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 84 ~~~~-~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~D 160 (291)
T 1xbb_A 84 IGIC-EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISD 160 (291)
T ss_dssp EEEE-ESSSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECC
T ss_pred EEEE-CCCCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEcc
Confidence 9999 566789999999999999999875 5699999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCC
Q 005886 158 FGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPP 236 (671)
Q Consensus 158 FGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~ 236 (671)
||++.................||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+......
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~ 239 (291)
T 1xbb_A 161 FGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 239 (291)
T ss_dssp CTTCEECCTTCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC
T ss_pred CCcceeeccCCCcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9998765333322222333457789999999987 568899999999999999999 99999988776655554443322
Q ss_pred CCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 237 GLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 237 ~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
..+..++..+.+||.+||..||.+||++.++++
T Consensus 240 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 240 ----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 234578999999999999999999999999976
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=381.57 Aligned_cols=256 Identities=24% Similarity=0.377 Sum_probs=216.7
Q ss_pred ccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcc-----cHHHHHHHHHHHHhCC--CCCceeeeeEEE
Q 005886 10 PVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-----DLDGIRREVQTMRVTN--HPNVLRAHCSFT 82 (671)
Q Consensus 10 ~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~-----~~~~i~~Ei~iL~~L~--HpNIVkl~~~~~ 82 (671)
....++|++.+.||+|+||.||+|.+..+|+.||||++....... ....+.+|+.+++.+. ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 345688999999999999999999999999999999997654321 2245678999999986 599999999999
Q ss_pred eCCEEEEEEeccCC-CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEc-CCCceEEecccc
Q 005886 83 TGHCLWVVMPYMAG-GSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILID-SNGAIKLADFGV 160 (671)
Q Consensus 83 ~~~~l~LVmEy~~g-gsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld-~~g~vKL~DFGl 160 (671)
....+++||||+.+ ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred cCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 99999999999986 8999999876 6799999999999999999999999999999999999999 778999999999
Q ss_pred ccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCc
Q 005886 161 SACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240 (671)
Q Consensus 161 s~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~ 240 (671)
+..... .......||+.|+|||++.+...++.++|||||||++|+|++|..||..... ..... .
T Consensus 197 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~-----~ 260 (320)
T 3a99_A 197 GALLKD-----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQ-----V 260 (320)
T ss_dssp CEECCS-----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHCC-----C
T ss_pred cccccc-----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhccc-----c
Confidence 875532 1233467999999999998744457889999999999999999999976321 11111 1
Q ss_pred cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccccc
Q 005886 241 ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSN 283 (671)
Q Consensus 241 ~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~ 283 (671)
.....++.++.+||.+||..||.+|||+.++++||||+.....
T Consensus 261 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~ 303 (320)
T 3a99_A 261 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 303 (320)
T ss_dssp CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCc
Confidence 2245688999999999999999999999999999999876543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=379.95 Aligned_cols=256 Identities=28% Similarity=0.422 Sum_probs=213.4
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LV 90 (671)
+..++|++.+.||+|+||+||+|.+..+|+.||+|++... .......+.+|+.+++.++||||+++++++.++..+|+|
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence 4678999999999999999999999999999999998532 234567889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCc
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR 170 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~ 170 (671)
|||+.||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+......
T Consensus 86 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp EECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred EEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 9999999999999874 357999999999999999999999999999999999999999999999999998765332221
Q ss_pred c-----------cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHH-----HHHHHhcC
Q 005886 171 Q-----------RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKV-----LLMTLQNA 234 (671)
Q Consensus 171 ~-----------~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~-----~~~~~~~~ 234 (671)
. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ .......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~- 242 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR- 242 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH-
T ss_pred ccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc-
Confidence 1 11125689999999999987 6789999999999999999999999876432110 0011111
Q ss_pred CCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcc
Q 005886 235 PPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278 (671)
Q Consensus 235 ~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk 278 (671)
..+..+++.+.+||.+||..||.+|||+.++++ |+.
T Consensus 243 ------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~ 278 (310)
T 3s95_A 243 ------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLE 278 (310)
T ss_dssp ------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHH
T ss_pred ------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHH
Confidence 113457789999999999999999999999986 554
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=378.76 Aligned_cols=256 Identities=22% Similarity=0.367 Sum_probs=207.6
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEE----EEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIV----AIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~V----AIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 86 (671)
+..++|++.+.||+|+||+||+|.+..+|+.+ |+|.+...........+.+|+.+++.++||||+++++++....
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 90 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence 45678999999999999999999998887754 7777755444455688999999999999999999999999765
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
.++||+|+.+|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred eEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 77899999999999998764 35699999999999999999999999999999999999999999999999999976533
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (671)
.. .........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+.... ....+..
T Consensus 170 ~~-~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~ 243 (327)
T 3poz_A 170 EE-KEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQPPI 243 (327)
T ss_dssp TC-C-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC----CCCCCTT
T ss_pred Cc-ccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC----CCCCCcc
Confidence 22 2222334567889999999987 679999999999999999999 999999877765544443332 2233556
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 246 FSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 246 ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
++..+.+||.+||..||.+||++.+++++
T Consensus 244 ~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 244 CTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp BCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 88999999999999999999999999874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=366.59 Aligned_cols=258 Identities=18% Similarity=0.206 Sum_probs=213.4
Q ss_pred ccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeeeEEEeCCEEE
Q 005886 10 PVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 10 ~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~~~l~ 88 (671)
.+..++|++.+.||+|+||.||+|.+..+|+.||||++..... ...+.+|+.+++.+ +|+||+++++++.....+|
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 82 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 82 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence 4567899999999999999999999999999999999865432 24578899999999 8999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCc-----eEEeccccccc
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGA-----IKLADFGVSAC 163 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~-----vKL~DFGls~~ 163 (671)
+||||+ |++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++..
T Consensus 83 lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 83 LVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 999999 99999999865 246999999999999999999999999999999999999987765 99999999976
Q ss_pred cccCCCcc----cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhcCCC
Q 005886 164 MFDAGDRQ----RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYP---PMKVLLMTLQNAPP 236 (671)
Q Consensus 164 ~~~~~~~~----~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~---~~~~~~~~~~~~~~ 236 (671)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.. .......+......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred cccccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 64332211 22355689999999999987 568999999999999999999999998743 22222222221111
Q ss_pred CCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 237 GLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 237 ~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.........++..+.+||.+||..||.+||++.++++
T Consensus 240 ~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 240 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 1112223467899999999999999999999999876
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=372.73 Aligned_cols=258 Identities=22% Similarity=0.336 Sum_probs=212.0
Q ss_pred cCCCCeEEEEEecccCceEEEEEE----EcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeC--
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRAL----CIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG-- 84 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~----~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~-- 84 (671)
+..+.|++++.||+|+||.||+|. +..+|+.||+|++...........+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 97 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 345679999999999999999998 56789999999998666556678899999999999999999999999876
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccc
Q 005886 85 HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACM 164 (671)
Q Consensus 85 ~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~ 164 (671)
..+|+||||+.||+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred ceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence 67999999999999999996552 56999999999999999999999999999999999999999999999999998766
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCC--------------ChHHHHHHH
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKY--------------PPMKVLLMT 230 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~--------------~~~~~~~~~ 230 (671)
..............||+.|+|||++.+ ..++.++|||||||++|+|++|..||... .........
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 443333334455678999999999987 56889999999999999999999886421 111112222
Q ss_pred HhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 231 LQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 231 ~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
+. .......+..++..+.+||.+||..||.+|||+.++++
T Consensus 256 ~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 256 LK---EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HH---TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred Hh---ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 22 12233445678999999999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=378.53 Aligned_cols=263 Identities=20% Similarity=0.364 Sum_probs=222.7
Q ss_pred ccccccCCCCeEEEEEecccCceEEEEEEEcCCCc-----EEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeee
Q 005886 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNE-----IVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHC 79 (671)
Q Consensus 6 e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~-----~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~ 79 (671)
...+.+..++|++.+.||+|+||.||+|.+..++. .||+|++...........+.+|+.+++.+ +||||+++++
T Consensus 38 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 38 NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp CGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 34688889999999999999999999999987765 79999997655445567899999999999 8999999999
Q ss_pred EEEeCCEEEEEEeccCCCCHHHHHHhhC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEE
Q 005886 80 SFTTGHCLWVVMPYMAGGSCLHIMKSAY------------PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILI 147 (671)
Q Consensus 80 ~~~~~~~l~LVmEy~~ggsL~~~l~~~~------------~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILl 147 (671)
++.....+|+||||+.||+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 9999999999999999999999987542 2458999999999999999999999999999999999999
Q ss_pred cCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHH
Q 005886 148 DSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKV 226 (671)
Q Consensus 148 d~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~ 226 (671)
+.++.+||+|||++....... .........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+......
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDS-NYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCT-TSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred CCCCeEEECcccccccccccc-ceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 999999999999987553322 1222344567889999999987 569999999999999999998 9999988766555
Q ss_pred HHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 227 LLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
......... ....+..++..+.+||.+||..||.+|||+.++++
T Consensus 276 ~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 276 FYKLVKDGY---QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHHHHTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCC---CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 544444322 22234567899999999999999999999999987
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=379.92 Aligned_cols=256 Identities=23% Similarity=0.382 Sum_probs=212.1
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcE----EEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEI----VAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~----VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 86 (671)
+..++|++++.||+|+||+||+|.+..+|.. ||+|++...........+.+|+.+++.++||||+++++++.. ..
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~ 88 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SS 88 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SS
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-Cc
Confidence 4678999999999999999999999988876 777777544434445667789999999999999999999874 56
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
+++||||+.||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred cEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 88999999999999998754 24688999999999999999999999999999999999999999999999999976533
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (671)
.. .........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+..... ...+..
T Consensus 168 ~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~ 241 (325)
T 3kex_A 168 DD-KQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER----LAQPQI 241 (325)
T ss_dssp CT-TCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB----CCCCTT
T ss_pred cc-ccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC----CCCCCc
Confidence 22 2223345678889999999987 569999999999999999999 9999998776665544443322 223445
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 246 FSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 246 ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
++..+.+||.+||..||.+||++.++++|
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 242 CTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp BCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 78889999999999999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=362.02 Aligned_cols=256 Identities=21% Similarity=0.370 Sum_probs=219.3
Q ss_pred ccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q 005886 8 RFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCL 87 (671)
Q Consensus 8 ~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l 87 (671)
+|.++.++|++.+.||+|+||.||+|.+. ++..||+|++.... ...+.+.+|+.+++.++||||+++++++.+...+
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 78 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTT--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence 57888999999999999999999999986 67889999997544 2346789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccC
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~ 167 (671)
|+||||+.|++|.+++... ...+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 79 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp EEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 9999999999999999764 356899999999999999999999999999999999999999999999999998755321
Q ss_pred CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (671)
.........||+.|+|||++.+ ..++.++||||||+++|+|++ |..||...........+..... ...+..+
T Consensus 158 --~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~----~~~~~~~ 230 (267)
T 3t9t_A 158 --QYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR----LYKPRLA 230 (267)
T ss_dssp --HHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC----CCCCTTS
T ss_pred --cccccccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc----CCCCccC
Confidence 1122234567889999999987 568999999999999999999 9999998877666555544322 2234567
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 247 SKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 247 s~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
+..+.+||.+||..||.+||++.+++++
T Consensus 231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 231 STHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 8999999999999999999999999873
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=377.44 Aligned_cols=264 Identities=23% Similarity=0.338 Sum_probs=218.3
Q ss_pred cccCCCCeEEEEEecccCceEEEEEE-----EcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRAL-----CIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT 83 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~-----~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~ 83 (671)
..+..++|++.+.||+|+||.||+|. +..++..||||++...........+.+|+.+++.++||||+++++++..
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 45678899999999999999999999 5678889999999755444556778899999999999999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCC---CceEE
Q 005886 84 GHCLWVVMPYMAGGSCLHIMKSAYP-----EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSN---GAIKL 155 (671)
Q Consensus 84 ~~~l~LVmEy~~ggsL~~~l~~~~~-----~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~---g~vKL 155 (671)
...+|+||||+.||+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999999987532 348999999999999999999999999999999999999844 46999
Q ss_pred eccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcC
Q 005886 156 ADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNA 234 (671)
Q Consensus 156 ~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~ 234 (671)
+|||++....... .........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||...........+....
T Consensus 185 ~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 262 (327)
T 2yfx_A 185 GDFGMARDIYRAS-YYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 262 (327)
T ss_dssp CCCHHHHHHHC-------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred Ccccccccccccc-ccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC
Confidence 9999987553222 1223345678999999999987 568999999999999999998 999999877766555554433
Q ss_pred CCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcc
Q 005886 235 PPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278 (671)
Q Consensus 235 ~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk 278 (671)
.. ..+..++..+.+||.+||..||.+||++.++++|.|+.
T Consensus 263 ~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 263 RM----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 22 23456889999999999999999999999999998875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=363.48 Aligned_cols=251 Identities=26% Similarity=0.480 Sum_probs=205.9
Q ss_pred ccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC---cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q 005886 10 PVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC---NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 10 ~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~---~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 86 (671)
.+..++|++.+.||+|+||.||+|.+. |..||||++..... ....+.+.+|+.+++.++||||+++++++.++..
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 467799999999999999999999975 88999999875432 2346788999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCCCcEEEcC--------CCceEE
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHG---HIHRDVKAGNILIDS--------NGAIKL 155 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~g---IVHrDLKPeNILld~--------~g~vKL 155 (671)
+|+||||+.|++|.+++.. ..+++..++.++.||+.||+|||++| |+||||||+|||++. ++.+||
T Consensus 81 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred eEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 9999999999999998853 47999999999999999999999999 899999999999986 678999
Q ss_pred eccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Q 005886 156 ADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP 235 (671)
Q Consensus 156 ~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~ 235 (671)
+|||++..+... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..............
T Consensus 158 ~Dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~- 230 (271)
T 3dtc_A 158 TDFGLAREWHRT-----TKMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK- 230 (271)
T ss_dssp CCCCC------------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC-
T ss_pred ccCCcccccccc-----cccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC-
Confidence 999998654221 2234579999999999987 568999999999999999999999999887766655554432
Q ss_pred CCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 236 PGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 236 ~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
.....+..++..+.+||.+||..||.+|||+.++++|
T Consensus 231 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 231 --LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 2233456789999999999999999999999999874
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=372.94 Aligned_cols=262 Identities=19% Similarity=0.341 Sum_probs=208.1
Q ss_pred cccCCCCeEEEEEecccCceEEEEEE----EcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe-
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRAL----CIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT- 83 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~----~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~- 83 (671)
..+..++|++++.||+|+||+||+|+ +..+|+.||||++.... ......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 45677899999999999999999998 56789999999986432 3345778999999999999999999999865
Q ss_pred -CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccc
Q 005886 84 -GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSA 162 (671)
Q Consensus 84 -~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~ 162 (671)
...+|+||||+.||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CCCceEEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 35689999999999999999765 2459999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHH------------HHHHH
Q 005886 163 CMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK------------VLLMT 230 (671)
Q Consensus 163 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~------------~~~~~ 230 (671)
.+..............||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... .....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 65433322233344567888999999987 569999999999999999999999986432110 00011
Q ss_pred HhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 231 LQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 231 ~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
..........+.+..++.++.+||.+||..||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1111112233446678999999999999999999999999976
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=372.11 Aligned_cols=266 Identities=24% Similarity=0.425 Sum_probs=213.8
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCC--CCCceeeeeEEEe
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTN--HPNVLRAHCSFTT 83 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~--HpNIVkl~~~~~~ 83 (671)
..+.+..++|++++.||+|+||.||+|.+. +|+.||||++...... .....+.+|+.+++.+. ||||+++++++..
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 346677889999999999999999999875 5889999999765432 34678899999999997 5999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccc
Q 005886 84 GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSAC 163 (671)
Q Consensus 84 ~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~ 163 (671)
+..+|+||| +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 175 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred CCEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccc
Confidence 999999999 5588999999876 5789999999999999999999999999999999999996 58999999999876
Q ss_pred cccCCCcccccccccCCCCCCChhHhhhc----------cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 005886 164 MFDAGDRQRSRNTFVGTPCWMAPEVMQQL----------HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQN 233 (671)
Q Consensus 164 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~----------~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~ 233 (671)
+..... ........||+.|+|||++.+. ..++.++|||||||++|+|++|..||...............
T Consensus 176 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 254 (313)
T 3cek_A 176 MQPDTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 254 (313)
T ss_dssp ---------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred ccCccc-cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh
Confidence 532211 1223355799999999998751 35888999999999999999999999876443222222222
Q ss_pred CCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 234 APPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 234 ~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
. ......+...+..+.+||.+||..||.+||++.++|+||||+..
T Consensus 255 ~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 255 P--NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp T--TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred c--ccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 1 12223345568899999999999999999999999999999854
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=375.21 Aligned_cols=262 Identities=21% Similarity=0.335 Sum_probs=219.0
Q ss_pred ccccCCCCeEEEEEecccCceEEEEEEE-----cCCCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeeeEE
Q 005886 8 RFPVDAKDYRLYEEVGEGVSATVYRALC-----IPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHCSF 81 (671)
Q Consensus 8 ~~~i~~~~Y~l~~~LG~G~fG~Vyka~~-----~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~ 81 (671)
.|.+..++|++.+.||+|+||.||+|.+ ..+++.||||++...........+.+|+.+++.+ +||||+++++++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 5677889999999999999999999985 3567899999997655445567889999999999 799999999998
Q ss_pred EeCC-EEEEEEeccCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEE
Q 005886 82 TTGH-CLWVVMPYMAGGSCLHIMKSAYP--------------EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNIL 146 (671)
Q Consensus 82 ~~~~-~l~LVmEy~~ggsL~~~l~~~~~--------------~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNIL 146 (671)
.... .+|+||||+.||+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil 180 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence 8754 59999999999999999986532 12889999999999999999999999999999999999
Q ss_pred EcCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHH
Q 005886 147 IDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMK 225 (671)
Q Consensus 147 ld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~ 225 (671)
++.++.+||+|||++..+.... .........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.....
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~ 258 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDP-DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCT-TSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred ECCCCCEEECCCccccccccCc-cceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence 9999999999999987553322 1222345578999999999987 679999999999999999998 999998876544
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 226 VLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
.....+.... ....+..+++.+.++|.+||..||.+|||+.++++|
T Consensus 259 ~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 259 EFCRRLKEGT---RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHHTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhccCc---cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4444443322 122345678999999999999999999999999885
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=363.34 Aligned_cols=255 Identities=18% Similarity=0.324 Sum_probs=217.1
Q ss_pred ccccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeC
Q 005886 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTG 84 (671)
Q Consensus 6 e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~ 84 (671)
.+.+.+..++|++.+.||+|+||.||+|.+. |..||||++...... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (271)
T 3kmu_A 2 NKHSGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP 79 (271)
T ss_dssp --CCCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT
T ss_pred CCcCCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC
Confidence 4567788899999999999999999999985 889999999765432 3456789999999999999999999999987
Q ss_pred --CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCCcEEEcCCCceEEecccc
Q 005886 85 --HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHG--HIHRDVKAGNILIDSNGAIKLADFGV 160 (671)
Q Consensus 85 --~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~g--IVHrDLKPeNILld~~g~vKL~DFGl 160 (671)
..+|+||||+.||+|.+++.......+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~ 159 (271)
T 3kmu_A 80 PAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADV 159 (271)
T ss_dssp TSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGS
T ss_pred CCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccc
Confidence 78999999999999999998764446999999999999999999999999 99999999999999999999999987
Q ss_pred ccccccCCCcccccccccCCCCCCChhHhhhcc--CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC
Q 005886 161 SACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLH--GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL 238 (671)
Q Consensus 161 s~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~--~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~ 238 (671)
+... ......||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+...............
T Consensus 160 ~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--- 228 (271)
T 3kmu_A 160 KFSF--------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL--- 228 (271)
T ss_dssp CCTT--------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCC---
T ss_pred eeee--------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCC---
Confidence 6432 223457899999999998622 233479999999999999999999998887776655554322
Q ss_pred CccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 239 DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 239 ~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
....+..++..+.+||.+||..||.+|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 229 RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 22345678999999999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=374.67 Aligned_cols=261 Identities=21% Similarity=0.324 Sum_probs=213.2
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcCCC----cEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEE
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLN----EIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFT 82 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg----~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~ 82 (671)
....+..++|++.+.||+|+||.||+|.+..++ ..||||++...........+.+|+.+++.++||||+++++++.
T Consensus 37 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 37 FTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116 (333)
T ss_dssp -CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 335778899999999999999999999987654 3599999975544445667899999999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccc
Q 005886 83 TGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSA 162 (671)
Q Consensus 83 ~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~ 162 (671)
....+|+||||+.||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence 999999999999999999998764 3569999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCcc
Q 005886 163 CMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYE 241 (671)
Q Consensus 163 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~ 241 (671)
................||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+.... ..+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~----~~~ 270 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF----RLP 270 (333)
T ss_dssp ---------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC----CCC
T ss_pred hhccccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC----cCC
Confidence 65433222222233456889999999986 568999999999999999998 999999887766655554432 223
Q ss_pred ccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 242 RDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 242 ~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.+..++..+.+||.+||..||.+||++.++++
T Consensus 271 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 302 (333)
T 1mqb_A 271 TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 302 (333)
T ss_dssp CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 34568899999999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=387.62 Aligned_cols=259 Identities=24% Similarity=0.362 Sum_probs=207.7
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEc---CCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCI---PLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH 85 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~---~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~ 85 (671)
..+..++|++.+.||+|+||.||+|+++ .++..||||++...........+.+|+.+++.++||||+++++++.+..
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 4566789999999999999999999887 4677899999976544445678999999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
.+|+|||||.||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred ceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 999999999999999999764 3469999999999999999999999999999999999999999999999999987664
Q ss_pred cCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccc
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (671)
.............+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+.... ..+.+.
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~----~~~~~~ 273 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY----RLPPPM 273 (373)
T ss_dssp ---------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE----ECCCCT
T ss_pred cCCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----CCCCCc
Confidence 33222222223356788999999987 679999999999999999998 999999887766655544332 222345
Q ss_pred cchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 245 RFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 245 ~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.++..+.+||.+||..||.+||++.++++
T Consensus 274 ~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp TCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 67899999999999999999999999976
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=374.55 Aligned_cols=259 Identities=22% Similarity=0.357 Sum_probs=215.7
Q ss_pred cccc-cCCCCeEEEEEecccCceEEEEEEEcCCCcEE--EEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeeeEEE
Q 005886 7 KRFP-VDAKDYRLYEEVGEGVSATVYRALCIPLNEIV--AIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHCSFT 82 (671)
Q Consensus 7 ~~~~-i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~V--AIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~ 82 (671)
..|| ++.++|++.+.||+|+||.||+|++..+|..+ |+|.+...........+.+|+.+++.+ +||||+++++++.
T Consensus 17 ~~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 96 (327)
T 1fvr_A 17 TIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE 96 (327)
T ss_dssp CCSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred cccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee
Confidence 3455 56689999999999999999999999999865 999987544445567789999999999 9999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEc
Q 005886 83 TGHCLWVVMPYMAGGSCLHIMKSAY--------------PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILID 148 (671)
Q Consensus 83 ~~~~l~LVmEy~~ggsL~~~l~~~~--------------~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld 148 (671)
+...+|+||||+.||+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 97 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 176 (327)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred eCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc
Confidence 9999999999999999999997642 23689999999999999999999999999999999999999
Q ss_pred CCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 005886 149 SNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVL 227 (671)
Q Consensus 149 ~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~ 227 (671)
.++.+||+|||++.... .........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+..
T Consensus 177 ~~~~~kL~Dfg~~~~~~----~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~ 251 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQE----VYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 251 (327)
T ss_dssp GGGCEEECCTTCEESSC----EECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred CCCeEEEcccCcCcccc----ccccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH
Confidence 99999999999986331 1122233467899999999987 568999999999999999998 99999988776655
Q ss_pred HHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 228 LMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
..+.... ....+..++..+.+||.+||..||.+|||+.++++|
T Consensus 252 ~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 252 EKLPQGY----RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHGGGTC----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhhcCC----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 5544432 223455788999999999999999999999999873
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=375.70 Aligned_cols=253 Identities=26% Similarity=0.400 Sum_probs=205.3
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcc-----cHHHHHHHHHHHHhC----CCCCceeeeeEE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-----DLDGIRREVQTMRVT----NHPNVLRAHCSF 81 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~-----~~~~i~~Ei~iL~~L----~HpNIVkl~~~~ 81 (671)
.-.++|++.+.||+|+||.||+|.+..+|+.||||++....... ....+.+|+.+++.+ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 34578999999999999999999999999999999997554221 223456799999888 899999999999
Q ss_pred EeCCEEEEEEec-cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEc-CCCceEEeccc
Q 005886 82 TTGHCLWVVMPY-MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILID-SNGAIKLADFG 159 (671)
Q Consensus 82 ~~~~~l~LVmEy-~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld-~~g~vKL~DFG 159 (671)
...+.+++|||| +.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 999999999999 7899999999876 5699999999999999999999999999999999999999 78999999999
Q ss_pred cccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC
Q 005886 160 VSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD 239 (671)
Q Consensus 160 ls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~ 239 (671)
++..... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.... . +... .
T Consensus 186 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~----~~~~-----~ 249 (312)
T 2iwi_A 186 SGALLHD-----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--E----ILEA-----E 249 (312)
T ss_dssp SCEECCS-----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----HHHT-----C
T ss_pred hhhhccc-----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--H----Hhhh-----c
Confidence 9876532 123456799999999999874444568999999999999999999997532 1 1111 1
Q ss_pred ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 240 YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 240 ~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
...+..++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 250 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 250 LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 123456789999999999999999999999999999998654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=367.96 Aligned_cols=250 Identities=20% Similarity=0.341 Sum_probs=209.4
Q ss_pred ccCCCCeEEEEEecccCceEEEEEEEcCCC-------cEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEE
Q 005886 10 PVDAKDYRLYEEVGEGVSATVYRALCIPLN-------EIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFT 82 (671)
Q Consensus 10 ~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg-------~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~ 82 (671)
.+..++|++.+.||+|+||+||+|.+..++ ..||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 356789999999999999999999999887 469999986443 344678999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCc--------eE
Q 005886 83 TGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGA--------IK 154 (671)
Q Consensus 83 ~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~--------vK 154 (671)
++...|+||||+.||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +|
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred eCCCCEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999999999865 234999999999999999999999999999999999999998886 99
Q ss_pred EeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHhc
Q 005886 155 LADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHG-HAPFSKYPPMKVLLMTLQN 233 (671)
Q Consensus 155 L~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG-~~PF~~~~~~~~~~~~~~~ 233 (671)
|+|||++.... ......||+.|+|||++.+...++.++|||||||++|+|++| .+||......... .....
T Consensus 162 l~Dfg~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~~ 233 (289)
T 4fvq_A 162 LSDPGISITVL-------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYED 233 (289)
T ss_dssp ECCCCSCTTTS-------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHT
T ss_pred eccCccccccc-------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhhc
Confidence 99999975431 123356899999999998756689999999999999999995 5566555544333 22222
Q ss_pred CCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 234 APPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 234 ~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
.. ..+..++.++.+||.+||..||.+|||+.++++|
T Consensus 234 ~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 234 RH-----QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp TC-----CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cC-----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 11 1234457789999999999999999999999874
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=373.73 Aligned_cols=255 Identities=22% Similarity=0.367 Sum_probs=210.2
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEE----EEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIV----AIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~V----AIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 86 (671)
+..++|++++.||+|+||+||+|.+..+++.| |+|.+...........+.+|+.+++.++||||+++++++....
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 90 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence 46789999999999999999999999888765 6666654444556788999999999999999999999999765
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
.++||+|+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred ceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 78899999999999998765 35699999999999999999999999999999999999999999999999999876532
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (671)
.. .........||+.|+|||++.+ ..|+.++|||||||++|+|++ |..||.+.........+.... ..+.+..
T Consensus 170 ~~-~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~ 243 (327)
T 3lzb_A 170 EE-KEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQPPI 243 (327)
T ss_dssp -----------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC----CCCCCTT
T ss_pred cc-ccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC----CCCCCcc
Confidence 22 2222334567889999999987 679999999999999999999 999999887766554444432 2233556
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 246 FSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 246 ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
++.++.+||.+||..||.+||++.++++
T Consensus 244 ~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 244 CTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8899999999999999999999999986
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=397.86 Aligned_cols=258 Identities=23% Similarity=0.419 Sum_probs=223.8
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 86 (671)
..|.+...+|++.+.||+|+||.||+|.++.++..||||++.... ...+.+.+|+.+|+.++||||+++++++.....
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 290 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 290 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc--cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 457778889999999999999999999999999999999986543 346789999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
+|||||||.||+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 99999999999999999876556799999999999999999999999999999999999999999999999999876532
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (671)
. .........+|+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.........+... .....+..
T Consensus 371 ~--~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~ 443 (495)
T 1opk_A 371 D--TYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD----YRMERPEG 443 (495)
T ss_dssp C--CEECCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT----CCCCCCTT
T ss_pred C--ceeecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC----CCCCCCCC
Confidence 2 1222234456789999999987 568999999999999999999 99999988766555444332 23344667
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 246 FSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 246 ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
++..+.+||.+||..||.+|||+.+|++
T Consensus 444 ~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 444 CPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 8999999999999999999999999976
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=363.06 Aligned_cols=259 Identities=22% Similarity=0.350 Sum_probs=215.2
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcC---CCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIP---LNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT 83 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~---tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~ 83 (671)
..+.+..++|++.+.||+|+||.||+|.+.. ++..||+|++.........+.+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp CCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred ccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 4577888999999999999999999998764 3456999998765544556789999999999999999999999876
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccc
Q 005886 84 GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSAC 163 (671)
Q Consensus 84 ~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~ 163 (671)
+ ..|+||||+.|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 85 ~-~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 85 E-PTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp S-SCEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred C-CCEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 5 468999999999999999765 24589999999999999999999999999999999999999999999999999875
Q ss_pred cccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccc
Q 005886 164 MFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYER 242 (671)
Q Consensus 164 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~ 242 (671)
..... ........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||................. ...
T Consensus 163 ~~~~~--~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~----~~~ 235 (281)
T 3cc6_A 163 IEDED--YYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR----LPK 235 (281)
T ss_dssp C-----------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCC----CCC
T ss_pred ccccc--ccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCC----CCC
Confidence 53221 112234567889999999987 578999999999999999998 9999987766655544443322 223
Q ss_pred cccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 243 DKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 243 ~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
+..+++.+.+||.+||..||.+||++.+++++
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 236 PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 45678999999999999999999999999873
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=368.98 Aligned_cols=265 Identities=25% Similarity=0.323 Sum_probs=205.9
Q ss_pred ccccccccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhCCCCCceeeee
Q 005886 2 DLVVEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPNVLRAHC 79 (671)
Q Consensus 2 ~~~~e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L~HpNIVkl~~ 79 (671)
+...+.+.....++|++.+.||+|+||.||+|.+..+|+.||||++...... .....+.+|+.+++.++||||+++++
T Consensus 22 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~ 101 (309)
T 2h34_A 22 DGTAESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD 101 (309)
T ss_dssp ------------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred ccccccCCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEE
Confidence 3333445556678999999999999999999999999999999999755322 23577899999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccc
Q 005886 80 SFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFG 159 (671)
Q Consensus 80 ~~~~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFG 159 (671)
++..+..+|+||||+.|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg 179 (309)
T 2h34_A 102 FGEIDGQLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFG 179 (309)
T ss_dssp EEEETTEEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCC
T ss_pred EEeeCCeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCc
Confidence 999999999999999999999999876 579999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC
Q 005886 160 VSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD 239 (671)
Q Consensus 160 ls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~ 239 (671)
++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... .....+....+ ..
T Consensus 180 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~-~~ 254 (309)
T 2h34_A 180 IASATTDEK--LTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIP-RP 254 (309)
T ss_dssp C------------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCCC-CG
T ss_pred cCccccccc--cccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCCC-Cc
Confidence 986553221 122335679999999999976 56899999999999999999999999876554 33333333222 12
Q ss_pred ccccccchHHHHHHHHHhhhcCCCCCC-CHHHHHh
Q 005886 240 YERDKRFSKSFKELVTACLVKDPKKRP-TAEKLMK 273 (671)
Q Consensus 240 ~~~~~~ls~~l~dLI~~cL~~dP~kRp-Sa~eiL~ 273 (671)
...+..++..+.+||.+||..||.+|| ++++++.
T Consensus 255 ~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 255 STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 234567899999999999999999999 7887764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=385.46 Aligned_cols=260 Identities=22% Similarity=0.376 Sum_probs=215.5
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC--EEE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH--CLW 88 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~--~l~ 88 (671)
+..++|++.+.||+|+||+||+|.+..+|+.||||++.........+.+.+|+.+++.++||||+++++++.... .+|
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 456789999999999999999999999999999999986655556788889999999999999999999998765 789
Q ss_pred EEEeccCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEE----cCCCceEEeccccccc
Q 005886 89 VVMPYMAGGSCLHIMKSAYP-EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILI----DSNGAIKLADFGVSAC 163 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~-~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILl----d~~g~vKL~DFGls~~ 163 (671)
+|||||.||+|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999999876422 339999999999999999999999999999999999999 7778899999999876
Q ss_pred cccCCCcccccccccCCCCCCChhHhhhc-------cCCCccchhhhHHHHHHHHHhCCCCCCCC----ChHHHHHHHHh
Q 005886 164 MFDAGDRQRSRNTFVGTPCWMAPEVMQQL-------HGYDFKADIWSFGITALELAHGHAPFSKY----PPMKVLLMTLQ 232 (671)
Q Consensus 164 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~-------~~~s~ksDIWSLGvILyeLltG~~PF~~~----~~~~~~~~~~~ 232 (671)
+... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|..||... ...+.+..++.
T Consensus 166 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 166 LEDD----EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp CCCG----GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred ccCC----CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 5321 223456899999999998752 34788999999999999999999999643 23344555555
Q ss_pred cCCCCCC--------------------ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 233 NAPPGLD--------------------YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 233 ~~~~~~~--------------------~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
..+.... ......++..+.+||.+||..||.+||++.+++++
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 4433211 11124567889999999999999999999998653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=361.37 Aligned_cols=253 Identities=26% Similarity=0.421 Sum_probs=211.7
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCccc------HHHHHHHHHHHHhCCCCCceeeeeEEE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNND------LDGIRREVQTMRVTNHPNVLRAHCSFT 82 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~------~~~i~~Ei~iL~~L~HpNIVkl~~~~~ 82 (671)
..+..++|++.+.||+|+||+||+|.+..+++.||||++........ ...+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (287)
T 4f0f_A 14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH 93 (287)
T ss_dssp CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence 45677899999999999999999999999999999999875543322 267899999999999999999999998
Q ss_pred eCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCCcEEEcCCCc-----eEE
Q 005886 83 TGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHG--HIHRDVKAGNILIDSNGA-----IKL 155 (671)
Q Consensus 83 ~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~g--IVHrDLKPeNILld~~g~-----vKL 155 (671)
+.. ++||||+.||+|.+.+... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++. +||
T Consensus 94 ~~~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 94 NPP--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp TTT--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred CCC--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 776 6899999999999988754 356999999999999999999999999 999999999999988776 999
Q ss_pred eccccccccccCCCcccccccccCCCCCCChhHhhh-ccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHH--HHHHHh
Q 005886 156 ADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQ-LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKV--LLMTLQ 232 (671)
Q Consensus 156 ~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~-~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~--~~~~~~ 232 (671)
+|||++.... .......||+.|+|||++.+ ...++.++|||||||++|+|++|..||........ ......
T Consensus 171 ~Dfg~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 244 (287)
T 4f0f_A 171 ADFGLSQQSV------HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244 (287)
T ss_dssp CCCTTCBCCS------SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH
T ss_pred CCCCcccccc------ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc
Confidence 9999986432 12344689999999999843 24478899999999999999999999987654433 222222
Q ss_pred cCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 233 NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 233 ~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
. ......+..+++.+.+||.+||..||.+|||+.++++
T Consensus 245 ~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 245 E---GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp S---CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred c---CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 2 1222345678999999999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=360.59 Aligned_cols=257 Identities=23% Similarity=0.390 Sum_probs=217.8
Q ss_pred ccccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC
Q 005886 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH 85 (671)
Q Consensus 6 e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~ 85 (671)
++.|.+..++|++++.||+|+||.||+|.+. ++..||||++.... ...+.+.+|+.+++.++||||+++++++.. +
T Consensus 5 ~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 80 (279)
T 1qpc_A 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (279)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred hhhcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-C
Confidence 5678899999999999999999999999975 56789999986543 345788999999999999999999999875 4
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
.+|+||||+.|++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 58999999999999999865422368999999999999999999999999999999999999999999999999987653
Q ss_pred cCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccc
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (671)
... ........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+.... ....+.
T Consensus 161 ~~~--~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~ 233 (279)
T 1qpc_A 161 DNE--YTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY----RMVRPD 233 (279)
T ss_dssp SSC--EECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC----CCCCCT
T ss_pred Ccc--cccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc----CCCCcc
Confidence 221 122334567889999999986 568999999999999999999 999999887766555444432 223355
Q ss_pred cchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 245 RFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 245 ~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.++..+.+||.+||..||.+|||+.++++
T Consensus 234 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 234 NCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 78899999999999999999999999976
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=387.17 Aligned_cols=251 Identities=22% Similarity=0.390 Sum_probs=216.3
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC-
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH- 85 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~- 85 (671)
..|.+..++|++.+.||+|+||.||+|.+. |+.||||++.... ..+.+.+|+.+|+.++||||+++++++....
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 260 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 260 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC
Confidence 457889999999999999999999999875 7899999997543 4567899999999999999999999987665
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
.+|+|||||.||+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 79999999999999999987754558999999999999999999999999999999999999999999999999986432
Q ss_pred cCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccc
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (671)
. ......+++.|+|||++.+ ..++.++|||||||++|||++ |..||.+....+....+.... ....+.
T Consensus 341 ~------~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~----~~~~p~ 409 (450)
T 1k9a_A 341 S------TQDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----KMDAPD 409 (450)
T ss_dssp ------------CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC----CCCCCT
T ss_pred c------cccCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----CCCCCC
Confidence 1 1123367899999999987 679999999999999999998 999999877666555544432 334456
Q ss_pred cchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 245 RFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 245 ~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.+++.+.+||.+||..||.+|||+.+++.
T Consensus 410 ~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 410 GCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 78999999999999999999999999975
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=373.31 Aligned_cols=258 Identities=22% Similarity=0.310 Sum_probs=206.1
Q ss_pred ccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC--
Q 005886 8 RFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH-- 85 (671)
Q Consensus 8 ~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~-- 85 (671)
.+.+..++|++.+.||+|+||+||+|++. |+.||||++.... .......+|+.+++.++||||+++++++....
T Consensus 18 n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (322)
T 3soc_A 18 NLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV 93 (322)
T ss_dssp CEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred ccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence 35678899999999999999999999876 8999999986442 23445667899999999999999999998743
Q ss_pred --EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC----------CcccccCCCCcEEEcCCCce
Q 005886 86 --CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH----------GHIHRDVKAGNILIDSNGAI 153 (671)
Q Consensus 86 --~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~----------gIVHrDLKPeNILld~~g~v 153 (671)
.+|+|||||.+|+|.+++... .+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+
T Consensus 94 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~ 170 (322)
T 3soc_A 94 DVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170 (322)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred CceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeE
Confidence 589999999999999999764 599999999999999999999999 99999999999999999999
Q ss_pred EEeccccccccccCCCcccccccccCCCCCCChhHhhhc----cCCCccchhhhHHHHHHHHHhCCCCCCCCCh------
Q 005886 154 KLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQL----HGYDFKADIWSFGITALELAHGHAPFSKYPP------ 223 (671)
Q Consensus 154 KL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~----~~~s~ksDIWSLGvILyeLltG~~PF~~~~~------ 223 (671)
||+|||+++.+.... ........+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+...
T Consensus 171 kL~DFg~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 249 (322)
T 3soc_A 171 CIADFGLALKFEAGK-SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249 (322)
T ss_dssp EECCCTTCEEECTTS-CCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred EEccCCccccccccc-CccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence 999999987653322 22233446899999999999863 2356688999999999999999999965321
Q ss_pred ---------HHHHHHHH-hcC-CCCCC-ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 224 ---------MKVLLMTL-QNA-PPGLD-YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 224 ---------~~~~~~~~-~~~-~~~~~-~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
........ ... .+.+. .......+..+.+||.+||..||.+|||+.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11121111 111 11111 1112234567999999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=366.35 Aligned_cols=262 Identities=22% Similarity=0.350 Sum_probs=209.8
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcC---CCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEE
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIP---LNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFT 82 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~---tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~ 82 (671)
..+.+..++|++.+.||+|+||.||+|.+.. ++..||+|++..... ....+.+.+|+.+++.++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 3467788999999999999999999998875 556899999876543 234577899999999999999999999998
Q ss_pred eCC-----EEEEEEeccCCCCHHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCce
Q 005886 83 TGH-----CLWVVMPYMAGGSCLHIMKSA----YPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAI 153 (671)
Q Consensus 83 ~~~-----~l~LVmEy~~ggsL~~~l~~~----~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~v 153 (671)
... .+|+||||+.+|+|..++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCE
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcE
Confidence 755 359999999999999998542 23569999999999999999999999999999999999999999999
Q ss_pred EEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 005886 154 KLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQ 232 (671)
Q Consensus 154 KL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~ 232 (671)
||+|||++....... .........|++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+............
T Consensus 187 kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 264 (313)
T 3brb_A 187 CVADFGLSKKIYSGD-YYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264 (313)
T ss_dssp EECSCSCC-----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred EEeecCcceeccccc-ccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc
Confidence 999999987553221 1122334567889999999987 679999999999999999999 9999998877666655554
Q ss_pred cCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 233 NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 233 ~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
.... ..+..++..+.+||.+||..||.+|||+.+++++
T Consensus 265 ~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 265 GHRL----KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp TCCC----CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCC----CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4322 3356788999999999999999999999999873
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=374.44 Aligned_cols=258 Identities=21% Similarity=0.335 Sum_probs=214.3
Q ss_pred cCCCCeEEEEEecccCceEEEEEE----EcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEE--eC
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRAL----CIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFT--TG 84 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~----~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~--~~ 84 (671)
+..++|++++.||+|+||.||+|. +..+++.||||++.... ....+.+.+|+.+++.++||||+++++++. ..
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 567899999999999999999999 46789999999986542 334567899999999999999999999987 56
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccc
Q 005886 85 HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACM 164 (671)
Q Consensus 85 ~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~ 164 (671)
..+|+||||+.|++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred ceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 67999999999999999997642 45999999999999999999999999999999999999999999999999998766
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChH--------------HHHHHH
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM--------------KVLLMT 230 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~--------------~~~~~~ 230 (671)
..............||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ......
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 433333333445678999999999987 56899999999999999999999998643221 111112
Q ss_pred HhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 231 LQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 231 ~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
+.. ......+..++..+.+||.+||..||.+|||+.+++++
T Consensus 257 ~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 257 LEE---GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHT---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhc---ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 221 22333456789999999999999999999999999763
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=362.40 Aligned_cols=247 Identities=23% Similarity=0.399 Sum_probs=210.2
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe----------
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT---------- 83 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~---------- 83 (671)
.+|++.+.||+|+||.||+|.+..+|+.||+|++.... ..+.+|+.+++.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 57999999999999999999999999999999986543 356789999999999999999999865
Q ss_pred ------CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEec
Q 005886 84 ------GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLAD 157 (671)
Q Consensus 84 ------~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~D 157 (671)
...+|+||||+.+|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~D 165 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGD 165 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECC
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECc
Confidence 45689999999999999999876556799999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC
Q 005886 158 FGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG 237 (671)
Q Consensus 158 FGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~ 237 (671)
||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... . ....+...
T Consensus 166 fg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~-~~~~~~~~--- 234 (284)
T 2a19_B 166 FGLVTSLKNDG----KRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETS--K-FFTDLRDG--- 234 (284)
T ss_dssp CTTCEESSCCS----CCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--H-HHHHHHTT---
T ss_pred chhheeccccc----cccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhHH--H-HHHHhhcc---
Confidence 99987653321 2334579999999999987 568999999999999999999999875321 1 22222211
Q ss_pred CCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccc
Q 005886 238 LDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKH 279 (671)
Q Consensus 238 ~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~ 279 (671)
..+..++..+++||.+||..||.+|||+.++++|.|...
T Consensus 235 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 235 ---IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred ---cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 113457889999999999999999999999999988754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=388.07 Aligned_cols=256 Identities=23% Similarity=0.417 Sum_probs=218.7
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 86 (671)
..+.+..++|++.+.||+|+||.||+|.+. .+..||||++.... ...+.+.+|+.+|+.++||||+++++++. ...
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~ 256 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEP 256 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence 457788899999999999999999999986 46789999997543 34678999999999999999999999987 567
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
+|+|||||.+|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 89999999999999999754334688999999999999999999999999999999999999999999999999976532
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (671)
. .........+|+.|+|||++.+ ..++.++|||||||++|||++ |..||.+....+....+.... ..+.+..
T Consensus 337 ~--~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~----~~~~~~~ 409 (454)
T 1qcf_A 337 N--EYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY----RMPRPEN 409 (454)
T ss_dssp H--HHHTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC----CCCCCTT
T ss_pred C--ceeccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----CCCCCCC
Confidence 1 1112233456888999999987 569999999999999999999 999999988777665555432 2334567
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 246 FSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 246 ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
++..+.+||.+||..||.+|||+.+|+.
T Consensus 410 ~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 410 CPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 8999999999999999999999999975
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=362.12 Aligned_cols=261 Identities=26% Similarity=0.455 Sum_probs=204.9
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH 85 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~ 85 (671)
....+..++|++.+.||+|+||+||+|.+. ..||+|++..... ......+.+|+.+++.++||||+++++++ ...
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 92 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP 92 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCC
Confidence 457889999999999999999999999764 3599999976543 23467889999999999999999999965 455
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
.+++||||+.|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred ccEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccc
Confidence 689999999999999988644 3569999999999999999999999999999999999999999999999999986543
Q ss_pred cCCCcccccccccCCCCCCChhHhhh--ccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-ccc
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQ--LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD-YER 242 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~--~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~-~~~ 242 (671)
... .........||+.|+|||++.. ...++.++|||||||++|+|++|..||.+..........+........ ...
T Consensus 172 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (289)
T 3og7_A 172 RWS-GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV 250 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSS
T ss_pred ccc-ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhc
Confidence 211 1223345679999999999862 255888999999999999999999999887666655555443322211 223
Q ss_pred cccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 243 DKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 243 ~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
...+++.+.+||.+||..||.+|||+.++++
T Consensus 251 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 251 RSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 4568899999999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=360.75 Aligned_cols=253 Identities=22% Similarity=0.381 Sum_probs=208.0
Q ss_pred cccccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeC
Q 005886 5 VEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG 84 (671)
Q Consensus 5 ~e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~ 84 (671)
....|.+..++|++.+.||+|+||.||+|.+. |+.||||++... ...+.+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (278)
T 1byg_A 12 YRSGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 86 (278)
T ss_dssp ---CCBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred hhccccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch---hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 34567889999999999999999999999875 889999998643 2457789999999999999999999997654
Q ss_pred -CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccc
Q 005886 85 -HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSAC 163 (671)
Q Consensus 85 -~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~ 163 (671)
..+|+||||+.|++|.+++.......+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++..
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~ 166 (278)
T 1byg_A 87 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 166 (278)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccc
Confidence 4789999999999999999765323489999999999999999999999999999999999999999999999999864
Q ss_pred cccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccc
Q 005886 164 MFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYER 242 (671)
Q Consensus 164 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~ 242 (671)
... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||...........+.... ....
T Consensus 167 ~~~------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~----~~~~ 235 (278)
T 1byg_A 167 ASS------TQDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----KMDA 235 (278)
T ss_dssp ---------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC----CCCC
T ss_pred ccc------cccCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC----CCCC
Confidence 421 1223467899999999987 678999999999999999998 999998877665554443332 2334
Q ss_pred cccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 243 DKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 243 ~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
+..+++.+.+||.+||..||.+|||+.++++
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 236 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 5678999999999999999999999999976
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=386.73 Aligned_cols=265 Identities=26% Similarity=0.332 Sum_probs=203.2
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeeeEEEeCCEE
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHCSFTTGHCL 87 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~~~l 87 (671)
+.+...+|.+.+.||+|+||+||. ....+|+.||||++..... ..+.+|+.+|+.+ +|||||++++++.+...+
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 93 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQ 93 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred EEEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence 455667799999999999999763 3456799999999864332 2356899999998 799999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcC---C--CceEEecccccc
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS---N--GAIKLADFGVSA 162 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~---~--g~vKL~DFGls~ 162 (671)
|||||||. |+|.+++.... ..+.+..++.++.||+.||+|||++||+||||||+|||++. + ..+||+|||+++
T Consensus 94 ~lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 94 YIAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred EEEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 99999996 59999987653 34555567899999999999999999999999999999953 2 358899999997
Q ss_pred ccccCCCcccccccccCCCCCCChhHhhh--ccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCC
Q 005886 163 CMFDAGDRQRSRNTFVGTPCWMAPEVMQQ--LHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLD 239 (671)
Q Consensus 163 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~--~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~ 239 (671)
.+.............+||+.|+|||++.+ ...++.++|||||||++|+|++ |..||......... ....... ...
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~~~~~~-~~~ 249 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-ILLGACS-LDC 249 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HHTTCCC-CTT
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HHhccCC-ccc
Confidence 66433222233455789999999999974 2457889999999999999999 99999765443322 2222211 111
Q ss_pred ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 240 YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 240 ~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
.......+..+++||.+||..||.+|||+.++|+||||+...+
T Consensus 250 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~ 292 (432)
T 3p23_A 250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK 292 (432)
T ss_dssp SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHH
T ss_pred cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHH
Confidence 2223445778999999999999999999999999999986543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=360.96 Aligned_cols=258 Identities=23% Similarity=0.340 Sum_probs=211.3
Q ss_pred ccCCCCeEEEEEecccCceEEEEEEEcCCC---cEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEE-eCC
Q 005886 10 PVDAKDYRLYEEVGEGVSATVYRALCIPLN---EIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFT-TGH 85 (671)
Q Consensus 10 ~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg---~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~-~~~ 85 (671)
.....+|++.+.||+|+||.||+|.+..++ ..||+|.+...........+.+|+.+++.++||||+++++++. .+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100 (298)
T ss_dssp CGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred CccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence 334567999999999999999999976443 3589999876554455678999999999999999999999854 566
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
..|+||||+.||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred ceEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccc
Confidence 889999999999999999764 3568999999999999999999999999999999999999999999999999987653
Q ss_pred cCCC-cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 005886 166 DAGD-RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERD 243 (671)
Q Consensus 166 ~~~~-~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (671)
.... .........||+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+................ ..+
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~ 254 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL----LQP 254 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC----CCC
T ss_pred ccchhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC----CCC
Confidence 3221 1122344578889999999987 579999999999999999999 77788777666655555544322 224
Q ss_pred ccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 244 KRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 244 ~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
..++..+.+||.+||..||.+|||+.++++
T Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 255 EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 567899999999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=377.12 Aligned_cols=260 Identities=16% Similarity=0.187 Sum_probs=201.8
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCC-----CcEEEEEEeccccCcc----------cHHHHHHHHHHHHhCCCCCce
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPL-----NEIVAIKVLDLEKCNN----------DLDGIRREVQTMRVTNHPNVL 75 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~t-----g~~VAIKvi~~~~~~~----------~~~~i~~Ei~iL~~L~HpNIV 75 (671)
+..++|++.+.||+|+||+||+|.+..+ ++.||||++....... ....+.+|+..++.+.||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 4456899999999999999999998765 5789999986543110 012233455566778899999
Q ss_pred eeeeEEEeC----CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEc--C
Q 005886 76 RAHCSFTTG----HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILID--S 149 (671)
Q Consensus 76 kl~~~~~~~----~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld--~ 149 (671)
++++++... ..+||||||| |++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++ .
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence 999999874 5689999999 99999999764 35799999999999999999999999999999999999998 8
Q ss_pred CCceEEeccccccccccCCCcc----cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHH
Q 005886 150 NGAIKLADFGVSACMFDAGDRQ----RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK 225 (671)
Q Consensus 150 ~g~vKL~DFGls~~~~~~~~~~----~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~ 225 (671)
++.+||+|||+++.+....... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.....
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 8999999999997664332211 12244579999999999987 569999999999999999999999998643222
Q ss_pred HHHH-HHhcCCCCCCc-----cccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 226 VLLM-TLQNAPPGLDY-----ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 226 ~~~~-~~~~~~~~~~~-----~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.... ........+.. .....++.++.+||..||..||.+||++.+|++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 2111 11110000000 001456899999999999999999999999875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=385.58 Aligned_cols=259 Identities=25% Similarity=0.328 Sum_probs=196.6
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEEEe
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
+.|.+.+.||+|+||+||.+ ...+|+.||||++... ..+.+.+|+.+|+.+ +||||+++++++.++..+|+|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred heeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 44556788999999999875 4567999999998643 245678999999876 89999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCC-----CCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCC-------------CceE
Q 005886 93 YMAGGSCLHIMKSAYPEG-----FEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSN-------------GAIK 154 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~-----l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~-------------g~vK 154 (671)
||. |+|.+++....... ..+..++.++.||+.||+|||++||+||||||+|||++.+ +.+|
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 996 59999997652211 1233467899999999999999999999999999999754 4899
Q ss_pred EeccccccccccCCCc-ccccccccCCCCCCChhHhhh------ccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHH
Q 005886 155 LADFGVSACMFDAGDR-QRSRNTFVGTPCWMAPEVMQQ------LHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKV 226 (671)
Q Consensus 155 L~DFGls~~~~~~~~~-~~~~~~~~GT~~Y~APEvl~~------~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~ 226 (671)
|+|||++..+...... .......+||+.|+|||++.+ ...++.++|||||||++|+|++ |..||.+......
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~ 248 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH
Confidence 9999998766332211 112335689999999999965 2458999999999999999999 9999976544332
Q ss_pred HHHHHhcC--CCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 227 LLMTLQNA--PPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 227 ~~~~~~~~--~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
.++... .+......+..++.++++||.+||..||.+|||+.++|+||||+..
T Consensus 249 --~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 249 --NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp --HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred --HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 222221 1112222244578899999999999999999999999999999743
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=356.86 Aligned_cols=255 Identities=19% Similarity=0.238 Sum_probs=205.7
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeE-EEeCCEEEEEE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCS-FTTGHCLWVVM 91 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~-~~~~~~l~LVm 91 (671)
.++|++.+.||+|+||.||+|++..+|+.||||++..... ...+.+|+.+++.+.|++++..+.+ +.....+|+||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS---CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc---hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 4789999999999999999999999999999999865432 2468899999999998886665554 46788899999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEE---cCCCceEEeccccccccccCC
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILI---DSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILl---d~~g~vKL~DFGls~~~~~~~ 168 (671)
||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 85 e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp ECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred Eec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 999 99999999754 3579999999999999999999999999999999999999 478899999999987654332
Q ss_pred Ccc----cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCCCCcc
Q 005886 169 DRQ----RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPP---MKVLLMTLQNAPPGLDYE 241 (671)
Q Consensus 169 ~~~----~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~---~~~~~~~~~~~~~~~~~~ 241 (671)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+... ...+..+...........
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred cccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH
Confidence 211 12345689999999999987 5689999999999999999999999986432 112222211110011111
Q ss_pred ccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 242 RDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 242 ~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
....++..+.+||.+||..||.+|||+.++++
T Consensus 242 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 23567899999999999999999999999876
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=357.94 Aligned_cols=254 Identities=26% Similarity=0.374 Sum_probs=210.7
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCc---EEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEE-EE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNE---IVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCL-WV 89 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~---~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l-~L 89 (671)
-.|.+.+.||+|+||+||+|.+..++. .||+|++.........+.+.+|+.+++.++||||+++++++.+.+.. ++
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 457778999999999999999876554 79999997655445567889999999999999999999999876655 99
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCC
Q 005886 90 VMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~ 169 (671)
||||+.+|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 101 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999999999763 35689999999999999999999999999999999999999999999999999875533221
Q ss_pred -cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccch
Q 005886 170 -RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFS 247 (671)
Q Consensus 170 -~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls 247 (671)
.........||+.|+|||++.+ ..++.++|||||||++|+|++ |.+||...........+..... ...+..++
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 254 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR----LPQPEYCP 254 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC----CCCCTTCC
T ss_pred cccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC----CCCCccch
Confidence 1222344578899999999987 568999999999999999999 5556666665555444443332 22355678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 248 KSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 248 ~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
..+.+||.+||..||.+|||+.++++
T Consensus 255 ~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 255 DSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=372.43 Aligned_cols=261 Identities=21% Similarity=0.319 Sum_probs=212.1
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LV 90 (671)
...++|++.+.||+|+||.||+|.+ .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 113 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI 113 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 3558999999999999999999985 478999999986543 34467899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 91 MPYMAGGSCLHIMKSAYP--EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~--~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
|||+.||+|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 193 (321)
T 2qkw_B 114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD 193 (321)
T ss_dssp EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSS
T ss_pred EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999999998865422 358999999999999999999999999999999999999999999999999986543221
Q ss_pred CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHH------HHHHHhc------CCC
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKV------LLMTLQN------APP 236 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~------~~~~~~~------~~~ 236 (671)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+..+... ....... ..+
T Consensus 194 -~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (321)
T 2qkw_B 194 -QTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP 271 (321)
T ss_dssp -CCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSS
T ss_pred -ccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcCh
Confidence 1222344579999999999987 5689999999999999999999999976433211 0011100 011
Q ss_pred CCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhch
Q 005886 237 GLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHH 275 (671)
Q Consensus 237 ~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hp 275 (671)
.........++..+.+||.+||..||.+|||+.++++|-
T Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 272 NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp SCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 111223445678899999999999999999999999754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=370.00 Aligned_cols=259 Identities=23% Similarity=0.375 Sum_probs=209.5
Q ss_pred cCCCCeEEEEEecccCceEEEEEEE----cCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe--C
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALC----IPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT--G 84 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~----~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~--~ 84 (671)
+..+.|++++.||+|+||+||++.. ..+|+.||||++...........+.+|+.+++.++||||+++++++.+ .
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 3444469999999999999988754 457899999999866544556789999999999999999999999998 4
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccc
Q 005886 85 HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACM 164 (671)
Q Consensus 85 ~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~ 164 (671)
..+|+||||+.+|+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred ceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence 6899999999999999998764 5999999999999999999999999999999999999999999999999998766
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHH-----------HHHHHHhc
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK-----------VLLMTLQN 233 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~-----------~~~~~~~~ 233 (671)
..............||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... ........
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence 433322233445578999999999987 568899999999999999999999996532210 00111111
Q ss_pred CCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 234 APPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 234 ~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.........+..++..+.+||.+||..||.+|||+.++++
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1112233445678999999999999999999999999985
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=359.89 Aligned_cols=255 Identities=27% Similarity=0.464 Sum_probs=201.1
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWV 89 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~L 89 (671)
..++|++.+.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.+++.++||||+++++++.....+|+
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 45689999999999999999999999999999999975432 2345778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccC
Q 005886 90 VMPYMAGGSCLHIMKSA--YPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~--~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~ 167 (671)
||||+.+++|.+++... ....+++..++.++.||+.||.|||++|++||||||+|||++.+|.+||+|||++......
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 99999999999988652 2356899999999999999999999999999999999999999999999999998654321
Q ss_pred CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhcCCCCCCcccccc
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPP--MKVLLMTLQNAPPGLDYERDKR 245 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 245 (671)
........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... ......+..... .......
T Consensus 190 ---~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 262 (310)
T 2wqm_A 190 ---TTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY---PPLPSDH 262 (310)
T ss_dssp ------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCS---CCCCTTT
T ss_pred ---CccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccC---CCCcccc
Confidence 122334579999999999987 5689999999999999999999999976432 222222222211 1122356
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 246 FSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 246 ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
++.++.+||.+||..||.+|||+.++++
T Consensus 263 ~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 263 YSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 7899999999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=357.20 Aligned_cols=255 Identities=19% Similarity=0.249 Sum_probs=202.5
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEE-EeCCEEEEEE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSF-TTGHCLWVVM 91 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~-~~~~~l~LVm 91 (671)
.++|++.+.||+|+||.||+|.+..+|+.||||++...... ..+.+|+.+++.+.|++++..+..+ ......++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C---CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc---hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 37899999999999999999999999999999987654322 3477899999999888776665544 6788999999
Q ss_pred eccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEE---cCCCceEEeccccccccccCC
Q 005886 92 PYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILI---DSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 92 Ey~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILl---d~~g~vKL~DFGls~~~~~~~ 168 (671)
||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 85 e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp ECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred Ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 999 99999998754 2569999999999999999999999999999999999999 788999999999997654332
Q ss_pred Ccc----cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChH---HHHHHHHhcCCCCCCcc
Q 005886 169 DRQ----RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM---KVLLMTLQNAPPGLDYE 241 (671)
Q Consensus 169 ~~~----~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~---~~~~~~~~~~~~~~~~~ 241 (671)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.... .....+...........
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred cCccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh
Confidence 211 22345689999999999987 56899999999999999999999999764322 11111111110011111
Q ss_pred ccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 242 RDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 242 ~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
....++..+.+||.+||..||.+|||+.++++
T Consensus 242 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 23567899999999999999999999999976
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=373.74 Aligned_cols=259 Identities=17% Similarity=0.191 Sum_probs=202.0
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcC---CCcEEEEEEeccccCcc----------cHHHHHHHHHHHHhCCCCCceee
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIP---LNEIVAIKVLDLEKCNN----------DLDGIRREVQTMRVTNHPNVLRA 77 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~---tg~~VAIKvi~~~~~~~----------~~~~i~~Ei~iL~~L~HpNIVkl 77 (671)
+..++|++.+.||+|+||.||+|.+.. ++..||||++....... ....+.+|+..++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 456789999999999999999999987 78899999987543210 12346678889999999999999
Q ss_pred eeEEEe----CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC--
Q 005886 78 HCSFTT----GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG-- 151 (671)
Q Consensus 78 ~~~~~~----~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g-- 151 (671)
++++.. ...+|+||||| |++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence 999988 78999999999 99999998765 4799999999999999999999999999999999999998877
Q ss_pred ceEEeccccccccccCCCc----ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCC-hHHH
Q 005886 152 AIKLADFGVSACMFDAGDR----QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYP-PMKV 226 (671)
Q Consensus 152 ~vKL~DFGls~~~~~~~~~----~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~-~~~~ 226 (671)
.+||+|||+++.+...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.. ....
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 9999999999766432211 112245689999999999987 568999999999999999999999996532 2221
Q ss_pred HHHHHhcCCCCCCcc-----ccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 227 LLMTLQNAPPGLDYE-----RDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 227 ~~~~~~~~~~~~~~~-----~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
...........+... ....++.++.+||.+||..||.+||++.++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 211111111111110 01267889999999999999999999999976
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=362.07 Aligned_cols=237 Identities=26% Similarity=0.414 Sum_probs=194.8
Q ss_pred CCCeEEE-EEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHH-HhCCCCCceeeeeEEEe----CCE
Q 005886 13 AKDYRLY-EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTM-RVTNHPNVLRAHCSFTT----GHC 86 (671)
Q Consensus 13 ~~~Y~l~-~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL-~~L~HpNIVkl~~~~~~----~~~ 86 (671)
.++|.+. +.||+|+||.||+|.+..+|+.||||++.. ...+.+|+.++ +.+.||||++++++|.. ...
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 4678887 789999999999999999999999999853 24677888888 67799999999999987 778
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcC---CCceEEeccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS---NGAIKLADFGVSAC 163 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~---~g~vKL~DFGls~~ 163 (671)
+|+||||+.||+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 999999999999999998865567999999999999999999999999999999999999998 78999999998753
Q ss_pred cccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc---CCCCCCc
Q 005886 164 MFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQN---APPGLDY 240 (671)
Q Consensus 164 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~---~~~~~~~ 240 (671)
.. + ..|+.++|||||||++|+|++|..||.+............. ....+..
T Consensus 170 ~~-------------------------~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (299)
T 3m2w_A 170 TT-------------------------G-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 223 (299)
T ss_dssp CT-------------------------T-CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCH
T ss_pred cc-------------------------c-ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCc
Confidence 31 0 23678899999999999999999999775543322111111 1111112
Q ss_pred cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 241 ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 241 ~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
..+..++.++++||.+||..||.+|||+.++|+||||+...
T Consensus 224 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred hhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 22356899999999999999999999999999999998654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=369.83 Aligned_cols=262 Identities=24% Similarity=0.364 Sum_probs=209.0
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEE----eC
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFT----TG 84 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~----~~ 84 (671)
+.+..++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+|+.+++.++||||+++++++. ..
T Consensus 24 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp EEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred EEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 5677889999999999999999999999999999999986432 344678899999999999999999999997 34
Q ss_pred CEEEEEEeccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccc
Q 005886 85 HCLWVVMPYMAGGSCLHIMKSA--YPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSA 162 (671)
Q Consensus 85 ~~l~LVmEy~~ggsL~~~l~~~--~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~ 162 (671)
..+|+||||+.+|+|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 5789999999999999988763 23569999999999999999999999999999999999999999999999999876
Q ss_pred ccccCCCcc------cccccccCCCCCCChhHhhhcc--CCCccchhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHhc
Q 005886 163 CMFDAGDRQ------RSRNTFVGTPCWMAPEVMQQLH--GYDFKADIWSFGITALELAHGHAPFSKYPPM-KVLLMTLQN 233 (671)
Q Consensus 163 ~~~~~~~~~------~~~~~~~GT~~Y~APEvl~~~~--~~s~ksDIWSLGvILyeLltG~~PF~~~~~~-~~~~~~~~~ 233 (671)
......... .......||+.|+|||++.+.. .++.++|||||||++|+|++|..||...... .........
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 262 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN 262 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc
Confidence 542111100 0112346899999999987522 2688999999999999999999999532110 011111222
Q ss_pred CCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 234 APPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 234 ~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
....+....++..+.+||.+||..||.+|||+.+++++
T Consensus 263 ---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 263 ---QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp ---C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 12223345688999999999999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=360.34 Aligned_cols=259 Identities=24% Similarity=0.373 Sum_probs=207.5
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcC-CCc--EEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEe
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIP-LNE--IVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTT 83 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~-tg~--~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~ 83 (671)
..+..++|++.+.||+|+||+||+|.+.. ++. .||||++..... ....+.+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence 34567899999999999999999998653 333 689999875432 2346788999999999999999999999987
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccc
Q 005886 84 GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSAC 163 (671)
Q Consensus 84 ~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~ 163 (671)
.. .++||||+.+++|.+++... ...+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++..
T Consensus 93 ~~-~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 93 PP-MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp SS-CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred CC-ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccc
Confidence 76 88999999999999998764 24689999999999999999999999999999999999999999999999999876
Q ss_pred cccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccc
Q 005886 164 MFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYER 242 (671)
Q Consensus 164 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~ 242 (671)
...............||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+..... ....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~ 246 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE---RLPR 246 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC---CCCC
T ss_pred ccccccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCC---CCCC
Confidence 6433332223344568889999999987 568899999999999999999 9999998887766655544322 2234
Q ss_pred cccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 243 DKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 243 ~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
+..++..+.+||.+||..||.+|||+.++++
T Consensus 247 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 247 PEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 5678999999999999999999999999987
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=395.70 Aligned_cols=260 Identities=23% Similarity=0.356 Sum_probs=214.5
Q ss_pred cccccCCCCeEEEE-EecccCceEEEEEEEc--CCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe
Q 005886 7 KRFPVDAKDYRLYE-EVGEGVSATVYRALCI--PLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT 83 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~-~LG~G~fG~Vyka~~~--~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~ 83 (671)
..+.+..++|.+.+ .||+|+||.||+|.+. .++..||||++.........+.+.+|+.+|+.++|||||++++++..
T Consensus 328 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 407 (613)
T 2ozo_A 328 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 407 (613)
T ss_dssp CCSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred cceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence 34556677788877 8999999999999876 35667999999766555567889999999999999999999999986
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccc
Q 005886 84 GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSAC 163 (671)
Q Consensus 84 ~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~ 163 (671)
+.+|+|||||.||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 408 -~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 408 -EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKA 485 (613)
T ss_dssp -SSEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred -CCeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence 4699999999999999998654 35699999999999999999999999999999999999999999999999999976
Q ss_pred cccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccc
Q 005886 164 MFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYER 242 (671)
Q Consensus 164 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~ 242 (671)
+..............+|+.|+|||++.+ ..++.++|||||||++|||++ |..||.+....+....+.... ....
T Consensus 486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~----~~~~ 560 (613)
T 2ozo_A 486 LGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK----RMEC 560 (613)
T ss_dssp CC--------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC----CCCC
T ss_pred ccCCCceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC----CCCC
Confidence 5332222222233456789999999987 679999999999999999998 999999988777665555443 2234
Q ss_pred cccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 243 DKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 243 ~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
+..++.++.+||.+||..||.+||++.++++
T Consensus 561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 5678999999999999999999999999854
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=371.15 Aligned_cols=266 Identities=24% Similarity=0.326 Sum_probs=211.9
Q ss_pred ccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q 005886 8 RFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCL 87 (671)
Q Consensus 8 ~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l 87 (671)
.+.+..++|++.+.||+|+||.||+|.+ .+|+.||||++...........+.+|+.+++.++||||+++++++.+....
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 102 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence 3556778999999999999999999974 468999999997665444445789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCCCcEEEcCCCceEEecccccc
Q 005886 88 WVVMPYMAGGSCLHIMKSAYP--EGFEEPVIATLLRETLKALVYLHFH---GHIHRDVKAGNILIDSNGAIKLADFGVSA 162 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~--~~l~e~~i~~i~~qIl~aL~yLHs~---gIVHrDLKPeNILld~~g~vKL~DFGls~ 162 (671)
++||||+.||+|.+++..... ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++.
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 182 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence 999999999999999986532 3489999999999999999999999 99999999999999999999999999987
Q ss_pred ccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCC----ChHHHHHHHHhcC----
Q 005886 163 CMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKY----PPMKVLLMTLQNA---- 234 (671)
Q Consensus 163 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~----~~~~~~~~~~~~~---- 234 (671)
...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||... .............
T Consensus 183 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 259 (326)
T 3uim_A 183 LMDYKD--THVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259 (326)
T ss_dssp ECCSSS--SCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSC
T ss_pred ccCccc--ccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhch
Confidence 553222 222344579999999999987 55899999999999999999999999521 0000011111110
Q ss_pred ------CCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 235 ------PPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 235 ------~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
............+..+.+||.+||..||.+|||+.++++|-+-
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 260 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp CSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 0111112234456889999999999999999999999987653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=384.64 Aligned_cols=257 Identities=25% Similarity=0.403 Sum_probs=214.3
Q ss_pred ccccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC
Q 005886 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH 85 (671)
Q Consensus 6 e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~ 85 (671)
...|.+..++|++.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.+|+.++||||+++++++.+ .
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 251 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence 45678888999999999999999999999875 4669999987543 335788999999999999999999999876 6
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
.+|+|||||.||+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 78999999999999999975433568999999999999999999999999999999999999999999999999987653
Q ss_pred cCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccc
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (671)
... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+.... ..+.+.
T Consensus 332 ~~~--~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~----~~~~~~ 404 (452)
T 1fmk_A 332 DNE--YTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY----RMPCPP 404 (452)
T ss_dssp -------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC----CCCCCT
T ss_pred CCc--eecccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----CCCCCC
Confidence 221 122234467889999999987 569999999999999999999 999999988777665554432 233456
Q ss_pred cchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 245 RFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 245 ~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.++..+.+||.+||..||.+|||+++++.
T Consensus 405 ~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 405 ECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 78999999999999999999999999976
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=361.30 Aligned_cols=253 Identities=27% Similarity=0.390 Sum_probs=200.4
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHh--CCCCCceeeeeEEEe----CC
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRV--TNHPNVLRAHCSFTT----GH 85 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~--L~HpNIVkl~~~~~~----~~ 85 (671)
..++|++.+.||+|+||+||+|.+ +|+.||||++... ....+.+|.+++.. ++||||+++++++.. ..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 457899999999999999999987 5899999998643 34556667777766 799999999998754 35
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCcccccCCCCcEEEcCCCceEEec
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLH--------FHGHIHRDVKAGNILIDSNGAIKLAD 157 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLH--------s~gIVHrDLKPeNILld~~g~vKL~D 157 (671)
.+|+||||+.+|+|.+++.. ..+++..++.++.||+.||+||| ++||+||||||+|||++.++.+||+|
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred eeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEee
Confidence 68999999999999999954 47999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccCCCcc-cccccccCCCCCCChhHhhhcc-----CCCccchhhhHHHHHHHHHhC----------CCCCCCC
Q 005886 158 FGVSACMFDAGDRQ-RSRNTFVGTPCWMAPEVMQQLH-----GYDFKADIWSFGITALELAHG----------HAPFSKY 221 (671)
Q Consensus 158 FGls~~~~~~~~~~-~~~~~~~GT~~Y~APEvl~~~~-----~~s~ksDIWSLGvILyeLltG----------~~PF~~~ 221 (671)
||+++......... ......+||+.|+|||++.+.. .++.++|||||||++|+|++| ..||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99987654332221 1233458999999999998632 244789999999999999999 8888653
Q ss_pred Ch----HHHHHHHHhcC--CCCCC-ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 222 PP----MKVLLMTLQNA--PPGLD-YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 222 ~~----~~~~~~~~~~~--~~~~~-~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.. ........... .+... ......++..+.+||.+||..||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 237 VPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 22 22222222111 11111 1112346788999999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=371.48 Aligned_cols=254 Identities=16% Similarity=0.239 Sum_probs=206.3
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCC--------CcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCcee-------
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPL--------NEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLR------- 76 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~t--------g~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVk------- 76 (671)
..++|++.+.||+|+||.||+|.+..+ ++.||||++... ..+.+|+.+++.+.||||++
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 458999999999999999999999874 889999998643 35789999999999999988
Q ss_pred --------eeeEEEe-CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEE
Q 005886 77 --------AHCSFTT-GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILI 147 (671)
Q Consensus 77 --------l~~~~~~-~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILl 147 (671)
+++++.. +..+|+||||+ |++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 6677776 78999999999 9999999987534579999999999999999999999999999999999999
Q ss_pred cCCC--ceEEeccccccccccCCCc----ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCC
Q 005886 148 DSNG--AIKLADFGVSACMFDAGDR----QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKY 221 (671)
Q Consensus 148 d~~g--~vKL~DFGls~~~~~~~~~----~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~ 221 (671)
+.++ .+||+|||+++.+...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 9998 8999999999765432221 112244589999999999987 56999999999999999999999999875
Q ss_pred C-hHHHHHHHH---hcCCCCCC--ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 222 P-PMKVLLMTL---QNAPPGLD--YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 222 ~-~~~~~~~~~---~~~~~~~~--~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
. ......... ...+..+. ...+..++..+.+||.+||..||.+||++.++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 4 222222222 11111111 1123467899999999999999999999999976
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=395.52 Aligned_cols=258 Identities=22% Similarity=0.317 Sum_probs=211.8
Q ss_pred ccccCCCCeEEEE-EecccCceEEEEEEE--cCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEe
Q 005886 8 RFPVDAKDYRLYE-EVGEGVSATVYRALC--IPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTT 83 (671)
Q Consensus 8 ~~~i~~~~Y~l~~-~LG~G~fG~Vyka~~--~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~ 83 (671)
.+.++.+.+.+.. .||+|+||+||+|.+ +.+++.||||++..... ....+.+.+|+.+|+.++|||||++++++..
T Consensus 362 ~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 441 (635)
T 4fl3_A 362 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA 441 (635)
T ss_dssp SSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred cccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3455556666654 799999999999955 46678999999975543 2346789999999999999999999999975
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccc
Q 005886 84 GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSAC 163 (671)
Q Consensus 84 ~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~ 163 (671)
+ .+++|||||.||+|.+++... ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++.
T Consensus 442 ~-~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 518 (635)
T 4fl3_A 442 E-SWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 518 (635)
T ss_dssp S-SEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHH
T ss_pred C-CEEEEEEccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccc
Confidence 4 588999999999999999765 6799999999999999999999999999999999999999999999999999976
Q ss_pred cccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccc
Q 005886 164 MFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYER 242 (671)
Q Consensus 164 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~ 242 (671)
+..............||+.|+|||++.+ ..|+.++|||||||++|||++ |..||.+....+....+..... ...
T Consensus 519 ~~~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~----~~~ 593 (635)
T 4fl3_A 519 LRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER----MGC 593 (635)
T ss_dssp TTC-------------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----CCC
T ss_pred cccCccccccccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----CCC
Confidence 6433322233334567889999999987 679999999999999999998 9999999888776655554432 233
Q ss_pred cccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 243 DKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 243 ~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
+..++.++.+||.+||..||.+||++.++++
T Consensus 594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 594 PAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 5678999999999999999999999999975
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=369.13 Aligned_cols=254 Identities=15% Similarity=0.125 Sum_probs=205.0
Q ss_pred cccccCCCCeEEEEEecccCceEEEEE-----EEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCC---CCCceeee
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRA-----LCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN---HPNVLRAH 78 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka-----~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~---HpNIVkl~ 78 (671)
..+.+..++|++.+.||+|+||+||+| .+..+++.||||++... ....+.+|+.+++.+. |+||++++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~ 133 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFY 133 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 456677889999999999999999999 46788999999998643 3457788888888887 99999999
Q ss_pred eEEEeCCEEEEEEeccCCCCHHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcC------
Q 005886 79 CSFTTGHCLWVVMPYMAGGSCLHIMKSA---YPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS------ 149 (671)
Q Consensus 79 ~~~~~~~~l~LVmEy~~ggsL~~~l~~~---~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~------ 149 (671)
+++...+..|+|||||.||+|.+++... ....+++..++.++.||+.||+|||++|||||||||+|||++.
T Consensus 134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-
T ss_pred eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc
Confidence 9999999999999999999999999753 2356999999999999999999999999999999999999988
Q ss_pred -----CCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChH
Q 005886 150 -----NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM 224 (671)
Q Consensus 150 -----~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~ 224 (671)
++.+||+|||+|+.+... .........+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||......
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 291 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLF-PKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGS-CTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred ccccccCCEEEeeCchhhhhhcc-CCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence 899999999999755322 12233455789999999999987 56999999999999999999999999643221
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhch
Q 005886 225 KVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHH 275 (671)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hp 275 (671)
.. .+... +. ....+..+.+++..||..+|.+|++..+.|.+.
T Consensus 292 ~~---~~~~~---~~---~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 292 EC---KPEGL---FR---RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp EE---EECSC---CT---TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred ce---eechh---cc---ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 10 00000 00 112467889999999999999997655555543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=373.97 Aligned_cols=256 Identities=23% Similarity=0.345 Sum_probs=202.7
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCC---cEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEE-eCCEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLN---EIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFT-TGHCL 87 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg---~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~-~~~~l 87 (671)
....|++.+.||+|+||+||+|.+..++ ..||+|.+...........+.+|+.+++.++||||+++++++. .++.+
T Consensus 87 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp TTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred hhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 3345889999999999999999976443 4689999875544455788999999999999999999999865 45688
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccC
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~ 167 (671)
|+||||+.||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus 167 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 9999999999999999754 346889999999999999999999999999999999999999999999999998765332
Q ss_pred CCc-ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Q 005886 168 GDR-QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245 (671)
Q Consensus 168 ~~~-~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (671)
... ........||+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+....+..... ...+..
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~----~~~p~~ 320 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR----LLQPEY 320 (373)
T ss_dssp ------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC----CCCCTT
T ss_pred ccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC----CCCCCC
Confidence 211 112234567889999999987 679999999999999999999 7889987766555544444322 223456
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 246 FSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 246 ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
++..+.+||.+||..||.+|||+.++++
T Consensus 321 ~~~~l~~li~~cl~~dp~~RPs~~ell~ 348 (373)
T 3c1x_A 321 CPDPLYEVMLKCWHPKAEMRPSFSELVS 348 (373)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 8899999999999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=357.70 Aligned_cols=246 Identities=28% Similarity=0.479 Sum_probs=200.9
Q ss_pred ccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q 005886 10 PVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWV 89 (671)
Q Consensus 10 ~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~L 89 (671)
.++.++|++.+.||+|+||+||+|.+. ++.||||++... .....+.+|+.+++.++||||+++++++.+. .|+
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~l 76 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCL 76 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCTTT--TEE
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--cEE
Confidence 467789999999999999999999875 788999998533 3457789999999999999999999988744 789
Q ss_pred EEeccCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCCCcEEEcCCCc-eEEecccccccc
Q 005886 90 VMPYMAGGSCLHIMKSAYP-EGFEEPVIATLLRETLKALVYLHF---HGHIHRDVKAGNILIDSNGA-IKLADFGVSACM 164 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~~~-~~l~e~~i~~i~~qIl~aL~yLHs---~gIVHrDLKPeNILld~~g~-vKL~DFGls~~~ 164 (671)
||||+.||+|.+++..... ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++. +||+|||++...
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 9999999999999986532 247899999999999999999999 89999999999999998886 799999998644
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChH--HHHHHHHhcCCCCCCccc
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM--KVLLMTLQNAPPGLDYER 242 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~--~~~~~~~~~~~~~~~~~~ 242 (671)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ........... ...
T Consensus 157 ~~------~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~ 225 (307)
T 2eva_A 157 QT------HMTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR----PPL 225 (307)
T ss_dssp --------------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC----CCC
T ss_pred cc------ccccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC----CCc
Confidence 21 1233479999999999987 56899999999999999999999999865332 22222222222 233
Q ss_pred cccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 243 DKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 243 ~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
...++..+.+||.+||..||.+|||+.++++
T Consensus 226 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 226 IKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 4568899999999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=362.32 Aligned_cols=261 Identities=21% Similarity=0.306 Sum_probs=192.8
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCC-CCCceeeeeEEE---
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN-HPNVLRAHCSFT--- 82 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~-HpNIVkl~~~~~--- 82 (671)
..+.+...+|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+|+.+++.+. ||||+++++++.
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK 99 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence 456677789999999999999999999999999999999985432 334567889999999995 999999999994
Q ss_pred -----eCCEEEEEEeccCCCCHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCCcEEEcCCCceE
Q 005886 83 -----TGHCLWVVMPYMAGGSCLHIMKSA-YPEGFEEPVIATLLRETLKALVYLHFHG--HIHRDVKAGNILIDSNGAIK 154 (671)
Q Consensus 83 -----~~~~l~LVmEy~~ggsL~~~l~~~-~~~~l~e~~i~~i~~qIl~aL~yLHs~g--IVHrDLKPeNILld~~g~vK 154 (671)
....+|+||||+. |+|.+++... ....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 100 EESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEE
T ss_pred cccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEE
Confidence 4456899999996 6888887652 2356999999999999999999999999 99999999999999999999
Q ss_pred EeccccccccccCCCcc---------cccccccCCCCCCChhHhh--hccCCCccchhhhHHHHHHHHHhCCCCCCCCCh
Q 005886 155 LADFGVSACMFDAGDRQ---------RSRNTFVGTPCWMAPEVMQ--QLHGYDFKADIWSFGITALELAHGHAPFSKYPP 223 (671)
Q Consensus 155 L~DFGls~~~~~~~~~~---------~~~~~~~GT~~Y~APEvl~--~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~ 223 (671)
|+|||++.......... .......||+.|+|||++. ....++.++|||||||++|+|++|..||.+...
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 99999987653322111 1112457999999999984 225588999999999999999999999977554
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchh
Q 005886 224 MKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHF 276 (671)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpw 276 (671)
....... ........++..+.+||.+||..||.+|||+.++++|-+
T Consensus 259 ~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 259 LRIVNGK-------YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp --------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHhhcCc-------ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 3322211 122234456778999999999999999999999998643
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=362.38 Aligned_cols=260 Identities=21% Similarity=0.363 Sum_probs=210.5
Q ss_pred ccccCCCCeEEEEEecccCceEEEEEEE----cCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe
Q 005886 8 RFPVDAKDYRLYEEVGEGVSATVYRALC----IPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT 83 (671)
Q Consensus 8 ~~~i~~~~Y~l~~~LG~G~fG~Vyka~~----~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~ 83 (671)
...+..++|++++.||+|+||.||+|.+ ..+|+.||||++.... ......+.+|+.+++.++||||+++++++..
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 113 (326)
T 2w1i_A 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYS 113 (326)
T ss_dssp --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence 4456678899999999999999999984 5689999999987532 3446788999999999999999999999876
Q ss_pred CC--EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccc
Q 005886 84 GH--CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVS 161 (671)
Q Consensus 84 ~~--~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls 161 (671)
.. .+++||||+.|++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 114 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 114 AGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred cCCCceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence 54 789999999999999999865 246999999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChH-----------H----H
Q 005886 162 ACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM-----------K----V 226 (671)
Q Consensus 162 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~-----------~----~ 226 (671)
.................|++.|+|||++.+ ..++.++|||||||++|+|++|..||...... . .
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 765433222222334567888999999987 56899999999999999999999998642110 0 0
Q ss_pred HHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 227 LLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
+...+.. ....+.+..++..+.+||.+||..||.+|||+.++++
T Consensus 272 ~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 272 LIELLKN---NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHT---TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhc---CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111111 1122335678999999999999999999999999976
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=388.19 Aligned_cols=257 Identities=25% Similarity=0.405 Sum_probs=219.0
Q ss_pred ccccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC
Q 005886 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH 85 (671)
Q Consensus 6 e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~ 85 (671)
.+.|.+..++|++.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.+|+.++||||+++++++.+ .
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 334 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence 45688889999999999999999999999875 4679999997543 335688999999999999999999999876 6
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
.+|||||||.+|+|.+++.......+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++.+.
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 78999999999999999975433568999999999999999999999999999999999999999999999999987553
Q ss_pred cCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccc
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (671)
.. .........++..|+|||++.+ ..++.++|||||||+||||++ |..||.+....+....+.... ....+.
T Consensus 415 ~~--~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~----~~~~~~ 487 (535)
T 2h8h_A 415 DN--EYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY----RMPCPP 487 (535)
T ss_dssp CH--HHHTTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC----CCCCCT
T ss_pred CC--ceecccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----CCCCCC
Confidence 21 1112233467889999999987 569999999999999999999 999999888777665554432 233456
Q ss_pred cchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 245 RFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 245 ~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.++..+.+||.+||..||.+|||+.+|+.
T Consensus 488 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 488 ECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 78999999999999999999999999976
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=357.44 Aligned_cols=251 Identities=25% Similarity=0.385 Sum_probs=196.4
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHh--CCCCCceeeeeEEEeC----CEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRV--TNHPNVLRAHCSFTTG----HCL 87 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~--L~HpNIVkl~~~~~~~----~~l 87 (671)
++|++.+.||+|+||.||+|++. |+.||||++... ......+|..++.. ++||||+++++++... ..+
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 68999999999999999999875 899999998533 23444556666554 4999999999999987 789
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccccCCCCcEEEcCCCceEEeccc
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH--------GHIHRDVKAGNILIDSNGAIKLADFG 159 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~--------gIVHrDLKPeNILld~~g~vKL~DFG 159 (671)
|+|||||.||+|.+++... .+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||
T Consensus 111 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp EEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence 9999999999999999764 699999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCCc-ccccccccCCCCCCChhHhhhccCCCcc------chhhhHHHHHHHHHhC----------CCCCCCCC
Q 005886 160 VSACMFDAGDR-QRSRNTFVGTPCWMAPEVMQQLHGYDFK------ADIWSFGITALELAHG----------HAPFSKYP 222 (671)
Q Consensus 160 ls~~~~~~~~~-~~~~~~~~GT~~Y~APEvl~~~~~~s~k------sDIWSLGvILyeLltG----------~~PF~~~~ 222 (671)
++..+...... .......+||+.|+|||++.+. .+... +|||||||++|+|++| ..||....
T Consensus 188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES-LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TCEECC---------CCSSCSCGGGCCHHHHTTC-CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CceeeccccccccCCCCCCccCcceeChhhcccc-cCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 98665332221 1122356899999999999873 34443 9999999999999999 77775432
Q ss_pred ----hHHHHHHHHh--cCCCCCCc-cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 223 ----PMKVLLMTLQ--NAPPGLDY-ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 223 ----~~~~~~~~~~--~~~~~~~~-~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
.......... ...+.+.. .....++..+.+||.+||..||.+|||+.++++|
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 1222222221 11121111 1123577889999999999999999999999874
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=363.85 Aligned_cols=257 Identities=21% Similarity=0.316 Sum_probs=194.2
Q ss_pred ccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHH--HHhCCCCCceeeeeEEEe--
Q 005886 8 RFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQT--MRVTNHPNVLRAHCSFTT-- 83 (671)
Q Consensus 8 ~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~i--L~~L~HpNIVkl~~~~~~-- 83 (671)
...+..++|++++.||+|+||.||+|++ +|+.||||++.... ...+..|..+ +..++||||+++++.+..
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 80 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVT 80 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccc
Confidence 4567889999999999999999999976 58999999986432 2334444444 456899999999986543
Q ss_pred ---CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CcccccCCCCcEEEcCCC
Q 005886 84 ---GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH---------GHIHRDVKAGNILIDSNG 151 (671)
Q Consensus 84 ---~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~---------gIVHrDLKPeNILld~~g 151 (671)
...+|+|||||.||+|.+++... .+++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 81 ~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~ 157 (336)
T 3g2f_A 81 ADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG 157 (336)
T ss_dssp TTSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred cCCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC
Confidence 34689999999999999999765 468899999999999999999999 999999999999999999
Q ss_pred ceEEeccccccccccCCC-----cccccccccCCCCCCChhHhhhc------cCCCccchhhhHHHHHHHHHhCCCCCCC
Q 005886 152 AIKLADFGVSACMFDAGD-----RQRSRNTFVGTPCWMAPEVMQQL------HGYDFKADIWSFGITALELAHGHAPFSK 220 (671)
Q Consensus 152 ~vKL~DFGls~~~~~~~~-----~~~~~~~~~GT~~Y~APEvl~~~------~~~s~ksDIWSLGvILyeLltG~~PF~~ 220 (671)
.+||+|||++..+..... ........+||+.|+|||++.+. ..++.++|||||||++|+|++|..||..
T Consensus 158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 999999999976533221 12223356799999999999752 2356789999999999999999776532
Q ss_pred C-C----------------hHHHHHHHHhcC--CCCCC--ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 221 Y-P----------------PMKVLLMTLQNA--PPGLD--YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 221 ~-~----------------~~~~~~~~~~~~--~~~~~--~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
. . ............ .+.+. +.....++..+.+||.+||..||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp TSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 1 1 111111111111 11111 1112346678999999999999999999999954
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=359.89 Aligned_cols=260 Identities=24% Similarity=0.395 Sum_probs=213.2
Q ss_pred ccccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeC
Q 005886 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG 84 (671)
Q Consensus 6 e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~ 84 (671)
...|.+..++|++.+.||+|+||.||+|.+.. .||+|++..... ......+.+|+.+++.++||||+++++++.+.
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 46788999999999999999999999998864 499999875543 23345677899999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccc
Q 005886 85 HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACM 164 (671)
Q Consensus 85 ~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~ 164 (671)
..+|+||||+.|++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++...
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred CceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 9999999999999999998754 24689999999999999999999999999999999999998 789999999997654
Q ss_pred ccCC--CcccccccccCCCCCCChhHhhh--------ccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC
Q 005886 165 FDAG--DRQRSRNTFVGTPCWMAPEVMQQ--------LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA 234 (671)
Q Consensus 165 ~~~~--~~~~~~~~~~GT~~Y~APEvl~~--------~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~ 234 (671)
.... ..........||+.|+|||++.+ ...++.++|||||||++|+|++|..||...........+....
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 259 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM 259 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTC
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCC
Confidence 2111 11222334569999999999975 2347889999999999999999999999887776665555443
Q ss_pred CCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 235 PPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 235 ~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.+.. ....++..+.+||.+||..||.+|||+.++++
T Consensus 260 ~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 260 KPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp CCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 3222 23357889999999999999999999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=354.89 Aligned_cols=253 Identities=24% Similarity=0.353 Sum_probs=203.9
Q ss_pred eEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC---cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC---NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 16 Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~---~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
|...+.||+|+||.||+|.+ ++..||||++..... ......+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 44458899999999999985 588999999865431 2346788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcc
Q 005886 93 YMAGGSCLHIMKSAY-PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 93 y~~ggsL~~~l~~~~-~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
|+.||+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 189 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA-QT 189 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCS-SC
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccc-cc
Confidence 999999999987432 2468999999999999999999999999999999999999999999999999986553221 11
Q ss_pred cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHH---HHHHHhcCCCC-------CCcc
Q 005886 172 RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKV---LLMTLQNAPPG-------LDYE 241 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~---~~~~~~~~~~~-------~~~~ 241 (671)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+...... +...+...... ....
T Consensus 190 ~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (307)
T 2nru_A 190 VMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND 267 (307)
T ss_dssp EECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSC
T ss_pred ccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccc
Confidence 22334689999999999876 378999999999999999999999976543221 11111111100 0111
Q ss_pred ccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 242 RDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 242 ~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.+..++..+.+||.+||..||.+|||+.++++
T Consensus 268 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~ 299 (307)
T 2nru_A 268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299 (307)
T ss_dssp CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 23456788999999999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=373.79 Aligned_cols=248 Identities=19% Similarity=0.263 Sum_probs=196.4
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-------cccHHHHHHHHHHHHhCC---------CCCc
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-------NNDLDGIRREVQTMRVTN---------HPNV 74 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-------~~~~~~i~~Ei~iL~~L~---------HpNI 74 (671)
+..++|++.+.||+|+||+||+|++ +|+.||||++..... ......+.+|+.+++.++ ||||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 4457899999999999999999998 689999999976532 234578999999998886 6666
Q ss_pred eeeeeEE-----------------Ee-------------CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHH
Q 005886 75 LRAHCSF-----------------TT-------------GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETL 124 (671)
Q Consensus 75 Vkl~~~~-----------------~~-------------~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl 124 (671)
|++++++ .+ ...+|||||||.+|++.+.+.. ..+++..++.++.||+
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLT 171 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHH
Confidence 6665554 33 7889999999999977666533 4689999999999999
Q ss_pred HHHHHHH-HCCcccccCCCCcEEEcCCC--------------------ceEEeccccccccccCCCcccccccccCCCCC
Q 005886 125 KALVYLH-FHGHIHRDVKAGNILIDSNG--------------------AIKLADFGVSACMFDAGDRQRSRNTFVGTPCW 183 (671)
Q Consensus 125 ~aL~yLH-s~gIVHrDLKPeNILld~~g--------------------~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y 183 (671)
.||+||| ++|||||||||+|||++.+| .+||+|||+|+.... ...+||+.|
T Consensus 172 ~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~--------~~~~gt~~y 243 (336)
T 2vuw_A 172 ASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD--------GIVVFCDVS 243 (336)
T ss_dssp HHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET--------TEEECCCCT
T ss_pred HHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC--------CcEEEeecc
Confidence 9999999 99999999999999999887 899999999975531 245899999
Q ss_pred CChhHhhhccCCCccchhhhHHHH-HHHHHhCCCCCCCCChHHHH-HHHHh--cCCCCCCccccccchHHHHHHHHHhhh
Q 005886 184 MAPEVMQQLHGYDFKADIWSFGIT-ALELAHGHAPFSKYPPMKVL-LMTLQ--NAPPGLDYERDKRFSKSFKELVTACLV 259 (671)
Q Consensus 184 ~APEvl~~~~~~s~ksDIWSLGvI-LyeLltG~~PF~~~~~~~~~-~~~~~--~~~~~~~~~~~~~ls~~l~dLI~~cL~ 259 (671)
+|||++.+. .+.++||||||++ .++++.|..||.+....... ..... ..........+..+++++++||.+||.
T Consensus 244 ~aPE~~~g~--~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~ 321 (336)
T 2vuw_A 244 MDEDLFTGD--GDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLN 321 (336)
T ss_dssp TCSGGGCCC--SSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGG
T ss_pred cChhhhcCC--CccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhc
Confidence 999999873 3889999998777 77888999998542111111 12221 112222233456789999999999999
Q ss_pred cCCCCCCCHHHHH-hchhcc
Q 005886 260 KDPKKRPTAEKLM-KHHFFK 278 (671)
Q Consensus 260 ~dP~kRpSa~eiL-~Hpwfk 278 (671)
+| |++++| +||||+
T Consensus 322 ~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 322 FS-----SATDLLCQHSLFK 336 (336)
T ss_dssp SS-----SHHHHHHHCGGGC
T ss_pred cC-----CHHHHHhcCCCcC
Confidence 77 999999 999995
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=374.12 Aligned_cols=256 Identities=17% Similarity=0.253 Sum_probs=208.5
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCC-CCceeeeeEEEeCCEEEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNH-PNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~H-pNIVkl~~~~~~~~~l~LV 90 (671)
..++|++++.||+|+||.||+|.+..+|+.||||++...... ..+.+|+.+++.+.| ++|..+..++......|||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 357899999999999999999999999999999998755432 347789999999976 5666677777888999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEE---cCCCceEEeccccccccccC
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILI---DSNGAIKLADFGVSACMFDA 167 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILl---d~~g~vKL~DFGls~~~~~~ 167 (671)
|||+ |++|.+++... ...+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+++.+...
T Consensus 82 me~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp EECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 9999 99999999754 3579999999999999999999999999999999999999 57899999999999766433
Q ss_pred CCcc----cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCCCCc
Q 005886 168 GDRQ----RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPP---MKVLLMTLQNAPPGLDY 240 (671)
Q Consensus 168 ~~~~----~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~---~~~~~~~~~~~~~~~~~ 240 (671)
.... ......+||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+... ...+..+..........
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred ccccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 2211 12336789999999999987 5699999999999999999999999987543 22222222211111111
Q ss_pred cccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 241 ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 241 ~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.....++.++.+||..||..||.+||++.+|++
T Consensus 239 ~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 223567899999999999999999999998865
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=386.92 Aligned_cols=258 Identities=24% Similarity=0.368 Sum_probs=215.7
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcCC---CcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPL---NEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT 83 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~t---g~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~ 83 (671)
..+.+..++|++.+.||+|+||.||+|.+..+ +..||||.+.........+.+.+|+.+++.++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 45677888999999999999999999998754 45799999865444444678899999999999999999999985
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccc
Q 005886 84 GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSAC 163 (671)
Q Consensus 84 ~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~ 163 (671)
++.+|+||||+.||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred cCceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 45689999999999999999764 24689999999999999999999999999999999999999999999999999876
Q ss_pred cccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccc
Q 005886 164 MFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYER 242 (671)
Q Consensus 164 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~ 242 (671)
..... ........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+...... ..
T Consensus 541 ~~~~~--~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~----~~ 613 (656)
T 2j0j_A 541 MEDST--YYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL----PM 613 (656)
T ss_dssp CCC------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC----CC
T ss_pred cCCCc--ceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC----CC
Confidence 53221 112233467889999999987 579999999999999999997 99999998877766665554322 23
Q ss_pred cccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 243 DKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 243 ~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
+..++..+.+||.+||..||.+|||+.++++
T Consensus 614 ~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 614 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 5578899999999999999999999999976
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=350.66 Aligned_cols=252 Identities=25% Similarity=0.351 Sum_probs=202.5
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHh--CCCCCceeeeeEEEeCC----EE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRV--TNHPNVLRAHCSFTTGH----CL 87 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~--L~HpNIVkl~~~~~~~~----~l 87 (671)
++|++.+.||+|+||.||+|.+ +|+.||||++... ....+.+|+.++.. ++||||+++++++.... .+
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence 6899999999999999999987 4899999998633 34667889999887 79999999999999876 89
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCcccccCCCCcEEEcCCCceEEeccc
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLH--------FHGHIHRDVKAGNILIDSNGAIKLADFG 159 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLH--------s~gIVHrDLKPeNILld~~g~vKL~DFG 159 (671)
|+||||+.+|+|.+++... .+++..++.++.||+.||+||| ++||+||||||+|||++.++.+||+|||
T Consensus 116 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp EEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECC
Confidence 9999999999999999764 6899999999999999999999 8999999999999999999999999999
Q ss_pred cccccccCCCcc-cccccccCCCCCCChhHhhhccC-----CCccchhhhHHHHHHHHHhC----------CCCCCCCCh
Q 005886 160 VSACMFDAGDRQ-RSRNTFVGTPCWMAPEVMQQLHG-----YDFKADIWSFGITALELAHG----------HAPFSKYPP 223 (671)
Q Consensus 160 ls~~~~~~~~~~-~~~~~~~GT~~Y~APEvl~~~~~-----~s~ksDIWSLGvILyeLltG----------~~PF~~~~~ 223 (671)
++.......... .......||+.|+|||++.+... ++.++|||||||++|+|++| ..||.....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~ 272 (342)
T 1b6c_B 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272 (342)
T ss_dssp TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence 987653322211 12345689999999999976322 23689999999999999999 789866422
Q ss_pred ----HHHHHHHHhc--CCCCCCcc-ccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 224 ----MKVLLMTLQN--APPGLDYE-RDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 224 ----~~~~~~~~~~--~~~~~~~~-~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
.......+.. ..+.+... ....++..+.+||.+||..||.+|||+.++++|
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 2222222221 11111111 122456789999999999999999999999874
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=372.65 Aligned_cols=253 Identities=14% Similarity=0.151 Sum_probs=196.7
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhCCC-CCcee-----------
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNH-PNVLR----------- 76 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L~H-pNIVk----------- 76 (671)
.....|++.+.||+|+||+||+|.+..+|+.||||++...... ...+.+.+|+.+++.+.| +|+..
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 3445688999999999999999999999999999998744322 336789999999999987 32211
Q ss_pred ----------eeeEEEe-----CCEEEEEEeccCCCCHHHHHHh-----hCCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 005886 77 ----------AHCSFTT-----GHCLWVVMPYMAGGSCLHIMKS-----AYPEGFEEPVIATLLRETLKALVYLHFHGHI 136 (671)
Q Consensus 77 ----------l~~~~~~-----~~~l~LVmEy~~ggsL~~~l~~-----~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIV 136 (671)
+..++.. ...++++|+++ +++|.+++.. .....+++..++.++.||+.||+|||++|||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ii 233 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 233 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 1111111 22467788876 6789988852 2223477888999999999999999999999
Q ss_pred cccCCCCcEEEcCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhh---------ccCCCccchhhhHHHH
Q 005886 137 HRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQ---------LHGYDFKADIWSFGIT 207 (671)
Q Consensus 137 HrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~---------~~~~s~ksDIWSLGvI 207 (671)
||||||+|||++.+|.+||+|||+++.... .....+| +.|+|||++.+ ...|+.++|||||||+
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA------SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTE------EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCC------ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 999999999999999999999999865421 1345688 99999999942 2347889999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 208 ALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 208 LyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
+|+|++|+.||.+.........+ +.....++..+++||.+||..||.+||++.++|+||||+..
T Consensus 307 l~elltg~~Pf~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGSEWI---------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCSGGG---------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHHHCCCCCCCcchhhhHHHH---------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 99999999999876543322111 12234678999999999999999999999999999999743
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=394.65 Aligned_cols=263 Identities=26% Similarity=0.326 Sum_probs=209.8
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe------CC
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT------GH 85 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~------~~ 85 (671)
..++|++.+.||+|+||+||+|.+..+|+.||||++...........+.+|+.+++.++||||+++++++.. ..
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 347899999999999999999999999999999998765444556788999999999999999999998765 67
Q ss_pred EEEEEEeccCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCc---eEEeccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAY-PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGA---IKLADFGVS 161 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~-~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~---vKL~DFGls 161 (671)
..|+|||||.||+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 7899999999999999998642 236899999999999999999999999999999999999997764 999999998
Q ss_pred cccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHH----------
Q 005886 162 ACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTL---------- 231 (671)
Q Consensus 162 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~---------- 231 (671)
...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.............
T Consensus 172 ~~~~~~----~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 172 KELDQG----ELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CBTTSC----CCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred cccccc----cccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 755221 22345689999999999986 579999999999999999999999997643221110000
Q ss_pred -hcCCCC--------CCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccc
Q 005886 232 -QNAPPG--------LDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKH 279 (671)
Q Consensus 232 -~~~~~~--------~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~ 279 (671)
...... ........++..+.+||.+||..||.+|||+.++|+||||+.
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 000000 011123457899999999999999999999999999999974
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=380.71 Aligned_cols=241 Identities=23% Similarity=0.271 Sum_probs=201.9
Q ss_pred CCCeEEEEEecccCceEEEEEEEcC-CCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE-----
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIP-LNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC----- 86 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~-tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~----- 86 (671)
.++|++.+.||+|+||+||+|.+.. +|+.||||++...........+.+|+.+++.++||||++++++|.....
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 4789999999999999999999986 7899999998654434456678899999999999999999999987655
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
+||||||+.|++|.+++.. .+++..++.|+.||+.||.|||++|||||||||+|||++.+ .+||+|||++.....
T Consensus 159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 7999999999999887653 68999999999999999999999999999999999999875 899999999875422
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (671)
....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+... ...+ .......+
T Consensus 234 -------~~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~~~~--------~~~~---~~~~~~~~ 293 (681)
T 2pzi_A 234 -------FGYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYV--------DGLP---EDDPVLKT 293 (681)
T ss_dssp -------CSCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETTEEC--------SSCC---TTCHHHHH
T ss_pred -------CCccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCccccc--------cccc---cccccccc
Confidence 145689999999999976 358999999999999999999999875321 0111 11112235
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHhchhcc
Q 005886 247 SKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278 (671)
Q Consensus 247 s~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk 278 (671)
+..+.+||.+||.+||.+||+..+.+.|+|+.
T Consensus 294 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 294 YDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 67899999999999999999999999999885
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=338.23 Aligned_cols=227 Identities=17% Similarity=0.132 Sum_probs=188.3
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~ 88 (671)
+..++|++.+.||+|+||.||+|.+..+|+.||||++...... .....+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 3457899999999999999999999999999999999765432 23577899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
+||||+.|++|.+++.. +.....+..++.||+.||+|||++||+||||||+|||++.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~----~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EEEEecCCCCHHHHHhc----CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 99999999999999853 24566788999999999999999999999999999999999999998554
Q ss_pred CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--CCCccccccc
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP--GLDYERDKRF 246 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~--~~~~~~~~~l 246 (671)
|++| ++.++|||||||++|+|++|+.||.+......+......... .........+
T Consensus 175 --------------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T 3uqc_A 175 --------------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDI 232 (286)
T ss_dssp --------------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTS
T ss_pred --------------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCC
Confidence 3332 688999999999999999999999876543211000010011 1111234568
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 247 SKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 247 s~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
+.++++||.+||.+||.+| |+.++++
T Consensus 233 ~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 233 PFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp CHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred CHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 9999999999999999999 9999987
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-34 Score=326.90 Aligned_cols=230 Identities=14% Similarity=0.157 Sum_probs=161.1
Q ss_pred EecccCceEEEEEEEcCCCcEEEEEEeccccCc---------ccHHHHHHHHHHHHhC-CCCCceeeeeEEEeCCEEEEE
Q 005886 21 EVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN---------NDLDGIRREVQTMRVT-NHPNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 21 ~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~---------~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~~~~l~LV 90 (671)
..+.|++|.+..++..-+|+.||+|++...... ...+.+.+|+++|+++ .|+||++++++|++++.+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 467788888888888888999999999754311 2356789999999999 799999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCc
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR 170 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~ 170 (671)
||||+|++|.++|... +.+++. .|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus 321 MEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~--- 392 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD--- 392 (569)
T ss_dssp EECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----
T ss_pred EecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC---
Confidence 9999999999999876 567764 58899999999999999999999999999999999999999999765332
Q ss_pred ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHH
Q 005886 171 QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSF 250 (671)
Q Consensus 171 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l 250 (671)
.....+.+||+.|||||++.+ .+..++|+||+|+++|+|.++..+|. ..+...+. ....+
T Consensus 393 ~~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~~~~---------~~l~~~~~---------~~~~~ 452 (569)
T 4azs_A 393 CSWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWSNWL---------YAVWQEPV---------ERWNF 452 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHHHH---------HHHHTSCG---------GGCSH
T ss_pred CccccCceechhhccHHHhCC--CCCCcccccccccchhhhccccchhH---------HHhhcCCC---------CCCcH
Confidence 223456799999999999986 36778999999999988877654431 11111111 01124
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHhchhcc
Q 005886 251 KELVTACLVKDPKKRPTAEKLMKHHFFK 278 (671)
Q Consensus 251 ~dLI~~cL~~dP~kRpSa~eiL~Hpwfk 278 (671)
..++..++..+|..|+.......|+|..
T Consensus 453 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~ 480 (569)
T 4azs_A 453 VLLLALFEKKAKLPSAEQQRGATEQWII 480 (569)
T ss_dssp HHHHHHHHTGGGSCCGGGSSCCHHHHHH
T ss_pred HHHHHHHhCCCCCCCCChhhhccchhHH
Confidence 5677778888898888877777777764
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-27 Score=269.40 Aligned_cols=188 Identities=17% Similarity=0.196 Sum_probs=146.0
Q ss_pred EEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcc-------cHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q 005886 18 LYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-------DLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 18 l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~-------~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LV 90 (671)
..+.||+|+||+||+|. ..+..+|+|++....... ..+.+.+|+.+|+.++||||+++..++......|||
T Consensus 340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 35689999999999994 457889999875433221 135579999999999999999666666677778999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCc
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR 170 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~ 170 (671)
||||+|++|.+++.. +..++.||+.||.|||++||+||||||+|||++. .+||+|||+++........
T Consensus 418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence 999999999998864 5689999999999999999999999999999998 9999999999765322111
Q ss_pred c----cccccccCCCCCCChhHhhh-ccCCCccchhhhHHHHHHHHHhCCCCCC
Q 005886 171 Q----RSRNTFVGTPCWMAPEVMQQ-LHGYDFKADIWSFGITALELAHGHAPFS 219 (671)
Q Consensus 171 ~----~~~~~~~GT~~Y~APEvl~~-~~~~s~ksDIWSLGvILyeLltG~~PF~ 219 (671)
. ......+||+.|||||++.. ...|+..+|+|+.++-..+-+.++.+|.
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 1 01246789999999999975 2357888999999998888887777663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.4e-24 Score=222.72 Aligned_cols=147 Identities=16% Similarity=0.183 Sum_probs=118.6
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-----------------ccHHHHHHHHHHHHhCCCCCcee
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-----------------NDLDGIRREVQTMRVTNHPNVLR 76 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-----------------~~~~~i~~Ei~iL~~L~HpNIVk 76 (671)
..|.+.+.||+|+||.||+|.+ .+|+.||||++...... .....+.+|+.+|+.++ | ++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 3455569999999999999999 88999999999643211 12456889999999998 4 66
Q ss_pred eeeEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEe
Q 005886 77 AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLA 156 (671)
Q Consensus 77 l~~~~~~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~ 156 (671)
+++++.. +..|+|||||.||+|.+ +. . .....++.||+.||.|||++||+||||||+|||++ +|.+||+
T Consensus 166 v~~~~~~-~~~~lvmE~~~g~~L~~-l~------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 166 VPKVYAW-EGNAVLMELIDAKELYR-VR------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp SCCEEEE-ETTEEEEECCCCEEGGG-CC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEEC
T ss_pred cCeEEec-cceEEEEEecCCCcHHH-cc------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEE
Confidence 6665544 45699999999999987 31 1 23557999999999999999999999999999999 9999999
Q ss_pred ccccccccccCCCcccccccccCCCCCCChhHhhh
Q 005886 157 DFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQ 191 (671)
Q Consensus 157 DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~ 191 (671)
|||+|+ ++..|+|||++.+
T Consensus 235 DFG~a~----------------~~~~~~a~e~l~r 253 (282)
T 1zar_A 235 DFPQSV----------------EVGEEGWREILER 253 (282)
T ss_dssp CCTTCE----------------ETTSTTHHHHHHH
T ss_pred ECCCCe----------------ECCCCCHHHHHHH
Confidence 999874 3456899999864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=2.6e-20 Score=191.29 Aligned_cols=138 Identities=13% Similarity=0.167 Sum_probs=108.1
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcE--EEEEEeccccCc--c---------------------cHHHHHHHHHHHHhC
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEI--VAIKVLDLEKCN--N---------------------DLDGIRREVQTMRVT 69 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~--VAIKvi~~~~~~--~---------------------~~~~i~~Ei~iL~~L 69 (671)
-|++.+.||+|+||.||+|.+..+|+. ||||++...... . ....+.+|+.+|+.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478999999999999999999788999 999997543211 0 013678999999999
Q ss_pred CCCCc--eeeeeEEEeCCEEEEEEeccCC-C----CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccccCC
Q 005886 70 NHPNV--LRAHCSFTTGHCLWVVMPYMAG-G----SCLHIMKSAYPEGFEEPVIATLLRETLKALVYLH-FHGHIHRDVK 141 (671)
Q Consensus 70 ~HpNI--Vkl~~~~~~~~~l~LVmEy~~g-g----sL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLH-s~gIVHrDLK 141 (671)
.|++| +.++++ ...+|||||+.+ | .|.++... .++..+..++.||+.||.||| .+||||||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlk 198 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLS 198 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCC
Confidence 88864 333332 246899999942 3 66665432 234567899999999999999 9999999999
Q ss_pred CCcEEEcCCCceEEeccccccc
Q 005886 142 AGNILIDSNGAIKLADFGVSAC 163 (671)
Q Consensus 142 PeNILld~~g~vKL~DFGls~~ 163 (671)
|+|||++. .++|+|||+|..
T Consensus 199 p~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEE
T ss_pred HHHEEEcC--cEEEEECccccc
Confidence 99999988 999999999853
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.68 E-value=8.9e-18 Score=182.38 Aligned_cols=136 Identities=18% Similarity=0.187 Sum_probs=99.1
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-------------ccHH--------HHHHHHHHHHhCCCCC
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-------------NDLD--------GIRREVQTMRVTNHPN 73 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-------------~~~~--------~i~~Ei~iL~~L~HpN 73 (671)
-|.+...||.|+||.||+|.+. +|+.||||+++..... .... ...+|...|.++.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 4899999999999999999874 6999999998532110 0011 1235677777775555
Q ss_pred ceeeeeEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC--
Q 005886 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG-- 151 (671)
Q Consensus 74 IVkl~~~~~~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g-- 151 (671)
+.-..-+....+ +|||||+.|++|..+. ....+..++.||+.+|.|||.+|||||||||.|||++.+|
T Consensus 175 v~vp~p~~~~~~--~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 175 FPVPEPIAQSRH--TIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CSCCCEEEEETT--EEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCCCeeeeccCc--eEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 432222222332 6899999998875432 1123567899999999999999999999999999998776
Q ss_pred --------ceEEeccccc
Q 005886 152 --------AIKLADFGVS 161 (671)
Q Consensus 152 --------~vKL~DFGls 161 (671)
.+.|+||+-+
T Consensus 245 ~d~~~~~~~~~iID~~Q~ 262 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQM 262 (397)
T ss_dssp SCTTSEEEEEEECCCTTC
T ss_pred ccccccccceEEEEeCCc
Confidence 3889999954
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=9.2e-12 Score=126.54 Aligned_cols=138 Identities=18% Similarity=0.177 Sum_probs=111.0
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCC-CCCceeeeeEEEeCCEEEEEEe
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN-HPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~-HpNIVkl~~~~~~~~~l~LVmE 92 (671)
..|++...+|.|+++.||++... |..+++|+...... .....+.+|+.+++.+. +..+.++++++...+..|+|||
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 56999999999999999999743 67899999864221 22345889999999884 6778899999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF---------------------------------------- 132 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs---------------------------------------- 132 (671)
|++|.+|...+. +......++.++..+|..||+
T Consensus 91 ~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 91 EADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred ecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 999999876521 112234788899999999998
Q ss_pred -------------------CCcccccCCCCcEEEcCCCceEEeccccc
Q 005886 133 -------------------HGHIHRDVKAGNILIDSNGAIKLADFGVS 161 (671)
Q Consensus 133 -------------------~gIVHrDLKPeNILld~~g~vKL~DFGls 161 (671)
.+++|+|++|.|||++.++.+.|+||+.+
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 45899999999999987666779999975
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.14 E-value=8.1e-11 Score=118.25 Aligned_cols=134 Identities=16% Similarity=0.125 Sum_probs=99.1
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCC--ceeeeeEEEeCCEEEEE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN--VLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpN--IVkl~~~~~~~~~l~LV 90 (671)
...|.+....+.|.++.||++. ..+|..+++|+.... ....+.+|+.+++.+.+.+ +.++++++..++..|+|
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred cCCCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence 3457765554566779999995 456778999997543 2245788999998885444 56688888888889999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC------------------------------------
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHG------------------------------------ 134 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~g------------------------------------ 134 (671)
|||++|.++. . .... ...++.++...|..||...
T Consensus 94 ~e~i~G~~l~--~-----~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 94 LGEVPGQDLL--S-----SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp EECCSSEETT--T-----SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEecCCcccC--c-----CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 9999998773 1 1112 2256677777777777643
Q ss_pred ----------------------cccccCCCCcEEEcCCCceEEeccccc
Q 005886 135 ----------------------HIHRDVKAGNILIDSNGAIKLADFGVS 161 (671)
Q Consensus 135 ----------------------IVHrDLKPeNILld~~g~vKL~DFGls 161 (671)
++|+|++|.||+++.++.+.|+|||.+
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a 212 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRL 212 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhc
Confidence 999999999999987766779999975
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.09 E-value=2.2e-10 Score=122.20 Aligned_cols=141 Identities=13% Similarity=0.196 Sum_probs=105.5
Q ss_pred eEEEEEecccCceEEEEEEEcCCCcEEEEEEec--cccCcccHHHHHHHHHHHHhCC--CCCceeeeeEEEeC---CEEE
Q 005886 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLD--LEKCNNDLDGIRREVQTMRVTN--HPNVLRAHCSFTTG---HCLW 88 (671)
Q Consensus 16 Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~--~~~~~~~~~~i~~Ei~iL~~L~--HpNIVkl~~~~~~~---~~l~ 88 (671)
...++.|+.|.++.||++... +..+++|+.. ..........+.+|+.+++.+. +..+++++.++.+. +..|
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 345688999999999998754 4678889875 3322223456889999999887 45578888888776 4588
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF------------------------------------ 132 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs------------------------------------ 132 (671)
+||||+.|..+.+. ....++......++.+++..|+.||.
T Consensus 118 ~vme~v~G~~l~~~----~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQ----SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EEEECCCCBCCCCT----TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEEEecCCeecCCC----ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 99999998766431 11346788888999999999999997
Q ss_pred ----------------------CCcccccCCCCcEEEcCCCc--eEEecccccc
Q 005886 133 ----------------------HGHIHRDVKAGNILIDSNGA--IKLADFGVSA 162 (671)
Q Consensus 133 ----------------------~gIVHrDLKPeNILld~~g~--vKL~DFGls~ 162 (671)
.++||+|++|.|||++.++. +.|+||+.+.
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST 247 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence 36899999999999987753 6899999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.99 E-value=1.9e-10 Score=119.95 Aligned_cols=178 Identities=19% Similarity=0.237 Sum_probs=120.2
Q ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCC--ceeeeeEEEeCC---EEEEEEe
Q 005886 19 YEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPN--VLRAHCSFTTGH---CLWVVMP 92 (671)
Q Consensus 19 ~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpN--IVkl~~~~~~~~---~l~LVmE 92 (671)
++.++.|.+..||++. ..+++|+.... .....+.+|+.+|+.+ .+.. +.+++....... ..|+||+
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 3558999999999863 45889986422 2356789999999887 3333 344444443333 3588999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF---------------------------------------- 132 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs---------------------------------------- 132 (671)
+++|..+..... ..++......++.++...|+.||.
T Consensus 97 ~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 97 KIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred ccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 999988765333 236777778888888888888886
Q ss_pred ------------------CCcccccCCCCcEEEcC--CCceEEeccccccccccCCCcccccccccCCCCC---CChh--
Q 005886 133 ------------------HGHIHRDVKAGNILIDS--NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCW---MAPE-- 187 (671)
Q Consensus 133 ------------------~gIVHrDLKPeNILld~--~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y---~APE-- 187 (671)
..++|+|++|.||+++. ++.+.|+||+.+... +.. .. +.....+ ..|+
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~-~~~---~D---l~~~~~~~~~~~~~~~ 245 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS-DPD---ND---FISLMEDDEEYGMEFV 245 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE-CTT---HH---HHTTCCTTTSCCHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC-ChH---HH---HHHHHhhccccCHHHH
Confidence 13699999999999988 456889999987432 110 00 0001111 2333
Q ss_pred --------------HhhhccCCCccchhhhHHHHHHHHHhCCCCC
Q 005886 188 --------------VMQQLHGYDFKADIWSFGITALELAHGHAPF 218 (671)
Q Consensus 188 --------------vl~~~~~~s~ksDIWSLGvILyeLltG~~PF 218 (671)
.... ...-.+.|++|.++|.+.+|..+|
T Consensus 246 ~~~l~~Y~~~~~~~~~~r---~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 246 SKILNHYKHKDIPTVLEK---YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHTCSCHHHHHHH---HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHcCCCCcHHHHHH---HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 3222 112358999999999999998876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=1.3e-06 Score=91.29 Aligned_cols=132 Identities=16% Similarity=0.109 Sum_probs=92.1
Q ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCC---CceeeeeEEE-eCCEEEEEEecc
Q 005886 19 YEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHP---NVLRAHCSFT-TGHCLWVVMPYM 94 (671)
Q Consensus 19 ~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~Hp---NIVkl~~~~~-~~~~l~LVmEy~ 94 (671)
++.++.|....||+. |..+++|+... ......+.+|+.+|+.+.+. .|.+++.+.. ..+..|+||+|+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 456899999999988 56688898421 23356789999999998652 3556666664 455678999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------
Q 005886 95 AGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH----------------------------------------- 133 (671)
Q Consensus 95 ~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~----------------------------------------- 133 (671)
+|..+....- ..++......++.++...|+.||+.
T Consensus 96 ~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 96 QGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred CCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 9988765322 1234444555555555555555532
Q ss_pred -------------------CcccccCCCCcEEEcC---CCc-eEEecccccc
Q 005886 134 -------------------GHIHRDVKAGNILIDS---NGA-IKLADFGVSA 162 (671)
Q Consensus 134 -------------------gIVHrDLKPeNILld~---~g~-vKL~DFGls~ 162 (671)
.++|+|++|.||+++. ++. +.|+||+.+.
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 3599999999999987 455 5899999753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=2.8e-06 Score=86.08 Aligned_cols=131 Identities=16% Similarity=0.162 Sum_probs=95.2
Q ss_pred EecccCce-EEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCC-CCCceeeeeEEEeCCEEEEEEeccCCCC
Q 005886 21 EVGEGVSA-TVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN-HPNVLRAHCSFTTGHCLWVVMPYMAGGS 98 (671)
Q Consensus 21 ~LG~G~fG-~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~-HpNIVkl~~~~~~~~~l~LVmEy~~ggs 98 (671)
.+..|..| .||+......+..+++|+-.. .....+.+|...|+.+. +--|.++++++.+.+..|+||++++|.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 34445555 689987777777899998542 23456888999998774 3336778899999999999999999988
Q ss_pred HHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---------------------------------------------
Q 005886 99 CLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH--------------------------------------------- 133 (671)
Q Consensus 99 L~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~--------------------------------------------- 133 (671)
+....... ......++.++...|..||..
T Consensus 107 ~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 107 AFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 87655432 112234555666666666621
Q ss_pred -------------CcccccCCCCcEEEcCCCceEEeccccc
Q 005886 134 -------------GHIHRDVKAGNILIDSNGAIKLADFGVS 161 (671)
Q Consensus 134 -------------gIVHrDLKPeNILld~~g~vKL~DFGls 161 (671)
.++|+|+.|.|||++.++.+-|+||+.+
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a 221 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRV 221 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccc
Confidence 2689999999999998777789999975
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=4.9e-06 Score=89.70 Aligned_cols=78 Identities=19% Similarity=0.143 Sum_probs=50.9
Q ss_pred EEEEecccCceEEEEEEEcCCCcEEEEEEeccccC------cccHHHHHHHHHHHHhCCC--CC-ceeeeeEEEeCCEEE
Q 005886 18 LYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC------NNDLDGIRREVQTMRVTNH--PN-VLRAHCSFTTGHCLW 88 (671)
Q Consensus 18 l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~------~~~~~~i~~Ei~iL~~L~H--pN-IVkl~~~~~~~~~l~ 88 (671)
-.+.||.|.++.||++.....++.|+||....... .....++..|..+|+.+.. |. +.+++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 46789999999999997665678899998642211 1234567789999887742 33 4455543 344467
Q ss_pred EEEeccCCC
Q 005886 89 VVMPYMAGG 97 (671)
Q Consensus 89 LVmEy~~gg 97 (671)
+||||+.|.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999774
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.04 E-value=5.1e-05 Score=79.01 Aligned_cols=136 Identities=19% Similarity=0.207 Sum_probs=77.7
Q ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCC--CCCceeeee------EEEeCCEEEEE
Q 005886 19 YEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN--HPNVLRAHC------SFTTGHCLWVV 90 (671)
Q Consensus 19 ~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~--HpNIVkl~~------~~~~~~~l~LV 90 (671)
++.|+.|..+.||++... +..+++|+.... ...+..|+.+++.|. .-.+.+++. +....+..|+|
T Consensus 37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~-----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l 109 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRP-----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVV 109 (346)
T ss_dssp EEECC----CEEEEEEET--TEEEEEEEECSC-----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEE
T ss_pred eeeccccccCcEEEEEeC--CCCEEEEecCCC-----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEE
Confidence 456777788999998753 345889998642 234445566555442 112333332 22356788999
Q ss_pred EeccCCCCHH--------------HHHHh---hC--CCCC-------CHH--------H---------------------
Q 005886 91 MPYMAGGSCL--------------HIMKS---AY--PEGF-------EEP--------V--------------------- 115 (671)
Q Consensus 91 mEy~~ggsL~--------------~~l~~---~~--~~~l-------~e~--------~--------------------- 115 (671)
|+|++|..+. ..+.. .. +... ... .
T Consensus 110 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 189 (346)
T 2q83_A 110 YDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYL 189 (346)
T ss_dssp EECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHH
T ss_pred EEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHH
Confidence 9999986431 11111 11 1000 010 0
Q ss_pred --HHHHHHHHHHHHHHHH-------------HCCcccccCCCCcEEEcCCCceEEeccccc
Q 005886 116 --IATLLRETLKALVYLH-------------FHGHIHRDVKAGNILIDSNGAIKLADFGVS 161 (671)
Q Consensus 116 --i~~i~~qIl~aL~yLH-------------s~gIVHrDLKPeNILld~~g~vKL~DFGls 161 (671)
+..+...+..++.+|+ ..++||+|+++.|||++.++.+.|+||+.+
T Consensus 190 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a 250 (346)
T 2q83_A 190 QEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTV 250 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred HHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhc
Confidence 1112222334566665 257999999999999988889999999965
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.95 E-value=6.7e-06 Score=87.05 Aligned_cols=84 Identities=15% Similarity=0.141 Sum_probs=55.9
Q ss_pred eEEEEEe-cccCceEEEEEEEc--C----CCcEEEEEEeccccC--cccHHHHHHHHHHHHhCC-C--CCceeeeeEEEe
Q 005886 16 YRLYEEV-GEGVSATVYRALCI--P----LNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTN-H--PNVLRAHCSFTT 83 (671)
Q Consensus 16 Y~l~~~L-G~G~fG~Vyka~~~--~----tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~-H--pNIVkl~~~~~~ 83 (671)
....+.| +.|....+|+.... . .+..+++|+...... ......+.+|+.+++.+. + ..+.+++.+..+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3446778 89999999988643 0 156788998653220 001245778888888774 2 356778877765
Q ss_pred C---CEEEEEEeccCCCCH
Q 005886 84 G---HCLWVVMPYMAGGSC 99 (671)
Q Consensus 84 ~---~~l~LVmEy~~ggsL 99 (671)
. ...|+||||++|..+
T Consensus 102 ~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp STTTSSCEEEEECCCCBCC
T ss_pred CCccCCceEEEEecCCCCh
Confidence 5 356889999988553
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00025 Score=77.10 Aligned_cols=75 Identities=13% Similarity=0.042 Sum_probs=45.7
Q ss_pred EEEEecccCceEEEEEEEcCCCcEEEEEEeccc-c--C---c--ccHHHHHHHHHHHH-hCCCCCceeeeeEEEeCCEEE
Q 005886 18 LYEEVGEGVSATVYRALCIPLNEIVAIKVLDLE-K--C---N--NDLDGIRREVQTMR-VTNHPNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 18 l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~-~--~---~--~~~~~i~~Ei~iL~-~L~HpNIVkl~~~~~~~~~l~ 88 (671)
-++.||.|..+.||++.. .+..++||..... . . . .....+..|+..+. ......+.+++.+. ....+
T Consensus 38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 467899999999999953 4678999943211 0 0 1 12233334443322 22334566777665 45678
Q ss_pred EEEecc-CC
Q 005886 89 VVMPYM-AG 96 (671)
Q Consensus 89 LVmEy~-~g 96 (671)
+||||+ .|
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 77
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00049 Score=72.31 Aligned_cols=76 Identities=11% Similarity=0.005 Sum_probs=60.5
Q ss_pred EEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCC---CCCceeeeeEEEeCCEEEEEEecc
Q 005886 18 LYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN---HPNVLRAHCSFTTGHCLWVVMPYM 94 (671)
Q Consensus 18 l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~---HpNIVkl~~~~~~~~~l~LVmEy~ 94 (671)
-.+.|+.|.+..+|+... .+..+++|+.... ....+.+|...|+.|. ...+.+++.+....+..|+||||+
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 467899999999999864 4667889986532 3567889999988773 356888998888888999999999
Q ss_pred CCCCH
Q 005886 95 AGGSC 99 (671)
Q Consensus 95 ~ggsL 99 (671)
+|..+
T Consensus 114 ~G~~~ 118 (312)
T 3jr1_A 114 NKSKN 118 (312)
T ss_dssp CCCCC
T ss_pred cCCCC
Confidence 98753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00033 Score=72.38 Aligned_cols=71 Identities=14% Similarity=0.074 Sum_probs=43.6
Q ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCc-eeeeeEEEeCCEEEEEEecc-CC
Q 005886 19 YEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNV-LRAHCSFTTGHCLWVVMPYM-AG 96 (671)
Q Consensus 19 ~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNI-Vkl~~~~~~~~~l~LVmEy~-~g 96 (671)
++.|+.|....+|++ ..+++|+..... .. .-...+|+.+++.+..-++ .++++++ ...-++|++|+ .|
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~-~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGT-EE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCc-cc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCC
Confidence 688999999999998 448889875321 11 1123468877776643233 3555443 33346799999 66
Q ss_pred CCH
Q 005886 97 GSC 99 (671)
Q Consensus 97 gsL 99 (671)
..+
T Consensus 93 ~~l 95 (301)
T 3dxq_A 93 QTM 95 (301)
T ss_dssp EEC
T ss_pred ccC
Confidence 433
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0025 Score=63.40 Aligned_cols=136 Identities=17% Similarity=0.090 Sum_probs=91.9
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccccc
Q 005886 97 GSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF-HGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRN 175 (671)
Q Consensus 97 gsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs-~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~ 175 (671)
.+|.+++... ..+++|.++|.++.|.+.+|.-+-. +.-..+=+-|..|++..+|.|-+.+ +.+.
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------- 97 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------- 97 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-------------
Confidence 3788988765 4789999999999999999887622 2222334567999999999987663 2110
Q ss_pred cccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHH
Q 005886 176 TFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVT 255 (671)
Q Consensus 176 ~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~ 255 (671)
.....+.|||... ...+.+.=|||||+++|.-+--..| ......+|+.+..||.
T Consensus 98 --~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~----------------------e~eE~eLS~~LE~LL~ 151 (229)
T 2yle_A 98 --AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLK----------------------ENEERELSPPLEQLID 151 (229)
T ss_dssp -----------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCC----------------------TTEEECCCHHHHHHHH
T ss_pred --ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCC----------------------cccchhhCHHHHHHHH
Confidence 1123456787653 2456788899999999998863332 1224568999999999
Q ss_pred Hhhhc-------------------------CCCCCCCHHHHHh
Q 005886 256 ACLVK-------------------------DPKKRPTAEKLMK 273 (671)
Q Consensus 256 ~cL~~-------------------------dP~kRpSa~eiL~ 273 (671)
.|..- .+..|+++.+|++
T Consensus 152 ~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~ 194 (229)
T 2yle_A 152 HMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK 194 (229)
T ss_dssp HHTTCCC--------------------CCSCCCCCCSHHHHHH
T ss_pred HHHhcccccccccccccccccccccccccccccCcCCHHHHHH
Confidence 99865 2467888888875
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.001 Score=68.28 Aligned_cols=80 Identities=13% Similarity=0.039 Sum_probs=56.4
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCC---CCceeeeeEEEeCCEEEE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNH---PNVLRAHCSFTTGHCLWV 89 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~H---pNIVkl~~~~~~~~~l~L 89 (671)
..+..-++.+|.|..+.||+... .+|+.|.+|+..... ......+.+|+..|+.|.- --+.+++++ .. -++
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~l 87 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTL 87 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEE
T ss_pred CCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceE
Confidence 45666788999999999999974 578899999865332 2234568899999988742 224455544 23 267
Q ss_pred EEeccCCCC
Q 005886 90 VMPYMAGGS 98 (671)
Q Consensus 90 VmEy~~ggs 98 (671)
||||+.++.
T Consensus 88 v~e~l~~~~ 96 (288)
T 3f7w_A 88 AMEWVDERP 96 (288)
T ss_dssp EEECCCCCC
T ss_pred EEEeecccC
Confidence 999988764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0095 Score=61.54 Aligned_cols=143 Identities=14% Similarity=0.109 Sum_probs=79.5
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCC--ceeeee------EEEeCC
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN--VLRAHC------SFTTGH 85 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpN--IVkl~~------~~~~~~ 85 (671)
....-++.|+.|....+|++... .| .+++|+..... ....+..|+.+++.+...+ +.+++. +....+
T Consensus 22 ~~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~---~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g 96 (322)
T 2ppq_A 22 GSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSG 96 (322)
T ss_dssp CCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETT
T ss_pred CcceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC---CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECC
Confidence 34445678889999999998753 34 57899986421 1234566777776653211 233331 122346
Q ss_pred EEEEEEeccCCCCHH-----------H---HHHhh---CCCC----CCHHHHHHH---------------HHHHHHHHHH
Q 005886 86 CLWVVMPYMAGGSCL-----------H---IMKSA---YPEG----FEEPVIATL---------------LRETLKALVY 129 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~-----------~---~l~~~---~~~~----l~e~~i~~i---------------~~qIl~aL~y 129 (671)
..+++|+|++|..+. . .+... .... ......... ...+...+++
T Consensus 97 ~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~ 176 (322)
T 2ppq_A 97 RPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDY 176 (322)
T ss_dssp EEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHH
T ss_pred EEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHH
Confidence 789999999885421 0 11111 0000 111110000 0113344555
Q ss_pred HHH-------CCcccccCCCCcEEEcCCCceEEeccccc
Q 005886 130 LHF-------HGHIHRDVKAGNILIDSNGAIKLADFGVS 161 (671)
Q Consensus 130 LHs-------~gIVHrDLKPeNILld~~g~vKL~DFGls 161 (671)
++. .++||+|+.+.|||++.++.+.|+||+.+
T Consensus 177 l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a 215 (322)
T 2ppq_A 177 LAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFA 215 (322)
T ss_dssp HHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred HHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhc
Confidence 553 36899999999999987766689999865
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0021 Score=67.09 Aligned_cols=137 Identities=9% Similarity=0.071 Sum_probs=70.7
Q ss_pred EEEecccCceE-EEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCC--CCceeeeeEEEeCCEEEEEEeccC
Q 005886 19 YEEVGEGVSAT-VYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNH--PNVLRAHCSFTTGHCLWVVMPYMA 95 (671)
Q Consensus 19 ~~~LG~G~fG~-Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~H--pNIVkl~~~~~~~~~l~LVmEy~~ 95 (671)
.+.|+.|+... +|+... .+|..+++|...... ...+..|+.+++.+.. -.+.+++.+....+ +++||++.
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~----~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~ 95 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE----GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLG 95 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTT----TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCC
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCC----CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCC
Confidence 45566665554 666642 235667777643221 0234566777766532 23556666543333 67999997
Q ss_pred CCCHHHHHHhhC------------------------CCCCCHHHHH-------H-HH------------HHHHHHHHHH-
Q 005886 96 GGSCLHIMKSAY------------------------PEGFEEPVIA-------T-LL------------RETLKALVYL- 130 (671)
Q Consensus 96 ggsL~~~l~~~~------------------------~~~l~e~~i~-------~-i~------------~qIl~aL~yL- 130 (671)
|..+...+.... ...+...... . +. ..+...+..+
T Consensus 96 ~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~ 175 (333)
T 3csv_A 96 DALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQIL 175 (333)
T ss_dssp SCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHH
T ss_pred CcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHH
Confidence 766654432110 0112222111 0 00 0111222333
Q ss_pred -----HHCCcccccCCCCcEEEcCC----CceEEecccccc
Q 005886 131 -----HFHGHIHRDVKAGNILIDSN----GAIKLADFGVSA 162 (671)
Q Consensus 131 -----Hs~gIVHrDLKPeNILld~~----g~vKL~DFGls~ 162 (671)
+..++||||+.+.|||++.+ +.+.|+||+.+.
T Consensus 176 ~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 176 SAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp HHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred HhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 12479999999999999874 679999999764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0088 Score=61.96 Aligned_cols=75 Identities=16% Similarity=0.109 Sum_probs=48.0
Q ss_pred EEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCC--CceeeeeE-----EEeCCEEEEEEe
Q 005886 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHP--NVLRAHCS-----FTTGHCLWVVMP 92 (671)
Q Consensus 20 ~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~Hp--NIVkl~~~-----~~~~~~l~LVmE 92 (671)
..|+ |....||++.. ..|+.+++|+..... .....+..|..+++.+... .+++++.. ....+..++||+
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~--~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCC--CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 4566 88889998753 346678999986332 2345677788888766421 23444432 233567789999
Q ss_pred ccCCCC
Q 005886 93 YMAGGS 98 (671)
Q Consensus 93 y~~ggs 98 (671)
|++|..
T Consensus 108 ~i~G~~ 113 (328)
T 1zyl_A 108 SVGGRQ 113 (328)
T ss_dssp CCCCEE
T ss_pred ecCCCC
Confidence 998743
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0027 Score=69.45 Aligned_cols=72 Identities=10% Similarity=0.067 Sum_probs=49.6
Q ss_pred EEEEecccCceEEEEEEEcC-------CCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCc-eeeeeEEEeCCEEEE
Q 005886 18 LYEEVGEGVSATVYRALCIP-------LNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNV-LRAHCSFTTGHCLWV 89 (671)
Q Consensus 18 l~~~LG~G~fG~Vyka~~~~-------tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNI-Vkl~~~~~~~~~l~L 89 (671)
-++.|+.|....||++.... .+..|++|+.... .....+.+|..+++.+...++ .++++.+.+ .+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 35778999999999997652 2577999987321 112456689999887753333 566666543 27
Q ss_pred EEeccCC
Q 005886 90 VMPYMAG 96 (671)
Q Consensus 90 VmEy~~g 96 (671)
||+|++|
T Consensus 150 v~e~l~G 156 (429)
T 1nw1_A 150 LEEYIPS 156 (429)
T ss_dssp EECCCCE
T ss_pred EEEEeCC
Confidence 9999986
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.66 E-value=0.0026 Score=67.61 Aligned_cols=75 Identities=8% Similarity=0.142 Sum_probs=44.3
Q ss_pred EEEEecccCceEEEEEEEcC--------CCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCC-ceeeeeEEEeCCEEE
Q 005886 18 LYEEVGEGVSATVYRALCIP--------LNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN-VLRAHCSFTTGHCLW 88 (671)
Q Consensus 18 l~~~LG~G~fG~Vyka~~~~--------tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpN-IVkl~~~~~~~~~l~ 88 (671)
-+..|+.|....+|++.... .+..|++|+..... ........|..+++.+...+ +.++++.+ .+ +
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~ 110 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV--DELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--G 110 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG--GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc--cceecHHHHHHHHHHHHhcCCCCceEEec--CC--c
Confidence 35678889999999987643 12678889864321 11112357888887774333 44666554 22 6
Q ss_pred EEEeccCCCC
Q 005886 89 VVMPYMAGGS 98 (671)
Q Consensus 89 LVmEy~~ggs 98 (671)
+||+|++|..
T Consensus 111 ~v~e~i~G~~ 120 (369)
T 3c5i_A 111 RIEEWLYGDP 120 (369)
T ss_dssp EEEECCCSEE
T ss_pred EEEEEecCCc
Confidence 7999998743
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.57 E-value=0.006 Score=65.73 Aligned_cols=137 Identities=17% Similarity=0.145 Sum_probs=81.2
Q ss_pred EEEecccCceEEEEEEEcC-------CCcEEEEEEeccccCcccHHHHHHHHHHHHhCC-CCCceeeeeEEEeCCEEEEE
Q 005886 19 YEEVGEGVSATVYRALCIP-------LNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN-HPNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 19 ~~~LG~G~fG~Vyka~~~~-------tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~-HpNIVkl~~~~~~~~~l~LV 90 (671)
++.|..|-...+|++.... .+..|++|+... .......+.+|..+++.+. +.-..++++.+.+ .+|
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~--~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA--ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC--ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 3567778889999987642 346789998532 1123556678999998774 2223566666654 289
Q ss_pred EeccCCCCHH--------------HHHHh---hC---CCCC--CHHHHHHHHHHHHH-------------------HHHH
Q 005886 91 MPYMAGGSCL--------------HIMKS---AY---PEGF--EEPVIATLLRETLK-------------------ALVY 129 (671)
Q Consensus 91 mEy~~ggsL~--------------~~l~~---~~---~~~l--~e~~i~~i~~qIl~-------------------aL~y 129 (671)
|||++|..|. ..+.+ .. .... -...+..++.++-. .+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 9999875431 11111 10 0111 23455566554422 2333
Q ss_pred HHH--------CCcccccCCCCcEEEcCC----CceEEeccccc
Q 005886 130 LHF--------HGHIHRDVKAGNILIDSN----GAIKLADFGVS 161 (671)
Q Consensus 130 LHs--------~gIVHrDLKPeNILld~~----g~vKL~DFGls 161 (671)
|.. ..++|+|+.+.||+++.+ +.+.|+||..+
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a 252 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYS 252 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTC
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccC
Confidence 332 258999999999999876 78999999875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.43 E-value=0.0088 Score=66.07 Aligned_cols=74 Identities=12% Similarity=0.190 Sum_probs=48.3
Q ss_pred EEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCc-eeeeeEEEeCCEEEEEEeccCC
Q 005886 18 LYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNV-LRAHCSFTTGHCLWVVMPYMAG 96 (671)
Q Consensus 18 l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNI-Vkl~~~~~~~~~l~LVmEy~~g 96 (671)
-++.|+.|....+|++.....+..|++|+..... .... ...+|..+++.|...++ .++++.+. + .+||+|++|
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 3577899999999999875445788899874321 1111 12589999988865554 46777663 2 249999987
Q ss_pred C
Q 005886 97 G 97 (671)
Q Consensus 97 g 97 (671)
.
T Consensus 186 ~ 186 (458)
T 2qg7_A 186 Y 186 (458)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.94 E-value=0.053 Score=56.99 Aligned_cols=30 Identities=27% Similarity=0.457 Sum_probs=26.5
Q ss_pred CCcccccCCCCcEEEcCCCceEEecccccc
Q 005886 133 HGHIHRDVKAGNILIDSNGAIKLADFGVSA 162 (671)
Q Consensus 133 ~gIVHrDLKPeNILld~~g~vKL~DFGls~ 162 (671)
.+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 368999999999999988889999998653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.50 E-value=0.07 Score=58.24 Aligned_cols=75 Identities=8% Similarity=0.162 Sum_probs=47.9
Q ss_pred EEEEecccCceEEEEEEEcCC-------CcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCC-ceeeeeEEEeCCEEEE
Q 005886 18 LYEEVGEGVSATVYRALCIPL-------NEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN-VLRAHCSFTTGHCLWV 89 (671)
Q Consensus 18 l~~~LG~G~fG~Vyka~~~~t-------g~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpN-IVkl~~~~~~~~~l~L 89 (671)
-++.|..|-...+|++..... +..|++++..... ...-...+|..+++.+..-+ ..++++.+. + ++
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~~ 147 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKFYDSKVELDVFRYLSNINIAPNIIADFP--E--GR 147 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--EE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--CE
Confidence 356778888999999986521 5778999864321 11112357888887774222 345565432 2 67
Q ss_pred EEeccCCCC
Q 005886 90 VMPYMAGGS 98 (671)
Q Consensus 90 VmEy~~ggs 98 (671)
||+|++|..
T Consensus 148 I~efI~G~~ 156 (424)
T 3mes_A 148 IEEFIDGEP 156 (424)
T ss_dssp EEECCCSEE
T ss_pred EEEEeCCcc
Confidence 999999855
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.54 E-value=0.92 Score=48.58 Aligned_cols=28 Identities=36% Similarity=0.599 Sum_probs=23.8
Q ss_pred cccccCCCCcEEE------cCCCceEEecccccc
Q 005886 135 HIHRDVKAGNILI------DSNGAIKLADFGVSA 162 (671)
Q Consensus 135 IVHrDLKPeNILl------d~~g~vKL~DFGls~ 162 (671)
++|+|+.+.|||+ +.++.+.++||-+|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6899999999999 345679999998763
|
| >1nkp_B MAX protein, MYC proto-oncogene protein; transcription, DNA, BHLHZ, heterodimer, transcription/DNA complex; 1.80A {Homo sapiens} SCOP: a.38.1.1 PDB: 1an2_A* 1r05_A 1nlw_B | Back alignment and structure |
|---|
Probab=88.87 E-value=0.69 Score=38.51 Aligned_cols=37 Identities=19% Similarity=0.256 Sum_probs=34.2
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhh
Q 005886 623 LQSQMITLQQRIASIAEELQRQKIKNAQLEKQLHAVV 659 (671)
Q Consensus 623 l~~~~~~lq~~~~~~~~e~~~~k~~~~q~~~~~~~~~ 659 (671)
-..+|..||..+..|.+|+..++.+|.+|+++|.+|-
T Consensus 45 Ai~YI~~L~~~~~~l~~e~~~L~~~~~~L~~~l~~L~ 81 (83)
T 1nkp_B 45 ATEYIQYMRRKNHTHQQDIDDLKRQNALLEQQVRALG 81 (83)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTCS
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc
Confidence 3568999999999999999999999999999999875
|
| >3m91_A Proteasome-associated ATPase; coil COIL alpha helix, ATP-binding, chaperone, nucleotide-BI proteasome, S-nitrosylation; 1.80A {Mycobacterium tuberculosis} PDB: 3m9h_A | Back alignment and structure |
|---|
Probab=82.21 E-value=3.8 Score=30.96 Aligned_cols=42 Identities=14% Similarity=0.253 Sum_probs=37.8
Q ss_pred hhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhh
Q 005886 618 TKEKELQSQMITLQQRIASIAEELQRQKIKNAQLEKQLHAVV 659 (671)
Q Consensus 618 ~~e~~l~~~~~~lq~~~~~~~~e~~~~k~~~~q~~~~~~~~~ 659 (671)
.|=++|..++..|-.|-..|++-|++.+.+.+.|..+|..|.
T Consensus 9 ~r~~~l~~~l~~L~~rN~rL~~~L~~AR~el~~Lkeele~La 50 (51)
T 3m91_A 9 RDIHQLEARIDSLAARNSKLMETLKEARQQLLALREEVDRLG 50 (51)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhh
Confidence 344499999999999999999999999999999999999874
|
| >1nkp_A C-MYC, MYC proto-oncogene protein; transcription, DNA, BHLHZ, heterodimer, transcription/DNA complex; 1.80A {Homo sapiens} SCOP: a.38.1.1 | Back alignment and structure |
|---|
Probab=80.79 E-value=3.2 Score=34.97 Aligned_cols=36 Identities=14% Similarity=0.229 Sum_probs=33.6
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhh
Q 005886 624 QSQMITLQQRIASIAEELQRQKIKNAQLEKQLHAVV 659 (671)
Q Consensus 624 ~~~~~~lq~~~~~~~~e~~~~k~~~~q~~~~~~~~~ 659 (671)
..+|.+||.....+++|+..++.+|.||.++|..|-
T Consensus 51 ~~YI~~L~~~~~~l~~~~~~L~~~n~~L~~rl~~L~ 86 (88)
T 1nkp_A 51 TAYILSVQAEEQKLISEEDLLRKRREQLKHKLEQLG 86 (88)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhh
Confidence 468999999999999999999999999999999874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 671 | ||||
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-78 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-78 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-77 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-74 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-72 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-72 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-72 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-71 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-71 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-70 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-69 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-68 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-68 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-67 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-65 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-64 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-63 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-63 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-62 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-61 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-61 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-61 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-60 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-60 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-60 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-60 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-60 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-60 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-59 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-59 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-59 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-59 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-59 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-58 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-57 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-57 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-56 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-56 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-55 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-55 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-55 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-55 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-54 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-54 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-53 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-53 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-53 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-53 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-52 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-52 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-52 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-51 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-51 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-50 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-50 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-48 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-38 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-18 |
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 249 bits (637), Expect = 2e-78
Identities = 98/274 (35%), Positives = 154/274 (56%), Gaps = 12/274 (4%)
Query: 10 PVDAKD-YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRV 68
++ +D + + E+G+G VY+A + + A KV+D + +L+ E+ +
Sbjct: 7 DLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILAS 65
Query: 69 TNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALV 128
+HPN+++ +F + LW+++ + AGG+ +M E I + ++TL AL
Sbjct: 66 CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALN 124
Query: 129 YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEV 188
YLH + IHRD+KAGNIL +G IKLADFGVSA R R++F+GTP WMAPEV
Sbjct: 125 YLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR---RDSFIGTPYWMAPEV 181
Query: 189 MQ----QLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244
+ + YD+KAD+WS GIT +E+A P + PM+VLL ++ PP L +
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL--AQPS 239
Query: 245 RFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278
R+S +FK+ + CL K+ R T +L++H F
Sbjct: 240 RWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 273
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (632), Expect = 8e-78
Identities = 67/266 (25%), Positives = 129/266 (48%), Gaps = 5/266 (1%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN 73
+D+ L + +GEG V A+ E VA+K++D+++ + + I++E+ ++ NH N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH 133
V++ + G+ ++ + Y +GG ++ G EP + + +VYLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 134 GHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLH 193
G HRD+K N+L+D +K++DFG+ A +F +R+R N GT ++APE++++
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGL-ATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 194 GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL 253
+ D+WS GI + G P+ + + L+ K+ + L
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--WKKIDSAPLAL 239
Query: 254 VTACLVKDPKKRPTAEKLMKHHFFKH 279
+ LV++P R T + K ++
Sbjct: 240 LHKILVENPSARITIPDIKKDRWYNK 265
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (632), Expect = 1e-77
Identities = 106/296 (35%), Positives = 165/296 (55%), Gaps = 23/296 (7%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN 73
K Y +E++G+G S TVY A+ + + VAI+ ++L++ + I E+ MR +PN
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPN 78
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH 133
++ S+ G LWVVM Y+AGGS ++ +E IA + RE L+AL +LH +
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 134 GHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLH 193
IHRD+K+ NIL+ +G++KL DFG A + Q R+T VGTP WMAPEV+ +
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAPEVVTR-K 191
Query: 194 GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKEL 253
Y K DIWS GI A+E+ G P+ P++ L + N P + + ++ S F++
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP--ELQNPEKLSAIFRDF 249
Query: 254 VTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGERFRMLKAKEA 309
+ CL D +KR +A++L++H F K A+ + +L PL + AKEA
Sbjct: 250 LNRCLDMDVEKRGSAKELLQHQFLKIAKP--------LSSLTPL-----IAAAKEA 292
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 239 bits (611), Expect = 2e-74
Identities = 105/305 (34%), Positives = 146/305 (47%), Gaps = 16/305 (5%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNND--LDGIRREVQTMRVTNH 71
K + E+G G VY A + +E+VAIK + ++ I +EV+ ++ H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 72 PNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLH 131
PN ++ + H W+VM Y G + + P +E IA + L+ L YLH
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLH 132
Query: 132 FHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQ 191
H IHRDVKAGNIL+ G +KL DFG ++ M A N+FVGTP WMAPEV+
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NSFVGTPYWMAPEVILA 185
Query: 192 LH--GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249
+ YD K D+WS GIT +ELA P M L QN P L +S+
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ---SGHWSEY 242
Query: 250 FKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGERFRMLKAKEA 309
F+ V +CL K P+ RPT+E L+KH F R + I + E + K
Sbjct: 243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMK 302
Query: 310 DLLVQ 314
+L Q
Sbjct: 303 KILFQ 307
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (595), Expect = 2e-72
Identities = 70/275 (25%), Positives = 126/275 (45%), Gaps = 19/275 (6%)
Query: 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTN 70
D + + E+G G TVY+ L VA L K ++ + E + ++
Sbjct: 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ 66
Query: 71 HPNVLRAHCSFTT----GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKA 126
HPN++R + S+ + C+ +V M G+ +K + V+ + R+ LK
Sbjct: 67 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKG 124
Query: 127 LVYLHFHGH--IHRDVKAGNILIDS-NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCW 183
L +LH IHRD+K NI I G++K+ D G++ R +GTP +
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-----RASFAKAVIGTPEF 179
Query: 184 MAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 243
MAPE+ ++ YD D+++FG+ LE+A P+S+ + + + + D
Sbjct: 180 MAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF--D 235
Query: 244 KRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278
K KE++ C+ ++ +R + + L+ H FF+
Sbjct: 236 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (597), Expect = 4e-72
Identities = 85/310 (27%), Positives = 137/310 (44%), Gaps = 48/310 (15%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNV 74
D+ E+G G V++ P ++A K++ LE + I RE+Q + N P +
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 75 LRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF-H 133
+ + +F + + + M +M GGS ++K A E ++ + +K L YL H
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKH 124
Query: 134 GHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLH 193
+HRDVK NIL++S G IKL DFGVS + D+ N+FVGT +M+PE +Q
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQG-T 178
Query: 194 GYDFKADIWSFGITALELAHGHAPF----------------------------------- 218
Y ++DIWS G++ +E+A G P
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238
Query: 219 ----SKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274
PPM + + FS F++ V CL+K+P +R ++LM H
Sbjct: 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298
Query: 275 HFFKHARSND 284
F K + + +
Sbjct: 299 AFIKRSDAEE 308
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (592), Expect = 7e-72
Identities = 71/268 (26%), Positives = 120/268 (44%), Gaps = 10/268 (3%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVT 69
+ + + +G G TVY+ + VA+K+L++ L + EV +R T
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 70 NHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVY 129
H N+L ++T L +V + G S H + FE + + R+T + + Y
Sbjct: 62 RHVNILL-FMGYSTAPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDY 119
Query: 130 LHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEV- 188
LH IHRD+K+ NI + + +K+ DFG+ A + G+ WMAPEV
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGL-ATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 189 -MQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY-ERDKRF 246
MQ + Y F++D+++FGI EL G P+S ++ + D +
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 247 SKSFKELVTACLVKDPKKRPTAEKLMKH 274
K+ K L+ CL K +RP +++
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (585), Expect = 4e-71
Identities = 69/274 (25%), Positives = 126/274 (45%), Gaps = 17/274 (6%)
Query: 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNND--LDGIRREVQ 64
+++ ++ D+ + +G+G VY A I+A+KVL + +RREV+
Sbjct: 1 RQWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 58
Query: 65 TMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETL 124
HPN+LR + F +++++ Y G+ ++ F+E AT + E
Sbjct: 59 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELA 116
Query: 125 KALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWM 184
AL Y H IHRD+K N+L+ S G +K+ADFG S R T GT ++
Sbjct: 117 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-----SRRTTLCGTLDYL 171
Query: 185 APEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244
PE+++ +D K D+WS G+ E G PF + + +++
Sbjct: 172 PPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR-----VEFTFPD 225
Query: 245 RFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278
++ ++L++ L +P +RP ++++H +
Sbjct: 226 FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (584), Expect = 7e-71
Identities = 67/274 (24%), Positives = 115/274 (41%), Gaps = 18/274 (6%)
Query: 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNH 71
A+DY + +G G + +I+ K LD + + EV +R H
Sbjct: 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 62
Query: 72 PNVLRAHCSFT--TGHCLWVVMPYMAGGSCLHIMKSAYPEG--FEEPVIATLLRETLKAL 127
PN++R + T L++VM Y GG ++ E +E + ++ + AL
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 128 VYLHFHGH-----IHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPC 182
H +HRD+K N+ +D +KL DFG++ + FVGTP
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL---NHDTSFAKAFVGTPY 179
Query: 183 WMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER 242
+M+PE M + Y+ K+DIWS G EL PF+ + ++ +
Sbjct: 180 YMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR----RI 234
Query: 243 DKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHF 276
R+S E++T L RP+ E+++++
Sbjct: 235 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 230 bits (587), Expect = 3e-70
Identities = 65/266 (24%), Positives = 123/266 (46%), Gaps = 10/266 (3%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNV 74
Y ++EE+G G V+R A K + +D + +R+E+QTM V HP +
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTL 85
Query: 75 LRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHG 134
+ H +F + + ++ +M+GG + + E +R+ K L ++H +
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENN 144
Query: 135 HIHRDVKAGNILIDS--NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQL 192
++H D+K NI+ + + +KL DFG++A + D ++S GT + APEV +
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL----DPKQSVKVTTGTAEFAAPEVAEG- 199
Query: 193 HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKE 252
+ D+WS G+ + L G +PF + L +++ +D S+ K+
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-TLRNVKSCDWNMDDSAFSGISEDGKD 258
Query: 253 LVTACLVKDPKKRPTAEKLMKHHFFK 278
+ L+ DP R T + ++H +
Sbjct: 259 FIRKLLLADPNTRMTIHQALEHPWLT 284
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 224 bits (573), Expect = 3e-69
Identities = 78/278 (28%), Positives = 126/278 (45%), Gaps = 21/278 (7%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--------NDLDGIRREVQTM 66
+Y E +G GVS+ V R + P + A+K++D+ + +EV +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 67 R-VTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLK 125
R V+ HPN+++ ++ T ++V M G + E ++R L+
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLE 121
Query: 126 ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMA 185
+ LH +HRD+K NIL+D + IKL DFG S + D GTP ++A
Sbjct: 122 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL----DPGEKLREVCGTPSYLA 177
Query: 186 PEVMQQLH-----GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDY 240
PE+++ GY + D+WS G+ L G PF M +L M +
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ-FGS 236
Query: 241 ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278
+S + K+LV+ LV P+KR TAE+ + H FF+
Sbjct: 237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 224 bits (571), Expect = 6e-68
Identities = 57/271 (21%), Positives = 119/271 (43%), Gaps = 10/271 (3%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNV 74
Y + EE+G G V+R + + K ++ D ++ E+ M +HP +
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKL 88
Query: 75 LRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHG 134
+ H +F + + +++ +++GG + + E + +R+ + L ++H H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHS 147
Query: 135 HIHRDVKAGNILIDS--NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQL 192
+H D+K NI+ ++ ++K+ DFG++ + + T + APE++ +
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKL----NPDEIVKVTTATAEFAAPEIVDR- 202
Query: 193 HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKE 252
F D+W+ G+ L G +PF+ ++ L + D + S K+
Sbjct: 203 EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE-FDEDAFSSVSPEAKD 261
Query: 253 LVTACLVKDPKKRPTAEKLMKHHFFKHARSN 283
+ L K+P+KR T ++H + K SN
Sbjct: 262 FIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 292
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 8e-68
Identities = 74/272 (27%), Positives = 126/272 (46%), Gaps = 17/272 (6%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHP 72
D++ + +GEG +TV A + + AIK+L+ N + + RE M +HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 73 NVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF 132
++ + +F L+ + Y G L ++ F+E E + AL YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHG 126
Query: 133 HGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQL 192
G IHRD+K NIL++ + I++ DFG A + +Q N+FVGT +++PE++ +
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGT-AKVLSPESKQARANSFVGTAQYVSPELLTE- 184
Query: 193 HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKE 252
+D+W+ G +L G PF + ++ L+Y+ ++F ++
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-----LEYDFPEKFFPKARD 239
Query: 253 LVTACLVKDPKKRPTAEK------LMKHHFFK 278
LV LV D KR E+ L H FF+
Sbjct: 240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 271
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 221 bits (564), Expect = 2e-67
Identities = 78/304 (25%), Positives = 136/304 (44%), Gaps = 12/304 (3%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNV 74
Y + +G G + V A ++VAIK + + + E+ + HPN+
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNI 69
Query: 75 LRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHG 134
+ + +G L+++M ++GG + + E + L+ + L A+ YLH G
Sbjct: 70 VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLHDLG 127
Query: 135 HIHRDVKAGNILI---DSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQ 191
+HRD+K N+L D + I ++DFG+S D +T GTP ++APEV+ Q
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME----DPGSVLSTACGTPGYVAPEVLAQ 183
Query: 192 LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251
Y D WS G+ A L G+ PF K+ L A D S S K
Sbjct: 184 -KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL-KAEYEFDSPYWDDISDSAK 241
Query: 252 ELVTACLVKDPKKRPTAEKLMKHHFFKHARSND-FLARSIVDNLAPLGERFRMLKAKEAD 310
+ + + KDP+KR T E+ ++H + + D + +S+ + + + + +A A
Sbjct: 242 DFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWKQAFNAT 301
Query: 311 LLVQ 314
+V+
Sbjct: 302 AVVR 305
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 4e-65
Identities = 62/266 (23%), Positives = 114/266 (42%), Gaps = 11/266 (4%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNV 74
Y + E++G G V+R + + K + ++ + L +++E+ + + H N+
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL--VKKEISILNIARHRNI 63
Query: 75 LRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHG 134
L H SF + L ++ +++G + + E I + + + +AL +LH H
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 135 HIHRDVKAGNILIDS--NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQL 192
H D++ NI+ + + IK+ +FG + + + P + APEV Q
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL----KPGDNFRLLFTAPEYYAPEVHQH- 177
Query: 193 HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKE 252
D+WS G L G PF + ++ + NA D E K S +
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIENIMNAEYTFDEEAFKEISIEAMD 236
Query: 253 LVTACLVKDPKKRPTAEKLMKHHFFK 278
V LVK+ K R TA + ++H + K
Sbjct: 237 FVDRLLVKERKSRMTASEALQHPWLK 262
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 211 bits (539), Expect = 8e-64
Identities = 77/284 (27%), Positives = 125/284 (44%), Gaps = 21/284 (7%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNH 71
+D+++ +G G V+ A+KVL E ++ E + + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 72 PNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLH 131
P ++R +F ++++M Y+ GG +++ + F PV E AL YLH
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLH 121
Query: 132 FHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQ 191
I+RD+K NIL+D NG IK+ DFG + + D T GTP ++APEV+
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD------VTYTLCGTPDYIAPEVVST 175
Query: 192 LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251
Y+ D WSFGI E+ G+ PF MK L + F++ K
Sbjct: 176 -KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-----ELRFPPFFNEDVK 229
Query: 252 ELVTACLVKDPKKR-----PTAEKLMKHHFFKHARSNDFLARSI 290
+L++ + +D +R E + H +FK L+R+I
Sbjct: 230 DLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNI 273
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 3e-63
Identities = 75/280 (26%), Positives = 131/280 (46%), Gaps = 15/280 (5%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTM-RVTNH 71
D+ L++ +G+G V+ A N+ AIK L + ++D++ E + + H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 72 PNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLH 131
P + C+F T L+ VM Y+ GG ++ ++S + F+ E + L +LH
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLH 120
Query: 132 FHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQ 191
G ++RD+K NIL+D +G IK+ADFG+ + NTF GTP ++APE++
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT---NTFCGTPDYIAPEILLG 177
Query: 192 LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251
Y+ D WSFG+ E+ G +PF ++ + P + K K
Sbjct: 178 -QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF-----YPRWLEKEAK 231
Query: 252 ELVTACLVKDPKKRPTAEK-LMKHHFFKHARSNDFLARSI 290
+L+ V++P+KR + +H F+ + + I
Sbjct: 232 DLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEI 271
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 5e-63
Identities = 78/318 (24%), Positives = 126/318 (39%), Gaps = 23/318 (7%)
Query: 15 DYRLYEEV-GEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTM-RVTNHP 72
DY++ +V G G++ V + E A+K+L D RREV+ R + P
Sbjct: 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML------QDCPKARREVELHWRASQCP 65
Query: 73 NVLRAHCSFTTGH----CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALV 128
+++R + + CL +VM + GG ++ + F E + +++ +A+
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 125
Query: 129 YLHFHGHIHRDVKAGNILIDS---NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMA 185
YLH HRDVK N+L S N +KL DFG + S T TP ++A
Sbjct: 126 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS----HNSLTTPCYTPYYVA 181
Query: 186 PEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQN---APPGLDYER 242
PEV+ YD D+WS G+ L G+ PF + +
Sbjct: 182 PEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240
Query: 243 DKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSIVDNLAPLGERFR 302
S+ K L+ L +P +R T + M H + + L ER+
Sbjct: 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWE 300
Query: 303 MLKAKEADLLVQNKALYE 320
+K + L + YE
Sbjct: 301 DVKEEMTSALATMRVDYE 318
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 8e-62
Identities = 67/272 (24%), Positives = 117/272 (43%), Gaps = 14/272 (5%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN 70
+ + RL ++G+G V+ VAIK L + + +E Q M+
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE--AFLQEAQVMKKLR 70
Query: 71 HPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYL 130
H +++ + + +++V YM+ GS L +K + P + + + + Y+
Sbjct: 71 HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 131 HFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQ 190
++HRD++A NIL+ N K+ADFG++ + D + +R W APE
Sbjct: 130 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL 187
Query: 191 QLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249
+ K+D+WSFGI EL G P+ +VL + G +S
Sbjct: 188 Y-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER----GYRMPCPPECPES 242
Query: 250 FKELVTACLVKDPKKRPTAEKLMK--HHFFKH 279
+L+ C K+P++RPT E L +F
Sbjct: 243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 1e-61
Identities = 58/276 (21%), Positives = 116/276 (42%), Gaps = 20/276 (7%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN 70
++ K+ +L + +G+G V VA+K + + E M
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDA---TAQAFLAEASVMTQLR 58
Query: 71 HPNVLRAH-CSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVY 129
H N+++ L++V YMA GS + ++S + + +A+ Y
Sbjct: 59 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 118
Query: 130 LHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVM 189
L + +HRD+ A N+L+ + K++DFG++ +++T W APE +
Sbjct: 119 LEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA------SSTQDTGKLPVKWTAPEAL 172
Query: 190 QQLHGYDFKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSK 248
++ + K+D+WSFGI E + G P+ + P V+ + G +
Sbjct: 173 RE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK----GYKMDAPDGCPP 227
Query: 249 SFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSND 284
+ E++ C D RP+ +L + +H ++++
Sbjct: 228 AVYEVMKNCWHLDAAMRPSFLQLREQ--LEHIKTHE 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 1e-61
Identities = 63/265 (23%), Positives = 119/265 (44%), Gaps = 12/265 (4%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN 70
+D KD +E+G G V VAIK++ + + D E + M +
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIK--EGSMSEDEFIEEAKVMMNLS 57
Query: 71 HPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYL 130
H +++ + T ++++ YMA G L+ ++ F+ + + ++ +A+ YL
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYL 116
Query: 131 HFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQ 190
+HRD+ A N L++ G +K++DFG+S + D D S W PEV+
Sbjct: 117 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD--DEYTSSVGSKFPVRWSPPEVLM 174
Query: 191 QLHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249
+ K+DIW+FG+ E+ + G P+ ++ + Q GL R S+
Sbjct: 175 Y-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ----GLRLYRPHLASEK 229
Query: 250 FKELVTACLVKDPKKRPTAEKLMKH 274
++ +C + +RPT + L+ +
Sbjct: 230 VYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 204 bits (521), Expect = 1e-61
Identities = 70/270 (25%), Positives = 123/270 (45%), Gaps = 10/270 (3%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNND--LDGIRREVQTMRVTNHP 72
Y L E +G G + V+ A + L+ VA+KVL + + RRE Q NHP
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67
Query: 73 NVLRAHCSFTT----GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALV 128
++ + + G ++VM Y+ G + I+ + P ++ + +AL
Sbjct: 68 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALN 125
Query: 129 YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEV 188
+ H +G IHRDVK NI+I + A+K+ DFG++ + D+G+ +GT +++PE
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 189 MQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSK 248
+ D ++D++S G E+ G PF+ P+ V ++ P R + S
Sbjct: 186 ARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI-PPSARHEGLSA 243
Query: 249 SFKELVTACLVKDPKKRPTAEKLMKHHFFK 278
+V L K+P+ R M+ +
Sbjct: 244 DLDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 3e-61
Identities = 71/286 (24%), Positives = 116/286 (40%), Gaps = 17/286 (5%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDG-----IRREVQTMRV 68
Y EE+G G A V + A K + + + G I REV ++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 69 TNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALV 128
HPNV+ H + + +++ +AGG + E E L++ L +
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVY 127
Query: 129 YLHFHGHIHRDVKAGNILIDSNGA----IKLADFGVSACMFDAGDRQRSRNTFVGTPCWM 184
YLH H D+K NI++ IK+ DFG++ + D GTP ++
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI----DFGNEFKNIFGTPEFV 183
Query: 185 APEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244
APE++ +AD+WS G+ L G +PF + L + + E
Sbjct: 184 APEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-VSAVNYEFEDEYFS 241
Query: 245 RFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSNDFLARSI 290
S K+ + LVKDPKKR T + ++H + K + L+ +
Sbjct: 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAW 287
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 1e-60
Identities = 58/302 (19%), Positives = 122/302 (40%), Gaps = 33/302 (10%)
Query: 1 MDLVVEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEI-----VAIKVLDLEKCNND 55
+ + ++ ++ + +G G V A +++ VA+K+L + +++
Sbjct: 24 REYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE 83
Query: 56 LDGIRREVQTM-RVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFE-- 112
+ + E++ M ++ +H N++ + T ++++ Y G L+ ++S + E
Sbjct: 84 REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDE 143
Query: 113 -------------------EPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAI 153
+ + K + +L F +HRD+ A N+L+ +
Sbjct: 144 IEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVV 203
Query: 154 KLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALE-LA 212
K+ DFG+ A + R WMAPE + + Y K+D+WS+GI E +
Sbjct: 204 KICDFGL-ARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFS 261
Query: 213 HGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLM 272
G P+ P +QN G ++ ++ ++ +C D +KRP+ L
Sbjct: 262 LGVNPYPGIPVDANFYKLIQN---GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318
Query: 273 KH 274
Sbjct: 319 SF 320
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 3e-60
Identities = 73/284 (25%), Positives = 119/284 (41%), Gaps = 18/284 (6%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNH 71
D+ + +G+G V A+K+L E +++ E + ++ T H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 72 PNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLH 131
P + +F T L VM Y GG + F E E + AL YLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLH 122
Query: 132 FHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQ 191
++RD+K N+++D +G IK+ DFG+ G TF GTP ++APEV++
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLAPEVLED 179
Query: 192 LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251
+ Y D W G+ E+ G PF ++ + L + + S K
Sbjct: 180 -NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-----EIRFPRTLSPEAK 233
Query: 252 ELVTACLVKDPKKRP-----TAEKLMKHHFFKHARSNDFLARSI 290
L+ L KDPK+R A+++M+H FF D + + +
Sbjct: 234 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL 277
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (513), Expect = 3e-60
Identities = 73/287 (25%), Positives = 121/287 (42%), Gaps = 32/287 (11%)
Query: 20 EEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR----REVQTMRVTNHPNVL 75
+ +GEG ATVY+A N+IVAIK + L + DGI RE++ ++ +HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 76 RAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGH 135
+F + +V +M + I ++ I + TL+ L YLH H
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV--LTPSHIKAYMLMTLQGLEYLHQHWI 121
Query: 136 IHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGY 195
+HRD+K N+L+D NG +KLADFG++ G R+ V T + APE++ Y
Sbjct: 122 LHRDLKPNNLLLDENGVLKLADFGLAKSF---GSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 196 DFKADIWSFGITALELAHGHAPFSKYPPMKVL-----------------------LMTLQ 232
D+W+ G EL + L +T +
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 233 NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKH 279
+ P + +L+ + +P R TA + +K +F +
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 203 bits (517), Expect = 6e-60
Identities = 65/286 (22%), Positives = 121/286 (42%), Gaps = 19/286 (6%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDG-----IRREVQTMRVT 69
D+ ++ +G G VY ++ A+K LD ++ R + +
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 70 NHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVY 129
+ P ++ +F T L ++ M GG + + F E + E + L +
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEH 122
Query: 130 LHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVM 189
+H ++RD+K NIL+D +G ++++D G+ AC F ++ + VGT +MAPEV+
Sbjct: 123 MHNRFVVYRDLKPANILLDEHGHVRISDLGL-ACDFS----KKKPHASVGTHGYMAPEVL 177
Query: 190 QQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249
Q+ YD AD +S G +L GH+PF ++ + + E FS
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLTMAVELPDSFSPE 235
Query: 250 FKELVTACLVKDPKKRPT-----AEKLMKHHFFKHARSNDFLARSI 290
+ L+ L +D +R A+++ + FF+ +
Sbjct: 236 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKY 281
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 8e-60
Identities = 62/270 (22%), Positives = 109/270 (40%), Gaps = 12/270 (4%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLN---EIVAIKVLDLEKCNND--LDGIRREVQT 65
+ KD RL E++G+G V R + VA+K L + + +D REV
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 66 MRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLK 125
M +H N++R + T + +V GS L ++ + F ++ + +
Sbjct: 65 MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAE 122
Query: 126 ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMA 185
+ YL IHRD+ A N+L+ + +K+ DFG+ + D + W A
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 186 PEVMQQLHGYDFKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244
PE ++ + +D W FG+T E +G P+ ++L + G R +
Sbjct: 183 PESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE---GERLPRPE 238
Query: 245 RFSKSFKELVTACLVKDPKKRPTAEKLMKH 274
+ ++ C P+ RPT L
Sbjct: 239 DCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 200 bits (510), Expect = 9e-60
Identities = 60/270 (22%), Positives = 105/270 (38%), Gaps = 12/270 (4%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNE---IVAIKVLDLEKCNNDLDGIRREVQTMR 67
+D ++ + +G G V + VAIK L E M
Sbjct: 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMG 82
Query: 68 VTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKAL 127
+HPNV+ T + ++ +M GS ++ + F + +LR +
Sbjct: 83 QFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIAAGM 141
Query: 128 VYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNT--FVGTPCWMA 185
YL ++HRD+ A NIL++SN K++DFG+S + D + W A
Sbjct: 142 KYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 201
Query: 186 PEVMQQLHGYDFKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244
PE +Q + +D+WS+GI E +++G P+ V+ Q+
Sbjct: 202 PEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL----PPPM 256
Query: 245 RFSKSFKELVTACLVKDPKKRPTAEKLMKH 274
+ +L+ C KD RP +++
Sbjct: 257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 1e-59
Identities = 65/270 (24%), Positives = 116/270 (42%), Gaps = 14/270 (5%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN 70
V + +L E +G G V+ + VA+K L + + D E M+
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLK--QGSMSPDAFLAEANLMKQLQ 66
Query: 71 HPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYL 130
H ++R + T ++++ YM GS + +K+ + + + + + ++
Sbjct: 67 HQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 131 HFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQ 190
+IHRD++A NIL+ + K+ADFG++ + D + +R W APE +
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAIN 183
Query: 191 QLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249
+ K+D+WSFGI E+ HG P+ +V +QN G R +
Sbjct: 184 Y-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV----IQNLERGYRMVRPDNCPEE 238
Query: 250 FKELVTACLVKDPKKRPTAEKLMK--HHFF 277
+L+ C + P+ RPT + L FF
Sbjct: 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 1e-59
Identities = 67/285 (23%), Positives = 119/285 (41%), Gaps = 14/285 (4%)
Query: 7 KRFPVDAKDYRLYE-EVGEGVSATVYRALCIPLNE--IVAIKVLDLEKCNNDLDGIRREV 63
K+ + + + + E+G G +V + + + VAIKVL D + + RE
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 64 QTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRET 123
Q M ++P ++R L +VM GG LH E +A LL +
Sbjct: 61 QIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGP-LHKFLVGKREEIPVSNVAELLHQV 118
Query: 124 LKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCW 183
+ YL +HRD+ A N+L+ + K++DFG+S + +R+ W
Sbjct: 119 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 178
Query: 184 MAPEVMQQLHGYDFKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER 242
APE + + ++D+WS+G+T E L++G P+ K +V+ Q E
Sbjct: 179 YAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM----EC 233
Query: 243 DKRFSKSFKELVTACLVKDPKKRPTA---EKLMKHHFFKHARSND 284
L++ C + + RP E+ M+ ++ A +
Sbjct: 234 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 199 bits (507), Expect = 2e-59
Identities = 64/280 (22%), Positives = 125/280 (44%), Gaps = 12/280 (4%)
Query: 8 RFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMR 67
++ ++ D + ++G G VY + + VA+K L + +++ +E M+
Sbjct: 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMK 68
Query: 68 VTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKAL 127
HPN+++ T +++ +M G+ L ++ + V+ + + A+
Sbjct: 69 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 128
Query: 128 VYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPE 187
YL IHRD+ A N L+ N +K+ADFG+S M GD + W APE
Sbjct: 129 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPE 186
Query: 188 VMQQLHGYDFKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246
+ + + K+D+W+FG+ E+A +G +P+ +V + ER +
Sbjct: 187 SLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV----YELLEKDYRMERPEGC 241
Query: 247 SKSFKELVTACLVKDPKKRPTAEKLMK--HHFFKHARSND 284
+ EL+ AC +P RP+ ++ + F+ + +D
Sbjct: 242 PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 281
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 2e-59
Identities = 62/274 (22%), Positives = 111/274 (40%), Gaps = 25/274 (9%)
Query: 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-----DLDGIRREVQTMR 67
Y++ +G G +VY + + N VAIK ++ ++ ++ + + EV ++
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 68 --VTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLK 125
+ V+R F +++ L + +E + + + L+
Sbjct: 63 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLE 121
Query: 126 ALVYLHFHGHIHRDVKAGNILIDSN-GAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWM 184
A+ + H G +HRD+K NILID N G +KL DFG A + + F GT +
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-----KDTVYTDFDGTRVYS 176
Query: 185 APEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244
PE ++ + A +WS GI ++ G PF + +
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR-----------GQVFFRQ 225
Query: 245 RFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278
R S + L+ CL P RPT E++ H + +
Sbjct: 226 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 2e-59
Identities = 57/265 (21%), Positives = 112/265 (42%), Gaps = 12/265 (4%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN 70
+D + +E+G G V+ + + VAIK + + + E + M +
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIR--EGAMSEEDFIEEAEVMMKLS 58
Query: 71 HPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYL 130
HP +++ + + +V +M G +++ F + + + + + YL
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAYL 117
Query: 131 HFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQ 190
IHRD+ A N L+ N IK++DFG++ + D D+ S W +PEV
Sbjct: 118 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD--DQYTSSTGTKFPVKWASPEVFS 175
Query: 191 QLHGYDFKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249
Y K+D+WSFG+ E + G P+ +V +++ G + + S
Sbjct: 176 F-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV----VEDISTGFRLYKPRLASTH 230
Query: 250 FKELVTACLVKDPKKRPTAEKLMKH 274
+++ C + P+ RP +L++
Sbjct: 231 VYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 5e-59
Identities = 58/296 (19%), Positives = 104/296 (35%), Gaps = 33/296 (11%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVL 75
Y +GEG V A VAIK + + RE++ + H N++
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 76 RAHCSFTTGHC----LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLH 131
+ ++ ++ G ++K+ + I L + L+ L Y+H
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIH 126
Query: 132 FHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQ 191
+HRD+K N+L+++ +K+ DFG++ D +V T + APE+M
Sbjct: 127 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 186
Query: 192 LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVL--LMTLQNAPPGLDYERD------ 243
GY DIWS G E+ F + L ++ + +P D
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246
Query: 244 ------------------KRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281
+L+ L +P KR E+ + H + +
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 6e-59
Identities = 57/275 (20%), Positives = 112/275 (40%), Gaps = 15/275 (5%)
Query: 11 VDAKDYRLYE-EVGEGVSATVYRALCI--PLNEIVAIKVLDLEKCNNDL-DGIRREVQTM 66
+D K L + E+G G TV + + + VA+K+L E + L D + E M
Sbjct: 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62
Query: 67 RVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKA 126
+ ++P ++R +VM G ++ ++ I L+ +
Sbjct: 63 QQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMG 119
Query: 127 LVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAP 186
+ YL +HRD+ A N+L+ + K++DFG+S + + +++ W AP
Sbjct: 120 MKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179
Query: 187 EVMQQLHGYDFKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245
E + + + K+D+WSFG+ E ++G P+ +V M +
Sbjct: 180 ECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM----GCPAG 234
Query: 246 FSKSFKELVTACLVKDPKKRPTAEKL--MKHHFFK 278
+ +L+ C D + RP + +++
Sbjct: 235 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 1e-58
Identities = 73/292 (25%), Positives = 124/292 (42%), Gaps = 29/292 (9%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPN 73
+++ E++GEG VY+A E+VA+K + L+ RE+ ++ NHPN
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH 133
+++ T + L++V ++ M ++ G P+I + L + L+ L + H H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 134 GHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLH 193
+HRD+K N+LI++ GAIKLADFG++ G R+ V T + APE++
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 194 GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD---------- 243
Y DIWS G E+ A F + L + +
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 244 --------------KRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281
+ + L++ L DP KR +A+ + H FF+
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 1e-58
Identities = 58/269 (21%), Positives = 107/269 (39%), Gaps = 13/269 (4%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNE----IVAIKVLDLEKCNNDLDGIRREVQTM 66
+ +++ + +G G TVY+ L IP E VAIK L I E M
Sbjct: 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 67 RVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKA 126
++P+V R T + M G L ++ + + + + K
Sbjct: 66 ASVDNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKG 123
Query: 127 LVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAP 186
+ YL +HRD+ A N+L+ + +K+ DFG++ + A +++ WMA
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA-KLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 187 EVMQQLHGYDFKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245
E + Y ++D+WS+G+T EL G P+ P ++ + + +
Sbjct: 183 ESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL----PQPPI 237
Query: 246 FSKSFKELVTACLVKDPKKRPTAEKLMKH 274
+ ++ C + D RP +L+
Sbjct: 238 CTIDVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 193 bits (492), Expect = 2e-57
Identities = 69/289 (23%), Positives = 115/289 (39%), Gaps = 31/289 (10%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPN 73
Y E++GEG VY+A E A+K + LEK + RE+ ++ H N
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFH 133
+++ + T L +V ++ + G E + L + L + Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 134 GHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLH 193
+HRD+K N+LI+ G +K+ADFG++ G R + T + AP+V+
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAF---GIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 194 GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQ--------------------- 232
Y DIWS G E+ +G F L+ +
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 233 ---NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278
P K +S +L++ L DP +R TA++ ++H +FK
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 2e-57
Identities = 66/312 (21%), Positives = 115/312 (36%), Gaps = 39/312 (12%)
Query: 5 VEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREV 63
VE F + Y ++G+G V++A + VA+K + +E RE+
Sbjct: 1 VECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREI 60
Query: 64 QTMRVTNHPNVLRAHCSFTTG--------HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPV 115
+ +++ H NV+ T +++V + L + S F
Sbjct: 61 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD--LAGLLSNVLVKFTLSE 118
Query: 116 IATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSR- 174
I +++ L L Y+H + +HRD+KA N+LI +G +KLADFG++ A + Q +R
Sbjct: 119 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 178
Query: 175 NTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPF---------------- 218
V T + PE++ Y D+W G E+
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238
Query: 219 -----------SKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPT 267
Y + L + D + +L+ LV DP +R
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 298
Query: 268 AEKLMKHHFFKH 279
++ + H FF
Sbjct: 299 SDDALNHDFFWS 310
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 8e-56
Identities = 64/270 (23%), Positives = 108/270 (40%), Gaps = 13/270 (4%)
Query: 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNE---IVAIKVLDLEKCNNDLDGIRREVQT 65
+ + + L +GEG V++ + + VAIK ++ + +E T
Sbjct: 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALT 61
Query: 66 MRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLK 125
MR +HP++++ T + +W++M G ++ + + +
Sbjct: 62 MRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLST 119
Query: 126 ALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMA 185
AL YL +HRD+ A N+L+ SN +KL DFG+S M D+ + S WMA
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS--KGKLPIKWMA 177
Query: 186 PEVMQQLHGYDFKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244
PE + + +D+W FG+ E L HG PF V+
Sbjct: 178 PESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL----PMPP 232
Query: 245 RFSKSFKELVTACLVKDPKKRPTAEKLMKH 274
+ L+T C DP +RP +L
Sbjct: 233 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (482), Expect = 9e-56
Identities = 59/293 (20%), Positives = 112/293 (38%), Gaps = 36/293 (12%)
Query: 9 FPVDAKDYRLYEEVGEGVSATVYRA-----LCIPLNEIVAIKVLDLEKCNNDLDGIRREV 63
+P + + ++GEG V++A L +VA+K+L E + +RE
Sbjct: 10 YPRN--NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREA 67
Query: 64 QTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKS------------------ 105
M ++PN+++ G + ++ YMA G ++S
Sbjct: 68 ALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 127
Query: 106 ----AYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVS 161
P + R+ + YL +HRD+ N L+ N +K+ADFG+S
Sbjct: 128 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 187
Query: 162 ACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALE-LAHGHAPFSK 220
++ A D ++ WM PE + + Y ++D+W++G+ E ++G P+
Sbjct: 188 RNIYSA-DYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYG 245
Query: 221 YPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273
+V+ + L+ C K P RP+ + +
Sbjct: 246 MAHEEVIYYVRDGNIL----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-55
Identities = 77/297 (25%), Positives = 123/297 (41%), Gaps = 38/297 (12%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPL-NEIVAIKVLDLEKCN-NDLDGIRREVQTMR---V 68
+ Y E+GEG V++A + VA+K + ++ REV +R
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 69 TNHPNVLRAHCSFTTGH-----CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRET 123
HPNV+R T L +V ++ ++ K P G I ++ +
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP-GVPTETIKDMMFQL 125
Query: 124 LKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCW 183
L+ L +LH H +HRD+K NIL+ S+G IKLADFG++ Q + + V T +
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY----SFQMALTSVVVTLWY 181
Query: 184 MAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVL--LMTLQNAPPGLDYE 241
APEV+ Q Y D+WS G E+ F + L ++ + P D+
Sbjct: 182 RAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 242 RD--------------------KRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278
RD + K+L+ CL +P KR +A + H +F+
Sbjct: 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 3e-55
Identities = 66/291 (22%), Positives = 120/291 (41%), Gaps = 31/291 (10%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHP 72
+ Y E++GEG TV++A +EIVA+K + L+ + RE+ ++ H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 73 NVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF 132
N++R H + L +V + + + ++ + L + LK L + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 133 HGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQL 192
+HRD+K N+LI+ NG +KLA+FG++ G R + V T + P+V+
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAF---GIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 193 HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYE----------- 241
Y D+WS G ELA+ P + L + E
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 242 --------------RDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278
+ + + ++L+ L +P +R +AE+ ++H +F
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 6e-55
Identities = 54/267 (20%), Positives = 102/267 (38%), Gaps = 9/267 (3%)
Query: 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNE----IVAIKVLDLEKCNNDLDGIRREVQTM 66
+ + +G G VY+ + + VAIK L E M
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 63
Query: 67 RVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKA 126
+H N++R + + ++ YM G+ ++ E F + +LR
Sbjct: 64 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAG 122
Query: 127 LVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAP 186
+ YL ++HRD+ A NIL++SN K++DFG+S + D + + + W AP
Sbjct: 123 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 187 EVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246
E + + +D+WSFGI E+ ++ + + G
Sbjct: 183 EAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND---GFRLPTPMDC 238
Query: 247 SKSFKELVTACLVKDPKKRPTAEKLMK 273
+ +L+ C ++ +RP ++
Sbjct: 239 PSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 187 bits (475), Expect = 7e-55
Identities = 55/299 (18%), Positives = 98/299 (32%), Gaps = 27/299 (9%)
Query: 1 MDLVVEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIR 60
M+L V R YRL ++G G +Y I E VAIK+ ++ +
Sbjct: 1 MELRVGNR-------YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLH 50
Query: 61 REVQTMRVTNHPNVLRA-HCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATL 119
E + ++ + G +VM + L + + F + L
Sbjct: 51 IESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPS--LEDLFNFCSRKFSLKTVLLL 108
Query: 120 LRETLKALVYLHFHGHIHRDVKAGNILIDSNGA---IKLADFGVSACMFDAGDRQ----R 172
+ + + Y+H IHRDVK N L+ + + DFG++ DA Q R
Sbjct: 109 ADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYR 168
Query: 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQ 232
GT + + + D+ S G + G P+ +
Sbjct: 169 ENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER 227
Query: 233 NAPPGLDY---ERDKRFSKSFKELVTACLVKDPKKRPTAE---KLMKHHFFKHARSNDF 285
+ + K + F + C +P +L ++ F + S D+
Sbjct: 228 ISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDY 286
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 8e-55
Identities = 74/289 (25%), Positives = 126/289 (43%), Gaps = 16/289 (5%)
Query: 14 KDYRLYEEVGEGVSATVYRALCI---PLNEIVAIKVLDLEKCNND---LDGIRREVQTM- 66
+++ L + +G G V+ I ++ A+KVL + R E Q +
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 67 RVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKA 126
+ P ++ H +F T L +++ Y+ GG + F E + + E + A
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLA 141
Query: 127 LVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAP 186
L +LH G I+RD+K NIL+DSNG + L DFG+ + F A + +R+ +
Sbjct: 142 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL-SKEFVADETERAYDFCGTIEYMAPD 200
Query: 187 EVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246
V G+D D WS G+ EL G +PF+ + + +
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EPPYPQEM 259
Query: 247 SKSFKELVTACLVKDPKKRP-----TAEKLMKHHFFKHARSNDFLARSI 290
S K+L+ L+KDPKKR A+++ +H FF+ +D A+ +
Sbjct: 260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKV 308
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 1e-54
Identities = 57/286 (19%), Positives = 110/286 (38%), Gaps = 28/286 (9%)
Query: 8 RFP-VDAKDYRLYEEVGEGVSATVYRALCIPLNEI--VAIKVLDLEKCNNDLDGIRREVQ 64
+P +D D + + +GEG V +A AIK + +D E++
Sbjct: 3 IYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE 62
Query: 65 TM-RVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYP--------------E 109
+ ++ +HPN++ + L++ + Y G+ L ++ +
Sbjct: 63 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 122
Query: 110 GFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD 169
+ + + + YL IHRD+ A NIL+ N K+ADFG+S +
Sbjct: 123 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ----E 178
Query: 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLL 228
+ WMA E + Y +D+WS+G+ E+ G P+ ++
Sbjct: 179 VYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-- 235
Query: 229 MTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274
+ P G E+ +L+ C + P +RP+ +++
Sbjct: 236 --YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 186 bits (473), Expect = 7e-54
Identities = 68/283 (24%), Positives = 113/283 (39%), Gaps = 21/283 (7%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN--DLDGIRREVQTMRVTNHP 72
+ + +G G V A+K+LD +K ++ E + ++ N P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 73 NVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF 132
+++ SF L++VM Y+AGG ++ F EP + + YLH
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHS 159
Query: 133 HGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQL 192
I+RD+K N+LID G I++ DFG + + T GTP +APE++
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEALAPEIILS- 212
Query: 193 HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKE 252
GY+ D W+ G+ E+A G+ PF P+++ + FS K+
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-----KVRFPSHFSSDLKD 267
Query: 253 LVTACLVKDPKKR-----PTAEKLMKHHFFKHARSNDFLARSI 290
L+ L D KR + H +F R +
Sbjct: 268 LLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKV 310
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 1e-53
Identities = 63/291 (21%), Positives = 121/291 (41%), Gaps = 29/291 (9%)
Query: 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNE-------IVAIKVLDLEKCNNDLDGI 59
R+ + L + +GEG V A I L++ VA+K+L + DL +
Sbjct: 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL 65
Query: 60 RREVQTM-RVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEG-------- 110
E++ M + H N++ + T L+V++ Y + G+ +++ P G
Sbjct: 66 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125
Query: 111 ------FEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACM 164
+ + + + + YL IHRD+ A N+L+ + +K+ADFG+ A
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL-ARD 184
Query: 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALE-LAHGHAPFSKYPP 223
D + WMAPE + Y ++D+WSFG+ E G +P+ P
Sbjct: 185 IHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243
Query: 224 MKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274
++ + + ++ + ++ C P +RPT ++L++
Sbjct: 244 EELFKLLKEGHRM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 185 bits (469), Expect = 1e-53
Identities = 65/301 (21%), Positives = 116/301 (38%), Gaps = 50/301 (16%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTM-RVTNHPN 73
DY+L ++G G + V+ A+ I NE V +K+L K I+RE++ + + PN
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK----IKREIKILENLRGGPN 91
Query: 74 VLRAHCSFT--TGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLH 131
++ +V ++ + ++ + I + E LKAL Y H
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCH 146
Query: 132 FHGHIHRDVKAGNILIDS-NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQ 190
G +HRDVK N++ID + ++L D+G+ A + G N V + + PE++
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL-AEFYHPGQEY---NVRVASRYFKGPELLV 202
Query: 191 QLHGYDFKADIWSFGITALELAHGHAPF------------------SKYPPMKVLLMTLQ 232
YD+ D+WS G + PF ++ + ++
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262
Query: 233 NAP---------------PGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277
P + E S + + L D + R TA + M+H +F
Sbjct: 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322
Query: 278 K 278
Sbjct: 323 Y 323
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 4e-53
Identities = 62/287 (21%), Positives = 116/287 (40%), Gaps = 20/287 (6%)
Query: 2 DLVVEKRFPVDAKDYRLYEEVGEGVSATVYRALC-----IPLNEIVAIKVLDLEKCNNDL 56
D+ V + V + + E+G+G VY + VAIK ++ +
Sbjct: 8 DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER 67
Query: 57 DGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVI 116
E M+ N +V+R + G V+M M G ++S P PV+
Sbjct: 68 IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 127
Query: 117 ATL--------LRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168
A E + YL+ + +HRD+ A N ++ + +K+ DFG++ +++
Sbjct: 128 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE-T 186
Query: 169 DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHG-HAPFSKYPPMKVL 227
D R + WM+PE ++ + +D+WSFG+ E+A P+ +VL
Sbjct: 187 DYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 245
Query: 228 LMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274
++ ++ EL+ C +PK RP+ +++
Sbjct: 246 RFVMEGGLL----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 5e-53
Identities = 58/295 (19%), Positives = 107/295 (36%), Gaps = 26/295 (8%)
Query: 1 MDLVVEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPL-----NEIVAIKVLDLEKCNND 55
L + ++ + +G G V A L VA+K+L +
Sbjct: 10 TQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE 69
Query: 56 LDGIRREVQTM-RVTNHPNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPE----- 109
+ + E++ + + NH N++ + T G V+ Y G L+ ++
Sbjct: 70 REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK 129
Query: 110 -----------GFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADF 158
+ + + + K + +L IHRD+ A NIL+ K+ DF
Sbjct: 130 TSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDF 189
Query: 159 GVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPF 218
G+ A + WMAPE + Y F++D+WS+GI EL +
Sbjct: 190 GL-ARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSP 247
Query: 219 SKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273
P+ + G + +++ C DP KRPT +++++
Sbjct: 248 YPGMPVDSKFYKMIK--EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 2e-52
Identities = 65/299 (21%), Positives = 107/299 (35%), Gaps = 41/299 (13%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNV 74
Y + +G G VY+A E+VAIK + +K RE+Q MR +H N+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNI 75
Query: 75 LRAHCSFTTGH------CLWVVMPYMAGGSCLHIMKSAYPEG-FEEPVIATLLRETLKAL 127
+R F + L +V+ Y+ + + + + + ++L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 128 VYLHFHGHIHRDVKAGNILIDSNGAI-KLADFGVSACMFDAGDRQRSRNTFVGTPCWMAP 186
Y+H G HRD+K N+L+D + A+ KL DFG + + +++ + + AP
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EPNVSYICSRYYRAP 191
Query: 187 EVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTL--------------- 231
E++ Y D+WS G EL G F + L+ +
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 232 ---------QNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281
Q R L + L P R T + H FF R
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 4e-52
Identities = 58/272 (21%), Positives = 104/272 (38%), Gaps = 12/272 (4%)
Query: 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLN---EIVAIKVLDLEKCNNDLDGIRREVQT 65
+ E +G G VY + + A+K L+ ++ E
Sbjct: 22 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 81
Query: 66 MRVTNHPNVLRAH-CSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETL 124
M+ +HPNVL + VV+PYM G + +++ + +
Sbjct: 82 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVA 140
Query: 125 KALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNT-FVGTPCW 183
K + +L +HRD+ A N ++D +K+ADFG++ M+D T W
Sbjct: 141 KGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 200
Query: 184 MAPEVMQQLHGYDFKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER 242
MA E +Q + K+D+WSFG+ E + G P+ + + LQ +
Sbjct: 201 MALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL----LQ 255
Query: 243 DKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274
+ E++ C + RP+ +L+
Sbjct: 256 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 6e-52
Identities = 65/296 (21%), Positives = 109/296 (36%), Gaps = 42/296 (14%)
Query: 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHP 72
A+ L E +G+G V+R E VA+K+ + + E+ + H
Sbjct: 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWF--REAEIYQTVMLRHE 57
Query: 73 NVLRAHCSFT----TGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALV 128
N+L + T LW+V Y GS + + L T L
Sbjct: 58 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLA 114
Query: 129 YLHFH--------GHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD-RQRSRNTFVG 179
+LH HRD+K+ NIL+ NG +AD G++ A D + N VG
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 180 TPCWMAPEVMQ-----QLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA 234
T +MAPEV+ + +ADI++ G+ E+A + + ++ L +
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234
Query: 235 PP------------GLDYERDKRFS-----KSFKELVTACLVKDPKKRPTAEKLMK 273
P L R+ + +++ C + R TA ++ K
Sbjct: 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 3e-51
Identities = 58/289 (20%), Positives = 110/289 (38%), Gaps = 25/289 (8%)
Query: 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLN-----EIVAIKVLDLEKCNNDLDGIRR 61
++ +L + +G G V A ++ VA+K+L +++ +
Sbjct: 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 65
Query: 62 EVQTMRVTNHPN--VLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKS-------------- 105
E++ + H V G L V++ + G+ ++S
Sbjct: 66 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 125
Query: 106 AYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165
Y + + + K + +L IHRD+ A NIL+ +K+ DFG++ ++
Sbjct: 126 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 185
Query: 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK 225
D R WMAPE + Y ++D+WSFG+ E+ A YP +K
Sbjct: 186 KDPDYVRK-GDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASP--YPGVK 241
Query: 226 VLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274
+ + G + + + C +P +RPT +L++H
Sbjct: 242 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 5e-51
Identities = 77/298 (25%), Positives = 116/298 (38%), Gaps = 43/298 (14%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHP 72
YR + VG G V A+ VAIK L + RE++ ++ H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 73 NVLRAHCSFTTGHCL------WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKA 126
NV+ FT L ++VMP+M G +MK E E I L+ + LK
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKG 133
Query: 127 LVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAP 186
L Y+H G IHRD+K GN+ ++ + +K+ DFG++ +V T + AP
Sbjct: 134 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA------DSEMTGYVVTRWYRAP 187
Query: 187 EVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKV--LLMTLQNAPPGLDYERD- 243
EV+ Y DIWS G E+ G F + +M + PP +R
Sbjct: 188 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247
Query: 244 -----------------------KRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278
S L+ LV D ++R TA + + H +F+
Sbjct: 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 175 bits (445), Expect = 1e-50
Identities = 46/274 (16%), Positives = 89/274 (32%), Gaps = 19/274 (6%)
Query: 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNH- 71
Y++ +GEG ++ + N+ VAIK +D +R E +T ++
Sbjct: 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR---SDAPQLRDEYRTYKLLAGC 60
Query: 72 PNVLRAHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLH 131
+ + G +V+ + G S ++ F +A ++ L + +H
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 132 FHGHIHRDVKAGNILIDS-----NGAIKLADFGVSACMFDAGDRQ----RSRNTFVGTPC 182
++RD+K N LI I + DFG+ D +Q R + GT
Sbjct: 119 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 183 WMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMT---LQNAPPGLD 239
+M+ + D+ + G + G P+ +
Sbjct: 179 YMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237
Query: 240 YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273
E F + F + + P + L
Sbjct: 238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 2e-50
Identities = 66/302 (21%), Positives = 110/302 (36%), Gaps = 41/302 (13%)
Query: 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPN 73
Y+ VG G +V A VA+K L + RE++ ++ H N
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 78
Query: 74 VLRAHCSFTTGHCLW-----VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALV 128
V+ FT L ++ ++ G +I+K + + + L+ + L+ L
Sbjct: 79 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLK 135
Query: 129 YLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEV 188
Y+H IHRD+K N+ ++ + +K+ DFG++ +V T + APE+
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT------DDEMTGYVATRWYRAPEI 189
Query: 189 MQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVL--------------------- 227
M Y+ DIWS G EL G F + L
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 228 -----LMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282
+ +L P + +L+ LV D KR TA + + H +F
Sbjct: 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309
Query: 283 ND 284
D
Sbjct: 310 PD 311
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (435), Expect = 2e-48
Identities = 70/309 (22%), Positives = 115/309 (37%), Gaps = 54/309 (17%)
Query: 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHP 72
K Y+ + +G G V A L+ VAIK L N RE+ M+ NH
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 73 NVLRAHCSFTT------GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKA 126
N++ FT +++VM M C I + ++ LL + L
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-----ELDHERMSYLLYQMLCG 131
Query: 127 LVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAP 186
+ +LH G IHRD+K NI++ S+ +K+ DFG++ +V T + AP
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMMTPYVVTRYYRAP 187
Query: 187 EVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQ-------------- 232
EV+ GY DIWS G E+ F + ++
Sbjct: 188 EVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246
Query: 233 -----------------------NAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAE 269
++ D E +K + ++L++ LV DP KR + +
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306
Query: 270 KLMKHHFFK 278
++H +
Sbjct: 307 DALQHPYIN 315
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 144 bits (364), Expect = 1e-38
Identities = 63/321 (19%), Positives = 115/321 (35%), Gaps = 61/321 (19%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVL 75
Y L ++G G +TV+ A + N VA+K++ +K + E++ ++ N +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE--AAEDEIKLLQRVNDADNT 72
Query: 76 RA-------------HCSFTTGHCLWVVM-PYMAGGSCLHIMKSAYPEGFEEPVIATLLR 121
+ H + + + VVM + G + L ++K G + + +
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 122 ETLKALVYLHFH-GHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGT 180
+ L L Y+H G IH D+K N+L++ + + A + +A + T
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192
Query: 181 PCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPP---------MKVLLMTL 231
+ +PEV+ + ADIWS EL G F + ++ L
Sbjct: 193 REYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251
Query: 232 QNAPPGL----------------------------------DYERDKRFSKSFKELVTAC 257
P L Y+ K +K + ++
Sbjct: 252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311
Query: 258 LVKDPKKRPTAEKLMKHHFFK 278
L DP+KR A L+ H + K
Sbjct: 312 LQLDPRKRADAGGLVNHPWLK 332
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 79.8 bits (196), Expect = 9e-18
Identities = 29/208 (13%), Positives = 63/208 (30%), Gaps = 31/208 (14%)
Query: 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN--HPN 73
+ + +GEG + V+ +K + + +R+ + + +
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 74 VLRAHCSFTTGHCLWVVMPYMAGGSCL--HIMKSAYPEGFEEPVIATLLRETLKALVYLH 131
+ L V Y G+ + ++ + +L L+ + +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 132 FHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQ 191
G +H D+ N+L+ G I + DF S V E++++
Sbjct: 121 HRGIVHGDLSQYNVLVSEEG-IWIIDFPQS----------------VEVGEEGWREILER 163
Query: 192 LHG---------YDFKADIWSFGITALE 210
Y + DI S L+
Sbjct: 164 DVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 671 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.19 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.92 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.47 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.36 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.13 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.42 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-59 Score=485.20 Aligned_cols=263 Identities=24% Similarity=0.423 Sum_probs=223.2
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
.++|++++.||+|+||+||+|+++.+|+.||||++.........+.+.+|+.+|+.++|||||+++++|.+++.+|||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 47899999999999999999999999999999999876555556778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
||.||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+... ....
T Consensus 84 y~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~-~~~~ 160 (271)
T d1nvra_ 84 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN-NRER 160 (271)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEET-TEEC
T ss_pred ccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccC-Cccc
Confidence 99999999988654 67999999999999999999999999999999999999999999999999999765332 2223
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHH
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKE 252 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~d 252 (671)
.....+||+.|||||++.+...++.++|||||||++|+|++|++||.................. ....+..+|+++++
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~ 238 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--YLNPWKKIDSAPLA 238 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT--TSTTGGGSCHHHHH
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--CCCccccCCHHHHH
Confidence 3456789999999999987444578899999999999999999999776544333333333222 22335678999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 253 LVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 253 LI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
||.+||..||.+|||++++|+||||++.
T Consensus 239 li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 239 LLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 9999999999999999999999999753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-58 Score=480.09 Aligned_cols=260 Identities=38% Similarity=0.694 Sum_probs=231.8
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
.++|++++.||+|+||+||+|.++.+|+.||||++..... ...+.+.+|+.+|+.++|||||+++++|.+++.+|||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC-hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 3579999999999999999999999999999999976543 345789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
||.||+|.+++... .+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.+.... .
T Consensus 98 y~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~---~ 171 (293)
T d1yhwa1 98 YLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---S 171 (293)
T ss_dssp CCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT---C
T ss_pred ecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc---c
Confidence 99999999988753 69999999999999999999999999999999999999999999999999997663322 2
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHH
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKE 252 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~d 252 (671)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+......+..+.....+.+ ..+..+|+++++
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~ 248 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL--QNPEKLSAIFRD 248 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC--SSGGGSCHHHHH
T ss_pred cccccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC--CCcccCCHHHHH
Confidence 3345689999999999987 6799999999999999999999999999888777777766654433 346778999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 253 LVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 253 LI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
||.+||.+||.+|||+.|+|+||||+....
T Consensus 249 li~~~L~~dP~~R~s~~eil~Hp~~~~~~~ 278 (293)
T d1yhwa1 249 FLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278 (293)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHHHHccCChhHCcCHHHHhcCHhhCCCCC
Confidence 999999999999999999999999986554
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-58 Score=475.86 Aligned_cols=258 Identities=27% Similarity=0.444 Sum_probs=228.4
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeC
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG 84 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~ 84 (671)
++|. .++|++++.||+|+||+||+|+++.+|+.||||++..... ......+.+|+.+|+.++|||||+++++|.++
T Consensus 1 r~~~--l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 78 (263)
T d2j4za1 1 RQWA--LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA 78 (263)
T ss_dssp CCCC--GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CCcc--hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC
Confidence 3554 4689999999999999999999999999999999975432 23467889999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccc
Q 005886 85 HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACM 164 (671)
Q Consensus 85 ~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~ 164 (671)
+.+|+|||||.||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|...
T Consensus 79 ~~~~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~ 156 (263)
T d2j4za1 79 TRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 156 (263)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCC
T ss_pred CEEEEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeec
Confidence 9999999999999999999876 67999999999999999999999999999999999999999999999999998654
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccc
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (671)
.. ......+||+.|||||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..+.... +..+.
T Consensus 157 ~~-----~~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-----~~~p~ 225 (263)
T d2j4za1 157 PS-----SRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-----FTFPD 225 (263)
T ss_dssp CC-----CCCEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-----CCCCT
T ss_pred CC-----CcccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-----CCCCc
Confidence 22 22345689999999999988 679999999999999999999999999887776665554432 23356
Q ss_pred cchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccc
Q 005886 245 RFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKH 279 (671)
Q Consensus 245 ~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~ 279 (671)
.+|+++++||.+||.+||.+|||++++|+||||..
T Consensus 226 ~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 226 FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 78999999999999999999999999999999974
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-57 Score=476.12 Aligned_cols=264 Identities=27% Similarity=0.458 Sum_probs=229.2
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWV 89 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~L 89 (671)
..++|++++.||+|+||+||+|+++.+|+.||||++..... ....+.+.+|+.+|+.++|||||+++++|.+++.+||
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 34689999999999999999999999999999999975432 3456789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCC
Q 005886 90 VMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~ 169 (671)
|||||.||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.+... .
T Consensus 86 vmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~-~ 162 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE-S 162 (288)
T ss_dssp EECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccC-C
Confidence 99999999999998877 67999999999999999999999999999999999999999999999999999765322 2
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHH
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
........+||+.|||||++.+ ..|+.++|||||||++|+|++|+.||.+.+.......+.... +..+..++++
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~-----~~~p~~~s~~ 236 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-----YDFPEKFFPK 236 (288)
T ss_dssp -------CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC-----CCCCTTCCHH
T ss_pred cccccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC-----CCCCccCCHH
Confidence 2223445689999999999987 679999999999999999999999999888777766665542 2335678999
Q ss_pred HHHHHHHhhhcCCCCCCCHHH------HHhchhccccccch
Q 005886 250 FKELVTACLVKDPKKRPTAEK------LMKHHFFKHARSND 284 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpSa~e------iL~Hpwfk~~~~~~ 284 (671)
+++||.+||.+||.+|||++| +++||||+...|..
T Consensus 237 ~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~ 277 (288)
T d1uu3a_ 237 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 277 (288)
T ss_dssp HHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred HHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHH
Confidence 999999999999999999987 68999999877654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-57 Score=472.50 Aligned_cols=260 Identities=37% Similarity=0.645 Sum_probs=229.6
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
+.|++++.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+.+|+.++|||||+++++|.+++.+||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 46999999999999999999999999999999997543 34567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCcccc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRS 173 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~ 173 (671)
|.||+|..++... ...+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+..... ...
T Consensus 91 ~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~---~~~ 166 (288)
T d2jfla1 91 CAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT---IQR 166 (288)
T ss_dssp CTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH---HHH
T ss_pred CCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC---ccc
Confidence 9999999987654 256999999999999999999999999999999999999999999999999998654321 122
Q ss_pred cccccCCCCCCChhHhhh----ccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHH
Q 005886 174 RNTFVGTPCWMAPEVMQQ----LHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 174 ~~~~~GT~~Y~APEvl~~----~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
..+.+||+.|||||++.. ...|+.++|||||||++|+|++|+.||.+....+.+..+....++.+ ..+..+|++
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~~s~~ 244 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL--AQPSRWSSN 244 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC--SSGGGSCHH
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC--CccccCCHH
Confidence 345789999999999852 24589999999999999999999999999888888877777655443 335678999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 250 FKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
+++||.+||.+||.+|||++|+|+||||+..
T Consensus 245 ~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 245 FKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999999753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-57 Score=481.02 Aligned_cols=261 Identities=33% Similarity=0.560 Sum_probs=222.0
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LV 90 (671)
+..++|++++.||+|+||+||+|+++.+|+.||+|+++..........+.+|+.+|+.++|||||+++++|.++..+|||
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 45678999999999999999999999999999999998765555567899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCcEEEcCCCceEEeccccccccccCCC
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF-HGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs-~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~ 169 (671)
||||.||+|..++.+. +.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+.+.+
T Consensus 83 mEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--- 157 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 157 (322)
T ss_dssp EECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---
T ss_pred EEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC---
Confidence 9999999999999876 679999999999999999999997 5999999999999999999999999999986532
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHH-------------------
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMT------------------- 230 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~------------------- 230 (671)
....+.+||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+.+........
T Consensus 158 --~~~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 158 --SMANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp --HTC---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred --CccccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 22345799999999999998 67999999999999999999999999765433221110
Q ss_pred -----------------------HhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 231 -----------------------LQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 231 -----------------------~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
....++. .....+|.++++||.+||..||.+|||++|+|+||||+...+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPK---LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 306 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCC---CCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred ccccccccccccchhHHHHHhhhhccCCcc---CccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence 0011111 012346889999999999999999999999999999986543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-57 Score=481.85 Aligned_cols=264 Identities=28% Similarity=0.454 Sum_probs=234.6
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~ 88 (671)
|..++|++++.||+|+||+||+|+++.+|+.||||++.+... ......+.+|+.+|+.++|||||+++++|.+++.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 566899999999999999999999999999999999976532 345688899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
+|||||.||+|..++... +.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+......
T Consensus 82 iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred cceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 999999999999999887 689999999999999999999999999999999999999999999999999997553222
Q ss_pred CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchH
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSK 248 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~ 248 (671)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+....+..... ..+..+|+
T Consensus 160 ---~~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~-----~~p~~~s~ 230 (337)
T d1o6la_ 160 ---ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-----RFPRTLSP 230 (337)
T ss_dssp ---CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----CCCTTSCH
T ss_pred ---cccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCC-----CCCccCCH
Confidence 23456799999999999987 6799999999999999999999999999888776666655432 33567899
Q ss_pred HHHHHHHHhhhcCCCCCCC-----HHHHHhchhccccccchH
Q 005886 249 SFKELVTACLVKDPKKRPT-----AEKLMKHHFFKHARSNDF 285 (671)
Q Consensus 249 ~l~dLI~~cL~~dP~kRpS-----a~eiL~Hpwfk~~~~~~~ 285 (671)
++++||.+||++||.+|++ ++++++||||+...+.+.
T Consensus 231 ~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l 272 (337)
T d1o6la_ 231 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272 (337)
T ss_dssp HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred HHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHHH
Confidence 9999999999999999994 999999999988765443
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-57 Score=475.99 Aligned_cols=260 Identities=27% Similarity=0.409 Sum_probs=212.8
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
.+.|++.+.||+|+||+||+|+++.+|+.||||++...........+.+|+.+|+.++|||||+++++|.+++.+|||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 35699999999999999999999999999999999876655555678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEc---CCCceEEeccccccccccCCC
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILID---SNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld---~~g~vKL~DFGls~~~~~~~~ 169 (671)
||.||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||+. .+|.+||+|||+|+....
T Consensus 88 ~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~--- 162 (307)
T d1a06a_ 88 LVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--- 162 (307)
T ss_dssp CCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred ccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC---
Confidence 99999999999865 6799999999999999999999999999999999999994 478999999999875422
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHH
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
.....+.+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.........+.... ..+..+.+..+|++
T Consensus 163 -~~~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~s~~ 239 (307)
T d1a06a_ 163 -GSVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE-YEFDSPYWDDISDS 239 (307)
T ss_dssp -----------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTC-CCCCTTTTTTSCHH
T ss_pred -CCeeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccC-CCCCCccccCCCHH
Confidence 223345789999999999987 679999999999999999999999999888777666555543 33444556789999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 250 FKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
+++||.+||.+||.+|||++|+|+||||+..
T Consensus 240 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 240 AKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999999999753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-56 Score=461.61 Aligned_cols=256 Identities=27% Similarity=0.462 Sum_probs=220.8
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEe----CCE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTT----GHC 86 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~----~~~ 86 (671)
+.+-|++.++||+|+||+||+|+++.+++.||+|++..... ....+.+.+|+++|+.++|||||+++++|.+ +..
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence 44446888899999999999999999999999999976553 3446788999999999999999999999975 457
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCCCcEEEc-CCCceEEeccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHG--HIHRDVKAGNILID-SNGAIKLADFGVSAC 163 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~g--IVHrDLKPeNILld-~~g~vKL~DFGls~~ 163 (671)
+|||||||.||+|.+++... ..+++..++.++.||+.||+|||++| ||||||||+|||++ .++.+||+|||+|+.
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 89999999999999999877 67999999999999999999999998 99999999999996 478999999999864
Q ss_pred cccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 005886 164 MFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERD 243 (671)
Q Consensus 164 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (671)
.. .....+.+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+......+...+..... ....+
T Consensus 165 ~~-----~~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~--~~~~~ 235 (270)
T d1t4ha_ 165 KR-----ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFD 235 (270)
T ss_dssp CC-----TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGG
T ss_pred cc-----CCccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC--CcccC
Confidence 32 122345789999999999875 5999999999999999999999999887666655555544322 23345
Q ss_pred ccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcc
Q 005886 244 KRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278 (671)
Q Consensus 244 ~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk 278 (671)
..+++++++||.+||.+||++|||++|+|+||||+
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 236 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 66889999999999999999999999999999996
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-57 Score=464.71 Aligned_cols=257 Identities=25% Similarity=0.430 Sum_probs=214.0
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEe--CCEEEE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTT--GHCLWV 89 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~--~~~l~L 89 (671)
.++|++++.||+|+||+||+|+++.+|+.||||++...... ...+.+.+|+++|+.++|||||+++++|.+ +..+||
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 46899999999999999999999999999999999876533 346778999999999999999999999965 456899
Q ss_pred EEeccCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccccCCCCcEEEcCCCceEEecccccc
Q 005886 90 VMPYMAGGSCLHIMKSA--YPEGFEEPVIATLLRETLKALVYLHFHG-----HIHRDVKAGNILIDSNGAIKLADFGVSA 162 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~--~~~~l~e~~i~~i~~qIl~aL~yLHs~g-----IVHrDLKPeNILld~~g~vKL~DFGls~ 162 (671)
|||||.||+|.+++... ....+++..++.++.||+.||.|||++| ||||||||+|||++.+|.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999988643 2357999999999999999999999976 9999999999999999999999999998
Q ss_pred ccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccc
Q 005886 163 CMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER 242 (671)
Q Consensus 163 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~ 242 (671)
.+... .......+||+.|||||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+....+....... .
T Consensus 163 ~~~~~---~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~----~ 234 (269)
T d2java1 163 ILNHD---TSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR----I 234 (269)
T ss_dssp HC--------------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC----C
T ss_pred ecccC---CCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC----C
Confidence 66322 122345789999999999987 679999999999999999999999999988877666665543332 3
Q ss_pred cccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhc
Q 005886 243 DKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFF 277 (671)
Q Consensus 243 ~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwf 277 (671)
+..+|+++++||.+||..||.+|||++|+|+|||+
T Consensus 235 ~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 235 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 45789999999999999999999999999999996
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-56 Score=464.00 Aligned_cols=262 Identities=26% Similarity=0.386 Sum_probs=228.7
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-----ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-----NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-----~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~ 88 (671)
++|++++.||+|+||+||+|+++.+|+.||||++.+.... ...+.+.+|+.+|+.++|||||+++++|.++..+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 6799999999999999999999999999999999765432 23678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC----ceEEecccccccc
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG----AIKLADFGVSACM 164 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g----~vKL~DFGls~~~ 164 (671)
||||||.||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||++.+| .+||+|||+|...
T Consensus 90 iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 999999999999999877 6799999999999999999999999999999999999998776 5999999998765
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccc
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (671)
... ....+.+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..+... ...+....+.
T Consensus 168 ~~~----~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~ 241 (293)
T d1jksa_ 168 DFG----NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV-NYEFEDEYFS 241 (293)
T ss_dssp TTS----CBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT-CCCCCHHHHT
T ss_pred CCC----ccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhc-CCCCCchhcC
Confidence 321 23345689999999999987 67999999999999999999999999998877766555443 3334445567
Q ss_pred cchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccccc
Q 005886 245 RFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARSN 283 (671)
Q Consensus 245 ~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~~ 283 (671)
.+|..+++||.+||..||.+|||++++|+||||+...+.
T Consensus 242 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~ 280 (293)
T d1jksa_ 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 280 (293)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC----
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChh
Confidence 789999999999999999999999999999999865543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-56 Score=469.15 Aligned_cols=256 Identities=38% Similarity=0.637 Sum_probs=226.5
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
.|++++.||+|+||+||+|+++.+|+.||||++...... ...+.+.+|+.+|+.++|||||+++++|.+++.+|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 499999999999999999999999999999999765433 335678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
||.||+|..++... ..+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|....
T Consensus 96 ~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~------- 166 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------- 166 (309)
T ss_dssp CCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS-------
T ss_pred ecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccC-------
Confidence 99999887766655 679999999999999999999999999999999999999999999999999986542
Q ss_pred ccccccCCCCCCChhHhhhc--cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHH
Q 005886 173 SRNTFVGTPCWMAPEVMQQL--HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSF 250 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~--~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l 250 (671)
.....+||+.|||||++.+. ..|+.++|||||||++|+|++|..||.+......+..+.....+.+. +..+|+++
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~s~~~ 243 (309)
T d1u5ra_ 167 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ---SGHWSEYF 243 (309)
T ss_dssp SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS---CTTSCHHH
T ss_pred CCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC---CCCCCHHH
Confidence 22356899999999999752 35899999999999999999999999998888877777776544432 45689999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 251 KELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 251 ~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
++||.+||.+||.+|||++++|+||||.....
T Consensus 244 ~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~ 275 (309)
T d1u5ra_ 244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275 (309)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred HHHHHHHCcCChhHCcCHHHHHhCHHhcCCCC
Confidence 99999999999999999999999999986443
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.1e-56 Score=470.39 Aligned_cols=259 Identities=29% Similarity=0.479 Sum_probs=231.4
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LV 90 (671)
.++|++++.||+|+||+||+|+++.+|+.||||++..... ....+.+.+|+.+|+.++|||||+++++|.+++.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 4689999999999999999999999999999999975432 34568899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCc
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR 170 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~ 170 (671)
||||.||+|..++... ..+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+....
T Consensus 83 mE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~---- 156 (316)
T d1fota_ 83 MDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 156 (316)
T ss_dssp ECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred eeecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc----
Confidence 9999999999998876 6789999999999999999999999999999999999999999999999999976532
Q ss_pred ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHH
Q 005886 171 QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSF 250 (671)
Q Consensus 171 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l 250 (671)
...+.+||+.|||||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+....+..... ..+..+++++
T Consensus 157 --~~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-----~~p~~~s~~~ 228 (316)
T d1fota_ 157 --VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-----RFPPFFNEDV 228 (316)
T ss_dssp --CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-----CCCTTSCHHH
T ss_pred --ccccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC-----CCCCCCCHHH
Confidence 2345789999999999987 6799999999999999999999999999888777776665432 2356789999
Q ss_pred HHHHHHhhhcCCCCCC-----CHHHHHhchhccccccchH
Q 005886 251 KELVTACLVKDPKKRP-----TAEKLMKHHFFKHARSNDF 285 (671)
Q Consensus 251 ~dLI~~cL~~dP~kRp-----Sa~eiL~Hpwfk~~~~~~~ 285 (671)
+++|.+||.+||.+|+ |++++|+||||+...+...
T Consensus 229 ~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l 268 (316)
T d1fota_ 229 KDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 268 (316)
T ss_dssp HHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHH
T ss_pred HHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHHH
Confidence 9999999999999996 9999999999998776543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.6e-55 Score=472.33 Aligned_cols=260 Identities=25% Similarity=0.397 Sum_probs=228.2
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
++|++++.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+.+|+.++|||||+++++|.+++.+||||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 58999999999999999999999999999999996543 33467889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcC--CCceEEeccccccccccCCCcc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS--NGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~--~g~vKL~DFGls~~~~~~~~~~ 171 (671)
|.||+|.+++... .+.+++..++.|+.||+.||+|||++|||||||||+|||++. +|.+||+|||+|+.+.. .
T Consensus 105 ~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~----~ 179 (350)
T d1koaa2 105 MSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP----K 179 (350)
T ss_dssp CCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT----T
T ss_pred CCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc----c
Confidence 9999999988643 256999999999999999999999999999999999999964 67899999999876532 2
Q ss_pred cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHH
Q 005886 172 RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~ 251 (671)
......+||+.|||||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..+.... ..+....+..+|++++
T Consensus 180 ~~~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~s~~~~ 257 (350)
T d1koaa2 180 QSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD-WNMDDSAFSGISEDGK 257 (350)
T ss_dssp SCEEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCSCCGGGGGCCHHHH
T ss_pred cccceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCcccccCCCHHHH
Confidence 23345789999999999987 679999999999999999999999999888777666655433 3334445667899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 252 ELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 252 dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
+||.+||.+||.+|||++++|+||||+...
T Consensus 258 ~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 258 DFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred HHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 999999999999999999999999998654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.6e-55 Score=472.55 Aligned_cols=259 Identities=21% Similarity=0.390 Sum_probs=227.8
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEec
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMPY 93 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmEy 93 (671)
++|++++.||+|+||+||+|+++.+|+.||||++.... ......+.+|+.+|+.++|||||+++++|.+++.+||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 56999999999999999999999999999999997543 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEc--CCCceEEeccccccccccCCCcc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILID--SNGAIKLADFGVSACMFDAGDRQ 171 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld--~~g~vKL~DFGls~~~~~~~~~~ 171 (671)
|.||+|.+.+... ...+++..++.|+.||+.||+|||++|||||||||+|||++ .+|.+||+|||+|+.+.. .
T Consensus 108 ~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~----~ 182 (352)
T d1koba_ 108 LSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP----D 182 (352)
T ss_dssp CCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT----T
T ss_pred CCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC----C
Confidence 9999999877654 24699999999999999999999999999999999999997 578999999999976532 2
Q ss_pred cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHH
Q 005886 172 RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251 (671)
Q Consensus 172 ~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~ 251 (671)
......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+....+..+.... ..+....+..+|++++
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~s~~~~ 260 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD-WEFDEDAFSSVSPEAK 260 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC-CCCCSSTTTTSCHHHH
T ss_pred CceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCcccccCCCHHHH
Confidence 23345689999999999987 679999999999999999999999999988877766665543 2334445567899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 252 ELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 252 dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
+||.+||.+||.+|||+.++|+||||+..
T Consensus 261 ~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 261 DFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 99999999999999999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-55 Score=471.48 Aligned_cols=259 Identities=26% Similarity=0.428 Sum_probs=231.1
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLW 88 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~ 88 (671)
...++|++++.||+|+||+||+|+++.+|+.||||++.+... ....+.+.+|+.+|+.++|||||+++++|.+...+|
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 117 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence 445789999999999999999999999999999999975432 245678899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
+||||+.||+|..++... +.+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+..
T Consensus 118 ~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~-- 193 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-- 193 (350)
T ss_dssp EEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred cccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc--
Confidence 999999999999999877 6799999999999999999999999999999999999999999999999999976522
Q ss_pred CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchH
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSK 248 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~ 248 (671)
...+.+||+.|||||++.+ ..|+.++|||||||++|+|++|+.||.+.+....+..+..... ..+..+++
T Consensus 194 ----~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-----~~p~~~s~ 263 (350)
T d1rdqe_ 194 ----RTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----RFPSHFSS 263 (350)
T ss_dssp ----CBCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----CCCTTCCH
T ss_pred ----ccccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-----CCCccCCH
Confidence 2345689999999999987 6799999999999999999999999999887777666665432 23567899
Q ss_pred HHHHHHHHhhhcCCCCCC-----CHHHHHhchhccccccc
Q 005886 249 SFKELVTACLVKDPKKRP-----TAEKLMKHHFFKHARSN 283 (671)
Q Consensus 249 ~l~dLI~~cL~~dP~kRp-----Sa~eiL~Hpwfk~~~~~ 283 (671)
++.+||.+||.+||.+|+ |+++||+||||+...+.
T Consensus 264 ~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~ 303 (350)
T d1rdqe_ 264 DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp HHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred HHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHH
Confidence 999999999999999995 99999999999877654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.7e-55 Score=472.85 Aligned_cols=267 Identities=23% Similarity=0.343 Sum_probs=223.4
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHH---HHHHHHhCCCCCceeeeeEEEeCC
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRR---EVQTMRVTNHPNVLRAHCSFTTGH 85 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~---Ei~iL~~L~HpNIVkl~~~~~~~~ 85 (671)
+..++|++++.||+|+||+||+|+++.+|+.||||++...... .....+.+ ++.+++.++|||||+++++|.+.+
T Consensus 1 lslddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~ 80 (364)
T d1omwa3 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 80 (364)
T ss_dssp CCSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CCHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC
Confidence 3568999999999999999999999999999999999654321 22233344 466677788999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
.+|||||||.||+|..++... ..+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.+.
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 999999999999999999877 678999999999999999999999999999999999999999999999999997653
Q ss_pred cCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (671)
. ......+||+.|+|||++.+...|+.++|||||||++|+|++|+.||.+.............. ......+..
T Consensus 159 ~-----~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~ 231 (364)
T d1omwa3 159 K-----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TMAVELPDS 231 (364)
T ss_dssp S-----SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS--SCCCCCCSS
T ss_pred C-----CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--cCCCCCCCC
Confidence 2 123456899999999999765679999999999999999999999998754432221111111 122344567
Q ss_pred chHHHHHHHHHhhhcCCCCCCC-----HHHHHhchhccccccchHH
Q 005886 246 FSKSFKELVTACLVKDPKKRPT-----AEKLMKHHFFKHARSNDFL 286 (671)
Q Consensus 246 ls~~l~dLI~~cL~~dP~kRpS-----a~eiL~Hpwfk~~~~~~~~ 286 (671)
+|+++++||.+||.+||.+||| |+++|+||||+...|....
T Consensus 232 ~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~ 277 (364)
T d1omwa3 232 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVF 277 (364)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHH
T ss_pred CCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHh
Confidence 8999999999999999999999 7999999999987765443
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.7e-54 Score=448.32 Aligned_cols=259 Identities=29% Similarity=0.497 Sum_probs=227.5
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcc--------cHHHHHHHHHHHHhCC-CCCceeeeeEEEeC
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN--------DLDGIRREVQTMRVTN-HPNVLRAHCSFTTG 84 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~--------~~~~i~~Ei~iL~~L~-HpNIVkl~~~~~~~ 84 (671)
++|++.+.||+|+||+||+|+++.+|+.||||++.+..... ..+.+.+|+.+|+.++ |||||+++++|.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 78999999999999999999999999999999997654321 2346889999999997 99999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccc
Q 005886 85 HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACM 164 (671)
Q Consensus 85 ~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~ 164 (671)
+.+|||||||.||+|.+++... +.+++..++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+++..
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 9999999999999999999876 67999999999999999999999999999999999999999999999999998765
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhc-----cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQL-----HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLD 239 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~-----~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~ 239 (671)
... ......+||+.|+|||++.+. ..|+.++||||+||++|+|++|++||.+.+.......+.... ..+.
T Consensus 161 ~~~----~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~-~~~~ 235 (277)
T d1phka_ 161 DPG----EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN-YQFG 235 (277)
T ss_dssp CTT----CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCC
T ss_pred cCC----CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC-CCCC
Confidence 321 123456899999999999742 346889999999999999999999999988777666555543 3344
Q ss_pred ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccc
Q 005886 240 YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKH 279 (671)
Q Consensus 240 ~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~ 279 (671)
.+....+|+++++||.+||+.||.+|||++++|+||||+.
T Consensus 236 ~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 4556689999999999999999999999999999999975
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-55 Score=461.07 Aligned_cols=261 Identities=28% Similarity=0.500 Sum_probs=227.9
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEecccc--CcccHHHHHHHHHHHH-hCCCCCceeeeeEEEeCCEEEE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEK--CNNDLDGIRREVQTMR-VTNHPNVLRAHCSFTTGHCLWV 89 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~--~~~~~~~i~~Ei~iL~-~L~HpNIVkl~~~~~~~~~l~L 89 (671)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. .......+.+|+.++. .++|||||+++++|.+++.+||
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 368999999999999999999999999999999997543 2344566777777765 7899999999999999999999
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCC
Q 005886 90 VMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~ 169 (671)
|||||.||+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 vmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~-- 156 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-- 156 (320)
T ss_dssp EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--
T ss_pred EEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc--
Confidence 99999999999999877 67999999999999999999999999999999999999999999999999998755322
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHH
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
.......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+.......+....+ ..+..+|++
T Consensus 157 -~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-----~~p~~~s~~ 229 (320)
T d1xjda_ 157 -DAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP-----FYPRWLEKE 229 (320)
T ss_dssp -TCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----CCCTTSCHH
T ss_pred -cccccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----CCCccCCHH
Confidence 233445689999999999987 6799999999999999999999999999887776666654432 234678999
Q ss_pred HHHHHHHhhhcCCCCCCCHH-HHHhchhccccccch
Q 005886 250 FKELVTACLVKDPKKRPTAE-KLMKHHFFKHARSND 284 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpSa~-eiL~Hpwfk~~~~~~ 284 (671)
+++||.+||.+||.+||++. ++++||||+...+..
T Consensus 230 ~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~~~ 265 (320)
T d1xjda_ 230 AKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEE 265 (320)
T ss_dssp HHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHH
T ss_pred HHHHHHHhcccCCCCCcCHHHHHHhCchhccCCHHH
Confidence 99999999999999999995 899999998765543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-55 Score=455.36 Aligned_cols=260 Identities=26% Similarity=0.355 Sum_probs=216.1
Q ss_pred EEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcc----cHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 17 RLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN----DLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 17 ~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~----~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
+.++.||+|+||+||+|+++.+|+.||||+++...... ....+.+|+.+|+.++|||||+++++|.+++++|||||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 35789999999999999999999999999997554322 23568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
||.|+++..+.... ..+++..++.+++||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..... ..
T Consensus 81 ~~~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~---~~ 155 (299)
T d1ua2a_ 81 FMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP---NR 155 (299)
T ss_dssp CCSEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC---CC
T ss_pred hhcchHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCC---cc
Confidence 99988776665433 67999999999999999999999999999999999999999999999999998755322 22
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CCCCC-----------
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA--PPGLD----------- 239 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~--~~~~~----------- 239 (671)
.....+||+.|+|||++.+...|+.++|||||||++|+|++|.+||.+....+.+..+.... +....
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence 33456899999999999876778999999999999999999999999988877766554321 00000
Q ss_pred ----------ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 240 ----------YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 240 ----------~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
......+++++++||.+||..||.+|||++|+|+||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 011235688999999999999999999999999999998643
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-54 Score=459.44 Aligned_cols=258 Identities=23% Similarity=0.369 Sum_probs=226.8
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
.++|++++.||+|+||+||+|.++.+|+.||||+++... .+...+.+|+.+|+.++|||||+++++|.+++.+|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 378999999999999999999999999999999997653 334568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCC--CceEEeccccccccccCCCc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSN--GAIKLADFGVSACMFDAGDR 170 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~--g~vKL~DFGls~~~~~~~~~ 170 (671)
||.||+|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 82 ~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~---- 156 (321)
T d1tkia_ 82 FISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---- 156 (321)
T ss_dssp CCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT----
T ss_pred cCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc----
Confidence 99999999999764 2369999999999999999999999999999999999999854 4899999999875522
Q ss_pred ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHH
Q 005886 171 QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSF 250 (671)
Q Consensus 171 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l 250 (671)
.......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+..+.+..+.... ..+....+..+|+++
T Consensus 157 ~~~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~s~~~ 234 (321)
T d1tkia_ 157 GDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE-YTFDEEAFKEISIEA 234 (321)
T ss_dssp TCEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CCCCHHHHTTSCHHH
T ss_pred CCcccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCChhhccCCCHHH
Confidence 222345689999999999987 569999999999999999999999999988877766665543 334445566789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHhchhccc
Q 005886 251 KELVTACLVKDPKKRPTAEKLMKHHFFKH 279 (671)
Q Consensus 251 ~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~ 279 (671)
++||.+||.+||.+|||+.++|+||||+.
T Consensus 235 ~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 235 MDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 99999999999999999999999999975
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=447.09 Aligned_cols=264 Identities=27% Similarity=0.430 Sum_probs=221.0
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
++|++++.||+|+||+||+|+++.+|+.||||++...... .....+.+|+.+|+.++|||||+++++|.++..+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999999999999999999765432 335788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
||.|+ +..++......++++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+..... ..
T Consensus 82 ~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~---~~ 157 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VR 157 (298)
T ss_dssp CCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC---SB
T ss_pred ecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC---cc
Confidence 99765 555555444577999999999999999999999999999999999999999999999999999765322 23
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--CCCc----------
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP--GLDY---------- 240 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~--~~~~---------- 240 (671)
.....+||+.|+|||++.....++.++|||||||++|+|++|+.||.+.+..+.+..+...... ...+
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence 3445689999999999887666789999999999999999999999988877766555432111 0000
Q ss_pred ------------cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 241 ------------ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 241 ------------~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
.....++.++++||.+||.+||.+|||+.|+|+||||++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence 01235678999999999999999999999999999998754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.5e-54 Score=446.88 Aligned_cols=259 Identities=22% Similarity=0.381 Sum_probs=222.2
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 86 (671)
++|+++.++|++.+.||+|+||+||+|.++.+|+.||||++.... ...+.+.+|+.+|+.++|||||+++++|.+++.
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc--chHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 358899999999999999999999999999999999999986543 446789999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
+|||||||.+|+|..++.......+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 99999999999999999876667899999999999999999999999999999999999999999999999999976533
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (671)
. .........||+.|+|||++.+ ..|+.++|||||||++|||++|..||........+...+... ...+.+..+
T Consensus 168 ~--~~~~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~---~~~~~~~~~ 241 (287)
T d1opja_ 168 D--TYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD---YRMERPEGC 241 (287)
T ss_dssp S--SSEEETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT---CCCCCCTTC
T ss_pred C--CceeeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC---CCCCCCccc
Confidence 2 2222334568999999999987 679999999999999999999666554433334344444332 233446678
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 247 SKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 247 s~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
++++++||.+||..||.+|||++++++
T Consensus 242 ~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 242 PEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 999999999999999999999999965
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-54 Score=459.63 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=213.9
Q ss_pred CCCeEEEE-EecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHH-hCCCCCceeeeeEEEe----CCE
Q 005886 13 AKDYRLYE-EVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMR-VTNHPNVLRAHCSFTT----GHC 86 (671)
Q Consensus 13 ~~~Y~l~~-~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~-~L~HpNIVkl~~~~~~----~~~ 86 (671)
.++|++++ .||+|+||+||+|+++.+|+.||||++.. ...+.+|+.++. .++|||||+++++|.+ +..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 46899875 59999999999999999999999999853 256788999865 5589999999999976 467
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcC---CCceEEeccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS---NGAIKLADFGVSAC 163 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~---~g~vKL~DFGls~~ 163 (671)
+|||||||.||+|.+++.......+++..++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+.
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence 999999999999999998764567999999999999999999999999999999999999975 46799999999976
Q ss_pred cccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc---CCCCCCc
Q 005886 164 MFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQN---APPGLDY 240 (671)
Q Consensus 164 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~---~~~~~~~ 240 (671)
.... ......+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.........+... ....++.
T Consensus 164 ~~~~----~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~ 238 (335)
T d2ozaa1 164 TTSH----NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 238 (335)
T ss_dssp CCCC----CCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred ccCC----CccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence 5332 23345689999999999987 56999999999999999999999999876554433332222 2222223
Q ss_pred cccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 241 ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 241 ~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
..+..+|+++++||.+||.+||.+|||+.++|+||||+..
T Consensus 239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 3455789999999999999999999999999999999754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-54 Score=442.48 Aligned_cols=250 Identities=25% Similarity=0.398 Sum_probs=214.1
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcc-----cHHHHHHHHHHHHhCC--CCCceeeeeEEEeCCE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNN-----DLDGIRREVQTMRVTN--HPNVLRAHCSFTTGHC 86 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~-----~~~~i~~Ei~iL~~L~--HpNIVkl~~~~~~~~~ 86 (671)
++|++.+.||+|+||+||+|+++.+|+.||||++....... ....+.+|+.+|+.++ |||||+++++|.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 67999999999999999999999999999999997654321 1234678999999986 8999999999999999
Q ss_pred EEEEEeccCC-CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCC-CceEEecccccccc
Q 005886 87 LWVVMPYMAG-GSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSN-GAIKLADFGVSACM 164 (671)
Q Consensus 87 l~LVmEy~~g-gsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~-g~vKL~DFGls~~~ 164 (671)
+|+||||+.+ +++.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 9999999976 6888888776 679999999999999999999999999999999999999854 79999999998654
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccc
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (671)
.. ....+.+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.. .+... ....+.
T Consensus 162 ~~-----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~-----~~~~~~ 225 (273)
T d1xwsa_ 162 KD-----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG-----QVFFRQ 225 (273)
T ss_dssp CS-----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-----CCCCSS
T ss_pred cc-----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc-----ccCCCC
Confidence 21 223457899999999999875556788999999999999999999997632 12222 122356
Q ss_pred cchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 245 RFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 245 ~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
.+|+++++||.+||.+||.+|||++|+|+||||++..
T Consensus 226 ~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 226 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred CCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 7899999999999999999999999999999998654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=439.08 Aligned_cols=263 Identities=28% Similarity=0.356 Sum_probs=215.5
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCC-CcEEEEEEeccccCc-ccHHHHHHHHHHHHhC---CCCCceeeeeEEEe----
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPL-NEIVAIKVLDLEKCN-NDLDGIRREVQTMRVT---NHPNVLRAHCSFTT---- 83 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~t-g~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L---~HpNIVkl~~~~~~---- 83 (671)
.++|++++.||+|+||+||+|++..+ ++.||||++...... .....+.+|+.+|+.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47899999999999999999999766 677999999754432 2234566777777655 89999999999863
Q ss_pred -CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccc
Q 005886 84 -GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSA 162 (671)
Q Consensus 84 -~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~ 162 (671)
...+|++||||.|+.+..... .....+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred cCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 357899999998876654443 334679999999999999999999999999999999999999999999999999986
Q ss_pred ccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----
Q 005886 163 CMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPG----- 237 (671)
Q Consensus 163 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~----- 237 (671)
... ........+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..++......
T Consensus 165 ~~~----~~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 165 IYS----FQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCC----GGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhc----ccccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 442 2233456789999999999987 679999999999999999999999999988777666554321100
Q ss_pred -----------------CCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 238 -----------------LDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 238 -----------------~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
........+++.+++||.+||.+||.+|||+.|+|+||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 00112345789999999999999999999999999999998764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-53 Score=448.07 Aligned_cols=264 Identities=21% Similarity=0.382 Sum_probs=223.4
Q ss_pred ccccccCCCCeEEEEEecccCceEEEEEEEcCCCc-----EEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeee
Q 005886 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNE-----IVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHC 79 (671)
Q Consensus 6 e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~-----~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~ 79 (671)
+.+|+++.++|++.+.||+|+||+||+|++..+++ .||+|.+...........+.+|+.+|+.+ +|||||++++
T Consensus 29 ~~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 29 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence 45678888999999999999999999999886654 69999987655555567889999999988 8999999999
Q ss_pred EEEeCCEEEEEEeccCCCCHHHHHHhhCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 005886 80 SFTTGHCLWVVMPYMAGGSCLHIMKSAYP---------------------EGFEEPVIATLLRETLKALVYLHFHGHIHR 138 (671)
Q Consensus 80 ~~~~~~~l~LVmEy~~ggsL~~~l~~~~~---------------------~~l~e~~i~~i~~qIl~aL~yLHs~gIVHr 138 (671)
+|.+.+.+|+|||||+||+|.+++..... ..+++..++.++.||+.||+|||++|||||
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR 188 (325)
T d1rjba_ 109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188 (325)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 99999999999999999999999976421 348899999999999999999999999999
Q ss_pred cCCCCcEEEcCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCC
Q 005886 139 DVKAGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAP 217 (671)
Q Consensus 139 DLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~P 217 (671)
||||+|||++.++.+||+|||+|+...... ......+..||+.|||||++.+ ..|+.++|||||||++|||++ |.+|
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDS-NYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCT-TSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCchhccccccCCeEEEeeccccccccCCC-ceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCC
Confidence 999999999999999999999997654322 2223345678999999999987 679999999999999999997 8999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 218 FSKYPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 218 F~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
|.+.+....+..++... ...+.+..+|+++++||.+||..||.+|||+++|++|
T Consensus 267 f~~~~~~~~~~~~~~~~---~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 267 YPGIPVDANFYKLIQNG---FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp STTCCCSHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHhcC---CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99887766666666543 2334466789999999999999999999999999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.5e-52 Score=433.65 Aligned_cols=262 Identities=26% Similarity=0.419 Sum_probs=217.7
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc--ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC----E
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN--NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH----C 86 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~--~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~----~ 86 (671)
.++|++.+.||+|+||+||+|+++.+|+.||||++...... .....+.+|+.+|+.++|||||++++++.... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999999999999999999765433 33567899999999999999999999998653 4
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
+|||||||.||+|..++... +.+++..++.++.||+.||+|||++|||||||||+|||++.++.++|+|||++.....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 89999999999999998877 6799999999999999999999999999999999999999999999999999866544
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (671)
...........+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..++...+. .....+..+
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 241 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI-PPSARHEGL 241 (277)
T ss_dssp ---------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC-CGGGTSSSC
T ss_pred ccccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCC-CCchhccCC
Confidence 4444444566789999999999987 67999999999999999999999999998888887777766443 233446678
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHhchhcc
Q 005886 247 SKSFKELVTACLVKDPKKRPTAEKLMKHHFFK 278 (671)
Q Consensus 247 s~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk 278 (671)
|+++++||.+||.+||.+||+..+.|.|+|++
T Consensus 242 s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 99999999999999999999545555678775
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.4e-52 Score=435.40 Aligned_cols=260 Identities=26% Similarity=0.355 Sum_probs=217.0
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
++|++++.||+|+||+||+|+++ +|+.||||++...... .....+.+|+.+|+.++|||||+++++|..++.+|++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 68999999999999999999986 7899999999765432 346789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
|+.++.+..+.... +.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|....... .
T Consensus 81 ~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~---~ 155 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV---R 155 (286)
T ss_dssp CCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred eehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc---c
Confidence 99887666665544 679999999999999999999999999999999999999999999999999987653222 2
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--CC------------
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP--GL------------ 238 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~--~~------------ 238 (671)
......|++.|+|||++.+...++.++|||||||++|||++|++||.+....+.+..+...... ..
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 2345579999999999987677899999999999999999999999988776665544321100 00
Q ss_pred ----------CccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccc
Q 005886 239 ----------DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKH 279 (671)
Q Consensus 239 ----------~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~ 279 (671)
.......+++.+++||.+||.+||++|||++|+|+||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 01123456889999999999999999999999999999973
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=437.81 Aligned_cols=264 Identities=23% Similarity=0.357 Sum_probs=224.9
Q ss_pred ccccCCCCeEEEEE-ecccCceEEEEEEEcC--CCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeC
Q 005886 8 RFPVDAKDYRLYEE-VGEGVSATVYRALCIP--LNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG 84 (671)
Q Consensus 8 ~~~i~~~~Y~l~~~-LG~G~fG~Vyka~~~~--tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~ 84 (671)
++-+..++|.+.+. ||+|+||+||+|.++. ++..||||+++........+.+.+|+.+|+.++|||||++++++.++
T Consensus 2 ~l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~ 81 (285)
T d1u59a_ 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE 81 (285)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred ceeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC
Confidence 45677788999985 9999999999998764 44579999997665555678899999999999999999999998754
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccc
Q 005886 85 HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACM 164 (671)
Q Consensus 85 ~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~ 164 (671)
.+|||||||+||+|.+++... ...+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.+
T Consensus 82 -~~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 82 -ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp -SEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred -eEEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcc
Confidence 589999999999999987543 257999999999999999999999999999999999999999999999999999877
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERD 243 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (671)
..............||+.|+|||++.+ ..|+.++|||||||++|||+| |..||.+....+....+..... .+.+
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~----~~~p 234 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR----MECP 234 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC----CCCC
T ss_pred cccccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----CCCC
Confidence 544443344455689999999999987 569999999999999999998 9999998887776655554432 2345
Q ss_pred ccchHHHHHHHHHhhhcCCCCCCCHHHH---Hhchhcc
Q 005886 244 KRFSKSFKELVTACLVKDPKKRPTAEKL---MKHHFFK 278 (671)
Q Consensus 244 ~~ls~~l~dLI~~cL~~dP~kRpSa~ei---L~Hpwfk 278 (671)
..+|+++.+||.+||..||.+|||+.+| |+|+|+.
T Consensus 235 ~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 6789999999999999999999999888 6777774
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=434.27 Aligned_cols=263 Identities=23% Similarity=0.386 Sum_probs=222.2
Q ss_pred cccccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeC
Q 005886 5 VEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG 84 (671)
Q Consensus 5 ~e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~ 84 (671)
.++.|+|..++|++.+.||+|+||+||+|.++ ++..||||++.... ...+.+.+|+.+|+.++|||||++++++.+
T Consensus 4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~- 79 (272)
T d1qpca_ 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ- 79 (272)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCCCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-
Confidence 36789999999999999999999999999975 67889999997543 345789999999999999999999998765
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccc
Q 005886 85 HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACM 164 (671)
Q Consensus 85 ~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~ 164 (671)
+.+|+|||||.+|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEc
Confidence 56789999999999998775543346999999999999999999999999999999999999999999999999999866
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHG-HAPFSKYPPMKVLLMTLQNAPPGLDYERD 243 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG-~~PF~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (671)
.... ........||+.|||||++.+ ..|+.++|||||||++|||+|| .+||......+....+.... ....+
T Consensus 160 ~~~~--~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~----~~~~p 232 (272)
T d1qpca_ 160 EDNE--YTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY----RMVRP 232 (272)
T ss_dssp SSSC--EECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC----CCCCC
T ss_pred cCCc--cccccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC----CCCCc
Confidence 4322 223345689999999999987 5699999999999999999995 55666666555544444332 23345
Q ss_pred ccchHHHHHHHHHhhhcCCCCCCCHHHHHh--chhcc
Q 005886 244 KRFSKSFKELVTACLVKDPKKRPTAEKLMK--HHFFK 278 (671)
Q Consensus 244 ~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~--Hpwfk 278 (671)
..+++++.+||.+||..||.+|||++++++ |+||.
T Consensus 233 ~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 678999999999999999999999999998 88885
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-53 Score=436.17 Aligned_cols=262 Identities=26% Similarity=0.426 Sum_probs=216.3
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccC-cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKC-NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH 85 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~-~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~ 85 (671)
+.|+++.++|++.+.||+|+||+||+|+.. ..||||+++.... ....+.+.+|+.+|+.++|||||++++++.. .
T Consensus 1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~ 76 (276)
T d1uwha_ 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-P 76 (276)
T ss_dssp CCCBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred CCcccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-c
Confidence 468899999999999999999999999753 3599999976543 3457889999999999999999999998754 5
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
.+|||||||.||+|.+++... ...+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+...
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 689999999999999999754 2569999999999999999999999999999999999999999999999999987653
Q ss_pred cCCCcccccccccCCCCCCChhHhhhc--cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCccc
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQL--HGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP-PGLDYER 242 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~--~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~-~~~~~~~ 242 (671)
.. ..........||+.|||||++.+. ..|+.++|||||||++|||+||+.||.+......+...+.... .......
T Consensus 156 ~~-~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 234 (276)
T d1uwha_ 156 RW-SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGS
T ss_pred cc-CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhc
Confidence 22 222234567899999999999752 3489999999999999999999999998877666555554332 2222334
Q ss_pred cccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 243 DKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 243 ~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
+..+++++++||.+||..||.+|||+.+|++|
T Consensus 235 ~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 56789999999999999999999999999985
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-52 Score=425.14 Aligned_cols=253 Identities=22% Similarity=0.367 Sum_probs=208.3
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LV 90 (671)
|+.++|++++.||+|+||+||+|.++ +++.||||++.... ...+.+.+|+.+++.++|||||++++++..++.+|+|
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc--CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence 57789999999999999999999976 57789999987543 3457799999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCc
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR 170 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~ 170 (671)
||||.+|+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 79 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~- 156 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 156 (263)
T ss_dssp EECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred EEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc-
Confidence 9999999999988764 35689999999999999999999999999999999999999999999999999976633222
Q ss_pred ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHH
Q 005886 171 QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 171 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
.......||+.|+|||++.+ ..|+.++|||||||++|||+| |.+||...+..+....+..... ...+..++++
T Consensus 157 -~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~----~~~p~~~~~~ 230 (263)
T d1sm2a_ 157 -TSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR----LYKPRLASTH 230 (263)
T ss_dssp ---------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC----CCCCTTSCHH
T ss_pred -eeecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC----CCCccccCHH
Confidence 22334679999999999987 579999999999999999999 5777777666665555544322 2335667899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 250 FKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
+.+||.+||..||.+|||+++|++|
T Consensus 231 l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 231 VYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHH
Confidence 9999999999999999999999985
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.1e-52 Score=435.45 Aligned_cols=259 Identities=24% Similarity=0.346 Sum_probs=211.2
Q ss_pred ccCCCCeEEEEEecccCceEEEEEEEcCCCc---EEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCE
Q 005886 10 PVDAKDYRLYEEVGEGVSATVYRALCIPLNE---IVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHC 86 (671)
Q Consensus 10 ~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~---~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 86 (671)
.++.++|++.+.||+|+||+||+|.++.+|+ .||||.+.........+.+.+|+.+|+.++|||||++++++.++..
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP 101 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 4677899999999999999999999987765 5889988765555566789999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
+|+|||||.||+|.+++... .+.+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.+..
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 99999999999999988764 35699999999999999999999999999999999999999999999999999986643
Q ss_pred CCCcc--cccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 005886 167 AGDRQ--RSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERD 243 (671)
Q Consensus 167 ~~~~~--~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (671)
..... .......||+.|||||++.+ ..|+.++|||||||++|||+| |..||.+....+....+..... .+.+
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~----~~~~ 255 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR----LPPP 255 (299)
T ss_dssp ---------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC----CCCC
T ss_pred CCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----CCCC
Confidence 32221 12223468999999999987 679999999999999999998 8999999888777666655432 2345
Q ss_pred ccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 244 KRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 244 ~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
..++.++.+||.+||..||.+|||+.+|+++
T Consensus 256 ~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 6789999999999999999999999999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-52 Score=431.18 Aligned_cols=257 Identities=21% Similarity=0.342 Sum_probs=212.4
Q ss_pred CCeEEE-EEecccCceEEEEEEEc--CCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEE
Q 005886 14 KDYRLY-EEVGEGVSATVYRALCI--PLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWV 89 (671)
Q Consensus 14 ~~Y~l~-~~LG~G~fG~Vyka~~~--~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~L 89 (671)
+.+.+. ++||+|+||+||+|.+. .+++.||||++...... ...+.+.+|+.+|+.++|||||++++++.++ .+||
T Consensus 6 ~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~l 84 (277)
T d1xbba_ 6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWML 84 (277)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEE
T ss_pred hhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEE
Confidence 334444 36999999999999865 45678999999754432 3457899999999999999999999999755 5789
Q ss_pred EEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCC
Q 005886 90 VMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 90 VmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~ 169 (671)
|||||+||+|.+++... ..+++..+..++.||+.||+|||++|||||||||+|||++.+|.+||+|||+++.+.....
T Consensus 85 vmE~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 85 VMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp EEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred EEEcCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 99999999999999876 6799999999999999999999999999999999999999999999999999987654444
Q ss_pred cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchH
Q 005886 170 RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSK 248 (671)
Q Consensus 170 ~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~ 248 (671)
.........||+.|||||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+....+..... .+.+..+|+
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~----~~~p~~~~~ 237 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER----MGCPAGCPR 237 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----CCCCTTCCH
T ss_pred ccccccccCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC----CCCCcccCH
Confidence 3344455689999999999987 568999999999999999998 9999999887766655554332 234567899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHH---Hhchhcc
Q 005886 249 SFKELVTACLVKDPKKRPTAEKL---MKHHFFK 278 (671)
Q Consensus 249 ~l~dLI~~cL~~dP~kRpSa~ei---L~Hpwfk 278 (671)
++++||.+||..||.+|||+++| |+|+|+.
T Consensus 238 ~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 238 EMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 99999999999999999999998 5666654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=434.13 Aligned_cols=272 Identities=22% Similarity=0.297 Sum_probs=217.6
Q ss_pred ccccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEe-
Q 005886 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTT- 83 (671)
Q Consensus 6 e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~- 83 (671)
|....-..++|+++++||+|+||+||+|+++.+|+.||||++...... .....+.+|+.+|+.++||||+++++++..
T Consensus 2 ~~~~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~ 81 (318)
T d3blha1 2 ECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK 81 (318)
T ss_dssp CCTTSCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred CCCCCCccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecc
Confidence 445556679999999999999999999999999999999998765433 346778899999999999999999999865
Q ss_pred -------CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEe
Q 005886 84 -------GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLA 156 (671)
Q Consensus 84 -------~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~ 156 (671)
+..+|+|||||.++.+...... ...+++..++.+++||+.||.|||++|||||||||+|||++.++.+||+
T Consensus 82 ~~~~~~~~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~ 159 (318)
T d3blha1 82 ASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLA 159 (318)
T ss_dssp ---------CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEEC
T ss_pred cccccccCceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEee
Confidence 3468999999987765544333 3679999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCC-cccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-
Q 005886 157 DFGVSACMFDAGD-RQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA- 234 (671)
Q Consensus 157 DFGls~~~~~~~~-~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~- 234 (671)
|||+++.+..... ........+||+.|+|||++.+...|+.++|||||||++|+|++|+.||.+..+......+....
T Consensus 160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~ 239 (318)
T d3blha1 160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 239 (318)
T ss_dssp CCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999865532221 22233456899999999999876679999999999999999999999999887766554433211
Q ss_pred --CCCCCcc-------------------c-----cccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccc
Q 005886 235 --PPGLDYE-------------------R-----DKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKH 279 (671)
Q Consensus 235 --~~~~~~~-------------------~-----~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~ 279 (671)
.+..... . ....++.+++||.+||.+||++|||++|+|+||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 1100000 0 0113667899999999999999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=437.54 Aligned_cols=262 Identities=28% Similarity=0.358 Sum_probs=214.7
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC--
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH-- 85 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~-- 85 (671)
|.+ .++|++++.||+|+||+||+|.++.+|+.||||++...... ...+.+.+|+.+|+.++|||||+++++|...+
T Consensus 14 ~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~ 92 (346)
T d1cm8a_ 14 WEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 92 (346)
T ss_dssp ECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred eec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccc
Confidence 444 47899999999999999999999999999999999755432 34677899999999999999999999998755
Q ss_pred ----EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccc
Q 005886 86 ----CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVS 161 (671)
Q Consensus 86 ----~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls 161 (671)
.+|+||||| |++|..+++. ..+++..++.+++||+.||+|||++|||||||||+|||++.++.+||+|||+|
T Consensus 93 ~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 93 DDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp TTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred cccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccce
Confidence 579999999 6678877765 47999999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC------
Q 005886 162 ACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAP------ 235 (671)
Q Consensus 162 ~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~------ 235 (671)
+... ......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+....+........
T Consensus 169 ~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 169 RQAD------SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp EECC------SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred eccC------CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence 7542 1234568999999999998766789999999999999999999999988776655433322110
Q ss_pred --------------------CCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 236 --------------------PGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 236 --------------------~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
..........+++.+.+||.+||..||.+|||+.+||+||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0001112345789999999999999999999999999999998654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-51 Score=421.16 Aligned_cols=253 Identities=24% Similarity=0.395 Sum_probs=221.2
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEE
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LV 90 (671)
++.++|++++.||+|+||+||+|+++ ++..||||+++... ...+.+.+|+.+++.++|||||+++++|.+++.+|+|
T Consensus 1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 1 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS--SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred CChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCc--CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence 46789999999999999999999985 78899999997654 3456899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCc
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR 170 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~ 170 (671)
||||.+|+|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+... .
T Consensus 78 ~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~--~ 154 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--E 154 (258)
T ss_dssp EECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS--S
T ss_pred EEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC--C
Confidence 99999999999876542 56899999999999999999999999999999999999999999999999999765432 2
Q ss_pred ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHH
Q 005886 171 QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRFSKS 249 (671)
Q Consensus 171 ~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ls~~ 249 (671)
........||+.|+|||++.+ ..|+.++|||||||++|||+| |+.||.+.+..+....+.... ....+..++++
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~----~~~~p~~~~~~ 229 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL----RLYRPHLASEK 229 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC----CCCCCTTCCHH
T ss_pred ceeecccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCC----CCCCcccccHH
Confidence 223344679999999999987 679999999999999999998 899999988877666555432 22345678899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 250 FKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 250 l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
+++||.+||+.||.+|||+++||+|
T Consensus 230 l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 230 VYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHH
Confidence 9999999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-51 Score=436.40 Aligned_cols=258 Identities=24% Similarity=0.343 Sum_probs=212.4
Q ss_pred CeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe------CCEEE
Q 005886 15 DYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT------GHCLW 88 (671)
Q Consensus 15 ~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~------~~~l~ 88 (671)
+|+.+++||+|+||+||+|+++.+|+.||||++...... ..+|+.+|+.++||||++++++|.. ..++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 699999999999999999999999999999999765422 2479999999999999999999854 34689
Q ss_pred EEEeccCCCCHHHHHHh-hCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC-ceEEecccccccccc
Q 005886 89 VVMPYMAGGSCLHIMKS-AYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG-AIKLADFGVSACMFD 166 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~-~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g-~vKL~DFGls~~~~~ 166 (671)
||||||.++.+..+... .....+++..++.|++||+.||+|||++||+||||||+|||++.++ .+||+|||++..+..
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 99999987644443321 2235799999999999999999999999999999999999999775 899999999876532
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC----------
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP---------- 236 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~---------- 236 (671)
. ....+.+||+.|+|||++.+...|+.++|||||||++|||++|++||......+.+..+......
T Consensus 176 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 176 G----EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp T----SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred C----cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 2 23345689999999999987677999999999999999999999999988776665554421100
Q ss_pred ------CC--------CccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 237 ------GL--------DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 237 ------~~--------~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
.+ .......+++++.+||.+||.+||.+|||+.|+|+||||+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 00 0011345789999999999999999999999999999998654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-51 Score=437.34 Aligned_cols=265 Identities=22% Similarity=0.311 Sum_probs=217.8
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC-----EEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH-----CLW 88 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~-----~l~ 88 (671)
.+|++++.||+|+||+||+|.++.+|+.||||++.........+.+.+|+.+|+.++||||+++++++.... .+|
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 469999999999999999999999999999999976554455678899999999999999999999997653 355
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAG 168 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~ 168 (671)
++ +|+.||+|.+++... .+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|.......
T Consensus 88 l~-~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 88 LV-THLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EE-EECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EE-EeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 55 456689999999764 69999999999999999999999999999999999999999999999999997665444
Q ss_pred CcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--------------
Q 005886 169 DRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNA-------------- 234 (671)
Q Consensus 169 ~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~-------------- 234 (671)
.........+||+.|+|||++.....|+.++||||+||++|+|++|+.||.+..............
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence 444445667899999999999776778999999999999999999999998876654443332111
Q ss_pred ---------CCCCC---ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 235 ---------PPGLD---YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 235 ---------~~~~~---~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
+.... ......++.++++||.+||.+||.+|||+.++|+||||+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 00000 0123457889999999999999999999999999999985543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-51 Score=423.30 Aligned_cols=257 Identities=24% Similarity=0.373 Sum_probs=211.2
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcCCC---cEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIPLN---EIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH 85 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg---~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~ 85 (671)
|+|+.++|++.+.||+|+||+||+|++..++ ..||||.+.........+.+.+|+.+|+.++|||||++++++. ++
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 80 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 80 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 7888899999999999999999999987554 4688998865554555678999999999999999999999996 46
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
.+|+|||||.+|+|..++... ...+++..++.++.||+.||+|||++|||||||||+||+++.++.+||+|||+|+.+.
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred eEEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 789999999999999987654 3578999999999999999999999999999999999999999999999999997653
Q ss_pred cCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccc
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (671)
... ........||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+....+....+..... .+.+.
T Consensus 160 ~~~--~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~----~~~~~ 232 (273)
T d1mp8a_ 160 DST--YYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER----LPMPP 232 (273)
T ss_dssp -------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----CCCCT
T ss_pred CCc--ceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----CCCCC
Confidence 222 122334578999999999987 679999999999999999998 8999999888777766655432 23467
Q ss_pred cchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 245 RFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 245 ~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
.+|+++++||.+||..||.+|||+.+|++|
T Consensus 233 ~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 233 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 789999999999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=420.99 Aligned_cols=258 Identities=21% Similarity=0.322 Sum_probs=209.9
Q ss_pred ccCCCCeEEEEEecccCceEEEEEEEcCCC----cEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC
Q 005886 10 PVDAKDYRLYEEVGEGVSATVYRALCIPLN----EIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH 85 (671)
Q Consensus 10 ~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg----~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~ 85 (671)
+|....|++.+.||+|+||+||+|.++.++ ..||||++...........+.+|+.+|+.++|||||++++++.+..
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~ 82 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 82 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence 577889999999999999999999988665 4699999976655555677899999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
.+++|||||.+|++.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+.
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred ceEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence 999999999999999887754 3579999999999999999999999999999999999999999999999999998764
Q ss_pred cCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHhcCCCCCCccccc
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHG-HAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG-~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (671)
.............||+.|||||++.+ ..|+.++|||||||++|||++| .+||.+.+..+....+.... ..+.+.
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~----~~~~~~ 236 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF----RLPTPM 236 (283)
T ss_dssp ------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC----CCCCCT
T ss_pred CCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC----CCCCch
Confidence 43333333445678999999999987 6799999999999999999995 55555555555544444332 233456
Q ss_pred cchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 245 RFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 245 ~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.++..+++||.+||..||.+|||+.+|++
T Consensus 237 ~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 237 DCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp TCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 78999999999999999999999999976
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.7e-51 Score=431.83 Aligned_cols=258 Identities=24% Similarity=0.370 Sum_probs=212.5
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCC-CCCceeeeeEEEe--CCEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN-HPNVLRAHCSFTT--GHCLW 88 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~-HpNIVkl~~~~~~--~~~l~ 88 (671)
..++|++++.||+|+||+||+|+++.+|+.||||+++.. ....+.+|+.+|+.+. ||||++++++|.. ...+|
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 346799999999999999999999999999999998643 3567899999999985 9999999999984 45799
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCC-ceEEeccccccccccC
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNG-AIKLADFGVSACMFDA 167 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g-~vKL~DFGls~~~~~~ 167 (671)
+|||||.+++|..+. +.+++..++.+++||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.....
T Consensus 109 ~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred EEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 999999999986653 4699999999999999999999999999999999999998755 6999999998765322
Q ss_pred CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHh------------c-
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMK-VLLMTLQ------------N- 233 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~-~~~~~~~------------~- 233 (671)
......+||+.|+|||++.+...|+.++|||||||++|+|++|..||....... ....+.. .
T Consensus 184 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 184 ----QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp ----CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred ----CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 223456899999999999886778999999999999999999999997654322 1111110 0
Q ss_pred -CCC------------------CCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccccc
Q 005886 234 -APP------------------GLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHARS 282 (671)
Q Consensus 234 -~~~------------------~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~~ 282 (671)
... .........+++++++||.+||.+||.+|||++|+|+||||+...+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 000 0011123457899999999999999999999999999999997654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=417.69 Aligned_cols=262 Identities=25% Similarity=0.356 Sum_probs=219.9
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEEEEEEe
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l~LVmE 92 (671)
++|++++.||+|+||+||+|+++.+|+.||||+++..... .....+.+|+.+|+.++||||++++++|.+...+++||+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 6899999999999999999999999999999999765533 346788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCccc
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDRQR 172 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~~~ 172 (671)
++.|++|..++... +.+++..++.++.|++.||+|||++|||||||||+|||++.++.+||+|||.|...... ..
T Consensus 82 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~---~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP---VR 156 (292)
T ss_dssp CCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC---CS
T ss_pred eccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCC---Cc
Confidence 99999888877655 78999999999999999999999999999999999999999999999999998765322 22
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCC-CCChHHHHHHHHhc--CCC-------------
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFS-KYPPMKVLLMTLQN--APP------------- 236 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~-~~~~~~~~~~~~~~--~~~------------- 236 (671)
......+++.|+|||++.+...++.++|||||||++|+|++|+.||. +.+..+.+..+... .+.
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence 33345788999999999876668999999999999999999999864 43433333322211 000
Q ss_pred ---------CCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhcccc
Q 005886 237 ---------GLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHA 280 (671)
Q Consensus 237 ---------~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~ 280 (671)
.........+++.+++||.+||..||.+||||+|+|+||||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 00111234568899999999999999999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-51 Score=424.49 Aligned_cols=265 Identities=25% Similarity=0.396 Sum_probs=218.6
Q ss_pred cccccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeC
Q 005886 5 VEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTG 84 (671)
Q Consensus 5 ~e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~ 84 (671)
..+.|.|+.++|++.+.||+|+||+||+|++..+ ..||||++.... ...+.+.+|+.+|+.++|||||++++++.+
T Consensus 8 ~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~- 83 (285)
T d1fmka3 8 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 83 (285)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc--CCHHHHHHHHHHHHhcccCCEeEEEEEEec-
Confidence 4677999999999999999999999999998755 569999986543 345789999999999999999999999865
Q ss_pred CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccc
Q 005886 85 HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACM 164 (671)
Q Consensus 85 ~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~ 164 (671)
+.+|+|||||.+|+|.+++.......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+..
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhc
Confidence 56789999999999999886554467999999999999999999999999999999999999999999999999999765
Q ss_pred ccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 005886 165 FDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHG-HAPFSKYPPMKVLLMTLQNAPPGLDYERD 243 (671)
Q Consensus 165 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG-~~PF~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (671)
.... ........||+.|+|||++.+ ..++.++|||||||++|||++| .+||.+....+.+..+.... ..+.+
T Consensus 164 ~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~----~~~~~ 236 (285)
T d1fmka3 164 EDNE--YTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY----RMPCP 236 (285)
T ss_dssp --------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC----CCCCC
T ss_pred cCCC--ceeeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC----CCCCC
Confidence 3222 223344679999999999987 6799999999999999999995 55566666655555554433 23346
Q ss_pred ccchHHHHHHHHHhhhcCCCCCCCHHHHHh--chhcccc
Q 005886 244 KRFSKSFKELVTACLVKDPKKRPTAEKLMK--HHFFKHA 280 (671)
Q Consensus 244 ~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~--Hpwfk~~ 280 (671)
..+++++++||.+||..||++||++++|+. |+||...
T Consensus 237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 678999999999999999999999999987 8898754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=433.29 Aligned_cols=272 Identities=29% Similarity=0.441 Sum_probs=223.8
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEc---CCCcEEEEEEeccccC---cccHHHHHHHHHHHHhCCC-CCceeeeeEEEe
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCI---PLNEIVAIKVLDLEKC---NNDLDGIRREVQTMRVTNH-PNVLRAHCSFTT 83 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~---~tg~~VAIKvi~~~~~---~~~~~~i~~Ei~iL~~L~H-pNIVkl~~~~~~ 83 (671)
+..++|++++.||+|+||+||+|++. .+|+.||||++++... ....+.+.+|+.+|++++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 45688999999999999999999984 4789999999975432 2335678899999999966 899999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccc
Q 005886 84 GHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSAC 163 (671)
Q Consensus 84 ~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~ 163 (671)
...+|+|||||.||+|..++... ..+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+++.
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred CCceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 99999999999999999999887 6789999999999999999999999999999999999999999999999999876
Q ss_pred cccCCCcccccccccCCCCCCChhHhhhcc-CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccc
Q 005886 164 MFDAGDRQRSRNTFVGTPCWMAPEVMQQLH-GYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYER 242 (671)
Q Consensus 164 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~-~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~~~~~ 242 (671)
+.... .....+..||+.|+|||++.+.. .++.++|||||||+||+|++|..||.+.........+..... ......
T Consensus 179 ~~~~~--~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~-~~~~~~ 255 (322)
T d1vzoa_ 179 FVADE--TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL-KSEPPY 255 (322)
T ss_dssp CCGGG--GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH-HCCCCC
T ss_pred hcccc--cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc-cCCCCC
Confidence 53322 22234568999999999997633 478899999999999999999999977644332222222110 011223
Q ss_pred cccchHHHHHHHHHhhhcCCCCCC-----CHHHHHhchhccccccchHHH
Q 005886 243 DKRFSKSFKELVTACLVKDPKKRP-----TAEKLMKHHFFKHARSNDFLA 287 (671)
Q Consensus 243 ~~~ls~~l~dLI~~cL~~dP~kRp-----Sa~eiL~Hpwfk~~~~~~~~~ 287 (671)
+..+++++.+||.+||.+||.+|| |++|+|+||||+...+.....
T Consensus 256 ~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~ 305 (322)
T d1vzoa_ 256 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAA 305 (322)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHT
T ss_pred cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHh
Confidence 457899999999999999999999 589999999999876654443
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-50 Score=421.96 Aligned_cols=256 Identities=22% Similarity=0.362 Sum_probs=210.4
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCc----EEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCCEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNE----IVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGHCL 87 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~----~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~~l 87 (671)
...+|++++.||+|+||+||+|.+..+|+ .||+|.+.........+.+.+|+.+|+.++|||||++++++.++ ..
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 34679999999999999999999998886 57888886555455678899999999999999999999999875 46
Q ss_pred EEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccC
Q 005886 88 WVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDA 167 (671)
Q Consensus 88 ~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~ 167 (671)
+++|+|+.+|+|.+.+... ...+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.+...
T Consensus 86 ~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred eEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 7788999999999887764 367999999999999999999999999999999999999999999999999999765432
Q ss_pred CCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Q 005886 168 GDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKRF 246 (671)
Q Consensus 168 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (671)
. .........||+.|||||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+....+..... .+.+..+
T Consensus 165 ~-~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~----~~~p~~~ 238 (317)
T d1xkka_ 165 E-KEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER----LPQPPIC 238 (317)
T ss_dssp C-C--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC----CCCCTTB
T ss_pred c-ccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC----CCCCccc
Confidence 2 2223344579999999999987 579999999999999999998 8999998877665554444332 2345678
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHhch
Q 005886 247 SKSFKELVTACLVKDPKKRPTAEKLMKHH 275 (671)
Q Consensus 247 s~~l~dLI~~cL~~dP~kRpSa~eiL~Hp 275 (671)
++++.+||.+||..||.+|||+.+|+.|.
T Consensus 239 ~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 239 TIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 99999999999999999999999999873
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=421.83 Aligned_cols=263 Identities=21% Similarity=0.327 Sum_probs=210.7
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeeeE
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIP-----LNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHCS 80 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~-----tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~ 80 (671)
++|++..++|++.+.||+|+||.||+|.+.. +++.||||++...........+.+|..++..+ +|+||+.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 4688888999999999999999999999765 44689999997655555566777888877665 79999999998
Q ss_pred EEeC-CEEEEEEeccCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcE
Q 005886 81 FTTG-HCLWVVMPYMAGGSCLHIMKSAY--------------PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNI 145 (671)
Q Consensus 81 ~~~~-~~l~LVmEy~~ggsL~~~l~~~~--------------~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNI 145 (671)
+... ..+|+|||||.||+|.+++.... ...+++..++.++.||+.||+|||++|||||||||+||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NI 165 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 165 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccce
Confidence 8764 56899999999999999997542 23488999999999999999999999999999999999
Q ss_pred EEcCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhC-CCCCCCCChH
Q 005886 146 LIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHG-HAPFSKYPPM 224 (671)
Q Consensus 146 Lld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG-~~PF~~~~~~ 224 (671)
|++.++.+||+|||+|+....... .......+||+.|||||++.+ ..|+.++|||||||++|||++| .+||.+....
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp EECGGGCEEECC------CCSCTT-SCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred eECCCCcEEEccCcchhhcccccc-ccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999976533322 233455689999999999987 6799999999999999999986 5688877665
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 225 KVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
..+...+.... ....+..+++++++||.+||..||.+|||+.++++|
T Consensus 244 ~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 244 EEFCRRLKEGT---RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHHHTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCC---CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 55555444322 223456789999999999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=425.50 Aligned_cols=258 Identities=26% Similarity=0.366 Sum_probs=205.1
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEe------CCE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTT------GHC 86 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~------~~~ 86 (671)
++|+++++||+|+||+||+|.++.+|+.||||++...... .....+.+|+.+|+.++|||||+++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 6799999999999999999999999999999999765433 345678999999999999999999999964 468
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
+|+|||||.|+ ++..+. ..+++..++.+++||+.||+|||++||+||||||+|||++.++.+|++|||+++...
T Consensus 97 ~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~- 170 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG- 170 (355)
T ss_dssp EEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred eEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc-
Confidence 99999999765 444442 468999999999999999999999999999999999999999999999999976542
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC----------
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPP---------- 236 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~---------- 236 (671)
........+||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+.......++.....
T Consensus 171 ---~~~~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 171 ---TSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp -------------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred ---cccccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 2233445689999999999988 67999999999999999999999999887665544433221110
Q ss_pred ---------------------------CCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 237 ---------------------------GLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 237 ---------------------------~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
......+..++.++++||.+||.+||.+||||+|+|+||||+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 001111234578899999999999999999999999999998643
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=428.35 Aligned_cols=265 Identities=24% Similarity=0.334 Sum_probs=216.8
Q ss_pred cccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-ccHHHHHHHHHHHHhCCCCCceeeeeEEEeC-
Q 005886 7 KRFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-NDLDGIRREVQTMRVTNHPNVLRAHCSFTTG- 84 (671)
Q Consensus 7 ~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~- 84 (671)
..|.+ .++|++++.||+|+||+||+|+++.+|+.||||++...... .....+.+|+.+|+.++|||||+++++|...
T Consensus 12 ~~~~~-~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~ 90 (348)
T d2gfsa1 12 TIWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 90 (348)
T ss_dssp SEEEE-ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred ccccC-CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecc
Confidence 34554 47899999999999999999999999999999999765432 3456788999999999999999999999643
Q ss_pred ----CEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccc
Q 005886 85 ----HCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGV 160 (671)
Q Consensus 85 ----~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGl 160 (671)
...+++|+|+.||+|.+++.. ..+++..++.+++||+.||+|||++||+||||||+|||++.+|.+|++|||+
T Consensus 91 ~~~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 91 SLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp STTTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred ccccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccch
Confidence 334556677789999998854 4799999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--
Q 005886 161 SACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGL-- 238 (671)
Q Consensus 161 s~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~~~~~~-- 238 (671)
+... .....+..||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+........
T Consensus 168 a~~~------~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~ 241 (348)
T d2gfsa1 168 ARHT------DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241 (348)
T ss_dssp --CC------TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred hccc------CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 8543 22334568999999999988766689999999999999999999999998776655544433211100
Q ss_pred -----------------------C-ccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhchhccccc
Q 005886 239 -----------------------D-YERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKHHFFKHAR 281 (671)
Q Consensus 239 -----------------------~-~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~Hpwfk~~~ 281 (671)
. ......+++++++||.+||..||.+|||+.|+|+||||++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 0 011235788999999999999999999999999999998754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=415.29 Aligned_cols=263 Identities=23% Similarity=0.427 Sum_probs=221.4
Q ss_pred cccccccCCCCeEEEEEecccCceEEEEEEEcCCC-------cEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCcee
Q 005886 5 VEKRFPVDAKDYRLYEEVGEGVSATVYRALCIPLN-------EIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLR 76 (671)
Q Consensus 5 ~e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg-------~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVk 76 (671)
.+++|+|+.++|++.+.||+|+||.||+|++..++ ..||||+++..........+.+|+..+..+ +|||||+
T Consensus 4 ~~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~ 83 (299)
T d1fgka_ 4 EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIIN 83 (299)
T ss_dssp CCTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cCCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEe
Confidence 45779999999999999999999999999987665 369999997766555667888899988877 8999999
Q ss_pred eeeEEEeCCEEEEEEeccCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCC
Q 005886 77 AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAYP--------------EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKA 142 (671)
Q Consensus 77 l~~~~~~~~~l~LVmEy~~ggsL~~~l~~~~~--------------~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKP 142 (671)
++++|.++..+|+|||||.+|+|.+++..... ..+++..++.++.||+.||+|||++|||||||||
T Consensus 84 ~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp 163 (299)
T d1fgka_ 84 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 163 (299)
T ss_dssp EEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred cccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecc
Confidence 99999999999999999999999999975532 3589999999999999999999999999999999
Q ss_pred CcEEEcCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCC
Q 005886 143 GNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKY 221 (671)
Q Consensus 143 eNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~ 221 (671)
+|||++.++.+||+|||+++....... ........||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~ 241 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCT-TCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cceeecCCCCeEeccchhhcccccccc-ccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCC
Confidence 999999999999999999976644332 233455689999999999987 679999999999999999998 79999888
Q ss_pred ChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 222 PPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
+.......+.... ..+.+..+++++++||.+||..||.+|||+.+|++
T Consensus 242 ~~~~~~~~i~~~~----~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 242 PVEELFKLLKEGH----RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp CHHHHHHHHHTTC----CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHcCC----CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 7766554444332 23445678999999999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=417.34 Aligned_cols=258 Identities=21% Similarity=0.341 Sum_probs=216.2
Q ss_pred ccc-cCCCCeEEEEEecccCceEEEEEEEcCCCcE--EEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeeeEEEe
Q 005886 8 RFP-VDAKDYRLYEEVGEGVSATVYRALCIPLNEI--VAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHCSFTT 83 (671)
Q Consensus 8 ~~~-i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~--VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~~~~~ 83 (671)
.|| |+.++|++.+.||+|+||+||+|+++.+|.. ||||.+.........+.+.+|+.+|+.+ +|||||++++++.+
T Consensus 3 ~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~ 82 (309)
T d1fvra_ 3 IYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 82 (309)
T ss_dssp CSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred CCCccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec
Confidence 455 7889999999999999999999999988875 6777776544445567899999999998 79999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhh--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcC
Q 005886 84 GHCLWVVMPYMAGGSCLHIMKSA--------------YPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS 149 (671)
Q Consensus 84 ~~~l~LVmEy~~ggsL~~~l~~~--------------~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~ 149 (671)
++.+|+|||||.||+|.+++... ....+++..++.++.||+.||.|||++|||||||||+|||++.
T Consensus 83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 162 (309)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcC
Confidence 99999999999999999998753 1256899999999999999999999999999999999999999
Q ss_pred CCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhC-CCCCCCCChHHHHH
Q 005886 150 NGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHG-HAPFSKYPPMKVLL 228 (671)
Q Consensus 150 ~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG-~~PF~~~~~~~~~~ 228 (671)
++.+||+|||+|+.... ........||+.|+|||.+.+ ..|+.++|||||||++|||++| .+||.+.+..+...
T Consensus 163 ~~~~kl~DfG~a~~~~~----~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~ 237 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEV----YVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237 (309)
T ss_dssp GGCEEECCTTCEESSCE----ECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred CCceEEccccccccccc----cccccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 99999999999865422 122234579999999999987 5699999999999999999996 56788877777666
Q ss_pred HHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHhc
Q 005886 229 MTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 229 ~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
.+.... ..+.+..+++++++||.+||..||++|||+.+|++|
T Consensus 238 ~i~~~~----~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 238 KLPQGY----RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HGGGTC----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcC----CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 555433 234466789999999999999999999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=410.41 Aligned_cols=250 Identities=22% Similarity=0.384 Sum_probs=210.0
Q ss_pred ccccCCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe-CCE
Q 005886 8 RFPVDAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT-GHC 86 (671)
Q Consensus 8 ~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~-~~~ 86 (671)
.|+++.++|++.+.||+|+||.||+|.++ |..||||+++.. ...+.+.+|+.+++.++|||||++++++.+ .+.
T Consensus 1 ~w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~ 75 (262)
T d1byga_ 1 GWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 75 (262)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred CCccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCc
Confidence 47899999999999999999999999985 788999999654 345778999999999999999999999865 456
Q ss_pred EEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecccccccccc
Q 005886 87 LWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFD 166 (671)
Q Consensus 87 l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~ 166 (671)
+|+||||+.+|+|.+++.......+++..++.++.||+.||.|||+++|+||||||+|||++.+|.+||+|||+++...
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~- 154 (262)
T d1byga_ 76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS- 154 (262)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC-
Confidence 8999999999999999876533458999999999999999999999999999999999999999999999999986542
Q ss_pred CCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Q 005886 167 AGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245 (671)
Q Consensus 167 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (671)
.......+|+.|+|||++.+ ..|+.++|||||||++|||+| |++||...+..+....+..... .+.+..
T Consensus 155 -----~~~~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~----~~~~~~ 224 (262)
T d1byga_ 155 -----STQDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK----MDAPDG 224 (262)
T ss_dssp ------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC----CCCCTT
T ss_pred -----CCCccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC----CCCCcc
Confidence 22334578999999999987 579999999999999999998 7999988877766666544332 334567
Q ss_pred chHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 246 FSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 246 ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
+++++++||.+||..||.+|||+.++++
T Consensus 225 ~~~~~~~li~~cl~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 225 CPPAVYEVMKNCWHLDAAMRPSFLQLRE 252 (262)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 8899999999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-49 Score=414.52 Aligned_cols=259 Identities=21% Similarity=0.364 Sum_probs=220.4
Q ss_pred cccCCCCeEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe
Q 005886 9 FPVDAKDYRLYEEVGEGVSATVYRALCIP-----LNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT 83 (671)
Q Consensus 9 ~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~-----tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~ 83 (671)
+++..++|++.+.||+|+||+||+|+++. ++..||||+++..........+.+|+.+|+.++||||+++++++..
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 45566789999999999999999999763 5678999999766555556789999999999999999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHhhC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCC
Q 005886 84 GHCLWVVMPYMAGGSCLHIMKSAY----------------------PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVK 141 (671)
Q Consensus 84 ~~~l~LVmEy~~ggsL~~~l~~~~----------------------~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLK 141 (671)
.+.+++||||+.+|+|.+++.... ...+++..++.++.||+.||+|||++||||||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK 167 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 167 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence 999999999999999999986532 1248899999999999999999999999999999
Q ss_pred CCcEEEcCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCC-CCCCC
Q 005886 142 AGNILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGH-APFSK 220 (671)
Q Consensus 142 PeNILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~-~PF~~ 220 (671)
|+|||++.++.+||+|||+|+.+.... ......+..||+.|+|||++.+ ..|+.++|||||||++|||++|. +||.+
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSAD-YYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGG-CBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ccceEECCCCcEEEccchhheeccCCc-cccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 999999999999999999997664332 2233445689999999999997 67999999999999999999984 68988
Q ss_pred CChHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 221 YPPMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.+..+....+..... .+.+..+++++.+||.+||..||.+|||+.+|++
T Consensus 246 ~~~~e~~~~v~~~~~----~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 246 MAHEEVIYYVRDGNI----LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp SCHHHHHHHHHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHcCCC----CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 888777666554432 2345678999999999999999999999999954
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=412.06 Aligned_cols=257 Identities=24% Similarity=0.368 Sum_probs=208.7
Q ss_pred cCCCCeEEEEEecccCceEEEEEEEcCC-C--cEEEEEEeccccC--cccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC
Q 005886 11 VDAKDYRLYEEVGEGVSATVYRALCIPL-N--EIVAIKVLDLEKC--NNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH 85 (671)
Q Consensus 11 i~~~~Y~l~~~LG~G~fG~Vyka~~~~t-g--~~VAIKvi~~~~~--~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~ 85 (671)
|+.++|++++.||+|+||.||+|++... + ..||||++..... ....+.+.+|+.+|+.++|||||++++++.++
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~- 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP- 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-
Confidence 5678999999999999999999987543 3 3689999875543 23457899999999999999999999999764
Q ss_pred EEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccc
Q 005886 86 CLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMF 165 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~ 165 (671)
.+++|||||.+|++.+.+.... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred chheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 6789999999999998776542 469999999999999999999999999999999999999999999999999998775
Q ss_pred cCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCccccc
Q 005886 166 DAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTLQNAPPGLDYERDK 244 (671)
Q Consensus 166 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (671)
.............||+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+....+.... ...+.+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~ 238 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG---ERLPRPE 238 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC---CCCCCCT
T ss_pred cCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCC---CCCCCcc
Confidence 44444334445578889999999987 669999999999999999998 899999988888776665542 2334567
Q ss_pred cchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 245 RFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 245 ~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
.+|..+++||.+||..||.+|||+.+|++
T Consensus 239 ~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 239 DCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 78999999999999999999999999863
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-49 Score=415.20 Aligned_cols=266 Identities=21% Similarity=0.363 Sum_probs=227.8
Q ss_pred ccccccccccCCCCeEEEEEecccCceEEEEEEEcC-----CCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCcee
Q 005886 2 DLVVEKRFPVDAKDYRLYEEVGEGVSATVYRALCIP-----LNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLR 76 (671)
Q Consensus 2 ~~~~e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~~-----tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVk 76 (671)
|+-+++.|+|+.++|++.+.||+|+||+||+|.+.. ++..||||+++..........+.+|+.+++.++|||||+
T Consensus 8 ~~~~~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~ 87 (308)
T d1p4oa_ 8 DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 87 (308)
T ss_dssp SCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCC
T ss_pred cCcCccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEee
Confidence 345677899999999999999999999999998863 357899999976554555677899999999999999999
Q ss_pred eeeEEEeCCEEEEEEeccCCCCHHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEc
Q 005886 77 AHCSFTTGHCLWVVMPYMAGGSCLHIMKSAY--------PEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILID 148 (671)
Q Consensus 77 l~~~~~~~~~l~LVmEy~~ggsL~~~l~~~~--------~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld 148 (671)
+++++..+..+++|||||.+|+|.+++.... ...+++..+..++.||+.||.|||+++||||||||+|||++
T Consensus 88 ~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld 167 (308)
T d1p4oa_ 88 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA 167 (308)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC
T ss_pred eeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeec
Confidence 9999999999999999999999999876431 13468899999999999999999999999999999999999
Q ss_pred CCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhC-CCCCCCCChHHHH
Q 005886 149 SNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHG-HAPFSKYPPMKVL 227 (671)
Q Consensus 149 ~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG-~~PF~~~~~~~~~ 227 (671)
.++.+||+|||+|+.+..... .......+||+.|+|||.+.+ ..++.++|||||||++|||++| .+||.+.+..+.+
T Consensus 168 ~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~ 245 (308)
T d1p4oa_ 168 EDFTVKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 245 (308)
T ss_dssp TTCCEEECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred CCceEEEeecccceeccCCcc-eeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999999976644322 223344579999999999987 6789999999999999999997 5889888887777
Q ss_pred HHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 228 LMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
..+..... .+.+..++..+.+||.+||..||.+|||+.+|++
T Consensus 246 ~~i~~~~~----~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 246 RFVMEGGL----LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HHHHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhCCC----CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 66655432 2345678999999999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=410.22 Aligned_cols=263 Identities=21% Similarity=0.365 Sum_probs=224.8
Q ss_pred ccccccCCCCeEEEEEecccCceEEEEEEEc-----CCCcEEEEEEeccccCcccHHHHHHHHHHHHhC-CCCCceeeee
Q 005886 6 EKRFPVDAKDYRLYEEVGEGVSATVYRALCI-----PLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVT-NHPNVLRAHC 79 (671)
Q Consensus 6 e~~~~i~~~~Y~l~~~LG~G~fG~Vyka~~~-----~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L-~HpNIVkl~~ 79 (671)
+..|++..++|++.+.||+|+||.||+|++. .+++.||||++...........+.+|+.+++.+ +|||||++++
T Consensus 15 ~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 4568889999999999999999999999864 466789999998766556677899999999998 7999999999
Q ss_pred EEEeCCEEEEEEeccCCCCHHHHHHhhCC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCC
Q 005886 80 SFTTGHCLWVVMPYMAGGSCLHIMKSAYP----------------EGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAG 143 (671)
Q Consensus 80 ~~~~~~~l~LVmEy~~ggsL~~~l~~~~~----------------~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPe 143 (671)
++.++..+|+|||||.||+|..++..... ..+++..+..++.||+.||+|||++|+|||||||+
T Consensus 95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~ 174 (311)
T d1t46a_ 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (311)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence 99999999999999999999999876531 25889999999999999999999999999999999
Q ss_pred cEEEcCCCceEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHh-CCCCCCCCC
Q 005886 144 NILIDSNGAIKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAH-GHAPFSKYP 222 (671)
Q Consensus 144 NILld~~g~vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLlt-G~~PF~~~~ 222 (671)
|||++.++.+||+|||+++...... ........+||+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+..
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDS-NYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCT-TSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccccccCcccccccchheeccCCC-cceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999987654322 2233455689999999999987 679999999999999999998 677777766
Q ss_pred hHHHHHHHHhcCCCCCCccccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 223 PMKVLLMTLQNAPPGLDYERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
....+..++.... ....+..++..+.+||.+||..||.+|||+++|++
T Consensus 253 ~~~~~~~~i~~~~---~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 253 VDSKFYKMIKEGF---RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp SSHHHHHHHHHTC---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhcCC---CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 6665555554422 22335568899999999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=396.10 Aligned_cols=251 Identities=23% Similarity=0.330 Sum_probs=205.2
Q ss_pred EEEEecccCceEEEEEEEcCCC---cEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEe-CCEEEEEEec
Q 005886 18 LYEEVGEGVSATVYRALCIPLN---EIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTT-GHCLWVVMPY 93 (671)
Q Consensus 18 l~~~LG~G~fG~Vyka~~~~tg---~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~-~~~l~LVmEy 93 (671)
+.++||+|+||+||+|.+..++ ..||||+++..........+.+|+++|++++|||||++++++.. +..+|+||||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 3678999999999999987654 36899999765555567889999999999999999999999875 5689999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEeccccccccccCCCc-cc
Q 005886 94 MAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADFGVSACMFDAGDR-QR 172 (671)
Q Consensus 94 ~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DFGls~~~~~~~~~-~~ 172 (671)
|.+|+|.+++... ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++........ ..
T Consensus 111 ~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~ 189 (311)
T d1r0pa_ 111 MKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 189 (311)
T ss_dssp CTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTT
T ss_pred eecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccce
Confidence 9999999988754 356788889999999999999999999999999999999999999999999999766433222 12
Q ss_pred ccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhcCCCCCCccccccchHHHH
Q 005886 173 SRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKY-PPMKVLLMTLQNAPPGLDYERDKRFSKSFK 251 (671)
Q Consensus 173 ~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~-~~~~~~~~~~~~~~~~~~~~~~~~ls~~l~ 251 (671)
......||+.|+|||++.+ ..++.++|||||||++|||++|..||... ...+....+..... ...+..+++++.
T Consensus 190 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~----~~~p~~~~~~l~ 264 (311)
T d1r0pa_ 190 NKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR----LLQPEYCPDPLY 264 (311)
T ss_dssp CTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC----CCCCTTCCHHHH
T ss_pred ecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC----CCCcccCcHHHH
Confidence 2334579999999999987 67999999999999999999977776543 33333333333322 233567889999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHhc
Q 005886 252 ELVTACLVKDPKKRPTAEKLMKH 274 (671)
Q Consensus 252 dLI~~cL~~dP~kRpSa~eiL~H 274 (671)
+||.+||..||.+||++.+|++|
T Consensus 265 ~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 265 EVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-46 Score=391.90 Aligned_cols=260 Identities=18% Similarity=0.240 Sum_probs=203.5
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCC-ceeeeeEEEeCCEEEEEEe
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPN-VLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpN-IVkl~~~~~~~~~l~LVmE 92 (671)
++|++.+.||+|+||+||+|++..+|+.||||++...... ..+.+|+++++.+.|+| |+.+++++.+....++|||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC---HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 5699999999999999999999999999999998755432 34778999999997766 5556677788899999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcC---CCceEEeccccccccccCCC
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS---NGAIKLADFGVSACMFDAGD 169 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~---~g~vKL~DFGls~~~~~~~~ 169 (671)
||. +++...+... ...+++..+..++.||+.||+|||++|||||||||+|||++. +..+||+|||+|+.+.....
T Consensus 84 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 84 LLG-PSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp CCC-CBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred EcC-Cchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 994 5666655443 367999999999999999999999999999999999999854 45799999999987644332
Q ss_pred c----ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc---CCCCCCccc
Q 005886 170 R----QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTLQN---APPGLDYER 242 (671)
Q Consensus 170 ~----~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~~~~~~~~~~---~~~~~~~~~ 242 (671)
. .......+||+.|||||++.+ ..|+.++|||||||++|||++|..||............... .........
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH
T ss_pred ccceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh
Confidence 1 123456789999999999987 66999999999999999999999999876544332221110 000011122
Q ss_pred cccchHHHHHHHHHhhhcCCCCCCCHHH---HHhchhccc
Q 005886 243 DKRFSKSFKELVTACLVKDPKKRPTAEK---LMKHHFFKH 279 (671)
Q Consensus 243 ~~~ls~~l~dLI~~cL~~dP~kRpSa~e---iL~Hpwfk~ 279 (671)
...+|+++.+||.+||..||.+||++.+ +|+|+|.+.
T Consensus 241 ~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 4568899999999999999999999875 567777653
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.2e-45 Score=381.14 Aligned_cols=255 Identities=17% Similarity=0.201 Sum_probs=208.0
Q ss_pred CCCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCC-CCceeeeeEEEeCCEEEEE
Q 005886 12 DAKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNH-PNVLRAHCSFTTGHCLWVV 90 (671)
Q Consensus 12 ~~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~H-pNIVkl~~~~~~~~~l~LV 90 (671)
..++|++.+.||+|+||+||+|+++.+|+.||||++..... ...+.+|+++++.+.| +||+.+++++..+...|+|
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 35789999999999999999999999999999999865432 2346789999998865 8999999999999999999
Q ss_pred EeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcC-----CCceEEeccccccccc
Q 005886 91 MPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDS-----NGAIKLADFGVSACMF 165 (671)
Q Consensus 91 mEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~-----~g~vKL~DFGls~~~~ 165 (671)
|||| |++|.+++... ...+++..+..++.|++.||+|||++|||||||||+|||++. ++.+||+|||+|+.+.
T Consensus 80 me~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 9999 78999888654 357999999999999999999999999999999999999964 5789999999998764
Q ss_pred cCCCc----ccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChH---HHHHHHHhcCCCCC
Q 005886 166 DAGDR----QRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM---KVLLMTLQNAPPGL 238 (671)
Q Consensus 166 ~~~~~----~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~---~~~~~~~~~~~~~~ 238 (671)
+.... .......+||+.|||||++.+ ..++.++|||||||++|||++|..||.+.... .....+........
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred cCccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 33221 123456789999999999987 67999999999999999999999999765332 22222211111111
Q ss_pred CccccccchHHHHHHHHHhhhcCCCCCCCHHHHH
Q 005886 239 DYERDKRFSKSFKELVTACLVKDPKKRPTAEKLM 272 (671)
Q Consensus 239 ~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL 272 (671)
.......+|+++.+|+..|+..+|.+||+++.+.
T Consensus 237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 1223456889999999999999999999987764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=386.32 Aligned_cols=254 Identities=24% Similarity=0.293 Sum_probs=194.9
Q ss_pred CCCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCceeeeeEEEeCC----EEE
Q 005886 13 AKDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNVLRAHCSFTTGH----CLW 88 (671)
Q Consensus 13 ~~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNIVkl~~~~~~~~----~l~ 88 (671)
.++|.+.+.||+|+||+||+|++ +|+.||||++.... ........|+..++.++|||||++++++.+.+ .+|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~--~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc--hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 36799999999999999999986 58999999986432 11122334555556789999999999998654 689
Q ss_pred EEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCcccccCCCCcEEEcCCCceEEecccc
Q 005886 89 VVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF--------HGHIHRDVKAGNILIDSNGAIKLADFGV 160 (671)
Q Consensus 89 LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs--------~gIVHrDLKPeNILld~~g~vKL~DFGl 160 (671)
+|||||.+|+|..+++.. .+++..++.++.|++.||+|||. +|||||||||+|||++.+|.+||+|||+
T Consensus 78 lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 999999999999999864 68999999999999999999996 5999999999999999999999999999
Q ss_pred ccccccCCCcc-cccccccCCCCCCChhHhhhcc-----CCCccchhhhHHHHHHHHHhCCCCCCCCC------------
Q 005886 161 SACMFDAGDRQ-RSRNTFVGTPCWMAPEVMQQLH-----GYDFKADIWSFGITALELAHGHAPFSKYP------------ 222 (671)
Q Consensus 161 s~~~~~~~~~~-~~~~~~~GT~~Y~APEvl~~~~-----~~s~ksDIWSLGvILyeLltG~~PF~~~~------------ 222 (671)
++......... ......+||+.|+|||++.+.. .++.++|||||||+||||++|..||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 98765433322 2334578999999999987532 25678999999999999999988774211
Q ss_pred --hHHHHHHHHhc--CCCCCCc-cccccchHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 005886 223 --PMKVLLMTLQN--APPGLDY-ERDKRFSKSFKELVTACLVKDPKKRPTAEKLMK 273 (671)
Q Consensus 223 --~~~~~~~~~~~--~~~~~~~-~~~~~ls~~l~dLI~~cL~~dP~kRpSa~eiL~ 273 (671)
........... ..+.+.. .........+.+||.+||..||.+|||+.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 11122222211 1112111 112234467999999999999999999999976
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.6e-43 Score=375.69 Aligned_cols=259 Identities=25% Similarity=0.336 Sum_probs=199.4
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCC-----------CCCceeeeeEEE
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN-----------HPNVLRAHCSFT 82 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~-----------HpNIVkl~~~~~ 82 (671)
++|+++++||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+.+++.++ |+||+++++++.
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc--cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 45999999999999999999999999999999997543 23466788999888775 578999998886
Q ss_pred e--CCEEEEEEeccCCC-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCCCcEEEcCCC------c
Q 005886 83 T--GHCLWVVMPYMAGG-SCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHF-HGHIHRDVKAGNILIDSNG------A 152 (671)
Q Consensus 83 ~--~~~l~LVmEy~~gg-sL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs-~gIVHrDLKPeNILld~~g------~ 152 (671)
. ....+++|.++.++ .............+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccce
Confidence 4 45667777766554 34444455555789999999999999999999998 8999999999999998765 3
Q ss_pred eEEeccccccccccCCCcccccccccCCCCCCChhHhhhccCCCccchhhhHHHHHHHHHhCCCCCCCCChH------HH
Q 005886 153 IKLADFGVSACMFDAGDRQRSRNTFVGTPCWMAPEVMQQLHGYDFKADIWSFGITALELAHGHAPFSKYPPM------KV 226 (671)
Q Consensus 153 vKL~DFGls~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~s~ksDIWSLGvILyeLltG~~PF~~~~~~------~~ 226 (671)
++|+|||.+.... ......+||+.|+|||++.+ ..|+.++||||+||++++|++|+.||...... ..
T Consensus 171 ~kl~dfg~s~~~~------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 171 IKIADLGNACWYD------EHYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEECCCTTCEETT------BCCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred eeEeecccccccc------cccccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 9999999986442 22345689999999999987 67999999999999999999999999654321 11
Q ss_pred HHHHH---hc------------------------CCCCC----------CccccccchHHHHHHHHHhhhcCCCCCCCHH
Q 005886 227 LLMTL---QN------------------------APPGL----------DYERDKRFSKSFKELVTACLVKDPKKRPTAE 269 (671)
Q Consensus 227 ~~~~~---~~------------------------~~~~~----------~~~~~~~ls~~l~dLI~~cL~~dP~kRpSa~ 269 (671)
+...+ .. ..... ........++++++||.+||.+||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 11111 00 00000 0111234578899999999999999999999
Q ss_pred HHHhchhccccc
Q 005886 270 KLMKHHFFKHAR 281 (671)
Q Consensus 270 eiL~Hpwfk~~~ 281 (671)
|+|+||||++..
T Consensus 324 e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 324 GLVNHPWLKDTL 335 (362)
T ss_dssp HHHTCGGGTTCT
T ss_pred HHhcCcccCCCC
Confidence 999999998543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=5.2e-24 Score=206.61 Aligned_cols=164 Identities=17% Similarity=0.158 Sum_probs=120.1
Q ss_pred eEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCc-----c------------cHHHHHHHHHHHHhCCCCCceeee
Q 005886 16 YRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCN-----N------------DLDGIRREVQTMRVTNHPNVLRAH 78 (671)
Q Consensus 16 Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~-----~------------~~~~i~~Ei~iL~~L~HpNIVkl~ 78 (671)
|.+.+.||+|+||+||+|.+. +|+.||||+++..... . ......+|...+..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 568899999999999999885 6899999997532110 0 123445788899999999999887
Q ss_pred eEEEeCCEEEEEEeccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCCCcEEEcCCCceEEecc
Q 005886 79 CSFTTGHCLWVVMPYMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLHFHGHIHRDVKAGNILIDSNGAIKLADF 158 (671)
Q Consensus 79 ~~~~~~~~l~LVmEy~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLHs~gIVHrDLKPeNILld~~g~vKL~DF 158 (671)
++.. .+++|||+.++.+. .+++..+..++.||+.+|.|||++||+||||||+|||++.++ ++|+||
T Consensus 81 ~~~~----~~lvme~~~~~~~~---------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDF 146 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELY---------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDF 146 (191)
T ss_dssp EEET----TEEEEECCCCEEGG---------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCC
T ss_pred EecC----CEEEEEeecccccc---------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEEC
Confidence 6532 26899999886532 244555778999999999999999999999999999998654 889999
Q ss_pred ccccccccCCCcccccccccCCCCCCC------hhHhhhccCCCccchhhhHHHH
Q 005886 159 GVSACMFDAGDRQRSRNTFVGTPCWMA------PEVMQQLHGYDFKADIWSFGIT 207 (671)
Q Consensus 159 Gls~~~~~~~~~~~~~~~~~GT~~Y~A------PEvl~~~~~~s~ksDIWSLGvI 207 (671)
|+|......... .|.. .+.+. +.|+.++|+||+.--
T Consensus 147 G~a~~~~~~~~~-----------~~l~rd~~~~~~~f~--r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 147 PQSVEVGEEGWR-----------EILERDVRNIITYFS--RTYRTEKDINSAIDR 188 (191)
T ss_dssp TTCEETTSTTHH-----------HHHHHHHHHHHHHHH--HHHCCCCCHHHHHHH
T ss_pred CCcccCCCCCcH-----------HHHHHHHHHHHHHHc--CCCCCcccHHHHHHH
Confidence 998644211100 0111 12222 358889999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.19 E-value=4.3e-06 Score=81.85 Aligned_cols=138 Identities=17% Similarity=0.171 Sum_probs=91.7
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCC-CCCceeeeeEEEeCCEEEEEEe
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTN-HPNVLRAHCSFTTGHCLWVVMP 92 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~-HpNIVkl~~~~~~~~~l~LVmE 92 (671)
..|++.+..+-++.+.||+.. ..+..+++|+..... ......+.+|...+..+. +--+.+++.++..++..|+||+
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~-~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~ 90 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRY-KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGG-TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCc-ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEE
Confidence 467777765555567899875 346667888875332 122345778888887764 3336778888888999999999
Q ss_pred ccCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 005886 93 YMAGGSCLHIMKSAYPEGFEEPVIATLLRETLKALVYLH----------------------------------------- 131 (671)
Q Consensus 93 y~~ggsL~~~l~~~~~~~l~e~~i~~i~~qIl~aL~yLH----------------------------------------- 131 (671)
+++|..+....... .. ...++.++...+..||
T Consensus 91 ~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 91 EADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred eccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 99998775432111 11 1122333333333333
Q ss_pred ------------H------CCcccccCCCCcEEEcCCCceEEeccccc
Q 005886 132 ------------F------HGHIHRDVKAGNILIDSNGAIKLADFGVS 161 (671)
Q Consensus 132 ------------s------~gIVHrDLKPeNILld~~g~vKL~DFGls 161 (671)
. ..++|+|+.|.|||++.++.+-|+||+.+
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a 211 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhc
Confidence 1 13789999999999987766679999975
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.92 E-value=1.6e-05 Score=83.51 Aligned_cols=78 Identities=21% Similarity=0.155 Sum_probs=51.2
Q ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEecc------ccCcccHHHHHHHHHHHHhCC-C--CCceeeeeEEEeCCEEEE
Q 005886 19 YEEVGEGVSATVYRALCIPLNEIVAIKVLDL------EKCNNDLDGIRREVQTMRVTN-H--PNVLRAHCSFTTGHCLWV 89 (671)
Q Consensus 19 ~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~------~~~~~~~~~i~~Ei~iL~~L~-H--pNIVkl~~~~~~~~~l~L 89 (671)
.+.||.|....||++....+|+.|++|.-.. ...+....+...|+..|+.+. + ..+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 5679999999999998877788899997431 112234566778998887663 2 335555544 4445578
Q ss_pred EEeccCCCC
Q 005886 90 VMPYMAGGS 98 (671)
Q Consensus 90 VmEy~~ggs 98 (671)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997644
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.47 E-value=0.00018 Score=69.45 Aligned_cols=75 Identities=15% Similarity=0.135 Sum_probs=51.7
Q ss_pred EEecccCc-eEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCC--CCceeeeeEEEeCCEEEEEEeccCC
Q 005886 20 EEVGEGVS-ATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNH--PNVLRAHCSFTTGHCLWVVMPYMAG 96 (671)
Q Consensus 20 ~~LG~G~f-G~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~H--pNIVkl~~~~~~~~~l~LVmEy~~g 96 (671)
+.+..|.. +.||+... ..+..+++|.-.... ...+..|...++.+.. -.+.+++.+..+++..|+||++++|
T Consensus 16 ~~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp EECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred EEcCCcccCCeEEEEEe-CCCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 34555554 67898864 456668889754322 2346778888876643 3366788888888899999999987
Q ss_pred CCH
Q 005886 97 GSC 99 (671)
Q Consensus 97 gsL 99 (671)
.++
T Consensus 91 ~~~ 93 (255)
T d1nd4a_ 91 QDL 93 (255)
T ss_dssp EET
T ss_pred ccc
Confidence 554
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.36 E-value=0.0059 Score=61.43 Aligned_cols=68 Identities=18% Similarity=0.138 Sum_probs=44.7
Q ss_pred ceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCc--eee-----eeEEEeCCEEEEEEeccCCC
Q 005886 27 SATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNV--LRA-----HCSFTTGHCLWVVMPYMAGG 97 (671)
Q Consensus 27 fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNI--Vkl-----~~~~~~~~~l~LVmEy~~gg 97 (671)
--.||++.. .+|..|++|+..... .....+..|...+..|....| +.. -..+..+...+.+++++.|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~--~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCC--CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 357999875 468889999975432 235678889988877642221 111 12345567889999998763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.13 E-value=0.011 Score=61.05 Aligned_cols=77 Identities=10% Similarity=0.097 Sum_probs=51.6
Q ss_pred CCeEEEEEecccCceEEEEEEEcC-------CCcEEEEEEeccccCcccHHHHHHHHHHHHhCCCCCc-eeeeeEEEeCC
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIP-------LNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNHPNV-LRAHCSFTTGH 85 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~-------tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~HpNI-Vkl~~~~~~~~ 85 (671)
+..+ ++.|+.|-.-.+|++.... ..+.|.+++.-.. ...-...+|..+++.+.-.++ .+++++|..
T Consensus 43 ~~l~-v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~---~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~-- 116 (395)
T d1nw1a_ 43 EHLR-ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG-- 116 (395)
T ss_dssp GGEE-EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT--
T ss_pred cceE-EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc---chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC--
Confidence 4444 4788999999999998653 2356777776421 223456689999887753344 467777653
Q ss_pred EEEEEEeccCCCC
Q 005886 86 CLWVVMPYMAGGS 98 (671)
Q Consensus 86 ~l~LVmEy~~ggs 98 (671)
++||+|+.|..
T Consensus 117 --g~I~efi~g~~ 127 (395)
T d1nw1a_ 117 --GRLEEYIPSRP 127 (395)
T ss_dssp --EEEECCCCEEE
T ss_pred --ceEEEEecccc
Confidence 57899998743
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.42 E-value=0.055 Score=53.23 Aligned_cols=143 Identities=14% Similarity=0.136 Sum_probs=74.7
Q ss_pred CCeEEEEEecccCceEEEEEEEcCCCcEEEEEEeccccCcccHHHHHHHHHHHHhCCC-----CCceeee---eEEEeCC
Q 005886 14 KDYRLYEEVGEGVSATVYRALCIPLNEIVAIKVLDLEKCNNDLDGIRREVQTMRVTNH-----PNVLRAH---CSFTTGH 85 (671)
Q Consensus 14 ~~Y~l~~~LG~G~fG~Vyka~~~~tg~~VAIKvi~~~~~~~~~~~i~~Ei~iL~~L~H-----pNIVkl~---~~~~~~~ 85 (671)
....-.+.|..|---+.|+.... .| .|++|++.... ....+..|+.+|..|.. |..+... .+.....
T Consensus 18 g~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~---~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~ 92 (316)
T d2ppqa1 18 GSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSG 92 (316)
T ss_dssp CCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETT
T ss_pred CCceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCCC---CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeec
Confidence 45555677788888899998754 34 48899986432 22345566666665532 2222210 1223345
Q ss_pred EEEEEEeccCCCCHH--------------HHHHhh---CC----CCCCHH------------------HHHHHHHHHHHH
Q 005886 86 CLWVVMPYMAGGSCL--------------HIMKSA---YP----EGFEEP------------------VIATLLRETLKA 126 (671)
Q Consensus 86 ~l~LVmEy~~ggsL~--------------~~l~~~---~~----~~l~e~------------------~i~~i~~qIl~a 126 (671)
..+.++.++.|.... ..+... .. ...... .....+..+...
T Consensus 93 ~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 172 (316)
T d2ppqa1 93 RPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDY 172 (316)
T ss_dssp EEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHH
T ss_pred ccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHh
Confidence 566677766553220 011100 00 000010 111222222333
Q ss_pred HHHHHH----CCcccccCCCCcEEEcCCCceEEeccccc
Q 005886 127 LVYLHF----HGHIHRDVKAGNILIDSNGAIKLADFGVS 161 (671)
Q Consensus 127 L~yLHs----~gIVHrDLKPeNILld~~g~vKL~DFGls 161 (671)
+.-.+. .|+||+|+.++||+++.+...-|+||+.+
T Consensus 173 ~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~ 211 (316)
T d2ppqa1 173 LAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFA 211 (316)
T ss_dssp HHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred hhccCccccccccccCCcchhhhhcccccceeEeccccc
Confidence 333222 47999999999999998877789999975
|